Psyllid ID: psy2676

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-
Protein Sequence
MYEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccEEEccccccccEEEEEEEEccccccEEEEEEEcccccccccccHHHHHHHHHHccccccccccEEEEEEEEccccccccccEEEEEEEcccccHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEccccccccccccccccccEEEEEccccHHHcccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHccccccccccccccccccccccccccHHHHHcccccHHHHHHHHHcccccccccccHHHHHccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccEEEEcccEEccHHcEEEEEEEEEEccEEEEEEEEcccccEEEEEEEEEEEEcccccEccHHHHHHHHHHHHHcccccEccEEEEEEEEEcccccEEEEEEEEEccccEHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEccccccccccHHHHHcccccccccccHHHHcccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHccccccccHHHccccccccHHHccccccHHHHHHHHHHccccccccccHHHHHccHHHcccccccc
Coil and Loop (DISEMBL)
MYEYSADTIQslnldsldlgdkkydELCQIGCGAygtvfkardlqnkgnYVAMKKLRVKLnedgipmstLREISILkqldtfehpnivRFFDVIHQNILSDERYLTVYLIFEHVDqdlgsymekcpppglsaskVKELTRQMLKGvdflhshriihrdlkpqnllitragglkiadfglaktfdydmMLTSVVVTLWYRapeillnlgygtpvdiWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVigtpsmnewpeNISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMltfnpadrisaadalehpyfkekenepl
Flexible Loop (DISEMBL)
myeysadtiqslnldSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLhshriihrdlkpqnlLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAlehpyfkekenepl
Low Complexity Region (SEG)
MYEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL
Disordered region (IsUnstruct)
***********LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKC*********VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI*******************
Disordered Region (DISOPRED)
**********************KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP*GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE**
Disordered Region (DISEMBL)
********IQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL
Disordered Region (DISPRO)
******DTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MYEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	321	2.2.26 [Sep-21-2011]
Q64261	326	Cyclin-dependent kinase 6	yes	N/A	0.940	0.926	0.509	3e-94
Q00534	326	Cyclin-dependent kinase 6	yes	N/A	0.940	0.926	0.509	3e-93
Q91727	319	Cyclin-dependent kinase 4	N/A	N/A	0.903	0.909	0.505	2e-86
P11802	303	Cyclin-dependent kinase 4	no	N/A	0.931	0.986	0.485	1e-85
P35426	303	Cyclin-dependent kinase 4	no	N/A	0.931	0.986	0.478	3e-85
P79432	303	Cyclin-dependent kinase 4	yes	N/A	0.931	0.986	0.481	1e-84
P30285	303	Cyclin-dependent kinase 4	no	N/A	0.928	0.983	0.476	2e-84
B2MVY4	303	Cyclin-dependent kinase 4	N/A	N/A	0.928	0.983	0.480	4e-84
Q32KY4	303	Cyclin-dependent kinase 4	no	N/A	0.928	0.983	0.480	4e-84
Q00526	305	Cyclin-dependent kinase 3	no	N/A	0.890	0.937	0.458	3e-67

>sp|Q64261|CDK6_MOUSE Cyclin-dependent kinase 6 OS=Mus musculus GN=Cdk6 PE=1 SV=2

 Score =  345 bits (885), Expect = 3e-94,   Method: Compositional matrix adjust.
 Identities = 155/304 (50%), Positives = 217/304 (71%), Gaps = 2/304 (0%)

Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           DSL   D++Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+ +E+G+P+ST+RE++
Sbjct: 4   DSLSRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTSEEGMPLSTIREVA 63

Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           +L+ L+TFEHPN+VR FDV    +   +R   + L+FEHVDQDL +Y++K P PG+    
Sbjct: 64  VLRHLETFEHPNVVRLFDVC--TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +K++  Q+L+G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTSVVV
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181

Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
           TLWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLF  S++V+QL  I  +IG P   
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDIIGLPGEE 241

Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           +WP +++L   +F   S         D       LL   LTFNPA RISA  AL HPYF+
Sbjct: 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYGALNHPYFQ 301

Query: 315 EKEN 318
           + E 
Sbjct: 302 DLER 305

Serine/threonine-protein kinase involved in the control of the cell cycle and differentiation; promotes G1/S transition. Phosphorylates pRB/RB1 and NPM1. Interacts with D-type G1 cyclins during interphase at G1 to form a pRB/RB1 kinase and controls the entrance into the cell cycle. Involved in initiation and maintenance of cell cycle exit during cell differentiation; prevents cell proliferation and regulates negatively cell differentiation, but is required for the proliferation of specific cell types (e.g. erythroid and hematopoietic cells). Essential for cell proliferation within the dentate gyrus of the hippocampus and the subventricular zone of the lateral ventricles. Required during thymocyte development. Promotes the production of newborn neurons, probably by modulating G1 length. Promotes, at least in astrocytes, changes in patterns of gene expression, changes in the actin cytoskeleton including loss of stress fibers, and enhanced motility during cell differentiation. Prevents myeloid differentiation by interfering with RUNX1 and reducing its transcription transactivation activity, but promotes proliferation of normal myeloid progenitors. Delays senescence. Promotes the proliferation of beta-cells in pancreatic islets of Langerhans.
Mus musculus (taxid: 10090)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 2

>sp|Q00534|CDK6_HUMAN Cyclin-dependent kinase 6 OS=Homo sapiens GN=CDK6 PE=1 SV=1

 Score =  342 bits (876), Expect = 3e-93,   Method: Compositional matrix adjust.
 Identities = 155/304 (50%), Positives = 215/304 (70%), Gaps = 2/304 (0%)

Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D L   D++Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+  E+G+P+ST+RE++
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63

Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           +L+ L+TFEHPN+VR FDV    +   +R   + L+FEHVDQDL +Y++K P PG+    
Sbjct: 64  VLRHLETFEHPNVVRLFDVC--TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +K++  Q+L+G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTSVVV
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181

Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
           TLWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLF  S++V+QL  I  VIG P   
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241

Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           +WP +++L   +F   S         D       LL   LTFNPA RISA  AL HPYF+
Sbjct: 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

Query: 315 EKEN 318
           + E 
Sbjct: 302 DLER 305

Serine/threonine-protein kinase involved in the control of the cell cycle and differentiation; promotes G1/S transition. Phosphorylates pRB/RB1 and NPM1. Interacts with D-type G1 cyclins during interphase at G1 to form a pRB/RB1 kinase and controls the entrance into the cell cycle. Involved in initiation and maintenance of cell cycle exit during cell differentiation; prevents cell proliferation and regulates negatively cell differentiation, but is required for the proliferation of specific cell types (e.g. erythroid and hematopoietic cells). Essential for cell proliferation within the dentate gyrus of the hippocampus and the subventricular zone of the lateral ventricles. Required during thymocyte development. Promotes the production of newborn neurons, probably by modulating G1 length. Promotes, at least in astrocytes, changes in patterns of gene expression, changes in the actin cytoskeleton including loss of stress fibers, and enhanced motility during cell differentiation. Prevents myeloid differentiation by interfering with RUNX1 and reducing its transcription transactivation activity, but promotes proliferation of normal myeloid progenitors. Delays senescence. Promotes the proliferation of beta-cells in pancreatic islets of Langerhans.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q91727|CDK4_XENLA Cyclin-dependent kinase 4 OS=Xenopus laevis GN=cdk4 PE=2 SV=1

 Score =  319 bits (817), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 148/293 (50%), Positives = 209/293 (71%), Gaps = 3/293 (1%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y+ + +IG GAYGTV+KARDLQ+ G +VA+K +RV+ NE+G+P+ST+RE+++LK+L+ F
Sbjct: 8   QYEPVAEIGVGAYGTVYKARDLQS-GKFVALKNVRVQTNENGLPLSTVREVTLLKRLEHF 66

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           +HPNIV+  DV        +R   V L+FEHVDQDL +Y+ K PPPGL    +K+L +Q 
Sbjct: 67  DHPNIVKLMDVCASA--RTDRETKVTLVFEHVDQDLKTYLSKVPPPGLPLETIKDLMKQF 124

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           L G++FLH + I+HRDLKP+N+L+T  G +K+ADFGLA+ +   M LT VVVTLWYRAPE
Sbjct: 125 LSGLEFLHLNCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE 184

Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
           +LL   Y TPVD+WS GC+ AEM++  PLFC ++E +QL  IF +IG PS  EWP +++L
Sbjct: 185 VLLQSTYATPVDVWSAGCIFAEMFKRKPLFCGNSEADQLCKIFDIIGLPSEEEWPVDVTL 244

Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+F   ++        +  +    LL +MLTF+P  RISA+DAL HP+F +
Sbjct: 245 PRSAFSPRTQQPVDKFVPEIDAMGADLLLAMLTFSPQKRISASDALLHPFFAD 297

Probably involved in the control of the cell cycle.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P11802|CDK4_HUMAN Cyclin-dependent kinase 4 OS=Homo sapiens GN=CDK4 PE=1 SV=2

 Score =  316 bits (809), Expect = 1e-85,   Method: Compositional matrix adjust.
 Identities = 148/305 (48%), Positives = 209/305 (68%), Gaps = 6/305 (1%)

Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK---LNEDGIPMSTLREISI 75
           +   +Y+ + +IG GAYGTV+KARD  + G++VA+K +RV        G+P+ST+RE+++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 59

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           L++L+ FEHPN+VR  DV   +    +R + V L+FEHVDQDL +Y++K PPPGL A  +
Sbjct: 60  LRRLEAFEHPNVVRLMDVCATS--RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI 117

Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVT 195
           K+L RQ L+G+DFLH++ I+HRDLKP+N+L+T  G +K+ADFGLA+ + Y M LT VVVT
Sbjct: 118 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 177

Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           LWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLFC ++E +QL  IF +IG P  ++
Sbjct: 178 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 237

Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           WP ++SL   +F         ++  +       LL  MLTFNP  RISA  AL+H Y  +
Sbjct: 238 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 297

Query: 316 KENEP 320
            E  P
Sbjct: 298 DEGNP 302

Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P35426|CDK4_RAT Cyclin-dependent kinase 4 OS=Rattus norvegicus GN=Cdk4 PE=2 SV=1

 Score =  315 bits (807), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 146/305 (47%), Positives = 209/305 (68%), Gaps = 6/305 (1%)

Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK---LNEDGIPMSTLREISI 75
           +   +Y+ + +IG GAYGTV+KARD  + G++VA+K +RV        G+P+ST+RE+++
Sbjct: 1   MATTRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGAAGGGLPVSTVREVAL 59

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           L++L+ FEHPN+VR  DV   +    +R + V L+FEH+DQDL +Y++K PPPGL    +
Sbjct: 60  LRRLEAFEHPNVVRLMDVCATS--RTDRDIKVTLVFEHIDQDLRTYLDKAPPPGLPVETI 117

Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVT 195
           K+L RQ L G+DFLH++ I+HRDLKP+N+L+T  G +K+ADFGLA+ + Y M LT VVVT
Sbjct: 118 KDLMRQFLSGLDFLHANCIVHRDLKPENILVTSNGTVKLADFGLARIYSYQMALTPVVVT 177

Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           LWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLFC ++E +QL  IF +IG P  ++
Sbjct: 178 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 237

Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           WP  +SL   +F         ++  +       LL  MLTFNP  RISA  AL+H Y  +
Sbjct: 238 WPREVSLPRGAFSPRGPRPVQSVVPEMEESGAQLLLEMLTFNPLKRISAFRALQHSYLHK 297

Query: 316 KENEP 320
           +E++P
Sbjct: 298 EESDP 302

Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P79432|CDK4_PIG Cyclin-dependent kinase 4 OS=Sus scrofa GN=CDK4 PE=3 SV=1

 Score =  313 bits (802), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 147/305 (48%), Positives = 206/305 (67%), Gaps = 6/305 (1%)

Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK---LNEDGIPMSTLREISI 75
           +   +Y+ + +IG GAYGTV+KARD  + G++VA+K +RV        G+P+ST+RE+++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGGAGGGLPISTVREVAL 59

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           L++L+ FEHPN+VR  DV        +R   V L+FEHVDQDL +Y++K PPPGL    +
Sbjct: 60  LRRLEAFEHPNVVRLMDVC--ATARTDRETKVTLVFEHVDQDLRTYLDKAPPPGLPVETI 117

Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVT 195
           K+L RQ L+G+DFLH++ I+HRDLKP+N+L+T  G +K+ADFGLA+ + Y M LT VVVT
Sbjct: 118 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 177

Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           LWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLFC ++E +QL  IF +IG P  ++
Sbjct: 178 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 237

Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           WP ++SL   +F         ++  +       LL  MLTFNP  RISA  AL+H Y  +
Sbjct: 238 WPRDVSLPRGAFSPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 297

Query: 316 KENEP 320
            E  P
Sbjct: 298 AEGNP 302

Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex.

Sus scrofa (taxid: 9823)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P30285|CDK4_MOUSE Cyclin-dependent kinase 4 OS=Mus musculus GN=Cdk4 PE=1 SV=1

 Score =  312 bits (800), Expect = 2e-84,   Method: Compositional matrix adjust.
 Identities = 145/304 (47%), Positives = 208/304 (68%), Gaps = 6/304 (1%)

Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK---LNEDGIPMSTLREISI 75
           +   +Y+ + +IG GAYGTV+KARD  + G++VA+K +RV        G+P+ST+RE+++
Sbjct: 1   MAATRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGAAGGGLPVSTVREVAL 59

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           L++L+ FEHPN+VR  DV   +    +R + V L+FEH+DQDL +Y++K PPPGL    +
Sbjct: 60  LRRLEAFEHPNVVRLMDVCATS--RTDRDIKVTLVFEHIDQDLRTYLDKAPPPGLPVETI 117

Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVT 195
           K+L RQ L G+DFLH++ I+HRDLKP+N+L+T  G +K+ADFGLA+ + Y M LT VVVT
Sbjct: 118 KDLMRQFLSGLDFLHANCIVHRDLKPENILVTSNGTVKLADFGLARIYSYQMALTPVVVT 177

Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           LWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLFC ++E +QL  IF +IG P  ++
Sbjct: 178 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 237

Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           WP  +SL   +F         ++  +       LL  MLTFNP  RISA  AL+H Y  +
Sbjct: 238 WPREVSLPRGAFAPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 297

Query: 316 KENE 319
           +E++
Sbjct: 298 EESD 301

Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|B2MVY4|CDK4_SHEEP Cyclin-dependent kinase 4 OS=Ovis aries PE=2 SV=1

 Score =  311 bits (797), Expect = 4e-84,   Method: Compositional matrix adjust.
 Identities = 146/304 (48%), Positives = 206/304 (67%), Gaps = 6/304 (1%)

Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK---LNEDGIPMSTLREISI 75
           +   +Y+ + +IG GAYGTV+KARD  + G++VA+K +RV        G+P+ST+RE+++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGGAGGGLPISTVREVAL 59

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           L++L+ FEHPN+VR  DV        +R   V L+FEHVDQDL +Y++K PPPGL    +
Sbjct: 60  LRRLEAFEHPNVVRLMDVC--ATARTDRETKVTLVFEHVDQDLRTYLDKAPPPGLPVETI 117

Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVT 195
           K+L RQ L+G+DFLH++ I+HRDLKP+N+L+T  G +K+ADFGLA+ + Y M LT VVVT
Sbjct: 118 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 177

Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           LWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLFC ++E +QL  IF +IG P  ++
Sbjct: 178 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 237

Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           WP ++SL   +F         ++  +       LL  MLTFNP  RISA  AL+H Y  +
Sbjct: 238 WPRDVSLPRGAFSPRGPRPVQSVVPELEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 297

Query: 316 KENE 319
            E +
Sbjct: 298 AEGD 301

Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex.

Ovis aries (taxid: 9940)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q32KY4|CDK4_BOVIN Cyclin-dependent kinase 4 OS=Bos taurus GN=CDK4 PE=2 SV=1

 Score =  311 bits (797), Expect = 4e-84,   Method: Compositional matrix adjust.
 Identities = 146/304 (48%), Positives = 206/304 (67%), Gaps = 6/304 (1%)

Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK---LNEDGIPMSTLREISI 75
           +   +Y+ + +IG GAYGTV+KARD  + G++VA+K +RV        G+P+ST+RE+++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGGAGGGLPISTVREVAL 59

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           L++L+ FEHPN+VR  DV        +R   V L+FEHVDQDL +Y++K PPPGL    +
Sbjct: 60  LRRLEAFEHPNVVRLMDVC--ATARTDRETKVTLVFEHVDQDLRTYLDKAPPPGLPVETI 117

Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVT 195
           K+L RQ L+G+DFLH++ I+HRDLKP+N+L+T  G +K+ADFGLA+ + Y M LT VVVT
Sbjct: 118 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 177

Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           LWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLFC ++E +QL  IF +IG P  ++
Sbjct: 178 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 237

Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           WP ++SL   +F         ++  +       LL  MLTFNP  RISA  AL+H Y  +
Sbjct: 238 WPRDVSLPRGAFSPRGPRPVQSVVPELEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 297

Query: 316 KENE 319
            E +
Sbjct: 298 AEGD 301

Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q00526|CDK3_HUMAN Cyclin-dependent kinase 3 OS=Homo sapiens GN=CDK3 PE=1 SV=1

 Score =  255 bits (652), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 138/301 (45%), Positives = 187/301 (62%), Gaps = 15/301 (4%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           + ++ +IG G YG V+KA++ +  G  VA+KK+R+ L  +G+P + +REIS+LK+L   +
Sbjct: 4   FQKVEKIGEGTYGVVYKAKN-RETGQLVALKKIRLDLEMEGVPSTAIREISLLKEL---K 59

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           HPNIVR  DV+H     +ER L  YL+FE + QDL  YM+  P   L    +K    Q+L
Sbjct: 60  HPNIVRLLDVVH-----NERKL--YLVFEFLSQDLKKYMDSTPGSELPLHLIKSYLFQLL 112

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAPE 202
           +GV F HSHR+IHRDLKPQNLLI   G +K+ADFGLA+ F   +   T  VVTLWYRAPE
Sbjct: 113 QGVSFCHSHRVIHRDLKPQNLLINELGAIKLADFGLARAFGVPLRTYTHEVVTLWYRAPE 172

Query: 203 ILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
           ILL    Y T VDIWSIGC+ AEM     LF   +E++QL  IFR++GTPS + WP    
Sbjct: 173 ILLGSKFYTTAVDIWSIGCIFAEMVTRKALFPGDSEIDQLFRIFRMLGTPSEDTWPGVTQ 232

Query: 262 L--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE 319
           L     SF ++++     I  +   +   LL  +L ++P+ RI+A  AL HPYF   E  
Sbjct: 233 LPDYKGSFPKWTRKGLEEIVPNLEPEGRDLLMQLLQYDPSQRITAKTALAHPYFSSPEPS 292

Query: 320 P 320
           P
Sbjct: 293 P 293

Serine/threonine-protein kinase that plays a critical role in the control of the eukaryotic cell cycle; involved in G0-G1 and G1-S cell cycle transitions. Interacts with CCNC/cyclin-C during interphase. Phosphorylates histone H1, ATF1, RB1 and CABLES1. ATF1 phosphorylation triggers ATF1 transactivation and transcriptional activities, and promotes cell proliferation and transformation. CDK3/cyclin-C mediated RB1 phosphorylation is required for G0-G1 transition. Promotes G1-S transition probably by contributing to the activation of E2F1, E2F2 and E2F3 in a RB1-independent manner.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	321
328710567	429	PREDICTED: cyclin-dependent kinase 6-lik	0.915	0.685	0.574	1e-102
156374066	319	predicted protein [Nematostella vectensi	0.909	0.915	0.542	6e-98
297748129	459	cyclin dependent kinase 6 [Apis cerana c	0.925	0.647	0.561	8e-98
291243878	309	PREDICTED: Cell division protein kinase	0.919	0.954	0.536	3e-96
387015344	326	Cyclin-dependent kinase 6-like [Crotalus	0.947	0.932	0.513	3e-93
157118645	317	cdk4/6 [Aedes aegypti] gi|108883256|gb|E	0.912	0.924	0.549	1e-92
74178317	326	unnamed protein product [Mus musculus]	0.940	0.926	0.513	2e-92
14149637	326	cyclin-dependent kinase 6 [Mus musculus]	0.940	0.926	0.509	2e-92
440896871	326	Cell division protein kinase 6 [Bos grun	0.940	0.926	0.509	2e-92
410911930	325	PREDICTED: cyclin-dependent kinase 6-lik	0.919	0.907	0.515	2e-92

>gi|328710567|ref|XP_001947810.2| PREDICTED: cyclin-dependent kinase 6-like [Acyrthosiphon pisum]

 Score =  379 bits (973), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 169/294 (57%), Positives = 224/294 (76%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + Y+EL QIG GAYGTV+K RDL NKG +VAMKK+++ L +DG+PM+TLREI++LKQLD 
Sbjct: 135 ENYEELNQIGNGAYGTVYKGRDLVNKGKFVAMKKIKIPLAQDGVPMTTLREIALLKQLDQ 194

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +HPNIV+  DV+H   L +E+ +T+YL+FEH++QDL +YM +CP PG+S+  +K + RQ
Sbjct: 195 QQHPNIVKLLDVVHGPRLYNEKCMTLYLVFEHIEQDLATYMARCPKPGMSSEIIKNVMRQ 254

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L GVDFLH +R++HRDLKPQN+L++    +KIADFGLAK +D+DM LTSVVVTLWYRAP
Sbjct: 255 ILSGVDFLHCNRVVHRDLKPQNVLVSSDLRIKIADFGLAKIYDFDMKLTSVVVTLWYRAP 314

Query: 202 EILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
           E+LL L Y T VD+W+ GC+M EM++L PLF   +E EQL  IFRVIG PS   WP+N+S
Sbjct: 315 EVLLGLPYATAVDVWACGCIMGEMYKLSPLFDGESEAEQLDRIFRVIGLPSALNWPKNVS 374

Query: 262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           L+ SSFE Y +     +  D CSK   LL  ML F+  +R+SA +AL+HPYF E
Sbjct: 375 LLRSSFESYPQTCLKTVIPDICSKGTDLLMKMLMFDSTERVSAREALKHPYFNE 428

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|156374066|ref|XP_001629630.1| predicted protein [Nematostella vectensis] gi|156216634|gb|EDO37567.1| predicted protein [Nematostella vectensis]

 Score =  363 bits (932), Expect = 6e-98,   Method: Compositional matrix adjust.
 Identities = 159/293 (54%), Positives = 225/293 (76%), Gaps = 1/293 (0%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY+E+ +IG GAYGTV+KA+DL N G +VA+K++R++ +E+G+P+ST+REI++LKQ+D F
Sbjct: 4   KYEEVAEIGTGAYGTVYKAKDLLNDGKFVALKRVRIQNSEEGMPLSTIREIALLKQIDNF 63

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            HPN+VR  D+ H  +L+  R   + L+FEHVDQDL +Y+E CP PGL   K+K+LT Q+
Sbjct: 64  AHPNVVRLLDIFHIPMLT-ARETHLNLVFEHVDQDLAAYLEYCPQPGLGEWKIKDLTYQI 122

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           L GVDFLH+HRI+HRD+KPQN+L+T+ G +KIADFGLA+ +   M LTSVVVTLWYRAPE
Sbjct: 123 LNGVDFLHTHRIVHRDIKPQNILVTKDGQVKIADFGLARVYKDAMALTSVVVTLWYRAPE 182

Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
           +LL   Y T VDIWS+ C++AE++   PLF    +V+QL  IF +IG+PS +EWP+N+SL
Sbjct: 183 VLLQSSYATSVDIWSVACILAELFNRRPLFEGKNDVDQLDKIFSIIGSPSQDEWPQNVSL 242

Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
            W+SF +Y+  +F A+  + C++  +LL+ ML F P  R SA++A+ HP+FKE
Sbjct: 243 PWTSFSRYTTGSFQALVPEMCTEGTTLLKEMLQFLPRSRPSASEAMNHPFFKE 295

Source: Nematostella vectensis

Species: Nematostella vectensis

Genus: Nematostella

Family: Edwardsiidae

Order: Actiniaria

Class: Anthozoa

Phylum: Cnidaria

Superkingdom: Eukaryota

>gi|297748129|gb|ADI52631.1| cyclin dependent kinase 6 [Apis cerana cerana]

 Score =  363 bits (931), Expect = 8e-98,   Method: Compositional matrix adjust.
 Identities = 173/308 (56%), Positives = 223/308 (72%), Gaps = 11/308 (3%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
           D  Y EL  IG GAYGTV+KA+DL N G  VA+KK+RV L  DG+P STLREI+ LKQL+
Sbjct: 153 DASYQELSLIGNGAYGTVYKAKDL-NTGQVVALKKVRVPLTADGLPTSTLREIATLKQLE 211

Query: 81  TFEHPNIVRFFDVIHQNIL----SD------ERYLTVYLIFEHVDQDLGSYMEKCPPPGL 130
            FEHP+IVR  DV   N L    +D      +R LT++L+FEHV++DL SYM  C   G+
Sbjct: 212 RFEHPHIVRLLDVCQGNYLHLPSADGRSERLDRGLTLWLVFEHVERDLASYMSSCSQTGI 271

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT 190
               VK++++++L+GV+FLHSHRIIHRDLKPQNLL+TR G +KIADFGLAKT+D++M LT
Sbjct: 272 PPHVVKQMSKEILRGVEFLHSHRIIHRDLKPQNLLVTREGRIKIADFGLAKTYDFEMRLT 331

Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
           SVVVT WYRAPE+LL   Y TPVDIWS+GC++AE+ RL PLF  ++E +QL  IF++IGT
Sbjct: 332 SVVVTQWYRAPEVLLGCSYATPVDIWSVGCILAELSRLEPLFPGTSEGDQLDRIFQIIGT 391

Query: 251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
           PS  EWPEN+SL W++F      +F+ I  D       L++ MLTFNP  R++AA AL H
Sbjct: 392 PSQGEWPENVSLSWTAFPYRQPKSFATIISDLNEYGLDLIKGMLTFNPHRRLTAAQALRH 451

Query: 311 PYFKEKEN 318
            YF E ++
Sbjct: 452 RYFAEDDS 459

Source: Apis cerana cerana

Species: Apis cerana

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|291243878|ref|XP_002741831.1| PREDICTED: Cell division protein kinase 6-like [Saccoglossus kowalevskii]

 Score =  357 bits (917), Expect = 3e-96,   Method: Compositional matrix adjust.
 Identities = 160/298 (53%), Positives = 225/298 (75%), Gaps = 3/298 (1%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           K+Y+E+ +IG GAYGTV+KARDL+  G YVA+KK+RV+  EDG+P+ST+REI++LKQL+ 
Sbjct: 12  KQYEEVAEIGTGAYGTVYKARDLET-GRYVALKKVRVQTGEDGMPLSTIREIAMLKQLEK 70

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
           FEHPN+VR  DV H      E  LT  L+FEH+DQDL +Y+EKCP PGL   K+++L+RQ
Sbjct: 71  FEHPNVVRLLDVYHGGRTDLETRLT--LVFEHIDQDLSTYLEKCPSPGLGPEKIRDLSRQ 128

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           ++ GVDFLHSHRI+HRDLKPQN+LIT  G +K+ADFGLA+ + + M LTSVVVTLWYRAP
Sbjct: 129 LVCGVDFLHSHRILHRDLKPQNILITGRGEVKLADFGLARVYGFQMALTSVVVTLWYRAP 188

Query: 202 EILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
           E+LL   Y TPVD+WS+GC++AE++  +PLF  +++++QL  IF +IG P+  EWP+++S
Sbjct: 189 EVLLQGRYATPVDMWSVGCIIAELFTRLPLFRGTSDIDQLHKIFDIIGLPAKAEWPDSVS 248

Query: 262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE 319
           + W++F      +   I  + C  +  LL+++LTF+P+ R SA D L H YFK ++ +
Sbjct: 249 VPWNAFRPSPPRSLKKIIPELCEDSADLLQNLLTFDPSQRSSAQDTLSHGYFKTEDGQ 306

Source: Saccoglossus kowalevskii

Species: Saccoglossus kowalevskii

Genus: Saccoglossus

Family: Harrimaniidae

Class: Enteropneusta

Phylum: Hemichordata

Superkingdom: Eukaryota

>gi|387015344|gb|AFJ49791.1| Cyclin-dependent kinase 6-like [Crotalus adamanteus]

 Score =  348 bits (892), Expect = 3e-93,   Method: Compositional matrix adjust.
 Identities = 157/306 (51%), Positives = 222/306 (72%), Gaps = 2/306 (0%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR 71
           ++ D++ L D++Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+ +E+G+P+ST+R
Sbjct: 1   MDKDNMSLADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTSEEGMPLSTIR 60

Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLS 131
           E+++LK L+TFEHPN+VR FDV    +   ER   + L+FEHVDQDL +Y+ K P PG+ 
Sbjct: 61  EVAVLKHLETFEHPNVVRLFDVC--TVSRTERETKLTLVFEHVDQDLTTYLNKVPEPGVP 118

Query: 132 ASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS 191
           +  +K++  Q+L+G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTS
Sbjct: 119 SETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178

Query: 192 VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           VVVTLWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLF  +++V+QL  IF VIG P
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGNSDVDQLGKIFEVIGLP 238

Query: 252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
              +WP +++L  ++F   S      +  D       LL   LTFNP  RISA DAL HP
Sbjct: 239 EEEDWPIDVALPRNAFASQSPQPIELLVTDIDELGKDLLIKCLTFNPMKRISAYDALTHP 298

Query: 312 YFKEKE 317
           YF + E
Sbjct: 299 YFHDLE 304

Source: Crotalus adamanteus

Species: Crotalus adamanteus

Genus: Crotalus

Family: Viperidae

Order: Squamata

Phylum: Chordata

Superkingdom: Eukaryota

>gi|157118645|ref|XP_001659194.1| cdk4/6 [Aedes aegypti] gi|108883256|gb|EAT47481.1| AAEL001407-PA [Aedes aegypti]

 Score =  346 bits (887), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 161/293 (54%), Positives = 214/293 (73%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y+EL  IG GAYGTV+KARDL N+GN VA+KK+RV L EDG+PMSTLREI++LKQLD F+
Sbjct: 23  YEELNVIGTGAYGTVYKARDLSNEGNIVALKKVRVALTEDGVPMSTLREIALLKQLDAFQ 82

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           HPN+V+  DV H   L  E  L ++L+FEH++QDL  Y+++ PP G+    ++ L+R++L
Sbjct: 83  HPNVVKLLDVCHGPRLEREGQLVLFLVFEHLEQDLDDYIKRLPPGGMPRMTIQRLSRELL 142

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            GVDFLHSHRIIHRDLKPQNLLI+  G LK+ADFGLAKT+D++M LT+VVVTLWYRAPE+
Sbjct: 143 TGVDFLHSHRIIHRDLKPQNLLISAQGQLKLADFGLAKTYDFEMKLTTVVVTLWYRAPEV 202

Query: 204 LLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM 263
           LL   Y + VDIWS GC++AEM++ V LF  ++E  QL+ IF + G PS ++WP  IS+ 
Sbjct: 203 LLGEPYHSSVDIWSSGCIIAEMFQRVALFPGTSEGNQLEKIFELTGRPSESQWPRGISVA 262

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK 316
             +F    +     +    C  +N LL+ ML FNP +R SA   L+HPYF ++
Sbjct: 263 RENFRPTQQREPRQMCPKLCDFSNDLLKKMLAFNPRERPSALQCLQHPYFTQE 315

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|74178317|dbj|BAE32432.1| unnamed protein product [Mus musculus]

 Score =  345 bits (885), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 156/304 (51%), Positives = 217/304 (71%), Gaps = 2/304 (0%)

Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           DSL   D++Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+ +E+G+P+ST+RE++
Sbjct: 4   DSLSRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTSEEGMPLSTIREVA 63

Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           +L+ L+TFEHPN+VR FDV    +   +R   + L+FEHVDQDL +Y++K P PG+    
Sbjct: 64  VLRHLETFEHPNVVRLFDVC--TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +K++  Q+L+G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTSVVV
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181

Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
           TLWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLF  S++V+QL  I  VIG P   
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241

Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           +WP +++L   +F   S         D       LL   LTFNPA RISA  AL HPYF+
Sbjct: 242 DWPTDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYGALNHPYFQ 301

Query: 315 EKEN 318
           + E 
Sbjct: 302 DLER 305

Source: Mus musculus

Species: Mus musculus

Genus: Mus

Family: Muridae

Order: Rodentia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|14149637|ref|NP_034003.1| cyclin-dependent kinase 6 [Mus musculus] gi|30316380|sp|Q64261.2|CDK6_MOUSE RecName: Full=Cyclin-dependent kinase 6; AltName: Full=CR2 protein kinase; Short=CRK2; AltName: Full=Cell division protein kinase 6; AltName: Full=Serine/threonine-protein kinase PLSTIRE gi|5453259|gb|AAD43504.1|AF132483_1 cyclin-dependent kinase 6 [Mus musculus] gi|26347681|dbj|BAC37489.1| unnamed protein product [Mus musculus] gi|111306682|gb|AAI20596.1| Cyclin-dependent kinase 6 [Mus musculus] gi|111600656|gb|AAI19361.1| Cyclin-dependent kinase 6 [Mus musculus] gi|117616304|gb|ABK42170.1| Cdk6 [synthetic construct] gi|148682651|gb|EDL14598.1| cyclin-dependent kinase 6 [Mus musculus]

 Score =  345 bits (885), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 155/304 (50%), Positives = 217/304 (71%), Gaps = 2/304 (0%)

Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           DSL   D++Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+ +E+G+P+ST+RE++
Sbjct: 4   DSLSRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTSEEGMPLSTIREVA 63

Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           +L+ L+TFEHPN+VR FDV    +   +R   + L+FEHVDQDL +Y++K P PG+    
Sbjct: 64  VLRHLETFEHPNVVRLFDVC--TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +K++  Q+L+G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTSVVV
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181

Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
           TLWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLF  S++V+QL  I  +IG P   
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDIIGLPGEE 241

Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           +WP +++L   +F   S         D       LL   LTFNPA RISA  AL HPYF+
Sbjct: 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYGALNHPYFQ 301

Query: 315 EKEN 318
           + E 
Sbjct: 302 DLER 305

Source: Mus musculus

Species: Mus musculus

Genus: Mus

Family: Muridae

Order: Rodentia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|440896871|gb|ELR48682.1| Cell division protein kinase 6 [Bos grunniens mutus]

 Score =  345 bits (884), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 157/308 (50%), Positives = 217/308 (70%), Gaps = 6/308 (1%)

Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D L   D++Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+  E+G+P+ST+RE++
Sbjct: 4   DGLSRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63

Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           +L+ L+TFEHPN+VR FDV    +   +R   + L+FEHVDQDL +Y++K P PG+    
Sbjct: 64  VLRHLETFEHPNVVRLFDVC--TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +K++  Q+L+G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTSVVV
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181

Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
           TLWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLF  S++V+QL  I  VIG P   
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241

Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF- 313
           +WP +++L   +F   S         D   +   LL   LTFNPA RISA  AL HPYF 
Sbjct: 242 DWPRDVALPRQAFHSKSPQPIEKFVTDIDEQGKDLLLKCLTFNPAKRISAYSALSHPYFH 301

Query: 314 ---KEKEN 318
              + KEN
Sbjct: 302 DLERRKEN 309

Source: Bos grunniens mutus

Species: Bos grunniens

Genus: Bos

Family: Bovidae

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|410911930|ref|XP_003969443.1| PREDICTED: cyclin-dependent kinase 6-like [Takifugu rubripes]

 Score =  345 bits (884), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 153/297 (51%), Positives = 214/297 (72%), Gaps = 2/297 (0%)

Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           D  + +Y+ + +IG GAYG V+KARDL+N+G +VA+KK+RV+  E+G+P+ST+RE+++L+
Sbjct: 4   DSANTRYEAVAEIGEGAYGKVYKARDLKNEGRFVALKKVRVQTEEEGMPLSTIREVAVLR 63

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE 137
           QL+ FEHPN+VR FDV   +    E  LT  L+FEHVDQDL +Y+EK P PG+    +K+
Sbjct: 64  QLEAFEHPNVVRLFDVCTVSRTDRETRLT--LVFEHVDQDLTTYLEKAPDPGVPPETIKD 121

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
           +  Q+L+G+DFLHSHR++HRDLKPQN+L+T  G +K+ADFGLA+ + + M LTSVVVTLW
Sbjct: 122 MMYQLLQGLDFLHSHRVVHRDLKPQNILVTSGGQIKLADFGLARIYSFQMALTSVVVTLW 181

Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           YRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLF  +++V+QL  IF V+G PS  +WP
Sbjct: 182 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRRPLFRGNSDVDQLGKIFDVVGVPSAEDWP 241

Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           + ++L  S+F             D   +  +LL   L FNP+ RISA  AL HPYF+
Sbjct: 242 QEVALPQSAFTPRPPKPIENFVPDMDEQGQALLMQFLAFNPSRRISAFAALSHPYFQ 298

Source: Takifugu rubripes

Species: Takifugu rubripes

Genus: Takifugu

Family: Tetraodontidae

Order: Tetraodontiformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	321
MGI|MGI:1277162	326	Cdk6 "cyclin-dependent kinase	0.937	0.923	0.518	2.4e-85
UNIPROTKB|E1BC36	326	CDK6 "Uncharacterized protein"	0.937	0.923	0.518	6.2e-85
UNIPROTKB|Q00534	326	CDK6 "Cyclin-dependent kinase	0.937	0.923	0.518	1e-84
UNIPROTKB|Q90771	326	cdk6 "Uncharacterized protein"	0.947	0.932	0.503	5.6e-84
ZFIN|ZDB-GENE-060503-786	324	cdk6 "cyclin-dependent kinase	0.919	0.910	0.511	3.9e-83
UNIPROTKB|E2RLM4	326	CDK6 "Uncharacterized protein"	0.937	0.923	0.508	1.3e-82
ZFIN|ZDB-GENE-060929-974	297	cdk4 "cyclin-dependent kinase	0.903	0.976	0.508	7.6e-80
UNIPROTKB|P11802	303	CDK4 "Cyclin-dependent kinase	0.931	0.986	0.485	4.8e-78
RGD|621120	303	Cdk4 "cyclin-dependent kinase	0.919	0.973	0.485	1.6e-77
UNIPROTKB|E2QUY0	303	CDK4 "Uncharacterized protein"	0.919	0.973	0.488	3.4e-77

MGI|MGI:1277162 Cdk6 "cyclin-dependent kinase 6" [Mus musculus (taxid:10090)]

 Score = 854 (305.7 bits), Expect = 2.4e-85, P = 2.4e-85
 Identities = 157/303 (51%), Positives = 217/303 (71%)

Query:    15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
             DSL   D++Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+ +E+G+P+ST+RE++
Sbjct:     4 DSLSRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTSEEGMPLSTIREVA 63

Query:    75 ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
             +L+ L+TFEHPN+VR FDV   +    E  LT  L+FEHVDQDL +Y++K P PG+    
Sbjct:    64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLT--LVFEHVDQDLTTYLDKVPEPGVPTET 121

Query:   135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
             +K++  Q+L+G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTSVVV
Sbjct:   122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181

Query:   195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
             TLWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLF  S++V+QL  I  +IG P   
Sbjct:   182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDIIGLPGEE 241

Query:   255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
             +WP +++L   +F   S         D       LL   LTFNPA RISA  AL HPYF+
Sbjct:   242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYGALNHPYFQ 301

Query:   315 EKE 317
             + E
Sbjct:   302 DLE 304

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=ISO

GO:0001726 "ruffle" evidence=ISO

GO:0001954 "positive regulation of cell-matrix adhesion" evidence=ISO

GO:0002244 "hematopoietic progenitor cell differentiation" evidence=IMP

GO:0003323 "type B pancreatic cell development" evidence=ISO

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=ISO

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0007049 "cell cycle" evidence=IEA

GO:0007219 "Notch signaling pathway" evidence=IGI;IDA

GO:0010468 "regulation of gene expression" evidence=ISO

GO:0010628 "positive regulation of gene expression" evidence=IDA

GO:0016301 "kinase activity" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030097 "hemopoiesis" evidence=IMP

GO:0030154 "cell differentiation" evidence=IEA

GO:0030332 "cyclin binding" evidence=ISO

GO:0033077 "T cell differentiation in thymus" evidence=IMP

GO:0042063 "gliogenesis" evidence=ISO

GO:0042995 "cell projection" evidence=IEA

GO:0043697 "cell dedifferentiation" evidence=ISO

GO:0045638 "negative regulation of myeloid cell differentiation" evidence=ISO

GO:0045646 "regulation of erythrocyte differentiation" evidence=ISO

GO:0045668 "negative regulation of osteoblast differentiation" evidence=ISO

GO:0045786 "negative regulation of cell cycle" evidence=ISO

GO:0048146 "positive regulation of fibroblast proliferation" evidence=ISO

GO:0050680 "negative regulation of epithelial cell proliferation" evidence=ISO

GO:0051301 "cell division" evidence=IEA

GO:0060218 "hematopoietic stem cell differentiation" evidence=IMP

GO:2000773 "negative regulation of cellular senescence" evidence=ISO

UNIPROTKB|E1BC36 CDK6 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 850 (304.3 bits), Expect = 6.2e-85, P = 6.2e-85
 Identities = 157/303 (51%), Positives = 215/303 (70%)

Query:    15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
             D L   D++Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+  E+G+P+ST+RE++
Sbjct:     4 DGLSRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63

Query:    75 ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
             +L+ L+TFEHPN+VR FDV   +    E  LT  L+FEHVDQDL +Y++K P PG+    
Sbjct:    64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLT--LVFEHVDQDLTTYLDKVPEPGVPTET 121

Query:   135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
             +K++  Q+L+G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTSVVV
Sbjct:   122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181

Query:   195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
             TLWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLF  S++V+QL  I  VIG P   
Sbjct:   182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241

Query:   255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
             +WP +++L   +F   S         D   +   LL   LTFNPA RISA  AL HPYF 
Sbjct:   242 DWPRDVALPRLAFHSKSPQPIEKFVTDIDEQGKDLLLKCLTFNPAKRISAYSALSHPYFH 301

Query:   315 EKE 317
             + E
Sbjct:   302 DLE 304

GO:2000773 "negative regulation of cellular senescence" evidence=IEA

GO:0060218 "hematopoietic stem cell differentiation" evidence=IEA

GO:0050680 "negative regulation of epithelial cell proliferation" evidence=IEA

GO:0048146 "positive regulation of fibroblast proliferation" evidence=IEA

GO:0045786 "negative regulation of cell cycle" evidence=IEA

GO:0045668 "negative regulation of osteoblast differentiation" evidence=IEA

GO:0045646 "regulation of erythrocyte differentiation" evidence=IEA

GO:0045638 "negative regulation of myeloid cell differentiation" evidence=IEA

GO:0043697 "cell dedifferentiation" evidence=IEA

GO:0042063 "gliogenesis" evidence=IEA

GO:0033077 "T cell differentiation in thymus" evidence=IEA

GO:0030332 "cyclin binding" evidence=IEA

GO:0010628 "positive regulation of gene expression" evidence=IEA

GO:0009615 "response to virus" evidence=IEA

GO:0007219 "Notch signaling pathway" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0003323 "type B pancreatic cell development" evidence=IEA

GO:0002244 "hematopoietic progenitor cell differentiation" evidence=IEA

GO:0001954 "positive regulation of cell-matrix adhesion" evidence=IEA

GO:0001726 "ruffle" evidence=IEA

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IEA

GO:0000080 "G1 phase of mitotic cell cycle" evidence=IEA

UNIPROTKB|Q00534 CDK6 "Cyclin-dependent kinase 6" [Homo sapiens (taxid:9606)]

 Score = 848 (303.6 bits), Expect = 1.0e-84, P = 1.0e-84
 Identities = 157/303 (51%), Positives = 215/303 (70%)

Query:    15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
             D L   D++Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+  E+G+P+ST+RE++
Sbjct:     4 DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63

Query:    75 ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
             +L+ L+TFEHPN+VR FDV   +    E  LT  L+FEHVDQDL +Y++K P PG+    
Sbjct:    64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLT--LVFEHVDQDLTTYLDKVPEPGVPTET 121

Query:   135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
             +K++  Q+L+G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTSVVV
Sbjct:   122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181

Query:   195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
             TLWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLF  S++V+QL  I  VIG P   
Sbjct:   182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241

Query:   255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
             +WP +++L   +F   S         D       LL   LTFNPA RISA  AL HPYF+
Sbjct:   242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

Query:   315 EKE 317
             + E
Sbjct:   302 DLE 304

GO:0051301 "cell division" evidence=IEA

GO:0002244 "hematopoietic progenitor cell differentiation" evidence=IEA

GO:0007219 "Notch signaling pathway" evidence=IEA

GO:0010628 "positive regulation of gene expression" evidence=IEA

GO:0033077 "T cell differentiation in thymus" evidence=IEA

GO:0060218 "hematopoietic stem cell differentiation" evidence=IEA

GO:0045786 "negative regulation of cell cycle" evidence=IDA

GO:0009615 "response to virus" evidence=IEP

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=TAS

GO:0007050 "cell cycle arrest" evidence=TAS

GO:0045596 "negative regulation of cell differentiation" evidence=TAS

GO:0008285 "negative regulation of cell proliferation" evidence=TAS

GO:0021542 "dentate gyrus development" evidence=ISS

GO:0021670 "lateral ventricle development" evidence=ISS

GO:0048699 "generation of neurons" evidence=ISS

GO:2000145 "regulation of cell motility" evidence=ISS

GO:0014002 "astrocyte development" evidence=ISS

GO:0045638 "negative regulation of myeloid cell differentiation" evidence=IDA

GO:2000773 "negative regulation of cellular senescence" evidence=IDA

GO:0003323 "type B pancreatic cell development" evidence=IDA

GO:0000080 "G1 phase of mitotic cell cycle" evidence=IEP;TAS

GO:0000278 "mitotic cell cycle" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0030332 "cyclin binding" evidence=IPI

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0005524 "ATP binding" evidence=IDA

GO:0043697 "cell dedifferentiation" evidence=IMP

GO:0042063 "gliogenesis" evidence=IMP

GO:0001726 "ruffle" evidence=IDA

GO:0001954 "positive regulation of cell-matrix adhesion" evidence=IDA

GO:0045646 "regulation of erythrocyte differentiation" evidence=IMP

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IDA

GO:0010468 "regulation of gene expression" evidence=IDA;IMP

GO:0048146 "positive regulation of fibroblast proliferation" evidence=IMP

GO:0045668 "negative regulation of osteoblast differentiation" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0050680 "negative regulation of epithelial cell proliferation" evidence=IMP

UNIPROTKB|Q90771 cdk6 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 841 (301.1 bits), Expect = 5.6e-84, P = 5.6e-84
 Identities = 154/306 (50%), Positives = 217/306 (70%)

Query:    12 LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR 71
             ++ D  +L D++Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+ +E+G+P+ST+R
Sbjct:     1 MDKDGTNLADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTSEEGMPLSTIR 60

Query:    72 EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLS 131
             E+++L+ L+TFEHPN+VR FDV   +    E  LT  L+FEHVDQDL +Y++K P PG+ 
Sbjct:    61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT--LVFEHVDQDLTTYLDKVPEPGVP 118

Query:   132 ASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS 191
                +K++  Q+ +G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTS
Sbjct:   119 TETIKDMMLQLFRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178

Query:   192 VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
             VVVTLWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLF  +++V+QL  IF VIG P
Sbjct:   179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGNSDVDQLGKIFDVIGLP 238

Query:   252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                +WP +++L  ++F             D       LL   L FNPA RISA  AL HP
Sbjct:   239 EEEDWPNDVALPRNAFASRPAQPIEKFVPDIDDMGKDLLLKCLAFNPAKRISAYAALSHP 298

Query:   312 YFKEKE 317
             YF + E
Sbjct:   299 YFHDLE 304

GO:0000080 "G1 phase of mitotic cell cycle" evidence=IEA

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IEA

GO:0001726 "ruffle" evidence=IEA

GO:0001954 "positive regulation of cell-matrix adhesion" evidence=IEA

GO:0002244 "hematopoietic progenitor cell differentiation" evidence=IEA

GO:0003323 "type B pancreatic cell development" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0007219 "Notch signaling pathway" evidence=IEA

GO:0009615 "response to virus" evidence=IEA

GO:0010628 "positive regulation of gene expression" evidence=IEA

GO:0030332 "cyclin binding" evidence=IEA

GO:0033077 "T cell differentiation in thymus" evidence=IEA

GO:0042063 "gliogenesis" evidence=IEA

GO:0043697 "cell dedifferentiation" evidence=IEA

GO:0045638 "negative regulation of myeloid cell differentiation" evidence=IEA

GO:0045646 "regulation of erythrocyte differentiation" evidence=IEA

GO:0045668 "negative regulation of osteoblast differentiation" evidence=IEA

GO:0045786 "negative regulation of cell cycle" evidence=IEA

GO:0048146 "positive regulation of fibroblast proliferation" evidence=IEA

GO:0050680 "negative regulation of epithelial cell proliferation" evidence=IEA

GO:0060218 "hematopoietic stem cell differentiation" evidence=IEA

GO:2000773 "negative regulation of cellular senescence" evidence=IEA

ZFIN|ZDB-GENE-060503-786 cdk6 "cyclin-dependent kinase 6" [Danio rerio (taxid:7955)]

 Score = 833 (298.3 bits), Expect = 3.9e-83, P = 3.9e-83
 Identities = 152/297 (51%), Positives = 215/297 (72%)

Query:    22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
             ++Y+ + +IG GAYG V+KARDL+N G +VA+K++RV+  E+G+P+ST+RE+++L+QL++
Sbjct:     8 QQYEPVAEIGEGAYGKVYKARDLKNGGRFVALKRVRVQTEEEGMPLSTIREVAVLRQLES 67

Query:    82 FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             FEHPN+VR FDV   +    E  LT  L+FEHVDQDL +Y+EK P PG+    +K++  Q
Sbjct:    68 FEHPNVVRLFDVCTVSRTDRETKLT--LVFEHVDQDLTTYLEKAPDPGVPPETIKDMMYQ 125

Query:   142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
             +L+G+DFLHSHR++HRDLKPQN+L+T  G +K+ADFGLA+ + + M LTSVVVTLWYRAP
Sbjct:   126 LLQGLDFLHSHRVVHRDLKPQNILVTSGGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 185

Query:   202 EILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
             E+LL   Y TPVD+WS+GC+ AEM+R  PLF  +++V+QL  IF V+G PS  +WP+ + 
Sbjct:   186 EVLLQSSYATPVDLWSVGCIFAEMFRRRPLFRGNSDVDQLGKIFDVVGVPSPEDWPQEVG 245

Query:   262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN 318
             L  S+F          +  D      SLL   L+FNP+ RISA DAL H YF+  ++
Sbjct:   246 LPQSAFSPRPAQPIENLVPDMDELGKSLLLRFLSFNPSRRISAYDALSHLYFQSLDS 302

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|E2RLM4 CDK6 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 828 (296.5 bits), Expect = 1.3e-82, P = 1.3e-82
 Identities = 154/303 (50%), Positives = 211/303 (69%)

Query:    15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
             D L   D++Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+  E+G+P+ST+    
Sbjct:     4 DGLSRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIPASG 63

Query:    75 ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
             +L+ L+TFEHP++VR FDV   +    E  LT  L+FEHVDQDL +Y++K P PG+    
Sbjct:    64 VLRHLETFEHPSVVRLFDVCTVSRTDRETKLT--LVFEHVDQDLTTYLDKVPEPGVPTET 121

Query:   135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
             +K++  Q+L+G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTSVVV
Sbjct:   122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181

Query:   195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
             TLWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLF  S++V+QL  I  VIG P   
Sbjct:   182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241

Query:   255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
             +WP +++L   +F   S         D   +   LL   LTFNPA RISA  AL HPYF 
Sbjct:   242 DWPRDVALPRQAFHSKSPQPIEKFVTDIDEQGKDLLLKCLTFNPAKRISAYSALSHPYFH 301

Query:   315 EKE 317
             + E
Sbjct:   302 DLE 304

GO:2000773 "negative regulation of cellular senescence" evidence=IEA

GO:0060218 "hematopoietic stem cell differentiation" evidence=IEA

GO:0050680 "negative regulation of epithelial cell proliferation" evidence=IEA

GO:0048146 "positive regulation of fibroblast proliferation" evidence=IEA

GO:0045786 "negative regulation of cell cycle" evidence=IEA

GO:0045668 "negative regulation of osteoblast differentiation" evidence=IEA

GO:0045646 "regulation of erythrocyte differentiation" evidence=IEA

GO:0045638 "negative regulation of myeloid cell differentiation" evidence=IEA

GO:0043697 "cell dedifferentiation" evidence=IEA

GO:0042063 "gliogenesis" evidence=IEA

GO:0033077 "T cell differentiation in thymus" evidence=IEA

GO:0030332 "cyclin binding" evidence=IEA

GO:0010628 "positive regulation of gene expression" evidence=IEA

GO:0009615 "response to virus" evidence=IEA

GO:0007219 "Notch signaling pathway" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0003323 "type B pancreatic cell development" evidence=IEA

GO:0002244 "hematopoietic progenitor cell differentiation" evidence=IEA

GO:0001954 "positive regulation of cell-matrix adhesion" evidence=IEA

GO:0001726 "ruffle" evidence=IEA

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IEA

GO:0000080 "G1 phase of mitotic cell cycle" evidence=IEA

ZFIN|ZDB-GENE-060929-974 cdk4 "cyclin-dependent kinase 4" [Danio rerio (taxid:7955)]

 Score = 802 (287.4 bits), Expect = 7.6e-80, P = 7.6e-80
 Identities = 149/293 (50%), Positives = 211/293 (72%)

Query:    23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
             +Y+ + +IG GAYGTV+KARD ++ G +VA+K +RV+ N+DG+P+ST+RE+++LK+L+ F
Sbjct:     8 QYEPVAEIGGGAYGTVYKARD-RDSGQFVALKSVRVQTNQDGLPLSTVREVALLKRLEQF 66

Query:    83 EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
             +HPNIVR  DV    + +D+    V L+FEHVDQDL +Y+EK P PGL   K+++L +Q+
Sbjct:    67 DHPNIVRLMDVC-ATLRTDQE-TKVTLVFEHVDQDLRAYLEKVPAPGLPVDKIRDLMQQL 124

Query:   143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
             L G+ FLH++R++HRDLKP+N+L+T  G +K+ADFGLA+ +   M LT VVVTLWYR+PE
Sbjct:   125 LCGLAFLHTNRVLHRDLKPENILVTSRGQVKLADFGLARIYSCHMALTPVVVTLWYRSPE 184

Query:   203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
             +LL   Y TPVDIWS GC+ AEM+R  PLFC  +E +QL  IF VIG P+ ++WP +++L
Sbjct:   185 VLLQSTYATPVDIWSTGCIFAEMFRRKPLFCGDSEADQLGKIFAVIGLPAEDQWPTDVTL 244

Query:   263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
                +F   S    +    D   K   LL  MLTF+P  RISA +AL+HP+F E
Sbjct:   245 SHHNFSPQSPRPITDCVPDITEKGAELLLKMLTFDPLKRISALNALDHPFFSE 297

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|P11802 CDK4 "Cyclin-dependent kinase 4" [Homo sapiens (taxid:9606)]

 Score = 785 (281.4 bits), Expect = 4.8e-78, P = 4.8e-78
 Identities = 148/305 (48%), Positives = 209/305 (68%)

Query:    19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG---IPMSTLREISI 75
             +   +Y+ + +IG GAYGTV+KARD  + G++VA+K +RV     G   +P+ST+RE+++
Sbjct:     1 MATSRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 59

Query:    76 LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
             L++L+ FEHPN+VR  DV   +    +R + V L+FEHVDQDL +Y++K PPPGL A  +
Sbjct:    60 LRRLEAFEHPNVVRLMDVCATS--RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI 117

Query:   136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVT 195
             K+L RQ L+G+DFLH++ I+HRDLKP+N+L+T  G +K+ADFGLA+ + Y M LT VVVT
Sbjct:   118 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 177

Query:   196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
             LWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLFC ++E +QL  IF +IG P  ++
Sbjct:   178 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 237

Query:   256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             WP ++SL   +F         ++  +       LL  MLTFNP  RISA  AL+H Y  +
Sbjct:   238 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 297

Query:   316 KENEP 320
              E  P
Sbjct:   298 DEGNP 302

GO:0005524 "ATP binding" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0005667 "transcription factor complex" evidence=IEA

GO:0005923 "tight junction" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0007623 "circadian rhythm" evidence=IEA

GO:0009636 "response to toxic substance" evidence=IEA

GO:0010288 "response to lead ion" evidence=IEA

GO:0030332 "cyclin binding" evidence=IEA

GO:0031100 "organ regeneration" evidence=IEA

GO:0032403 "protein complex binding" evidence=IEA

GO:0033574 "response to testosterone stimulus" evidence=IEA

GO:0043065 "positive regulation of apoptotic process" evidence=IEA

GO:0045727 "positive regulation of translation" evidence=IEA

GO:0045793 "positive regulation of cell size" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0051726 "regulation of cell cycle" evidence=IEA

GO:0055093 "response to hyperoxia" evidence=IEA

GO:0042493 "response to drug" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0031965 "nuclear membrane" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0000785 "chromatin" evidence=IDA

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IDA

GO:0005829 "cytosol" evidence=IDA;TAS

GO:0000080 "G1 phase of mitotic cell cycle" evidence=TAS

GO:0000084 "S phase of mitotic cell cycle" evidence=TAS

GO:0000278 "mitotic cell cycle" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0010468 "regulation of gene expression" evidence=IMP

GO:0048146 "positive regulation of fibroblast proliferation" evidence=IMP

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IMP

GO:0008284 "positive regulation of cell proliferation" evidence=IMP

RGD|621120 Cdk4 "cyclin-dependent kinase 4" [Rattus norvegicus (taxid:10116)]

 Score = 780 (279.6 bits), Expect = 1.6e-77, P = 1.6e-77
 Identities = 146/301 (48%), Positives = 208/301 (69%)

Query:    23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE---DGIPMSTLREISILKQL 79
             +Y+ + +IG GAYGTV+KARD  + G++VA+K +RV        G+P+ST+RE+++L++L
Sbjct:     5 RYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGAAGGGLPVSTVREVALLRRL 63

Query:    80 DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT 139
             + FEHPN+VR  DV   +    +R + V L+FEH+DQDL +Y++K PPPGL    +K+L 
Sbjct:    64 EAFEHPNVVRLMDVCATS--RTDRDIKVTLVFEHIDQDLRTYLDKAPPPGLPVETIKDLM 121

Query:   140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
             RQ L G+DFLH++ I+HRDLKP+N+L+T  G +K+ADFGLA+ + Y M LT VVVTLWYR
Sbjct:   122 RQFLSGLDFLHANCIVHRDLKPENILVTSNGTVKLADFGLARIYSYQMALTPVVVTLWYR 181

Query:   200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
             APE+LL   Y TPVD+WS+GC+ AEM+R  PLFC ++E +QL  IF +IG P  ++WP  
Sbjct:   182 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRE 241

Query:   260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE 319
             +SL   +F         ++  +       LL  MLTFNP  RISA  AL+H Y  ++E++
Sbjct:   242 VSLPRGAFSPRGPRPVQSVVPEMEESGAQLLLEMLTFNPLKRISAFRALQHSYLHKEESD 301

Query:   320 P 320
             P
Sbjct:   302 P 302

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IEA;ISO

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IEA;ISO

GO:0000785 "chromatin" evidence=IEA;ISO

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISO;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005667 "transcription factor complex" evidence=IEA;ISO

GO:0005730 "nucleolus" evidence=IEA;ISO

GO:0005737 "cytoplasm" evidence=IDA

GO:0005829 "cytosol" evidence=IEA;ISO

GO:0005923 "tight junction" evidence=IEA;ISO

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0007165 "signal transduction" evidence=IEA;ISO

GO:0007623 "circadian rhythm" evidence=IEP

GO:0008284 "positive regulation of cell proliferation" evidence=ISO;IMP

GO:0009636 "response to toxic substance" evidence=IEP

GO:0010033 "response to organic substance" evidence=IMP

GO:0010288 "response to lead ion" evidence=IMP

GO:0010468 "regulation of gene expression" evidence=ISO

GO:0016301 "kinase activity" evidence=ISO

GO:0030332 "cyclin binding" evidence=IPI

GO:0031100 "organ regeneration" evidence=IEP

GO:0031965 "nuclear membrane" evidence=IEA;ISO

GO:0032403 "protein complex binding" evidence=IPI

GO:0033574 "response to testosterone stimulus" evidence=IDA

GO:0042127 "regulation of cell proliferation" evidence=ISO

GO:0042493 "response to drug" evidence=IEA;ISO

GO:0043065 "positive regulation of apoptotic process" evidence=IMP

GO:0045727 "positive regulation of translation" evidence=IMP

GO:0045787 "positive regulation of cell cycle" evidence=TAS

GO:0045793 "positive regulation of cell size" evidence=IMP

GO:0048146 "positive regulation of fibroblast proliferation" evidence=IEA;ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=IDA

GO:0051301 "cell division" evidence=IEA

GO:0051726 "regulation of cell cycle" evidence=ISO;TAS

GO:0055093 "response to hyperoxia" evidence=IEP

UNIPROTKB|E2QUY0 CDK4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 777 (278.6 bits), Expect = 3.4e-77, P = 3.4e-77
 Identities = 147/301 (48%), Positives = 205/301 (68%)

Query:    23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED---GIPMSTLREISILKQL 79
             +Y+ + +IG GAYGTV+KARD  + G++VA+K +RV        G+P+ST+RE+++L++L
Sbjct:     5 RYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGGAGGGLPISTVREVALLRRL 63

Query:    80 DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT 139
             + FEHPN+VR  DV        +R   V L+FEHVDQDL +Y++K PPPGL    +K+L 
Sbjct:    64 EAFEHPNVVRLMDVCAT--ARTDRETKVTLVFEHVDQDLRTYLDKAPPPGLPVETIKDLM 121

Query:   140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
             RQ L+G+DFLH++ I+HRDLKP+N+L+T  G +K+ADFGLA+ + Y M LT VVVTLWYR
Sbjct:   122 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR 181

Query:   200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
             APE+LL   Y TPVD+WS+GC+ AEM+R  PLFC ++E +QL  IF +IG P  ++WP +
Sbjct:   182 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 241

Query:   260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE 319
             +SL   +F          +  +       LL  MLTFNP  RISA  AL+H Y ++ E  
Sbjct:   242 VSLPRGAFSPRGPRPVQTVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLQKAEGN 301

Query:   320 P 320
             P
Sbjct:   302 P 302

GO:0051726 "regulation of cell cycle" evidence=IEA

GO:0048146 "positive regulation of fibroblast proliferation" evidence=IEA

GO:0042493 "response to drug" evidence=IEA

GO:0031965 "nuclear membrane" evidence=IEA

GO:0010468 "regulation of gene expression" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0005923 "tight junction" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005730 "nucleolus" evidence=IEA

GO:0005667 "transcription factor complex" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0000785 "chromatin" evidence=IEA

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IEA

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q64261	CDK6_MOUSE	2, ., 7, ., 1, 1, ., 2, 2	0.5098	0.9408	0.9263	yes	N/A
Q27032	CDC2H_THEPA	2, ., 7, ., 1, 1, ., 2, 3	0.4554	0.8909	0.9597	yes	N/A
Q26671	CDC2H_THEAN	2, ., 7, ., 1, 1, ., 2, 3	0.4597	0.8753	0.9429	yes	N/A
P79432	CDK4_PIG	2, ., 7, ., 1, 1, ., 2, 2	0.4819	0.9314	0.9867	yes	N/A
Q91727	CDK4_XENLA	2, ., 7, ., 1, 1, ., 2, 2	0.5051	0.9034	0.9090	N/A	N/A
P24100	CDKA1_ARATH	2, ., 7, ., 1, 1, ., 2, 3	0.4328	0.8785	0.9591	yes	N/A
P61075	CDC2H_PLAF7	2, ., 7, ., 1, 1, ., 2, 3	0.4463	0.8753	0.9756	yes	N/A
Q00534	CDK6_HUMAN	2, ., 7, ., 1, 1, ., 2, 2	0.5098	0.9408	0.9263	yes	N/A
P29618	CDKA1_ORYSJ	2, ., 7, ., 1, 1, ., 2, 3	0.4451	0.8878	0.9693	yes	N/A
P34112	CDK1_DICDI	2, ., 7, ., 1, 1, ., 2, 3	0.4554	0.8785	0.9527	yes	N/A
P04551	CDK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 3	0.4224	0.8878	0.9595	yes	N/A
P00546	CDK1_YEAST	2, ., 7, ., 1, 1, ., 2, 2	0.4448	0.8816	0.9496	yes	N/A
O96821	CDC2H_PLAKH	2, ., 7, ., 1, 1, ., 2, 3	0.4496	0.8753	0.9756	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	321
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-173
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-126
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-122
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-117
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-111
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-106
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-102
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-97
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-97
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-95
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-93
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-93
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-91
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-90
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-89
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-88
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-87
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-87
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-86
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-84
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-82
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-79
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-77
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-75
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-73
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-72
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-72
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-69
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-69
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-69
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-68
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-66
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-66
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-65
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-64
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-63
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-63
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-62
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-61
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-61
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-61
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-60
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-60
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-57
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-57
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-57
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-56
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-56
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-56
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-55
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-54
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-53
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-53
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-51
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-49
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-49
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-49
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-48
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-47
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-46
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-46
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-46
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-45
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-41
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-40
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-40
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-39
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-39
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-39
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-37
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-35
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-34
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-34
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-33
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-33
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-33
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-33
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-33
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-32
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-32
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-31
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-30
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-30
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-30
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-30
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-30
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-30
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-30
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-30
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-29
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-29
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-28
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-28
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-28
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-27
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-27
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-27
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-27
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-27
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-26
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-26
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-26
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-26
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-25
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-25
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-25
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-25
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-24
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-24
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-23
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-23
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-22
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-22
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-22
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-22
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-22
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-22
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-22
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-22
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-22
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-21
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-21
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-20
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-20
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-20
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-20
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-19
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-19
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-19
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-19
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-19
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-19
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-19
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-19
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-19
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-19
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-18
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-18
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-18
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-18
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-17
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-17
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-17
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-16
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-16
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-16
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-16
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-16
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-16
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-15
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-15
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-15
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-14
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-14
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-14
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-14
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-14
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-14
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-13
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-13
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-13
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-13
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-12
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-12
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-12
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-12
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-12
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-12
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-12
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-11
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-11
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-11
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-10
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-10
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	7e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-08
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-08
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-08
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-07
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	7e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	7e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	7e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.002
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.002
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.002

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  482 bits (1242), Expect = e-173
 Identities = 173/290 (59%), Positives = 221/290 (76%), Gaps = 3/290 (1%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y+EL +IG GAYGTV+KARDL   G +VA+KK+RV L+E+GIP+STLREI++LKQL++FE
Sbjct: 1   YEELAEIGEGAYGTVYKARDLN-TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE 59

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           HPNIVR  DV H      +R L + L+FEHVDQDL +Y+ KCP PGL    +K+L RQ+L
Sbjct: 60  HPNIVRLLDVCH--GPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL 117

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
           +GVDFLHSHRI+HRDLKPQN+L+T  G +KIADFGLA+ + ++M LTSVVVTLWYRAPE+
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEV 177

Query: 204 LLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM 263
           LL   Y TPVD+WS+GC+ AE++R  PLF  ++E +QL  IF VIG PS  EWP N+SL 
Sbjct: 178 LLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
            SSF  Y+  +F +   + C +   LL+ MLTFNP  RISA +AL+HPYF
Sbjct: 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  362 bits (933), Expect = e-126
 Identities = 136/289 (47%), Positives = 184/289 (63%), Gaps = 18/289 (6%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G YG V+KARD +  G  VA+KK+R+   E+GIP + LREIS+LK+L    HPNIV+
Sbjct: 7   LGEGTYGVVYKARDKKT-GEIVALKKIRLDNEEEGIPSTALREISLLKELK---HPNIVK 62

Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFL 149
             DVIH           +YL+FE+ D DL  Y++K P P LS + +K +  Q+L+G+ + 
Sbjct: 63  LLDVIHTER-------KLYLVFEYCDMDLKKYLDKRPGP-LSPNLIKSIMYQLLRGLAYC 114

Query: 150 HSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM-LTSVVVTLWYRAPEILLN-L 207
           HSHRI+HRDLKPQN+LI R G LK+ADFGLA+ F   +   T  VVTLWYRAPEILL   
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSK 174

Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM---W 264
            Y T VDIWS+GC+ AEM    PLF   +E++QL  IF+++GTP+   WP  ++ +    
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP-GVTKLPDYK 233

Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
            +F ++       +      +   LL  ML +NPA RISA +AL+HPYF
Sbjct: 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  352 bits (904), Expect = e-122
 Identities = 149/291 (51%), Positives = 208/291 (71%), Gaps = 3/291 (1%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y+ + +IG GAYGTV+KARD  + G++VA+K +RV+ NEDG+P+ST+RE+++LK+L+ F
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHS-GHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAF 59

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           +HPNIVR  DV        +R   V L+FEHVDQDL +Y++K PPPGL A  +K+L RQ 
Sbjct: 60  DHPNIVRLMDVCAT--SRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF 117

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           L+G+DFLH++ I+HRDLKP+N+L+T  G +K+ADFGLA+ +   M LT VVVTLWYRAPE
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177

Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
           +LL   Y TPVD+WS+GC+ AEM+R  PLFC ++E +QL  IF +IG P  ++WP +++L
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237

Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
              +F         ++  +       LL  MLTFNP  RISA  AL+HP+F
Sbjct: 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  338 bits (867), Expect = e-117
 Identities = 153/292 (52%), Positives = 209/292 (71%), Gaps = 2/292 (0%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+  E+G+P+ST+RE+++L+ L+T
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
           FEHPN+VR FDV   +    E  LT  L+FEHVDQDL +Y++K P PG+    +K++  Q
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLT--LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTSVVVTLWYRAP
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178

Query: 202 EILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
           E+LL   Y TPVD+WS+GC+ AEM+R  PLF  S++V+QL  I  VIG P   +WP +++
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238

Query: 262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
           L   +F   S         D       LL   LTFNPA RISA  AL HPYF
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  323 bits (830), Expect = e-111
 Identities = 142/296 (47%), Positives = 187/296 (63%), Gaps = 19/296 (6%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y ++ +IG G YG V+KARD    G  VA+KK+R++  ++G+P + +REIS+LK+L    
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLT-GEIVALKKIRLETEDEGVPSTAIREISLLKEL---N 56

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           HPNIVR  DV+H      E  L  YL+FE +D DL  YM+  P  GL    +K    Q+L
Sbjct: 57  HPNIVRLLDVVHS-----ENKL--YLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAPE 202
           +G+ + HSHR++HRDLKPQNLLI R G LK+ADFGLA+ F   +   T  VVTLWYRAPE
Sbjct: 110 QGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 169

Query: 203 ILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           IL  LG   Y TPVDIWSIGC+ AEM    PLF   +E++QL  IFR +GTP  + WP  
Sbjct: 170 IL--LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227

Query: 260 ISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
            SL     +F ++++   S +  +       LL  ML ++PA RISA  AL+HPYF
Sbjct: 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  311 bits (800), Expect = e-106
 Identities = 116/306 (37%), Positives = 182/306 (59%), Gaps = 35/306 (11%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y+++ QIG G YG V+KAR+ +  G  VA+KK+R++  ++G P++ +REI +L++L    
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKT-GELVALKKIRMENEKEGFPITAIREIKLLQKLR--- 56

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           HPNIVR  +++           ++Y++FE++D DL   ++  P    + S++K   +Q+L
Sbjct: 57  HPNIVRLKEIVTSKGKG-----SIYMVFEYMDHDLTGLLD-SPEVKFTESQIKCYMKQLL 110

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM--LTSVVVTLWYRAP 201
           +G+ +LHS+ I+HRD+K  N+LI   G LK+ADFGLA+ +        T+ V+TLWYR P
Sbjct: 111 EGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170

Query: 202 EILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           E+L  LG   YG  VD+WS+GC++AE++   P+F  STE+EQL+ IF + G+P+   WP 
Sbjct: 171 ELL--LGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG 228

Query: 259 NISLMW-----------SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
              L W               ++ K       +D       LL+ +LT +P  RISA  A
Sbjct: 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALD-------LLDKLLTLDPKKRISADQA 281

Query: 308 LEHPYF 313
           L+H YF
Sbjct: 282 LQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  302 bits (775), Expect = e-102
 Identities = 132/295 (44%), Positives = 178/295 (60%), Gaps = 17/295 (5%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y +L +IG G YG V+KARD    G  VA+KK++++   +GIP + LREI +LK+L    
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLT-GEIVAIKKIKLRFESEGIPKTALREIKLLKEL---N 56

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           HPNI++  DV             +YL+FE +D DL   + K    GL  S +K    Q+L
Sbjct: 57  HPNIIKLLDVFRHK-------GDLYLVFEFMDTDLYKLI-KDRQRGLPESLIKSYLYQLL 108

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLWYRAPE 202
           +G+ F HSH I+HRDLKP+NLLI   G LK+ADFGLA++F       T  VVT WYRAPE
Sbjct: 109 QGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPE 168

Query: 203 ILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
           +LL   GY TPVDIWS+GC+ AE+    PLF   +E++QL  IFR +GTP    WP+  S
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228

Query: 262 LMWS---SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
           L  +   SF + + +    +F +   +A  LL  ML ++P  RI+A  AL HPYF
Sbjct: 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  288 bits (739), Expect = 4e-97
 Identities = 135/298 (45%), Positives = 181/298 (60%), Gaps = 12/298 (4%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
            Y++L +IG G YG V+KARD    G  VA+KK R++++E+GIP + LREIS+L+ L   
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNT-GKLVALKKTRLEMDEEGIPPTALREISLLQMLS-- 58

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYME---KCPPPGLSASKVKELT 139
           E   IVR  DV H  +       ++YL+FE++D DL  +M+   + P   L A  +K   
Sbjct: 59  ESIYIVRLLDVEH--VEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM 116

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYDM-MLTSVVVTLW 197
            Q+LKGV   H H ++HRDLKPQNLL+ +  G LKIAD GL + F   +   T  +VTLW
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW 176

Query: 198 YRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW 256
           YRAPE+LL    Y TPVDIWS+GC+ AEM R  PLF   +E++QL  IF+++GTP+   W
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236

Query: 257 PENISLM-WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
           P    L  W  F Q+     S    D   +   LL+ ML ++PA RISA  AL HPYF
Sbjct: 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  287 bits (737), Expect = 5e-97
 Identities = 133/289 (46%), Positives = 176/289 (60%), Gaps = 15/289 (5%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +IG G YG V+KAR+    G  VA+KK+R+    +G+P + +REIS+LK+L+   HPNIV
Sbjct: 7   KIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELN---HPNIV 62

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
           +  DVIH      E  L  YL+FE + QDL  +M+  P  G+    +K    Q+L+G+ F
Sbjct: 63  KLLDVIH-----TENKL--YLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNL 207
            HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +   T  VVTLWYRAPEILL  
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 175

Query: 208 G-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL--MW 264
             Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP   SL    
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235

Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
            SF ++++  FS +          LL  ML ++P  RISA  AL HP+F
Sbjct: 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  283 bits (726), Expect = 2e-95
 Identities = 135/296 (45%), Positives = 187/296 (63%), Gaps = 16/296 (5%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
            Y ++ +IG G YG V+K R+ +  G  VAMKK+R++  E+G+P + +REIS+LK+L   
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRN-KKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL--- 56

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELTRQ 141
           +HPNIV   DV+ Q    + R   +YLIFE +  DL  Y++  P    + A  VK    Q
Sbjct: 57  QHPNIVCLQDVLMQ----ESR---LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQ 109

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRA 200
           +L+G+ F HS R++HRDLKPQNLLI   G +K+ADFGLA+ F   + + T  VVTLWYRA
Sbjct: 110 ILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRA 169

Query: 201 PEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           PE+LL +  Y TPVDIWSIG + AEM    PLF   +E++QL  IFR++GTP+ + WP  
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229

Query: 260 ISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
            SL    ++F ++ K +  +   +       LLE ML ++PA RISA  AL HPYF
Sbjct: 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  279 bits (716), Expect = 1e-93
 Identities = 121/305 (39%), Positives = 174/305 (57%), Gaps = 34/305 (11%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y  L +IG GA+G VFKA+D +  G  VA+KK+ ++  E GIP   LREI  L+     
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRET-GETVALKKVALRRLEGGIPNQALREIKALQAC--- 56

Query: 83  EHPNIVRFFDVIHQNILSDERYLT-VYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
           +HP +V+  DV          + +   L+ E++  DL   +     P L  ++VK   R 
Sbjct: 57  QHPYVVKLLDVF--------PHGSGFVLVMEYMPSDLSEVLRDEERP-LPEAQVKSYMRM 107

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD--MMLTSVVVTLWYR 199
           +LKGV ++H++ I+HRDLKP NLLI+  G LKIADFGLA+ F  +   + +  V T WYR
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYR 167

Query: 200 APEILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW 256
           APE+L   G   Y   VD+W++GC+ AE+    PLF    ++EQL  +FR +GTP+   W
Sbjct: 168 APELL--YGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETW 225

Query: 257 PENISLMWSSFEQYSKVAFSA--------IFMDCCSKANSLLESMLTFNPADRISAADAL 308
           P   SL       Y+K+ F          IF D   +A  LL+ +L ++P+ R+SAA+AL
Sbjct: 226 PGLTSL-----PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEAL 280

Query: 309 EHPYF 313
            HPYF
Sbjct: 281 RHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  277 bits (710), Expect = 3e-93
 Identities = 106/291 (36%), Positives = 153/291 (52%), Gaps = 38/291 (13%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y+ L ++G G++G V+ ARD    G  VA+K ++ K          LREI ILK+L    
Sbjct: 1   YEILEKLGEGSFGKVYLARDK-KTGKLVAIKVIK-KKKIKKDRERILREIKILKKLK--- 55

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQM 142
           HPNIVR +DV       DE  L  YL+ E+ +  DL   ++K     LS  + +   RQ+
Sbjct: 56  HPNIVRLYDVFE-----DEDKL--YLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQI 106

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           L  +++LHS  I+HRDLKP+N+L+   G +K+ADFGLA+  D    LT+ V T  Y APE
Sbjct: 107 LSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPE 166

Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
           +LL  GYG  VDIWS+G ++ E+    P F      +QL  +F+ IG P     P     
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPP---- 219

Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
                             D   +A  L+  +L  +P  R++A +AL+HP+F
Sbjct: 220 ----------------EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  272 bits (699), Expect = 5e-91
 Identities = 121/305 (39%), Positives = 173/305 (56%), Gaps = 28/305 (9%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRV---KLNEDGIPMSTLREISILKQL 79
           +Y++  ++G G Y  V+KARD +  G  VA+KK+++   K  +DGI  + LREI +L++L
Sbjct: 1   RYEKGKKLGEGTYAVVYKARD-KETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL 59

Query: 80  DTFEHPNIVRFFDVI--HQNILSDERYLTVYLIFEHVDQDLGSYME-KCPPPGLSASKVK 136
               HPNI+   DV     NI          L+FE ++ DL   ++ K     L+ + +K
Sbjct: 60  K---HPNIIGLLDVFGHKSNI---------NLVFEFMETDLEKVIKDKSIV--LTPADIK 105

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVT 195
                 L+G+++LHS+ I+HRDLKP NLLI   G LK+ADFGLA++F      +T  VVT
Sbjct: 106 SYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT 165

Query: 196 LWYRAPEILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
            WYRAPE+L   G   YG  VD+WS+GC+ AE+   VP     ++++QL  IF  +GTP+
Sbjct: 166 RWYRAPELL--FGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPT 223

Query: 253 MNEWPENISLM-WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
              WP   SL  +  F+ +       IF      A  LL+ +LT NP  RI+A  ALEHP
Sbjct: 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283

Query: 312 YFKEK 316
           YF   
Sbjct: 284 YFSND 288

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  270 bits (693), Expect = 4e-90
 Identities = 125/299 (41%), Positives = 180/299 (60%), Gaps = 21/299 (7%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y++L +I  G YG V++ARD +  G  VA+KKL+++  ++G P+++LREI+IL +L    
Sbjct: 7   YEKLNRIEEGTYGVVYRARDKK-TGEIVALKKLKMEKEKEGFPITSLREINILLKLQ--- 62

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           HPNIV   +V+  + L       +Y++ E+V+ DL S ME    P    S+VK L  Q+L
Sbjct: 63  HPNIVTVKEVVVGSNLDK-----IYMVMEYVEHDLKSLMETMKQP-FLQSEVKCLMLQLL 116

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLTSVVVTLWYRAPE 202
            GV  LH + I+HRDLK  NLL+   G LKI DFGLA+ +       T +VVTLWYRAPE
Sbjct: 117 SGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPE 176

Query: 203 ILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
           +LL    Y T +D+WS+GC+ AE+    PLF   +E++QL  IF+++GTP+   WP    
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236

Query: 262 L-MWSSF----EQYSKVA--FSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
           L            Y+++   F A+ +        LL  +LT++PA RISA DAL+HPYF
Sbjct: 237 LPGAKKKTFTKYPYNQLRKKFPALSLS--DNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  268 bits (688), Expect = 1e-89
 Identities = 128/296 (43%), Positives = 180/296 (60%), Gaps = 17/296 (5%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY++L +IG G YGTVFKA++ +     VA+K++R+  +++G+P S LREI +LK+L   
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKN-RETHEIVALKRVRLDDDDEGVPSSALREICLLKEL--- 56

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           +H NIVR +DV+H      ++ LT  L+FE+ DQDL  Y + C    +    VK    Q+
Sbjct: 57  KHKNIVRLYDVLHS-----DKKLT--LVFEYCDQDLKKYFDSCNGD-IDPEIVKSFMFQL 108

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-VVTLWYRAP 201
           LKG+ F HSH ++HRDLKPQNLLI + G LK+ADFGLA+ F   +   S  VVTLWYR P
Sbjct: 109 LKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPP 168

Query: 202 EILLNL-GYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           ++L     Y T +D+WS GC+ AE+     PLF  +   +QLK IFR++GTP+   WP  
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228

Query: 260 ISLM-WSSFEQYSKVA-FSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
             L  +  +  Y        +     S    LL+++L  NP  RISA +AL+HPYF
Sbjct: 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  265 bits (680), Expect = 3e-88
 Identities = 131/303 (43%), Positives = 192/303 (63%), Gaps = 16/303 (5%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y+++ +IG G YG V+KARD +     +A+KK+R++  ++G+P + +REIS+LK++   
Sbjct: 3   QYEKVEKIGEGTYGVVYKARD-RVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM--- 58

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           +H NIVR  DV+H    S++R   +YL+FE++D DL  +M+  P    +   +K    Q+
Sbjct: 59  QHGNIVRLQDVVH----SEKR---LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQI 111

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITR-AGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRA 200
           L+G+ + HSHR++HRDLKPQNLLI R    LK+ADFGLA+ F   +   T  VVTLWYRA
Sbjct: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRA 171

Query: 201 PEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           PEILL +  Y TPVDIWS+GC+ AEM    PLF   +E+++L  IFR++GTP+   WP  
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231

Query: 260 ISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE 317
            SL    S+F ++     + +          LL  ML  +P+ RI+A  ALEH YFK+  
Sbjct: 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291

Query: 318 NEP 320
           + P
Sbjct: 292 DAP 294

Length = 294

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  264 bits (678), Expect = 1e-87
 Identities = 125/305 (40%), Positives = 182/305 (59%), Gaps = 25/305 (8%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
            ++++L +IG G YG V++ARD  + G  VA+KK+R+    DGIP+S+LREI++L  L  
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTS-GEIVALKKVRMDNERDGIPISSLREITLLLNL-- 63

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             HPNIV   +V+    L      +++L+ E+ +QDL S ++  P P  S S+VK L  Q
Sbjct: 64  -RHPNIVELKEVVVGKHLD-----SIFLVMEYCEQDLASLLDNMPTP-FSESQVKCLMLQ 116

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY-DMMLTSVVVTLWYRA 200
           +L+G+ +LH + IIHRDLK  NLL+T  G LKIADFGLA+T+      +T  VVTLWYRA
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRA 176

Query: 201 PEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           PE+LL    Y T +D+W++GC++AE+    PL    +E+EQL  I +++GTP+ + WP  
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG- 235

Query: 260 ISLMWSSFEQYSKVAFSA-------IFMDCCSKAN-SLLESMLTFNPADRISAADALEHP 311
               +S      K                  S+A   LL  +L ++P  R +A +ALE  
Sbjct: 236 ----FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291

Query: 312 YFKEK 316
           YFKEK
Sbjct: 292 YFKEK 296

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  263 bits (675), Expect = 1e-87
 Identities = 127/295 (43%), Positives = 180/295 (61%), Gaps = 17/295 (5%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           + +L ++G G Y TV+K R+    G  VA+K++ +   E+G P + +REIS++K+L   +
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTT-GEIVALKEIHLD-AEEGTPSTAIREISLMKEL---K 56

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELTRQM 142
           H NIVR  DVIH      E  L   L+FE++D+DL  YM+     G L  + VK  T Q+
Sbjct: 57  HENIVRLHDVIHT-----ENKLM--LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL 109

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAP 201
           LKG+ F H +R++HRDLKPQNLLI + G LK+ADFGLA+ F   +   ++ VVTLWYRAP
Sbjct: 110 LKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAP 169

Query: 202 EILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP--E 258
           ++LL +  Y T +DIWS+GC+MAEM    PLF  +   +QL  IFR++GTP+ + WP   
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
            +     +F +Y       +F         LL  +L  NP  RISA DAL+HP+F
Sbjct: 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  260 bits (667), Expect = 2e-86
 Identities = 114/296 (38%), Positives = 177/296 (59%), Gaps = 19/296 (6%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN--EDGIPMSTLREISILKQLDT 81
           Y  + Q+G G +G+V+ AR+ +  G  VA+KK++ K    E+ +    LRE+  L++L+ 
Sbjct: 1   YKVIKQLGDGTFGSVYLARN-KETGELVAIKKMKKKFYSWEECMN---LREVKSLRKLN- 55

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            EHPNIV+  +V  +N   DE    +Y +FE+++ +L   M+       S S ++ +  Q
Sbjct: 56  -EHPNIVKLKEVFREN---DE----LYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQ 107

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+  +H H   HRDLKP+NLL++    +KIADFGLA+        T  V T WYRAP
Sbjct: 108 ILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAP 167

Query: 202 EILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           EILL    Y +PVDIW++GC+MAE++ L PLF  S+E++QL  I  V+GTP+  +WPE  
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227

Query: 261 SLMWS---SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
            L       F Q++  +   +  +   +A  L++ ML ++P  R +A+ AL+HPYF
Sbjct: 228 KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  256 bits (656), Expect = 4e-84
 Identities = 118/307 (38%), Positives = 165/307 (53%), Gaps = 27/307 (8%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI-PMSTLREISILKQLDT 81
           +Y+ L  IG GAYG V  A D +  G  VA+KK+   + +D I     LREI +L+ L  
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRT-GRKVAIKKIS-NVFDDLIDAKRILREIKLLRHLR- 57

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             H NI+   D++      D     VY++ E ++ DL   + K P P L+   ++    Q
Sbjct: 58  --HENIIGLLDILRPPSPEDFN--DVYIVTELMETDLHKVI-KSPQP-LTDDHIQYFLYQ 111

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD----MMLTSVVVTLW 197
           +L+G+ +LHS  +IHRDLKP N+L+     LKI DFGLA+  D D      LT  VVT W
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 198 YRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW 256
           YRAPE+LL+   Y   +DIWS+GC+ AE+    PLF     ++QL  I  V+GTPS    
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS---- 227

Query: 257 PENISLMWS--------SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL 308
            E++  + S        S  +  K   S +F     +A  LLE ML F+P  RI+A +AL
Sbjct: 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287

Query: 309 EHPYFKE 315
            HPY  +
Sbjct: 288 AHPYLAQ 294

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  250 bits (641), Expect = 2e-82
 Identities = 125/304 (41%), Positives = 176/304 (57%), Gaps = 33/304 (10%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y +L ++G G+Y TV+K R     G  VA+K++R++ +E+G P + +RE S+LK L   +
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLT-GQLVALKEIRLE-HEEGAPFTAIREASLLKDL---K 61

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV   D+IH      ++ LT  L+FE++D DL  YM+ C   GLS   V+    Q+L
Sbjct: 62  HANIVTLHDIIHT-----KKTLT--LVFEYLDTDLKQYMDDCGG-GLSMHNVRLFLFQLL 113

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA-------KTFDYDMMLTSVVVTL 196
           +G+ + H  R++HRDLKPQNLLI+  G LK+ADFGLA       KT+      ++ VVTL
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY------SNEVVTL 167

Query: 197 WYRAPEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV-EQLKCIFRVIGTPSMN 254
           WYR P++LL +  Y T +D+W +GC+  EM    PLF  ST+V +QL  IFRV+GTP+  
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227

Query: 255 EWP---ENISLMWSSFEQYSKVAFSAIF--MDCCSKANSLLESMLTFNPADRISAADALE 309
            WP    N      SF  Y           +D       L    L + P  RISAA+A++
Sbjct: 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287

Query: 310 HPYF 313
           HPYF
Sbjct: 288 HPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  241 bits (616), Expect = 6e-79
 Identities = 103/288 (35%), Positives = 160/288 (55%), Gaps = 36/288 (12%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G++GTV+KA+  +  G  VA+K L+ +  +     +  REI IL++L    HPNIV
Sbjct: 6   KLGSGSFGTVYKAKH-KGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS---HPNIV 61

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           R  D        D+ +L  YL+ E+ +  DL  Y+ +  P  LS  + K++  Q+L+G++
Sbjct: 62  RLIDAFE-----DKDHL--YLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLE 112

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY-DMMLTSVVVTLWYRAPEILL- 205
           +LHS+ IIHRDLKP+N+L+   G +KIADFGLAK        LT+ V T WY APE+LL 
Sbjct: 113 YLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLG 172

Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS 265
             GYG  VD+WS+G ++ E+    P F     ++QL+ I R++G P   + P+  S    
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGS-- 230

Query: 266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
                              +A  L++  L  +P+ R +A + L+HP+F
Sbjct: 231 ------------------EEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  239 bits (611), Expect = 1e-77
 Identities = 112/309 (36%), Positives = 171/309 (55%), Gaps = 23/309 (7%)

Query: 20  GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQL 79
              KY++L +IG G +G VFKAR  + K   VA+KK+ ++  ++G P++ LREI IL+ L
Sbjct: 10  EVSKYEKLAKIGQGTFGEVFKARHKKTK-QIVALKKVLMENEKEGFPITALREIKILQLL 68

Query: 80  DTFEHPNIVRFFDVIHQNILSDERYL-TVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
              +H N+V   ++         RY  + YL+FE  + DL   +        + S++K++
Sbjct: 69  ---KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN-KNVKFTLSEIKKV 124

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-----MLTSVV 193
            + +L G+ ++H ++I+HRD+K  N+LIT+ G LK+ADFGLA+ F           T+ V
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184

Query: 194 VTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
           VTLWYR PE+LL    YG P+D+W  GC+MAEMW   P+   +TE  QL  I ++ G+ +
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244

Query: 253 MNEWP--ENISLMWSSFE----QYSKVA--FSAIFMDCCSKANSLLESMLTFNPADRISA 304
              WP  + + L +   E    Q  KV         D    A  L++ +L  +PA RI A
Sbjct: 245 PEVWPGVDKLEL-FKKMELPQGQKRKVKERLKPYVKD--PHALDLIDKLLVLDPAKRIDA 301

Query: 305 ADALEHPYF 313
             AL H +F
Sbjct: 302 DTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  233 bits (596), Expect = 3e-75
 Identities = 119/312 (38%), Positives = 179/312 (57%), Gaps = 32/312 (10%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y+ L ++G G +G V+KAR ++  G  VA+KK+ +   +DG P++ LREI ILK+L   +
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKT-GRVVALKKILMHNEKDGFPITALREIKILKKL---K 65

Query: 84  HPNIVRFFDVI--HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
           HPN+V   D+     +    +R  +VY++  ++D DL   +E  P   L+ S++K    Q
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKR-GSVYMVTPYMDHDLSGLLEN-PSVKLTESQIKCYMLQ 123

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD------------YDMML 189
           +L+G+++LH + I+HRD+K  N+LI   G LKIADFGLA+ +D                 
Sbjct: 124 LLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183

Query: 190 TSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           T++VVT WYR PE+LL    Y T VDIW IGCV AEM+   P+    ++++QL  IF++ 
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243

Query: 249 GTPSMNEWPENISL----MWSSFEQYS---KVAFSAIFMDCCSKANSLLESMLTFNPADR 301
           GTP+   WP   SL       SF  Y    +  F  +  +       LL  +L+ +P  R
Sbjct: 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGL----DLLSKLLSLDPYKR 299

Query: 302 ISAADALEHPYF 313
           ++A+DALEHPYF
Sbjct: 300 LTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  228 bits (583), Expect = 6e-73
 Identities = 122/312 (39%), Positives = 162/312 (51%), Gaps = 26/312 (8%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
             +Y  L  +G GAYG V  A D    G  VA+KKL            T RE+ +LK +D
Sbjct: 14  PDRYQNLSPVGSGAYGQVCSAFD-TKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD 72

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
              H N++   DV      S E +  VYL+   +  DL + + KC    LS   ++ L  
Sbjct: 73  ---HENVIGLLDVFTPAS-SLEDFQDVYLVTHLMGADLNNIV-KCQK--LSDDHIQFLVY 125

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           Q+L+G+ ++HS  IIHRDLKP N+ +     LKI DFGLA+  D +M  T  V T WYRA
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRA 183

Query: 201 PEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           PEI+LN + Y   VDIWS+GC+MAE+     LF  S  ++QLK I  ++GTP      E 
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD----EEL 239

Query: 260 ISLMWS--------SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
           +  + S        S  Q  K  F  +F      A  LLE ML  +P  RI+AA+AL HP
Sbjct: 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299

Query: 312 YFKE---KENEP 320
           Y  E    E+EP
Sbjct: 300 YLAEYHDPEDEP 311

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  224 bits (574), Expect = 3e-72
 Identities = 108/306 (35%), Positives = 166/306 (54%), Gaps = 34/306 (11%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY+ L  +G GAYG V K R+    G  VA+KK +   +++ +  + LRE+ +L+QL   
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNK-ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL--- 57

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            H NIV   +          R    YL+FE+V++ L   +E   P GL    V+    Q+
Sbjct: 58  RHENIVNLKEAF----RRKGRL---YLVFEYVERTLLELLEA-SPGGLPPDAVRSYIWQL 109

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF--DYDMMLTSVVVTLWYRA 200
           L+ + + HSH IIHRD+KP+N+L++ +G LK+ DFG A+         LT  V T WYRA
Sbjct: 110 LQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRA 169

Query: 201 PEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG--TPSMNEWP 257
           PE+L+ +  YG PVD+W+IGC+MAE+    PLF   ++++QL  I + +G   PS  E  
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE-- 227

Query: 258 ENISLMWSSFEQYSKVAFSAIFM----------DCCSKANSLLESMLTFNPADRISAADA 307
                ++SS  +++ VAF                  S A   L++ L  +P +R++  + 
Sbjct: 228 -----LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDEL 282

Query: 308 LEHPYF 313
           L+HPYF
Sbjct: 283 LQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  225 bits (576), Expect = 3e-72
 Identities = 117/329 (35%), Positives = 173/329 (52%), Gaps = 51/329 (15%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNK-GNYVAMKKLR-VKLNEDGIPMSTLREISILKQLD 80
           KY+    IG G YG V+KA+    K G   A+KK +  K    GI  S  REI++L++L 
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLG------SYMEKCPPPGLSASK 134
              H N+V   +V     L      +VYL+F++ + DL          ++     +  S 
Sbjct: 61  ---HENVVSLVEVF----LEHAD-KSVYLLFDYAEHDLWQIIKFHRQAKRVS---IPPSM 109

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG----LKIADFGLAKTFD------ 184
           VK L  Q+L GV +LHS+ ++HRDLKP N+L+   G     +KI D GLA+ F+      
Sbjct: 110 VKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169

Query: 185 YDMMLTSVVVTLWYRAPEILLNLGYGTP-VDIWSIGCVMAEMWRLVPLF-CASTE----- 237
            D  L  VVVT+WYRAPE+LL   + T  +DIW+IGC+ AE+  L P+F     +     
Sbjct: 170 AD--LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSN 227

Query: 238 ---VEQLKCIFRVIGTPSMNEWPENISL-MWSSFEQYSKVAFS-----AIFMDCCSKANS 288
               +QL+ IF V+GTP+  +WP+   +  + +  +  K         A +M+   K +S
Sbjct: 228 PFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDS 287

Query: 289 ----LLESMLTFNPADRISAADALEHPYF 313
               LL  +L ++P  RI+A +ALEHPYF
Sbjct: 288 QGFDLLRKLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  219 bits (561), Expect = 1e-69
 Identities = 113/322 (35%), Positives = 171/322 (53%), Gaps = 43/322 (13%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY+ L ++G GAYG V+KA D + K   VA+KK+            T REI  L++L  
Sbjct: 7   RKYEILQKLGKGAYGIVWKAIDRRTK-EVVALKKIFDAFRNATDAQRTFREIMFLQELG- 64

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR- 140
            +HPNIV+  +VI      D     +YL+FE+++ DL + +       +    ++++ + 
Sbjct: 65  -DHPNIVKLLNVIKAENDKD-----IYLVFEYMETDLHAVIRA----NI----LEDVHKR 110

Query: 141 ----QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF------DYDMMLT 190
               Q+LK + ++HS  +IHRDLKP N+L+     +K+ADFGLA++         + +LT
Sbjct: 111 YIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170

Query: 191 SVVVTLWYRAPEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG 249
             V T WYRAPEILL +  Y   VD+WS+GC++ EM    PLF  ++ + QL+ I  VIG
Sbjct: 171 DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG 230

Query: 250 TPSMNEWPENI--------SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADR 301
            PS     E+I        + M  S     +     +       A  LL+ +L FNP  R
Sbjct: 231 PPS----AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKR 286

Query: 302 ISAADALEHPY---FKEKENEP 320
           ++A +ALEHPY   F    +EP
Sbjct: 287 LTAEEALEHPYVAQFHNPSDEP 308

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  218 bits (557), Expect = 1e-69
 Identities = 113/306 (36%), Positives = 181/306 (59%), Gaps = 28/306 (9%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           K+D + QIG G YG V+KARD ++ G  VA+KK+R+   ++G P++ +REI IL+QL   
Sbjct: 8   KFDIIGQIGEGTYGQVYKARD-KDTGELVALKKVRLDNEKEGFPITAIREIKILRQL--- 63

Query: 83  EHPNIVRFFDVIHQNILS-DERYLT--VYLIFEHVDQDLGSYMEKCPPPGL---SASKVK 136
            H NIV   +++     + D +      YL+FE++D DL   +E     GL   S   +K
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES----GLVHFSEDHIK 119

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD--MMLTSVVV 194
              +Q+L+G+++ H    +HRD+K  N+L+   G +K+ADFGLA+ ++ +     T+ V+
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179

Query: 195 TLWYRAPEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
           TLWYR PE+LL    YG  +D+WS GC++ E++   P+F A+ E+ QL+ I R+ G+P  
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239

Query: 254 NEWPENISL-MWSSFE---QYS---KVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
             WP+ I L  +++ +   QY    +  FS I     + A  LL+ MLT +P+ R +A +
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFI----PTPALDLLDHMLTLDPSKRCTAEE 295

Query: 307 ALEHPY 312
           AL  P+
Sbjct: 296 ALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  217 bits (555), Expect = 8e-69
 Identities = 118/301 (39%), Positives = 160/301 (53%), Gaps = 19/301 (6%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
             +Y  L  IG GAYG V  A      G  VA+KK+            TLREI IL++  
Sbjct: 4   GPRYQNLSYIGEGAYGMVCSATHKPT-GVKVAIKKIS-PFEHQTFCQRTLREIKILRR-- 59

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
            F+H NI+   D+      S E +  VY++ E ++ DL   ++      LS   ++    
Sbjct: 60  -FKHENIIGILDI--IRPPSFESFNDVYIVQELMETDLYKLIKTQH---LSNDHIQYFLY 113

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK----TFDYDMMLTSVVVTL 196
           Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+      D+   LT  V T 
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 197 WYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           WYRAPEI+LN  GY   +DIWS+GC++AEM    PLF     + QL  I  V+GTPS  +
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233

Query: 256 WPENISL----MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
               ISL       S     KV ++ +F +   KA  LL+ MLTFNP  RI+  +AL HP
Sbjct: 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293

Query: 312 Y 312
           Y
Sbjct: 294 Y 294

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  215 bits (549), Expect = 5e-68
 Identities = 113/321 (35%), Positives = 168/321 (52%), Gaps = 45/321 (14%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL------------RVKLNEDGIPMSTLREISILK 77
           +G G YG V KA D    G  VA+KK+            R  +   GI  +TLRE+ I+ 
Sbjct: 17  LGEGTYGKVEKAYDT-LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE 137
           ++   +H NI+   DV  +       ++   L+ + +  DL   +++     L+ S+VK 
Sbjct: 76  EI---KHENIMGLVDVYVE-----GDFIN--LVMDIMASDLKKVVDR--KIRLTESQVKC 123

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM--------- 188
           +  Q+L G++ LH    +HRDL P N+ I   G  KIADFGLA+ + Y            
Sbjct: 124 ILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183

Query: 189 ------LTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL 241
                 +TS VVTLWYRAPE+L+    Y   VD+WS+GC+ AE+    PLF    E++QL
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243

Query: 242 KCIFRVIGTPSMNEWPENISL-MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD 300
             IF ++GTP+ + WP+   L +++ F          IF +    A  LL+S+L  NP +
Sbjct: 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLE 303

Query: 301 RISAADALEHPYFKEKENEPL 321
           RISA +AL+H YFK   ++PL
Sbjct: 304 RISAKEALKHEYFK---SDPL 321

Length = 335

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  210 bits (536), Expect = 1e-66
 Identities = 113/301 (37%), Positives = 172/301 (57%), Gaps = 26/301 (8%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY++L +IG G+YG VFK R+ +  G  VA+KK     ++  I    LREI +LKQL   
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRET-GQIVAIKKFVESEDDPVIKKIALREIRMLKQL--- 57

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           +HPN+V   +V  +      R L  +L+FE+ D  + + +EK  P G+    +K++  Q 
Sbjct: 58  KHPNLVNLIEVFRRK-----RKL--HLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQT 109

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-YDMMLTSVVVTLWYRAP 201
           L+ V+F H H  IHRD+KP+N+LIT+ G +K+ DFG A+         T  V T WYRAP
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAP 169

Query: 202 EILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG--TP------S 252
           E+L+ +  YG PVD+W+IGCV AE+    PL+   ++V+QL  I + +G   P      S
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229

Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
            N++ + +S+     E  ++    + F +  S A S L+  L  +P +R+S  + LEHPY
Sbjct: 230 TNQFFKGLSIP----EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Query: 313 F 313
           F
Sbjct: 286 F 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  209 bits (533), Expect = 3e-66
 Identities = 122/295 (41%), Positives = 169/295 (57%), Gaps = 18/295 (6%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y +L ++G G Y TVFK R  +   N VA+K++R++ +E+G P + +RE+S+LK L   +
Sbjct: 7   YVKLDKLGEGTYATVFKGRS-KLTENLVALKEIRLE-HEEGAPCTAIREVSLLKNL---K 61

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV   D+IH      ER LT  L+FE++D DL  Y++ C    +S   VK    Q+L
Sbjct: 62  HANIVTLHDIIHT-----ERCLT--LVFEYLDSDLKQYLDNCGNL-MSMHNVKIFMFQLL 113

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS-VVVTLWYRAPE 202
           +G+ + H  +I+HRDLKPQNLLI   G LK+ADFGLA+         S  VVTLWYR P+
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 173

Query: 203 ILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP---E 258
           +LL +  Y TP+D+W +GC++ EM    P+F  ST  E+L  IFR++GTP+   WP    
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
           N       F QY             +    LL S+L +    RISA  AL H YF
Sbjct: 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  207 bits (528), Expect = 2e-65
 Identities = 101/293 (34%), Positives = 157/293 (53%), Gaps = 14/293 (4%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y  L +IG G +  V KA+  +  G Y A+K ++ K  +    ++ LREI  L++L    
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKT-GKYYAIKCMK-KHFKSLEQVNNLREIQALRRLS--P 56

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           HPNI+R  +V+      D +   + L+FE +D +L   ++    P L   +VK    Q+L
Sbjct: 57  HPNILRLIEVLF-----DRKTGRLALVFELMDMNLYELIKGRKRP-LPEKRVKSYMYQLL 110

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
           K +D +H + I HRD+KP+N+LI +   LK+ADFG  +        T  + T WYRAPE 
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILI-KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPEC 169

Query: 204 LLNLGYGTP-VDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS--MNEWPENI 260
           LL  GY  P +DIW++GCV  E+  L PLF  + E++Q+  I  V+GTP   + +     
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229

Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
             M  +F          +  +  ++   LL+ +L ++P +RI+A  AL HPYF
Sbjct: 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  204 bits (519), Expect = 5e-64
 Identities = 120/302 (39%), Positives = 176/302 (58%), Gaps = 28/302 (9%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y +L ++G G Y TV+K R  +   N VA+K++R++ +E+G P + +RE+S+LK L   +
Sbjct: 8   YIKLDKLGEGTYATVYKGRS-KLTDNLVALKEIRLE-HEEGAPCTAIREVSLLKDL---K 62

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV   D+IH      E+ LT  L+FE++D+DL  Y++ C    ++   VK    Q+L
Sbjct: 63  HANIVTLHDIIHT-----EKSLT--LVFEYLDKDLKQYLDDCGNS-INMHNVKLFLFQLL 114

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAPE 202
           +G+++ H  +++HRDLKPQNLLI   G LK+ADFGLA+         ++ VVTLWYR P+
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPD 174

Query: 203 ILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
           ILL +  Y T +D+W +GC+  EM    PLF  ST  EQL  IFR++GTP+   WP  + 
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL- 233

Query: 262 LMWSSFEQYSKVAFSAIFMDCC--------SKANSLLESMLTFNPADRISAADALEHPYF 313
               S E++    +     DC         S    LL  +L F    RISA +A++HPYF
Sbjct: 234 ----SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289

Query: 314 KE 315
             
Sbjct: 290 HC 291

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  203 bits (519), Expect = 2e-63
 Identities = 113/303 (37%), Positives = 161/303 (53%), Gaps = 22/303 (7%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
           D KY  +  IG GAYG V  A++ +     VA+KK+    +       TLREI +L+ LD
Sbjct: 4   DTKYVPIKPIGRGAYGIVCSAKNSET-NEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD 62

Query: 81  TFEHPNIVRFFDVI---HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE 137
              H N++   D++   H+   +D     VY+++E +D DL   +       LS    + 
Sbjct: 63  ---HENVIAIKDIMPPPHREAFND-----VYIVYELMDTDLHQIIRS--SQTLSDDHCQY 112

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD--YDMMLTSVVVT 195
              Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+T     D M T  VVT
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM-TEYVVT 171

Query: 196 LWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
            WYRAPE+LLN   Y T +D+WS+GC+ AE+    PLF     V QLK I  ++G+PS  
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231

Query: 255 EWP----ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
           +      E       S     + +F+ +F      A  LLE ML F+P+ RI+  +AL H
Sbjct: 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291

Query: 311 PYF 313
           PY 
Sbjct: 292 PYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  202 bits (517), Expect = 4e-63
 Identities = 107/318 (33%), Positives = 165/318 (51%), Gaps = 30/318 (9%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
             +Y  +  IG GAYG V  A D    G  VA+KK+    +   +   TLRE+ IL+   
Sbjct: 4   GSRYKPIENIGSGAYGVVCSAID-TRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRH-- 60

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
            F+H NI+   D++         +  VY++ + ++ DL   +    P  L+   ++    
Sbjct: 61  -FKHDNIIAIRDILRPP---GADFKDVYVVMDLMESDLHHIIHSDQP--LTEEHIRYFLY 114

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-----DYDMMLTSVVVT 195
           Q+L+G+ ++HS  +IHRDLKP NLL+     L+I DFG+A+       ++   +T  V T
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 196 LWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
            WYRAPE+LL+L  Y T +D+WS+GC+ AEM     LF     V QLK I  V+G+PS  
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS-- 232

Query: 255 EWPENISLMWS--------SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
              E ++ + S        +  +   V +S IF     +A  LL  ML F+P +RI+   
Sbjct: 233 --EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290

Query: 307 ALEHPYFKE---KENEPL 321
           AL+HP+  +    ++EP 
Sbjct: 291 ALQHPFLAQYHDPDDEPT 308

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  199 bits (507), Expect = 2e-62
 Identities = 116/299 (38%), Positives = 164/299 (54%), Gaps = 23/299 (7%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y  L ++G G+Y TV+K     N G  VA+K + +K  E+G+P + +RE S+LK L   +
Sbjct: 7   YLNLEKLGEGSYATVYKGISRIN-GQLVALKVISMK-TEEGVPFTAIREASLLKGL---K 61

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV   D+IH          T+  +FE++  DL  YM +  P GL    V+    Q+L
Sbjct: 62  HANIVLLHDIIHTK-------ETLTFVFEYMHTDLAQYMIQ-HPGGLHPYNVRLFMFQLL 113

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY-DMMLTSVVVTLWYRAPE 202
           +G+ ++H   I+HRDLKPQNLLI+  G LK+ADFGLA+         +S VVTLWYR P+
Sbjct: 114 RGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPD 173

Query: 203 ILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV-EQLKCIFRVIGTPSMNEWPENI 260
           +LL    Y + +DIW  GC+  EM +  P F   ++V EQL+ I+ V+G P+ + WP  +
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP-GV 232

Query: 261 SLMWSSFEQYSKVAFSAIFMDCCS------KANSLLESMLTFNPADRISAADALEHPYF 313
           S + +   ++                    KA  L   ML   P DRISA DAL HPYF
Sbjct: 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  196 bits (500), Expect = 2e-61
 Identities = 83/290 (28%), Positives = 140/290 (48%), Gaps = 39/290 (13%)

Query: 28  CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
             +G G++G+V+ A D    G  +A+K + +  + +    +  REI IL  L    HPNI
Sbjct: 6   ELLGRGSFGSVYLALDKDT-GELMAVKSVELSGDSEEELEALEREIRILSSLQ---HPNI 61

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           VR++         ++  L ++L  E+V    L S ++K     L    +++ TRQ+L+G+
Sbjct: 62  VRYYGSERDE---EKNTLNIFL--EYVSGGSLSSLLKKFGK--LPEPVIRKYTRQILEGL 114

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRAPEI 203
            +LHS+ I+HRD+K  N+L+   G +K+ADFG AK     +      SV  T ++ APE+
Sbjct: 115 AYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 204 LLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM 263
           +    YG   DIWS+GC + EM    P +           ++++  +    E PE++   
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA--LYKIGSSGEPPEIPEHL--- 229

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
                  S+ A    F+  C          L  +P  R +A + L+HP+ 
Sbjct: 230 -------SEEAKD--FLRKC----------LRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  197 bits (501), Expect = 3e-61
 Identities = 114/296 (38%), Positives = 171/296 (57%), Gaps = 18/296 (6%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y +L ++G G Y TVFK R    + N VA+K++R++ +E+G P + +RE+S+LK L   +
Sbjct: 8   YIKLEKLGEGTYATVFKGRSKLTE-NLVALKEIRLE-HEEGAPCTAIREVSLLKDL---K 62

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV   D++H      ++ LT  L+FE++D+DL  YM+ C    +S   VK    Q+L
Sbjct: 63  HANIVTLHDIVHT-----DKSLT--LVFEYLDKDLKQYMDDCGNI-MSMHNVKIFLYQIL 114

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAPE 202
           +G+ + H  +++HRDLKPQNLLI   G LK+ADFGLA+         ++ VVTLWYR P+
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 174

Query: 203 ILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP---E 258
           +LL    Y T +D+W +GC+  EM    PLF  ST  ++L  IFR++GTP+   WP    
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           N      +F +Y             ++   LL   L +    RISA +A++H YF+
Sbjct: 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  197 bits (501), Expect = 8e-61
 Identities = 119/306 (38%), Positives = 168/306 (54%), Gaps = 18/306 (5%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y +L Q+G GAYGTV  A D +  G  VA+KKL      +       RE+ +LK +   
Sbjct: 16  RYRDLKQVGSGAYGTVCSALDRRT-GAKVAIKKLYRPFQSELFAKRAYRELRLLKHM--- 71

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           +H N++   DV   + LS +R+   YL+   +  DLG  M+      LS  +++ L  QM
Sbjct: 72  KHENVIGLLDVFTPD-LSLDRFHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFLVYQM 127

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           LKG+ ++H+  IIHRDLKP NL +     LKI DFGLA+  D +M  T  VVT WYRAPE
Sbjct: 128 LKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM--TGYVVTRWYRAPE 185

Query: 203 ILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN----EWP 257
           ++LN + Y   VDIWS+GC+MAEM    PLF     ++QL  I +V GTPS         
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245

Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF---K 314
           E+         ++ K  F ++  +    A ++LE ML  +   RI+AA+AL HPYF    
Sbjct: 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305

Query: 315 EKENEP 320
           + E+E 
Sbjct: 306 DPEDET 311

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  196 bits (499), Expect = 2e-60
 Identities = 116/300 (38%), Positives = 161/300 (53%), Gaps = 18/300 (6%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L Q+G GAYG+V  A D +  G  VA+KKL      +       RE+++LK +  
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRT-GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-- 71

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV    +  DE     YL+  ++  DL   M       LS  KV+ L  Q
Sbjct: 72  -QHENVIGLLDVFTSAVSGDEFQ-DFYLVMPYMQTDLQKIMGH----PLSEDKVQYLVYQ 125

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           ML G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  VVT WYRAP
Sbjct: 126 MLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM--TGYVVTRWYRAP 183

Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           E++LN + Y   VDIWS+GC+MAEM     LF     ++QL  I +V G P   E+ + +
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG-PEFVQKL 242

Query: 261 SLMWS-----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
               +     S  +Y +  FS +F     +A  LLE ML  +   R++A +ALEHPYF  
Sbjct: 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  194 bits (496), Expect = 4e-60
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 31/311 (9%)

Query: 30  IGCGAYGTVFKARDLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G GAYG V  AR+ + ++   VA+KK+    ++  +    LRE+ +L+      H NI 
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR--GHKNIT 65

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
             +D+   +I+    +  +YL  E ++ DL   +    P  L+ +  +    Q+L G+ +
Sbjct: 66  CLYDM---DIVFPGNFNELYLYEELMEADLHQIIRSGQP--LTDAHFQSFIYQILCGLKY 120

Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-----DYDMMLTSVVVTLWYRAPEI 203
           +HS  ++HRDLKP NLL+     LKI DFGLA+ F     +    +T  V T WYRAPEI
Sbjct: 121 IHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180

Query: 204 LL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI-- 260
           +L    Y   +D+WS+GC++AE+    P+F     V+QL  I +V+GTP      E    
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP-----DEETLS 235

Query: 261 ----SLMWS---SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY- 312
                   +   S     K  F +IF +    A  LLE +L F+P  RIS  +ALEHPY 
Sbjct: 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295

Query: 313 --FKEKENEPL 321
             + + ++EP+
Sbjct: 296 AIWHDPDDEPV 306

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  188 bits (479), Expect = 1e-57
 Identities = 114/297 (38%), Positives = 150/297 (50%), Gaps = 20/297 (6%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y +L  +G GA+G V  ARD Q  G  VA+KK+    +   +   T RE+ +LK L   
Sbjct: 11  RYVDLQPVGMGAFGLVCSARD-QLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL--- 66

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            H NI+   D I  + L D     +Y + E +  DL   +   P   L    ++    Q+
Sbjct: 67  RHENIISLSD-IFISPLED-----IYFVTELLGTDLHRLLTSRP---LEKQFIQYFLYQI 117

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           L+G+ ++HS  ++HRDLKP N+LI     LKI DFGLA+  D  M  T  V T +YRAPE
Sbjct: 118 LRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM--TGYVSTRYYRAPE 175

Query: 203 ILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM----NEWP 257
           I+L    Y   VDIWS GC+ AEM    PLF     V Q   I  ++GTP          
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235

Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           EN      S  +   V FS  F +    A  LLE ML F+P  RISAA+AL HPY  
Sbjct: 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  187 bits (475), Expect = 2e-57
 Identities = 117/300 (39%), Positives = 171/300 (57%), Gaps = 21/300 (7%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y++L ++G G+Y TV+K +   N G  VA+K +R++  E+G P + +RE S+LK L   +
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVN-GKLVALKVIRLQ-EEEGTPFTAIREASLLKGL---K 61

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV   D+IH          T+ L+FE+V  DL  YM+K  P GL    VK    Q+L
Sbjct: 62  HANIVLLHDIIHTK-------ETLTLVFEYVHTDLCQYMDK-HPGGLHPENVKLFLFQLL 113

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY-DMMLTSVVVTLWYRAPE 202
           +G+ ++H   I+HRDLKPQNLLI+  G LK+ADFGLA+         ++ VVTLWYR P+
Sbjct: 114 RGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPD 173

Query: 203 ILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE-QLKCIFRVIGTPSMNEWPENI 260
           +LL +  Y T +D+W +GC+  EM + V  F    +++ QL+ IF V+GTP+ + WP   
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233

Query: 261 SLMW---SSFEQYSKVAFSAIF--MDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           SL       F  YS       +  +   + A  L   +L   P +R+SA  AL H YF +
Sbjct: 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  187 bits (477), Expect = 4e-57
 Identities = 105/314 (33%), Positives = 169/314 (53%), Gaps = 28/314 (8%)

Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPM-STLREISIL 76
           DLG  +Y +L  +GCG+ G VF A D  +    VA+KK+ +    D   +   LREI I+
Sbjct: 2   DLG-SRYMDLRPLGCGSNGLVFSAVD-SDCDKRVAVKKIVLT---DPQSVKHALREIKII 56

Query: 77  KQLDTFEHPNIVRFFDVI-------HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG 129
           ++LD   H NIV+ ++V+        +++ S     +VY++ E+++ DL + +E+ P   
Sbjct: 57  RRLD---HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP--- 110

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDM- 187
           LS    +    Q+L+G+ ++HS  ++HRDLKP N+ I T    LKI DFGLA+  D    
Sbjct: 111 LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170

Query: 188 ---MLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKC 243
               L+  +VT WYR+P +LL+   Y   +D+W+ GC+ AEM    PLF  + E+EQ++ 
Sbjct: 171 HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230

Query: 244 IFRVIGTPSMNEWPENISLMWSSFEQYS---KVAFSAIFMDCCSKANSLLESMLTFNPAD 300
           I   +      +  E ++++ S         +     +      +A   LE +LTFNP D
Sbjct: 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMD 290

Query: 301 RISAADALEHPYFK 314
           R++A +AL HPY  
Sbjct: 291 RLTAEEALMHPYMS 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  186 bits (475), Expect = 2e-56
 Identities = 107/302 (35%), Positives = 158/302 (52%), Gaps = 30/302 (9%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
            IG GA+G V+   D ++ G  VA+KK+   + ++   +S  R    LK L  F+H N++
Sbjct: 7   PIGYGAFGVVWSVTDPRD-GKRVALKKM-PNVFQN--LVSCKRVFRELKMLCFFKHDNVL 62

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
              D++    +    +  +Y++ E +  DL   +    P  LS+  VK    Q+L+G+ +
Sbjct: 63  SALDILQPPHID--PFEEIYVVTELMQSDLHKII--VSPQPLSSDHVKVFLYQILRGLKY 118

Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT--FDYDMMLTSVVVTLWYRAPEILLN 206
           LHS  I+HRD+KP NLL+     LKI DFGLA+    D    +T  VVT +YRAPEIL+ 
Sbjct: 119 LHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178

Query: 207 LG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS 265
              Y + VDIWS+GC+ AE+     LF A + ++QL  I  ++GTPS+         M S
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA-------MRS 231

Query: 266 SFE---------QYSKVAFSAIFM---DCCSKANSLLESMLTFNPADRISAADALEHPYF 313
           + E          +   +   ++        +A  LL  ML F+P  RISAADAL HPY 
Sbjct: 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291

Query: 314 KE 315
            E
Sbjct: 292 DE 293

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  180 bits (460), Expect = 4e-56
 Identities = 75/200 (37%), Positives = 118/200 (59%), Gaps = 17/200 (8%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G +GTV+ ARD +  G  VA+K ++ K +   +    LREI ILK+L+   HPNIV+
Sbjct: 1   LGEGGFGTVYLARDKKT-GKKVAIKIIK-KEDSSSLLEELLREIEILKKLN---HPNIVK 55

Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
            + V             +YL+ E+ +   L   +++     LS  ++  +  Q+L+G+++
Sbjct: 56  LYGVFEDE-------NHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEY 107

Query: 149 LHSHRIIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYD-MMLTSVVVTLWYRAPEILLN 206
           LHS+ IIHRDLKP+N+L+    G +K+ADFGL+K    D  +L ++V T  Y APE+LL 
Sbjct: 108 LHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG 167

Query: 207 LG-YGTPVDIWSIGCVMAEM 225
            G Y    DIWS+G ++ E+
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  182 bits (464), Expect = 7e-56
 Identities = 103/317 (32%), Positives = 163/317 (51%), Gaps = 58/317 (18%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY+ L  +G G+YG V K +  +  G  VA+KK     ++  +    +REI +LKQL   
Sbjct: 2   KYENLGLVGEGSYGMVMKCKH-KETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL--- 57

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            H N+V   +V         R   +YL+FE VD  +   +EK P  GL  S+V++   Q+
Sbjct: 58  RHENLVNLIEVF-------RRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQI 109

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-----DYDMMLTSVVVTLW 197
           L+G++F HSH IIHRD+KP+N+L++++G +K+ DFG A+T       Y    T  V T W
Sbjct: 110 LRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY----TDYVATRW 165

Query: 198 YRAPEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT------ 250
           YRAPE+L+ +  YG  VDIW++GC++ EM    PLF   ++++QL  I + +G       
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225

Query: 251 --------------PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTF 296
                         P + E  E +       +++ K++   +          L +  L  
Sbjct: 226 EIFQKNPLFAGMRLPEVKE-IEPLE------KRFPKLSGLVL---------DLAKQCLRI 269

Query: 297 NPADRISAADALEHPYF 313
           +P DR S++  L H +F
Sbjct: 270 DPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  182 bits (463), Expect = 5e-55
 Identities = 116/327 (35%), Positives = 160/327 (48%), Gaps = 37/327 (11%)

Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
              S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL          
Sbjct: 1   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQN-VAIKKLSRPFQNVTHA 59

Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGS--YME 123
               RE+ ++K      H NI+   +V   Q  L +  +  VYL+ E +D +L     M+
Sbjct: 60  KRAYRELVLMK---LVNHKNIIGLLNVFTPQKSLEE--FQDVYLVMELMDANLCQVIQMD 114

Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF 183
                 L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T 
Sbjct: 115 ------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168

Query: 184 DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKC 243
               M+T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF  +  ++Q   
Sbjct: 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK 228

Query: 244 IFRVIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMD-------------CCSKAN 287
           I   +GTPS   M+     +     +  +Y+  +F  +F D               S+A 
Sbjct: 229 IIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQAR 288

Query: 288 SLLESMLTFNPADRISAADALEHPYFK 314
            LL  ML  +P  RIS  DAL+HPY  
Sbjct: 289 DLLSKMLVIDPEKRISVDDALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  181 bits (460), Expect = 1e-54
 Identities = 119/311 (38%), Positives = 167/311 (53%), Gaps = 26/311 (8%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +   
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM--- 73

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q+
Sbjct: 74  KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQK--LTDDHVQFLIYQI 129

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAPE
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPE 187

Query: 203 ILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
           I+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP      E + 
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG----AELLK 243

Query: 262 LMWS--------SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
            + S        S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF
Sbjct: 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303

Query: 314 KE---KENEPL 321
            +    ++EP+
Sbjct: 304 AQYHDPDDEPV 314

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  177 bits (449), Expect = 5e-53
 Identities = 117/307 (38%), Positives = 163/307 (53%), Gaps = 18/307 (5%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D + +   VA+KKL            T RE+ +LK +  
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLR-QKVAVKKLSRPFQSLIHARRTYRELRLLKHM-- 71

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    LS   V+ L  Q
Sbjct: 72  -KHENVIGLLDVFTPAT-SIENFNEVYLVTNLMGADLNNIV-KCQ--KLSDEHVQFLIYQ 126

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP N+ +     L+I DFGLA+  D +M  T  V T WYRAP
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM--TGYVATRWYRAP 184

Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS----MNEW 256
           EI+LN + Y   VDIWS+GC+MAE+ +   LF  +  ++QLK I  V+GTPS        
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244

Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S     +     IF      A  LLE ML  +   RISA++AL HPYF + 
Sbjct: 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304

Query: 316 --KENEP 320
              E+EP
Sbjct: 305 HDPEDEP 311

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  174 bits (443), Expect = 5e-53
 Identities = 80/297 (26%), Positives = 144/297 (48%), Gaps = 45/297 (15%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRV-KLNEDGIPMSTLREISILKQLDT 81
           KY+ + QIG G++G V+  R   + G    +K++ +  ++E     + L E+ ILK+L+ 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSD-GKLYVLKEIDLSNMSEKEREDA-LNEVKILKKLN- 57

Query: 82  FEHPNIVRFFDV-IHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG--LSASKVKE 137
             HPNI+++++    +  L         ++ E+ D  DL   ++K    G      ++ +
Sbjct: 58  --HPNIIKYYESFEEKGKL--------CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD 107

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTL 196
              Q+   + +LHS +I+HRD+KPQN+ +T  G +K+ DFG++K     + +  +VV T 
Sbjct: 108 WFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTP 167

Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW 256
           +Y +PE+  N  Y    DIWS+GCV+ E+  L   F     + +L    +++        
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLEL--ALKIL-----KGQ 219

Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
              I        QYS             +  +L+ S+L  +P +R S A  L+ P+ 
Sbjct: 220 YPPIP------SQYSS------------ELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  172 bits (436), Expect = 7e-51
 Identities = 113/309 (36%), Positives = 158/309 (51%), Gaps = 30/309 (9%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           K+Y +L  IG GA G V  A D    G  VA+KKL              RE+ +LK ++ 
Sbjct: 21  KRYQQLKPIGSGAQGIVCAAFDTV-LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN- 78

Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGS--YMEKCPPPGLSASKVKEL 138
             H NI+   +V   Q  L  E +  VYL+ E +D +L    +ME      L   ++  L
Sbjct: 79  --HKNIISLLNVFTPQKSL--EEFQDVYLVMELMDANLCQVIHME------LDHERMSYL 128

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWY 198
             QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T   + M+T  VVT +Y
Sbjct: 129 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYY 188

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS---MNE 255
           RAPE++L +GY   VDIWS+GC+M E+ +   +F  +  ++Q   +   +GTPS   MN 
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248

Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCC------------SKANSLLESMLTFNPADRIS 303
               +     +  QY  ++F  +F D              S+A  LL  ML  +P  RIS
Sbjct: 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS 308

Query: 304 AADALEHPY 312
             +AL HPY
Sbjct: 309 VDEALRHPY 317

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  168 bits (426), Expect = 1e-49
 Identities = 110/309 (35%), Positives = 156/309 (50%), Gaps = 31/309 (10%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           IG G+YG V  A D  + G  VA+KK+             LREI +L+ L    HP+IV 
Sbjct: 8   IGKGSYGVVCSAID-THTGEKVAIKKINDVFEHVSDATRILREIKLLRLL---RHPDIV- 62

Query: 90  FFDVIHQNILSDER-YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
             ++ H  +    R +  +Y++FE ++ DL   ++      L+    +    Q+L+ + +
Sbjct: 63  --EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHHQFFLYQLLRALKY 118

Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD----MMLTSVVVTLWYRAPEIL 204
           +H+  + HRDLKP+N+L      LKI DFGLA+    D    +  T  V T WYRAPE+ 
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178

Query: 205 LNL--GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
            +    Y   +DIWSIGC+ AE+    PLF     V QL  I  ++GTPS    PE IS 
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS----PETISR 234

Query: 263 M--------WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           +         SS  +   V FS  F +    A  LLE +L F+P DR +A +AL  PYFK
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294

Query: 315 ---EKENEP 320
              + E EP
Sbjct: 295 GLAKVEREP 303

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  167 bits (424), Expect = 3e-49
 Identities = 114/319 (35%), Positives = 161/319 (50%), Gaps = 32/319 (10%)

Query: 16  SLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL             
Sbjct: 5   SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRA 63

Query: 70  LREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
            RE+ ++K ++   H NI+   +V   Q  L  E +  VYL+ E +D +L   ++     
Sbjct: 64  YRELVLMKCVN---HKNIISLLNVFTPQKSL--EEFQDVYLVMELMDANLCQVIQM---- 114

Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174

Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234

Query: 249 GTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESM 293
           GTP    M +    +     +  +Y+ + F  +F D              S+A  LL  M
Sbjct: 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294

Query: 294 LTFNPADRISAADALEHPY 312
           L  +PA RIS  +AL+HPY
Sbjct: 295 LVIDPAKRISVDEALQHPY 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  164 bits (417), Expect = 4e-49
 Identities = 83/299 (27%), Positives = 136/299 (45%), Gaps = 55/299 (18%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
            ++ L +IG G +G V+KAR  +  G  VA+K +  KL         + EI ILK+    
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRT-GKEVAIKVI--KLESKEKKEKIINEIQILKKCK-- 55

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT--- 139
            HPNIV+++    +          ++++ E      GS  +      L  S  + LT   
Sbjct: 56  -HPNIVKYYGSYLKK-------DELWIVMEFCS--GGSLKD------LLKSTNQTLTESQ 99

Query: 140 -----RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
                +++LKG+++LHS+ IIHRD+K  N+L+T  G +K+ DFGL+          ++V 
Sbjct: 100 IAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG 159

Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRVIGTPSM 253
           T ++ APE++    Y    DIWS+G    E+     P      E+  +K +F++    + 
Sbjct: 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYS----ELPPMKALFKI----AT 211

Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
           N  P   +             +S  F D        L+  L  NP  R +A   L+HP+
Sbjct: 212 NGPPGLRNPEK----------WSDEFKD-------FLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  160 bits (408), Expect = 6e-48
 Identities = 86/291 (29%), Positives = 133/291 (45%), Gaps = 48/291 (16%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVK--LNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G++G V   R       Y AMK L+ K  +    +   TL E +IL +++   HP I
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLY-AMKVLKKKKIIKRKEVEH-TLTERNILSRIN---HPFI 55

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+            E  L  YL+ E+    +L S++ K      S  + +    +++  +
Sbjct: 56  VKLHYAFQ-----TEEKL--YLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLAL 106

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT-SVVVTLWYRAPEILL 205
           ++LHS  II+RDLKP+N+L+   G +K+ DFGLAK    +   T +   T  Y APE+LL
Sbjct: 107 EYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL 166

Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS 265
             GYG  VD WS+G ++ EM    P F A    E    I+  I    +  +PE +S    
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE----IYEKILKDPL-RFPEFLS---- 217

Query: 266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE---HPYF 313
                              +A  L+  +L  +P  R+ +  A E   HP+F
Sbjct: 218 ------------------PEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  163 bits (412), Expect = 3e-47
 Identities = 93/312 (29%), Positives = 143/312 (45%), Gaps = 47/312 (15%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG-IPMSTLREISILKQLDT 81
            Y  L ++G G++G V+ ARD +     VA+K L  KL          LREI IL  L+ 
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK----LVALKVLAKKLESKSKEVERFLREIQILASLN- 55

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPG-LSASKVKELT 139
              PNIV+ +D             ++YL+ E+VD   L   ++K    G LS S+   + 
Sbjct: 56  -HPPNIVKLYDFFQDE-------GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFIL 107

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG-LKIADFGLAKTFD-------YDMMLTS 191
            Q+L  +++LHS  IIHRD+KP+N+L+ R G  +K+ DFGLAK             + ++
Sbjct: 108 AQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167

Query: 192 VVVTLWYRAPEILLNLG---YGTPVDIWSIGCVMAEM---WRLVPLFCASTEVEQLKCIF 245
            V T  Y APE+LL L      +  DIWS+G  + E+            S+   Q   I 
Sbjct: 168 SVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII 227

Query: 246 RVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA 305
             + TPS+   P + S      +                 A+ LL+ +L  +P +R+S++
Sbjct: 228 LELPTPSLA-SPLSPSNPELISKA----------------ASDLLKKLLAKDPKNRLSSS 270

Query: 306 DALEHPYFKEKE 317
             L H      +
Sbjct: 271 SDLSHDLLAHLK 282

Length = 384

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  159 bits (402), Expect = 1e-46
 Identities = 101/309 (32%), Positives = 156/309 (50%), Gaps = 41/309 (13%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           K++ L  +G GAYG V K R  + K   VA+KK +     + +  +TLRE   LK L T 
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETK-EIVAIKKFKDSEENEEVKETTLRE---LKMLRTL 57

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           +  NIV   +          R   +YL+FE+V++++   +E+ P  G+   KV+    Q+
Sbjct: 58  KQENIVELKEAF-------RRRGKLYLVFEYVEKNMLELLEEMPN-GVPPEKVRSYIYQL 109

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD--YDMMLTSVVVTLWYRA 200
           +K + + H + I+HRD+KP+NLLI+    LK+ DFG A+      +   T  V T WYR+
Sbjct: 110 IKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRS 169

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           PE+LL   YG  VD+WS+GC++ E+    PLF   +E++QL  I +V+G        E +
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLP----AEQM 225

Query: 261 SLMWS----------------SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA 304
            L +S                S E+      S + +D       L++++L  NP DR   
Sbjct: 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLD-------LMKNLLKLNPTDRYLT 278

Query: 305 ADALEHPYF 313
              L HP F
Sbjct: 279 EQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  160 bits (406), Expect = 2e-46
 Identities = 110/321 (34%), Positives = 162/321 (50%), Gaps = 30/321 (9%)

Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
           N  S+++GD      K+Y  L  IG GA G V  A D   + N VA+KKL          
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67

Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
               RE+ ++K ++   H NI+   +V      S E +  VY++ E +D +L   ++   
Sbjct: 68  KRAYRELVLMKCVN---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLCQVIQM-- 121

Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
              L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T    
Sbjct: 122 --ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179

Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
            M+T  VVT +YRAPE++L +GY   VDIWS+GC+M EM +   LF  +  ++Q   +  
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

Query: 247 VIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLE 291
            +GTP    M +    +     +  +Y+  +F  +F D              S+A  LL 
Sbjct: 240 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 299

Query: 292 SMLTFNPADRISAADALEHPY 312
            ML  + + RIS  +AL+HPY
Sbjct: 300 KMLVIDASKRISVDEALQHPY 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  158 bits (400), Expect = 4e-46
 Identities = 112/327 (34%), Positives = 175/327 (53%), Gaps = 53/327 (16%)

Query: 26  ELCQIGCGAYGTVFKAR--DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           E C++G G YG V+KA+  D ++  +Y A+K++       GI MS  REI++L++L   +
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDY-ALKQIE----GTGISMSACREIALLREL---K 56

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYME-------KCPPPGLSASKVK 136
           HPN++       Q +        V+L+F++ + DL   ++          P  L    VK
Sbjct: 57  HPNVISL-----QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 111

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT----RAGGLKIADFGLAKTFDYDMM---- 188
            L  Q+L G+ +LH++ ++HRDLKP N+L+       G +KIAD G A+ F+  +     
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171

Query: 189 LTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLF-CASTEV-------- 238
           L  VVVT WYRAPE+LL    Y   +DIW+IGC+ AE+    P+F C   ++        
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 231

Query: 239 EQLKCIFRVIGTPSMNEW------PENISLMWSSFEQYSKVAFSAI-FMDCC-----SKA 286
           +QL  IF V+G P+  +W      PE+ +LM   F + +    S I +M+       SKA
Sbjct: 232 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLM-KDFRRNTYTNCSLIKYMEKHKVKPDSKA 290

Query: 287 NSLLESMLTFNPADRISAADALEHPYF 313
             LL+ +LT +P  RI++  A++ PYF
Sbjct: 291 FHLLQKLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  156 bits (395), Expect = 2e-45
 Identities = 114/327 (34%), Positives = 176/327 (53%), Gaps = 53/327 (16%)

Query: 26  ELCQIGCGAYGTVFKAR--DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           E C++G G YG V+KA+  D +++  Y A+K++       GI MS  REI++L++L   +
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKEY-ALKQIE----GTGISMSACREIALLREL---K 56

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYME-------KCPPPGLSASKVK 136
           HPN++    V   +  SD +   V+L+F++ + DL   ++          P  L  S VK
Sbjct: 57  HPNVIALQKVFLSH--SDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK 111

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT----RAGGLKIADFGLAKTFDYDMM---- 188
            L  Q+L G+ +LH++ ++HRDLKP N+L+       G +KIAD G A+ F+  +     
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171

Query: 189 LTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLF-CASTEV-------- 238
           L  VVVT WYRAPE+LL    Y   +DIW+IGC+ AE+    P+F C   ++        
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHH 231

Query: 239 EQLKCIFRVIGTPSMNEW------PENISLMWSSFEQYSKVAFSAI-FMDCC-----SKA 286
           +QL  IF V+G P+  +W      PE  +L    F + +    S I +M+       SK 
Sbjct: 232 DQLDRIFSVMGFPADKDWEDIRKMPEYPTLQ-KDFRRTTYANSSLIKYMEKHKVKPDSKV 290

Query: 287 NSLLESMLTFNPADRISAADALEHPYF 313
             LL+ +LT +P  RI++  AL+ PYF
Sbjct: 291 FLLLQKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  143 bits (364), Expect = 2e-41
 Identities = 89/290 (30%), Positives = 140/290 (48%), Gaps = 49/290 (16%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRV-KLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           IG GA+G V+K  +    G++VA+K++ + K+ E+ +  S ++EI +LK L   +HPNIV
Sbjct: 8   IGRGAFGVVYKGLN-LETGDFVAIKQISLEKIKEEALK-SIMQEIDLLKNL---KHPNIV 62

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELTRQMLKGVD 147
           ++   I          L  Y+I E+ +   GS  +     G    S V     Q+L+G+ 
Sbjct: 63  KYIGSIE-----TSDSL--YIILEYAEN--GSLRQIIKKFGPFPESLVAVYVYQVLQGLA 113

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA-KTFDYDMMLTSVVVTLWYRAPEILLN 206
           +LH   +IHRD+K  N+L T+ G +K+ADFG+A K  D      SVV T ++ APE++  
Sbjct: 114 YLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173

Query: 207 LGYGTPVDIWSIGCVMAEMWRLV---PLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM 263
            G  T  DIWS+GC + E+  L    P +    ++  +  +FR++        PE IS  
Sbjct: 174 SGASTASDIWSLGCTVIEL--LTGNPPYY----DLNPMAALFRIVQDDHP-PLPEGIS-- 224

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
                           M C  K           +P  R +A   L+HP+ 
Sbjct: 225 ---------PELKDFLMQCFQK-----------DPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  141 bits (358), Expect = 2e-40
 Identities = 75/289 (25%), Positives = 144/289 (49%), Gaps = 45/289 (15%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL----REISILKQLDTFEHP 85
           +G G++G+V++  +L + G++ A+K++ +  ++       +    +EI++L +L   +HP
Sbjct: 8   LGSGSFGSVYEGLNLDD-GDFFAVKEVSL-ADDGQTGQEAVKQLEQEIALLSKL---QHP 62

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLK 144
           NIV++          +E  L ++L  E V    L   ++K          ++  TRQ+L 
Sbjct: 63  NIVQYLGTE-----REEDNLYIFL--ELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILL 113

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEIL 204
           G+++LH    +HRD+K  N+L+   G +K+ADFG+AK         S   + ++ APE++
Sbjct: 114 GLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVI 173

Query: 205 LNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM 263
              G YG   DIWS+GC + EM    P +   +++E +  +F++  +  +   P+++S  
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPIPDHLSD- 229

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                                +A   +   L  +P+ R +AA+ LEHP+
Sbjct: 230 ---------------------EAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  140 bits (355), Expect = 7e-40
 Identities = 84/305 (27%), Positives = 139/305 (45%), Gaps = 56/305 (18%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST------LREISIL 76
            Y+ L  IG G++GTV K R   + G  +  K++      D   M+       + E++IL
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRK-SDGKILVWKEI------DYGNMTEKEKQQLVSEVNIL 53

Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSA--S 133
           ++L   +HPNIVR++D I      D    T+Y++ E+ +  DL   ++KC          
Sbjct: 54  REL---KHPNIVRYYDRII-----DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEE 105

Query: 134 KVKELTRQMLKGVDFLH-----SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            +  +  Q+L  +   H      + ++HRDLKP N+ +     +K+ DFGLAK   +D  
Sbjct: 106 FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS 165

Query: 189 LTSVVV-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
                V T +Y +PE L ++ Y    DIWS+GC++ E+  L P F A  +++    +   
Sbjct: 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ----LASK 221

Query: 248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           I        P           +YS            S+ N +++SML  +P  R S  + 
Sbjct: 222 IKEGKFRRIP----------YRYS------------SELNEVIKSMLNVDPDKRPSTEEL 259

Query: 308 LEHPY 312
           L+ P 
Sbjct: 260 LQLPL 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  139 bits (353), Expect = 1e-39
 Identities = 84/300 (28%), Positives = 135/300 (45%), Gaps = 49/300 (16%)

Query: 27  LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +  +G G+ G V+K R  +  G   A+KK+ V  +E+      LRE+  L+     E P 
Sbjct: 6   VKVLGQGSSGVVYKVRH-KPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSC---ESPY 60

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVD----QDLGSYMEKCPPPGLSASKVKELTRQM 142
           +V+ +   ++          + ++ E++D     DL   + K P P L+      + RQ+
Sbjct: 61  VVKCYGAFYKE-------GEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQI 108

Query: 143 LKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT-SVVVTLWYRA 200
           LKG+D+LH+   IIHRD+KP NLLI   G +KIADFG++K  +  +    + V T+ Y +
Sbjct: 109 LKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMS 168

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEM-WRLVPLFCA-STEVEQLKCIFRVIGTPSMNEWPE 258
           PE +    Y    DIWS+G  + E      P          +L     +   P     P 
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA--ICDGPPP-SLPA 225

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN 318
                     ++S       F+  C          L  +P  R SAA+ L+HP+ K+ +N
Sbjct: 226 E---------EFSPEFRD--FISAC----------LQKDPKKRPSAAELLQHPFIKKADN 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  139 bits (352), Expect = 1e-39
 Identities = 87/301 (28%), Positives = 149/301 (49%), Gaps = 52/301 (17%)

Query: 20  GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQL 79
            ++ +D L ++G G+YG+V+KA   +  G  VA+K + V   ED   +   +EISILKQ 
Sbjct: 1   PEEVFDILEKLGEGSYGSVYKAIHKET-GQVVAIKVVPV--EEDLQEII--KEISILKQC 55

Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY---MEKCPPPGLSASKVK 136
           D    P IV+++    +N         ++++ E+     GS    M+      L+  ++ 
Sbjct: 56  D---SPYIVKYYGSYFKNT-------DLWIVMEYCG--AGSVSDIMKITNKT-LTEEEIA 102

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-T 195
            +  Q LKG+++LHS++ IHRD+K  N+L+   G  K+ADFG++      M   + V+ T
Sbjct: 103 AILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGT 162

Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT---PS 252
            ++ APE++  +GY    DIWS+G    EM    P +   +++  ++ IF +I     P+
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPY---SDIHPMRAIF-MIPNKPPPT 218

Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
           +++ PE     WS         F+     C  K           +P +R SA   L+HP+
Sbjct: 219 LSD-PEK----WSP-------EFNDFVKKCLVK-----------DPEERPSAIQLLQHPF 255

Query: 313 F 313
            
Sbjct: 256 I 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  139 bits (351), Expect = 3e-39
 Identities = 78/302 (25%), Positives = 130/302 (43%), Gaps = 65/302 (21%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           IG G +G V+ A +L   G  +A+K++R++ N+         E+ +L+ L    HPN+V+
Sbjct: 8   IGGGTFGKVYTAVNLDT-GELMAVKEIRIQDNDPKTIKEIADEMKVLELLK---HPNLVK 63

Query: 90  FFDV-IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV-KELTRQMLKGVD 147
           ++ V +H+          VY+  E+     G+  E      +    V +  T Q+L+G+ 
Sbjct: 64  YYGVEVHRE--------KVYIFMEYCSG--GTLEELLEHGRILDEHVIRVYTLQLLEGLA 113

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-----TFDYDMMLTSVVVTLWYRAPE 202
           +LHSH I+HRD+KP N+ +   G +K+ DFG A      T      + S+  T  Y APE
Sbjct: 114 YLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173

Query: 203 ILLN---LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           ++      G+G   DIWS+GCV+ EM                       G          
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEM---------------------ATGKRP------- 205

Query: 260 ISLMWSSFEQYSKVAFSAIFMDC---------CSKANSLLESMLTFNPADRISAADALEH 310
               WS  +   ++ F                  +    L+  L  +P  R +A++ L+H
Sbjct: 206 ----WSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261

Query: 311 PY 312
           P+
Sbjct: 262 PF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  134 bits (340), Expect = 1e-37
 Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 19/206 (9%)

Query: 27  LCQIGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
             ++G GA+G V+K             VA+K L+   +E  I    LRE  I+++LD   
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI-EEFLREARIMRKLD--- 59

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQM 142
           HPNIV+   V       +E      ++ E++   DL  Y+ K  P  LS S +     Q+
Sbjct: 60  HPNIVKLLGVC----TEEEPL---MIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQI 112

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL---WYR 199
            +G+++L S   IHRDL  +N L+     +KI+DFGL++    D         L   W  
Sbjct: 113 ARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM- 171

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEM 225
           APE L    + +  D+WS G ++ E+
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEI 197

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  133 bits (336), Expect = 7e-37
 Identities = 96/321 (29%), Positives = 155/321 (48%), Gaps = 67/321 (20%)

Query: 15  DSLDLGD--KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRV-KLNEDGIPMSTLR 71
           D +  GD  + Y  L +IG GA G V+KA D    G  VA+KK+R+ K N++ I    + 
Sbjct: 10  DIVSEGDPRELYKNLEKIGEGASGEVYKATDRA-TGKEVAIKKMRLRKQNKELI----IN 64

Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYL---TVYLIFEHVDQ-DLGSYMEKCPP 127
           EI I+K     +HPNIV ++D           YL    ++++ E++D   L   + +   
Sbjct: 65  EILIMKDC---KHPNIVDYYDS----------YLVGDELWVVMEYMDGGSLTDIITQNFV 111

Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM 187
             ++  ++  + R++L+G+++LHS  +IHRD+K  N+L+++ G +K+ADFG A       
Sbjct: 112 R-MNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQ----- 165

Query: 188 MLT-------SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQ 240
            LT       SVV T ++ APE++    YG  VDIWS+G +  EM    P +        
Sbjct: 166 -LTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY---LREPP 221

Query: 241 LKCIFRVI--GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNP 298
           L+ +F +   G P +   PE     WS                   +    L   L  +P
Sbjct: 222 LRALFLITTKGIPPLKN-PEK----WS------------------PEFKDFLNKCLVKDP 258

Query: 299 ADRISAADALEHPYFKEKENE 319
             R SA + L+HP+ K+   +
Sbjct: 259 EKRPSAEELLQHPFLKKACPK 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  129 bits (326), Expect = 1e-35
 Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 28/210 (13%)

Query: 27  LCQIGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
             ++G GA+G V+K +     G     VA+K L+   +E  I    LRE  I+++LD   
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI-EEFLREARIMRKLD--- 59

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQM 142
           HPN+V+   V       +E     Y++ E+++  DL SY+ K  P  LS S +     Q+
Sbjct: 60  HPNVVKLLGVC----TEEEPL---YIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQI 111

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMMLTSVVVTL----- 196
            +G+++L S   IHRDL  +N L+     +KI+DFGL++  +D D               
Sbjct: 112 ARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY----RKRGGKLPI 167

Query: 197 -WYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            W  APE L    + +  D+WS G ++ E+
Sbjct: 168 RWM-APESLKEGKFTSKSDVWSFGVLLWEI 196

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  125 bits (315), Expect = 4e-34
 Identities = 79/293 (26%), Positives = 139/293 (47%), Gaps = 48/293 (16%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ----LDTFEHP 85
           +G GA+G V+   D+ + G  +A+K  +V  + D     T +E++ L+     L   +H 
Sbjct: 10  LGQGAFGRVYLCYDV-DTGRELAVK--QVPFDPDS--PETKKEVNALECEIQLLKNLQHE 64

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELTRQMLK 144
            IV+++       L D+  L++++ +       GS  ++    G L+ +  ++ TRQ+L+
Sbjct: 65  RIVQYY-----GCLRDDETLSIFMEY----MPGGSVKDQLKAYGALTETVTRKYTRQILE 115

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM----LTSVVVTLWYRA 200
           GV++LHS+ I+HRD+K  N+L   AG +K+ DFG +K           + SV  T ++ +
Sbjct: 116 GVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           PE++   GYG   D+WS+GC + EM    P +    E E +  IF++   P+  + P ++
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPQLPSHV 232

Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
           S                        A + L      N   R SA + L H + 
Sbjct: 233 S----------------------PDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  125 bits (315), Expect = 5e-34
 Identities = 87/303 (28%), Positives = 137/303 (45%), Gaps = 58/303 (19%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL--RVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           I  GAYG VF A+  ++ G+  A+K +     + ++ +    L E  IL Q    + P +
Sbjct: 1   ISKGAYGRVFLAKK-KSTGDIYAIKVIKKADMIRKNQVD-QVLTERDILSQ---AQSPYV 55

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEK--CPPPGLSASKVKELTRQMLK 144
           V+ +          ++ L  YL+ E++   DL S +E        L     +    +++ 
Sbjct: 56  VKLYYSF-----QGKKNL--YLVMEYLPGGDLASLLENVGS----LDEDVARIYIAEIVL 104

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS---------VVVT 195
            +++LHS+ IIHRDLKP N+LI   G LK+ DFGL+K       +           +V T
Sbjct: 105 ALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
             Y APE++L  G+   VD WS+GC++ E    +P F   T  E    IF+ I    + E
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----IFQNILNGKI-E 219

Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE---HPY 312
           WPE++ +        S  A              L+  +L  +P  R+ A    E   HP+
Sbjct: 220 WPEDVEV--------SDEAI------------DLISKLLVPDPEKRLGAKSIEEIKNHPF 259

Query: 313 FKE 315
           FK 
Sbjct: 260 FKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  124 bits (312), Expect = 1e-33
 Identities = 71/226 (31%), Positives = 111/226 (49%), Gaps = 31/226 (13%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPM--------STLREISI 75
           Y  L  +G GA+G V+K R   N  N +A+K++ V     G             + E++I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLI--------FEHVDQDLGSYMEKCPP 127
           +K+     HPNIVR++    +N   D  Y+ + LI        F  + +    + E+   
Sbjct: 62  IKE--QLRHPNIVRYYKTFLEN---DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE--- 113

Query: 128 PGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
                 ++  +  QM+  + +LH   RI+HRDL P N+++     + I DFGLAK    +
Sbjct: 114 ------RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE 167

Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLF 232
             LTSVV T+ Y  PEI+ N  YG   D+W+ GC++ +M  L P F
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 2e-33
 Identities = 88/303 (29%), Positives = 142/303 (46%), Gaps = 53/303 (17%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
            + Y+ + +IG G YG V+KARD+   G  VA+K   +KL          +EIS+LK+  
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIAT-GELVAIKV--IKLEPGDDFEIIQQEISMLKECR 58

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD----QDLGSYMEKCPPPGLSASKVK 136
              HPNIV +F        S  R   ++++ E+      QD+  Y     P  LS  ++ 
Sbjct: 59  ---HPNIVAYFG-------SYLRRDKLWIVMEYCGGGSLQDI--YQVTRGP--LSELQIA 104

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM-LTSVVVT 195
            + R+ LKG+ +LH    IHRD+K  N+L+T  G +K+ADFG++      +    S + T
Sbjct: 105 YVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGT 164

Query: 196 LWYRAPEIL---LNLGYGTPVDIWSIGCV---MAEMWRLVPLFCASTEVEQLKCIFRVIG 249
            ++ APE+       GY    DIW++G     +AE+    P+F    ++  ++ +F +  
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIELAEL--QPPMF----DLHPMRALFLI-- 216

Query: 250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE 309
               N  P          E++S V     F+  C          LT +P  R +A   L+
Sbjct: 217 -SKSNFPPP----KLKDKEKWSPVFHD--FIKKC----------LTKDPKKRPTATKLLQ 259

Query: 310 HPY 312
           HP+
Sbjct: 260 HPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 2e-33
 Identities = 84/295 (28%), Positives = 151/295 (51%), Gaps = 47/295 (15%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G GA+G V+KA+  +  G + A K ++++  E+        EI IL      +HPNIV
Sbjct: 12  ELGDGAFGKVYKAQH-KETGLFAAAKIIQIESEEELEDFMV--EIDILS---ECKHPNIV 65

Query: 89  RFFDV-IHQNILSDERYLTVYLIFEHVDQD-LGSYMEKCPPPGLSASKVKELTRQMLKGV 146
             ++   ++N L        +++ E  D   L S M +     L+  +++ + RQML+ +
Sbjct: 66  GLYEAYFYENKL--------WILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEAL 116

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL-AKTFDYDMMLTSVVVTLWYRAPEILL 205
           +FLHSH++IHRDLK  N+L+T  G +K+ADFG+ AK         + + T ++ APE++ 
Sbjct: 117 NFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA 176

Query: 206 -----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
                +  Y    DIWS+G  + E+ ++ P      E+  ++ + +++ +          
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEP---PHHELNPMRVLLKILKSEP-------- 225

Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
                + +Q SK  +S+ F D        L+S L  +P DR +AA+ L+HP+  +
Sbjct: 226 ----PTLDQPSK--WSSSFND-------FLKSCLVKDPDDRPTAAELLKHPFVSD 267

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  123 bits (310), Expect = 4e-33
 Identities = 79/314 (25%), Positives = 129/314 (41%), Gaps = 72/314 (22%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           IG G++ TV  A++ +      A+K L + +L ++        E  +L +L+   HP I+
Sbjct: 9   IGEGSFSTVVLAKEKET-NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN--GHPGII 65

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + +         DE  L  Y + E+    +L  Y+ K     L     +    ++L  ++
Sbjct: 66  KLYYTFQ-----DEENL--YFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALE 116

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM------------------- 188
           +LHS  IIHRDLKP+N+L+ +   +KI DFG AK  D +                     
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 189 --LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
               S V T  Y +PE+L     G   D+W++GC++ +M    P F  S E       F+
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----TFQ 232

Query: 247 VIGTPSMN---EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS 303
            I    +     +P N               F     D       L+E +L  +P DR+ 
Sbjct: 233 KI----LKLEYSFPPN---------------FPPDAKD-------LIEKLLVLDPQDRLG 266

Query: 304 AADALE----HPYF 313
             +  +    HP+F
Sbjct: 267 VNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  122 bits (308), Expect = 6e-33
 Identities = 95/301 (31%), Positives = 144/301 (47%), Gaps = 56/301 (18%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR--------EISILKQLDT 81
           IG G YG V+ A ++   G  +A+K++ +     G   S  +        EI  LK LD 
Sbjct: 9   IGKGTYGRVYLALNVTT-GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD- 66

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIF-EHVDQ-DLGSYMEKCPPPGLSASKVKELT 139
             H NIV++        L  E       IF E+V    +GS +            V+  T
Sbjct: 67  --HLNIVQY--------LGFETTEEYLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFT 114

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD--YD-MMLTSVVVTL 196
            Q+L+G+ +LHS  I+HRDLK  NLL+   G  KI+DFG++K  D  YD     S+  ++
Sbjct: 115 EQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174

Query: 197 WYRAPEILLN--LGYGTPVDIWSIGCVMAEMW---RLVPLFCASTEVEQLKCIFRVIGTP 251
           ++ APE++ +   GY   VDIWS+GCV+ EM+   R  P    S E E +  +F++    
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR--PW---SDE-EAIAAMFKLGNKR 228

Query: 252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
           S    P ++S+        S VA    F++ C           T NP +R +A + L+HP
Sbjct: 229 SAPPIPPDVSM------NLSPVALD--FLNAC----------FTINPDNRPTARELLQHP 270

Query: 312 Y 312
           +
Sbjct: 271 F 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  124 bits (312), Expect = 2e-32
 Identities = 90/293 (30%), Positives = 149/293 (50%), Gaps = 17/293 (5%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           IG G++G V++A  + +    VA+KK+     +D  P    RE+ I+K L+   H NI+ 
Sbjct: 74  IGNGSFGVVYEAICI-DTSEKVAIKKVL----QD--PQYKNRELLIMKNLN---HINIIF 123

Query: 90  FFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCP--PPGLSASKVKELTRQMLKGV 146
             D  + +    +E+ + + ++ E + Q +  YM+        L    VK  + Q+ + +
Sbjct: 124 LKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183

Query: 147 DFLHSHRIIHRDLKPQNLLIT-RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL 205
            ++HS  I HRDLKPQNLLI      LK+ DFG AK         S + + +YRAPE++L
Sbjct: 184 AYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELML 243

Query: 206 -NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE-NISLM 263
               Y T +D+WS+GC++AEM    P+F   + V+QL  I +V+GTP+ ++  E N +  
Sbjct: 244 GATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA 303

Query: 264 WSSFEQYSKVAFSAIF-MDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
              F          +F       A + +   L + P  R++  +AL  P+F +
Sbjct: 304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356

Length = 440

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  119 bits (300), Expect = 7e-32
 Identities = 88/307 (28%), Positives = 149/307 (48%), Gaps = 72/307 (23%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP--------MSTL-REISILKQLD 80
           IG G++G+V+   +  + G  +A+K+  V+L              +  L REI++LK+L 
Sbjct: 8   IGSGSFGSVYLGMNASS-GELMAVKQ--VELPSVSASSKDRKRSMLDALAREIALLKEL- 63

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPPGLSA 132
             +H NIV++          D  +L ++L  E+V          + G++ E         
Sbjct: 64  --QHENIVQYLGSS-----LDADHLNIFL--EYVPGGSVAALLNNYGAFEE--------- 105

Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT-- 190
           + V+   RQ+LKG+++LH+  IIHRD+K  N+L+   GG+KI+DFG++K  + + + T  
Sbjct: 106 TLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKT 165

Query: 191 -----SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIF 245
                S+  ++++ APE++    Y    DIWS+GC++ EM      F    +  QL+ IF
Sbjct: 166 NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF---PDCTQLQAIF 222

Query: 246 RVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA 305
           + IG  +  E P NIS                      S+A   LE     +   R +AA
Sbjct: 223 K-IGENASPEIPSNIS----------------------SEAIDFLEKTFEIDHNKRPTAA 259

Query: 306 DALEHPY 312
           + L+HP+
Sbjct: 260 ELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  118 bits (299), Expect = 1e-31
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 21/207 (10%)

Query: 27  LCQIGCGAYGTVFKAR---DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
             ++G GA+G V+K     D +     VA+K L+   +E+      L E SI+K+L    
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER-EEFLEEASIMKKLS--- 59

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQM 142
           HPNIVR   V      +    L  Y++ E++   DL  ++ K     L+   + ++  Q+
Sbjct: 60  HPNIVRLLGVC-----TQGEPL--YIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQI 111

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT---FDYDMMLTSVVVTL-WY 198
            KG+++L S   +HRDL  +N L+T    +KI+DFGL++     DY        + + W 
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM 171

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEM 225
            APE L +  + +  D+WS G ++ E+
Sbjct: 172 -APESLKDGKFTSKSDVWSFGVLLWEI 197

Length = 258

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  116 bits (294), Expect = 1e-30
 Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 23/201 (11%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQLDTFEHP 85
           +G G++G V   R  +  G Y A+K L     VKL +       L E  IL+ +    HP
Sbjct: 9   LGTGSFGRVMLVR-HKGSGKYYALKILSKAKIVKLKQV---EHVLNEKRILQSIR---HP 61

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLK 144
            +V  +         D+  L  YL+ E+V   +L S++ K        ++      Q++ 
Sbjct: 62  FLVNLYGSFQ-----DDSNL--YLVMEYVPGGELFSHLRKSGRFPEPVARF--YAAQVVL 112

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEIL 204
            +++LHS  I++RDLKP+NLL+   G +KI DFG AK         ++  T  Y APEI+
Sbjct: 113 ALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY--TLCGTPEYLAPEII 170

Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
           L+ GYG  VD W++G ++ EM
Sbjct: 171 LSKGYGKAVDWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  115 bits (289), Expect = 2e-30
 Identities = 92/298 (30%), Positives = 148/298 (49%), Gaps = 59/298 (19%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR---------EISILKQL 79
           ++G G++GTV+  +D +      A ++L+V L E  IP+  L          E  +L +L
Sbjct: 7   RLGKGSFGTVYLVKDKKAV----AEERLKV-LKE--IPVGELNPNETVQANQEAQLLSKL 59

Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG--LSASKVKE 137
           D   HP IV+F    H + L  + +  +    E   +DL   +E+    G  LS ++V E
Sbjct: 60  D---HPAIVKF----HASFLERDAFCIITEYCE--GRDLDCKLEELKHTGKTLSENQVCE 110

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML-TSVVVTL 196
              Q+L GV ++H  RI+HRDLK +N+ + +   LKI DFG+++       L T+   T 
Sbjct: 111 WFIQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTP 169

Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI--GTPSMN 254
           +Y +PE L + GY +  DIWS+GC++ EM  L   F        L  + R++   TPS+ 
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---FLSVVLRIVEGPTPSLP 226

Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                        E YS+            + NS+++SML  +P+ R SAA+ L +P+
Sbjct: 227 -------------ETYSR------------QLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  115 bits (289), Expect = 3e-30
 Identities = 85/303 (28%), Positives = 142/303 (46%), Gaps = 58/303 (19%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKL---RVKLNEDGIPMSTLR-EISILKQLDTFEH 84
           Q+G GA+ + ++ARD++  G  +A+K++   R   +E    +  LR EI ++ +L+   H
Sbjct: 7   QLGTGAFSSCYQARDVKT-GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN---H 62

Query: 85  PNIVRFFDVI----HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
           P+I+R         H N+  +  ++    +  H+    G++ E         + +   T 
Sbjct: 63  PHIIRMLGATCEDSHFNLFVE--WMAGGSV-SHLLSKYGAFKE---------AVIINYTE 110

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYDMMLT-----SVVV 194
           Q+L+G+ +LH ++IIHRD+K  NLLI   G  L+IADFG A                ++ 
Sbjct: 111 QLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLG 170

Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV---IGTP 251
           T+ + APE+L    YG   D+WS+GCV+ EM    P + A      L  IF++      P
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230

Query: 252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
           S+   PE++S                + + C       LE      P DR  + + L+HP
Sbjct: 231 SI---PEHLS-----------PGLRDVTLRC-------LEL----QPEDRPPSRELLKHP 265

Query: 312 YFK 314
            F+
Sbjct: 266 VFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  115 bits (289), Expect = 3e-30
 Identities = 82/296 (27%), Positives = 118/296 (39%), Gaps = 57/296 (19%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           IG GA+G V   +    K    AMK + + K  E G   + L E  IL++L    HP +V
Sbjct: 8   IGKGAFGKVCIVQKRDTK-KMFAMKYMNKQKCVEKGSVRNVLNERRILQEL---NHPFLV 63

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLG-------SYMEKCPPPGLSASKVKELTRQ 141
             +         DE  +  YL+   VD  LG       S   K      S  +VK    +
Sbjct: 64  NLW-----YSFQDEENM--YLV---VDLLLGGDLRYHLSQKVK-----FSEEQVKFWICE 108

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           ++  +++LHS  IIHRD+KP N+L+   G + I DF +A     D + TS   T  Y AP
Sbjct: 109 IVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAP 168

Query: 202 EILLNLGYGTPVDIWSIGCVMAEMWR-LVPL-FCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           E+L   GY   VD WS+G    E  R   P    + T  +Q++             W   
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWS-- 226

Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA--DALEHPYF 313
                                   ++A   +  +L  +P  R+     D   HPYF
Sbjct: 227 ------------------------TEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  115 bits (289), Expect = 3e-30
 Identities = 81/289 (28%), Positives = 137/289 (47%), Gaps = 43/289 (14%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G YG V+ ARDL  +   +A+K++  + +    P+    EI++   L   +H NIV+
Sbjct: 16  LGKGTYGIVYAARDLSTQVR-IAIKEIPERDSRYVQPLH--EEIALHSYL---KHRNIVQ 69

Query: 90  FFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYME-KCPPPGLSASKVKELTRQMLKGVD 147
           +     +N      +  +++  E V    L + +  K  P   +   +   T+Q+L+G+ 
Sbjct: 70  YLGSDSEN-----GFFKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLK 122

Query: 148 FLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTF-DYDMMLTSVVVTLWYRAPEILL 205
           +LH ++I+HRD+K  N+L+ T +G +KI+DFG +K     +    +   TL Y APE++ 
Sbjct: 123 YLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVID 182

Query: 206 N--LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM 263
               GYG P DIWS+GC + EM    P F    E +    +F+V       E PE++S  
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKVGMFKIHPEIPESLSA- 239

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                                +A + +      +P  R SA D L+ P+
Sbjct: 240 ---------------------EAKNFILRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  114 bits (288), Expect = 4e-30
 Identities = 73/293 (24%), Positives = 126/293 (43%), Gaps = 47/293 (16%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V   +  ++K    A+K + +  + E G       E  IL++ +   HP IV
Sbjct: 1   LGVGGFGRVELVKV-KSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN---HPFIV 56

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPG-LSASKVKELTRQMLKGV 146
           + +         D++Y  +Y++ E+    +L + +      G       +     ++   
Sbjct: 57  KLY-----RTFKDKKY--IYMLMEYCLGGELWTILRD---RGLFDEYTARFYIACVVLAF 106

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN 206
           ++LH+  II+RDLKP+NLL+   G +K+ DFG AK         +   T  Y APEI+LN
Sbjct: 107 EYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN 166

Query: 207 LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI-GTPSMNEWPENISLMWS 265
            GY   VD WS+G ++ E+    P F    + + ++ I+  I       E+P  I     
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME-IYNDILKGNGKLEFPNYID---- 220

Query: 266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYF 313
                               A  L++ +L  NP +R+        D  +H +F
Sbjct: 221 ------------------KAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  115 bits (289), Expect = 5e-30
 Identities = 81/304 (26%), Positives = 144/304 (47%), Gaps = 42/304 (13%)

Query: 18  DLGDKKY--DELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISI 75
           D GD +   D   +IG G+ G V  A D    G  VA+KK+ ++  +    +    E+ I
Sbjct: 13  DPGDPRSYLDNFVKIGEGSTGIVCIATDKST-GRQVAVKKMDLRKQQRRELL--FNEVVI 69

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           ++    ++HPNIV  +      ++ DE    ++++ E ++   G+  +      ++  ++
Sbjct: 70  MRD---YQHPNIVEMYS---SYLVGDE----LWVVMEFLEG--GALTDIVTHTRMNEEQI 117

Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVV 194
             +   +LK + FLH+  +IHRD+K  ++L+T  G +K++DFG       ++    S+V 
Sbjct: 118 ATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVG 177

Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
           T ++ APE++  L YGT VDIWS+G ++ EM    P +     ++ +K I R    P + 
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-RDNLPPKLK 236

Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
                +S    SF                      L+ ML  +PA R +AA+ L HP+  
Sbjct: 237 N-LHKVSPRLRSF----------------------LDRMLVRDPAQRATAAELLNHPFLA 273

Query: 315 EKEN 318
           +   
Sbjct: 274 KAGP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  113 bits (286), Expect = 8e-30
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 26/211 (12%)

Query: 29  QIGCGAYGTVFKA--RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           ++G GA+G V+K   +    K   VA+K L+   +E+      L+E  ++K+L    HPN
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDF-LKEARVMKKLG---HPN 57

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML-- 143
           +VR   V  +          +YL+ E+++  DL  Y+ K  P   S  K     + +L  
Sbjct: 58  VVRLLGVCTEEE-------PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110

Query: 144 -----KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT---FDYDMMLTSVVVT 195
                KG+++L S + +HRDL  +N L+     +KI+DFGL++     DY    T   + 
Sbjct: 111 AIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP 170

Query: 196 L-WYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           + W  APE L +  + +  D+WS G ++ E+
Sbjct: 171 IRWM-APESLKDGIFTSKSDVWSFGVLLWEI 200

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  113 bits (284), Expect = 2e-29
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 28/213 (13%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRV------KLNEDGIPMSTLREISILK 77
           +    +IG G +  V+KA  L + G  VA+KK+++      K  +D      L+EI +LK
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLD-GRVVALKKVQIFEMMDAKARQD-----CLKEIDLLK 57

Query: 78  QLDTFEHPNIVRFFD-VIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG--LSAS 133
           QLD   HPN++++    I  N L+        ++ E  D  DL   ++        +   
Sbjct: 58  QLD---HPNVIKYLASFIENNELN--------IVLELADAGDLSRMIKHFKKQKRLIPER 106

Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT-SV 192
            + +   Q+   ++ +HS RI+HRD+KP N+ IT  G +K+ D GL + F        S+
Sbjct: 107 TIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 166

Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           V T +Y +PE +   GY    DIWS+GC++ EM
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 3e-29
 Identities = 84/295 (28%), Positives = 131/295 (44%), Gaps = 53/295 (17%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH----- 84
           I  GA+G+V+ A+  ++ G+Y A+K L+ K +     M    +++ +K            
Sbjct: 4   ISKGAFGSVYLAKK-RSTGDYFAIKVLK-KSD-----MIAKNQVTNVKAERAIMMIQGES 56

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P + + +          + YL  YL+ E+++  D  S ++      L     K+   +++
Sbjct: 57  PYVAKLYYS-----FQSKDYL--YLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVV 107

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            GV+ LH   IIHRD+KP+NLLI + G LK+ DFGL++     +     V T  Y APE 
Sbjct: 108 LGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPET 164

Query: 204 LLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIF-RVIGTPSMNEWPENISL 262
           +L +G     D WS+GCV+ E     P F A T       I  R I       WPE    
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN------WPEE--- 215

Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE---HPYFK 314
                          +   C  +A  L+  +L  +PA R+ A    E   HP+FK
Sbjct: 216 ---------------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  109 bits (275), Expect = 2e-28
 Identities = 72/293 (24%), Positives = 120/293 (40%), Gaps = 55/293 (18%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G+YG+V+K + L +   Y A+K++ +           + EI IL  +    HPNI+
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFY-ALKEVDLGSMSQKEREDAVNEIRILASV---NHPNII 62

Query: 89  RFFDV-IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTR------ 140
            + +  +  N L         ++ E+    DL   + K         K K +        
Sbjct: 63  SYKEAFLDGNKL--------CIVMEYAPFGDLSKAISK------RKKKRKLIPEQEIWRI 108

Query: 141 --QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWY 198
             Q+L+G+  LH  +I+HRDLK  N+L+     +KI D G++K      M  + + T  Y
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK-KNMAKTQIGTPHY 167

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
            APE+     Y    DIWS+GC++ EM    P F A + ++ L+  ++V           
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLR--YKVQRG-------- 216

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                           +  I         + + SML   P  R +    L  P
Sbjct: 217 ---------------KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  109 bits (274), Expect = 5e-28
 Identities = 87/301 (28%), Positives = 146/301 (48%), Gaps = 42/301 (13%)

Query: 17  LDLGD--KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           + +GD  KKY    +IG GA GTVF A D+   G  VA+K+  + L +       + EI 
Sbjct: 12  VSIGDPKKKYTRYEKIGQGASGTVFTAIDVA-TGQEVAIKQ--INLQKQPKKELIINEIL 68

Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           ++K+L   ++PNIV F D     ++ DE    ++++ E++    GS  +      +  ++
Sbjct: 69  VMKEL---KNPNIVNFLD---SFLVGDE----LFVVMEYLAG--GSLTDVVTETCMDEAQ 116

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +  + R+ L+ ++FLH++++IHRD+K  N+L+   G +K+ DFG       +    S +V
Sbjct: 117 IAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176

Query: 195 -TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++    YG  VDIWS+G +  EM    P +     +  L  I    GTP +
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPEL 235

Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
              PE +S ++  F                      L   L  +   R SA + L+HP+ 
Sbjct: 236 QN-PEKLSPIFRDF----------------------LNRCLEMDVEKRGSAKELLQHPFL 272

Query: 314 K 314
           K
Sbjct: 273 K 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  109 bits (272), Expect = 7e-28
 Identities = 75/242 (30%), Positives = 127/242 (52%), Gaps = 26/242 (10%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN--EDGIPMSTLR-EISILKQLDTFEHPN 86
           +G GA+G V+   D+ + G  +A K+++      E    +S L  EI +LK L   +H  
Sbjct: 10  LGQGAFGRVYLCYDV-DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL---QHER 65

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFE---HVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           IV+++  +       E+ LT+++ +     V   L +Y        L+ S  ++ TRQ+L
Sbjct: 66  IVQYYGCLRDR---AEKTLTIFMEYMPGGSVKDQLKAY------GALTESVTRKYTRQIL 116

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM----LTSVVVTLWYR 199
           +G+ +LHS+ I+HRD+K  N+L   AG +K+ DFG +K      M    + SV  T ++ 
Sbjct: 117 EGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           +PE++   GYG   D+WS+GC + EM    P +    E E +  IF++   P+  + P +
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTNPQLPSH 233

Query: 260 IS 261
           IS
Sbjct: 234 IS 235

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  108 bits (271), Expect = 2e-27
 Identities = 91/319 (28%), Positives = 139/319 (43%), Gaps = 63/319 (19%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +K  EL ++G GA G+V K R     G   A+K +    N D +    LRE+ I K   +
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNT-GMIFALKTITTDPNPD-LQKQILRELEINK---S 55

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSAS-----KV 135
            + P IV+++         DE   ++ +  E+ +   L S  +K    G         K+
Sbjct: 56  CKSPYIVKYY-----GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKI 110

Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG--------LAKTFDYDM 187
            E    +LKG+ +LHS +IIHRD+KP N+L+TR G +K+ DFG        LA TF    
Sbjct: 111 AE---SVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF---- 163

Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE-----VEQLK 242
                  T +Y APE +    Y    D+WS+G  + E+ +    F    E     +E L 
Sbjct: 164 -----TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS 218

Query: 243 CIFRVIGTPSMNEWPENISLMWS-SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADR 301
            I   +  P + + P N  + WS  F+          F+  C          L  +P  R
Sbjct: 219 YIVN-MPNPELKDEPGN-GIKWSEEFKD---------FIKQC----------LEKDPTRR 257

Query: 302 ISAADALEHPYFKEKENEP 320
            +  D LEHP+ K +  + 
Sbjct: 258 PTPWDMLEHPWIKAQMKKK 276

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  108 bits (271), Expect = 2e-27
 Identities = 84/297 (28%), Positives = 141/297 (47%), Gaps = 44/297 (14%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL--REISILKQ 78
            KKY    +IG GA GTV+ A D+   G  VA+K++ ++      P   L   EI ++++
Sbjct: 18  KKKYTRFEKIGQGASGTVYTAIDVAT-GQEVAIKQMNLQQQ----PKKELIINEILVMRE 72

Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
               +HPNIV + D     ++ DE    ++++ E++    GS  +      +   ++  +
Sbjct: 73  N---KHPNIVNYLD---SYLVGDE----LWVVMEYLAG--GSLTDVVTETCMDEGQIAAV 120

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLW 197
            R+ L+ ++FLHS+++IHRD+K  N+L+   G +K+ DFG       +    S +V T +
Sbjct: 121 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           + APE++    YG  VDIWS+G +  EM    P +     +  L  I    GTP +   P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPELQN-P 238

Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           E +S ++  F                      L   L  +   R SA + L+HP+ K
Sbjct: 239 EKLSAIFRDF----------------------LNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  109 bits (273), Expect = 2e-27
 Identities = 94/303 (31%), Positives = 139/303 (45%), Gaps = 50/303 (16%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILK 77
           K +  L Q+G G YG VF A+  ++ G  VA+K+++     KLNE    + T R+I    
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKK-KDTGEIVALKRMKKSLLFKLNEVR-HVLTERDI---- 54

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVK 136
            L T +   +V+           D+ YL  YL  E+V   D  + +       LS    +
Sbjct: 55  -LTTTKSEWLVKLL-----YAFQDDEYL--YLAMEYVPGGDFRTLL--NNLGVLSEDHAR 104

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT---SVV 193
               +M + VD LH    IHRDLKP+N LI  +G +K+ DFGL+K       +T   SVV
Sbjct: 105 FYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI-----VTYANSVV 159

Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            +  Y APE+L   GY   VD WS+GC++ E     P F  ST  E  + +         
Sbjct: 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY------- 212

Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-SAADALEHPY 312
             W E  +L    ++   +   S        +A  L+  ++  +P+ R  S  D   HP+
Sbjct: 213 --WKE--TLQRPVYDD-PRFNLS-------DEAWDLITKLIN-DPSRRFGSLEDIKNHPF 259

Query: 313 FKE 315
           FKE
Sbjct: 260 FKE 262

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  107 bits (268), Expect = 4e-27
 Identities = 87/301 (28%), Positives = 145/301 (48%), Gaps = 42/301 (13%)

Query: 17  LDLGD--KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           + +GD  KKY    +IG GA GTV+ A D+   G  VA+K++   L +       + EI 
Sbjct: 12  VSVGDPKKKYTRFEKIGQGASGTVYTAIDIAT-GQEVAIKQM--NLQQQPKKELIINEIL 68

Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           ++++    ++PNIV + D     ++ DE    ++++ E++    GS  +      +   +
Sbjct: 69  VMRE---NKNPNIVNYLD---SYLVGDE----LWVVMEYLAG--GSLTDVVTETCMDEGQ 116

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +  + R+ L+ +DFLHS+++IHRD+K  N+L+   G +K+ DFG       +    S +V
Sbjct: 117 IAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176

Query: 195 -TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++    YG  VDIWS+G +  EM    P +     +  L  I    GTP +
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPEL 235

Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
              PE +               SA+F D        L   L  +   R SA + L+HP+ 
Sbjct: 236 QN-PERL---------------SAVFRD-------FLNRCLEMDVDRRGSAKELLQHPFL 272

Query: 314 K 314
           K
Sbjct: 273 K 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 8e-27
 Identities = 76/308 (24%), Positives = 135/308 (43%), Gaps = 68/308 (22%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL-REISILKQLD 80
           + +  L  IG G++G V+KA D +     VA+K   + L E    +  + +EI  L Q  
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRT-NQVVAIKV--IDLEEAEDEIEDIQQEIQFLSQCR 57

Query: 81  TFEHPNIVRFFDVIHQNILSDERYL---TVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE 137
           +   P I +++            +L    +++I E+     GS ++   P  L  + +  
Sbjct: 58  S---PYITKYY----------GSFLKGSKLWIIMEYCGG--GSCLDLLKPGKLDETYIAF 102

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA----------KTFDYDM 187
           + R++L G+++LH    IHRD+K  N+L++  G +K+ADFG++           TF    
Sbjct: 103 ILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF---- 158

Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
                V T ++ APE++   GY    DIWS+G    E+ +  P      ++  ++ +F +
Sbjct: 159 -----VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS---DLHPMRVLFLI 210

Query: 248 IGTPSMNEWPENISLMWS-SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                 N  P      +S  F+          F+  C          L  +P +R SA +
Sbjct: 211 ----PKNNPPSLEGNKFSKPFKD---------FVSLC----------LNKDPKERPSAKE 247

Query: 307 ALEHPYFK 314
            L+H + K
Sbjct: 248 LLKHKFIK 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  105 bits (265), Expect = 9e-27
 Identities = 82/306 (26%), Positives = 128/306 (41%), Gaps = 64/306 (20%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G  G V K       G  +A+K +R+++NE  I    LRE+ IL + +    P IV
Sbjct: 8   ELGAGNSGVVSKVLHRPT-GKIMAVKTIRLEINEA-IQKQILRELDILHKCN---SPYIV 62

Query: 89  RFFDVIHQNILSDERYLTVYLIFEH-----VDQDLGSYMEKCPPPGLSASKVKELTRQML 143
            F+   + N         + +  E+     +D+ L     + P   L       +   +L
Sbjct: 63  GFYGAFYNNG-------DISICMEYMDGGSLDKILKEVQGRIPERILGK-----IAVAVL 110

Query: 144 KGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           KG+ +LH  H+IIHRD+KP N+L+   G +K+ DFG++      +  T  V T  Y APE
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF-VGTSSYMAPE 169

Query: 203 ILLNLGYGTPVDIWSIGCVMAEM---------WRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            +    Y    DIWS+G  + E+             P        E L+ I        +
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD----GIFELLQYI--------V 217

Query: 254 NEWPENI-SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
           NE P  + S  +S         F      C  K           +P +R S  + LEHP+
Sbjct: 218 NEPPPRLPSGKFSP-------DFQDFVNLCLIK-----------DPRERPSYKELLEHPF 259

Query: 313 FKEKEN 318
            K+ E+
Sbjct: 260 IKKYES 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  105 bits (263), Expect = 1e-26
 Identities = 74/240 (30%), Positives = 127/240 (52%), Gaps = 22/240 (9%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN--EDGIPMSTLR-EISILKQLDTFEHPN 86
           +G GA+G V+   D  + G  +A+K+++      E    ++ L  EI +LK L    H  
Sbjct: 10  LGQGAFGRVYLCYDA-DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL---LHER 65

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELTRQMLKG 145
           IV+++  +       ER L++++  EH+    GS  ++    G L+ +  ++ TRQ+L+G
Sbjct: 66  IVQYYGCLRD---PMERTLSIFM--EHMPG--GSIKDQLKSYGALTENVTRKYTRQILEG 118

Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM----LTSVVVTLWYRAP 201
           V +LHS+ I+HRD+K  N+L    G +K+ DFG +K      +    + SV  T ++ +P
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 202 EILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
           E++   GYG   DIWS+GC + EM    P +    E E +  IF++   P+    P ++S
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVLPPHVS 235

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  105 bits (262), Expect = 1e-26
 Identities = 70/241 (29%), Positives = 122/241 (50%), Gaps = 24/241 (9%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL----KQLDTFEHP 85
           +G GA+G V+   D  + G  +A+K+  V  + D     T +E++ L    + L    H 
Sbjct: 10  LGRGAFGEVYLCYDA-DTGRELAVKQ--VPFDPDS--QETSKEVNALECEIQLLKNLRHD 64

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV-KELTRQMLK 144
            IV+++  +      +E+ L++++ +       GS  ++    G     V +  TRQ+L+
Sbjct: 65  RIVQYYGCLRDP---EEKKLSIFVEY----MPGGSIKDQLKAYGALTENVTRRYTRQILQ 117

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM----LTSVVVTLWYRA 200
           GV +LHS+ I+HRD+K  N+L   AG +K+ DFG +K      M    + SV  T ++ +
Sbjct: 118 GVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           PE++   GYG   D+WS+ C + EM    P +    E E +  IF++   P+    P+ +
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPDGV 234

Query: 261 S 261
           S
Sbjct: 235 S 235

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 2e-26
 Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 23/214 (10%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR----EISILKQL 79
            + +  +G G +G V   RD +   +Y A+K + +    + I +   +    E  +LK++
Sbjct: 3   LERIKTVGTGTFGRVHLVRD-RISEHYYALKVMAIP---EVIRLKQEQHVHNEKRVLKEV 58

Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKEL 138
               HP I+R F   H     D+R+L  Y++ E+V   +L SY+        S S     
Sbjct: 59  ---SHPFIIRLFWTEH-----DQRFL--YMLMEYVPGGELFSYLRNSGR--FSNSTGLFY 106

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWY 198
             +++  +++LHS  I++RDLKP+N+L+ + G +K+ DFG AK    D   T +  T  Y
Sbjct: 107 ASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT-LCGTPEY 164

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLF 232
            APE++ + G+   VD W++G ++ EM    P F
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  104 bits (262), Expect = 9e-26
 Identities = 91/301 (30%), Positives = 131/301 (43%), Gaps = 68/301 (22%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +IG GA GTV+K    +  G   A+K +    +ED +     REI IL+      HPN+V
Sbjct: 81  RIGSGAGGTVYKVIH-RPTGRLYALKVIYGN-HEDTVRRQICREIEILR---DVNHPNVV 135

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV------KELTRQM 142
           +  D+   N         + ++ E +D   GS         L  + +       ++ RQ+
Sbjct: 136 KCHDMFDHN-------GEIQVLLEFMDG--GS---------LEGTHIADEQFLADVARQI 177

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG----LAKTFDYDMMLTSVVVTLWY 198
           L G+ +LH   I+HRD+KP NLLI  A  +KIADFG    LA+T D      S V T+ Y
Sbjct: 178 LSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD---PCNSSVGTIAY 234

Query: 199 RAPEIL---LNLGY--GTPVDIWSIGCVMAEMWRLVPLFCASTEVE--QLKCIFRVIGTP 251
            +PE +   LN G   G   DIWS+G  + E +     F    + +   L C        
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI------ 288

Query: 252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
            M++ PE  +     F           F+ CC          L   PA R SA   L+HP
Sbjct: 289 CMSQPPEAPATASREFRH---------FISCC----------LQREPAKRWSAMQLLQHP 329

Query: 312 Y 312
           +
Sbjct: 330 F 330

Length = 353

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  102 bits (257), Expect = 1e-25
 Identities = 74/310 (23%), Positives = 135/310 (43%), Gaps = 61/310 (19%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR-EISILKQLD 80
             Y+ +  IG GA   V+ A  L N    VA+K  R+ L +    +  LR E+  + Q +
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNN-EKVAIK--RIDLEKCQTSVDELRKEVQAMSQCN 57

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYME----KCPPPGLSASKVK 136
              HPN+V++    + + +  +    ++L+  ++    GS ++      P  GL  + + 
Sbjct: 58  ---HPNVVKY----YTSFVVGD---ELWLVMPYLSG--GSLLDIMKSSYPRGGLDEAIIA 105

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-----MLTS 191
            + +++LKG+++LHS+  IHRD+K  N+L+   G +KIADFG++ +          +  +
Sbjct: 106 TVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165

Query: 192 VVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            V T  + APE++  + GY    DIWS G    E+                       G 
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIEL---------------------ATGA 204

Query: 251 PSMNEWPENISLMWSSF-------EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS 303
              +++P    LM +                +S  F         ++   L  +P+ R +
Sbjct: 205 APYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRK-------MISLCLQKDPSKRPT 257

Query: 304 AADALEHPYF 313
           A + L+H +F
Sbjct: 258 AEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  103 bits (257), Expect = 1e-25
 Identities = 68/225 (30%), Positives = 127/225 (56%), Gaps = 18/225 (8%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           + +L +IG G++G VFK  D + +   VA+K + ++  ED I     +EI++L Q D+  
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQ-KVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDS-- 61

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
            P + +++     + L D +   +++I E++    GS ++   P  L  +++  + R++L
Sbjct: 62  -PYVTKYYG----SYLKDTK---LWIIMEYLGG--GSALDLLEPGPLDETQIATILREIL 111

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLTSVVVTLWYRAPE 202
           KG+D+LHS + IHRD+K  N+L++  G +K+ADFG+A    D  +   + V T ++ APE
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171

Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
           ++    Y +  DIWS+G    E+ +  P     +E+  +K +F +
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEP---PHSELHPMKVLFLI 213

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  101 bits (253), Expect = 5e-25
 Identities = 85/301 (28%), Positives = 146/301 (48%), Gaps = 42/301 (13%)

Query: 17  LDLGD--KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           + +GD  KKY    +IG GA GTV+ A D+   G  VA++++   L +       + EI 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVAT-GQEVAIRQM--NLQQQPKKELIINEIL 69

Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           ++++    ++PNIV + D     ++ DE    ++++ E++    GS  +      +   +
Sbjct: 70  VMRE---NKNPNIVNYLD---SYLVGDE----LWVVMEYLAG--GSLTDVVTETCMDEGQ 117

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL-AKTFDYDMMLTSVV 193
           +  + R+ L+ ++FLHS+++IHRD+K  N+L+   G +K+ DFG  A+        +++V
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177

Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++    YG  VDIWS+G +  EM    P +     +  L  I    GTP +
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPEL 236

Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
              PE +               SAIF D        L   L  +   R SA + L+H + 
Sbjct: 237 QN-PEKL---------------SAIFRD-------FLNRCLDMDVEKRGSAKELLQHQFL 273

Query: 314 K 314
           K
Sbjct: 274 K 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  100 bits (251), Expect = 7e-25
 Identities = 67/211 (31%), Positives = 117/211 (55%), Gaps = 15/211 (7%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
           ++ + +L +IG G++G V+K  D + K   VA+K + ++  ED I     +EI++L Q D
Sbjct: 3   EELFTKLERIGKGSFGEVYKGIDNRTK-EVVAIKIIDLEEAEDEIE-DIQQEITVLSQCD 60

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
           +   P I R++        S  +   +++I E++    GS ++   P  L  + +  + R
Sbjct: 61  S---PYITRYYG-------SYLKGTKLWIIMEYLGG--GSALDLLKPGPLEETYIATILR 108

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLTSVVVTLWYR 199
           ++LKG+D+LHS R IHRD+K  N+L++  G +K+ADFG+A    D  +   + V T ++ 
Sbjct: 109 EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVP 230
           APE++    Y    DIWS+G    E+ +  P
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 99.7 bits (248), Expect = 2e-24
 Identities = 86/312 (27%), Positives = 139/312 (44%), Gaps = 68/312 (21%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G GA+G V+KA++ +  G   A K +  K +E+ +    + EI IL    T  HP IV
Sbjct: 19  ELGDGAFGKVYKAKN-KETGALAAAKVIETK-SEEELE-DYMVEIEILA---TCNHPYIV 72

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP-----------PPGLSASKVKE 137
           +     +                   D  L   +E CP             GL+  +++ 
Sbjct: 73  KLLGAFYW------------------DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 114

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL-AKTFDYDMMLTSVVVTL 196
           + RQML+ + +LHS +IIHRDLK  N+L+T  G +K+ADFG+ AK         S + T 
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTP 174

Query: 197 WYRAPEILL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT- 250
           ++ APE+++     +  Y    DIWS+G  + EM ++ P      E+  ++ + ++  + 
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP---PHHELNPMRVLLKIAKSE 231

Query: 251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
           P     P   S+ +  F                      L++ L  +P  R SAA  LEH
Sbjct: 232 PPTLSQPSKWSMEFRDF----------------------LKTALDKHPETRPSAAQLLEH 269

Query: 311 PYFKE-KENEPL 321
           P+      N PL
Sbjct: 270 PFVSSVTSNRPL 281

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 5e-24
 Identities = 87/327 (26%), Positives = 129/327 (39%), Gaps = 76/327 (23%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMS----TLREISILKQL 79
           ++ +  IG GA+G V+  RD    G   AMK LR     D I  +       E  IL   
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKD-TGQVYAMKVLR---KSDMIKRNQIAHVRAERDILADA 58

Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKEL 138
           D+   P IV+ +    Q    DE +L  YL+ E++   DL + + +           +  
Sbjct: 59  DS---PWIVKLY-YSFQ----DEEHL--YLVMEYMPGGDLMNLLIRKDV--FPEETARFY 106

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-------------- 184
             +++  +D +H    IHRD+KP N+LI   G +K+ADFGL K  +              
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166

Query: 185 ----------------YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
                             +   S V T  Y APE+L    YG   D WS+G ++ EM   
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Query: 229 VPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANS 288
            P F + T  E    I        +N W E       S         S   +D       
Sbjct: 227 FPPFYSDTLQETYNKI--------IN-WKE-------SLRFPPDPPVSPEAID------- 263

Query: 289 LLESMLTFNPADRISAA-DALEHPYFK 314
           L+  +L  +P DR+ +  +   HP+FK
Sbjct: 264 LICRLLC-DPEDRLGSFEEIKSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 98.0 bits (244), Expect = 6e-24
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 13/204 (6%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           ++ L +IG G++G VFK     +K  Y AMK++ +           + E  +L +LD   
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVY-AMKQIDLSKMNRREREEAIDEARVLAKLD--- 57

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQM 142
              I+R+++    + L   +   + ++ E+ +  DL   ++      L   +V     Q+
Sbjct: 58  SSYIIRYYE----SFLDKGK---LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQI 110

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAP 201
           L G+  LHS +I+HRD+K  NL +     +KI D G+AK    +    + +V T +Y +P
Sbjct: 111 LLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170

Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E+  +  Y    D+W++G V+ E 
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYEC 194

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 96.5 bits (240), Expect = 3e-23
 Identities = 80/295 (27%), Positives = 137/295 (46%), Gaps = 50/295 (16%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ----LDTFEHP 85
           +G GAYGTV+    L N+G  +A+K++ +  +     ++  +E   L++    L + +H 
Sbjct: 8   LGKGAYGTVYCG--LTNQGQLIAVKQVELDTSNV---LAAEKEYEKLQEEVDLLKSLKHV 62

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           NIV++      +        T+ +  E V    + S + +  P  L      + T+Q+L 
Sbjct: 63  NIVQYLGTCLDDN-------TISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILD 113

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-------DYDMMLTSVVVTLW 197
           GV +LH++ ++HRD+K  N+++   G +K+ DFG A+          +  ML S+  T +
Sbjct: 114 GVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           + APE++   GYG   DIWSIGC + EM    P       +++L  +F  IG        
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMF-YIGA------- 222

Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
            +  LM    + +S  A    F+  C          LT +  +R SA   L H +
Sbjct: 223 -HRGLMPRLPDSFSAAA--IDFVTSC----------LTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 96.4 bits (240), Expect = 7e-23
 Identities = 86/302 (28%), Positives = 136/302 (45%), Gaps = 62/302 (20%)

Query: 30  IGCGAYGTVFKARDL--QNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQLDTFE 83
           +G G YG VF+ R +   + G   AMK L+    V+  +D       R I     L+  +
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNI-----LEAVK 58

Query: 84  HPNIVRFFDVIHQNILSDERYLTV-YL----IFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
           HP IV   D+I+      + YL + YL    +F H++++ G +ME      LS       
Sbjct: 59  HPFIV---DLIYAFQTGGKLYLILEYLSGGELFMHLERE-GIFMEDTACFYLS------- 107

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLW 197
             ++   ++ LH   II+RDLKP+N+L+   G +K+ DFGL K   ++  +T     T+ 
Sbjct: 108 --EISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIE 165

Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           Y APEIL+  G+G  VD WS+G +M +M    P F A    + +  I +           
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK----------- 214

Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPY 312
                         K+           +A  LL+ +L  NP+ R+      AA+   HP+
Sbjct: 215 -------------GKLNLPPYLTP---EARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258

Query: 313 FK 314
           F+
Sbjct: 259 FR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 94.4 bits (235), Expect = 2e-22
 Identities = 77/308 (25%), Positives = 140/308 (45%), Gaps = 54/308 (17%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y  L  IG GAYG V++ + +   G  VA+K + +   +D +     RE+++L QL   +
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPT-GRVVALKIINLDTPDDDVS-DIQREVALLSQLRQSQ 60

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKEL---- 138
            PNI ++    + + L   R   +++I E+ +   + + M+        A  + E     
Sbjct: 61  PPNITKY----YGSYLKGPR---LWIIMEYAEGGSVRTLMK--------AGPIAEKYISV 105

Query: 139 -TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TL 196
             R++L  + ++H   +IHRD+K  N+L+T  G +K+ DFG+A   + +    S  V T 
Sbjct: 106 IIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTP 165

Query: 197 WYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT--PSM 253
           ++ APE++     Y T  DIWS+G  + EM    P +    +V+  + +  +  +  P +
Sbjct: 166 YWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS---DVDAFRAMMLIPKSKPPRL 222

Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
            +              YSK+     F+  C          L   P +R+SA + L+  + 
Sbjct: 223 ED------------NGYSKLLRE--FVAAC----------LDEEPKERLSAEELLKSKWI 258

Query: 314 KEKENEPL 321
           K     P+
Sbjct: 259 KAHSKTPV 266

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 94.3 bits (234), Expect = 2e-22
 Identities = 73/290 (25%), Positives = 143/290 (49%), Gaps = 41/290 (14%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           + +L +IG G++G VFK  D + +   VA+K + ++  ED I     +EI++L Q D+  
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQ-QVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDS-- 61

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
            P + +++        S  +   +++I E++    GS ++          ++  + +++L
Sbjct: 62  -PYVTKYYG-------SYLKGTKLWIIMEYLGG--GSALDLLRAGPFDEFQIATMLKEIL 111

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLTSVVVTLWYRAPE 202
           KG+D+LHS + IHRD+K  N+L++  G +K+ADFG+A    D  +   + V T ++ APE
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171

Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
           ++    Y +  DIWS+G    E+ +  P    ++++  ++ +F +         P     
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEP---PNSDMHPMRVLFLIPKNNP----PTLTGE 224

Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
               F++         F+D C          L  +P+ R +A + L+H +
Sbjct: 225 FSKPFKE---------FIDAC----------LNKDPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 95.7 bits (238), Expect = 2e-22
 Identities = 72/263 (27%), Positives = 123/263 (46%), Gaps = 28/263 (10%)

Query: 68  STLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP 127
           +TL E  +L+ ++   HP+++R  D +    ++        ++  H   DL +Y+ K   
Sbjct: 103 TTLIEAMLLQNVN---HPSVIRMKDTLVSGAIT-------CMVLPHYSSDLYTYLTKRSR 152

Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM 187
           P L   +   + +Q+L+G+ +LH+ RIIHRD+K +N+ I     + I D G A+      
Sbjct: 153 P-LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211

Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW---RLVPLFCASTEVEQLKC- 243
               +  T+   APE+L    Y +  DIWS G V+ EM      +     ST  E +K  
Sbjct: 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSC 271

Query: 244 ---IFRVIGTPSMN--EWP-ENISLMWSSFEQYSKVAFSA-IFMDCCSKAN------SLL 290
              + ++I T  ++  E+P +  S +   F +Y+ +         C  + N       L+
Sbjct: 272 HSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLV 331

Query: 291 ESMLTFNPADRISAADALEHPYF 313
             MLTF+ A R SA + L +P F
Sbjct: 332 HKMLTFDAAMRPSAEEILNYPMF 354

Length = 357

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 93.7 bits (233), Expect = 2e-22
 Identities = 68/248 (27%), Positives = 110/248 (44%), Gaps = 46/248 (18%)

Query: 70  LREISILKQLDTFEHPNIVRFFD-VIHQNILSDE-RYL---TVYLIFEHVDQDLGSYMEK 124
           L EI IL  L   +HPNI+ +++  +  N L  E  Y    T+Y         L      
Sbjct: 47  LNEIVILSLL---QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL------ 97

Query: 125 CPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD 184
                     V     Q++  V ++H   I+HRD+K  N+ +T+AG +K+ DFG++K   
Sbjct: 98  -----FEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152

Query: 185 YD-MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKC 243
            +  M  +VV T +Y +PE+   + Y    DIW++GCV+ E+  L   F A+  +  +  
Sbjct: 153 SEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK 212

Query: 244 IFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS 303
           I +   TP +                YS            S+  SL+ S+L  +P  R +
Sbjct: 213 IVQGNYTPVV--------------SVYS------------SELISLVHSLLQQDPEKRPT 246

Query: 304 AADALEHP 311
           A + L+ P
Sbjct: 247 ADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 93.4 bits (232), Expect = 3e-22
 Identities = 56/214 (26%), Positives = 109/214 (50%), Gaps = 13/214 (6%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY ++ +IG G++G     +  ++   YV +K++ +          + +E+++L  +   
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYV-IKEINISKMSPKEREESRKEVAVLSNM--- 56

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQ 141
           +HPNIV++ +       S E    +Y++ ++ +  DL   +           ++ +   Q
Sbjct: 57  KHPNIVQYQE-------SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ 109

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRA 200
           +   +  +H  +I+HRD+K QN+ +T+ G +K+ DFG+A+  +  + L    + T +Y +
Sbjct: 110 ICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLS 169

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCA 234
           PEI  N  Y    DIW++GCV+ EM  L   F A
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 94.5 bits (235), Expect = 3e-22
 Identities = 89/307 (28%), Positives = 144/307 (46%), Gaps = 66/307 (21%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRV---KLNEDGIPMSTLREISILK 77
           +K + +L +IG G++G V+ ARD++     VA+KK+     + NE       ++E+  L+
Sbjct: 14  EKLFTDLREIGHGSFGAVYFARDVRT-NEVVAIKKMSYSGKQSNEKW--QDIIKEVRFLQ 70

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYL---TVYLIFEHVDQDLGSY--MEKCPPPGLSA 132
           QL    HPN + +             YL   T +L+ E+    LGS   + +     L  
Sbjct: 71  QL---RHPNTIEYKGC----------YLREHTAWLVMEYC---LGSASDILEVHKKPLQE 114

Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV 192
            ++  +    L+G+ +LHSH  IHRD+K  N+L+T  G +K+ADFG A          S 
Sbjct: 115 VEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS---PANSF 171

Query: 193 VVTLWYRAPEILLNLG---YGTPVDIWSIG--CV-MAEMWRLVPLFCASTEVEQLKCIFR 246
           V T ++ APE++L +    Y   VD+WS+G  C+ +AE  R  PLF     +  +  ++ 
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE--RKPPLF----NMNAMSALYH 225

Query: 247 VIGTPSMNEWPENISLMWS-SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA 305
           +    + N+ P   S  WS  F           F+D C          L   P DR S+ 
Sbjct: 226 I----AQNDSPTLSSNDWSDYFRN---------FVDSC----------LQKIPQDRPSSE 262

Query: 306 DALEHPY 312
           + L+H +
Sbjct: 263 ELLKHRF 269

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 93.2 bits (231), Expect = 4e-22
 Identities = 87/295 (29%), Positives = 146/295 (49%), Gaps = 47/295 (15%)

Query: 26  ELCQ-IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           EL Q IG G YG V+KAR++ N G   A+K ++++  ED   +   +EI ++K     +H
Sbjct: 12  ELIQRIGSGTYGDVYKARNV-NTGELAAIKVIKLEPGEDFAVVQ--QEIIMMKDC---KH 65

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
            NIV +F      +  D+ ++ +        QD+  Y    P   LS S++  ++R+ L+
Sbjct: 66  SNIVAYFG---SYLRRDKLWICMEFCGGGSLQDI--YHVTGP---LSESQIAYVSRETLQ 117

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM-LTSVVVTLWYRAPEI 203
           G+ +LHS   +HRD+K  N+L+T  G +K+ADFG++      +    S + T ++ APE+
Sbjct: 118 GLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177

Query: 204 LL---NLGYGTPVDIWSIGCVMAEMWRLV-PLFCASTEVEQLKCIFRVIGTPSMNEWPE- 258
                  GY    DIW++G    E+  L  P+F    ++  ++ +F  + T S  + P+ 
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPPMF----DLHPMRALF--LMTKSNFQPPKL 231

Query: 259 NISLMWS-SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
              + WS SF  + K+A                   LT NP  R +A   L+HP+
Sbjct: 232 KDKMKWSNSFHHFVKMA-------------------LTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 5e-22
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 50/297 (16%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           IG G YG V+KAR     G  VA+K + +  +E+        E +IL++     HPNI  
Sbjct: 14  IGEGTYGKVYKARHK-KTGQLVAIKIMDIIEDEE---EEIKEEYNILRKYS--NHPNIAT 67

Query: 90  FFDVIHQN---ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE-----LTRQ 141
           F+    +       D+    ++L+ E      GS  +          ++KE     + R+
Sbjct: 68  FYGAFIKKNPPGNDDQ----LWLVMELCGG--GSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT-SVVVTLWYRA 200
            L+G+ +LH +++IHRD+K QN+L+T+   +K+ DFG++   D  +    + + T ++ A
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181

Query: 201 PEIL-----LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           PE++      +  Y    D+WS+G    E+    P  C   ++  ++ +F++        
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC---DMHPMRALFKI-------- 230

Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
            P N      S E +SK            K N  +   L  N   R    + LEHP+
Sbjct: 231 -PRNPPPTLKSPENWSK------------KFNDFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 93.6 bits (232), Expect = 6e-22
 Identities = 77/300 (25%), Positives = 147/300 (49%), Gaps = 42/300 (14%)

Query: 17  LDLGDKK--YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           +D GD +   +   +IG G+ G V  AR+ ++ G  VA+K + ++  +    +    E+ 
Sbjct: 14  VDQGDPRSLLENYIKIGEGSTGIVCIARE-KHSGRQVAVKMMDLRKQQRRELL--FNEVV 70

Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           I++    ++H N+V  +    ++ L  E    ++++ E +    G+  +      L+  +
Sbjct: 71  IMRD---YQHQNVVEMY----KSYLVGEE---LWVLMEFLQG--GALTDIVSQTRLNEEQ 118

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVV 193
           +  +   +L+ + +LHS  +IHRD+K  ++L+T  G +K++DFG       D+    S+V
Sbjct: 119 IATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 178

Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++    YGT VDIWS+G ++ EM    P + + + V+ +K   R+  +P  
Sbjct: 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSPP- 234

Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
                         +   K+  S +  D        LE MLT  P +R +A + L+HP+ 
Sbjct: 235 -----------PKLKNAHKI--SPVLRD-------FLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 92.3 bits (229), Expect = 7e-22
 Identities = 61/213 (28%), Positives = 112/213 (52%), Gaps = 22/213 (10%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYV----AMKKLRVKLNEDGIPMSTLREISILKQ 78
           +Y+ + +IG G++G ++ A+   +  + V     + K+ VK  E     ++ +E+ +L +
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKE-----ASKKEVILLAK 55

Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKE 137
           +   +HPNIV FF    +N         ++++ E+ D  DL   + +      S  ++  
Sbjct: 56  M---KHPNIVTFFASFQENG-------RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILS 105

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL-KIADFGLAKTFDYDMMLTSVVV-T 195
              Q+  G+  +H  +I+HRD+K QN+ +++ G + K+ DFG+A+  +  M L    V T
Sbjct: 106 WFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGT 165

Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
            +Y +PEI  N  Y    DIWS+GCV+ E+  L
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 92.4 bits (229), Expect = 9e-22
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 18/203 (8%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRV-KLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +IG G +  V++A  L ++   VA+KK+++ ++ +       ++EI +LKQL+   HPN+
Sbjct: 9   KIGRGQFSEVYRATCLLDR-KPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN---HPNV 64

Query: 88  VRFFD-VIHQNILSDERYLTVYLIFEHVDQ-DLGSYME--KCPPPGLSASKVKELTRQML 143
           +++ D  I  N L+        ++ E  D  DL   ++  K     +    V +   Q+ 
Sbjct: 65  IKYLDSFIEDNELN--------IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC 116

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT-SVVVTLWYRAPE 202
             V+ +HS R++HRD+KP N+ IT  G +K+ D GL + F        S+V T +Y +PE
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +   GY    DIWS+GC++ EM
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 92.5 bits (229), Expect = 2e-21
 Identities = 81/297 (27%), Positives = 140/297 (47%), Gaps = 46/297 (15%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP-MSTLREISILKQL 79
           +K + +L +IG G++G V+ ARD++     VA+KK+     +        ++E+  L+++
Sbjct: 24  EKLFTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI 82

Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT 139
              +HPN + +            R  T +L+ E+        +E    P L   ++  +T
Sbjct: 83  ---KHPNSIEYKGCYL-------REHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAIT 131

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
              L+G+ +LHSH +IHRD+K  N+L+T  G +K+ADFG A          S V T ++ 
Sbjct: 132 HGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS---PANSFVGTPYWM 188

Query: 200 APEILLNLG---YGTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           APE++L +    Y   VD+WS+G    E+  R  PLF     +  +  ++ +    + NE
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF----NMNAMSALYHI----AQNE 240

Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
            P   S  WS + +         F+D C          L   P DR ++ + L+H +
Sbjct: 241 SPTLQSNEWSDYFRN--------FVDSC----------LQKIPQDRPTSEELLKHMF 279

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 91.8 bits (228), Expect = 3e-21
 Identities = 85/314 (27%), Positives = 142/314 (45%), Gaps = 60/314 (19%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF- 82
           ++ +  I  GAYG V+  R  + +  + AMKK+     ++ I  + ++++ + + + TF 
Sbjct: 3   FETIKLISNGAYGAVYLVRHKETRQRF-AMKKIN---KQNLILRNQIQQVFVERDILTFA 58

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQ 141
           E+P +V  F          +R+L   ++ E+V+  D  + ++      L     +    +
Sbjct: 59  ENPFVVSMF-----CSFETKRHLC--MVMEYVEGGDCATLLKNIGA--LPVDMARMYFAE 109

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-------TFDYD-------- 186
            +  +++LH++ I+HRDLKP NLLIT  G +K+ DFGL+K       T  Y+        
Sbjct: 110 TVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 187 -MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAE-MWRLVPLFCASTEVEQLKCI 244
             +   V  T  Y APE++L  GYG PVD W++G ++ E +   VP F  + E    + I
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229

Query: 245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA 304
              I      EWPE               A  A        A  L+  +L  NP +R+  
Sbjct: 230 SDDI------EWPE------------GDEALPA-------DAQDLISRLLRQNPLERLGT 264

Query: 305 ADALE---HPYFKE 315
             A E   H +F  
Sbjct: 265 GGAFEVKQHRFFLG 278

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 89.9 bits (223), Expect = 6e-21
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 23/213 (10%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY+++  +G GA+G V   R        V +K++ V+       ++   E  +LK L   
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL--- 56

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVY------LIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            HPNI+ +++    N L D+  + V        + E++ +   S +++          + 
Sbjct: 57  SHPNIIEYYE----NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE--------DTIL 104

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYDMMLTSVVVT 195
               Q+L  +  +H+  I+HRDLK QN+L+ +    +KI DFG++K         +VV T
Sbjct: 105 HFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGT 164

Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
             Y +PE+     Y    DIW++GCV+ E+  L
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVLYELASL 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 90.1 bits (223), Expect = 9e-21
 Identities = 77/272 (28%), Positives = 129/272 (47%), Gaps = 33/272 (12%)

Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRV---KLNEDGIPMSTLREIS 74
           D  +K + +L +IG G++G V+ ARD++N    VA+KK+     + NE       ++E+ 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNS-EVVAIKKMSYSGKQSNEKW--QDIIKEVR 67

Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
            L++L    HPN +++            R  T +L+ E+        +E    P L   +
Sbjct: 68  FLQKL---RHPNTIQYRGCYL-------REHTAWLVMEYCLGSASDLLEVHKKP-LQEVE 116

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +  +T   L+G+ +LHSH +IHRD+K  N+L++  G +K+ DFG A            V 
Sbjct: 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANXFVG 173

Query: 195 TLWYRAPEILLNLG---YGTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGT 250
           T ++ APE++L +    Y   VD+WS+G    E+  R  PLF     +  +  ++ +   
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF----NMNAMSALYHI--- 226

Query: 251 PSMNEWPENISLMWS-SFEQYSKVAFSAIFMD 281
            + NE P   S  WS  F  +       I  D
Sbjct: 227 -AQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 89.3 bits (221), Expect = 1e-20
 Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 18/210 (8%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRV-KLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +IG G +  V++A  L + G  VA+KK+++  L +       ++EI +LKQL+   HPN+
Sbjct: 9   KIGRGQFSEVYRATCLLD-GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN---HPNV 64

Query: 88  VRFF-DVIHQNILSDERYLTVYLIFEHVDQ-DLGSYME--KCPPPGLSASKVKELTRQML 143
           ++++   I  N L+        ++ E  D  DL   ++  K     +    V +   Q+ 
Sbjct: 65  IKYYASFIEDNELN--------IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT-SVVVTLWYRAPE 202
             ++ +HS R++HRD+KP N+ IT  G +K+ D GL + F        S+V T +Y +PE
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLF 232
            +   GY    DIWS+GC++ EM  L   F
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 89.3 bits (221), Expect = 1e-20
 Identities = 82/302 (27%), Positives = 138/302 (45%), Gaps = 49/302 (16%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYV--AMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           ++G GA+G V+KA   QNK   V  A K +  K  E+      + EI IL   D   HPN
Sbjct: 12  ELGDGAFGKVYKA---QNKETGVLAAAKVIDTKSEEE--LEDYMVEIDILASCD---HPN 63

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           IV+  D  +      E  L + + F      + + M +   P L+  +++ + +Q L+ +
Sbjct: 64  IVKLLDAFYY-----ENNLWILIEF-CAGGAVDAVMLELERP-LTEPQIRVVCKQTLEAL 116

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL-AKTFDYDMMLTSVVVTLWYRAPEILL 205
           ++LH ++IIHRDLK  N+L T  G +K+ADFG+ AK         S + T ++ APE+++
Sbjct: 117 NYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 176

Query: 206 -----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT-PSMNEWPEN 259
                +  Y    D+WS+G  + EM ++ P      E+  ++ + ++  + P     P  
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEP---PHHELNPMRVLLKIAKSEPPTLAQPSR 233

Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE 319
               WS                  S+    L+  L  N   R +    L+HP+     N+
Sbjct: 234 ----WS------------------SEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271

Query: 320 PL 321
           P+
Sbjct: 272 PI 273

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 89.0 bits (220), Expect = 2e-20
 Identities = 74/292 (25%), Positives = 133/292 (45%), Gaps = 43/292 (14%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G YG V+K R ++  G   A+K + V  +E+       +EI++LK+     H NI  
Sbjct: 14  VGNGTYGQVYKGRHVKT-GQLAAIKVMDVTGDEE---EEIKQEINMLKKYS--HHRNIAT 67

Query: 90  FFDV-IHQNI--LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           ++   I +N   + D+ +L +         DL   ++      L    +  + R++L+G+
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL---IKNTKGNTLKEEWIAYICREILRGL 124

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAPEILL 205
             LH H++IHRD+K QN+L+T    +K+ DFG++   D  +    + + T ++ APE++ 
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184

Query: 206 -----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
                +  Y    D+WS+G    EM    P  C   ++  ++ +F +   P+    P   
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLC---DMHPMRALFLIPRNPA----PRLK 237

Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
           S  WS                   K  S +ES L  N + R +    ++HP+
Sbjct: 238 SKKWS------------------KKFQSFIESCLVKNHSQRPTTEQLMKHPF 271

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 88.2 bits (219), Expect = 5e-20
 Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 49/295 (16%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G++G V  A  L+      A+K L+  V L +D +   T+ E  +L      +HP  
Sbjct: 3   LGKGSFGKVLLAE-LKGTDELYAVKVLKKDVILQDDDVE-CTMTEKRVLALAG--KHP-- 56

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
             F   +H    + +R   ++ + E+V+  DL  ++++         + +    +++ G+
Sbjct: 57  --FLTQLHSCFQTKDR---LFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGL 109

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEILL 205
            FLH   II+RDLK  N+L+   G +KIADFG+ K      + TS    T  Y APEIL 
Sbjct: 110 QFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS 169

Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS 265
              YG  VD W++G ++ EM      F    E E    +F+ I    + +          
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE----LFQSI----LED---------- 211

Query: 266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA-----ADALEHPYFKE 315
                 +V +         +A S+L+S LT NP  R+        D   HP+F+E
Sbjct: 212 ------EVRYPRWLSK---EAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 87.5 bits (217), Expect = 6e-20
 Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 22/207 (10%)

Query: 29  QIGCGAYGTVFKAR-DLQ--NKGNYVAMKKLRVKLNEDGIPMSTL-REISILKQLDTFEH 84
           Q+G G +G V   R D    N G  VA+K L     E     S   REI IL+ LD   H
Sbjct: 11  QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQ--HRSDFEREIEILRTLD---H 65

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
            NIV++     + +       ++ LI E++    L  Y+++     ++  ++   + Q+ 
Sbjct: 66  ENIVKY-----KGVCEKPGGRSLRLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQIC 119

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+D+L S R IHRDL  +N+L+     +KI+DFGLAK    D     V         WY
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEM 225
            APE L    + +  D+WS G  + E+
Sbjct: 180 -APECLRTSKFSSASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 87.6 bits (217), Expect = 9e-20
 Identities = 79/304 (25%), Positives = 136/304 (44%), Gaps = 54/304 (17%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGI--PMSTLREISILKQLDTFEHP 85
           +G G++G V  AR L+  G   A+K L+  V L +D +   M+  R +S+ +      HP
Sbjct: 3   LGKGSFGKVMLAR-LKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-----HP 56

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLK 144
            + + +        + +R   ++ + E V+  DL  +++K        ++ +    ++  
Sbjct: 57  FLTQLYCCFQ----TPDR---LFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITS 107

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEI 203
            + FLH   II+RDLK  N+L+   G  K+ADFG+ K   ++   TS    T  Y APEI
Sbjct: 108 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI 167

Query: 204 LLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM 263
           L  + YG  VD W++G ++ EM      F A  E +  + I              N  ++
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL-------------NDEVV 214

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD------ALEHPYFKEKE 317
           + ++     V               +L++ +T NP  R+ +         L HP+FKE +
Sbjct: 215 YPTWLSQDAVD--------------ILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260

Query: 318 NEPL 321
            E L
Sbjct: 261 WEKL 264

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 86.4 bits (214), Expect = 1e-19
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 20/205 (9%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +IG G +G V+K   L+     VA+K  R  L  D +    L+E  ILKQ   ++HPNIV
Sbjct: 2   KIGKGNFGDVYKGV-LKGNTE-VAVKTCRSTLPPD-LKRKFLQEAEILKQ---YDHPNIV 55

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           +   V  Q          +Y++ E V    L +++ K     L+  K+ +++     G++
Sbjct: 56  KLIGVCVQK-------QPIYIVMELVPGGSLLTFLRK-KKNRLTVKKLLQMSLDAAAGME 107

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV---VVTLWYRAPEIL 204
           +L S   IHRDL  +N L+     LKI+DFG+++  +  +   S     + + + APE  
Sbjct: 108 YLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEA- 166

Query: 205 LNLG-YGTPVDIWSIGCVMAEMWRL 228
           LN G Y +  D+WS G ++ E + L
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 86.2 bits (213), Expect = 1e-19
 Identities = 65/223 (29%), Positives = 109/223 (48%), Gaps = 28/223 (12%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y+ L  +G G++G     + + +   Y AMK++R+  +   +  S  R+ ++L  L   
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKY-AMKEIRLPKSSSAVEDS--RKEAVL--LAKM 55

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR-- 140
           +HPNIV F +       S E    +Y++ E+ D   G  M+K     +   + K      
Sbjct: 56  KHPNIVAFKE-------SFEADGHLYIVMEYCDG--GDLMQK-----IKLQRGKLFPEDT 101

Query: 141 ------QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
                 QM  GV  +H  R++HRD+K +N+ +T+ G +K+ DFG A+            V
Sbjct: 102 ILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV 161

Query: 195 -TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST 236
            T +Y  PEI  N+ Y    DIWS+GC++ E+  L   F A++
Sbjct: 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 86.2 bits (213), Expect = 1e-19
 Identities = 80/268 (29%), Positives = 128/268 (47%), Gaps = 35/268 (13%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +IG G +G VF  R L+     VA+K  R  L  D +    L+E  ILKQ   + HPNIV
Sbjct: 2   RIGRGNFGEVFSGR-LRADNTPVAVKSCRETLPPD-LKAKFLQEARILKQ---YSHPNIV 56

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQM---LK 144
           R   V  Q          +Y++ E V   D  +++    P      KVKEL + +     
Sbjct: 57  RLIGVCTQK-------QPIYIVMELVQGGDFLTFLRTEGP----RLKVKELIQMVENAAA 105

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV----VVTLWYRA 200
           G+++L S   IHRDL  +N L+T    LKI+DFG+++  + D +  S      + + + A
Sbjct: 106 GMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTA 164

Query: 201 PEILLNLG-YGTPVDIWSIGCVMAEMWRL--VPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           PE  LN G Y +  D+WS G ++ E + L  VP +   +  +  + I + +  P     P
Sbjct: 165 PEA-LNYGRYSSESDVWSFGILLWEAFSLGAVP-YANLSNQQTREAIEQGVRLPCPELCP 222

Query: 258 ENI-SLM---WSSFEQYSKVAFSAIFMD 281
           + +  LM   W  ++   + +FS +  +
Sbjct: 223 DAVYRLMERCW-EYDPGQRPSFSTVHQE 249

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 93/332 (28%), Positives = 132/332 (39%), Gaps = 87/332 (26%)

Query: 30  IGCGAYGTVFKARDLQNK--GNYVAMKKLR-VKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG GA+G V   R +Q K  G+  AMKKLR  ++ E         E  IL + D   +P 
Sbjct: 9   IGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD---NPW 62

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKELTR----Q 141
           +V+ +         DE YL  YLI E++   D+ + + K        +  +E TR    +
Sbjct: 63  VVKLY-----YSFQDENYL--YLIMEYLPGGDMMTLLMK------KDTFTEEETRFYIAE 109

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF------DYDMMLT----- 190
            +  +D +H    IHRD+KP NLL+   G +K++DFGL          ++  +L+     
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169

Query: 191 ----------------------------SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVM 222
                                       S V T  Y APE+ L  GY    D WS+G +M
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229

Query: 223 AEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDC 282
            EM    P FC+    E  + I        +N W E   L +      S  A   I   C
Sbjct: 230 YEMLVGYPPFCSDNPQETYRKI--------IN-WKET--LQFPDEVPLSPEAKDLIKRLC 278

Query: 283 CSKANSLLESMLTFNPADRISAADALEHPYFK 314
           C       E  L  N  + I       HP+FK
Sbjct: 279 CEA-----ERRLGNNGVNEIK-----SHPFFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 87.0 bits (215), Expect = 1e-19
 Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 52/296 (17%)

Query: 27  LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRV---KLNEDGIPMSTLREISILKQLDTFE 83
           L +IG G++G V+ A +  +    VA+KK+     + NE       ++E+  L+QL   +
Sbjct: 26  LHEIGHGSFGAVYFATN-SHTNEVVAVKKMSYSGKQTNEKW--QDIIKEVKFLQQL---K 79

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           HPN + +        L +    T +L+ E+        +E    P L   ++  +T   L
Sbjct: 80  HPNTIEY----KGCYLKEH---TAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAITHGAL 131

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
           +G+ +LHSH +IHRD+K  N+L+T  G +K+ADFG A          S V T ++ APE+
Sbjct: 132 QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFVGTPYWMAPEV 188

Query: 204 LLNLG---YGTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           +L +    Y   VD+WS+G    E+  R  PLF     +  +  ++ +    + N+ P  
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLF----NMNAMSALYHI----AQNDSPTL 240

Query: 260 ISLMWS-SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
            S  W+ SF           F+D C          L   P +R ++A+ L H + +
Sbjct: 241 QSNEWTDSFRG---------FVDYC----------LQKIPQERPASAELLRHDFVR 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 86.2 bits (213), Expect = 1e-19
 Identities = 85/304 (27%), Positives = 146/304 (48%), Gaps = 62/304 (20%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR-EISILKQLDTF 82
           Y+ + ++G G YG V+KAR+L   G   A+K +++   E G   S ++ EI ++K+    
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHT-GELAAVKIIKL---EPGDDFSLIQQEIFMVKEC--- 63

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD----QDLGSYMEKCPPPGLSASKVKEL 138
           +H NIV +F     + LS E+   +++  E+      QD+  Y    P   LS  ++  +
Sbjct: 64  KHCNIVAYFG----SYLSREK---LWICMEYCGGGSLQDI--YHVTGP---LSELQIAYV 111

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM-LTSVVVTLW 197
            R+ L+G+ +LHS   +HRD+K  N+L+T  G +K+ADFG+A      +    S + T +
Sbjct: 112 CRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY 171

Query: 198 YRAPEILL---NLGYGTPVDIWSIGCVMAEMWRLV-PLFCASTEVEQLKCIFRVIGT--- 250
           + APE+     N GY    DIW++G    E+  L  P+F    ++  ++ +F +  +   
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF----DLHPMRALFLMSKSNFQ 227

Query: 251 -PSMNEWPENISLMWSS-FEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL 308
            P + +        WSS F  + K++                   LT NP  R +A   L
Sbjct: 228 PPKLKD-----KTKWSSTFHNFVKIS-------------------LTKNPKKRPTAERLL 263

Query: 309 EHPY 312
            H +
Sbjct: 264 THLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 86.0 bits (213), Expect = 2e-19
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 28/203 (13%)

Query: 117 DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD 176
           DL  ++     PG    +      ++  G++ LH  RI++RDLKP+N+L+   G ++I+D
Sbjct: 86  DLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISD 145

Query: 177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST 236
            GLA        +   V T+ Y APE++ N  Y    D W +GC++ EM           
Sbjct: 146 LGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMI---------- 195

Query: 237 EVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTF 296
              + K  FR        +  E    +    E+YS+  FS         A S+   +LT 
Sbjct: 196 ---EGKSPFR--QRKEKVKREEVERRVKEDQEEYSE-KFS-------EAARSICRQLLTK 242

Query: 297 NPADRI-----SAADALEHPYFK 314
           +P  R+      A +   HP+F+
Sbjct: 243 DPGFRLGCRGEGAEEVKAHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 85.4 bits (211), Expect = 2e-19
 Identities = 78/287 (27%), Positives = 130/287 (45%), Gaps = 42/287 (14%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G+YG V   R   +   YV +KKL ++        +  +E  +L QL   +HPNIV 
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYV-IKKLNLRNASRRERKAAEQEAQLLSQL---KHPNIVA 63

Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFL 149
           +     ++   ++  L + + F     DL   +++     L  ++V E   Q+   + +L
Sbjct: 64  Y----RESWEGEDGLLYIVMGFCE-GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118

Query: 150 HSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD--YDMMLTSVVVTLWYRAPEILLNL 207
           H   I+HRDLK QN+ +TR   +K+ D G+A+  +   DM  T ++ T +Y +PE+  N 
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNK 177

Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI--GTPSMNEWPENISLMWS 265
            Y    D+W++GC + EM  L   F A    +    ++R+I    P M   P++      
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAK---DMNSLVYRIIEGKLPPM---PKD------ 225

Query: 266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
               YS             +   L+ +ML+  P  R S    L  PY
Sbjct: 226 ----YSP------------ELGELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 85.9 bits (212), Expect = 3e-19
 Identities = 71/291 (24%), Positives = 142/291 (48%), Gaps = 40/291 (13%)

Query: 25  DELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           D   +IG G+ G V  A + ++ G  VA+KK+ ++  +    +    E+ I++    + H
Sbjct: 25  DSFIKIGEGSTGIVCIATE-KHTGKQVAVKKMDLRKQQRRELL--FNEVVIMRD---YHH 78

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
            N+V   D+ +  ++ DE    ++++ E ++   G+  +      ++  ++  +   +L+
Sbjct: 79  ENVV---DMYNSYLVGDE----LWVVMEFLEG--GALTDIVTHTRMNEEQIATVCLSVLR 129

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAPEI 203
            + +LH+  +IHRD+K  ++L+T  G +K++DFG       ++    S+V T ++ APE+
Sbjct: 130 ALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEV 189

Query: 204 LLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM 263
           +  L YGT VDIWS+G ++ EM    P +     ++ ++ I         +  P  +   
Sbjct: 190 ISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--------RDNLPPRV--- 238

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
               +   KV+         S     L+ ML   P+ R +A + L+HP+ K
Sbjct: 239 ----KDSHKVS---------SVLRGFLDLMLVREPSQRATAQELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 85.2 bits (211), Expect = 4e-19
 Identities = 83/317 (26%), Positives = 138/317 (43%), Gaps = 74/317 (23%)

Query: 26  ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD----T 81
            + ++G GAYG V K R +   G  +A+K++R  +N       +  +  +L  LD    +
Sbjct: 5   VIEELGRGAYGVVDKMRHVPT-GTIMAVKRIRATVN-------SQEQKRLLMDLDISMRS 56

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE---- 137
            + P  V F+  + +    D     V++  E +D  L  + +K    GL    + E    
Sbjct: 57  VDCPYTVTFYGALFRE--GD-----VWICMEVMDTSLDKFYKKVYDKGL---TIPEDILG 106

Query: 138 -LTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVT 195
            +   ++K +++LHS   +IHRD+KP N+LI R G +K+ DFG++      +  T     
Sbjct: 107 KIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGC 166

Query: 196 LWYRAPEIL---LNL-GYGTPVDIWSIGCVMAEM---------WRLVPLFCASTEVEQLK 242
             Y APE +   LN  GY    D+WS+G  M E+         W+        T  +QLK
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK--------TPFQQLK 218

Query: 243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI 302
              +V+  PS  + P                 FS  F D  +K        L  N  +R 
Sbjct: 219 ---QVVEEPS-PQLPAE--------------KFSPEFQDFVNKC-------LKKNYKERP 253

Query: 303 SAADALEHPYFKEKENE 319
           +  + L+HP+F+   ++
Sbjct: 254 NYPELLQHPFFELHLSK 270

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (212), Expect = 5e-19
 Identities = 81/300 (27%), Positives = 134/300 (44%), Gaps = 56/300 (18%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMS-TLREISILKQLDTFEHPNIV 88
           IG G +G V++ R  ++     AMK L  K       ++ T+ E +IL +    E P IV
Sbjct: 1   IGKGTFGQVYQVRK-KDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59

Query: 89  RFFDVIHQNILSDERYLTVYL----IFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
                   +  SD   +T Y+    +F H+ ++ G + E          + K    +++ 
Sbjct: 60  GLKFSFQTD--SDLYLVTDYMSGGELFWHLQKE-GRFSED---------RAKFYIAELVL 107

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEI 203
            ++ LH + I++RDLKP+N+L+   G + + DFGL+K    D   T+    T  Y APE+
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEV 167

Query: 204 LLN-LGYGTPVDIWSIGCVMAEM---WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           LL+  GY   VD WS+G ++ EM   W   P +      E  + ++R I           
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWS--PFY-----AEDTQQMYRNIA---------- 210

Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA-ADALE---HPYFKE 315
                     + KV F    +    +    ++ +L  NP  R+ A  DA+E   HP+F +
Sbjct: 211 ----------FGKVRFPKNVLS--DEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 85.1 bits (210), Expect = 5e-19
 Identities = 72/300 (24%), Positives = 144/300 (48%), Gaps = 42/300 (14%)

Query: 17  LDLGDKK--YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           +D GD +   D   +IG G+ G V  A  +++ G  VA+KK+ ++  +    +    E+ 
Sbjct: 13  VDPGDPRTYLDNFIKIGEGSTGIVCIA-TVKSSGKLVAVKKMDLRKQQRRELL--FNEVV 69

Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           I++    ++H N+V  ++     ++ DE    ++++ E ++   G+  +      ++  +
Sbjct: 70  IMRD---YQHENVVEMYN---SYLVGDE----LWVVMEFLEG--GALTDIVTHTRMNEEQ 117

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVV 193
           +  +   +LK +  LH+  +IHRD+K  ++L+T  G +K++DFG       ++    S+V
Sbjct: 118 IAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177

Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++  L YG  VDIWS+G ++ EM    P +     ++ +K I         
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------- 228

Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
               +N+     +  + S                  L+ +L  +PA R +AA+ L+HP+ 
Sbjct: 229 ---RDNLPPKLKNLHKVSPS------------LKGFLDRLLVRDPAQRATAAELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 84.9 bits (210), Expect = 5e-19
 Identities = 82/309 (26%), Positives = 128/309 (41%), Gaps = 61/309 (19%)

Query: 27  LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH-- 84
           L ++G G YG+V+K    +  G  +AMK++R++L+E     S   +I  + +LD      
Sbjct: 6   LDELGKGNYGSVYKVLH-RPTGVTMAMKEIRLELDE-----SKFNQI--IMELDILHKAV 57

Query: 85  -PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGS----YMEKCPPPGLSASKVKELT 139
            P IV F+               VY+  E++D   GS    Y       G+    ++ +T
Sbjct: 58  SPYIVDFYGAFFIE-------GAVYMCMEYMDA--GSLDKLYAGGVATEGIPEDVLRRIT 108

Query: 140 RQMLKGVDFL-HSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWY 198
             ++KG+ FL   H IIHRD+KP N+L+   G +K+ DFG++      +  T++     Y
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS-Y 167

Query: 199 RAPEILLNLG------YGTPVDIWSIGCVMAEMWR---LVPLFCASTEVEQLKCIFRVIG 249
            APE + + G      Y    D+WS+G  + EM       P    +    QL  I  V G
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI--VDG 225

Query: 250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE 309
            P     P   S                        A   +   L   P  R + A  LE
Sbjct: 226 DPP--TLPSGYS----------------------DDAQDFVAKCLNKIPNRRPTYAQLLE 261

Query: 310 HPYFKEKEN 318
           HP+  + +N
Sbjct: 262 HPWLVKYKN 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 84.5 bits (209), Expect = 6e-19
 Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 30/218 (13%)

Query: 30  IGCGAYGTVFK--ARDLQNKGN---YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           +G GA+G V++  A D+   G+    VA+K LR K   D      L+E  ++     F H
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR-KGATDQEKKEFLKEAHLMSN---FNH 58

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSY-----MEKCPPPGLSASKVKEL 138
           PNIV+   V   N          Y+I E ++  DL SY     +E+  PP L+  ++ ++
Sbjct: 59  PNIVKLLGVCLLN-------EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDI 111

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG-----LKIADFGLAKTF---DYDMMLT 190
              + KG  +L     IHRDL  +N L++  G      +KI DFGLA+     DY     
Sbjct: 112 CLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171

Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
             ++ + + APE LL+  + T  D+WS G +M E+  L
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTL 209

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 83.7 bits (207), Expect = 1e-18
 Identities = 78/294 (26%), Positives = 127/294 (43%), Gaps = 45/294 (15%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL---RVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G G +G V   + ++  G   A KKL   R+K  + G  M+ L E  IL+++ +     
Sbjct: 1   LGKGGFGEVCACQ-VKATGKMYACKKLDKKRLKKRK-GEQMA-LNEKKILEKVSS---RF 54

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           IV            D+  L + L+      DL  ++     PG   ++      Q++ G+
Sbjct: 55  IVSLAYAFET---KDDLCLVMTLM---NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGL 108

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN 206
           + LH  RI++RDLKP+N+L+   G ++I+D GLA        +     T  Y APE+L  
Sbjct: 109 EHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG 168

Query: 207 LGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS 265
             Y   VD +++GC + EM     P      +VE+ +   R +      E+P+       
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV--EYPD------- 219

Query: 266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFK 314
            F   +K                L E++L  +P  R+     SA +  EHP FK
Sbjct: 220 KFSPEAK---------------DLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 85.6 bits (211), Expect = 2e-18
 Identities = 63/237 (26%), Positives = 117/237 (49%), Gaps = 48/237 (20%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y+ + +IG G +G VF  +  + +  +   K +  +  ++      + E++++++L   
Sbjct: 14  EYEVIKKIGNGRFGEVFLVKHKRTQ-EFFCWKAISYRGLKEREKSQLVIEVNVMREL--- 69

Query: 83  EHPNIVRFFDVIHQNILSDERYLT-----VYLIFEHVDQ-DLGSYMEKCPP--PGLSASK 134
           +H NIVR+ D          R+L      +Y++ E  D  DL   ++KC      +    
Sbjct: 70  KHKNIVRYID----------RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119

Query: 135 VKELTRQMLKGVDFLHS-------HRIIHRDLKPQNLLIT-----------RAGGL---- 172
           + ++TRQ+L  + + H+        R++HRDLKPQN+ ++           +A  L    
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179

Query: 173 --KIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN--LGYGTPVDIWSIGCVMAEM 225
             KI DFGL+K    + M  S V T +Y +PE+LL+    Y    D+W++GC++ E+
Sbjct: 180 IAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236

Length = 1021

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 83.2 bits (206), Expect = 2e-18
 Identities = 66/224 (29%), Positives = 108/224 (48%), Gaps = 32/224 (14%)

Query: 27  LCQIGCGAYGTVFKAR----DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
              +G GA+G V KA     D  N+ + VA+K L+    E  +    + E+ ++K +   
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL-SDLVSEMEMMKMIG-- 73

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKV------ 135
           +H NI+    V  Q          +Y++ E+    +L  ++    PPG  AS        
Sbjct: 74  KHKNIINLLGVCTQE-------GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126

Query: 136 -----KELTR---QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFD 184
                K+L     Q+ +G++FL S + IHRDL  +N+L+T    +KIADFGLA+     D
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186

Query: 185 YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           Y    T+  + + + APE L +  Y    D+WS G ++ E++ L
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 45/291 (15%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G++G V  A +L+    + A+K L+  V L +D +   T+ E  +L     +EHP +
Sbjct: 3   LGKGSFGKVMLA-ELKGTNEFFAIKALKKDVVLEDDDVE-CTMVERRVLAL--AWEHPFL 58

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
              F            +L  + + E+++  DL  +++         ++ +    +++ G+
Sbjct: 59  THLFCTFQTK-----EHL--FFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGL 109

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY-DMMLTSVVVTLWYRAPEILL 205
            FLH   II+RDLK  N+L+ + G +KIADFG+ K     +   ++   T  Y APEIL 
Sbjct: 110 QFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK 169

Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS 265
              Y   VD WS G ++ EM      F    E E    I  +   P    W         
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI--LNDRPHFPRWIS------- 220

Query: 266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-SAADALEHPYFKE 315
                              +A   L  +   +P  R+    D  +HP+F+ 
Sbjct: 221 ------------------KEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 82.9 bits (205), Expect = 4e-18
 Identities = 83/296 (28%), Positives = 137/296 (46%), Gaps = 54/296 (18%)

Query: 30  IGCGAYGTVFKARDL--QNKGNYVAMKKLR---VKLNEDGIPMSTLREISILKQLDTFEH 84
           +G G++G VF  R +   + G   AMK L+   +K+ +    + T  E  IL +++   H
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDR---VRTKMERDILAEVN---H 57

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKELTRQML 143
           P IV+    +H    ++ +   +YLI + +   DL + + K      +   VK    ++ 
Sbjct: 58  PFIVK----LHYAFQTEGK---LYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELA 108

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMMLTSVVVTLWYRAPE 202
             +D LHS  II+RDLKP+N+L+   G +K+ DFGL+K + D++    S   T+ Y APE
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168

Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
           ++   G+    D WS G +M EM      F      E +  I +      M   P+ +S 
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK--AKLGM---PQFLS- 222

Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-SAADALE----HPYF 313
                                 +A SLL ++   NPA+R+ +  D +E    HP+F
Sbjct: 223 ---------------------PEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF 257

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 82.6 bits (204), Expect = 7e-18
 Identities = 80/302 (26%), Positives = 128/302 (42%), Gaps = 67/302 (22%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMS----TLREISILKQLDTFEHP 85
           +G G++G V  A+  +  G Y A+K L+     + + M       +E SIL +L    HP
Sbjct: 26  LGTGSFGRVRIAK-HKGTGEYYAIKCLK---KREILKMKQVQHVAQEKSILMELS---HP 78

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKV-KELTRQML 143
            IV        +   + R   VY + E V   +L +++ K    G   + V K    +++
Sbjct: 79  FIVNMM----CSFQDENR---VYFLLEFVVGGELFTHLRKA---GRFPNDVAKFYHAELV 128

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-----TFDYDMMLTSVVVTLWY 198
              ++LHS  II+RDLKP+NLL+   G +K+ DFG AK     TF       ++  T  Y
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF-------TLCGTPEY 181

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
            APE++ + G+G  VD W++G ++ E     P F   T     + I  + G      W +
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI--LAGRLKFPNWFD 239

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA-----ADALEHPYF 313
                                     +A  L++ +L  +   R+       AD   HPYF
Sbjct: 240 -------------------------GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274

Query: 314 KE 315
             
Sbjct: 275 HG 276

Length = 329

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 81.2 bits (200), Expect = 7e-18
 Identities = 57/216 (26%), Positives = 110/216 (50%), Gaps = 28/216 (12%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR 71
           LNL  L LG+        IG G +G V +       G  VA+K ++     D    + L 
Sbjct: 3   LNLQKLTLGE-------IIGEGEFGAVLQGEYT---GQKVAVKNIKC----DVTAQAFLE 48

Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGL 130
           E +++ +L    H N+VR   VI  N L        Y++ E + + +L +++       +
Sbjct: 49  ETAVMTKL---HHKNLVRLLGVILHNGL--------YIVMELMSKGNLVNFLRTRGRALV 97

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT 190
           S  ++ + +  + +G+++L S +++HRDL  +N+L++  G  K++DFGLA+     M + 
Sbjct: 98  SVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVD 155

Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           +  + + + APE L +  + +  D+WS G ++ E++
Sbjct: 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVF 191

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 82.4 bits (203), Expect = 8e-18
 Identities = 84/340 (24%), Positives = 144/340 (42%), Gaps = 70/340 (20%)

Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           +L D  ++++ ++G G  G VFK          +  +KL     +  I    +RE+ +L 
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKV--SHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE 137
           + ++   P IV F+   +    SD     + +  EH+D   G  +++       A ++ E
Sbjct: 59  ECNS---PYIVGFYGAFY----SDGE---ISICMEHMD---GGSLDQVLK---KAGRIPE 102

Query: 138 -----LTRQMLKGVDFL-HSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS 191
                ++  ++KG+ +L   H+I+HRD+KP N+L+   G +K+ DFG++     D M  S
Sbjct: 103 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANS 161

Query: 192 VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM----WRLVPLFCASTEVEQLKCIF-- 245
            V T  Y +PE L    Y    DIWS+G  + EM    + + P      + ++L+ +F  
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP-----PDAKELELMFGC 216

Query: 246 ---------------RVIGTPSMNEWPENISLMWSSFE-----------QYSKVAFSAIF 279
                          R  G P  +  P++   M + FE           +     F A F
Sbjct: 217 PVEGDPAESETSPRPRPPGRPLSSYGPDSRPPM-AIFELLDYIVNEPPPKLPSGVFGAEF 275

Query: 280 MDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE 319
            D  +K        L  NPA+R      + H + K  E E
Sbjct: 276 QDFVNKC-------LIKNPAERADLKQLMVHAFIKRSEAE 308

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 81.0 bits (200), Expect = 1e-17
 Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 19/208 (9%)

Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           + Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE--REIEILKSL---Q 63

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + R +  YL +  +   L  + E+         K+     Q+ 
Sbjct: 64  HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL-----DHRKLLLYASQIC 118

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L S R +HRDL  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMW 226
            APE L    +    D+WS G V+ E++
Sbjct: 179 -APESLTESKFSVASDVWSFGVVLYELF 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 78/274 (28%), Positives = 126/274 (45%), Gaps = 43/274 (15%)

Query: 68  STLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP 127
           S++ E  +L++L    HP ++   DV    ++     LT  L+      DL +Y+     
Sbjct: 206 SSVHEARLLRRLS---HPAVLALLDV---RVVGG---LTC-LVLPKYRSDLYTYLGARLR 255

Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA------- 180
           P L  ++V  + RQ+L  +D++H   IIHRD+K +N+L+     + + DFG A       
Sbjct: 256 P-LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314

Query: 181 -KTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW-RLVPLFCASTEV 238
              F Y      +  T+   APE+L    Y   VDIWS G V+ E       LF AS   
Sbjct: 315 STPFHY-----GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD 369

Query: 239 EQLKC---IFRVIGTPSM--NEWPENI-SLMWSSFEQ---------YSKVAFSAIF-MDC 282
           E+      I R+I    +  +E+P++  S + S +           Y++ A++  + +D 
Sbjct: 370 ERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLD- 428

Query: 283 CSKANSLLESMLTFNPADRISAADALEHPYFKEK 316
                 L+   LTF+ A R SAA+ L  P F+ K
Sbjct: 429 -LDVEYLVCRALTFDGARRPSAAELLRLPLFQSK 461

Length = 461

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 79.7 bits (197), Expect = 2e-17
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 25/207 (12%)

Query: 29  QIGCGAYGTVFKARDLQNKGNY--VAMKKLR-VKLNEDGIPMSTLREISILKQLDTFEHP 85
           ++G G++G V +     + G    VA+K L+  KL++  I    L+E +I+  LD   H 
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLD---HE 56

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QM 142
           N++R + V+  + L         ++ E     LGS +++     L    +  L     Q+
Sbjct: 57  NLIRLYGVVLTHPLM--------MVTELAP--LGSLLDRLRKDALGHFLISTLCDYAVQI 106

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYDMMLTSVVVTLWY 198
             G+ +L S R IHRDL  +N+L+     +KI DFGL +      D+ +M   + V   +
Sbjct: 107 ANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAW 166

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEM 225
            APE L    +    D+W  G  + EM
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 80.0 bits (197), Expect = 3e-17
 Identities = 75/296 (25%), Positives = 132/296 (44%), Gaps = 42/296 (14%)

Query: 26  ELCQI-GCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           EL ++ G G YG V+K R ++  G   A+K + V  +E+        EI++LK+     H
Sbjct: 19  ELVEVVGNGTYGQVYKGRHVKT-GQLAAIKVMDVTEDEE---EEIKLEINMLKKYS--HH 72

Query: 85  PNIVRFFDV-IHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQM 142
            NI  ++   I ++    +  L  +L+ E      +   ++      L    +  + R++
Sbjct: 73  RNIATYYGAFIKKSPPGHDDQL--WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI 130

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAP 201
           L+G+  LH+H++IHRD+K QN+L+T    +K+ DFG++   D  +    + + T ++ AP
Sbjct: 131 LRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190

Query: 202 EILL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW 256
           E++      +  Y    DIWS+G    EM    P  C   ++  ++ +F +   P     
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC---DMHPMRALFLIPRNPP---- 243

Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
           P+  S  WS                   K    +E  L  N   R S    L+HP+
Sbjct: 244 PKLKSKKWS------------------KKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 80.3 bits (198), Expect = 3e-17
 Identities = 81/297 (27%), Positives = 135/297 (45%), Gaps = 51/297 (17%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G++G V  A +L+      A+K L+  V L +D +   T+ E  IL      +HP  
Sbjct: 3   LGKGSFGKVMLA-ELKGTDEVYAIKVLKKDVILQDDDVD-CTMTEKRILAL--AAKHP-- 56

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
             F   +H    + +R   ++ + E+V+  DL   +++         + +    ++   +
Sbjct: 57  --FLTALHCCFQTKDR---LFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLAL 109

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT-FDYDMMLTSVVVTLWYRAPEILL 205
            FLH H +I+RDLK  N+L+   G  K+ADFG+ K      +  T+   T  Y APEIL 
Sbjct: 110 MFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQ 169

Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS 265
            L YG  VD W++G +M EM    P F A  E +  + I        +++  + +  +W 
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI--------LHD--DVLYPVWL 219

Query: 266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA-------LEHPYFKE 315
           S E                 A S+L++ +T NP  R+    +        +HP+FKE
Sbjct: 220 SKE-----------------AVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 79.4 bits (196), Expect = 4e-17
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 27/216 (12%)

Query: 26  ELCQIGCGAYGTVFKAR----DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           E+  +G G +G VF A+    + +     V +K L+ K  ++ +     RE+ + ++L  
Sbjct: 9   EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ-KTKDENLQSEFRRELDMFRKL-- 65

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYM-------EKCPPPGLSAS 133
             H N+VR   +  +     E +   Y+I E+ D  DL  ++       EK  PP LS  
Sbjct: 66  -SHKNVVRLLGLCREA----EPH---YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK 117

Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLT 190
           +   L  Q+  G+D L + R +HRDL  +N L++    +K++   L+K     +Y   L 
Sbjct: 118 QKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY-YKLR 176

Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           + ++ L + APE +    + T  D+WS G +M E++
Sbjct: 177 NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 79.6 bits (196), Expect = 4e-17
 Identities = 76/291 (26%), Positives = 132/291 (45%), Gaps = 35/291 (12%)

Query: 30  IGCGAYGTVFKAR---DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G G +G V   R   +  N G  VA+K L+ +   + I     +EI IL+ L    H N
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA-DLKKEIEILRNL---YHEN 67

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QML 143
           IV++     + I +++    + LI E +    GS  E  P    +   +K+  +   Q+ 
Sbjct: 68  IVKY-----KGICTEDGGNGIKLIMEFLPS--GSLKEYLPR-NKNKINLKQQLKYAVQIC 119

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL-----WY 198
           KG+D+L S + +HRDL  +N+L+     +KI DFGL K  + D    +V   L     WY
Sbjct: 120 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
            APE L+   +    D+WS G  + E+      +C S E   +    ++IG P+  +   
Sbjct: 180 -APECLIQSKFYIASDVWSFGVTLYELLT----YCDS-ESSPMTLFLKMIG-PTHGQM-- 230

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE 309
            ++ +    E+  ++       +C  +   L+     F P+ R +  + +E
Sbjct: 231 TVTRLVRVLEEGKRLPRPP---NCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 79.7 bits (196), Expect = 5e-17
 Identities = 71/251 (28%), Positives = 115/251 (45%), Gaps = 41/251 (16%)

Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D     + D L LG         +G G +G V  A      +D   +   VA+K 
Sbjct: 2   YELPEDPRWEFSRDKLTLGKP-------LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKM 54

Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 55  LKDDATEKDLS-DLVSEMEMMKMIG--KHKNIINLLGACTQD-------GPLYVIVEYAS 104

Query: 116 Q-DLGSYMEKCPPPGLSAS-----------KVKEL---TRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y+    PPG+  S             K+L   T Q+ +G+++L S + IHRDL 
Sbjct: 105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA 164

Query: 161 PQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 224

Query: 218 IGCVMAEMWRL 228
            G +M E++ L
Sbjct: 225 FGVLMWEIFTL 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 17/200 (8%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G++G VF A +L+    + A+K L+  V L +D +   T+ E  +L     +EHP +
Sbjct: 3   LGKGSFGKVFLA-ELKGTNQFFAIKALKKDVVLMDDDVE-CTMVEKRVLSL--AWEHPFL 58

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
              +               ++ + E+++  DL  +++ C    L  +       +++ G+
Sbjct: 59  THLYCTFQTK-------ENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGL 109

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMMLTSVVVTLWYRAPEILL 205
            FLHS  I++RDLK  N+L+   G +KIADFG+ K     D    +   T  Y APEILL
Sbjct: 110 QFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL 169

Query: 206 NLGYGTPVDIWSIGCVMAEM 225
              Y T VD WS G ++ EM
Sbjct: 170 GQKYNTSVDWWSFGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 27/215 (12%)

Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISIL 76
           +L D  ++ + ++G G  G V K   +Q+K + + M +  + L  +  I    +RE+ +L
Sbjct: 1   ELKDDDFERISELGAGNGGVVTK---VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL 57

Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            + ++   P IV F+   +    SD     + +  EH+D   G  +++       A ++ 
Sbjct: 58  HECNS---PYIVGFYGAFY----SDGE---ISICMEHMD---GGSLDQVLK---EAKRIP 101

Query: 137 E-----LTRQMLKGVDFL-HSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT 190
           E     ++  +L+G+ +L   H+I+HRD+KP N+L+   G +K+ DFG++     D M  
Sbjct: 102 EEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMAN 160

Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           S V T  Y +PE L    Y    DIWS+G  + E+
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 77.4 bits (191), Expect = 1e-16
 Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 30/218 (13%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR 71
           +N   L LG         IG G +G V        +G  VA+K L+   ++     + L 
Sbjct: 3   INSKELKLGA-------TIGKGEFGDVMLG---DYRGQKVAVKCLK---DDSTAAQAFLA 49

Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLS 131
           E S++  L    HPN+V+   V+ Q          +Y++ E++ +  GS ++     G +
Sbjct: 50  EASVMTTL---RHPNLVQLLGVVLQGN-------PLYIVTEYMAK--GSLVDYLRSRGRA 97

Query: 132 ASKVKEL---TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
              + +       + +G+++L     +HRDL  +N+L++     K++DFGLAK  +    
Sbjct: 98  VITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQG 155

Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
             S  + + + APE L    + T  D+WS G ++ E++
Sbjct: 156 QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 193

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 72/238 (30%), Positives = 112/238 (47%), Gaps = 39/238 (16%)

Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR---- 57
           YE +A+ I  L + + D     +D +  IG GA+G V   R   +K  Y AMK L     
Sbjct: 28  YEKAAEKITKLRMKAED-----FDVIKVIGRGAFGEVQLVRHKSSKQVY-AMKLLSKFEM 81

Query: 58  VKLNEDGIPMSTLREISILKQLDTFEHPN---IVRFFDVIHQNILSDERYLTVYLIFEHV 114
           +K ++              ++ D   H N   IV+           D++YL  Y++ E++
Sbjct: 82  IKRSDSAF---------FWEERDIMAHANSEWIVQLHYA-----FQDDKYL--YMVMEYM 125

Query: 115 -DQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK 173
              DL + M     P   A   +  T +++  +D +HS   IHRD+KP N+L+ ++G LK
Sbjct: 126 PGGDLVNLMSNYDIPEKWA---RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 182

Query: 174 IADFGLAKTFDYDMMLTS--VVVTLWYRAPEILLNLG----YGTPVDIWSIGCVMAEM 225
           +ADFG     D + M+     V T  Y +PE+L + G    YG   D WS+G  + EM
Sbjct: 183 LADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 68/251 (27%), Positives = 114/251 (45%), Gaps = 41/251 (16%)

Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D    +  D L LG         +G G +G V  A      ++  N+   VA+K 
Sbjct: 5   YELPEDPRWEVPRDRLVLGKP-------LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKM 57

Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 58  LKSDATEKDLS-DLISEMEMMKMIG--KHKNIINLLGACTQD-------GPLYVIVEYAS 107

Query: 116 Q-DLGSYMEKCPPPGLSAS-----------KVKELTR---QMLKGVDFLHSHRIIHRDLK 160
           + +L  Y+    PPG+                K+L     Q+ +G+++L S + IHRDL 
Sbjct: 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA 167

Query: 161 PQNLLITRAGGLKIADFGLAKT---FDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 227

Query: 218 IGCVMAEMWRL 228
            G ++ E++ L
Sbjct: 228 FGVLLWEIFTL 238

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 24/215 (11%)

Query: 30  IGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G++G V  A+   +   Y   V  KK  +K  E    M+   E ++L  L   +HP 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMA---ERNVL--LKNVKHPF 57

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM--EKCPPPGLSASKVKELTRQML 143
           +V     +H +  + ++   +Y + ++V+  +L  ++  E+  P      + +    ++ 
Sbjct: 58  LVG----LHYSFQTADK---LYFVLDYVNGGELFFHLQRERSFP----EPRARFYAAEIA 106

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT-FDYDMMLTSVVVTLWYRAPE 202
             + +LHS  II+RDLKP+N+L+   G + + DFGL K   ++    ++   T  Y APE
Sbjct: 107 SALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPE 166

Query: 203 ILLNLGYGTPVDIWSIGCVMAEM-WRLVPLFCAST 236
           +L    Y   VD W +G V+ EM + L P +   T
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (191), Expect = 3e-16
 Identities = 81/300 (27%), Positives = 132/300 (44%), Gaps = 62/300 (20%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQLDTFEHP 85
           IG G++G V + R    +  Y A+K +R    V  +E      TL E ++L Q++    P
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIY-ALKTIRKAHIVSRSE---VTHTLAERTVLAQVNC---P 53

Query: 86  NIVRFFDVIHQNILSDER-YLTVYLI-----FEHVDQDLGSYMEKCPPPGLSASKVKELT 139
            IV     +  +  S E+ YL +  I     F H+ ++ G +           S+ +  T
Sbjct: 54  FIVP----LKFSFQSPEKLYLVLAFINGGELFHHLQRE-GRFDL---------SRARFYT 99

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWY 198
            ++L  ++ LH   +I+RDLKP+N+L+   G + + DFGL K    D   T+    T  Y
Sbjct: 100 AELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
            APE+LL  GY   VD W++G ++ EM   +P F      E +  ++R I    +  +P+
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD----ENVNEMYRKILQEPL-RFPD 214

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE---HPYFKE 315
                                      A  LL  +L+ +P  R+    A E   HP+F +
Sbjct: 215 GFD----------------------RDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 77.1 bits (190), Expect = 3e-16
 Identities = 75/307 (24%), Positives = 131/307 (42%), Gaps = 66/307 (21%)

Query: 30  IGCGAYGTVFKARDLQNK--GNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G GAYG VF  R +     G   AMK               L++ +I+++  T EH   
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMK--------------VLKKATIVQKAKTAEHTRT 53

Query: 88  VR----------FFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVK 136
            R          F   +H    +D +   ++LI ++V+  +L +++        + S+V+
Sbjct: 54  ERQVLEAVRRCPFLVTLHYAFQTDTK---LHLILDYVNGGELFTHL--YQREHFTESEVR 108

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF--DYDMMLTSVVV 194
               +++  +D LH   II+RD+K +N+L+   G + + DFGL+K F  + +    S   
Sbjct: 109 VYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCG 168

Query: 195 TLWYRAPEILL--NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT-- 250
           T+ Y APE++   + G+   VD WS+G +  E+      F    E      I R I    
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK 228

Query: 251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE- 309
           P     P+ +S                      ++A   ++ +L  +P  R+ A  A E 
Sbjct: 229 PPF---PKTMS----------------------AEARDFIQKLLEKDPKKRLGANGADEI 263

Query: 310 --HPYFK 314
             HP+F+
Sbjct: 264 KNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 77.0 bits (189), Expect = 4e-16
 Identities = 82/318 (25%), Positives = 139/318 (43%), Gaps = 53/318 (16%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL- 70
           L L+SL      ++ +  IG G YG V+K  + +  G+  A+K L         P+S + 
Sbjct: 12  LGLESLGDPTDTWEIIETIGKGTYGKVYKVTN-KKDGSLAAVKILD--------PISDVD 62

Query: 71  ----REISILKQLDTFEHPNIVRFFDVIHQ--NILSDERYLTVYLIFEHVDQDLGSYMEK 124
                E +IL+ L    HPN+V+F+ + ++   ++  + +L + L       +L   +  
Sbjct: 63  EEIEAEYNILQSLPN--HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120

Query: 125 CPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD 184
           C    L  + +  +    L G+  LH++RIIHRD+K  N+L+T  GG+K+ DFG++    
Sbjct: 121 CGQR-LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179

Query: 185 YDMML--TSVVVTLWYRAPEIL-----LNLGYGTPVDIWSIGCVMAEMWR-LVPLFCAST 236
              +   TSV    W  APE++      +  Y    D+WS+G    E+     PLF    
Sbjct: 180 STRLRRNTSVGTPFWM-APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF---- 234

Query: 237 EVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTF 296
           ++  +K +F++         P N        E++            C   N  +   L  
Sbjct: 235 DMHPVKTLFKI---------PRNPPPTLLHPEKW------------CRSFNHFISQCLIK 273

Query: 297 NPADRISAADALEHPYFK 314
           +   R S    LEHP+ K
Sbjct: 274 DFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 76.9 bits (189), Expect = 4e-16
 Identities = 56/183 (30%), Positives = 87/183 (47%), Gaps = 17/183 (9%)

Query: 48  GNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTV 107
           G  VA+K L+ +           +EI+ILK L    H NIV++     +   S++    +
Sbjct: 33  GEMVAVKTLKRE-CGQQNTSGWKKEINILKTLY---HENIVKY-----KGCCSEQGGKGL 83

Query: 108 YLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT 167
            LI E+V   LGS  +  P   L+ +++    +Q+ +G+ +LHS   IHRDL  +N+L+ 
Sbjct: 84  QLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD 141

Query: 168 RAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVM 222
               +KI DFGLAK        Y +         WY A E L    +    D+WS G  +
Sbjct: 142 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENKFSYASDVWSFGVTL 200

Query: 223 AEM 225
            E+
Sbjct: 201 YEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 76.2 bits (187), Expect = 5e-16
 Identities = 69/211 (32%), Positives = 107/211 (50%), Gaps = 35/211 (16%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G +G VFK   L++K   VA+K  +  L ++ + +  L E  ILKQ D   HPNIV+
Sbjct: 3   LGKGNFGEVFKG-TLKDK-TPVAVKTCKEDLPQE-LKIKFLSEARILKQYD---HPNIVK 56

Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKEL-TRQMLK--- 144
              V  Q          +Y++ E V   D  S++ K         K  EL T+Q++K   
Sbjct: 57  LIGVCTQR-------QPIYIVMELVPGGDFLSFLRK---------KKDELKTKQLVKFAL 100

Query: 145 ----GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV--VTLWY 198
               G+ +L S   IHRDL  +N L+     LKI+DFG+++  D  +  +S +  + + +
Sbjct: 101 DAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW 160

Query: 199 RAPEILLNLG-YGTPVDIWSIGCVMAEMWRL 228
            APE  LN G Y +  D+WS G ++ E + L
Sbjct: 161 TAPEA-LNYGRYSSESDVWSYGILLWETFSL 190

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.8 bits (187), Expect = 6e-16
 Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 25/206 (12%)

Query: 29  QIGCGAYGTVFKARDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           ++G G +G+V K   L   G    VA+K L+ + +        LRE S++ QLD   HP 
Sbjct: 2   ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLD---HPC 57

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQD-LGSYMEKCPPPGLSASKVKELTRQMLKG 145
           IVR   V     L         L+ E      L  Y++K     +  S +KEL  Q+  G
Sbjct: 58  IVRLIGVCKGEPL--------MLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMG 107

Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYDMMLTSVVVTL-WYRA 200
           + +L S   +HRDL  +N+L+      KI+DFG+++      DY    T+    L WY A
Sbjct: 108 MAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY-A 166

Query: 201 PEILLNLG-YGTPVDIWSIGCVMAEM 225
           PE  +N G + +  D+WS G  + E 
Sbjct: 167 PEC-INYGKFSSKSDVWSYGVTLWEA 191

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 76.2 bits (187), Expect = 7e-16
 Identities = 68/246 (27%), Positives = 117/246 (47%), Gaps = 23/246 (9%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           IG G YG VFK  + +N G+  A+K L    +   I      E +ILK L   +HPN+V+
Sbjct: 26  IGKGTYGKVFKVLNKKN-GSKAAVKILDPIHD---IDEEIEAEYNILKALS--DHPNVVK 79

Query: 90  FFDVIHQN--ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           F+ + ++      D+ +L + L       DL     K     +    +  +  + L G+ 
Sbjct: 80  FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQ 138

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGL-AKTFDYDMMLTSVVVTLWYRAPEIL-- 204
            LH ++ IHRD+K  N+L+T  GG+K+ DFG+ A+     +   + V T ++ APE++  
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 198

Query: 205 ---LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN-EWPENI 260
              L+  Y    D+WS+G    E+    P      ++  ++ +F++   P      PE  
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRNPPPTLHQPE-- 253

Query: 261 SLMWSS 266
             +WS+
Sbjct: 254 --LWSN 257

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 28/203 (13%)

Query: 117 DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD 176
           DL  ++     PG    +      ++L G++ LH    ++RDLKP+N+L+   G ++I+D
Sbjct: 86  DLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISD 145

Query: 177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST 236
            GLA        +   V T+ Y APE+L N  Y    D W +GC++ EM      F    
Sbjct: 146 LGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205

Query: 237 EVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTF 296
           E  + + + R +                      ++  +SA F +   +A S+ + +LT 
Sbjct: 206 EKVKREEVDRRV--------------------LETEEVYSAKFSE---EAKSICKMLLTK 242

Query: 297 NPADRI-----SAADALEHPYFK 314
           +P  R+      A +   HP+F+
Sbjct: 243 DPKQRLGCQEEGAGEVKRHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 75.9 bits (186), Expect = 1e-15
 Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 18/200 (9%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   R+ +  G Y AMK L+  V + +D +   TL E  +LK      HP  
Sbjct: 3   LGKGTFGKVILVRE-KASGKYYAMKILKKEVIIAKDEVA-HTLTESRVLKNT---RHP-- 55

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
             F   +  +  + +R   +  + E+V+  +L  ++ +      S  + +    +++  +
Sbjct: 56  --FLTSLKYSFQTKDR---LCFVMEYVNGGELFFHLSR--ERVFSEDRTRFYGAEIVSAL 108

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLWYRAPEILL 205
           D+LHS +I++RDLK +NL++ + G +KI DFGL K    D   + +   T  Y APE+L 
Sbjct: 109 DYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE 168

Query: 206 NLGYGTPVDIWSIGCVMAEM 225
           +  YG  VD W +G VM EM
Sbjct: 169 DNDYGRAVDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 74/264 (28%), Positives = 112/264 (42%), Gaps = 35/264 (13%)

Query: 71  REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGL 130
           REI ILK   T  H  I+                 TV ++      DL +Y+++  P  L
Sbjct: 135 REIDILK---TISHRAIINLIHAYRWKS-------TVCMVMPKYKCDLFTYVDRSGP--L 182

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD---YDM 187
              +   + R++L+ + +LH   IIHRD+K +N+ +       + DFG A   D      
Sbjct: 183 PLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242

Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW-RLVPLFC--ASTEVEQLKCI 244
                  TL   +PE+L    Y    DIWS G V+ EM  + V LF     +   QL+ I
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSI 302

Query: 245 FRVIGTPSMNEWPENISL-MWSSFEQYSK-----------VAFSAIFMDCCSKANSLLES 292
            R +    + E+P+N S  +   F+QY+            +    + MD       L+  
Sbjct: 303 IRCMQVHPL-EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMD----VEYLIAK 357

Query: 293 MLTFNPADRISAADALEHPYFKEK 316
           MLTF+   R SA D L  P F ++
Sbjct: 358 MLTFDQEFRPSAQDILSLPLFTKE 381

Length = 392

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 74.6 bits (183), Expect = 2e-15
 Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 11/197 (5%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V  A  ++N G   A KKL + +L +       L E  IL+++++    N+ 
Sbjct: 1   LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
             F+         + +L + +   +   DL  ++      GL   +V   + Q+  G+  
Sbjct: 60  YAFE--------SKTHLCLVMSLMN-GGDLKYHIYNVGERGLEMERVIHYSAQITCGILH 110

Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLG 208
           LHS  I++RD+KP+N+L+   G  +++D GLA        +T    T  Y APEIL    
Sbjct: 111 LHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP 170

Query: 209 YGTPVDIWSIGCVMAEM 225
           Y  PVD +++GC + EM
Sbjct: 171 YSYPVDWFAMGCSIYEM 187

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 40/182 (21%)

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEIL 204
           G++ LH  RI++RDLKP+N+L+   G ++I+D GLA        +   V T+ Y APE++
Sbjct: 114 GLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 173

Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLF------CASTEVEQLKCIFRVIGTPSMNEWPE 258
            N  Y    D W++GC++ EM      F          EVE+L           + E  E
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL-----------VKEVQE 222

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYF 313
                           +S  F      A SL + +L  +P +R+      A +  EHP F
Sbjct: 223 E---------------YSEKFSPD---ARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264

Query: 314 KE 315
           K+
Sbjct: 265 KQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 74.6 bits (183), Expect = 3e-15
 Identities = 78/302 (25%), Positives = 126/302 (41%), Gaps = 48/302 (15%)

Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           LG   + E+C     A G ++  + L+ K         R+K    G  M+ L E  IL++
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKK---------RIK-KRKGEAMA-LNEKRILEK 56

Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
           +++       RF   +     + +    V  I      DL  ++     PG    +    
Sbjct: 57  VNS-------RFVVSLAYAYETKDALCLVLTIMN--GGDLKFHIYNMGNPGFDEQRAIFY 107

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWY 198
             ++  G++ L   RI++RDLKP+N+L+   G ++I+D GLA        +   V T+ Y
Sbjct: 108 AAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGY 167

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
            APE++ N  Y    D W +GC++ EM +    F    E        RV       +  E
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE--------RV-------KREE 212

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYF 313
               +    E+YS+  FS         A S+   +LT NP +R+      AA   +HP F
Sbjct: 213 VDRRVKEDQEEYSE-KFS-------EDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF 264

Query: 314 KE 315
           K 
Sbjct: 265 KN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 50/182 (27%), Positives = 75/182 (41%), Gaps = 45/182 (24%)

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW----YRA 200
           G+ +LH ++I++RDLK  NLL+   G +KIADFGL K     M       T      + A
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE---GMGFGDRTSTFCGTPEFLA 169

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE---WP 257
           PE+L    Y   VD W +G ++ EM      F    E E    I        +N+   +P
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI--------VNDEVRYP 221

Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPY 312
             +S                       +A S++  +L  NP  R+      A D  + P+
Sbjct: 222 RFLSR----------------------EAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259

Query: 313 FK 314
           F+
Sbjct: 260 FR 261

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 37/181 (20%)

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT-FDYDMMLTSVVVTLWYR 199
           +++  + +LHS  +++RDLK +NL++ + G +KI DFGL K        + +   T  Y 
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 162

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMW--RLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           APE+L +  YG  VD W +G VM EM   RL P +    E      +F +I    +  +P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRL-PFYNQDHEK-----LFELILMEEI-RFP 215

Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA--DALE---HPY 312
             +S                       +A SLL  +L  +P  R+     DA E   H +
Sbjct: 216 RTLS----------------------PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253

Query: 313 F 313
           F
Sbjct: 254 F 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 74.6 bits (183), Expect = 3e-15
 Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 34/223 (15%)

Query: 30  IGCGAYGTVFKA------RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +G G +G V +A      +   ++   VA+K L+    +  +    + E+ ++K +   +
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLA-DLISEMELMKLIG--K 76

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG------------- 129
           H NI+    V  Q          +Y+I E+  + +L  ++    PPG             
Sbjct: 77  HKNIINLLGVCTQE-------GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129

Query: 130 -LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDY 185
            LS   +     Q+ +G+++L S R IHRDL  +N+L+T    +KIADFGLA+     DY
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY 189

Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
               ++  + + + APE L +  Y    D+WS G +M E++ L
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 65/236 (27%), Positives = 111/236 (47%), Gaps = 34/236 (14%)

Query: 30  IGCGAYGTVFKA------RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +G G +G V  A      +D  NK   VA+K L+    +  +    + E+ ++K +   +
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS-DLVSEMEMMKMIG--K 76

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSAS--------- 133
           H NI+       Q+         +Y++ E+  + +L  Y+    PPG+  S         
Sbjct: 77  HKNIINLLGACTQD-------GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE 129

Query: 134 --KVKELTR---QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDY 185
               K+L     Q+ +G+++L S + IHRDL  +N+L+T    +KIADFGLA+     DY
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY 189

Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL 241
               T+  + + + APE L +  Y    D+WS G ++ E++ L         VE+L
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 48/213 (22%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 29  QIGCGAYGTVFK--ARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           ++G G++G V++  A+ +        VA+K +    +     +  L E S++K+ +    
Sbjct: 13  ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER-IEFLNEASVMKEFNC--- 68

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM--------EKCPPPGLSASKV 135
            ++VR   V+     S  +     ++ E + + DL SY+                +  K 
Sbjct: 69  HHVVRLLGVV-----STGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121

Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSV 192
            ++  ++  G+ +L + + +HRDL  +N ++     +KI DFG+ +     DY       
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKG 181

Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           ++ + + APE L +  + T  D+WS G V+ EM
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 67/238 (28%), Positives = 114/238 (47%), Gaps = 39/238 (16%)

Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN 61
           Y+ + + I+ L + + D     Y+ +  IG GA+G V               + +R K  
Sbjct: 28  YKDTINKIRDLRMKAED-----YEVVKVIGRGAFGEV---------------QLVRHKST 67

Query: 62  EDGIPMSTLREISILKQLDT---FEHPNIVRFFD----VIHQNILSDERYLTVYLIFEHV 114
                M  L +  ++K+ D+   +E  +I+ F +    V       D+RYL  Y++ E++
Sbjct: 68  RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL--YMVMEYM 125

Query: 115 -DQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK 173
              DL + M     P   A   +  T +++  +D +HS   IHRD+KP N+L+ ++G LK
Sbjct: 126 PGGDLVNLMSNYDVPEKWA---RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 182

Query: 174 IADFGLAKTFDYDMML--TSVVVTLWYRAPEILLNLG----YGTPVDIWSIGCVMAEM 225
           +ADFG     + + M+   + V T  Y +PE+L + G    YG   D WS+G  + EM
Sbjct: 183 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 33/176 (18%)

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEI 203
           G+ FLHS  II+RDLK  N+++   G +KIADFG+ K   +    T     T  Y APEI
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEI 172

Query: 204 LLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM 263
           +    YG  VD W+ G ++ EM    P F    E E    +F+ I   +++ +P+++S  
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----LFQSIMEHNVS-YPKSLS-- 225

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA-----DALEHPYFK 314
                                +A S+ + +LT +PA R+        D  EH +F+
Sbjct: 226 --------------------KEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 17/200 (8%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G++G V  A +L+ KG Y A+K L+  V L +D +   T+ E  +L     +E+P  
Sbjct: 3   LGKGSFGKVLLA-ELKGKGEYFAVKALKKDVVLIDDDVE-CTMVEKRVLAL--AWENP-- 56

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELTRQMLKGV 146
             F   ++    + E    ++ + E ++   G  M      G     +      +++ G+
Sbjct: 57  --FLTHLYCTFQTKEH---LFFVMEFLNG--GDLMFHIQDKGRFDLYRATFYAAEIVCGL 109

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY-DMMLTSVVVTLWYRAPEILL 205
            FLHS  II+RDLK  N+++ R G +KIADFG+ K   + D   ++   T  Y APEIL 
Sbjct: 110 QFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ 169

Query: 206 NLGYGTPVDIWSIGCVMAEM 225
            L Y   VD WS G ++ EM
Sbjct: 170 GLKYTFSVDWWSFGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 71.7 bits (176), Expect = 2e-14
 Identities = 62/238 (26%), Positives = 114/238 (47%), Gaps = 34/238 (14%)

Query: 29  QIGCGAYGTVFKA--RDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           ++G GA+G VF      L+ + +   VA+K L+ +   +       RE  +L     F+H
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLT---NFQH 67

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM------------EKCPPPGLS 131
            NIV+F+ V  +    D       ++FE+++  DL  ++               P   L+
Sbjct: 68  ENIVKFYGVCTE---GDP----PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120

Query: 132 ASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYDMM 188
            S++ ++  Q+  G+ +L S   +HRDL  +N L+     +KI DFG+++   T DY  +
Sbjct: 121 LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRV 180

Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL--VPLFCASTEVEQLKCI 244
               ++ + +  PE ++   + T  D+WS G V+ E++     P +  S E E ++CI
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-EVIECI 237

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 71.3 bits (175), Expect = 2e-14
 Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 20/201 (9%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V++   L N    VA+K L+    +   P   L E  I+K+L    HP ++
Sbjct: 13  KLGAGQFGEVWEG--LWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKL---RHPKLI 64

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + + V       +E    +Y++ E +    L  Y++      L   ++ ++  Q+  G+ 
Sbjct: 65  QLYAVCTL----EE---PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL---WYRAPEIL 204
           +L +   IHRDL  +N+L+      K+ADFGLA+    D+            W  APE  
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKW-TAPEAA 176

Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
           L   +    D+WS G ++ E+
Sbjct: 177 LYNRFSIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 70.8 bits (173), Expect = 3e-14
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 19/202 (9%)

Query: 29  QIGCGAYGTVFKARDLQNKG-NYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           ++G G +GTV K      K    VA+K L+   N+  +    LRE ++++QLD   +P I
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD---NPYI 58

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           VR        I   E ++ V  + E     L  +++K     ++   + EL  Q+  G+ 
Sbjct: 59  VRMI-----GICEAESWMLVMELAEL--GPLNKFLQK--NKHVTEKNITELVHQVSMGMK 109

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWYRAPE 202
           +L     +HRDL  +N+L+      KI+DFGL+K        Y           WY APE
Sbjct: 110 YLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APE 168

Query: 203 ILLNLGYGTPVDIWSIGCVMAE 224
            +    + +  D+WS G +M E
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 71.3 bits (175), Expect = 3e-14
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 41/224 (18%)

Query: 29  QIGCGAYGTVFKARDLQNKGNY----VAMKKLR----VKLNEDGIPMSTLREISILKQLD 80
           ++G GA+G V+K              VA+K L+     K+ ++       +E  ++  L 
Sbjct: 12  ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE-----FRQEAELMSDL- 65

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPP---PG------- 129
             +HPNIV    V  +            ++FE++   DL  ++ +  P    G       
Sbjct: 66  --QHPNIVCLLGVCTKEQ-------PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116

Query: 130 ----LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---T 182
               L  S    +  Q+  G+++L SH  +HRDL  +N L+     +KI+DFGL++   +
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176

Query: 183 FDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
            DY  + +  ++ + +  PE +L   + T  DIWS G V+ E++
Sbjct: 177 ADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 70.9 bits (174), Expect = 5e-14
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 25/208 (12%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTF 82
           +++L ++G G  G V K          +  +KL + L  +  I    +RE+ +L + ++ 
Sbjct: 3   FEKLGELGAGNGGVVTKVL--HRPSGLIMARKL-IHLEIKPAIRNQIIRELKVLHECNS- 58

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC---PPPGLSASKVKEL 138
             P IV F+   +    SD     + +  EH+D   L   ++K    P   L      ++
Sbjct: 59  --PYIVGFYGAFY----SDGE---ISICMEHMDGGSLDQVLKKAGRIPENILG-----KI 104

Query: 139 TRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
           +  +L+G+ +L   H+I+HRD+KP N+L+   G +K+ DFG++     D M  S V T  
Sbjct: 105 SIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRS 163

Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           Y +PE L    Y    DIWS+G  + EM
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 71.2 bits (174), Expect = 5e-14
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQLDTFEHP 85
           IG G++G V  A+  ++ G++ A+K L+    +K  E    M+   E ++L  L   +HP
Sbjct: 3   IGKGSFGKVLLAKR-KSDGSFYAVKVLQKKTILKKKEQNHIMA---ERNVL--LKNLKHP 56

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM--EKCPPPGLSASKVKELTRQM 142
            +V     +H +  + E+   +Y + ++V+  +L  ++  E+C        + +    ++
Sbjct: 57  FLVG----LHYSFQTAEK---LYFVLDYVNGGELFFHLQRERC----FLEPRARFYAAEV 105

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAP 201
              + +LHS  II+RDLKP+N+L+   G + + DFGL K        TS    T  Y AP
Sbjct: 106 ASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAP 165

Query: 202 EILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL 241
           E+L    Y   VD W +G V+ EM   +P F  S +V Q+
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF-YSRDVSQM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 57/196 (29%), Positives = 87/196 (44%), Gaps = 25/196 (12%)

Query: 33  GAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD 92
           GA G  F   D +   + V      +K  + G    T  E  IL+ ++   HP+I++   
Sbjct: 103 GAEGFAFACIDNKTCEHVV------IKAGQRG---GTATEAHILRAIN---HPSIIQLKG 150

Query: 93  VIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH 152
               N  +        LI      DL  Y+       ++   +  + R +L+ + +LH +
Sbjct: 151 TFTYNKFT-------CLILPRYKTDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHEN 201

Query: 153 RIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV---VVTLWYRAPEILLNLGY 209
           RIIHRD+K +N+ I   G + + DFG A  F  D+          T+   APE+L    Y
Sbjct: 202 RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIATNAPELLARDPY 260

Query: 210 GTPVDIWSIGCVMAEM 225
           G  VDIWS G V+ EM
Sbjct: 261 GPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 70.6 bits (173), Expect = 6e-14
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 39/225 (17%)

Query: 30  IGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP 85
           IG GA+G VF+AR            VA+K L+ + + D +     RE +++ +   F+HP
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQADFQREAALMAE---FDHP 68

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC------------------- 125
           NIV+   V             + L+FE++   DL  ++                      
Sbjct: 69  NIVKLLGVCAVG-------KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121

Query: 126 -PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF- 183
             P  LS ++   + +Q+  G+ +L   + +HRDL  +N L+     +KIADFGL++   
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 184 --DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
             DY     +  + + +  PE +    Y T  D+W+ G V+ E++
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 226

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 70/238 (29%), Positives = 113/238 (47%), Gaps = 39/238 (16%)

Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN 61
           YE     I+ L + + D     YD +  IG GA+G V               + +R K +
Sbjct: 28  YEKIVRKIRKLQMKAED-----YDVVKVIGRGAFGEV---------------QLVRHKSS 67

Query: 62  EDGIPMSTLREISILKQLDT---FEHPNIVRFFD----VIHQNILSDERYLTVYLIFEHV 114
           +    M  L +  ++K+ D+   +E  +I+ F +    V       D++YL  Y++ E++
Sbjct: 68  QKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL--YMVMEYM 125

Query: 115 -DQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK 173
              DL + M     P   A   K  T +++  +D +HS  +IHRD+KP N+L+ + G LK
Sbjct: 126 PGGDLVNLMSNYDVPEKWA---KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLK 182

Query: 174 IADFGLAKTFDYDMML--TSVVVTLWYRAPEILLNLG----YGTPVDIWSIGCVMAEM 225
           +ADFG     D   M+   + V T  Y +PE+L + G    YG   D WS+G  + EM
Sbjct: 183 LADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 38/95 (40%), Positives = 58/95 (61%), Gaps = 2/95 (2%)

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           Q++   ++L S  I++RDLKP+NLL+ + G +K+ DFG AK    D    ++  T  Y A
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYTLCGTPEYIA 196

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAS 235
           PEILLN+G+G   D W++G  + E+    P F A+
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231

Length = 340

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 70.3 bits (172), Expect = 7e-14
 Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 18/149 (12%)

Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA------- 180
           PG    +    T Q++ G++ LH  RII+RDLKP+N+L+   G ++I+D GLA       
Sbjct: 92  PGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ 151

Query: 181 -KTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV-PLFCASTEV 238
            KT  Y         T  + APE+L    Y   VD +++G  + EM     P      +V
Sbjct: 152 SKTKGY-------AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV 204

Query: 239 EQLKCIFRVIGTPSMNEWPENISLMWSSF 267
           E  +   R++       +P+  S    SF
Sbjct: 205 ENKELKQRILNDSV--TYPDKFSPASKSF 231

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 69.5 bits (170), Expect = 9e-14
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)

Query: 27  LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           L ++G G +G V         G +     + +K+ ++G  MS    I   K +    H  
Sbjct: 9   LKELGTGQFGVV-------KYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEK 60

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQD-LGSYMEKCPPPGLSASKVKELTRQMLKG 145
           +V+ + V      + +R   +Y++ E++    L +Y+ +        S++ E+ + + +G
Sbjct: 61  LVQLYGVC-----TKQR--PIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEG 112

Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR--APEI 203
           + +L S + IHRDL  +N L+   G +K++DFGL++    D   +SV      R   PE+
Sbjct: 113 MAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172

Query: 204 LLNLGYGTPVDIWSIGCVMAEMWRL 228
           LL   + +  D+W+ G +M E++ L
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSL 197

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 75/304 (24%), Positives = 121/304 (39%), Gaps = 46/304 (15%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLRE-ISILKQLD 80
           K +D    +G G +G V   R+    G+  AMK ++  +      +S   E   IL   +
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELT 139
           +   P +        Q    D+  L  YL+ E     DL S + +           +   
Sbjct: 60  SPWIPQL--------QYAFQDKDNL--YLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYL 108

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV--VVTLW 197
            +++  +  +H    +HRD+KP+N+LI R G +K+ADFG A     + M+ S   V T  
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168

Query: 198 YRAPEILLNLG------YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           Y APE+L  +       YG   D WS+G +  EM      F   T  +    I       
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI------- 221

Query: 252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
            MN +   +      F +  KV+         S    L++S+L     +R+       HP
Sbjct: 222 -MN-FQRFL-----KFPEDPKVS---------SDFLDLIQSLLC-GQKERLGYEGLCCHP 264

Query: 312 YFKE 315
           +F +
Sbjct: 265 FFSK 268

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 20/201 (9%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHP-- 85
           +G G +G V   R+ +  G Y AMK LR  V + +D +   T+ E  +L+      HP  
Sbjct: 3   LGKGTFGKVILVRE-KATGRYYAMKILRKEVIIAKDEVA-HTVTESRVLQNT---RHPFL 57

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKG 145
             +++    H  +     Y     +F H+ +      E+      +  + +    +++  
Sbjct: 58  TALKYAFQTHDRLCFVMEYANGGELFFHLSR------ERV----FTEERARFYGAEIVSA 107

Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLWYRAPEIL 204
           +++LHS  +++RD+K +NL++ + G +KI DFGL K    D   + +   T  Y APE+L
Sbjct: 108 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 167

Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
            +  YG  VD W +G VM EM
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEM 188

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 69.1 bits (169), Expect = 1e-13
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 25/203 (12%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V+      N    VA+K L+        P + L E +++KQL   +HP +V
Sbjct: 13  KLGAGQFGEVWMG--YYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQL---QHPRLV 64

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           R + V+ Q          +Y+I E+++   L  +++      L+ +K+ ++  Q+ +G+ 
Sbjct: 65  RLYAVVTQE--------PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT--SVVVTLWYRAPEILL 205
           F+     IHRDL+  N+L++     KIADFGLA+  + +           + + APE   
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA-- 174

Query: 206 NLGYGT---PVDIWSIGCVMAEM 225
            + YGT     D+WS G ++ E+
Sbjct: 175 -INYGTFTIKSDVWSFGILLTEI 196

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 69.1 bits (169), Expect = 1e-13
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 19/201 (9%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 13  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 64

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    ++A  +  +  Q+   +
Sbjct: 65  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML--TSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++    D           + + APE L
Sbjct: 118 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 177

Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
               +    D+W+ G ++ E+
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 21/202 (10%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   ++ +  G Y AMK L+  V + +D +   TL E  +L+      HP +
Sbjct: 3   LGKGTFGKVILVKE-KATGRYYAMKILKKEVIVAKDEVA-HTLTENRVLQN---SRHPFL 57

Query: 88  --VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKG 145
             +++    H  +     Y     +F H+ ++             S  + +    +++  
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHLSRE----------RVFSEDRARFYGAEIVSA 107

Query: 146 VDFLHSHR-IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLWYRAPEI 203
           +D+LHS + +++RDLK +NL++ + G +KI DFGL K    D   + +   T  Y APE+
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 167

Query: 204 LLNLGYGTPVDIWSIGCVMAEM 225
           L +  YG  VD W +G VM EM
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 31/226 (13%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G++G V  A + +      A+K L+  V + +D +   T+ E  +L   D  + P  
Sbjct: 8   LGKGSFGKVMLA-ERKGTDELYAIKILKKDVVIQDDDVE-CTMVEKRVLALQD--KPP-- 61

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPPGLSASKVKELT 139
             F   +H    + +R   +Y + E+V+        Q +G + E  P     A+++    
Sbjct: 62  --FLTQLHSCFQTVDR---LYFVMEYVNGGDLMYHIQQVGKFKE--PQAVFYAAEIS--- 111

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWY 198
                G+ FLH   II+RDLK  N+++   G +KIADFG+ K    D + T     T  Y
Sbjct: 112 ----VGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDY 167

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI 244
            APEI+    YG  VD W+ G ++ EM    P F    E E  + I
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 68.8 bits (168), Expect = 2e-13
 Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 19/201 (9%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +IG G +G V+        G ++  +K+ +K   +G  MS    I   + +    HP +V
Sbjct: 11  EIGSGQFGLVWL-------GYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLV 62

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
           + + V  +          + L+FE ++    S   +      S   +  +   + +G+ +
Sbjct: 63  QLYGVCTERS-------PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAY 115

Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW---YRAPEILL 205
           L S  +IHRDL  +N L+     +K++DFG+ + F  D   TS   T +   + +PE+  
Sbjct: 116 LESSNVIHRDLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFS 174

Query: 206 NLGYGTPVDIWSIGCVMAEMW 226
              Y +  D+WS G +M E++
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVF 195

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 69/268 (25%), Positives = 118/268 (44%), Gaps = 37/268 (13%)

Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYM-----EKCP 126
           EI  L +L+   H NI++      + IL  E     Y+I +  D DL S+M     +   
Sbjct: 213 EILALGRLN---HENILKI-----EEILRSEAN--TYMITQKYDFDLYSFMYDEAFDWKD 262

Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-- 184
            P L   + + + +Q+L  V+++H  ++IHRD+K +N+ +   G + + DFG A  F+  
Sbjct: 263 RPLLK--QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320

Query: 185 ---YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW--RLVPLFCASTEVE 239
              +D      V T    +PEIL   GY    DIWS G ++ +M      P+     +  
Sbjct: 321 REAFDYGWVGTVAT---NSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377

Query: 240 QLKCIFRVIGTPSM--NEWPENISLMWS--SFEQYSKVAFSAI----FMDCCSKANSLLE 291
           +   + ++I + S+   E+P+    ++      +      S       +   +     L 
Sbjct: 378 KQ--LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLV 435

Query: 292 SMLTFNPADRISAADALEHPYFKEKENE 319
            MLTF+   R  AA+ L  P F  +E E
Sbjct: 436 KMLTFDWHLRPGAAELLALPLFSAEEEE 463

Length = 501

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 92/337 (27%), Positives = 128/337 (37%), Gaps = 92/337 (27%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQLDTFEHP 85
           IG GA+G V   R +     Y AMK LR    +  N+         E  IL + D     
Sbjct: 9   IGIGAFGEVCLVRKVDTNALY-AMKTLRKADVLMRNQAA---HVKAERDILAEADN---E 61

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCP--PPGLSASKVKELTRQM 142
            +V+ +        S +    +Y + +++   D+ S + +       L+   + ELT   
Sbjct: 62  WVVKLY-------YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTC-- 112

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---------------DM 187
              ++ +H    IHRD+KP N+LI R G +K+ DFGL   F +               D 
Sbjct: 113 --AIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 188 M-----------------------------LTSVVVTLWYRAPEILLNLGYGTPVDIWSI 218
           M                               S+V T  Y APE+LL  GY    D WS+
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230

Query: 219 GCVMAEMWRLVPLFCASTEVE-QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSA 277
           G ++ EM    P F A T  E QLK I           W    +L   S  + S+ A   
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLKVI----------NWET--TLHIPSQAKLSREASDL 278

Query: 278 IFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           I   CC       E  L  N AD I A     HP+FK
Sbjct: 279 ILRLCCGA-----EDRLGKNGADEIKA-----HPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 53/215 (24%), Positives = 104/215 (48%), Gaps = 27/215 (12%)

Query: 29  QIGCGAYGTVFKAR--DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           ++G GA+G VF A   +L  + + + +    +K   D       RE  +L  L   +H +
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL---QHEH 68

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM-----------EKCPPPGLSASK 134
           IV+F+ V  +          + ++FE++   DL  ++           E   P  L+ S+
Sbjct: 69  IVKFYGVCVEGD-------PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYDMMLTS 191
           +  + +Q+  G+ +L S   +HRDL  +N L+     +KI DFG+++   + DY  +   
Sbjct: 122 MLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181

Query: 192 VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
            ++ + +  PE ++   + T  D+WS+G V+ E++
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 23/217 (10%)

Query: 30  IGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G++G V  AR    +  Y   V  KK  +K  E+   MS   E ++L  L   +HP 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMS---ERNVL--LKNVKHP- 56

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY---MEKCPPPGLSASKVKELTRQML 143
              F   +H +  + ++   +Y + ++++     Y    E+C        + +    ++ 
Sbjct: 57  ---FLVGLHFSFQTADK---LYFVLDYINGGELFYHLQRERC----FLEPRARFYAAEIA 106

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMMLTSVVVTLWYRAPE 202
             + +LHS  I++RDLKP+N+L+   G + + DFGL K   +++   ++   T  Y APE
Sbjct: 107 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE 166

Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           +L    Y   VD W +G V+ EM   +P F +    E
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 58/227 (25%)

Query: 26  ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF--- 82
           +L +IG GA+GTV K    +  G  +A+K  R++   D      L     L  LD     
Sbjct: 8   DLGEIGRGAFGTVNKMLH-KPSGTIMAVK--RIRSTVDEKEQKRL-----LMDLDVVMRS 59

Query: 83  -EHPNIVRFFDVIHQ-----------NILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPG 129
            + P IV+F+  + +           +I  D+ Y  VY + +  + +++           
Sbjct: 60  SDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK-------- 111

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL--------AK 181
           ++ + VK L    LK        +IIHRD+KP N+L+ R G +K+ DFG+        AK
Sbjct: 112 IAVATVKAL--NYLK-----EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164

Query: 182 TFDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEM 225
           T D             Y APE +      GY    D+WS+G  + E+
Sbjct: 165 TRD--------AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 67.9 bits (166), Expect = 3e-13
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 39/211 (18%)

Query: 29  QIGCGAYGTVFKARDLQNKGNY-VAMKKLRV-KLNEDGIPMSTLREISILKQLDTFEHPN 86
           ++G G +G V   +    +G   VA+K +R   ++ED      + E  ++ +L    HPN
Sbjct: 11  ELGSGQFGVVHLGK---WRGKIDVAIKMIREGAMSEDDF----IEEAKVMMKL---SHPN 60

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK-CPPPGLSASKVKELTRQML-- 143
           +V+ + V         +   ++++ E        YM   C    L   K K  T  +L  
Sbjct: 61  LVQLYGVC-------TKQRPIFIVTE--------YMANGCLLNYLRERKGKLGTEWLLDM 105

Query: 144 -----KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW- 197
                + +++L S+  IHRDL  +N L+     +K++DFGLA+ +  D   TS   T + 
Sbjct: 106 CSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR-YVLDDQYTSSQGTKFP 164

Query: 198 --YRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
             +  PE+     + +  D+WS G +M E++
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVF 195

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 68.3 bits (167), Expect = 4e-13
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 32/214 (14%)

Query: 30  IGCGAYGTVFKAR--DLQNKGNY----VAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +G GA+G V +A    L          V M K     +E    MS L+ +S L       
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN----- 97

Query: 84  HPNIVRFFDVIHQNILSD-ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQ 141
           H NIV        N+L        + +I E+    DL +++ +     L+   +   + Q
Sbjct: 98  HENIV--------NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVT------ 195
           + KG+ FL S   IHRDL  +N+L+T    +KI DFGLA+    D+M  S  V       
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR----DIMNDSNYVVKGNARL 205

Query: 196 -LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
            + + APE + N  Y    D+WS G ++ E++ L
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 239

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 68.0 bits (166), Expect = 5e-13
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 20/198 (10%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
            +G G  GTV+KA  L      +A+K + + +  + +    + E+ IL + D+   P I+
Sbjct: 8   ILGHGNGGTVYKAYHLLT-RRILAVKVIPLDITVE-LQKQIMSELEILYKCDS---PYII 62

Query: 89  RFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
            F+     +N +S        +  E +D        K P   L    V      ++KG+ 
Sbjct: 63  GFYGAFFVENRIS--------ICTEFMDGGSLDVYRKIPEHVLGRIAVA-----VVKGLT 109

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           +L S +I+HRD+KP N+L+   G +K+ DFG++     + +  + V T  Y APE +   
Sbjct: 110 YLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTYVGTNAYMAPERISGE 168

Query: 208 GYGTPVDIWSIGCVMAEM 225
            YG   D+WS+G    E+
Sbjct: 169 QYGIHSDVWSLGISFMEL 186

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 94/340 (27%), Positives = 132/340 (38%), Gaps = 92/340 (27%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVK--LNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G GA+G V  A  +     Y AMK LR K  LN + +      E  IL + D   +  +
Sbjct: 9   LGIGAFGEVCLACKVDTHALY-AMKTLRKKDVLNRNQVA-HVKAERDILAEAD---NEWV 63

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCP--PPGLSASKVKELTRQMLK 144
           V+ +        S +    +Y + +++   D+ S + +    P  L+   + ELT     
Sbjct: 64  VKLY-------YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTL---- 112

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY------------------- 185
            ++ +H    IHRD+KP N+LI   G +K+ DFGL   F +                   
Sbjct: 113 AIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172

Query: 186 --------------DMMLT---------------SVVVTLWYRAPEILLNLGYGTPVDIW 216
                         D + T               S+V T  Y APE+LL  GY    D W
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232

Query: 217 SIGCVMAEMWRLVPLFCASTEVE-QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAF 275
           S+G ++ EM    P F A T  E QLK    VI   +    P  + L        S  A 
Sbjct: 233 SVGVILFEMLVGQPPFLAPTPTETQLK----VINWENTLHIPPQVKL--------SPEAV 280

Query: 276 SAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             I   CCS      E  L  N AD I A     HP+F E
Sbjct: 281 DLITKLCCSA-----EERLGRNGADDIKA-----HPFFSE 310

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 67.1 bits (164), Expect = 9e-13
 Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 35/219 (15%)

Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           DL ++  + +  +G G  G+V K + +   G  +A K + +      +    LRE+ I+ 
Sbjct: 1   DLRNEDLETISDLGAGNGGSVSKVKHIPT-GTVMAKKVVHIGAKSS-VRKQILRELQIMH 58

Query: 78  QLDTFEHPNIVRFFDV-IHQNILSDERYLTVYLIFEHVDQD-LGSYMEKCPPPGLSASKV 135
           +  +   P IV F+   +++N         + +  E +D   L    +K  P  +    +
Sbjct: 59  ECRS---PYIVSFYGAFLNEN--------NICMCMEFMDCGSLDRIYKKGGP--IPVEIL 105

Query: 136 KELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFG--------LAKTFDYD 186
            ++   +++G+ +L++ HRI+HRD+KP N+L+   G +K+ DFG        +A TF   
Sbjct: 106 GKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF--- 162

Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V T  Y +PE +    Y    D+WS+G  + E+
Sbjct: 163 ------VGTSTYMSPERIQGGKYTVKSDVWSLGISIIEL 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 28/217 (12%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ----LDTFEHP 85
           IG G++G V  A+  +  G   A+K L+ K     I ++   +  I+ +    L   +HP
Sbjct: 3   IGKGSFGKVLLAKR-KLDGKCYAVKVLQKK-----IVLNRKEQKHIMAERNVLLKNVKHP 56

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEK---CPPPGLSASKVKELTRQ 141
               F   +H +  + E+   +Y + + V+  +L  ++++    P P     + +    +
Sbjct: 57  ----FLVGLHYSFQTTEK---LYFVLDFVNGGELFFHLQRERSFPEP-----RARFYAAE 104

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT-FDYDMMLTSVVVTLWYRA 200
           +   + +LHS  I++RDLKP+N+L+   G + + DFGL K         T+   T  Y A
Sbjct: 105 IASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLA 164

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEM-WRLVPLFCAST 236
           PE++    Y   VD W +G V+ EM + L P +C   
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV 201

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 19/204 (9%)

Query: 26  ELC-QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL-REISILKQLDTFE 83
            L  ++G G +G V++          VA+K L+   ++D +      +E+  LK+L    
Sbjct: 9   TLERKLGSGYFGEVWEGLWKNRV--RVAIKILK---SDDLLKQQDFQKEVQALKRL---R 60

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQM 142
           H +++  F V        E    VY+I E +++  L +++       L  + + ++  Q+
Sbjct: 61  HKHLISLFAVCS----VGE---PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQV 113

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS-VVVTLWYRAP 201
            +G+ +L     IHRDL  +N+L+      K+ADFGLA+    D+ L+S   +   + AP
Sbjct: 114 AEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAP 173

Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E   +  + T  D+WS G ++ EM
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 22/203 (10%)

Query: 30  IGCGAYGTVFKARDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V + R          VA+K L+   + D   +  L E SI+ Q   F+HPNI
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQ---FDHPNI 67

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +R   V+        +   V +I E+++   L  ++ +      +  ++  + R +  G+
Sbjct: 68  IRLEGVV-------TKSRPVMIITEYMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGM 119

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWYRAP 201
            +L     +HRDL  +N+L+      K++DFGL++  +     Y      + +  W  AP
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI-RW-TAP 177

Query: 202 EILLNLGYGTPVDIWSIGCVMAE 224
           E +    + +  D+WS G VM E
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWE 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 75/315 (23%), Positives = 134/315 (42%), Gaps = 72/315 (22%)

Query: 26  ELCQI-GCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           EL ++ G GAYG VF  R +   + G   AMK               L++ +++++  T 
Sbjct: 3   ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMK--------------VLQKAALVQKAKTV 48

Query: 83  EHPNIVR----------FFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLS 131
           EH    R          F   +H    ++ +   ++LI ++V   ++ +++ +      S
Sbjct: 49  EHTRTERNVLEHVRQSPFLVTLHYAFQTEAK---LHLILDYVSGGEMFTHLYQ--RDNFS 103

Query: 132 ASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF--DYDMML 189
             +V+  + +++  ++ LH   I++RD+K +N+L+   G + + DFGL+K F  +     
Sbjct: 104 EDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT 163

Query: 190 TSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFC----ASTEVEQLKCI 244
            S   T+ Y APEI+    G+G  VD WS+G ++ E+      F      +T+ E  + I
Sbjct: 164 YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI 223

Query: 245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA 304
            +    P     P  I                         A  LL  +L  +P  R+ A
Sbjct: 224 LKC--DPPF---PSFIGPE----------------------AQDLLHKLLRKDPKKRLGA 256

Query: 305 A-----DALEHPYFK 314
                 +  EHP+FK
Sbjct: 257 GPQGASEIKEHPFFK 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 28/207 (13%)

Query: 30  IGCGAYGTVFKAR---DLQNKGNYVAMKKLRVKLNEDGIPMST---LREISILKQLDTFE 83
           +G GA+GTV+K     + +     VA+K LR    E+  P +    L E  ++  +D   
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR----EETSPKANKEILDEAYVMASVD--- 67

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYME--KCPPPGLSASKVKELTRQ 141
           HP++VR   +     LS      V LI + +   LG  ++  +     + +  +     Q
Sbjct: 68  HPHVVRLLGIC----LSS----QVQLITQLMP--LGCLLDYVRNHKDNIGSQYLLNWCVQ 117

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWY 198
           + KG+ +L   R++HRDL  +N+L+     +KI DFGLAK  D D          V + +
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEM 225
            A E +L+  Y    D+WS G  + E+
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 66.6 bits (162), Expect = 1e-12
 Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 36/213 (16%)

Query: 30  IGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G GAYG VF  R +   + G   AMK               L++ +I+++  T EH   
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMK--------------VLKKATIVQKAKTTEHTRT 53

Query: 88  VR----------FFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVK 136
            R          F   +H    +D +   ++LI ++++  +L +++ +         +V+
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTK---LHLILDYINGGELFTHLSQ--RERFKEQEVQ 108

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF--DYDMMLTSVVV 194
             + +++  ++ LH   II+RD+K +N+L+   G + + DFGL+K F  D      S   
Sbjct: 109 IYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG 168

Query: 195 TLWYRAPEILL--NLGYGTPVDIWSIGCVMAEM 225
           T+ Y AP+I+   + G+   VD WS+G +M E+
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 31/179 (17%)

Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEIL 204
           ++FLH   II+RDLK  N+L+   G +K+ D+G+ K        TS    T  Y APEIL
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168

Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS--- 261
               YG  VD W++G +M EM                +  F ++G   M++ P+  +   
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMM-------------AGRSPFDIVG---MSDNPDQNTEDY 212

Query: 262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA------ADALEHPYFK 314
           L     E+  ++  S        KA+S+L+  L  +P +R+         D   HP+F+
Sbjct: 213 LFQVILEKQIRIPRS-----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 76/294 (25%), Positives = 129/294 (43%), Gaps = 39/294 (13%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR-EISILKQLDTFEHPNIV 88
           IG G+Y  V   R L+      AMK ++ +L  D   +  ++ E  + +Q     HP   
Sbjct: 3   IGRGSYAKVLLVR-LKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN--HP--- 56

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
            F   +H    ++ R   ++ + E+V+  DL  +M++     L     +  + ++   ++
Sbjct: 57  -FLVGLHSCFQTESR---LFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALN 110

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEILLN 206
           +LH   II+RDLK  N+L+   G +K+ D+G+ K        TS    T  Y APEIL  
Sbjct: 111 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170

Query: 207 LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSS 266
             YG  VD W++G +M EM                +  F ++G+    +      L    
Sbjct: 171 EDYGFSVDWWALGVLMFEMM-------------AGRSPFDIVGSSDNPDQNTEDYLFQVI 217

Query: 267 FEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA------ADALEHPYFK 314
            E+  ++  S        KA S+L+S L  +P +R+        AD   HP+F+
Sbjct: 218 LEKQIRIPRSL-----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 27/206 (13%)

Query: 29  QIGCGAYGTVFKA-RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           ++G G +G V K    ++ K   VA+K L+ + NE  +    +RE  I+ QLD   +P I
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLD---NPYI 57

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEH-----VDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           VR   V     L         L+ E      +++ L    ++        S V EL  Q+
Sbjct: 58  VRMIGVCEAEAL--------MLVMEMASGGPLNKFLSGKKDEIT-----VSNVVELMHQV 104

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYDMMLTSVVVTLWY 198
             G+ +L     +HRDL  +N+L+      KI+DFGL+K       Y    ++    L +
Sbjct: 105 SMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKW 164

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAE 224
            APE +    + +  D+WS G  M E
Sbjct: 165 YAPECINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 63/255 (24%), Positives = 117/255 (45%), Gaps = 30/255 (11%)

Query: 30  IGCGAYGTVFKARDLQNKG----NYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP 85
           +G G +G V KA   + KG      VA+K L+   +   +    L E ++LKQ++   HP
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSEL-RDLLSEFNLLKQVN---HP 63

Query: 86  NIVRFFDVIHQN-----ILSDERY--LTVYLIFE------HVDQDLGSYMEKCPPPGLSA 132
           ++++ +    Q+     I+   +Y  L  +L         ++  D          P   A
Sbjct: 64  HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123

Query: 133 SKVKELTR---QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMM 188
             + +L     Q+ +G+ +L   +++HRDL  +N+L+     +KI+DFGL++  ++ D  
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 189 L--TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
           +  +   + + + A E L +  Y T  D+WS G +   +W +V L          + +F 
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVL---LWEIVTLGGNPYPGIAPERLFN 240

Query: 247 VIGTPSMNEWPENIS 261
           ++ T    E PEN S
Sbjct: 241 LLKTGYRMERPENCS 255

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 71/259 (27%), Positives = 108/259 (41%), Gaps = 55/259 (21%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNK--GNYVAMKKLRVKLNEDGIPMSTLR-EISILKQLD 80
           ++ L  IG GA+G V   R +Q K  G+  AMK LR     +   +  +R E  IL + D
Sbjct: 3   FESLKVIGRGAFGEV---RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD 59

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKELT 139
           +     +V+ F        S +  L +YLI E +   D+ + + K     L+  + +   
Sbjct: 60  SLW---VVKMF-------YSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYI 107

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA------------------- 180
            + +  +D +H    IHRD+KP NLL+   G +K++DFGL                    
Sbjct: 108 AETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167

Query: 181 -KTFDYDMMLTSVVVTLWYR----------------APEILLNLGYGTPVDIWSIGCVMA 223
              F +  M +      W R                APE+ +  GY    D WS+G +M 
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227

Query: 224 EMWRLVPLFCASTEVEQLK 242
           EM    P FC+ T  E  K
Sbjct: 228 EMLIGYPPFCSETPQETYK 246

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 65.5 bits (160), Expect = 3e-12
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 37/220 (16%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREI-SILKQLD-------- 80
           +G GA+G V++       G Y       V+L    + + TL E  S   + D        
Sbjct: 14  LGHGAFGEVYE-------GLYRGRDGDAVEL---QVAVKTLPESCSEQDESDFLMEALIM 63

Query: 81  -TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKC-----PPPGLSASK 134
             F H NIVR   V  +      R++ + L+      DL S++ +       P  L+   
Sbjct: 64  SKFNHQNIVRLIGVSFE---RLPRFILLELM---AGGDLKSFLRENRPRPERPSSLTMKD 117

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTF---DYDMM 188
           +    R + KG  +L  +  IHRD+  +N L+T  G     KIADFG+A+      Y   
Sbjct: 118 LLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177

Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
               ++ + +  PE  L+  + +  D+WS G ++ E++ L
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 51/190 (26%), Positives = 81/190 (42%), Gaps = 22/190 (11%)

Query: 51  VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLI 110
           VA+K LR   + D      L+E+ IL +L     PNI R   V       D     +   
Sbjct: 49  VAVKVLRPDAS-DNAREDFLKEVKILSRL---SDPNIARLLGVC----TVDPPLCMIMEY 100

Query: 111 FEHVDQDLGSYMEKC-PPPGLSASKVKELTRQMLK--------GVDFLHSHRIIHRDLKP 161
            E+   DL  +++K        A   K L+   L         G+ +L S   +HRDL  
Sbjct: 101 MEN--GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158

Query: 162 QNLLITRAGGLKIADFGL---AKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSI 218
           +N L+ +   +KIADFG+     + DY  +     + + + A E +L   + T  D+W+ 
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218

Query: 219 GCVMAEMWRL 228
           G  + E+  L
Sbjct: 219 GVTLWEILTL 228

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 70/317 (22%), Positives = 126/317 (39%), Gaps = 57/317 (17%)

Query: 31  GCGAYGTVFKARDLQNKGNYVAMKK--LRVKLNEDGIPMSTL-REISILKQLDTFEHPNI 87
                  V  A+        VA+KK  L     ED   +  L +EI   +Q    +HPNI
Sbjct: 9   CFEDLMIVHLAKHKPT-NTLVAVKKINLDSCSKED---LKLLQQEIITSRQ---LQHPNI 61

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD----QDLGSYMEKCPPPGLSASKVKELTRQML 143
           +      +      +  L  Y++   +     +DL   ++   P GL    +  + + +L
Sbjct: 62  LP-----YVTSFIVDSEL--YVVSPLMAYGSCEDL---LKTHFPEGLPELAIAFILKDVL 111

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF---------GLAKTFDYDMMLTSVVV 194
             +D++HS   IHR +K  ++L++  G + ++           G  +   +D   +SV  
Sbjct: 112 NALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171

Query: 195 TLWYRAPEIL-LNL-GYGTPVDIWSIGCVMAEMWR-LVPLF-CASTE--VEQLK-CIFRV 247
             W  +PE+L  NL GY    DI+S+G    E+    VP     +T+  +E+++  +  +
Sbjct: 172 LPWL-SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCL 230

Query: 248 I---------GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNP 298
           +          + S +           S +      FS  F       +  +E  L  +P
Sbjct: 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHF-------HQFVELCLQRDP 283

Query: 299 ADRISAADALEHPYFKE 315
             R SA+  L H +FK+
Sbjct: 284 ESRPSASQLLNHSFFKQ 300

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 13/198 (6%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           IG G+Y  V   R  +N   Y AMK ++ +L  D   +  ++      +   FE  +   
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIY-AMKVVKKELVHDDEDIDWVQ-----TEKHVFEQASSNP 56

Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
           F   +H    +  R   ++L+ E+V+  DL  +M++     L     +    ++   ++F
Sbjct: 57  FLVGLHSCFQTTSR---LFLVIEYVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNF 111

Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEILLNL 207
           LH   II+RDLK  N+L+   G +K+ D+G+ K        TS    T  Y APEIL   
Sbjct: 112 LHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE 171

Query: 208 GYGTPVDIWSIGCVMAEM 225
            YG  VD W++G +M EM
Sbjct: 172 EYGFSVDWWALGVLMFEM 189

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 64.8 bits (158), Expect = 5e-12
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 20/202 (9%)

Query: 30  IGCGAYGTVFKA--RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V++      +N+   VA+K  +       +    L+E  I++Q D   HP+I
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFD---HPHI 69

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   VI +N         V+++ E     +L SY++      L  + +   + Q+   +
Sbjct: 70  VKLIGVITEN--------PVWIVMELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTAL 120

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL---WYRAPEI 203
            +L S R +HRD+  +N+L++    +K+ DFGL++  + +    +    L   W  APE 
Sbjct: 121 AYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM-APES 179

Query: 204 LLNLGYGTPVDIWSIGCVMAEM 225
           +    + +  D+W  G  M E+
Sbjct: 180 INFRRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 74/322 (22%), Positives = 136/322 (42%), Gaps = 72/322 (22%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ-LDTFEHPNI 87
            +G G  G VF  R L+  G   A+K   V   ++ I  + ++ +   ++ L T +HP +
Sbjct: 8   LLGKGDVGRVFLVR-LKGTGKLFALK---VLDKKEMIKRNKVKRVLTEQEILATLDHPFL 63

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
              +          E YL   L+ ++    +L   +++ P   LS    +    ++L  +
Sbjct: 64  PTLYASFQT-----ETYL--CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT---------------- 190
           ++LH   I++RDLKP+N+L+  +G + ++DF L+K  D +                    
Sbjct: 117 EYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 191 --------------SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST 236
                         S V T  Y APE++   G+G+ VD W++G ++ EM     L+  + 
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM-----LYGTTP 231

Query: 237 EVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTF 296
                   F+     + +E   NI     +F     V+ S         A  L+  +L  
Sbjct: 232 --------FK---GSNRDETFSNILKKEVTFPGSPPVSSS---------ARDLIRKLLVK 271

Query: 297 NPADRI----SAADALEHPYFK 314
           +P+ R+     AA+  +HP+F+
Sbjct: 272 DPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 32/86 (37%), Positives = 51/86 (59%), Gaps = 13/86 (15%)

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMMLTSVVVT---- 195
           ++   +D+LH H IIHRDLKP N+LI+  G +K+ DFGL+K T + ++ +  ++ T    
Sbjct: 112 EVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMA 171

Query: 196 ----LWYRAPEILL----NLGYGTPV 213
                + R P  +L    +LG+ TPV
Sbjct: 172 KPKNDYSRTPGQVLSLISSLGFNTPV 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 75/276 (27%), Positives = 113/276 (40%), Gaps = 72/276 (26%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK---LNEDGIPMSTLREISILKQLD 80
           + ++  +G GA+G V  AR +  K  Y AMK LR K   L      +   R+I     L 
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALY-AMKTLRKKDVLLRNQVAHVKAERDI-----LA 56

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCP--PPGLSASKVKE 137
             ++  +VR +        S +    +Y + +++   D+ S + +    P  L+   + E
Sbjct: 57  EADNEWVVRLY-------YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE 109

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-------------- 183
           LT      V+ +H    IHRD+KP N+LI R G +K+ DFGL   F              
Sbjct: 110 LT----CAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDH 165

Query: 184 ------DYDM----------------------------MLTSVVVTLWYRAPEILLNLGY 209
                 D+                              +  S+V T  Y APE+LL  GY
Sbjct: 166 VRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY 225

Query: 210 GTPVDIWSIGCVMAEMWRLVPLFCASTEVE-QLKCI 244
               D WS+G ++ EM    P F A T +E Q+K I
Sbjct: 226 TQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 33/211 (15%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQLDTFEHP 85
           IG GA+G V   + ++N G   AMK L     +K  E     +  RE     + D   + 
Sbjct: 9   IGRGAFGEVAVVK-MKNTGQVYAMKILNKWEMLKRAE----TACFRE-----ERDVLVNG 58

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEH-VDQDLGSYMEKCP---PPGLSASKVKELTRQ 141
           +  R+   +H     DE  L  YL+ ++ V  DL + + K     P  ++   + E    
Sbjct: 59  D-RRWITNLHY-AFQDENNL--YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAE---- 110

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV--TLWYR 199
           M+  +D +H    +HRD+KP N+L+ + G +++ADFG       D  + S V   T  Y 
Sbjct: 111 MVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYI 170

Query: 200 APEILLNLG-----YGTPVDIWSIGCVMAEM 225
           +PEIL  +      YG   D WS+G  M EM
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEM 201

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 64.3 bits (156), Expect = 7e-12
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 15/206 (7%)

Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G+V + +  Q+     VA+K +++ +         L E   +K+   F+HPN++
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKE---FDHPNVM 63

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM-----EKCPPPGLSASKVKELTRQM 142
           R   V  Q +   E Y +  +I   +   DL S++       CP    +   VK +T  +
Sbjct: 64  RLIGVCLQTV-ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT-DI 121

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYR 199
             G+++L S   IHRDL  +N ++     + +ADFGL+K     DY        + + + 
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEM 225
           A E L +  Y T  D+WS G  M E+
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 65.0 bits (158), Expect = 8e-12
 Identities = 72/259 (27%), Positives = 107/259 (41%), Gaps = 55/259 (21%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNK--GNYVAMKKLRVKLNEDGIPMSTLR-EISILKQLD 80
           ++ L  IG GA+G V   R +Q K  G+  AMK LR     +   ++ +R E  IL + D
Sbjct: 3   FESLKVIGRGAFGEV---RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD 59

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKELT 139
                 +V+ F         D+R L  YLI E +   D+ + + K     LS    +   
Sbjct: 60  G---AWVVKMF-----YSFQDKRNL--YLIMEFLPGGDMMTLLMK--KDTLSEEATQFYI 107

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA------------------- 180
            + +  +D +H    IHRD+KP NLL+   G +K++DFGL                    
Sbjct: 108 AETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167

Query: 181 -KTFDYDMMLTSVVVTLW----------------YRAPEILLNLGYGTPVDIWSIGCVMA 223
              F +  M +      W                Y APE+ +  GY    D WS+G +M 
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227

Query: 224 EMWRLVPLFCASTEVEQLK 242
           EM    P FC+ T  E  +
Sbjct: 228 EMLIGYPPFCSETPQETYR 246

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 40/101 (39%), Positives = 54/101 (53%), Gaps = 1/101 (0%)

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEI 203
           G+ FLHS  II+RDLK  N+++   G +KIADFG+ K   +D + T     T  Y APEI
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI 172

Query: 204 LLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI 244
           +    YG  VD W+ G ++ EM      F    E E  + I
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 50/191 (26%), Positives = 89/191 (46%), Gaps = 32/191 (16%)

Query: 44  LQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK--QLDTFEHPNIVRFFDVIH-QNILS 100
            +NKG+Y+ MK+         +PM  ++E S     Q   ++ P   +  +    +N+LS
Sbjct: 171 FENKGDYMDMKQAD---TTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLS 227

Query: 101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLK 160
           D+                          GL+   +   T Q+ +G++FL S   +HRDL 
Sbjct: 228 DDGS-----------------------EGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA 264

Query: 161 PQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+ +   +KI DFGLA+   +D   +   S  + + + APE + +  Y T  D+WS
Sbjct: 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS 324

Query: 218 IGCVMAEMWRL 228
            G ++ E++ L
Sbjct: 325 YGILLWEIFSL 335

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 19/203 (9%)

Query: 30  IGCGAYGTVFKAR-DLQNKGN-YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V   R  L  K    VA+K L+    E       L E SI+ Q   F+HPNI
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQ---FDHPNI 67

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +    V+        +   V ++ E+++   L +++ K      +  ++  + R +  G+
Sbjct: 68  IHLEGVV-------TKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGM 119

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD----MMLTSVVVTLWYRAPE 202
            +L     +HRDL  +N+L+      K++DFGL++  + D           + + + APE
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179

Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G VM E+
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEV 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 34/207 (16%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP--MST---LREISILKQLDTFEH 84
           +G G +G V+      N    VA+K L+        P  MS    L+E  I+K+L    H
Sbjct: 14  LGAGQFGEVWMG--TWNGTTKVAVKTLK--------PGTMSPEAFLQEAQIMKKLR---H 60

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL---TRQ 141
             +V+ + V      S+E    +Y++ E++ +  GS ++          ++ +L     Q
Sbjct: 61  DKLVQLYAVC-----SEEE--PIYIVTEYMSK--GSLLDFLKSGEGKKLRLPQLVDMAAQ 111

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL---WY 198
           + +G+ +L S   IHRDL  +N+L+      KIADFGLA+  + D             W 
Sbjct: 112 IAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKW- 170

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEM 225
            APE      +    D+WS G ++ E+
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 33/219 (15%)

Query: 29  QIGCGAYGTVFKAR----DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           ++G GA+G VF A       +     VA+K L+ + +E        RE  +L  L   +H
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESA-RQDFQREAELLTVL---QH 66

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM-------------EKCPPPGL 130
            +IVRF+ V      ++ R L   ++FE++   DL  ++             E   P  L
Sbjct: 67  QHIVRFYGVC-----TEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYDM 187
           +  ++  +  Q+  G+ +L S   +HRDL  +N L+ +   +KI DFG+++   + DY  
Sbjct: 120 TLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179

Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           +    ++ + +  PE +L   + T  DIWS G V+ E++
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 55/190 (28%), Positives = 82/190 (43%), Gaps = 24/190 (12%)

Query: 48  GNYVAMKKLRVKLNEDGIPMSTL-REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT 106
           G+ VA+K LR    E+    +   RE ++  +L    HPNIV   D              
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARL---YHPNIVALLD---SGEAPPGLLFA 56

Query: 107 VYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLL 165
           V   FE+V  + L   +       L A +   L  Q+L  +   H+  I+HRDLKPQN++
Sbjct: 57  V---FEYVPGRTLREVLAADGA--LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIM 111

Query: 166 ITRAGG---LKIADFG----LAKTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVD 214
           +++ G     K+ DFG    L    D D+      T V+ T  Y APE L         D
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171

Query: 215 IWSIGCVMAE 224
           +++ G +  E
Sbjct: 172 LYAWGLIFLE 181

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 19/199 (9%)

Query: 41  ARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS 100
           A +   +   VA+K LR  + +       L+EI I+ +L   ++PNI+R   V     +S
Sbjct: 37  APEFDGQPVLVAVKMLRADVTKTA-RNDFLKEIKIMSRL---KNPNIIRLLGVC----VS 88

Query: 101 DERYLTVYLIFEHVDQDL--------GSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH 152
           D+    +    E+ D +          ++      P +S + +  +  Q+  G+ +L S 
Sbjct: 89  DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL 148

Query: 153 RIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRAPEILLNLGY 209
             +HRDL  +N L+     +KIADFG+++     DY  +    V+ + + A E +L   +
Sbjct: 149 NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF 208

Query: 210 GTPVDIWSIGCVMAEMWRL 228
            T  D+W+ G  + EM+ L
Sbjct: 209 TTASDVWAFGVTLWEMFTL 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 37/104 (35%), Positives = 56/104 (53%), Gaps = 3/104 (2%)

Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD- 186
           P LS   +   + Q+  G++FL S   +HRDL  +N+LI     +KI DFGLA+    D 
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDS 293

Query: 187 --MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
             +   S  + L + APE + N  Y T  D+WS G ++ E++ L
Sbjct: 294 NYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL 337

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 62.2 bits (151), Expect = 4e-11
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 21/205 (10%)

Query: 30  IGCGAYGTVFKARDLQ--NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V + R      +  +VA+K L+    E       L E SI+ Q   F+HPNI
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQ---FDHPNI 67

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +    V+ ++         V +I E ++   L S++ +      +  ++  + R +  G+
Sbjct: 68  IHLEGVVTKS-------RPVMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGIAAGM 119

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD---YDMMLTSVV---VTLWYRA 200
            +L     +HRDL  +N+L+      K++DFGL++  +    D   TS +   + + + A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEM 225
           PE +    + +  D+WS G VM E+
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEV 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 56/220 (25%), Positives = 87/220 (39%), Gaps = 75/220 (34%)

Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA----KTFDYD--------------- 186
           ++ +H    IHRD+KP N+LI R G +K++DFGL+    K  D                 
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173

Query: 187 -----MMLTSVVVTL--------W----------------YRAPEILLNLGYGTPVDIWS 217
                + + S+ +T+        W                Y APEI L  GYG   D WS
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233

Query: 218 IGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSA 277
           +G +M E     P FC+    E  +   ++I       +P++I L   S E         
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYR---KIINWRETLYFPDDIHL---SVE--------- 278

Query: 278 IFMDCCSKANSLLESMLTFNPADRI---SAADALEHPYFK 314
                   A  L+  ++T N  +R+    A +   HP+F+
Sbjct: 279 --------AEDLIRRLIT-NAENRLGRGGAHEIKSHPFFR 309

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 61.5 bits (149), Expect = 6e-11
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 17/202 (8%)

Query: 30  IGCGAYGTVFKA--RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G VF+   +    K   VA+K L+    E       L E SI+ Q   F H NI
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQ---FSHHNI 68

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           +R   V+        ++    +I E+++        +      S+ ++  + R +  G+ 
Sbjct: 69  IRLEGVV-------TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMK 121

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAPEI 203
           +L     +HRDL  +N+L+      K++DFGL++  + D   T       + + + APE 
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181

Query: 204 LLNLGYGTPVDIWSIGCVMAEM 225
           +    + +  D+WS G VM E+
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEV 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 34/92 (36%), Positives = 55/92 (59%), Gaps = 5/92 (5%)

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYDMMLTSVVVTL 196
           Q+ +G++FL S + IHRDL  +N+L++    +KI DFGLA+      DY +   S  + L
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLPL 240

Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
            + APE + +  Y T  D+WS G ++ E++ L
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 272

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 60/244 (24%), Positives = 109/244 (44%), Gaps = 43/244 (17%)

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEH-----VDQDLGSYMEKCPPPGLSASKVKE 137
           +H  IV+ FD    +  SD++ L   LI E+     +++ +   +++  P      +V  
Sbjct: 123 DHFGIVKHFD----DFKSDDKLL---LIMEYGSGGDLNKQIKQRLKEHLP--FQEYEVGL 173

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML---TSVVV 194
           L  Q++  +D +HS +++HRDLK  N+ +   G +K+ DFG +K +   + L   +S   
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
           T +Y APE+     Y    D+WS+G ++ E+  L   F   ++ E    I + +     +
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE----IMQQVLYGKYD 289

Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
            +P  +S                      S   +LL+ +L+ NPA R +    L   + K
Sbjct: 290 PFPCPVS----------------------SGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327

Query: 315 EKEN 318
              N
Sbjct: 328 YVAN 331

Length = 478

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 61.5 bits (149), Expect = 8e-11
 Identities = 53/191 (27%), Positives = 94/191 (49%), Gaps = 24/191 (12%)

Query: 51  VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLI 110
           VA+K LR   N++      L+EI I+ +L   + PNI+R   V    I SD     + +I
Sbjct: 49  VAVKMLREDANKNA-RNDFLKEIKIMSRL---KDPNIIRLLAVC---ITSD----PLCMI 97

Query: 111 FEHVDQ-DLGSYMEKCPPPG---------LSASKVKELTRQMLKGVDFLHSHRIIHRDLK 160
            E+++  DL  ++ +  P           +S S +  +  Q+  G+ +L S   +HRDL 
Sbjct: 98  TEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157

Query: 161 PQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N L+ +   +KIADFG+++     DY  +    V+ + + + E +L   + T  D+W+
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWA 217

Query: 218 IGCVMAEMWRL 228
            G  + E+  L
Sbjct: 218 FGVTLWEILTL 228

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 60.8 bits (147), Expect = 9e-11
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 19/198 (9%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           IG G +G V        +GN VA+K ++     D    + L E S++ QL    H N+V+
Sbjct: 14  IGKGEFGDVMLG---DYRGNKVAVKCIK----NDATAQAFLAEASVMTQL---RHSNLVQ 63

Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
              VI       E    +Y++ E++ +  L  Y+       L    + + +  + + +++
Sbjct: 64  LLGVIV------EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117

Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLG 208
           L ++  +HRDL  +N+L++     K++DFGL K        T  +   W  APE L    
Sbjct: 118 LEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-STQDTGKLPVKW-TAPEALREKK 175

Query: 209 YGTPVDIWSIGCVMAEMW 226
           + T  D+WS G ++ E++
Sbjct: 176 FSTKSDVWSFGILLWEIY 193

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 61.6 bits (149), Expect = 9e-11
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 26/212 (12%)

Query: 47  KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF---EHPNIV-----RFFDVIHQNI 98
           +G +  +  +++K  E    M  L +  +LK+ +T    E  N++     ++   +H   
Sbjct: 11  RGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY-A 69

Query: 99  LSDERYLTVYLIFEH-VDQDLGSYMEKCP---PPGLSASKVKELTRQMLKGVDFLHSHRI 154
             DE YL  YL+ ++ V  DL + + K     P  ++   + E    M+  +  +H    
Sbjct: 70  FQDENYL--YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAE----MVLAIHSIHQLHY 123

Query: 155 IHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV--TLWYRAPEILLNL----- 207
           +HRD+KP N+L+   G +++ADFG     + D  + S V   T  Y +PEIL  +     
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183

Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
            YG   D WS+G  M EM      F A + VE
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYDMMLTSVVVTL 196
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+      DY +      + L
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPL 245

Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
            + APE + +  Y    D+WS G ++ E++ L
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 33/220 (15%)

Query: 29  QIGCGAYGTVFKARDL---QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP 85
           ++G  A+G ++K        +    VA+K L+  +N         +E S++ +L    HP
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAEL---HHP 67

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPP---------------PG 129
           NIV    V+ Q          V ++FE+++Q DL  ++    P                 
Sbjct: 68  NIVCLLGVVTQE-------QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYD 186
           L       +  Q+  G+++L SH  +H+DL  +N+LI     +KI+D GL++   + DY 
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY 180

Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
            +    ++ + +  PE ++   + +  DIWS G V+ E++
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 53/192 (27%), Positives = 92/192 (47%), Gaps = 18/192 (9%)

Query: 51  VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN----ILSDERY-- 104
           VA+K LR   N++      L+E+ IL +L   + PNI+R   V        ++++     
Sbjct: 49  VAVKILRPDANKNA-RNDFLKEVKILSRL---KDPNIIRLLGVCVDEDPLCMITEYMENG 104

Query: 105 -LTVYLIFEHVDQDLGSYMEKCPP----PGLSASKVKELTRQMLKGVDFLHSHRIIHRDL 159
            L  +L   H+D    +  +  PP    P +S S +  +  Q+  G+ +L S   +HRDL
Sbjct: 105 DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164

Query: 160 KPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIW 216
             +N L+     +KIADFG+++     DY  +    V+ + + A E +L   + T  D+W
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224

Query: 217 SIGCVMAEMWRL 228
           + G  + E+  L
Sbjct: 225 AFGVTLWEILML 236

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 59.5 bits (144), Expect = 2e-10
 Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 48/235 (20%)

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           PN+V     +H+ I+S++   +V+L+ +H +   L S++ K     +    VK    +M+
Sbjct: 45  PNMVC----LHKYIVSED---SVFLVLQHAEGGKLWSHISK--FLNIPEECVKRWAAEMV 95

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
             +D LH   I+ RDL P N+L+   G +++  F   +  + +       V   Y APE+
Sbjct: 96  VALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENMYCAPEV 153

Query: 204 LLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM 263
                     D WS+G ++ E+          T    ++C    I T +    PE +S  
Sbjct: 154 GGISEETEACDWWSLGAILFELL---------TGKTLVECHPSGINTHTTLNIPEWVS-- 202

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA-----LEHPYF 313
                                +A SLL+ +L FNP +R+ A  A       HP+F
Sbjct: 203 --------------------EEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 40/122 (32%), Positives = 63/122 (51%), Gaps = 9/122 (7%)

Query: 113 HVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL 172
           ++DQD+ S + +     L    +   + Q+ KG+ FL S   IHRDL  +N+L+T     
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253

Query: 173 KIADFGLAKTFDYDMMLTSVVVT------LWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           KI DFGLA+    D   ++ VV       + + APE + N  Y    D+WS G ++ E++
Sbjct: 254 KICDFGLARDIRND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 310

Query: 227 RL 228
            L
Sbjct: 311 SL 312

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.5 bits (144), Expect = 5e-10
 Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 5/92 (5%)

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA----KTFDYDMMLTSVVVTL 196
           Q+ +G++FL S + IHRDL  +N+L++    +KI DFGLA    K  DY +      + L
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPL 239

Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
            + APE + +  Y T  D+WS G ++ E++ L
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 67/236 (28%), Positives = 100/236 (42%), Gaps = 41/236 (17%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG-IPMSTLREISILKQLDT 81
           +YD +  IG G  G V+ A D       VA+KK+R  L+E+  +    LRE  I   L  
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVC-SRRVALKKIREDLSENPLLKKRFLREAKIAADL-- 59

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTV-YLIFEHVDQDLGSYMEK--CPPPGLSASKVKEL 138
             HP IV  + +       D  Y T+ Y+    +   L S  +K          + V   
Sbjct: 60  -IHPGIVPVYSICSD---GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115

Query: 139 TRQMLK---GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT----------FDY 185
                K    ++++HS  ++HRDLKP N+L+   G + I D+G A             D 
Sbjct: 116 LSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 186 DMM------LT---SVVVTLWYRAPEILLNLGYGTP----VDIWSIGCVMAEMWRL 228
           D        +T    +V T  Y APE LL    G P     DI+++G ++ +M  L
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLL----GVPASESTDIYALGVILYQMLTL 227

Length = 932

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.8 bits (142), Expect = 5e-10
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 33/193 (17%)

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
            S ++++    +++ G++ +H+  +++RDLKP N+L+   G ++I+D GLA  F      
Sbjct: 94  FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153

Query: 190 TSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
            S V T  Y APE+L   + Y +  D +S+GC++ ++ R    F      ++ +      
Sbjct: 154 AS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DR 209

Query: 249 GTPSMN-EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI----- 302
            T +M  E P++ S                       +  SLLE +L  +   R+     
Sbjct: 210 MTLTMAVELPDSFSP----------------------ELRSLLEGLLQRDVNRRLGCLGR 247

Query: 303 SAADALEHPYFKE 315
            A +  EHP+F+ 
Sbjct: 248 GAQEVKEHPFFRS 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 58.5 bits (141), Expect = 6e-10
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 21/201 (10%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V+      N    VA+K L+        P S L E  I+K+L    H  +V
Sbjct: 13  KLGNGQFGEVW--MGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKL---RHDKLV 64

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + + V+ +          +Y++ E++ +  L  +++      L    + ++  Q+  G+ 
Sbjct: 65  QLYAVVSEE--------PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS---VVVTLWYRAPEIL 204
           ++     IHRDL+  N+L+      KIADFGLA+  + D   T+       + + APE  
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 175

Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
           L   +    D+WS G ++ E+
Sbjct: 176 LYGRFTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 65/263 (24%), Positives = 120/263 (45%), Gaps = 37/263 (14%)

Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDG-IPMSTLR 71
           + +D+  +++  L  +G G +G V +A D + K  Y A+K +R   K   D  I +  + 
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRK-EYCAVKIVRNVPKYTRDAKIEIQFME 180

Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLS 131
           ++      D F    I R+F    QN   +  ++ +  +       L  ++ K  P   S
Sbjct: 181 KVRQADPADRFPLMKIQRYF----QN---ETGHMCI--VMPKYGPCLLDWIMKHGP--FS 229

Query: 132 ASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRAGG----------------LKI 174
              + ++  Q    +D+ H+   ++H DLKP+N+L+  +                  ++I
Sbjct: 230 HRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRI 289

Query: 175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCA 234
            D G     D     T++V T  YR+PE++L LG+    D+WS+GC++ E++    L+  
Sbjct: 290 CDLG--GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347

Query: 235 STEVEQLKCIFRVIGT-PSMNEW 256
              +E L  + + +G  PS  EW
Sbjct: 348 HDNLEHLHLMEKTLGRLPS--EW 368

Length = 467

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.5 bits (141), Expect = 8e-10
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 26/207 (12%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G +G V+  R   + G   AMK   K R+K+ +       L E  +L  + T + P 
Sbjct: 2   IGRGGFGEVYGCRK-ADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPF 58

Query: 87  IVRFFDVIHQNILSDERYLTVYL-----IFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
           IV      H     D+    + L     +  H+ Q  G + EK         +++    +
Sbjct: 59  IVCMTYAFHT---PDKLCFILDLMNGGDLHYHLSQH-GVFSEK---------EMRFYATE 105

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           ++ G++ +H+  +++RDLKP N+L+   G ++I+D GLA  F       S V T  Y AP
Sbjct: 106 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAP 164

Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWR 227
           E+L     Y +  D +S+GC++ ++ R
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 58.5 bits (142), Expect = 8e-10
 Identities = 81/329 (24%), Positives = 129/329 (39%), Gaps = 79/329 (24%)

Query: 17  LDLGDKKYD-------ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           L +  +KY         L +IG G  G V+K R  +  G+ +A+K++R   N++      
Sbjct: 3   LTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKT-GHVMAVKQMRRTGNKE------ 55

Query: 70  LREIS-ILKQLD----TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK 124
             E   IL  LD    + + P IV+ +     +  SD     V++  E         M  
Sbjct: 56  --ENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SD-----VFICME--------LMST 98

Query: 125 C----------PPPGLSASKVKELTRQMLKGVDFL-HSHRIIHRDLKPQNLLITRAGGLK 173
           C          P P     K   +T  ++K + +L   H +IHRD+KP N+L+  +G +K
Sbjct: 99  CLDKLLKRIQGPIPEDILGK---MTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVK 155

Query: 174 IADFGLAKTFDYDMMLTSVVVTLWYRAPEIL----LNLGYGTPVDIWSIGCVMAEMWR-L 228
           + DFG++         T       Y APE +     N  Y    D+WS+G  + E+    
Sbjct: 156 LCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Query: 229 VPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANS 288
            P     TE E L        T  + E P ++              FS  F        S
Sbjct: 216 FPYKNCKTEFEVL--------TKILQEEPPSLPP---------NEGFSPDFC-------S 251

Query: 289 LLESMLTFNPADRISAADALEHPYFKEKE 317
            ++  LT +   R    + L+HP+ +  E
Sbjct: 252 FVDLCLTKDHRKRPKYRELLQHPFIRRYE 280

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 25/203 (12%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST---LREISILKQLDTFEHP 85
           ++G G +G V+ A    NK   VA+K ++         MS    L E +++K L   +H 
Sbjct: 13  KLGAGQFGEVWMAT--YNKHTKVAVKTMKPG------SMSVEAFLAEANVMKTL---QHD 61

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLK 144
            +V+   V+ +          +Y+I E + +  L  +++          K+ + + Q+ +
Sbjct: 62  KLVKLHAVVTKE--------PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT--SVVVTLWYRAPE 202
           G+ F+     IHRDL+  N+L++ +   KIADFGLA+  + +           + + APE
Sbjct: 114 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173

Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    +    D+WS G ++ E+
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEI 196

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 57.8 bits (139), Expect = 1e-09
 Identities = 47/201 (23%), Positives = 95/201 (47%), Gaps = 21/201 (10%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V+      N    VA+K L+        P + L+E  ++K+L    H  +V
Sbjct: 13  KLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKL---RHEKLV 64

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + + V+ +          +Y++ E++ +  L  +++      L   ++ ++  Q+  G+ 
Sbjct: 65  QLYAVVSEE--------PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS---VVVTLWYRAPEIL 204
           ++     +HRDL+  N+L+      K+ADFGLA+  + D   T+       + + APE  
Sbjct: 117 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 175

Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
           L   +    D+WS G ++ E+
Sbjct: 176 LYGRFTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 42/156 (26%), Positives = 78/156 (50%), Gaps = 11/156 (7%)

Query: 82  FEHPNIVRFFDVIHQN-----ILSDERY--LTVYLIFEHVDQDLGSYME-KCPPPGLSAS 133
            +HPNIV    V+ +      I S   +  L  +L+      D+GS  + K     L  +
Sbjct: 65  LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124

Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYDMMLT 190
               +  Q+  G++FL SH ++H+DL  +N+L+     +KI+D GL +     DY  ++ 
Sbjct: 125 DFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184

Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           + ++ + + +PE ++   +    DIWS G V+ E++
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 11/95 (11%)

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVT----- 195
           Q+ +G+DFL S   IHRD+  +N+L+T     KI DFGLA+    D+M  S  V      
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR----DIMNDSNYVVKGNAR 275

Query: 196 --LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
             + + APE + +  Y    D+WS G ++ E++ L
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 310

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 40/223 (17%)

Query: 29  QIGCGAYGTVFKAR----DLQNKGNYVAMKKLR---VKLNEDGIPMSTLREISILKQLDT 81
           ++G GA+G VF A             VA+K L+   +   +D       RE  +L  L  
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-----FQREAELLTNL-- 64

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG----------- 129
            +H +IV+F+ V             + ++FE++   DL  ++    P             
Sbjct: 65  -QHEHIVKFYGVCGDGD-------PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116

Query: 130 ---LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TF 183
              L  S++  +  Q+  G+ +L S   +HRDL  +N L+     +KI DFG+++   + 
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176

Query: 184 DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           DY  +    ++ + +  PE ++   + T  D+WS G ++ E++
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 56.2 bits (135), Expect = 4e-09
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 24/203 (11%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST---LREISILKQLDTFEHP 85
           ++G G +G V+      N    VA+K L+         MS    L E +++K   T +H 
Sbjct: 13  KLGAGQFGEVWMG--YYNNSTKVAVKTLKPG------TMSVQAFLEEANLMK---TLQHD 61

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLK 144
            +VR + V+        +   +Y+I E++ +  L  +++      +   K+ + + Q+ +
Sbjct: 62  KLVRLYAVV-------TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT--SVVVTLWYRAPE 202
           G+ ++     IHRDL+  N+L++ +   KIADFGLA+  + +           + + APE
Sbjct: 115 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174

Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    +    D+WS G ++ E+
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 25/203 (12%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG--IPMSTLREISILKQLDTFEHPN 86
           ++G G +G V+        G +    K+ +K  + G  +P + L+E  I+K+L    H  
Sbjct: 13  KLGQGCFGEVWM-------GTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKL---RHDK 62

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           +V  + V+ +          +Y++ E + +  L  ++++     L   ++ ++  Q+  G
Sbjct: 63  LVPLYAVVSEE--------PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADG 114

Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS---VVVTLWYRAPE 202
           + ++     IHRDL+  N+L+      KIADFGLA+  + D   T+       + + APE
Sbjct: 115 MAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173

Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
             L   +    D+WS G ++ E+
Sbjct: 174 AALYGRFTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 55.8 bits (134), Expect = 7e-09
 Identities = 67/245 (27%), Positives = 112/245 (45%), Gaps = 39/245 (15%)

Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYV--AMKKLRVKLNEDGIPMSTLREIS 74
           L+  D K+ ++  IG G +G V KAR ++  G  +  A+K+++   ++D        E+ 
Sbjct: 4   LEWNDIKFQDV--IGEGNFGQVLKAR-IKKDGLRMDAAIKRMKEYASKDD-HRDFAGELE 59

Query: 75  ILKQLDTFEHPNIVRFFDVI-HQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC------P 126
           +L +L    HPNI+       H+  L        YL  E+    +L  ++ K       P
Sbjct: 60  VLCKLG--HHPNIINLLGACEHRGYL--------YLAIEYAPHGNLLDFLRKSRVLETDP 109

Query: 127 PPGLSASKVKELTRQML--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG 178
              ++ S    L+ Q L        +G+D+L   + IHRDL  +N+L+      KIADFG
Sbjct: 110 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 169

Query: 179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPL----FCA 234
           L++  +  +  T   + + + A E L    Y T  D+WS G +   +W +V L    +C 
Sbjct: 170 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL---LWEIVSLGGTPYCG 226

Query: 235 STEVE 239
            T  E
Sbjct: 227 MTCAE 231

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 55.8 bits (134), Expect = 8e-09
 Identities = 38/106 (35%), Positives = 56/106 (52%), Gaps = 7/106 (6%)

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG-LAKTFDYDMMLTSVVV-TLWY 198
           +M+  +D +H    +HRD+KP N+L+   G +++ADFG   K  +   + +SV V T  Y
Sbjct: 110 EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 169

Query: 199 RAPEILLNLG-----YGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
            +PEIL  +      YG   D WS+G  M EM      F A + VE
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 20/203 (9%)

Query: 30  IGCGAYGTVFK---ARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G GA+GTV+K     D +N    VA+K LR    E+  P +    +     +     P 
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR----ENTSPKANKEILDEAYVMAGVGSPY 70

Query: 87  IVRFFDVIHQNILSDERYLTVY-LIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           + R   +   + +     L  Y  + ++V ++            + +  +     Q+ KG
Sbjct: 71  VCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDR---------IGSQDLLNWCVQIAKG 121

Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV---VVTLWYRAPE 202
           + +L   R++HRDL  +N+L+     +KI DFGLA+  D D          V + + A E
Sbjct: 122 MSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +L+  +    D+WS G  + E+
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 3/91 (3%)

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD---YDMMLTSVVVTLW 197
           Q+L  V  +HS  +IHRD+K  N+L+   G +K+ DFG +K +     D +  +   T +
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210

Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           Y APEI     Y    D++S+G ++ E+  L
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTL 241

Length = 496

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 43/149 (28%), Positives = 75/149 (50%), Gaps = 22/149 (14%)

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKELTRQ 141
           ++PN ++ +  +    L         LI +++ D DL   ++K     LS ++VK++ RQ
Sbjct: 67  DNPNFIKLYYSVT--TLK-----GHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQ 117

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGG-LKIADFGLAKTFD----YDMMLTSVVVTL 196
           +++ ++ LH H IIH D+K +N+L  RA   + + D+GL K       YD        TL
Sbjct: 118 LVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG-------TL 170

Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            Y +PE +    Y    D W++G +  E+
Sbjct: 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYEL 199

Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 38/157 (24%), Positives = 76/157 (48%), Gaps = 18/157 (11%)

Query: 90  FFDVIHQNIL-----SDERYLTVYLIFEHVDQ-DLGSYMEKC------PPPGLSASKVKE 137
            + + HQNIL       E     ++++ +++  +L  ++++C       P  LS  ++  
Sbjct: 62  LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVV 194
           +  Q+  G+ +LH   +IH+D+  +N +I     +KI D  L++     DY  +  +   
Sbjct: 122 MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181

Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPL 231
            + + A E L+N  Y +  D+WS G +   +W L+ L
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVL---LWELMTL 215

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 12/205 (5%)

Query: 30  IGCGAYGTVFKARDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G+V +A+     G++  VA+K L+  +         LRE + +K+   F+HPN+
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKE---FDHPNV 63

Query: 88  VRFFDV-IHQNILSDERYLTVYLIF-EHVDQDLGSYMEKC--PPPGLSASKVKELTRQML 143
           ++   V +            V L F +H D      M +    P  L    +      + 
Sbjct: 64  IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRA 200
            G+++L S   IHRDL  +N ++     + +ADFGL+K     DY     +  + + + A
Sbjct: 124 SGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEM 225
            E L +  Y T  D+W+ G  M E+
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEI 208

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 55.5 bits (133), Expect = 2e-08
 Identities = 24/46 (52%), Positives = 33/46 (71%)

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA 180
           +K + RQ+L G+  LH   I+HRD+KP+NLL+T  G +KI DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 43/171 (25%), Positives = 82/171 (47%), Gaps = 22/171 (12%)

Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPP- 127
           L E S++K+   F   ++VR   V+ Q            +I E + + DL SY+    P 
Sbjct: 57  LNEASVMKE---FNCHHVVRLLGVVSQG-------QPTLVIMELMTRGDLKSYLRSLRPE 106

Query: 128 ----PGLSA---SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA 180
               P  +     K+ ++  ++  G+ +L++++ +HRDL  +N ++     +KI DFG+ 
Sbjct: 107 MENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 166

Query: 181 KTF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           +     DY       ++ + + +PE L +  + T  D+WS G V+ E+  L
Sbjct: 167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 217

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 31/225 (13%)

Query: 22  KKYDELCQIGCGAYGTVFK--ARDLQNKGN---YVAMKKLR--VKLNEDGIPMSTLREIS 74
           +K   L ++G G++G V++  ARD+  KG     VA+K +     L E    +  L E S
Sbjct: 6   EKITLLRELGQGSFGMVYEGNARDII-KGEAETRVAVKTVNESASLRER---IEFLNEAS 61

Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP-----PG 129
           ++K    F   ++VR   V+ +     +  L V  +  H   DL SY+    P     PG
Sbjct: 62  VMK---GFTCHHVVRLLGVVSKG----QPTLVVMELMAH--GDLKSYLRSLRPEAENNPG 112

Query: 130 LSASKVKELTR---QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF--- 183
                ++E+ +   ++  G+ +L++ + +HRDL  +N ++     +KI DFG+ +     
Sbjct: 113 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 172

Query: 184 DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           DY       ++ + + APE L +  + T  D+WS G V+ E+  L
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSL 217

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 32/216 (14%)

Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    + + G   + A+K L  ++ +       L+E  I+K    F HPN+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLN-RITDLEEVEQFLKEGIIMKD---FSHPNV 58

Query: 88  VRFFDVIHQNILSDERYLTVYLIF-EHVDQDLGSYM--EKCPPPGLSASKVKELTR---Q 141
           +    +     L  E    V L + +H   DL +++  E   P       VK+L     Q
Sbjct: 59  LSLLGIC----LPSEGSPLVVLPYMKH--GDLRNFIRSETHNP------TVKDLIGFGLQ 106

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           + KG+++L S + +HRDL  +N ++  +  +K+ADFGLA+   YD    SV      + P
Sbjct: 107 VAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDI-YDKEYYSVHNHTGAKLP 165

Query: 202 ------EILLNLGYGTPVDIWSIGCVMAE-MWRLVP 230
                 E L    + T  D+WS G ++ E M R  P
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 53.4 bits (128), Expect = 4e-08
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 16/201 (7%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISI-LKQLDTFEHPNIV 88
           +G G +GTV K   +  +G+ + +  + +K  +D     T +EI+  +  + + +H  IV
Sbjct: 15  LGSGVFGTVHKGIWIP-EGDSIKIP-VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 89  RFFDVIHQNILS-DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           R   +     L    +   +  + +HV Q   S         L   ++     Q+ KG+ 
Sbjct: 73  RLLGICPGASLQLVTQLSPLGSLLDHVRQHRDS---------LDPQRLLNWCVQIAKGMY 123

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRAPEIL 204
           +L  HR++HR+L  +N+L+     ++IADFG+A      D     +     + + A E +
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183

Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
           L   Y    D+WS G  + EM
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEM 204

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 34/221 (15%)

Query: 19  LGDKKYDELCQIGCGAYGTVFKA---RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISI 75
           L + ++ ++  +G GA+GTV+K     + +     VA+K+LR    E   P +    +  
Sbjct: 4   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDE 59

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPP 127
              + + ++P++ R   +    + S  + +T  + F        EH D     Y+     
Sbjct: 60  AYVMASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL----- 111

Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD- 186
                        Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK    D 
Sbjct: 112 --------LNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163

Query: 187 --MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                    V + + A E +L+  Y    D+WS G  + E+
Sbjct: 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 30/214 (14%)

Query: 30  IGCGAYGTVFKARDLQNKGNY--VAMKKLRVKLNEDGIPMST----LREISILKQLDTFE 83
           +G G +G+V + +  Q+ G+   VA+K +++    D    S     L E + +K  D   
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL----DIHTYSEIEEFLSEAACMKDFD--- 59

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQM 142
           HPN+++   V  +   S ++     +I   +   DL S++      GL     ++L  Q 
Sbjct: 60  HPNVMKLIGVCFE-ASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP----EKLPLQT 114

Query: 143 L--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTS 191
           L         G+++L +   IHRDL  +N ++     + +ADFGL+K     DY      
Sbjct: 115 LLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174

Query: 192 VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
             + + + A E L +  Y +  D+W+ G  M E+
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.8 bits (126), Expect = 6e-08
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 30/208 (14%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G GA+GTV+K   +  +G  V +      LNE   P + +  +     + + +HP++VR
Sbjct: 15  LGSGAFGTVYKGIWVP-EGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 90  FFDVIHQNILSDERYLTVYL---------IFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
              V     LS    L   L         + EH D ++GS +            +     
Sbjct: 74  LLGVC----LSPTIQLVTQLMPHGCLLDYVHEHKD-NIGSQL------------LLNWCV 116

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV---VVTLW 197
           Q+ KG+ +L   R++HRDL  +N+L+     +KI DFGLA+  + D    +     + + 
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176

Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           + A E +    +    D+WS G  + E+
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWEL 204

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 33/208 (15%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V       + G + A  K+ +K   +G  MS    I   K +    HP +V
Sbjct: 11  ELGSGQFGVV-------HLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLV 62

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML----- 143
           + + V  Q          +Y++ E        +ME          +  +L++ ML     
Sbjct: 63  QLYGVCTQQ-------KPLYIVTE--------FMENGCLLNYLRQRQGKLSKDMLLSMCQ 107

Query: 144 ---KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS--VVVTLWY 198
              +G+++L  +  IHRDL  +N L++  G +K++DFG+ +    D   +S      + +
Sbjct: 108 DVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW 167

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMW 226
             PE+     Y +  D+WS G +M E++
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVF 195

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 40/173 (23%), Positives = 76/173 (43%), Gaps = 35/173 (20%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVK---LNEDGIPMSTL--------REISILKQ 78
           IGCG +G V+   + Q   ++    +   K   L  + I M TL         +I++ K 
Sbjct: 20  IGCGGFGCVY---ETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN 76

Query: 79  LDTFEHPNIVRFFD--------VIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGL 130
           +   +H  I +++         + ++ IL ++       IF+ +         KC    L
Sbjct: 77  IHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI---------KCKNKKL 127

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF 183
               +K + + ML  ++++H H I H D+KP+N+++       I D+G+A  F
Sbjct: 128 ----IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHF 176

Length = 294

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 56/238 (23%), Positives = 100/238 (42%), Gaps = 33/238 (13%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
           D K++++  IG G +G V +A   ++     A  K+  +   +        E+ +L +L 
Sbjct: 3   DIKFEDV--IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG 60

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEH---------------VDQDLGSYMEKC 125
              HPNI+            +  YL  Y+  E+               ++ D     E  
Sbjct: 61  --HHPNIINLLGACE-----NRGYL--YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111

Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
               L++ ++ +    +  G+ +L   + IHRDL  +N+L+      KIADFGL++  + 
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV 171

Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPL----FCASTEVE 239
            +  T   + + + A E L    Y T  D+WS G +   +W +V L    +C  T  E
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVL---LWEIVSLGGTPYCGMTCAE 226

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 49.7 bits (118), Expect = 5e-07
 Identities = 35/114 (30%), Positives = 58/114 (50%), Gaps = 7/114 (6%)

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
           LS+ ++      + +G+D+L   + IHRDL  +N+L+      KIADFGL++  +  +  
Sbjct: 109 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 168

Query: 190 TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPL----FCASTEVE 239
           T   + + + A E L    Y T  D+WS G +   +W +V L    +C  T  E
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL---LWEIVSLGGTPYCGMTCAE 219

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 49.5 bits (118), Expect = 7e-07
 Identities = 54/218 (24%), Positives = 86/218 (39%), Gaps = 32/218 (14%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +IG G +G V           +  M K RV + E       LR  +   +   F    + 
Sbjct: 2   EIGNGWFGKVLLGE------AHRGMSKARVVVKE-------LRASATPDEQLLFLQ-EVQ 47

Query: 89  RFFDVIHQNIL----SDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTR--- 140
            + ++ H N+L         +   L+ E     DL +Y+          ++   L R   
Sbjct: 48  PYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMAC 107

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLW 197
           ++  G+ +LH    IH DL  +N  +T    +KI D+GLA      DY +      V L 
Sbjct: 108 EVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR 167

Query: 198 YRAPEILLNLGYG-TPVD------IWSIGCVMAEMWRL 228
           + APE++   G    P D      IWS+G  M E++  
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 46/179 (25%), Positives = 77/179 (43%), Gaps = 17/179 (9%)

Query: 51  VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLI 110
           VA+  LR   + D      L E   L Q   F+H NIVR   VI        R  T+ ++
Sbjct: 36  VAIHTLRAGCS-DKQRRGFLAEALTLGQ---FDHSNIVRLEGVI-------TRGNTMMIV 84

Query: 111 FEHVDQD-LGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA 169
            E++    L S++ K     L A ++  +   +  G+ +L     +H+ L    +L+   
Sbjct: 85  TEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD 143

Query: 170 GGLKIADFGLAKTFDYDMMLTSV---VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
              KI+ F   +    + + T++      LW  APE +    + +  D+WS G VM E+
Sbjct: 144 LVCKISGFRRLQEDKSEAIYTTMSGKSPVLW-AAPEAIQYHHFSSASDVWSFGIVMWEV 201

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 24/57 (42%), Positives = 35/57 (61%), Gaps = 3/57 (5%)

Query: 127 PPGLSASK--VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT-RAGGLKIADFGLA 180
           P GL      ++ + RQ+L  +D LHS  I+HRD+KPQN++ +  +G  KI D G A
Sbjct: 247 PKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 41/158 (25%), Positives = 71/158 (44%), Gaps = 24/158 (15%)

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTV---YLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
           F HPNI+  +      + +   +L V   ++ +   +  L +Y     P G+S + +  +
Sbjct: 56  FRHPNIMTSW-----TVFTTGSWLWVISPFMAYGSANSLLKTYF----PEGMSEALIGNI 106

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-----GLK----IADFGLAKTFDYDMML 189
               L+G+++LH +  IHR++K  ++LI+  G     GL     +   G      YD   
Sbjct: 107 LFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQ 166

Query: 190 TSVVVTLWYRAPEILLN--LGYGTPVDIWSIGCVMAEM 225
            S  V  W  +PE+L     GY    DI+S+G    E+
Sbjct: 167 FSTSVLPWL-SPELLRQDLYGYNVKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 52/215 (24%), Positives = 97/215 (45%), Gaps = 31/215 (14%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF---EHP 85
           +IG G +G V  +        Y      RV + E     S+  +   L+Q D +   +HP
Sbjct: 2   EIGNGWFGKVLLSEI------YTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHP 55

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTR---Q 141
           NI++    + Q + +    +   L+FE+ +  DL SY+ +        S++  L R   +
Sbjct: 56  NILQ---CLGQCVEA----IPYLLVFEYCELGDLKSYLSQ-EQWHRRNSQLLLLQRMACE 107

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT-FDYDMMLTS--VVVTLWY 198
           +  GV  +H H  +H DL  +N  +T    +K+ D+G+  + +  D + T     V L +
Sbjct: 108 IAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167

Query: 199 RAPEI-------LLNLGYGTPVDIWSIGCVMAEMW 226
            APE+       L+      P ++W++G  + E++
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 36/125 (28%), Positives = 57/125 (45%), Gaps = 13/125 (10%)

Query: 117 DLGSYMEKCPPPGLSASKVKELTR---QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK 173
           DL  Y+  C    L       L R   ++  G+  LH +  IH DL  +N L+T    +K
Sbjct: 81  DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVK 140

Query: 174 IADFGLAKTF---DYDMMLTSVVVTLWYRAPEI-------LLNLGYGTPVDIWSIGCVMA 223
           I D+GL+      DY +    + V L + APE+       LL +      ++WS+G  + 
Sbjct: 141 IGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIW 200

Query: 224 EMWRL 228
           E++ L
Sbjct: 201 ELFEL 205

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.4 bits (102), Expect = 7e-05
 Identities = 72/318 (22%), Positives = 124/318 (38%), Gaps = 70/318 (22%)

Query: 48  GNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTV 107
           G YV ++++ ++   + +      E+ + K    F HPNIV +       I  +E ++  
Sbjct: 25  GEYVTVRRINLEACTNEMVTFLQGELHVSK---LFNHPNIVPYRATF---IADNELWVVT 78

Query: 108 YLIFEHVDQDL--GSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLL 165
             +     +DL    +M+     G+S   +  + + +LK +D++H    +HR +K  ++L
Sbjct: 79  SFMAYGSAKDLICTHFMD-----GMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHIL 133

Query: 166 ITRAGGLKIADFGLAKTFD-----------YDMMLTSVVVTLWYRAPEIL-LNL-GYGTP 212
           I+  G  K+   GL                +D    SV V  W  +PE+L  NL GY   
Sbjct: 134 ISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWL-SPEVLQQNLQGYDAK 190

Query: 213 VDIWSIG---CVMA-----------------EMWRLVPLFCASTEVEQLKCIFRVI---- 248
            DI+S+G   C +A                 ++   VP    +T +   +   +      
Sbjct: 191 SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGA 250

Query: 249 ------GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI 302
                  T      P N     SS   Y++  FS  F       +  +E  L  NP  R 
Sbjct: 251 NSGLGESTTVSTPRPSNGE---SSSHPYNR-TFSPHF-------HHFVEQCLQRNPDARP 299

Query: 303 SAADALEHPYFKEKENEP 320
           SA+  L H +FK+ +   
Sbjct: 300 SASTLLNHSFFKQIKRRA 317

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.0 bits (96), Expect = 6e-04
 Identities = 34/116 (29%), Positives = 50/116 (43%), Gaps = 24/116 (20%)

Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           Y APE+LL   +G  VD W++G  + E    +P F  + E  Q   +F+ I    +  WP
Sbjct: 546 YLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPF--NDETPQQ--VFQNILNRDI-PWP 600

Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
           E         E+ S  A +AI            E +LT +P  R    +  +HP F
Sbjct: 601 E-------GEEKLSVNAQNAI------------EILLTMDPTKRAGLKELKQHPLF 637

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 39.9 bits (94), Expect = 7e-04
 Identities = 19/52 (36%), Positives = 30/52 (57%), Gaps = 2/52 (3%)

Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           LHS  IIH DL   N+++   G + + DFGLA+ F  D+   +V + +  R+
Sbjct: 111 LHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAE-FSKDLEDRAVDLHVLLRS 160

Length = 211

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 38.4 bits (90), Expect = 0.002
 Identities = 27/92 (29%), Positives = 37/92 (40%), Gaps = 10/92 (10%)

Query: 98  ILSDERYLTV---YLIFEHVDQDLGS-YMEKCPPPGLSA---SKVKELTRQMLKGVDFLH 150
           IL+  R   V    +    VD D G   ME      L         +L R++ + V  LH
Sbjct: 52  ILAKAREAGVPVPIVYD--VDPDNGLIVMEYIEGELLKDALEEARPDLLREVGRLVGKLH 109

Query: 151 SHRIIHRDLKPQNLLITRAGGLKIADFGLAKT 182
              I+H DL   N +I   G +   DFGL + 
Sbjct: 110 KAGIVHGDLTTSN-IILSGGRIYFIDFGLGEF 140

Length = 204

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 37.8 bits (88), Expect = 0.002
 Identities = 25/120 (20%), Positives = 44/120 (36%), Gaps = 22/120 (18%)

Query: 75  ILKQLDTFEHP----NIVRFFDVIHQNIL-------SDERYLTVYLIFEHVDQDLGSYME 123
           +LK   + E        V    ++ +  L       S E     YL+ E +        E
Sbjct: 25  VLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI--------E 76

Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRI---IHRDLKPQNLLITRAGGLKIADFGLA 180
                 +S  + +++  Q+ + +  LH   +    H DL P N+L+     L I D+  A
Sbjct: 77  GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 38.4 bits (90), Expect = 0.002
 Identities = 15/38 (39%), Positives = 20/38 (52%), Gaps = 1/38 (2%)

Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
           LH   I+H DL   N+++ R   L + DFGL K  D  
Sbjct: 106 LHKAGIVHGDLTTSNIIV-RDDKLYLIDFGLGKYSDEI 142

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	321
KOG0661|consensus	538		100.0
KOG0575|consensus	592		100.0
KOG0659|consensus	318		100.0
KOG0581|consensus	364		100.0
KOG0615|consensus	475		100.0
KOG0592|consensus	604		100.0
KOG0593|consensus	396		100.0
KOG0598|consensus	357		100.0
KOG0663|consensus	419		100.0
KOG0600|consensus	560		100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0594|consensus	323		100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0660|consensus	359		100.0
KOG0605|consensus	550		100.0
KOG0595|consensus	429		100.0
KOG0616|consensus	355		100.0
KOG0658|consensus	364		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0667|consensus	586		100.0
KOG0583|consensus	370		100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0591|consensus	375		100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0597|consensus	808		100.0
KOG0610|consensus	459		100.0
KOG0694|consensus	694		100.0
KOG0198|consensus	313		100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0588|consensus	786		100.0
KOG0578|consensus	550		100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0033|consensus	355		100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0582|consensus	516		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0599|consensus	411		100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0585|consensus	576		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0032|consensus	382		100.0
KOG0192|consensus	362		100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0580|consensus	281		100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0589|consensus	426		100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0662|consensus	292		100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0197|consensus	468		100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0611|consensus	668		100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0201|consensus	467		100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0986|consensus	591		100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0671|consensus	415		100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG4717|consensus	864		100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0596|consensus	677		100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG1989|consensus	738		100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0666|consensus	438		100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0612|consensus	1317		100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0604|consensus	400		100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG2345|consensus	302		100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0577|consensus	948		100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0193|consensus	678		100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG4236|consensus	888		100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0574|consensus	502		100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0690|consensus	516		100.0
KOG0579|consensus	1187		100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0983|consensus	391		100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0669|consensus	376		100.0
KOG1290|consensus	590		100.0
KOG4721|consensus	904		100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0584|consensus	632		100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0668|consensus	338		100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0586|consensus	596		100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG1187|consensus	361		100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0614|consensus	732		100.0
KOG0607|consensus	463		100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG1026|consensus	774		100.0
KOG0670|consensus	752		100.0
KOG0194|consensus	474		100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0603|consensus	612		100.0
KOG4279|consensus	1226		100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0696|consensus	683		100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0665|consensus	369		100.0
KOG4645|consensus	1509		100.0
KOG1095|consensus	1025		100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG1035|consensus	1351		100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0695|consensus	593		100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0587|consensus	953		100.0
KOG0608|consensus	1034		100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG4278|consensus	1157		100.0
KOG1094|consensus	807		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4257|consensus	974		100.0
KOG0196|consensus	996		100.0
KOG4250|consensus	732		100.0
KOG1006|consensus	361		100.0
KOG0199|consensus	1039		100.0
KOG1027|consensus	903		100.0
KOG1151|consensus	775		100.0
KOG0664|consensus	449		100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1167|consensus	418		100.0
KOG1152|consensus	772		100.0
KOG2052|consensus	513		100.0
KOG0200|consensus	609		100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG3653|consensus	534		100.0
KOG0984|consensus	282		100.0
KOG1025|consensus	1177		100.0
KOG0576|consensus	829		100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	99.98
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1345|consensus	378		99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG1024|consensus	563		99.97
KOG1164|consensus	322		99.96
KOG1165|consensus	449		99.96
KOG1163|consensus	341		99.96
KOG0590|consensus	601		99.95
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG1240|consensus	1431		99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0603|consensus	612		99.93
KOG0195|consensus	448		99.92
KOG4158|consensus	598		99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
KOG1166|consensus	974		99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG0606|consensus	1205		99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
smart00090	237	RIO RIO-like kinase.	99.83
PRK10345	210	hypothetical protein; Provisional	99.82
KOG1033|consensus	516		99.82
KOG1023|consensus	484		99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
KOG0590|consensus	601		99.76
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
KOG0601|consensus	524		99.7
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
KOG1243|consensus	690		99.6
KOG1266|consensus	458		99.56
KOG0606|consensus	1205		99.54
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.53
COG4248	637	Uncharacterized protein with protein kinase and he	99.49
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
KOG3087|consensus	229		99.45
KOG3741|consensus	655		99.45
KOG2137|consensus	700		99.38
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.37
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.36
KOG0601|consensus	524		99.36
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.31
PRK09902	216	hypothetical protein; Provisional	99.29
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.27
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.25
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.23
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.21
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	99.1
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.91
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.71
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.69
PF01636	239	APH: Phosphotransferase enzyme family This family	98.64
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.57
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.56
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.56
KOG1035|consensus	1351		98.55
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.49
KOG0576|consensus	829		98.4
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.24
KOG1093|consensus	725		98.16
PLN02876	822	acyl-CoA dehydrogenase	98.15
PRK10593	297	hypothetical protein; Provisional	98.14
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.14
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.14
KOG2268|consensus	465		98.11
KOG1235|consensus	538		98.07
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.05
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.03
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.01
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.95
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.86
PLN02756	418	S-methyl-5-thioribose kinase	97.85
PLN02236	344	choline kinase	97.77
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.76
PRK12396	409	5-methylribose kinase; Reviewed	97.73
PRK05231	319	homoserine kinase; Provisional	97.73
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.72
KOG2270|consensus	520		97.7
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.66
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.6
PTZ00384	383	choline kinase; Provisional	97.47
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.46
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.02
PRK11768	325	serine/threonine protein kinase; Provisional	96.95
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.94
KOG1826|consensus	2724		96.75
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.69
PTZ00296	442	choline kinase; Provisional	96.57
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.39
PRK06148	1013	hypothetical protein; Provisional	95.98
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.93
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.77
PRK10271	188	thiK thiamine kinase; Provisional	95.73

>KOG0661|consensus

Probab=100.00  E-value=1.9e-59  Score=390.46  Aligned_cols=287  Identities=37%  Similarity=0.688  Sum_probs=256.9

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      +..+||.++++||.|.||.||+|+. ..++..||||.++.+... .....-.+|+..|+++..  ||||+++.+++.+..
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~-~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~--hpniikL~Evi~d~~   82 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKS-KETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNP--HPNIIKLKEVIRDND   82 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeee-cCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCC--CCcchhhHHHhhccC
Confidence            4568999999999999999999999 688999999999876333 233355689999999885  999999999998871


Q ss_pred             cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676          99 LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                            ..+++|||+++.+|+.+++.+ +..+++..++.|+.||++||+|+|.+|++|||+||+||||..+..+||+|||
T Consensus        83 ------~~L~fVfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFG  155 (538)
T KOG0661|consen   83 ------RILYFVFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFG  155 (538)
T ss_pred             ------ceEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccc
Confidence                  289999999999999999998 5569999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      +|+.+......+....|.+|.|||++.. ..|+.+.|||++||+++|+.+.++.|.+.++.+.+.+|...+|+|....|+
T Consensus       156 LARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~  235 (538)
T KOG0661|consen  156 LAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP  235 (538)
T ss_pred             cccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence            9999998888889999999999998754 558999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhh---hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         258 ENISLMW---SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       258 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      +...+..   -.+++........+...++.++.++|.+||.+||.+||||.++|+||||+.-
T Consensus       236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence            8644332   2455666667788888899999999999999999999999999999999864

>KOG0575|consensus

Probab=100.00  E-value=4.4e-57  Score=387.48  Aligned_cols=263  Identities=33%  Similarity=0.502  Sum_probs=233.6

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      +-...|....+|...+.||+|+|++||++++ ..+|+.||+|++.++.. .........+|+++.+.++   |||||+++
T Consensus         9 p~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~-~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~---HpnIV~f~   84 (592)
T KOG0575|consen    9 PEVIEDPRSKRYKRGRFLGKGGFARCYEARD-LDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK---HPNIVQFY   84 (592)
T ss_pred             CCeeecCCcceeeeeeeeccCcceEEEEEEE-cCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC---CCcEEeee
Confidence            3344455557899999999999999999999 58999999999987533 3445678889999999999   99999999


Q ss_pred             eeeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG  170 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~  170 (321)
                      ++|+|.       ..+|+|+|.|. ++|.++++.  .+.++|.+++.+++||+.||.|||+++|+|||||..|++++++.
T Consensus        85 ~~FEDs-------~nVYivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~  155 (592)
T KOG0575|consen   85 HFFEDS-------NNVYIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM  155 (592)
T ss_pred             eEeecC-------CceEEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC
Confidence            999999       89999999999 799999996  45599999999999999999999999999999999999999999


Q ss_pred             CEEEeecCCcccccCC-CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhC
Q psy2676         171 GLKIADFGLAKTFDYD-MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      ++|++|||+|+....+ ......+||+-|+|||++.....+..+||||+|||+|.|+.|++||...+-.+...++...--
T Consensus       156 ~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y  235 (592)
T KOG0575|consen  156 NVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY  235 (592)
T ss_pred             cEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc
Confidence            9999999999988755 567788999999999999999999999999999999999999999999988888887765321


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      ..                           ...++.++++||.+||++||.+|||+++||.|+||++
T Consensus       236 ~~---------------------------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  236 SM---------------------------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             cc---------------------------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence            11                           1245589999999999999999999999999999954

>KOG0659|consensus

Probab=100.00  E-value=7.8e-57  Score=349.09  Aligned_cols=286  Identities=44%  Similarity=0.772  Sum_probs=258.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      .||...+++|+|.||.||+|++ ..+|+.||+|.++.....++......+|+..|+.++   |+||+.++++|...    
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d-~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~---h~nIi~LiD~F~~~----   73 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARD-TETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK---HPNIIELIDVFPHK----   73 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEe-cCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc---CcchhhhhhhccCC----
Confidence            5899999999999999999999 589999999999988777777888999999999999   99999999999776    


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                         ..+.+|+|+++.+|...++.... .++..++..++.+++.||+|||++.|.||||||.|++++++|.+|++|||+++
T Consensus        74 ---~~l~lVfEfm~tdLe~vIkd~~i-~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr  149 (318)
T KOG0659|consen   74 ---SNLSLVFEFMPTDLEVVIKDKNI-ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLAR  149 (318)
T ss_pred             ---CceEEEEEeccccHHHHhccccc-ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchh
Confidence               67899999999999999987654 49999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCc-cccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         182 TFDYDMM-LTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       182 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      .+..... ......|..|.|||++.+.. |+...|+||+||++.||+.|.+.|.+.++.+++..+++.+|+|....||..
T Consensus       150 ~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~  229 (318)
T KOG0659|consen  150 FFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM  229 (318)
T ss_pred             ccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence            8865443 44457899999999988765 899999999999999999999999999999999999999999999999998


Q ss_pred             hhhh-hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         260 ISLM-WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       260 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      .+.. +..+.+........++..++.++.+|+.+||..||.+|+|+.|+|+|+||++.+..
T Consensus       230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p  290 (318)
T KOG0659|consen  230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP  290 (318)
T ss_pred             cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence            7765 34555555666666888999999999999999999999999999999999987543

>KOG0581|consensus

Probab=100.00  E-value=5e-57  Score=366.63  Aligned_cols=261  Identities=27%  Similarity=0.494  Sum_probs=221.5

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      .+.+.++.||+|..|+||+|++ +.++..+|+|++... .+......+.+|+++++...   |||||++|++|.++    
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~H-k~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~---spyIV~~ygaF~~~----  149 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRH-KPTGKIYALKVILLN-IDPALQKQILRELEILRSCQ---SPYIVGFYGAFYSN----  149 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEE-cCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCC---CCCeeeEeEEEEeC----
Confidence            4788899999999999999999 699999999999433 33445567889999999987   99999999999888    


Q ss_pred             ccce-EEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         102 ERYL-TVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       102 ~~~~-~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                         . .++++||||+ |+|.+++...  +.++|..+.+++.+|++||.|||+ ++|+||||||+|||++..|++||||||
T Consensus       150 ---~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFG  224 (364)
T KOG0581|consen  150 ---GEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFG  224 (364)
T ss_pred             ---CceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEecccc
Confidence               5 5899999999 5999999985  559999999999999999999995 999999999999999999999999999


Q ss_pred             CcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCC--ChHHHHHHHHHHhCCCCCCCc
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAS--TEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      .+...... ...+..||..|||||.+.+..|+.++||||||++++|+.+|+.||...  ........+......+++. .
T Consensus       225 VS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~-l  302 (364)
T KOG0581|consen  225 VSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR-L  302 (364)
T ss_pred             ccHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC-C
Confidence            99877644 667789999999999999999999999999999999999999999764  2223333333333222221 1


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      |.                     ..+++++++|+..||++||.+|||+.|+++|||+++...+
T Consensus       303 P~---------------------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  303 PE---------------------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             Cc---------------------ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence            11                     0367999999999999999999999999999999976554

>KOG0615|consensus

Probab=100.00  E-value=3.2e-57  Score=370.99  Aligned_cols=267  Identities=33%  Similarity=0.441  Sum_probs=224.4

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC-----CCchhHHHHHHHHhcccCCCCceeEE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG-----IPMSTLREISILKQLDTFEHPNIVRF   90 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~i~~~   90 (321)
                      ......+.|.+.+.||+|+||.|-+|.. +.+++.||+|++.+.-....     ......+|+++|+++.   ||||+++
T Consensus       166 ~pks~~d~yii~~~LGsGafg~Vkla~e-~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~---HP~IV~~  241 (475)
T KOG0615|consen  166 PPKSFNDYYIISKTLGSGAFGLVKLAYE-KKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS---HPNIVRI  241 (475)
T ss_pred             ccchhcceeEeeeeecCCceeEEEEEEE-cccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC---CCCEEEE
Confidence            3344667899999999999999999999 69999999999977633321     2334579999999999   9999999


Q ss_pred             EeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA  169 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~  169 (321)
                      +++|..+       ...|+|+||++| .|.+.+-.  ++.+.+..-..+++||+.|+.|||++||+||||||+|||+..+
T Consensus       242 ~d~f~~~-------ds~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~  312 (475)
T KOG0615|consen  242 KDFFEVP-------DSSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSND  312 (475)
T ss_pred             eeeeecC-------CceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccC
Confidence            9999988       778999999995 99999988  5568899999999999999999999999999999999999766


Q ss_pred             ---CCEEEeecCCcccccCCCccccccccccccchhhhhcCCC---CCcchHHHHHHHHHHHHhcCCCCCCCChHH-HHH
Q psy2676         170 ---GGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGY---GTPVDIWSIGCVMAEMWRLVPLFCASTEVE-QLK  242 (321)
Q Consensus       170 ---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~  242 (321)
                         -.+|++|||++...+........+||+.|.|||++.+...   ..+.|+|||||+||-+++|.+||+...... ...
T Consensus       313 ~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e  392 (475)
T KOG0615|consen  313 AEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE  392 (475)
T ss_pred             CcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH
Confidence               4599999999999887777788999999999999987663   347899999999999999999998765444 333


Q ss_pred             HHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ++..+.-.                       -.+..+..++++..+||.+||..||+.|||++|+|+||||+..+.
T Consensus       393 QI~~G~y~-----------------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  393 QILKGRYA-----------------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC  445 (475)
T ss_pred             HHhcCccc-----------------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence            33332111                       112234477899999999999999999999999999999997653

>KOG0592|consensus

Probab=100.00  E-value=3.8e-56  Score=376.20  Aligned_cols=263  Identities=29%  Similarity=0.483  Sum_probs=233.7

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ..++|.+.+.||+|+|++|++|++ ..+++.||+|++.++.. .+.....+..|..+|.+|..  ||.|++++-.|+|. 
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~-~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~--hPgivkLy~TFQD~-  146 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLARE-KATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSG--HPGIVKLYFTFQDE-  146 (604)
T ss_pred             ChhhcchhheeccccceeEEEeee-cCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhC--CCCeEEEEEEeecc-
Confidence            346899999999999999999999 58999999999977633 33445567789999999973  99999999999999 


Q ss_pred             cccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ..+|+|+||++ |+|.+++...  +.+++..++.++.+|+.||+|||++||+||||||+|||+++||+++|+||
T Consensus       147 ------~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDF  218 (604)
T KOG0592|consen  147 ------ESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDF  218 (604)
T ss_pred             ------cceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeec
Confidence                  88999999999 7999999995  55999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCc--------------cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHH
Q psy2676         178 GLAKTFDYDMM--------------LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKC  243 (321)
Q Consensus       178 g~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  243 (321)
                      |.+..++....              ..+..||..|.+||++.....+..+|+|+|||++|+|+.|.+||.+.++.-..++
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk  298 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK  298 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH
Confidence            99987753221              1457899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q psy2676         244 IFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL  321 (321)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~~~  321 (321)
                      |+..--.     |+                      .+.++.+.+||+++|..||.+|+|+.+|-+||||.+++|+.|
T Consensus       299 I~~l~y~-----fp----------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl  349 (604)
T KOG0592|consen  299 IQALDYE-----FP----------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL  349 (604)
T ss_pred             HHHhccc-----CC----------------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence            9875321     22                      234488999999999999999999999999999999999864

>KOG0593|consensus

Probab=100.00  E-value=1.1e-56  Score=354.35  Aligned_cols=278  Identities=36%  Similarity=0.632  Sum_probs=240.1

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      +.|+.+.++|+|+||+||+|++ +.+|+-||||.+..+..+.......++|+.++++++   |+|+|.++++|...    
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrn-k~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk---H~NLVnLiEVFrrk----   73 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRN-KDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK---HENLVNLIEVFRRK----   73 (396)
T ss_pred             cHHhhhhccccCcceEEEEecc-CCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc---cchHHHHHHHHHhc----
Confidence            5799999999999999999999 799999999999876555555667889999999999   99999999999877    


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                         ..+++|+|||+-++.+.+...+++ ++++.+..++.|++.|+.++|+++++||||||+||+|+.+|.+||||||+++
T Consensus        74 ---rklhLVFE~~dhTvL~eLe~~p~G-~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR  149 (396)
T KOG0593|consen   74 ---RKLHLVFEYCDHTVLHELERYPNG-VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFAR  149 (396)
T ss_pred             ---ceeEEEeeecchHHHHHHHhccCC-CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhH
Confidence               789999999999888888887766 9999999999999999999999999999999999999999999999999999


Q ss_pred             ccc-CCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         182 TFD-YDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       182 ~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ... +....+....|.+|.|||++.+ .+|..+.||||+||++.||++|.+.|.+..+.+.+..|...+|...+.    .
T Consensus       150 ~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr----h  225 (396)
T KOG0593|consen  150 TLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR----H  225 (396)
T ss_pred             hhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH----H
Confidence            887 4555677889999999999988 668999999999999999999999999999999999999998865443    2


Q ss_pred             hhhhh-------hhhhhhh-hhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         260 ISLMW-------SSFEQYS-KVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       260 ~~~~~-------~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      .+.+.       -.++... ....+.-..+++.-+.+|+++||+.||.+|++.++++.||||.+
T Consensus       226 q~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  226 QSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             HHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence            22221       0111111 11233345567778999999999999999999999999999964

>KOG0598|consensus

Probab=100.00  E-value=1.4e-55  Score=357.99  Aligned_cols=265  Identities=31%  Similarity=0.469  Sum_probs=233.2

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      ....++|+++++||+|+||+||.|+. +.+++.+|+|+++++.... ........|..++.+++   ||.|++++-.|++
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk-~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~---hPFiv~l~ysFQt   96 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRK-KDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK---HPFIVKLIYSFQT   96 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEE-cccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC---CCcEeeeEEeccc
Confidence            34567999999999999999999999 5999999999998764433 34567788999999987   9999999999999


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ..+|+|+||+.| .|...+.+  .+.+++..++.++..|+.||.|||++||+||||||+|||++.+|+++|+
T Consensus        97 ~-------~kLylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~Lt  167 (357)
T KOG0598|consen   97 E-------EKLYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLT  167 (357)
T ss_pred             C-------CeEEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEe
Confidence            8       889999999995 99999988  5569999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCC-CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         176 DFGLAKTFDYD-MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       176 dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      |||+|...-.. ......+||+.|+|||++.+..++.++|-||||+++|+|++|.+||.+.+......++.......+..
T Consensus       168 DFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~  247 (357)
T KOG0598|consen  168 DFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG  247 (357)
T ss_pred             ccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc
Confidence            99999855433 34455799999999999999999999999999999999999999999999888888887654222211


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC----CHHHHhCCCCCCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI----SAADALEHPYFKEKENEPL  321 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~~ll~h~~f~~~~~~~~  321 (321)
                                                -.+.+++++++++|..||++|.    ++.+|-+||||+..+|+.|
T Consensus       248 --------------------------~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l  292 (357)
T KOG0598|consen  248 --------------------------YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL  292 (357)
T ss_pred             --------------------------cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence                                      1348899999999999999996    7999999999999999753

>KOG0663|consensus

Probab=100.00  E-value=2e-54  Score=345.78  Aligned_cols=287  Identities=40%  Similarity=0.732  Sum_probs=249.7

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      +.|+.++.|++|+||.||+|+| +.+++.||+|.++.+....+......+|+.++.+++   |||||.+-.+....    
T Consensus        76 ~efe~lnrI~EGtyGiVYRakd-k~t~eIVALKr~kmekek~GFPItsLREIniLl~~~---H~NIV~vkEVVvG~----  147 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKD-KKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR---HPNIVEVKEVVVGS----  147 (419)
T ss_pred             HHHHHHhhcccCcceeEEEecc-CCcceeEEeeecccccccCCCcchhHHHHHHHHhcC---CCCeeeeEEEEecc----
Confidence            5699999999999999999999 689999999999887666677778889999999999   99999999998544    


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                       ....+|+|||||+.+|..++...+. .+...++..++.|++.|++|||.+.|+||||||+|++++..|.+|++|||+++
T Consensus       148 -~~d~iy~VMe~~EhDLksl~d~m~q-~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  148 -NMDKIYIVMEYVEHDLKSLMETMKQ-PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             -ccceeeeeHHHHHhhHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhh
Confidence             3356899999999999999999774 59999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC-ccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         182 TFDYDM-MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       182 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      .++.+. ..++...|+.|.|||++.+.+ ++.+.|+||+||++.+|+++++.|.+....+++.+|+..+|.|....||..
T Consensus       226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            887653 466778899999999998766 899999999999999999999999999999999999999999999999887


Q ss_pred             hhhhhh---hhhhhhhhhhhhhhhh--cchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         260 ISLMWS---SFEQYSKVAFSAIFMD--CCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       260 ~~~~~~---~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ......   .+...........+..  .++...+|+..+|..||.+|.||.+.|+|+||.+.+.
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~  369 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL  369 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence            655422   2222222222222222  4588999999999999999999999999999999643

>KOG0600|consensus

Probab=100.00  E-value=1.5e-54  Score=363.58  Aligned_cols=287  Identities=40%  Similarity=0.728  Sum_probs=251.1

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ...+.|+.+++||+|.||.||+|++ ..+++.||+|.++..........-..+|+.+|+++.   ||||+++.++..+. 
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~-~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~---HpNIikL~eivt~~-  188 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARD-LETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD---HPNIIKLEEIVTSK-  188 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeee-cccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC---CCcccceeeEEEec-
Confidence            3446799999999999999999999 689999999999988777777778889999999999   99999999998655 


Q ss_pred             cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676          99 LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                          ....+|+|+|||+-+|.-++..-. -.+++.++..+++||+.||+|||++|+.|||||.+|||||.+|.+||+|||
T Consensus       189 ----~~~siYlVFeYMdhDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFG  263 (560)
T KOG0600|consen  189 ----LSGSIYLVFEYMDHDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFG  263 (560)
T ss_pred             ----CCceEEEEEecccchhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEecccc
Confidence                125789999999999999887743 349999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCC--ccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         179 LAKTFDYDM--MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       179 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ++..+....  ..+....|++|.|||++.+.. |+.+.|+||+||+|.||+.|++.|.+.+..+++..|++..|.|....
T Consensus       264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~  343 (560)
T KOG0600|consen  264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY  343 (560)
T ss_pred             ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence            999665443  567888999999999998866 89999999999999999999999999999999999999999999999


Q ss_pred             cchhhhhhh-hhhh--hhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         256 WPENISLMW-SSFE--QYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       256 ~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      |+. ..... ..+.  +..+..+.+.....+....+|+..||..||.+|.||.++|+|+||+..
T Consensus       344 W~~-~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  344 WPV-SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             ccc-ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence            982 22221 1121  112445666688999999999999999999999999999999999654

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.3e-53  Score=361.45  Aligned_cols=290  Identities=52%  Similarity=0.962  Sum_probs=243.3

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      .+|++.+.||+|+||+||+|++...+++.+|+|+++.............+|+.+++.+..+.||||+++++++.....  
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~--   78 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT--   78 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC--
Confidence            479999999999999999999855667899999987655444445567789999998887789999999999854311  


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                      .....+++|+|+++++|.+++.......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+.
T Consensus        79 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          79 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            12246899999999999999987666668999999999999999999999999999999999999999999999999997


Q ss_pred             cccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhh
Q psy2676         182 TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS  261 (321)
Q Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (321)
                      ............+++.|+|||++.+..++.++||||+|+++|+|++|++||.+.+..+....+....+.+....|+....
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  238 (290)
T ss_pred             eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence            76544444556789999999999988899999999999999999999999999999999999998888777777665543


Q ss_pred             hhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      .....+.............++++.+.+++.+||+.||++|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            3322333333334445556788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0594|consensus

Probab=100.00  E-value=4.5e-53  Score=343.12  Aligned_cols=293  Identities=47%  Similarity=0.837  Sum_probs=256.6

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCc-eeEEEeeeecccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN-IVRFFDVIHQNIL   99 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~-i~~~~~~~~~~~~   99 (321)
                      ...|..+++||+|+||+||+|++ +.+|+.||+|.+......+.......+|+.+++.++   |+| |+.+++++.....
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~-~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~---~~~~iv~L~dv~~~~~~   85 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARS-KRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS---HANHIVRLHDVIHTSNN   85 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEE-ecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC---CCcceEEEEeeeeeccc
Confidence            45688899999999999999999 688899999999887666677888899999999999   888 9999999987732


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPP--PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                       ......+++|+|+++-+|..+++..+.  ..++...++.+++||+.||.|||++||+||||||+||+|+++|.+||+||
T Consensus        86 -~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDF  164 (323)
T KOG0594|consen   86 -HRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADF  164 (323)
T ss_pred             -ccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeecc
Confidence             233347899999999999999999774  35888999999999999999999999999999999999999999999999


Q ss_pred             CCccccc-CCCccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         178 GLAKTFD-YDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       178 g~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      |.+.... +....++..+|..|.|||++.+. .++...||||+||++.||+++++.|.+..+.+...+++..++.|....
T Consensus       165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9998766 33446778899999999999887 489999999999999999999999999999999999999999999999


Q ss_pred             cchhhhhhh--hhhhhhh-hhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         256 WPENISLMW--SSFEQYS-KVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       256 ~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ||...+...  ..+..+. ............++..+++.+||+.+|..|.|+..+|+||||.+.+.
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            998765442  2344444 55566666666689999999999999999999999999999998743

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.6e-52  Score=353.06  Aligned_cols=288  Identities=52%  Similarity=0.976  Sum_probs=241.2

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|++.+.||+|++|+||+|++ ..+++.+++|.++.............+|+.+++.+..++||||+++++++....  ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~--~~   77 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSR--TD   77 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEE-CCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecccc--CC
Confidence            699999999999999999999 578999999998765444444456678899998887777999999999986542  22


Q ss_pred             cceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         103 RYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       103 ~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      ....+++++|++.++|.+++.......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus        78 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          78 RETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             CCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence            23568999999999999999876666699999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhh
Q psy2676         183 FDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL  262 (321)
Q Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (321)
                      ...........++..|+|||++.+..++.++||||+|+++|+|++|.+||.+....+...++....+.+....|+.....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07863         158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL  237 (288)
T ss_pred             ccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence            65444445567789999999999888999999999999999999999999998888888888888777776666654333


Q ss_pred             hhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ....+..............++..+.++|.+||++||.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            222333333334445556788899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0660|consensus

Probab=100.00  E-value=1.4e-53  Score=345.12  Aligned_cols=290  Identities=40%  Similarity=0.665  Sum_probs=250.5

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ....+|..++.||.|+||.|+.|.+ +.+++.||+|.+...-..........+|+.+++.++   |+||+.+.+++..+ 
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~-~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~---HeNIi~l~di~~p~-   93 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKD-KRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR---HENIIGLLDIFRPP-   93 (359)
T ss_pred             eccceecccccccCcceeeEEEEEE-cCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc---CCCcceEEeecccc-
Confidence            3446777789999999999999999 688899999998744344444567789999999998   99999999999763 


Q ss_pred             cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676          99 LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                       .......+|+|+|.++.+|...++.  +..+++..+..++.|++.||+|+|+.+++||||||.|++++.+..+|++|||
T Consensus        94 -~~~~f~DvYiV~elMetDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen   94 -SRDKFNDVYLVFELMETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             -cccccceeEEehhHHhhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccc
Confidence             3455578999999999999999999  4449999999999999999999999999999999999999999999999999


Q ss_pred             CcccccC---CCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         179 LAKTFDY---DMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       179 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      +++..+.   ....+....|..|.|||++.+ ..++.+.||||+||++.||++|++.|.+.+..+++..+...+|.|...
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence            9998864   344567788999999998765 458999999999999999999999999999999999999999999655


Q ss_pred             Ccchh----hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         255 EWPEN----ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       255 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .+..-    ....-...++..+..++..+.+.++.+.+|+++||..||.+|+|++|+|+||||...
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence            43221    112234556667778899999999999999999999999999999999999999865

>KOG0605|consensus

Probab=100.00  E-value=1.2e-52  Score=354.85  Aligned_cols=272  Identities=32%  Similarity=0.501  Sum_probs=233.3

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      ++....+..++|+++..||+|+||.||+|+. +.+|..+|+|+++++..- .+....+..|..+|....   +|+||+++
T Consensus       132 R~~R~r~~~~DFe~Lk~IgkGAfGeVrLarK-k~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d---s~~vVKLy  207 (550)
T KOG0605|consen  132 RLRRTRLSLDDFELLKVIGKGAFGEVRLARK-KDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD---SPWVVKLY  207 (550)
T ss_pred             HhccccCCcccchhheeeccccceeEEEEEE-ccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC---CCcEEEEE
Confidence            4444456778999999999999999999999 699999999999876333 344556778999998866   99999999


Q ss_pred             eeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG  170 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~  170 (321)
                      -.|++.       ..+|+||||++| ++..++..  ...+++..++.++.+++.|+..+|+.|++||||||+|+|||..|
T Consensus       208 YsFQD~-------~~LYLiMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G  278 (550)
T KOG0605|consen  208 YSFQDK-------EYLYLIMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG  278 (550)
T ss_pred             EEecCC-------CeeEEEEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC
Confidence            999999       899999999995 99999988  45699999999999999999999999999999999999999999


Q ss_pred             CEEEeecCCcccccC-----------------------CCc-------------------------cccccccccccchh
Q psy2676         171 GLKIADFGLAKTFDY-----------------------DMM-------------------------LTSVVVTLWYRAPE  202 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~-----------------------~~~-------------------------~~~~~~~~~y~aPE  202 (321)
                      ++||+|||+|.....                       ...                         ..+..|||.|+|||
T Consensus       279 HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPE  358 (550)
T KOG0605|consen  279 HIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPE  358 (550)
T ss_pred             CEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchH
Confidence            999999999854311                       000                         01246899999999


Q ss_pred             hhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhc
Q psy2676         203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDC  282 (321)
Q Consensus       203 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (321)
                      ++.+..++..+|.|||||++|||+.|-+||.+.++.+...++..-......+.                       -..+
T Consensus       359 Vll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-----------------------~~~~  415 (550)
T KOG0605|consen  359 VLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-----------------------EVDL  415 (550)
T ss_pred             HHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-----------------------cCcc
Confidence            99999999999999999999999999999999999999998877443322222                       1245


Q ss_pred             chhHHHHHHHhcccCCCCCC---CHHHHhCCCCCCCCCCCCC
Q psy2676         283 CSKANSLLESMLTFNPADRI---SAADALEHPYFKEKENEPL  321 (321)
Q Consensus       283 ~~~~~~li~~~l~~dp~~Rp---s~~~ll~h~~f~~~~~~~~  321 (321)
                      +.++++||.+||. ||.+|.   +++||-+||||++++|+.|
T Consensus       416 s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l  456 (550)
T KOG0605|consen  416 SDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHL  456 (550)
T ss_pred             cHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchh
Confidence            5899999999999 999998   5999999999999999875

>KOG0595|consensus

Probab=100.00  E-value=2.4e-52  Score=342.51  Aligned_cols=259  Identities=34%  Similarity=0.555  Sum_probs=226.7

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|.+.+.||+|+||+||+|++ +.++..||||.+..+............|+.+|+.++   ||||++++++++.+    
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h-~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~---H~nIV~l~d~~~~~----   81 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRH-KKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK---HPNIVRLLDCIEDD----   81 (429)
T ss_pred             ccceehhhccCcceEEEEEeEe-ccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC---CcceeeEEEEEecC----
Confidence            5899999999999999999999 577799999999776444444556788999999999   99999999999988    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC------CCEEE
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA------GGLKI  174 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~------~~~kl  174 (321)
                         ..+|+|||||. |+|.+++..++  .+++..++.++.||+.||++||+++|+||||||+||+++.+      ..+||
T Consensus        82 ---~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKI  156 (429)
T KOG0595|consen   82 ---DFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKI  156 (429)
T ss_pred             ---CeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEe
Confidence               79999999999 69999999954  59999999999999999999999999999999999999875      45899


Q ss_pred             eecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       175 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      +|||+++............|++-|||||++....|+.|+|+||+|+++|++++|++||...+..+....+.......+. 
T Consensus       157 ADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~-  235 (429)
T KOG0595|consen  157 ADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV-  235 (429)
T ss_pred             cccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc-
Confidence            9999999999888888899999999999999999999999999999999999999999998888877755443222111 


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                                             ....+++.+.+++...|+.+|.+|.+..+-+.|++....+
T Consensus       236 -----------------------~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  236 -----------------------LPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             -----------------------hhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence                                   1223447777999999999999999999999999988764

>KOG0616|consensus

Probab=100.00  E-value=8e-53  Score=331.50  Aligned_cols=260  Identities=31%  Similarity=0.507  Sum_probs=229.9

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ..-.+|++++.||.|+||.|.+++. +.++..+|+|++.+...- ........+|..+++.+.   ||.++++++.+.+.
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~-k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~---~PFlv~l~~t~~d~  116 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVRE-KHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS---HPFLVKLYGTFKDN  116 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEE-ccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc---CceeEEEEEeeccC
Confidence            4557899999999999999999999 688999999999765222 223345678999999998   99999999999998


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ..+++||||.+| .|..++++++  ++++..++.++.||+.||+|||+++|++|||||+||++|.+|.+|++|
T Consensus       117 -------~~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitD  187 (355)
T KOG0616|consen  117 -------SNLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITD  187 (355)
T ss_pred             -------CeEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEe
Confidence                   889999999995 9999999954  499999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      ||++......  .-..+||+.|+|||.+...+++.++|-||||+++|||+.|.+||...+...+..+|....-     .+
T Consensus       188 FGFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-----~f  260 (355)
T KOG0616|consen  188 FGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-----KF  260 (355)
T ss_pred             ccceEEecCc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-----cC
Confidence            9999988744  4567899999999999999999999999999999999999999999999888888876422     22


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCC-----CCHHHHhCCCCCCCCCCCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADR-----ISAADALEHPYFKEKENEP  320 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R-----ps~~~ll~h~~f~~~~~~~  320 (321)
                      |.                      -.++++++||+++|+.|-.+|     ...++|.+||||++..|+.
T Consensus       261 P~----------------------~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~  307 (355)
T KOG0616|consen  261 PS----------------------YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA  307 (355)
T ss_pred             Cc----------------------ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence            22                      233899999999999999999     4788999999999999875

>KOG0658|consensus

Probab=100.00  E-value=8.1e-53  Score=341.34  Aligned_cols=286  Identities=35%  Similarity=0.571  Sum_probs=242.5

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      =+|+-.+.+|+|+||.||.|.. ..+++.+|||..-..      ..-..+|+++++.+.   ||||+++.-+|...... 
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~-~e~~~~vAIKKv~~d------~r~knrEl~im~~l~---HpNIV~L~~~f~~~~~~-   92 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKL-RETEEEVAIKKVLQD------KRYKNRELQIMRKLD---HPNIVRLLYFFSSSTES-   92 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEE-cCCCceeEEEEecCC------CCcCcHHHHHHHhcC---CcCeeeEEEEEEecCCC-
Confidence            3699999999999999999999 567899999987542      124458999999888   99999999999766222 


Q ss_pred             ccceEEEEEeccCccCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC-CCEEEeecC
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA-GGLKIADFG  178 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~-~~~kl~dfg  178 (321)
                       ......+||||++.+|...++..  .+..++.-.++-++.||++||.|||+.||+||||||.|++||.+ |.+||||||
T Consensus        93 -d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFG  171 (364)
T KOG0658|consen   93 -DEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFG  171 (364)
T ss_pred             -chhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCC
Confidence             24567899999999999999852  23458899999999999999999999999999999999999987 889999999


Q ss_pred             CcccccCCCccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      +|..........+..-+..|.|||++.+.. ++.+.||||.||++.||+.|++.|.+.+..+++..+.+.+|.|...+..
T Consensus       172 SAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  172 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             cceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            999988777777888899999999998766 8999999999999999999999999999999999999999999887665


Q ss_pred             hhhhhh-hhhhhhhhhhhhhh-hhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         258 ENISLM-WSSFEQYSKVAFSA-IFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       258 ~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      .....- ...+.+........ .....++++.+|+.++|..+|.+|.++.|++.||||.++...
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            543321 22334444444333 566889999999999999999999999999999999987543

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.2e-51  Score=344.36  Aligned_cols=280  Identities=41%  Similarity=0.720  Sum_probs=230.4

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++.+.||.|+||+||+|++ ..+++.||+|+++.... ........+|+.++++++   ||||+++++++.+.   
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~---   75 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRS-KLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLK---HANIVTLHDIIHTE---   75 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEE-CCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCC---CCCEeeEEEEEcCC---
Confidence            35799999999999999999998 67899999999875432 223446778999999998   99999999998776   


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                          ...++|+|+++++|.+++..... .+++..+..++.||+.||.+||++|++||||||+||+++.++.+||+|||++
T Consensus        76 ----~~~~lv~e~~~~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~  150 (288)
T cd07871          76 ----RCLTLVFEYLDSDLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLA  150 (288)
T ss_pred             ----CeEEEEEeCCCcCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcce
Confidence                67899999999999999876543 4789999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCC-ccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      ....... ......+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.+..+....+....+.++...|+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07871         151 RAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG  230 (288)
T ss_pred             eeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence            7543222 2334567889999999876 4579999999999999999999999999998888888988888888777665


Q ss_pred             hhhhhh---hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         259 NISLMW---SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       259 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ......   ..++.............++.++++||++||.+||.+|||++|+++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            332110   0111121222223344677899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0667|consensus

Probab=100.00  E-value=7.3e-52  Score=358.86  Aligned_cols=291  Identities=30%  Similarity=0.481  Sum_probs=238.2

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcc---cCCCCceeE
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD---TFEHPNIVR   89 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~~~~i~~   89 (321)
                      .+...+....||.|++.||+|+||.|.+|.| ..+++.||||+++.   ..........|+.+|+.++   ..+.-|+++
T Consensus       177 ~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d-~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vr  252 (586)
T KOG0667|consen  177 QLVVNDHIAYRYEVLEVLGKGSFGQVVKAYD-HKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVR  252 (586)
T ss_pred             eEEecceeEEEEEEEEEecccccceeEEEEe-cCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEE
Confidence            3444555666999999999999999999999 68999999999973   3334456678999999998   344568999


Q ss_pred             EEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA  169 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~  169 (321)
                      ++++|...       .+.|+|+|.+..+|+++++.+.-..++...++.++.||+.||..||+.||+|.||||+|||+..-
T Consensus       253 m~d~F~fr-------~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~  325 (586)
T KOG0667|consen  253 MLDYFYFR-------NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP  325 (586)
T ss_pred             eeeccccc-------cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC
Confidence            99999888       89999999999999999999887889999999999999999999999999999999999999654


Q ss_pred             C--CEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q psy2676         170 G--GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       170 ~--~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  247 (321)
                      +  .+||+|||+++..+....  ....+..|.|||++.+.+++.+.|||||||++.||++|.+.|.+.+..+++..|.+.
T Consensus       326 ~r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~  403 (586)
T KOG0667|consen  326 KRSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEV  403 (586)
T ss_pred             CcCceeEEecccccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHH
Confidence            4  599999999987664333  677889999999999999999999999999999999999999999999999999999


Q ss_pred             hCCCCCCCcchh------hhh---------hhhh----------------hhhhhhh----hhhhhhh-hcchhHHHHHH
Q psy2676         248 IGTPSMNEWPEN------ISL---------MWSS----------------FEQYSKV----AFSAIFM-DCCSKANSLLE  291 (321)
Q Consensus       248 ~~~~~~~~~~~~------~~~---------~~~~----------------~~~~~~~----~~~~~~~-~~~~~~~~li~  291 (321)
                      +|.|+...+...      ...         .+..                .......    ....... .....+.+||+
T Consensus       404 lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk  483 (586)
T KOG0667|consen  404 LGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLK  483 (586)
T ss_pred             hCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHH
Confidence            998876532110      000         0000                0000001    1111111 23357899999


Q ss_pred             HhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         292 SMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       292 ~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      +||.+||.+|+|+.++|+||||++.
T Consensus       484 ~~L~~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  484 RCLEWDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             HHhccCchhcCCHHHHhcCcccccc
Confidence            9999999999999999999999954

>KOG0583|consensus

Probab=100.00  E-value=1.2e-50  Score=347.72  Aligned_cols=259  Identities=32%  Similarity=0.523  Sum_probs=223.5

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC---CCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE---DGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ....++|++.+.||+|+||+|+.|.+ ..++..||+|++..+...   ......+.+|+.+++++..  ||||+++++++
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~-~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~--HpnI~~l~ev~   89 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKH-RLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRS--HPNIIRLLEVF   89 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeee-ccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhcc--CCCEeEEEEEE
Confidence            35567999999999999999999999 578899999987765222   1234466689999999986  99999999999


Q ss_pred             eccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC-CCE
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA-GGL  172 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~-~~~  172 (321)
                      ...       ..+++||||+.| +|.+++..  .+.+.|..++.+++||+.|++|||++|++||||||+||+++.+ +++
T Consensus        90 ~t~-------~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~  160 (370)
T KOG0583|consen   90 ATP-------TKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNL  160 (370)
T ss_pred             ecC-------CeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCE
Confidence            888       679999999995 99999999  4559999999999999999999999999999999999999999 999


Q ss_pred             EEeecCCcccc-cCCCccccccccccccchhhhhcCC-CC-CcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhC
Q psy2676         173 KIADFGLAKTF-DYDMMLTSVVVTLWYRAPEILLNLG-YG-TPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       173 kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      ||+|||++... ..........|++.|+|||++.+.. ++ .++||||+|++||.|++|..||...+.......+.... 
T Consensus       161 Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~-  239 (370)
T KOG0583|consen  161 KLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE-  239 (370)
T ss_pred             EEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC-
Confidence            99999999987 4556677889999999999999987 74 79999999999999999999999877766666644321 


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhc-chhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDC-CSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                       ..   +|.                      .+ +.++++|+++||.+||.+|+|+.++++||||+.
T Consensus       240 -~~---~p~----------------------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  240 -FK---IPS----------------------YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             -cc---CCC----------------------CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence             11   111                      12 589999999999999999999999999999997

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-50  Score=348.27  Aligned_cols=288  Identities=36%  Similarity=0.576  Sum_probs=226.8

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|++.+.||+|+||.||+|++ ..++..||+|.+............+.+|+.++++++   ||||+++++++...  ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~--~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAID-THTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR---HPDIVEIKHIMLPP--SRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEE-CCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC---CCCEeeecceEecc--CCC
Confidence            699999999999999999999 578899999998754332223345778999999998   99999999988654  122


Q ss_pred             cceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         103 RYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       103 ~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      ....+++|||+++++|.+++...  ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||.+..
T Consensus        75 ~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          75 EFKDIYVVFELMESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             CCceEEEEEecCCCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            23468999999999999998773  3489999999999999999999999999999999999999999999999999875


Q ss_pred             ccCCC----ccccccccccccchhhhhc--CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         183 FDYDM----MLTSVVVTLWYRAPEILLN--LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       183 ~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      .....    ......+++.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.+.......+....+.++...+
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            43221    1234568899999999876  56899999999999999999999999988887777777777666544322


Q ss_pred             chhhhh----hhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         257 PENISL----MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       257 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ......    ....+........+.....+++.+.++|.+||+.||++|||++++++||||++...
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence            211100    00111111112233334467788999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0591|consensus

Probab=100.00  E-value=4.5e-53  Score=330.82  Aligned_cols=249  Identities=29%  Similarity=0.501  Sum_probs=214.1

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe-eeecccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD-VIHQNIL   99 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~-~~~~~~~   99 (321)
                      -..|+|+++||+|+||.||+|++ ..++..+|.|.+.....+.........|+.+|++|+   ||||++.++ .|...  
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~-~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~---HpNIVqYy~~~f~~~--   91 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQC-LLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN---HPNIVQYYAHSFIED--   91 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeee-ccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC---CchHHHHHHHhhhcc--
Confidence            35699999999999999999999 589999999999877777666778889999999999   999999998 34332  


Q ss_pred             ccccceEEEEEeccCc-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeccCCCCcEEEeeCCCE
Q psy2676         100 SDERYLTVYLIFEHVD-QDLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHS--HR--IIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~--~~--~~H~di~p~Nilv~~~~~~  172 (321)
                          ...+++|||+|. |+|...+...  ....+++..+|+++.|++.||.++|+  .+  ++||||||.||+++.+|.+
T Consensus        92 ----~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvv  167 (375)
T KOG0591|consen   92 ----NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVV  167 (375)
T ss_pred             ----chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCce
Confidence                134899999999 7999998753  34559999999999999999999998  45  9999999999999999999


Q ss_pred             EEeecCCcccccCCCc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         173 KIADFGLAKTFDYDMM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      ||+|||++...+.... ..+..|||.|+|||.+.+.+++.+|||||+||++|||+..++||.+.+-.+.-.+|..+ ..|
T Consensus       168 KLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~  246 (375)
T KOG0591|consen  168 KLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYP  246 (375)
T ss_pred             eeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCC
Confidence            9999999998876654 44689999999999999999999999999999999999999999999777776666654 222


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA  304 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  304 (321)
                      +.+.                        .-+|..+..+|..|+.+||+.||+.
T Consensus       247 ~~p~------------------------~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  247 PLPD------------------------EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCcH------------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence            2111                        1355899999999999999999985

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.1e-50  Score=340.80  Aligned_cols=285  Identities=40%  Similarity=0.710  Sum_probs=223.1

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++.+.||+|+||+||+|++ ..+++.+|+|++..... ........+|+.+++.+.   ||||+++++++.+.   
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~---   75 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKS-KVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLK---HANIVLLHDIIHTK---   75 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEE-CCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCC---CCCcCeEEEEEecC---
Confidence            46899999999999999999999 57889999999875432 223345678999999988   99999999999776   


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                          ...++||||+.++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++
T Consensus        76 ----~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  150 (303)
T cd07869          76 ----ETLTLVFEYVHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLA  150 (303)
T ss_pred             ----CeEEEEEECCCcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcc
Confidence                6789999999999999887654 34899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC-CccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCC-hHHHHHHHHHHhCCCCCCCcc
Q psy2676         181 KTFDYD-MMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCAST-EVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       181 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      ...... .......+++.|+|||++.+. .++.++||||+||++|+|++|..||.+.. ..+....+....+.+....|+
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (303)
T cd07869         151 RAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP  230 (303)
T ss_pred             eeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence            654322 223445678999999998764 47889999999999999999999998753 345555666666666555444


Q ss_pred             hhhhhhh---hhhhhhhhhhhhh--hhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         258 ENISLMW---SSFEQYSKVAFSA--IFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       258 ~~~~~~~---~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      .......   ..+..........  .....++.+.+|+++||+.||++|||+.++++||||++.++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence            3221110   0000000000111  11134578999999999999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0597|consensus

Probab=100.00  E-value=7.5e-52  Score=351.60  Aligned_cols=255  Identities=31%  Similarity=0.563  Sum_probs=227.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|.+.+.||+|+||.||+++. +.+.+.||+|++.+....+.....+.+|+++++.++   ||||+.+++.|+..    
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrr-K~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk---Hpniv~m~esfEt~----   73 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRR-KYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK---HPNIVEMLESFETS----   73 (808)
T ss_pred             cchhHHHHhcCCccceeeeccc-ccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC---CcchhhHHHhhccc----
Confidence            6899999999999999999999 689999999999877666666677889999999999   99999999999888    


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                         .++++|+||+.|+|..++..  ++.++|+.++.++.|+..||.|||+.+|.|+|+||.||++..+|.+|+||||+++
T Consensus        74 ---~~~~vVte~a~g~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar  148 (808)
T KOG0597|consen   74 ---AHLWVVTEYAVGDLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLAR  148 (808)
T ss_pred             ---ceEEEEehhhhhhHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhh
Confidence               89999999999999999999  6669999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         182 TFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       182 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      .++... ..++..||+-|+|||+..+.+++..+|+|||||++||+++|++||-...-.+..+.|..     ....||.  
T Consensus       149 ~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~-----d~v~~p~--  221 (808)
T KOG0597|consen  149 AMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK-----DPVKPPS--  221 (808)
T ss_pred             hcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc-----CCCCCcc--
Confidence            887654 35567899999999999999999999999999999999999999976655555555443     2222222  


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                                          .++..+++|++.+|.+||.+|.|..+++.|||.++.
T Consensus       222 --------------------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  222 --------------------TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             --------------------cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                                455899999999999999999999999999999875

>KOG0610|consensus

Probab=100.00  E-value=7.4e-51  Score=333.97  Aligned_cols=270  Identities=28%  Similarity=0.400  Sum_probs=232.3

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ....+.-+.|++++.||.|.-|+||+|+. ..++..+|+|++.+.... .........|.++|..++   ||.++++|+.
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l-~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD---HPFlPTLYa~  145 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVEL-RGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD---HPFLPTLYAS  145 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEEe-cCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC---CCccchhhhe
Confidence            34455667899999999999999999999 567799999999776433 344567788999999999   9999999999


Q ss_pred             eeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      |+.+       ...|++||||+| +|..+.++++++.+++..++.++..|+.||+|||.+|||+|||||+||||-++|++
T Consensus       146 fet~-------~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHI  218 (459)
T KOG0610|consen  146 FETD-------KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHI  218 (459)
T ss_pred             eecc-------ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcE
Confidence            9888       889999999995 99999999999999999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCC----------------------------------C-----------------------cccccccc
Q psy2676         173 KIADFGLAKTFDYD----------------------------------M-----------------------MLTSVVVT  195 (321)
Q Consensus       173 kl~dfg~~~~~~~~----------------------------------~-----------------------~~~~~~~~  195 (321)
                      .|+||.++......                                  .                       ...+..||
T Consensus       219 MLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGT  298 (459)
T KOG0610|consen  219 MLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGT  298 (459)
T ss_pred             EeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccc
Confidence            99999987433100                                  0                       01124577


Q ss_pred             ccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhh
Q psy2676         196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAF  275 (321)
Q Consensus       196 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (321)
                      -+|+|||++.+...+.+.|-|+||+++|||+.|..||.+.+..+....+...-  +..+..                   
T Consensus       299 hEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~--l~Fp~~-------------------  357 (459)
T KOG0610|consen  299 HEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP--LKFPEE-------------------  357 (459)
T ss_pred             cccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC--CcCCCC-------------------
Confidence            88999999999999999999999999999999999999999999988876521  111111                   


Q ss_pred             hhhhhhcchhHHHHHHHhcccCCCCCCC----HHHHhCCCCCCCCCCCC
Q psy2676         276 SAIFMDCCSKANSLLESMLTFNPADRIS----AADALEHPYFKEKENEP  320 (321)
Q Consensus       276 ~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~f~~~~~~~  320 (321)
                          ..++..+++||+++|.+||.+|..    |+||-+||||++++|+-
T Consensus       358 ----~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaL  402 (459)
T KOG0610|consen  358 ----PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWAL  402 (459)
T ss_pred             ----CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhh
Confidence                145589999999999999999997    99999999999999973

>KOG0694|consensus

Probab=100.00  E-value=2e-50  Score=350.53  Aligned_cols=265  Identities=27%  Similarity=0.412  Sum_probs=230.4

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecc-cCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ....-++|+++++||+|+||+|+++.. +.+++.+|||++++. ...++.......|..++....+  ||.++.++.+|+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~-k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~--HPFL~~L~~~fQ  439 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAEL-KGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANR--HPFLVNLFSCFQ  439 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEE-cCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhcc--CCeEeecccccc
Confidence            345567899999999999999999999 688889999999886 3344556678889999999884  999999999999


Q ss_pred             ccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          96 QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      ..       .++|+||||+.|.-  ++.......+++..++.++..|+.||.|||++||+|||||.+||++|.+|.+||+
T Consensus       440 T~-------~~l~fvmey~~Ggd--m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiA  510 (694)
T KOG0694|consen  440 TK-------EHLFFVMEYVAGGD--LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIA  510 (694)
T ss_pred             cC-------CeEEEEEEecCCCc--EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEec
Confidence            88       89999999999722  4433334569999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccc-CCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         176 DFGLAKTFD-YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       176 dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      |||+|...- .....+...||+.|+|||++.+..|+.+.|-||||++||+|+.|..||.+.+.++....|..     ...
T Consensus       511 DFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~-----d~~  585 (694)
T KOG0694|consen  511 DFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN-----DEV  585 (694)
T ss_pred             ccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-----CCC
Confidence            999998654 44456778999999999999999999999999999999999999999999999998888765     222


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKENEP  320 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~~~  320 (321)
                      .+|.                      .++.++.++++++|..+|++|..     +++|..||||++++|+.
T Consensus       586 ~yP~----------------------~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~  634 (694)
T KOG0694|consen  586 RYPR----------------------FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD  634 (694)
T ss_pred             CCCC----------------------cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence            2332                      45589999999999999999995     58899999999999864

>KOG0198|consensus

Probab=100.00  E-value=8.3e-51  Score=335.45  Aligned_cols=261  Identities=30%  Similarity=0.500  Sum_probs=213.8

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ..++...+.||+|+||+||++.+ ..++...|+|.+.......  ...+.+|+.+++++.   |||||++++....... 
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~-~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~---~p~IV~~~G~~~~~~~-   88 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATN-KKTGELMAVKSVELEDSPT--SESLEREIRILSRLN---HPNIVQYYGSSSSREN-   88 (313)
T ss_pred             cchhhhhccccCccceEEEEEEe-cCCCcceeeeeeecccchh--HHHHHHHHHHHHhCC---CCCEEeeCCccccccC-
Confidence            45689999999999999999999 4669999999987653222  456889999999999   9999999997543310 


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee-CCCEEEeecC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR-AGGLKIADFG  178 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~-~~~~kl~dfg  178 (321)
                          ..+++.|||+. |+|.+++...++ .+++..++.+.+||++||+|||++|++|+||||+||+++. ++.+||+|||
T Consensus        89 ----~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG  163 (313)
T KOG0198|consen   89 ----DEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFG  163 (313)
T ss_pred             ----eeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCc
Confidence                46899999999 599999999776 6999999999999999999999999999999999999999 7999999999


Q ss_pred             CcccccC----CCccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         179 LAKTFDY----DMMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       179 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      .+.....    ........||+.|+|||++..+. ...++|||||||++.+|+||..||...  .+....+.........
T Consensus       164 ~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~~  241 (313)
T KOG0198|consen  164 LAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDSL  241 (313)
T ss_pred             cccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCCC
Confidence            9887663    22244578999999999999643 346999999999999999999999763  2222222222222222


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      +.+|                      ..++.++++||++|+..||.+||||+++|+|||.++..
T Consensus       242 P~ip----------------------~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  242 PEIP----------------------DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             CCCC----------------------cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            2333                      24669999999999999999999999999999998753

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=9e-50  Score=337.38  Aligned_cols=280  Identities=33%  Similarity=0.592  Sum_probs=219.9

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||+|++|+||+|++ ..+++.+++|++............+.+|+.++++++   ||||+++++++...    
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~----   72 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRH-KETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK---QENIVELKEAFRRR----   72 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEE-CCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC---CccccchhhhEecC----
Confidence            5799999999999999999999 578899999999765444444556778999999998   99999999998776    


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                         ...++||||+.+++.+.+.... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.
T Consensus        73 ---~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  148 (287)
T cd07848          73 ---GKLYLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR  148 (287)
T ss_pred             ---CEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence               6789999999986666655433 348999999999999999999999999999999999999999999999999988


Q ss_pred             cccCCC--ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         182 TFDYDM--MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       182 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ......  ......+++.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.+..+....+....+..+...+...
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd07848         149 NLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLF  228 (287)
T ss_pred             cccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhh
Confidence            764322  223356789999999999888999999999999999999999999987776666665555444332211100


Q ss_pred             hhhh-h--hhhhh--hhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         260 ISLM-W--SSFEQ--YSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       260 ~~~~-~--~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      .... .  .....  ............++.++.+||++||++||++|||++++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            0000 0  00000  00001112233477899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0588|consensus

Probab=100.00  E-value=2.3e-50  Score=348.36  Aligned_cols=259  Identities=30%  Similarity=0.467  Sum_probs=232.5

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecc-cCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      .-+-|++.+.||.|+.|.|-+|++ ..+|+..|||++.+. .........+.+|+.+|+.+.   |||++++|+.+++. 
T Consensus        10 tiGpwkLgkTLG~Gstg~vrlakh-~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~---HpnVl~LydVwe~~-   84 (786)
T KOG0588|consen   10 TIGPWKLGKTLGKGSTGCVRLAKH-AETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE---HPNVLRLYDVWENK-   84 (786)
T ss_pred             cccceeccccccCCCCceehhhhc-ccccceeEEEeeccccccccccccchhhhhHHHHHhc---CCCeeeeeeeeccC-
Confidence            346799999999999999999999 799999999999776 344445668889999999999   99999999999888 


Q ss_pred             cccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ..+|+|.||++ |.|.+++..  .+.+++.+++.+++||+.|+.|||..+|+|||+||+|++++..+++|++||
T Consensus        85 ------~~lylvlEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADF  156 (786)
T KOG0588|consen   85 ------QHLYLVLEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADF  156 (786)
T ss_pred             ------ceEEEEEEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeecc
Confidence                  89999999999 599999988  556999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcCCC-CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      |+|....+.......+|++.|.+||++.+.+| ..++||||.|++||.|++|+.||.+.+-...+.++..+....     
T Consensus       157 GMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~M-----  231 (786)
T KOG0588|consen  157 GMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEM-----  231 (786)
T ss_pred             ceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccC-----
Confidence            99998877777888999999999999999998 789999999999999999999999888777777766543222     


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                                            ...++.++++||++||.+||.+|.|.+||++|||+.+-..
T Consensus       232 ----------------------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  232 ----------------------PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             ----------------------CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence                                  2467799999999999999999999999999999987643

>KOG0578|consensus

Probab=100.00  E-value=1.1e-50  Score=345.35  Aligned_cols=264  Identities=30%  Similarity=0.519  Sum_probs=230.5

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ++........|....++|+|+.|.||.|+. ..+++.||+|.+......  ....+.+|+.+++...   |+|||.+++.
T Consensus       265 v~~~~dP~~~y~~~~kigqgaSG~vy~A~~-~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~---H~NiVnfl~S  338 (550)
T KOG0578|consen  265 VVSQGDPRSKYTDFKKIGQGATGGVYVARK-ISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLH---HPNIVNFLDS  338 (550)
T ss_pred             eccCCChhhhhcchhhhccccccceeeeee-ccCCceEEEEEEEeccCC--chhhhHHHHHHHHhcc---chHHHHHHHH
Confidence            344555667899999999999999999999 578888999999875433  3567889999999998   9999999999


Q ss_pred             eeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      |...       ..+++||||++| +|.+.+....   ++|.+++.|++++++||+|||.+||+|||||.+||+++.+|.+
T Consensus       339 ylv~-------deLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~v  408 (550)
T KOG0578|consen  339 YLVG-------DELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSV  408 (550)
T ss_pred             hccc-------ceeEEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcE
Confidence            8777       679999999995 9999888733   8999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         173 KIADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       173 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      ||+|||+|..+.... ......||+.|+|||+.....|.++.||||||+|+.||+-|.+||-..++...+..|.. .|.|
T Consensus       409 KltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P  487 (550)
T KOG0578|consen  409 KLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP  487 (550)
T ss_pred             EEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCC
Confidence            999999999887666 56678999999999999999999999999999999999999999988777666666544 3444


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      .....                       ..+++.+++|+.+||..|+.+|++|.|||+||||+...
T Consensus       488 ~lk~~-----------------------~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~  530 (550)
T KOG0578|consen  488 KLKNP-----------------------EKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK  530 (550)
T ss_pred             CcCCc-----------------------cccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence            43332                       24569999999999999999999999999999997654

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-49  Score=336.34  Aligned_cols=263  Identities=25%  Similarity=0.372  Sum_probs=215.9

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      .|++.+.||+|+||+||++.+ ..+++.+|+|.+...... ......+.+|+.+++++.   |++++++++++.+.    
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---~~~iv~~~~~~~~~----   72 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQV-RATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN---SRFVVSLAYAYETK----   72 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEE-ecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC---CCcEEEEEEEEccC----
Confidence            488999999999999999998 578999999998754322 122335678999999988   99999999998776    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++|+|+++ |+|..++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++
T Consensus        73 ---~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~  149 (285)
T cd05631          73 ---DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA  149 (285)
T ss_pred             ---CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence               67899999998 58988886655556899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         181 KTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      .............++..|+|||++.+..++.++||||+|+++|+|++|+.||...........+........ .      
T Consensus       150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~------  222 (285)
T cd05631         150 VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-E------  222 (285)
T ss_pred             EEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc-c------
Confidence            876544444456789999999999999999999999999999999999999987654332222222211111 0      


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKENE  319 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~~  319 (321)
                                      ......++++.+||++||+.||.+||+     ++++++||||++.+++
T Consensus       223 ----------------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05631         223 ----------------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK  270 (285)
T ss_pred             ----------------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence                            112245689999999999999999997     8999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0033|consensus

Probab=100.00  E-value=1.3e-51  Score=316.77  Aligned_cols=262  Identities=31%  Similarity=0.444  Sum_probs=229.8

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ...++|++.+.||+|.|+.|+++.+ ..+|+.+++|++....-.......+.+|+.+-+.|+   ||||+++++.+... 
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~-~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq---HP~IvrL~~ti~~~-   82 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVH-KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ---HPNIVRLHDSIQEE-   82 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHh-ccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC---CCcEeehhhhhccc-
Confidence            3457899999999999999999998 688999999988655444445567888999999998   99999999998776 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC---CEEE
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG---GLKI  174 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~---~~kl  174 (321)
                            ...|+|+|++.| +|..-+-.+  .-+++..+.-.++||++||.|+|.+||+|||+||+|+++....   -+||
T Consensus        83 ------~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL  154 (355)
T KOG0033|consen   83 ------SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKL  154 (355)
T ss_pred             ------ceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceee
Confidence                  678999999996 777666553  3479999999999999999999999999999999999995433   3999


Q ss_pred             eecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       175 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      +|||.+...+.....-...||+.|+|||++...+++.++|||+-|++||-++.|.+||.+.+......++....-..+.+
T Consensus       155 ~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~  234 (355)
T KOG0033|consen  155 ADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSP  234 (355)
T ss_pred             cccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCc
Confidence            99999998886667778899999999999999999999999999999999999999999988888888888766655555


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .|+                       .+++++++|+++||..||.+|+|+.|.|+|||++++
T Consensus       235 ~w~-----------------------~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  235 EWD-----------------------TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             ccC-----------------------cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            554                       577999999999999999999999999999999986

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.1e-49  Score=349.27  Aligned_cols=290  Identities=31%  Similarity=0.499  Sum_probs=226.1

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ....++|++.+.||+|+||+||+|.+ ..+++.||+|.+...      .....+|+.+++.++   ||||+++++++...
T Consensus        62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~---h~niv~l~~~~~~~  131 (440)
T PTZ00036         62 RSPNKSYKLGNIIGNGSFGVVYEAIC-IDTSEKVAIKKVLQD------PQYKNRELLIMKNLN---HINIIFLKDYYYTE  131 (440)
T ss_pred             cCcCCeEEEeEEEEeCCCEEEEEEEE-CCCCCEEEEEEEecC------cchHHHHHHHHHhcC---CCCCcceeeeEeec
Confidence            34557899999999999999999998 578899999987532      224557999999998   99999999987654


Q ss_pred             ccc-cccceEEEEEeccCccCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC-CEE
Q psy2676          98 ILS-DERYLTVYLIFEHVDQDLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-GLK  173 (321)
Q Consensus        98 ~~~-~~~~~~~~~v~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~-~~k  173 (321)
                      ... ......+++||||++++|.+++...  ....+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+|
T Consensus       132 ~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vk  211 (440)
T PTZ00036        132 CFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLK  211 (440)
T ss_pred             ccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCcee
Confidence            222 2223467899999999998887642  234589999999999999999999999999999999999998665 699


Q ss_pred             EeecCCcccccCCCccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         174 IADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       174 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |+|||++.............+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+....+.+.
T Consensus       212 L~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~  291 (440)
T PTZ00036        212 LCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT  291 (440)
T ss_pred             eeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9999999876544444456779999999998765 589999999999999999999999999888888888888777665


Q ss_pred             CCCcchhhhhh-hhhhhhhhhhhh-hhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         253 MNEWPENISLM-WSSFEQYSKVAF-SAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       253 ~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ...+....... ...+........ .......+.++.+||.+||.+||.+|||+.++++||||++..
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence            43322111000 000011111111 112234678999999999999999999999999999998764

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.1e-48  Score=334.04  Aligned_cols=284  Identities=39%  Similarity=0.703  Sum_probs=231.3

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|.+.+.||+|+||+||++++ ..+++.+++|.++.... ........+|+.++++++   |||++++++++...   
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~---   76 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRS-KLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLK---HANIVTLHDIVHTD---   76 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEe-cCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCC---CCCcceEEEEEeeC---
Confidence            36899999999999999999998 57888999999875432 223345678999999987   99999999999776   


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                          ...++|+||++++|.+++..... .+++..++.++.||+.||.+||+.|++||||+|+||+++.++.++|+|||.+
T Consensus        77 ----~~~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  151 (309)
T cd07872          77 ----KSLTLVFEYLDKDLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLA  151 (309)
T ss_pred             ----CeEEEEEeCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccc
Confidence                67899999999999998876543 4899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCC-ccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      ....... ......+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.+..+....+....+.+....|+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (309)
T cd07872         152 RAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG  231 (309)
T ss_pred             eecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence            7543222 2234567889999999865 4578999999999999999999999999988888888888888777766654


Q ss_pred             hhhhhh---hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         259 NISLMW---SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       259 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ......   ..+..............+++++.++|++||..||.+|||+.|+++||||+...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         232 ISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            322111   01111111112223346788999999999999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0582|consensus

Probab=100.00  E-value=7.1e-49  Score=325.02  Aligned_cols=276  Identities=25%  Similarity=0.406  Sum_probs=228.4

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +...+....+.|++...||.|..++||+|+. ...++.||||++........ ...+.+|++.++.+.   ||||++.+.
T Consensus        17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c-~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~---HPNIv~~~~   91 (516)
T KOG0582|consen   17 SEKEFPLNAKDYELQEVIGVGASAVVYLARC-IPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLID---HPNIVTYHC   91 (516)
T ss_pred             ccccCCCCccceeEEEEEeccceeEeeeeee-cccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcC---CCCcceEEE
Confidence            4456777889999999999999999999999 46779999999988755554 567889999999998   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      .|...       ..+++||+++. |++.+++...-...++|..++.|+++++.||.|||.+|.+|||||+.||+|+.+|.
T Consensus        92 sFvv~-------~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~  164 (516)
T KOG0582|consen   92 SFVVD-------SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT  164 (516)
T ss_pred             EEEec-------ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc
Confidence            99888       78999999999 69999998765556999999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCCc-----cccccccccccchhhhhcC--CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q psy2676         172 LKIADFGLAKTFDYDMM-----LTSVVVTLWYRAPEILLNL--GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI  244 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  244 (321)
                      ++|+|||.+..+.....     +....+++.|+|||++...  .|+.|+||||||++..|+.+|..||....+...+-..
T Consensus       165 VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t  244 (516)
T KOG0582|consen  165 VKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT  244 (516)
T ss_pred             EEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence            99999998765543321     1445889999999996543  4899999999999999999999999887776665433


Q ss_pred             HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      .  .+.|+.....        .+..       +.....+..++++|..||..||.+|||++++|+|+||++..
T Consensus       245 L--qn~pp~~~t~--------~~~~-------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  245 L--QNDPPTLLTS--------GLDK-------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             h--cCCCCCcccc--------cCCh-------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            3  3333322200        0000       11123446899999999999999999999999999999864

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-49  Score=335.63  Aligned_cols=256  Identities=27%  Similarity=0.445  Sum_probs=215.3

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++++.||+|+||+||+|.+ ..+++.+|+|++...... ......+.+|+.+++++.   ||||+++++++.+.   
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~---   73 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRD-RISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS---HPFIIRLFWTEHDQ---   73 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEE-cCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC---CCcHhhhHhhhccC---
Confidence            4799999999999999999999 578899999998754221 122345678999999998   99999999988776   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..+++||||+. ++|.+++...  +.+++..++.++.||+.||.+||++|++||||+|+||+++.++.++|+|||+
T Consensus        74 ----~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~  147 (291)
T cd05612          74 ----RFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGF  147 (291)
T ss_pred             ----CeEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCc
Confidence                68899999998 5999999873  4589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      +......  .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+....  .   .++  
T Consensus       148 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~---~~~--  218 (291)
T cd05612         148 AKKLRDR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--L---EFP--  218 (291)
T ss_pred             chhccCC--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--c---CCC--
Confidence            8765432  223468899999999999889999999999999999999999998877666555554321  1   111  


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKENE  319 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~~  319 (321)
                                          ..++..+.+||++||..||.+||+     ++++++||||+..+|.
T Consensus       219 --------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         219 --------------------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             --------------------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence                                134578999999999999999995     9999999999987664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.5e-48  Score=339.87  Aligned_cols=287  Identities=36%  Similarity=0.551  Sum_probs=224.2

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.+.||+|+||.||++++ ..++..+|+|++............+.+|+.+++.++   ||||+++++++.....
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~   94 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFD-TVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN---HKNIISLLNVFTPQKS   94 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEE-cCCCceeEEEEecccccchhHHHHHHHHHHHHHhCC---CCCEeeeeeeeccCCC
Confidence            347999999999999999999999 578999999998765444444556778999998887   9999999999865421


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                       ......+++|||+++++|...+..    .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus        95 -~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          95 -LEEFQDVYLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             -ccccceeEEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCC
Confidence             122245799999999988887743    378999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      +.............+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+....+.+........
T Consensus       170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            87655444445567899999999999999999999999999999999999999988877777777766655443211110


Q ss_pred             hhhhh---hh------------hhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         260 ISLMW---SS------------FEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       260 ~~~~~---~~------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      .....   ..            +..+............++.+.+||.+||..||++|||+.|+++||||+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence            00000   00            0000000011111234578999999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-48  Score=340.85  Aligned_cols=279  Identities=25%  Similarity=0.331  Sum_probs=218.4

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      +..++|++++.||+|+||.||+|.+ ..+++.||+|....        ....+|++++++++   ||||+++++++... 
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d-~~~~~~vaiK~~~~--------~~~~~E~~il~~l~---HpnIv~~~~~~~~~-  155 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACID-NKTCEHVVIKAGQR--------GGTATEAHILRAIN---HPSIIQLKGTFTYN-  155 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEE-CCCCCEEEEechhh--------hhhHHHHHHHHhCC---CCCCCCEeEEEEEC-
Confidence            4557899999999999999999999 68889999996532        25678999999998   99999999999776 


Q ss_pred             cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676          99 LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                            ...++|+|++.++|..++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||
T Consensus       156 ------~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG  227 (391)
T PHA03212        156 ------KFTCLILPRYKTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG  227 (391)
T ss_pred             ------CeeEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCC
Confidence                  678999999999999988773  458999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCC--CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCC-------ChHHHHHHHHHHhC
Q psy2676         179 LAKTFDYD--MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAS-------TEVEQLKCIFRVIG  249 (321)
Q Consensus       179 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-------~~~~~~~~~~~~~~  249 (321)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||-..       ........+....+
T Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g  307 (391)
T PHA03212        228 AACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSG  307 (391)
T ss_pred             cccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhc
Confidence            98643221  1223457899999999999989999999999999999999999776432       23445566666666


Q ss_pred             CCCCCCcchhhhhhhhhh---hh-----hhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         250 TPSMNEWPENISLMWSSF---EQ-----YSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~---~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      .++..............+   ..     ............++.++.+||.+||+.||.+|||+.|+|+||||++.+.
T Consensus       308 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~  384 (391)
T PHA03212        308 THPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD  384 (391)
T ss_pred             CChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence            544322111110000000   00     0001111222356778999999999999999999999999999998743

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-49  Score=339.38  Aligned_cols=264  Identities=31%  Similarity=0.444  Sum_probs=219.1

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++++.||+|+||.||+|++ ..+++.||+|+++...... .....+.+|+.+++.+.   ||||+++++++.+.   
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~---h~~iv~~~~~~~~~---   73 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKK-KDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK---SEWLVKLLYAFQDD---   73 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEE-CCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC---CCCCccEEEEEEcC---
Confidence            4799999999999999999999 5788999999997653221 22345678899999888   99999999999877   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++||||++ ++|.+++...  ..+++..++.++.||+.||.+||+.|++||||||+||+++.++.+||+|||+
T Consensus        74 ----~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~  147 (333)
T cd05600          74 ----EYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGL  147 (333)
T ss_pred             ----CEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcC
Confidence                68899999998 4999999773  4589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      +.....  ......+++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.........+.+.  
T Consensus       148 a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--  223 (333)
T cd05600         148 SKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD--  223 (333)
T ss_pred             Cccccc--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCC--
Confidence            876543  2344578999999999999999999999999999999999999998877766655554322111111100  


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                                       .....++.++.++|.+||..+|.+||++.++++||||++.+|+
T Consensus       224 -----------------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~  266 (333)
T cd05600         224 -----------------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN  266 (333)
T ss_pred             -----------------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence                             0012456899999999999999999999999999999987653

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8e-49  Score=337.27  Aligned_cols=258  Identities=28%  Similarity=0.439  Sum_probs=216.7

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      .-++|++.+.||+|+||.||+|++ ..+++.+|+|++..... .......+.+|+.+++++.   ||||+++++.+.+. 
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~-   90 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKH-KGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS---HPFIVNMMCSFQDE-   90 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEE-CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC---CCCCCcEEEEEEcC-
Confidence            346899999999999999999999 57889999999975422 1222345778999999987   99999999999877 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ...++||||+.| +|.+++...  ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+||
T Consensus        91 ------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Df  162 (329)
T PTZ00263         91 ------NRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDF  162 (329)
T ss_pred             ------CEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeec
Confidence                  688999999985 999999873  45899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      |++.......  ....+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...  ...   ++
T Consensus       163 g~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~---~p  235 (329)
T PTZ00263        163 GFAKKVPDRT--FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RLK---FP  235 (329)
T ss_pred             cCceEcCCCc--ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CcC---CC
Confidence            9987664332  2356899999999999999999999999999999999999999887766555544331  111   11


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKENE  319 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~~  319 (321)
                                            ..++..+.+||++||+.||.+||+     ++++++||||++..|+
T Consensus       236 ----------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        236 ----------------------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             ----------------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence                                  124478899999999999999996     7999999999987654

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=9.8e-49  Score=337.42  Aligned_cols=264  Identities=25%  Similarity=0.392  Sum_probs=220.6

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ....+..++|++.+.||+|+||.||+|.+...++..+|+|++..... .......+.+|+.+++.+.   ||||++++++
T Consensus        23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~Iv~~~~~   99 (340)
T PTZ00426         23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN---HPFCVNLYGS   99 (340)
T ss_pred             cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC---CCCCcceEEE
Confidence            34556667899999999999999999987544557899999865422 2223345678999999998   9999999999


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +.+.       ...++||||+. |+|.+++...  ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+
T Consensus       100 ~~~~-------~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~i  170 (340)
T PTZ00426        100 FKDE-------SYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFI  170 (340)
T ss_pred             EEeC-------CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCE
Confidence            9877       68899999998 5999999873  458999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         173 KIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      +|+|||++......  .....||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+.......+.....   
T Consensus       171 kL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~---  245 (340)
T PTZ00426        171 KMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII---  245 (340)
T ss_pred             EEecCCCCeecCCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---
Confidence            99999998765432  2345689999999999998899999999999999999999999988777666555543211   


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                        .++                      ..+++.+.++|++||+.||.+|+     +++++++||||++.+|.
T Consensus       246 --~~p----------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        246 --YFP----------------------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             --CCC----------------------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence              111                      13447889999999999999995     89999999999998764

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.6e-48  Score=329.02  Aligned_cols=284  Identities=40%  Similarity=0.723  Sum_probs=231.5

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      -++|++.+.||.|++|.||++.+ ..+++.|++|.+..... ........+|+.++++++   ||||+++++++...   
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~-~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~---h~nI~~~~~~~~~~---   76 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRS-KLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLK---HANIVTLHDIIHTE---   76 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEE-cCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcC---CCCcceEEEEEecC---
Confidence            36899999999999999999998 57889999999875432 223345678999999998   99999999999776   


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                          ...++|+||+.++|.+++..... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        77 ----~~~~lv~e~~~~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  151 (301)
T cd07873          77 ----KSLTLVFEYLDKDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLA  151 (301)
T ss_pred             ----CeEEEEEeccccCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcch
Confidence                67899999999999998876543 4899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCC-ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      ....... ......+++.|+|||++.+. .++.++||||||+++|+|++|++||...+..+....+....+.+....|+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (301)
T cd07873         152 RAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG  231 (301)
T ss_pred             hccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence            7543222 22334568889999998764 478899999999999999999999999888888888888877777666654


Q ss_pred             hhhhhh---hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         259 NISLMW---SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       259 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ..+...   .................+++.+.+||.+||+.||.+|||++++++||||+...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            332211   11111222222334456788999999999999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0599|consensus

Probab=100.00  E-value=4e-50  Score=313.24  Aligned_cols=259  Identities=31%  Similarity=0.525  Sum_probs=227.3

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCC------chhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP------MSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~------~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      +.|.-.+.||.|..++|-++.+ +.++..+++|++..........      .....|+.+++++.+  ||||+++.+.|+
T Consensus        17 ~~y~pkeilgrgvss~vrRci~-k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~G--HP~II~l~D~ye   93 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIH-KETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMG--HPYIIDLQDVYE   93 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhh-cccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcC--CCcEEEeeeecc
Confidence            5688889999999999999998 6888888888886542222111      233469999999996  999999999998


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      .+       ..+++|+|.++ |.|.+++..  .-.+++...++|++|++++++|||.++|+||||||+||+++++.+++|
T Consensus        94 s~-------sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~i  164 (411)
T KOG0599|consen   94 SD-------AFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKI  164 (411)
T ss_pred             Cc-------chhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEE
Confidence            88       78999999999 799999988  455999999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCccccccccccccchhhhhcC------CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHh
Q psy2676         175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL------GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       175 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      +|||+++...+.......+||++|+|||.+.+.      .++...|+|++|+++|.++.|.+||....+.-++..++.+.
T Consensus       165 sDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk  244 (411)
T KOG0599|consen  165 SDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK  244 (411)
T ss_pred             eccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence            999999999988888899999999999998653      36778999999999999999999999888888888888776


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      .....++|.                       +++...++||.+||++||.+|.|++|+|+||||.+
T Consensus       245 yqF~speWa-----------------------dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  245 YQFRSPEWA-----------------------DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             cccCCcchh-----------------------hccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            655555553                       67789999999999999999999999999999954

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.5e-48  Score=340.12  Aligned_cols=262  Identities=28%  Similarity=0.403  Sum_probs=213.1

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++++.||+|+||+||+|++ ..+++.+|+|++...... ......+.+|+.++..++   ||||+++++.+.+.   
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~---~~~iv~~~~~~~~~---   73 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQK-KDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD---SLWVVKMFYSFQDK---   73 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEE-CCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC---CCCcceEEEEEecC---
Confidence            4799999999999999999998 578999999999754221 222345667888888887   99999999999877   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..+++||||+.| +|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus        74 ----~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGl  147 (363)
T cd05628          74 ----LNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL  147 (363)
T ss_pred             ----CeEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccC
Confidence                688999999985 999999873  4589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC------------------------------------ccccccccccccchhhhhcCCCCCcchHHHHHHHHH
Q psy2676         180 AKTFDYDM------------------------------------MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMA  223 (321)
Q Consensus       180 ~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~  223 (321)
                      +.......                                    ......||+.|+|||++.+..++.++|||||||++|
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~  227 (363)
T cd05628         148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY  227 (363)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence            86543210                                    012346899999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCC---C
Q psy2676         224 EMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPA---D  300 (321)
Q Consensus       224 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~---~  300 (321)
                      +|++|..||.+.+..+....+.........+..                       ..+++++.++|.+|+. +|.   .
T Consensus       228 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~-----------------------~~~s~~~~~li~~l~~-~~~~r~~  283 (363)
T cd05628         228 EMLIGYPPFCSETPQETYKKVMNWKETLIFPPE-----------------------VPISEKAKDLILRFCC-EWEHRIG  283 (363)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCc-----------------------CCCCHHHHHHHHHHcC-ChhhcCC
Confidence            999999999988777766665542211111110                       1245788999999765 444   4


Q ss_pred             CCCHHHHhCCCCCCCCCCCC
Q psy2676         301 RISAADALEHPYFKEKENEP  320 (321)
Q Consensus       301 Rps~~~ll~h~~f~~~~~~~  320 (321)
                      ||+++++++||||++.+|+.
T Consensus       284 r~~~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         284 APGVEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             CCCHHHHhCCCCCCCCCHHH
Confidence            68999999999999987753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.1e-48  Score=339.45  Aligned_cols=286  Identities=35%  Similarity=0.532  Sum_probs=225.5

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++.+.||+|+||.||++.+ ...++.+|+|++............+.+|+.+++.+.   ||||+++++++..... 
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~ii~~~~~~~~~~~-   97 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIGLLNVFTPQKS-   97 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEE-CCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC---CCCccccceeeccccc-
Confidence            47999999999999999999999 578899999998765444444456778999998887   9999999998865421 


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                      ......+++|||+++++|...+..    .+++..++.++.|++.||.+||++|++||||||+||+++.++.++|+|||++
T Consensus        98 ~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875          98 LEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             ccccCeEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            122246899999999999888754    2789999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         181 KTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      .............++..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....+.+....+....
T Consensus       174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            87665544455678999999999999999999999999999999999999999988888888887776665432111110


Q ss_pred             hhhhh---hhh------------hhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         261 SLMWS---SFE------------QYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       261 ~~~~~---~~~------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      .....   ...            ..............+..+++||.+||+.||.+|||+.++|+||||+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence            00000   000            00000001111123467899999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.9e-48  Score=325.18  Aligned_cols=280  Identities=48%  Similarity=0.830  Sum_probs=227.8

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      .|++++.||+|++|.||+|++ ..++..+++|.++...........+.+|+.+++++.   |||++++++++.+.     
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~-----   71 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRN-KKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ---HPNIVCLQDVLMQE-----   71 (285)
T ss_pred             CceEeeEecccCceEEEEEEE-CCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC---CCCEeeeEEEEeeC-----
Confidence            489999999999999999998 578899999998765444444456778999999998   99999999999876     


Q ss_pred             cceEEEEEeccCccCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVDQDLGSYMEKCPP-PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                        ...++|+|++.++|.+++..... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        72 --~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  149 (285)
T cd07861          72 --SRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR  149 (285)
T ss_pred             --CeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECccccee
Confidence              67899999999999998876443 458999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCC-ccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         182 TFDYDM-MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       182 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ...... ......+++.|+|||.+.+.. ++.++|+||||+++++|++|+.||.+....+....+....+.+....|+..
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd07861         150 AFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV  229 (285)
T ss_pred             ecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence            554322 223345678899999887644 688999999999999999999999988887777777776666555544432


Q ss_pred             hhhh--hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         260 ISLM--WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       260 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ....  ...+..+...........+++++.++|++||..||.+|||+.++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            2211  11222222233334445688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-49  Score=341.14  Aligned_cols=261  Identities=30%  Similarity=0.439  Sum_probs=219.0

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++.+.||+|+||+||+|++ ..+++.+|+|+++...... .....+.+|+.+++.+.   ||||+++++++.+.   
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~---~~~i~~~~~~~~~~---   73 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRD-KDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD---SPWIVKLYYSFQDE---   73 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEE-CCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC---CCCccchhhheecC---
Confidence            4799999999999999999999 5789999999997653222 23445677888998888   99999999999777   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++||||+. ++|.+++...  ..+++..++.++.||+.||.+||+.|++||||||+||+++.++.++|+|||+
T Consensus        74 ----~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~  147 (350)
T cd05573          74 ----EHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGL  147 (350)
T ss_pred             ----CeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCC
Confidence                68899999998 5999999874  4589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC------------------------------ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcC
Q psy2676         180 AKTFDYDM------------------------------MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV  229 (321)
Q Consensus       180 ~~~~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  229 (321)
                      +.......                              ......+++.|+|||++.+..++.++|||||||++|+|++|+
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~  227 (350)
T cd05573         148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF  227 (350)
T ss_pred             CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence            87664332                              233456899999999999999999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-HHHHh
Q psy2676         230 PLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-AADAL  308 (321)
Q Consensus       230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~~ll  308 (321)
                      .||...+.......+.........+.                       ...+++++.++|.+||. ||.+||+ +.+++
T Consensus       228 ~Pf~~~~~~~~~~~i~~~~~~~~~p~-----------------------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll  283 (350)
T cd05573         228 PPFYSDTLQETYNKIINWKESLRFPP-----------------------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIK  283 (350)
T ss_pred             CCCCCCCHHHHHHHHhccCCcccCCC-----------------------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence            99988876666655544211111111                       01256899999999997 9999999 99999


Q ss_pred             CCCCCCCCCCC
Q psy2676         309 EHPYFKEKENE  319 (321)
Q Consensus       309 ~h~~f~~~~~~  319 (321)
                      +||||++.+|+
T Consensus       284 ~hp~~~~~~~~  294 (350)
T cd05573         284 SHPFFKGIDWE  294 (350)
T ss_pred             cCCCcCCCCHH
Confidence            99999988764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0585|consensus

Probab=100.00  E-value=5.2e-49  Score=328.01  Aligned_cols=261  Identities=32%  Similarity=0.488  Sum_probs=213.9

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC------------CCCchhHHHHHHHHhcccCCCCce
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED------------GIPMSTLREISILKQLDTFEHPNI   87 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~~~~i   87 (321)
                      .-|+|++.+.||+|.||.|-+|++ ..+++.||+|++.+.....            .......+|+.+++++.   ||||
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~-~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~---H~nV  170 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARD-EVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH---HPNV  170 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEee-cCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC---CcCe
Confidence            347999999999999999999999 6899999999996652221            11236678999999999   9999


Q ss_pred             eEEEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q psy2676          88 VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI  166 (321)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~-~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv  166 (321)
                      |+++++.-++     ....+|+|+|||..  ..+.-...+.. +++.+++.+++++..||+|||.+||+||||||+|+|+
T Consensus       171 V~LiEvLDDP-----~s~~~YlVley~s~--G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl  243 (576)
T KOG0585|consen  171 VKLIEVLDDP-----ESDKLYLVLEYCSK--GEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL  243 (576)
T ss_pred             eEEEEeecCc-----ccCceEEEEEeccC--CccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE
Confidence            9999997544     44679999999993  23333333444 8999999999999999999999999999999999999


Q ss_pred             eeCCCEEEeecCCccccc------CCCccccccccccccchhhhhcCC----CCCcchHHHHHHHHHHHHhcCCCCCCCC
Q psy2676         167 TRAGGLKIADFGLAKTFD------YDMMLTSVVVTLWYRAPEILLNLG----YGTPVDIWSIGCVMAEMWRLVPLFCAST  236 (321)
Q Consensus       167 ~~~~~~kl~dfg~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~  236 (321)
                      +++|.+||+|||.+....      .........||+.|+|||++.+..    .+.+.||||+|++||.|+.|+.||-+..
T Consensus       244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~  323 (576)
T KOG0585|consen  244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF  323 (576)
T ss_pred             cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence            999999999999987662      222344578999999999987632    4678999999999999999999999988


Q ss_pred             hHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         237 EVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ..+...+|....-     .+|..                    .++.+++++||.+||.+||.+|.+..+|..|||...-
T Consensus       324 ~~~l~~KIvn~pL-----~fP~~--------------------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  324 ELELFDKIVNDPL-----EFPEN--------------------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHHHHHHHhcCcc-----cCCCc--------------------ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            8888877765321     11111                    1445899999999999999999999999999998754

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.4e-49  Score=336.77  Aligned_cols=252  Identities=26%  Similarity=0.401  Sum_probs=209.7

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||+|+||.||+|++ ..+++.+|+|+++..... ........+|+.+++++.   ||||+++++++...       ..
T Consensus         1 ~~lG~G~~g~Vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---hp~i~~~~~~~~~~-------~~   69 (323)
T cd05571           1 KLLGKGTFGKVILVRE-KATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFLTALKYSFQTH-------DR   69 (323)
T ss_pred             CeeeeCCCeEEEEEEE-CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC---CCCCCCEEEEEEcC-------CE
Confidence            4689999999999999 678999999999764322 222335667888888887   99999999999777       68


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccC
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY  185 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~  185 (321)
                      +++||||+.+ +|.+++..  ...+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus        70 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  147 (323)
T cd05571          70 LCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS  147 (323)
T ss_pred             EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence            8999999995 99998877  34589999999999999999999999999999999999999999999999999875322


Q ss_pred             -CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhh
Q psy2676         186 -DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW  264 (321)
Q Consensus       186 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
                       ........|++.|+|||++.+..++.++||||+||++|+|++|..||...+.......+....     ..+        
T Consensus       148 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-----~~~--------  214 (323)
T cd05571         148 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-----IRF--------  214 (323)
T ss_pred             CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-----CCC--------
Confidence             223344568999999999999999999999999999999999999998776655554443211     011        


Q ss_pred             hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                                    ...+++++.+||++||..||++||     ++.++++||||++.+|+
T Consensus       215 --------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~  260 (323)
T cd05571         215 --------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ  260 (323)
T ss_pred             --------------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                          124568899999999999999999     89999999999987664

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.4e-48  Score=338.10  Aligned_cols=287  Identities=37%  Similarity=0.555  Sum_probs=224.6

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.+.||+|+||.||++.+ ...++.+++|.+..............+|+.+++.++   ||||+++++++.....
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~   90 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYD-AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIISLLNVFTPQKS   90 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEe-cCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC---CCchhceeeeeecccc
Confidence            347999999999999999999998 578899999998765443333456678899998887   9999999999865421


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                       .......++|||+++++|...+..    .+++..++.++.|++.||.+||+.|++||||||+||+++.++.++|+|||+
T Consensus        91 -~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          91 -LEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             -ccccceeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence             122346799999999988887754    378999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      +.............++..|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+....+.+....+...
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            98766554455667899999999999988999999999999999999999999998887777777776665433221111


Q ss_pred             hhhhhhhh---hhhh------------hhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         260 ISLMWSSF---EQYS------------KVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       260 ~~~~~~~~---~~~~------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      ........   ....            ...........+.++.+||.+||..||++|||+.|+++||||+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~  316 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV  316 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence            00000000   0000            00001111224567899999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0032|consensus

Probab=100.00  E-value=8.1e-48  Score=329.97  Aligned_cols=264  Identities=35%  Similarity=0.542  Sum_probs=233.6

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      .+.....|++.+.||+|.||.||+++. ..+|+.+|+|++.+..... .....+.+|+++++++..  ||||+.+++.|.
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~-~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~--hpniv~l~~~~e  106 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCRE-KSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSG--HPNIVQLKDAFE  106 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEe-cCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccC--CCCEEEEEEEEE
Confidence            344567899999999999999999999 5789999999997764432 234578899999999986  999999999999


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC----C
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA----G  170 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~----~  170 (321)
                      +.       ..+++|||++. |.|.+.+...   .+++.++..++.|++.+++|||+.|++|+||||+|+++...    +
T Consensus       107 ~~-------~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~  176 (382)
T KOG0032|consen  107 DP-------DSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSG  176 (382)
T ss_pred             cC-------CeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCC
Confidence            98       78999999999 5999999886   39999999999999999999999999999999999999543    4


Q ss_pred             CEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCC
Q psy2676         171 GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      .++++|||++.............||+.|+|||++...+++..+||||+|+++|.|++|.+||.+.+.......+...-..
T Consensus       177 ~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~  256 (382)
T KOG0032|consen  177 RIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFD  256 (382)
T ss_pred             cEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCC
Confidence            69999999999988766778899999999999999999999999999999999999999999999988888777665443


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .....|                       .+++..++++|+.||..||.+|+|+.++|+|||+++.
T Consensus       257 f~~~~w-----------------------~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  257 FTSEPW-----------------------DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             CCCCCc-----------------------cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            344443                       3667999999999999999999999999999999976

>KOG0192|consensus

Probab=100.00  E-value=3.1e-48  Score=329.78  Aligned_cols=257  Identities=28%  Similarity=0.403  Sum_probs=218.9

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcE-EEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~-~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ....+......+.+.+|+|+||+||++..   .|+. +|+|++............+.+|+.++++++   ||||++++++
T Consensus        34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~---~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~---HpNIV~f~G~  107 (362)
T KOG0192|consen   34 PEEEIDPDELPIEEVLGSGSFGTVYKGKW---RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLR---HPNIVQFYGA  107 (362)
T ss_pred             cceecChHHhhhhhhcccCCceeEEEEEe---CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCC---CCCeeeEEEE
Confidence            44555566777778899999999999965   4555 999999765444433568899999999998   9999999999


Q ss_pred             eeccccccccce-EEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCcEEEeeCC
Q psy2676          94 IHQNILSDERYL-TVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR-IIHRDLKPQNLLITRAG  170 (321)
Q Consensus        94 ~~~~~~~~~~~~-~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~-~~H~di~p~Nilv~~~~  170 (321)
                      +..+       . ..++||||++ |+|..++.......++...+..++.||+.|+.|||+++ |+|+||||+|||++.++
T Consensus       108 ~~~~-------~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~  180 (362)
T KOG0192|consen  108 CTSP-------PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG  180 (362)
T ss_pred             EcCC-------CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC
Confidence            9777       3 6899999999 69999998854556999999999999999999999999 99999999999999997


Q ss_pred             -CEEEeecCCcccccCC-Cccccccccccccchhhhh--cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q psy2676         171 -GLKIADFGLAKTFDYD-MMLTSVVVTLWYRAPEILL--NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR  246 (321)
Q Consensus       171 -~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  246 (321)
                       ++||+|||++...... ...+...||..|+|||++.  ...++.++||||||+++|||+||+.||......+....+..
T Consensus       181 ~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~  260 (362)
T KOG0192|consen  181 KTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVV  260 (362)
T ss_pred             CEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence             9999999999876644 3444578999999999999  66899999999999999999999999999888776666665


Q ss_pred             HhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         247 VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ....|..+.                         .+++.+..++..||..||.+||+..+++.
T Consensus       261 ~~~Rp~~p~-------------------------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  261 GGLRPPIPK-------------------------ECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             cCCCCCCCc-------------------------cCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            554444333                         36689999999999999999999999874

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.4e-48  Score=339.93  Aligned_cols=286  Identities=35%  Similarity=0.567  Sum_probs=225.4

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|++.+.||+|+||+||++.+ ..+++.||+|.+............+.+|+.+++.++   ||||+++++++.....  .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~--~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTD-PRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK---HDNVLSALDILQPPHI--D   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEE-CCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC---CCCcCCHhheecCCCc--c
Confidence            478999999999999999998 578999999988654322223346778999999988   9999999999876621  2


Q ss_pred             cceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         103 RYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       103 ~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      .....++|+||+.++|.+.+..  ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus        75 ~~~~~~lv~e~~~~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          75 PFEEIYVVTELMQSDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             ccceEEEEeeccccCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceee
Confidence            2236899999999999988876  34589999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCC--ccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         183 FDYDM--MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       183 ~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      .....  ......+++.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.+..+....+....+.+....+...
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            53222  223346788899999988754 789999999999999999999999999988888888888777665433221


Q ss_pred             hhhhhhhhhhh--hh---hhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         260 ISLMWSSFEQY--SK---VAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       260 ~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .......+...  ..   ..........++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            11000000000  00   00111233567899999999999999999999999999999984

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.4e-48  Score=336.32  Aligned_cols=268  Identities=26%  Similarity=0.379  Sum_probs=219.5

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ....+..++|++.+.||+|+||.||+|++ ..+++.+|+|++...... ......+.+|+.+++.++   ||||++++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~---h~~iv~~~~~  111 (370)
T cd05596          36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRH-KSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN---SEWIVQLHYA  111 (370)
T ss_pred             ccCCCCHHHcEEEEEEeeCCCEEEEEEEE-CCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC---CCCcceEEEE
Confidence            35566778999999999999999999999 578999999999753222 222334667889998887   9999999999


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +.+.       ...++||||+. |+|.+++...   .+++..+..++.||+.||+|||+.|++||||||+||+++.++.+
T Consensus       112 ~~~~-------~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~  181 (370)
T cd05596         112 FQDD-------KYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL  181 (370)
T ss_pred             EecC-------CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCE
Confidence            9877       78999999998 5999988763   37899999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCC--ccccccccccccchhhhhcC----CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q psy2676         173 KIADFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNL----GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR  246 (321)
Q Consensus       173 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  246 (321)
                      +|+|||.+.......  ......|++.|+|||++.+.    .++.++|||||||++|+|++|..||.+.+.......+..
T Consensus       182 kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  261 (370)
T cd05596         182 KLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD  261 (370)
T ss_pred             EEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc
Confidence            999999987664332  22345689999999998754    378899999999999999999999988777666655544


Q ss_pred             HhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCCC
Q psy2676         247 VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD--RISAADALEHPYFKEKENE  319 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~h~~f~~~~~~  319 (321)
                      ......   ++.                    ...++.++.+||++||..+|.+  |+|++++++||||++.+|.
T Consensus       262 ~~~~~~---~~~--------------------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~  313 (370)
T cd05596         262 HKNSLT---FPD--------------------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT  313 (370)
T ss_pred             CCCcCC---CCC--------------------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence            221111   111                    1145689999999999999988  9999999999999987653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-48  Score=338.12  Aligned_cols=261  Identities=28%  Similarity=0.466  Sum_probs=214.7

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||+|++..... .......+.+|+.+++.+.   ||||+++++++.+.   
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~---h~~iv~~~~~~~~~---   73 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQK-KDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD---NPWVVKLYYSFQDE---   73 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEE-CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC---CCCCcceEEEEEcC---
Confidence            4799999999999999999999 57889999999976422 1222345667999999988   99999999999887   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..+++||||+. |+|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus        74 ----~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  147 (364)
T cd05599          74 ----NYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL  147 (364)
T ss_pred             ----CeEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeeccc
Confidence                78999999998 5999998773  4589999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCC---------------------------------------ccccccccccccchhhhhcCCCCCcchHHHHHH
Q psy2676         180 AKTFDYDM---------------------------------------MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGC  220 (321)
Q Consensus       180 ~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  220 (321)
                      +.......                                       ......||+.|+|||++....++.++|||||||
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~  227 (364)
T cd05599         148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV  227 (364)
T ss_pred             ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence            86542111                                       001235899999999999989999999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCC
Q psy2676         221 VMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD  300 (321)
Q Consensus       221 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  300 (321)
                      ++|+|++|..||...+..+....+.........+.                       ...+++++.+||++||. +|.+
T Consensus       228 il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-----------------------~~~~s~~~~~li~~ll~-~p~~  283 (364)
T cd05599         228 IMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPD-----------------------EVPLSPEAKDLIKRLCC-EAER  283 (364)
T ss_pred             HHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCC-----------------------CCCCCHHHHHHHHHHcc-CHhh
Confidence            99999999999988877666555543211111111                       01345889999999997 9999


Q ss_pred             CCC---HHHHhCCCCCCCCCCC
Q psy2676         301 RIS---AADALEHPYFKEKENE  319 (321)
Q Consensus       301 Rps---~~~ll~h~~f~~~~~~  319 (321)
                      |++   +.++++||||++.+|+
T Consensus       284 R~~~~~~~~ll~h~~~~~~~~~  305 (364)
T cd05599         284 RLGNNGVNEIKSHPFFKGVDWE  305 (364)
T ss_pred             cCCCCCHHHHhcCCCcCCCCHH
Confidence            998   9999999999987664

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.9e-48  Score=330.63  Aligned_cols=257  Identities=26%  Similarity=0.361  Sum_probs=213.9

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      |++++.||+|++|.||+|.+ ..+++.||+|+++..... ......+.+|+.++..+..+.||||+++++++.+.     
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-----   74 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEY-KKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-----   74 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEE-CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-----
Confidence            78999999999999999998 578899999999764322 22234566788777777767799999999999777     


Q ss_pred             cceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                        ...++||||+.| +|...+..   ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++.
T Consensus        75 --~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05589          75 --DHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK  149 (324)
T ss_pred             --CEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence              688999999995 88877754   348999999999999999999999999999999999999999999999999886


Q ss_pred             cccC-CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         182 TFDY-DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       182 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      .... ........+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+......     .    
T Consensus       150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~-----~----  220 (324)
T cd05589         150 EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR-----Y----  220 (324)
T ss_pred             cCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----C----
Confidence            5332 22233456899999999999989999999999999999999999999888776665554432111     1    


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKEN  318 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~  318 (321)
                                        ...++..+.++|++||+.||.+||     ++.++++||||++..+
T Consensus       221 ------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         221 ------------------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             ------------------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence                              123558889999999999999999     7999999999998754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-47  Score=323.58  Aligned_cols=263  Identities=25%  Similarity=0.376  Sum_probs=215.9

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      .|++.+.||+|+||+||++.+ ..+++.||+|++....... .....+.+|+.+++.++   ||||+++++.+...    
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~----   72 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQV-RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN---SRFVVSLAYAYETK----   72 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEE-cCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC---CCCEeeeeeeecCC----
Confidence            489999999999999999998 5788999999987543222 12334667999999997   99999999998776    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++||||+. ++|.+.+.......+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||++
T Consensus        73 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~  149 (285)
T cd05605          73 ---DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             ---CeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCc
Confidence               67899999998 59988887655556899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         181 KTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      .............++..|+|||++.+..++.++||||+|+++|+|++|..||.+.........+........ .      
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~------  222 (285)
T cd05605         150 VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-E------  222 (285)
T ss_pred             eecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc-c------
Confidence            776544443445788999999999988899999999999999999999999987655433333322211111 0      


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                                      .....++..+.+|+.+||..||.+||     +++++++||||++.+|+
T Consensus       223 ----------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         223 ----------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             ----------------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence                            01124568899999999999999999     99999999999987664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-48  Score=335.03  Aligned_cols=287  Identities=38%  Similarity=0.617  Sum_probs=226.3

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++++.||.|+||+||+|.+ ..++..||+|.+............+.+|+.++++++   ||||+++++++..... 
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~-   88 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYD-TRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK---HENVIGLLDVFTPATS-   88 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEE-CCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC---CCchhhhhhhhccccc-
Confidence            47899999999999999999998 578889999998754333333345668999999988   9999999998864421 


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                      .......++++++++++|.+++..   ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~~~~~~~~~~~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          89 IENFNEVYLVTNLMGADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             ccccCcEEEEeecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence            222345799999998899888764   34899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         181 KTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ......  .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+....+.+........
T Consensus       166 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         166 RQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             eecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            865432  234567899999999877 45799999999999999999999999988888888877776665543322111


Q ss_pred             hhhh----hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         260 ISLM----WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       260 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ....    .................+.++.+.+||.+||..||.+|||+.++++||||.+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence            1000    011111222223334445677899999999999999999999999999998753

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0580|consensus

Probab=100.00  E-value=2.6e-49  Score=302.88  Aligned_cols=260  Identities=28%  Similarity=0.436  Sum_probs=230.7

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeeccc-CCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKL-NEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      ...-++|++.+.||+|-||.||+|+. +.++.-||+|++.++. ........+.+|+++...|+   ||||+++|++|.+
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlare-kks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~---hpnilrlY~~fhd   93 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLARE-KKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR---HPNILRLYGYFHD   93 (281)
T ss_pred             ccchhhccccccccCCccccEeEeee-ccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC---CccHHhhhhheec
Confidence            34446899999999999999999999 6889999999987653 33345667788999999998   9999999999999


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ..+|+++||.. |+++..+.......+++...+.++.|++.||.|+|..+++||||||+|++++..+.+|++
T Consensus        94 ~-------~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiA  166 (281)
T KOG0580|consen   94 S-------KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIA  166 (281)
T ss_pred             c-------ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeecc
Confidence            8       89999999999 799999997777889999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      |||-+...+ .......+||..|.|||...+...+...|+|++|++.|+++.|.+||......+..+++.+.--..+   
T Consensus       167 dfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p---  242 (281)
T KOG0580|consen  167 DFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP---  242 (281)
T ss_pred             CCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC---
Confidence            999998766 5556678999999999999999999999999999999999999999999888777777765322111   


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                                              ..++..+.++|.+||..+|.+|.+..|++.|||....
T Consensus       243 ------------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  243 ------------------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             ------------------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                                    3566899999999999999999999999999998753

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-48  Score=339.21  Aligned_cols=261  Identities=29%  Similarity=0.460  Sum_probs=211.2

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++++.||+|+||+||++++ ..+++.||+|++..... .......+.+|+.++++++   ||||+++++++.+.   
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~---hp~iv~~~~~~~~~---   73 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQK-KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD---SPWVVSLYYSFQDA---   73 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEE-CCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC---CCCcceEEEEEEcC---
Confidence            4799999999999999999999 57889999999865322 1222345667899998887   99999999999877   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++||||+. |+|.+++...  ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||+
T Consensus        74 ----~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGl  147 (377)
T cd05629          74 ----QYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGL  147 (377)
T ss_pred             ----CeeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccc
Confidence                78899999998 5999999763  4589999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCC------------------------------------------------ccccccccccccchhhhhcCCCCC
Q psy2676         180 AKTFDYDM------------------------------------------------MLTSVVVTLWYRAPEILLNLGYGT  211 (321)
Q Consensus       180 ~~~~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~  211 (321)
                      +.......                                                ......||+.|+|||++.+..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  227 (377)
T cd05629         148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ  227 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence            85321100                                                001235899999999999988999


Q ss_pred             cchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHH
Q psy2676         212 PVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLE  291 (321)
Q Consensus       212 ~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  291 (321)
                      ++|||||||++|+|++|..||...+..+....+.........+.                       ...++.++.+||.
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-----------------------~~~~s~~~~dli~  284 (377)
T cd05629         228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPD-----------------------DIHLSVEAEDLIR  284 (377)
T ss_pred             ceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCC-----------------------CCCCCHHHHHHHH
Confidence            99999999999999999999988776665555443211111111                       0135578999999


Q ss_pred             HhcccCCCCC---CCHHHHhCCCCCCCCCCC
Q psy2676         292 SMLTFNPADR---ISAADALEHPYFKEKENE  319 (321)
Q Consensus       292 ~~l~~dp~~R---ps~~~ll~h~~f~~~~~~  319 (321)
                      +||. +|.+|   +++.++++||||++.+|+
T Consensus       285 ~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~  314 (377)
T cd05629         285 RLIT-NAENRLGRGGAHEIKSHPFFRGVDWD  314 (377)
T ss_pred             HHhc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            9998 77765   599999999999987654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-47  Score=336.20  Aligned_cols=262  Identities=26%  Similarity=0.390  Sum_probs=211.1

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ..|++++.||+|+||+||+|++ ..+++.+|+|++...... ......+.+|+.+++++.   ||||+++++++.+.   
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~---h~~iv~l~~~~~~~---   73 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACK-VDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD---NEWVVKLYYSFQDK---   73 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEE-CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC---CCCeeeeEEEEecC---
Confidence            3689999999999999999999 678999999999764322 222345678999999987   99999999999877   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..+++||||++ |+|.+++...  ..+++..++.++.||+.||.+||+.|++||||||+||+++.++.++|+|||+
T Consensus        74 ----~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl  147 (381)
T cd05626          74 ----DNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGL  147 (381)
T ss_pred             ----CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcC
Confidence                67999999998 5999998873  4589999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCC------------------------------------------------ccccccccccccchhhhhcCCCCC
Q psy2676         180 AKTFDYDM------------------------------------------------MLTSVVVTLWYRAPEILLNLGYGT  211 (321)
Q Consensus       180 ~~~~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~  211 (321)
                      +.......                                                ......||+.|+|||++.+..++.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (381)
T cd05626         148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ  227 (381)
T ss_pred             CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence            75321000                                                011346899999999999888999


Q ss_pred             cchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHH
Q psy2676         212 PVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLE  291 (321)
Q Consensus       212 ~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  291 (321)
                      ++|||||||++|+|++|..||...+..+....+.........+.                       ...+++++.+||.
T Consensus       228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-----------------------~~~~s~~~~dli~  284 (381)
T cd05626         228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPP-----------------------QVKLSPEAVDLIT  284 (381)
T ss_pred             ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCC-----------------------CCCCCHHHHHHHH
Confidence            99999999999999999999988776655544432211111111                       1135688999999


Q ss_pred             Hhc--ccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         292 SML--TFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       292 ~~l--~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      +||  ..+|..|++++++++||||++..|.
T Consensus       285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~  314 (381)
T cd05626         285 KLCCSAEERLGRNGADDIKAHPFFSEVDFS  314 (381)
T ss_pred             HHccCcccccCCCCHHHHhcCcccCCCChh
Confidence            955  4556669999999999999987653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.5e-48  Score=334.77  Aligned_cols=262  Identities=26%  Similarity=0.361  Sum_probs=215.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++.+.||+|+||+||+|++ ..+++.+|+|+++.... .......+.+|+.+++.+.   ||||+++++++.+.   
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~---~~~i~~~~~~~~~~---   73 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVRE-KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN---SPWIPQLQYAFQDK---   73 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEE-CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC---CCCCcceeeEEecC---
Confidence            4799999999999999999999 57899999999986533 1222345667888888877   99999999999776   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++||||++ ++|.+++.... ..+++..++.++.||+.||.+||+.|++||||||+||+++.++.++|+|||+
T Consensus        74 ----~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~  148 (330)
T cd05601          74 ----DNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGS  148 (330)
T ss_pred             ----CeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCC
Confidence                67899999998 59999998753 3489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc--cccccccccccchhhhh------cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         180 AKTFDYDMM--LTSVVVTLWYRAPEILL------NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       180 ~~~~~~~~~--~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      +........  .....+++.|+|||++.      ...++.++||||||+++|+|++|..||...+.......+.......
T Consensus       149 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~  228 (330)
T cd05601         149 AARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL  228 (330)
T ss_pred             CeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc
Confidence            976653332  22346889999999986      4457889999999999999999999998877766665554321111


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      ..+.                       ...++..+.+||++||. +|.+|||++++++||||++.+|+
T Consensus       229 ~~~~-----------------------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         229 KFPE-----------------------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             CCCC-----------------------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence            1111                       11356889999999998 99999999999999999987665

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-47  Score=320.73  Aligned_cols=287  Identities=60%  Similarity=1.071  Sum_probs=236.4

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      |++.+.||.|++|.||++++ ..+++.+++|+++...........+.+|+.+++++....|||++++++++.....  ..
T Consensus         1 y~~~~~l~~g~~~~v~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~--~~   77 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARD-LNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT--DR   77 (287)
T ss_pred             CeEEEEecccCceEEEEEEE-CCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC--CC
Confidence            78899999999999999998 5678999999997654444334466678889988887779999999999977621  12


Q ss_pred             ceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccc
Q psy2676         104 YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF  183 (321)
Q Consensus       104 ~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~  183 (321)
                      ....++++|++.++|.+++.......+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+...
T Consensus        78 ~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          78 ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             CceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence            34589999999999999988765556899999999999999999999999999999999999999999999999998776


Q ss_pred             cCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhh
Q psy2676         184 DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM  263 (321)
Q Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
                      ..........++..|+|||.+.+..++.++|+||+|+++|+|++|.+||......+...++......+....++......
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP  237 (287)
T ss_pred             cCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence            54444444557888999999999889999999999999999999999999988888888887766655544444433222


Q ss_pred             hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ...+.............+.+..+.++|.+||+.||.+||++.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            23333333334455555677899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.9e-47  Score=332.91  Aligned_cols=267  Identities=28%  Similarity=0.401  Sum_probs=217.6

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      .......++|++.+.||+|+||.||++++ ..+++.+|+|++...... ......+.+|+.+++.+.   ||||++++++
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~---hp~iv~~~~~  111 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRH-KSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN---SPWVVQLFCA  111 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEE-CCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC---CCCEeeEEEE
Confidence            44566778999999999999999999999 578899999998753221 222334667888888887   9999999999


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +.+.       ..+++||||++ |+|.+++...   .+++..+..++.||+.||++||++|++||||||+||+++.++.+
T Consensus       112 ~~~~-------~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~  181 (370)
T cd05621         112 FQDD-------KYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL  181 (370)
T ss_pred             EEcC-------CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCE
Confidence            9877       78999999998 5999998763   38999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCc--cccccccccccchhhhhcCC----CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q psy2676         173 KIADFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLG----YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR  246 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  246 (321)
                      ||+|||++........  .....||+.|+|||++.+..    ++.++|+||+||++|+|++|..||.+.+.......+..
T Consensus       182 kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~  261 (370)
T cd05621         182 KLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD  261 (370)
T ss_pred             EEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            9999999987643322  23456899999999997643    67899999999999999999999988877666666554


Q ss_pred             HhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCC
Q psy2676         247 VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD--RISAADALEHPYFKEKEN  318 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~h~~f~~~~~  318 (321)
                      .......+.                       ...++..+++++..||..++.+  |+++.++++||||++..|
T Consensus       262 ~~~~~~~p~-----------------------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         262 HKNSLNFPE-----------------------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             CCcccCCCC-----------------------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence            322211111                       1135688999999999865544  899999999999998654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.4e-47  Score=328.53  Aligned_cols=282  Identities=24%  Similarity=0.413  Sum_probs=216.8

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      +..++|++++.||+|+||.||++++ ..++..+++|++..... ......+.+|++++++++   ||||+++++++.+. 
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~-   75 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQH-KPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECN---SPYIVGFYGAFYSD-   75 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEE-CCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCC---CCCCCeEEEEEEEC-
Confidence            4578999999999999999999999 67889999999875422 122346778999999987   99999999999776 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeeCCCEEEee
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                            ...++||||+++ +|.+++...  ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|
T Consensus        76 ------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~D  147 (331)
T cd06649          76 ------GEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCD  147 (331)
T ss_pred             ------CEEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEcc
Confidence                  678999999995 999999874  3489999999999999999999986 699999999999999999999999


Q ss_pred             cCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC--
Q psy2676         177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN--  254 (321)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  254 (321)
                      ||++...... ......++..|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+    +.+...  
T Consensus       148 fg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~----~~~~~~~~  222 (331)
T cd06649         148 FGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF----GRPVVDGE  222 (331)
T ss_pred             Cccccccccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh----cccccccc
Confidence            9998765432 233456889999999999988999999999999999999999999877655433221    111100  


Q ss_pred             -Ccchhhh-----------------h----hhhhhhhhhhhhhhh-hhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCC
Q psy2676         255 -EWPENIS-----------------L----MWSSFEQYSKVAFSA-IFMDCCSKANSLLESMLTFNPADRISAADALEHP  311 (321)
Q Consensus       255 -~~~~~~~-----------------~----~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  311 (321)
                       ..+....                 .    ............... ....+++++.+||++||+.||++|||+.++++||
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         223 EGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence             0000000                 0    000000000000000 0123668899999999999999999999999999


Q ss_pred             CCCCCCCC
Q psy2676         312 YFKEKENE  319 (321)
Q Consensus       312 ~f~~~~~~  319 (321)
                      ||+....+
T Consensus       303 ~~~~~~~~  310 (331)
T cd06649         303 FIKRSEVE  310 (331)
T ss_pred             HHhhcccc
Confidence            99876543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.6e-47  Score=327.98  Aligned_cols=253  Identities=29%  Similarity=0.443  Sum_probs=209.2

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||+|+||+||+|++ ..+++.||+|++..... ..........|..++..+..  ||||+++++++...       ..
T Consensus         1 ~~lg~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~--h~~iv~~~~~~~~~-------~~   70 (320)
T cd05590           1 RVLGKGSFGKVMLARL-KESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFLTQLYCCFQTP-------DR   70 (320)
T ss_pred             CeeeeCCCeEEEEEEE-cCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccC--CCchhceeeEEEcC-------CE
Confidence            4689999999999998 57889999999876432 22223355677777777643  99999999999777       67


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccC
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY  185 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~  185 (321)
                      +++||||+++ +|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        71 ~~iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~  148 (320)
T cd05590          71 LFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF  148 (320)
T ss_pred             EEEEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence            8999999995 999888773  4589999999999999999999999999999999999999999999999999875422


Q ss_pred             -CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhh
Q psy2676         186 -DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW  264 (321)
Q Consensus       186 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
                       ........|++.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.....  .   .+       
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~--~---~~-------  216 (320)
T cd05590         149 NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--V---YP-------  216 (320)
T ss_pred             CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC--C---CC-------
Confidence             2233345689999999999988899999999999999999999999998877766655543111  0   11       


Q ss_pred             hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH------HHHhCCCCCCCCCCC
Q psy2676         265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA------ADALEHPYFKEKENE  319 (321)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~h~~f~~~~~~  319 (321)
                                     ..++.++.++|++||+.||.+||++      +++++||||++..|+
T Consensus       217 ---------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~  262 (320)
T cd05590         217 ---------------TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE  262 (320)
T ss_pred             ---------------CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence                           1345789999999999999999998      999999999987664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.8e-47  Score=321.65  Aligned_cols=279  Identities=44%  Similarity=0.806  Sum_probs=221.0

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|++.+.||.|++|.||+|++ ..+++.+++|.++...........+.+|+.++++++   |||++++++++.+.     
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~-~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~---h~~i~~~~~~~~~~-----   71 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKN-RETHEIVALKRVRLDDDDEGVPSSALREICLLKELK---HKNIVRLYDVLHSD-----   71 (284)
T ss_pred             CceeEEEecccCCeEEEEEEE-CCCCcEEEEEEeecccccccCccchhHHHHHHHhcC---CCCeeeHHHHhccC-----
Confidence            689999999999999999999 578899999999765444444556778999999998   99999999998776     


Q ss_pred             cceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         103 RYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       103 ~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                        ...++++|+++++|.+++.... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        72 --~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  148 (284)
T cd07839          72 --KKLTLVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA  148 (284)
T ss_pred             --CceEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhc
Confidence              6789999999999998887643 3489999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCC-ccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCC-CCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         183 FDYDM-MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLF-CASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       183 ~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ..... ......++..|+|||++.+.. ++.++||||||+++|+|++|..|+ .+.+..+....+....+.+....|+..
T Consensus       149 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07839         149 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV  228 (284)
T ss_pred             cCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence            54322 223345678899999987754 689999999999999999998774 556666666667666665544433321


Q ss_pred             hhhhh-hhhhhhhh-hhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         260 ISLMW-SSFEQYSK-VAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       260 ~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ..... ..+..... .........+++++.++|++||+.||.+|||++++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            11100 00111110 11123344577899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.2e-47  Score=326.86  Aligned_cols=258  Identities=28%  Similarity=0.405  Sum_probs=213.3

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      +|++++.||+|+||.||+|++ ..+++.+|+|++..... .......+..|..++..+..  |++++++++++.+.    
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~--~~~i~~~~~~~~~~----   73 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAER-KGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK--PPFLTQLHSCFQTM----   73 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEE-CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCC--CCceeeeEEEEEcC----
Confidence            589999999999999999998 57788999999976432 12223456678888888872  56788999998776    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ..+++||||+. |+|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus        74 ---~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~  148 (324)
T cd05587          74 ---DRLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMC  148 (324)
T ss_pred             ---CEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcc
Confidence               67899999998 5999998773  44899999999999999999999999999999999999999999999999988


Q ss_pred             cccc-CCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         181 KTFD-YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       181 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      .... .........|++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.+..+....+.....     .++  
T Consensus       149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-----~~~--  221 (324)
T cd05587         149 KENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-----SYP--  221 (324)
T ss_pred             eecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----CCC--
Confidence            6432 22233445689999999999999999999999999999999999999988877666655543211     111  


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH-----HHHhCCCCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA-----ADALEHPYFKEKENE  319 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~h~~f~~~~~~  319 (321)
                                          ..+++++.+++++||..||.+|++.     .++++||||+..+|+
T Consensus       222 --------------------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~  266 (324)
T cd05587         222 --------------------KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE  266 (324)
T ss_pred             --------------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                                2355889999999999999999976     899999999987664

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.6e-47  Score=335.98  Aligned_cols=261  Identities=28%  Similarity=0.432  Sum_probs=211.8

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++++.||+|+||+||+|++ ..+++.+|+|++...... ......+.+|+.+++++.   ||||+++++.+.+.   
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~-~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~---h~~iv~~~~~~~~~---   73 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARK-VDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD---NEWVVRLYYSFQDK---   73 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEE-CCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC---CCcCCeEEEEEEeC---
Confidence            3699999999999999999999 578899999998754221 122345678999999987   99999999999877   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..+++||||+. |+|.+++...  ..+++..++.++.||+.||.+||++|++||||||+||+++.++.++|+|||+
T Consensus        74 ----~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGl  147 (382)
T cd05625          74 ----DNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL  147 (382)
T ss_pred             ----CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCC
Confidence                68999999998 4999998773  4489999999999999999999999999999999999999999999999998


Q ss_pred             cccccCC------------------------------------------------CccccccccccccchhhhhcCCCCC
Q psy2676         180 AKTFDYD------------------------------------------------MMLTSVVVTLWYRAPEILLNLGYGT  211 (321)
Q Consensus       180 ~~~~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~  211 (321)
                      +......                                                .......||+.|+|||++.+..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (382)
T cd05625         148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ  227 (382)
T ss_pred             CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence            7432100                                                0011246889999999999999999


Q ss_pred             cchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHH
Q psy2676         212 PVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLE  291 (321)
Q Consensus       212 ~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  291 (321)
                      ++|||||||++|+|++|..||.+.+..+....+.........+.                       ...+++++.++|.
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-----------------------~~~~s~~~~~li~  284 (382)
T cd05625         228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP-----------------------QAKLSPEASDLII  284 (382)
T ss_pred             eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCC-----------------------cccCCHHHHHHHH
Confidence            99999999999999999999988776665555443211111111                       1135588999999


Q ss_pred             HhcccCCCCCCC---HHHHhCCCCCCCCCCC
Q psy2676         292 SMLTFNPADRIS---AADALEHPYFKEKENE  319 (321)
Q Consensus       292 ~~l~~dp~~Rps---~~~ll~h~~f~~~~~~  319 (321)
                      +|+ .+|.+|++   ++++++||||++..+.
T Consensus       285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~  314 (382)
T cd05625         285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDFS  314 (382)
T ss_pred             HHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence            987 49999997   9999999999987553

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.2e-47  Score=320.05  Aligned_cols=280  Identities=46%  Similarity=0.837  Sum_probs=229.3

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      .|++++.||.|++|.||+|++ ..+++.+++|.+............+.+|++++++++   |||++++++++.+.     
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~-----   71 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN---HPNIVKLLDVIHTE-----   71 (284)
T ss_pred             CceeeeeecCCCceEEEEEEE-CCCCCEEEEEEccccccccccchHHHHHHHHHHhcC---CCCCcchhhhcccC-----
Confidence            489999999999999999998 578899999998765444444457788999999998   99999999998766     


Q ss_pred             cceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         103 RYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       103 ~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                        ...++|+||+.++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        72 --~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~  149 (284)
T cd07860          72 --NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA  149 (284)
T ss_pred             --CcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhh
Confidence              678999999998999999876666789999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCC-ccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         183 FDYDM-MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       183 ~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      ..... ......++..|+|||++.+.. ++.++|+||||+++|+|++|+.||...+..+...++....+.+....++...
T Consensus       150 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07860         150 FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT  229 (284)
T ss_pred             cccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence            54322 223345678899999887655 5889999999999999999999999888888888877777766554443221


Q ss_pred             h--hhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         261 S--LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       261 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      .  .....+..+...........++.++.++|.+||+.||.+|||+.++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            1  1112223333333344445677899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.4e-47  Score=340.34  Aligned_cols=286  Identities=21%  Similarity=0.370  Sum_probs=216.8

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhccc---CCCCceeEEEee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT---FEHPNIVRFFDV   93 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~~~~i~~~~~~   93 (321)
                      ++...++|++++.||+|+||+||+|.+ ...++.||+|+++...   ........|+.+++.+..   ..|.++++++++
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~-~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWD-RKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEE-cCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            455678999999999999999999999 5788999999986421   112344567777776652   235668999998


Q ss_pred             eeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeeCC--
Q psy2676          94 IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAG--  170 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~--  170 (321)
                      +....      ..+++|+++++++|.+++...  ..+++..++.++.||+.||.|||+ .||+||||||+||+++.++  
T Consensus       200 ~~~~~------~~~~iv~~~~g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~  271 (467)
T PTZ00284        200 FQNET------GHMCIVMPKYGPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTV  271 (467)
T ss_pred             EEcCC------ceEEEEEeccCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcc
Confidence            86541      468999999998999988773  458999999999999999999998 5999999999999998765  


Q ss_pred             --------------CEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCC
Q psy2676         171 --------------GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST  236 (321)
Q Consensus       171 --------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  236 (321)
                                    .+||+|||.+....  .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus       272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        272 VDPVTNRALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             cccccccccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                          49999999875432  22345678999999999999999999999999999999999999999988


Q ss_pred             hHHHHHHHHHHhCCCCCCCcchhhh----hhhhhhhhh----hhhhhhh-------hhhhcchhHHHHHHHhcccCCCCC
Q psy2676         237 EVEQLKCIFRVIGTPSMNEWPENIS----LMWSSFEQY----SKVAFSA-------IFMDCCSKANSLLESMLTFNPADR  301 (321)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~----~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~R  301 (321)
                      ..+....+....+.++.........    .........    .......       ......+.+.+||.+||++||.+|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            8888888877776654321111000    000000000    0000000       000123678899999999999999


Q ss_pred             CCHHHHhCCCCCCCC
Q psy2676         302 ISAADALEHPYFKEK  316 (321)
Q Consensus       302 ps~~~ll~h~~f~~~  316 (321)
                      ||++|+|+||||++.
T Consensus       430 ~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        430 LNARQMTTHPYVLKY  444 (467)
T ss_pred             CCHHHHhcCcccccc
Confidence            999999999999985

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.7e-47  Score=335.12  Aligned_cols=260  Identities=27%  Similarity=0.419  Sum_probs=211.4

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      +.|++++.||+|+||+||+|++ ..+++.+|+|++..... .......+.+|+.+++.+.   ||||+++++.+.+.   
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---h~~iv~~~~~~~~~---   73 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRK-VDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD---NEWVVKLYYSFQDK---   73 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEE-CCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC---CCCcceEEEEEEcC---
Confidence            4799999999999999999999 57899999999865422 2223345678999999988   99999999999877   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..+++||||+. |+|.+++...  +.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||+
T Consensus        74 ----~~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~  147 (376)
T cd05598          74 ----DNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL  147 (376)
T ss_pred             ----CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCC
Confidence                78999999998 5999999873  4589999999999999999999999999999999999999999999999998


Q ss_pred             cccccCC--------------------------------------------CccccccccccccchhhhhcCCCCCcchH
Q psy2676         180 AKTFDYD--------------------------------------------MMLTSVVVTLWYRAPEILLNLGYGTPVDI  215 (321)
Q Consensus       180 ~~~~~~~--------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  215 (321)
                      +......                                            .......||+.|+|||++.+..++.++||
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  227 (376)
T cd05598         148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  227 (376)
T ss_pred             CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence            7432100                                            00112468999999999999999999999


Q ss_pred             HHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcc
Q psy2676         216 WSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLT  295 (321)
Q Consensus       216 ~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  295 (321)
                      |||||++|+|++|+.||.+.+..+....+.........+.                       ...+++++.++|.+|+ 
T Consensus       228 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-----------------------~~~~s~~~~~li~~l~-  283 (376)
T cd05598         228 WSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPS-----------------------QAKLSREASDLILRLC-  283 (376)
T ss_pred             eeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCC-----------------------CCCCCHHHHHHHHHHh-
Confidence            9999999999999999988776655444432111111100                       1245688899999987 


Q ss_pred             cCCCCCC---CHHHHhCCCCCCCCCC
Q psy2676         296 FNPADRI---SAADALEHPYFKEKEN  318 (321)
Q Consensus       296 ~dp~~Rp---s~~~ll~h~~f~~~~~  318 (321)
                      .+|.+|+   ++.++++||||++.++
T Consensus       284 ~~p~~R~~~~t~~ell~h~~~~~~~~  309 (376)
T cd05598         284 CGAEDRLGKNGADEIKAHPFFKGIDF  309 (376)
T ss_pred             cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence            5999999   9999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.1e-47  Score=327.63  Aligned_cols=252  Identities=25%  Similarity=0.400  Sum_probs=208.7

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||+|+||.||++++ ..++..||+|++...... ......+.+|+.+++.+.   ||||+++++++...       ..
T Consensus         1 ~~lG~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~i~~~~~~~~~~-------~~   69 (323)
T cd05595           1 KLLGKGTFGKVILVRE-KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFLTALKYAFQTH-------DR   69 (323)
T ss_pred             CeeeeCCCEEEEEEEE-CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC---CCCCcceeeEEecC-------CE
Confidence            4689999999999998 578999999999765322 122334567888888887   99999999999777       67


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccC
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY  185 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~  185 (321)
                      .++||||+++ +|..++..  ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        70 ~~lv~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  147 (323)
T cd05595          70 LCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  147 (323)
T ss_pred             EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence            8999999994 99888876  34589999999999999999999999999999999999999999999999998865322


Q ss_pred             -CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhh
Q psy2676         186 -DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW  264 (321)
Q Consensus       186 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
                       ........+++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.....     .+        
T Consensus       148 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~-----~~--------  214 (323)
T cd05595         148 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-----RF--------  214 (323)
T ss_pred             CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----CC--------
Confidence             2223345689999999999988999999999999999999999999987776655554432110     01        


Q ss_pred             hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                                    ...+++++.++|++||..||.+|+     ++.++++||||.+..|.
T Consensus       215 --------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~  260 (323)
T cd05595         215 --------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  260 (323)
T ss_pred             --------------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence                          124568999999999999999998     99999999999987653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.8e-47  Score=328.64  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=207.9

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||+|+||.||++++ ..+++.+|+|++...... ......+.+|+.+++.+.   ||||+++++.+...       ..
T Consensus         1 ~~lG~G~~g~Vy~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~-------~~   69 (328)
T cd05593           1 KLLGKGTFGKVILVRE-KASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR---HPFLTSLKYSFQTK-------DR   69 (328)
T ss_pred             CeeeeCCCEEEEEEEE-CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC---CCCCcceEEEEEcC-------CE
Confidence            4689999999999999 678999999999764322 222345667888888887   99999999999777       68


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccC
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY  185 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~  185 (321)
                      .++||||+.+ +|..++..  ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus        70 ~~lv~Ey~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~  147 (328)
T cd05593          70 LCFVMEYVNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT  147 (328)
T ss_pred             EEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence            8999999984 99888876  34589999999999999999999999999999999999999999999999999875322


Q ss_pred             -CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhh
Q psy2676         186 -DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW  264 (321)
Q Consensus       186 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
                       ........+++.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+...  ..   .+        
T Consensus       148 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~~---~~--------  214 (328)
T cd05593         148 DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--DI---KF--------  214 (328)
T ss_pred             cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--Cc---cC--------
Confidence             22233456899999999999888999999999999999999999999877665544433211  00   11        


Q ss_pred             hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                                    ...++.++.++|++||..||.+|+     ++.++++||||.+.+|.
T Consensus       215 --------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         215 --------------PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             --------------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                          124558899999999999999997     89999999999987653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.7e-47  Score=333.15  Aligned_cols=262  Identities=29%  Similarity=0.452  Sum_probs=213.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++++.||+|+||+||+|++ ..+++.+|+|++..... .......+.+|+.++..++   ||+++++++.+.+.   
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~iv~~~~~~~~~---   73 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQK-KDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD---GAWVVKMFYSFQDK---   73 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEE-CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC---CCCEeeEEEEEEcC---
Confidence            4799999999999999999999 57899999999975422 2223345667888888887   99999999999877   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..+++||||++| +|.+++...  ..+++..++.++.|++.||.+||+.|++||||||+||+++.++.++|+|||+
T Consensus        74 ----~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~  147 (360)
T cd05627          74 ----RNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL  147 (360)
T ss_pred             ----CEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccC
Confidence                688999999985 999998773  4589999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCC------------------------------------ccccccccccccchhhhhcCCCCCcchHHHHHHHHH
Q psy2676         180 AKTFDYDM------------------------------------MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMA  223 (321)
Q Consensus       180 ~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~  223 (321)
                      +.......                                    ......||+.|+|||++.+..++.++|+|||||++|
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily  227 (360)
T cd05627         148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY  227 (360)
T ss_pred             CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence            86442110                                    011346899999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-
Q psy2676         224 EMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-  302 (321)
Q Consensus       224 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-  302 (321)
                      +|++|..||...+.......+........   ++.                    ...+++++.++|.+|+. ||.+|+ 
T Consensus       228 el~tG~~Pf~~~~~~~~~~~i~~~~~~~~---~p~--------------------~~~~s~~~~~li~~l~~-~p~~R~~  283 (360)
T cd05627         228 EMLIGYPPFCSETPQETYRKVMNWKETLV---FPP--------------------EVPISEKAKDLILRFCT-DSENRIG  283 (360)
T ss_pred             ecccCCCCCCCCCHHHHHHHHHcCCCcee---cCC--------------------CCCCCHHHHHHHHHhcc-ChhhcCC
Confidence            99999999988877666655543211111   110                    01245789999999875 999998 


Q ss_pred             --CHHHHhCCCCCCCCCCCC
Q psy2676         303 --SAADALEHPYFKEKENEP  320 (321)
Q Consensus       303 --s~~~ll~h~~f~~~~~~~  320 (321)
                        ++.++++||||++.+|+.
T Consensus       284 ~~~~~ei~~hp~f~~~~~~~  303 (360)
T cd05627         284 SNGVEEIKSHPFFEGVDWGH  303 (360)
T ss_pred             CCCHHHHhcCCCCCCCCHHH
Confidence              589999999999987753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-47  Score=324.60  Aligned_cols=249  Identities=28%  Similarity=0.449  Sum_probs=206.1

Q ss_pred             eecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEE
Q psy2676          30 IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVY  108 (321)
Q Consensus        30 lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  108 (321)
                      ||+|+||+||+|++ ..+++.+|+|++..... .......+.+|+.++++++   ||||+++++++...       ...+
T Consensus         1 lg~G~~g~Vy~~~~-~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~-------~~~~   69 (312)
T cd05585           1 IGKGSFGKVMQVRK-RDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN---CPFIVPLKFSFQSP-------EKLY   69 (312)
T ss_pred             CCcCCCeEEEEEEE-CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC---CCcEeceeeEEecC-------CeEE
Confidence            69999999999999 57888999999875422 2222345667888998887   99999999999776       6789


Q ss_pred             EEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCC-
Q psy2676         109 LIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-  186 (321)
Q Consensus       109 ~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~-  186 (321)
                      +||||+.+ +|.+++..  ...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++...... 
T Consensus        70 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  147 (312)
T cd05585          70 LVLAFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD  147 (312)
T ss_pred             EEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence            99999994 99999977  345899999999999999999999999999999999999999999999999998754222 


Q ss_pred             CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhh
Q psy2676         187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSS  266 (321)
Q Consensus       187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
                      .......|++.|+|||++.+..++.++||||+|+++|+|++|..||...+..+....+...   +  ..+          
T Consensus       148 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~---~--~~~----------  212 (312)
T cd05585         148 DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE---P--LRF----------  212 (312)
T ss_pred             CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC---C--CCC----------
Confidence            2233456899999999999999999999999999999999999999887766555444321   0  011          


Q ss_pred             hhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC---CHHHHhCCCCCCCCCC
Q psy2676         267 FEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI---SAADALEHPYFKEKEN  318 (321)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~h~~f~~~~~  318 (321)
                                  ...+++.+.++|.+||..||.+||   ++.++++||||++..+
T Consensus       213 ------------~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~  255 (312)
T cd05585         213 ------------PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW  255 (312)
T ss_pred             ------------CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence                        124558899999999999999997   5899999999998643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.4e-47  Score=324.48  Aligned_cols=258  Identities=26%  Similarity=0.399  Sum_probs=213.5

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      +|++.+.||+|+||.||+|++ ..+++.+|+|+++..... .........|..++..+..  |++++++++++.+.    
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~--~~~i~~~~~~~~~~----   73 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAER-KGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK--PPFLTQLHSCFQTM----   73 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccC--CCeEeeEEEEEecC----
Confidence            588999999999999999998 578899999999764322 1122345567777777653  89999999999777    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++||||+. |+|.+++...  ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus        74 ---~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~  148 (323)
T cd05616          74 ---DRLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMC  148 (323)
T ss_pred             ---CEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCc
Confidence               67899999998 5999988773  44899999999999999999999999999999999999999999999999998


Q ss_pred             ccccC-CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         181 KTFDY-DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       181 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ..... ........|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....     .++  
T Consensus       149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-----~~p--  221 (323)
T cd05616         149 KENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-----AYP--  221 (323)
T ss_pred             eecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCC--
Confidence            75432 2223345689999999999999999999999999999999999999998877766665554211     111  


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKENE  319 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~~  319 (321)
                                          ..++.++.+++.+||+.||.+|++     ..++++||||+..+|+
T Consensus       222 --------------------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~  266 (323)
T cd05616         222 --------------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  266 (323)
T ss_pred             --------------------CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                                135588999999999999999997     4899999999988764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.3e-47  Score=330.01  Aligned_cols=268  Identities=26%  Similarity=0.378  Sum_probs=217.2

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +....+..++|++.+.||+|+||.||+|++ ..+++.+|+|++...... ......+.+|+.+++.++   ||||+++++
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~-~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~---hp~iv~~~~  110 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRH-KSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN---SPWVVQLFY  110 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEE-CCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC---CCCCCeEEE
Confidence            445667779999999999999999999999 688999999998653221 122234567888888887   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      .+.+.       ...++||||++ |+|.+++...   .+++..++.++.||+.||.+||++|++||||||+||+++.++.
T Consensus       111 ~~~~~-------~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~  180 (371)
T cd05622         111 AFQDD-------RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH  180 (371)
T ss_pred             EEEcC-------CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC
Confidence            99776       68999999998 5999998763   3899999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCC--ccccccccccccchhhhhcCC----CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q psy2676         172 LKIADFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNLG----YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIF  245 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  245 (321)
                      ++|+|||++.......  ......||+.|+|||++....    ++.++|||||||++|+|++|..||.+.+.......+.
T Consensus       181 ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  260 (371)
T cd05622         181 LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  260 (371)
T ss_pred             EEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999987665332  223456899999999987643    7889999999999999999999999887766666655


Q ss_pred             HHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCC
Q psy2676         246 RVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD--RISAADALEHPYFKEKEN  318 (321)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~h~~f~~~~~  318 (321)
                      ........+.                       ...++..+.++|.+||..++.+  |++++++++||||++.+|
T Consensus       261 ~~~~~~~~~~-----------------------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         261 NHKNSLTFPD-----------------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             cCCCcccCCC-----------------------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence            4322111111                       1245688999999999844433  789999999999998654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.6e-47  Score=325.45  Aligned_cols=253  Identities=29%  Similarity=0.419  Sum_probs=209.4

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||+|+||.||+|++ ..+++.+|+|+++..... .........|..+++.+.  .||||+++++++.+.       ..
T Consensus         1 ~~lG~G~~g~Vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~--~hp~i~~~~~~~~~~-------~~   70 (321)
T cd05591           1 KVLGKGSFGKVMLAEL-KGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA--KHPFLTALHCCFQTK-------DR   70 (321)
T ss_pred             CccccCCCeEEEEEEE-CCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhcc--CCCCccceeeEEEcC-------Ce
Confidence            4689999999999998 578899999999764322 222334567888887664  399999999999877       67


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccC
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY  185 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~  185 (321)
                      .++||||+++ +|..++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        71 ~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~  148 (321)
T cd05591          71 LFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL  148 (321)
T ss_pred             EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence            8999999985 999888763  4589999999999999999999999999999999999999999999999998875432


Q ss_pred             -CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhh
Q psy2676         186 -DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW  264 (321)
Q Consensus       186 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
                       ........+++.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.....  .   .+       
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~--~---~p-------  216 (321)
T cd05591         149 NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV--L---YP-------  216 (321)
T ss_pred             CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--C---CC-------
Confidence             2223345689999999999998999999999999999999999999998887776665543211  0   01       


Q ss_pred             hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-------CHHHHhCCCCCCCCCCC
Q psy2676         265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-------SAADALEHPYFKEKENE  319 (321)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-------s~~~ll~h~~f~~~~~~  319 (321)
                                     ..++.++.++|.+||..||.+||       ++.++++||||.+.+|+
T Consensus       217 ---------------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~  263 (321)
T cd05591         217 ---------------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV  263 (321)
T ss_pred             ---------------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence                           12457899999999999999999       99999999999987664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-46  Score=329.97  Aligned_cols=282  Identities=27%  Similarity=0.390  Sum_probs=218.7

Q ss_pred             CCcceeeeeeeecccceeEEEEEEec-CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ...+|++++.||.|+||.||++.... ..+..+++|.+...       ....+|+.++++++   ||||+++++++... 
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~---h~~iv~~~~~~~~~-  158 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTIS---HRAIINLIHAYRWK-  158 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcC---CCCccceeeeEeeC-
Confidence            34579999999999999999997632 34678888887532       24568999999998   99999999998776 


Q ss_pred             cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676          99 LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                            ...+++||++.++|.+++..  ...+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||
T Consensus       159 ------~~~~lv~e~~~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG  230 (392)
T PHA03207        159 ------STVCMVMPKYKCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG  230 (392)
T ss_pred             ------CEEEEEehhcCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCc
Confidence                  67899999999999999855  3458999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCC---hHHHHHHHHHHhCCCC
Q psy2676         179 LAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST---EVEQLKCIFRVIGTPS  252 (321)
Q Consensus       179 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~  252 (321)
                      ++........   .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+..   ....+..+.+..+..+
T Consensus       231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~  310 (392)
T PHA03207        231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP  310 (392)
T ss_pred             cccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence            9876543321   224568999999999999999999999999999999999999997643   3445555555555433


Q ss_pred             CCCcchhhh-hhhhhhhhhh---hh--hhhhh--hhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q psy2676         253 MNEWPENIS-LMWSSFEQYS---KV--AFSAI--FMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL  321 (321)
Q Consensus       253 ~~~~~~~~~-~~~~~~~~~~---~~--~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~~~  321 (321)
                      .. ++.... .....+.++.   ..  ..+..  ....+.++.++|++||..||.+|||+.++|+||||++.+++.+
T Consensus       311 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~  386 (392)
T PHA03207        311 LE-FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLL  386 (392)
T ss_pred             cc-cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhh
Confidence            32 221110 0001111110   00  01111  1245678999999999999999999999999999999887653

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.6e-46  Score=319.29  Aligned_cols=285  Identities=41%  Similarity=0.766  Sum_probs=226.4

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC---CCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE---DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      +|++.+.||.|++|.||+|.+ ..+++.+++|.++.....   ......+..|+.++++++   |+|++++++++.+.  
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~--   74 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARD-KETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK---HPNIIGLLDVFGHK--   74 (298)
T ss_pred             CceeeeeeeeccccEEEEEEE-CCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC---CCCChhhhheeecC--
Confidence            588999999999999999998 567899999999765433   222334567888888887   99999999999776  


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                           ...++|+|++.++|.+++.... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.
T Consensus        75 -----~~~~lv~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~  148 (298)
T cd07841          75 -----SNINLVFEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGL  148 (298)
T ss_pred             -----CEEEEEEcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEcccee
Confidence                 6789999999779999997744 2589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-ccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         180 AKTFDYDM-MLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       180 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      +....... ......++..|+|||.+.+ ..++.++|+||||+++++|++|.+||.+....+...++....+.+....++
T Consensus       149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (298)
T cd07841         149 ARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP  228 (298)
T ss_pred             eeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence            87765432 2233456778999998865 447899999999999999999999998888777777777666555544443


Q ss_pred             hhhhhh-hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         258 ENISLM-WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       258 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      ...... ...................+..+.++|.+||++||++|||+.++++||||++.+.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~  291 (298)
T cd07841         229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP  291 (298)
T ss_pred             hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence            321111 11111111122233445667899999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6e-47  Score=326.43  Aligned_cols=263  Identities=27%  Similarity=0.404  Sum_probs=207.1

Q ss_pred             ceeeeeeeecccceeEEEEEEe--cCCCcEEEEEEeecccCC--CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNE--DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~--~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      +|++++.||+|+||+||+|++.  ..+++.+|+|++......  .........|+.+++.+..  ||+|+++++++... 
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~~i~~~~~~~~~~-   77 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQ--SPFLVTLHYAFQTE-   77 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccC--CCCcccEEEEEecC-
Confidence            4899999999999999999873  246889999998754221  1223356678999998864  99999999998776 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ..+++||||+.+ +|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+||
T Consensus        78 ------~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~Df  149 (332)
T cd05614          78 ------AKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDF  149 (332)
T ss_pred             ------CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeC
Confidence                  678999999995 999998773  44899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCC--ccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         178 GLAKTFDYDM--MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       178 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      |++.......  ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||...........+........  
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--  227 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--  227 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--
Confidence            9987543222  223456899999999998754 78899999999999999999999964322111111111110000  


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                                           ......+++.+.++|.+||..||++||     +++++++||||++..|+
T Consensus       228 ---------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  276 (332)
T cd05614         228 ---------------------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE  276 (332)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                                 001124568899999999999999999     88899999999987653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.8e-46  Score=317.01  Aligned_cols=280  Identities=42%  Similarity=0.761  Sum_probs=229.1

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|++.+.||.|++|.||+|.+ ..+++.+++|++............+.+|+.++++++   |||++++++++...     
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~-~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~---~~~i~~~~~~~~~~-----   71 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKD-RETGETVALKKVALRRLEGGIPNQALREIKALQACQ---HPYVVKLLDVFPHG-----   71 (286)
T ss_pred             CceEEeecccCCCcEEEEEEE-CCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC---CCCCcceeeEEecC-----
Confidence            689999999999999999998 577899999998776544444567888999999998   99999999999776     


Q ss_pred             cceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         103 RYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       103 ~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                        ...++|+|++.++|.+++.... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        72 --~~~~~v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~  148 (286)
T cd07832          72 --SGFVLVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARL  148 (286)
T ss_pred             --CeeEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence              6889999999779999987654 4489999999999999999999999999999999999999999999999999887


Q ss_pred             ccCCC--ccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         183 FDYDM--MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       183 ~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      .....  ......++..|+|||.+.+.. .+.++||||+|+++++|++|.+||.+.........+....+.+....|+..
T Consensus       149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07832         149 FSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGL  228 (286)
T ss_pred             ccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhc
Confidence            65433  233456788999999986554 689999999999999999999999888888888888887776655544432


Q ss_pred             hhhh-hh--hhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q psy2676         260 ISLM-WS--SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK  314 (321)
Q Consensus       260 ~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~  314 (321)
                      .... +.  .+.............+.+..+.++|++||+.+|.+|||++++++||||.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            2111 00  0111111123344456779999999999999999999999999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.2e-46  Score=315.18  Aligned_cols=288  Identities=47%  Similarity=0.809  Sum_probs=227.4

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||.|++|.||++.+ ..+++.|++|.+............+.+|+.+++++..  |||++++++++.....  
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~-~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~--~~~i~~~~~~~~~~~~--   75 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARD-KNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSE--SIYIVRLLDVEHVEEK--   75 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEE-CCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccC--CCCccceeeeEeecCC--
Confidence            4799999999999999999999 5788999999987654444445577889999999973  7999999999876521  


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee-CCCEEEeec
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCP---PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR-AGGLKIADF  177 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~-~~~~kl~df  177 (321)
                      ......++++||++++|.+++....   ...+++..++.++.||+.||.+||++|++|+||+|+||+++. ++.++|+||
T Consensus        76 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          76 NGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             CCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeec
Confidence            1223579999999999999886543   234899999999999999999999999999999999999998 889999999


Q ss_pred             CCcccccCCC-ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         178 GLAKTFDYDM-MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       178 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      |.+....... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.+.......+....+.+....
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            9887553221 22234567889999988654 478999999999999999999999998888877777777666655544


Q ss_pred             cchhhhhh-hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q psy2676         256 WPENISLM-WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK  314 (321)
Q Consensus       256 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~  314 (321)
                      ++...... ...+.+............++.++.+||.+||.+||.+||++.+++.||||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            43221111 111222222333334456789999999999999999999999999999996

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0589|consensus

Probab=100.00  E-value=1e-47  Score=325.00  Aligned_cols=258  Identities=32%  Similarity=0.516  Sum_probs=235.1

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|..++++|+|+||.++++++ +.++..+++|.+.........+....+|..+++++.   ||||+.+.+.|....  
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrh-k~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~---hP~iv~y~ds~~~~~--   76 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRH-KSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL---HPNIVEYKDSFEEDG--   76 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhh-ccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc---CCCeeeeccchhcCC--
Confidence            46899999999999999999999 688889999999887777767778889999999988   999999999998771  


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..++|||+||+| ++.+.+....+..++++.+..++.|++.|+.|||++++.|||||+.||+++.++.++|+|||+
T Consensus        77 ----~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGl  152 (426)
T KOG0589|consen   77 ----QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGL  152 (426)
T ss_pred             ----ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhh
Confidence                348999999995 999999887777799999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         180 AKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       180 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      +....... ...+..||+.|++||.+.+.++..++|||||||++|||++-+++|.+.+......++......|.+.    
T Consensus       153 aK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~----  228 (426)
T KOG0589|consen  153 AKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPS----  228 (426)
T ss_pred             hhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCc----
Confidence            99998776 6677899999999999999999999999999999999999999999999999999888876544433    


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK  314 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~  314 (321)
                                            ..+.+++.+|+.||+.+|..||++.++|.+|..+
T Consensus       229 ----------------------~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  229 ----------------------MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             ----------------------cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence                                  3458999999999999999999999999998776

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2e-46  Score=315.11  Aligned_cols=257  Identities=26%  Similarity=0.368  Sum_probs=205.9

Q ss_pred             eecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEE
Q psy2676          30 IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVY  108 (321)
Q Consensus        30 lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  108 (321)
                      ||+|+||+||++++ ..+++.+++|.+....... ........|++++++++   ||||+++++.+.+.       ...+
T Consensus         1 lg~G~~g~Vy~~~~-~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~---hp~i~~~~~~~~~~-------~~~~   69 (277)
T cd05607           1 LGKGGFGEVCAVQV-KNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN---SPFIVNLAYAFESK-------THLC   69 (277)
T ss_pred             CCCCCceEEEEEEE-ccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC---CCcEEEEEEEEecC-------CeEE
Confidence            69999999999998 5789999999986543222 12334556899999987   99999999999776       6789


Q ss_pred             EEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCC
Q psy2676         109 LIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM  187 (321)
Q Consensus       109 ~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~  187 (321)
                      +||||+.| +|.+++.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        70 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~  149 (277)
T cd05607          70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK  149 (277)
T ss_pred             EEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc
Confidence            99999985 99888876555568999999999999999999999999999999999999999999999999987765444


Q ss_pred             ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhh
Q psy2676         188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF  267 (321)
Q Consensus       188 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
                      ......++..|+|||++.+..++.++|+||+|+++|+|++|..||...........+.........              
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------  215 (277)
T cd05607         150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV--------------  215 (277)
T ss_pred             eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc--------------
Confidence            444567889999999999988999999999999999999999999764332111111111100000              


Q ss_pred             hhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH----HHHhCCCCCCCCCCC
Q psy2676         268 EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA----ADALEHPYFKEKENE  319 (321)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~h~~f~~~~~~  319 (321)
                              ......+++++.+++++||+.||.+||++    +++++||||+..++.
T Consensus       216 --------~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~  263 (277)
T cd05607         216 --------KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP  263 (277)
T ss_pred             --------ccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence                    00112456889999999999999999999    678899999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-46  Score=326.59  Aligned_cols=275  Identities=27%  Similarity=0.397  Sum_probs=208.3

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ..+|++++.||+|+||.||+|++ ..+++.+++|+...        .....|+.++++++   ||||+++++++...   
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~valK~~~~--------~~~~~E~~~l~~l~---h~~iv~~~~~~~~~---  129 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATK-PGQPDPVVLKIGQK--------GTTLIEAMLLQNVN---HPSVIRMKDTLVSG---  129 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEE-CCCCceEEEEeCCc--------cccHHHHHHHHhCC---CCCCcChhheEEeC---
Confidence            45799999999999999999998 57788999997432        13457899999988   99999999999776   


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                          ...++|+|++.++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||.+
T Consensus       130 ----~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  204 (357)
T PHA03209        130 ----AITCMVLPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAA  204 (357)
T ss_pred             ----CeeEEEEEccCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccc
Confidence                6789999999999999987644 34899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcC-CCCCCCCh---------HHHHHHHHHHhCC
Q psy2676         181 KTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV-PLFCASTE---------VEQLKCIFRVIGT  250 (321)
Q Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~~---------~~~~~~~~~~~~~  250 (321)
                      .............++..|+|||++.+..++.++|||||||++|+|+++. .+|.....         ...+..+....+.
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~  284 (357)
T PHA03209        205 QFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKV  284 (357)
T ss_pred             cccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhcc
Confidence            7544333344566899999999999989999999999999999999864 44443221         1222333333332


Q ss_pred             CCCCCcchh-hhhhhhhhhhh---hh----hhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         251 PSMNEWPEN-ISLMWSSFEQY---SK----VAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       251 ~~~~~~~~~-~~~~~~~~~~~---~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .+. .++.. .......+..+   .+    ........+++.++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       285 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        285 HPE-EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             Chh-hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            221 12110 00000000000   00    00011122567788899999999999999999999999999874

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.7e-46  Score=317.84  Aligned_cols=287  Identities=42%  Similarity=0.723  Sum_probs=228.1

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.+.||.|++|.||++.+ ..+++.|++|.++.............+|+.++++++   |+|++++++++.... 
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~-   79 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARD-TTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR---HPNIVELKEVVVGKH-   79 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEE-CCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC---CCCCcceEEEEecCC-
Confidence            346899999999999999999999 578899999998765444433445668999999998   999999999986431 


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ....++|+|++.++|.+++.... ..+++.+++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        80 ----~~~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~  154 (309)
T cd07845          80 ----LDSIFLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGL  154 (309)
T ss_pred             ----CCeEEEEEecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccce
Confidence                13579999999999999987654 4489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-ccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         180 AKTFDYDM-MLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       180 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      +....... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+....+....+.+....|+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         155 ARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP  234 (309)
T ss_pred             eeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhch
Confidence            87765332 2233445778999999876 447899999999999999999999999999888888888877766655554


Q ss_pred             hhhhhhhhhhhhhh---hhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         258 ENISLMWSSFEQYS---KVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       258 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ..............   ...........++.+.++|.+||++||++|||+.++++||||++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence            32211110000000   001111223357889999999999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.6e-46  Score=315.24  Aligned_cols=287  Identities=45%  Similarity=0.804  Sum_probs=230.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||.|++|+||++.+ ..+++.+++|.+............+.+|++++++++   |||++++++++.+.    
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~----   73 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARD-RVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ---HGNIVRLQDVVHSE----   73 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEe-cCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc---CCCEeeEEEEEecC----
Confidence            5899999999999999999998 578899999998765443334456778999999997   99999999999776    


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee-CCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR-AGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~-~~~~kl~dfg~~  180 (321)
                         ...++|+||++++|.+.+.......+++..++.++.||+.||.+||++|++|+||+|+||+++. ++.+||+|||.+
T Consensus        74 ---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~  150 (294)
T PLN00009         74 ---KRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA  150 (294)
T ss_pred             ---CeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccc
Confidence               6889999999999999887765555789999999999999999999999999999999999985 456999999998


Q ss_pred             ccccCCC-ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      ....... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+...++....+.+....|..
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (294)
T PLN00009        151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG  230 (294)
T ss_pred             cccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            7654322 22334567889999998764 478999999999999999999999998888888777777777666555543


Q ss_pred             hhhhhh--hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         259 NISLMW--SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       259 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      ......  .....+............++++.+++.+||+.+|++||++.++++||||++.+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~  293 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA  293 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhcC
Confidence            222111  1111222223333445678899999999999999999999999999999987543

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.6e-46  Score=322.93  Aligned_cols=253  Identities=26%  Similarity=0.363  Sum_probs=203.1

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||+|+||.||+|++ ..+++.||+|+++...... .....+..|..+++++..  ||||+++++++.+.       ..
T Consensus         1 ~~lG~G~~g~V~~~~~-~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~--hp~Iv~~~~~~~~~-------~~   70 (329)
T cd05588           1 RVIGRGSYAKVLLVEL-KKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN--HPFLVGLHSCFQTE-------SR   70 (329)
T ss_pred             CeEeeCCCeEEEEEEE-CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccC--CCCCCceEEEEEcC-------CE
Confidence            4689999999999998 5789999999998653322 223346678888888853  99999999999877       68


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccccc-
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-  184 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~-  184 (321)
                      +++||||++| +|..++..  .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.... 
T Consensus        71 ~~lv~e~~~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  148 (329)
T cd05588          71 LFFVIEFVSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR  148 (329)
T ss_pred             EEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence            8999999985 99888876  3459999999999999999999999999999999999999999999999999886432 


Q ss_pred             CCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCCh--------HHHHHHHHHHhCCCCCCCc
Q psy2676         185 YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE--------VEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~  256 (321)
                      .........|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....        .+........  .      
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~------  220 (329)
T cd05588         149 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--K------  220 (329)
T ss_pred             CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc--C------
Confidence            22233445789999999999998999999999999999999999999963211        0111110000  0      


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC------HHHHhCCCCCCCCCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS------AADALEHPYFKEKEN  318 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~~ll~h~~f~~~~~  318 (321)
                                        .......++..+.++|++||+.||.+|+|      ++++++||||++.+|
T Consensus       221 ------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         221 ------------------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             ------------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                              00111245688999999999999999987      789999999998765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-46  Score=323.18  Aligned_cols=264  Identities=26%  Similarity=0.339  Sum_probs=211.1

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++.+.||+|+||+||++++ ..+++.+|+|++..... .......+.+|+.+++.+.   |+||+++++++.+.   
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~---~~~i~~~~~~~~~~---   73 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKM-KNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD---RRWITNLHYAFQDE---   73 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEE-CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC---CCCCCceEEEEecC---
Confidence            4799999999999999999999 57889999999875322 1222334667888888887   99999999999877   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..+++||||+. |+|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus        74 ----~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  148 (331)
T cd05597          74 ----NNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGS  148 (331)
T ss_pred             ----CeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCc
Confidence                78999999998 59999997643 3489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc--cccccccccccchhhhhc-----CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         180 AKTFDYDMM--LTSVVVTLWYRAPEILLN-----LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       180 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      +........  .....+++.|+|||++..     ..++.++||||+||++|+|++|+.||...+..+....+........
T Consensus       149 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~  228 (331)
T cd05597         149 CLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ  228 (331)
T ss_pred             eeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc
Confidence            876543322  223468999999999873     3468899999999999999999999988776666555443221111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD--RISAADALEHPYFKEKENE  319 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~h~~f~~~~~~  319 (321)
                      ...                      ....++..++++|++||..++.+  |+++.++++||||.+.+|.
T Consensus       229 ~~~----------------------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~  275 (331)
T cd05597         229 FPP----------------------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD  275 (331)
T ss_pred             CCC----------------------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence            110                      11236688999999988664443  7899999999999987664

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.1e-46  Score=320.43  Aligned_cols=252  Identities=29%  Similarity=0.417  Sum_probs=205.0

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||+|+||.||+|++ ..+++.+|+|+++..... .........|..++....  .||||+++++++.+.       ..
T Consensus         1 ~~lg~G~~g~V~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~~i~~~~~~~~~~-------~~   70 (316)
T cd05620           1 KVLGKGSFGKVLLAEL-KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAW--ENPFLTHLYCTFQTK-------EH   70 (316)
T ss_pred             CeeeeCCCeEEEEEEE-CCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhcc--CCCCccCeeEEEEeC-------CE
Confidence            4699999999999999 578899999999765321 122334556777776553  399999999999877       78


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccccc-
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-  184 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~-  184 (321)
                      +++||||+.+ +|..++..  ...+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.... 
T Consensus        71 ~~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05620          71 LFFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF  148 (316)
T ss_pred             EEEEECCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence            9999999985 99988877  3458999999999999999999999999999999999999999999999999886432 


Q ss_pred             CCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhh
Q psy2676         185 YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW  264 (321)
Q Consensus       185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
                      .........|++.|+|||++.+..++.++||||+|+++|+|++|..||.+.+..+....+...  .+..+          
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~~~----------  216 (316)
T cd05620         149 GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPHYP----------  216 (316)
T ss_pred             CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCC----------
Confidence            122233456899999999999999999999999999999999999999887766555444321  11111          


Q ss_pred             hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH-HHHhCCCCCCCCCC
Q psy2676         265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA-ADALEHPYFKEKEN  318 (321)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~ll~h~~f~~~~~  318 (321)
                                     ..++.++.++|++||..||.+||++ +++++||||++..|
T Consensus       217 ---------------~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         217 ---------------RWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             ---------------CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence                           1245789999999999999999998 58899999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0662|consensus

Probab=100.00  E-value=4.8e-47  Score=278.99  Aligned_cols=282  Identities=45%  Similarity=0.828  Sum_probs=245.5

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      .|.-.++||+|.||+||++++ ..+.+-||+|.++....++....+..+|+-+++.++   |.||+++++....+     
T Consensus         3 ~ydkmekigegtygtvfkarn-~~t~eivalkrvrlddddegvpssalreicllkelk---hknivrl~dvlhsd-----   73 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARN-RETHEIVALKRVRLDDDDEGVPSSALREICLLKELK---HKNIVRLHDVLHSD-----   73 (292)
T ss_pred             chHHHHhhcCCcceeeEeccc-CCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh---hcceeehhhhhccC-----
Confidence            466678999999999999999 689999999999998888889999999999999999   99999999998766     


Q ss_pred             cceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         103 RYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       103 ~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                        ..+.+|+|+|..+|..++...++ .++.+.++.++.|++.+|.++|++++.|||+||.|.+|+.+|++||.|||++..
T Consensus        74 --kkltlvfe~cdqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglara  150 (292)
T KOG0662|consen   74 --KKLTLVFEFCDQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARA  150 (292)
T ss_pred             --ceeEEeHHHhhHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhh
Confidence              77899999999999999999765 499999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCC-ccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         183 FDYDM-MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       183 ~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      .+-+- -.+....|..|.+|.++.+.. ++.+.|+||.||++.|+.. |++.|.+.+..++..+++..+|.|....||..
T Consensus       151 fgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~  230 (292)
T KOG0662|consen  151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM  230 (292)
T ss_pred             cCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence            76554 244566799999999998876 7999999999999999985 78999999999999999999999999999875


Q ss_pred             hhhh-hhhhhhhh-hhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         260 ISLM-WSSFEQYS-KVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       260 ~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .... +...+-+. ....+.+.......-+++++++|.-+|.+|.++++.++||||...
T Consensus       231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            4432 11121111 123444555666788899999999999999999999999999864

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.5e-46  Score=321.77  Aligned_cols=252  Identities=28%  Similarity=0.422  Sum_probs=207.9

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||+|+||+||+|++ ..+++.+|+|+++..... .........|..+++.+.  .||||+++++++.+.       ..
T Consensus         1 ~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~--~h~~i~~~~~~~~~~-------~~   70 (318)
T cd05570           1 KVLGKGSFGKVLLAEL-KGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFLTQLHSCFQTK-------DR   70 (318)
T ss_pred             CeeeeCCCeEEEEEEE-CCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc--CCCCccceeeEEEcC-------CE
Confidence            4699999999999998 578889999999865322 222335567888888775  399999999999777       67


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccC
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY  185 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~  185 (321)
                      +++||||+.| +|...+...  ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        71 ~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  148 (318)
T cd05570          71 LFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL  148 (318)
T ss_pred             EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence            8999999984 998888773  4589999999999999999999999999999999999999999999999998865322


Q ss_pred             -CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhh
Q psy2676         186 -DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW  264 (321)
Q Consensus       186 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
                       ........+++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+.......+.....     ..        
T Consensus       149 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~-----~~--------  215 (318)
T cd05570         149 GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-----RY--------  215 (318)
T ss_pred             CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----CC--------
Confidence             2223345688999999999999999999999999999999999999987776655544432110     01        


Q ss_pred             hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH-----HHHhCCCCCCCCCC
Q psy2676         265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA-----ADALEHPYFKEKEN  318 (321)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~h~~f~~~~~  318 (321)
                                    ...++..+.+||++||..||.+|||+     .++++||||++..|
T Consensus       216 --------------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         216 --------------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             --------------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                          12355889999999999999999999     99999999998765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.1e-46  Score=315.48  Aligned_cols=257  Identities=26%  Similarity=0.355  Sum_probs=204.8

Q ss_pred             eecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEE
Q psy2676          30 IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVY  108 (321)
Q Consensus        30 lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  108 (321)
                      ||+|+||+||++.+ ..+++.+++|.+....... .....+..|+.+++++.   |||++++.+++...       ...+
T Consensus         1 lg~G~~g~Vy~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---~~~i~~~~~~~~~~-------~~~~   69 (280)
T cd05608           1 LGKGGFGEVSACQM-RATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH---SRFIVSLAYAFQTK-------TDLC   69 (280)
T ss_pred             CCCCCceeEEEEEE-ccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC---CCcEeeeeEEEcCC-------CeEE
Confidence            69999999999998 5788999999987543221 11234567888999887   99999999998776       6789


Q ss_pred             EEeccCc-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccC
Q psy2676         109 LIFEHVD-QDLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY  185 (321)
Q Consensus       109 ~v~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~  185 (321)
                      +||||++ |+|..++...  ....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        70 lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  149 (280)
T cd05608          70 LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD  149 (280)
T ss_pred             EEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence            9999998 4898877442  234589999999999999999999999999999999999999999999999999876543


Q ss_pred             CCc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhh
Q psy2676         186 DMM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW  264 (321)
Q Consensus       186 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
                      ... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...................+. .         
T Consensus       150 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~---------  219 (280)
T cd05608         150 GQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV-T---------  219 (280)
T ss_pred             CCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC-C---------
Confidence            322 23356789999999999999999999999999999999999999765432222222111111110 1         


Q ss_pred             hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCCC
Q psy2676         265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENEP  320 (321)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~~  320 (321)
                                   ....++..+.+++.+||+.||.+||     +++++++||||++..|+.
T Consensus       220 -------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~  267 (280)
T cd05608         220 -------------YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ  267 (280)
T ss_pred             -------------CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence                         1124668899999999999999999     889999999999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.2e-46  Score=320.33  Aligned_cols=252  Identities=27%  Similarity=0.417  Sum_probs=205.1

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||+|+||+||+|++ ..+++.||+|+++..... .........|..++....  .||||+++++++...       ..
T Consensus         1 ~~lG~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~hp~i~~~~~~~~~~-------~~   70 (316)
T cd05592           1 KVLGKGSFGKVMLAEL-KGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW--EHPFLTHLFCTFQTK-------EH   70 (316)
T ss_pred             CeeeeCCCeEEEEEEE-CCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhcc--CCCCccceeeEEEcC-------CE
Confidence            4699999999999998 578899999999765322 222234455666666543  399999999998776       67


Q ss_pred             EEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccC
Q psy2676         107 VYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY  185 (321)
Q Consensus       107 ~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~  185 (321)
                      .++||||+. |+|..++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        71 ~~lv~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~  148 (316)
T cd05592          71 LFFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN  148 (316)
T ss_pred             EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence            899999998 5999988773  4589999999999999999999999999999999999999999999999999875432


Q ss_pred             -CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhh
Q psy2676         186 -DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW  264 (321)
Q Consensus       186 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
                       ........|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...  .+.   .        
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~---~--------  215 (316)
T cd05592         149 GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPH---F--------  215 (316)
T ss_pred             CCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC---C--------
Confidence             22334456899999999999988999999999999999999999999887776655554321  111   1        


Q ss_pred             hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH-HHHhCCCCCCCCCC
Q psy2676         265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA-ADALEHPYFKEKEN  318 (321)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~ll~h~~f~~~~~  318 (321)
                                    ...++.++.++|.+||..||.+||++ .++++||||+...|
T Consensus       216 --------------~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         216 --------------PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             --------------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence                          11345788999999999999999986 58889999998765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.9e-46  Score=315.36  Aligned_cols=262  Identities=25%  Similarity=0.371  Sum_probs=212.0

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC-CCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG-IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      .|++.+.||+|+||+||++.+ ..+++.+++|.+........ ....+.+|+.++++++   |++++++++.+.+.    
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---~~~i~~~~~~~~~~----   72 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQV-RATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN---SRFVVSLAYAYETK----   72 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEE-cCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC---CCCeeeeeEEEecC----
Confidence            478899999999999999999 57889999999875432221 1234567999999887   99999999998776    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++|+||+. ++|.+++.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        73 ---~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~  149 (285)
T cd05630          73 ---DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA  149 (285)
T ss_pred             ---CEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccce
Confidence               67899999998 59999887655556999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         181 KTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      .............++..|+|||++.+..++.++|+||+|+++|+|++|..||..................          
T Consensus       150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~----------  219 (285)
T cd05630         150 VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----------  219 (285)
T ss_pred             eecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh----------
Confidence            7655444334457889999999999988999999999999999999999999764432111111110000          


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKEN  318 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~  318 (321)
                                   ........+++++.+|+++||+.||.+|||     ++++++||||++..+
T Consensus       220 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05630         220 -------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF  269 (285)
T ss_pred             -------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence                         000112346688999999999999999999     999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.5e-47  Score=325.09  Aligned_cols=252  Identities=26%  Similarity=0.398  Sum_probs=206.7

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||+|+||+||++++ ..++..+|+|+++...... .......+|+.+++.+.   ||||+++++++...       ..
T Consensus         1 ~~lG~G~~g~V~~~~~-~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~---hp~i~~~~~~~~~~-------~~   69 (325)
T cd05594           1 KLLGKGTFGKVILVKE-KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFLTALKYSFQTH-------DR   69 (325)
T ss_pred             CeeeeCCCEEEEEEEE-CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC---CCCCCceEEEEEcC-------CE
Confidence            4689999999999998 5789999999997653221 22234566778887777   99999999999777       68


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      .++||||+.+ +|..++..  ...+++..++.++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++....
T Consensus        70 ~~lv~E~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~  147 (325)
T cd05594          70 LCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  147 (325)
T ss_pred             EEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence            8999999994 89888876  3458999999999999999999997 799999999999999999999999999986532


Q ss_pred             C-CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhh
Q psy2676         185 Y-DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM  263 (321)
Q Consensus       185 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
                      . ........+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+....  .   .+       
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--~---~~-------  215 (325)
T cd05594         148 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--I---RF-------  215 (325)
T ss_pred             CCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--C---CC-------
Confidence            2 222334568999999999999899999999999999999999999998776655544433211  0   01       


Q ss_pred             hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                                     ...+++++.++|++||+.||.+|+     ++.++++||||++..|+
T Consensus       216 ---------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         216 ---------------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             ---------------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence                           123558899999999999999997     99999999999987554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.7e-46  Score=319.90  Aligned_cols=258  Identities=27%  Similarity=0.410  Sum_probs=212.8

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      +|++.+.||+|+||+||+|++ ..+++.||+|++...... .........|..+++.+..  |++++++++++.+.    
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~--~~~i~~~~~~~~~~----   73 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAER-KGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK--PPFLTQLHSCFQTV----   73 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEE-CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccC--CCchhheeeEEecC----
Confidence            478999999999999999998 578999999999764322 2223345678888877763  78888999998776    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ..+++||||+. |+|.+++...  ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus        74 ---~~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~  148 (323)
T cd05615          74 ---DRLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMC  148 (323)
T ss_pred             ---CEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccc
Confidence               67899999998 5999988773  45899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ....... ......|++.|+|||++.+..++.++|+||+|+++|+|++|..||.+.+.......+.....     .++  
T Consensus       149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-----~~p--  221 (323)
T cd05615         149 KEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-----SYP--  221 (323)
T ss_pred             cccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCC--
Confidence            7543222 23345689999999999998899999999999999999999999988877666655544211     111  


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKENE  319 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~~  319 (321)
                                          ..++.++.+++.+||+.+|.+|++     ..++++||||++.+|.
T Consensus       222 --------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~  266 (323)
T cd05615         222 --------------------KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD  266 (323)
T ss_pred             --------------------ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence                                134578899999999999999997     5799999999998653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-46  Score=322.70  Aligned_cols=253  Identities=30%  Similarity=0.453  Sum_probs=208.1

Q ss_pred             eeeeecccceeEEEEEEe--cCCCcEEEEEEeecccCC--CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          27 LCQIGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNE--DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~--~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      ++.||+|+||.||+|++.  ..+++.+|+|+++.....  ......+.+|+.++++++   ||||+++++++...     
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~---hp~iv~~~~~~~~~-----   72 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK---HPFIVDLIYAFQTG-----   72 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC---CCchhceeeEEecC-----
Confidence            368999999999999863  246889999998754221  122335567899999988   99999999999776     


Q ss_pred             cceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                        ...++||||+.+ +|.+.+..  .+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        73 --~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  148 (323)
T cd05584          73 --GKLYLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK  148 (323)
T ss_pred             --CeEEEEEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCe
Confidence              678999999995 99999877  3458899999999999999999999999999999999999999999999999886


Q ss_pred             cccC-CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         182 TFDY-DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       182 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      .... ........+++.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+.....     ..    
T Consensus       149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~-----~~----  219 (323)
T cd05584         149 ESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-----NL----  219 (323)
T ss_pred             ecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----CC----
Confidence            4322 2223345689999999999988899999999999999999999999988776665555443210     11    


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKEN  318 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~  318 (321)
                                        ...+++.+.++|++||+.||.+||     ++.++++||||+...|
T Consensus       220 ------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         220 ------------------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             ------------------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                              123458899999999999999999     8999999999988655

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.9e-47  Score=324.96  Aligned_cols=254  Identities=30%  Similarity=0.422  Sum_probs=210.2

Q ss_pred             eeeeecccceeEEEEEEe--cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccc
Q psy2676          27 LCQIGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERY  104 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~  104 (321)
                      ++.||+|+||.||++++.  ..+++.+++|++..............+|++++++++   ||||+++++++.+.       
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~-------   70 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN---HPFIVKLHYAFQTE-------   70 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC---CCCcccEEEEEEcC-------
Confidence            367999999999999873  356899999999765433333345667888998887   99999999999877       


Q ss_pred             eEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccc
Q psy2676         105 LTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF  183 (321)
Q Consensus       105 ~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~  183 (321)
                      ...++|+||+. ++|.+++..  ...+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++...
T Consensus        71 ~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  148 (318)
T cd05582          71 GKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  148 (318)
T ss_pred             CEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCccc
Confidence            67899999998 599999876  345899999999999999999999999999999999999999999999999998765


Q ss_pred             cCC-CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhh
Q psy2676         184 DYD-MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL  262 (321)
Q Consensus       184 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (321)
                      ... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+.....     ..      
T Consensus       149 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~-----~~------  217 (318)
T cd05582         149 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-----GM------  217 (318)
T ss_pred             CCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC-----CC------
Confidence            433 223345688999999999988899999999999999999999999988776666555433111     01      


Q ss_pred             hhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCC
Q psy2676         263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKENE  319 (321)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~~  319 (321)
                                      ...+++.+.++|++||+.||.+||+     +.++++||||++..|+
T Consensus       218 ----------------p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~  263 (318)
T cd05582         218 ----------------PQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN  263 (318)
T ss_pred             ----------------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence                            1235588999999999999999999     7789999999987553

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0197|consensus

Probab=100.00  E-value=8.2e-47  Score=320.69  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=224.4

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +.+.+++....+++++.||+|.||.||++..  ++...+++|.++..   .-....+.+|+++|++|+   |++|+++++
T Consensus       197 ~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~--~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~---H~~lV~l~g  268 (468)
T KOG0197|consen  197 ARDPWEIPREELKLIRELGSGQFGEVWLGKW--NGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLR---HEKLVKLYG  268 (468)
T ss_pred             ccCCeeecHHHHHHHHHhcCCccceEEEEEE--cCCCcccceEEecc---ccChhHHHHHHHHHHhCc---ccCeEEEEE
Confidence            3667788888899999999999999999986  56668999998754   223457889999999999   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      ++...       ..++|||||+. |+|.++++......++..+...++.|||+|++||+++++|||||-.+||||+++..
T Consensus       269 V~~~~-------~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~  341 (468)
T KOG0197|consen  269 VCTKQ-------EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV  341 (468)
T ss_pred             EEecC-------CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce
Confidence            99776       56899999999 89999999877777999999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCC--ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHh
Q psy2676         172 LKIADFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      +|++|||+++....+.  ......-+..|.|||.+....++.+|||||||++|+||+| |+.||.+.+..+.+..+.++.
T Consensus       342 vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy  421 (468)
T KOG0197|consen  342 VKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY  421 (468)
T ss_pred             EEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC
Confidence            9999999999655333  2333445678999999999999999999999999999997 899999999999999888776


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .-|.+.                          .||+++.+++..||+.+|++|||++.+..
T Consensus       422 Rlp~P~--------------------------~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  422 RLPRPE--------------------------GCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             cCCCCC--------------------------CCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            555544                          57789999999999999999999997764

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.4e-46  Score=320.69  Aligned_cols=286  Identities=24%  Similarity=0.392  Sum_probs=214.1

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ++..++|++.+.||.|+||.||++.+ ..++..+++|++..... ......+.+|++++++++   ||||+++++++.+.
T Consensus         1 ~l~~~~y~~~~~lg~g~~g~V~~~~~-~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~   75 (333)
T cd06650           1 ELKDDDFEKISELGAGNGGVVFKVSH-KPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECN---SPYIVGFYGAFYSD   75 (333)
T ss_pred             CcchhhhheeccccCCCCEEEEEEEE-CCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCC---CCcccceeEEEEEC
Confidence            35678999999999999999999999 57888999998865422 122345778999999998   99999999999877


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeeCCCEEEe
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                             ...++||||+.+ +|.+++...  +.+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+
T Consensus        76 -------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~  146 (333)
T cd06650          76 -------GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC  146 (333)
T ss_pred             -------CEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEe
Confidence                   678999999984 999999873  3489999999999999999999975 79999999999999999999999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhC-CCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG-TPSMN  254 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~  254 (321)
                      |||++...... ......++..|+|||++.+..++.++|+|||||++|+|++|+.||......+....+..... .+...
T Consensus       147 Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (333)
T cd06650         147 DFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES  225 (333)
T ss_pred             eCCcchhhhhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccc
Confidence            99998755322 22334678899999999988899999999999999999999999987655433222110000 00000


Q ss_pred             Ccchhhhh---hhhh--------------hhhhhhhhhhhh-hhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         255 EWPENISL---MWSS--------------FEQYSKVAFSAI-FMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       255 ~~~~~~~~---~~~~--------------~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ........   ....              ............ ....+.++.+||.+||+.||.+|||+.++++||||+..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             ccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence            00000000   0000              000000000000 11246789999999999999999999999999999876


Q ss_pred             CC
Q psy2676         317 EN  318 (321)
Q Consensus       317 ~~  318 (321)
                      ..
T Consensus       306 ~~  307 (333)
T cd06650         306 EA  307 (333)
T ss_pred             cc
Confidence            43

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.4e-46  Score=324.23  Aligned_cols=286  Identities=38%  Similarity=0.588  Sum_probs=223.2

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.+.||+|++|+||+|.+ ..+++.+++|.+............+.+|+.++++++   |||++++++++.....
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~   89 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYD-TVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN---HKNIIGLLNVFTPQKS   89 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEE-CCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC---CCCCcceeeeeccCCC
Confidence            357899999999999999999999 578999999998654333333445667999999887   9999999999865421


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                       .......++|+|++.++|.+.+...    +++..+..++.|++.||++||+.|++|+||||+||+++.++.++|+|||.
T Consensus        90 -~~~~~~~~lv~e~~~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          90 -LEEFQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             -ccccCcEEEEEeccCCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence             1222467999999999999988652    89999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      +.............++..|+|||.+.+..++.++||||+|+++++|++|+.||...+.......+....+.++...... 
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-  243 (353)
T cd07850         165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR-  243 (353)
T ss_pred             ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH-
Confidence            9876554444455678899999999999999999999999999999999999998887777777777666554321111 


Q ss_pred             hhhhhhh-h---hhhhhhhhhh-------------hhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         260 ISLMWSS-F---EQYSKVAFSA-------------IFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       260 ~~~~~~~-~---~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      ....... .   ..........             .....+..+.++|.+||+.||++|||+.++|+||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence            0000000 0   0000000000             01234567899999999999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.7e-46  Score=321.43  Aligned_cols=257  Identities=28%  Similarity=0.392  Sum_probs=202.3

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||+|+||+||+|++ ..+++.+|+|+++...... .....+.+|+.++.++..  ||||+++++++...       ..
T Consensus         1 ~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~--hp~iv~~~~~~~~~-------~~   70 (329)
T cd05618           1 RVIGRGSYAKVLLVRL-KKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN--HPFLVGLHSCFQTE-------SR   70 (329)
T ss_pred             CeeeeCCCeEEEEEEE-CCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCC--CCcCCceeeEEEeC-------CE
Confidence            4799999999999999 5788999999998653322 222345678888777643  99999999999877       68


Q ss_pred             EEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccC
Q psy2676         107 VYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY  185 (321)
Q Consensus       107 ~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~  185 (321)
                      .++||||+. ++|..++..  ...+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        71 ~~lv~E~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~  148 (329)
T cd05618          71 LFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  148 (329)
T ss_pred             EEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence            899999999 489888876  34589999999999999999999999999999999999999999999999999875322


Q ss_pred             -CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChH-----HHHHHHHHHhCCCCCCCcchh
Q psy2676         186 -DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV-----EQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       186 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  259 (321)
                       ........|++.|+|||++.+..++.++|+||||+++|+|++|..||......     .....+......         
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------  219 (329)
T cd05618         149 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence             22233456899999999999999999999999999999999999999531100     000000000000         


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC------HHHHhCCCCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS------AADALEHPYFKEKENE  319 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~~ll~h~~f~~~~~~  319 (321)
                                    ........++..+.++|++||+.||.+||+      +.++++||||++.+|+
T Consensus       220 --------------~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~  271 (329)
T cd05618         220 --------------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  271 (329)
T ss_pred             --------------CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence                          000112245688999999999999999998      5899999999987663

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.3e-46  Score=313.79  Aligned_cols=263  Identities=24%  Similarity=0.377  Sum_probs=216.4

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      .|+..+.||+|+||+||++.+ ..+++.+|+|.+....... .....+.+|++++++++   |+|++++++.+...    
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~---~~~i~~~~~~~~~~----   72 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQV-RATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN---SQFVVNLAYAYETK----   72 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEE-CCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC---CcCceeEEEEEecC----
Confidence            478899999999999999999 5789999999987543222 12334677999999988   99999999998776    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++++|++.+ +|.+.+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        73 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~  149 (285)
T cd05632          73 ---DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             ---CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcc
Confidence               678999999995 8988887655556999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         181 KTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      .............++..|+|||++.+..++.++|+||+|+++|+|++|..||...........+..........      
T Consensus       150 ~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~------  223 (285)
T cd05632         150 VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV------  223 (285)
T ss_pred             eecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccc------
Confidence            76554433345578999999999998889999999999999999999999998766554444433322211111      


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKENE  319 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~~  319 (321)
                                       ....++.++.+|+.+||+.||.+||+     +.++++|+||++..+.
T Consensus       224 -----------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         224 -----------------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             -----------------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence                             11245578899999999999999999     8999999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-46  Score=312.85  Aligned_cols=257  Identities=32%  Similarity=0.561  Sum_probs=209.5

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      |++++.||+|+||+||++.+ ..+++.+|+|++..............+|+.+++.+.   ||||+++++++.+.      
T Consensus         1 y~~~~~lg~G~~g~v~~~~~-~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~---~~~i~~~~~~~~~~------   70 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKN-KKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR---HPNIVQILDVFQDD------   70 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEE-TTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT---BTTBCHEEEEEEES------
T ss_pred             CEEeEEEEeCCCEEEEEEEE-CCCCeEEEEEEeccccccccccchhhhhhhcccccc---cccccccccccccc------
Confidence            88999999999999999999 678889999999865433322223345888999997   99999999999876      


Q ss_pred             ceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         104 YLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       104 ~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                       ...++++|++.+ +|.+++..  ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        71 -~~~~~v~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~  147 (260)
T PF00069_consen   71 -NYLYIVMEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVK  147 (260)
T ss_dssp             -SEEEEEEEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred             -ccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence             788999999997 99999984  34589999999999999999999999999999999999999999999999999876


Q ss_pred             c-cCCCccccccccccccchhhhh-cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         183 F-DYDMMLTSVVVTLWYRAPEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       183 ~-~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      . ..........++..|+|||++. +...+.++|+||||+++++|++|..||......+....+.........       
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-------  220 (260)
T PF00069_consen  148 LSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP-------  220 (260)
T ss_dssp             STSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH-------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc-------
Confidence            3 2333455667889999999998 778899999999999999999999999877444444333332110000       


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                                   .........+..+.++|++||+.||++|||+.++++||||
T Consensus       221 -------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  221 -------------SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -------------HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -------------ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                         0000001123799999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.8e-46  Score=317.61  Aligned_cols=253  Identities=29%  Similarity=0.460  Sum_probs=205.9

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||+|+||+||+|++ ..+++.+|+|+++..... .........|..+++...  .||||+++++++.+.       ..
T Consensus         1 ~~lG~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~hp~iv~~~~~~~~~-------~~   70 (316)
T cd05619           1 KMLGKGSFGKVFLAEL-KGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW--EHPFLTHLYCTFQTK-------EN   70 (316)
T ss_pred             CeeeeCCCEEEEEEEE-CCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhcc--CCCcCcceEEEEEeC-------CE
Confidence            4689999999999998 578899999999765321 222334556777776653  399999999999877       67


Q ss_pred             EEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccC
Q psy2676         107 VYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY  185 (321)
Q Consensus       107 ~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~  185 (321)
                      +++||||+. |+|.+++...  ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        71 ~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05619          71 LFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML  148 (316)
T ss_pred             EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence            899999998 5999999773  3489999999999999999999999999999999999999999999999998865321


Q ss_pred             -CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhh
Q psy2676         186 -DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW  264 (321)
Q Consensus       186 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
                       ........++..|+|||++.+..++.++||||+||++|+|++|..||.+.+..+....+...  .+.   ++       
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~---~~-------  216 (316)
T cd05619         149 GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPC---YP-------  216 (316)
T ss_pred             CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCC---CC-------
Confidence             22233456899999999999988999999999999999999999999887766555443321  111   11       


Q ss_pred             hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHH-HHhCCCCCCCCCCC
Q psy2676         265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA-DALEHPYFKEKENE  319 (321)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-~ll~h~~f~~~~~~  319 (321)
                                     ..++.++.++|.+||+.||.+||++. ++++||||++..|+
T Consensus       217 ---------------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         217 ---------------RWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             ---------------ccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence                           12447889999999999999999996 89999999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.2e-46  Score=320.21  Aligned_cols=289  Identities=38%  Similarity=0.632  Sum_probs=228.3

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|.+.+.||.|++|+||++++ ..++..|++|.+..............+|+.+++.++   |+|++++++++....  
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~~~~~~~~~~--   77 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKN-SETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD---HENVIAIKDIMPPPH--   77 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEe-cCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC---CCCccchHHheeccc--
Confidence            46899999999999999999999 578899999998754333333446678999999887   999999999876541  


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                      .......++++|++.++|.+++...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        78 ~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          78 REAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             ccccCcEEEEEeCCCCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            2222458999999999999998763  45899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC-Cccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         181 KTFDYD-MMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       181 ~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      ...... .......++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.+.......+....+.+....+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            766433 22234456888999998875 4589999999999999999999999998887777777777776665444321


Q ss_pred             hhhhhh----hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         259 NISLMW----SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       259 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ......    ................++++++.++|++||+.+|++|||+.++++||||+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence            111000    00111111222333457889999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-45  Score=326.52  Aligned_cols=276  Identities=26%  Similarity=0.350  Sum_probs=209.0

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      .+.+|.+.+.||+|+||.||++.+ ...++.|++|...        .....+|++++++++   |+||+++++++...  
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~-~~~~~~vavK~~~--------~~~~~~E~~iL~~L~---HpnIv~l~~~~~~~--  232 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSH-PDYPQRVVVKAGW--------YASSVHEARLLRRLS---HPAVLALLDVRVVG--  232 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEE-CCCCCEEEEeccc--------ccCHHHHHHHHHHCC---CCCCCcEEEEEEEC--
Confidence            356899999999999999999999 5778899999642        224678999999998   99999999998766  


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                           ...++|+|++.++|.+++..... .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+
T Consensus       233 -----~~~~lv~e~~~~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGl  306 (461)
T PHA03211        233 -----GLTCLVLPKYRSDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGA  306 (461)
T ss_pred             -----CEEEEEEEccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCC
Confidence                 67899999999999999876443 489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCC-CCCC------hHHHHHHHHHHhC
Q psy2676         180 AKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLF-CAST------EVEQLKCIFRVIG  249 (321)
Q Consensus       180 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~------~~~~~~~~~~~~~  249 (321)
                      +........   .....||..|+|||++.+..++.++|||||||++|+|++|..++ ....      ......++....+
T Consensus       307 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~  386 (461)
T PHA03211        307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQ  386 (461)
T ss_pred             ceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhc
Confidence            876543221   22346899999999999999999999999999999999987554 2211      1223333333322


Q ss_pred             CCCCCCcchhh-hhhhhhhhhh--------hhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         250 TPSMNEWPENI-SLMWSSFEQY--------SKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       250 ~~~~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ... ..++... ......+...        ............+.++.+||.+||+.||.+|||+.|+|+||||+++
T Consensus       387 ~~~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~~  461 (461)
T PHA03211        387 VHV-DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQSK  461 (461)
T ss_pred             ccc-ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCCC
Confidence            211 1222111 0000111000        0000011112455789999999999999999999999999999864

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.9e-46  Score=333.49  Aligned_cols=272  Identities=24%  Similarity=0.307  Sum_probs=218.9

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      .+.....++|++.+.||+|+||+||+|++ ..+++.||+|++............+.+|+..+..+.   |+|++++++.+
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~---h~~iv~~~~~~  100 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKR-VSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD---FFSIVKCHEDF  100 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEE-cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCC---CCcEEEeecce
Confidence            35566778999999999999999999998 578999999998765433333345667777777776   99999999887


Q ss_pred             eccccc-cccceEEEEEeccCc-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC
Q psy2676          95 HQNILS-DERYLTVYLIFEHVD-QDLGSYMEKCP--PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG  170 (321)
Q Consensus        95 ~~~~~~-~~~~~~~~~v~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~  170 (321)
                      ...... ......+++|+||+. |+|.+++....  ...+++..++.++.|++.||.|||+.|++||||||+||+++.++
T Consensus       101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG  180 (496)
T ss_pred             ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC
Confidence            544211 222245789999999 59999886532  34589999999999999999999999999999999999999999


Q ss_pred             CEEEeecCCcccccCC---CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q psy2676         171 GLKIADFGLAKTFDYD---MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  247 (321)
                      .+||+|||++......   .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+...
T Consensus       181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~  260 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG  260 (496)
T ss_pred             CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            9999999998765422   1223456899999999999999999999999999999999999999887766655544332


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ...+                          ....+++++.+++.+||+.||.+||++.++++|||++..
T Consensus       261 ~~~~--------------------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        261 RYDP--------------------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCCC--------------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            1111                          112456889999999999999999999999999998753

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.6e-46  Score=322.33  Aligned_cols=252  Identities=26%  Similarity=0.405  Sum_probs=204.2

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHH-HHHhcccCCCCceeEEEeeeeccccccccce
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREIS-ILKQLDTFEHPNIVRFFDVIHQNILSDERYL  105 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~-~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~  105 (321)
                      +.||+|+||+||+|++ ..+++.+|+|++....... .....+..|.. +++.++   ||||+++++.+.+.       .
T Consensus         1 ~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~---hp~iv~~~~~~~~~-------~   69 (323)
T cd05575           1 KVIGKGSFGKVLLAKH-KADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK---HPFLVGLHYSFQTA-------D   69 (323)
T ss_pred             CeeeeCCCeEEEEEEE-CCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC---CCCCCCeeEEEEeC-------C
Confidence            4689999999999999 6789999999987542221 11223344444 345565   99999999999776       6


Q ss_pred             EEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         106 TVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       106 ~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      ..++||||+.+ +|..++..  ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus        70 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~  147 (323)
T cd05575          70 KLYFVLDYVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI  147 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence            78999999995 99998876  3458999999999999999999999999999999999999999999999999886532


Q ss_pred             C-CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhh
Q psy2676         185 Y-DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM  263 (321)
Q Consensus       185 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
                      . ........|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.....     .        
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----~--------  214 (323)
T cd05575         148 EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL-----R--------  214 (323)
T ss_pred             cCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-----C--------
Confidence            2 2233345689999999999998999999999999999999999999988776665555443110     0        


Q ss_pred             hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH----HHHhCCCCCCCCCCC
Q psy2676         264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA----ADALEHPYFKEKENE  319 (321)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~h~~f~~~~~~  319 (321)
                                    ....++..+.++|++||+.||.+||++    .++++||||.+..|+
T Consensus       215 --------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~  260 (323)
T cd05575         215 --------------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWD  260 (323)
T ss_pred             --------------CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence                          112345889999999999999999988    699999999987653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-45  Score=310.30  Aligned_cols=279  Identities=43%  Similarity=0.753  Sum_probs=218.4

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||+|++|.||++.+ ..+++.+++|.+...... .....+.+|+.++++++   ||||+++++++.+.    
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~-~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~----   75 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRS-KLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLK---HANIVTLHDIIHTK----   75 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEE-cCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCC---CcceeeEEEEEecC----
Confidence            6899999999999999999998 578899999998764322 23345678999999998   99999999998776    


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                         ...++|+||+.++|.+++..... .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus        76 ---~~~~lv~e~~~~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  151 (291)
T cd07844          76 ---KTLTLVFEYLDTDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR  151 (291)
T ss_pred             ---CeEEEEEecCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECcccccc
Confidence               68899999999999998876543 48999999999999999999999999999999999999999999999999886


Q ss_pred             cccCCC-ccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCC-hHHHHHHHHHHhCCCCCCCcch
Q psy2676         182 TFDYDM-MLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCAST-EVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       182 ~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      ...... ......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.... ..+....+.+..+.+....++.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07844         152 AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG  231 (291)
T ss_pred             ccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence            543221 1122345778999999876 447899999999999999999999997665 5566666666666555444433


Q ss_pred             hhhhhh---hhhhhhhhhhhhhhhhhcc--hhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         259 NISLMW---SSFEQYSKVAFSAIFMDCC--SKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       259 ~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ......   .................++  .++.+++.+||+.+|.+|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            221110   0011111111222222344  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.2e-46  Score=320.87  Aligned_cols=264  Identities=26%  Similarity=0.345  Sum_probs=211.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++.+.||+|+||+||++++ ..+++.+++|++..... .......+.+|+.++..+.   |++|+++++++.+.   
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~---~~~i~~~~~~~~~~---   73 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKL-KNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD---NQWITTLHYAFQDE---   73 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEE-CCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC---CCCEeeEEEEEecC---
Confidence            4799999999999999999998 57888999999865321 1122234667888887776   99999999999877   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++||||+. |+|.+++.... ..+++..++.++.||+.||.+||++|++||||||+||+++.++.++|+|||+
T Consensus        74 ----~~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~  148 (332)
T cd05623          74 ----NNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS  148 (332)
T ss_pred             ----CEEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecch
Confidence                67899999998 59999997643 3489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc--cccccccccccchhhhhc-----CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         180 AKTFDYDMM--LTSVVVTLWYRAPEILLN-----LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       180 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      +........  .....|++.|+|||++..     ..++.++||||||+++|+|++|+.||...+..+....+........
T Consensus       149 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~  228 (332)
T cd05623         149 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ  228 (332)
T ss_pred             heecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc
Confidence            875533222  223568999999999863     4578899999999999999999999988877676665543221111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD--RISAADALEHPYFKEKENE  319 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~h~~f~~~~~~  319 (321)
                         ++                   .....++.++.+||++||..++.+  |++++++++||||++.+|+
T Consensus       229 ---~p-------------------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~  275 (332)
T cd05623         229 ---FP-------------------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD  275 (332)
T ss_pred             ---CC-------------------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence               11                   112356789999999999665544  6899999999999998764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9.9e-46  Score=313.58  Aligned_cols=282  Identities=43%  Similarity=0.763  Sum_probs=225.4

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||.|++|.||+|.+ ..+++.+++|.++...........+.+|+.+++++.   |||++++++++....   
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~---   77 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARD-KKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ---HPNIVTVKEVVVGSN---   77 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEE-CCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC---CCCEEEEEEEEEecC---
Confidence            5799999999999999999998 577899999999765444333445678999999998   999999999885441   


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                        ....++|+|++.++|.+++..... .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        78 --~~~~~lv~e~~~~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~  154 (293)
T cd07843          78 --LDKIYMVMEYVEHDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR  154 (293)
T ss_pred             --CCcEEEEehhcCcCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCcee
Confidence              246899999999999999877543 48999999999999999999999999999999999999999999999999888


Q ss_pred             cccCC-CccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         182 TFDYD-MMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       182 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ..... .......++..|+|||.+.+.. .+.++|+||+|+++++|++|..||......+...++....+.+....|+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         155 EYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             eccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence            66543 2233456688899999987654 688999999999999999999999998888888888887776665554432


Q ss_pred             hhhhhhhhhhhhhh---hhhhhhhh--cchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         260 ISLMWSSFEQYSKV---AFSAIFMD--CCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       260 ~~~~~~~~~~~~~~---~~~~~~~~--~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ..............   ........  +++.+.++|++||+.+|++|||+.|+++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            21111110011111   11111222  47889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.6e-45  Score=308.48  Aligned_cols=279  Identities=38%  Similarity=0.660  Sum_probs=214.1

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||+|++|.||++.+ ..+++.+++|++............+.+|+.+++++.   |||++++++++...    
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~----   72 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRN-RETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK---HPNLVNLIEVFRRK----   72 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEE-CCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC---CCCEeeeeeEEeeC----
Confidence            5799999999999999999998 578899999998754333333445678999999998   99999999999777    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++|+||+++ +|..++..  ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        73 ---~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  147 (286)
T cd07847          73 ---RKLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFA  147 (286)
T ss_pred             ---CEEEEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccc
Confidence               678999999997 45444443  234899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC-ccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      ....... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.+....+....+....+.........
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07847         148 RILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI  227 (286)
T ss_pred             eecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            8765433 2233456788999999876 4478999999999999999999999988777666655554433221100000


Q ss_pred             hhhhh----hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         259 NISLM----WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       259 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      .....    .................+.+..+.+|+.+||+.+|++||++.+++.||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            00000    00000000011122234567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.2e-46  Score=320.64  Aligned_cols=264  Identities=24%  Similarity=0.327  Sum_probs=212.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++.+.||+|+||+||++++ ..+++.+|+|++..... .......+.+|..++..+.   |++|+++++++.+.   
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~---~~~i~~l~~~~~~~---   73 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKM-KHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD---CQWITTLHYAFQDE---   73 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC---CCCEeeEEEEEEcC---
Confidence            5799999999999999999998 57889999999875321 1222334567888888777   99999999999877   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++||||+. |+|.+++.... ..+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||+
T Consensus        74 ----~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~  148 (331)
T cd05624          74 ----NYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGS  148 (331)
T ss_pred             ----CEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccc
Confidence                78899999998 59999997743 3489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc--cccccccccccchhhhhc-----CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         180 AKTFDYDMM--LTSVVVTLWYRAPEILLN-----LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       180 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      +........  .....|++.|+|||++.+     ..++.++|+||+|+++|+|++|+.||...+..+....+.......+
T Consensus       149 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~  228 (331)
T cd05624         149 CLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ  228 (331)
T ss_pred             eeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc
Confidence            876653332  223568999999999876     4578899999999999999999999988776666555543221111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD--RISAADALEHPYFKEKENE  319 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~h~~f~~~~~~  319 (321)
                      .   +                   ....+++.++.++|.+||..++.+  |++++++++||||++.+|+
T Consensus       229 ~---p-------------------~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~  275 (331)
T cd05624         229 F---P-------------------SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE  275 (331)
T ss_pred             C---C-------------------CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence            1   1                   111246689999999999876654  5699999999999988764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-45  Score=311.55  Aligned_cols=279  Identities=50%  Similarity=0.898  Sum_probs=226.3

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      |++.+.||.|++|.||++.+ ..++..+++|++............+.+|+.+++.++   |||++++++++.+.      
T Consensus         1 y~~~~~l~~g~~~~vy~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~---~~~iv~~~~~~~~~------   70 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARD-KLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN---HPNIVRLLDVVHSE------   70 (283)
T ss_pred             CchheEecCCCCeEEEEEEE-cCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC---CCCccCHhheeccC------
Confidence            67889999999999999998 578999999998765444444456778999999998   99999999998766      


Q ss_pred             ceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccc
Q psy2676         104 YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF  183 (321)
Q Consensus       104 ~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~  183 (321)
                       ...++++|+++++|.+++.......+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+...
T Consensus        71 -~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~  149 (283)
T cd07835          71 -NKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF  149 (283)
T ss_pred             -CeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence             6789999999989999998866456899999999999999999999999999999999999999999999999998765


Q ss_pred             cCCC-ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhh
Q psy2676         184 DYDM-MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS  261 (321)
Q Consensus       184 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (321)
                      .... ......++..|+|||++.+. .++.++|+||+|+++|+|++|..||...+.......+.+..+.+....|+....
T Consensus       150 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         150 GVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             CCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence            4222 22334557889999987664 468899999999999999999999998888777777777666665544433211


Q ss_pred             hh--hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         262 LM--WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       262 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ..  ...+..............++.++.++|.+||+.||.+|||+.++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            11  11222222233334455677899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.3e-46  Score=318.30  Aligned_cols=254  Identities=27%  Similarity=0.366  Sum_probs=204.0

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||+|+||+||+|++ ..+++.+|+|+++...... .....+.+|..++.++..  ||+|+++++++.+.       ..
T Consensus         1 ~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~--~~~i~~~~~~~~~~-------~~   70 (327)
T cd05617           1 RVIGRGSYAKVLLVRL-KKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS--NPFLVGLHSCFQTT-------SR   70 (327)
T ss_pred             CeeeeCCCeEEEEEEE-CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcC--CCCEeeEEEEEEeC-------CE
Confidence            4799999999999999 5788999999998653222 223346678888888854  99999999999777       67


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccccc-
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-  184 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~-  184 (321)
                      +++||||+.+ +|..++...  ..+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++.... 
T Consensus        71 ~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  148 (327)
T cd05617          71 LFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG  148 (327)
T ss_pred             EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence            8999999984 998888763  459999999999999999999999999999999999999999999999999887532 


Q ss_pred             CCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCC------hHHHHHHHHHHhCCCCCCCcch
Q psy2676         185 YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST------EVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      .........|++.|+|||++.+..++.++||||||+++|+|++|..||....      ..+........  .+  .    
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~--~----  220 (327)
T cd05617         149 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KP--I----  220 (327)
T ss_pred             CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CC--C----
Confidence            2223344668999999999999999999999999999999999999995421      11111111110  00  0    


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC------HHHHhCCCCCCCCCCC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS------AADALEHPYFKEKENE  319 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~~ll~h~~f~~~~~~  319 (321)
                                        .....++..+.++|++||..||.+|++      ..++++||||++..|+
T Consensus       221 ------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         221 ------------------RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence                              011235578899999999999999997      5799999999988764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0611|consensus

Probab=100.00  E-value=3e-47  Score=312.27  Aligned_cols=254  Identities=28%  Similarity=0.466  Sum_probs=225.3

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ...||++.+.||+|.||.|-+|++ ...|+.||||.+++.... +.....+.+|++++..|+   ||||+.+|++|++. 
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e-~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN---HPhII~IyEVFENk-  125 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYE-HKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN---HPHIIQIYEVFENK-  125 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhh-ccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC---CCceeehhhhhcCC-
Confidence            446899999999999999999998 688999999999765333 223446778999999998   99999999999888 


Q ss_pred             cccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ..+.+||||.. |.|++|+..++.  +++.+++.+++||..|+.|+|.++++|||||.+||++|.|+++|+.||
T Consensus       126 ------dKIvivMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADF  197 (668)
T KOG0611|consen  126 ------DKIVIVMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADF  197 (668)
T ss_pred             ------ceEEEEEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeecc
Confidence                  78999999998 699999999654  999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcCCC-CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      |++-.+......+..+|++-|.+||.+.+.+| .+..|.||||++||.+..|..||.+.+......+|..+.-..+    
T Consensus       198 GLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP----  273 (668)
T KOG0611|consen  198 GLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP----  273 (668)
T ss_pred             chhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC----
Confidence            99998887778888999999999999999998 6899999999999999999999999988888877766433222    


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK  314 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~  314 (321)
                                              ..|..+.-||++||.++|++|.|+++|..|=|..
T Consensus       274 ------------------------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  274 ------------------------ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             ------------------------CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                                    2236677899999999999999999999998865

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-45  Score=315.57  Aligned_cols=262  Identities=28%  Similarity=0.438  Sum_probs=216.0

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++.+.||+|++|+||+|.+ ..+++.+++|.+....... .....+.+|++++++++   ||||+++++.+.+.   
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~---   73 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRL-KGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD---HPFLPTLYASFQTE---   73 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEE-cCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC---CCCchhheeeeecC---
Confidence            4799999999999999999998 5678999999987643221 23345678889999888   99999999998776   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++++|++.| +|.+++.......+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||+
T Consensus        74 ----~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~  149 (316)
T cd05574          74 ----TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDL  149 (316)
T ss_pred             ----CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecch
Confidence                678999999985 999999876556699999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCc------------------------------cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcC
Q psy2676         180 AKTFDYDMM------------------------------LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV  229 (321)
Q Consensus       180 ~~~~~~~~~------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  229 (321)
                      +........                              .....++..|+|||++.+..++.++||||||+++|+|++|.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~  229 (316)
T cd05574         150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT  229 (316)
T ss_pred             hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence            865432211                              11235678899999999888999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC----HH
Q psy2676         230 PLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS----AA  305 (321)
Q Consensus       230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~  305 (321)
                      .||.+.+.......+....  ..   ++.                    ....+..+.++|++||..||.+|||    ++
T Consensus       230 ~pf~~~~~~~~~~~~~~~~--~~---~~~--------------------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~  284 (316)
T cd05574         230 TPFKGSNRDETFSNILKKE--VT---FPG--------------------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAA  284 (316)
T ss_pred             CCCCCCchHHHHHHHhcCC--cc---CCC--------------------ccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence            9998877665554433211  00   100                    0125689999999999999999999    99


Q ss_pred             HHhCCCCCCCCCCC
Q psy2676         306 DALEHPYFKEKENE  319 (321)
Q Consensus       306 ~ll~h~~f~~~~~~  319 (321)
                      ++++||||++.+|.
T Consensus       285 ~ll~~~~~~~~~~~  298 (316)
T cd05574         285 EIKQHPFFRGVNWA  298 (316)
T ss_pred             HHHcCchhhcCChh
Confidence            99999999998764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.9e-45  Score=315.33  Aligned_cols=275  Identities=37%  Similarity=0.689  Sum_probs=206.2

Q ss_pred             eeeeecccceeEEEEEEe-cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccce
Q psy2676          27 LCQIGCGAYGTVFKARDL-QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYL  105 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~  105 (321)
                      .++||+|+||+||+|++. ..+++.+++|.+...    .......+|+.++++++   ||||+++++++....     ..
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~-----~~   73 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT----GISMSACREIALLRELK---HPNVISLQKVFLSHA-----DR   73 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC----CCcHHHHHHHHHHHhcC---CCCCcceeeeEecCC-----Cc
Confidence            368999999999999873 246788999988643    22346778999999998   999999999885431     14


Q ss_pred             EEEEEeccCccCHHHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----eeCCCEEE
Q psy2676         106 TVYLIFEHVDQDLGSYMEKCP-------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI----TRAGGLKI  174 (321)
Q Consensus       106 ~~~~v~e~~~~~L~~~~~~~~-------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv----~~~~~~kl  174 (321)
                      .+++++|+++++|.+++....       ...+++..++.++.||+.||.|||+.|++|+||||+||++    +.++.+||
T Consensus        74 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl  153 (317)
T cd07868          74 KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI  153 (317)
T ss_pred             EEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEE
Confidence            689999999999988876421       1248999999999999999999999999999999999999    45578999


Q ss_pred             eecCCcccccCCC----ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCCh---------HHH
Q psy2676         175 ADFGLAKTFDYDM----MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTE---------VEQ  240 (321)
Q Consensus       175 ~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------~~~  240 (321)
                      +|||++.......    ......+|+.|+|||++.+. .++.++||||+||++|+|++|++||.....         ...
T Consensus       154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~  233 (317)
T cd07868         154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  233 (317)
T ss_pred             eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence            9999997654322    22345778999999999875 479999999999999999999999975432         345


Q ss_pred             HHHHHHHhCCCCCCCcchhhhhhh--hhhhhhhh---------hhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         241 LKCIFRVIGTPSMNEWPENISLMW--SSFEQYSK---------VAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ...+....+.+....|........  ........         ...+......+.++.+||++||++||.+|||++|+|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            556666666655554433211100  00000000         0011111223467899999999999999999999999


Q ss_pred             CCCC
Q psy2676         310 HPYF  313 (321)
Q Consensus       310 h~~f  313 (321)
                      ||||
T Consensus       314 hp~f  317 (317)
T cd07868         314 DPYF  317 (317)
T ss_pred             CCCC
Confidence            9998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-45  Score=305.78  Aligned_cols=254  Identities=27%  Similarity=0.454  Sum_probs=208.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC---CCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG---IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      +.|.+.+.||+|++|.||.+.+ ..++..+++|.+........   ....+.+|+.+++++.   ||||+++++++.+. 
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~-   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYD-VDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ---HERIVQYYGCLRDD-   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEE-cCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC---CCCeeeeEEEEccC-
Confidence            4699999999999999999998 57889999999875432221   1235667888888887   99999999999777 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ...++++|++++ +|.+++...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus        77 ------~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~df  148 (263)
T cd06625          77 ------ETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDF  148 (263)
T ss_pred             ------CeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeec
Confidence                  689999999985 999998874  34899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCcc----ccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         178 GLAKTFDYDMML----TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       178 g~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      |.+.........    ....++..|+|||++.+..++.++||||+|+++|+|++|+.||...+..............   
T Consensus       149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---  225 (263)
T cd06625         149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN---  225 (263)
T ss_pred             ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC---
Confidence            998755432211    2345677899999999988999999999999999999999999876555444333221111   


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ...                      ...++..+.++|++||..+|.+|||+.++++||||
T Consensus       226 ~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         226 PQL----------------------PSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             CCC----------------------CccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            111                      12456889999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8e-45  Score=302.26  Aligned_cols=255  Identities=28%  Similarity=0.455  Sum_probs=209.8

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|++.+.||+|++|.||++.+ ..+++.+++|.+............+.+|+.++++++   |+|++++++.+...     
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~-----   71 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRH-RTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK---HPNIVAYRESWEGE-----   71 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEE-cCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC---CCCeeeeeeeecCC-----
Confidence            589999999999999999999 577889999998755433333446778888888887   99999999887432     


Q ss_pred             cceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                       ...+++++|++++ +|.+.+.......+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        72 -~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~  150 (257)
T cd08223          72 -DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIAR  150 (257)
T ss_pred             -CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceE
Confidence             1467999999984 99999887555568999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         182 TFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       182 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      ...... ......+++.|+|||++.+..++.++|+||+|++++++++|+.||...+.......+......+         
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---------  221 (257)
T cd08223         151 VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---------  221 (257)
T ss_pred             EecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---------
Confidence            654322 2233457888999999999989999999999999999999999998766555444333211100         


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                                       ....+++.+.+++.+||+.+|.+||++.++++||||
T Consensus       222 -----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         222 -----------------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             -----------------CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                             112455889999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0201|consensus

Probab=100.00  E-value=5.8e-48  Score=319.15  Aligned_cols=261  Identities=30%  Similarity=0.450  Sum_probs=221.9

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      .......|+....||+|+||.||+|.+ ..+++.||+|++....... ....+.+|+.++.+++   ++||.+.|+.+..
T Consensus         8 ~~~~~~~~~~~~~IgrGsfG~Vyk~~d-~~t~k~vAiKii~Le~~~d-eIediqqei~~Ls~~~---~~~it~yygsyl~   82 (467)
T KOG0201|consen    8 KIDPELLYTKLELIGRGSFGEVYKAID-NKTKKVVAIKIIDLEEAED-EIEDIQQEISVLSQCD---SPNITEYYGSYLK   82 (467)
T ss_pred             cCCcccccccchhccccccceeeeeee-ccccceEEEEEechhhcch-hhHHHHHHHHHHHhcC---cchHHhhhhheee
Confidence            344567899999999999999999999 6899999999998764443 3457888999999998   9999999999988


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ..++++||||.| ++.+++..  .+.+++..+..++++++.||.|||..+.+|+|||+.||++..+|.+||+
T Consensus        83 g-------~~LwiiMey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~  153 (467)
T KOG0201|consen   83 G-------TKLWIIMEYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLA  153 (467)
T ss_pred             c-------ccHHHHHHHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEE
Confidence            7       788999999995 99999988  3446999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         176 DFGLAKTFDYDMM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       176 dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      |||.+........ .....||+.|||||++....|+.++||||||+++++|++|.+|+....+...+..|-       ..
T Consensus       154 DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-------k~  226 (467)
T KOG0201|consen  154 DFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-------KS  226 (467)
T ss_pred             ecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-------CC
Confidence            9999987764443 356889999999999998899999999999999999999999998876633222111       11


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                                         ..+.+...+++.+++|+..||..||+.||+|.++|+|+|++...
T Consensus       227 -------------------~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  227 -------------------APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             -------------------CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence                               11112235678999999999999999999999999999998754

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.1e-44  Score=309.66  Aligned_cols=288  Identities=37%  Similarity=0.677  Sum_probs=219.6

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      -++|++.+.||+|++|.||+|.+ ..+++.+++|.+..............+|+.+++++.   |||++++++++......
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~   86 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARH-KKTKQIVALKKVLMENEKEGFPITALREIKILQLLK---HENVVNLIEICRTKATP   86 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEE-CCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC---CCCccceEEEEeccccc
Confidence            35899999999999999999998 578999999998755433333445567999999998   99999999988655221


Q ss_pred             -cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 -DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 -~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                       .......++|+|++.++|.+++.... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.
T Consensus        87 ~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          87 YNRYKGSFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ccCCCceEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence             22234679999999999998887643 3489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc-----cccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         180 AKTFDYDMM-----LTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       180 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      +........     .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||.+.+.......+....+..+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            876543221     12345677899999887654 688999999999999999999999888777776666666655544


Q ss_pred             CCcchhhhhhh-h--hhhhhhhhhhhh--hhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         254 NEWPENISLMW-S--SFEQYSKVAFSA--IFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       254 ~~~~~~~~~~~-~--~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ..++....... .  .+.+........  .....+..+.++|.+||..||.+|||++++++||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            44333211110 0  000000000000  011134678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.8e-45  Score=317.43  Aligned_cols=288  Identities=35%  Similarity=0.623  Sum_probs=229.2

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      +++|++.+.||.|++|.||++.+ ..+++.|++|++............+.+|+.+++++.   ||||+++++++....  
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~-~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~--   77 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAID-TRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK---HDNIIAIRDILRPPG--   77 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEE-cCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC---CCCccCHHHhccccC--
Confidence            47899999999999999999999 578999999998765433334456778999999998   999999999886542  


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                       ......++|+|++.++|.+++...  ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        78 -~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~  154 (334)
T cd07855          78 -ADFKDVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMA  154 (334)
T ss_pred             -CCCceEEEEEehhhhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccc
Confidence             223568999999999999988763  44899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCc-----cccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         181 KTFDYDMM-----LTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       181 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      ........     .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.+.......+....+.++..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~  234 (334)
T cd07855         155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE  234 (334)
T ss_pred             eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence            65532221     123467888999999866 457899999999999999999999999888888888777777766554


Q ss_pred             Ccchhhhhh----hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         255 EWPENISLM----WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       255 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      .+.......    .................+.+.++.++|++||+.+|.+|||+.+++.||||++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~  301 (334)
T cd07855         235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH  301 (334)
T ss_pred             hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence            332211111    111111111222334456789999999999999999999999999999998764

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.8e-45  Score=302.89  Aligned_cols=254  Identities=25%  Similarity=0.399  Sum_probs=213.5

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      .|.+.+.||+|++|.||++.+ ..+++.+++|.+............+.+|+.++++++   |||++++++++...     
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~-----   71 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVR-KADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD---SSYIIRYYESFLDK-----   71 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEE-cCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC---CCCeehheeeeccC-----
Confidence            488999999999999999998 578899999998765444444556778899998887   99999999998776     


Q ss_pred             cceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                        ...++|+|++.+ +|.+++.......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        72 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~  149 (256)
T cd08529          72 --GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAK  149 (256)
T ss_pred             --CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccce
Confidence              678999999984 99999988655669999999999999999999999999999999999999999999999999887


Q ss_pred             cccCCCc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         182 TFDYDMM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       182 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      ....... .....+++.|+|||++.+..++.++|+||||+++++|++|..||...+.......+......+         
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------  220 (256)
T cd08529         150 LLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP---------  220 (256)
T ss_pred             eccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence            6653322 233467888999999999889999999999999999999999998877655544433211110         


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                                       ....++..+.+++++||+.+|++||++.++++|||+
T Consensus       221 -----------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         221 -----------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             -----------------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                             111455889999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.2e-45  Score=320.73  Aligned_cols=256  Identities=29%  Similarity=0.447  Sum_probs=201.7

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++++.||+|+||+||++++ ..+++.|++|++.... .......+.+|+.++++++   |+||+++++++...  
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~--  144 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIH-RPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVN---HPNVVKCHDMFDHN--  144 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEE-CCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCC---CCCcceeeeEeccC--
Confidence            346799999999999999999998 5788999999986432 1222346778999999988   99999999999776  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ..+++|+||+.+ +|...      ...++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||
T Consensus       145 -----~~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG  213 (353)
T PLN00034        145 -----GEIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFG  213 (353)
T ss_pred             -----CeEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccc
Confidence                 678999999995 66542      225788889999999999999999999999999999999999999999999


Q ss_pred             CcccccCCC-ccccccccccccchhhhhc-----CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         179 LAKTFDYDM-MLTSVVVTLWYRAPEILLN-----LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       179 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ++....... ......++..|+|||++..     ...+.++|||||||++|+|++|+.||......+....+...... .
T Consensus       214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-~  292 (353)
T PLN00034        214 VSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-Q  292 (353)
T ss_pred             cceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc-C
Confidence            987654322 2234578999999998743     22456899999999999999999999743322222111111100 0


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .                      ......++.++.+||.+||..||++|||+.|+++||||.+.
T Consensus       293 ~----------------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        293 P----------------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             C----------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            0                      01112456889999999999999999999999999999976

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.4e-45  Score=317.35  Aligned_cols=259  Identities=22%  Similarity=0.327  Sum_probs=202.1

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +++..++|++.+.||.|+||.||+|.+.    ..++..||+|+++.... ......+.+|+.+++++..  ||||+++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~--h~niv~~~~   78 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-ASEHKALMSELKILIHIGN--HLNVVNLLG   78 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-hHHHHHHHHHHHHHHHhcc--CcceeeEEe
Confidence            5678899999999999999999999752    24457899999864321 1223467789999999943  999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCC---------------------------------------------
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP---------------------------------------------  126 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~---------------------------------------------  126 (321)
                      ++....      ..++++|||++ |+|.+++....                                             
T Consensus        79 ~~~~~~------~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (338)
T cd05102          79 ACTKPN------GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPS  152 (338)
T ss_pred             EecCCC------CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccc
Confidence            875431      35799999999 59999987532                                             


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCC---c
Q psy2676         127 ---------------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---M  188 (321)
Q Consensus       127 ---------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~  188 (321)
                                     ...+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.......   .
T Consensus       153 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~  232 (338)
T cd05102         153 TSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR  232 (338)
T ss_pred             cCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhc
Confidence                           1237788899999999999999999999999999999999999999999999987653222   1


Q ss_pred             cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhh
Q psy2676         189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF  267 (321)
Q Consensus       189 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
                      .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+...........+.               
T Consensus       233 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  297 (338)
T cd05102         233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR---------------  297 (338)
T ss_pred             ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC---------------
Confidence            123345678999999999899999999999999999997 9999987554333222221111100               


Q ss_pred             hhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         268 EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                ....+++.+.+++.+||+.||.+|||+.++++
T Consensus       298 ----------~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         298 ----------APENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             ----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                      01245578999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-45  Score=316.83  Aligned_cols=289  Identities=39%  Similarity=0.654  Sum_probs=234.4

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|++.+.||.|++|.||+|++ ..++..+++|.+............+.+|+.+++.++   |||++++++++.....  .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~--~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVD-KRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR---HENIIGLLDILRPPSP--E   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEe-CCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC---CcchhhhhhhhcccCc--c
Confidence            689999999999999999998 577899999998765433444557888999999998   9999999999876621  3


Q ss_pred             cceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         103 RYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       103 ~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      ....+++++|+++++|.+++....  .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~~~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          75 DFNDVYIVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             cccceEEEecchhhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            334689999999999999887633  589999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCC----ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         183 FDYDM----MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       183 ~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      .....    ......++..|+|||.+.+. .++.++|+||+|+++++|++|..||.+.+..+....+....+.+....+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            65443    23345678889999999887 78999999999999999999999999999888888888877766654332


Q ss_pred             hhhh----hhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         258 ENIS----LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       258 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      ....    ...................+.+..+.++|++||+++|.+||++.++++||||++...+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence            1100    0011112222233334455678999999999999999999999999999999877543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4e-45  Score=308.37  Aligned_cols=261  Identities=26%  Similarity=0.449  Sum_probs=205.3

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHH-HHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISI-LKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++.+.||+|+||.||++++ ..+++.||+|.++...... .......|+.. ++.+.   |||++++++++...   
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~-~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~---~~~iv~~~~~~~~~---   72 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRH-VPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVD---CPYTVTFYGALFRE---   72 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEE-cCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcC---CCCeeeeeEEEecC---
Confidence            4799999999999999999999 5789999999987543222 12344455554 44444   99999999998766   


Q ss_pred             cccceEEEEEeccCccCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeeCCCEEEeec
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~-~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                          ...++++|+++++|.+++...  ....+++..++.++.||+.||.+||++ +++|+||+|+||+++.++.++|+||
T Consensus        73 ----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~df  148 (283)
T cd06617          73 ----GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDF  148 (283)
T ss_pred             ----CcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeec
Confidence                568999999999998888653  234589999999999999999999997 9999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhc----CCCCCcchHHHHHHHHHHHHhcCCCCCCC-ChHHHHHHHHHHhCCCC
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLN----LGYGTPVDIWSIGCVMAEMWRLVPLFCAS-TEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~  252 (321)
                      |.+.............++..|+|||.+.+    ..++.++|+||+|+++|+|++|..||... ...+.........   .
T Consensus       149 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~  225 (283)
T cd06617         149 GISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP---S  225 (283)
T ss_pred             ccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC---C
Confidence            99876654333334567888999998865    34688999999999999999999999643 2222222222110   0


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                       ...+                     ...++.++.++|.+||..+|.+||++.++++||||++...+
T Consensus       226 -~~~~---------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         226 -PQLP---------------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             -CCCC---------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence             0000                     11356889999999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.3e-45  Score=316.61  Aligned_cols=251  Identities=26%  Similarity=0.388  Sum_probs=201.7

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHH-HHHhcccCCCCceeEEEeeeeccccccccce
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREIS-ILKQLDTFEHPNIVRFFDVIHQNILSDERYL  105 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~-~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~  105 (321)
                      +.||+|+||+||+|++ ..+++.+++|++...... ......+..|.. +++.+.   ||||+++++.+.+.       .
T Consensus         1 ~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~---h~~iv~~~~~~~~~-------~   69 (321)
T cd05603           1 KVIGKGSFGKVLLAKR-KSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK---HPFLVGLHYSFQTA-------E   69 (321)
T ss_pred             CeeeeCCCEEEEEEEE-CCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC---CCCccceeeEEEcC-------C
Confidence            4689999999999999 678999999998754321 111223344443 455666   99999999999777       6


Q ss_pred             EEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         106 TVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       106 ~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      ..++||||+++ +|...+..  ...+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus        70 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  147 (321)
T cd05603          70 KLYFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV  147 (321)
T ss_pred             EEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence            78999999995 99888876  3458999999999999999999999999999999999999999999999999887532


Q ss_pred             -CCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhh
Q psy2676         185 -YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM  263 (321)
Q Consensus       185 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
                       .........+++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+...   +  ...       
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~--~~~-------  215 (321)
T cd05603         148 EPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P--LQL-------  215 (321)
T ss_pred             CCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C--CCC-------
Confidence             222334456899999999999888999999999999999999999999887665554444321   1  011       


Q ss_pred             hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH----HHHhCCCCCCCCCC
Q psy2676         264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA----ADALEHPYFKEKEN  318 (321)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~h~~f~~~~~  318 (321)
                                     ....+..+.++|.+||+.||.+||++    .++++|+||....|
T Consensus       216 ---------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         216 ---------------PGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             ---------------CCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence                           11344788999999999999999976    59999999987655

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.4e-44  Score=305.13  Aligned_cols=279  Identities=44%  Similarity=0.811  Sum_probs=223.2

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|++.+.||.|++|.||+|++ ..+++.+++|+++.... ......+.+|+.++++++   |||++++++++.+.     
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~-~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~-----   70 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRN-RTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELK---HENIVRLHDVIHTE-----   70 (284)
T ss_pred             CceEeeeeccCCceEEEEEEE-CCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhc---CCCEeeeeeeEeeC-----
Confidence            589999999999999999999 57899999999876533 223446678999999987   99999999999776     


Q ss_pred             cceEEEEEeccCccCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVDQDLGSYMEKCP-PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                        ...++|+|++.++|.+++.... ...+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+.
T Consensus        71 --~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~  148 (284)
T cd07836          71 --NKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLAR  148 (284)
T ss_pred             --CcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence              6789999999999999887643 2348999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCC-ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         182 TFDYDM-MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       182 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ...... ......++..|+|||++.+. .++.++|+||+|+++|+|++|..||.+.+..+....+......+....+...
T Consensus       149 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07836         149 AFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI  228 (284)
T ss_pred             hhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHH
Confidence            554322 22334567889999998664 4688999999999999999999999998888888877777665554443221


Q ss_pred             hhhh--hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         260 ISLM--WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       260 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ....  ...+..............+++.+.+++.+||+.||.+||++.++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            1000  01111111122233344568999999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8e-45  Score=304.80  Aligned_cols=264  Identities=25%  Similarity=0.426  Sum_probs=210.4

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ....++|++.+.||+|+||.||+|++ ...++.+++|++....   .....+..|+.+++++..  |||++++++++...
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~-~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~--h~~i~~~~~~~~~~   75 (272)
T cd06637           2 RDPAGIFELVELVGNGTYGQVYKGRH-VKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSH--HRNIATYYGAFIKK   75 (272)
T ss_pred             CChhhhhhHHHheeecCCeEEEEEEE-cCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcC--CCCeeeEeeEEeec
Confidence            34678999999999999999999998 5788999999986432   223467789999988853  99999999998764


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                      .. .......++++||+.+ +|.+++.......+++..+..++.|++.||.|||+++++|+||+|+||++++++.++|+|
T Consensus        76 ~~-~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          76 NP-PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CC-CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEcc
Confidence            21 1122468999999984 999999875555689999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCC-Cccccccccccccchhhhhc-----CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCC
Q psy2676         177 FGLAKTFDYD-MMLTSVVVTLWYRAPEILLN-----LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       177 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      ||++...... .......++..|+|||++.+     ..++.++|+||+|+++|+|++|..||...............   
T Consensus       155 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---  231 (272)
T cd06637         155 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---  231 (272)
T ss_pred             CCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---
Confidence            9998765432 22334567889999999863     34788999999999999999999999765443333222110   


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      + ...                     .....++..+.+|+.+||..+|.+|||+.++++||||
T Consensus       232 ~-~~~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         232 P-APR---------------------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             C-CCC---------------------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            0 000                     0112456789999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-45  Score=317.40  Aligned_cols=252  Identities=25%  Similarity=0.397  Sum_probs=203.7

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHH-HHHhcccCCCCceeEEEeeeeccccccccce
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREIS-ILKQLDTFEHPNIVRFFDVIHQNILSDERYL  105 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~-~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~  105 (321)
                      +.||+|+||+||+|++ ..+++.+|+|++....... .....+..|.. +++.+.   ||||+++++++...       .
T Consensus         1 ~~lg~G~fg~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~---h~~Iv~~~~~~~~~-------~   69 (325)
T cd05602           1 KVIGKGSFGKVLLARH-KAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK---HPFLVGLHFSFQTA-------D   69 (325)
T ss_pred             CeeeeCCCeEEEEEEE-CCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC---CCCCCceeEEEEcC-------C
Confidence            4699999999999999 5788899999997542211 11223333333 345555   99999999999777       6


Q ss_pred             EEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         106 TVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       106 ~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      ..++||||+.+ +|.+++..  ...+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus        70 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~  147 (325)
T cd05602          70 KLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  147 (325)
T ss_pred             eEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence            78999999995 99998877  3448899999999999999999999999999999999999999999999999986532


Q ss_pred             -CCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhh
Q psy2676         185 -YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM  263 (321)
Q Consensus       185 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
                       .........|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....    .         
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----~---------  214 (325)
T cd05602         148 EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL----Q---------  214 (325)
T ss_pred             cCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc----C---------
Confidence             22233445689999999999999999999999999999999999999988776665555433110    0         


Q ss_pred             hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHH----HHhCCCCCCCCCCC
Q psy2676         264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA----DALEHPYFKEKENE  319 (321)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~----~ll~h~~f~~~~~~  319 (321)
                                    ....++..+.++|++||+.||.+|+++.    ++++|+||...+|+
T Consensus       215 --------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~  260 (325)
T cd05602         215 --------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWD  260 (325)
T ss_pred             --------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHH
Confidence                          1124568899999999999999999876    89999999887664

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-45  Score=317.04  Aligned_cols=251  Identities=26%  Similarity=0.409  Sum_probs=202.5

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHH-HHHhcccCCCCceeEEEeeeeccccccccce
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREIS-ILKQLDTFEHPNIVRFFDVIHQNILSDERYL  105 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~-~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~  105 (321)
                      +.||+|+||+||+|++ ..+++.+++|++....... .....+..|.. +++.+.   ||||+++++.+...       .
T Consensus         1 ~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~---hp~iv~~~~~~~~~-------~   69 (325)
T cd05604           1 KVIGKGSFGKVLLAKR-KLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK---HPFLVGLHYSFQTT-------E   69 (325)
T ss_pred             CceeeCCCeEEEEEEE-CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC---CCCCccEEEEEecC-------C
Confidence            4689999999999998 6789999999997643221 11223344444 345555   99999999999777       6


Q ss_pred             EEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         106 TVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       106 ~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      ..++||||+.+ +|..++..  ...+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++....
T Consensus        70 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~  147 (325)
T cd05604          70 KLYFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGI  147 (325)
T ss_pred             EEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence            78999999995 89888876  3458999999999999999999999999999999999999999999999999986532


Q ss_pred             -CCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhh
Q psy2676         185 -YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM  263 (321)
Q Consensus       185 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
                       .........+++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....              
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--------------  213 (325)
T cd05604         148 AQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--------------  213 (325)
T ss_pred             CCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--------------
Confidence             22233445689999999999999999999999999999999999999988776665544432110              


Q ss_pred             hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH----HHHhCCCCCCCCCC
Q psy2676         264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA----ADALEHPYFKEKEN  318 (321)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~h~~f~~~~~  318 (321)
                                   ......+..+.++|++||..+|.+||++    .++++||||+...|
T Consensus       214 -------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         214 -------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             -------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence                         0012345788999999999999999977    59999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-45  Score=314.05  Aligned_cols=287  Identities=41%  Similarity=0.663  Sum_probs=223.6

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      +++|++.+.||+|++|.||++.+ ..+++.|++|+++... .......+.+|+.++++++   |||++++++++....  
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~-~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~--   76 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATH-KPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFK---HENIIGILDIIRPPS--   76 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEE-cCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCC---CCCcCchhheeeccc--
Confidence            47899999999999999999999 5788999999986422 2223345677999999998   999999999876542  


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                      .......++++|++.++|..++..   ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        77 ~~~~~~~~lv~e~~~~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          77 FESFNDVYIVQELMETDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             ccccceEEEEehhcccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccce
Confidence            222346799999999999888865   34899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCc----cccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         181 KTFDYDMM----LTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       181 ~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ........    .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.+.......+....+.+....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED  233 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            76543221    123457888999998765 4579999999999999999999999988887777777777666654443


Q ss_pred             cchhhhhhh----hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         256 WPENISLMW----SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       256 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      +........    ..................+.++.+++.+||+.+|.+|||+.++++||||+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            321111000    01111111222333445678999999999999999999999999999998763

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0986|consensus

Probab=100.00  E-value=8e-47  Score=313.29  Aligned_cols=280  Identities=27%  Similarity=0.371  Sum_probs=239.2

Q ss_pred             cccccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCC
Q psy2676           7 DTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHP   85 (321)
Q Consensus         7 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~   85 (321)
                      +-.++..++.+.+..+.|+.-++||+|+||.||-++. ..+|.-||.|.+.++... ........+|..++.++.   .+
T Consensus       170 rFlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqv-raTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~---s~  245 (591)
T KOG0986|consen  170 RFLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQV-RATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS---SP  245 (591)
T ss_pred             HHHHHHHHHhhhccccceeeeEEEecccccceeEEEE-ecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc---cC
Confidence            3456667778899999999999999999999999988 689999999988655333 233456789999999998   88


Q ss_pred             ceeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q psy2676          86 NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNL  164 (321)
Q Consensus        86 ~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Ni  164 (321)
                      .||-+--.|+..       ..+|+|+..|+| +|.-.+...+++.+++..+..++.+|+.||++||+.+||+||+||+||
T Consensus       246 FiVslaYAfeTk-------d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNI  318 (591)
T KOG0986|consen  246 FIVSLAYAFETK-------DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENI  318 (591)
T ss_pred             cEEEEeeeecCC-------CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhhe
Confidence            999988888777       789999999995 999999888888899999999999999999999999999999999999


Q ss_pred             EEeeCCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q psy2676         165 LITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI  244 (321)
Q Consensus       165 lv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  244 (321)
                      ++|+.|+++|+|+|++..+..........||.+|||||++.+..|+.+.|-|||||++|+|+.|+.||...........+
T Consensus       319 LLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv  398 (591)
T KOG0986|consen  319 LLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV  398 (591)
T ss_pred             eeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH
Confidence            99999999999999999999888888889999999999999999999999999999999999999999765433332222


Q ss_pred             HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                      ....-. ...+                      .....+++++++.+.+|..||.+|.     +++++-+||||+.++|.
T Consensus       399 drr~~~-~~~e----------------------y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~  455 (591)
T KOG0986|consen  399 DRRTLE-DPEE----------------------YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR  455 (591)
T ss_pred             HHHHhc-chhh----------------------cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence            221111 1122                      2235569999999999999999998     78899999999999986


Q ss_pred             C
Q psy2676         320 P  320 (321)
Q Consensus       320 ~  320 (321)
                      .
T Consensus       456 r  456 (591)
T KOG0986|consen  456 R  456 (591)
T ss_pred             H
Confidence            4

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.2e-45  Score=307.03  Aligned_cols=272  Identities=26%  Similarity=0.434  Sum_probs=216.1

Q ss_pred             ccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeE
Q psy2676          10 QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR   89 (321)
Q Consensus        10 ~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~   89 (321)
                      +..++.......+.|++.+.||.|+||.||++++ ..+++.+++|++....   .....+..|+.+++++..  |+|+++
T Consensus         4 ~~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~--h~~i~~   77 (282)
T cd06636           4 DDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRH-VKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSH--HRNIAT   77 (282)
T ss_pred             hhhhhhhhcChhhhhhhheeeccCCCeEEEEEEE-cCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcC--CCcEEE
Confidence            3456777777889999999999999999999999 5788999999986432   223456778888888853  999999


Q ss_pred             EEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR  168 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~  168 (321)
                      +++++..... .......+++|||+++ +|.+++.......+++..++.++.||+.||.|||+.|++|+||+|+||+++.
T Consensus        78 ~~~~~~~~~~-~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~  156 (282)
T cd06636          78 YYGAFIKKSP-PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTE  156 (282)
T ss_pred             Eeeehhcccc-cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence            9999864321 1223578999999985 9999998765566899999999999999999999999999999999999999


Q ss_pred             CCCEEEeecCCcccccCC-Cccccccccccccchhhhh-----cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHH
Q psy2676         169 AGGLKIADFGLAKTFDYD-MMLTSVVVTLWYRAPEILL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLK  242 (321)
Q Consensus       169 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  242 (321)
                      ++.++|+|||.+...... .......++..|+|||.+.     ...++.++|+||||+++|+|++|..||..........
T Consensus       157 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~  236 (282)
T cd06636         157 NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF  236 (282)
T ss_pred             CCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence            999999999998765422 2233456788999999986     3457889999999999999999999997654433322


Q ss_pred             HHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      .+..   .....                      .....++.++.+||++||+.||.+||++.++++||||
T Consensus       237 ~~~~---~~~~~----------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         237 LIPR---NPPPK----------------------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             hHhh---CCCCC----------------------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            2111   00000                      0112466899999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-46  Score=319.98  Aligned_cols=253  Identities=27%  Similarity=0.365  Sum_probs=201.7

Q ss_pred             eecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEE
Q psy2676          30 IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVY  108 (321)
Q Consensus        30 lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  108 (321)
                      ||+|+||+||+|++ ..+++.+|+|++....... ........|..++.......||||+++++.+...       ..++
T Consensus         1 lG~G~~g~Vy~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-------~~~~   72 (330)
T cd05586           1 IGKGTFGQVYQVRK-KDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-------SDLY   72 (330)
T ss_pred             CCCCCceEEEEEEE-CCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-------CeEE
Confidence            69999999999999 5789999999986542211 1122334566666555322499999999999877       6889


Q ss_pred             EEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccC-C
Q psy2676         109 LIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY-D  186 (321)
Q Consensus       109 ~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~-~  186 (321)
                      +||||+. |+|..++..  ...+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++..... .
T Consensus        73 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  150 (330)
T cd05586          73 LVTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN  150 (330)
T ss_pred             EEEcCCCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence            9999998 499988876  44589999999999999999999999999999999999999999999999999865432 2


Q ss_pred             CccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhh
Q psy2676         187 MMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS  265 (321)
Q Consensus       187 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
                      .......|+..|+|||++.+.. ++.++||||+|+++|+|++|..||.+.+..+....+.......+             
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------  217 (330)
T cd05586         151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP-------------  217 (330)
T ss_pred             CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence            2333456899999999987654 79999999999999999999999988776665544432111100             


Q ss_pred             hhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC----CHHHHhCCCCCCCCCC
Q psy2676         266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI----SAADALEHPYFKEKEN  318 (321)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~~ll~h~~f~~~~~  318 (321)
                                   ...+++++.++|++||..||.+||    ++.++++||||++..|
T Consensus       218 -------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~  261 (330)
T cd05586         218 -------------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW  261 (330)
T ss_pred             -------------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence                         012457889999999999999998    7999999999987654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.6e-45  Score=301.61  Aligned_cols=254  Identities=25%  Similarity=0.470  Sum_probs=212.7

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|++.+.||+|++|.+|++++ ..+++.+++|.+............+.+|+.++++++   |||++++++++...     
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~-----   71 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKS-KEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK---HPNIVQYQESFEEN-----   71 (256)
T ss_pred             CceEEEEeccCCceEEEEEEE-cCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC---CCCeeeeEeeecCC-----
Confidence            689999999999999999999 578899999998764333333446778899998887   99999999998776     


Q ss_pred             cceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                        ...++|+|++.+ +|.+++.......+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus        72 --~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~  149 (256)
T cd08218          72 --GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR  149 (256)
T ss_pred             --CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeecccee
Confidence              688999999985 99999877554558999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         182 TFDYDMM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       182 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      ....... .....+++.|+|||++.+...+.++|+||+|+++++|++|..||...+..+....+......+         
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---------  220 (256)
T cd08218         150 VLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP---------  220 (256)
T ss_pred             ecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC---------
Confidence            6643322 223457888999999998889999999999999999999999998776666554443221111         


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                                       ....++.++.++|.+||+.+|.+||++.++++||||
T Consensus       221 -----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         221 -----------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             -----------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                             112455889999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.3e-45  Score=313.27  Aligned_cols=285  Identities=38%  Similarity=0.680  Sum_probs=228.1

Q ss_pred             CCcceee-eeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCC------------CchhHHHHHHHHhcccCCCCc
Q psy2676          20 GDKKYDE-LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI------------PMSTLREISILKQLDTFEHPN   86 (321)
Q Consensus        20 ~~~~y~~-~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~------------~~~~~~e~~~l~~l~~~~~~~   86 (321)
                      ..++|.. .+.||.|++|+||+|.+ ...++.+++|.++........            ...+.+|+.+++++.   |||
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~   81 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYD-TLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK---HEN   81 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEE-CCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC---Ccc
Confidence            3467865 57799999999999998 578899999998754332210            124668999999988   999


Q ss_pred             eeEEEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q psy2676          87 IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI  166 (321)
Q Consensus        87 i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv  166 (321)
                      ++++++++...       ...++|+|++.++|.+++..  ...+++..+..++.|++.||.+||+.|++|+||+|+||++
T Consensus        82 iv~~~~~~~~~-------~~~~lv~e~~~~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill  152 (335)
T PTZ00024         82 IMGLVDVYVEG-------DFINLVMDIMASDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI  152 (335)
T ss_pred             eeeeeEEEecC-------CcEEEEEeccccCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE
Confidence            99999998766       67899999999999999976  3458999999999999999999999999999999999999


Q ss_pred             eeCCCEEEeecCCcccccCC---------------CccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCC
Q psy2676         167 TRAGGLKIADFGLAKTFDYD---------------MMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVP  230 (321)
Q Consensus       167 ~~~~~~kl~dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~  230 (321)
                      +.++.++|+|||.+......               .......++..|+|||.+.+.. ++.++|+||||+++++|++|..
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~  232 (335)
T PTZ00024        153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP  232 (335)
T ss_pred             CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999999988765411               1122334577899999987654 6899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCCCCcchhhhhh-hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         231 LFCASTEVEQLKCIFRVIGTPSMNEWPENISLM-WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ||.+.+..+....+....+.+....|+...... ...+...............+.++.++|.+||+.+|++|||+++++.
T Consensus       233 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        233 LFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            999998888888888888877766665432211 0111111222333344567789999999999999999999999999


Q ss_pred             CCCCCCCC
Q psy2676         310 HPYFKEKE  317 (321)
Q Consensus       310 h~~f~~~~  317 (321)
                      ||||++.+
T Consensus       313 ~~~~~~~~  320 (335)
T PTZ00024        313 HEYFKSDP  320 (335)
T ss_pred             CcccCCCC
Confidence            99999764

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-45  Score=306.08  Aligned_cols=258  Identities=26%  Similarity=0.440  Sum_probs=214.0

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||.|++|.||++.+ ..+++.+++|.+...... .....+.+|+.+++.++   |+|++++++++.+.    
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~----   71 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAID-KRTNQVVAIKVIDLEEAE-DEIEDIQQEIQFLSQCR---SPYITKYYGSFLKG----   71 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEE-CCCCeEEEEEEeeccccc-hHHHHHHHHHHHHHHcC---CCCeeeeeEEEEEC----
Confidence            4799999999999999999998 578899999998754322 22345678899999888   99999999998776    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++|+|++.+ +|.+++...   .+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+
T Consensus        72 ---~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~  145 (274)
T cd06609          72 ---SKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVS  145 (274)
T ss_pred             ---CeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccc
Confidence               678999999985 999998874   5899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.... .+....    
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~----  220 (274)
T cd06609         146 GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-PPSLEG----  220 (274)
T ss_pred             eeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-CCCCcc----
Confidence            8775442 2334567788999999998889999999999999999999999998766544433322211 110000    


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                                          ..++.++.+++.+||..+|++|||++++++||||++....
T Consensus       221 --------------------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         221 --------------------NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             --------------------cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence                                0155789999999999999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.9e-45  Score=307.21  Aligned_cols=256  Identities=28%  Similarity=0.464  Sum_probs=215.1

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++.+.||+|++|.||++.+ ..+++.+++|++...... ......+.+|+++++++.   ||||+++++++.+.   
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~---   73 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRH-KGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR---HPFLVNLYGSFQDD---   73 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEE-cCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC---CCCccceeeEEEcC---
Confidence            4799999999999999999999 578899999998754222 122345778999999998   99999999999777   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++|+|++. ++|.+++...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        74 ----~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~  147 (290)
T cd05580          74 ----SNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGF  147 (290)
T ss_pred             ----CeEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCC
Confidence                68899999996 6999999874  4589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      +......  .....+++.|+|||.+.+...+.++|+||||+++|+|++|..||...+.......+...  .+.   .   
T Consensus       148 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~---~---  217 (290)
T cd05580         148 AKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KVR---F---  217 (290)
T ss_pred             ccccCCC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--Ccc---C---
Confidence            8776543  23446788999999998888899999999999999999999999877655444443321  111   1   


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                                         ....+..+.++|++||..||.+|+     +++++++||||+..+|.
T Consensus       218 -------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         218 -------------------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             -------------------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence                               113358899999999999999999     99999999999998764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=306.34  Aligned_cols=280  Identities=36%  Similarity=0.668  Sum_probs=218.9

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||+|++|.||+|.+ ..+++.+++|.++...........+.+|+++++++.   |+|++++++++...    
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~-~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~----   72 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRN-KATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR---HENIVNLKEAFRRK----   72 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEe-CCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC---CCCeeehhheEEEC----
Confidence            4799999999999999999998 567899999998765554445567889999999998   99999999999776    


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                         ...++++||+++++.+.+.... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        73 ---~~~~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~  148 (288)
T cd07833          73 ---GRLYLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFAR  148 (288)
T ss_pred             ---CEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeeccc
Confidence               6789999999986655544433 348999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCC--ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         182 TFDYDM--MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       182 ~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      ......  ......++..|+|||++.+. .++.++|+||+|+++|+|++|+.||.+....+....+....+..+......
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07833         149 ALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL  228 (288)
T ss_pred             ccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhh
Confidence            765443  23345667889999999888 789999999999999999999999988777766666655544333221111


Q ss_pred             hhhhh-hh--hhhhh-hhhhhhh-hhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         259 NISLM-WS--SFEQY-SKVAFSA-IFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       259 ~~~~~-~~--~~~~~-~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ..... ..  ..... ....... ....++.++.+||++||..+|++|||++++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            00000 00  00000 0000111 112347899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.5e-45  Score=338.14  Aligned_cols=268  Identities=27%  Similarity=0.497  Sum_probs=214.4

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ...+...++|++++.||.|+||+||+|.+ ..++..+++|++............+..|+.+++++.   ||||++++++|
T Consensus         6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkd-k~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~---HPNIVrl~d~f   81 (1021)
T PTZ00266          6 DDGESRLNEYEVIKKIGNGRFGEVFLVKH-KRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK---HKNIVRYIDRF   81 (1021)
T ss_pred             cCCccccCCEEEEEEEecCCCeEEEEEEE-CCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC---CCCcCeEEEEE
Confidence            44556678999999999999999999999 578889999998765433333456778999999998   99999999988


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeccCCCCcE
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--PPGLSASKVKELTRQMLKGVDFLHSH-------RIIHRDLKPQNL  164 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~~-------~~~H~di~p~Ni  164 (321)
                      .+..     ...+++||||+. ++|.+++....  ...+++..++.|+.||+.||.|||+.       +|+|+||||+||
T Consensus        82 ~de~-----~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNI  156 (1021)
T PTZ00266         82 LNKA-----NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNI  156 (1021)
T ss_pred             EecC-----CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHe
Confidence            5431     146899999999 59999987532  24589999999999999999999985       499999999999


Q ss_pred             EEeeC-----------------CCEEEeecCCcccccCCCccccccccccccchhhhhc--CCCCCcchHHHHHHHHHHH
Q psy2676         165 LITRA-----------------GGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN--LGYGTPVDIWSIGCVMAEM  225 (321)
Q Consensus       165 lv~~~-----------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l  225 (321)
                      |++.+                 +.++|+|||++.............+++.|+|||++.+  ..++.++|||||||++|+|
T Consensus       157 LL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL  236 (1021)
T PTZ00266        157 FLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL  236 (1021)
T ss_pred             EeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence            99642                 3489999999987654444455678999999999865  3478999999999999999


Q ss_pred             HhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHH
Q psy2676         226 WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA  305 (321)
Q Consensus       226 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  305 (321)
                      ++|..||................  +..+                        ....+.++.+||..||..+|.+||++.
T Consensus       237 LTGk~PF~~~~~~~qli~~lk~~--p~lp------------------------i~~~S~eL~dLI~~~L~~dPeeRPSa~  290 (1021)
T PTZ00266        237 CSGKTPFHKANNFSQLISELKRG--PDLP------------------------IKGKSKELNILIKNLLNLSAKERPSAL  290 (1021)
T ss_pred             HHCCCCCCcCCcHHHHHHHHhcC--CCCC------------------------cCCCCHHHHHHHHHHhcCChhHCcCHH
Confidence            99999997655444333222211  1100                        113457899999999999999999999


Q ss_pred             HHhCCCCCCCCC
Q psy2676         306 DALEHPYFKEKE  317 (321)
Q Consensus       306 ~ll~h~~f~~~~  317 (321)
                      ++|.||||+...
T Consensus       291 QlL~h~~ik~i~  302 (1021)
T PTZ00266        291 QCLGYQIIKNVG  302 (1021)
T ss_pred             HHhccHHHhhcC
Confidence            999999998663

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.1e-44  Score=308.06  Aligned_cols=288  Identities=40%  Similarity=0.694  Sum_probs=226.0

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++.+.||.|++|.||+|++ ..+++.+++|.+..............+|+++++.++   ||||+++++++......
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~   82 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQ-IKTGRVVALKKILMHNEKDGFPITALREIKILKKLK---HPNVVPLIDMAVERPDK   82 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEE-CCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC---CCCccchhhheeccccc
Confidence            47999999999999999999998 578889999998765444434446678999999998   99999999987655222


Q ss_pred             -cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 -DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 -~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                       ......+++|+||+.++|...+.... ..+++..++.++.||+.||.+||+.|++|+||+|+||++++++.++|+|||+
T Consensus        83 ~~~~~~~~~lv~~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          83 SKRKRGSVYMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             ccccCceEEEEEecCCcCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence             23335679999999998888876533 3599999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc------------cccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q psy2676         180 AKTFDYDMM------------LTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR  246 (321)
Q Consensus       180 ~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  246 (321)
                      +........            .....+++.|+|||.+.+. .++.++||||+|+++|+|++|++||.+.+.......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            876542221            1123457789999988654 478999999999999999999999999888888888888


Q ss_pred             HhCCCCCCCcchhhhhhhh---hhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         247 VIGTPSMNEWPENISLMWS---SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ..+.+....++........   .................++.+.++|.+||..||.+|||+.++++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            7776665554432211110   000011111222334566889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.2e-45  Score=326.72  Aligned_cols=256  Identities=25%  Similarity=0.359  Sum_probs=210.7

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ..|.+.+.||+|++|.||+|.+....+..+++|.+...  .......+.+|+.+++.++   ||||+++++++...    
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~---Hpniv~~~~~~~~~----  137 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACD---HFGIVKHFDDFKSD----  137 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCC---CCCEeEEEEEEEEC----
Confidence            34999999999999999999984443788888876432  1222335667899988887   99999999999877    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                         ...++||||+. |+|.+++...  ....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||
T Consensus       138 ---~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFg  214 (478)
T PTZ00267        138 ---DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFG  214 (478)
T ss_pred             ---CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCc
Confidence               68999999998 5999887542  23458999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         179 LAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       179 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+.   
T Consensus       215 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---  291 (478)
T PTZ00267        215 FSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---  291 (478)
T ss_pred             CceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---
Confidence            998664332   12345689999999999998899999999999999999999999988777666555543211111   


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                                             ...++.++.++|.+||..||.+||++.+++.|+|++.
T Consensus       292 -----------------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        292 -----------------------PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             -----------------------CccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence                                   1135578999999999999999999999999999864

>KOG0671|consensus

Probab=100.00  E-value=1.5e-46  Score=305.64  Aligned_cols=287  Identities=27%  Similarity=0.449  Sum_probs=228.1

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCC----ceeEEE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP----NIVRFF   91 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~----~i~~~~   91 (321)
                      ..|...+||.++..+|+|.||.|-++.| ...+..+|+|+++.   -........-|++++.++..- -|    -++++.
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D-~~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~-DP~g~~rcv~m~  157 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWD-RETKEHVALKIIKN---VDKYREAALIEIEVLQKINES-DPNGKFRCVQMR  157 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEee-cCCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhc-CCCCceEEEeee
Confidence            3455689999999999999999999999 45599999999863   233344666789999998531 22    377888


Q ss_pred             eeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee---
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR---  168 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~---  168 (321)
                      ++|...       .+.|+|+|.++.++.+++...+..+++...++.++.|+++++++||+.+++|.||||+||++..   
T Consensus       158 ~wFdyr-------ghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~  230 (415)
T KOG0671|consen  158 DWFDYR-------GHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEY  230 (415)
T ss_pred             hhhhcc-------CceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccce
Confidence            888766       7899999999999999999988888999999999999999999999999999999999999842   


Q ss_pred             -----------------CCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCC
Q psy2676         169 -----------------AGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPL  231 (321)
Q Consensus       169 -----------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  231 (321)
                                       +..++|+|||.++...+..  +....|..|.|||++.+-.++.++||||+||+|+|+.+|...
T Consensus       231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L  308 (415)
T KOG0671|consen  231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL  308 (415)
T ss_pred             EEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence                             2349999999998765443  567789999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCCCCcchh----------------hhhhhhhhhhhhhhh--hh---hhhhhcchhHHHHH
Q psy2676         232 FCASTEVEQLKCIFRVIGTPSMNEWPEN----------------ISLMWSSFEQYSKVA--FS---AIFMDCCSKANSLL  290 (321)
Q Consensus       232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~--~~---~~~~~~~~~~~~li  290 (321)
                      |...++.+.+..+...+|+.|.......                .....  .....+.+  ..   .........+.+||
T Consensus       309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~--~k~v~~~ckpl~~~~~~~d~e~~~LfDLl  386 (415)
T KOG0671|consen  309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGK--SKYVFEPCKPLKKYMLQDDLEHVQLFDLL  386 (415)
T ss_pred             cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCcccccccc--chhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence            9999899988888888886554432221                11110  00000000  00   00111224688999


Q ss_pred             HHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         291 ESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       291 ~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ++||..||.+|+|+.|+|.||||+....
T Consensus       387 ~~mL~fDP~~RiTl~EAL~HpFF~~~~~  414 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALSHPFFARLTP  414 (415)
T ss_pred             HHHHccCccccccHHHHhcCHHhhcCCC
Confidence            9999999999999999999999998754

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-44  Score=300.11  Aligned_cols=254  Identities=27%  Similarity=0.453  Sum_probs=213.1

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|++.+.||.|++|.||+|.+ ..+++.+++|.+............+.+|+.++++++   |||++++++.+...     
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~---~~~i~~~~~~~~~~-----   71 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS---HPNIIEYYENFLED-----   71 (256)
T ss_pred             CceEEEEecccCceEEEEEEE-cCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC---CCchhheeeeEecC-----
Confidence            589999999999999999998 578899999998765444444556778999999987   99999999998766     


Q ss_pred             cceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC-CEEEeecCCc
Q psy2676         103 RYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLA  180 (321)
Q Consensus       103 ~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~-~~kl~dfg~~  180 (321)
                        ...++|+|++++ +|.+++.......+++..+..++.+++.+|.+||++|++|+||+|+||+++.++ .++|+|||.+
T Consensus        72 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~  149 (256)
T cd08220          72 --KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGIS  149 (256)
T ss_pred             --CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCc
Confidence              678999999985 999999876555689999999999999999999999999999999999998654 5799999999


Q ss_pred             ccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         181 KTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      .............++..|+|||.+.+..++.++|+||+|+++++|++|..||...+.......+......+         
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---------  220 (256)
T cd08220         150 KILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---------  220 (256)
T ss_pred             eecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---------
Confidence            87765544444567889999999988888999999999999999999999998776555444433211111         


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                                       ....++..+.+++.+||..+|.+|||+.++++||||
T Consensus       221 -----------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         221 -----------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             -----------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                             112355889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG4717|consensus

Probab=100.00  E-value=1.3e-45  Score=310.78  Aligned_cols=258  Identities=30%  Similarity=0.471  Sum_probs=232.7

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      +-|.+.+.||+|.|+.|-+|++ --+|+.||||++.+...+.-....++.|++.++.++   |||||++|++....    
T Consensus        18 GLYDLekTlG~GHFAVVKLArH-VFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ---HpNiVRLYEViDTQ----   89 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARH-VFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ---HPNIVRLYEVIDTQ----   89 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhh-hcccceeEEEEecccccchhhhhHHHHHHHHHHHhc---CcCeeeeeehhccc----
Confidence            5699999999999999999999 589999999999887666667778899999999999   99999999997555    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee-CCCEEEeecCC
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR-AGGLKIADFGL  179 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~-~~~~kl~dfg~  179 (321)
                         ..+|+|+|.-++ +|++|+.+...+ +++..+.+++.||+.|+.|+|+..+|||||||+||.+.+ -|-+||+|||+
T Consensus        90 ---TKlyLiLELGD~GDl~DyImKHe~G-l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGF  165 (864)
T KOG4717|consen   90 ---TKLYLILELGDGGDLFDYIMKHEEG-LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGF  165 (864)
T ss_pred             ---ceEEEEEEecCCchHHHHHHhhhcc-ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccc
Confidence               678999999994 999999998765 999999999999999999999999999999999997754 57799999999


Q ss_pred             cccccCCCccccccccccccchhhhhcCCCC-CcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGYG-TPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      +-.+.+.......+|++.|.|||.+.+..|+ ++.||||||++||-+.+|++||...++-+.+..|+++.-..|      
T Consensus       166 SNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP------  239 (864)
T KOG4717|consen  166 SNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP------  239 (864)
T ss_pred             cccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc------
Confidence            9999888888889999999999999999985 589999999999999999999999999999888887643322      


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                                           ..++.++++||..||..||.+|.+.++|..|+|++..+.
T Consensus       240 ---------------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  240 ---------------------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             ---------------------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence                                 245589999999999999999999999999999998754

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.9e-45  Score=314.44  Aligned_cols=279  Identities=21%  Similarity=0.304  Sum_probs=206.0

Q ss_pred             eeeeeecc--cceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccccc
Q psy2676          26 ELCQIGCG--AYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        26 ~~~~lg~g--~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      ++++||+|  ++++||++.+ +.+++.||+|.+............+.+|+.+++.++   ||||+++++++...      
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~------   71 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARY-KPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN---HPNIVPYRATFIAD------   71 (327)
T ss_pred             hhhhccccccceEEEEEEee-cccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcC---CCCeeeEEEEEEEC------
Confidence            56789999  6789999999 688999999998765443333446677899998887   99999999999877      


Q ss_pred             ceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         104 YLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       104 ~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                       ...++|+|++. ++|.+++.......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++++||+....
T Consensus        72 -~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~  150 (327)
T cd08227          72 -NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS  150 (327)
T ss_pred             -CEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhc
Confidence             67899999999 5999999765445589999999999999999999999999999999999999999999999986543


Q ss_pred             ccCCCc--------cccccccccccchhhhhc--CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         183 FDYDMM--------LTSVVVTLWYRAPEILLN--LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       183 ~~~~~~--------~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ......        .....++..|+|||++.+  ..++.++||||+||++++|++|..||..............  +..+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~  228 (327)
T cd08227         151 MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVP  228 (327)
T ss_pred             cccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCcc
Confidence            321110        112345677999999976  3588999999999999999999999976554433322221  1100


Q ss_pred             CC-C---cchh-hhh------hhhhh----------hhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCC
Q psy2676         253 MN-E---WPEN-ISL------MWSSF----------EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP  311 (321)
Q Consensus       253 ~~-~---~~~~-~~~------~~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  311 (321)
                      .. .   .+.. ...      ....+          ..............+++.+.+||++||+.||++|||++++++||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p  308 (327)
T cd08227         229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS  308 (327)
T ss_pred             ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence            00 0   0000 000      00000          00000001112234567899999999999999999999999999


Q ss_pred             CCCCCC
Q psy2676         312 YFKEKE  317 (321)
Q Consensus       312 ~f~~~~  317 (321)
                      ||++..
T Consensus       309 ~f~~~~  314 (327)
T cd08227         309 FFKQIK  314 (327)
T ss_pred             hhhhcc
Confidence            999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-45  Score=306.63  Aligned_cols=278  Identities=50%  Similarity=0.883  Sum_probs=228.8

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      |++.+.||+|.+|.||+++. ..+++.+++|++............+..|+.+++++.   |+|++++++++.+.      
T Consensus         1 y~~~~~ig~g~~~~vy~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~---~~~i~~~~~~~~~~------   70 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARD-KKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK---HPNIVKLLDVIHTE------   70 (282)
T ss_pred             CeeehcccccCcceEEEeee-cCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC---CCCHHHHHhhhhcC------
Confidence            67889999999999999998 577999999999876544444556778999999887   99999999998766      


Q ss_pred             ceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccc
Q psy2676         104 YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF  183 (321)
Q Consensus       104 ~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~  183 (321)
                       ...++|+|+++++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        71 -~~~~~v~e~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~  148 (282)
T cd07829          71 -RKLYLVFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAF  148 (282)
T ss_pred             -CceEEEecCcCcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCccccc
Confidence             6789999999999999998753 34899999999999999999999999999999999999999999999999998766


Q ss_pred             cCCC-ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhh
Q psy2676         184 DYDM-MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS  261 (321)
Q Consensus       184 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (321)
                      .... .......+..|+|||.+.+. .++.++|+||||++++++++|..||...+.......+....+.+....|+....
T Consensus       149 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         149 GIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             CCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence            4332 23334557789999998776 689999999999999999999999999888888888887777666554443322


Q ss_pred             hh--hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         262 LM--WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       262 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ..  ...+..+............+..+.++|++||..||++||++.++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            21  12222232333334444567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-45  Score=306.15  Aligned_cols=278  Identities=47%  Similarity=0.849  Sum_probs=227.9

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      |++.+.||.|++|.||++.+ ..+++.+++|.+............+.+|+.++++++   |+|++++++++.+.      
T Consensus         1 y~~~~~i~~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~------   70 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARD-KLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN---HPNIIKLLDVFRHK------   70 (283)
T ss_pred             CccceeeecCCCceEEEEEc-CCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc---CCCcchHHHhhccC------
Confidence            67889999999999999998 578999999998765444344557778999999998   99999999998776      


Q ss_pred             ceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccc
Q psy2676         104 YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF  183 (321)
Q Consensus       104 ~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~  183 (321)
                       ...++++|++.++|.+.+.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        71 -~~~~~v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~  148 (283)
T cd05118          71 -GDLYLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSF  148 (283)
T ss_pred             -CCEEEEEeccCCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence             6789999999999998887754 35899999999999999999999999999999999999999999999999998776


Q ss_pred             cCCC-ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhh
Q psy2676         184 DYDM-MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS  261 (321)
Q Consensus       184 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (321)
                      .... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+..+....+....+.+....++....
T Consensus       149 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         149 GSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             CCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence            5443 23345577889999998877 689999999999999999999999999888888888777766665544433222


Q ss_pred             hh---hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         262 LM---WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       262 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ..   ...+.............+++.++.++|.+||++||.+||++.+++.||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            11   11111112222334455678999999999999999999999999999998

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0596|consensus

Probab=100.00  E-value=1.7e-45  Score=312.13  Aligned_cols=266  Identities=27%  Similarity=0.442  Sum_probs=214.1

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ..+-+.+..|+++++||+|+.+.||+|..  .+.+.|++|.+.....+......+.+|+..|.+|+.  |.+|+++++|-
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~--s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg--~~~IIqL~DYE  429 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLN--SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKG--HDKIIQLYDYE  429 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeec--CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcC--CceEEEEeeee
Confidence            45667888999999999999999999986  556677777776665666667788899999999997  99999999998


Q ss_pred             eccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ..+       ..+|+|||+-+-+|...+.+.... .+...++.+..||+.|+.+.|..||||.||||.|+++- .|.+||
T Consensus       430 v~d-------~~lYmvmE~Gd~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKL  500 (677)
T KOG0596|consen  430 VTD-------GYLYMVMECGDIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKL  500 (677)
T ss_pred             ccC-------ceEEEEeecccccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEe
Confidence            776       789999999999999999986543 34348899999999999999999999999999999985 788999


Q ss_pred             eecCCcccccCCCc---cccccccccccchhhhhcCC-----------CCCcchHHHHHHHHHHHHhcCCCCCCCChHHH
Q psy2676         175 ADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLG-----------YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQ  240 (321)
Q Consensus       175 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-----------~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  240 (321)
                      +|||.+..+..+.+   ..+..||+.|+|||.+....           ++.++|||||||+||+|+.|++||....  ..
T Consensus       501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~  578 (677)
T KOG0596|consen  501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQ  578 (677)
T ss_pred             eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HH
Confidence            99999988876543   55789999999999986433           5678999999999999999999996432  12


Q ss_pred             HHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         241 LKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ..++.....+.-..++|....                   .  .++.++++.||..||.+|||..++|+|||++..
T Consensus       579 ~aKl~aI~~P~~~Iefp~~~~-------------------~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  579 IAKLHAITDPNHEIEFPDIPE-------------------N--DELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             HHHHHhhcCCCccccccCCCC-------------------c--hHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            222222222111112221111                   1  348999999999999999999999999999864

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.4e-44  Score=297.61  Aligned_cols=254  Identities=28%  Similarity=0.448  Sum_probs=214.8

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|++.+.||.|++|.||.+++ ..+++.+++|.+............+.+|++++++++   |+|++++++++.+.     
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~-----   71 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRR-TEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ---HPNIIAYYNHFMDD-----   71 (256)
T ss_pred             CceEeeEecccCCceEEEEEE-cCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC---CCCeeEEEeEEecC-----
Confidence            699999999999999999998 578889999998765444444456778999999987   99999999999777     


Q ss_pred             cceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                        ...++++||+. ++|.+++.......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        72 --~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~  149 (256)
T cd08221          72 --NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISK  149 (256)
T ss_pred             --CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceE
Confidence              67899999998 499999987655568999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         182 TFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       182 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      ...... ......++..|.|||.+.+..++.++|+||+|+++++|++|..||...+..+....+......+.        
T Consensus       150 ~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~--------  221 (256)
T cd08221         150 ILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV--------  221 (256)
T ss_pred             EcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence            664333 23345678899999999888889999999999999999999999988766665555432111110        


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                                        ...++.++.+++.+||..+|.+||++.++++|||+
T Consensus       222 ------------------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         222 ------------------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             ------------------ccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                              12456889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.5e-44  Score=303.57  Aligned_cols=264  Identities=27%  Similarity=0.481  Sum_probs=214.8

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      .........+|++.+.||.|++|.||++.+ ..++..+++|.+......  ....+.+|+.+++.+.   |||++++++.
T Consensus        12 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~---h~~v~~~~~~   85 (296)
T cd06654          12 IVSVGDPKKKYTRFEKIGQGASGTVYTAMD-VATGQEVAIRQMNLQQQP--KKELIINEILVMRENK---NPNIVNYLDS   85 (296)
T ss_pred             ccccCCcccceeeEEEecCCCCeEEEEEEE-CCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCC---CCCEeeEEEE
Confidence            345556668999999999999999999998 578889999988754322  2346778899998887   9999999999


Q ss_pred             eeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +...       ...++|+||+.+ +|.+++..   ..+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.+
T Consensus        86 ~~~~-------~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~  155 (296)
T cd06654          86 YLVG-------DELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSV  155 (296)
T ss_pred             EEeC-------CEEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCE
Confidence            8776       678999999985 99998865   347899999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         173 KIADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       173 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      +|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......... .+.+
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~  234 (296)
T cd06654         156 KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP  234 (296)
T ss_pred             EECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCC
Confidence            999999887654322 22334678899999999988899999999999999999999999977665433322211 1111


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ....                       ...++..+.+++.+||..+|.+||++.++++||||+...
T Consensus       235 ~~~~-----------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         235 ELQN-----------------------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             CCCC-----------------------ccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence            1100                       124557899999999999999999999999999998664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.5e-44  Score=304.17  Aligned_cols=263  Identities=29%  Similarity=0.496  Sum_probs=216.1

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      .+......+|++.+.||.|++|+||++.+ ..+++.+++|.+.....  .....+.+|+..++.+.   |||++++++.+
T Consensus        12 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~-~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~---h~~iv~~~~~~   85 (296)
T cd06655          12 VSIGDPKKKYTRYEKIGQGASGTVFTAID-VATGQEVAIKQINLQKQ--PKKELIINEILVMKELK---NPNIVNFLDSF   85 (296)
T ss_pred             HhcCCCcceEEEEEEEecCCCeEEEEEEE-cCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcC---CCceeeeeeeE
Confidence            34455567899999999999999999998 57889999999865422  22446678899988887   99999999999


Q ss_pred             eccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      ...       ...++|+|++.+ +|.+++..   ..+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++
T Consensus        86 ~~~-------~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~k  155 (296)
T cd06655          86 LVG-------DELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVK  155 (296)
T ss_pred             ecC-------ceEEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence            776       678999999985 89888865   3489999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCCc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         174 IADFGLAKTFDYDMM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       174 l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|++++|..||...+.......+... ..+.
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~  234 (296)
T cd06655         156 LTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE  234 (296)
T ss_pred             EccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc
Confidence            999998876543322 23346788899999999888999999999999999999999999887765544433221 1111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ..                       ....+++.+.++|++||..||.+||++.+++.||||+...
T Consensus       235 ~~-----------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         235 LQ-----------------------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             cC-----------------------CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            11                       0124568899999999999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.5e-44  Score=304.80  Aligned_cols=262  Identities=28%  Similarity=0.470  Sum_probs=209.0

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..+.|++++.||.|++|.||++++ ..++..+++|++....  ......+.+|+.++++++   |||++++++.+...  
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~-~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~--   81 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKN-KETGALAAAKVIETKS--EEELEDYMVEIEILATCN---HPYIVKLLGAFYWD--   81 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEE-CCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCC---CCcEeeeEEEEEeC--
Confidence            446799999999999999999998 5788999999986431  112345667888888887   99999999998776  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ...++|||++++ +|..++.... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus        82 -----~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg  155 (292)
T cd06644          82 -----GKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFG  155 (292)
T ss_pred             -----CeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCc
Confidence                 678999999996 7777765533 348999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCC-Cccccccccccccchhhhh-----cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         179 LAKTFDYD-MMLTSVVVTLWYRAPEILL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       179 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      .+...... .......++..|+|||++.     ...++.++|+||||+++|+|++|..||...+.......+....  ++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~  233 (292)
T cd06644         156 VSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP  233 (292)
T ss_pred             cceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC--Cc
Confidence            87654322 2223456788899999885     3446889999999999999999999997766544433332110  00


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      ...                      ....++.++.++|++||..+|++||++.++++||||+...+.
T Consensus       234 ~~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         234 TLS----------------------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             cCC----------------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence            000                      012455788999999999999999999999999999987664

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.7e-44  Score=302.27  Aligned_cols=278  Identities=35%  Similarity=0.619  Sum_probs=215.1

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      |++++.||+|++|.||++.+ ..+++.+++|.++...... ......+|+.+++++..  |+|++++++++.+..     
T Consensus         1 y~~~~~lg~g~~~~v~~~~~-~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~--h~~i~~~~~~~~~~~-----   71 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQS-RKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSP--HPNILRLIEVLFDRK-----   71 (282)
T ss_pred             CceEeeccccccceEEEEEE-cCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCC--CCCccceEEEEecCC-----
Confidence            78899999999999999998 5788999999987543222 22234568888887754  999999999986541     


Q ss_pred             ceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccc
Q psy2676         104 YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF  183 (321)
Q Consensus       104 ~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~  183 (321)
                      ....++|+|+++++|.+.+.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+...
T Consensus        72 ~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          72 TGRLALVFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             CCcEEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccc
Confidence            13579999999999998887643 34899999999999999999999999999999999999999 99999999999876


Q ss_pred             cCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhh
Q psy2676         184 DYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL  262 (321)
Q Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (321)
                      ..........++..|+|||.+.. ..++.++|+||+|+++|+|++|..||.+.+..+....+....+.+..... .....
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  228 (282)
T cd07831         150 YSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL-KKFRK  228 (282)
T ss_pred             ccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHH-Hhhcc
Confidence            54444444567889999997654 45788999999999999999999999988887777777665554433110 00000


Q ss_pred             hh---hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         263 MW---SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       263 ~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ..   ..+..............++..+.++|.+||+++|++||++.++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            00   0000111111222334678999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.8e-44  Score=301.05  Aligned_cols=280  Identities=41%  Similarity=0.714  Sum_probs=211.3

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++++.||+|++|.||++.+ ..++..+++|++..... ........+|+.+++.++   |+|++++++++.+.   
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~---   75 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGIS-RINGQLVALKVISMKTE-EGVPFTAIREASLLKGLK---HANIVLLHDIIHTK---   75 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEE-cCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcC---CCCEeEEEEEEecC---
Confidence            36899999999999999999998 57788999999865432 223346678999999987   99999999998766   


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                          ...++|+|++.++|.+.+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        76 ----~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  150 (291)
T cd07870          76 ----ETLTFVFEYMHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLA  150 (291)
T ss_pred             ----CeEEEEEecccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccc
Confidence                6789999999988888876543 34788899999999999999999999999999999999999999999999988


Q ss_pred             ccccCCC-ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCCh-HHHHHHHHHHhCCCCCCCcc
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTE-VEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~  257 (321)
                      ....... ......++..|+|||.+.+. .++.++|+||||+++++|++|..||..... .+....+....+.+....++
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (291)
T cd07870         151 RAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP  230 (291)
T ss_pred             cccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence            7543221 22334568889999998764 478899999999999999999999976543 34444444444444333222


Q ss_pred             hhhhhhhh---hhhhhhhhhhhhhhh--hcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         258 ENISLMWS---SFEQYSKVAFSAIFM--DCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       258 ~~~~~~~~---~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ........   ...............  ..+..+.+++.+||..||++|||+.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            11110000   000000000111111  235788999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3e-44  Score=299.70  Aligned_cols=253  Identities=28%  Similarity=0.439  Sum_probs=208.9

Q ss_pred             eecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEE
Q psy2676          30 IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVY  108 (321)
Q Consensus        30 lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  108 (321)
                      ||.|++|.||+|++ ..+++.+++|++...... ......+.+|+.++++++   |||++++++.+.+.       ...+
T Consensus         1 lg~g~~~~v~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~-------~~~~   69 (262)
T cd05572           1 LGVGGFGRVELVKV-KSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN---HPFIVKLYRTFKDK-------KYIY   69 (262)
T ss_pred             CCCCCceEEEEEEE-CCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC---CCCEeeeeeeEEcC-------CccE
Confidence            68999999999999 567899999998764322 223456778999999887   99999999998776       6789


Q ss_pred             EEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCC
Q psy2676         109 LIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM  187 (321)
Q Consensus       109 ~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~  187 (321)
                      +++|+++ ++|.+++...  ..+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        70 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~  147 (262)
T cd05572          70 MLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ  147 (262)
T ss_pred             EEEecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence            9999998 5999999773  348999999999999999999999999999999999999999999999999988765443


Q ss_pred             ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCC--hHHHHHHHHHHhCCCCCCCcchhhhhhhh
Q psy2676         188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST--EVEQLKCIFRVIGTPSMNEWPENISLMWS  265 (321)
Q Consensus       188 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
                      ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....  .......+......+   ..+        
T Consensus       148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~--------  216 (262)
T cd05572         148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL---EFP--------  216 (262)
T ss_pred             ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC---CCC--------
Confidence            3334567888999999988889999999999999999999999998765  333333333211111   111        


Q ss_pred             hhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCCC
Q psy2676         266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKENEP  320 (321)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~~~  320 (321)
                                    ..+++++.++|.+||..+|.+||+     +.|+++||||++..|+.
T Consensus       217 --------------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~  262 (262)
T cd05572         217 --------------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWEG  262 (262)
T ss_pred             --------------cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCCC
Confidence                          123588999999999999999999     99999999999998874

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.1e-44  Score=306.47  Aligned_cols=274  Identities=37%  Similarity=0.707  Sum_probs=203.2

Q ss_pred             eeeecccceeEEEEEEe-cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDL-QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      .+||+|+||+||+|++. ..++..+++|.+...    .......+|+.++++++   |||++++++++....     ...
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~-----~~~   74 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT----GISMSACREIALLRELK---HPNVIALQKVFLSHS-----DRK   74 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCC----CCcHHHHHHHHHHHhCC---CCCeeeEEEEEeccC-----CCe
Confidence            57999999999999863 235678999987643    22346778999999998   999999999985431     146


Q ss_pred             EEEEeccCccCHHHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----eeCCCEEEe
Q psy2676         107 VYLIFEHVDQDLGSYMEKCP-------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI----TRAGGLKIA  175 (321)
Q Consensus       107 ~~~v~e~~~~~L~~~~~~~~-------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv----~~~~~~kl~  175 (321)
                      .++|+|+++++|.+++....       ...+++..++.++.||+.||.+||+.|++|+||||+||++    +.++.++|+
T Consensus        75 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07867          75 VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             EEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence            79999999999988875321       2248899999999999999999999999999999999999    456789999


Q ss_pred             ecCCcccccCCC----ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCCh---------HHHH
Q psy2676         176 DFGLAKTFDYDM----MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTE---------VEQL  241 (321)
Q Consensus       176 dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------~~~~  241 (321)
                      |||++.......    ......+++.|+|||++.+. .++.++||||+|+++|+|++|.+||.....         ....
T Consensus       155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~  234 (317)
T cd07867         155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL  234 (317)
T ss_pred             eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence            999997664332    12345678899999998764 479999999999999999999999975432         2345


Q ss_pred             HHHHHHhCCCCCCCcchhhhhh-hhhh-hhh-----hhh----hhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         242 KCIFRVIGTPSMNEWPENISLM-WSSF-EQY-----SKV----AFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~-----~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ..+....+.+....|....... .... ...     ...    .........+..+.+||.+||..||.+|||+.|+|+|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence            5556666655554443321100 0000 000     000    0011111234678899999999999999999999999


Q ss_pred             CCC
Q psy2676         311 PYF  313 (321)
Q Consensus       311 ~~f  313 (321)
                      |||
T Consensus       315 p~f  317 (317)
T cd07867         315 PYF  317 (317)
T ss_pred             CCC
Confidence            998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.1e-44  Score=299.69  Aligned_cols=252  Identities=29%  Similarity=0.527  Sum_probs=206.2

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC-------CCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG-------IPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      +|.+...||.|++|.||+|.+ ..+++.+++|.+........       ....+.+|+.+++++.   |||++++++++.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~   76 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMN-ASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ---HENIVQYLGSSL   76 (267)
T ss_pred             CccccceeecCCCeEEEEEEe-cCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC---CCCeeeEEEEEE
Confidence            578899999999999999998 57788999998865433221       1134667889999997   999999999987


Q ss_pred             ccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ..       ...++++|++++ +|.+++...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|
T Consensus        77 ~~-------~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l  147 (267)
T cd06628          77 DA-------DHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKI  147 (267)
T ss_pred             eC-------CccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEe
Confidence            76       678999999985 999999874  44899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCc-------cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q psy2676         175 ADFGLAKTFDYDMM-------LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       175 ~dfg~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  247 (321)
                      +|||.+........       .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+...
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  227 (267)
T cd06628         148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN  227 (267)
T ss_pred             cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc
Confidence            99999876642211       11234678899999999888999999999999999999999999876554443332221


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ..    .                      .....++..+.++|++||+.||.+||++.++++||||
T Consensus       228 ~~----~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 AS----P----------------------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CC----C----------------------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            00    0                      1112456889999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG1989|consensus

Probab=100.00  E-value=2.4e-45  Score=327.97  Aligned_cols=261  Identities=27%  Similarity=0.435  Sum_probs=211.6

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      .+.+...+.+|.+.|.+|+|+.||+|++ ...+..+|+|++...  ++.....+.+|+.++++|..  |+|||.+++...
T Consensus        31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~-~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~g--h~nIV~yidss~  105 (738)
T KOG1989|consen   31 TFTVGSHRVTVEKVLAEGGFAQVYLAQD-VKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSG--HKNIVSYIDSSA  105 (738)
T ss_pred             EEEECCEEEEEEEEEccCCcEEEEEEEe-cCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcC--CCceeeEecccc
Confidence            5667788999999999999999999999 355589999988654  34445677899999999996  999999999533


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeeCCCE
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~--~~H~di~p~Nilv~~~~~~  172 (321)
                      ...........+.++||||. |.|.+++..+....|++.++++|+.|+++|+.+||..+  |+|||||-+|||++.++++
T Consensus       106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~  185 (738)
T KOG1989|consen  106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNY  185 (738)
T ss_pred             ccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCE
Confidence            33222332467899999999 59999999887777999999999999999999999998  9999999999999999999


Q ss_pred             EEeecCCcccccCCCccc----------cccccccccchhhh---hcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHH
Q psy2676         173 KIADFGLAKTFDYDMMLT----------SVVVTLWYRAPEIL---LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE  239 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~~~----------~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  239 (321)
                      ||||||.++.........          ....|+.|+|||.+   .+.+++.|+|||+|||+||.|+....||+..-...
T Consensus       186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la  265 (738)
T KOG1989|consen  186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA  265 (738)
T ss_pred             EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee
Confidence            999999987553332111          23568999999987   46778999999999999999999999997653333


Q ss_pred             HHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         240 QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ++..-.   ..|+.                          ..++..+.+||+.||++||.+||++.+++.+
T Consensus       266 Ilng~Y---~~P~~--------------------------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  266 ILNGNY---SFPPF--------------------------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             EEeccc---cCCCC--------------------------ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            222111   11111                          2455899999999999999999999999854

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.2e-44  Score=304.65  Aligned_cols=263  Identities=29%  Similarity=0.483  Sum_probs=213.2

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ........+|++++.||.|++|.||++.+ ..+++.+++|.+......  ....+.+|+.+++.++   |||++++++++
T Consensus        12 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~-~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~---h~~i~~~~~~~   85 (297)
T cd06656          12 VSVGDPKKKYTRFEKIGQGASGTVYTAID-IATGQEVAIKQMNLQQQP--KKELIINEILVMRENK---NPNIVNYLDSY   85 (297)
T ss_pred             cccCChhhhceeeeeeccCCCeEEEEEEE-CCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCC---CCCEeeEEEEE
Confidence            34455568999999999999999999998 578899999998653222  2345677888888887   99999999999


Q ss_pred             eccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      ...       ...++|+||+++ +|.+++..   ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++
T Consensus        86 ~~~-------~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~  155 (297)
T cd06656          86 LVG-------DELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVK  155 (297)
T ss_pred             ecC-------CEEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence            776       678999999985 99998865   3478999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         174 IADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       174 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |+|||.+....... ......+++.|+|||.+.+..++.++|+||+|+++|++++|..||...+.......+.. .+.+.
T Consensus       156 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~  234 (297)
T cd06656         156 LTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE  234 (297)
T ss_pred             ECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC
Confidence            99999887654332 22335678889999999988899999999999999999999999976554332221111 11111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ..                       ....++..+.+++.+||..+|.+||++.++++||||+...
T Consensus       235 ~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         235 LQ-----------------------NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             CC-----------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            00                       0123557889999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0666|consensus

Probab=100.00  E-value=3.7e-45  Score=290.22  Aligned_cols=288  Identities=39%  Similarity=0.704  Sum_probs=235.7

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCC---cEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKG---NYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ..|++++.||+|.||.||+|..++.+.   ..+|+|.++.+....+...+.-+|+..++.++   |||++.+..+|....
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~---h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK---HPNVISLVKVFLSHD  100 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc---CCcchhHHHHHhccC
Confidence            479999999999999999996532222   37899999887777778888999999999999   999999999986631


Q ss_pred             cccccceEEEEEeccCccCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC----CC
Q psy2676          99 LSDERYLTVYLIFEHVDQDLGSYMEKCPP---PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA----GG  171 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~----~~  171 (321)
                            ..+++++||.+-+|...+.-...   ..++...+..|+.||+.|+.|||++-+.||||||.||+|..+    |.
T Consensus       101 ------~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~  174 (438)
T KOG0666|consen  101 ------KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGR  174 (438)
T ss_pred             ------ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCe
Confidence                  68999999999999999875432   348999999999999999999999999999999999999887    88


Q ss_pred             EEEeecCCcccccCCC----ccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCC---------Ch
Q psy2676         172 LKIADFGLAKTFDYDM----MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCAS---------TE  237 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~---------~~  237 (321)
                      +|++|+|+++.+...-    .......|..|.|||++.+.. +|.+.|||+.||++.||++..+.|.+.         -.
T Consensus       175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq  254 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ  254 (438)
T ss_pred             eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence            9999999998876432    234567799999999998877 899999999999999999999999663         35


Q ss_pred             HHHHHHHHHHhCCCCCCCcchhhhhhh-----hhhh-h-hhh---hhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHH
Q psy2676         238 VEQLKCIFRVIGTPSMNEWPENISLMW-----SSFE-Q-YSK---VAFSAIFMDCCSKANSLLESMLTFNPADRISAADA  307 (321)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-~-~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  307 (321)
                      .+.+.+|+..+|.|....||..-....     +.++ . +..   ...-.....-++...+|+.+||..||.+|.|++++
T Consensus       255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA  334 (438)
T KOG0666|consen  255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA  334 (438)
T ss_pred             HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence            678899999999999999976533321     1111 1 111   11122233345668999999999999999999999


Q ss_pred             hCCCCCCCCCC
Q psy2676         308 LEHPYFKEKEN  318 (321)
Q Consensus       308 l~h~~f~~~~~  318 (321)
                      ++|+||++.+-
T Consensus       335 leh~yF~~d~l  345 (438)
T KOG0666|consen  335 LEHPYFTEDPL  345 (438)
T ss_pred             hcccccccCCC
Confidence            99999998743

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.3e-44  Score=298.95  Aligned_cols=259  Identities=25%  Similarity=0.430  Sum_probs=210.2

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||.|++|+||+|.. ..++..+++|++....... ....+.+|+..++.++   |+|++++++.+...    
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~----   71 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAIC-LPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCN---HPNVVKYYTSFVVG----   71 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEE-cCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcC---CCCEEEEEEEEeeC----
Confidence            4799999999999999999998 5688899999986543332 3456778898888887   99999999998776    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPP-PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                         ...++++|++.+ +|.+++..... ..+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.
T Consensus        72 ---~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~  148 (267)
T cd06610          72 ---DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGV  148 (267)
T ss_pred             ---CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccch
Confidence               678999999985 99999876432 4589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc-----ccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         180 AKTFDYDMML-----TSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       180 ~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      +.........     ....++..|+|||.+... ..+.++|+||||+++++|++|+.||...+...........   .+ 
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~-  224 (267)
T cd06610         149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DP-  224 (267)
T ss_pred             HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CC-
Confidence            8766533221     234578889999998877 6899999999999999999999999876655444333321   10 


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ..++.                 ......+++.+.+++.+||..||.+||++.++++||||
T Consensus       225 ~~~~~-----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         225 PSLET-----------------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             CCcCC-----------------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            00000                 00023556889999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.8e-44  Score=305.75  Aligned_cols=282  Identities=23%  Similarity=0.391  Sum_probs=210.3

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||+|+||.||++.+ ..++..+++|.+..... ......+.+|++++++++   ||||+++++++.+.    
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~----   71 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLH-RPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECN---SPYIVGFYGAFYSD----   71 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEE-cCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCC---CCCCCeEEEEEeeC----
Confidence            4799999999999999999998 57788899998864322 112235678999999987   99999999999877    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                         ..+++|+||+++ +|.+++...  ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus        72 ---~~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~  146 (308)
T cd06615          72 ---GEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV  146 (308)
T ss_pred             ---CEEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCC
Confidence               688999999985 999999874  448999999999999999999997 5999999999999999999999999998


Q ss_pred             cccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch-
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE-  258 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-  258 (321)
                      +...... ......++..|+|||++.+..++.++|+||+|+++++|++|..||...+...................... 
T Consensus       147 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (308)
T cd06615         147 SGQLIDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP  225 (308)
T ss_pred             ccccccc-ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccc
Confidence            8655322 22345678899999999888899999999999999999999999976654332222211110000000000 


Q ss_pred             ------hhhhh---hhhhhhhhhhhhhhh-hhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         259 ------NISLM---WSSFEQYSKVAFSAI-FMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       259 ------~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                            .....   ............... ...++.++.+++.+||..+|++|||+.++++||||++...
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  295 (308)
T cd06615         226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL  295 (308)
T ss_pred             ccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence                  00000   000000000000000 1125678999999999999999999999999999987543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.3e-44  Score=298.35  Aligned_cols=253  Identities=30%  Similarity=0.525  Sum_probs=209.2

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++.+.||.|++|.||++.. ..+++.+++|.++....    ...+.+|+.++++++   |||++++++++...   
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~-~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~---~~~i~~~~~~~~~~---   70 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIH-KETGQVVAIKVVPVEED----LQEIIKEISILKQCD---SPYIVKYYGSYFKN---   70 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEE-cCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCC---CCcEeeeeeeeecC---
Confidence            47899999999999999999998 46788999999875422    457788999999986   99999999999776   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++++|++++ +|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        71 ----~~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~  145 (256)
T cd06612          71 ----TDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGV  145 (256)
T ss_pred             ----CcEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEccccc
Confidence                678999999995 9999987644 3489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         180 AKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       180 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      +....... ......++..|+|||.+.+..++.++||||+|+++++|++|+.||...........+..   . ....+. 
T Consensus       146 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~-~~~~~~-  220 (256)
T cd06612         146 SGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---K-PPPTLS-  220 (256)
T ss_pred             chhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---C-CCCCCC-
Confidence            88765433 23344578889999999888899999999999999999999999976554433222111   0 000000 


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                                         ....++..+.++|.+||+.||.+|||+.++++||||
T Consensus       221 -------------------~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         221 -------------------DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             -------------------chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                               012355789999999999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=296.28  Aligned_cols=256  Identities=29%  Similarity=0.479  Sum_probs=209.1

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++.+.||.|++|.||+|.+ ..+++.+++|++......  ....+.+|+.++++++   |||++++++++.+.   
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~---   72 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARD-IATGELVAIKVIKLEPGD--DFEIIQQEISMLKECR---HPNIVAYFGSYLRR---   72 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEe-cCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCC---CCChhceEEEEEeC---
Confidence            46899999999999999999998 567889999998754322  3456778889988887   99999999998776   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..++++||++++ +|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        73 ----~~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~  147 (262)
T cd06613          73 ----DKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGV  147 (262)
T ss_pred             ----CEEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECcccc
Confidence                678999999995 9999887642 3489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-ccccccccccccchhhhhcC---CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         180 AKTFDYDM-MLTSVVVTLWYRAPEILLNL---GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       180 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      +....... ......++..|+|||.+...   .++.++|+||+|+++++|++|..||..................+....
T Consensus       148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  227 (262)
T cd06613         148 SAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLK  227 (262)
T ss_pred             chhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcccc
Confidence            87665332 22344677889999999776   788999999999999999999999987665554433322110111000


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY  312 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  312 (321)
                                            ....++.++.+++++||..+|..|||+.+++.|+|
T Consensus       228 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         228 ----------------------DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             ----------------------chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                                  01134578999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.1e-44  Score=302.22  Aligned_cols=258  Identities=22%  Similarity=0.361  Sum_probs=203.7

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||.|++|.||++.+ ..+++.+++|++..... ......+.+|+.+++++.   |||++++++.+...    
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~----   71 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYH-LLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCD---SPYIIGFYGAFFVE----   71 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEE-cCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCC---CCCeeeEEEEEEEC----
Confidence            4688999999999999999998 57889999999865321 112345778999998887   99999999999877    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++|+||+++ +|..+      ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        72 ---~~~~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~  142 (279)
T cd06619          72 ---NRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS  142 (279)
T ss_pred             ---CEEEEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence               678999999996 66443      23689999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHH---HHHHHHHhCCCCCCCcc
Q psy2676         181 KTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQ---LKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~  257 (321)
                      ...... ......++..|+|||++.+..++.++|+||||+++|+|++|+.||........   ................ 
T Consensus       143 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-  220 (279)
T cd06619         143 TQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL-  220 (279)
T ss_pred             eecccc-cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC-
Confidence            765432 23345678899999999998899999999999999999999999965321110   0011111110000000 


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                                          .....++++.+++.+||+.+|.+||++.++++||||++....
T Consensus       221 --------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~  262 (279)
T cd06619         221 --------------------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDG  262 (279)
T ss_pred             --------------------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence                                012345789999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.2e-44  Score=302.84  Aligned_cols=290  Identities=37%  Similarity=0.700  Sum_probs=225.6

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ...++|++.+.||.|++|+||+|.+ ..+++.+++|+++.............+|+.++++++   |||++++++++.+..
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~---h~~i~~~~~~~~~~~   79 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARD-KDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN---HRNIVNLKEIVTDKQ   79 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEE-CCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC---CCCeeeeeheecCcc
Confidence            4557899999999999999999999 578899999998765444444456678999999998   999999999987652


Q ss_pred             cc---cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          99 LS---DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        99 ~~---~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      ..   ......+++|+|++++++...+.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          80 DALDFKKDKGAFYLVFEYMDHDLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             hhhhccccCCcEEEEEcccCccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeC
Confidence            00   11123789999999998888887642 358999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCC--ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         176 DFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       176 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |||.+.......  ......++..|+|||.+.+. ..+.++||||+|+++++|++|++||...+..+....+....+.+.
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC  238 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999887654322  11223457789999988654 468899999999999999999999998888888888887777666


Q ss_pred             CCCcchhhhhhh-hhhhhh--hhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         253 MNEWPENISLMW-SSFEQY--SKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       253 ~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ...++....... ......  ...........++..+.+++.+||+.||.+||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            555543221110 000000  0011112233467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-43  Score=305.02  Aligned_cols=285  Identities=38%  Similarity=0.599  Sum_probs=223.7

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ...++|++.+.||.|++|.||+|.+ ..++..+++|.+............+..|+.++++++   |||++++++++....
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~   82 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARD-QLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR---HENIISLSDIFISPL   82 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEE-CCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC---CCCeeeEeeeEecCC
Confidence            4568899999999999999999998 578999999988654444444556778999999998   999999999986531


Q ss_pred             cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676          99 LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                            ...++++|+++++|..++..   ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus        83 ------~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          83 ------EDIYFVTELLGTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             ------CcEEEEeehhccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccc
Confidence                  35789999998899888865   337889999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      .+......  .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...........+.+..+.++.....
T Consensus       154 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         154 LARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             cccccCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            98755422  233456788999998765 558999999999999999999999998888777766666666655422111


Q ss_pred             hh----hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         258 EN----ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       258 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ..    ......................++..+.++|++||+.+|++|||+++++.||||+....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~  296 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD  296 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence            00    00000111111112223334467789999999999999999999999999999986643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.4e-44  Score=303.13  Aligned_cols=279  Identities=35%  Similarity=0.627  Sum_probs=213.9

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||+|++|.||+|.+ ..+++.+++|.+............+.+|+++++.++   |||++++++++...    
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~----   72 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKH-KETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR---HENLVNLIEVFRRK----   72 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEE-CCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC---CcchhhHHHhcccC----
Confidence            4799999999999999999998 577899999998665443333456778999999887   99999999999766    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++|+||+.+ +|..+...  ...+++..++.++.||+.||.|||+.|++|+||+|+||++++++.++|+|||.+
T Consensus        73 ---~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~  147 (286)
T cd07846          73 ---KRLYLVFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA  147 (286)
T ss_pred             ---CeEEEEEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeee
Confidence               678999999997 55555544  234899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCC-ccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      ....... ......++..|+|||.+.+.. ++.++||||+|+++++|++|.+||......+....+....+.........
T Consensus       148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07846         148 RTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI  227 (286)
T ss_pred             eeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence            7654322 223345788899999987644 68899999999999999999999988776666666555444322110000


Q ss_pred             hhh---hhhhhhhhh-hhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         259 NIS---LMWSSFEQY-SKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       259 ~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ...   ......... ...........++..+.+|+.+||..+|.+||++.++++||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            000   000000000 0011112234678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.3e-44  Score=308.62  Aligned_cols=292  Identities=39%  Similarity=0.657  Sum_probs=222.7

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ..+++ .++|.+.+.||.|++|.||+|.+ ..+++.+++|++............+.+|+.+++.+.   ||||+++++++
T Consensus         9 ~~~~~-~~~y~~~~~ig~g~~g~v~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~   83 (342)
T cd07879           9 TVWEL-PERYTSLKQVGSGAYGSVCSAID-KRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ---HENVIGLLDVF   83 (342)
T ss_pred             hhhcc-ccceEEEEEeeecCCeEEEEEEe-CCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC---CCCccchhhee
Confidence            34444 36899999999999999999998 578899999998765433333456778999999987   99999999998


Q ss_pred             eccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ...... ......++|+|++..+|..+..    ..+++..+..++.|++.||.+||+.|++||||+|+||+++.++.++|
T Consensus        84 ~~~~~~-~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL  158 (342)
T cd07879          84 TSAVSG-DEFQDFYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKI  158 (342)
T ss_pred             cccccC-CCCceEEEEecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEE
Confidence            654211 1224569999999888777653    24899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       175 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      +|||.+......  .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.......+....+.+..
T Consensus       159 ~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (342)
T cd07879         159 LDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP  236 (342)
T ss_pred             eeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            999998765322  233456788999999876 45789999999999999999999999988777777666665543332


Q ss_pred             CCcchhhhhh----hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         254 NEWPENISLM----WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       254 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ..........    ...................+.++.+||++||+.||.+||++.+++.||||++.++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            1111100000    0000111112222333456788999999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-44  Score=300.43  Aligned_cols=280  Identities=41%  Similarity=0.780  Sum_probs=225.4

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      |++.+.||.|++|.||+|.+ ..+++.+++|.+............+.+|+.+++++.   |||++++++++.+..     
T Consensus         1 y~~~~~l~~g~~~~vy~~~~-~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~-----   71 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARN-KKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR---HPNIVRLKEIVTSKG-----   71 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEE-CCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc---CCCeeeheeeEecCC-----
Confidence            78899999999999999998 577899999999876433334456778999999998   999999999986541     


Q ss_pred             ceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccc
Q psy2676         104 YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF  183 (321)
Q Consensus       104 ~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~  183 (321)
                      ....++|+|+++++|.+++.... ..+++..++.++.||+.||++||+.|++|+||+|+||++++++.++|+|||.+...
T Consensus        72 ~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          72 KGSIYMVFEYMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             CCcEEEEeccccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            24689999999999999987753 35899999999999999999999999999999999999999999999999998876


Q ss_pred             cCCC--ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         184 DYDM--MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       184 ~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      ....  ......++..|+|||.+.+. .++.++||||||+++++|++|..||...+.......+....+.+....|+...
T Consensus       151 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         151 TKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             cCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence            5443  23344567889999987654 47899999999999999999999999988888888888877777666665432


Q ss_pred             hhhhhhh---hhhhhhhhhhhhhh-cchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         261 SLMWSSF---EQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       261 ~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      .......   .............. ++..+.+++++||+.+|.+||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            2211100   00011112222333 38899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-44  Score=302.92  Aligned_cols=260  Identities=30%  Similarity=0.539  Sum_probs=210.4

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      +.++|++.+.||.|++|+||++.+ ..++..+++|++....  ......+..|+.++++++   |||++++++.+...  
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~-~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~--   74 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQH-KETGLFAAAKIIQIES--EEELEDFMVEIDILSECK---HPNIVGLYEAYFYE--   74 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEE-cCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCC---CCceeEEEEEEecC--
Confidence            346899999999999999999998 4688999999986432  112335667888998888   99999999999776  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ...++|||++++ +|.+++..... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus        75 -----~~~~lv~e~~~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g  148 (280)
T cd06611          75 -----NKLWILIEFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFG  148 (280)
T ss_pred             -----CeEEEEeeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCc
Confidence                 678999999995 99988876443 48999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCC-ccccccccccccchhhhh-----cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         179 LAKTFDYDM-MLTSVVVTLWYRAPEILL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       179 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      .+....... ......++..|+|||.+.     ...++.++|+||||+++|+|++|+.||...+.......+...  .++
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~  226 (280)
T cd06611         149 VSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EPP  226 (280)
T ss_pred             cchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CCC
Confidence            876553322 233456788899999975     344678999999999999999999999877655544433221  111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ....                      ...++.++.++|.+||+.+|.+||++.++++||||++..
T Consensus       227 ~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         227 TLDQ----------------------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             CcCC----------------------cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence            0000                      123557899999999999999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.2e-44  Score=308.68  Aligned_cols=287  Identities=34%  Similarity=0.594  Sum_probs=217.2

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      +++|++.+.||.|++|.||+|++ ..++..+++|.+.....  .......+|+.++++++   |||++++++.+......
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~-~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~---h~~i~~~~~~~~~~~~~   77 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVD-SDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLD---HDNIVKVYEVLGPSGSD   77 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEE-CCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcC---CCcchhhHhhhcccccc
Confidence            57999999999999999999999 57889999999865432  23456778999999997   99999999887654211


Q ss_pred             -------cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee-CCCE
Q psy2676         101 -------DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR-AGGL  172 (321)
Q Consensus       101 -------~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~-~~~~  172 (321)
                             .......++|+|+++++|.+++..   ..+++..++.++.||+.||.+||+.|++|+||+|+||+++. ++.+
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          78 LTEDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccccccccceEEEEeecccccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence                   111235799999999999888865   34899999999999999999999999999999999999974 5568


Q ss_pred             EEeecCCcccccCCC----ccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q psy2676         173 KIADFGLAKTFDYDM----MLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       173 kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  247 (321)
                      +|+|||.+.......    ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+..+........
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999999987653221    1123356788999998755 45788999999999999999999999988877776666554


Q ss_pred             hCCCCCCCcchhhhhhhhhh---hhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         248 IGTPSMNEWPENISLMWSSF---EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ....................   ...............+.++.+||++||+.||.+|||+.++++||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            33222211111111000000   0111112223344677899999999999999999999999999999843

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.1e-43  Score=299.07  Aligned_cols=271  Identities=27%  Similarity=0.421  Sum_probs=212.7

Q ss_pred             ccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          12 LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        12 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      +.+..+....++|.+.+.||+|++|.||++.+ ..+++.+++|++....   .....+.+|+.+++++..  |||+++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~-~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~--h~ni~~~~   85 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTN-KKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPN--HPNVVKFY   85 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEE-CCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcC--CCCeEEEE
Confidence            46677777889999999999999999999998 5788999999986431   123356678888888843  99999999


Q ss_pred             eeeeccccccccceEEEEEeccCcc-CHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR  168 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~  168 (321)
                      +++....  .......++|+||+++ +|.+++...  ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.
T Consensus        86 ~~~~~~~--~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~  163 (291)
T cd06639          86 GMFYKAD--KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT  163 (291)
T ss_pred             EEEEecc--ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC
Confidence            9986541  1122467999999985 999988642  2345899999999999999999999999999999999999999


Q ss_pred             CCCEEEeecCCcccccCCC-ccccccccccccchhhhhcCC-----CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHH
Q psy2676         169 AGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLG-----YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLK  242 (321)
Q Consensus       169 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  242 (321)
                      ++.++|+|||.+....... ......++..|+|||.+....     ++.++|+||+|+++|+|++|+.||..........
T Consensus       164 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~  243 (291)
T cd06639         164 EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF  243 (291)
T ss_pred             CCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH
Confidence            9999999999987654322 223345788899999976433     6889999999999999999999998765544433


Q ss_pred             HHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q psy2676         243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK  314 (321)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~  314 (321)
                      .+...   +... ..                    .....+..+.++|.+||+.+|++||++.++++||||+
T Consensus       244 ~~~~~---~~~~-~~--------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         244 KIPRN---PPPT-LL--------------------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HHhcC---CCCC-CC--------------------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            32211   1100 00                    0113446799999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2e-44  Score=300.07  Aligned_cols=254  Identities=28%  Similarity=0.430  Sum_probs=210.3

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      +|++.+.||.|++|.||+|.+ ..+++.+++|++....... .....+.+|++++++++   |||++++++++...    
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~----   72 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQK-RDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN---HPFLVNLWYSFQDE----   72 (258)
T ss_pred             CceEEEEeccCCCceEEEEEE-ccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC---CCChHHHHHhhcCC----
Confidence            589999999999999999998 5788999999997643322 33456778899999887   99999999998766    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++|+|++.| +|.+++...  ..+++..+..++.||+.||.+||+.|++|+||+|+||++++++.++|+|||.+
T Consensus        73 ---~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~  147 (258)
T cd05578          73 ---ENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIA  147 (258)
T ss_pred             ---CeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccc
Confidence               678999999985 999999874  45899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         181 KTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      .............++..|+|||.+.....+.++|+||+|+++|+|++|..||......... .+...... ....     
T Consensus       148 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~-~~~~-----  220 (258)
T cd05578         148 TKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD-QIRAKQET-ADVL-----  220 (258)
T ss_pred             cccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH-HHHHHhcc-cccc-----
Confidence            8766554445566788899999999888999999999999999999999999876642111 11111110 1111     


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH--HHHhCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA--ADALEHPYF  313 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~--~~ll~h~~f  313 (321)
                                       ....++..+.++|++||..||.+||++  .++++||||
T Consensus       221 -----------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         221 -----------------YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             -----------------CcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                             112455899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-44  Score=311.66  Aligned_cols=287  Identities=40%  Similarity=0.640  Sum_probs=224.2

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.+.||.|++|+||+|++ ..+++.+++|++............+.+|+.+++++.   |||++++++++.....
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~   88 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFD-TKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD---HENVIGLLDVFTPASS   88 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEE-CCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc---CCCHHHHHHHhhcccc
Confidence            456899999999999999999999 578899999988654333323345667999999987   9999999998765421


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                       .......++|+|+++++|.+++..   ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        89 -~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          89 -LEDFQDVYLVTHLMGADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             -ccccccEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccc
Confidence             123345899999999899999876   3489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      +......  .....++..|+|||.+.+. .++.++||||||+++|++++|+.||.+.+.......+....+.++...+..
T Consensus       165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (343)
T cd07851         165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK  242 (343)
T ss_pred             ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence            8766433  2334567889999998664 578999999999999999999999998888777777776655443221111


Q ss_pred             hhhhh----hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         259 NISLM----WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       259 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .....    ........+..........+.++.++|++||..+|.+|||+.++++||||++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~  304 (343)
T cd07851         243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY  304 (343)
T ss_pred             ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence            10000    01111112222333444568899999999999999999999999999999865

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-43  Score=296.69  Aligned_cols=253  Identities=29%  Similarity=0.461  Sum_probs=205.4

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC----CCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG----IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      +|++.+.||.|+||.||++.+  .+++.+++|.+........    ....+.+|++++++++   |+|++++++++.+. 
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~-   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT--NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK---HVNIVQYLGTCLDD-   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE--cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC---CCCEeeEeeEeecC-
Confidence            588999999999999999986  5788999998875432211    1134667888888887   99999999999776 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ...++++|++.+ +|.+++...  ..+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|+||
T Consensus        75 ------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~df  146 (265)
T cd06631          75 ------NTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDF  146 (265)
T ss_pred             ------CeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccc
Confidence                  788999999985 999999763  34899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCC-------CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCC
Q psy2676         178 GLAKTFDYD-------MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       178 g~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      |.+......       .......++..|+|||.+.+..++.++|+||||+++++|++|..||...+.......+......
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~  226 (265)
T cd06631         147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL  226 (265)
T ss_pred             hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC
Confidence            988754311       1122345788899999999888999999999999999999999999876554433332221111


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      .  +.                      ....++.++.++|++||..+|.+||++.++++||||
T Consensus       227 ~--~~----------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 M--PR----------------------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             C--CC----------------------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            0  11                      112456889999999999999999999999999998

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.3e-44  Score=300.53  Aligned_cols=256  Identities=27%  Similarity=0.370  Sum_probs=207.2

Q ss_pred             eecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEE
Q psy2676          30 IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVY  108 (321)
Q Consensus        30 lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  108 (321)
                      ||+|+||+||+|.+ ..+++.+++|.+...... ......+.+|+.++++++   |||++++++.+...       ...+
T Consensus         1 lg~g~~g~vy~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~-------~~~~   69 (277)
T cd05577           1 LGKGGFGEVCACQV-KATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS---SRFIVSLAYAFETK-------DDLC   69 (277)
T ss_pred             CCCCCceeEEEEEE-cCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC---CCCEeeeeeEEecC-------CeEE
Confidence            68999999999998 578999999998754322 222335567999999988   99999999999776       6789


Q ss_pred             EEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCC
Q psy2676         109 LIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM  187 (321)
Q Consensus       109 ~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~  187 (321)
                      +|+||+++ +|.+++.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        70 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~  149 (277)
T cd05577          70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK  149 (277)
T ss_pred             EEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC
Confidence            99999994 99999987655569999999999999999999999999999999999999999999999999887655443


Q ss_pred             ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhh
Q psy2676         188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF  267 (321)
Q Consensus       188 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
                      ......++..|+|||.+.+..++.++|+||+|+++++|++|+.||...........+.......                
T Consensus       150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------  213 (277)
T cd05577         150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM----------------  213 (277)
T ss_pred             ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc----------------
Confidence            3444567788999999988889999999999999999999999997654422211111111000                


Q ss_pred             hhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         268 EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                             .......+++.+.++|++||+.||.+||     ++.++++||||++.+|.
T Consensus       214 -------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~  263 (277)
T cd05577         214 -------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR  263 (277)
T ss_pred             -------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence                   0011124568899999999999999999     89999999999988774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-43  Score=306.16  Aligned_cols=286  Identities=40%  Similarity=0.692  Sum_probs=222.0

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++++.||+|++|+||++.+ ..++..|++|.+............+.+|+.+++++.   ||||+++++++.....
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~   88 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALD-RRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK---HENVIGLLDVFTPDLS   88 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEE-CCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC---CCCccceeeeecCCcc
Confidence            467899999999999999999998 578899999998654333333345778999999998   9999999999865421


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                       .......++|+|+++++|.+++..   ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        89 -~~~~~~~~lv~e~~~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          89 -LDRFHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             -ccccceEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence             112245799999998899888865   3489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      +......  .....+++.|+|||.+.+. .++.++|+||+|++++++++|..||...+.......+....+.++.. +..
T Consensus       165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~  241 (343)
T cd07880         165 ARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE-FVQ  241 (343)
T ss_pred             ccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH-HHH
Confidence            8765432  2234568889999998763 47899999999999999999999999887776666666544433211 111


Q ss_pred             hhh-----hhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         259 NIS-----LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       259 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ...     ....................++..+.++|.+||..||.+|||+.++++||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            000     0001111111122333445678899999999999999999999999999999875

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-44  Score=301.52  Aligned_cols=279  Identities=39%  Similarity=0.734  Sum_probs=224.2

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      |.+.+.||.|++|+||+|++ ..+++.+++|.+....... ......+|+..++++..  |||++++++++.+.      
T Consensus         1 y~~~~~ig~g~~g~v~~~~~-~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~--h~~i~~~~~~~~~~------   70 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARN-KETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNE--HPNIVKLKEVFREN------   70 (283)
T ss_pred             CeeheeeccCCceEEEEEEE-CCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccC--CCCchhHHHHhhcC------
Confidence            67899999999999999998 5778899999986543321 12234457777776653  99999999998776      


Q ss_pred             ceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccc
Q psy2676         104 YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF  183 (321)
Q Consensus       104 ~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~  183 (321)
                       ...++|+|+++++|.+++.......+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        71 -~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~  149 (283)
T cd07830          71 -DELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI  149 (283)
T ss_pred             -CcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceec
Confidence             6789999999889999998765456899999999999999999999999999999999999999999999999999877


Q ss_pred             cCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhh
Q psy2676         184 DYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL  262 (321)
Q Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (321)
                      ..........++..|+|||++.. ..++.++|+||+|+++++|++|..||......+....+....+.+....|+.....
T Consensus       150 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07830         150 RSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL  229 (283)
T ss_pred             cCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence            65444445667888999998754 44789999999999999999999999998888888888887777776655443322


Q ss_pred             hhh---hhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         263 MWS---SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       263 ~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ...   .+...............+..+.++|++||+.+|.+|||+.|++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            211   111111112223333446889999999999999999999999999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.6e-44  Score=308.02  Aligned_cols=290  Identities=39%  Similarity=0.623  Sum_probs=223.2

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +....++|.+.+.||+|+||.||++.+ ..+++.||+|++............+.+|+.++++++   ||||+++++++..
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~~iv~~~~~~~~   87 (345)
T cd07877          12 IWEVPERYQNLSPVGSGAYGSVCAAFD-TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK---HENVIGLLDVFTP   87 (345)
T ss_pred             HhhccCceEEEEEeeecCCeEEEEEEE-cCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC---CCcccceeeeeee
Confidence            344568999999999999999999998 578899999998754333222345667999999988   9999999998865


Q ss_pred             cccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          97 NILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                      .... ......++++++++++|.+++..   ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        88 ~~~~-~~~~~~~lv~~~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~d  163 (345)
T cd07877          88 ARSL-EEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD  163 (345)
T ss_pred             cccc-cccccEEEEehhcccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEec
Confidence            4211 11235789999998899888765   2489999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ||.+......  .....++..|+|||.+.+ ..++.++||||+|+++++|++|..||...+.......+....+.++...
T Consensus       164 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T cd07877         164 FGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  241 (345)
T ss_pred             cccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9998765422  234466888999999876 4578899999999999999999999988777777777666655444332


Q ss_pred             cchhhhhh----hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         256 WPENISLM----WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       256 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .+......    ...................++++.++|.+||+.||.+||++.++++||||++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence            21111100    01111111222233334567889999999999999999999999999999865

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.9e-43  Score=295.50  Aligned_cols=256  Identities=27%  Similarity=0.481  Sum_probs=203.8

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC---CCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG---IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ..|++.+.||+|++|.||++.+ ..++..+++|.+........   ....+.+|+.++++++   |||++++++++....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~   77 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYD-VDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ---HERIVQYYGCLRDRA   77 (266)
T ss_pred             CCccccceecCCCCEEEEEEEE-cCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC---CCCeeeEEEEEEcCC
Confidence            4799999999999999999998 57788999998865432221   1234667899999987   999999999886431


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                           ....++++|++.+ +|.+++...  ..+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+||
T Consensus        78 -----~~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~df  150 (266)
T cd06651          78 -----EKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDF  150 (266)
T ss_pred             -----CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccC
Confidence                 1467899999985 999999773  34899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCC----ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         178 GLAKTFDYDM----MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       178 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      |.+.......    ......++..|+|||++.+..++.++|+||+|+++|++++|+.||..............   .+..
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~~  227 (266)
T cd06651         151 GASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTN  227 (266)
T ss_pred             CCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCCC
Confidence            9887553211    11234577889999999988899999999999999999999999987655444433222   1111


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK  314 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~  314 (321)
                      ...+                      ..+++.+.+++ +||..+|++||+++++++||||+
T Consensus       228 ~~~~----------------------~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         228 PQLP----------------------SHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CCCc----------------------hhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            1111                      13447788888 67788999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-44  Score=326.00  Aligned_cols=289  Identities=23%  Similarity=0.336  Sum_probs=206.8

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEee--------------cc-cCCCCCCchhHHHHHHHHhcccCCC
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--------------VK-LNEDGIPMSTLREISILKQLDTFEH   84 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~--------------~~-~~~~~~~~~~~~e~~~l~~l~~~~~   84 (321)
                      ..++|++++.||+|+||+||++......+...+.|.+.              +. .........+.+|+.++++++   |
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~---H  222 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN---H  222 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC---C
Confidence            34689999999999999999987643343333333111              00 011111234568999999998   9


Q ss_pred             CceeEEEeeeeccccccccceEEEEEeccCccCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q psy2676          85 PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP---PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKP  161 (321)
Q Consensus        85 ~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p  161 (321)
                      |||+++++++.+.       ...+++++++.++|.+++....   ........++.++.||+.||.|||++|++||||||
T Consensus       223 pnIv~l~~~~~~~-------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP  295 (501)
T PHA03210        223 ENILKIEEILRSE-------ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKL  295 (501)
T ss_pred             CCcCcEeEEEEEC-------CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence            9999999999877       6789999999998888875422   12234677889999999999999999999999999


Q ss_pred             CcEEEeeCCCEEEeecCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCC-CC--CC
Q psy2676         162 QNLLITRAGGLKIADFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLF-CA--ST  236 (321)
Q Consensus       162 ~Nilv~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~--~~  236 (321)
                      +||+++.++.+||+|||++........  .....|+..|+|||++.+..++.++|||||||++|+|++|..++ ..  ..
T Consensus       296 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~  375 (501)
T PHA03210        296 ENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK  375 (501)
T ss_pred             HHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence            999999999999999999976653322  22356899999999999999999999999999999999987544 32  23


Q ss_pred             hHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhh----hhhhhhh--hhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         237 EVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYS----KVAFSAI--FMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      .......+....+... ..++......+..+....    .......  ...++.++.++|.+||+.||.+|||+.|+|+|
T Consensus       376 ~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        376 PGKQLLKIIDSLSVCD-EEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHHHHhcccCh-hhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            3444444444433222 222222111111111100    0011111  12366788999999999999999999999999


Q ss_pred             CCCCCCCCC
Q psy2676         311 PYFKEKENE  319 (321)
Q Consensus       311 ~~f~~~~~~  319 (321)
                      |||.+...+
T Consensus       455 p~f~~~~~~  463 (501)
T PHA03210        455 PLFSAEEEE  463 (501)
T ss_pred             hhhhcCCch
Confidence            999876544

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-43  Score=296.89  Aligned_cols=257  Identities=29%  Similarity=0.524  Sum_probs=205.8

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC----CCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG----IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      +|+..+.||+|++|.||++.+ ..+++.+++|++........    ....+.+|+.++++++   |+|++++++++.+. 
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~-~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~-   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARD-VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN---HPHIIRMLGATCED-   75 (268)
T ss_pred             CccccceecCcCceEEEEEEE-cCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC---CCceehhhceeccC-
Confidence            478889999999999999998 57889999999875432221    1245678899999987   99999999999776 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC-CEEEee
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-GLKIAD  176 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~-~~kl~d  176 (321)
                            ...++|+|++.| +|.+++...  ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++ .++|+|
T Consensus        76 ------~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~d  147 (268)
T cd06630          76 ------SHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIAD  147 (268)
T ss_pred             ------CeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcc
Confidence                  678999999995 999998763  4589999999999999999999999999999999999998776 599999


Q ss_pred             cCCcccccCCCc-----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         177 FGLAKTFDYDMM-----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       177 fg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      ||.+........     .....++..|+|||.+.+..++.++|+||+|++++++++|..||...........+.......
T Consensus       148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  227 (268)
T cd06630         148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT  227 (268)
T ss_pred             cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC
Confidence            999876643321     123456788999999988889999999999999999999999997544322222222211111


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK  314 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~  314 (321)
                      ....                      .....++++.+++.+||..+|.+||++.++++||||+
T Consensus       228 ~~~~----------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         228 TAPS----------------------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             CCCC----------------------CchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            1111                      1124558899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.6e-43  Score=305.13  Aligned_cols=286  Identities=35%  Similarity=0.605  Sum_probs=223.2

Q ss_pred             ceeeeeeeecccceeEEEEEEecCC--CcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNK--GNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      +|++.+.||+|+||.||++++ ...  +..+|+|.+............+.+|+.+++++..  ||||+++++.....   
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~iv~~~~~~~~~---   74 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARN-AETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG--HKNITCLYDMDIVF---   74 (332)
T ss_pred             CceEEEEccccCCeEEEEEEe-CCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcC--CCChheeeeeeeec---
Confidence            589999999999999999998 455  7899999986543333334466789999988853  99999999875432   


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                      ......+++++++++++|.+++..  ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        75 ~~~~~~~~~~~e~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          75 PGNFNELYLYEELMEADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             cccCCcEEEEEecccCCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            122245789999999999999876  345899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCc-----cccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         181 KTFDYDMM-----LTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       181 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      ........     .....++..|+|||.+.+ ..++.++|+||+|++++++++|..||...+.......+....+.++..
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            76543221     223467889999998766 457999999999999999999999999988888888888887765543


Q ss_pred             Ccchhhhhhh----hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         255 EWPENISLMW----SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       255 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .+........    .................++..+.+++.+||+.||.+|||+.+++.||||++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence            2211111100    0111111223333444567899999999999999999999999999999854

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0612|consensus

Probab=100.00  E-value=7.7e-46  Score=336.62  Aligned_cols=270  Identities=28%  Similarity=0.381  Sum_probs=233.8

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ..+.+..++|+|++.||+|+||.|.+++. +.+++.||+|++.+-..- .....-+.+|..++.--.   .+=|++++-.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~-k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n---s~Wiv~LhyA  143 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRH-KSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN---SEWIVQLHYA  143 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEe-eccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC---cHHHHHHHHH
Confidence            35567778999999999999999999999 689999999998763222 223446677888887766   8899999999


Q ss_pred             eeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      |+|+       .++|+||||++| +|..++....  .+++.-++.++..|..||..+|+.|+|||||||+||++|..|++
T Consensus       144 FQD~-------~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHi  214 (1317)
T KOG0612|consen  144 FQDE-------RYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHI  214 (1317)
T ss_pred             hcCc-------cceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcE
Confidence            9999       899999999995 9999999966  59999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCc--cccccccccccchhhhhc-----CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q psy2676         173 KIADFGLAKTFDYDMM--LTSVVVTLWYRAPEILLN-----LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIF  245 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  245 (321)
                      ||+|||.|-.+..++.  .....|||.|.|||++..     +.|+...|-||+|+++|+|+.|..||....-.+...+|+
T Consensus       215 kLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm  294 (1317)
T KOG0612|consen  215 KLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM  294 (1317)
T ss_pred             eeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh
Confidence            9999999998876554  445789999999999853     458899999999999999999999999999999999999


Q ss_pred             HHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC---HHHHhCCCCCCCCCCCCC
Q psy2676         246 RVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS---AADALEHPYFKEKENEPL  321 (321)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~f~~~~~~~~  321 (321)
                      .+......+.                       ..++|.++++||++++. +|..|.+   ++++-.||||.+++|+.+
T Consensus       295 ~hk~~l~FP~-----------------------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~i  349 (1317)
T KOG0612|consen  295 NHKESLSFPD-----------------------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNI  349 (1317)
T ss_pred             chhhhcCCCc-----------------------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhh
Confidence            8754433331                       12577999999999996 8999998   999999999999999754

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-43  Score=302.48  Aligned_cols=282  Identities=39%  Similarity=0.709  Sum_probs=212.6

Q ss_pred             ceeeeeeeecccceeEEEEEEecC--CCcEEEEEEeeccc-CCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQN--KGNYVAMKKLRVKL-NEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~--~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      +|++.+.||+|++|.||+|.+ ..  .++.+++|.+.... ..........+|+.++++++   |||++++++++.+.  
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~-~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~--   74 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKR-KNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK---HENVVSLVEVFLEH--   74 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEe-cCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC---CCCccceEEEEeCC--
Confidence            589999999999999999998 45  78999999987643 22333456678999999988   99999999998654  


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee----CCCE
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCP---PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR----AGGL  172 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~----~~~~  172 (321)
                         ....+++|+|+++++|.+++....   ...+++..++.++.||+.||.|||+.+++|+||+|+||+++.    ++.+
T Consensus        75 ---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~  151 (316)
T cd07842          75 ---ADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVV  151 (316)
T ss_pred             ---CCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceE
Confidence               124689999999998888775432   235899999999999999999999999999999999999999    8899


Q ss_pred             EEeecCCcccccCCCc----cccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChH---------
Q psy2676         173 KIADFGLAKTFDYDMM----LTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEV---------  238 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------  238 (321)
                      +|+|||.+........    .....++..|+|||++.+. .++.++|+||||+++++|++|++||.+....         
T Consensus       152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~  231 (316)
T cd07842         152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR  231 (316)
T ss_pred             EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence            9999999876543221    2234567889999988764 4789999999999999999999999765433         


Q ss_pred             HHHHHHHHHhCCCCCCCcchhhhhhh-hh------hhhhh---hhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHh
Q psy2676         239 EQLKCIFRVIGTPSMNEWPENISLMW-SS------FEQYS---KVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL  308 (321)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~------~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  308 (321)
                      .....+...++.+....++....... ..      .....   ...........+..+.+++.+||++||++|||+.+++
T Consensus       232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil  311 (316)
T cd07842         232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL  311 (316)
T ss_pred             HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence            23445555555444433321111000 00      00000   0000111125668899999999999999999999999


Q ss_pred             CCCCC
Q psy2676         309 EHPYF  313 (321)
Q Consensus       309 ~h~~f  313 (321)
                      +||||
T Consensus       312 ~~~~f  316 (316)
T cd07842         312 EHPYF  316 (316)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.1e-43  Score=299.38  Aligned_cols=260  Identities=27%  Similarity=0.450  Sum_probs=207.7

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      +-|++.+.||.|++|.||++.+ ..++..+++|.+.....  .....+.+|+.+++.+.   |||++++++++...    
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~-~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~---h~~ii~~~~~~~~~----   74 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQN-KETGVLAAAKVIDTKSE--EELEDYMVEIDILASCD---HPNIVKLLDAFYYE----   74 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEE-CCCCeEEEEEEeCCCCH--HHHHHHHHHHHHHHHCC---CCCeeeEEEEEeeC----
Confidence            3478999999999999999998 57788899998854321  12335667888888887   99999999998776    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++|+||+.+ +|..++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        75 ---~~~~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  150 (282)
T cd06643          75 ---NNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVS  150 (282)
T ss_pred             ---CEEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccc
Confidence               678999999995 8877775532 34899999999999999999999999999999999999999999999999988


Q ss_pred             ccccCCC-ccccccccccccchhhhh-----cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      ....... ......++..|+|||++.     ...++.++|+||+|+++|+|++|..||...+..+....+......  ..
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~  228 (282)
T cd06643         151 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP--TL  228 (282)
T ss_pred             ccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC--CC
Confidence            6543221 223456788999999984     344778999999999999999999999877665554444332111  00


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      .                      ....++.++.++|++||+.||.+||+++++++||||+.....
T Consensus       229 ~----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  271 (282)
T cd06643         229 A----------------------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK  271 (282)
T ss_pred             C----------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCCC
Confidence            0                      012355789999999999999999999999999999976543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.9e-44  Score=303.07  Aligned_cols=267  Identities=22%  Similarity=0.389  Sum_probs=207.4

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|...+.||+|+||.||++.+ ..+++.+++|.+...... .....+.+|+.++.++..  ||||+++++++...    
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~--~~~iv~~~~~~~~~----   75 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLH-KPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSD--CPYIVKFYGALFRE----   75 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEE-CCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcC--CCCEeeeeeEEecC----
Confidence            4677888999999999999999 578899999998754322 223456678888888753  99999999998766    


Q ss_pred             ccceEEEEEeccCccCHHHHHh---hCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeeCCCEEEeec
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYME---KCPPPGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~---~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                         ...++++|++.+++.++..   ......+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+||
T Consensus        76 ---~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~df  152 (288)
T cd06616          76 ---GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDF  152 (288)
T ss_pred             ---CcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeec
Confidence               5678999999877665443   22335589999999999999999999974 9999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcC---CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNL---GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      |++.............++..|+|||++.+.   .++.++||||+|+++|+|++|+.||.....  ....+.......+. 
T Consensus       153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~-  229 (288)
T cd06616         153 GISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPP-  229 (288)
T ss_pred             chhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCC-
Confidence            998765544333445678889999998776   588999999999999999999999976541  22222221111110 


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP  320 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~~  320 (321)
                      ..+.                  .....++.++.+||++||+.+|.+|||++++++||||+...+..
T Consensus       230 ~~~~------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~  277 (288)
T cd06616         230 ILSN------------------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERN  277 (288)
T ss_pred             cCCC------------------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcc
Confidence            0000                  01124668899999999999999999999999999999876553

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.8e-44  Score=297.65  Aligned_cols=256  Identities=27%  Similarity=0.425  Sum_probs=204.0

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.+.||+|+||.||++++ ..+++.+++|++.....  .....+.+|+.++++++   |||++++++.+...  
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~-~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~---h~~ii~~~~~~~~~--   78 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARN-LHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECK---HCNIVAYFGSYLSR--   78 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEE-CCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcC---CCCeeeeeEEEEeC--
Confidence            456899999999999999999998 57889999999865322  22335678899998887   99999999998766  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ...++|+||+++ +|.+++...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus        79 -----~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg  151 (267)
T cd06646          79 -----EKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFG  151 (267)
T ss_pred             -----CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCc
Confidence                 678999999994 999988763  448999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCC-ccccccccccccchhhhh---cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         179 LAKTFDYDM-MLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       179 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      ++....... ......++..|+|||.+.   ...++.++|+||+|+++|+|++|..||...........+......++..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  231 (267)
T cd06646         152 VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL  231 (267)
T ss_pred             cceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCC
Confidence            987664322 223456788899999874   3446889999999999999999999996554333222211110000000


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY  312 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  312 (321)
                                            .....++..+.++|++||..+|++|||++++++|+|
T Consensus       232 ----------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         232 ----------------------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ----------------------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                                  001245678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.3e-43  Score=300.62  Aligned_cols=261  Identities=27%  Similarity=0.410  Sum_probs=210.9

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      +.|++.+.||+|++|.||++.+ ...++.+++|.+...... ......+.+|+.+++.++   ||||+++++.+...   
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~---~~~i~~~~~~~~~~---   73 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRH-KETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE---NPFVVSMFCSFETK---   73 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEE-CCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC---CCCeeeeEEEEecC---
Confidence            4799999999999999999998 678899999988754321 112335668888888887   99999999998766   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..+++|+|++.| +|.+++...  +.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        74 ----~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~  147 (305)
T cd05609          74 ----RHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGL  147 (305)
T ss_pred             ----CEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCC
Confidence                678999999985 999999774  4589999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCC----------------ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHH
Q psy2676         180 AKTFDYDM----------------MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKC  243 (321)
Q Consensus       180 ~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  243 (321)
                      +.......                ......++..|+|||.+.+..++.++|+||||+++|++++|..||.+....+....
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~  227 (305)
T cd05609         148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ  227 (305)
T ss_pred             ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            75321000                01123467789999999888899999999999999999999999987766555544


Q ss_pred             HHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC---HHHHhCCCCCCCCCCC
Q psy2676         244 IFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS---AADALEHPYFKEKENE  319 (321)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~f~~~~~~  319 (321)
                      ........+..                        ...++.++.++|++||+.||.+||+   +.++++||||++.++.
T Consensus       228 ~~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~  282 (305)
T cd05609         228 VISDDIEWPEG------------------------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN  282 (305)
T ss_pred             HHhcccCCCCc------------------------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence            43321111100                        0135588999999999999999997   7999999999887664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-43  Score=297.40  Aligned_cols=265  Identities=26%  Similarity=0.436  Sum_probs=210.2

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ....++|++.+.||.|++|.||+|++ ..+++.+++|++.....   ....+.+|+.+++++..  |+|++++++++...
T Consensus         2 ~~~~~~y~~~~~l~~g~~~~v~~~~~-~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~--h~~i~~~~~~~~~~   75 (275)
T cd06608           2 PDPTGIFELVEVIGEGTYGKVYKARH-KKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSN--HPNIATFYGAFIKK   75 (275)
T ss_pred             CCchhheeheeeecCCCCeEEEEEEE-CCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcC--CCChheEEEEEEec
Confidence            34568999999999999999999999 56788999999875422   23467789999999843  99999999999765


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCP--PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ... .....+++|+|++++ +|.+++....  +..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|
T Consensus        76 ~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          76 NPP-GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             CCC-CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEE
Confidence            211 223568999999995 9998887643  455899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCC-ccccccccccccchhhhhc-----CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHh
Q psy2676         175 ADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLN-----LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       175 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      +|||.+....... ......++..|+|||.+..     ..++.++||||||+++++|++|..||...........+... 
T Consensus       155 ~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-  233 (275)
T cd06608         155 VDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN-  233 (275)
T ss_pred             CCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc-
Confidence            9999887654322 2234567888999998754     23678999999999999999999999765544444333221 


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                        +. ....                    ....+++.+.++|++||..||++|||+.++++|||+
T Consensus       234 --~~-~~~~--------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         234 --PP-PTLK--------------------SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             --CC-CCCC--------------------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence              11 0000                    011356789999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0604|consensus

Probab=100.00  E-value=4.8e-45  Score=288.10  Aligned_cols=259  Identities=26%  Similarity=0.410  Sum_probs=218.2

Q ss_pred             cceeee-eeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDEL-CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~-~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|.+- .+||-|-.|.|-.+.+ +.+++.+|+|++..       .....+|++..-....  |||||.++++|.+..  
T Consensus        61 edY~is~qvLG~GinGkV~~C~~-k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~--h~~iV~IidVyeNs~--  128 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVH-KRTQEKFALKVLLD-------SPKARREVELHWMASG--HPHIVSIIDVYENSY--  128 (400)
T ss_pred             hhheehhhhhccccCCceEEEEe-ccchhhhHHHHHhc-------CHHHHhHhhhhhhhcC--CCceEEeehhhhhhc--
Confidence            456554 5789999999999999 68999999999863       2356788888777775  999999999997663  


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC---CCEEEee
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIAD  176 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~---~~~kl~d  176 (321)
                       .....+.+|||.++| .|...+..+++..++|.++..|++||+.|+.|||+.+|.||||||+|++....   ..+||+|
T Consensus       129 -~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  129 -QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             -cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecc
Confidence             334678999999995 99999999998889999999999999999999999999999999999999754   4599999


Q ss_pred             cCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCCh----HHHHHHHHHHhCCCC
Q psy2676         177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE----VEQLKCIFRVIGTPS  252 (321)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~  252 (321)
                      ||++.....+.......-|+.|.|||++....++...|+||+|+++|-|++|-+||.....    ..+..+|.......+
T Consensus       208 fGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP  287 (400)
T KOG0604|consen  208 FGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP  287 (400)
T ss_pred             cccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence            9999988767777778889999999999998999999999999999999999999966433    333444443333333


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .++|                       ..+|++.+++|+.+|+.+|++|.|+.++++|||+.+-
T Consensus       288 ~pEW-----------------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  288 EPEW-----------------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             ChhH-----------------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            3333                       3677899999999999999999999999999999864

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.2e-43  Score=294.76  Aligned_cols=256  Identities=31%  Similarity=0.541  Sum_probs=209.8

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|++.+.||.|++|.||+|.+ ..++..+++|++............+.+|+.+++++.   |||++++++++...     
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~-----   71 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRR-KSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK---HPNIVRYYDRIIDR-----   71 (265)
T ss_pred             CceeeeeeccCCCeEEEEeee-cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC---CCccceeeeeeecC-----
Confidence            588999999999999999998 578889999998765433333445667888888888   99999999987543     


Q ss_pred             cceEEEEEeccCcc-CHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeccCCCCcEEEeeCCCEEE
Q psy2676         103 RYLTVYLIFEHVDQ-DLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLH-----SHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus       103 ~~~~~~~v~e~~~~-~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh-----~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      .....++++|++++ +|.+++...  ....+++..++.++.||+.||.+||     +.+++|+||+|+||+++.++.++|
T Consensus        72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl  151 (265)
T cd08217          72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL  151 (265)
T ss_pred             CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence            11467999999985 999998764  2345899999999999999999999     899999999999999999999999


Q ss_pred             eecCCcccccCCCc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         175 ADFGLAKTFDYDMM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       175 ~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      +|||.+........ .....++..|+|||.+.+..++.++|+||||+++++|++|..||...+.......+...    ..
T Consensus       152 ~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~  227 (265)
T cd08217         152 GDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG----KF  227 (265)
T ss_pred             ecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC----CC
Confidence            99999887754443 34456788999999999888999999999999999999999999887654443333221    11


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ..                      ....++..+.+++.+||..+|.+||++.++++|||+
T Consensus       228 ~~----------------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         228 RR----------------------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             CC----------------------CccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            11                      112455889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.6e-44  Score=299.64  Aligned_cols=259  Identities=27%  Similarity=0.477  Sum_probs=209.0

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||.|++|.||++.+ ..+++.+++|.+...... .....+.+|+++++++.   |||++++++.+...    
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~---~~~i~~~~~~~~~~----   71 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLH-RPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCN---SPYIVGFYGAFYNN----   71 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEE-cCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCC---CCchhhhheeeecC----
Confidence            4788999999999999999999 578899999998765332 23446778888888887   99999999998777    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                         ...++++|++. ++|.+++.... ..+++..+..++.|++.||.+||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus        72 ---~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~  147 (265)
T cd06605          72 ---GDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGV  147 (265)
T ss_pred             ---CEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence               78899999999 59999998754 458999999999999999999999 9999999999999999999999999998


Q ss_pred             cccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCCh--HHHHHHHHHHhCCCCCCCcc
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE--VEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~  257 (321)
                      +.......... ..++..|+|||.+.+..++.++|+||+|+++++|++|..||.....  ......+........ ...+
T Consensus       148 ~~~~~~~~~~~-~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~  225 (265)
T cd06605         148 SGQLVNSLAKT-FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-PRLP  225 (265)
T ss_pred             chhhHHHHhhc-ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-CCCC
Confidence            87654332222 6678889999999988899999999999999999999999965421  111111111111111 1100


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                                           ...++..+.++|.+||..||.+|||+.++++||||++-
T Consensus       226 ---------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         226 ---------------------SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             ---------------------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence                                 00156889999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=8.9e-44  Score=297.64  Aligned_cols=256  Identities=28%  Similarity=0.465  Sum_probs=205.1

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.+.||+|++|.||+|++ ..+++.+++|+++....  .....+.+|+.+++.++   |||++++++.+...  
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~---h~~ii~~~~~~~~~--   78 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARN-VNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCK---HSNIVAYFGSYLRR--   78 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEE-cCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCC---CCCeeeEEEEEEeC--
Confidence            456899999999999999999998 57889999999875422  12235667888888887   99999999998776  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ...++++|++++ +|.+++...  +.+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus        79 -----~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd06645          79 -----DKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFG  151 (267)
T ss_pred             -----CEEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcce
Confidence                 678999999995 999998773  458999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCC-ccccccccccccchhhhh---cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         179 LAKTFDYDM-MLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       179 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      .+....... ......++..|+|||++.   ...++.++|+||||+++|+|++|..||..................++  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--  229 (267)
T cd06645         152 VSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--  229 (267)
T ss_pred             eeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC--
Confidence            987554322 223456788999999974   44578899999999999999999999866544333322211111110  


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY  312 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  312 (321)
                      .+.                    ....++..+.++|++||..+|++||+++++++|||
T Consensus       230 ~~~--------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         230 KLK--------------------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ccc--------------------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            000                    01135578899999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=7.7e-44  Score=307.72  Aligned_cols=285  Identities=38%  Similarity=0.631  Sum_probs=223.8

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhc-ccCCCCceeEEEeeeeccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQL-DTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~i~~~~~~~~~~~   98 (321)
                      ..++|++.+.||.|++|.||+|.+ ..+++.+++|.+..............+|+.+++++ +   ||||+++++++... 
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~---h~ni~~~~~~~~~~-   79 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAID-RRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD---HPNIVKLLNVIKAE-   79 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEE-cCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcC---CCCccceeeeeccC-
Confidence            346899999999999999999998 57788999998864322223334566799999999 6   99999999987543 


Q ss_pred             cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676          99 LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                          .....++|+|++.++|.+++...   .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus        80 ----~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g  152 (337)
T cd07852          80 ----NDKDIYLVFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFG  152 (337)
T ss_pred             ----CCceEEEEecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeecc
Confidence                11467999999999999988763   58899999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCC------ccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         179 LAKTFDYDM------MLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       179 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      .+.......      ......++..|+|||.+.+ ...+.++|+||+|+++|+|++|+.||.+....+...++....+.+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07852         153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP  232 (337)
T ss_pred             chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            887654322      1223457888999998765 447889999999999999999999999888888777777766555


Q ss_pred             CCCCcchhhhhhh----hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         252 SMNEWPENISLMW----SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       252 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ....+........    .................++.++.++|.+||+.||++|||+.++++||||++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence            4332221111110    1111122223334445578999999999999999999999999999999876

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.7e-43  Score=293.12  Aligned_cols=253  Identities=29%  Similarity=0.517  Sum_probs=207.6

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC---CCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED---GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      +|+..+.||+|++|+||+|.+ ..+++.+++|.+.......   .....+.+|+.+++.++   |+|++++++++.+.  
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~--   74 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLN-LDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ---HPNIVQYLGTEREE--   74 (258)
T ss_pred             CccccceeeecCCceEEEEEE-cCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC---CCCchheeeeEecC--
Confidence            578889999999999999998 5688999999987543221   12345677888888887   99999999998776  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ...++++||+++ +|.+++...  ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus        75 -----~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~  147 (258)
T cd06632          75 -----DNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFG  147 (258)
T ss_pred             -----CeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCc
Confidence                 678999999985 999999774  348999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      .+.............++..|+|||.+.... ++.++|+||+|+++|+|++|..||...........+......+      
T Consensus       148 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------  221 (258)
T cd06632         148 MAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP------  221 (258)
T ss_pred             cceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCC------
Confidence            987665444344566788899999987776 8999999999999999999999997665433333322211111      


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                                         .....+++.+.+++++||+.+|.+||++.++++|||+
T Consensus       222 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         222 -------------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             -------------------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                               1112455889999999999999999999999999997

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.3e-43  Score=300.96  Aligned_cols=262  Identities=28%  Similarity=0.442  Sum_probs=211.3

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      .+....+|++.+.||+|++|+||++++ ..+++.+++|++....... .....+.+|+.+++.++   |||++++++++.
T Consensus        10 ~~~~~~~y~~~~~lg~g~~g~vy~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~~~~~~~   85 (307)
T cd06607          10 KDDPEKLFTDLREIGHGSFGAVYFARD-VRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR---HPNTIEYKGCYL   85 (307)
T ss_pred             CCCcchhhhhheeecCCCCeEEEEEEE-cCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC---CCCEEEEEEEEE
Confidence            355567899999999999999999998 5788999999886432221 12235678888888887   999999999998


Q ss_pred             ccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          96 QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      +.       ...++|+||+.|++.+++..... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+
T Consensus        86 ~~-------~~~~lv~e~~~g~l~~~~~~~~~-~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~  157 (307)
T cd06607          86 RE-------HTAWLVMEYCLGSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLA  157 (307)
T ss_pred             eC-------CeEEEEHHhhCCCHHHHHHHccc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEe
Confidence            76       67899999999999888865433 48999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhh---cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |||.+......   ....++..|+|||++.   ...++.++||||+|+++|+|++|..||...+.......+...  .+ 
T Consensus       158 dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~-  231 (307)
T cd06607         158 DFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS-  231 (307)
T ss_pred             ecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC-
Confidence            99988755432   2345678899999874   355788999999999999999999999776654443332211  00 


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                       ...+                     ...++..+.++|++||..+|.+||++.+++.||||.....
T Consensus       232 -~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  275 (307)
T cd06607         232 -PTLS---------------------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP  275 (307)
T ss_pred             -CCCC---------------------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence             0000                     1135578999999999999999999999999999987653

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.1e-43  Score=292.67  Aligned_cols=254  Identities=30%  Similarity=0.537  Sum_probs=213.5

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|++.+.||.|++|.||++.+ ..++..+++|++............+.+|++.++.++   |||++++++.+...     
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~~~~~~~~~~~~-----   71 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRR-KSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN---HPNIIKYYESFEEK-----   71 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEE-cCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC---CCChhheEEEEecC-----
Confidence            589999999999999999999 568899999998765444344556778999999988   99999999998776     


Q ss_pred             cceEEEEEeccCcc-CHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         103 RYLTVYLIFEHVDQ-DLGSYMEKCP--PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       103 ~~~~~~~v~e~~~~-~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                        ...++++|++++ +|.+++....  ...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        72 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~  149 (258)
T cd08215          72 --GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGI  149 (258)
T ss_pred             --CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccc
Confidence              678999999995 9999998753  35589999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         180 AKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       180 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      +....... ......+++.|+|||......++.++|+||+|+++++|++|..||...+..+.........    ....  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~--  223 (258)
T cd08215         150 SKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ----YPPI--  223 (258)
T ss_pred             eeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC----CCCC--
Confidence            87665443 2334567888999999988889999999999999999999999998776555444433211    1111  


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                                          ...++..+.+++++||..+|++|||+.++++||||
T Consensus       224 --------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         224 --------------------PSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             --------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                                11455889999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.8e-43  Score=294.08  Aligned_cols=256  Identities=29%  Similarity=0.502  Sum_probs=212.8

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||.|++|.||+|++ ..+++.+++|++...... .....+.+|+..+.+++   |+|++++++++...    
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~-~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~----   71 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRH-KPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCE---SPYVVKCYGAFYKE----   71 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEE-cCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcC---CCCeeeEEEEEccC----
Confidence            4789999999999999999999 568899999998765332 23456778899999888   99999999999776    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                         ...++++|+++ ++|.+++...  ..+++..++.++.|++.||.+||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus        72 ---~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~  146 (264)
T cd06623          72 ---GEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGI  146 (264)
T ss_pred             ---CeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCcc
Confidence               67899999999 5999999874  458999999999999999999999 9999999999999999999999999999


Q ss_pred             cccccCCCcc-ccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCC---hHHHHHHHHHHhCCCCCCC
Q psy2676         180 AKTFDYDMML-TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST---EVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       180 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~  255 (321)
                      +......... ....++..|+|||.+....++.++|+||||+++|+|++|..||....   ..+....+..    .....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~  222 (264)
T cd06623         147 SKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----GPPPS  222 (264)
T ss_pred             ceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc----CCCCC
Confidence            8876543332 24567888999999988889999999999999999999999997764   2222222221    11111


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhh-cchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                                            .... ++..+.++|++||..+|++||++.++++||||++.+
T Consensus       223 ----------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         223 ----------------------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             ----------------------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                                  1123 668999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-43  Score=300.06  Aligned_cols=260  Identities=27%  Similarity=0.444  Sum_probs=207.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||+|++|.||++.+ ..++..+++|.++..... .....+.+|+.+++++.   |||++++++.+...    
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~-~~~~~~~a~k~~~~~~~~-~~~~~~~~e~~~l~~~~---~~~i~~~~~~~~~~----   71 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLH-RPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAV---SPYIVDFYGAFFIE----   71 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEE-cCCCcEEEEEEeecccCH-HHHHHHHHHHHHHHhcC---CCcHHhhhhheecC----
Confidence            4789999999999999999998 578899999988653221 12246678999999887   99999999998776    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCP-PPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                         ...++|+||+++ +|..++.... ...+++..+..++.|++.||.+||+ .|++|+||+|+||+++.++.++|+|||
T Consensus        72 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg  148 (286)
T cd06622          72 ---GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFG  148 (286)
T ss_pred             ---CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecC
Confidence               678999999996 8888886632 2358999999999999999999996 599999999999999999999999999


Q ss_pred             CcccccCCCccccccccccccchhhhhcCC------CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLG------YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      .+...... ......++..|+|||.+.+..      ++.++|+||+|+++|+|++|+.||...........+.......+
T Consensus       149 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd06622         149 VSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP  227 (286)
T ss_pred             CcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC
Confidence            98765422 223345778899999985543      47899999999999999999999976544433333222221111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ..                       ...+++.++.++|++||..+|.+||++.++++||||....
T Consensus       228 ~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         228 PT-----------------------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             CC-----------------------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            11                       1124568899999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.7e-43  Score=293.08  Aligned_cols=254  Identities=26%  Similarity=0.490  Sum_probs=210.5

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|.+.+.||+|++|.||++.+ ..++..+++|.+............+.+|+.++++++   |+|++++++.+...     
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~---h~~i~~~~~~~~~~-----   71 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKA-KSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK---HPNIVTFFASFQEN-----   71 (257)
T ss_pred             CceEEEEecCCCcceEEEEEE-cCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC---CCChhhhhheeccC-----
Confidence            589999999999999999999 578889999998765433334456778999999998   99999999998776     


Q ss_pred             cceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC-EEEeecCCc
Q psy2676         103 RYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG-LKIADFGLA  180 (321)
Q Consensus       103 ~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~-~kl~dfg~~  180 (321)
                        ...++++|++.+ +|.+++.......+++..+..++.|++.||.+||+.+++|+||+|+||++++++. ++|+|||.+
T Consensus        72 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~  149 (257)
T cd08225          72 --GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA  149 (257)
T ss_pred             --CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccc
Confidence              678999999985 9999997755555899999999999999999999999999999999999988865 699999988


Q ss_pred             ccccCCCc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         181 KTFDYDMM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       181 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ........ .....++..|+|||++.+..++.++|+||+|+++++|++|..||...+..+....+....    ..     
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~-----  220 (257)
T cd08225         150 RQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY----FA-----  220 (257)
T ss_pred             hhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc----CC-----
Confidence            76654332 223457888999999988889999999999999999999999998766554443322211    00     


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                                       ......+..+.++|.+||..+|++|||+.++++||||
T Consensus       221 -----------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         221 -----------------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                             0112455789999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.5e-43  Score=296.28  Aligned_cols=270  Identities=25%  Similarity=0.393  Sum_probs=210.8

Q ss_pred             ccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          12 LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        12 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      +.++.+....++|++.+.||+|++|.||+|.+ ..+++.+++|++....   .....+.+|+.+++.+..  |||+++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~--h~~i~~~~   81 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLN-KKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSD--HPNVVKFY   81 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEE-CCCCceeEEEeecccc---chHHHHHHHHHHHHHHhc--CCCeeeee
Confidence            45677778889999999999999999999999 5788999999875421   123456788899988843  99999999


Q ss_pred             eeeeccccccccceEEEEEeccCcc-CHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR  168 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~  168 (321)
                      +++....  .......++||||++| +|.+++...  ....+++..++.++.|++.||.+||+.+++|+||+|+||+++.
T Consensus        82 ~~~~~~~--~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~  159 (286)
T cd06638          82 GMYYKKD--VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT  159 (286)
T ss_pred             eeeeecc--cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECC
Confidence            9875431  1122468999999985 998887532  2345889999999999999999999999999999999999999


Q ss_pred             CCCEEEeecCCcccccCCC-ccccccccccccchhhhhc-----CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHH
Q psy2676         169 AGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLN-----LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLK  242 (321)
Q Consensus       169 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  242 (321)
                      ++.++|+|||.+....... ......++..|+|||.+..     ..++.++|+||+|+++|+|++|..||..........
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~  239 (286)
T cd06638         160 EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF  239 (286)
T ss_pred             CCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh
Confidence            9999999999987654322 2334568899999998853     347889999999999999999999997665433332


Q ss_pred             HHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      .....  .++...                      ....++..+.+++.+||+.||++|||+.++++|+||
T Consensus       240 ~~~~~--~~~~~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         240 KIPRN--PPPTLH----------------------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             hcccc--CCCccc----------------------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            21111  000000                      011244689999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.3e-43  Score=295.75  Aligned_cols=256  Identities=27%  Similarity=0.392  Sum_probs=199.5

Q ss_pred             eeecccceeEEEEEEecCCCcEEEEEEeecccCCCCC-CchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEE
Q psy2676          29 QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI-PMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTV  107 (321)
Q Consensus        29 ~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~  107 (321)
                      .||+|+||.||++.+ ..+++.+++|.+......... .....+|..+++.+....||+++.+++.+...       ...
T Consensus         1 ~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-------~~~   72 (279)
T cd05633           1 IIGRGGFGEVYGCRK-ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-------DKL   72 (279)
T ss_pred             CcccCCCeEEEEEEE-CCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-------CeE
Confidence            489999999999998 578899999998754332221 22344566566665545599999999998776       678


Q ss_pred             EEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCC
Q psy2676         108 YLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD  186 (321)
Q Consensus       108 ~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~  186 (321)
                      ++||||+.+ +|.+++...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        73 ~lv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~  150 (279)
T cd05633          73 CFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (279)
T ss_pred             EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc
Confidence            999999995 999888763  44899999999999999999999999999999999999999999999999988655432


Q ss_pred             Cccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhh
Q psy2676         187 MMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS  265 (321)
Q Consensus       187 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
                      . .....++..|+|||.+.. ..++.++|+||+|+++|+|++|..||.......... +...... ..            
T Consensus       151 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~-~~------------  215 (279)
T cd05633         151 K-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT-VN------------  215 (279)
T ss_pred             C-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhhc-CC------------
Confidence            2 233568899999999864 557899999999999999999999997543221111 1110000 00            


Q ss_pred             hhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                                ......++.++.++|++||..||.+||     |+.++++||||++.++.
T Consensus       216 ----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~  264 (279)
T cd05633         216 ----------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ  264 (279)
T ss_pred             ----------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence                      011224568999999999999999999     69999999999997653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.3e-43  Score=309.55  Aligned_cols=260  Identities=23%  Similarity=0.310  Sum_probs=203.0

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEE
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRF   90 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~   90 (321)
                      ..+....++|++.+.||+|+||.||+|++.    ..++..||+|+++..... .....+.+|+++++.+..  |+||+++
T Consensus        31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~--h~nIv~~  107 (374)
T cd05106          31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQ--HKNIVNL  107 (374)
T ss_pred             ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhcc--CCceeeE
Confidence            355677789999999999999999999863    223457999998754322 223456789999999842  9999999


Q ss_pred             EeeeeccccccccceEEEEEeccCc-cCHHHHHhhCC-------------------------------------------
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP-------------------------------------------  126 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~-------------------------------------------  126 (321)
                      ++++...       ..+++||||+. |+|.+++....                                           
T Consensus       108 ~~~~~~~-------~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (374)
T cd05106         108 LGACTHG-------GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDT  180 (374)
T ss_pred             eeEecCC-------CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccc
Confidence            9998776       67899999999 59998885421                                           


Q ss_pred             -------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         127 -------------------------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       127 -------------------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                                               ...+++..+++++.||+.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~  260 (374)
T cd05106         181 YVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR  260 (374)
T ss_pred             ccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeee
Confidence                                     1237888999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         182 TFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       182 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      .......   .....++..|+|||++....++.++||||||+++|+|++ |..||..................+..    
T Consensus       261 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~----  336 (374)
T cd05106         261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR----  336 (374)
T ss_pred             eccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC----
Confidence            6543221   112234567999999998889999999999999999997 99999765443333333221111111    


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                           ...+++++.+++.+||+.||.+|||+.++++
T Consensus       337 ---------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         337 ---------------------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ---------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                 0124588999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5e-43  Score=292.57  Aligned_cols=255  Identities=28%  Similarity=0.509  Sum_probs=206.7

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      ||.+.+.||+|++|.||++.+ ..++..+++|.++...........+.+|+.++++++   |+||+++++.+...     
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~---~~~i~~~~~~~~~~-----   71 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVN-LDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK---HPNLVKYYGVEVHR-----   71 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEE-CCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC---CCChhheeeeEecC-----
Confidence            689999999999999999998 578899999998765433234456778999999997   99999999998666     


Q ss_pred             cceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                        ...++|+|++. ++|.+++...  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        72 --~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~  147 (264)
T cd06626          72 --EKVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAV  147 (264)
T ss_pred             --CEEEEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccccccc
Confidence              67899999998 4999998773  347899999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCcc-----ccccccccccchhhhhcCC---CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         182 TFDYDMML-----TSVVVTLWYRAPEILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       182 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      ........     ....++..|+|||.+.+..   .+.++||||+|++++++++|..||..................+..
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  227 (264)
T cd06626         148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPI  227 (264)
T ss_pred             ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCC
Confidence            76533221     1245678899999998766   789999999999999999999999765432222221111111111


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      +.                       ...+++.+.++|++||+.+|.+||++.+++.|||+
T Consensus       228 ~~-----------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         228 PD-----------------------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             Cc-----------------------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            11                       11345888999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.3e-43  Score=291.14  Aligned_cols=256  Identities=27%  Similarity=0.479  Sum_probs=204.3

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCC---CchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI---PMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      +.|++.+.||+|++|.||++.+ ..++..+++|.+.........   ...+.+|+.+++++.   |||++++++++.+..
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~   77 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYD-ADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL---HERIVQYYGCLRDPM   77 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEE-cCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC---CCCeeeEEeEeccCC
Confidence            5799999999999999999998 578899999988653222211   235567899999987   999999999876531


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                           ...+++++|++++ +|.+++...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus        78 -----~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Df  150 (265)
T cd06652          78 -----ERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDF  150 (265)
T ss_pred             -----CceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcC
Confidence                 1357899999984 999998774  34789999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCC----ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         178 GLAKTFDYDM----MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       178 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      |.+.......    ......++..|+|||++.+..++.++|+||||+++|+|++|+.||.............   ..+..
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~  227 (265)
T cd06652         151 GASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPTN  227 (265)
T ss_pred             ccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCCC
Confidence            9887543211    1223457788999999988889999999999999999999999997765444433322   22221


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK  314 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~  314 (321)
                      ...+                      ...+..+.++|++|+. +|.+||+++++++|||+.
T Consensus       228 ~~~~----------------------~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         228 PVLP----------------------PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             CCCc----------------------hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            2211                      1334778899999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG2345|consensus

Probab=100.00  E-value=2.6e-45  Score=282.30  Aligned_cols=260  Identities=23%  Similarity=0.324  Sum_probs=208.8

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      -.++-+.++||++.+.||.|+|+.||+++. -.++..||+|++..+.  .......++|+...++++   |||++++++.
T Consensus        13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~-~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~---s~~vl~l~dh   86 (302)
T KOG2345|consen   13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKG-LSTGHLYALKKILCHS--QEDIEEALREIDNHRKFN---SPNVLRLVDH   86 (302)
T ss_pred             CCcEEEcCceEEEeeeecCCCceeeeeecc-cCcccchhhheeeccc--hHHHHHHHHHHHHHHhhC---CcchHHHHHH
Confidence            446677899999999999999999999998 4788999999988754  334567889999999999   9999999998


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEee
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--PPGLSASKVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLITR  168 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~~~--~~H~di~p~Nilv~~  168 (321)
                      ......+  .....|++++|.. |+|.+.+..+.  +..+++.++..++.+|+.||++||+..  +.|+||||.||++++
T Consensus        87 ~l~~~~D--~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~  164 (302)
T KOG2345|consen   87 QLREEKD--GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD  164 (302)
T ss_pred             HHHhhcc--CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC
Confidence            7766333  4467899999998 79999987654  334999999999999999999999998  999999999999999


Q ss_pred             CCCEEEeecCCcccccCCC----------ccccccccccccchhhhhc---CCCCCcchHHHHHHHHHHHHhcCCCCCCC
Q psy2676         169 AGGLKIADFGLAKTFDYDM----------MLTSVVVTLWYRAPEILLN---LGYGTPVDIWSIGCVMAEMWRLVPLFCAS  235 (321)
Q Consensus       169 ~~~~kl~dfg~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~  235 (321)
                      ++.++|.|||+++...-.-          ......-|..|.|||++..   ...+.++|||||||++|.|+.|..||+..
T Consensus       165 ~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~  244 (302)
T KOG2345|consen  165 SGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI  244 (302)
T ss_pred             CCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence            9999999999998764221          1122334778999999864   44788999999999999999999999532


Q ss_pred             ChHHHHHHHHHHhCCCC------CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         236 TEVEQLKCIFRVIGTPS------MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       236 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      -         ...++..      .-.+|.                    ...+|+.+.++|++||++||.+||++.+++.
T Consensus       245 ~---------~~GgSlaLAv~n~q~s~P~--------------------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~  295 (302)
T KOG2345|consen  245 Y---------QQGGSLALAVQNAQISIPN--------------------SSRYSEALHQLIKSMLQVDPNQRPTIPELLS  295 (302)
T ss_pred             h---------hcCCeEEEeeeccccccCC--------------------CCCccHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            1         1111100      001111                    0136689999999999999999999999986


Q ss_pred             C
Q psy2676         310 H  310 (321)
Q Consensus       310 h  310 (321)
                      +
T Consensus       296 ~  296 (302)
T KOG2345|consen  296 K  296 (302)
T ss_pred             H
Confidence            4

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.7e-43  Score=294.94  Aligned_cols=266  Identities=28%  Similarity=0.468  Sum_probs=206.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|+..+.||.|++|.||++.+ ..+++.+++|.+...... .....+.+|++++++++   ||||+++++++.+..   
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~---   72 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRL-KNTGMIFALKTITTDPNP-DLQKQILRELEINKSCK---SPYIVKYYGAFLDES---   72 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEE-CCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCC---CCCeeeeeeEEEccC---
Confidence            4799999999999999999999 578899999998754222 23446778999998887   999999999985541   


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                        ...+++|||++++ +|.+++...  ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus        73 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg  150 (287)
T cd06621          73 --SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG  150 (287)
T ss_pred             --CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecc
Confidence              1467999999985 998876542  23448999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCCh-----HHHHHHHHHHhCCCCC
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE-----VEQLKCIFRVIGTPSM  253 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~  253 (321)
                      .+....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.....     .+....+.. ...+..
T Consensus       151 ~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~  228 (287)
T cd06621         151 VSGELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPEL  228 (287)
T ss_pred             ccccccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhh
Confidence            986554222 2234567889999999988899999999999999999999999976521     111111111 000000


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ...                   .......++.+.++|.+||..+|.+|||+.|+++||||++...
T Consensus       229 ~~~-------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         229 KDE-------------------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             ccC-------------------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence            000                   0000123468899999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=8.2e-43  Score=291.53  Aligned_cols=248  Identities=24%  Similarity=0.396  Sum_probs=197.4

Q ss_pred             cceeeeeee--ecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          22 KKYDELCQI--GCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        22 ~~y~~~~~l--g~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      +.|++.+.+  |+|+||.||++++ ..++..+++|.+.......       .|+.....+.  +|||++++++.+...  
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~--~h~~iv~~~~~~~~~--   81 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKH-KPTQKLFVQKIIKAKNFNA-------IEPMVHQLMK--DNPNFIKLYYSVTTL--   81 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEE-cCCCcEEEEEEEehhhcch-------hhHHHHHHhh--cCCCEEEEEEEEecC--
Confidence            567777776  9999999999998 5788899999986542211       1233333232  399999999999877  


Q ss_pred             ccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC-CEEEeec
Q psy2676         100 SDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADF  177 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~-~~kl~df  177 (321)
                           ...++||||++ ++|.+++....  .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+||
T Consensus        82 -----~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         82 -----KGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             -----CeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence                 67899999998 59999998743  589999999999999999999999999999999999999998 9999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHH-HHHHHHHhCCCCCCCc
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQ-LKCIFRVIGTPSMNEW  256 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  256 (321)
                      |.+.......   ...++..|+|||++.+..++.++|+||+|+++++|++|..||........ ........ ....   
T Consensus       155 g~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~---  227 (267)
T PHA03390        155 GLCKIIGTPS---CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKL---  227 (267)
T ss_pred             ccceecCCCc---cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccC---
Confidence            9987665332   33578889999999988899999999999999999999999975543321 11111111 1000   


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-HHHHhCCCCCCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-AADALEHPYFKE  315 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~~ll~h~~f~~  315 (321)
                                          .....+++.+.++|.+||+.+|.+||+ .+++++||||++
T Consensus       228 --------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        228 --------------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             --------------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                                111256689999999999999999996 599999999985

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-43  Score=292.77  Aligned_cols=254  Identities=31%  Similarity=0.497  Sum_probs=201.2

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||.|++|.||+|.+ ..+++.+++|++...... .........|..++....  .|+|++++++++...       ..
T Consensus         2 ~~l~~g~~~~v~~a~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~~-------~~   71 (260)
T cd05611           2 KPISKGAFGSVYLAKK-RSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQG--ESPYVAKLYYSFQSK-------DY   71 (260)
T ss_pred             ccCCcCCCeeEEEEEe-cCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcC--CCCCeeeeeeeEEcC-------Ce
Confidence            5789999999999998 578899999998653211 111122334444433332  399999999999776       67


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccC
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY  185 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~  185 (321)
                      .++++||+++ +|.+++...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        72 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  149 (260)
T cd05611          72 LYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE  149 (260)
T ss_pred             EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence            8999999985 999999774  3489999999999999999999999999999999999999999999999998875442


Q ss_pred             CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhh
Q psy2676         186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS  265 (321)
Q Consensus       186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
                         .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+......     ++        
T Consensus       150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~--------  213 (260)
T cd05611         150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN-----WP--------  213 (260)
T ss_pred             ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC-----CC--------
Confidence               22345678899999998888899999999999999999999999877665554443321110     00        


Q ss_pred             hhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC---HHHHhCCCCCCCCCCC
Q psy2676         266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS---AADALEHPYFKEKENE  319 (321)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~f~~~~~~  319 (321)
                                ......++..+.+++.+||..+|++||+   ++|+++||||++.+|+
T Consensus       214 ----------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         214 ----------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD  260 (260)
T ss_pred             ----------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence                      0111246689999999999999999995   5799999999999885

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7e-43  Score=293.00  Aligned_cols=257  Identities=31%  Similarity=0.490  Sum_probs=204.3

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCC--------CchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI--------PMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~--------~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      +|.+.+.||.|++|.||+|.+ ..+++.+++|.++........        ...+.+|+.++++++   |||++++++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~-~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALN-VTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD---HLNIVQYLGFE   77 (272)
T ss_pred             ceeecceecccCceEEEEEee-cCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC---CCCcceEEEEe
Confidence            688999999999999999998 567899999988643222111        124567888888887   99999999998


Q ss_pred             eccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      ...       ...++|+|++.+ +|.+++...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++
T Consensus        78 ~~~-------~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~  148 (272)
T cd06629          78 TTE-------EYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICK  148 (272)
T ss_pred             ccC-------CceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEE
Confidence            766       678999999985 999999874  4589999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCC---ccccccccccccchhhhhcCC--CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHh
Q psy2676         174 IADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLG--YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       174 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      |+|||.+.......   ......++..|+|||.+....  ++.++|+||||++++++++|..||......+.........
T Consensus       149 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  228 (272)
T cd06629         149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR  228 (272)
T ss_pred             EeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc
Confidence            99999987653221   122345778899999987755  7899999999999999999999997654443332221111


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                         .....+                  ......++..+.++|.+||.++|.+|||++++++||||
T Consensus       229 ---~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         229 ---SAPPIP------------------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ---cCCcCC------------------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence               111111                  01123567899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.6e-43  Score=306.96  Aligned_cols=260  Identities=22%  Similarity=0.287  Sum_probs=203.0

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      .+.+..++|++.+.||+|+||+||+|+..    ..++..+|+|+++.... ......+.+|+.+++.+..  ||||++++
T Consensus        29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~--HpnIv~l~  105 (375)
T cd05104          29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGN--HINIVNLL  105 (375)
T ss_pred             ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcC--Ccceeeee
Confidence            44566679999999999999999999752    24566899999864322 2223467789999999942  99999999


Q ss_pred             eeeeccccccccceEEEEEeccCc-cCHHHHHhhCC--------------------------------------------
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--------------------------------------------  126 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--------------------------------------------  126 (321)
                      +++...       ...++||||++ |+|.+++....                                            
T Consensus       106 ~~~~~~-------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  178 (375)
T cd05104         106 GACTVG-------GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYV  178 (375)
T ss_pred             eeeccC-------CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccc
Confidence            999776       67899999999 59998886532                                            


Q ss_pred             -----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676         127 -----------------------------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus       127 -----------------------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                                                   ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+||
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Df  258 (375)
T cd05104         179 VPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDF  258 (375)
T ss_pred             cccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecC
Confidence                                         123688899999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         178 GLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       178 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      |++........   .....++..|+|||++.+..++.++||||||+++|+|++ |..||..........+.......+..
T Consensus       259 G~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~  338 (375)
T cd05104         259 GLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS  338 (375)
T ss_pred             ccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCC
Confidence            99876543321   112334567999999999999999999999999999998 89999765544333333221111110


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                                               ....+.++.+++.+||+.||++|||+.++++.
T Consensus       339 -------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         339 -------------------------PECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             -------------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                     11235789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-43  Score=294.93  Aligned_cols=260  Identities=25%  Similarity=0.450  Sum_probs=210.0

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      .|++.+.||.|++|.||+|.+ ..+++.+++|++..... ......+.+|+.+++++....|||++++++++...     
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~-~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-----   74 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKH-VPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-----   74 (277)
T ss_pred             hhhhhhheeccCCceEEEEEE-cCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-----
Confidence            588899999999999999998 57889999999865422 22334677899999999766699999999998766     


Q ss_pred             cceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                        ...++|+|++.+ +|.+++...   .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        75 --~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06917          75 --PRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAA  149 (277)
T ss_pred             --CEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCcee
Confidence              678999999985 999988662   48999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCC-ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         182 TFDYDM-MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       182 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ...... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+..    ...+.++  
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----~~~~~~~--  223 (277)
T cd06917         150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK----SKPPRLE--  223 (277)
T ss_pred             ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc----CCCCCCC--
Confidence            665333 22334678889999988654 468999999999999999999999977654333221111    0001110  


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                                         ....+.++.+++.+||..||.+||++.++++||||++....
T Consensus       224 -------------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~  264 (277)
T cd06917         224 -------------------DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKT  264 (277)
T ss_pred             -------------------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence                               01255789999999999999999999999999999987543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.5e-43  Score=295.93  Aligned_cols=262  Identities=23%  Similarity=0.404  Sum_probs=209.6

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      +..++|++.+.||+|++|+||++.+ ..++..+++|++..... ......+.+|+++++.++   |||++++++++... 
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~-~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~-   75 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKH-IPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECR---SPYIVSFYGAFLNE-   75 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEE-cCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcC---CCCcceEeeeEecC-
Confidence            4567899999999999999999998 57789999998865422 223456778999999887   99999999999877 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeeCCCEEEee
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                            ...++|+||+++ +|.+++...  +.+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|
T Consensus        76 ------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d  147 (284)
T cd06620          76 ------NNICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCD  147 (284)
T ss_pred             ------CEEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEcc
Confidence                  678999999995 898888773  458999999999999999999997 6999999999999999999999999


Q ss_pred             cCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHH--------HHHHHHHh
Q psy2676         177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQ--------LKCIFRVI  248 (321)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------~~~~~~~~  248 (321)
                      ||++...... ......++..|+|||++.+..++.++|+||+|+++|++++|..||........        ........
T Consensus       148 ~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd06620         148 FGVSGELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV  226 (284)
T ss_pred             CCcccchhhh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh
Confidence            9988654322 22345678899999999888899999999999999999999999976543211        01011100


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      .. .....+                     ...++..+.+|+.+||+.||.+|||+.++++|+||.+..
T Consensus       227 ~~-~~~~~~---------------------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         227 QE-PPPRLP---------------------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             hc-cCCCCC---------------------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            00 000000                     113567899999999999999999999999999997664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.7e-43  Score=298.15  Aligned_cols=260  Identities=22%  Similarity=0.306  Sum_probs=200.2

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEec---------------CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCC
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQ---------------NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE   83 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~---------------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   83 (321)
                      +..++|++.+.||+|+||.||+|.+..               ..+..||+|++..... ......+.+|+.++++++   
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~---   77 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLK---   77 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcC---
Confidence            456799999999999999999998521               2344799998865322 122345778999999887   


Q ss_pred             CCceeEEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCC-----------------CCCCCHHHHHHHHHHHHHH
Q psy2676          84 HPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP-----------------PPGLSASKVKELTRQMLKG  145 (321)
Q Consensus        84 ~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~-----------------~~~~~~~~~~~i~~~l~~~  145 (321)
                      ||||+++++++.+.       ...++|+||+. ++|.+++....                 ...+++..++.++.||+.|
T Consensus        78 h~niv~~~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a  150 (304)
T cd05096          78 DPNIIRLLGVCVDE-------DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASG  150 (304)
T ss_pred             CCCeeEEEEEEecC-------CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999776       56899999998 59999886532                 1236788899999999999


Q ss_pred             HHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHH
Q psy2676         146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVM  222 (321)
Q Consensus       146 l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l  222 (321)
                      |.+||+.|++|+||||+||+++.++.+||+|||.+........   .....++..|+|||++....++.++||||||+++
T Consensus       151 l~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l  230 (304)
T cd05096         151 MKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL  230 (304)
T ss_pred             HHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHH
Confidence            9999999999999999999999999999999999876543221   1223446789999999988899999999999999


Q ss_pred             HHHHh--cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCC
Q psy2676         223 AEMWR--LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD  300 (321)
Q Consensus       223 ~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  300 (321)
                      |+|++  +..||......+.................                   ......++..+.+++.+||..||.+
T Consensus       231 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~li~~cl~~~p~~  291 (304)
T cd05096         231 WEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVY-------------------LFRPPPCPQGLYELMLQCWSRDCRE  291 (304)
T ss_pred             HHHHHccCCCCCCcCCHHHHHHHHHHHhhhcccccc-------------------ccCCCCCCHHHHHHHHHHccCCchh
Confidence            99987  56788776655554443322111100000                   0011246688999999999999999


Q ss_pred             CCCHHHHh
Q psy2676         301 RISAADAL  308 (321)
Q Consensus       301 Rps~~~ll  308 (321)
                      |||+.+|.
T Consensus       292 RPs~~~i~  299 (304)
T cd05096         292 RPSFSDIH  299 (304)
T ss_pred             CcCHHHHH
Confidence            99999994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.9e-43  Score=296.06  Aligned_cols=257  Identities=25%  Similarity=0.440  Sum_probs=210.1

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ...|+..+.||.|++|.||+|.+ ..++..+++|++...... .....+.+|+.+++++.   |||++++++++.+.   
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~-~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~---   74 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGID-NRTQQVVAIKIIDLEEAE-DEIEDIQQEITVLSQCD---SPYVTKYYGSYLKG---   74 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEE-ccCCEEEEEEEEeccccH-HHHHHHHHHHHHHHhCC---CCCEeeEEEEEEEC---
Confidence            35788999999999999999998 577889999998754221 12345677888888887   99999999999877   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++|+|+++| +|.+++..   ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.
T Consensus        75 ----~~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~  147 (277)
T cd06640          75 ----TKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGV  147 (277)
T ss_pred             ----CEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEccccc
Confidence                689999999985 99998875   3489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         180 AKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       180 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      +....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.. .   ..+    
T Consensus       148 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~---~~~----  219 (277)
T cd06640         148 AGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK-N---NPP----  219 (277)
T ss_pred             ceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc-C---CCC----
Confidence            87654332 22334567889999999888899999999999999999999999987655433322211 0   000    


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                                        .....++..+.+++.+||+.+|.+||++.++++||||.+...
T Consensus       220 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         220 ------------------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             ------------------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence                              111245578899999999999999999999999999988754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7e-43  Score=295.32  Aligned_cols=265  Identities=22%  Similarity=0.367  Sum_probs=208.5

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +++..++|++.+.||+|+||.||+|....    ..+..+++|.+...... .....+.+|+..++++.   |||++++++
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~---~~~i~~~~~   76 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFT---CHHVVRLLG   76 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-HHHHHHHHHHHHHHhCC---CCCeeeEEE
Confidence            46677899999999999999999997531    23558999987543211 11234567888888887   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQN  163 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~N  163 (321)
                      ++.+.       ...++||||+. |+|.+++....        ....+...+..++.||+.||.+||++|++|+||||+|
T Consensus        77 ~~~~~-------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~n  149 (288)
T cd05061          77 VVSKG-------QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARN  149 (288)
T ss_pred             EEcCC-------CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChhe
Confidence            98766       56799999998 59999997532        1235677889999999999999999999999999999


Q ss_pred             EEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHH
Q psy2676         164 LLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVE  239 (321)
Q Consensus       164 ilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~  239 (321)
                      |+++.++.++|+|||.+........   .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+
T Consensus       150 ili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~  229 (288)
T cd05061         150 CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ  229 (288)
T ss_pred             EEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999998875432221   112234667999999998889999999999999999998 788998766655


Q ss_pred             HHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC------CCCC
Q psy2676         240 QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE------HPYF  313 (321)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------h~~f  313 (321)
                      ....+.... .+.   .                      ...+++.+.+++.+||+.||++|||+.++++      ||||
T Consensus       230 ~~~~~~~~~-~~~---~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  283 (288)
T cd05061         230 VLKFVMDGG-YLD---Q----------------------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF  283 (288)
T ss_pred             HHHHHHcCC-CCC---C----------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCC
Confidence            444333211 110   0                      1134578999999999999999999999987      9999


Q ss_pred             CCCCC
Q psy2676         314 KEKEN  318 (321)
Q Consensus       314 ~~~~~  318 (321)
                      +++.|
T Consensus       284 ~~~~~  288 (288)
T cd05061         284 PEVSF  288 (288)
T ss_pred             CCCCC
Confidence            99876

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.6e-43  Score=292.57  Aligned_cols=253  Identities=21%  Similarity=0.283  Sum_probs=202.6

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEec--CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQ--NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +..++|++.+.||+|+||.||++....  ..+..+++|.++..... .....+.+|+..+++++   |||++++++++..
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~   77 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-KQRRGFLAEALTLGQFD---HSNIVRLEGVITR   77 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-HHHHHHHHHHHHHhcCC---CCCcCeEEEEEec
Confidence            466789999999999999999997642  34678999988653221 22335677888888887   9999999999876


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ...++||||+++ +|.+++.... ..+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++++
T Consensus        78 ~-------~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~  149 (266)
T cd05064          78 G-------NTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKIS  149 (266)
T ss_pred             C-------CCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEEC
Confidence            5       678999999995 8998887643 348999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCccc--cccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         176 DFGLAKTFDYDMMLT--SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       176 dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |||.+..........  ...++..|+|||.+.+..++.++||||+|+++|++++ |..||......+....+......+.
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~  229 (266)
T cd05064         150 GFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA  229 (266)
T ss_pred             CCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC
Confidence            999765443221111  2234567999999999999999999999999999775 9999988776665555433211111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                                ...++..+.+++.+||+.+|.+||++++|++
T Consensus       230 --------------------------~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         230 --------------------------PRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             --------------------------CCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                                      1246688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-42  Score=290.46  Aligned_cols=252  Identities=23%  Similarity=0.382  Sum_probs=206.8

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ++....|.+.+.||+|++|.||+|.+ ...++.+++|.+...   ......+.+|+..+++++   |||++++++++...
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~-~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~   74 (263)
T cd05052           2 EMERTDITMKHKLGGGQYGEVYEGVW-KKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIK---HPNLVQLLGVCTRE   74 (263)
T ss_pred             CCchHHeEEeeecCCcccceEEEEEE-ecCCceEEEEEecCC---chHHHHHHHHHHHHHhCC---CCChhheEEEEcCC
Confidence            55677899999999999999999998 577889999987632   222346778999999987   99999999998766


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ..+++++|+++ ++|.+++.......+++..++.++.|++.||++||+.|++|+||+|+||++++++.++|+|
T Consensus        75 -------~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~d  147 (263)
T cd05052          75 -------PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVAD  147 (263)
T ss_pred             -------CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCC
Confidence                   56799999998 5999999876556689999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCccc--cccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         177 FGLAKTFDYDMMLT--SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       177 fg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      ||.+..........  ....+..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+.....    
T Consensus       148 f~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~----  223 (263)
T cd05052         148 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR----  223 (263)
T ss_pred             CccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC----
Confidence            99987664332211  1223567999999998889999999999999999998 9999987666554444332111    


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ..                      ....++.++.++|.+||+.+|++|||+.++++
T Consensus       224 ~~----------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         224 ME----------------------RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             CC----------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            11                      11245689999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0577|consensus

Probab=100.00  E-value=5.6e-45  Score=311.35  Aligned_cols=264  Identities=28%  Similarity=0.446  Sum_probs=223.6

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      .+.+...|.=++.||+|+||.||.|++ ..+++.||||.+..+.... ..-.++..|+..|+++.   |||++.+.+||.
T Consensus        21 k~DPEklf~dLrEIGHGSFGAVYfArd-~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~---HPntieYkgCyL   96 (948)
T KOG0577|consen   21 KDDPEKLFSDLREIGHGSFGAVYFARD-VRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR---HPNTIEYKGCYL   96 (948)
T ss_pred             cCCHHHHHHHHHHhcCCccceeEEeec-cCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc---CCCcccccceee
Confidence            455567789999999999999999999 6899999999987653322 22346778999999998   999999999998


Q ss_pred             ccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          96 QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      ..       .+.++|||||-|+-.+++.-...+ +.+-.++.|+.+.+.||+|||+.+.+|||||.-||++++.|.+||+
T Consensus        97 re-------~TaWLVMEYClGSAsDlleVhkKp-lqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLa  168 (948)
T KOG0577|consen   97 RE-------HTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLA  168 (948)
T ss_pred             cc-------chHHHHHHHHhccHHHHHHHHhcc-chHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeec
Confidence            87       788999999999988888876544 9999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhh---cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |||.+....+.   .+.+|||.|+|||++.   .+.|+-++||||||++..++...++|.=..+....+..|...-.+..
T Consensus       169 DFGSAsi~~PA---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtL  245 (948)
T KOG0577|consen  169 DFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL  245 (948)
T ss_pred             cccchhhcCch---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCC
Confidence            99999876643   4678999999999985   46699999999999999999999999877777766666543211111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP  320 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~~  320 (321)
                       .                        ..+++..|++|+..||++-|.+|||.+++|+|+|..--++.+
T Consensus       246 -q------------------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~t  288 (948)
T KOG0577|consen  246 -Q------------------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPT  288 (948)
T ss_pred             -C------------------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCch
Confidence             0                        135668999999999999999999999999999987655443

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.1e-42  Score=293.99  Aligned_cols=265  Identities=31%  Similarity=0.526  Sum_probs=218.4

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      .+.+...+.|++.+.||+|++|.||++.+ ..++..+++|++.....   ....+.+|+..+++++   |+|++++++++
T Consensus        12 ~~~~~~~~~~~~~~~l~~g~~~~v~~~~~-~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~---~~~i~~~~~~~   84 (286)
T cd06614          12 VSEGDPRELYKNLEKIGEGASGEVYKATD-RATGKEVAIKKMRLRKQ---NKELIINEILIMKDCK---HPNIVDYYDSY   84 (286)
T ss_pred             cCCCCccccchHhHhccCCCCeEEEEEEE-ccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCC---CCCeeEEEEEE
Confidence            34556778899999999999999999998 56788999999875432   2446778999998887   99999999999


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      ...       ...++++|+++ ++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++
T Consensus        85 ~~~-------~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~  156 (286)
T cd06614          85 LVG-------DELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVK  156 (286)
T ss_pred             EEC-------CEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEE
Confidence            877       68899999999 59999998854 2589999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         174 IADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       174 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+... ..+.
T Consensus       157 l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~  235 (286)
T cd06614         157 LADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP  235 (286)
T ss_pred             ECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC
Confidence            99999886554322 122345678899999998888999999999999999999999999876655444333221 1111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ...                       ...++..+.++|++||+.+|.+||++.++++||||++..+
T Consensus       236 ~~~-----------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         236 LKN-----------------------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             Ccc-----------------------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence            110                       1135688999999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.5e-43  Score=294.33  Aligned_cols=244  Identities=20%  Similarity=0.226  Sum_probs=197.7

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCC-CchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI-PMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      ..+|+|+++.||++..   +++.||+|+++........ ...+.+|+.++++++   ||||+++++++.+..   .....
T Consensus        26 ~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~g~~~~~~---~~~~~   96 (283)
T PHA02988         26 VLIKENDQNSIYKGIF---NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID---SNNILKIYGFIIDIV---DDLPR   96 (283)
T ss_pred             eEEeeCCceEEEEEEE---CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC---CCCEEEEeeeEEecc---cCCCc
Confidence            6789999999999965   6889999998754222111 245568999999998   999999999986621   11146


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      .++|+||+.+ +|.+++...  ..+++.....++.|++.||.+||+ .+++||||+|+||+++.++.+||+|||++....
T Consensus        97 ~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988         97 LSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             eEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            7999999994 999999874  458999999999999999999998 499999999999999999999999999987654


Q ss_pred             CCCccccccccccccchhhhhc--CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhh
Q psy2676         185 YDMMLTSVVVTLWYRAPEILLN--LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL  262 (321)
Q Consensus       185 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (321)
                      ...  ....++..|+|||++.+  ..++.++||||||+++|+|++|..||...+..+....+......++.+        
T Consensus       175 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--------  244 (283)
T PHA02988        175 SPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--------  244 (283)
T ss_pred             ccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--------
Confidence            322  23467889999999976  678999999999999999999999999877766655554332222111        


Q ss_pred             hhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                       ..+++.+.+++.+||+.||.+|||+.++++
T Consensus       245 -----------------~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        245 -----------------LDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -----------------CcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                             145688999999999999999999999985

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-42  Score=289.73  Aligned_cols=252  Identities=20%  Similarity=0.354  Sum_probs=206.5

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +++..++|+++++||+|++|.||+|.+  .++..+++|.+....   .....+.+|+.++++++   |+|++++++++.+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~   72 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYY--NNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQ---HDKLVRLYAVVTK   72 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEe--cCCceEEEEEccCCc---hhHHHHHHHHHHHHhCC---CCCeeeEEEEEcC
Confidence            356778999999999999999999986  456779999876422   12346778999999988   9999999999876


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ...++++|++. ++|.+++.......+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+
T Consensus        73 ~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~  145 (261)
T cd05072          73 E-------EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIA  145 (261)
T ss_pred             C-------CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEEC
Confidence            6       56899999998 599999987655668999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         176 DFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       176 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |||.+........  .....++..|+|||.+....++.++|+||||+++|+|++ |..||...........+......+.
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~  225 (261)
T cd05072         146 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR  225 (261)
T ss_pred             CCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9999976643221  122334667999999988889999999999999999998 9999987766655554433211111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                                ...++.++.+++.+||..+|++||+++++++
T Consensus       226 --------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         226 --------------------------MENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             --------------------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                      1235578999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0193|consensus

Probab=100.00  E-value=1.6e-44  Score=309.38  Aligned_cols=260  Identities=23%  Similarity=0.321  Sum_probs=217.6

Q ss_pred             ccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          12 LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        12 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      .+...+++..++..+...||+|+||+||++++.   | .||||++............+.+|+.++++.+   |.||+-+.
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR---H~NIlLFM  454 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH---G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR---HENILLFM  454 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeecccc---c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcc---hhhheeee
Confidence            356889999999999999999999999999762   2 6999999877666666678889999999999   99999999


Q ss_pred             eeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG  170 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~  170 (321)
                      |++..+       .. .||+.+|+| +|+.++..... .++......|++|+++|+.|||.++|+|+|||..||++.+++
T Consensus       455 G~~~~p-------~~-AIiTqwCeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~  525 (678)
T KOG0193|consen  455 GACMNP-------PL-AIITQWCEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL  525 (678)
T ss_pred             hhhcCC-------ce-eeeehhccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC
Confidence            999777       33 999999998 99999987653 499999999999999999999999999999999999999999


Q ss_pred             CEEEeecCCcccc---cCCCccccccccccccchhhhh---cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q psy2676         171 GLKIADFGLAKTF---DYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI  244 (321)
Q Consensus       171 ~~kl~dfg~~~~~---~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  244 (321)
                      .+||+|||++..-   ..........+...|+|||+++   ..+++..+||||||+++|||++|..||...+.++++-.+
T Consensus       526 kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV  605 (678)
T KOG0193|consen  526 KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV  605 (678)
T ss_pred             cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe
Confidence            9999999998643   2233344566778899999986   355899999999999999999999999855554443332


Q ss_pred             HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      -++...                      .+......+++.++++|+..||..++++||.+.+||.
T Consensus       606 GrG~l~----------------------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  606 GRGYLM----------------------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             cccccC----------------------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            222111                      2233445688899999999999999999999999886

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.4e-42  Score=288.37  Aligned_cols=250  Identities=28%  Similarity=0.447  Sum_probs=206.2

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|++.+.||.|++|.||++.+ ..++..+++|.++..... .....+.+|+.+++.++   |||++++++.+.+.     
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~-~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~-----   70 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQH-VNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMK---HPNIVAFKESFEAD-----   70 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEE-cCCCceEEEEEEEcCcch-HHHHHHHHHHHHHHhCC---CCCcceEEEEEEEC-----
Confidence            589999999999999999999 578899999998654222 23346677888888887   99999999999777     


Q ss_pred             cceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                        ..+++++||++ ++|.+++.......+++..++.++.|++.||.+||++|++|+||+|+||++++++.++|+|||.+.
T Consensus        71 --~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~  148 (255)
T cd08219          71 --GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR  148 (255)
T ss_pred             --CEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcce
Confidence              68899999998 599998876555568999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         182 TFDYDMM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       182 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      ....... .....++..|+|||++.+..++.++|+||+|+++|+|++|..||...+.......+......+    .    
T Consensus       149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~----  220 (255)
T cd08219         149 LLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP----L----  220 (255)
T ss_pred             eecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC----C----
Confidence            6543322 233567888999999998889999999999999999999999998766555444332211111    0    


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                                        ...++..+.++|++||+.||.+|||+.++++-
T Consensus       221 ------------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 ------------------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ------------------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                              11345788999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2e-42  Score=296.37  Aligned_cols=263  Identities=27%  Similarity=0.440  Sum_probs=212.8

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +...+.|...+.||+|+||.||++++ ..++..+++|.+....... .....+.+|+++++++.   |||++++++++.+
T Consensus        21 ~~~~~~f~~~~~lg~G~~~~v~~~~~-~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~   96 (317)
T cd06635          21 EDPEKLFTDLREIGHGSFGAVYFARD-VRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK---HPNSIEYKGCYLR   96 (317)
T ss_pred             CCchhhhhhhheeccCCCeEEEEEEE-cCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC---CCCEEEEEEEEee
Confidence            44456799999999999999999998 5788999999986542221 12235667888888887   9999999999877


Q ss_pred             cccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          97 NILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                      .       ...++|+||+.|+|.+.+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        97 ~-------~~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~d  168 (317)
T cd06635          97 E-------HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLAD  168 (317)
T ss_pred             C-------CeEEEEEeCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEec
Confidence            6       6789999999999888876543 3489999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCccccccccccccchhhhh---cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         177 FGLAKTFDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      ||.+......   ....++..|+|||.+.   ...++.++|+||+|+++|+|++|..||...+.......+......+..
T Consensus       169 fg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  245 (317)
T cd06635         169 FGSASIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ  245 (317)
T ss_pred             CCCccccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC
Confidence            9988654422   2345778899999974   345789999999999999999999999776655555444432211110


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP  320 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~~  320 (321)
                                               ...+++.+.+++.+||+.+|.+||++.++++|+|+.....++
T Consensus       246 -------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         246 -------------------------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             -------------------------CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence                                     113457889999999999999999999999999998776554

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.3e-42  Score=291.66  Aligned_cols=257  Identities=28%  Similarity=0.528  Sum_probs=210.2

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      .+|...+.||.|++|.||++.+ ..+++.+++|.+....  ......+.+|+.+++++.   |||++++++++...    
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~---h~~vv~~~~~~~~~----   88 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATD-KSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQ---HPNIVEMYSSYLVG----   88 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEE-CCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcC---CCChheEEEEEEcC----
Confidence            4677788999999999999998 5778899999875432  222345678899999887   99999999998766    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++++|++.| +|.+++..   ..+++..++.++.|++.||.+||++|++||||+|+||+++.++.++|+|||.+
T Consensus        89 ---~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~  162 (285)
T cd06648          89 ---DELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFC  162 (285)
T ss_pred             ---CeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccc
Confidence               678999999985 99998877   34899999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ....... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||...+.......+... ..+....    
T Consensus       163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~----  237 (285)
T cd06648         163 AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKN----  237 (285)
T ss_pred             hhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcc----
Confidence            6554322 222345788999999998888999999999999999999999999876665554443322 1111000    


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                                         ...++..+.+++++||+.+|.+||++.++++||||++...
T Consensus       238 -------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         238 -------------------LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             -------------------cccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence                               1135578999999999999999999999999999988754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.6e-43  Score=296.48  Aligned_cols=263  Identities=29%  Similarity=0.487  Sum_probs=212.1

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      .......++|++.+.||+|+||.||++.+ ..++..+++|.+....  ......+.+|+.+++++.   |||++++++.+
T Consensus        12 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~---hp~i~~~~~~~   85 (293)
T cd06647          12 VSVGDPKKKYTRFEKIGQGASGTVYTAID-VATGQEVAIKQMNLQQ--QPKKELIINEILVMRENK---HPNIVNYLDSY   85 (293)
T ss_pred             eeccCchhhceeeeEecCCCCeEEEEEEE-cCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcC---CCCeeehhhee
Confidence            34455568999999999999999999988 5678899999986432  222346678888888887   99999999998


Q ss_pred             eccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      ...       ...++|+|++.+ +|.+++...   .+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++
T Consensus        86 ~~~-------~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~k  155 (293)
T cd06647          86 LVG-------DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVK  155 (293)
T ss_pred             eeC-------CcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEE
Confidence            776       678999999985 999988762   378999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         174 IADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       174 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |+|||.+....... ......+++.|+|||.+....++.++|+||+|+++|++++|..||...+.......+.. .+.+.
T Consensus       156 L~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~  234 (293)
T cd06647         156 LTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE  234 (293)
T ss_pred             EccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC
Confidence            99999876554332 22334677889999999888889999999999999999999999977654333222111 01111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ..                       ....++..+.++|++||..+|.+||++.+++.||||++..
T Consensus       235 ~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         235 LQ-----------------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             CC-----------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            00                       0123457899999999999999999999999999999765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.6e-42  Score=291.56  Aligned_cols=257  Identities=26%  Similarity=0.384  Sum_probs=200.4

Q ss_pred             eeecccceeEEEEEEecCCCcEEEEEEeecccCCCCC-CchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEE
Q psy2676          29 QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI-PMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTV  107 (321)
Q Consensus        29 ~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~  107 (321)
                      .||+|+||.||+|.+ ..+++.|++|.+......... ......|..+++.+....||+++++++++...       ...
T Consensus         1 ~ig~g~~g~Vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-------~~~   72 (278)
T cd05606           1 IIGRGGFGEVYGCRK-ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-------DKL   72 (278)
T ss_pred             CcccCCCeEEEEEEE-ecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-------CEE
Confidence            479999999999998 577899999998764332211 22344555555555444599999999999877       678


Q ss_pred             EEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCC
Q psy2676         108 YLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD  186 (321)
Q Consensus       108 ~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~  186 (321)
                      ++|+||+.| +|..++..  ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        73 ~~v~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~  150 (278)
T cd05606          73 SFILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (278)
T ss_pred             EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence            999999985 89888876  345899999999999999999999999999999999999999999999999998755432


Q ss_pred             CccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhh
Q psy2676         187 MMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS  265 (321)
Q Consensus       187 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
                      . .....++..|+|||++.+. .++.++|+||+|+++|+|++|+.||................ .. ...          
T Consensus       151 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~-~~~----------  217 (278)
T cd05606         151 K-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TM-AVE----------  217 (278)
T ss_pred             C-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-cc-CCC----------
Confidence            2 2344688999999998754 57899999999999999999999997653222111111000 00 001          


Q ss_pred             hhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCCC
Q psy2676         266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENEP  320 (321)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~~  320 (321)
                                  ....++..+.+++.+||..+|.+||     ++.++++||||+..+|..
T Consensus       218 ------------~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~  265 (278)
T cd05606         218 ------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM  265 (278)
T ss_pred             ------------CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence                        1123468999999999999999999     999999999999987753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG4236|consensus

Probab=100.00  E-value=2.4e-44  Score=303.90  Aligned_cols=258  Identities=27%  Similarity=0.402  Sum_probs=228.2

Q ss_pred             ceee--eeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          23 KYDE--LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        23 ~y~~--~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      -|+|  .+.||+|.||+||-+.+ ..+|+.||+|++.+..-.........+|+++|..+.   ||.|+.+--.|+.+   
T Consensus       563 vYQif~devLGSGQFG~VYgg~h-RktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~---HPGiV~le~M~ET~---  635 (888)
T KOG4236|consen  563 VYQIFADEVLGSGQFGTVYGGKH-RKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH---HPGIVNLECMFETP---  635 (888)
T ss_pred             HHHhhhHhhccCCcceeeeccee-cccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC---CCCeeEEEEeecCC---
Confidence            3544  47899999999999999 699999999999887777777788999999999999   99999999999887   


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC---CCEEEeec
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIADF  177 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~---~~~kl~df  177 (321)
                          ..+++|||.+.|+..+.+-....+++++..-..++.||+.||.|||.++|+|.||||+||++...   .++|||||
T Consensus       636 ----ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDF  711 (888)
T KOG4236|consen  636 ----ERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDF  711 (888)
T ss_pred             ----ceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccc
Confidence                78999999999999999988888899999999999999999999999999999999999999655   35999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      |+++.+++.....+..||+.|+|||+++++.++.+-|+||+|+++|--++|..||...  +++..+|.+....-+.+.  
T Consensus       712 GfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~P--  787 (888)
T KOG4236|consen  712 GFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNP--  787 (888)
T ss_pred             cceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCc--
Confidence            9999999888888999999999999999999999999999999999999999999654  333344433332223232  


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                                           ++++++.+.+||..+|++.-++|.|.+..|.|||+++-
T Consensus       788 ---------------------W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  788 ---------------------WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             ---------------------hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence                                 34778999999999999999999999999999999874

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.2e-43  Score=297.00  Aligned_cols=257  Identities=25%  Similarity=0.487  Sum_probs=208.4

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      +.|.....||.|++|.||++.+ ..++..+++|.+....  ......+.+|+..+++++   |||++++++.+...    
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~---h~~ii~~~~~~~~~----   91 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATE-KHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYH---HENVVDMYNSYLVG----   91 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEE-CCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCC---CCcHHHHHHheecC----
Confidence            5567778899999999999998 5778899999876432  122345678888888887   99999999998766    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++|+|++++ +|.+++..   +.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        92 ---~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~  165 (292)
T cd06658          92 ---DELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFC  165 (292)
T ss_pred             ---CeEEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcch
Confidence               678999999985 88887754   34899999999999999999999999999999999999999999999999988


Q ss_pred             ccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+........ ..    
T Consensus       166 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~----  240 (292)
T cd06658         166 AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV-KD----  240 (292)
T ss_pred             hhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc-cc----
Confidence            6553222 22335678899999999888899999999999999999999999987766554444332211100 00    


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                                         ....+..+.+++.+||..||.+|||++++++||||+....
T Consensus       241 -------------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         241 -------------------SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             -------------------ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence                               1134578899999999999999999999999999996643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3e-42  Score=294.68  Aligned_cols=259  Identities=27%  Similarity=0.452  Sum_probs=209.1

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ..+.|...+.||+|++|+||+|++ ..++..+++|.+....... .....+.+|+.+++.++   |||++++++++.+. 
T Consensus        19 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~-   93 (313)
T cd06633          19 PEEIFVGLHEIGHGSFGAVYFATN-SHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK---HPNTIEYKGCYLKE-   93 (313)
T ss_pred             HHHHhhcceeeccCCCeEEEEEEE-CCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC---CCCCccEEEEEEeC-
Confidence            345588888999999999999998 5788999999986542221 12235667888888887   99999999999877 


Q ss_pred             cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676          99 LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                            ...++|+|++.+++.+++..... .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus        94 ------~~~~lv~e~~~~~l~~~l~~~~~-~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg  166 (313)
T cd06633          94 ------HTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG  166 (313)
T ss_pred             ------CEEEEEEecCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecC
Confidence                  67899999999999888876443 48999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCccccccccccccchhhhh---cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      .+.....   .....++..|+|||++.   ...++.++|+||+|+++++|++|..||...+.......+.... .+... 
T Consensus       167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-  241 (313)
T cd06633         167 SASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTLQ-  241 (313)
T ss_pred             CCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCCC-
Confidence            8864332   23446788899999984   3557889999999999999999999998776555554433211 11000 


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                                             ...++..+.+|+.+||+.+|.+||++.++++||||+..+.
T Consensus       242 -----------------------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~  281 (313)
T cd06633         242 -----------------------SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP  281 (313)
T ss_pred             -----------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence                                   1134567899999999999999999999999999997643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-42  Score=287.19  Aligned_cols=251  Identities=24%  Similarity=0.382  Sum_probs=205.4

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ++..++|++.+.||+|++|.||++.+  .+++.+++|.++...   .....+.+|+.+++++.   |||++++++++...
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~   73 (261)
T cd05068           2 EIDRTSIQLLRKLGAGQFGEVWEGLW--NNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLR---HPKLIQLYAVCTLE   73 (261)
T ss_pred             ccchhheeeEEEecccCCccEEEEEe--cCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCC---CCCccceeEEEecC
Confidence            56778999999999999999999987  355789999886432   12446778999999998   99999999998766


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ...++++|++. ++|.+++.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        74 -------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d  146 (261)
T cd05068          74 -------EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVAD  146 (261)
T ss_pred             -------CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECC
Confidence                   56899999996 6999999876545689999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCcc--ccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         177 FGLAKTFDYDMML--TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       177 fg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      ||.+.........  .....+..|+|||.+.+..++.++|+||||+++++|++ |+.||.+.+.......+......+. 
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-  225 (261)
T cd05068         147 FGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC-  225 (261)
T ss_pred             cceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-
Confidence            9998766532211  11122357999999998889999999999999999999 9999987766655554432211110 


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                               ...++..+.+++.+||+.+|.+||++.++++
T Consensus       226 -------------------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         226 -------------------------PPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             -------------------------CCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                                     1145588999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.9e-44  Score=298.92  Aligned_cols=256  Identities=27%  Similarity=0.439  Sum_probs=207.8

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .+.|++.+.||.|++|.||++.+ ..++..+++|.+...... .....+.+|+.+++++.   |||++++++.+...   
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~-~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~---   74 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGID-NRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCD---SPYITRYYGSYLKG---   74 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEE-cCCCeEEEEEEeccccch-HHHHHHHHHHHHHHcCC---CCccHhhhcccccC---
Confidence            35688899999999999999998 577889999988644222 22345778888888887   99999999998766   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++|+|++++ +|.+++..   ..+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.
T Consensus        75 ----~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~  147 (277)
T cd06642          75 ----TKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGV  147 (277)
T ss_pred             ----CceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccc
Confidence                678999999995 89888865   3489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         180 AKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       180 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      +....... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||...........+...    ..+    
T Consensus       148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~----~~~----  219 (277)
T cd06642         148 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN----SPP----  219 (277)
T ss_pred             cccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC----CCC----
Confidence            87654332 122345788899999999888999999999999999999999999765443332221110    000    


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                                        .....++..+.++|.+||+.+|.+||++.++++||||+...
T Consensus       220 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         220 ------------------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             ------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence                              01124557899999999999999999999999999998654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.1e-43  Score=291.32  Aligned_cols=251  Identities=32%  Similarity=0.541  Sum_probs=206.2

Q ss_pred             eecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEE
Q psy2676          30 IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVY  108 (321)
Q Consensus        30 lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  108 (321)
                      ||.|++|.||++++ ..+++.+++|++...... ......+.+|++.++++.   |||++++++.+...       ...+
T Consensus         1 lg~g~~~~vy~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~-------~~~~   69 (265)
T cd05579           1 ISKGAYGRVFLAKK-KSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ---SPYVVKLYYSFQGK-------KNLY   69 (265)
T ss_pred             CCCCCceEEEEEEE-CCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC---CcchhHHHHheecC-------cEEE
Confidence            68999999999998 577899999998654221 123446677888888887   99999999988766       6789


Q ss_pred             EEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCC
Q psy2676         109 LIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM  187 (321)
Q Consensus       109 ~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~  187 (321)
                      +++|++.+ +|.+++....  .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        70 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~  147 (265)
T cd05579          70 LVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR  147 (265)
T ss_pred             EEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence            99999985 9999998744  58999999999999999999999999999999999999999999999999887554321


Q ss_pred             ---------ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         188 ---------MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       188 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                               ......++..|+|||.......+.++|+||||++++++++|..||......+....+...  ...   ++.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~---~~~  222 (265)
T cd05579         148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KIE---WPE  222 (265)
T ss_pred             ccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CcC---CCc
Confidence                     122345678899999998888999999999999999999999999877766655444331  111   110


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH---HHHhCCCCCCCCCC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA---ADALEHPYFKEKEN  318 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~~ll~h~~f~~~~~  318 (321)
                      .                    ...+..+.+++++||+.+|.+|||+   .++++||||++..|
T Consensus       223 ~--------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         223 D--------------------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             c--------------------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence            0                    0135889999999999999999999   99999999998876

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.8e-42  Score=291.17  Aligned_cols=256  Identities=26%  Similarity=0.451  Sum_probs=208.7

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      +-|++.+.||+|+||.||++.+ ..++..+++|.+...... .....+.+|+..++++.   |||++++++.+...    
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~-~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~----   74 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGID-NRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCD---SPYVTKYYGSYLKD----   74 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEE-CCCCcEEEEEEeccccch-HHHHHHHHHHHHHHhcC---CCCEeEEEEEEEeC----
Confidence            4588899999999999999988 577899999987643221 22345677888888887   99999999999777    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++|+||+++ +|.+++..   ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        75 ---~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~  148 (277)
T cd06641          75 ---TKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA  148 (277)
T ss_pred             ---CeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccc
Confidence               678999999995 89888865   34899999999999999999999999999999999999999999999999988


Q ss_pred             ccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ....... ......++..|+|||.+.+...+.++|+||+|+++++|++|..||...........+... ..   +.    
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~---~~----  220 (277)
T cd06641         149 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NP---PT----  220 (277)
T ss_pred             eecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CC---CC----
Confidence            6654322 123345788899999998888899999999999999999999999776554433332111 01   00    


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                                        ....++.++.+++.+||+.+|.+||++.++++||||.+...
T Consensus       221 ------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         221 ------------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             ------------------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence                              11245688999999999999999999999999999987644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.5e-42  Score=286.86  Aligned_cols=251  Identities=24%  Similarity=0.393  Sum_probs=205.4

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +++..++|+++++||+|+||.||+|..  .+++.+++|.+.....   ....+.+|+.+++++.   |||++++++++..
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~--~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~   72 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYY--NGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQ---HPRLVRLYAVVTQ   72 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeec--CCCceEEEEEecCCCC---cHHHHHHHHHHHHhcC---CcCeeeEEEEEcc
Confidence            356788999999999999999999986  4678899998864322   2346788999999998   9999999998643


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .        ..++++|++. ++|.+++.......+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+
T Consensus        73 ~--------~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~  144 (260)
T cd05067          73 E--------PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIA  144 (260)
T ss_pred             C--------CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEc
Confidence            2        4799999998 599999877655668999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         176 DFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       176 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |||.+........  .....++..|+|||.+....++.++|+||||+++|++++ |+.||.+.+..+....+......+ 
T Consensus       145 dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-  223 (260)
T cd05067         145 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP-  223 (260)
T ss_pred             cCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC-
Confidence            9999876542221  122344678999999998889999999999999999998 999998777655554443221111 


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                               .....+.++.+++.+||..+|++||+++++++
T Consensus       224 -------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         224 -------------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             -------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                     01234578999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.6e-42  Score=294.25  Aligned_cols=266  Identities=23%  Similarity=0.378  Sum_probs=208.8

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ......+.|++.+.||+|++|.||+|.+ ..+++.+++|.++...... ....+..|+.++.+..  .||||+++++++.
T Consensus         9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~   84 (296)
T cd06618           9 KYPADLNDLENLGEIGSGTCGQVYKMRF-KKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSH--DCPYIVKCYGYFI   84 (296)
T ss_pred             eccCCcchheeeeEeeccCCeEEEEEEE-CCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhcc--CCCchHhhheeee
Confidence            4456678899999999999999999998 5678999999987543221 2234455666565554  3999999999997


Q ss_pred             ccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      +.       ...++++|++.+++.+++..... .+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|
T Consensus        85 ~~-------~~~~~v~e~~~~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL  156 (296)
T cd06618          85 TD-------SDVFICMELMSTCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKL  156 (296)
T ss_pred             cC-------CeEEEEeeccCcCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEE
Confidence            76       67899999999888888776443 58999999999999999999997 59999999999999999999999


Q ss_pred             eecCCcccccCCCccccccccccccchhhhhcCC----CCCcchHHHHHHHHHHHHhcCCCCCCCCh-HHHHHHHHHHhC
Q psy2676         175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLG----YGTPVDIWSIGCVMAEMWRLVPLFCASTE-VEQLKCIFRVIG  249 (321)
Q Consensus       175 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~  249 (321)
                      +|||.+.............++..|+|||.+.+..    ++.++|+||||+++|+|++|+.||..... .+....+.... 
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-  235 (296)
T cd06618         157 CDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-  235 (296)
T ss_pred             CccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-
Confidence            9999987665443334445678899999987554    78899999999999999999999976433 22222222111 


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                         ...++.                    ...++.++.+|+.+||..||.+||++.++++||||+...
T Consensus       236 ---~~~~~~--------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         236 ---PPSLPP--------------------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             ---CCCCCC--------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence               000000                    013557899999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.4e-42  Score=283.35  Aligned_cols=252  Identities=29%  Similarity=0.525  Sum_probs=209.2

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      .|++.+.||.|++|.||++.+ ..+++.+++|++.....  .....+.+|++.++++.   |+|++++++.+...     
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~-~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~-----   69 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARH-KRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCK---HPNIVKYYGSYLKK-----   69 (253)
T ss_pred             CceeeeeeccCCceEEEEEEE-CCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCC---CCCEeEEEEEEecC-----
Confidence            488999999999999999998 56889999999875432  23456778999999888   99999999998776     


Q ss_pred             cceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                        ...++++|+++ ++|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        70 --~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~  146 (253)
T cd05122          70 --DELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSA  146 (253)
T ss_pred             --CeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccc
Confidence              67899999999 59999988753 358999999999999999999999999999999999999999999999999988


Q ss_pred             cccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhh
Q psy2676         182 TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS  261 (321)
Q Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (321)
                      ............++..|+|||.+.+...+.++|+||||+++++|++|..||...+.......... ...+   ..+.   
T Consensus       147 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~---~~~~---  219 (253)
T cd05122         147 QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPP---GLRN---  219 (253)
T ss_pred             cccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCC---CcCc---
Confidence            77644333456678899999999888899999999999999999999999987654444333222 1111   1100   


Q ss_pred             hhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q psy2676         262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY  312 (321)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  312 (321)
                                       ...++..+.++|.+||+.||++|||+.++++|||
T Consensus       220 -----------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         220 -----------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             -----------------ccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                             0123588999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.7e-42  Score=286.71  Aligned_cols=251  Identities=23%  Similarity=0.375  Sum_probs=204.0

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +++..++|++.+.||+|++|.||+|.+  .++..+++|.+.....   ....+.+|+.++++++   |+|++++++++..
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~--~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~---~~~i~~~~~~~~~   72 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTW--NGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLR---HDKLVQLYAVVSE   72 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEe--cCCceeEEEEecCCCC---CHHHHHHHHHHHHhcC---CCceEEEEeEECC
Confidence            356778999999999999999999976  4566799998865322   2346788999999998   9999999998743


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .        ..+++||++.+ +|.+++.......+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|+
T Consensus        73 ~--------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~  144 (260)
T cd05070          73 E--------PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIA  144 (260)
T ss_pred             C--------CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeC
Confidence            2        36899999984 99999987655568999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         176 DFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       176 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |||.+........  .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+......+ 
T Consensus       145 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-  223 (260)
T cd05070         145 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP-  223 (260)
T ss_pred             CceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence            9999876543221  112334567999999988889999999999999999999 899998776655555443211110 


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                               ...+.+..+.+++.+||..+|.+|||++++.+
T Consensus       224 -------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         224 -------------------------CPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             -------------------------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                                     01245578999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.1e-42  Score=285.81  Aligned_cols=247  Identities=22%  Similarity=0.360  Sum_probs=201.1

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++.+.||+|+||.||+++.  ..+..+++|.+...   ......+.+|+.+++++.   |||++++++++...   
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~--~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~---   71 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKW--RAQIKVAIKAINEG---AMSEEDFIEEAKVMMKLS---HPKLVQLYGVCTQQ---   71 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEe--ccCceEEEEecccC---CccHHHHHHHHHHHHHCC---CCCceeEEEEEccC---
Confidence            46799999999999999999987  34567899987532   222346788999999998   99999999998766   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++||||++ |+|.+++..... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        72 ----~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~  146 (256)
T cd05114          72 ----KPLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGM  146 (256)
T ss_pred             ----CCEEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCC
Confidence                67899999998 599999876432 489999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCcc--ccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         180 AKTFDYDMML--TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       180 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      +.........  ....++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||...+..+....+.......    .
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~----~  222 (256)
T cd05114         147 TRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY----R  222 (256)
T ss_pred             ccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC----C
Confidence            8765322221  12234567999999988889999999999999999999 899998877666655554321110    0


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      +                      ...+..+.+++.+||+.+|.+||+++++++
T Consensus       223 ~----------------------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         223 P----------------------KLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             C----------------------CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            1                      123467899999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-42  Score=293.21  Aligned_cols=255  Identities=25%  Similarity=0.389  Sum_probs=203.9

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCC----CcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNK----GNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      +.-++|++.+.||+|++|.||+|.+....    ...+++|.+..... ......+.+|+..++++.   |||++++++++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~---h~~i~~~~~~~   77 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQ---HPNIVCLLGVC   77 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcC---CcccceEEEEE
Confidence            34568999999999999999999874222    25788898764321 112335678899998887   99999999998


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP--------------PGLSASKVKELTRQMLKGVDFLHSHRIIHRDL  159 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~--------------~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di  159 (321)
                      .+.       ...++++|+++ ++|.+++.....              ..+++..++.++.||+.||.+||+.|++|+||
T Consensus        78 ~~~-------~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dl  150 (283)
T cd05048          78 TKE-------QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDL  150 (283)
T ss_pred             cCC-------CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence            766       56799999998 599999876421              34788999999999999999999999999999


Q ss_pred             CCCcEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCC
Q psy2676         160 KPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCAS  235 (321)
Q Consensus       160 ~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~  235 (321)
                      ||+||+++.++.++|+|||.+.......   ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.
T Consensus       151 kp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05048         151 AARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF  230 (283)
T ss_pred             ccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999987553221   2233455788999999998889999999999999999998 99999887


Q ss_pred             ChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         236 TEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ...+....+.....    ..                      ....++.++.+|+.+||+.||.+||++.+++++
T Consensus       231 ~~~~~~~~i~~~~~----~~----------------------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         231 SNQEVIEMIRSRQL----LP----------------------CPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             CHHHHHHHHHcCCc----CC----------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            76665544432111    11                      112567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-42  Score=284.71  Aligned_cols=252  Identities=31%  Similarity=0.510  Sum_probs=209.7

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|++.+.||+|++|.||++++ ..+++.+++|.+............+.+|+++++++.   |||++++++++.+.     
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~-----   71 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLN-LETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK---HPNIVKYIGSIETS-----   71 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEE-cCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC---CCCccEEEEEEEeC-----
Confidence            589999999999999999998 577889999999765433233456778889888887   99999999998766     


Q ss_pred             cceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                        ...++++|++.+ +|.+++...  ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        72 --~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~  147 (254)
T cd06627          72 --DSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVAT  147 (254)
T ss_pred             --CEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccce
Confidence              678999999985 999999874  458999999999999999999999999999999999999999999999999988


Q ss_pred             cccCCCc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         182 TFDYDMM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       182 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      ....... .....++..|+|||...+...+.++|+||+|+++++|++|..||...............    ....     
T Consensus       148 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~-----  218 (254)
T cd06627         148 KLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD----DHPP-----  218 (254)
T ss_pred             ecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc----CCCC-----
Confidence            7654332 23456788899999998888899999999999999999999999776544433332211    0001     


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                                       ....++..+.+++.+||..+|++|||+.+++.||||
T Consensus       219 -----------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         219 -----------------LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             -----------------CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                             112456889999999999999999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.7e-42  Score=286.85  Aligned_cols=253  Identities=26%  Similarity=0.437  Sum_probs=210.0

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|++.+.||+|++|.||++.+ ..+++.+++|.+............+.+|+.++++++   |+||+++++++.+.     
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~-----   71 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKR-LSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN---HPNIISYKEAFLDG-----   71 (256)
T ss_pred             CceEeeeecCCCceeEEEEEE-CCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC---CCCchhhhhhhccC-----
Confidence            589999999999999999998 578889999998765444334446677888888887   99999999998766     


Q ss_pred             cceEEEEEeccCcc-CHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         103 RYLTVYLIFEHVDQ-DLGSYMEKCP--PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       103 ~~~~~~~v~e~~~~-~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                        ...++|+|++++ +|.+++....  ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        72 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~  149 (256)
T cd08530          72 --NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGI  149 (256)
T ss_pred             --CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccc
Confidence              678999999985 9999886632  24489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      +...... ......++..|+|||.+.+..++.++|+||+|+++++|++|+.||...+..+....+....    ...    
T Consensus       150 ~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~----  220 (256)
T cd08530         150 SKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK----YPP----  220 (256)
T ss_pred             hhhhccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC----CCC----
Confidence            8776544 3334567889999999998889999999999999999999999998776654443332211    111    


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                                        ....++.++.+++.+||..+|.+||++.++++||++
T Consensus       221 ------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         221 ------------------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             ------------------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                              112455789999999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0574|consensus

Probab=100.00  E-value=6.6e-46  Score=293.69  Aligned_cols=258  Identities=28%  Similarity=0.475  Sum_probs=216.8

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .+-|.++.+||+|+||.||+|.+ +..|+.+|+|.+....    ....+..|+.++.+..   .|++++.|+.+...   
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH-~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~---S~yVVKYYGSYFK~---  100 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIH-RESGHVLAIKKVPVDT----DLQEIIKEISIMQQCK---SKYVVKYYGSYFKH---  100 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHH-hccCcEEEEEecCccc----hHHHHHHHHHHHHHcC---CchhhhhhhhhccC---
Confidence            35699999999999999999999 6999999999886532    2346778888988888   99999999988776   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..+++|||||+ |+..+.++.+.. .+++.++..+++.-+.+|+|||..+-+|||||.-||+++.+|..||.|||.
T Consensus       101 ----sDLWIVMEYCGAGSiSDI~R~R~K-~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGV  175 (502)
T KOG0574|consen  101 ----SDLWIVMEYCGAGSISDIMRARRK-PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGV  175 (502)
T ss_pred             ----CceEeehhhcCCCcHHHHHHHhcC-CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccc
Confidence                67899999999 799999988764 499999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC-CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         180 AKTFDYD-MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       180 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      +...... .......||+.|+|||++..-.|+.++||||||++..+|..|++||..-.+...+..+    ...+++.+..
T Consensus       176 AGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI----PT~PPPTF~K  251 (502)
T KOG0574|consen  176 AGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI----PTKPPPTFKK  251 (502)
T ss_pred             cchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec----cCCCCCCCCC
Confidence            8765422 2345678999999999999999999999999999999999999999775543322111    1111111111


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                                          ...++.++.+|+++||-+.|++|.|+.++++|||.++.+.
T Consensus       252 --------------------PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  252 --------------------PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             --------------------hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence                                1246689999999999999999999999999999998764

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.2e-42  Score=287.08  Aligned_cols=258  Identities=28%  Similarity=0.435  Sum_probs=200.9

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      +...+.+.....||+|+||.||++++ ..++..+++|.+......  ....+.+|+.++++++   |+||+++++++...
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~v~~k~~~~~~~~--~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~   77 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARD-LSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLK---HRNIVQYLGSDSEN   77 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEe-cCCCcEEEEEEecCCCHH--HHHHHHHHHHHHHhcC---CCCeeeeeeeeccC
Confidence            34455566667999999999999998 577889999987653221  2346778999999887   99999999998776


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee-CCCEE
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGL--SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR-AGGLK  173 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~--~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~-~~~~k  173 (321)
                             ...++++|++.+ +|.+++..... .+  ++..+..++.||+.||.+||+.|++|+||+|+||+++. ++.++
T Consensus        78 -------~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~  149 (268)
T cd06624          78 -------GFFKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVK  149 (268)
T ss_pred             -------CEEEEEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEE
Confidence                   678999999984 99999876422 24  78889999999999999999999999999999999976 67899


Q ss_pred             EeecCCcccccCCC-ccccccccccccchhhhhcCC--CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCC
Q psy2676         174 IADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLG--YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       174 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      |+|||.+....... ......++..|+|||.+....  ++.++|+||+|+++|+|++|..||................. 
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~-  228 (268)
T cd06624         150 ISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK-  228 (268)
T ss_pred             EecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc-
Confidence            99999887654222 222345788999999986644  78899999999999999999999965432221111110000 


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                       .                      .......+++++.+++++||+.+|.+|||+.++++||||
T Consensus       229 -~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 -I----------------------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             -c----------------------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence             0                      001122455889999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.7e-42  Score=293.94  Aligned_cols=256  Identities=26%  Similarity=0.477  Sum_probs=209.0

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      .-|.....||+|+||.||++.+ ..+++.+++|++.....  .....+.+|+.+++.+.   |||++++++++...    
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~-~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~---hp~i~~~~~~~~~~----   90 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIARE-KHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQ---HQNVVEMYKSYLVG----   90 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEE-cCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCC---CCchhhhhhheeeC----
Confidence            4567778999999999999998 57889999999865422  22446778888888887   99999999998776    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++++|++++ +|..++..   ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        91 ---~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~  164 (297)
T cd06659          91 ---EELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFC  164 (297)
T ss_pred             ---CeEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhH
Confidence               678999999995 88887755   34899999999999999999999999999999999999999999999999988


Q ss_pred             ccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ....... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||......+....+...    ....+   
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~---  237 (297)
T cd06659         165 AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS----PPPKL---  237 (297)
T ss_pred             hhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc----CCCCc---
Confidence            7554322 223456788999999999888999999999999999999999999876655544433211    10000   


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                                       .....++..+.++|++||+.+|.+||++.++++||||.+..
T Consensus       238 -----------------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         238 -----------------KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             -----------------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence                             00123557899999999999999999999999999998763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-42  Score=285.73  Aligned_cols=252  Identities=23%  Similarity=0.358  Sum_probs=207.5

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +++..++|++.+.||+|++|+||+|.+  .++..+++|.+....   .....+.+|+.+++++.   |+|++++++++..
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~--~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~   72 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTW--NGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLR---HDKLVQLYAVCSE   72 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEE--cCCceEEEEEecCCc---cCHHHHHHHHHHHhhCC---CCCEeeeeeeeec
Confidence            457789999999999999999999987  355789999886432   22356788999999988   9999999999876


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ...++++|++.+ +|.+++.......+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+
T Consensus        73 ~-------~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~  145 (261)
T cd05034          73 E-------EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIA  145 (261)
T ss_pred             C-------CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEEC
Confidence            5       568999999985 99999987665568999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         176 DFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       176 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |||.+........  ......+..|+|||.+.+...+.++|+||+|++++++++ |+.||.+.+.......+......+.
T Consensus       146 d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~  225 (261)
T cd05034         146 DFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR  225 (261)
T ss_pred             ccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9999876643211  112233567999999998889999999999999999998 9999988776665555543221111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .                          .+.+.++.+++.+||..+|.+||+++++++
T Consensus       226 ~--------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         226 P--------------------------PNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             C--------------------------CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            1                          134578999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.5e-42  Score=286.42  Aligned_cols=250  Identities=21%  Similarity=0.348  Sum_probs=202.1

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      .+..++|++.++||+|++|+||+|++  .++..+++|+++....   ....+.+|++++++++   |||++++++.+...
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~---~~~i~~~~~~~~~~   73 (262)
T cd05071           2 EIPRESLRLEVKLGQGCFGEVWMGTW--NGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLR---HEKLVQLYAVVSEE   73 (262)
T ss_pred             CCChHHeeEeeecCCCCCCcEEEEEe--cCCceEEEEecccCcc---CHHHHHHHHHHHHhCC---CCCcceEEEEECCC
Confidence            45678999999999999999999987  2345699999874322   2346778999999987   99999999886432


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                              ..++|+|++. ++|.+++.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        74 --------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~d  145 (262)
T cd05071          74 --------PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD  145 (262)
T ss_pred             --------CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEecc
Confidence                    4689999999 4999999875445589999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         177 FGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       177 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      ||.+........  .....++..|+|||+..+..++.++|+||||+++|+|++ |..||.+....+....+......+  
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--  223 (262)
T cd05071         146 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--  223 (262)
T ss_pred             CCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCC--
Confidence            999876543321  122345667999999988889999999999999999999 888998776655544433211100  


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                              ....++..+.+++.+||+.+|.+||++.++++
T Consensus       224 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         224 ------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             ------------------------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                                    01245688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.9e-42  Score=284.71  Aligned_cols=256  Identities=31%  Similarity=0.515  Sum_probs=210.1

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +|.+.+.||+|++|.||++.+ ..+++.+++|++............+.+|+..++++.   |||++++++.+....    
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~----   72 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALD-KDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ---HPNIVRYYGSERDEE----   72 (260)
T ss_pred             CceeeeEeeecCceEEEEEEE-CCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC---CCCEeeEEEEEecCC----
Confidence            588899999999999999998 568999999998765433333456778999999988   999999999986541    


Q ss_pred             cceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                       ....++++|++. ++|.+++....  .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        73 -~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~  149 (260)
T cd06606          73 -KNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAK  149 (260)
T ss_pred             -CCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEE
Confidence             246799999996 59999998754  58999999999999999999999999999999999999999999999999988


Q ss_pred             cccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         182 TFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       182 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      .......   .....++..|+|||.+.....+.++|+||||+++++|++|..||.......  ..............   
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~---  224 (260)
T cd06606         150 RLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKIGSSGEPPE---  224 (260)
T ss_pred             ecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhccccCCCcC---
Confidence            7765543   345667889999999988889999999999999999999999997765211  11111111011111   


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                                         ....++..+.++|.+||..+|.+||++.++++||||
T Consensus       225 -------------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         225 -------------------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             -------------------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                               112346899999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0690|consensus

Probab=100.00  E-value=2e-44  Score=287.93  Aligned_cols=262  Identities=26%  Similarity=0.382  Sum_probs=222.7

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      +..++|..+++||+|.||.|-+++. +.+++.+|+|++++...- .........|-++++..+   ||.+..+.-.|+..
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rE-Kat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~---HPFLt~LKYsFQt~  240 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCRE-KATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR---HPFLTSLKYSFQTQ  240 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEee-cccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc---CcHHHHhhhhhccC
Confidence            3557899999999999999999999 699999999999876333 233445567778887777   99999988888777


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ..+|+||||..| .|.-.+..  ...+++...+.+...|+.||.|||+++|++||+|.+|.++|++|++|+.|
T Consensus       241 -------drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitD  311 (516)
T KOG0690|consen  241 -------DRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITD  311 (516)
T ss_pred             -------ceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeee
Confidence                   789999999995 88777766  34599999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccC-CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         177 FGLAKTFDY-DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       177 fg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ||+|...-. .......+||+.|+|||++....+..+.|-|.+|+++|+|++|+.||...+.......|.-.--     .
T Consensus       312 FGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~-----k  386 (516)
T KOG0690|consen  312 FGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL-----K  386 (516)
T ss_pred             cccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc-----c
Confidence            999975433 3445678999999999999999999999999999999999999999988777666555443211     1


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENEP  320 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~~  320 (321)
                      +                      ...++++++.|+..+|.+||.+|.     .+.||.+|+||..++|+.
T Consensus       387 F----------------------Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  387 F----------------------PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             C----------------------CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence            1                      235669999999999999999998     789999999999999975

>KOG0579|consensus

Probab=100.00  E-value=2e-44  Score=310.37  Aligned_cols=260  Identities=27%  Similarity=0.430  Sum_probs=215.9

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .+-|+|+..||.|+||.||+|.. +.++-..|-|++...  .......+.-|+.+|....   ||+|+++++.|+..   
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~n-ket~~lAAaKvIetk--seEELEDylVEIeILa~Cd---HP~ivkLl~ayy~e---  101 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVN-KETKLLAAAKVIETK--SEEELEDYLVEIEILAECD---HPVIVKLLSAYYFE---  101 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhc-ccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCC---ChHHHHHHHHHhcc---
Confidence            35689999999999999999988 467777778887543  3334556777899988887   99999999998777   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..++|+.|+|+| -+...+-..+ ..+.+.++..+++|++.||.|||+++|+|||||.-||+++-+|.++|.|||.
T Consensus       102 ----nkLwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGV  176 (1187)
T KOG0579|consen  102 ----NKLWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGV  176 (1187)
T ss_pred             ----CceEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccc
Confidence                678999999996 6666665554 4499999999999999999999999999999999999999999999999998


Q ss_pred             ccccc-CCCccccccccccccchhhhh-----cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         180 AKTFD-YDMMLTSVVVTLWYRAPEILL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       180 ~~~~~-~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      +.... ......+.+||+.|+|||+..     ..+|++++||||||++|.+|..+.+|....++...+-++.+.-   |+
T Consensus       177 SAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe---PP  253 (1187)
T KOG0579|consen  177 SAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PP  253 (1187)
T ss_pred             cccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC---CC
Confidence            76543 233456789999999999875     4668999999999999999999999998888877766665421   11


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ..                     -....++..+.+|+.+||.+||..||+++++++||||++.+.
T Consensus       254 TL---------------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  254 TL---------------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             cc---------------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence            11                     012356689999999999999999999999999999998764

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6e-42  Score=284.71  Aligned_cols=249  Identities=20%  Similarity=0.332  Sum_probs=201.1

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.+.||+|++|+||++..  .++..+++|.+.....   ....+.+|+.+++++.   ||||+++++++...  
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~--~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~--   71 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLS---HEKLVQLYGVCTKQ--   71 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEe--cCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCC---CCCeeeEEEEEccC--
Confidence            346899999999999999999976  3455699998764321   2346788999999887   99999999998665  


Q ss_pred             ccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ...+++||++. ++|.+++..... .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus        72 -----~~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g  145 (256)
T cd05113          72 -----RPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFG  145 (256)
T ss_pred             -----CCcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCc
Confidence                 56799999998 599999876543 48999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCcc--ccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         179 LAKTFDYDMML--TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       179 ~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      .+.........  ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.........  
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  223 (256)
T cd05113         146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP--  223 (256)
T ss_pred             cceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC--
Confidence            88755433211  12334567999999998889999999999999999998 99999877665555544332111110  


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                                              ...+..+.+++.+||+.+|.+||++.+++++
T Consensus       224 ------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         224 ------------------------HLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ------------------------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                                    1234789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-42  Score=299.68  Aligned_cols=260  Identities=23%  Similarity=0.318  Sum_probs=201.9

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      |++..++|++.+.||+|+||.||+|.+..    .+++.|++|++..... ......+..|+.+++++..  |+||+++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~--h~niv~~~~   78 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGH--HLNVVNLLG   78 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhcc--Ccchhheee
Confidence            56788899999999999999999997532    3457899998864321 1122356679999998843  999999999


Q ss_pred             eeeccccccccceEEEEEeccCcc-CHHHHHhhCCC--------------------------------------------
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPP--------------------------------------------  127 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~--------------------------------------------  127 (321)
                      ++....      ..+++++||+.+ +|.+++.....                                            
T Consensus        79 ~~~~~~------~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (337)
T cd05054          79 ACTKPG------GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKS  152 (337)
T ss_pred             eEecCC------CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcc
Confidence            875431      467899999995 99988864321                                            


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCC---cc
Q psy2676         128 ---------------PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---ML  189 (321)
Q Consensus       128 ---------------~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~  189 (321)
                                     ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......   ..
T Consensus       153 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~  232 (337)
T cd05054         153 LSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK  232 (337)
T ss_pred             hhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhc
Confidence                           247899999999999999999999999999999999999999999999999987653222   12


Q ss_pred             ccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhh
Q psy2676         190 TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFE  268 (321)
Q Consensus       190 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (321)
                      ....++..|+|||++.+..++.++|||||||++++|++ |..||.+....+...........+.                
T Consensus       233 ~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----------------  296 (337)
T cd05054         233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR----------------  296 (337)
T ss_pred             cCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC----------------
Confidence            23345677999999999999999999999999999998 9999976544333322222111100                


Q ss_pred             hhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         269 QYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                               ....+++++.+++.+||+.+|++||++.++++|
T Consensus       297 ---------~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         297 ---------APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                     011345789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.5e-42  Score=284.22  Aligned_cols=250  Identities=22%  Similarity=0.368  Sum_probs=201.8

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ++..++|++.+.||+|++|.||++.+  ..+..+++|.+....   .....+.+|+.+++++.   |||++++++++...
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~--~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~   73 (260)
T cd05069           2 EIPRESLRLDVKLGQGCFGEVWMGTW--NGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLR---HDKLVPLYAVVSEE   73 (260)
T ss_pred             cCChHHeeeeeeecCcCCCeEEEEEE--cCCceEEEEEcccCC---ccHHHHHHHHHHHHhCC---CCCeeeEEEEEcCC
Confidence            55678999999999999999999987  344568999875422   22346778999999988   99999999987432


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                              ..+++||++.+ +|.+++.......+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|
T Consensus        74 --------~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~d  145 (260)
T cd05069          74 --------PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIAD  145 (260)
T ss_pred             --------CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECC
Confidence                    36899999985 999999875555589999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         177 FGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       177 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      ||.+........  .....++..|+|||...+...+.++|+||||+++|+|++ |..||.+....+....+......+  
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--  223 (260)
T cd05069         146 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP--  223 (260)
T ss_pred             CccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence            999876543221  122345677999999988889999999999999999999 899998876665554443221110  


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                              ...+.+..+.+++++||.+||.+||+++++++
T Consensus       224 ------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         224 ------------------------CPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             ------------------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                    01245588999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-42  Score=289.38  Aligned_cols=248  Identities=28%  Similarity=0.444  Sum_probs=196.4

Q ss_pred             eeeeeeecccceeEEEEEEe---cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          25 DELCQIGCGAYGTVFKARDL---QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        25 ~~~~~lg~g~~g~v~~~~~~---~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      .+.+.||.|.||.||+|...   ...+..|++|.++.... ......+.+|++.+++++   ||||+++++++...    
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~-~~~~~~~~~e~~~l~~l~---h~ni~~~~g~~~~~----   73 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS-EEEEEEFLNEIQILRKLR---HPNIVKLYGFCIEN----   73 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS-HHHHHHHHHHHHHHHTHS---BTTBE-EEEEEESS----
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc-cccceeeeeccccccccc---cccccccccccccc----
Confidence            56789999999999999984   24567899999854211 112457788999999887   99999999999754    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++|+|++. |+|.+++.......+++..++.++.||+.||.|||+++++|++|+++||+++.++.+||+|||++
T Consensus        74 ---~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~  150 (259)
T PF07714_consen   74 ---EPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLS  150 (259)
T ss_dssp             ---SSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred             ---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence               45899999998 69999999975566999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         181 KTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       181 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      .......   ..........|+|||.+.+..++.++||||||+++|++++ |+.||...+..+....+......+     
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~-----  225 (259)
T PF07714_consen  151 RPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP-----  225 (259)
T ss_dssp             EETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT-----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce-----
Confidence            8763221   1233456778999999999999999999999999999999 689998887766665553322111     


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                           ....++..+.+++.+||..||.+|||+.++++
T Consensus       226 ---------------------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  226 ---------------------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             ---------------------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ---------------------eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                                 12246688999999999999999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0983|consensus

Probab=100.00  E-value=2.4e-43  Score=275.41  Aligned_cols=261  Identities=24%  Similarity=0.407  Sum_probs=211.5

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      .-++.+++..||+|+-|+||+++. ..++...|||.+......+ ..+.+...+.++.+-.  .+|+||+++++|..+  
T Consensus        90 dindl~~l~dlGsGtcG~V~k~~~-rs~~~iiAVK~M~rt~Nke-e~kRILmDldvv~~s~--dcpyIV~c~GyFi~n--  163 (391)
T KOG0983|consen   90 DINDLENLGDLGSGTCGQVWKMRF-RSTGHIIAVKQMRRTGNKE-ENKRILMDLDVVLKSH--DCPYIVQCFGYFITN--  163 (391)
T ss_pred             ChHHhhhHHhhcCCCccceEEEEE-cccceEEEEEeecccCCHH-HHHHHHHhhhHHhhcc--CCCeeeeeeeEEeeC--
Confidence            335567889999999999999999 6889999999998654333 2335555555554433  499999999999877  


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ..+.+.||.+..-+..++....+ +++|..+-.+...++.||.||.. +|++|||+||+||++|+.|++||||||
T Consensus       164 -----~dV~IcMelMs~C~ekLlkrik~-piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  164 -----TDVFICMELMSTCAEKLLKRIKG-PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             -----chHHHHHHHHHHHHHHHHHHhcC-CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccc
Confidence                 67789999988766777666543 49999999999999999999995 589999999999999999999999999


Q ss_pred             CcccccCCCccccccccccccchhhhhc---CCCCCcchHHHHHHHHHHHHhcCCCCCC-CChHHHHHHHHHHhCCCCCC
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILLN---LGYGTPVDIWSIGCVMAEMWRLVPLFCA-STEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~  254 (321)
                      .+..+-.+...+...|-+.|+|||-+.-   ..|+..+||||||+.++++.||+.||.+ ..+-+.+.++.+.. +|   
T Consensus       238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e-PP---  313 (391)
T KOG0983|consen  238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE-PP---  313 (391)
T ss_pred             ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC-CC---
Confidence            9988877777777888899999999854   3488899999999999999999999987 44556666665521 11   


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .++..                    ...++.+.+|+..||++|+.+||...++|+|||++.-
T Consensus       314 ~L~~~--------------------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  314 LLPGH--------------------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             CCCcc--------------------cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            11111                    1356899999999999999999999999999998743

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.4e-42  Score=288.88  Aligned_cols=257  Identities=21%  Similarity=0.340  Sum_probs=202.3

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +++..++|++.+.||+|++|.||++.+..    ..+..+++|++..... ......+.+|+.+++.++   |||++++++
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~---~~~iv~~~~   76 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFN---CHHVVRLLG   76 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCC---CCCeeeEEE
Confidence            45677899999999999999999998631    3456799998753211 112235678888888887   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP--------PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQN  163 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~--------~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~N  163 (321)
                      ++...       ...++|+|++. ++|.+++.....        ..+++..+..++.|++.||.+||+.|++|+||||+|
T Consensus        77 ~~~~~-------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~N  149 (277)
T cd05062          77 VVSQG-------QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARN  149 (277)
T ss_pred             EEcCC-------CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchhe
Confidence            98666       57899999999 599999875321        235778899999999999999999999999999999


Q ss_pred             EEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHH
Q psy2676         164 LLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVE  239 (321)
Q Consensus       164 ilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~  239 (321)
                      |++++++.++|+|||++........   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.....
T Consensus       150 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~  229 (277)
T cd05062         150 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ  229 (277)
T ss_pred             EEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9999999999999999875532221   112344678999999998889999999999999999999 789998776655


Q ss_pred             HHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         240 QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ....+.... .+.   .                      ...++..+.+++.+||+.+|++|||+.+++++
T Consensus       230 ~~~~~~~~~-~~~---~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         230 VLRFVMEGG-LLD---K----------------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HHHHHHcCC-cCC---C----------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            444333211 111   0                      12455789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.2e-42  Score=293.16  Aligned_cols=260  Identities=27%  Similarity=0.449  Sum_probs=209.2

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +...++|...+.||+|++|.||++++ ..++..+++|.+...... ......+.+|+.+++.+.   |+|++++++++..
T Consensus        11 ~~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~   86 (308)
T cd06634          11 DDPEKLFSDLREIGHGSFGAVYFARD-VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR---HPNTIQYRGCYLR   86 (308)
T ss_pred             CCcHHHHHHHHheeeCCCEEEEEEEE-cCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC---CCCcccEEEEEEc
Confidence            34667899999999999999999999 577889999988643211 112235667888899887   9999999999877


Q ss_pred             cccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          97 NILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                      .       ...++|+||+.|++.+.+.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        87 ~-------~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~d  158 (308)
T cd06634          87 E-------HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGD  158 (308)
T ss_pred             C-------CeeEEEEEccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECC
Confidence            6       6789999999999888876544 3489999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCccccccccccccchhhhhc---CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLN---LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      ||.+......   ....++..|+|||.+.+   ...+.++||||||+++|+|++|..||...+..+....+..... +..
T Consensus       159 fg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~  234 (308)
T cd06634         159 FGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PAL  234 (308)
T ss_pred             cccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-CCc
Confidence            9988765432   23456788999999853   4578899999999999999999999977655444433322111 100


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      .                        ...++..+.++|++||..+|.+||++.++++||||.+..
T Consensus       235 ~------------------------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         235 Q------------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             C------------------------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence            0                        124557889999999999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0669|consensus

Probab=100.00  E-value=2.3e-44  Score=278.06  Aligned_cols=295  Identities=38%  Similarity=0.688  Sum_probs=240.2

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ...+.|+-..++|+|.||.||+|+. +++++.|++|.+-......+......+|+.++..++   |+|++.+++++....
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~-~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk---Henv~nliEic~tk~   89 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARS-KNTGKKVALKKVLMENEKEGFPITALREIKILQLLK---HENVVNLIEICRTKA   89 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhh-cCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc---chhHHHHHHHHhhcc
Confidence            3457788899999999999999999 688888988877665555666778889999999998   999999998886542


Q ss_pred             cc-cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LS-DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~-~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                      .. -....++|+|+.+|..+|..++.... ..++...+.+++++++.||.|+|+..|.|||+|+.|++|+.+|.+||+||
T Consensus        90 Tp~~r~r~t~ylVf~~cehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   90 TPTNRDRATFYLVFDFCEHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             CCcccccceeeeeHHHhhhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence            22 12335689999999999999987754 34999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCC-----ccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         178 GLAKTFDYDM-----MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       178 g~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      |+++.++...     ..+....|+.|.+||.+.+.. ++++.|||+.||++.+|+++.+.+.+.+....+..+....|..
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            9997664332     233455699999999987755 8999999999999999999999999999999999999999998


Q ss_pred             CCCCcchhhhhh-hhhh--h---hhhhhhhhhhhh--hcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         252 SMNEWPENISLM-WSSF--E---QYSKVAFSAIFM--DCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       252 ~~~~~~~~~~~~-~~~~--~---~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ...-||+..... +..+  +   +...+......+  .-.++..+|+.++|..||.+|++++++++|.||...+.
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~  323 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM  323 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence            888888754433 3333  2   111222222211  12357889999999999999999999999999987654

>KOG1290|consensus

Probab=100.00  E-value=3.7e-42  Score=287.90  Aligned_cols=289  Identities=29%  Similarity=0.449  Sum_probs=220.2

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccC-----CCCceeEEEeee
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF-----EHPNIVRFFDVI   94 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~-----~~~~i~~~~~~~   94 (321)
                      .++||-+.++||-|.|+|||+|.| ..+.+.||+|+.+..   .-.......|+.+|++++.-     +..+||++++.|
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawD-tq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWD-TQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             cCceEEEEEeccccccceeEEEee-ccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            348999999999999999999999 588899999998743   22344677899999998742     345899999999


Q ss_pred             eccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeeC----
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRA----  169 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-~~~H~di~p~Nilv~~~----  169 (321)
                      ...   +++..++|+|+|+++.+|..++.......++...++.|++||+.||.|||.. ||+|.||||+|||+..+    
T Consensus       152 khs---GpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~  228 (590)
T KOG1290|consen  152 KHS---GPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDP  228 (590)
T ss_pred             eec---CCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccch
Confidence            544   6777899999999999999999999888899999999999999999999955 99999999999999500    


Q ss_pred             --------------------------------------------------------------------------------
Q psy2676         170 --------------------------------------------------------------------------------  169 (321)
Q Consensus       170 --------------------------------------------------------------------------------  169 (321)
                                                                                                      
T Consensus       229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~  308 (590)
T KOG1290|consen  229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR  308 (590)
T ss_pred             hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q psy2676         170 --------------------------------------------------------------------------------  169 (321)
Q Consensus       170 --------------------------------------------------------------------------------  169 (321)
                                                                                                      
T Consensus       309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~  388 (590)
T KOG1290|consen  309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE  388 (590)
T ss_pred             CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence                                                                                            


Q ss_pred             --CCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCC------CChHHHH
Q psy2676         170 --GGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCA------STEVEQL  241 (321)
Q Consensus       170 --~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~------~~~~~~~  241 (321)
                        -.+||.|||-++-..  ..++.-+.|..|.|||++.+..|+..+||||++|+++||+||...|..      ..+++.+
T Consensus       389 ~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi  466 (590)
T KOG1290|consen  389 CDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI  466 (590)
T ss_pred             cceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence              003344444333211  112233567789999999999999999999999999999999999954      4578889


Q ss_pred             HHHHHHhCCCCCCCcch-hhhhh-h------hhhhhhhhhhhhh-------hhhhcchhHHHHHHHhcccCCCCCCCHHH
Q psy2676         242 KCIFRVIGTPSMNEWPE-NISLM-W------SSFEQYSKVAFSA-------IFMDCCSKANSLLESMLTFNPADRISAAD  306 (321)
Q Consensus       242 ~~~~~~~~~~~~~~~~~-~~~~~-~------~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~  306 (321)
                      ..|+..+|..|..-... .-+.. .      ..+.+...-....       ...+-..++.+||.-||+.+|++||||.+
T Consensus       467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~  546 (590)
T KOG1290|consen  467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ  546 (590)
T ss_pred             HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence            99999988766541110 00000 0      0011111101111       12234478899999999999999999999


Q ss_pred             HhCCCCCCCCC
Q psy2676         307 ALEHPYFKEKE  317 (321)
Q Consensus       307 ll~h~~f~~~~  317 (321)
                      +|+|||+....
T Consensus       547 cl~hPwLn~~~  557 (590)
T KOG1290|consen  547 CLKHPWLNPVA  557 (590)
T ss_pred             HhcCccccCCC
Confidence            99999999653

>KOG4721|consensus

Probab=100.00  E-value=6.8e-44  Score=303.52  Aligned_cols=253  Identities=29%  Similarity=0.407  Sum_probs=214.5

Q ss_pred             cccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCcee
Q psy2676           9 IQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV   88 (321)
Q Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~   88 (321)
                      ++...-+.|++.-+...-++-||+|+.|.||+++   ..++.||||.++.         ....++.-|++|+   ||||+
T Consensus       111 ~k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Gr---l~netVAVKKV~e---------lkETdIKHLRkLk---H~NII  175 (904)
T KOG4721|consen  111 HKQQQEELWEIPFEEISELEWLGSGAQGAVFLGR---LHNETVAVKKVRE---------LKETDIKHLRKLK---HPNII  175 (904)
T ss_pred             hhhhhhhhccCCHHHhhhhhhhccCcccceeeee---ccCceehhHHHhh---------hhhhhHHHHHhcc---Cccee
Confidence            3444556677777778888999999999999995   4778899998752         3446888899998   99999


Q ss_pred             EEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q psy2676          89 RFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT  167 (321)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~  167 (321)
                      .+.+++...       ..+|||||||. |.|.+.++.  ...+....+..+..+|+.++.|||.++|+|||||.=||||+
T Consensus       176 ~FkGVCtqs-------PcyCIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs  246 (904)
T KOG4721|consen  176 TFKGVCTQS-------PCYCIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS  246 (904)
T ss_pred             eEeeeecCC-------ceeEEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee
Confidence            999999776       68899999999 799999998  45589999999999999999999999999999999999999


Q ss_pred             eCCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q psy2676         168 RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       168 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  247 (321)
                      .+..+|++|||.+.......+..+..||..|||||++++.+++.+.||||||++||||+||..||...+...+   |.. 
T Consensus       247 ~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---IwG-  322 (904)
T KOG4721|consen  247 YDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---IWG-  322 (904)
T ss_pred             ccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---EEe-
Confidence            9999999999999988777778889999999999999999999999999999999999999999976543222   111 


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      .|...                     ..--....||.-++=|+++||+-.|.-||++.+++.|
T Consensus       323 VGsNs---------------------L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  323 VGSNS---------------------LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             ccCCc---------------------ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            11100                     0001234788999999999999999999999999998

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1e-42  Score=299.61  Aligned_cols=280  Identities=21%  Similarity=0.295  Sum_probs=203.2

Q ss_pred             eeeecc--cceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccce
Q psy2676          28 CQIGCG--AYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYL  105 (321)
Q Consensus        28 ~~lg~g--~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~  105 (321)
                      ..||.|  ++|+||++++ ..+++.|++|++............+.+|+.+++.++   ||||+++++++...       .
T Consensus         4 ~~ig~g~~~~~~v~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~---h~niv~~~~~~~~~-------~   72 (328)
T cd08226           4 VEIGRGFCNLTSVYLARH-TPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFR---HPNIMTSWTVFTTG-------S   72 (328)
T ss_pred             HHhCCcccCceeEEEEEE-cCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCC---CCCcceEeeeEecC-------C
Confidence            456666  8899999998 678999999998754333223346677888888787   99999999999876       6


Q ss_pred             EEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         106 TVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       106 ~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      ..++|+|++.+ +|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++++||+.+....
T Consensus        73 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~  152 (328)
T cd08226          73 WLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLV  152 (328)
T ss_pred             ceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence            78999999994 99999887655558999999999999999999999999999999999999999999999997554332


Q ss_pred             CCCcc--------ccccccccccchhhhhcC--CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         185 YDMML--------TSVVVTLWYRAPEILLNL--GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       185 ~~~~~--------~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      .....        ....++..|+|||++.+.  .++.++||||+|+++++|++|..||...................+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd08226         153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD  232 (328)
T ss_pred             ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcc
Confidence            11110        112235569999998764  36889999999999999999999998766554443333211111110


Q ss_pred             --Ccchhhhhhhhhhhhh------------------hhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q psy2676         255 --EWPENISLMWSSFEQY------------------SKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK  314 (321)
Q Consensus       255 --~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~  314 (321)
                        .++...+.........                  ...........++..+.+|+++||..||.+|||+.++++||||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~  312 (328)
T cd08226         233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK  312 (328)
T ss_pred             ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence              0000000000000000                  00001111234667899999999999999999999999999998


Q ss_pred             CCCC
Q psy2676         315 EKEN  318 (321)
Q Consensus       315 ~~~~  318 (321)
                      +...
T Consensus       313 ~~~~  316 (328)
T cd08226         313 QVKE  316 (328)
T ss_pred             HHHH
Confidence            7643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.6e-42  Score=287.76  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=207.5

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      +...++|++.+.||.|++|.||+|.+. . +..+++|++.....  .....+.+|+.+++.++   |||++++++++.+.
T Consensus         2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~-~-~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~   74 (261)
T cd05148           2 ERPREEFTLERKLGSGYFGEVWEGLWK-N-RVRVAIKILKSDDL--LKQQDFQKEVQALKRLR---HKHLISLFAVCSVG   74 (261)
T ss_pred             cCcHHHHHHhhhhccCCCccEEEeEec-C-CCcEEEEeccccch--hhHHHHHHHHHHHhcCC---CcchhheeeeEecC
Confidence            345678999999999999999999983 3 88999999865422  12346778888888887   99999999998776


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ...++|+|++++ +|.+++.......+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        75 -------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d  147 (261)
T cd05148          75 -------EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVAD  147 (261)
T ss_pred             -------CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEcc
Confidence                   668999999985 999999876666689999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         177 FGLAKTFDYDMM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       177 fg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      ||.+........ .....++..|+|||.+....++.++|+||||+++++|++ |..||...+..+....+......+.  
T Consensus       148 ~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--  225 (261)
T cd05148         148 FGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC--  225 (261)
T ss_pred             ccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC--
Confidence            999876543221 223345667999999988889999999999999999998 8999988776666555543211111  


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                              ...+++.+.+++.+||+.||.+|||+.++++
T Consensus       226 ------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         226 ------------------------PAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ------------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                    1245588999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.4e-42  Score=289.99  Aligned_cols=253  Identities=28%  Similarity=0.481  Sum_probs=209.3

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|.+.+.||+|++|.||++++ ..+++.+++|++..+... ......+.+|..+++++.  +||||+++++++.+.   
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~--~~~~i~~~~~~~~~~---   74 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKE-KETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN--GHPGIIKLYYTFQDE---   74 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEE-cCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc--cCCCchhHHHHhcCC---
Confidence            4799999999999999999999 578999999998764221 222345677888888886  499999999998766   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++|||++. ++|.+++...  +.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        75 ----~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~  148 (280)
T cd05581          75 ----ENLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGT  148 (280)
T ss_pred             ----ceEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCcc
Confidence                67899999996 6999999874  3599999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc---------------------cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChH
Q psy2676         180 AKTFDYDMM---------------------LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV  238 (321)
Q Consensus       180 ~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  238 (321)
                      +........                     .....++..|+|||......++.++|+||||++++++++|..||......
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  228 (280)
T cd05581         149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY  228 (280)
T ss_pred             ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence            876543221                     12235678899999998888999999999999999999999999887655


Q ss_pred             HHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH----HHHhCCCCC
Q psy2676         239 EQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA----ADALEHPYF  313 (321)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~h~~f  313 (321)
                      .....+..... .                          ....+++.+.++|++||+.+|.+||++    .++++||||
T Consensus       229 ~~~~~~~~~~~-~--------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         229 LTFQKILKLEY-S--------------------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHHhcCC-C--------------------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            54444332111 0                          112345889999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.9e-42  Score=287.33  Aligned_cols=254  Identities=24%  Similarity=0.370  Sum_probs=201.2

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecC-----CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQN-----KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      +..++|.+.+.||+|++|.||+|.+. .     .+..+++|.+..... ......+.+|+.++++++   |+||++++++
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~-~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~---~~~i~~~~~~   77 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYR-GRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSKFN---HQNIVRLIGV   77 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEe-cCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCC---CCCEeeEEEE
Confidence            45678999999999999999999984 4     567888898754321 112345778888898887   9999999998


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP-----PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT  167 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~  167 (321)
                      +.+.       ...++|+|++. ++|.+++.....     ..+++..+..++.||+.||.+||+++++|+||+|+||+++
T Consensus        78 ~~~~-------~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~  150 (277)
T cd05036          78 SFER-------LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLT  150 (277)
T ss_pred             EccC-------CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEe
Confidence            8665       45689999998 599999876432     2488999999999999999999999999999999999998


Q ss_pred             eCC---CEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHH
Q psy2676         168 RAG---GLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQ  240 (321)
Q Consensus       168 ~~~---~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~  240 (321)
                      .++   .++|+|||++........   ......+..|+|||++.+..++.++|||||||++|+|++ |..||...+....
T Consensus       151 ~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~  230 (277)
T cd05036         151 CKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV  230 (277)
T ss_pred             ccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            765   499999999876632221   112233567999999999899999999999999999997 9999987766555


Q ss_pred             HHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         241 LKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ...+.... .   ...                      ...++..+.+++++||+.+|++|||+.++++|
T Consensus       231 ~~~~~~~~-~---~~~----------------------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         231 MEFVTGGG-R---LDP----------------------PKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HHHHHcCC-c---CCC----------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            44332211 1   111                      12456889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.3e-42  Score=289.44  Aligned_cols=253  Identities=24%  Similarity=0.381  Sum_probs=204.6

Q ss_pred             CCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ..++|.+.+.||+|++|.||+|++..    .++..+++|.++..... .....+.+|+++++++.   |||++++++++.
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~   78 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQ---HENIVKFYGVCT   78 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-HHHHHHHHHHHHHHhcC---CCCchheeeEEe
Confidence            45689999999999999999998732    23578999998654222 12357788999999987   999999999997


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCP------------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQ  162 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~  162 (321)
                      ..       ...++|||++. ++|.+++....            ...+++..+..++.|++.||.+||+.|++|+||+|+
T Consensus        79 ~~-------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~  151 (280)
T cd05049          79 EG-------DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATR  151 (280)
T ss_pred             cC-------CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccc
Confidence            76       67899999998 49999997642            234788999999999999999999999999999999


Q ss_pred             cEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChH
Q psy2676         163 NLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEV  238 (321)
Q Consensus       163 Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  238 (321)
                      ||+++.++.++|+|||.+.......   ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..
T Consensus       152 nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~  231 (280)
T cd05049         152 NCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE  231 (280)
T ss_pred             eEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            9999999999999999987543222   1223345678999999999999999999999999999998 99999877666


Q ss_pred             HHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         239 EQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      +....+........                          ...++..+.+++++||..||.+||++.|+++
T Consensus       232 ~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         232 EVIECITQGRLLQR--------------------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHHHHcCCcCCC--------------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            65544432111111                          1245588999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-41  Score=281.16  Aligned_cols=255  Identities=26%  Similarity=0.455  Sum_probs=205.0

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC---CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED---GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ..|++.+.||+|++|.||++++ ..++..+++|.+.......   .....+.+|++++++++   |||++++++++.+..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~---h~~i~~~~~~~~~~~   77 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYD-ADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR---HDRIVQYYGCLRDPE   77 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEE-cCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC---CCCcceEEEEEEcCC
Confidence            5799999999999999999998 5788999999875432111   12235667999999998   999999999985531


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                           ....++++|++++ +|.+++...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus        78 -----~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~df  150 (264)
T cd06653          78 -----EKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDF  150 (264)
T ss_pred             -----CCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcc
Confidence                 1357899999985 999998763  34889999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCC----CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         178 GLAKTFDYD----MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       178 g~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      |.+......    .......++..|+|||++.+...+.++|+||||++++++++|+.||..........++   ...+..
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~  227 (264)
T cd06653         151 GASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQPTK  227 (264)
T ss_pred             ccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCCCC
Confidence            998765321    1112345788899999999888999999999999999999999999876554443332   222222


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      ...+                      ..+++.+.++|++||. +|..||++.++++|||.
T Consensus       228 ~~~p----------------------~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         228 PMLP----------------------DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CCCC----------------------cccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            2222                      2455889999999999 57999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0584|consensus

Probab=100.00  E-value=3.8e-43  Score=302.54  Aligned_cols=257  Identities=30%  Similarity=0.441  Sum_probs=213.0

Q ss_pred             Ccce-eeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC--CCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          21 DKKY-DELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG--IPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        21 ~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      .+|| +....||+|+|-+||+|.| ..+|-.||.-.++.......  ....+..|+++|+.|+   ||||+++|+.+.+.
T Consensus        38 ~gRy~k~~evLGrGafKtVYka~D-e~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~---H~NIirfy~SW~d~  113 (632)
T KOG0584|consen   38 TGRYLKFDEVLGRGAFKTVYKAFD-EEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK---HPNIIRFYDSWVDT  113 (632)
T ss_pred             CCceeehhhhcccccceeeeeccc-cccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC---CCceeeeeeheecC
Confidence            3455 7778999999999999999 78888888665554433332  2367888999999988   99999999999877


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeeC-CCEE
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLITRA-GGLK  173 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~--~~H~di~p~Nilv~~~-~~~k  173 (321)
                      .+     ..+.+|+|.+. |+|..|+.+..  ..+...+..|++||+.||.|||++.  |+|||||-+||+|+.+ |.+|
T Consensus       114 ~n-----~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VK  186 (632)
T KOG0584|consen  114 DN-----KTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVK  186 (632)
T ss_pred             CC-----ceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCcee
Confidence            32     56899999999 79999999954  4899999999999999999999984  9999999999999764 7899


Q ss_pred             EeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCC-CChHHHHHHHHHHhCCCC
Q psy2676         174 IADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCA-STEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       174 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~  252 (321)
                      ++|+|+|+........ +..|||.|||||++. ..|+...||||||++++||+|+..||.. .+..++.+++..+..+-.
T Consensus       187 IGDLGLAtl~r~s~ak-svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s  264 (632)
T KOG0584|consen  187 IGDLGLATLLRKSHAK-SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA  264 (632)
T ss_pred             ecchhHHHHhhccccc-eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence            9999999988755443 489999999999987 6789999999999999999999999975 566666666655432111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ..                         +--.+++++||.+||.. .++|||+.|+|.||||+..
T Consensus       265 l~-------------------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  265 LS-------------------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             hh-------------------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            11                         11128999999999999 9999999999999999975

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7e-42  Score=292.93  Aligned_cols=251  Identities=23%  Similarity=0.344  Sum_probs=198.0

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCc----EEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGN----YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ..++|++.+.||+|+||+||+|++. .++.    .+++|+++.... ......+.+|+.+++.+.   ||||+++++++.
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~g~~~   79 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVD---NPHVCRLLGICL   79 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEe-cCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCC---CCCCCeEEEEEc
Confidence            4578999999999999999999873 3443    488898864321 222346778888888887   999999999986


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ..        ..+++++++. |+|.+++.... ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++.+||
T Consensus        80 ~~--------~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl  150 (316)
T cd05108          80 TS--------TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKI  150 (316)
T ss_pred             CC--------CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEE
Confidence            54        3578899988 69999998754 34889999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCcc---ccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCC
Q psy2676         175 ADFGLAKTFDYDMML---TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       175 ~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      +|||.+.........   .....+..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+ .....
T Consensus       151 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~  229 (316)
T cd05108         151 TDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER  229 (316)
T ss_pred             ccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hCCCC
Confidence            999999866533221   12233567999999999999999999999999999997 99999876655443322 21111


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ++..                         ..++..+.+++.+||..+|.+||++.+++.+
T Consensus       230 ~~~~-------------------------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         230 LPQP-------------------------PICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCC-------------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            1111                         1344788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=284.58  Aligned_cols=253  Identities=24%  Similarity=0.368  Sum_probs=202.3

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecC--CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQN--KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ..++|++.+.||+|+||+||+|.....  +...+++|.++.... ......+.+|+..+++++   |||++++++.+...
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~   77 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFD---HPNIIRLEGVVTKS   77 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCC---CCCcceEeEEEecC
Confidence            356899999999999999999987422  345789998764322 222345677888888887   99999999998766


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ...++++|++.+ +|.+++..... .+++..++.++.|++.||.+||++|++|+||+|+||++++++.++|+|
T Consensus        78 -------~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~d  149 (266)
T cd05033          78 -------RPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSD  149 (266)
T ss_pred             -------CceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECc
Confidence                   568999999985 99999877443 589999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCC-c--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         177 FGLAKTFDYDM-M--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       177 fg~~~~~~~~~-~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ||.+....... .  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+......+.
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  229 (266)
T cd05033         150 FGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP  229 (266)
T ss_pred             cchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99998764211 1  112334567999999998889999999999999999997 9999977665554444432211111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                                                ..+++..+.+++.+||+.+|++||++.+++++
T Consensus       230 --------------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         230 --------------------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             --------------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                      12456889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.6e-42  Score=292.29  Aligned_cols=273  Identities=21%  Similarity=0.274  Sum_probs=198.3

Q ss_pred             cceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEEEEecc
Q psy2676          34 AYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEH  113 (321)
Q Consensus        34 ~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~  113 (321)
                      +++.||.++. ..+++.+|+|++............+.+|+..+++++   ||||+++++++...       ...++++|+
T Consensus        12 ~~~~v~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~~i~~~~~~~~~~-------~~~~~~~e~   80 (314)
T cd08216          12 DLMIVHLAKH-KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ---HPNILPYVTSFIVD-------SELYVVSPL   80 (314)
T ss_pred             CCceEEEEEe-cCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC---CcchhhhhheeecC-------CeEEEEEec
Confidence            4455666666 468999999999765333344457788999999988   99999999999776       678999999


Q ss_pred             Cc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCCc----
Q psy2676         114 VD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM----  188 (321)
Q Consensus       114 ~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~----  188 (321)
                      +. ++|.+++.......+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++++|||.+........    
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            99 5999999875445589999999999999999999999999999999999999999999999998865432211    


Q ss_pred             ----cccccccccccchhhhhcC--CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC--Ccchhh
Q psy2676         189 ----LTSVVVTLWYRAPEILLNL--GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN--EWPENI  260 (321)
Q Consensus       189 ----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  260 (321)
                          .....++..|+|||.+...  .++.++|+||+|+++++|++|..||......................  .++...
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence                1233456789999998764  47889999999999999999999998765443322211111000000  000000


Q ss_pred             hhhhh-----hhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         261 SLMWS-----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       261 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      .....     .................+.++.+|+++||..||++|||+.++++||||++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence            00000     0000000111112224457899999999999999999999999999999763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0668|consensus

Probab=100.00  E-value=1.7e-43  Score=269.54  Aligned_cols=279  Identities=27%  Similarity=0.483  Sum_probs=223.5

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++++++|+|-|+.||.+.. -.+++.+++|+++.-     ....+.+|+.++..+.+  +|||++++++..++..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~-~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~g--g~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGIN-ITNNEKCVIKILKPV-----KKKKIKREIKILQNLRG--GPNIIKLLDIVKDPES  107 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccc-cCCCceEEEeeechH-----HHHHHHHHHHHHHhccC--CCCeeehhhhhcCccc
Confidence            346899999999999999999998 478889999998742     23478899999999996  9999999999987732


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC-CEEEeec
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADF  177 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~-~~kl~df  177 (321)
                           .+..+++|+++. +...+...     ++..+++.++.+++.||.|+|++||+|||+||+|++|+... .++|+||
T Consensus       108 -----ktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDW  177 (338)
T KOG0668|consen  108 -----KTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDW  177 (338)
T ss_pred             -----cCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeec
Confidence                 467899999996 55555444     88999999999999999999999999999999999998654 5999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCC-CCCChHHHHHHHHHHhCCCCCCC
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLF-CASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      |++....+.....-...+..|-.||++...+ ++.+-|+|||||++..|++.+.|| .+.++.+++-++.+.+|+.....
T Consensus       178 GLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~  257 (338)
T KOG0668|consen  178 GLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA  257 (338)
T ss_pred             chHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence            9999888777666677788899999987655 799999999999999999987775 67788888888888887654332


Q ss_pred             cchh-----hhhhhhhhhhhhhh-----hhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         256 WPEN-----ISLMWSSFEQYSKV-----AFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       256 ~~~~-----~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      +-..     .......+.+..+.     -.++...-.++++.+|+.++|..|-.+|+|+.|++.||||..+
T Consensus       258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence            2111     01111122222222     2222223356899999999999999999999999999999865

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-41  Score=282.01  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=205.1

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      .+..++|++.+.||.|++|.||++..   .++.+++|.++....   ....+.+|+.+++.+.   |+|++++++++.+.
T Consensus         2 ~~~~~~~~~~~~ig~g~~g~v~~~~~---~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~   72 (256)
T cd05039           2 AINSKELKLGATIGKGEFGDVMLGDY---RGQKVAVKCLKDDST---AAQAFLAEASVMTTLR---HPNLVQLLGVVLQG   72 (256)
T ss_pred             ccChhhccceeeeecCCCceEEEEEe---cCcEEEEEEeccchh---HHHHHHHHHHHHHhcC---CcceeeeEEEEcCC
Confidence            35678999999999999999999976   478899999875432   3446778999999988   99999999998765


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ...++|+|+++ ++|.+++.......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        73 -------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d  145 (256)
T cd05039          73 -------NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSD  145 (256)
T ss_pred             -------CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcc
Confidence                   67899999999 5999999876655689999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ||.+........  ....+..|+|||.+....++.++|+||||++++++++ |..||......+....+....    ...
T Consensus       146 ~g~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----~~~  219 (256)
T cd05039         146 FGLAKEASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY----RME  219 (256)
T ss_pred             cccccccccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC----CCC
Confidence            999877643222  3344667999999988889999999999999999997 999997766555443332210    001


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                            ....+++.+.++|++||..+|.+|||+.++++
T Consensus       220 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         220 ----------------------APEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             ----------------------CccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                                  11245688999999999999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-41  Score=287.83  Aligned_cols=264  Identities=25%  Similarity=0.408  Sum_probs=207.6

Q ss_pred             ceeeeeeeecccceeEEEEEEec--CCCcEEEEEEeecccCCC--CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQ--NKGNYVAMKKLRVKLNED--GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~--~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      .|++.+.||.|++|.||+|++..  .++..+++|+++......  .....+.+|+++++++..  |++|+++++++... 
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~~i~~~~~~~~~~-   77 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ--SPFLVTLHYAFQTD-   77 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhccc--CCChhceeeEeecC-
Confidence            48899999999999999998742  368899999987542221  223456789999999863  99999999998776 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ...++|+|++++ +|.+++...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus        78 ------~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          78 ------TKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             ------CeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeC
Confidence                  678999999995 999999874  34899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCC--ccccccccccccchhhhhcC--CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         178 GLAKTFDYDM--MLTSVVVTLWYRAPEILLNL--GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       178 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      |.+.......  ......++..|+|||.+...  ..+.++||||+|+++|+|++|..||...........+........ 
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-  228 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-  228 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-
Confidence            9987654322  12234578889999998753  367899999999999999999999964332222111111110000 


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENEP  320 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~~  320 (321)
                      ..                      ....+++.+.+++++||..||.+||     ++.++++||||+...|+.
T Consensus       229 ~~----------------------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~  278 (290)
T cd05613         229 PP----------------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD  278 (290)
T ss_pred             CC----------------------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence            00                      0123557889999999999999997     899999999999998763

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.2e-41  Score=298.24  Aligned_cols=259  Identities=23%  Similarity=0.298  Sum_probs=203.1

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecC----CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQN----KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      .+.+..++|++.+.||+|+||+||+|++...    .+..||+|+++.... ......+.+|+++++++..  ||||++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~--HpnIv~l~  107 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGP--HLNIVNLL  107 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCC--CCCeeeEE
Confidence            6677788999999999999999999987322    234799999865322 2223467789999999864  99999999


Q ss_pred             eeeeccccccccceEEEEEeccCc-cCHHHHHhhCC--------------------------------------------
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--------------------------------------------  126 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--------------------------------------------  126 (321)
                      +++...       ..+++||||+. |+|.+++....                                            
T Consensus       108 ~~~~~~-------~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (400)
T cd05105         108 GACTKS-------GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDM  180 (400)
T ss_pred             EEEccC-------CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccc
Confidence            999766       67899999998 59988876431                                            


Q ss_pred             --------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy2676         127 --------------------------------------------------PPGLSASKVKELTRQMLKGVDFLHSHRIIH  156 (321)
Q Consensus       127 --------------------------------------------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H  156 (321)
                                                                        ...+++..+..++.||+.||.|||+.+++|
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH  260 (400)
T cd05105         181 KQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVH  260 (400)
T ss_pred             ccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence                                                              123778888999999999999999999999


Q ss_pred             ccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCC
Q psy2676         157 RDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLF  232 (321)
Q Consensus       157 ~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf  232 (321)
                      +||||+||+++.++.++|+|||++........   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus       261 ~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~  340 (400)
T cd05105         261 RDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY  340 (400)
T ss_pred             CCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            99999999999999999999999876532221   122345678999999998889999999999999999997 89999


Q ss_pred             CCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         233 CASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ..................+.                         ....++..+.+++.+||+.||++||++.++.+
T Consensus       341 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         341 PGMIVDSTFYNKIKSGYRMA-------------------------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             cccchhHHHHHHHhcCCCCC-------------------------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            76544333322222111111                         01245688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.2e-41  Score=284.70  Aligned_cols=253  Identities=26%  Similarity=0.428  Sum_probs=201.1

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++.+.||+|++|.||+|++ ..+++.+++|.+...... ......+.+|+.+++.++   |||++++++++.+.   
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~---   74 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATC-LLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN---HPNVIKYLDSFIED---   74 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEE-eCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC---CcceeeeeeeEEEC---
Confidence            5899999999999999999998 578899999987653222 222335677999999887   99999999998776   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCP--PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                          ...++++|++++ +|.+++....  ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+||
T Consensus        75 ----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~  150 (267)
T cd08228          75 ----NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             ----CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECcc
Confidence                678999999995 9988886422  234899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChH-HHHHHHHHHhCCCCCCC
Q psy2676         178 GLAKTFDYDMM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV-EQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       178 g~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~  255 (321)
                      |.+........ .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ............++.. 
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  229 (267)
T cd08228         151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLP-  229 (267)
T ss_pred             ccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCC-
Confidence            98876643322 22345778899999999888999999999999999999999999654321 1111111111111110 


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                             ...++..+.+++.+||..+|++||++.++++
T Consensus       230 -----------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         230 -----------------------TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             -----------------------hhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                                   1235578999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=286.20  Aligned_cols=256  Identities=22%  Similarity=0.372  Sum_probs=204.0

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +++..++|++.+.||+|+||.||++.+..    ..+..+++|.+...... .....+.+|+.+++.+.   |||++++++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~~~---~~~i~~~~~   76 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-RERIEFLNEASVMKEFN---CHHVVRLLG   76 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH-HHHHHHHHHHHHHHhCC---CCceeEEEE
Confidence            35678899999999999999999998742    23478999987543211 11235667888888887   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP--------PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQN  163 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~--------~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~N  163 (321)
                      ++...       ...++|+|++. ++|.+++.....        ..+++..+..++.|++.||.|||+.|++|+||+|+|
T Consensus        77 ~~~~~-------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~n  149 (277)
T cd05032          77 VVSTG-------QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARN  149 (277)
T ss_pred             EEcCC-------CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChhe
Confidence            98766       67899999998 599999875321        236788999999999999999999999999999999


Q ss_pred             EEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHH
Q psy2676         164 LLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVE  239 (321)
Q Consensus       164 ilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~  239 (321)
                      |+++.++.++|+|||.+.......   ......++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+
T Consensus       150 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  229 (277)
T cd05032         150 CMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE  229 (277)
T ss_pred             EEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH
Confidence            999999999999999987654322   1223345678999999988889999999999999999998 999998776665


Q ss_pred             HHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         240 QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ....+... ..+..                         ...++.++.+++.+||+.+|++|||+.++++
T Consensus       230 ~~~~~~~~-~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         230 VLKFVIDG-GHLDL-------------------------PENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HHHHHhcC-CCCCC-------------------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            55444311 11111                         1134588999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1e-41  Score=288.38  Aligned_cols=255  Identities=26%  Similarity=0.511  Sum_probs=206.7

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      |.-...||+|++|.||++.. ..++..+++|.+...  .......+.+|+.+++.++   |+|++++++.+...      
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~-~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~------   89 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATV-KSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQ---HENVVEMYNSYLVG------   89 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEE-cCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcC---CcchhheeeEEEeC------
Confidence            44456899999999999998 578899999987532  1222345778999999888   99999999999876      


Q ss_pred             ceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         104 YLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       104 ~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                       ...++++|++++ +|.+++..   ..+++..++.++.|++.||++||+.|++|+||+|+||++++++.++|+|||.+..
T Consensus        90 -~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~  165 (292)
T cd06657          90 -DELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ  165 (292)
T ss_pred             -CEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEccccccee
Confidence             688999999985 88887754   3479999999999999999999999999999999999999999999999998876


Q ss_pred             ccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhh
Q psy2676         183 FDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS  261 (321)
Q Consensus       183 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (321)
                      ..... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.........+..... +....      
T Consensus       166 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~------  238 (292)
T cd06657         166 VSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLKN------  238 (292)
T ss_pred             cccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-cccCC------
Confidence            54322 22335678889999999888889999999999999999999999987665554443322111 11000      


Q ss_pred             hhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                                       ...++..+.+++.+||..+|.+||++.++++||||.....
T Consensus       239 -----------------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         239 -----------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             -----------------cccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence                             1235578899999999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.6e-41  Score=288.74  Aligned_cols=259  Identities=22%  Similarity=0.299  Sum_probs=205.1

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      .+....++|.+.+.||+|+||.||++.+.    ...+..+++|+++.... ......+.+|+.+++++..  ||||++++
T Consensus        29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~--h~~iv~~~  105 (302)
T cd05055          29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGN--HENIVNLL  105 (302)
T ss_pred             cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccC--CCCcceEE
Confidence            45677789999999999999999999863    23455788998764322 1123356789999999942  99999999


Q ss_pred             eeeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG  170 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~  170 (321)
                      +++...       ...++++|++. ++|.+++.......+++.++..++.|++.||.|||+.+++|+||+|+||+++.++
T Consensus       106 ~~~~~~-------~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~  178 (302)
T cd05055         106 GACTIG-------GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK  178 (302)
T ss_pred             EEEecC-------CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC
Confidence            998766       56899999998 5999999765444489999999999999999999999999999999999999999


Q ss_pred             CEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHH
Q psy2676         171 GLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFR  246 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~  246 (321)
                      .++|+|||.+........   .....++..|+|||.+.+..++.++||||+|+++|+|++ |..||......+.......
T Consensus       179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~  258 (302)
T cd05055         179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK  258 (302)
T ss_pred             eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH
Confidence            999999999876543321   112345678999999999899999999999999999998 9999977655444333332


Q ss_pred             HhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         247 VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ....+..                         ....++++.+++.+||..+|++|||+.++++
T Consensus       259 ~~~~~~~-------------------------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         259 EGYRMAQ-------------------------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             cCCcCCC-------------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            1111100                         1134578999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG0586|consensus

Probab=100.00  E-value=9.1e-43  Score=299.71  Aligned_cols=260  Identities=30%  Similarity=0.445  Sum_probs=226.5

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      +...+-|.+.+.||+|.|++|.++++ ..++..||+|.+.+...+......+.+|+++++.+.   ||||++++.+....
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~-~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~---HPnIvkl~~v~~t~  127 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARH-ILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLN---HPNIVKLFSVIETE  127 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEe-cCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcC---Ccceeeeeeeeeec
Confidence            34446799999999999999999999 588999999999887666555566889999999998   99999999999877


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ..+|+||||+. |.+++++..  ++...+..++.++.|+..|++|||+++|+|||||++|++++.+.++||+|
T Consensus       128 -------~~lylV~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaD  198 (596)
T KOG0586|consen  128 -------ATLYLVMEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIAD  198 (596)
T ss_pred             -------ceeEEEEEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeec
Confidence                   88999999999 599999999  45578899999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCccccccccccccchhhhhcCCC-CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ||++..+.........+|++.|.|||++.+..+ .+.+|+||+|+++|.|+.|..||.+.+-.+...+........+   
T Consensus       199 fgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp---  275 (596)
T KOG0586|consen  199 FGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP---  275 (596)
T ss_pred             cccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc---
Confidence            999999998888889999999999999999886 7899999999999999999999988765444433332211111   


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                                              --++.++.++|+++|-.+|.+|++.+++.+|+|.....
T Consensus       276 ------------------------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  276 ------------------------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             ------------------------ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence                                    12447889999999999999999999999999987553

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.7e-42  Score=289.57  Aligned_cols=252  Identities=23%  Similarity=0.307  Sum_probs=197.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCc--EEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ++|++.+.||+|+||.||+|.+. .++.  .+++|.++... .......+.+|+.+++++..  ||||+++++++...  
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~--hp~iv~~~~~~~~~--   75 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIK-KDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGH--HPNIINLLGACENR--   75 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEec-CCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcC--CCchhheEEEEccC--
Confidence            57999999999999999999883 4443  46777765321 11123456789999988843  99999999998766  


Q ss_pred             ccccceEEEEEeccCc-cCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q psy2676         100 SDERYLTVYLIFEHVD-QDLGSYMEKCP--------------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNL  164 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~-~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Ni  164 (321)
                           ..+++++|+++ ++|.+++....              ...+++..++.++.|++.||++||++|++|+||||+||
T Consensus        76 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Ni  150 (297)
T cd05089          76 -----GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNV  150 (297)
T ss_pred             -----CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceE
Confidence                 56899999998 59999987532              12478999999999999999999999999999999999


Q ss_pred             EEeeCCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHH
Q psy2676         165 LITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKC  243 (321)
Q Consensus       165 lv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  243 (321)
                      +++.++.++|+|||++..............+..|+|||.+.+..++.++||||||+++|+|++ |..||......+....
T Consensus       151 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~  230 (297)
T cd05089         151 LVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK  230 (297)
T ss_pred             EECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999999999998864332212222233456999999998889999999999999999997 9999987766655444


Q ss_pred             HHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         244 IFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      +......+                          ....++..+.+|+.+||..+|.+||+++++++.
T Consensus       231 ~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         231 LPQGYRME--------------------------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             HhcCCCCC--------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            32211110                          012456889999999999999999999999653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=281.85  Aligned_cols=248  Identities=20%  Similarity=0.308  Sum_probs=199.9

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ..+|++.+.||+|++|.||++.+  .++..+++|++....   .....+.+|+.++++++   |||++++++++...   
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~--~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~---   71 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKW--RGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLS---HPNLVQLYGVCTKQ---   71 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEe--cCCccEEEEEeccCC---CCHHHHHHHHHHHHhCC---CCCEEEEEEEEcCC---
Confidence            45799999999999999999987  356689999875432   12346778999999987   99999999998666   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++|+|++++ +|.+++..... .+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        72 ----~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~  146 (256)
T cd05059          72 ----RPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGL  146 (256)
T ss_pred             ----CceEEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCccc
Confidence                568999999985 99999876543 489999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCccc--cccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         180 AKTFDYDMMLT--SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       180 ~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      +..........  ...++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+......+     
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-----  221 (256)
T cd05059         147 ARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLY-----  221 (256)
T ss_pred             ceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCC-----
Confidence            87654322111  1223457999999998889999999999999999998 899998766655544433211110     


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                                           ....++.++.+++.+||..+|++|||+.++++.
T Consensus       222 ---------------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         222 ---------------------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ---------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                                 012356899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG1187|consensus

Probab=100.00  E-value=5.2e-42  Score=293.80  Aligned_cols=274  Identities=24%  Similarity=0.312  Sum_probs=211.4

Q ss_pred             ccccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCce
Q psy2676           8 TIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI   87 (321)
Q Consensus         8 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i   87 (321)
                      .++.++..++....+.|.-.+.||+|+||+||++..  .++..+|||.+.......  ..++.+|+.++.+++   |||+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l--~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~---H~Nl  133 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVL--SDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLR---HPNL  133 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEE--CCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCC---CcCc
Confidence            455677888888889999999999999999999987  455899999776543321  446999999999999   9999


Q ss_pred             eEEEeeeeccccccccce-EEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCC
Q psy2676          88 VRFFDVIHQNILSDERYL-TVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR---IIHRDLKPQ  162 (321)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~-~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~---~~H~di~p~  162 (321)
                      ++++||+.+.       . ..++|+||+. |+|.+.+.......++|....+|+.++|.||+|||...   ++||||||+
T Consensus       134 v~LlGyC~e~-------~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKss  206 (361)
T KOG1187|consen  134 VKLLGYCLEG-------GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSS  206 (361)
T ss_pred             ccEEEEEecC-------CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHH
Confidence            9999999877       4 5899999999 79999998865426899999999999999999999764   999999999


Q ss_pred             cEEEeeCCCEEEeecCCcccccC-CCccccc-cccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCC--hH
Q psy2676         163 NLLITRAGGLKIADFGLAKTFDY-DMMLTSV-VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST--EV  238 (321)
Q Consensus       163 Nilv~~~~~~kl~dfg~~~~~~~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~  238 (321)
                      ||++|++.+.||+|||++..... ....... .||.+|++||....+..+.++||||||++++|+++|+.+.....  ..
T Consensus       207 NILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~  286 (361)
T KOG1187|consen  207 NILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGE  286 (361)
T ss_pred             HeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccc
Confidence            99999999999999999965554 3322223 89999999999999999999999999999999999998876432  11


Q ss_pred             HHHHHH-HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhh--hhhh-hcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         239 EQLKCI-FRVIGTPSMNEWPENISLMWSSFEQYSKVAFS--AIFM-DCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       239 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ...... ..........              .+-.....  .... .....+..+..+|++.+|..||++.++++
T Consensus       287 ~~l~~w~~~~~~~~~~~--------------eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  287 LSLVEWAKPLLEEGKLR--------------EIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             ccHHHHHHHHHHCcchh--------------heeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            111111 1111111000              00000000  0000 22255788999999999999999999764

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.8e-41  Score=286.69  Aligned_cols=253  Identities=23%  Similarity=0.379  Sum_probs=202.2

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      +....|.+.+.||+|+||+||++.+..    .++..+++|.+....  ......+.+|+.+++++.   |||++++++++
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~   76 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQ---HEHIVKFYGVC   76 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCC---CCCcceEEEEE
Confidence            356789999999999999999998522    234568888875431  222346778999999998   99999999998


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP-----------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQ  162 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~  162 (321)
                      ...       ...++|+|++. ++|.+++....           ...+++..++.++.|++.||++||+.|++|+||||+
T Consensus        77 ~~~-------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~  149 (288)
T cd05093          77 VEG-------DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATR  149 (288)
T ss_pred             ecC-------CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcc
Confidence            766       67899999998 59999987532           124899999999999999999999999999999999


Q ss_pred             cEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChH
Q psy2676         163 NLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEV  238 (321)
Q Consensus       163 Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  238 (321)
                      ||++++++.++|+|||.+........   .....++..|+|||.+.+..++.++|+||||+++++|++ |..||......
T Consensus       150 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~  229 (288)
T cd05093         150 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN  229 (288)
T ss_pred             eEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999876532221   122334678999999998889999999999999999998 89999877766


Q ss_pred             HHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         239 EQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      +....+......+                          ....++.++.+++.+||+.||.+|||+.++++
T Consensus       230 ~~~~~i~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         230 EVIECITQGRVLQ--------------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHHHHHcCCcCC--------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            6555443321110                          01135578999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-41  Score=289.93  Aligned_cols=253  Identities=25%  Similarity=0.334  Sum_probs=196.5

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcE--EEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~--~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      -++|++.+.||+|+||.||+|++. .++..  +++|.++... .......+.+|+.++.++..  |||++++++++... 
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~-~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~--h~~iv~~~~~~~~~-   80 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGH--HPNIINLLGACEHR-   80 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEc-cCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcC--CCCcceEEEEECCC-
Confidence            468999999999999999999983 45543  4666654321 11223356679999999843  99999999998766 


Q ss_pred             cccccceEEEEEeccCc-cCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q psy2676          99 LSDERYLTVYLIFEHVD-QDLGSYMEKCP--------------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQN  163 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~N  163 (321)
                            ..+++|+||+. ++|.+++....              ...+++..++.++.||+.||.+||++|++|+||+|+|
T Consensus        81 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~N  154 (303)
T cd05088          81 ------GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN  154 (303)
T ss_pred             ------CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchhe
Confidence                  57899999998 59999987532              1347899999999999999999999999999999999


Q ss_pred             EEEeeCCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHH
Q psy2676         164 LLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLK  242 (321)
Q Consensus       164 ilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~  242 (321)
                      |+++.++.++|+|||++..............+..|+|||.+.+..++.++||||||+++++|++ |..||...+..+...
T Consensus       155 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  234 (303)
T cd05088         155 ILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  234 (303)
T ss_pred             EEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence            9999999999999998864322212222233567999999988889999999999999999998 999997766554433


Q ss_pred             HHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      .+...    ....                      ....+++++.+++.+||+.+|++||++.+++.+
T Consensus       235 ~~~~~----~~~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         235 KLPQG----YRLE----------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHhcC----CcCC----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            32111    0000                      011355789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.8e-41  Score=282.09  Aligned_cols=242  Identities=25%  Similarity=0.369  Sum_probs=193.9

Q ss_pred             eeecccceeEEEEEEe-cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEE
Q psy2676          29 QIGCGAYGTVFKARDL-QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTV  107 (321)
Q Consensus        29 ~lg~g~~g~v~~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~  107 (321)
                      .||+|+||.||+|... ..++..+++|+++...........+.+|+.+++.+.   ||||+++++++...        ..
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~--------~~   70 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD---NPYIVRMIGICEAE--------SW   70 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC---CCCcceEEEEEcCC--------Cc
Confidence            5899999999999652 346788999998754333333456778889999887   99999999987433        45


Q ss_pred             EEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCC
Q psy2676         108 YLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD  186 (321)
Q Consensus       108 ~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~  186 (321)
                      ++|+|+++ ++|.+++...  ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        71 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~  148 (257)
T cd05116          71 MLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence            89999999 5899999763  35899999999999999999999999999999999999999999999999998766433


Q ss_pred             Cc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhh
Q psy2676         187 MM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS  261 (321)
Q Consensus       187 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (321)
                      ..    .....++..|+|||.+....++.++|+||||+++|+|++ |..||......+....+.... .++   .     
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~---~-----  219 (257)
T cd05116         149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-RME---C-----  219 (257)
T ss_pred             CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CCC---C-----
Confidence            22    112233578999999988888999999999999999998 999998776655544443211 111   1     


Q ss_pred             hhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                       ...+++++.++|++||+.||++||++++|..
T Consensus       220 -----------------~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         220 -----------------PQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             -----------------CCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                             1245689999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.1e-41  Score=285.64  Aligned_cols=253  Identities=23%  Similarity=0.366  Sum_probs=200.7

Q ss_pred             CcceeeeeeeecccceeEEEEEEe---cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDL---QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      -.+|++.+.||+|+||+||+|...   ...+..+++|.+..... ......+.+|+.+++++.   |||++++++++...
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~   79 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELH---HPNIVCLLGVVTQE   79 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCC---CCCeeeEEEEEecC
Confidence            468999999999999999999852   23557899998864322 112235678999999987   99999999998776


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCP---------------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKP  161 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~---------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p  161 (321)
                             ...+++|||+. ++|.+++....               ...+++..+..++.|++.||.|||++|++|+||+|
T Consensus        80 -------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp  152 (283)
T cd05090          80 -------QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAA  152 (283)
T ss_pred             -------CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhcccc
Confidence                   57899999999 59999985422               12378899999999999999999999999999999


Q ss_pred             CcEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCCh
Q psy2676         162 QNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTE  237 (321)
Q Consensus       162 ~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~  237 (321)
                      +||+++.++.++|+|||++.......   ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+...
T Consensus       153 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~  232 (283)
T cd05090         153 RNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN  232 (283)
T ss_pred             ceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999999999987653222   1223344667999999988889999999999999999998 9999977665


Q ss_pred             HHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         238 VEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ......+.... .++                         ....+++.+.+++.+||+.||.+||++.+++++
T Consensus       233 ~~~~~~~~~~~-~~~-------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         233 QEVIEMVRKRQ-LLP-------------------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHHcCC-cCC-------------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            54444433211 111                         112456889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.4e-41  Score=280.27  Aligned_cols=247  Identities=23%  Similarity=0.350  Sum_probs=200.5

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      +...+|++.+.||+|++|.||++..   .+..+++|.++..    .....+.+|+.+++++.   |+|++++++++....
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~---~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~   72 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKND----ATAQAFLAEASVMTQLR---HSNLVQLLGVIVEEK   72 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEE---cCCcEEEEEeCCC----chHHHHHHHHHHHHhCC---CCCeeeEEEEEEcCC
Confidence            4567899999999999999999965   4778999987532    22346778999999987   999999999764321


Q ss_pred             cccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ...++++|+++ ++|.+++.......+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+||
T Consensus        73 ------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df  146 (256)
T cd05082          73 ------GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDF  146 (256)
T ss_pred             ------CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCC
Confidence                  45799999998 59999998766556899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      |++.......  .....+..|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.....    .. 
T Consensus       147 g~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~----~~-  219 (256)
T cd05082         147 GLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----MD-  219 (256)
T ss_pred             ccceeccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----CC-
Confidence            9887554322  23334567999999998889999999999999999997 9999977665554443322110    00 


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                           ....+++.+.+++.+||+.+|++|||+.++++
T Consensus       220 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         220 ---------------------APDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             ---------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                 11246689999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.6e-41  Score=287.77  Aligned_cols=259  Identities=25%  Similarity=0.378  Sum_probs=205.6

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      .+.+..++|++.+.||+|++|.||++....    .....+++|.+...... .....+.+|+.+++++..  |+||++++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~E~~~l~~l~~--h~~i~~~~   82 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGK--HKNIINLL   82 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH-HHHHHHHHHHHHHHhhcC--CCCeeeEE
Confidence            567788899999999999999999998742    23468899988643221 122356788999988842  99999999


Q ss_pred             eeeeccccccccceEEEEEeccCc-cCHHHHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKC--------------PPPGLSASKVKELTRQMLKGVDFLHSHRIIH  156 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~--------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H  156 (321)
                      +++...       ..+++++||+. ++|.+++...              ....+++..+..++.|++.||.|||+.|++|
T Consensus        83 ~~~~~~-------~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH  155 (293)
T cd05053          83 GVCTQE-------GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIH  155 (293)
T ss_pred             EEEcCC-------CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            998766       56899999998 5999998652              2345899999999999999999999999999


Q ss_pred             ccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCC
Q psy2676         157 RDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLF  232 (321)
Q Consensus       157 ~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf  232 (321)
                      +||+|+||+++.++.++|+|||.+........   .....++..|+|||++.+..++.++||||||+++|++++ |..||
T Consensus       156 ~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  235 (293)
T cd05053         156 RDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY  235 (293)
T ss_pred             cccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCC
Confidence            99999999999999999999999876543221   112234567999999988889999999999999999997 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         233 CASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ......+....+.....    ...                      ...++..+.+|+.+||..||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~----~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         236 PGIPVEELFKLLKEGYR----MEK----------------------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             CCCCHHHHHHHHHcCCc----CCC----------------------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            87766555444332111    010                      12445789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.5e-41  Score=281.71  Aligned_cols=243  Identities=27%  Similarity=0.435  Sum_probs=193.4

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTV  107 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~  107 (321)
                      +.||+|+||.||+|++ ..+++.+++|.+..... ......+.+|+++++++.   ||||+++++++...       ...
T Consensus         1 ~~lg~g~~g~vy~~~~-~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~-------~~~   68 (252)
T cd05084           1 ERIGRGNFGEVFSGRL-RADNTPVAVKSCRETLP-PDLKAKFLQEARILKQYS---HPNIVRLIGVCTQK-------QPI   68 (252)
T ss_pred             CccCcccCccEEEEEE-ecCCceEEEEecCccCC-HHHHHHHHHHHHHHHhCC---CCCcceEEEEEcCC-------CCe
Confidence            4689999999999999 57889999998764321 222346778999999987   99999999998766       678


Q ss_pred             EEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCC
Q psy2676         108 YLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD  186 (321)
Q Consensus       108 ~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~  186 (321)
                      ++|+||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        69 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  147 (252)
T cd05084          69 YIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG  147 (252)
T ss_pred             EEEEeeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccc
Confidence            999999985 9999987643 34899999999999999999999999999999999999999999999999998754322


Q ss_pred             Ccc---ccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhh
Q psy2676         187 MML---TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL  262 (321)
Q Consensus       187 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (321)
                      ...   .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+..... .   ..      
T Consensus       148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~-~---~~------  217 (252)
T cd05084         148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR-L---PC------  217 (252)
T ss_pred             cccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-C---CC------
Confidence            111   11122456999999988889999999999999999998 8899976655444333322111 1   11      


Q ss_pred             hhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                      ...++..+.+++++||..+|++|||+.++++
T Consensus       218 ----------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         218 ----------------PELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             ----------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                            1134578999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0614|consensus

Probab=100.00  E-value=7e-44  Score=299.59  Aligned_cols=266  Identities=26%  Similarity=0.405  Sum_probs=234.5

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      ++.-.+++++..||-|+||.|-++.. ......+|+|++++.+. +......+..|.+++....   .|.|+++|..|.+
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~-~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~---s~fIvrLYrTfrd  491 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKV-NSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR---SDFIVRLYRTFRD  491 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEe-cccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC---chHHHHHHHHhcc
Confidence            34446788899999999999999976 33334589999877643 3444567778999999888   9999999999999


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ..+|++||.|- |.|+..++.+  +.+++..++.++..+++|+.|||++||++|||||+|.+++.+|=+||.
T Consensus       492 ~-------kyvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLV  562 (732)
T KOG0614|consen  492 S-------KYVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLV  562 (732)
T ss_pred             c-------hhhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEe
Confidence            8       89999999998 4999999984  459999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      |||++..+......-..+||+.|.|||.+.++..+.++|.||||+++||+++|.+||++.++....+.|.+++...   .
T Consensus       563 DFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i---~  639 (732)
T KOG0614|consen  563 DFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI---E  639 (732)
T ss_pred             ehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh---h
Confidence            9999999998887778899999999999999999999999999999999999999999999999999998876432   2


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKENEPL  321 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~~~~  321 (321)
                      ||                      ..++....+||++++..+|.+|..     +.+|-+|.||.+.+|+.+
T Consensus       640 ~P----------------------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl  688 (732)
T KOG0614|consen  640 FP----------------------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL  688 (732)
T ss_pred             cc----------------------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence            22                      245588899999999999999984     999999999999999864

>KOG0607|consensus

Probab=100.00  E-value=1.1e-42  Score=277.28  Aligned_cols=270  Identities=24%  Similarity=0.369  Sum_probs=206.9

Q ss_pred             eeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          27 LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      .+.||+|+|+.|-.+.. -.++..||||++.+.  ..-.+..+.+|++++.+.+.  |+||++++++|+++       ..
T Consensus        83 ~e~LGeGAyasVqtcv~-i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqg--h~nilqLiefFEdd-------~~  150 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVS-IQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQG--HKNILQLIEFFEDD-------TR  150 (463)
T ss_pred             HHHhcCccceeeeeeee-eccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcC--CccHHHHHHHhccc-------ce
Confidence            36799999999999988 478999999999764  44456789999999999996  99999999999998       78


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC---EEEeecCCccc
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKT  182 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~---~kl~dfg~~~~  182 (321)
                      .|+|||-+.| +|...+.++  ..+++.++.++.++|+.||.+||.+||.|||+||+||+......   +|||||.+...
T Consensus       151 FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             EEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence            8999999995 999998884  45999999999999999999999999999999999999976554   89999987654


Q ss_pred             ccCC--------Cccccccccccccchhhhhc-----CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhC
Q psy2676         183 FDYD--------MMLTSVVVTLWYRAPEILLN-----LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       183 ~~~~--------~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      +...        .......|+..|||||+..-     ..|+.+.|.||||+++|-|++|-+||.+.-..+=        |
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------G  300 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------G  300 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--------C
Confidence            4211        12335678889999998742     2378899999999999999999999976321100        0


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ...-+....-.......+......-...-+..++.+.+++++.+|..|+.+|.++.++++|||++....
T Consensus       301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence            000000000001011111111111111224568899999999999999999999999999999997644

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.2e-41  Score=312.29  Aligned_cols=252  Identities=27%  Similarity=0.390  Sum_probs=198.4

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++.+.||+|+||.||+|++ ..+++.||+|++....... .....+.+|+.+++++.   |||++++++++.+.   
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d-~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~---HPNIVkl~~v~~d~---   74 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYD-PVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI---HPGIVPVYSICSDG---   74 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEE-CCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC---CcCcCeEEEEEeeC---
Confidence            6899999999999999999999 5789999999987543222 12345778999999988   99999999998776   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCP---------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG  170 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~---------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~  170 (321)
                          ...+++||+++| +|.+++....         ....+...+..++.||+.||.+||+.|++||||||+||+++.++
T Consensus        75 ----~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg  150 (932)
T PRK13184         75 ----DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG  150 (932)
T ss_pred             ----CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC
Confidence                678999999995 9999886421         12256678899999999999999999999999999999999999


Q ss_pred             CEEEeecCCcccccCCC-------------------ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCC
Q psy2676         171 GLKIADFGLAKTFDYDM-------------------MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPL  231 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  231 (321)
                      .++|+|||++.......                   ......||+.|+|||++.+..++.++||||+||++|+|++|..|
T Consensus       151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P  230 (932)
T PRK13184        151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP  230 (932)
T ss_pred             CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence            99999999987652110                   01124589999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHh
Q psy2676         232 FCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL  308 (321)
Q Consensus       232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  308 (321)
                      |...........  .....+.  .                    .....++++.+.+++.+||..||++|++..+.+
T Consensus       231 F~~~~~~ki~~~--~~i~~P~--~--------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL  283 (932)
T PRK13184        231 YRRKKGRKISYR--DVILSPI--E--------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQEL  283 (932)
T ss_pred             CCCcchhhhhhh--hhccChh--h--------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            976443322211  0000000  0                    001235678899999999999999998766555

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-40  Score=278.65  Aligned_cols=252  Identities=28%  Similarity=0.459  Sum_probs=201.9

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++.+.||.|++|.||+|.+ ..+++.+++|.++..... ......+.+|+.+++++.   |++++++++++...   
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~---~~~i~~~~~~~~~~---   74 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAIC-LLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD---HPNVIKYLASFIEN---   74 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEE-cCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC---CCCeeeeeeeeecC---
Confidence            5899999999999999999999 578899999988753222 223456778999999987   99999999999776   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCP--PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                          ...++++||+++ +|.+++....  ...+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus        75 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~  150 (267)
T cd08224          75 ----NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             ----CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEecc
Confidence                678999999995 9999886532  344899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCCh--HHHHHHHHHHhCCCCCC
Q psy2676         178 GLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE--VEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       178 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~  254 (321)
                      |.+....... ......++..|.|||.+.+..++.++|+||+|+++|+|++|..||.....  .+....+...    ...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~  226 (267)
T cd08224         151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC----DYP  226 (267)
T ss_pred             ceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC----CCC
Confidence            9887654322 22334678889999999988899999999999999999999999965431  1111111110    000


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ..+                     ...++..+.++|.+||..+|++|||+.++++
T Consensus       227 ~~~---------------------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         227 PLP---------------------ADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             CCC---------------------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            000                     1145578999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-41  Score=280.30  Aligned_cols=245  Identities=28%  Similarity=0.437  Sum_probs=202.4

Q ss_pred             eeeecccceeEEEEEEecCC---CcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccc
Q psy2676          28 CQIGCGAYGTVFKARDLQNK---GNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERY  104 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~  104 (321)
                      +.||+|+||.||+|.+. ..   +..+++|.+....... ....+.+|+..++.+.   |+|++++++++...       
T Consensus         1 ~~ig~g~~g~v~~~~~~-~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~---~~~i~~~~~~~~~~-------   68 (262)
T cd00192           1 KKLGEGAFGEVYKGKLK-GKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLG---HPNVVRLLGVCTEE-------   68 (262)
T ss_pred             CccccCCceEEEEEEEe-cCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcC---CCChheeeeeecCC-------
Confidence            46899999999999984 44   8889999987653332 3456778999999888   99999999998775       


Q ss_pred             eEEEEEeccCc-cCHHHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676         105 LTVYLIFEHVD-QDLGSYMEKCP-------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus       105 ~~~~~v~e~~~-~~L~~~~~~~~-------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                      ..+++++|++. ++|.+++....       ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|
T Consensus        69 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~d  148 (262)
T cd00192          69 EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISD  148 (262)
T ss_pred             CceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcc
Confidence            67899999996 69999998752       24589999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         177 FGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       177 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ||.+.......   ......++..|+|||.+....++.++||||+|+++|+|++ |..||......+....+.....   
T Consensus       149 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---  225 (262)
T cd00192         149 FGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR---  225 (262)
T ss_pred             cccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---
Confidence            99998765432   2334556788999999988889999999999999999999 6999988766655554443110   


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                       ..                      ....++.++.+++.+||..+|.+|||+.+++++
T Consensus       226 -~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         226 -LP----------------------KPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             -CC----------------------CCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence             01                      112446899999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.7e-41  Score=286.25  Aligned_cols=254  Identities=22%  Similarity=0.355  Sum_probs=201.2

Q ss_pred             CCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ...+|++.+.||.|+||.||++.+..    ..+..+++|+++.... ......+.+|+.+++++.   ||||+++++++.
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~---h~~iv~~~~~~~   78 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQ---HPNIVCLLGVVT   78 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCC---CCCcCeEEEEEc
Confidence            44679999999999999999998742    2357899999874321 112234667888888887   999999999987


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--------------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLK  160 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~  160 (321)
                      ..       ...++++|++. ++|.+++....              ...+++..+..++.|++.||.+||++|++|+|||
T Consensus        79 ~~-------~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlk  151 (283)
T cd05091          79 KE-------QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLA  151 (283)
T ss_pred             CC-------CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence            76       56799999998 58998885321              2347888999999999999999999999999999


Q ss_pred             CCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCC
Q psy2676         161 PQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCAST  236 (321)
Q Consensus       161 p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~  236 (321)
                      |+||++++++.+||+|||++........   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus       152 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  231 (283)
T cd05091         152 TRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  231 (283)
T ss_pred             hhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9999999999999999998875532221   123345678999999988889999999999999999998 888998776


Q ss_pred             hHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         237 EVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ..+....+......    .                      ...+++..+.+++.+||+.+|.+||++++|+..
T Consensus       232 ~~~~~~~i~~~~~~----~----------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         232 NQDVIEMIRNRQVL----P----------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHHHHHcCCcC----C----------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            65555444332111    1                      112566889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.3e-41  Score=282.84  Aligned_cols=256  Identities=24%  Similarity=0.322  Sum_probs=197.3

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCc--EEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      |.+.+.||+|+||.||++++. .++.  .+++|.++...........+..|+.++++++   ||||+++++++..... .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~-~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~-~   75 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLN-QDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD---HPNVMRLIGVCLQTVE-S   75 (272)
T ss_pred             CccccccCcccCceEEEeEEc-cCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC---CCCcceEEEEEccCCc-c
Confidence            357789999999999999883 4443  6899988764333333446677888888887   9999999998654311 1


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKC----PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                      ......++++||+. |+|.+++...    ....+++..+..++.||+.||.|||++|++|+||||+||++++++.++|+|
T Consensus        76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D  155 (272)
T cd05075          76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVAD  155 (272)
T ss_pred             cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECC
Confidence            12235789999998 5998887432    123489999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         177 FGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       177 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ||.+........   .....++..|++||.+.+..++.++|+||||+++|+|++ |..||......+....+..... +.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~  234 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-LK  234 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-CC
Confidence            999876543221   122345678999999999889999999999999999999 7999987665554443332111 00


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                                               ....++..+.++|.+||+.||.+|||+.+++++
T Consensus       235 -------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         235 -------------------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                     012455789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.7e-41  Score=285.74  Aligned_cols=263  Identities=25%  Similarity=0.394  Sum_probs=204.6

Q ss_pred             ceeeeeeeecccceeEEEEEEe--cCCCcEEEEEEeecccCC--CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNE--DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~--~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      +|++.+.||+|++|.||++++.  ..++..+++|+++.....  ......+.+|+.+++++..  |||++++++.+... 
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~--~~~i~~~~~~~~~~-   77 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR--CPFLVTLHYAFQTD-   77 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccC--CcchhhhheeeecC-
Confidence            4889999999999999999863  246788999998754221  1223456789999999864  99999999998766 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ...++|+||+.+ +|.+++...  ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+||
T Consensus        78 ------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~df  149 (288)
T cd05583          78 ------TKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDF  149 (288)
T ss_pred             ------CEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEEC
Confidence                  678999999985 999988763  34899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCc--cccccccccccchhhhhcCC--CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         178 GLAKTFDYDMM--LTSVVVTLWYRAPEILLNLG--YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       178 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      |++........  .....++..|+|||.+.+..  .+.++|+||+|+++++|++|..||...........+........ 
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-  228 (288)
T cd05583         150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK-  228 (288)
T ss_pred             ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC-
Confidence            98876543321  22345788999999987665  68899999999999999999999964322111111111100000 


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC---HHHHhCCCCCCCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS---AADALEHPYFKEKENE  319 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~f~~~~~~  319 (321)
                                            ......++..+.++|.+||+.||++|||   +.++++||||++..|+
T Consensus       229 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         229 ----------------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             ----------------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence                                  0011235578899999999999999998   5677999999998875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.9e-41  Score=278.36  Aligned_cols=251  Identities=22%  Similarity=0.354  Sum_probs=202.3

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +++..++|++.+.||+|++|.||++.+  ..+..+++|.+...   ......+.+|+.+++++.   |+|++++++.+..
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~--~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~   72 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATY--NKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQ---HDKLVKLHAVVTK   72 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEe--cCCccEEEEecCCC---hhHHHHHHHHHHHHHhcC---CCCcceEEEEEcC
Confidence            456788999999999999999999976  45667999987642   112346778999999987   9999999998754


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .        ..++++|+++ ++|.+++.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+
T Consensus        73 ~--------~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~  144 (260)
T cd05073          73 E--------PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIA  144 (260)
T ss_pred             C--------CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEEC
Confidence            2        4689999998 599999987655568899999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         176 DFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       176 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |||.+........  .....++..|+|||.+....++.++|+||||+++|++++ |..||...+.......+......+ 
T Consensus       145 d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-  223 (260)
T cd05073         145 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-  223 (260)
T ss_pred             CCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC-
Confidence            9998876543221  122334567999999988889999999999999999998 899998766555444332211100 


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                               .....+.++.+++.+||+.+|++||++.++++
T Consensus       224 -------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         224 -------------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             -------------------------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                                     01245578999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.2e-41  Score=284.31  Aligned_cols=252  Identities=22%  Similarity=0.367  Sum_probs=200.8

Q ss_pred             CCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ...+|.+.+.||+|++|.||++.+..    .++..+++|.++...  ......+.+|+..+++++   |||++++++++.
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~   77 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQ---HEHIVKFYGVCG   77 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCC---CCCcceEEEEEc
Confidence            45689999999999999999998632    234567888775321  112245778889888887   999999999987


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--------------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLK  160 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~  160 (321)
                      ..       ...++||||+. ++|.+++....              ...+++..++.++.||+.||++||++|++|+||+
T Consensus        78 ~~-------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk  150 (291)
T cd05094          78 DG-------DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLA  150 (291)
T ss_pred             cC-------CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccC
Confidence            66       56899999998 59999997632              2347899999999999999999999999999999


Q ss_pred             CCcEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCC
Q psy2676         161 PQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCAST  236 (321)
Q Consensus       161 p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~  236 (321)
                      |+||+++.++.++|+|||.+.......   ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus       151 p~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  230 (291)
T cd05094         151 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS  230 (291)
T ss_pred             cceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999987654322   1223445678999999999889999999999999999998 999998776


Q ss_pred             hHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         237 EVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ..+....+....    ....                      ...++..+.+++.+||+.+|.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~----~~~~----------------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         231 NTEVIECITQGR----VLER----------------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHHHHHhCCC----CCCC----------------------CccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            665544432211    0000                      1235578999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-41  Score=278.61  Aligned_cols=244  Identities=32%  Similarity=0.533  Sum_probs=202.8

Q ss_pred             eecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEE
Q psy2676          30 IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVY  108 (321)
Q Consensus        30 lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  108 (321)
                      ||.|++|.||++.+ ..+++.+++|++....... .....+.+|+.+++++.   |||++++++.+...       ...+
T Consensus         1 lg~G~~~~v~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~-------~~~~   69 (250)
T cd05123           1 LGKGSFGKVLLVRK-KDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN---HPFIVKLHYAFQTE-------EKLY   69 (250)
T ss_pred             CCCCCceEEEEEEE-CCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC---CCcHHHHHHHeecC-------CeeE
Confidence            68999999999998 5678999999987653322 13346778899999988   99999999998776       7889


Q ss_pred             EEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCC-
Q psy2676         109 LIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-  186 (321)
Q Consensus       109 ~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~-  186 (321)
                      +++|++. ++|.+++...  ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        70 ~v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~  147 (250)
T cd05123          70 LVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG  147 (250)
T ss_pred             EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence            9999996 6999999874  34899999999999999999999999999999999999999999999999998766533 


Q ss_pred             CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhh
Q psy2676         187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSS  266 (321)
Q Consensus       187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
                      .......++..|+|||...+...+.++|+||||+++|++++|..||...+.......+..  ...   ..+         
T Consensus       148 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~---~~~---------  213 (250)
T cd05123         148 SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPL---RFP---------  213 (250)
T ss_pred             CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCC---CCC---------
Confidence            223445678889999999888889999999999999999999999987765444443332  111   111         


Q ss_pred             hhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH---HHHhCCCCC
Q psy2676         267 FEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA---ADALEHPYF  313 (321)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~~ll~h~~f  313 (321)
                                   ...+..+.+++++||..||.+||++   .++++||||
T Consensus       214 -------------~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         214 -------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             -------------CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                         1235889999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.6e-41  Score=285.46  Aligned_cols=261  Identities=21%  Similarity=0.308  Sum_probs=202.6

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecC---------------CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCC
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQN---------------KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE   83 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~---------------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   83 (321)
                      ...++|++++.||+|+||.||+|.+...               .+..+++|.+...... .....+.+|+++++++.   
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~---   77 (296)
T cd05051           2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLS---   77 (296)
T ss_pred             CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcC---
Confidence            3567999999999999999999987322               2245789988654322 22346677999999998   


Q ss_pred             CCceeEEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy2676          84 HPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP---------PPGLSASKVKELTRQMLKGVDFLHSHR  153 (321)
Q Consensus        84 ~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~---------~~~~~~~~~~~i~~~l~~~l~~lh~~~  153 (321)
                      |||++++++++...       ...++++|++. ++|.+++....         ...+++..++.++.|++.||.+||+.|
T Consensus        78 ~~~i~~~~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~  150 (296)
T cd05051          78 DPNIARLLGVCTVD-------PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN  150 (296)
T ss_pred             CCCEeEEEEEEecC-------CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence            99999999998766       57899999998 59999987643         124899999999999999999999999


Q ss_pred             ceeccCCCCcEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh--c
Q psy2676         154 IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR--L  228 (321)
Q Consensus       154 ~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g  228 (321)
                      ++|+||||+||+++.++.++|+|||.+.......   ......++..|+|||.+.+..++.++||||||+++|+|++  +
T Consensus       151 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  230 (296)
T cd05051         151 FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR  230 (296)
T ss_pred             ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCC
Confidence            9999999999999999999999999987553222   1223445678999999998889999999999999999998  6


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHh
Q psy2676         229 VPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL  308 (321)
Q Consensus       229 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  308 (321)
                      ..||......+.................                   ......++.++.+++.+||+.||.+|||+.+++
T Consensus       231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~  291 (296)
T cd05051         231 EQPYEHLTDQQVIENAGHFFRDDGRQIY-------------------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIH  291 (296)
T ss_pred             CCCCCCcChHHHHHHHHhcccccccccc-------------------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence            7888776655554444322111100000                   001124557899999999999999999999996


Q ss_pred             C
Q psy2676         309 E  309 (321)
Q Consensus       309 ~  309 (321)
                      +
T Consensus       292 ~  292 (296)
T cd05051         292 L  292 (296)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.8e-41  Score=282.36  Aligned_cols=250  Identities=22%  Similarity=0.325  Sum_probs=196.7

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCc----EEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGN----YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ..++|++.+.||.|+||+||+|+.. .++.    .|++|+++..... .....+.+|+.+++.+.   |||++++++++.
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~~~---~~~i~~~~~~~~   79 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWI-PDGENVKIPVAIKVLRENTSP-KANKEILDEAYVMAGVG---SPYVCRLLGICL   79 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEe-cCCCccceEEEEEEecCCCCH-HHHHHHHHHHHHHHhcC---CCCCceEEEEEc
Confidence            4578999999999999999999873 3443    4789988643221 12335667888888777   999999999886


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ..        ..++++++++ |+|.+++.... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|
T Consensus        80 ~~--------~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL  150 (279)
T cd05109          80 TS--------TVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKI  150 (279)
T ss_pred             CC--------CcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEE
Confidence            43        3578999998 69999987643 34899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCC
Q psy2676         175 ADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       175 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      +|||++........   .....++..|+|||...+..++.++||||||+++|+|++ |..||...........+.. ...
T Consensus       151 ~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~  229 (279)
T cd05109         151 TDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GER  229 (279)
T ss_pred             CCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCc
Confidence            99999876643322   112234567999999988889999999999999999998 8999977655444333222 111


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ++.                         ...++..+.+++.+||..||++||++.++++
T Consensus       230 ~~~-------------------------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         230 LPQ-------------------------PPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCC-------------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            111                         1135578899999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-41  Score=282.06  Aligned_cols=257  Identities=21%  Similarity=0.282  Sum_probs=199.0

Q ss_pred             eeeeeeeecccceeEEEEEEecC--CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQN--KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      |.+.+.||+|+||.||+|.....  .+..+++|.++...........+.+|+..++.+.   |||++++++++..... .
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~-~   76 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD---HPNVMKLIGVCFEASS-L   76 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC---CCCeeeEEeeeccCCc-c
Confidence            67889999999999999987422  2478999998754333222345677888888887   9999999998765411 1


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKC----PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                      ......++++||+. ++|..++...    ....+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|
T Consensus        77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECC
Confidence            12245799999999 5998888543    223589999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         177 FGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       177 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ||.+........   ......+..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+....    
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----  232 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN----  232 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----
Confidence            999876543321   112234567999999988889999999999999999999 899998766655444333211    


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ...                      ....++..+.+++.+||+.||.+|||+.+++++
T Consensus       233 ~~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 RLK----------------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCC----------------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            111                      112456889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7e-41  Score=284.21  Aligned_cols=261  Identities=22%  Similarity=0.327  Sum_probs=199.7

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEe---------------cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCC
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDL---------------QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE   83 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~---------------~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   83 (321)
                      ++.++|++.+.||+|+||+||++.+.               ..+...+++|++.... .......+.+|+.+++.++   
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~---   77 (296)
T cd05095           2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLK---   77 (296)
T ss_pred             CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCC---
Confidence            46789999999999999999998642               1234468889886432 1122346778999999998   


Q ss_pred             CCceeEEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy2676          84 HPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP---------PGLSASKVKELTRQMLKGVDFLHSHR  153 (321)
Q Consensus        84 ~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~---------~~~~~~~~~~i~~~l~~~l~~lh~~~  153 (321)
                      |+|++++++++...       ...++++|++. ++|.+++.....         ..+++..++.++.|++.||++||+.|
T Consensus        78 ~~~i~~~~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~  150 (296)
T cd05095          78 DPNIIRLLAVCITS-------DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN  150 (296)
T ss_pred             CCCcceEEEEEecC-------CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999998776       56899999998 599999876432         23677899999999999999999999


Q ss_pred             ceeccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh--c
Q psy2676         154 IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR--L  228 (321)
Q Consensus       154 ~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g  228 (321)
                      ++|+||||+||+++.++.++|+|||.+........   ......+..|++||......++.++|+||||+++|+|++  |
T Consensus       151 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~  230 (296)
T cd05095         151 FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK  230 (296)
T ss_pred             eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCC
Confidence            99999999999999999999999999876533221   112334577999999988889999999999999999998  7


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHh
Q psy2676         229 VPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL  308 (321)
Q Consensus       229 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  308 (321)
                      ..||...+..+...............                   ........++..+.+|+.+||+.||.+||++.+++
T Consensus       231 ~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~  291 (296)
T cd05095         231 EQPYSQLSDEQVIENTGEFFRDQGRQ-------------------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIH  291 (296)
T ss_pred             CCCccccChHHHHHHHHHHHhhcccc-------------------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence            78987766555443322211000000                   00001124568899999999999999999999987


Q ss_pred             C
Q psy2676         309 E  309 (321)
Q Consensus       309 ~  309 (321)
                      +
T Consensus       292 ~  292 (296)
T cd05095         292 A  292 (296)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=9.9e-41  Score=285.56  Aligned_cols=258  Identities=24%  Similarity=0.347  Sum_probs=203.2

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEe------cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDL------QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR   89 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~   89 (321)
                      .+++..++|.+.+.||+|++|.||+|++.      ......+++|.++.... ......+.+|+.+++++..  ||||++
T Consensus         6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~--h~~iv~   82 (314)
T cd05099           6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGK--HKNIIN   82 (314)
T ss_pred             cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccC--CCCeee
Confidence            35777889999999999999999999753      12345788998764322 1123356678888888843  999999


Q ss_pred             EEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--------------PPGLSASKVKELTRQMLKGVDFLHSHRI  154 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~  154 (321)
                      +++++.+.       ..+++++||+. |+|.+++....              ...+++..+..++.||+.||.+||++|+
T Consensus        83 ~~~~~~~~-------~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi  155 (314)
T cd05099          83 LLGVCTQE-------GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC  155 (314)
T ss_pred             EEEEEccC-------CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            99998766       56899999998 59999997642              2347889999999999999999999999


Q ss_pred             eeccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCC
Q psy2676         155 IHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVP  230 (321)
Q Consensus       155 ~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~  230 (321)
                      +|+||+|+||+++.++.++|+|||.+........   .....++..|+|||++.+..++.++||||||+++|+|++ |..
T Consensus       156 ~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~  235 (314)
T cd05099         156 IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGS  235 (314)
T ss_pred             eeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999976542211   112233457999999998889999999999999999999 899


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         231 LFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ||.+....+....+.....    ..                      ....++.++.+++.+||..+|.+|||+.++++
T Consensus       236 p~~~~~~~~~~~~~~~~~~----~~----------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         236 PYPGIPVEELFKLLREGHR----MD----------------------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CCCCCCHHHHHHHHHcCCC----CC----------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            9977665554444332110    00                      01245578999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3e-41  Score=282.38  Aligned_cols=252  Identities=26%  Similarity=0.448  Sum_probs=200.3

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++.+.||.|++|.||++++ ..++..+++|.+..... .......+.+|+.+++.+.   |||++++++++...   
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~-~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~---   74 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATC-LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN---HPNVIKYYASFIED---   74 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEee-cCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc---CCchhhhhheeEeC---
Confidence            4789999999999999999998 57889999998765322 1122346678899999887   99999999999776   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                          ...++++|++++ +|.+++...  ....+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+||
T Consensus        75 ----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df  150 (267)
T cd08229          75 ----NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             ----CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcc
Confidence                678999999995 999988642  2344899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChH--HHHHHHHHHhCCCCCC
Q psy2676         178 GLAKTFDYDMM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV--EQLKCIFRVIGTPSMN  254 (321)
Q Consensus       178 g~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~  254 (321)
                      |.+........ .....++..|+|||++.+...+.++|+||+|+++|+|++|..||.+....  .....+.. ...++. 
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-  228 (267)
T cd08229         151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPPL-  228 (267)
T ss_pred             hhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc-CCCCCC-
Confidence            98876543322 22346788899999999888999999999999999999999999654322  11111111 111100 


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                             .....+..+.+++.+||..||.+|||+.+|++
T Consensus       229 -----------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         229 -----------------------PSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             -----------------------CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                                   01235578999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.7e-41  Score=285.39  Aligned_cols=259  Identities=24%  Similarity=0.357  Sum_probs=202.1

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEec------CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQ------NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR   89 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~   89 (321)
                      .+++..++|.+.+.||+|+||.||++++..      .+...+++|.+..... ......+.+|+.+++++..  |||+++
T Consensus        12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~--h~~i~~   88 (307)
T cd05098          12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGK--HKNIIN   88 (307)
T ss_pred             cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcC--CCCEee
Confidence            345556899999999999999999998632      1235689998865322 1223356678999998843  999999


Q ss_pred             EEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP--------------PGLSASKVKELTRQMLKGVDFLHSHRI  154 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~--------------~~~~~~~~~~i~~~l~~~l~~lh~~~~  154 (321)
                      +++++...       ...++|+|++. ++|.+++.....              ..+++.+++.++.|++.||++||++|+
T Consensus        89 ~~~~~~~~-------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi  161 (307)
T cd05098          89 LLGACTQD-------GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC  161 (307)
T ss_pred             EEEEEecC-------CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            99998766       56899999998 599999976421              347889999999999999999999999


Q ss_pred             eeccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCC
Q psy2676         155 IHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVP  230 (321)
Q Consensus       155 ~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~  230 (321)
                      +|+||+|+||+++.++.++|+|||.+........   .....++..|+|||.+.+..++.++|+||||+++|+|++ |..
T Consensus       162 ~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~  241 (307)
T cd05098         162 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS  241 (307)
T ss_pred             ccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999999875542211   111233467999999998889999999999999999998 889


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         231 LFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ||......+....+... .   ....                      ...++.++.+++.+||..+|.+|||+.+++++
T Consensus       242 p~~~~~~~~~~~~~~~~-~---~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         242 PYPGVPVEELFKLLKEG-H---RMDK----------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             CCCcCCHHHHHHHHHcC-C---CCCC----------------------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            99776554443333211 1   0011                      12455899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=8e-41  Score=279.75  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=200.6

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCC--CcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNK--GNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ...+|++.+.||+|+||.||+|++...+  +..+++|.++..... .....+.+|+.++++++   |||++++++++...
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~   77 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-KQRRDFLSEASIMGQFD---HPNIIHLEGVVTKS   77 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH-HHHHHHHHHHHHHHhCC---CCCcceEEEEEecC
Confidence            3468999999999999999999874332  337888887643221 12346678899998887   99999999998665


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ...++|||++++ +|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        78 -------~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~d  149 (267)
T cd05066          78 -------KPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSD  149 (267)
T ss_pred             -------CccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCC
Confidence                   568999999984 9999997754 3489999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCcc----ccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         177 FGLAKTFDYDMML----TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       177 fg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      ||.+.........    ....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+......+
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (267)
T cd05066         150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP  229 (267)
T ss_pred             CCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCC
Confidence            9998765432211    11223457999999998889999999999999999886 999998776655544443321111


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .                          ...+++.+.+++.+||+.+|.+||++.++++
T Consensus       230 ~--------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         230 A--------------------------PMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             C--------------------------CCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            0                          1245688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.5e-41  Score=279.67  Aligned_cols=253  Identities=30%  Similarity=0.483  Sum_probs=199.5

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC---CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN---EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ||.+.+.||+|++|+||++.+ ...+..+++|+++....   ..........|+.++++++   |||++++++++.+.  
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~--   74 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKD-KKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD---HPAIVKFHASFLER--   74 (260)
T ss_pred             CceeeeeecCCCCceEEEEEe-cCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC---CCcHHHHHHHHhcC--
Confidence            689999999999999999998 45555666666554222   1122334556888888887   99999999998766  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                           ...++|+|++.+ +|.+++...  ....+++..++.++.|++.||.+||+.|++|+||+|+||+++. +.++|+|
T Consensus        75 -----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d  148 (260)
T cd08222          75 -----DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGD  148 (260)
T ss_pred             -----CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecc
Confidence                 568999999985 998888642  2345899999999999999999999999999999999999974 6699999


Q ss_pred             cCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         177 FGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       177 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ||.+....... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||...........+...    ....
T Consensus       149 ~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~  224 (260)
T cd08222         149 FGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG----PTPS  224 (260)
T ss_pred             cCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC----CCCC
Confidence            99887653322 233445678899999998888899999999999999999999999766554444333221    1111


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                                            ....++.++.++|.+||..+|++||++.++++||||
T Consensus       225 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         225 ----------------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ----------------------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                                  112455789999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-41  Score=285.35  Aligned_cols=261  Identities=21%  Similarity=0.319  Sum_probs=200.1

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecC-------------CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCC
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQN-------------KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP   85 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~-------------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   85 (321)
                      ...++|++.+.||+|+||.||+|++...             ....+++|.++.... ......+.+|++++++++   ||
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~---h~   77 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLK---NP   77 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCC---CC
Confidence            4567999999999999999999976311             123588998864322 222335778999999998   99


Q ss_pred             ceeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy2676          86 NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPP----------PGLSASKVKELTRQMLKGVDFLHSHRI  154 (321)
Q Consensus        86 ~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~----------~~~~~~~~~~i~~~l~~~l~~lh~~~~  154 (321)
                      |++++++++...       ...++|||++.+ +|.+++.....          ..+++..++.++.|++.||.|||+.|+
T Consensus        78 ~i~~~~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  150 (295)
T cd05097          78 NIIRLLGVCVSD-------DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF  150 (295)
T ss_pred             CcCeEEEEEcCC-------CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCe
Confidence            999999999766       578999999995 99998865321          236888999999999999999999999


Q ss_pred             eeccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh--cC
Q psy2676         155 IHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR--LV  229 (321)
Q Consensus       155 ~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~  229 (321)
                      +|+||+|+||+++.++.++|+|||.+........   .....++..|+|||.+.+..++.++|+||||+++++|++  +.
T Consensus       151 ~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~  230 (295)
T cd05097         151 VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE  230 (295)
T ss_pred             eccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999999875432221   122334678999999998889999999999999999998  67


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         230 PLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .||......+................                   .......+++.+.+|+++||+.||.+|||++++++
T Consensus       231 ~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         231 QPYSLLSDEQVIENTGEFFRNQGRQI-------------------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             CCCcccChHHHHHHHHHhhhhccccc-------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            88877666555544332211100000                   00111235688999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8e-41  Score=284.94  Aligned_cols=259  Identities=24%  Similarity=0.355  Sum_probs=205.4

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEe------cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDL------QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR   89 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~   89 (321)
                      .++....+|.+.+.||+|+||.||+|+..      ...+..+++|.+..... ......+.+|+.+++.+..  ||||++
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~--h~~i~~   85 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGK--HKNIIN   85 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-hHHHHHHHHHHHHHHhhcc--CCCchh
Confidence            35678899999999999999999999752      12345789998764321 2223467789999998843  999999


Q ss_pred             EEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--------------PPGLSASKVKELTRQMLKGVDFLHSHRI  154 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~  154 (321)
                      +++++...       ...++++|++. ++|.+++....              ...++...+..++.||+.||.|||++|+
T Consensus        86 ~~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~gi  158 (304)
T cd05101          86 LLGACTQD-------GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC  158 (304)
T ss_pred             eeEEEecC-------CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCe
Confidence            99998776       67899999998 59999997642              2347888899999999999999999999


Q ss_pred             eeccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCC
Q psy2676         155 IHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVP  230 (321)
Q Consensus       155 ~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~  230 (321)
                      +|+||||+||+++.++.++|+|||.+........   .....++..|+|||++.+..++.++||||||+++|++++ |..
T Consensus       159 vH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~  238 (304)
T cd05101         159 IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS  238 (304)
T ss_pred             eecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999999876643221   122344567999999998889999999999999999998 788


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         231 LFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ||.+....+....+.....    ..                      ....++..+.+++.+||+.+|.+|||+.++++.
T Consensus       239 p~~~~~~~~~~~~~~~~~~----~~----------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         239 PYPGIPVEELFKLLKEGHR----MD----------------------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             CcccCCHHHHHHHHHcCCc----CC----------------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            9977666555444322110    00                      012466899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.4e-40  Score=278.57  Aligned_cols=250  Identities=20%  Similarity=0.286  Sum_probs=190.6

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCc----EEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGN----YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ..++|++.+.||+|+||+||+|.+. .+++    .+++|.+.... .......+..|+..++++.   ||||+++++++.
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~---h~~iv~~~~~~~   79 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWI-PEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLD---HAYIVRLLGICP   79 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEc-CCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCC---CCCcceEEEEEC
Confidence            3468999999999999999999883 4454    35666654221 1111123445555666665   999999999874


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ..        ..++++|++. |+|.+++..... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|
T Consensus        80 ~~--------~~~~i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl  150 (279)
T cd05111          80 GA--------SLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQI  150 (279)
T ss_pred             CC--------ccEEEEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEE
Confidence            33        3578899988 699999976443 4899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCC
Q psy2676         175 ADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       175 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      +|||.+.......   ......++..|+|||.+.+..++.++||||||+++|++++ |..||.+.........+.. ...
T Consensus       151 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~  229 (279)
T cd05111         151 ADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK-GER  229 (279)
T ss_pred             cCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCc
Confidence            9999987653222   1223445678999999998889999999999999999998 9999987655443332221 111


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ++..                         ..++.++.+++.+||..||.+|||+.++++
T Consensus       230 ~~~~-------------------------~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         230 LAQP-------------------------QICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCCC-------------------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            1111                         124467889999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=276.77  Aligned_cols=242  Identities=26%  Similarity=0.383  Sum_probs=192.9

Q ss_pred             eeeecccceeEEEEEEecCC--CcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccce
Q psy2676          28 CQIGCGAYGTVFKARDLQNK--GNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYL  105 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~  105 (321)
                      +.||+|+||.||+|.....+  +..+++|.+...... .....+.+|+.+++++.   |||++++++++...        
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~--------   68 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLD---HPCIVRLIGVCKGE--------   68 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcC---CCCeeeEEEEEcCC--------
Confidence            47899999999999874333  378999988754332 23346778899999887   99999999987533        


Q ss_pred             EEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         106 TVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       106 ~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      ..++|+|+++ ++|.+++....  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        69 ~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~  146 (257)
T cd05060          69 PLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALG  146 (257)
T ss_pred             ceEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceee
Confidence            4689999998 59999998744  58999999999999999999999999999999999999999999999999987664


Q ss_pred             CCCcc----ccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         185 YDMML----TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       185 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      .....    ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.... ..+       
T Consensus       147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~-------  218 (257)
T cd05060         147 AGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-RLP-------  218 (257)
T ss_pred             cCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-cCC-------
Confidence            33221    11223467999999998889999999999999999998 999998776655444432211 100       


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                        ....++..+.++|.+||..+|.+||++.++++
T Consensus       219 ------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         219 ------------------RPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             ------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                              11245688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.5e-40  Score=276.63  Aligned_cols=245  Identities=26%  Similarity=0.364  Sum_probs=197.4

Q ss_pred             eeeecccceeEEEEEEecCCCc--EEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccce
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYL  105 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~  105 (321)
                      +.||+|++|+||++.+...+++  .+++|.+...... .....+.+|+..+++++   |||++++++.+.+        .
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~--------~   68 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLD---HENLIRLYGVVLT--------H   68 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcC---CCCccceeEEEcC--------C
Confidence            4689999999999998433443  6899998764332 23446778888888887   9999999998754        3


Q ss_pred             EEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         106 TVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       106 ~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      ..++++|+++ ++|.+++.......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        69 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~  148 (257)
T cd05040          69 PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALP  148 (257)
T ss_pred             eEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccc
Confidence            5799999998 599999987553458999999999999999999999999999999999999999999999999987664


Q ss_pred             CCC----ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         185 YDM----MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       185 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ...    ......++..|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+........   .   
T Consensus       149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~---  222 (257)
T cd05040         149 QNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE---R---  222 (257)
T ss_pred             ccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC---C---
Confidence            322    1122345678999999998889999999999999999998 9999987777665555443111110   0   


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                         ....+..+.+++.+||+.+|++||++.++++
T Consensus       223 -------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         223 -------------------PEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             -------------------CccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                               1135578999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6e-41  Score=290.04  Aligned_cols=260  Identities=22%  Similarity=0.309  Sum_probs=199.8

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +++..++|++.+.||+|+||+||+|.+.    ..+++.||+|+++.... ......+.+|+.++.++..  |||++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~--h~niv~~~~   78 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGH--HLNVVNLLG   78 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccC--CccHhhhcc
Confidence            4667789999999999999999999852    24578999999864322 1123457789999999963  899999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCC--------------------------------------------
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP--------------------------------------------  127 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~--------------------------------------------  127 (321)
                      ++....      ..+++++||++ |+|.+++.....                                            
T Consensus        79 ~~~~~~------~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (343)
T cd05103          79 ACTKPG------GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGF  152 (343)
T ss_pred             eeecCC------CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccc
Confidence            875431      35789999999 599998865321                                            


Q ss_pred             ---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCC
Q psy2676         128 ---------------------PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD  186 (321)
Q Consensus       128 ---------------------~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~  186 (321)
                                           ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~  232 (343)
T cd05103         153 VEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD  232 (343)
T ss_pred             cCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccC
Confidence                                 22677888999999999999999999999999999999999999999999998765322


Q ss_pred             Cc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhh
Q psy2676         187 MM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL  262 (321)
Q Consensus       187 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (321)
                      ..   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..................+..+        
T Consensus       233 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------  304 (343)
T cd05103         233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--------  304 (343)
T ss_pred             cchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCC--------
Confidence            11   112334567999999988889999999999999999997 899997654332222222111111111        


Q ss_pred             hhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                                       ..+++++.+++.+||+.||.+|||+.++++|
T Consensus       305 -----------------~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         305 -----------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             -----------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                             1234688999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG1026|consensus

Probab=100.00  E-value=4.8e-42  Score=305.73  Aligned_cols=258  Identities=28%  Similarity=0.442  Sum_probs=217.2

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeE
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR   89 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~   89 (321)
                      ....++...+-...+.||+|+||.||+++-..    .....||||.++.... .....+|.+|++++..++   |||||+
T Consensus       478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~---H~nIVr  553 (774)
T KOG1026|consen  478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQ---HPNIVR  553 (774)
T ss_pred             cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhcc---CCCeEE
Confidence            34456667788899999999999999998632    3457889999875422 224668999999999999   999999


Q ss_pred             EEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP------------PGLSASKVKELTRQMLKGVDFLHSHRIIH  156 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~------------~~~~~~~~~~i~~~l~~~l~~lh~~~~~H  156 (321)
                      ++|.+...       .-.++|+||+. |+|.+++..+..            +.++..+...|+.|||.|+.||-++.+||
T Consensus       554 LlGVC~~~-------~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVH  626 (774)
T KOG1026|consen  554 LLGVCREG-------DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVH  626 (774)
T ss_pred             EEEEEccC-------CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccc
Confidence            99999887       78899999999 899999986421            22788999999999999999999999999


Q ss_pred             ccCCCCcEEEeeCCCEEEeecCCcccccCC---CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCC
Q psy2676         157 RDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLF  232 (321)
Q Consensus       157 ~di~p~Nilv~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf  232 (321)
                      |||-.+|++|.++..+|++|||+++.+=..   .......-+.+|||||.+..+.+|.+|||||+|++|||+++ |+-||
T Consensus       627 RDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy  706 (774)
T KOG1026|consen  627 RDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPY  706 (774)
T ss_pred             cchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcc
Confidence            999999999999999999999999765221   12223455788999999999999999999999999999996 89999


Q ss_pred             CCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHh
Q psy2676         233 CASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL  308 (321)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  308 (321)
                      .+..+.+.++.+..+--                          -....+||.++.+|+..||+.+|.+||++.||-
T Consensus       707 ~glSn~EVIe~i~~g~l--------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  707 YGLSNQEVIECIRAGQL--------------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             cccchHHHHHHHHcCCc--------------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            99999998888765422                          112347889999999999999999999999984

>KOG0670|consensus

Probab=100.00  E-value=1.4e-42  Score=292.49  Aligned_cols=292  Identities=28%  Similarity=0.494  Sum_probs=233.6

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccC---CCCceeE
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF---EHPNIVR   89 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~~~~i~~   89 (321)
                      .....++..++|.+....|+|-||+|..|.| ...++.||||++...   +.--..-+.|+++|++|...   ..-|+++
T Consensus       423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D-~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclr  498 (752)
T KOG0670|consen  423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARD-QARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLR  498 (752)
T ss_pred             EEehhhhhcceeEEEeccccceeeeeeeccc-cCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence            3445667789999999999999999999999 688889999999732   11123456899999998853   2237788


Q ss_pred             EEeeeeccccccccceEEEEEeccCccCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP-PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR  168 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~  168 (321)
                      ++..|...       .++|+|+|.+.-+|.+++...+. -.+....++.++.||+.||..|...|++|.||||+||||++
T Consensus       499 l~r~F~hk-------nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE  571 (752)
T KOG0670|consen  499 LFRHFKHK-------NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE  571 (752)
T ss_pred             HHHHhhhc-------ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc
Confidence            88777666       79999999999999999988653 33888999999999999999999999999999999999998


Q ss_pred             CCC-EEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q psy2676         169 AGG-LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       169 ~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  247 (321)
                      ..+ +||||||.+...+.+ ..++...+..|.|||.+.+.++++..|+||+||+||++.||+..|.+.++.+++...+..
T Consensus       572 ~k~iLKLCDfGSA~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  572 SKNILKLCDFGSASFASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             CcceeeeccCccccccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence            765 799999999887744 456777788899999999999999999999999999999999999999999999999998


Q ss_pred             hCCCCCCCcchhhhhh----------hhhhhhh------------hh-hh----------hhhhhhhcchhHHHHHHHhc
Q psy2676         248 IGTPSMNEWPENISLM----------WSSFEQY------------SK-VA----------FSAIFMDCCSKANSLLESML  294 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~----------~~~~~~~------------~~-~~----------~~~~~~~~~~~~~~li~~~l  294 (321)
                      .|..+........=..          +......            .. ..          .+.-...+...+.+|+.+||
T Consensus       651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml  730 (752)
T KOG0670|consen  651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML  730 (752)
T ss_pred             cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence            8877765332211000          0000000            00 01          11112224467999999999


Q ss_pred             ccCCCCCCCHHHHhCCCCCCCC
Q psy2676         295 TFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       295 ~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ..||++|.|..++|.||||+++
T Consensus       731 ~LdP~KRit~nqAL~HpFi~~k  752 (752)
T KOG0670|consen  731 ILDPEKRITVNQALKHPFITEK  752 (752)
T ss_pred             ccChhhcCCHHHHhcCCcccCC
Confidence            9999999999999999999864

>KOG0194|consensus

Probab=100.00  E-value=1.2e-41  Score=293.47  Aligned_cols=261  Identities=23%  Similarity=0.355  Sum_probs=218.8

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCC---cEEEEEEeecc-cCCCCCCchhHHHHHHHHhcccCCCCcee
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKG---NYVAMKKLRVK-LNEDGIPMSTLREISILKQLDTFEHPNIV   88 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~~iK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~~~i~   88 (321)
                      ....|++.+++-.+.++||+|+||.||+++....++   ..||+|..+.+ .........+.+|++++++++   ||||+
T Consensus       148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~---H~NVV  224 (474)
T KOG0194|consen  148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN---HPNVV  224 (474)
T ss_pred             cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC---CCCEE
Confidence            455788888999999999999999999999864433   23889988752 233344567889999999998   99999


Q ss_pred             EEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q psy2676          89 RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT  167 (321)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~  167 (321)
                      ++||+..+.       .-+++|||+|.| +|.+++...+. .++..+...++.+.+.||+|||+++++||||-.+|+|++
T Consensus       225 r~yGVa~~~-------~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~  296 (474)
T KOG0194|consen  225 RFYGVAVLE-------EPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS  296 (474)
T ss_pred             EEEEEEcCC-------CccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec
Confidence            999998777       678999999995 99999999664 499999999999999999999999999999999999999


Q ss_pred             eCCCEEEeecCCcccccCCCccc-cccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHH
Q psy2676         168 RAGGLKIADFGLAKTFDYDMMLT-SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIF  245 (321)
Q Consensus       168 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~  245 (321)
                      .++.+|++|||++.......... ...-+..|+|||.+....++.++||||+|+++||+++ |..||.+....+....+.
T Consensus       297 ~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~  376 (474)
T KOG0194|consen  297 KKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV  376 (474)
T ss_pred             CCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH
Confidence            99999999999987665333322 3346788999999999999999999999999999998 788999999988888884


Q ss_pred             HHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         246 RVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ......+.+.                         ..|.++..++.+|+..+|++||++.++.+
T Consensus       377 ~~~~r~~~~~-------------------------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  377 KNGYRMPIPS-------------------------KTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             hcCccCCCCC-------------------------CCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            4322222221                         34578889999999999999999998864

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.9e-40  Score=277.69  Aligned_cols=252  Identities=26%  Similarity=0.378  Sum_probs=200.8

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCC---cEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKG---NYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      +..++|+..+.||+|++|.||+|.+. .++   ..+++|.+...... .....+..|+.+++++.   |||++++++++.
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~-~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~   76 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILK-MPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFS---HHNIIRLEGVVT   76 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEe-cCCCCceEEEEEeccccCCH-HHHHHHHHHHHHHhcCC---CCCeeEEEEEEc
Confidence            45678999999999999999999984 333   37888887643221 12345677888888887   999999999987


Q ss_pred             ccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      +.       ...++|||++++ +|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|
T Consensus        77 ~~-------~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl  148 (268)
T cd05063          77 KF-------KPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKV  148 (268)
T ss_pred             cC-------CCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEE
Confidence            66       567999999995 9999987643 34899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCccc----cccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhC
Q psy2676         175 ADFGLAKTFDYDMMLT----SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       175 ~dfg~~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      +|||.+..........    ....+..|+|||++.+..++.++|+||+|+++|++++ |..||...+..+....+.....
T Consensus       149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~  228 (268)
T cd05063         149 SDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR  228 (268)
T ss_pred             CCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC
Confidence            9999987654222111    1223456999999998889999999999999999997 9999987766655555433211


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .+.                          ..+++.++.+++.+||+.+|.+||++.++++
T Consensus       229 ~~~--------------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         229 LPA--------------------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCC--------------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            111                          1145588999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.5e-40  Score=280.10  Aligned_cols=256  Identities=18%  Similarity=0.289  Sum_probs=202.2

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecC---CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQN---KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      .+..++|++.+.||+|+||.||+|.+...   .+..+++|.+... ........+.+|+.+++++.   |||++++++++
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~   77 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLS---HQNILPILHVC   77 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCC---CCCCCeEEEEE
Confidence            46788999999999999999999998532   2688899987532 12222345667888888887   99999999986


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP------PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT  167 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~------~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~  167 (321)
                      ....      ...+++++++. ++|.+++.....      ..+++..++.++.|++.||.|||+.+++|+||+|+||+++
T Consensus        78 ~~~~------~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~  151 (280)
T cd05043          78 IEDG------EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID  151 (280)
T ss_pred             ecCC------CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc
Confidence            5431      45689999998 699999876432      3489999999999999999999999999999999999999


Q ss_pred             eCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHH
Q psy2676         168 RAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKC  243 (321)
Q Consensus       168 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  243 (321)
                      +++.++|+|||++........   .....++..|+|||++.+..++.++||||||+++|++++ |..||...+..+....
T Consensus       152 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~  231 (280)
T cd05043         152 EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY  231 (280)
T ss_pred             CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence            999999999999876543221   112344667999999998889999999999999999999 9999987666554433


Q ss_pred             HHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         244 IFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      +.... .+.                         ....+++++.+++.+||..||++|||+.++++
T Consensus       232 ~~~~~-~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         232 LKDGY-RLA-------------------------QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             HHcCC-CCC-------------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            32211 000                         01235578999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.2e-40  Score=280.45  Aligned_cols=252  Identities=24%  Similarity=0.396  Sum_probs=200.2

Q ss_pred             CCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ...+|.+.+.||+|+||.||+++..    ...+..+++|.+....  ......+.+|++.++++.   |+||+++++++.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~   77 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQ---HQHIVRFYGVCT   77 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCC---CCCCceEEEEEe
Confidence            4568899999999999999999752    2245678888765321  222346778899998887   999999999987


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP-------------PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKP  161 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~-------------~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p  161 (321)
                      +.       ...++++|++. ++|.+++.....             ..+++..++.++.||+.||+|||+.|++|+||+|
T Consensus        78 ~~-------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp  150 (280)
T cd05092          78 EG-------RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLAT  150 (280)
T ss_pred             cC-------CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccH
Confidence            66       56899999998 599999876432             2478999999999999999999999999999999


Q ss_pred             CcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCCh
Q psy2676         162 QNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTE  237 (321)
Q Consensus       162 ~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~  237 (321)
                      +||++++++.++|+|||++........   .....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.....
T Consensus       151 ~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  230 (280)
T cd05092         151 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN  230 (280)
T ss_pred             hhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence            999999999999999998865532221   122334678999999999899999999999999999998 8999977666


Q ss_pred             HHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         238 VEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .+....+.......                          ....+++.+.+++.+||+.||.+||++.++++
T Consensus       231 ~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         231 TEAIECITQGRELE--------------------------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHHHHcCccCC--------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            55544433221110                          01245688999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.1e-40  Score=279.55  Aligned_cols=265  Identities=23%  Similarity=0.281  Sum_probs=196.2

Q ss_pred             cce-eeeeeeecccceeEEEEEE---ecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          22 KKY-DELCQIGCGAYGTVFKARD---LQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        22 ~~y-~~~~~lg~g~~g~v~~~~~---~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      +|| ++.+.||+|+||+||++..   ...++..+++|+++.... ......+.+|++++++++   |||++++++++...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~   78 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLY---HENIVKYKGCCSEQ   78 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCC---CCCEeeEEEEEecC
Confidence            566 9999999999999988652   135678899999865422 122346678999999987   99999999987543


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                           .....+++||++.+ +|.+++...   .+++.+++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|
T Consensus        79 -----~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~d  150 (283)
T cd05080          79 -----GGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGD  150 (283)
T ss_pred             -----CCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEee
Confidence                 11467999999994 999998762   389999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         177 FGLAKTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       177 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ||.+........    .....++..|+|||.+.+..++.++||||||+++++|++|..||.......  ......   ..
T Consensus       151 fg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~---~~  225 (283)
T cd05080         151 FGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGP---KQ  225 (283)
T ss_pred             cccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcc---cc
Confidence            999876543221    112334566999999988889999999999999999999999986543211  011100   00


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ........   ...   ............++..+.+++.+||+.+|++|||++++++
T Consensus       226 ~~~~~~~~---~~~---~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         226 GQMTVVRL---IEL---LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             cccchhhh---hhh---hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            00000000   000   0000001112356789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.9e-40  Score=290.63  Aligned_cols=263  Identities=24%  Similarity=0.306  Sum_probs=206.8

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCcee
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV   88 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~   88 (321)
                      .-.++++..++|.+.+.||+|+||.||+|++.    ...+..||+|+++..... .....+.+|+.++.++..  ||||+
T Consensus        28 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~--H~niv  104 (401)
T cd05107          28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGP--HLNIV  104 (401)
T ss_pred             CCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCC--CCCeE
Confidence            34468888899999999999999999999862    234568999999754222 222357789999998864  99999


Q ss_pred             EEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCC----------------------------------------
Q psy2676          89 RFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP----------------------------------------  127 (321)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~----------------------------------------  127 (321)
                      ++++++...       ...++|+||+. |+|.+++.....                                        
T Consensus       105 ~~~~~~~~~-------~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (401)
T cd05107         105 NLLGACTKG-------GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGG  177 (401)
T ss_pred             EEEEEEccC-------CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcc
Confidence            999998776       56899999999 599999865321                                        


Q ss_pred             --------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHh
Q psy2676         128 --------------------------------------------------------PGLSASKVKELTRQMLKGVDFLHS  151 (321)
Q Consensus       128 --------------------------------------------------------~~~~~~~~~~i~~~l~~~l~~lh~  151 (321)
                                                                              ..+++..+..++.||+.||.|||+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~  257 (401)
T cd05107         178 YMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS  257 (401)
T ss_pred             ccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence                                                                    236777889999999999999999


Q ss_pred             CCceeccCCCCcEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-
Q psy2676         152 HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-  227 (321)
Q Consensus       152 ~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-  227 (321)
                      .+++|+||+|+||++++++.++|+|||++.......   ......++..|+|||.+.+..++.++||||+|+++++|++ 
T Consensus       258 ~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~  337 (401)
T cd05107         258 KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL  337 (401)
T ss_pred             CCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHc
Confidence            999999999999999999999999999987543221   1222345778999999998889999999999999999998 


Q ss_pred             cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHH
Q psy2676         228 LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA  307 (321)
Q Consensus       228 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  307 (321)
                      |..||......+...........+..                         ...++.++.+++.+||..+|.+||++.+|
T Consensus       338 g~~P~~~~~~~~~~~~~~~~~~~~~~-------------------------p~~~~~~l~~li~~cl~~~P~~RPs~~el  392 (401)
T cd05107         338 GGTPYPELPMNEQFYNAIKRGYRMAK-------------------------PAHASDEIYEIMQKCWEEKFEIRPDFSQL  392 (401)
T ss_pred             CCCCCCCCCchHHHHHHHHcCCCCCC-------------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            89999765544443333221111110                         12355889999999999999999999999


Q ss_pred             hCC
Q psy2676         308 LEH  310 (321)
Q Consensus       308 l~h  310 (321)
                      ++.
T Consensus       393 l~~  395 (401)
T cd05107         393 VHL  395 (401)
T ss_pred             HHH
Confidence            863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0603|consensus

Probab=100.00  E-value=2.3e-41  Score=292.57  Aligned_cols=245  Identities=29%  Similarity=0.471  Sum_probs=203.6

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ...|.+...+|.|+|+.|-.+.+ ..+++..++|++..+      .....+|+.++.....  |||++++++.+.+.   
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~-~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~--h~niv~~~~v~~~~---  388 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCES-SPTDQEPAVKIISKR------ADDNQDEIPISLLVRD--HPNIVKSHDVYEDG---  388 (612)
T ss_pred             chhhccccccCCCCccceeeeec-cccccchhheecccc------ccccccccchhhhhcC--CCcceeecceecCC---
Confidence            46789999999999999999999 688899999998765      2345567777776664  99999999999888   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE-eeCCCEEEeecC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFG  178 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv-~~~~~~kl~dfg  178 (321)
                          ...++|||.+.| -+.+.+...+   .....+..|+.+|+.|+.+||++|++||||||+||++ +..++++|+|||
T Consensus       389 ----~~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG  461 (612)
T KOG0603|consen  389 ----KEIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFG  461 (612)
T ss_pred             ----ceeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEec
Confidence                899999999996 5555555522   2337788899999999999999999999999999999 588999999999


Q ss_pred             CcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChH-HHHHHHHHHhCCCCCCCcc
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV-EQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  257 (321)
                      .+......  .....-|..|.|||++....++.++|+||||++||+|++|+.||...... +...+    ++.+...   
T Consensus       462 ~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~----i~~~~~s---  532 (612)
T KOG0603|consen  462 FWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR----IQMPKFS---  532 (612)
T ss_pred             hhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh----hcCCccc---
Confidence            99877644  33456688999999999999999999999999999999999999875544 33222    2222222   


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                                            ..+|..+++||++||+.||.+||++.+++.||||-+
T Consensus       533 ----------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~  568 (612)
T KOG0603|consen  533 ----------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLS  568 (612)
T ss_pred             ----------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhc
Confidence                                  357799999999999999999999999999999933

>KOG4279|consensus

Probab=100.00  E-value=8.8e-42  Score=296.72  Aligned_cols=252  Identities=32%  Similarity=0.513  Sum_probs=206.8

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTV  107 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~  107 (321)
                      -+||+|.||+||.++| ..+...+|||-+..+..  .......+|+...++++   |.|||+.+|.+...       .++
T Consensus       581 vVLGKGTYG~VYA~RD-~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~Lr---HkNIVrYLGs~sen-------Gf~  647 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARD-MDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLR---HKNIVRYLGSVSEN-------GFF  647 (1226)
T ss_pred             EEeecCceeEEEeecc-ccceeEEEeeecccccc--hhhccHHHHHHHHHHHh---hHhHHHHhhccCCC-------CeE
Confidence            4799999999999999 57888899998865433  23556789999999999   99999999998665       578


Q ss_pred             EEEeccCcc-CHHHHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe-eCCCEEEeecCCcccc
Q psy2676         108 YLIFEHVDQ-DLGSYMEKCPPPGL--SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT-RAGGLKIADFGLAKTF  183 (321)
Q Consensus       108 ~~v~e~~~~-~L~~~~~~~~~~~~--~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~-~~~~~kl~dfg~~~~~  183 (321)
                      -|.||.++| +|.++++..=++ +  ++..+..+.+||++||.|||++.|||||||-+||+|+ -.|.+|++|||.+...
T Consensus       648 kIFMEqVPGGSLSsLLrskWGP-lKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL  726 (1226)
T KOG4279|consen  648 KIFMEQVPGGSLSSLLRSKWGP-LKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL  726 (1226)
T ss_pred             EEEeecCCCCcHHHHHHhccCC-CccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhh
Confidence            899999995 999999874332 5  7889999999999999999999999999999999996 4788999999999876


Q ss_pred             cC-CCccccccccccccchhhhhcCC--CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         184 DY-DMMLTSVVVTLWYRAPEILLNLG--YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       184 ~~-~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      .. ........||+.|+|||++..++  |..++|||||||++.||.||++||-.....+.  .+++.....--+..|.  
T Consensus       727 AginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--AMFkVGmyKvHP~iPe--  802 (1226)
T KOG4279|consen  727 AGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--AMFKVGMYKVHPPIPE--  802 (1226)
T ss_pred             ccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--hhhhhcceecCCCCcH--
Confidence            43 33455678999999999998766  78899999999999999999999965433322  2333222222222332  


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                                          +++.+++.||.+|+.+||..||+|.++|..||++..+
T Consensus       803 --------------------elsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  803 --------------------ELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             --------------------HHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence                                4558999999999999999999999999999999663

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.9e-40  Score=273.89  Aligned_cols=248  Identities=22%  Similarity=0.344  Sum_probs=200.1

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ..+|++.+.||.|++|.||++.+  ..+..+++|.+.....   ....+.+|+++++++.   |||++++++++...   
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~---   71 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYW--LEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLS---HPKLVQLYGVCTER---   71 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEE--eCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCC---CCCeeeEEEEEccC---
Confidence            45899999999999999999987  3467899998764322   2346788999999987   99999999998766   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++++|++.+ +|.+++.... ..+++..++.++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        72 ----~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~  146 (256)
T cd05112          72 ----SPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGM  146 (256)
T ss_pred             ----CceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcc
Confidence                568999999985 9999887643 3478999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         180 AKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       180 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      +........  .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...........+........    
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----  222 (256)
T cd05112         147 TRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK----  222 (256)
T ss_pred             eeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC----
Confidence            875543221  112234568999999998889999999999999999998 9999987666555544332111100    


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                                            ....+..+.+|+.+||..+|++|||+.+++++
T Consensus       223 ----------------------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         223 ----------------------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ----------------------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                                  01234789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.8e-40  Score=277.92  Aligned_cols=251  Identities=24%  Similarity=0.372  Sum_probs=199.0

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCC--CcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNK--GNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      .+.|++.+.||+|++|.||+|++....  +..+++|++..... ......+..|+.+++++.   |||++++++++... 
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~-   77 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFD---HPNIIHLEGVVTKS-   77 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCC---CcCcceEEEEECCC-
Confidence            357999999999999999999984222  23699998865322 122346778999999887   99999999998666 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ...++|+|++.+ +|.+++.... +.+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+||
T Consensus        78 ------~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~df  150 (269)
T cd05065          78 ------RPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDF  150 (269)
T ss_pred             ------CceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCC
Confidence                  567999999985 9999887643 34899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCcc---cccc---ccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCC
Q psy2676         178 GLAKTFDYDMML---TSVV---VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       178 g~~~~~~~~~~~---~~~~---~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      |.+.........   ....   .+..|+|||.+.+..++.++||||+|+++|++++ |..||......+....+......
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~  230 (269)
T cd05065         151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL  230 (269)
T ss_pred             ccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            988655432211   1111   1346999999998889999999999999999886 99999877665555444321111


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      +.                          ..+++..+.+++.+||..+|.+||++.+++.
T Consensus       231 ~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         231 PP--------------------------PMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CC--------------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            11                          1245678899999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.6e-40  Score=275.90  Aligned_cols=243  Identities=24%  Similarity=0.418  Sum_probs=198.4

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++.+.||+|+||.||++.   ..++.+++|.++...    ....+.+|+.++++++   |||++++++++...   
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~---~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~---~~~i~~~~~~~~~~---   71 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGE---YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLH---HKNLVRLLGVILHN---   71 (254)
T ss_pred             HHHceeeeeeccCCCCceEecc---cCCCceEEEeecCcc----hHHHHHHHHHHHHhCC---CCCcCeEEEEEcCC---
Confidence            3679999999999999999984   467789999886432    2346778999998887   99999999998543   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                           ..++++|++. ++|.+++.......+++..++.++.|++.||.+||+.|++||||+|+||+++.++.++|+|||.
T Consensus        72 -----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~  146 (254)
T cd05083          72 -----GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGL  146 (254)
T ss_pred             -----CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcc
Confidence                 3589999998 5999999876655689999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      +......  ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.......       
T Consensus       147 ~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------  217 (254)
T cd05083         147 ARVGSMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME-------  217 (254)
T ss_pred             ceecccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC-------
Confidence            8754322  122334567999999988889999999999999999997 999998776655444332211110       


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                         ....++..+.+++++||+.+|.+||++++++.
T Consensus       218 -------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         218 -------------------PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             -------------------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                               01245688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.1e-40  Score=274.71  Aligned_cols=249  Identities=27%  Similarity=0.419  Sum_probs=202.0

Q ss_pred             eeeeeeeecccceeEEEEEEecCC---CcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNK---GNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      +++.+.||.|+||.||++.+....   +..+++|+++..... .....+..|+..++.+.   |+|++++++.+.+.   
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~---   73 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKLD---HPNIVKLLGVCTEE---   73 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhcC---CCchheEEEEEcCC---
Confidence            467889999999999999984322   488999998654222 13457778999999986   99999999998776   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++++|++.+ +|.+++.......+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        74 ----~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~  149 (258)
T smart00219       74 ----EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGL  149 (258)
T ss_pred             ----CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCC
Confidence                678999999985 999999875443389999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccc--cccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         180 AKTFDYDMMLT--SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       180 ~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      +..........  ...++..|+|||.+.+..++.++|+||+|+++++|++ |..||...+.......+.......     
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-----  224 (258)
T smart00219      150 SRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP-----  224 (258)
T ss_pred             ceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-----
Confidence            87665432211  2335688999999988889999999999999999998 789998766665555443321110     


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                           ....++.++.+++.+||..+|.+|||+.++++
T Consensus       225 ---------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      225 ---------------------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ---------------------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                                 01135688999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-40  Score=285.84  Aligned_cols=260  Identities=23%  Similarity=0.342  Sum_probs=204.1

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecC------CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCcee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQN------KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV   88 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~   88 (321)
                      ..+++...+|++.+.||+|+||.||+|++...      ....+++|.++... .......+.+|+++++++..  ||||+
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~--h~~iv   81 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGK--HKNII   81 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcC--CCCee
Confidence            35677778999999999999999999986321      23368899876432 12223467789999999843  99999


Q ss_pred             EEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy2676          89 RFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--------------PPGLSASKVKELTRQMLKGVDFLHSHR  153 (321)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~l~~lh~~~  153 (321)
                      ++++++...       ...++++||++ |+|.+++....              ...++...+..++.|++.||.+||++|
T Consensus        82 ~~~~~~~~~-------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g  154 (334)
T cd05100          82 NLLGACTQD-------GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK  154 (334)
T ss_pred             eeeEEEccC-------CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999998765       56899999998 59999987632              223778889999999999999999999


Q ss_pred             ceeccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cC
Q psy2676         154 IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LV  229 (321)
Q Consensus       154 ~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~  229 (321)
                      ++|+||+|+||+++.++.++|+|||.+........   .....++..|+|||++.+..++.++||||||+++|+|++ |.
T Consensus       155 ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~  234 (334)
T cd05100         155 CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG  234 (334)
T ss_pred             eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCC
Confidence            99999999999999999999999999876543221   112233467999999999899999999999999999998 88


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         230 PLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .||.+.+..+....+..... +   .                      ....++..+.+++.+||+.+|.+|||+.++++
T Consensus       235 ~p~~~~~~~~~~~~~~~~~~-~---~----------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~  288 (334)
T cd05100         235 SPYPGIPVEELFKLLKEGHR-M---D----------------------KPANCTHELYMIMRECWHAVPSQRPTFKQLVE  288 (334)
T ss_pred             CCCCCCCHHHHHHHHHcCCC-C---C----------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            99987665554444322110 0   0                      11245578999999999999999999999987


Q ss_pred             C
Q psy2676         310 H  310 (321)
Q Consensus       310 h  310 (321)
                      +
T Consensus       289 ~  289 (334)
T cd05100         289 D  289 (334)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.1e-40  Score=277.72  Aligned_cols=254  Identities=22%  Similarity=0.378  Sum_probs=201.5

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecC--CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQN--KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ++..++|.+.+.||.|++|.||+|.+...  ....+++|....... ......+.+|+.+++++.   |||++++++++.
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~---h~~i~~~~~~~~   77 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFD---HPHIVKLIGVIT   77 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCC---CCchhceeEEEc
Confidence            45677899999999999999999987432  234688888764322 122346778999999887   999999999886


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      +.        ..++|+|++. ++|.+++..... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|
T Consensus        78 ~~--------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l  148 (270)
T cd05056          78 EN--------PVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKL  148 (270)
T ss_pred             CC--------CcEEEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEE
Confidence            54        3579999998 599999977443 4899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         175 ADFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       175 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      +|||.+........  .....++..|+|||.+....++.++||||||++++++++ |..||......+....+......+
T Consensus       149 ~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~  228 (270)
T cd05056         149 GDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP  228 (270)
T ss_pred             ccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            99999876543321  112233467999999988889999999999999999986 999998776655544433211111


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                                                ....++..+.+++.+|+..+|.+|||+.++++.
T Consensus       229 --------------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         229 --------------------------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             --------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      112456899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.9e-40  Score=280.71  Aligned_cols=250  Identities=22%  Similarity=0.339  Sum_probs=195.8

Q ss_pred             ceeeeeeeecccceeEEEEEEecC----CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQN----KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      +|++.+.||+|+||.||+|.+...    ....+++|.+...... .....+.+|+.+++++.   ||||+++++.+... 
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~-   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS-SELRDLLSEFNLLKQVN---HPHVIKLYGACSQD-   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH-HHHHHHHHHHHHHhhCC---CCCEeeEEEEEecC-
Confidence            478899999999999999987422    2356888877543221 11235677889898887   99999999998766 


Q ss_pred             cccccceEEEEEeccCc-cCHHHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy2676          99 LSDERYLTVYLIFEHVD-QDLGSYMEKCP----------------------PPGLSASKVKELTRQMLKGVDFLHSHRII  155 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~-~~L~~~~~~~~----------------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~  155 (321)
                            ...++++||+. ++|.+++....                      ...+++..++.++.|++.||.+||+.|++
T Consensus        76 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iv  149 (290)
T cd05045          76 ------GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLV  149 (290)
T ss_pred             ------CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence                  56799999999 59999886532                      12378899999999999999999999999


Q ss_pred             eccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCC
Q psy2676         156 HRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPL  231 (321)
Q Consensus       156 H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p  231 (321)
                      |+||+|+||++++++.++|+|||.+........   .....++..|+|||.+.+..++.++||||||+++++|++ |..|
T Consensus       150 H~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p  229 (290)
T cd05045         150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  229 (290)
T ss_pred             hhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCC
Confidence            999999999999999999999999875532221   122344668999999988889999999999999999998 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         232 FCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      |.+................+                          ....++.++.+++.+||+.+|.+||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         230 YPGIAPERLFNLLKTGYRME--------------------------RPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCCCCHHHHHHHHhCCCCCC--------------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            98766555443332211110                          01245688999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.8e-40  Score=280.73  Aligned_cols=254  Identities=25%  Similarity=0.384  Sum_probs=200.8

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      +..++|++.+.||+|+||.||+|.+..    .++..+++|++...... .....+.+|+.+++++.   |||++++++++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~ei~~l~~l~---h~~iv~~~~~~   77 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFD---HPNIVKLLGVC   77 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-HHHHHHHHHHHHHHhcC---CCchheEEEEE
Confidence            456789999999999999999998732    35678999988643221 12235677899999887   99999999998


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--------------------PPGLSASKVKELTRQMLKGVDFLHSHR  153 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--------------------~~~~~~~~~~~i~~~l~~~l~~lh~~~  153 (321)
                      .+.       ...++++|++. ++|.+++....                    ...+++..++.++.|++.||.+||+.|
T Consensus        78 ~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~  150 (288)
T cd05050          78 AVG-------KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK  150 (288)
T ss_pred             cCC-------CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence            766       56799999999 59999987431                    123788899999999999999999999


Q ss_pred             ceeccCCCCcEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cC
Q psy2676         154 IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LV  229 (321)
Q Consensus       154 ~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~  229 (321)
                      ++|+||+|+||+++.++.++|+|||.+.......   .......+..|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus       151 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~  230 (288)
T cd05050         151 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM  230 (288)
T ss_pred             eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999887543221   1122334567999999998889999999999999999997 88


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         230 PLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .||.+....+....+..... .   .                      ....++.++.+|+.+||+.+|.+|||+.|+++
T Consensus       231 ~p~~~~~~~~~~~~~~~~~~-~---~----------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         231 QPYYGMAHEEVIYYVRDGNV-L---S----------------------CPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCCCCCCHHHHHHHHhcCCC-C---C----------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            89877666555444332110 0   0                      01235578999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0696|consensus

Probab=100.00  E-value=7.1e-42  Score=281.36  Aligned_cols=261  Identities=27%  Similarity=0.417  Sum_probs=224.2

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      -.+|.++.+||+|+||.|.++.. +.+.+.+|||++++... .++...-.+.|.++|....+  -|.+++++.+|+..  
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaer-kgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~k--ppFL~qlHScFQTm--  422 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAER-KGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK--PPFLVQLHSCFQTM--  422 (683)
T ss_pred             ecccceEEEeccCccceeeeecc-cCcchhhhhhhhccceeeecCcccceehhhhheecCCC--CchHHHHHHHhhhh--
Confidence            35799999999999999999988 57788999999987632 23333455678888887774  78899999999887  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ..+|.||||+.| +|--.+++.+  .+.+..+..++..|+.||-+||++||++||||.+||+++.+|++||.|||
T Consensus       423 -----DRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFG  495 (683)
T KOG0696|consen  423 -----DRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFG  495 (683)
T ss_pred             -----hheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecc
Confidence                 789999999995 8887787744  48999999999999999999999999999999999999999999999999


Q ss_pred             Ccccc-cCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         179 LAKTF-DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       179 ~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      ++..- -...+.....||+.|+|||.+...+|+.+.|-||+|++||||+.|++||.+.+.++..+.|....     ..+|
T Consensus       496 mcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-----vsyP  570 (683)
T KOG0696|consen  496 MCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN-----VSYP  570 (683)
T ss_pred             cccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-----CcCc
Confidence            98743 33445667899999999999999999999999999999999999999999999999999888753     2233


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCCC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENEP  320 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~~  320 (321)
                      .                      ..|.++.++++..|.+.|.+|.     .-.+|-.||||+.++|+-
T Consensus       571 K----------------------slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek  616 (683)
T KOG0696|consen  571 K----------------------SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK  616 (683)
T ss_pred             c----------------------cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence            3                      4458999999999999999998     346888999999999974

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.9e-40  Score=273.32  Aligned_cols=242  Identities=26%  Similarity=0.370  Sum_probs=191.2

Q ss_pred             eeecccceeEEEEEEe-cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEE
Q psy2676          29 QIGCGAYGTVFKARDL-QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTV  107 (321)
Q Consensus        29 ~lg~g~~g~v~~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~  107 (321)
                      .||+|+||.||++... ...+..+++|++..... ......+.+|+.+++++.   ||||+++++++...        ..
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~---h~~ii~~~~~~~~~--------~~   69 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLD---NPYIVRMIGVCEAE--------AL   69 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcC---CCCeEEEEEEEcCC--------Ce
Confidence            3899999999999763 23455789998865422 222345778999999987   99999999987432        46


Q ss_pred             EEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCC
Q psy2676         108 YLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD  186 (321)
Q Consensus       108 ~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~  186 (321)
                      ++|+|+++ ++|.+++.... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        70 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  148 (257)
T cd05115          70 MLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             EEEEEeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCC
Confidence            89999998 59999887543 34899999999999999999999999999999999999999999999999998755332


Q ss_pred             Cc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhh
Q psy2676         187 MM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS  261 (321)
Q Consensus       187 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (321)
                      ..    .....++..|+|||++....++.++||||||+++|++++ |..||......+....+.... .+.   .     
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~---~-----  219 (257)
T cd05115         149 DSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-RLD---C-----  219 (257)
T ss_pred             ccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-CCC---C-----
Confidence            21    111223567999999988889999999999999999996 999998776655544333211 111   1     


Q ss_pred             hhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                       ...+++++.+++.+||..+|++||++.++.+
T Consensus       220 -----------------~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         220 -----------------PAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             -----------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                             1245689999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.5e-40  Score=275.01  Aligned_cols=254  Identities=29%  Similarity=0.514  Sum_probs=201.3

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC--------CCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG--------IPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      .|++.+.||+|++|.||++.+...+++.+++|.+........        ....+..|+.++++..  .|||++++++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~--~h~~i~~~~~~~   78 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL--RHPNIVRYYKTF   78 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcC--CCCCeeeEEeeE
Confidence            488899999999999999998544788999998865432211        1123445666665422  399999999998


Q ss_pred             eccccccccceEEEEEeccCcc-CHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeeCC
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAG  170 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~  170 (321)
                      ...       ...++++||+.+ +|.+++...  ....+++..++.++.|++.+|.+||+ .|++|+||+|+||+++.++
T Consensus        79 ~~~-------~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~  151 (269)
T cd08528          79 LEN-------DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD  151 (269)
T ss_pred             ccC-------CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC
Confidence            776       678999999985 998887542  23458999999999999999999996 7899999999999999999


Q ss_pred             CEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCC
Q psy2676         171 GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      .++|+|||.+.............++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+......
T Consensus       152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~  231 (269)
T cd08528         152 KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE  231 (269)
T ss_pred             cEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence            99999999998766544445567788999999999888999999999999999999999999876665554444332211


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      +...                         ..+++.+.++|++||+.||++||++.++..+
T Consensus       232 ~~~~-------------------------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         232 PLPE-------------------------GMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             cCCc-------------------------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            1111                         1345789999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.2e-40  Score=278.91  Aligned_cols=267  Identities=16%  Similarity=0.241  Sum_probs=193.0

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCC---CcEEEEEEeecccCCCCCCc------hhHHHHHHHHhcccCCCCc
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNK---GNYVAMKKLRVKLNEDGIPM------STLREISILKQLDTFEHPN   86 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~---~~~~~iK~~~~~~~~~~~~~------~~~~e~~~l~~l~~~~~~~   86 (321)
                      ..++.+++|++.+.||+|+||+||+|.+. .+   +..+++|+............      ....++..+..+....|++
T Consensus         6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~-~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~   84 (294)
T PHA02882          6 LIDITGKEWKIDKLIGCGGFGCVYETQCA-SDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG   84 (294)
T ss_pred             eeccCCCceEEeeEEecCCCceEEEEEEc-CCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence            45677889999999999999999999873 44   55667775433211100000      0112333344445556999


Q ss_pred             eeEEEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q psy2676          87 IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI  166 (321)
Q Consensus        87 i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv  166 (321)
                      +++++++.....   ......+++++.+..++.+.+....  ..++..++.++.|++.||.+||+.+++||||||+||++
T Consensus        85 i~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill  159 (294)
T PHA02882         85 IPKYYGCGSFKR---CRMYYRFILLEKLVENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV  159 (294)
T ss_pred             CCcEEEeeeEec---CCceEEEEEEehhccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            999999765431   1113457888988888887776632  35788899999999999999999999999999999999


Q ss_pred             eeCCCEEEeecCCcccccCCC--------ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChH
Q psy2676         167 TRAGGLKIADFGLAKTFDYDM--------MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV  238 (321)
Q Consensus       167 ~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  238 (321)
                      +.++.++|+|||++.......        ......+|+.|+|||++.+..++.++||||||+++++|++|..||.+....
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~  239 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN  239 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence            999999999999987653221        112346899999999999999999999999999999999999999876332


Q ss_pred             HHHHHHHH--HhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         239 EQLKCIFR--VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       239 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ........  ......                   ..  ......++..+.++++.|+..+|.+||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~-------------------~~--~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        240 GNLIHAAKCDFIKRLH-------------------EG--KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             hHHHHHhHHHHHHHhh-------------------hh--hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            22111111  000000                   00  0012356788999999999999999999999875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.4e-40  Score=305.43  Aligned_cols=147  Identities=29%  Similarity=0.459  Sum_probs=127.5

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|.+++.||.|+||+||+|.+ ..+++.||+|+++..... ......+..|+.+++.++   ||||+++++.+...   
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~-~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~---hp~Iv~~~~~~~~~---   76 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRK-KNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK---SPFIVHLYYSLQSA---   76 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEE-CCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC---CCCcCeEEEEEEEC---
Confidence            6899999999999999999999 578899999998753221 111245677888888887   99999999998766   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..+++||||+. ++|.+++...  ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+
T Consensus        77 ----~~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGl  150 (669)
T cd05610          77 ----NNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGL  150 (669)
T ss_pred             ----CEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCC
Confidence                67899999997 5999999763  3489999999999999999999999999999999999999999999999998


Q ss_pred             cc
Q psy2676         180 AK  181 (321)
Q Consensus       180 ~~  181 (321)
                      +.
T Consensus       151 s~  152 (669)
T cd05610         151 SK  152 (669)
T ss_pred             Cc
Confidence            74

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-40  Score=271.51  Aligned_cols=242  Identities=27%  Similarity=0.412  Sum_probs=193.9

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTV  107 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~  107 (321)
                      +.||.|++|.||++.+ .. ++.+++|.+...... .....+.+|+.+++++.   ||||+++++++.+.       ...
T Consensus         1 ~~lg~g~~g~v~~~~~-~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~-------~~~   67 (251)
T cd05041           1 EKIGKGNFGDVYKGVL-KG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYD---HPNIVKLIGVCVQK-------QPI   67 (251)
T ss_pred             CccccCCCceEEEEEE-eC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCC---CCCeEEEEEEEecC-------CCe
Confidence            4689999999999998 34 899999988654332 22346778999999887   99999999998777       678


Q ss_pred             EEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCC
Q psy2676         108 YLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD  186 (321)
Q Consensus       108 ~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~  186 (321)
                      ++|+|++. ++|.+++..... .+++..+..++.+++.||.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        68 ~~v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  146 (251)
T cd05041          68 YIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG  146 (251)
T ss_pred             EEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence            99999998 489999876433 4789999999999999999999999999999999999999999999999998765422


Q ss_pred             Ccc---ccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhh
Q psy2676         187 MML---TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL  262 (321)
Q Consensus       187 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (321)
                      ...   .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+......+           
T Consensus       147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~-----------  215 (251)
T cd05041         147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP-----------  215 (251)
T ss_pred             cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC-----------
Confidence            111   11223567999999988889999999999999999999 889997766544444332211100           


Q ss_pred             hhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                     ....++.++.+++.+||..+|.+|||+.++++
T Consensus       216 ---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         216 ---------------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             ---------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                           01245578999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.2e-40  Score=270.99  Aligned_cols=242  Identities=26%  Similarity=0.406  Sum_probs=193.1

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTV  107 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~  107 (321)
                      +.||+|++|.||++..  .++..+++|++..... ......+.+|+++++++.   |||++++++++...       ...
T Consensus         1 ~~ig~g~~g~vy~~~~--~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~-------~~~   67 (250)
T cd05085           1 ELLGKGNFGEVFKGTL--KDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYD---HPNIVKLIGVCTQR-------QPI   67 (250)
T ss_pred             CccCCCCCceEEEEEe--cCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCC---CCCcCeEEEEEecC-------Ccc
Confidence            3689999999999986  4678899998764322 112235678999999887   99999999998766       568


Q ss_pred             EEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCC
Q psy2676         108 YLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD  186 (321)
Q Consensus       108 ~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~  186 (321)
                      ++|+|++. ++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        68 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  146 (250)
T cd05085          68 YIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG  146 (250)
T ss_pred             EEEEECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc
Confidence            99999998 59999887643 34799999999999999999999999999999999999999999999999988654322


Q ss_pred             Cc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhh
Q psy2676         187 MM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM  263 (321)
Q Consensus       187 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
                      ..  .....++..|+|||++.+..++.++|+||||+++|++++ |..||...........+.....    ..        
T Consensus       147 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~----~~--------  214 (250)
T cd05085         147 IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR----MS--------  214 (250)
T ss_pred             ccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC----CC--------
Confidence            21  112233567999999988889999999999999999998 9999987766554444332110    00        


Q ss_pred             hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                    ....++..+.+++.+||..+|.+||++.++++
T Consensus       215 --------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         215 --------------CPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             --------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                          01245688999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.3e-40  Score=274.49  Aligned_cols=255  Identities=25%  Similarity=0.421  Sum_probs=201.2

Q ss_pred             CCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ..++|++.+.||+|+||+||+|+...    .....+++|.+..... ......+.+|+++++++.   |+|++++++++.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~   78 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLS---HKNVVRLLGLCR   78 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcC---CcceeeeEEEEC
Confidence            44789999999999999999998732    2346788888754211 112346788999999997   999999999987


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP-------PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT  167 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~  167 (321)
                      +.       ...++|+|+++ ++|.+++.....       ..+++..+..++.||+.||.|||+.|++|+||+|+||+++
T Consensus        79 ~~-------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~  151 (275)
T cd05046          79 EA-------EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS  151 (275)
T ss_pred             CC-------CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe
Confidence            66       56799999999 599999976541       1589999999999999999999999999999999999999


Q ss_pred             eCCCEEEeecCCcccccCCC--ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHH
Q psy2676         168 RAGGLKIADFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCI  244 (321)
Q Consensus       168 ~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~  244 (321)
                      .++.++++|||++.......  ......++..|+|||.+.+...+.++||||||++++++++ |..||............
T Consensus       152 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~  231 (275)
T cd05046         152 SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL  231 (275)
T ss_pred             CCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH
Confidence            99999999999876443221  2233455677999999988888999999999999999998 78899766554444333


Q ss_pred             HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      .....  .   ++                    ....++..+.+++.+||+.+|.+|||+.++++.
T Consensus       232 ~~~~~--~---~~--------------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         232 QAGKL--E---LP--------------------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             HcCCc--C---CC--------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            21110  0   00                    012456889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=274.59  Aligned_cols=251  Identities=25%  Similarity=0.365  Sum_probs=198.6

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCc----EEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGN----YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      +...+|++.+.||+|+||+||+|.+. .++.    .+++|....... ......+.+|+..++++.   |||++++++++
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~   78 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWI-PEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVD---HPHVVRLLGIC   78 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEe-cCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCC---CCCcceEEEEE
Confidence            45678999999999999999999874 3333    588887754322 112345667888888887   99999999988


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      ..        ...++|+|++. |+|.+++..... .+++..+..++.||+.||++||+.|++|+||+|+||+++.++.++
T Consensus        79 ~~--------~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~k  149 (279)
T cd05057          79 LS--------SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVK  149 (279)
T ss_pred             ec--------CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEE
Confidence            54        25789999998 599999877543 389999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCCcc---ccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhC
Q psy2676         174 IADFGLAKTFDYDMML---TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       174 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      |+|||.+.........   ....++..|+|||.+....++.++|+||+|++++++++ |..||......+....+.... 
T Consensus       150 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-  228 (279)
T cd05057         150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-  228 (279)
T ss_pred             ECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-
Confidence            9999998765432211   11223567999999988889999999999999999998 999998876665554443211 


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ..+..                         ..++..+.+++.+||..+|.+||++.++++
T Consensus       229 ~~~~~-------------------------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         229 RLPQP-------------------------PICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCCCC-------------------------CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            11111                         124467889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-40  Score=273.89  Aligned_cols=245  Identities=26%  Similarity=0.361  Sum_probs=190.0

Q ss_pred             eeeecccceeEEEEEEecCCCc--EEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccce
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYL  105 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~  105 (321)
                      +.||+|+||.||++++. .++.  .+++|.++.. ........+.+|++++.++..  ||||+++++++...       .
T Consensus         1 ~~lg~g~~g~v~~~~~~-~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~--h~~iv~~~~~~~~~-------~   69 (270)
T cd05047           1 DVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGH--HPNIINLLGACEHR-------G   69 (270)
T ss_pred             CcCCCCCCceEEEEEEc-CCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhcc--CCCeeeEEEEEecC-------C
Confidence            36899999999999984 4444  4677777532 112223466789999999853  99999999998766       5


Q ss_pred             EEEEEeccCc-cCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC
Q psy2676         106 TVYLIFEHVD-QDLGSYMEKCP--------------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG  170 (321)
Q Consensus       106 ~~~~v~e~~~-~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~  170 (321)
                      ..+++||++. ++|.+++....              ...+++..+..++.|++.||++||+.|++|+||+|+||++++++
T Consensus        70 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~  149 (270)
T cd05047          70 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  149 (270)
T ss_pred             CceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC
Confidence            6799999998 59999987532              12478999999999999999999999999999999999999999


Q ss_pred             CEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhC
Q psy2676         171 GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      .++|+|||++..............+..|+|||++....++.++|+||||+++++|++ |..||...+..+....+.....
T Consensus       150 ~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~  229 (270)
T cd05047         150 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  229 (270)
T ss_pred             eEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC
Confidence            999999998754322211222233567999999988889999999999999999997 9999977665544433321100


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                          ..                      ....++.++.+++.+||..+|.+|||+.+++.
T Consensus       230 ----~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         230 ----LE----------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             ----CC----------------------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                00                      01235578999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-39  Score=274.01  Aligned_cols=267  Identities=26%  Similarity=0.383  Sum_probs=195.7

Q ss_pred             CcceeeeeeeecccceeEEEEEEe---cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDL---QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ..+|++++.||+|+||.||++...   ..++..+++|.+....  ......+.+|+++++++.   |||++++++++...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~   77 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQ---HDNIVKYKGVCYSA   77 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCC---CCCeeEEEEEEccC
Confidence            468999999999999999999731   3568899999976432  112345678999999987   99999999987543


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                      .     ...+++|+||++ ++|.+++.... ..+++..++.++.|++.||.+||++|++|+||||+||++++++.++|+|
T Consensus        78 ~-----~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~d  151 (284)
T cd05081          78 G-----RRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGD  151 (284)
T ss_pred             C-----CCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECC
Confidence            1     135799999998 59999997643 3489999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCcc----ccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         177 FGLAKTFDYDMML----TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       177 fg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ||.+.........    ....++..|+|||.+.+..++.++|+||||+++++|++|..++....... ...    .+...
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~~~----~~~~~  226 (284)
T cd05081         152 FGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-MRM----MGNDK  226 (284)
T ss_pred             CcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-hhh----ccccc
Confidence            9998866433211    11223445999999988889999999999999999999987764432211 100    00000


Q ss_pred             C-CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         253 M-NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       253 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      . ......      ...............+++.++.+++.+||..+|++|||+.++++
T Consensus       227 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         227 QGQMIVYH------LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             ccccchHH------HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0 000000      00000000000112356789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.1e-40  Score=275.79  Aligned_cols=269  Identities=23%  Similarity=0.374  Sum_probs=198.5

Q ss_pred             CcceeeeeeeecccceeEEEEEEe---cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDL---QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      +.-|++++.||+|+||.||+++..   ..++..+++|.++.... ......+.+|+.+++++.   |||++++++++...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~   78 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLY---HENIVKYKGICTED   78 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCC---CCCeeeeeeEEecC
Confidence            456799999999999999999742   35678899999864422 223346778999999987   99999999988553


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                           .....++|+||++ ++|.+++.... ..+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|
T Consensus        79 -----~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~d  152 (284)
T cd05079          79 -----GGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGD  152 (284)
T ss_pred             -----CCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECC
Confidence                 1135799999998 59999987643 2489999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         177 FGLAKTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       177 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ||.+........    .....++..|+|||.+.+..++.++||||||+++|+|+++..|+.......     ....+.. 
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~-----~~~~~~~-  226 (284)
T cd05079         153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF-----LKMIGPT-  226 (284)
T ss_pred             CccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh-----hhhcccc-
Confidence            999876543321    123345667999999988889999999999999999999877654321110     0000000 


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      .......     .................++..+.+|+.+||+.+|.+|||+.+++++
T Consensus       227 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         227 HGQMTVT-----RLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cccccHH-----HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            0000000     0000000001111223577899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0665|consensus

Probab=100.00  E-value=8.4e-41  Score=266.35  Aligned_cols=287  Identities=39%  Similarity=0.599  Sum_probs=236.2

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      -....||.-++.+|.|.. .|..|-| .-.+++|++|.............+..+|...+..+.   |+|+++++.+|.-.
T Consensus        13 ftv~~Ry~nL~p~~~g~~-~v~~a~D-~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~---~~nii~l~n~ftP~   87 (369)
T KOG0665|consen   13 FTVPKRYVNLKPIGSGAQ-IVVAAFD-QVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN---HKNIISLLNVFTPQ   87 (369)
T ss_pred             eeeeeeeeeecccCCCCc-eEEecch-hhccCceehhhhcCccccCccchhhhhhhhhhhhhc---ccceeeeeeccCcc
Confidence            345579999999999999 7878878 688999999988777555556678889999999988   99999999998544


Q ss_pred             ccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          98 ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                      . .......+|+|||++..+|...+..    .++-+.+..++.|++.|++|||+.||+||||||+||++..+..+|+.||
T Consensus        88 ~-~l~~~~e~y~v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~df  162 (369)
T KOG0665|consen   88 K-TLEEFQEVYLVMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDF  162 (369)
T ss_pred             c-cHHHHHhHHHHHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccc
Confidence            2 2233356899999999999999874    2788999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      |++.........++...+..|.|||++.+..+...+||||+||++.+|++|+..|.+.+..+.-.++...+|.|...-..
T Consensus       163 g~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  163 GLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             hhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence            99998887767778889999999999999999999999999999999999999999999999999999999988765332


Q ss_pred             hhhhhhh---hhhhhhhhhhhhhhhh------------hcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q psy2676         258 ENISLMW---SSFEQYSKVAFSAIFM------------DCCSKANSLLESMLTFNPADRISAADALEHPYFK  314 (321)
Q Consensus       258 ~~~~~~~---~~~~~~~~~~~~~~~~------------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~  314 (321)
                      ...+..-   ...+++.....+..++            --+..+++++.+||..||++|.|++++|+||||+
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence            2221111   0111111112222211            1235788999999999999999999999999997

>KOG4645|consensus

Probab=100.00  E-value=1.1e-41  Score=313.37  Aligned_cols=258  Identities=29%  Similarity=0.472  Sum_probs=216.6

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .-|+.-...+|.|.||.||.|.+ -.+|+..|+|-++...........+.+|..++..++   |||+++.|++-...   
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN-~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln---HpNlV~YyGVEvHR--- 1306 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVN-LDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN---HPNLVRYYGVEVHR--- 1306 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeec-CCccchhhhhhhhcCccccccCcchHHHHHHHHhcc---CccccccCceeecH---
Confidence            34778889999999999999999 589999999988877666666778889999999998   99999999997766   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..++|.||||. |+|.+++..  .+..++.....+..|++.|+.|||+.|||||||||.||+++.+|.+|++|||.
T Consensus      1307 ----ekv~IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1307 ----EKVYIFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred             ----HHHHHHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccc
Confidence                67899999999 599999988  34478888888999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-----ccccccccccccchhhhhcCC---CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         180 AKTFDYDM-----MLTSVVVTLWYRAPEILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       180 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      +.++..+.     ......||+.|||||++.+..   -..++|||||||++.||+||+.||...+.+=.+.--..-...|
T Consensus      1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP 1460 (1509)
T ss_pred             eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC
Confidence            99886553     234578999999999997755   4669999999999999999999997654433322222223333


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      +.++                         .++++..+||..||..||++|.++.|+++|-|=+..
T Consensus      1461 q~P~-------------------------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1461 QIPE-------------------------RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             CCch-------------------------hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            3332                         355899999999999999999999999999987654

>KOG1095|consensus

Probab=100.00  E-value=8.1e-40  Score=301.44  Aligned_cols=254  Identities=25%  Similarity=0.385  Sum_probs=212.7

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCc----EEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGN----YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      +....-...+.||+|.||.||.+.-...++.    .|++|.++.. .+......+.+|..++++++   ||||++++|+.
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~---HpNiv~liGv~  764 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFD---HPNIVSLIGVC  764 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCC---CcceeeEEEee
Confidence            5667788999999999999999998656665    3788877643 33344568889999999998   99999999999


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP-----PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR  168 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~  168 (321)
                      .+.       ...++++|||. |+|..+++...     ...++..++..++.|||.|+.||+++++|||||..+|+|+++
T Consensus       765 l~~-------~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~  837 (1025)
T KOG1095|consen  765 LDS-------GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDE  837 (1025)
T ss_pred             cCC-------CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecc
Confidence            876       67799999999 59999999861     233899999999999999999999999999999999999999


Q ss_pred             CCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHH
Q psy2676         169 AGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCI  244 (321)
Q Consensus       169 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~  244 (321)
                      ...+|++|||+++.+-...   ......-+..|+|||.+....++.++||||||+++||+++ |..||...++.+.+...
T Consensus       838 ~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~  917 (1025)
T KOG1095|consen  838 RRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV  917 (1025)
T ss_pred             cCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH
Confidence            9999999999998442111   1112234578999999999999999999999999999998 78999998888887766


Q ss_pred             HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .... ..+.+                         ..||..+.+++..||+.+|++||++..|++
T Consensus       918 ~~gg-RL~~P-------------------------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  918 LEGG-RLDPP-------------------------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             HhCC-ccCCC-------------------------CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            6554 22222                         257789999999999999999999999987

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.7e-39  Score=272.07  Aligned_cols=245  Identities=28%  Similarity=0.423  Sum_probs=192.5

Q ss_pred             eeeecccceeEEEEEEec-----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          28 CQIGCGAYGTVFKARDLQ-----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +.||+|++|.||++++..     .++..+++|.+..... ......+.+|+.+++.+.   ||||+++++++.+.     
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~-----   71 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFN---HPNIVKLLGVCLLN-----   71 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcC---CCCeeeEeeeecCC-----
Confidence            468999999999998731     2236789998764322 123446778899998887   99999999998766     


Q ss_pred             cceEEEEEeccCc-cCHHHHHhhC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC-----C
Q psy2676         103 RYLTVYLIFEHVD-QDLGSYMEKC-----PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-----G  171 (321)
Q Consensus       103 ~~~~~~~v~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~-----~  171 (321)
                        ...++++|+++ ++|.+++...     ....+++.++..++.|++.||.|||+.+++|+||+|+||+++.++     .
T Consensus        72 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~  149 (269)
T cd05044          72 --EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRV  149 (269)
T ss_pred             --CCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcc
Confidence              56899999998 5999998753     223478899999999999999999999999999999999999877     7


Q ss_pred             EEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHH
Q psy2676         172 LKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  247 (321)
                      ++|+|||++........   ......+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+...
T Consensus       150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  229 (269)
T cd05044         150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG  229 (269)
T ss_pred             eEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC
Confidence            99999999875532221   122344678999999999899999999999999999998 99999876665544333211


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      . ..                         .....++..+.++|.+||..+|.+||++.++++
T Consensus       230 ~-~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         230 G-RL-------------------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             C-cc-------------------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            0 00                         011245578999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3e-39  Score=271.16  Aligned_cols=257  Identities=22%  Similarity=0.300  Sum_probs=197.1

Q ss_pred             eeeeeeeecccceeEEEEEEec--CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQ--NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      |.+.+.||+|++|.||+|.+..  .++..+++|++............+.+|+++++++.   |||++++++++...... 
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~-   76 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD---HPNVIKLIGVSLRSRAK-   76 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC---CCCcceEEEEEccCCCC-
Confidence            6788999999999999998642  24688999998765433333445678888888887   99999999987654111 


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCP----PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                      ......+++++++. |+|..++....    ...++...++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|
T Consensus        77 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECc
Confidence            11134578889998 58888764321    12478999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         177 FGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       177 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ||.+.......   ......++..|++||.+.+...+.++||||||+++|+|++ |..||...+..+....+.... .. 
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~-  234 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RL-  234 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cC-
Confidence            99987654322   1122334567999999998889999999999999999999 899997766544433333211 00 


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                        .                      ....++..+.+++.+||+.+|++|||+.+++++
T Consensus       235 --~----------------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         235 --K----------------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             --C----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              0                      012455789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.6e-39  Score=266.99  Aligned_cols=228  Identities=26%  Similarity=0.359  Sum_probs=182.5

Q ss_pred             ccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEEEEec
Q psy2676          33 GAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFE  112 (321)
Q Consensus        33 g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e  112 (321)
                      |.+|.||+|++ ..+++.+++|.+....       ...+|...+....   |||++++++++...       ...++++|
T Consensus         4 g~~~~v~~~~~-~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~---~~~i~~~~~~~~~~-------~~~~lv~e   65 (237)
T cd05576           4 GVIDKVLLVMD-TRTQQTFILKGLRKSS-------EYSRERLTIIPHC---VPNMVCLHKYIVSE-------DSVFLVLQ   65 (237)
T ss_pred             cccceEEEEEE-ccCCcEEEEEeecchh-------hhhhHHHHHHhcC---CCceeehhhheecC-------CeEEEEEe
Confidence            88999999999 6889999999987542       2223444444444   99999999998776       67899999


Q ss_pred             cCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCCcccc
Q psy2676         113 HVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS  191 (321)
Q Consensus       113 ~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~  191 (321)
                      ++.| +|.+++...  ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++++|||.+.......  ..
T Consensus        66 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--~~  141 (237)
T cd05576          66 HAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DG  141 (237)
T ss_pred             cCCCCCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--cc
Confidence            9995 999998774  348999999999999999999999999999999999999999999999999876554321  23


Q ss_pred             ccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhh
Q psy2676         192 VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYS  271 (321)
Q Consensus       192 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (321)
                      ..++..|+|||.+....++.++|+||+|+++|+|++|..|+.......         ......                 
T Consensus       142 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------~~~~~~-----------------  195 (237)
T cd05576         142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------NTHTTL-----------------  195 (237)
T ss_pred             CCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------cccccc-----------------
Confidence            345667999999988888999999999999999999998875321100         000000                 


Q ss_pred             hhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH-----HHHhCCCCC
Q psy2676         272 KVAFSAIFMDCCSKANSLLESMLTFNPADRISA-----ADALEHPYF  313 (321)
Q Consensus       272 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~h~~f  313 (321)
                           .....+++.+.++|++||+.||.+||++     +++++||||
T Consensus       196 -----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         196 -----NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             -----CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence                 0112355789999999999999999986     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.1e-39  Score=273.60  Aligned_cols=251  Identities=21%  Similarity=0.308  Sum_probs=194.7

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCc----EEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGN----YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ..++|+..+.||+|++|.||++.+. .++.    .+++|.+..... ......+.+|+.+++++.   ||||+++++++.
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~---h~niv~~~~~~~   79 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWV-PEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMD---HPHLVRLLGVCL   79 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEe-cCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCC---CCCcccEEEEEc
Confidence            4568899999999999999999884 4444    467777653321 111224667888888887   999999999885


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ..        ..++++|+++ |+|.+++..... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||
T Consensus        80 ~~--------~~~~v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL  150 (303)
T cd05110          80 SP--------TIQLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKI  150 (303)
T ss_pred             CC--------CceeeehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEE
Confidence            43        2468899998 699999876432 4889999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCC
Q psy2676         175 ADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       175 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      +|||.+........   .....++..|+|||.+.+..++.++||||||+++|++++ |..||.+....+....+.. ...
T Consensus       151 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~  229 (303)
T cd05110         151 TDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-GER  229 (303)
T ss_pred             ccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCC
Confidence            99999976543221   122334678999999998889999999999999999997 8999977654443332221 111


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ++.                         ...++..+.+++.+||..+|++||++.++++.
T Consensus       230 ~~~-------------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         230 LPQ-------------------------PPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCC-------------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            110                         01244688899999999999999999998863

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1035|consensus

Probab=100.00  E-value=3.1e-40  Score=302.37  Aligned_cols=263  Identities=30%  Similarity=0.503  Sum_probs=198.5

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc----
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN----   97 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~----   97 (321)
                      ++|+.++.||+|+||.||+|++ +-+|+.||||.+.... .......+.+|+..+.++.   ||||++++..+...    
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRN-KlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLn---HpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRN-KLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLN---HPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEee-cccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcC---CcceeeeehhhhccCCcc
Confidence            5689999999999999999999 6999999999998765 4445567888999999998   99999988765210    


Q ss_pred             -------------------------------------------------cc-----------------------------
Q psy2676          98 -------------------------------------------------IL-----------------------------   99 (321)
Q Consensus        98 -------------------------------------------------~~-----------------------------   99 (321)
                                                                       ..                             
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                             00                             


Q ss_pred             -----------------------cccc-------ceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH
Q psy2676         100 -----------------------SDER-------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFL  149 (321)
Q Consensus       100 -----------------------~~~~-------~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~l  149 (321)
                                             ....       ...+||=||||+.++...+...+...-.....|+++++|++||.|+
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence                                   0000       0247999999997555444443332115788999999999999999


Q ss_pred             HhCCceeccCCCCcEEEeeCCCEEEeecCCccccc-------------------CCCccccccccccccchhhhhcCC--
Q psy2676         150 HSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-------------------YDMMLTSVVVTLWYRAPEILLNLG--  208 (321)
Q Consensus       150 h~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~~~--  208 (321)
                      |++|++||||||.||++++++++||+|||+++...                   .....+...||.-|.|||++.+..  
T Consensus       714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence            99999999999999999999999999999997721                   112445678999999999997765  


Q ss_pred             -CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHH
Q psy2676         209 -YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKAN  287 (321)
Q Consensus       209 -~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (321)
                       ++.|+|+||||++++||+.-   |..  ..+-...+... ..+..+..+                   +....-.+.-.
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~yP---F~T--sMERa~iL~~L-R~g~iP~~~-------------------~f~~~~~~~e~  848 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLYP---FGT--SMERASILTNL-RKGSIPEPA-------------------DFFDPEHPEEA  848 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhcc---CCc--hHHHHHHHHhc-ccCCCCCCc-------------------ccccccchHHH
Confidence             89999999999999999764   532  23332222221 122211110                   11112225667


Q ss_pred             HHHHHhcccCCCCCCCHHHHhCCCCCC
Q psy2676         288 SLLESMLTFNPADRISAADALEHPYFK  314 (321)
Q Consensus       288 ~li~~~l~~dp~~Rps~~~ll~h~~f~  314 (321)
                      .+|++||+.||.+||||.|+|++.||-
T Consensus       849 slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  849 SLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            899999999999999999999999997

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.2e-39  Score=272.44  Aligned_cols=268  Identities=27%  Similarity=0.359  Sum_probs=198.5

Q ss_pred             CcceeeeeeeecccceeEEEEEEe---cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDL---QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ...|++.+.||+|+||.||+++..   ..++..+++|++...... .....+.+|+..++.+.   |||++++++++...
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~---~~~i~~~~~~~~~~   78 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLD---HENIVKYKGVCEKP   78 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCC---CCChheEEeeeecC
Confidence            467899999999999999999862   234789999998754332 22446778999998887   99999999988653


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                      .     ....++++|+++ ++|.+++..... .+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        79 ~-----~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~d  152 (284)
T cd05038          79 G-----GRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISD  152 (284)
T ss_pred             C-----CCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcc
Confidence            1     146799999998 599999977543 489999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         177 FGLAKTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       177 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ||.+........    .....++..|+|||.+.+..++.++|+||||+++++|++|..|+.........  +   .+...
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~---~~~~~  227 (284)
T cd05038         153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--M---IGIAQ  227 (284)
T ss_pred             cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc--c---ccccc
Confidence            999887653221    11233455699999998888999999999999999999999998654321100  0   00000


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .......   ....+.   ..........++.++.+++.+||+.+|.+|||+.++++
T Consensus       228 ~~~~~~~---~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         228 GQMIVTR---LLELLK---EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             ccccHHH---HHHHHH---cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000000   000000   00000011245688999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.8e-39  Score=268.09  Aligned_cols=239  Identities=19%  Similarity=0.313  Sum_probs=180.8

Q ss_pred             eeeecccceeEEEEEEec-----------CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          28 CQIGCGAYGTVFKARDLQ-----------NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~-----------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +.||+|++|.||+++...           .....+++|++....  ......+.+|+.+++.+.   ||||+++++++..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~---hp~iv~~~~~~~~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVS---HKHIVLLYGVCVR   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCC---CCCEeeEEEEEec
Confidence            368999999999997521           122357788765431  222335667788888887   9999999999876


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC----
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG----  171 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~----  171 (321)
                      .       ...++++|++++ +|..++.... ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.    
T Consensus        76 ~-------~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~  147 (262)
T cd05077          76 D-------VENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGEC  147 (262)
T ss_pred             C-------CCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCC
Confidence            6       567899999995 7877776533 34899999999999999999999999999999999999987664    


Q ss_pred             ---EEEeecCCcccccCCCccccccccccccchhhhh-cCCCCCcchHHHHHHHHHHHH-hcCCCCCCCChHHHHHHHHH
Q psy2676         172 ---LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL-NLGYGTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFR  246 (321)
Q Consensus       172 ---~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~~~~~~  246 (321)
                         ++++|||.+......   ....++..|+|||++. +..++.++||||||+++|+|+ .|..||......+... ...
T Consensus       148 ~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~  223 (262)
T cd05077         148 GPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYE  223 (262)
T ss_pred             CceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHh
Confidence               899999988654322   2345678899999886 456899999999999999998 5888886654333221 111


Q ss_pred             HhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         247 VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      .   ...                        .....+.++.+|+.+||+.||.+||++.+|+++
T Consensus       224 ~---~~~------------------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         224 G---QCM------------------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             c---Ccc------------------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            0   000                        001123678899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.8e-39  Score=267.78  Aligned_cols=245  Identities=20%  Similarity=0.293  Sum_probs=185.9

Q ss_pred             eeeecccceeEEEEEEecC--CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccce
Q psy2676          28 CQIGCGAYGTVFKARDLQN--KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYL  105 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~  105 (321)
                      +.||+|+||.||+|.+...  ....+++|.+.... .......+.+|+.+++.++   |||++++++++....      .
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~------~   70 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFS---HPNVLSLLGICLPSE------G   70 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCC---CCCcceEEEEeecCC------C
Confidence            4689999999999986422  34578999874321 1112235567888888877   999999999764321      3


Q ss_pred             EEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         106 TVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       106 ~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      ..++++|++. ++|.+++..... ..++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus        71 ~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          71 SPLVVLPYMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             CcEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCcccccccc
Confidence            4689999998 599999876433 36788889999999999999999999999999999999999999999999987553


Q ss_pred             CCC-----ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhc-CCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         185 YDM-----MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       185 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      ...     ......++..|+|||.+....++.++||||||+++|+|++| .+||...+..+....+.... .+..     
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----  223 (262)
T cd05058         150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RLLQ-----  223 (262)
T ss_pred             CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CCCC-----
Confidence            221     11233456789999999888899999999999999999995 66776655544433332211 1100     


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                          ...+++.+.+++.+||..+|++||++.++++
T Consensus       224 --------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         224 --------------------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             --------------------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                1134578999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-39  Score=271.06  Aligned_cols=238  Identities=20%  Similarity=0.269  Sum_probs=182.6

Q ss_pred             eeeecccceeEEEEEEecCCC-------cEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          28 CQIGCGAYGTVFKARDLQNKG-------NYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~-------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      +.||+|+||.||+|.+. ..+       ..+++|.+....  ......+.+|..+++.+.   |||++++++++...   
T Consensus         1 ~~lg~G~~~~Vy~~~~~-~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~---h~~iv~~~~~~~~~---   71 (258)
T cd05078           1 ESLGQGTFTKIFKGIRR-EVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLS---HKHLVLNYGVCVCG---   71 (258)
T ss_pred             CCCCcccchhheeeeec-ccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCC---CCChhheeeEEEeC---
Confidence            36899999999999873 332       347777764321  112335667888888887   99999999999776   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC--------
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG--------  171 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~--------  171 (321)
                          ...++||||+. |+|.+++..... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++.        
T Consensus        72 ----~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~  146 (258)
T cd05078          72 ----DESIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPF  146 (258)
T ss_pred             ----CCcEEEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCce
Confidence                56789999998 599999876543 4899999999999999999999999999999999999987765        


Q ss_pred             EEEeecCCcccccCCCccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhc-CCCCCCCChHHHHHHHHHHhC
Q psy2676         172 LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      ++++|||.+......   ....++..|+|||++.+. .++.++||||||+++|+|++| ..||...+..........   
T Consensus       147 ~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~---  220 (258)
T cd05078         147 IKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED---  220 (258)
T ss_pred             EEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc---
Confidence            699999988655422   234567889999999764 479999999999999999998 466655444333221111   


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ...   .                      ....+.++.+++.+||+.||++|||++++++.
T Consensus       221 ~~~---~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 RHQ---L----------------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ccc---C----------------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            000   0                      11223678999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.2e-38  Score=266.82  Aligned_cols=249  Identities=21%  Similarity=0.303  Sum_probs=186.8

Q ss_pred             eeeecccceeEEEEEEe-cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDL-QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||+|+||.||++... ..++..+++|.++..... .....+.+|+.++++++   |||++++++++.+.       ..
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~-------~~   69 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQ---HSNLLQCLGQCTEV-------TP   69 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCC---CCCEeeEEEEEcCC-------CC
Confidence            46899999999999763 234567888887654221 12235777999999988   99999999998766       56


Q ss_pred             EEEEeccCc-cCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         107 VYLIFEHVD-QDLGSYMEKCP---PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       107 ~~~v~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      .++||||++ |+|.+++....   ....++..+..++.|++.||.|||+.|++|+||||+||+++.+++++|+|||.+..
T Consensus        70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~  149 (269)
T cd05087          70 YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHN  149 (269)
T ss_pred             cEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCcccccc
Confidence            799999999 59999987532   22357778889999999999999999999999999999999999999999998865


Q ss_pred             ccCCC---ccccccccccccchhhhhcC-------CCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         183 FDYDM---MLTSVVVTLWYRAPEILLNL-------GYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       183 ~~~~~---~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      .....   ......++..|+|||++.+.       .++.++|+||+|+++|+|++ |..||......+............
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (269)
T cd05087         150 KYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLK  229 (269)
T ss_pred             ccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCC
Confidence            43221   11234457789999998643       35789999999999999996 999998766555433322211110


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ...                     .......++.+.++++.|+ .+|++|||+++|+.
T Consensus       230 ~~~---------------------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         230 LPK---------------------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCC---------------------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            000                     0111234577889999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.7e-39  Score=292.39  Aligned_cols=283  Identities=23%  Similarity=0.284  Sum_probs=181.7

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCC----CcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNK----GNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ....++|.+.+.||+|+||.||+|++ ..+    +..+|+|.+....         ..|..+..++....+.++..+...
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~-~~~~~~~~~~vAvK~~~~~~---------~~e~~~~e~l~~~~~~~~~~~~~~  197 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASL-VNKQSKKEGKYVLKKATEYG---------AVEIWMNERVRRACPNSCADFVYG  197 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEE-cCCccccCcEEEEEEecccc---------hhHHHHHHHHHhhchhhHHHHHHh
Confidence            34567999999999999999999998 466    7899999865321         122222222221113333333332


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPP------------------GLSASKVKELTRQMLKGVDFLHSHRI  154 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~------------------~~~~~~~~~i~~~l~~~l~~lh~~~~  154 (321)
                      +..... .......++|+||++ ++|.+++......                  ......+..++.||+.||.|||+.||
T Consensus       198 ~~~~~~-~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gI  276 (566)
T PLN03225        198 FLEPVS-SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI  276 (566)
T ss_pred             hhcccc-cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCE
Confidence            222211 123356899999999 4999988753211                  11234567899999999999999999


Q ss_pred             eeccCCCCcEEEee-CCCEEEeecCCcccccCC--CccccccccccccchhhhhcCC----------------------C
Q psy2676         155 IHRDLKPQNLLITR-AGGLKIADFGLAKTFDYD--MMLTSVVVTLWYRAPEILLNLG----------------------Y  209 (321)
Q Consensus       155 ~H~di~p~Nilv~~-~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~----------------------~  209 (321)
                      +||||||+||+++. ++.+||+|||++......  .......+++.|+|||.+....                      +
T Consensus       277 iHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~  356 (566)
T PLN03225        277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL  356 (566)
T ss_pred             EeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence            99999999999986 578999999999755322  2233456789999999764322                      2


Q ss_pred             CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHH
Q psy2676         210 GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSL  289 (321)
Q Consensus       210 ~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  289 (321)
                      +.++||||+||++|+|+++..++.  .............+.. ...|.....   ... ...................+|
T Consensus       357 ~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~-~~~~~~~~~---~~~-~~~~~~~~~~~d~~~~~~~dL  429 (566)
T PLN03225        357 PDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYD-LVAWRKLVE---PRA-SPDLRRGFEVLDLDGGAGWEL  429 (566)
T ss_pred             CCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCc-HHHHHHhhc---ccc-chhhhhhhhhccccchHHHHH
Confidence            335699999999999998766542  2233333332221111 000100000   000 000000011111223456799


Q ss_pred             HHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         290 LESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       290 i~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      |.+||+.||.+|||+.++|+||||++..+
T Consensus       430 i~~mL~~dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        430 LKSMMRFKGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             HHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence            99999999999999999999999998654

>KOG0695|consensus

Probab=100.00  E-value=1.3e-39  Score=261.67  Aligned_cols=268  Identities=26%  Similarity=0.366  Sum_probs=221.5

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC-CCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG-IPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ..+.+.-++|+++++||+|+|+.|.+++. +.+.+-||+|++++...+++ ...-.+.|..++.+..  +||.++-++.+
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~-~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as--n~pflvglhsc  319 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRL-KKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS--NNPFLVGLHSC  319 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheeh-cccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc--CCCeEEehhhh
Confidence            34556668999999999999999999999 68899999999998865544 3456678999999988  49999999999


Q ss_pred             eeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      |+.+       ..+++|.||++| +|--.+.+  ...++++.++.+...|+.||.+||++||++||||.+||+++..|++
T Consensus       320 fqte-------srlffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghi  390 (593)
T KOG0695|consen  320 FQTE-------SRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHI  390 (593)
T ss_pred             hccc-------ceEEEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCce
Confidence            9888       789999999995 77666666  3449999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccc-cCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCC-------CChHHHHHHH
Q psy2676         173 KIADFGLAKTF-DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCA-------STEVEQLKCI  244 (321)
Q Consensus       173 kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-------~~~~~~~~~~  244 (321)
                      ||+|+|++..- .+....+...||+.|.|||.+++..+..+.|-|+||+++++|+.|+.||.-       .+.++.+.++
T Consensus       391 kltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv  470 (593)
T KOG0695|consen  391 KLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV  470 (593)
T ss_pred             eecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH
Confidence            99999999754 334456678999999999999999999999999999999999999999953       1222222222


Q ss_pred             HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC------CHHHHhCCCCCCCCCC
Q psy2676         245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI------SAADALEHPYFKEKEN  318 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~~ll~h~~f~~~~~  318 (321)
                      +-..+.                          .+...++-.+..+++..|++||.+|.      ...++-.|+||+.++|
T Consensus       471 ilekqi--------------------------riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw  524 (593)
T KOG0695|consen  471 ILEKQI--------------------------RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW  524 (593)
T ss_pred             Hhhhcc--------------------------cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence            111100                          01123445667889999999999997      6889999999999998


Q ss_pred             CC
Q psy2676         319 EP  320 (321)
Q Consensus       319 ~~  320 (321)
                      +-
T Consensus       525 d~  526 (593)
T KOG0695|consen  525 DL  526 (593)
T ss_pred             HH
Confidence            74

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.6e-38  Score=266.17  Aligned_cols=249  Identities=21%  Similarity=0.321  Sum_probs=186.4

Q ss_pred             eeeecccceeEEEEEEec-CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||+|+||.||++.... .....+++|.+..... ......+.+|+..++.++   ||||+++++.+...       ..
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~---h~nii~~~~~~~~~-------~~   69 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT-PDEQLLFLQEVQPYRELN---HPNVLQCLGQCIES-------IP   69 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC-hHHHHHHHHHHHHHHhCC---CCCcceEEEEECCC-------Cc
Confidence            368999999999997522 2445678887653321 112235667888888887   99999999998766       66


Q ss_pred             EEEEeccCc-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         107 VYLIFEHVD-QDLGSYMEKCPP---PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       107 ~~~v~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      .++|||++. |+|.+++.....   ...++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+..
T Consensus        70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  149 (269)
T cd05042          70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALE  149 (269)
T ss_pred             eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccc
Confidence            899999998 599999976432   2246788899999999999999999999999999999999999999999998865


Q ss_pred             ccCCC---ccccccccccccchhhhhc-------CCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         183 FDYDM---MLTSVVVTLWYRAPEILLN-------LGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       183 ~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      .....   ......++..|+|||++..       ..++.++||||+|+++|+|++ |..||......+............
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~  229 (269)
T cd05042         150 QYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK  229 (269)
T ss_pred             cccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc
Confidence            32221   1123345677999999753       346789999999999999999 788998776655544443322111


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ...                     ......+++.+.+++..|+ .||++|||+++|++
T Consensus       230 ~~~---------------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         230 LPK---------------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             CCC---------------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            110                     0112245578888999998 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.3e-39  Score=268.34  Aligned_cols=238  Identities=19%  Similarity=0.278  Sum_probs=179.8

Q ss_pred             eeecccceeEEEEEEec-----------------------CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCC
Q psy2676          29 QIGCGAYGTVFKARDLQ-----------------------NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP   85 (321)
Q Consensus        29 ~lg~g~~g~v~~~~~~~-----------------------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   85 (321)
                      +||+|+||.||++....                       .....+++|++.....  .....+.+|+.+++++.   ||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~---h~   76 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVS---HI   76 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCC---CC
Confidence            68999999999987421                       1123577887754321  12235566777777777   99


Q ss_pred             ceeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q psy2676          86 NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNL  164 (321)
Q Consensus        86 ~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Ni  164 (321)
                      ||+++++++...       ...++||||+++ +|..++.... +.+++..+..++.||+.||.|||++|++|+||||+||
T Consensus        77 niv~~~~~~~~~-------~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Ni  148 (274)
T cd05076          77 HLAFVHGVCVRG-------SENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNI  148 (274)
T ss_pred             CeeeEEEEEEeC-------CceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccE
Confidence            999999998776       577999999995 8888876532 3489999999999999999999999999999999999


Q ss_pred             EEeeCC-------CEEEeecCCcccccCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHH-hcCCCCCCC
Q psy2676         165 LITRAG-------GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMW-RLVPLFCAS  235 (321)
Q Consensus       165 lv~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~-~g~~pf~~~  235 (321)
                      +++..+       .++++|||.+......   ....++..|+|||.+.+ ..++.++||||||+++|+++ +|..||...
T Consensus       149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  225 (274)
T cd05076         149 LLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER  225 (274)
T ss_pred             EEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            998654       3899999987543221   22356778999998865 45799999999999999985 689999776


Q ss_pred             ChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         236 TEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ...+......... ..+                           ...++.+.++|.+||+.+|.+|||+.+++++
T Consensus       226 ~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         226 TPSEKERFYEKKH-RLP---------------------------EPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             ChHHHHHHHHhcc-CCC---------------------------CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            5444322211100 000                           1123678899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-38  Score=265.53  Aligned_cols=235  Identities=20%  Similarity=0.325  Sum_probs=182.9

Q ss_pred             eeeecccceeEEEEEEecCCC----------cEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          28 CQIGCGAYGTVFKARDLQNKG----------NYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~----------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      +.||+|+||.||++.+. ..+          ..+++|.+.....   ....+.+|+.+++++.   |||++++++++...
T Consensus         1 ~~lg~G~~~~v~~~~~~-~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLR-VQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLS---HKHLVKLYGVCVRD   73 (259)
T ss_pred             CcccccccceEEEEEEe-ccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCC---CcchhheeeEEecC
Confidence            46899999999999984 333          3467776654321   1457778888888887   99999999987542


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC------
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG------  170 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~------  170 (321)
                              ..++|+|++. ++|.+++..... .+++..+..++.||+.||.|||++|++|+||||+||+++.++      
T Consensus        74 --------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~  144 (259)
T cd05037          74 --------ENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYV  144 (259)
T ss_pred             --------CcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCc
Confidence                    3489999999 599999887543 489999999999999999999999999999999999999887      


Q ss_pred             -CEEEeecCCcccccCCCccccccccccccchhhhhcC--CCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHH
Q psy2676         171 -GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL--GYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFR  246 (321)
Q Consensus       171 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~  246 (321)
                       .++|+|||++.....   .....++..|+|||++...  .++.++|+||||++++++++ |..||...+..+.......
T Consensus       145 ~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~  221 (259)
T cd05037         145 PFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD  221 (259)
T ss_pred             eeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc
Confidence             799999999876543   2234456779999999876  68999999999999999999 5788866543322222110


Q ss_pred             HhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         247 VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                       ...     .+                      ......+.+++.+||..+|.+|||+.++++
T Consensus       222 -~~~-----~~----------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         222 -QHR-----LP----------------------MPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             -CCC-----CC----------------------CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence             000     00                      001168889999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0587|consensus

Probab=100.00  E-value=6.5e-39  Score=285.23  Aligned_cols=275  Identities=25%  Similarity=0.432  Sum_probs=229.6

Q ss_pred             ccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeE
Q psy2676          10 QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR   89 (321)
Q Consensus        10 ~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~   89 (321)
                      ..+.++.+......|+++..+|.|.+|.||+++. ..+++..|+|+....   .+...++..|.++++....  |||++.
T Consensus         7 ~~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~-~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~--hpnv~~   80 (953)
T KOG0587|consen    7 MDIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRH-VKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSH--HPNVAT   80 (953)
T ss_pred             cccchhhCCCCCCccEEEEEEeeccceeEEEEee-eecCceeeeEeecCC---ccccHHHHHHHHHHHhccC--CCCcce
Confidence            3456778888889999999999999999999999 588999999987643   3334578889999999885  999999


Q ss_pred             EEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR  168 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~  168 (321)
                      ++++|...  .......+++|||+|. |+..++++...+..+.|+.++.|++.++.||.+||...++|||||-.||+++.
T Consensus        81 fyg~~~k~--~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~  158 (953)
T KOG0587|consen   81 FYGAFIKK--DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTE  158 (953)
T ss_pred             EEEEEEEe--cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEec
Confidence            99998765  2344578999999999 59999999888888999999999999999999999999999999999999999


Q ss_pred             CCCEEEeecCCcccccCC-CccccccccccccchhhhhcCC-----CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHH
Q psy2676         169 AGGLKIADFGLAKTFDYD-MMLTSVVVTLWYRAPEILLNLG-----YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLK  242 (321)
Q Consensus       169 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  242 (321)
                      ++.+||+|||.+...... .......||+.|+|||++.+.+     ++..+|+||||++..||.-|.+|+....+...+ 
T Consensus       159 e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-  237 (953)
T KOG0587|consen  159 NAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-  237 (953)
T ss_pred             cCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-
Confidence            999999999998776533 3455689999999999986543     677899999999999999999999876654433 


Q ss_pred             HHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                        +.....|++..-                     -...++.++.+||..||.+|..+||+..++|+|||+++-
T Consensus       238 --F~IpRNPPPkLk---------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  238 --FLIPRNPPPKLK---------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             --ccCCCCCCcccc---------------------chhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence              222222222211                     122456899999999999999999999999999999843

>KOG0608|consensus

Probab=100.00  E-value=1.2e-39  Score=280.86  Aligned_cols=271  Identities=26%  Similarity=0.412  Sum_probs=218.1

Q ss_pred             ccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEE
Q psy2676          12 LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRF   90 (321)
Q Consensus        12 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~   90 (321)
                      +.+..--+...-|..++.||-|+||.|.+++. -.+...||.|.+++...-. +.......|..+|....   .+-||++
T Consensus       619 iRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~K-vDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD---n~WVVrL  694 (1034)
T KOG0608|consen  619 IRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRK-VDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD---NEWVVRL  694 (1034)
T ss_pred             HHHHHhhccccceEEEeeecccccceeEEEee-cchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC---CcceEEE
Confidence            34555566777899999999999999999998 4678899999987753322 23445567888888888   8999999


Q ss_pred             EeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA  169 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~  169 (321)
                      |-.|++.       ..+|+||+|++| ++-.++.+  .+-+.|..++.++..+..|+++.|..|++||||||+|||||.+
T Consensus       695 yySFQDk-------dnLYFVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd  765 (1034)
T KOG0608|consen  695 YYSFQDK-------DNLYFVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD  765 (1034)
T ss_pred             EEEeccC-------CceEEEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC
Confidence            9999998       789999999995 99888888  3458999999999999999999999999999999999999999


Q ss_pred             CCEEEeecCCcccccCCC-------------------------------------------ccccccccccccchhhhhc
Q psy2676         170 GGLKIADFGLAKTFDYDM-------------------------------------------MLTSVVVTLWYRAPEILLN  206 (321)
Q Consensus       170 ~~~kl~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~~y~aPE~~~~  206 (321)
                      |++||+|||+|+-+.+..                                           ..-+..||+.|+|||++..
T Consensus       766 GHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r  845 (1034)
T KOG0608|consen  766 GHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR  845 (1034)
T ss_pred             CceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc
Confidence            999999999997652110                                           0113468999999999999


Q ss_pred             CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhH
Q psy2676         207 LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKA  286 (321)
Q Consensus       207 ~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (321)
                      ..++..+|-||.|++||+|+.|++||-..+..+.-.++.+         |...+              .-....+++.++
T Consensus       846 ~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n---------w~~~l--------------~~~~~~~ls~e~  902 (1034)
T KOG0608|consen  846 TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN---------WRNFL--------------HIPYQGNLSKEA  902 (1034)
T ss_pred             cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee---------hhhcc--------------ccccccccCHHH
Confidence            9999999999999999999999999987766554333221         21111              111123566889


Q ss_pred             HHHHHHhcccCCCCCC---CHHHHhCCCCCCCCCCC
Q psy2676         287 NSLLESMLTFNPADRI---SAADALEHPYFKEKENE  319 (321)
Q Consensus       287 ~~li~~~l~~dp~~Rp---s~~~ll~h~~f~~~~~~  319 (321)
                      .++|.+++. +++.|.   .+++|-.||||+.+++-
T Consensus       903 ~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfs  937 (1034)
T KOG0608|consen  903 LDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFS  937 (1034)
T ss_pred             HHHHHHHhc-ChhhhhcccchhhhhcCccccccchH
Confidence            999998765 788887   67889999999999764

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.1e-37  Score=260.95  Aligned_cols=248  Identities=19%  Similarity=0.333  Sum_probs=184.6

Q ss_pred             eeeecccceeEEEEEEecC-CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          28 CQIGCGAYGTVFKARDLQN-KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      +.||+|+||.||++..... ....+++|.++.... ......+.+|+..++.++   |||++++++.+.+.       ..
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~---h~~iv~~~~~~~~~-------~~   69 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQ---HPNILQCLGQCVEA-------IP   69 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccC---CcchhheEEEecCC-------Cc
Confidence            3689999999999976322 234556666554322 122346778888888887   99999999998766       56


Q ss_pred             EEEEeccCc-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccc
Q psy2676         107 VYLIFEHVD-QDLGSYMEKCP--PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF  183 (321)
Q Consensus       107 ~~~v~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~  183 (321)
                      .++||||+. |+|.+++....  ....++..++.++.||+.||.|||+.+++|+||||+||+++.++.++|+|||.+...
T Consensus        70 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~  149 (268)
T cd05086          70 YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSR  149 (268)
T ss_pred             cEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEeccccccccc
Confidence            899999999 59999987642  233677788999999999999999999999999999999999999999999987543


Q ss_pred             cCC---Cccccccccccccchhhhhc-------CCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCC-
Q psy2676         184 DYD---MMLTSVVVTLWYRAPEILLN-------LGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTP-  251 (321)
Q Consensus       184 ~~~---~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~-  251 (321)
                      ...   .......++..|+|||++..       ...+.++||||||+++|+|++ |..||...+..+....+....... 
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~  229 (268)
T cd05086         150 YKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL  229 (268)
T ss_pred             CcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccccc
Confidence            211   11223456788999998753       235789999999999999997 577887766655555543321111 


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ..+.                      .....++.+.+++..|| .+|.+||++.++++
T Consensus       230 ~~~~----------------------~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         230 FKPQ----------------------LELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCCc----------------------cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            1111                      11134578889999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG4278|consensus

Probab=100.00  E-value=4.2e-39  Score=277.14  Aligned_cols=256  Identities=23%  Similarity=0.371  Sum_probs=219.8

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +.+.|++...+..+.++||.|.||.||.+.+ +.-.-.||||.++....   ....++.|+.+++.+.   |||++++++
T Consensus       258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvW-KkyslTvAVKtLKEDtM---eveEFLkEAAvMKeik---HpNLVqLLG  330 (1157)
T KOG4278|consen  258 NADKWEMERTDITMKHKLGGGQYGEVYEGVW-KKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIK---HPNLVQLLG  330 (1157)
T ss_pred             CcchhhccchheeeeeccCCCcccceeeeee-eccceeeehhhhhhcch---hHHHHHHHHHHHHhhc---CccHHHHhh
Confidence            3478899999999999999999999999999 56777899999875432   3558899999999999   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      ++..+       .-+|||+|||. |+|.+|++.++...++.-.+..++.||..|++||..++++||||-..|++|.++..
T Consensus       331 VCT~E-------pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi  403 (1157)
T KOG4278|consen  331 VCTHE-------PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI  403 (1157)
T ss_pred             hhccC-------CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce
Confidence            99766       66899999998 89999999999888999999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHh
Q psy2676         172 LKIADFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      +|+.|||+++.+..+..  .....-+..|.|||-+-...++.++|||+||++||++.| |..||.+-+--+....+.+..
T Consensus       404 VKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy  483 (1157)
T KOG4278|consen  404 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY  483 (1157)
T ss_pred             EEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc
Confidence            99999999998865442  222334677999999999999999999999999999986 789998877666555544432


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHh
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL  308 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  308 (321)
                      ....                          ..+||+.+.+|++.||+++|.+||+++|+-
T Consensus       484 RM~~--------------------------PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  484 RMDG--------------------------PEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             cccC--------------------------CCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence            2211                          237889999999999999999999999874

>KOG1094|consensus

Probab=100.00  E-value=1.5e-38  Score=271.58  Aligned_cols=262  Identities=22%  Similarity=0.288  Sum_probs=218.7

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      -.++...+..++++||+|-||.|.+++.  ..+..||+|.++.... ...+.++.+|+++|.+++   ||||+.+++++.
T Consensus       532 l~EfPRs~L~~~ekiGeGqFGEVhLCev--eg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLk---hPNIveLvGVC~  605 (807)
T KOG1094|consen  532 LVEFPRSRLRFKEKIGEGQFGEVHLCEV--EGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLK---HPNIVELLGVCV  605 (807)
T ss_pred             hhhcchhheehhhhhcCcccceeEEEEe--cCceEEEEeecCcccc-hhHHHHHHHHHHHHhccC---CCCeeEEEeeee
Confidence            4567778899999999999999999986  4579999999976533 334678999999999997   999999999987


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      .+       ..+++++||++ |+|..++....-+........+|+.||+.|++||.+.++|||||.+.|+++++++++|+
T Consensus       606 ~D-------ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKi  678 (807)
T KOG1094|consen  606 QD-------DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKI  678 (807)
T ss_pred             cC-------CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEe
Confidence            66       67899999999 89999999975555667777889999999999999999999999999999999999999


Q ss_pred             eecCCcccccCC---CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh--cCCCCCCCChHHHHHHHHHHhC
Q psy2676         175 ADFGLAKTFDYD---MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR--LVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       175 ~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      +|||+++..-..   .......-+.+|+|||.+..+.++.+||+|++|+++||+++  ...||+..++++..........
T Consensus       679 adfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~  758 (807)
T KOG1094|consen  679 ADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFR  758 (807)
T ss_pred             cCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcC
Confidence            999999854222   12223455788999999999999999999999999999875  6899999888888777666554


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .+...-...                   ...-|+..+.+++.+||+.|-.+||+++++-.
T Consensus       759 ~~~~~~~l~-------------------~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  759 DQGRQVVLS-------------------RPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             CCCcceecc-------------------CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            444332221                   12367889999999999999999999999853

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.8e-37  Score=255.49  Aligned_cols=243  Identities=39%  Similarity=0.642  Sum_probs=198.7

Q ss_pred             cceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEEEEecc
Q psy2676          34 AYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEH  113 (321)
Q Consensus        34 ~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~  113 (321)
                      ++|.||++.+ ..+++.+++|++........ ...+.+|++.+++++   |+|++++++++...       ...++++|+
T Consensus         1 ~~g~v~~~~~-~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~---~~~i~~~~~~~~~~-------~~~~l~~e~   68 (244)
T smart00220        1 SFGKVYLARD-KKTGKLVAIKVIKKEKIKKK-RERILREISILKKLK---HPNIVRLYDVFEDE-------DKLYLVMEY   68 (244)
T ss_pred             CceEEEEEEE-CCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCC---CCcHHHHHhheeeC-------CEEEEEEeC
Confidence            5799999998 56789999999875433221 457778999998886   99999999998766       678999999


Q ss_pred             Ccc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCCccccc
Q psy2676         114 VDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV  192 (321)
Q Consensus       114 ~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~  192 (321)
                      +++ +|.+++.....  ++...++.++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+............
T Consensus        69 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~  146 (244)
T smart00220       69 CDGGDLFDLLKKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTF  146 (244)
T ss_pred             CCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccc
Confidence            997 99999987433  899999999999999999999999999999999999999999999999999887655445566


Q ss_pred             cccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhh
Q psy2676         193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSK  272 (321)
Q Consensus       193 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (321)
                      .++..|+|||.+.+...+.++|+||+|++++++++|..||.......................                 
T Consensus       147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------  209 (244)
T smart00220      147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP-----------------  209 (244)
T ss_pred             cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccc-----------------
Confidence            778899999999988889999999999999999999999977333333222222111111000                 


Q ss_pred             hhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         273 VAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       273 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                            ...++.++.+++.+||..+|++||++.++++||||
T Consensus       210 ------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      210 ------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ------cccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence                  00155789999999999999999999999999998

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4257|consensus

Probab=100.00  E-value=8.2e-39  Score=275.16  Aligned_cols=253  Identities=23%  Similarity=0.386  Sum_probs=208.9

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecC---CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQN---KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ++..+.....++||.|-||.||++.-...   ..-.||||+-+.....+ ....+..|..+++.++   ||||++++|++
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-~tekflqEa~iMrnfd---HphIikLIGv~  460 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-DTEKFLQEASIMRNFD---HPHIIKLIGVC  460 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh-hHHHHHHHHHHHHhCC---Ccchhheeeee
Confidence            34445556778999999999999986322   23457788776544333 3668899999999999   99999999999


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      .+.        -.++|||.++ |.|++++....+ .++......++.||+.||.|||+.++|||||-.+||+|....-+|
T Consensus       461 ~e~--------P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVK  531 (974)
T KOG4257|consen  461 VEQ--------PMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVK  531 (974)
T ss_pred             ecc--------ceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceee
Confidence            765        5799999999 899999988654 499999999999999999999999999999999999999998999


Q ss_pred             EeecCCcccccCCCcccc--ccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCC
Q psy2676         174 IADFGLAKTFDYDMMLTS--VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       174 l~dfg~~~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      |+|||+++.+........  ..-+..|+|||.+....++.+||||.||+++||++. |..||.+..+.+.+..+.++-..
T Consensus       532 LaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl  611 (974)
T KOG4257|consen  532 LADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL  611 (974)
T ss_pred             ecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC
Confidence            999999998875543222  233567999999999999999999999999999875 89999988777776666554333


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      |-++                          +||+.+..|+.+||.++|.+||++.++..
T Consensus       612 P~P~--------------------------nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  612 PCPP--------------------------NCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             CCCC--------------------------CCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence            3222                          67799999999999999999999888753

>KOG0196|consensus

Probab=100.00  E-value=3.5e-39  Score=283.56  Aligned_cols=255  Identities=24%  Similarity=0.350  Sum_probs=222.5

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCC---CcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNK---GNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +.++..+.-.|.++||.|.||.|++++.+ ..   ...||||.++.-..+ .....|+.|+.++-++.   ||||+++-+
T Consensus       623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk-~pgkre~~VAIKTLK~Gyte-kqrrdFL~EAsIMGQFd---HPNIIrLEG  697 (996)
T KOG0196|consen  623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLK-LPGKREITVAIKTLKAGYTE-KQRRDFLSEASIMGQFD---HPNIIRLEG  697 (996)
T ss_pred             hhhcChhheEEEEEEecccccceeccccc-CCCCcceeEEEeeeccCccH-HHHhhhhhhhhhcccCC---CCcEEEEEE
Confidence            34566677899999999999999999984 43   468899999765433 35668999999999998   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      .....       .-+.||+|||+ |+|..+++.+.++ +...++..+++.|+.|++||-++++|||||-.+||||+.+-.
T Consensus       698 VVTks-------~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv  769 (996)
T KOG0196|consen  698 VVTKS-------KPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV  769 (996)
T ss_pred             EEecC-------ceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE
Confidence            99777       78999999999 8999999998755 999999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCCc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHH-hcCCCCCCCChHHHHHHHHH
Q psy2676         172 LKIADFGLAKTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFR  246 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~~~~~~  246 (321)
                      +|++|||+++....+..    ......+.+|.|||.+..+.++.+|||||+|+++||.+ .|..||....+-+.++.+..
T Consensus       770 CKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~  849 (996)
T KOG0196|consen  770 CKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ  849 (996)
T ss_pred             EEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh
Confidence            99999999987744331    22233468899999999999999999999999999977 59999999999999999998


Q ss_pred             HhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         247 VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ...-|++-                          +||..+.+|+..||++|-.+||.+.+|+.
T Consensus       850 gyRLPpPm--------------------------DCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  850 GYRLPPPM--------------------------DCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             ccCCCCCC--------------------------CCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            87766654                          56689999999999999999999999986

>KOG4250|consensus

Probab=100.00  E-value=1e-38  Score=278.70  Aligned_cols=211  Identities=30%  Similarity=0.456  Sum_probs=181.8

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ..+.-+...+.||+|+||.||++++ +.+|+.+|+|.+.... .........+|++++++++   |||||+.+++-....
T Consensus        10 ~~~y~W~~~e~LG~Ga~g~V~rgrn-ketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLn---h~NIVk~f~iee~~~   84 (732)
T KOG4250|consen   10 GENYLWEMDERLGKGAFGNVYRGRN-KETGRLVAVKTFNKES-SLRPRERWCREIEILKKLN---HPNIVKLFDIEETKF   84 (732)
T ss_pred             CCCcceeehhhhcCCccceeeeecc-cccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcC---chhhhhhcccCCccc
Confidence            3446788889999999999999999 6999999999997654 3344557778999999999   999999999865543


Q ss_pred             cccccceEEEEEeccCc-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe--eCCC--E
Q psy2676          99 LSDERYLTVYLIFEHVD-QDLGSYMEKCPP-PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT--RAGG--L  172 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~--~~~~--~  172 (321)
                      . ..-.....++||||. |+|+..++.-.+ ..+++.+++.++.++..||.|||++||+||||||.||++-  ++|+  .
T Consensus        85 ~-~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~Iy  163 (732)
T KOG4250|consen   85 L-GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIY  163 (732)
T ss_pred             c-CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEE
Confidence            2 222356789999999 599999987443 3399999999999999999999999999999999999884  3344  7


Q ss_pred             EEeecCCcccccCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCC
Q psy2676         173 KIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCAS  235 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~  235 (321)
                      ||+|||.++..+.+....+..||..|++||++.. +.++...|.||+|+++|+++||..||...
T Consensus       164 KLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  164 KLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             eeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            9999999999999999999999999999999984 77899999999999999999999999653

>KOG1006|consensus

Probab=100.00  E-value=2.6e-40  Score=257.34  Aligned_cols=269  Identities=23%  Similarity=0.383  Sum_probs=209.9

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ..++.....+-+..||.|+||+|++..+ +..++..|||.++..... .....+..|.....+-.  ++|||+++|++..
T Consensus        58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~h-k~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~--~cp~IVkfyGa~F  133 (361)
T KOG1006|consen   58 LHTFTSDNLQDLGEIGNGAFGTVNKMLH-KPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSS--NCPNIVKFYGALF  133 (361)
T ss_pred             ccccccchHHHHHHhcCCcchhhhhhhc-CccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhc--CCcHHHHHhhhhh
Confidence            3455556667778999999999999999 689999999999865432 22335556666655544  5999999999987


Q ss_pred             ccccccccceEEEEEeccCccCHHHH---HhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeeCCC
Q psy2676          96 QNILSDERYLTVYLIFEHVDQDLGSY---MEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~~L~~~---~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~~  171 (321)
                      .+       ...++.||.++-+|..+   .....+..++|+.+..|......||.||.. .+++|||+||+||+++..|.
T Consensus       134 ~E-------GdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~  206 (361)
T KOG1006|consen  134 SE-------GDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD  206 (361)
T ss_pred             cC-------CceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC
Confidence            77       67899999999766544   333445569999999999999999999984 58999999999999999999


Q ss_pred             EEEeecCCcccccCCCccccccccccccchhhhhc--CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH-h
Q psy2676         172 LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN--LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV-I  248 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~  248 (321)
                      +||||||.+.....+-..+.-.|-..|+|||-+..  ..++.+||+||||++|||+.||..|+..-+.  ...++... .
T Consensus       207 vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~  284 (361)
T KOG1006|consen  207 VKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVI  284 (361)
T ss_pred             EeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHc
Confidence            99999999987765655566677788999999854  3488999999999999999999999976433  33333222 2


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      +.|+.-..+..                   ....+..+..+|..||.+|-+.||...+++++||++.-
T Consensus       285 gdpp~l~~~~~-------------------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  285 GDPPILLFDKE-------------------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             CCCCeecCccc-------------------ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence            22332222111                   12466889999999999999999999999999999854

>KOG0199|consensus

Probab=100.00  E-value=4.1e-38  Score=273.90  Aligned_cols=257  Identities=25%  Similarity=0.373  Sum_probs=216.9

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCc--EEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ..++..+.++||+|+||.|+++.++..+|+  .||||+++..... ....++.+|+.++.++.   |+|++++|++..+.
T Consensus       108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-~~mddflrEas~M~~L~---H~hliRLyGvVl~q  183 (1039)
T KOG0199|consen  108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-AIMDDFLREASHMLKLQ---HPHLIRLYGVVLDQ  183 (1039)
T ss_pred             cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-hhHHHHHHHHHHHHhcc---CcceeEEeeeeccc
Confidence            346778889999999999999998655554  6789998754322 25668999999999999   99999999998664


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                              -..+|+|.+. |+|.+.++......+-...+..++.||+.|+.||.++++|||||-..|+++.....+|++|
T Consensus       184 --------p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~D  255 (1039)
T KOG0199|consen  184 --------PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICD  255 (1039)
T ss_pred             --------hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeec
Confidence                    4689999999 7999999987777799999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCccc----cccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         177 FGLAKTFDYDMMLT----SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       177 fg~~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      ||+....+......    .......|+|||.+....++.++|||++|+++|||++ |..||.+....++++.+.+.-. .
T Consensus       256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er-L  334 (1039)
T KOG0199|consen  256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER-L  334 (1039)
T ss_pred             ccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-C
Confidence            99998887655322    2334567999999999999999999999999999997 6899999999998888774322 2


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK  314 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~  314 (321)
                      +.+                         +.|++++.+++..||..+|.+|||+.+|.+.-+.+
T Consensus       335 pRP-------------------------k~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  335 PRP-------------------------KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             CCC-------------------------CCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence            222                         25779999999999999999999999987544443

>KOG1027|consensus

Probab=100.00  E-value=1.5e-38  Score=281.62  Aligned_cols=249  Identities=33%  Similarity=0.454  Sum_probs=194.0

Q ss_pred             eeeeeeeeccccee-EEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          24 YDELCQIGCGAYGT-VFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        24 y~~~~~lg~g~~g~-v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      |.-.+.+|.|+.|+ ||++.   ..++.||||.+-..     ......+|+..++.-+.  ||||++.+..-.+.     
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~---ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~--H~NviRyyc~E~d~-----  575 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGV---YEGREVAVKRLLEE-----FFDFAQREIQLLQESDE--HPNVIRYYCSEQDR-----  575 (903)
T ss_pred             eccHHHcccCCCCcEEEEEe---eCCceehHHHHhhH-----hHHHHHHHHHHHHhccC--CCceEEEEeeccCC-----
Confidence            44456788998875 78884   58899999987543     23367799999998885  99999999998777     


Q ss_pred             cceEEEEEeccCccCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee---CC--CEEEe
Q psy2676         103 RYLTVYLIFEHVDQDLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR---AG--GLKIA  175 (321)
Q Consensus       103 ~~~~~~~v~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~---~~--~~kl~  175 (321)
                        .+.||..|.|..+|.+++...  ..........+.++.|++.||++||+.+|+||||||.||+|+.   ++  .++|+
T Consensus       576 --qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iS  653 (903)
T KOG1027|consen  576 --QFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKIS  653 (903)
T ss_pred             --ceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEec
Confidence              889999999999999999883  1111222556888999999999999999999999999999976   34  48999


Q ss_pred             ecCCcccccCCC----ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhc-CCCCCCCChHHHHHHHHHHhCC
Q psy2676         176 DFGLAKTFDYDM----MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       176 dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      |||+|.+.....    ......||.+|+|||++.....+.++|||||||++|+.++| ..||...-..+.  .|....  
T Consensus       654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~--  729 (903)
T KOG1027|consen  654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGN--  729 (903)
T ss_pred             ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCc--
Confidence            999999886443    24457899999999999999989999999999999999987 999965433221  111100  


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      ......                   . ...++  ++.+||.+|++++|..||+|.++|.||||=.
T Consensus       730 ~~L~~L-------------------~-~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  730 YTLVHL-------------------E-PLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             cceeee-------------------c-cCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence            000000                   0 00111  8899999999999999999999999999943

>KOG1151|consensus

Probab=100.00  E-value=1.5e-38  Score=264.06  Aligned_cols=269  Identities=26%  Similarity=0.438  Sum_probs=209.7

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCC-----chhHHHHHHHHhcccCCCCcee
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP-----MSTLREISILKQLDTFEHPNIV   88 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~i~   88 (321)
                      .......++||-+++.||+|+|+.||+|-|. ...++||+|+-.....+.+..     ....+|..+.+.|.   ||.||
T Consensus       455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl-~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD---HpRIV  530 (775)
T KOG1151|consen  455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDL-TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD---HPRIV  530 (775)
T ss_pred             hccCcchHHHHHHHHHhccccHHHHHHhccc-chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC---cceee
Confidence            3445667789999999999999999999994 788899999876544443222     23457899999998   99999


Q ss_pred             EEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCcEE
Q psy2676          89 RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH--RIIHRDLKPQNLL  165 (321)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~--~~~H~di~p~Nil  165 (321)
                      ++|++|.-+.      ..+|.|+|||+| +|.-|+..  +..+++.+++.|+.||..||.||...  .|+|-||||.||+
T Consensus       531 KlYDyfslDt------dsFCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNIL  602 (775)
T KOG1151|consen  531 KLYDYFSLDT------DSFCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNIL  602 (775)
T ss_pred             eeeeeeeecc------ccceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEE
Confidence            9999996431      567999999998 89889988  55699999999999999999999977  5999999999999


Q ss_pred             Eee---CCCEEEeecCCcccccCCCc--------cccccccccccchhhhhcC----CCCCcchHHHHHHHHHHHHhcCC
Q psy2676         166 ITR---AGGLKIADFGLAKTFDYDMM--------LTSVVVTLWYRAPEILLNL----GYGTPVDIWSIGCVMAEMWRLVP  230 (321)
Q Consensus       166 v~~---~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~~g~~  230 (321)
                      +-.   -|.+|++|||++..+.....        .+...||.+|++||++.-.    .++.+.||||+|+++|.++.|+.
T Consensus       603 Lv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrK  682 (775)
T KOG1151|consen  603 LVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRK  682 (775)
T ss_pred             EecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCC
Confidence            943   46699999999988864432        3346789999999998644    26889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         231 LFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ||.....-..+-..-..+ .-....+|.                    ..-++.++++||++||++.-++|....++..|
T Consensus       683 PFGhnqsQQdILqeNTIl-kAtEVqFP~--------------------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  683 PFGHNQSQQDILQENTIL-KATEVQFPP--------------------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             CCCCchhHHHHHhhhchh-cceeccCCC--------------------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            997643322211110000 000000110                    12455899999999999999999999999999


Q ss_pred             CCCCC
Q psy2676         311 PYFKE  315 (321)
Q Consensus       311 ~~f~~  315 (321)
                      |+|..
T Consensus       742 pyllP  746 (775)
T KOG1151|consen  742 PYLLP  746 (775)
T ss_pred             ccccc
Confidence            99963

>KOG0664|consensus

Probab=100.00  E-value=2.5e-39  Score=253.17  Aligned_cols=285  Identities=34%  Similarity=0.573  Sum_probs=225.2

Q ss_pred             eeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccc
Q psy2676          25 DELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERY  104 (321)
Q Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~  104 (321)
                      +-.+.||.|+||.||.++| ..+++.|++|.+.---..-...+.+.+|+.++.-++   |.|++..+++.+-+  .-..+
T Consensus        56 ~PDRPIGYGAFGVVWsVTD-PRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk---HdNVLSaLDILQPp--h~dfF  129 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTD-PRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR---HDNVLSLLDILQPA--NPSFF  129 (449)
T ss_pred             CCCCcccccceeEEEeccC-CCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc---cccHHHHHHhcCCC--CchHH
Confidence            3458899999999999999 689999999987533233334557788999998888   99999999887655  22333


Q ss_pred             eEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         105 LTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       105 ~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      ..+|+++|.+..+|...+-.  ...++...+.-++.||+.||+|||+.||.||||||-|.+++.|-.+|+||||+++...
T Consensus       130 qEiYV~TELmQSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  130 QELYVLTELMQSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHHHHHhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc
Confidence            56789999999999998877  5569999999999999999999999999999999999999999999999999998765


Q ss_pred             CCC--ccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhh
Q psy2676         185 YDM--MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS  261 (321)
Q Consensus       185 ~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (321)
                      ...  ..+....|..|.|||.+++.. ++.+.||||+||++.|++..+..|...++.+.+..+.+.+|+|..+.....-+
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            433  233455688899999999876 89999999999999999999999999999999999999999987764322111


Q ss_pred             hhhhhh-hh-hhhhhhhhh---hh--hcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         262 LMWSSF-EQ-YSKVAFSAI---FM--DCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       262 ~~~~~~-~~-~~~~~~~~~---~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      .....+ +. .+....+.+   .+  +--.+...++.++|.+||++|.+.++.+.|++..+.+
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence            111111 00 011111111   11  2224678899999999999999999999999987653

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.1e-36  Score=264.05  Aligned_cols=284  Identities=20%  Similarity=0.310  Sum_probs=187.5

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEe---------------cCCCcEEEEEEeecccCC------------CCCCchhH
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDL---------------QNKGNYVAMKKLRVKLNE------------DGIPMSTL   70 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~---------------~~~~~~~~iK~~~~~~~~------------~~~~~~~~   70 (321)
                      ....++|++.++||+|+||+||++.+.               ...++.|++|.+......            ........
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            345789999999999999999999642               134567999998643211            01122233


Q ss_pred             HHHHHHHhcccC--CCCceeEEEeeeeccccc-cccceEEEEEeccCc-cCHHHHHhhCCC-------------------
Q psy2676          71 REISILKQLDTF--EHPNIVRFFDVIHQNILS-DERYLTVYLIFEHVD-QDLGSYMEKCPP-------------------  127 (321)
Q Consensus        71 ~e~~~l~~l~~~--~~~~i~~~~~~~~~~~~~-~~~~~~~~~v~e~~~-~~L~~~~~~~~~-------------------  127 (321)
                      .|+.++.++...  .+.+++++++++...... .-.....++|+||+. ++|.+++.....                   
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            466667666621  123346677776543111 111235799999999 599988864211                   


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCCccc--cccccccccchh
Q psy2676         128 ---PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT--SVVVTLWYRAPE  202 (321)
Q Consensus       128 ---~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~y~aPE  202 (321)
                         ..+++..++.++.|++.+|.+||+.+++|+||||+||+++.++.++|+|||++..........  ....++.|+|||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence               124567889999999999999999999999999999999999999999999987654332222  233478999999


Q ss_pred             hhhcCCC----------------------CCcchHHHHHHHHHHHHhcCC-CCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         203 ILLNLGY----------------------GTPVDIWSIGCVMAEMWRLVP-LFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       203 ~~~~~~~----------------------~~~~Di~slG~~l~~l~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      .+.....                      ..+.|+||+||++++|+++.. ||...............    ....|   
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~----~~~~~---  453 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDN----DLNRW---  453 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccc----hHHHH---
Confidence            8754321                      124699999999999999875 66432211110000000    00000   


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCC---CCCCCHHHHhCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNP---ADRISAADALEHPYFKE  315 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp---~~Rps~~~ll~h~~f~~  315 (321)
                           ..... ..... .....+++..++|+.+||..+|   .+|+|++|+|+||||..
T Consensus       454 -----r~~~~-~~~~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        454 -----RMYKG-QKYDF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             -----Hhhcc-cCCCc-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence                 00000 00011 1234567899999999999866   78999999999999974

>KOG1167|consensus

Probab=100.00  E-value=8.5e-37  Score=252.02  Aligned_cols=281  Identities=30%  Similarity=0.496  Sum_probs=209.5

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecC--CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQN--KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ....+.|.+++++|.|.|++||++.+...  .++.+++|.+.....    ...+.+|++++..+.+  +.||+++.+++.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG--~~ni~~~~~~~r  105 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGG--SDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhcc--chhhhcchhhhc
Confidence            34457899999999999999999998422  788999999876433    4479999999999996  999999999998


Q ss_pred             ccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee-CCCEE
Q psy2676          96 QNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR-AGGLK  173 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~-~~~~k  173 (321)
                      ..       ..+.+|+||++- +..++...     ++..+++.+++.++.||.++|..||+||||||.|++.+. .+...
T Consensus       106 nn-------d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~  173 (418)
T KOG1167|consen  106 NN-------DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGV  173 (418)
T ss_pred             cC-------CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCce
Confidence            88       789999999995 77777766     789999999999999999999999999999999999975 45689


Q ss_pred             EeecCCccccc-----------------C----------------------------CCccccccccccccchhhhhcCC
Q psy2676         174 IADFGLAKTFD-----------------Y----------------------------DMMLTSVVVTLWYRAPEILLNLG  208 (321)
Q Consensus       174 l~dfg~~~~~~-----------------~----------------------------~~~~~~~~~~~~y~aPE~~~~~~  208 (321)
                      |+|||++....                 .                            ........||++|.|||++...+
T Consensus       174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~  253 (418)
T KOG1167|consen  174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP  253 (418)
T ss_pred             EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence            99999986210                 0                            00112356899999999987666


Q ss_pred             -CCCcchHHHHHHHHHHHHhcCCCCC-CCChHHHHHHHHHHhCCCCCC----------Ccc-hh---hhhhhhhhhhh--
Q psy2676         209 -YGTPVDIWSIGCVMAEMWRLVPLFC-ASTEVEQLKCIFRVIGTPSMN----------EWP-EN---ISLMWSSFEQY--  270 (321)
Q Consensus       209 -~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~----------~~~-~~---~~~~~~~~~~~--  270 (321)
                       .+.+.||||.|+++..+++++.||- ..++.+.+..+....|.....          -|. .+   .......++..  
T Consensus       254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~  333 (418)
T KOG1167|consen  254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI  333 (418)
T ss_pred             CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence             6999999999999999999999873 344444444433333321111          111 00   00000011111  


Q ss_pred             ---hhh----hhhhhhhh-cchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         271 ---SKV----AFSAIFMD-CCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       271 ---~~~----~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                         ...    .......+ .+..+.+|+.+||..||.+|.|++++|+||||...
T Consensus       334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence               110    11112223 34489999999999999999999999999999854

>KOG1152|consensus

Probab=100.00  E-value=2.4e-36  Score=257.86  Aligned_cols=201  Identities=29%  Similarity=0.441  Sum_probs=178.9

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC------CCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE------DGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ..|..++.+|.|+||.|++|.+ +.+...|++|.+.++..-      +.....+.-|+++|.+++...|+||++++++|+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~-K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIH-KENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             ccceeeeeccccccceEEEeee-cccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3589999999999999999999 567889999998775211      222334567999999999888999999999999


Q ss_pred             ccccccccceEEEEEeccCc-c-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          96 QNILSDERYLTVYLIFEHVD-Q-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      +.       ..+|++||..+ | +|.+++..  .++++|.++..|++||+.|+++||+.||+|||||-+||.++.+|-+|
T Consensus       640 dd-------d~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~k  710 (772)
T KOG1152|consen  640 DD-------DYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVK  710 (772)
T ss_pred             cC-------CeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEE
Confidence            98       88999999998 5 99999999  55599999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCCccccccccccccchhhhhcCCC-CCcchHHHHHHHHHHHHhcCCCCC
Q psy2676         174 IADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFC  233 (321)
Q Consensus       174 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~  233 (321)
                      |+|||.+.... +..+....||.+|.|||++.+.+| ...-|||++|++||.+.....||.
T Consensus       711 lidfgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  711 LIDFGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             Eeeccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999998766 455677899999999999999887 678999999999999999999984

>KOG2052|consensus

Probab=100.00  E-value=6.1e-35  Score=242.31  Aligned_cols=262  Identities=26%  Similarity=0.350  Sum_probs=198.9

Q ss_pred             ccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeE
Q psy2676          10 QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR   89 (321)
Q Consensus        10 ~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~   89 (321)
                      +.+++--+.....+..+.+.+|+|.||.||++.   .-|+.||||+|...     .+.+..+|.+++++.. +.|+||+.
T Consensus       199 SGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~---wrGe~VAVKiF~sr-----dE~SWfrEtEIYqTvm-LRHENILg  269 (513)
T KOG2052|consen  199 SGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGR---WRGEDVAVKIFSSR-----DERSWFRETEIYQTVM-LRHENILG  269 (513)
T ss_pred             CCchhHhHHhhhheeEEEEEecCccccceeecc---ccCCceEEEEeccc-----chhhhhhHHHHHHHHH-hccchhhh
Confidence            445555666677889999999999999999995   57899999999743     2457888899888743 34999999


Q ss_pred             EEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCC
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH--------RIIHRDLK  160 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~--------~~~H~di~  160 (321)
                      +++.-...   .+....+++|++|.+ |+|++++..   ..++.+...+++..++.||+|||..        .|.|||||
T Consensus       270 FIaaD~~~---~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlK  343 (513)
T KOG2052|consen  270 FIAADNKD---NGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLK  343 (513)
T ss_pred             hhhccccC---CCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccc
Confidence            99886443   344467899999999 899999998   3489999999999999999999943        49999999


Q ss_pred             CCcEEEeeCCCEEEeecCCcccccCCC-----ccccccccccccchhhhhcCCC-----C-CcchHHHHHHHHHHHHhc-
Q psy2676         161 PQNLLITRAGGLKIADFGLAKTFDYDM-----MLTSVVVTLWYRAPEILLNLGY-----G-TPVDIWSIGCVMAEMWRL-  228 (321)
Q Consensus       161 p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~-----~-~~~Di~slG~~l~~l~~g-  228 (321)
                      +.||+|.+++.+.++|+|++.......     ......||.+|+|||++...-.     + ..+||||||.++||++.. 
T Consensus       344 SKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc  423 (513)
T KOG2052|consen  344 SKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRC  423 (513)
T ss_pred             cccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHh
Confidence            999999999999999999998776542     3456789999999999976542     1 258999999999999742 


Q ss_pred             ---------CCCCCC-----CChHHHHHHHHH-HhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHh
Q psy2676         229 ---------VPLFCA-----STEVEQLKCIFR-VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESM  293 (321)
Q Consensus       229 ---------~~pf~~-----~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  293 (321)
                               ++||.+     +..+++..-+.- .+.+..++.|...                     .+-..+.++++.|
T Consensus       424 ~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~---------------------~~l~~m~klMkeC  482 (513)
T KOG2052|consen  424 ESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSD---------------------PALRVMAKLMKEC  482 (513)
T ss_pred             hcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccC---------------------HHHHHHHHHHHHh
Confidence                     467743     222232222211 1112222222111                     1225677899999


Q ss_pred             cccCCCCCCCHHHH
Q psy2676         294 LTFNPADRISAADA  307 (321)
Q Consensus       294 l~~dp~~Rps~~~l  307 (321)
                      |..+|..|.|+--+
T Consensus       483 W~~Np~aRltALri  496 (513)
T KOG2052|consen  483 WYANPAARLTALRI  496 (513)
T ss_pred             hcCCchhhhHHHHH
Confidence            99999999987554

>KOG0200|consensus

Probab=100.00  E-value=2.6e-34  Score=263.24  Aligned_cols=258  Identities=26%  Similarity=0.401  Sum_probs=208.0

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecC------CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQN------KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR   89 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~   89 (321)
                      .+++..++..+.+.||+|.||.|+++.-...      ....||+|.++..... .....+..|+++++.+..  |+|++.
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~--H~niv~  366 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGK--HPNIVN  366 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcC--Ccchhh
Confidence            5777788888889999999999999975322      2567899998765444 456688899999999996  999999


Q ss_pred             EEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP------------P--PGLSASKVKELTRQMLKGVDFLHSHRI  154 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~------------~--~~~~~~~~~~i~~~l~~~l~~lh~~~~  154 (321)
                      +++++...       ..+++|.||+. |+|.++++...            .  ..++..+...++.||+.|++||++.++
T Consensus       367 llG~~t~~-------~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~  439 (609)
T KOG0200|consen  367 LLGACTQD-------GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPC  439 (609)
T ss_pred             heeeeccC-------CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCc
Confidence            99998664       67899999999 79999998865            1  128889999999999999999999999


Q ss_pred             eeccCCCCcEEEeeCCCEEEeecCCcccccCCCcc--cccc--ccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cC
Q psy2676         155 IHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML--TSVV--VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LV  229 (321)
Q Consensus       155 ~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~--~~~~--~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~  229 (321)
                      +||||-.+||++.++..+|++|||+++........  ....  -+..|+|||.+....++.+|||||+|++|||+++ |.
T Consensus       440 vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~  519 (609)
T KOG0200|consen  440 VHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGG  519 (609)
T ss_pred             cchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCC
Confidence            99999999999999999999999999855433221  1112  3556999999999999999999999999999998 68


Q ss_pred             CCCCCCC-hHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHh
Q psy2676         230 PLFCAST-EVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL  308 (321)
Q Consensus       230 ~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  308 (321)
                      .||.+-. ..+... ..+.......+.                         .|++++.++++.||+.+|++||++.++.
T Consensus       520 ~PYp~~~~~~~l~~-~l~~G~r~~~P~-------------------------~c~~eiY~iM~~CW~~~p~~RP~F~~~~  573 (609)
T KOG0200|consen  520 TPYPGIPPTEELLE-FLKEGNRMEQPE-------------------------HCSDEIYDLMKSCWNADPEDRPTFSECV  573 (609)
T ss_pred             CCCCCCCcHHHHHH-HHhcCCCCCCCC-------------------------CCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence            8887744 333333 222222222222                         4568999999999999999999999986


Q ss_pred             C
Q psy2676         309 E  309 (321)
Q Consensus       309 ~  309 (321)
                      +
T Consensus       574 ~  574 (609)
T KOG0200|consen  574 E  574 (609)
T ss_pred             H
Confidence            4

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.3e-34  Score=282.09  Aligned_cols=252  Identities=20%  Similarity=0.275  Sum_probs=183.5

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ..|...+.||+|+||.||+|++ ..++..||+|.+....      .....|++.+++++   ||||+++++++.+.    
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~~vavK~~~~~~------~~~~~~~~~l~~l~---HpnIv~~~~~~~~~----  755 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKS-IKNGMQFVVKEINDVN------SIPSSEIADMGKLQ---HPNIVKLIGLCRSE----  755 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEE-CCCCcEEEEEEccCCc------cccHHHHHHHhhCC---CCCcceEEEEEEcC----
Confidence            3567778999999999999998 5788999999875321      12235677788776   99999999999776    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLH---SHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh---~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                         ...++||||++ |+|.+++..     +++..+..++.|++.||+|||   +.+++||||||+||+++.++..++. +
T Consensus       756 ---~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~  826 (968)
T PLN00113        756 ---KGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L  826 (968)
T ss_pred             ---CCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-e
Confidence               56799999998 599999964     789999999999999999999   6699999999999999988887765 5


Q ss_pred             CCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChH-HHHHHHHHHhC-CCCCCC
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV-EQLKCIFRVIG-TPSMNE  255 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~-~~~~~~  255 (321)
                      +.......   .....++..|+|||++.+..++.++||||+|+++|||++|+.||...... ........... ......
T Consensus       827 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  903 (968)
T PLN00113        827 SLPGLLCT---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM  903 (968)
T ss_pred             cccccccc---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhh
Confidence            54432221   12336788999999999989999999999999999999999998532110 00111111000 000000


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      +..      ....     ...........++.+++.+||+.||++|||+.++++.
T Consensus       904 ~~~------~~~~-----~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        904 WID------PSIR-----GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             eeC------cccc-----CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            000      0000     0000011223567899999999999999999999863

>KOG3653|consensus

Probab=100.00  E-value=3.3e-35  Score=245.61  Aligned_cols=249  Identities=24%  Similarity=0.296  Sum_probs=189.4

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ....+...+|+|.||.||+|   +.+++.||||++....     ..++.+|.++++.. .++|+||++++++-...  +.
T Consensus       210 ~pl~l~eli~~Grfg~V~Ka---qL~~~~VAVKifp~~~-----kqs~~~Ek~Iy~lp-~m~h~nIl~Fi~~ekr~--t~  278 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKA---QLDNRLVAVKIFPEQE-----KQSFQNEKNIYSLP-GMKHENILQFIGAEKRG--TA  278 (534)
T ss_pred             CchhhHHHhhcCccceeehh---hccCceeEEEecCHHH-----HHHHHhHHHHHhcc-CccchhHHHhhchhccC--Cc
Confidence            34567789999999999999   4577999999997542     34788999999876 46799999999986544  21


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCcEEEeeCCC
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH---------RIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~---------~~~H~di~p~Nilv~~~~~  171 (321)
                      . ...+++|+++.+ |+|.+++..   ..+++....+++..|++||+|||+-         .|+|||||+.||||..|++
T Consensus       279 ~-~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT  354 (534)
T KOG3653|consen  279 D-RMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT  354 (534)
T ss_pred             c-ccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc
Confidence            2 457899999999 799999998   3489999999999999999999954         4999999999999999999


Q ss_pred             EEEeecCCcccccCCC---ccccccccccccchhhhhcCCC-C-----CcchHHHHHHHHHHHHhcCCCCC-C-------
Q psy2676         172 LKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGY-G-----TPVDIWSIGCVMAEMWRLVPLFC-A-------  234 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~-----~~~Di~slG~~l~~l~~g~~pf~-~-------  234 (321)
                      +.|+|||++..+....   ......||.+|||||++.+... .     .+.||||+|.+||||++....+. +       
T Consensus       355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql  434 (534)
T KOG3653|consen  355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL  434 (534)
T ss_pred             EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence            9999999998776433   2334789999999999977552 2     26899999999999998654432 1       


Q ss_pred             ---------CChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHH
Q psy2676         235 ---------STEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA  305 (321)
Q Consensus       235 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  305 (321)
                               +.-+++-.........|..++.                    ..-......+.+.++.||+.||+.|.|+.
T Consensus       435 pfe~evG~hPt~e~mq~~VV~kK~RP~~p~~--------------------W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  435 PFEAEVGNHPTLEEMQELVVRKKQRPKIPDA--------------------WRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             chhHHhcCCCCHHHHHHHHHhhccCCCChhh--------------------hhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence                     1122222222222222222110                    00012336788999999999999999985

>KOG0984|consensus

Probab=100.00  E-value=4.6e-34  Score=214.74  Aligned_cols=223  Identities=27%  Similarity=0.456  Sum_probs=181.5

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      ....+++..+...-+..||+|++|.|-+.++ ..+|+..|+|.+....... ......+|+.+..+..  .||.++++|+
T Consensus        37 ~~~~~eV~ad~L~~i~elGrGayG~vekmrh-~~sg~imAvKri~~tvn~q-~q~r~L~dldi~~r~~--~CPf~V~FyG  112 (282)
T KOG0984|consen   37 GDRNFEVPADDLVGIEELGRGAYGVVEKMRH-IQSGTIMAVKRIRATVNSQ-EQKRLLMDLDIIMRTV--DCPFTVHFYG  112 (282)
T ss_pred             ecCccccchhhhhhhhhhcCCccchhhheee-ccCCeEEEEeeehhhcChH-HHHHHHHhhhhhccCC--CCCeEEEeeh
Confidence            3445677777788889999999999999999 5899999999997664432 2334556666655444  4999999999


Q ss_pred             eeeccccccccceEEEEEeccCccCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeeC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVDQDLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRA  169 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~-~~~H~di~p~Nilv~~~  169 (321)
                      .+.+.       ..+++.||.+..+|..+....  .+..++|..+-+|+..+..||.|||++ .++|||+||+||+++.+
T Consensus       113 a~~re-------gdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~  185 (282)
T KOG0984|consen  113 ALFRE-------GDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD  185 (282)
T ss_pred             hhhcc-------ccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC
Confidence            98777       678999999998887665432  245599999999999999999999976 89999999999999999


Q ss_pred             CCEEEeecCCcccccCCCccccccccccccchhhhhc----CCCCCcchHHHHHHHHHHHHhcCCCCCC-CChHHHHHHH
Q psy2676         170 GGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN----LGYGTPVDIWSIGCVMAEMWRLVPLFCA-STEVEQLKCI  244 (321)
Q Consensus       170 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~  244 (321)
                      |++|+||||.+.....+-..+...|-..|+|||.+..    ..|+.+|||||||+.+.||.+++.||.. .++-+.++++
T Consensus       186 GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv  265 (282)
T KOG0984|consen  186 GQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV  265 (282)
T ss_pred             CcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence            9999999999987765555555667778999998743    3589999999999999999999999965 4566666655


Q ss_pred             HH
Q psy2676         245 FR  246 (321)
Q Consensus       245 ~~  246 (321)
                      ..
T Consensus       266 Ve  267 (282)
T KOG0984|consen  266 VE  267 (282)
T ss_pred             hc
Confidence            54

>KOG1025|consensus

Probab=100.00  E-value=2.2e-33  Score=248.44  Aligned_cols=248  Identities=24%  Similarity=0.318  Sum_probs=202.4

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCc----EEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGN----YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ...+-.++||+|+||+||++...-. ++    +|++|++... .......++.+|+.++..+.   |||++++++++..+
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pe-ge~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masld---Hpnl~RLLgvc~~s  770 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPE-GENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLD---HPNLLRLLGVCMLS  770 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecC-CceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCC---CchHHHHhhhcccc
Confidence            3456778999999999999998533 43    6778877544 33334567889999999998   99999999998665


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                              .+.+|++|++ |+|.++++...++ +...+...|..||+.|+.|||.++++||||-.+||||.+...+|+.|
T Consensus       771 --------~~qlvtq~mP~G~LlDyvr~hr~~-igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitd  841 (1177)
T KOG1025|consen  771 --------TLQLVTQLMPLGCLLDYVREHRDN-IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITD  841 (1177)
T ss_pred             --------hHHHHHHhcccchHHHHHHHhhcc-ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEe
Confidence                    3789999999 7999999986544 88999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCcc---ccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         177 FGLAKTFDYDMML---TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       177 fg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ||++.........   ......+.|+|-|.+....++.++||||+|+++||++| |..|+.+....++-..+..... .+
T Consensus       842 fgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-Ls  920 (1177)
T KOG1025|consen  842 FGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LS  920 (1177)
T ss_pred             cchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CC
Confidence            9999887654432   22334667999999999999999999999999999986 8999988766665544433222 11


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .                         ...|+-++..++.+||..|+..||+++++..
T Consensus       921 q-------------------------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  921 Q-------------------------PPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             C-------------------------CCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            1                         2256688999999999999999999998764

>KOG0576|consensus

Probab=100.00  E-value=3.4e-34  Score=248.38  Aligned_cols=260  Identities=28%  Similarity=0.460  Sum_probs=219.6

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ....+|+++..+|+|.||.||+++| ..+++..++|+++..-.  ....-.+.|+-+++..+   ||||+.+++.+... 
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd-~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~---h~nivay~gsylr~-   84 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARD-KRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCR---HPNIVAYFGSYLRR-   84 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcc-cccCchhhheeeeccCC--ccccccccceeeeecCC---CcChHHHHhhhhhh-
Confidence            4667999999999999999999999 68999999999986532  33456778888888887   99999999988766 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ...++.||||+| +|.+.-..  .+.+++.++..+++..+++|+|||++|-+|||||-.||++++.|.+||.||
T Consensus        85 ------dklwicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDf  156 (829)
T KOG0576|consen   85 ------DKLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADF  156 (829)
T ss_pred             ------cCcEEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeeccc
Confidence                  678999999995 88887766  455999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCC-ccccccccccccchhhh---hcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         178 GLAKTFDYDM-MLTSVVVTLWYRAPEIL---LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       178 g~~~~~~~~~-~~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      |.+..+...- ...+..||+.|+|||+-   +...+...+|||++|+...++-..++|.-...+......+.+....|+.
T Consensus       157 gvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~  236 (829)
T KOG0576|consen  157 GVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT  236 (829)
T ss_pred             CchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc
Confidence            9987765332 34578999999999975   4556899999999999999999888887777676666666655555444


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      -+.+.                      .+++.+.+|++.+|.++|++||+++-+|.|||...
T Consensus       237 lkDk~----------------------kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  237 LKDKT----------------------KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             ccCCc----------------------cchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence            43322                      45588999999999999999999999999999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.4e-31  Score=215.51  Aligned_cols=211  Identities=39%  Similarity=0.687  Sum_probs=181.0

Q ss_pred             eecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEEE
Q psy2676          30 IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYL  109 (321)
Q Consensus        30 lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  109 (321)
                      ||+|.+|.||++.+ ..+++.+++|++....... ....+.+|+..++.+.   |++++++++++...       ...++
T Consensus         1 l~~g~~~~v~~~~~-~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~---~~~i~~~~~~~~~~-------~~~~~   68 (215)
T cd00180           1 LGEGGFGTVYLARD-KKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLN---HPNIVKLYGVFEDE-------NHLYL   68 (215)
T ss_pred             CCcCCceEEEEEEe-cCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcC---CCCeeeEeeeeecC-------CeEEE
Confidence            68999999999998 4568999999987543221 2346888999999998   89999999999776       67899


Q ss_pred             EeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee-CCCEEEeecCCcccccCCC
Q psy2676         110 IFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR-AGGLKIADFGLAKTFDYDM  187 (321)
Q Consensus       110 v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~-~~~~kl~dfg~~~~~~~~~  187 (321)
                      ++|+++ ++|.+++.... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+.......
T Consensus        69 ~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~  147 (215)
T cd00180          69 VMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK  147 (215)
T ss_pred             EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence            999999 59999998753 34899999999999999999999999999999999999999 8999999999987665432


Q ss_pred             -ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhh
Q psy2676         188 -MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS  265 (321)
Q Consensus       188 -~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
                       ......+...|++||..... ..+.++|+|++|++++++                                        
T Consensus       148 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------  187 (215)
T cd00180         148 SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------  187 (215)
T ss_pred             chhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------
Confidence             13345678889999999887 788999999999999999                                        


Q ss_pred             hhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCC
Q psy2676         266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP  311 (321)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  311 (321)
                                        ..+.+++.+|+..+|.+||++.++++|+
T Consensus       188 ------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                              2456899999999999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.98  E-value=1.4e-32  Score=261.27  Aligned_cols=204  Identities=16%  Similarity=0.225  Sum_probs=146.4

Q ss_pred             C-CceeEEEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q psy2676          84 H-PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQ  162 (321)
Q Consensus        84 ~-~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~  162 (321)
                      | +||..+++.|.....++.....++.++|+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus        31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~  109 (793)
T PLN00181         31 HIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPS  109 (793)
T ss_pred             HHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCch
Confidence            5 577777777643322222224578889999899999997533 44999999999999999999999999999999999


Q ss_pred             cEEEeeCCC-------------------EEEeecCCcccccCCC-----------------ccccccccccccchhhhhc
Q psy2676         163 NLLITRAGG-------------------LKIADFGLAKTFDYDM-----------------MLTSVVVTLWYRAPEILLN  206 (321)
Q Consensus       163 Nilv~~~~~-------------------~kl~dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~  206 (321)
                      ||+++..+.                   +|++|||++.......                 ......+|+.|+|||++.+
T Consensus       110 NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~  189 (793)
T PLN00181        110 CFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG  189 (793)
T ss_pred             hEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc
Confidence            999965444                   5555555554321000                 0011346888999999999


Q ss_pred             CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhH
Q psy2676         207 LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKA  286 (321)
Q Consensus       207 ~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (321)
                      ..++.++|||||||++|||++|.+|+.....  ....+.... .++.                         .....+..
T Consensus       190 ~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-~~~~-------------------------~~~~~~~~  241 (793)
T PLN00181        190 SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-LPPQ-------------------------ILLNWPKE  241 (793)
T ss_pred             CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-cChh-------------------------hhhcCHHH
Confidence            9999999999999999999999888753211  111111110 0000                         00112455


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         287 NSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       287 ~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .+++.+||+++|.+||++.++++||||++.
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            688999999999999999999999999864

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.5e-30  Score=210.55  Aligned_cols=202  Identities=40%  Similarity=0.653  Sum_probs=171.2

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      |++.+.||.|++|+||++.+ ..++..+++|.+...... .....+.+|+..++.++   |+|++++++++...      
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~-~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~---~~~i~~~~~~~~~~------   69 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARD-KGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLK---HPNIVKLYGVFEDP------   69 (225)
T ss_pred             CceeeEeecCCCeEEEEEEE-cCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCC---CCChhhheeeeecC------
Confidence            67889999999999999998 466889999998754332 12446777888888886   99999999998766      


Q ss_pred             ceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         104 YLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       104 ~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                       ...++++|++++ +|.+++...... +++..++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+..
T Consensus        70 -~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~  147 (225)
T smart00221       70 -EPLYLVMEYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARF  147 (225)
T ss_pred             -CceEEEEeccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence             578999999997 999999874432 78999999999999999999999999999999999999999999999999887


Q ss_pred             ccCCC--ccccccccccccchhhh-hcCCCCCcchHHHHHHHHHHHHhcCCCCCC-CChH
Q psy2676         183 FDYDM--MLTSVVVTLWYRAPEIL-LNLGYGTPVDIWSIGCVMAEMWRLVPLFCA-STEV  238 (321)
Q Consensus       183 ~~~~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~  238 (321)
                      .....  ......++..|++||.+ ....++.++|+|++|+++++|++|+.||.. .+..
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      148 IHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             ecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence            65443  33445677889999998 666678899999999999999999999977 4444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345|consensus

Probab=99.97  E-value=4.1e-32  Score=212.35  Aligned_cols=243  Identities=23%  Similarity=0.339  Sum_probs=185.0

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee-eeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV-IHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~-~~~~~~~  100 (321)
                      +.|.|.+.||+|.||.+-+|++ +.+.+.+++|.+...   .....++.+|...---|..  |.||+.-|+. |+..   
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eH-r~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~--H~hIi~tY~vaFqt~---   94 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEH-RQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSP--HQHIIDTYEVAFQTS---   94 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeec-cCCceEEEeeccCcc---hhhHHHHHHHhccceeecc--chhhhHHHHHHhhcC---
Confidence            6899999999999999999999 678889999988754   2335578888877666664  8999988875 4444   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee--CCCEEEeec
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR--AGGLKIADF  177 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~--~~~~kl~df  177 (321)
                          ..+++++|+++ |+|.+-+...   .+-|.....++.|+++|+.+||+.++||||||.+||+|-.  ...+|||||
T Consensus        95 ----d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   95 ----DAYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             ----ceEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeec
Confidence                57889999999 7998887763   3789999999999999999999999999999999999943  335999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcCC-----CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLG-----YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |.+...+.--.  .......|.+||+....+     ..+.+|+|.||+++|.+++|..||......+...--.       
T Consensus       168 G~t~k~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~-------  238 (378)
T KOG1345|consen  168 GLTRKVGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEW-------  238 (378)
T ss_pred             ccccccCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHH-------
Confidence            99987663221  222345689999875432     5778999999999999999999996432222111100       


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADR  301 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  301 (321)
                                  ....+......+..+.-.++.+..++++-|.++|.+|
T Consensus       239 ------------~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  239 ------------EQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             ------------HHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence                        1111112223444455677889999999999999999

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=1.9e-30  Score=203.27  Aligned_cols=167  Identities=19%  Similarity=0.216  Sum_probs=129.1

Q ss_pred             cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCCcccccccc
Q psy2676         116 QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVT  195 (321)
Q Consensus       116 ~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  195 (321)
                      |+|.+++.... ..+++.+++.++.|++.||.|||+.+      ||+||+++.++.+++  ||.+.......    ..++
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~   67 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVD   67 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCc
Confidence            68899998643 34999999999999999999999998      999999999999999  99887654322    2578


Q ss_pred             ccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChH-HHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhh
Q psy2676         196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV-EQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVA  274 (321)
Q Consensus       196 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (321)
                      +.|+|||++.+..++.++||||+|+++|+|++|+.||...... .....+............+                 
T Consensus        68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------  130 (176)
T smart00750       68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRS-----------------  130 (176)
T ss_pred             ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccc-----------------
Confidence            9999999999999999999999999999999999999765432 2222222221111000000                 


Q ss_pred             hhhhhhhcc--hhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         275 FSAIFMDCC--SKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       275 ~~~~~~~~~--~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                         ....++  .++.+++++||..+|.+||++.++++|+|+..
T Consensus       131 ---~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      131 ---NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             ---cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence               001122  36899999999999999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024|consensus

Probab=99.97  E-value=1.2e-30  Score=213.72  Aligned_cols=261  Identities=18%  Similarity=0.295  Sum_probs=203.8

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCcee
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV   88 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~   88 (321)
                      .+..+.+...|++....+-+|.||.||.+...    -++.+.+.+|.++...+. -....+..|.-.+.-+.   |||++
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~-iQv~~~L~es~lly~~s---H~nll  350 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ-IQVNLLLQESMLLYGAS---HPNLL  350 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH-HHHHHHHHHHHHHhcCc---CCCcc
Confidence            34566777889999999999999999999652    234456677776543221 11223445555555555   99999


Q ss_pred             EEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q psy2676          89 RFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP------PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKP  161 (321)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~------~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p  161 (321)
                      .+.++....      ....+.++.+.+ |+|..++..+..      +.++..++..++.|++.|++|||+.|++|.||-.
T Consensus       351 ~V~~V~ie~------~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAa  424 (563)
T KOG1024|consen  351 SVLGVSIED------YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAA  424 (563)
T ss_pred             ceeEEEeec------cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhh
Confidence            999987543      156788889998 899999984431      2367788889999999999999999999999999


Q ss_pred             CcEEEeeCCCEEEeecCCcccccCC---CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCCh
Q psy2676         162 QNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTE  237 (321)
Q Consensus       162 ~Nilv~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~  237 (321)
                      +|++|++.-++||+|=.+++..-+.   ..-...-.+..|+|||.+.+..++.++|+||||+++|||+| |+.|+..-++
T Consensus       425 RNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP  504 (563)
T KOG1024|consen  425 RNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP  504 (563)
T ss_pred             hcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH
Confidence            9999999999999998887655322   12223345678999999999999999999999999999997 7999988888


Q ss_pred             HHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         238 VEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .++...+.++..-.++                          -+||+++..++.-||...|++||+.+|+..
T Consensus       505 fEm~~ylkdGyRlaQP--------------------------~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  505 FEMEHYLKDGYRLAQP--------------------------FNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             HHHHHHHhccceecCC--------------------------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            8887776665433222                          267899999999999999999999999864

>KOG1164|consensus

Probab=99.96  E-value=4.9e-28  Score=206.89  Aligned_cols=255  Identities=21%  Similarity=0.244  Sum_probs=192.1

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhccc-CCCCceeEEEeeee-ccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT-FEHPNIVRFFDVIH-QNILS  100 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~~~~i~~~~~~~~-~~~~~  100 (321)
                      +|.+.+.||+|+||.||+|.+.......+|+|+........  ...+..|..++..+.. ...+++..+++... ..   
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~---   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE---   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC---
Confidence            89999999999999999999853334678888876542222  2267788888888873 12468999998874 33   


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC-----CCEEEe
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA-----GGLKIA  175 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~-----~~~kl~  175 (321)
                          ...++||+.++.+|.++....+.+.++...+..++.|++.+|+++|+.|++||||||.|+.+...     ..+.|.
T Consensus        94 ----~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen   94 ----DFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             ----ceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEE
Confidence                56799999999999999988776779999999999999999999999999999999999999765     359999


Q ss_pred             ecCCcc--ccc-CC-------Cc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q psy2676         176 DFGLAK--TFD-YD-------MM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI  244 (321)
Q Consensus       176 dfg~~~--~~~-~~-------~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  244 (321)
                      |||++.  ... ..       .. .....||..|+|++++.+...+.+.|+||+++++.+++.|..||............
T Consensus       170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~  249 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF  249 (322)
T ss_pred             ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence            999998  321 11       11 22345999999999999999999999999999999999999999765543333322


Q ss_pred             HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHh
Q psy2676         245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL  308 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  308 (321)
                      ...........                      .....+.++.++...+-..+...+|....+.
T Consensus       250 ~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~  291 (322)
T KOG1164|consen  250 EKDPRKLLTDR----------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLA  291 (322)
T ss_pred             HHHhhhhcccc----------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence            22111111100                      1112335666666666667777778666554

>KOG1165|consensus

Probab=99.96  E-value=5.4e-29  Score=200.18  Aligned_cols=215  Identities=22%  Similarity=0.294  Sum_probs=183.6

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      .-+-+-.|++.++||+|+||.++++.. -.++++||||.-..+..    ...+..|...++.|..  .++|...|-+-..
T Consensus        23 ~~~VG~hyrVGkKIGeGsFG~lf~G~N-l~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g--~~GIP~vYYFGqe   95 (449)
T KOG1165|consen   23 VLMVGPHYRVGKKIGEGSFGVLFLGKN-LYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGG--TEGIPQVYYFGQE   95 (449)
T ss_pred             ceEecccceeccccccCcceeeecccc-cccCceEEEEeccccCC----cchHHHHHHHHHHHcC--CCCCCceeeeccc
Confidence            335677899999999999999999998 48899999998765432    3478889999999996  9999999877655


Q ss_pred             cccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC-----C
Q psy2676          97 NILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-----G  171 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~-----~  171 (321)
                      .       .+-.+|+|.++.+|.++++.|+.. ++...++.++.|++.-++++|++.+++|||||+|+||...+     .
T Consensus        96 G-------~~NiLVidLLGPSLEDLFD~CgR~-FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~  167 (449)
T KOG1165|consen   96 G-------KYNILVIDLLGPSLEDLFDLCGRR-FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANV  167 (449)
T ss_pred             c-------chhhhhhhhhCcCHHHHHHHhcCc-ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCce
Confidence            4       677899999999999999999865 99999999999999999999999999999999999996544     3


Q ss_pred             EEEeecCCcccccCC--------CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCC---hHHH
Q psy2676         172 LKIADFGLAKTFDYD--------MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST---EVEQ  240 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~  240 (321)
                      +.++|||++.....+        ....+..||.+||+-..+.+...+...|+-|||-+++.++.|..||.+..   ..+.
T Consensus       168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k  247 (449)
T KOG1165|consen  168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK  247 (449)
T ss_pred             EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH
Confidence            999999999877433        34456789999999999999999999999999999999999999998754   4444


Q ss_pred             HHHHHH
Q psy2676         241 LKCIFR  246 (321)
Q Consensus       241 ~~~~~~  246 (321)
                      .++|-.
T Consensus       248 YeKIGe  253 (449)
T KOG1165|consen  248 YEKIGE  253 (449)
T ss_pred             HHHhcc
Confidence            444433

>KOG1163|consensus

Probab=99.96  E-value=2.1e-28  Score=188.59  Aligned_cols=212  Identities=22%  Similarity=0.282  Sum_probs=179.2

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      +..+.|+++++||+|+||.+|++.. -.+|+.||+|+-+..    ..-.....|..+++.++.  ...|..+..+.... 
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~-i~~ge~VAiK~Es~~----a~hpqL~yEskvY~iL~~--g~GiP~i~~y~~e~-   83 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGIS-ITSGEEVAIKLESSK----AKHPQLLYESKVYRILQG--GVGIPHIRHYGTEK-   83 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeee-ccCCceEEEEeeccc----CCCcchhHHHHHHHHhcc--CCCCchhhhhcccc-
Confidence            3457899999999999999999999 488999999986543    233477889999999995  77888888777555 


Q ss_pred             cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC---CCEEEe
Q psy2676          99 LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIA  175 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~---~~~kl~  175 (321)
                            .+-.+||+..+.+|.+++.-+... ++-.++.-++.|++.-++|+|.++++||||||+|+++.-+   ..+.|+
T Consensus        84 ------~ynvlVMdLLGPsLEdLfnfC~R~-ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LI  156 (341)
T KOG1163|consen   84 ------DYNVLVMDLLGPSLEDLFNFCSRR-FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLI  156 (341)
T ss_pred             ------ccceeeeeccCccHHHHHHHHhhh-hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEE
Confidence                  567999999999999999988754 9999999999999999999999999999999999999644   359999


Q ss_pred             ecCCcccccCC--------CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q psy2676         176 DFGLAKTFDYD--------MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIF  245 (321)
Q Consensus       176 dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  245 (321)
                      |||++......        .......||..|.|-..+.+...+...|+-|+|.+|..+-.|..||.+.......++..
T Consensus       157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE  234 (341)
T KOG1163|consen  157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE  234 (341)
T ss_pred             eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence            99999877432        23445788999999999999999999999999999999999999998865544444433

>KOG0590|consensus

Probab=99.95  E-value=5.5e-29  Score=225.52  Aligned_cols=263  Identities=27%  Similarity=0.346  Sum_probs=195.0

Q ss_pred             eeeeeeecccceeEEEEEEecCCCcEEEEEEeecc----cCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          25 DELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK----LNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ...+.+|.|++|.|+.+.. .........|.+...    .........+..|+-+-..+.   |||++..++.+.+.   
T Consensus       321 ~~~~~~g~ga~g~~~~~~~-~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~---h~~~~e~l~~~~~~---  393 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKR-RSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS---HPNIIETLDIVQEI---  393 (601)
T ss_pred             CccceeeecccCceEEEEe-cCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc---CCchhhhHHHHhhc---
Confidence            5678899999998887776 344444555544321    111111111333444444455   99998877776554   


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                          ....-.||||+++|..++...  ..+...++..+++|++.|+.|+|+.|+.|+|+|++|+++..+|.+|++|||.+
T Consensus       394 ----~~~~~~mE~~~~Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~  467 (601)
T KOG0590|consen  394 ----DGILQSMEYCPYDLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAA  467 (601)
T ss_pred             ----ccchhhhhcccHHHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcc
Confidence                333444999999999999884  45899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCc-----cccccccccccchhhhhcCCCCC-cchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         181 KTFDYDMM-----LTSVVVTLWYRAPEILLNLGYGT-PVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       181 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      ........     .....|+..|+|||++.+..+.+ ..||||.|+++..|.+|+.||..+...+....-....      
T Consensus       468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~------  541 (601)
T KOG0590|consen  468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS------  541 (601)
T ss_pred             eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc------
Confidence            76654332     33467788899999999999855 7899999999999999999997765544321000000      


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                                  ...........+....+...+.+|.+||++||.+|.|+++|++.+||+.+..
T Consensus       542 ------------~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  542 ------------DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             ------------cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence                        0011122334456678899999999999999999999999999999998753

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=1.6e-25  Score=183.02  Aligned_cols=246  Identities=22%  Similarity=0.289  Sum_probs=151.8

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCC-CchhHHHHHHHHhcccCC-------CCceeEEEee
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI-PMSTLREISILKQLDTFE-------HPNIVRFFDV   93 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~-------~~~i~~~~~~   93 (321)
                      ..+...+.||.|+++.||.++| ..+++.+++|++......... ...+.+|.-....+....       |-.++..++.
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d-~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTD-VETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEE-TTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             eEEEEccccccCCceEEEEEEE-ccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            4577889999999999999999 789999999999765422211 122223332333322111       2234444444


Q ss_pred             eeccc-----cccc--cce---EEEEEeccCccCHHHHHhh---CCCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecc
Q psy2676          94 IHQNI-----LSDE--RYL---TVYLIFEHVDQDLGSYMEK---CPPPG--LSASKVKELTRQMLKGVDFLHSHRIIHRD  158 (321)
Q Consensus        94 ~~~~~-----~~~~--~~~---~~~~v~e~~~~~L~~~~~~---~~~~~--~~~~~~~~i~~~l~~~l~~lh~~~~~H~d  158 (321)
                      .....     ....  ...   ..+++|+-..++|.+++..   .....  +.......+..|++..+++||+.|++|+|
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd  170 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD  170 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence            33220     0011  011   2477888888888777543   22221  12223344567999999999999999999


Q ss_pred             CCCCcEEEeeCCCEEEeecCCcccccCCCccccccccccccchhhhhcC--------CCCCcchHHHHHHHHHHHHhcCC
Q psy2676         159 LKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL--------GYGTPVDIWSIGCVMAEMWRLVP  230 (321)
Q Consensus       159 i~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~Di~slG~~l~~l~~g~~  230 (321)
                      |+|+|++++.+|.++|+||+.....+.....  ...+..|.|||.....        .++.+.|.|+||+++|.|+++..
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            9999999999999999999988766543332  4456789999987543        36889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCC
Q psy2676         231 LFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADR  301 (321)
Q Consensus       231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  301 (321)
                      ||.........                              ...+.... ++|+.++.||+.+|+.||.+|
T Consensus       249 Pf~~~~~~~~~------------------------------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADP------------------------------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTS------------------------------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccc------------------------------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99754321110                              00122223 788999999999999999987

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=8.4e-26  Score=192.65  Aligned_cols=172  Identities=21%  Similarity=0.199  Sum_probs=129.2

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC---CCCCCchhHHHHHHHHhcccCCCCceeE
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN---EDGIPMSTLREISILKQLDTFEHPNIVR   89 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~i~~   89 (321)
                      +-+......++|.+.+.||+|+||+||+|++...+++.+|+|+......   .......+.+|+++++++.   |+|+++
T Consensus         9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~---h~~iv~   85 (365)
T PRK09188          9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR---GIGVVP   85 (365)
T ss_pred             cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc---CCCCCc
Confidence            3445566678999999999999999999998545788889998653211   1112345789999999998   999885


Q ss_pred             -EEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCcEEE
Q psy2676          90 -FFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDL-KPQNLLI  166 (321)
Q Consensus        90 -~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di-~p~Nilv  166 (321)
                       +++.           ...++||||++| +|.. +..  .   ..   ..++.+++.+|.+||++|++|||| ||+||++
T Consensus        86 ~l~~~-----------~~~~LVmE~~~G~~L~~-~~~--~---~~---~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv  145 (365)
T PRK09188         86 QLLAT-----------GKDGLVRGWTEGVPLHL-ARP--H---GD---PAWFRSAHRALRDLHRAGITHNDLAKPQNWLM  145 (365)
T ss_pred             EEEEc-----------CCcEEEEEccCCCCHHH-hCc--c---ch---HHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE
Confidence             4432           235999999996 6752 211  1   11   467889999999999999999999 9999999


Q ss_pred             eeCCCEEEeecCCcccccCCCcc---------ccccccccccchhhhhcC
Q psy2676         167 TRAGGLKIADFGLAKTFDYDMML---------TSVVVTLWYRAPEILLNL  207 (321)
Q Consensus       167 ~~~~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~  207 (321)
                      +.++.++|+|||++.........         ....++..|.+||.+...
T Consensus       146 ~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        146 GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99999999999999866533211         234567778999988543

>KOG1240|consensus

Probab=99.93  E-value=1.4e-26  Score=211.60  Aligned_cols=248  Identities=25%  Similarity=0.303  Sum_probs=179.6

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      .+..++.||++.|=.|.++++  ..|. +++|++-+.... -....+.+++...+ +...++||++++--.....     
T Consensus        24 e~~~~~~LGstRFlKv~r~k~--~eG~-vVvKVFvk~~p~-~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~-----   93 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKD--REGL-VVVKVFVKQDPT-ISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD-----   93 (1431)
T ss_pred             ceeeecccCchhhhhhhhccC--CCce-EEEEEEeccCCC-CCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh-----
Confidence            788999999999999999987  4554 999999765322 23345555444444 3334599999988776555     


Q ss_pred             cceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         103 RYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       103 ~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                        ...|+|-+|...+|++.+..++-  +..-+.+.|+.||+.||..+|..|++|||||.+||+|+.=+=+.|+||..-+.
T Consensus        94 --kAAylvRqyvkhnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen   94 --KAAYLVRQYVKHNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             --HHHHHHHHHHhhhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCC
Confidence              67799999999999999999554  88899999999999999999999999999999999998766689999986533


Q ss_pred             c--cC--CCcc----ccccccccccchhhhhcCC-----------CCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHH
Q psy2676         183 F--DY--DMML----TSVVVTLWYRAPEILLNLG-----------YGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLK  242 (321)
Q Consensus       183 ~--~~--~~~~----~~~~~~~~y~aPE~~~~~~-----------~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~  242 (321)
                      .  ..  +...    .....-.+|+|||-+....           .+++.||||+||++.|+++ |++||.-.       
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-------  242 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-------  242 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------
Confidence            2  11  1111    2233445799999885421           5778999999999999987 68888421       


Q ss_pred             HHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      +++......  ...+.              ...+.   --...++.+|..|++.||++|.++++.|+-
T Consensus       243 QL~aYr~~~--~~~~e--------------~~Le~---Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  243 QLLAYRSGN--ADDPE--------------QLLEK---IEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHhHhccC--ccCHH--------------HHHHh---CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            111100000  00000              00000   011578999999999999999999999974

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=9.5e-24  Score=182.06  Aligned_cols=261  Identities=34%  Similarity=0.521  Sum_probs=202.6

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC-CCchhHHHHHHHHhcccCCCC-ceeEEEeeeecccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG-IPMSTLREISILKQLDTFEHP-NIVRFFDVIHQNILSD  101 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~~~-~i~~~~~~~~~~~~~~  101 (321)
                      |.+...||.|+|+.||++.+.    ..+++|.+........ ....+.+|...++.+.   |+ +++++.+.+...    
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~---~~~~i~~~~~~~~~~----   70 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLN---HPPNIVKLYDFFQDE----   70 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec----cEEEEEeechhhccchhHHHHHHHHHHHHHHcc---CCcceeeEEEEEecC----
Confidence            789999999999999999873    7889999877655443 4557788899888888   66 799999999555    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC-CEEEeecC
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPP-PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFG  178 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~-~~kl~dfg  178 (321)
                         ...+++++++.+ ++.+++..... ..++......++.|++.++.++|+.+++|+|+||+||+++..+ .++++|||
T Consensus        71 ---~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg  147 (384)
T COG0515          71 ---GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFG  147 (384)
T ss_pred             ---CEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccC
Confidence               447999999995 78866666432 1589999999999999999999999999999999999999988 69999999


Q ss_pred             CcccccCCC-------ccccccccccccchhhhhc---CCCCCcchHHHHHHHHHHHHhcCCCCCCCCh---HHHHHHHH
Q psy2676         179 LAKTFDYDM-------MLTSVVVTLWYRAPEILLN---LGYGTPVDIWSIGCVMAEMWRLVPLFCASTE---VEQLKCIF  245 (321)
Q Consensus       179 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~  245 (321)
                      .+.......       ......++..|.+||.+.+   ...+...|+||+|++++++++|..||.....   ........
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  227 (384)
T COG0515         148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII  227 (384)
T ss_pred             cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH
Confidence            987554332       2456788999999999988   5789999999999999999999999877664   23333333


Q ss_pred             HHhCCC-CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         246 RVIGTP-SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       246 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .....+ ..........                  ......+.+++..++..+|..|.+..+...+++....
T Consensus       228 ~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         228 LELPTPSLASPLSPSNP------------------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             HhcCCcccccccCcccc------------------chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            222222 0100000000                  1222578899999999999999999999988766544

>KOG0603|consensus

Probab=99.93  E-value=9.2e-27  Score=202.28  Aligned_cols=244  Identities=27%  Similarity=0.382  Sum_probs=199.3

Q ss_pred             eeecccceeEEEEEEe--cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          29 QIGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        29 ~lg~g~~g~v~~~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      .+|.|++|.|++++..  ...+..+++|+.++.............|..++.....  ||.+++++..|+.+       ..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~--~~f~v~lhyafqt~-------~k   71 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHN--TPFLVKLHYAFQTD-------GK   71 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccC--CCceeeeeeeeccc-------cc
Confidence            3789999999988643  2356788999987765554444456678888888875  99999999999888       77


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccC
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY  185 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~  185 (321)
                      .++++++..| .|...+...  ..+.+...+.+...++.++.++|+.+++|+|+|++||+++.+|++++.|||.+...-.
T Consensus        72 l~l~ld~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~  149 (612)
T KOG0603|consen   72 LYLILDFLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK  149 (612)
T ss_pred             hhHhhhhcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh
Confidence            8999999996 777777663  4488999999999999999999999999999999999999999999999999876543


Q ss_pred             CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhh
Q psy2676         186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS  265 (321)
Q Consensus       186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
                      ....   +|+..|+|||++.  ....++|-||+|+++++|++|..||..    +....|.+....     .         
T Consensus       150 ~~~~---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~-----~---------  206 (612)
T KOG0603|consen  150 EKIA---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE-----M---------  206 (612)
T ss_pred             hhhc---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC-----C---------
Confidence            3322   8899999999998  668899999999999999999999977    455555442111     1         


Q ss_pred             hhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                                   ....+..+++++..++..+|..|.     .+.++++|+||+.++|.
T Consensus       207 -------------p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  207 -------------PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             -------------chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence                         123448889999999999999998     45899999999999875

>KOG0195|consensus

Probab=99.92  E-value=7.1e-26  Score=177.84  Aligned_cols=243  Identities=17%  Similarity=0.182  Sum_probs=193.3

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      .+..+.-+|.....|..|+++.   .+..++.|++............+.+|...++.+.   ||||+++++.+..+    
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrw---qgndivakil~vr~~t~risrdfneefp~lrifs---hpnilpvlgacnsp----  259 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRW---QGNDIVAKILNVREVTARISRDFNEEFPALRIFS---HPNILPVLGACNSP----  259 (448)
T ss_pred             hhhhhhhhhccCCCcccccccc---cCcchhhhhhhhhhcchhhcchhhhhCcceeeec---CCchhhhhhhccCC----
Confidence            3456677888999999999954   6777899998887777777888999999998888   99999999999777    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeeCCCEEEe--e
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLITRAGGLKIA--D  176 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~--~~H~di~p~Nilv~~~~~~kl~--d  176 (321)
                         ..+.++..|++ |+|+..+....+--.+..++.+++.+++.+++|||+..  +.--.|++..++||++.+.++.  |
T Consensus       260 ---pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad  336 (448)
T KOG0195|consen  260 ---PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMAD  336 (448)
T ss_pred             ---CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccc
Confidence               67899999999 79999999866655789999999999999999999885  4445589999999999886653  4


Q ss_pred             cCCcccccCCCccccccccccccchhhhhcCCC---CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGY---GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      --++..      .......+.|++||.+...+-   -.++|+|||++++||+.|...||....+.+-..++.-..-.+  
T Consensus       337 ~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv--  408 (448)
T KOG0195|consen  337 TKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV--  408 (448)
T ss_pred             ceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc--
Confidence            332222      123455788999999987763   358999999999999999999998877766555443211111  


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHh
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL  308 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  308 (321)
                                             .+..++++.+..|+.-|+..||.+||.++.++
T Consensus       409 -----------------------~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  409 -----------------------HIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             -----------------------cCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                                   12235668899999999999999999988764

>KOG4158|consensus

Probab=99.92  E-value=7.7e-25  Score=180.52  Aligned_cols=195  Identities=26%  Similarity=0.328  Sum_probs=147.8

Q ss_pred             CCCceeEEEeeeeccc--------------------cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHH
Q psy2676          83 EHPNIVRFFDVIHQNI--------------------LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM  142 (321)
Q Consensus        83 ~~~~i~~~~~~~~~~~--------------------~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l  142 (321)
                      +||||+++..+|.+..                    ..-+...++|+||...+.+|..++-.+.   .+....+-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH---RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---CchHHHHHHHHHH
Confidence            6999999999987641                    1112235799999999999999998843   6888899999999


Q ss_pred             HHHHHHHHhCCceeccCCCCcEEEeeC--C--CEEEeecCCcccccCC-------CccccccccccccchhhhhcCCC--
Q psy2676         143 LKGVDFLHSHRIIHRDLKPQNLLITRA--G--GLKIADFGLAKTFDYD-------MMLTSVVVTLWYRAPEILLNLGY--  209 (321)
Q Consensus       143 ~~~l~~lh~~~~~H~di~p~Nilv~~~--~--~~kl~dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~--  209 (321)
                      ++|+.|||.+|+.|||+|++||++.-+  +  .+.+.|||+|-.-...       .......|...-+|||+....+-  
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            999999999999999999999999433  2  3899999987433221       11223456777899999876552  


Q ss_pred             ----CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchh
Q psy2676         210 ----GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSK  285 (321)
Q Consensus       210 ----~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (321)
                          -.++|.|+.|.+.||++....||.........                         .+.+.+...+.+...+++.
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-------------------------~r~Yqe~qLPalp~~vpp~  485 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-------------------------TRTYQESQLPALPSRVPPV  485 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccccchheec-------------------------hhhhhhhhCCCCcccCChH
Confidence                23799999999999999999999652211110                         1122333344445578899


Q ss_pred             HHHHHHHhcccCCCCCCCHH
Q psy2676         286 ANSLLESMLTFNPADRISAA  305 (321)
Q Consensus       286 ~~~li~~~l~~dp~~Rps~~  305 (321)
                      +++++..+|+.||++|+++.
T Consensus       486 ~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  486 ARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             HHHHHHHHhcCCccccCCcc
Confidence            99999999999999999864

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=8.7e-25  Score=173.61  Aligned_cols=183  Identities=15%  Similarity=0.121  Sum_probs=135.8

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCC-ch------hHHHHHHHHhcccCCCCcee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP-MS------TLREISILKQLDTFEHPNIV   88 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~-~~------~~~e~~~l~~l~~~~~~~i~   88 (321)
                      ..++..++|++++.+|.|+||.||++.+   ++..+++|++.......... ..      +.+|++.+.++.   |++|.
T Consensus        25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~---~~GI~   98 (232)
T PRK10359         25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR---SEGLA   98 (232)
T ss_pred             HHHHhhCceEEEEEecCCCceEEEEEec---CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH---HCCCC
Confidence            3456689999999999999999999754   46689999997654333211 11      467888888887   99999


Q ss_pred             EEEeeeecccccc-ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q psy2676          89 RFFDVIHQNILSD-ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI  166 (321)
Q Consensus        89 ~~~~~~~~~~~~~-~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv  166 (321)
                      .+.+++....... ......+++|||++| +|.++..      +++.    ...+++.+|..+|+.|++|||++|.||++
T Consensus        99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili  168 (232)
T PRK10359         99 SLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIV  168 (232)
T ss_pred             cceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEE
Confidence            9999876541110 011347899999998 8877631      3332    45699999999999999999999999999


Q ss_pred             eeCCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHH
Q psy2676         167 TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW  226 (321)
Q Consensus       167 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~  226 (321)
                      +.++ ++|+|||...........           ........+..++|+||||+.+..+.
T Consensus       169 ~~~g-i~liDfg~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        169 SKNG-LRIIDLSGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             eCCC-EEEEECCCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence            9888 999999987655322211           11444555678999999999887663

>KOG1166|consensus

Probab=99.91  E-value=4.2e-24  Score=197.98  Aligned_cols=209  Identities=22%  Similarity=0.258  Sum_probs=171.6

Q ss_pred             ccccccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCC
Q psy2676           6 ADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP   85 (321)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   85 (321)
                      +...+.-+....++.+..|.|-+.+|.|+||+||+|.+  .+++.+|+|+-+....+     .+.--.+++.+|+..--+
T Consensus       682 ~~~~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~--~~~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~  754 (974)
T KOG1166|consen  682 SRVPKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATH--SNGKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLP  754 (974)
T ss_pred             ccccccCccceeeecceeEEEEeeeccccceEEEEeec--CCCcEEEEEeecCCCce-----eeeehHHHHHhhchhhhc
Confidence            44555567788999999999999999999999999998  34999999998765544     444445555555522245


Q ss_pred             ceeEEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q psy2676          86 NIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNL  164 (321)
Q Consensus        86 ~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Ni  164 (321)
                      .|+.+..++...       ..-++|+||.+ |+|.+++..  .+.+++..+..++.||+..+++||..||+||||||+|+
T Consensus       755 ~~~~~~~a~~~~-------~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNf  825 (974)
T KOG1166|consen  755 SIMHISSAHVFQ-------NASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNF  825 (974)
T ss_pred             chHHHHHHHccC-------CcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCccee
Confidence            666766665544       55689999999 899999995  55699999999999999999999999999999999999


Q ss_pred             EEee-------CCCEEEeecCCcccc---cCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCC
Q psy2676         165 LITR-------AGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVP  230 (321)
Q Consensus       165 lv~~-------~~~~kl~dfg~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~  230 (321)
                      ++..       +..++|+|||.+.-+   .....+.....|-.+-.+|...++++++..|.|+++.+++-|++|+.
T Consensus       826 ll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  826 LLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9942       334999999988644   33345667788999999999999999999999999999999999965

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=2.7e-23  Score=163.36  Aligned_cols=141  Identities=25%  Similarity=0.264  Sum_probs=105.5

Q ss_pred             eeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCC-------Cc-----------------hhHHHHHHHHhcccC
Q psy2676          27 LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI-------PM-----------------STLREISILKQLDTF   82 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~-------~~-----------------~~~~e~~~l~~l~~~   82 (321)
                      ...||+|++|.||+|.+ . +|+.||+|+++........       ..                 ....|++.+.++.  
T Consensus         2 ~~~ig~G~~~~Vy~a~~-~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--   77 (190)
T cd05147           2 NGCISTGKEANVYHATT-A-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV--   77 (190)
T ss_pred             CCccccccceEEEEEEC-C-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH--
Confidence            57899999999999998 3 7999999999765322111       01                 1234888899887  


Q ss_pred             CCCceeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCC
Q psy2676          83 EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFL-HSHRIIHRDLK  160 (321)
Q Consensus        83 ~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~l-h~~~~~H~di~  160 (321)
                       ++++.....+...         ..++||||++| ++......  ...+++..+..++.|++.+|.++ |+.|++|+|||
T Consensus        78 -~~~v~~p~~~~~~---------~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlk  145 (190)
T cd05147          78 -TAGIPCPEPILLK---------SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLS  145 (190)
T ss_pred             -HCCCCCCcEEEec---------CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence             5554332222111         12799999997 44443322  24589999999999999999999 79999999999


Q ss_pred             CCcEEEeeCCCEEEeecCCccccc
Q psy2676         161 PQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       161 p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      |+||+++ ++.++|+|||++....
T Consensus       146 P~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         146 EYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             HHHEEEE-CCcEEEEEccccccCC
Confidence            9999998 5789999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0606|consensus

Probab=99.90  E-value=7.6e-24  Score=193.39  Aligned_cols=226  Identities=33%  Similarity=0.508  Sum_probs=170.6

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|+.++.+..|+||-||.+++ +...+++++|+=+....-.       +   ++....   .|.++           
T Consensus        81 ~e~df~~IklisngAygavylvrh-~~trqrfa~kiNkq~lilR-------n---ilt~a~---npfvv-----------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRH-KETRQRFAMKINKQNLILR-------N---ILTFAG---NPFVV-----------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeec-cccccchhhcccccchhhh-------c---cccccC---Cccee-----------
Confidence            346899999999999999999999 5788888885432211100       0   111111   22222           


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                                      |+=...+...+  .++..        ++.+++|||+-||+|+|+||+|.+|+.-|++|++|||+
T Consensus       136 ----------------gDc~tllk~~g--~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgL  189 (1205)
T KOG0606|consen  136 ----------------GDCATLLKNIG--PLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGL  189 (1205)
T ss_pred             ----------------chhhhhcccCC--CCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhh
Confidence                            33233343322  23322        27899999999999999999999999999999999999


Q ss_pred             cccccCCC----------------ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHH
Q psy2676         180 AKTFDYDM----------------MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKC  243 (321)
Q Consensus       180 ~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  243 (321)
                      +.......                ......+|+.|.|||++.-..|....|-|++|+++|+.+.|..||-+.+.++....
T Consensus       190 sk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~  269 (1205)
T KOG0606|consen  190 SKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ  269 (1205)
T ss_pred             hhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh
Confidence            86553211                12235789999999999999999999999999999999999999999999998887


Q ss_pred             HHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC---CHHHHhCCCCCCCCCCCC
Q psy2676         244 IFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI---SAADALEHPYFKEKENEP  320 (321)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~h~~f~~~~~~~  320 (321)
                      .+.-     ...|++..                   ...+++++++|.++|+.+|..|.   ++-++.+|+||+..+|..
T Consensus       270 visd-----~i~wpE~d-------------------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~  325 (1205)
T KOG0606|consen  270 VISD-----DIEWPEED-------------------EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKS  325 (1205)
T ss_pred             hhhh-----hccccccC-------------------cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccch
Confidence            7653     23333321                   24558999999999999999996   778888999999999864

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=3.9e-22  Score=155.14  Aligned_cols=187  Identities=16%  Similarity=0.044  Sum_probs=139.3

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC--CCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG--IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      +.++..|++|+||+|+.+.   .++..++.+.+........  ....+.+|+++++++..  ++++++++++        
T Consensus         4 ~~~~~~l~~~~f~~v~~~~---~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~--~~~vP~ll~~--------   70 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVR---GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDG--LPRTPRLLHW--------   70 (218)
T ss_pred             cccceeecCCCcceEEEee---cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCC--CCCCCEEEEE--------
Confidence            4577899999999999774   4788888777654322211  11146789999999974  6889999886        


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCcEEEeeCCCEEEeecCC
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDL-KPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di-~p~Nilv~~~~~~kl~dfg~  179 (321)
                         ...+++|+|+.| +|......        . ...++.|++.+|.++|++|++|+|| ||+||+++.++.++|+|||+
T Consensus        71 ---~~~~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~  138 (218)
T PRK12274         71 ---DGRHLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQL  138 (218)
T ss_pred             ---cCEEEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCC
Confidence               235899999997 66543211        1 1357789999999999999999999 79999999999999999999


Q ss_pred             cccccCCCcc--------------ccccccccccchhhhhcC-CCC-CcchHHHHHHHHHHHHhcCCCCCCC
Q psy2676         180 AKTFDYDMML--------------TSVVVTLWYRAPEILLNL-GYG-TPVDIWSIGCVMAEMWRLVPLFCAS  235 (321)
Q Consensus       180 ~~~~~~~~~~--------------~~~~~~~~y~aPE~~~~~-~~~-~~~Di~slG~~l~~l~~g~~pf~~~  235 (321)
                      +.........              .....++.+++|+...-. ..+ ...+-++.|+.+|.++|+..+..+.
T Consensus       139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            9865543321              012357778888765433 334 5678888999999999999987554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=7.6e-22  Score=155.86  Aligned_cols=142  Identities=21%  Similarity=0.211  Sum_probs=108.0

Q ss_pred             eeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCC------------------------CchhHHHHHHHHhccc
Q psy2676          26 ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI------------------------PMSTLREISILKQLDT   81 (321)
Q Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~~   81 (321)
                      +.+.||+|++|+||+|++ . +|+.||+|++.........                        ......|...+.++. 
T Consensus         1 ~~~~ig~G~~~~Vy~a~~-~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-   77 (190)
T cd05145           1 INGCISTGKEANVYHART-G-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-   77 (190)
T ss_pred             CCceeecCCCcEEEEEEc-C-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-
Confidence            357899999999999998 3 8999999999865321100                        001246788888887 


Q ss_pred             CCCCceeEEEeeeeccccccccceEEEEEeccCccC-HHH-HHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecc
Q psy2676          82 FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQD-LGS-YMEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRD  158 (321)
Q Consensus        82 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~-L~~-~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~d  158 (321)
                        ++++.....+....         .++|||+++|. +.. .+..   ..++...+..++.|++.++.++|+ .|++|+|
T Consensus        78 --~~~i~~p~~~~~~~---------~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrD  143 (190)
T cd05145          78 --EAGVPVPEPILLKK---------NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGD  143 (190)
T ss_pred             --hCCCCCceEEEecC---------CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence              77764444332211         37999999973 333 2332   347889999999999999999999 9999999


Q ss_pred             CCCCcEEEeeCCCEEEeecCCcccccC
Q psy2676         159 LKPQNLLITRAGGLKIADFGLAKTFDY  185 (321)
Q Consensus       159 i~p~Nilv~~~~~~kl~dfg~~~~~~~  185 (321)
                      |||+||+++ ++.++|+|||++...+.
T Consensus       144 lkP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         144 LSEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CChhhEEEE-CCCEEEEEcccceecCC
Confidence            999999998 88999999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=4.5e-20  Score=149.99  Aligned_cols=151  Identities=20%  Similarity=0.162  Sum_probs=112.9

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCC----------------------CchhHHHHHHH
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI----------------------PMSTLREISIL   76 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~----------------------~~~~~~e~~~l   76 (321)
                      ..+.-|.+.+.||.|++|.||+|.+...+++.||+|+++........                      ......|+..+
T Consensus        25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L  104 (237)
T smart00090       25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL  104 (237)
T ss_pred             hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence            34446899999999999999999832578999999998754321100                      01245799999


Q ss_pred             HhcccCCCCceeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-c
Q psy2676          77 KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR-I  154 (321)
Q Consensus        77 ~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~-~  154 (321)
                      +++.. ....+.++++.   .        ..++|||+++| +|......  ...+....+..++.|++.+|.+||+.| +
T Consensus       105 ~~L~~-~~i~~p~~~~~---~--------~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~i  170 (237)
T smart00090      105 QRLYE-AGVPVPKPIAW---R--------RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGEL  170 (237)
T ss_pred             HHHHh-cCCCCCeeeEe---c--------CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCE
Confidence            99872 12334444443   1        23799999998 56554433  233667778899999999999999999 9


Q ss_pred             eeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         155 IHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       155 ~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      +|+||||+||+++ ++.++|+|||.+....
T Consensus       171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      171 VHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            9999999999999 8899999999887554

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=3.6e-19  Score=141.22  Aligned_cols=141  Identities=21%  Similarity=0.301  Sum_probs=103.6

Q ss_pred             eeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhccc--CCCCceeEEEeeeecccccccc
Q psy2676          26 ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT--FEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      -...||+|++|.||.  + ..++.. ++|++.....  .....+.+|+.+++.+..  ..||||+++++++.++.   +.
T Consensus         6 ~~~~LG~G~~~~Vy~--h-p~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~---g~   76 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--H-PEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC---GT   76 (210)
T ss_pred             CcceecCCCceEEEE--C-CCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC---CC
Confidence            357899999999995  4 344444 6888765322  234578899999999941  23899999999997761   11


Q ss_pred             ceEEEEEeccCc---cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCceeccCCCCcEEEeeC----CCEEEe
Q psy2676         104 YLTVYLIFEHVD---QDLGSYMEKCPPPGLSASKVKELTRQMLKGV-DFLHSHRIIHRDLKPQNLLITRA----GGLKIA  175 (321)
Q Consensus       104 ~~~~~~v~e~~~---~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l-~~lh~~~~~H~di~p~Nilv~~~----~~~kl~  175 (321)
                      ...+.+|+|+.+   ++|.+++...   .+++.  ..++.+++.++ +|||+++|+|+||||+||+++..    +.++|+
T Consensus        77 g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         77 GYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             eEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            123447899954   5999999762   25555  35677888777 99999999999999999999743    379999


Q ss_pred             ecCCc
Q psy2676         176 DFGLA  180 (321)
Q Consensus       176 dfg~~  180 (321)
                      |++.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95433

>KOG1033|consensus

Probab=99.82  E-value=8.5e-21  Score=162.32  Aligned_cols=178  Identities=27%  Similarity=0.466  Sum_probs=136.9

Q ss_pred             eEEEEEeccCc-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         105 LTVYLIFEHVD-QDLGSYMEKC-PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       105 ~~~~~v~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      .+.||.|++|. .+|.+++..+ .....+......++.|++.|+.|   +|.+|+|++|.||+...+..++++|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            35899999999 5999999743 33447788889999999999999   9999999999999999999999999999887


Q ss_pred             ccCCC-------ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhc-CCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         183 FDYDM-------MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       183 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      .....       ..+...||..|++||.+.+..++.++||||||++|++++.- ...+..      .......    ...
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------~~t~~d~----r~g  475 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------IATLTDI----RDG  475 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------HHhhhhh----hcC
Confidence            76554       45668899999999999999999999999999999999872 222211      1111000    001


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK  314 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~  314 (321)
                      .+|.                  ....+. +.-..|+.+||.+.|.+||++.+.--|+|.+
T Consensus       476 ~ip~------------------~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  476 IIPP------------------EFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             CCCh------------------HHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence            1110                  001122 4556899999999999999888888888753

>KOG1023|consensus

Probab=99.82  E-value=1.8e-19  Score=156.85  Aligned_cols=199  Identities=21%  Similarity=0.224  Sum_probs=152.1

Q ss_pred             CCCceeEEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeccCC
Q psy2676          83 EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRI-IHRDLK  160 (321)
Q Consensus        83 ~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-~H~di~  160 (321)
                      .|.|+.++++...+.       ...++|.++|. |+|.+.+..... .+++.....++++|+.||.|+|+-.+ .||.++
T Consensus         5 ~h~n~~~f~g~~~~~-------~~~~~i~~~c~rGsl~D~i~~~~~-~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~   76 (484)
T KOG1023|consen    5 DHDNLNKFIGASVDG-------PEMIVIWEYCSRGSLLDILSNEDI-KLDYFFILSFIRDISKGLAYLHNSPIGYHGALK   76 (484)
T ss_pred             chhhhhhheeeEecC-------CceEEEEeeecCccHHhHHhcccc-CccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence            499999999999887       77899999999 799999988443 48999999999999999999997755 999999


Q ss_pred             CCcEEEeeCCCEEEeecCCcccccC---CCccccccccccccchhhhhcCC-------CCCcchHHHHHHHHHHHHhcCC
Q psy2676         161 PQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYRAPEILLNLG-------YGTPVDIWSIGCVMAEMWRLVP  230 (321)
Q Consensus       161 p~Nilv~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~l~~g~~  230 (321)
                      +.|++++....+||.|||+......   ...........-|.|||.+.+..       .+.+.|+||+|++++++++...
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            9999999999999999998876532   11112222345599999997742       4667999999999999999999


Q ss_pred             CCCCCC----hHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHH
Q psy2676         231 LFCAST----EVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD  306 (321)
Q Consensus       231 pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  306 (321)
                      ||....    ..+....+.+....+..+....                   . .+.++++..++++||..+|..||++++
T Consensus       157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~-------------------~-~e~~~~l~~l~~~cw~e~P~~rPs~~~  216 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIEL-------------------L-NELPPELLLLVARCWEEIPEKRPSIEQ  216 (484)
T ss_pred             ccccccccCChHHHHHHHHhcCCCCcCcchhh-------------------h-hhcchHHHHHHHHhcccChhhCccHHH
Confidence            997632    2233333333121222222111                   0 144468999999999999999999998


Q ss_pred             HhC
Q psy2676         307 ALE  309 (321)
Q Consensus       307 ll~  309 (321)
                      +-.
T Consensus       217 i~~  219 (484)
T KOG1023|consen  217 IRS  219 (484)
T ss_pred             HHh
Confidence            753

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=9.5e-19  Score=139.34  Aligned_cols=146  Identities=24%  Similarity=0.221  Sum_probs=108.9

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC--------------------CCchhHHHHHH
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG--------------------IPMSTLREISI   75 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~--------------------~~~~~~~e~~~   75 (321)
                      ++...+..|.+.+.||.|++|.||++..  .+++.+++|++........                    .......|..+
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   86 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALD--PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA   86 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEc--CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence            3344455689999999999999999986  3799999999765321100                    01124567888


Q ss_pred             HHhcccCCCC--ceeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy2676          76 LKQLDTFEHP--NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH  152 (321)
Q Consensus        76 l~~l~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~  152 (321)
                      +.++.   ++  .+...++.           ...++||||++| +|......        .....++.+++.++.++|+.
T Consensus        87 l~~l~---~~~i~v~~~~~~-----------~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~  144 (198)
T cd05144          87 LKALY---EEGFPVPKPIDW-----------NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH  144 (198)
T ss_pred             HHHHH---HcCCCCCceeec-----------CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC
Confidence            88886   54  34444432           234899999997 66654321        34567889999999999999


Q ss_pred             CceeccCCCCcEEEeeCCCEEEeecCCcccccC
Q psy2676         153 RIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY  185 (321)
Q Consensus       153 ~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~  185 (321)
                      |++|+||+|+||++++++.++|+|||.+.....
T Consensus       145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            999999999999999999999999999976553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=4.4e-18  Score=137.09  Aligned_cols=135  Identities=23%  Similarity=0.249  Sum_probs=106.6

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC------CCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG------IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      +.||+|++|.||++..   .+..+++|+.........      ......+|+.++..+.   ++++.....++.+.    
T Consensus         2 ~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---~~~i~~p~~~~~~~----   71 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR---KAGVNVPAVYFVDP----   71 (211)
T ss_pred             cccccCceEEEEEEee---CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH---HCCCCCCeEEEEeC----
Confidence            6789999999999975   667788997653322111      1124567888998887   88877666665444    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...+++||+++| +|.+++...     .. ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.+
T Consensus        72 ---~~~~lv~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a  141 (211)
T PRK14879         72 ---ENFIIVMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLA  141 (211)
T ss_pred             ---CCCEEEEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcc
Confidence               346899999986 999888652     22 7889999999999999999999999999999999 888999999987


Q ss_pred             cc
Q psy2676         181 KT  182 (321)
Q Consensus       181 ~~  182 (321)
                      ..
T Consensus       142 ~~  143 (211)
T PRK14879        142 EF  143 (211)
T ss_pred             cC
Confidence            65

>KOG0590|consensus

Probab=99.76  E-value=3.8e-20  Score=168.25  Aligned_cols=265  Identities=25%  Similarity=0.349  Sum_probs=203.7

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ....|.+.+.||+|+++.|-.+.........++.|.+...............|..+-+.+.+  |+|++.+++...+.  
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~--h~n~~~~~~~~~~~--   93 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSK--HSNTVHMIEPSSSP--   93 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccc--cccccccCCccCCC--
Confidence            57789999999999999999887755556666677665543333334455567777777775  99999999998777  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcEEEeeCC-CEEEee
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLH-SHRIIHRDLKPQNLLITRAG-GLKIAD  176 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh-~~~~~H~di~p~Nilv~~~~-~~kl~d  176 (321)
                           ...++.+++..| ++.+-+........+...+..++.|+..++.|+| ..++.|+|++|+|.+++..+ .++..|
T Consensus        94 -----~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~d  168 (601)
T KOG0590|consen   94 -----RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIAD  168 (601)
T ss_pred             -----cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCC
Confidence                 678999999875 7777773222224788888999999999999999 99999999999999999999 999999


Q ss_pred             cCCcccccC-CC---ccccccc-cccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCC
Q psy2676         177 FGLAKTFDY-DM---MLTSVVV-TLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       177 fg~~~~~~~-~~---~~~~~~~-~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      ||++..... ..   ......| ++.|.|||...+.. .....|+||.|+++..+++|..|+...........-      
T Consensus       169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~------  242 (601)
T KOG0590|consen  169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS------  242 (601)
T ss_pred             chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee------
Confidence            999987765 22   2334566 99999999998854 477899999999999999999999765443311000      


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                           |..           .........+..++....+++.+++..+|..|.+.+++-.+||+..
T Consensus       243 -----~~~-----------~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  243 -----WKS-----------NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             -----ecc-----------cccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                 000           0001112223456688889999999999999999999999999987

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=8e-18  Score=134.31  Aligned_cols=132  Identities=22%  Similarity=0.224  Sum_probs=98.8

Q ss_pred             eeecccceeEEEEEEecCCCcEEEEEEeecccCCCC------CCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          29 QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG------IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        29 ~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      .||+|++|.||++..   .+..+++|+.........      ......+|+++++.+.   ++++.....++...     
T Consensus         1 ~ig~G~~~~vy~~~~---~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---~~~i~~p~~~~~~~-----   69 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF---LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR---KAGVNTPVVYDVDP-----   69 (199)
T ss_pred             CCCCCceEEEEEeec---CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH---HCCCCCCEEEEEEC-----
Confidence            379999999999974   567899998654321111      0134557999999987   66544333333333     


Q ss_pred             cceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                        ...+++||+++| +|.+++....     .    .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||.+.
T Consensus        70 --~~~~lv~e~~~g~~l~~~~~~~~-----~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~  137 (199)
T TIGR03724        70 --DNKTIVMEYIEGKPLKDVIEEGN-----D----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGK  137 (199)
T ss_pred             --CCCEEEEEEECCccHHHHHhhcH-----H----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence              235899999986 8888775521     1    7899999999999999999999999999999 8899999999886


Q ss_pred             cc
Q psy2676         182 TF  183 (321)
Q Consensus       182 ~~  183 (321)
                      ..
T Consensus       138 ~~  139 (199)
T TIGR03724       138 YS  139 (199)
T ss_pred             CC
Confidence            53

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=2.4e-17  Score=150.38  Aligned_cols=139  Identities=24%  Similarity=0.223  Sum_probs=105.6

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC------CCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG------IPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ...|...+.||+|++|+||++..   .+..+++|+...+.....      ....+.+|+++++.+.   |++++....+.
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~---~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---~~~i~~p~~~~  405 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEY---LGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR---RAGVPTPVIYD  405 (535)
T ss_pred             ccccCccceeccCCcEEEEEEee---cCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc---ccCCCeeEEEE
Confidence            34567789999999999999976   233344444322211110      1234668999999998   89988777665


Q ss_pred             eccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      .+.       ...++||||++| +|.+++.          ....++.+++.+|.+||+.|++||||||+||++ .++.++
T Consensus       406 ~~~-------~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~  467 (535)
T PRK09605        406 VDP-------EEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLY  467 (535)
T ss_pred             EeC-------CCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEE
Confidence            544       345899999996 8888775          346789999999999999999999999999999 688999


Q ss_pred             EeecCCcccc
Q psy2676         174 IADFGLAKTF  183 (321)
Q Consensus       174 l~dfg~~~~~  183 (321)
                      |+|||++...
T Consensus       468 liDFGla~~~  477 (535)
T PRK09605        468 LIDFGLGKYS  477 (535)
T ss_pred             EEeCcccccC
Confidence            9999998754

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=3.8e-17  Score=129.06  Aligned_cols=140  Identities=24%  Similarity=0.251  Sum_probs=97.6

Q ss_pred             eeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCch----------------------hHHHHHHHHhcccCC
Q psy2676          26 ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMS----------------------TLREISILKQLDTFE   83 (321)
Q Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~----------------------~~~e~~~l~~l~~~~   83 (321)
                      +.+.||+|++|+||+|.+ . +++.|++|++............                      ...|...+.++... 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~-~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-   77 (187)
T cd05119           1 VGGPIGTGKEADVYLALD-G-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA-   77 (187)
T ss_pred             CCcccccccceeEEEEEC-C-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc-
Confidence            357899999999999987 3 7899999998754222111111                      12455555555421 


Q ss_pred             CCceeEEEeeeeccccccccceEEEEEeccCcc-CHH-HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCC
Q psy2676          84 HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLG-SYMEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLK  160 (321)
Q Consensus        84 ~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~-~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~  160 (321)
                      ...+.+++++.           ..++|||++++ ++. ..+....   .. ..++.++.+++.++.++|. .|++|+||+
T Consensus        78 ~~~~~~~~~~~-----------~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~  142 (187)
T cd05119          78 GVPVPKPIDLN-----------RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLS  142 (187)
T ss_pred             CCCCCceEecC-----------CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCC
Confidence            12244444431           24899999997 221 2222211   11 6778899999999999999 999999999


Q ss_pred             CCcEEEeeCCCEEEeecCCccccc
Q psy2676         161 PQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       161 p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      |+||+++ ++.++|+|||.+....
T Consensus       143 p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         143 EYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             hhhEEEE-CCcEEEEECccccccc
Confidence            9999999 8999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601|consensus

Probab=99.70  E-value=1.9e-17  Score=144.51  Aligned_cols=261  Identities=24%  Similarity=0.238  Sum_probs=202.0

Q ss_pred             cccCCcceeeeeeeec--ccceeEEEEEEe-cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          17 LDLGDKKYDELCQIGC--GAYGTVFKARDL-QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~--g~~g~v~~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      .+....+|.+...+|.  |.+|.+|.+... ...+..+++|.-+...........-.+|+...+++..  |++.++.+..
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~--~~~~v~~~~~  186 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDS--HENPVRDSPA  186 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCc--cccccccCcc
Confidence            4445577899999999  999999998651 2466788888765555544555667788888888886  9999997777


Q ss_pred             eeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCceeccCCCCcEEEeeC
Q psy2676          94 IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK----GVDFLHSHRIIHRDLKPQNLLITRA  169 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~----~l~~lh~~~~~H~di~p~Nilv~~~  169 (321)
                      +...       ...++-+|.|+.+|..+...... .++...++..+.+...    ||.++|+.+++|.|++|.||+..++
T Consensus       187 ~e~~-------~~lfiqtE~~~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~  258 (524)
T KOG0601|consen  187 WEGS-------GILFIQTELCGESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSD  258 (524)
T ss_pred             cccC-------CcceeeeccccchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccc
Confidence            7666       67899999999999888877432 3788999999999999    9999999999999999999999999


Q ss_pred             -CCEEEeecCCcccccCCCcc-c-----cccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCC--ChHHH
Q psy2676         170 -GGLKIADFGLAKTFDYDMML-T-----SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAS--TEVEQ  240 (321)
Q Consensus       170 -~~~kl~dfg~~~~~~~~~~~-~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~--~~~~~  240 (321)
                       ..++++|||....++..... .     ...+...|++||...+ .++.++|++++|.+..+..++..++...  +....
T Consensus       259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~  337 (524)
T KOG0601|consen  259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ  337 (524)
T ss_pred             cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence             88999999999888755421 1     1256778999998755 4588999999999999999987766443  22111


Q ss_pred             HHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         241 LKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ....                          .  ...+.....+.++...+..|++.+|..|+++..+.+|++..+.
T Consensus       338 ~r~~--------------------------~--ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  338 LRQG--------------------------Y--IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             cccc--------------------------c--CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            1111                          0  0111122344666779999999999999999999999998754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=4.9e-16  Score=126.67  Aligned_cols=141  Identities=17%  Similarity=0.228  Sum_probs=103.7

Q ss_pred             eeeee-cccceeEEEEEEecCCCcEEEEEEeecccC-----C------CCCCchhHHHHHHHHhcccCCCCce--eEEEe
Q psy2676          27 LCQIG-CGAYGTVFKARDLQNKGNYVAMKKLRVKLN-----E------DGIPMSTLREISILKQLDTFEHPNI--VRFFD   92 (321)
Q Consensus        27 ~~~lg-~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-----~------~~~~~~~~~e~~~l~~l~~~~~~~i--~~~~~   92 (321)
                      ...|| .|+.|+||.+..   ++..+++|.+.....     .      ........+|+.++.++.   ++++  ++.++
T Consensus        36 ~~~lg~~~g~gtv~~v~~---~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~---~~gi~vP~pl~  109 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT---PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY---EAGLPVPRPIA  109 (239)
T ss_pred             CceeecCCCCccEEEEEe---CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH---hCCCCCceeEe
Confidence            35677 899999999965   477888988854211     1      112345678999999998   6664  66666


Q ss_pred             eeeccccccccceEEEEEeccCcc--CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVDQ--DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG  170 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~~--~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~  170 (321)
                      +....   .......++|+|+++|  +|.+++..   ..+++.    .+.+|+.+|.+||+.|++|+||||.||+++.++
T Consensus       110 ~~~~~---~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~  179 (239)
T PRK01723        110 ARVVR---HGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG  179 (239)
T ss_pred             eeeee---cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC
Confidence            64332   1112234699999995  88888765   235554    356899999999999999999999999999999


Q ss_pred             CEEEeecCCcccc
Q psy2676         171 GLKIADFGLAKTF  183 (321)
Q Consensus       171 ~~kl~dfg~~~~~  183 (321)
                      .++|+|||.+...
T Consensus       180 ~v~LIDfg~~~~~  192 (239)
T PRK01723        180 KFWLIDFDRGELR  192 (239)
T ss_pred             CEEEEECCCcccC
Confidence            9999999988653

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=1.5e-15  Score=115.68  Aligned_cols=133  Identities=20%  Similarity=0.247  Sum_probs=106.8

Q ss_pred             eeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccce
Q psy2676          26 ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYL  105 (321)
Q Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~  105 (321)
                      +++.+|+|.++.||++..   ++..+++|.......    ...+.+|+..++.+... ..++++++.+....       .
T Consensus         2 ~~~~i~~g~~~~v~~~~~---~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~-~~~~p~~~~~~~~~-------~   66 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGT---KDEDYVLKINPSREK----GADREREVAILQLLARK-GLPVPKVLASGESD-------G   66 (155)
T ss_pred             cceecccccccceEEEEe---cCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHc-CCCCCeEEEEcCCC-------C
Confidence            568899999999999986   336789998754322    34788999999999831 26888888877544       4


Q ss_pred             EEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         106 TVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH---RIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       106 ~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~---~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                      ..++++|++.| .+..+         +......++.+++.+|+.+|..   +++|+|++|+||++++++.++++|||.+.
T Consensus        67 ~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          67 WSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             ccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            57999999987 44433         4566677889999999999985   69999999999999998999999999876


Q ss_pred             c
Q psy2676         182 T  182 (321)
Q Consensus       182 ~  182 (321)
                      .
T Consensus       138 ~  138 (155)
T cd05120         138 Y  138 (155)
T ss_pred             C
Confidence            4

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243|consensus

Probab=99.60  E-value=3e-14  Score=126.04  Aligned_cols=164  Identities=21%  Similarity=0.369  Sum_probs=123.1

Q ss_pred             cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEEEEeccCccCHHHHHhh
Q psy2676          45 QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK  124 (321)
Q Consensus        45 ~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~  124 (321)
                      +.++.++.+.+++.+..  .......+-+..++.++   ||||+++++.+...       ...|+|+|.+.. |..++..
T Consensus        34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlR---HP~Il~yL~t~e~~-------~~~ylvTErV~P-l~~~lk~  100 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLR---HPNILSYLDTTEEE-------GTLYLVTERVRP-LETVLKE  100 (690)
T ss_pred             eccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhcc---Cchhhhhhhhhccc-------CceEEEeecccc-HHHHHHH
Confidence            46788888888765432  22334556666677777   99999999999877       689999999874 4556655


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCCc-cccccccccccchh
Q psy2676         125 CPPPGLSASKVKELTRQMLKGVDFLH-SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM-LTSVVVTLWYRAPE  202 (321)
Q Consensus       125 ~~~~~~~~~~~~~i~~~l~~~l~~lh-~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE  202 (321)
                           +....+...+.||+.||.+|| +.+++|++|+-+.|+|++.|+.||++|..+........ ......--.|..|+
T Consensus       101 -----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~  175 (690)
T KOG1243|consen  101 -----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE  175 (690)
T ss_pred             -----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence                 447778888999999999997 67899999999999999999999999998866543332 11112222356666


Q ss_pred             hhhcCCCCCcchHHHHHHHHHHHHhc
Q psy2676         203 ILLNLGYGTPVDIWSIGCVMAEMWRL  228 (321)
Q Consensus       203 ~~~~~~~~~~~Di~slG~~l~~l~~g  228 (321)
                      .+....  ...|.|.|||++++++.|
T Consensus       176 ~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  176 EIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hcCccc--cchhhhhHHHHHHHHhCc
Confidence            543322  457999999999999999

>KOG1266|consensus

Probab=99.56  E-value=4e-15  Score=120.71  Aligned_cols=201  Identities=23%  Similarity=0.232  Sum_probs=141.3

Q ss_pred             CCceeEEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC--Cceecc
Q psy2676          84 HPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--PPGLSASKVKELTRQMLKGVDFLHSH--RIIHRD  158 (321)
Q Consensus        84 ~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~~--~~~H~d  158 (321)
                      |.|+++++.|+.+.  .......+.+++||+. |++..++++..  ...+......+++.||+.||.|||+.  -++|++
T Consensus       126 HsnlvkfH~yw~d~--K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgn  203 (458)
T KOG1266|consen  126 HSNLVKFHKYWTDK--KYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGN  203 (458)
T ss_pred             HHHHHHHHHhhccc--ccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCC
Confidence            99999999998665  2223346788999999 79988887532  34488899999999999999999988  499999


Q ss_pred             CCCCcEEEeeCCCEEEeecCCccccc-----CCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCC
Q psy2676         159 LKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFC  233 (321)
Q Consensus       159 i~p~Nilv~~~~~~kl~dfg~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  233 (321)
                      ++.+.|++..+|-+|++--.......     .........+.++|.+||.=.....+.++|||++|+...+|..+..--.
T Consensus       204 lTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~t  283 (458)
T KOG1266|consen  204 LTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQST  283 (458)
T ss_pred             cchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccC
Confidence            99999999988888886432221111     1112223455778999997666667789999999999999988765432


Q ss_pred             C-CChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q psy2676         234 A-STEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY  312 (321)
Q Consensus       234 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  312 (321)
                      . ....+.-..+.+.+...                              -...-+.++.+||...|..||++.+++.||-
T Consensus       284 nseS~~~~ee~ia~~i~~l------------------------------en~lqr~~i~kcl~~eP~~rp~ar~llfHpl  333 (458)
T KOG1266|consen  284 NSESKVEVEENIANVIIGL------------------------------ENGLQRGSITKCLEGEPNGRPDARLLLFHPL  333 (458)
T ss_pred             CCcceeehhhhhhhheeec------------------------------cCccccCcCcccccCCCCCCcchhhhhcCce
Confidence            2 11111111111111000                              0022236799999999999999999999997


Q ss_pred             CCCC
Q psy2676         313 FKEK  316 (321)
Q Consensus       313 f~~~  316 (321)
                      +=+.
T Consensus       334 lfeV  337 (458)
T KOG1266|consen  334 LFEV  337 (458)
T ss_pred             eeec
Confidence            6544

>KOG0606|consensus

Probab=99.54  E-value=3.1e-15  Score=137.87  Aligned_cols=267  Identities=27%  Similarity=0.338  Sum_probs=187.8

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      ....+.+.+.+-+.+|+++.++.+.- ...+.....|+...... ..........+-+++-...   +|-++...--+  
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~p-a~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~---~P~v~~~~~s~--  873 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASP-AGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR---SPAVVRSFPSF--  873 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCc-cccccccchhhhccchhhccccccccCCccCccccCC---CCceecccCCC--
Confidence            35567888999999999999998865 34443444443322100 0001111221111111111   23333322221  


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                           ....-.++++++.++ +|...+...+  ..+++-++..+..+..++++||+..+.|+|++|.|.++..++..++.
T Consensus       874 -----~~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~  946 (1205)
T KOG0606|consen  874 -----PCRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLT  946 (1205)
T ss_pred             -----CCCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccC
Confidence                 112457899999985 8888887744  46777888888899999999999999999999999999999999999


Q ss_pred             ecCCcccccCC--------------------------------CccccccccccccchhhhhcCCCCCcchHHHHHHHHH
Q psy2676         176 DFGLAKTFDYD--------------------------------MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMA  223 (321)
Q Consensus       176 dfg~~~~~~~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~  223 (321)
                      ||+.....+.-                                .......+|+.|.+||...+......+|.|++|++++
T Consensus       947 ~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~ 1026 (1205)
T KOG0606|consen  947 DFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLF 1026 (1205)
T ss_pred             ccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhh
Confidence            99843222100                                0122346789999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC
Q psy2676         224 EMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS  303 (321)
Q Consensus       224 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  303 (321)
                      +.++|.+||...........+.+.  ..   .|+..                   ....+.++++++...|..+|.+|..
T Consensus      1027 e~l~g~pp~na~tpq~~f~ni~~~--~~---~~p~g-------------------~~~~s~~aq~~~~~ll~~~~~qr~~ 1082 (1205)
T KOG0606|consen 1027 EVLTGIPPFNAETPQQIFENILNR--DI---PWPEG-------------------PEEGSYEAQDLINRLLTEEPTQRLG 1082 (1205)
T ss_pred             hhhcCCCCCCCcchhhhhhccccC--CC---CCCCC-------------------ccccChhhhhhhhhhhccCchhccC
Confidence            999999999988877766554432  11   22221                   1245588999999999999999998


Q ss_pred             HH---HHhCCCCCCCCCCCCC
Q psy2676         304 AA---DALEHPYFKEKENEPL  321 (321)
Q Consensus       304 ~~---~ll~h~~f~~~~~~~~  321 (321)
                      +.   ++-.|+||+...|++|
T Consensus      1083 a~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1083 AKGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred             cccccccccCCccCCCCcccc
Confidence            88   8999999999999875

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.53  E-value=1.6e-13  Score=106.97  Aligned_cols=142  Identities=19%  Similarity=0.192  Sum_probs=100.2

Q ss_pred             eeeeecccceeEEEEEEecC-----CCcEEEEEEeecccCCC---------C-----------CCchh----HHHHHHHH
Q psy2676          27 LCQIGCGAYGTVFKARDLQN-----KGNYVAMKKLRVKLNED---------G-----------IPMST----LREISILK   77 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~~~-----~~~~~~iK~~~~~~~~~---------~-----------~~~~~----~~e~~~l~   77 (321)
                      ...||.|--+.||.|.....     .+..+|+|+++.....-         +           ....+    .+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            45789999999999976211     35799999986442110         0           01122    26888998


Q ss_pred             hcccCCCCceeEEEeeeeccccccccceEEEEEeccCccC-HH-HHHhhCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCc
Q psy2676          78 QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQD-LG-SYMEKCPPPGLSASKVKELTRQMLKGVDFL-HSHRI  154 (321)
Q Consensus        78 ~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~-L~-~~~~~~~~~~~~~~~~~~i~~~l~~~l~~l-h~~~~  154 (321)
                      ++...+ -++.+++++ .          .-++|||+++++ +. ..+..   ..+++.++..+..+++.+|..| |+.|+
T Consensus        82 rl~~~G-v~vP~pi~~-~----------~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~gl  146 (197)
T cd05146          82 RMQKAG-IPCPEVVVL-K----------KHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNL  146 (197)
T ss_pred             HHHHcC-CCCCeEEEe-c----------CCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCe
Confidence            887532 345555554 1          238999999863 21 22222   2356667788889999999998 89999


Q ss_pred             eeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         155 IHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       155 ~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      +||||++.||+++ ++.++++|||.+....
T Consensus       147 VHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         147 VHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             ecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            9999999999997 5789999999887665

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.49  E-value=2.5e-12  Score=108.29  Aligned_cols=264  Identities=10%  Similarity=0.046  Sum_probs=166.1

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ..+.-....+.||+|+.+.+|-.-.    -...+-|++....     .........+|.+...  ||-+..-+.+-...-
T Consensus         8 ~~ge~i~~gr~LgqGgea~ly~l~e----~~d~VAKIYh~Pp-----pa~~aqk~a~la~~p~--~p~~~~rvaWPqa~L   76 (637)
T COG4248           8 VYGEPIPPGRPLGQGGEADLYTLGE----VRDQVAKIYHAPP-----PAAQAQKVAELAATPD--APLLNYRVAWPQATL   76 (637)
T ss_pred             ccCcccCCCccccCCccceeeecch----hhchhheeecCCC-----chHHHHHHHHhccCCC--CcchhhhhcccHHHh
Confidence            3344456678999999999997632    2234667765431     2223344455544442  554443222211111


Q ss_pred             cccccceEEEEEeccCcc--CHHHHHhh----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          99 LSDERYLTVYLIFEHVDQ--DLGSYMEK----CPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~--~L~~~~~~----~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      ........+.++|+.+.|  ....+..-    +.-+..++..+.+.++.|+.+.+.||..|.+-||++++|++|++++.+
T Consensus        77 ~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V  156 (637)
T COG4248          77 HGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKV  156 (637)
T ss_pred             hCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceE
Confidence            112222347888988886  44444321    223347899999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCccccccccccccchhhhhc-----CCCCCcchHHHHHHHHHHHHhc-CCCCCCCC-------hHH
Q psy2676         173 KIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN-----LGYGTPVDIWSIGCVMAEMWRL-VPLFCAST-------EVE  239 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~-------~~~  239 (321)
                      .|+|=..-.............+...|.+||...-     -.-+..+|.|.||+++++++.| +.||++-.       ..+
T Consensus       157 ~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E  236 (637)
T COG4248         157 VLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE  236 (637)
T ss_pred             EEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence            9998654444344555667788999999998752     3346789999999999999987 99997631       111


Q ss_pred             HHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhccc--CCCCCCCHHH
Q psy2676         240 QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTF--NPADRISAAD  306 (321)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--dp~~Rps~~~  306 (321)
                      .  .|..+...    .       ...+-..+.....+..+.-.++++..++.+|+..  ++.-|||++.
T Consensus       237 ~--~Ia~g~f~----y-------a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         237 T--DIAHGRFA----Y-------ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             h--hhhcceee----e-------chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            0  00000000    0       0000011111222233445678899999999875  3568998764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.49  E-value=2.9e-13  Score=119.79  Aligned_cols=146  Identities=21%  Similarity=0.286  Sum_probs=96.7

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCC---------------------CC-----------------Cchh
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED---------------------GI-----------------PMST   69 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~---------------------~~-----------------~~~~   69 (321)
                      +.||.|++|+||+|+.  .+|+.||||+.+......                     ..                 +.++
T Consensus       123 ~plasaSigQVh~A~l--~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       123 KPLAAASIAQVHRARL--VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             cceeeeehhheEEEEe--cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            5799999999999987  478999999985432110                     00                 0123


Q ss_pred             HHHHHHHHhccc-CCCCceeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHH-HH
Q psy2676          70 LREISILKQLDT-FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLK-GV  146 (321)
Q Consensus        70 ~~e~~~l~~l~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~-~l  146 (321)
                      .+|...+.++.. +.+..-+.+-..+.+-   +   ...++||||++| +|.+.......+ .+   ...++.+++. .+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~---~---~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDR---T---SERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhh---c---CCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHH
Confidence            345555555542 1122223333333221   0   235899999997 787766542111 22   2345555555 47


Q ss_pred             HHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccC
Q psy2676         147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY  185 (321)
Q Consensus       147 ~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~  185 (321)
                      ..+|..|++|+|++|.||+++.++.++++|||++...+.
T Consensus       271 ~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       271 NQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            889999999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=4.4e-13  Score=104.10  Aligned_cols=128  Identities=19%  Similarity=0.185  Sum_probs=93.2

Q ss_pred             eeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          27 LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      ++.++.|..+.||+++.   .+..+++|+......   .......|+.+++.+..  ...+.+++.....         .
T Consensus         3 ~~~l~~G~~~~vy~~~~---~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~--~~~~P~~~~~~~~---------~   65 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV---ANKKYVVRIPGNGTE---LLINRENEAENSKLAAE--AGIGPKLYYFDPE---------T   65 (170)
T ss_pred             eeecCCcccCceEEEEE---CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHH--hCCCCceEEEeCC---------C
Confidence            56789999999999975   477899998754321   23356789999999873  2224455544321         1


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRI-----IHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-----~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                      -++|||+++| ++...  .     ..   ...++.+++.+|..||+.++     +|+|++|.||+++ ++.++++||+.+
T Consensus        66 ~~lv~e~i~G~~l~~~--~-----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a  134 (170)
T cd05151          66 GVLITEFIEGSELLTE--D-----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYA  134 (170)
T ss_pred             CeEEEEecCCCccccc--c-----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccc
Confidence            3799999998 54432  0     11   13456789999999999985     9999999999998 678999999987


Q ss_pred             cc
Q psy2676         181 KT  182 (321)
Q Consensus       181 ~~  182 (321)
                      ..
T Consensus       135 ~~  136 (170)
T cd05151         135 GM  136 (170)
T ss_pred             cC
Confidence            64

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3087|consensus

Probab=99.45  E-value=7.6e-13  Score=99.31  Aligned_cols=145  Identities=21%  Similarity=0.245  Sum_probs=105.7

Q ss_pred             eeeeeecccceeEEEEEEecCCCcEEEEEEe-ecccCC-----CCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          26 ELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNE-----DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~-~~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ....+.+|+-+.|+++.   ..|+.++||.- .+.-..     .-......+|+..+.++..+   .|.-..-+|.|.  
T Consensus        11 ~l~likQGAEArv~~~~---~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~---GI~~P~l~~~D~--   82 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS---FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL---GIPAPRLIFIDT--   82 (229)
T ss_pred             cceeeeccceeeEeeec---cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh---CCCCceEEEEec--
Confidence            67788999999999994   57777777743 222111     11233456788888887743   344333344444  


Q ss_pred             ccccceEEEEEeccCcc--CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC---EEE
Q psy2676         100 SDERYLTVYLIFEHVDQ--DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKI  174 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~--~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~---~kl  174 (321)
                           ..-.++||+++|  ++.+++...-.......-...++.+|-+.+.-||..+++||||+.+||++..++.   +.+
T Consensus        83 -----~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~l  157 (229)
T KOG3087|consen   83 -----YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPIL  157 (229)
T ss_pred             -----CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEE
Confidence                 344799999998  8999987765544455555889999999999999999999999999999977664   589


Q ss_pred             eecCCcccc
Q psy2676         175 ADFGLAKTF  183 (321)
Q Consensus       175 ~dfg~~~~~  183 (321)
                      +|||++..-
T Consensus       158 Idfgls~~s  166 (229)
T KOG3087|consen  158 IDFGLSSVS  166 (229)
T ss_pred             Eeecchhcc
Confidence            999988653

>KOG3741|consensus

Probab=99.45  E-value=1e-11  Score=107.13  Aligned_cols=218  Identities=18%  Similarity=0.220  Sum_probs=152.7

Q ss_pred             cceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEEEEecc
Q psy2676          34 AYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEH  113 (321)
Q Consensus        34 ~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~  113 (321)
                      .-.+.|++.. ..+|..|++|++..  ...........-+++.+++.   |+|++++.++|...-...   ..+++|++|
T Consensus       288 ~~~Ttyk~~s-~~DG~~YvLkRlhg--~r~~~~nk~t~lve~wkkl~---h~NvV~frevf~t~tF~D---~SlvlvYDY  358 (655)
T KOG3741|consen  288 FSITTYKATS-NVDGNAYVLKRLHG--DRDQSTNKDTSLVEAWKKLC---HTNVVPFREVFLTYTFGD---LSLVLVYDY  358 (655)
T ss_pred             ccceeEeeee-ccCCceeeeeeecc--ccccCcccchHHHHHHHHhc---cCceeehhhhhhhhccCc---ceEEEEEec
Confidence            3468899998 68999999999832  12222334455677888888   999999999997331111   568999999


Q ss_pred             Ccc--CHHHHHhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         114 VDQ--DLGSYMEKCP-------------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       114 ~~~--~L~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                      .++  +|.++.-...             +...+++.+|.++.||..||.++|+.|+..+-|.|.+|+++.+..+++...|
T Consensus       359 yP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~  438 (655)
T KOG3741|consen  359 YPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCG  438 (655)
T ss_pred             CCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEeccc
Confidence            994  8888764321             2236789999999999999999999999999999999999999999999888


Q ss_pred             CcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      .......+..           +|  +.   --.+-|.=.||.+++.|.+|..--...+.....                 
T Consensus       439 i~Dvl~~d~~-----------~~--le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s-----------------  485 (655)
T KOG3741|consen  439 IMDVLQEDPT-----------EP--LE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSS-----------------  485 (655)
T ss_pred             ceeeecCCCC-----------cc--hh---HHhhhhHHHHHHHHHHHhhcccccccccchHHH-----------------
Confidence            7766553330           11  00   123679999999999999996532111111110                 


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                     ....+...++.+++++|.-+...++++ -++.+++.
T Consensus       486 ---------------~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp  520 (655)
T KOG3741|consen  486 ---------------HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP  520 (655)
T ss_pred             ---------------HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence                           011122345577778888877777776 56666654

>KOG2137|consensus

Probab=99.38  E-value=1.2e-13  Score=122.66  Aligned_cols=154  Identities=18%  Similarity=0.300  Sum_probs=115.9

Q ss_pred             HHHHHHHHHHh-CCceeccCCCCcEEEeeCCCEEEeecCCcccccCCCc----------cccccccccccchhhhhcCCC
Q psy2676         141 QMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM----------LTSVVVTLWYRAPEILLNLGY  209 (321)
Q Consensus       141 ~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~  209 (321)
                      +++.|+.++|. .++||++|.|++|.++.++.+|++.|+++....+...          .........|.+||.+.....
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            34489999994 5999999999999999999999999999876654211          112334667999999999889


Q ss_pred             CCcchHHHHHHHHHHHH-hcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHH
Q psy2676         210 GTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANS  288 (321)
Q Consensus       210 ~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (321)
                      +.++|+||+|+++|.+. .|+..+.+..............+.                       .......++|+++++
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~-----------------------~~~~~s~~~p~el~~  243 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA-----------------------GAFGYSNNLPSELRE  243 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc-----------------------ccccccccCcHHHHH
Confidence            99999999999999999 455555544333322221111110                       011112578899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         289 LLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       289 li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      =+.+++..++.-||++..++..|||+...
T Consensus       244 ~l~k~l~~~~~~rp~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  244 SLKKLLNGDSAVRPTLDLLLSIPFFSDPG  272 (700)
T ss_pred             HHHHHhcCCcccCcchhhhhcccccCCch
Confidence            99999999999999999999999998753

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.37  E-value=2.2e-13  Score=121.96  Aligned_cols=148  Identities=20%  Similarity=0.296  Sum_probs=94.8

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC---------------------CC-----------------
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE---------------------DG-----------------   64 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~---------------------~~-----------------   64 (321)
                      .|+. +.||+|++|+||+|+. ..+|+.||||+.+.....                     ..                 
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l-~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARL-KDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEE-CCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            4666 7899999999999998 456999999999754210                     00                 


Q ss_pred             CCchhHHHHHHHHhccc-CCCCceeEEEeeeeccccccccceEEEEEeccCcc-CHHHHH--hhCCC--CCCCHHHHHHH
Q psy2676          65 IPMSTLREISILKQLDT-FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM--EKCPP--PGLSASKVKEL  138 (321)
Q Consensus        65 ~~~~~~~e~~~l~~l~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~--~~~~~--~~~~~~~~~~i  138 (321)
                      .+.++.+|+..+.++.. +.+...+.+-.++.+-   +   ...++||||+.| .+.+.-  ...+.  ..+.+..+..+
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~---s---t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~  272 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY---C---SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF  272 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc---C---CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH
Confidence            00123445555555542 1233334444444321   0   345899999997 776642  22110  01233333333


Q ss_pred             HHHHHHHHHHHHhCCceeccCCCCcEEEeeCC----CEEEeecCCcccccC
Q psy2676         139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDY  185 (321)
Q Consensus       139 ~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~----~~kl~dfg~~~~~~~  185 (321)
                      +.|       +...|++|+|+||.||+++.++    .++++|||++...+.
T Consensus       273 ~~Q-------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        273 FTQ-------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHH-------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            444       4469999999999999999988    899999999987754

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.36  E-value=3.3e-12  Score=96.33  Aligned_cols=132  Identities=23%  Similarity=0.262  Sum_probs=91.4

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecc-cCCCC-----CCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK-LNEDG-----IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~-~~~~~-----~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ..+++|+-+.++.+..   -+.++++|.=..+ -....     ......+|+.++.++..+ --+...++++  ++    
T Consensus         2 ~~i~~GAEa~i~~~~~---~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~-GV~~P~v~dv--D~----   71 (204)
T COG3642           2 DLIKQGAEAIIYLTDF---LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREA-GVPVPIVYDV--DP----   71 (204)
T ss_pred             chhhCCcceeEEeeec---cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHc-CCCCCeEEEE--cC----
Confidence            3578899999998843   3444666643222 11111     123445799999888743 2233334444  34    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ....++|||++| .|.+++...     .    ..++..+-..+.-||..||+||||+++||++..++ +.++|||++
T Consensus        72 ---~~~~I~me~I~G~~lkd~l~~~-----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg  138 (204)
T COG3642          72 ---DNGLIVMEYIEGELLKDALEEA-----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLG  138 (204)
T ss_pred             ---CCCEEEEEEeCChhHHHHHHhc-----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcc
Confidence               345799999998 777788773     1    45777788888999999999999999999997554 999999998


Q ss_pred             cc
Q psy2676         181 KT  182 (321)
Q Consensus       181 ~~  182 (321)
                      ..
T Consensus       139 ~~  140 (204)
T COG3642         139 EF  140 (204)
T ss_pred             cc
Confidence            64

>KOG0601|consensus

Probab=99.36  E-value=3.8e-13  Score=117.80  Aligned_cols=254  Identities=21%  Similarity=0.209  Sum_probs=179.3

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ...+|..+..||.|.++.|+.+.....++..|++|..............-..|+.+...+..  |.+++..+..+...  
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~--~~~~~g~~~~W~~~--  338 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGS--HLPSVGKNSSWSQL--  338 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhc--ccccCCCCCCcccc--
Confidence            34679999999999999999887423678888888876655444444445567777777775  88888877766544  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC-CCEEEeec
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA-GGLKIADF  177 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~-~~~kl~df  177 (321)
                           ...++-.|+|.+ ++......  ...+++...+++..|++.++.++|+..++|+|++|+||++..+ +..+++||
T Consensus       339 -----r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  339 -----RQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             -----ccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccc
Confidence                 445688899975 44443322  2237888999999999999999999999999999999999876 67899999


Q ss_pred             CCcccccCCCccccccccccc-cchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWY-RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      ++.+...-. .......+..| .++..........+.|++|||.-+.+.+++.+.-........+..     +     ..
T Consensus       412 ~~~t~~~~~-~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~-----~-----~~  480 (524)
T KOG0601|consen  412 GCWTRLAFS-SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRS-----G-----DT  480 (524)
T ss_pred             cccccccee-cccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeec-----c-----cc
Confidence            988653211 11112223333 355555666788899999999999999988665433222111100     0     00


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                                          ....+....+..+.+.+..+++..||.+.++..|+=|-.
T Consensus       481 --------------------p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  481 --------------------PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             --------------------cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                                001122266778889999999999999999998876643

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.31  E-value=3.7e-11  Score=99.08  Aligned_cols=139  Identities=17%  Similarity=0.118  Sum_probs=94.6

Q ss_pred             EEEEEEecCCCcEEEEEEeecccCCC---------CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEE
Q psy2676          38 VFKARDLQNKGNYVAMKKLRVKLNED---------GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVY  108 (321)
Q Consensus        38 v~~~~~~~~~~~~~~iK~~~~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  108 (321)
                      |.++.   .+|+.+.+|.........         .......+|...+.++...+.|- ++++++....  ........+
T Consensus        38 vvr~~---~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIpt-P~pVa~~e~~--~~~~~~~s~  111 (268)
T PRK15123         38 TLRFE---LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDT-MTGVAFGERG--SNPATRTSF  111 (268)
T ss_pred             EEEEE---ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCC-CCeeEEEEec--CCCccceeE
Confidence            55553   466788888764322110         11124778999998886432222 2333333222  111123568


Q ss_pred             EEeccCcc--CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee-------CCCEEEeecCC
Q psy2676         109 LIFEHVDQ--DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR-------AGGLKIADFGL  179 (321)
Q Consensus       109 ~v~e~~~~--~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~-------~~~~kl~dfg~  179 (321)
                      +|+|++++  +|.+++........+......++.+++..+..||..|++|+|+++.||+++.       +..+.|+||+.
T Consensus       112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            99999997  7999886433334567788899999999999999999999999999999985       45799999997


Q ss_pred             ccc
Q psy2676         180 AKT  182 (321)
Q Consensus       180 ~~~  182 (321)
                      +..
T Consensus       192 ~~~  194 (268)
T PRK15123        192 AQI  194 (268)
T ss_pred             ccc
Confidence            753

>PRK09902 hypothetical protein; Provisional

Probab=99.29  E-value=1.2e-10  Score=91.12  Aligned_cols=145  Identities=12%  Similarity=0.115  Sum_probs=107.9

Q ss_pred             ecccceeEEEEEEecCCCcEEEEEEeecccCC----CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          31 GCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE----DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        31 g~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      |+|+-|.|+....   .|..+-+|.-.-....    ......+.+|...++++...+-| +.++. ++... . .+....
T Consensus        27 ~rgG~SgV~r~~~---~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pv-f~~~~-k-~~~~~r   99 (216)
T PRK09902         27 RRNGMSGVQCVER---NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIV-FGEAV-K-IEGEWR   99 (216)
T ss_pred             CCCCcceEEEEEe---CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccc-eeeee-c-cCCceE
Confidence            6688888998754   4446777765421111    22456888999999999876666 55555 33211 1 122356


Q ss_pred             EEEEeccCcc--CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC--EEEeecCCccc
Q psy2676         107 VYLIFEHVDQ--DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG--LKIADFGLAKT  182 (321)
Q Consensus       107 ~~~v~e~~~~--~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~--~kl~dfg~~~~  182 (321)
                      .++|+|-++|  +|.+++....-...+......++.+++.++.-||+.|+.|+|+.+.||+++.++.  +.++||.-+..
T Consensus       100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            7899999985  9999987754445688888999999999999999999999999999999987777  99999986643

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.27  E-value=3.2e-11  Score=93.82  Aligned_cols=130  Identities=25%  Similarity=0.271  Sum_probs=81.8

Q ss_pred             eEEEEEEecCCCcEEEEEEeecccCCC----------CC--------------CchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          37 TVFKARDLQNKGNYVAMKKLRVKLNED----------GI--------------PMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        37 ~v~~~~~~~~~~~~~~iK~~~~~~~~~----------~~--------------~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      .||.|..  .++..+|+|+.+.....-          ..              .....+|.+.|.++...+ -++.++++
T Consensus         1 ~Vy~~~~--~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~G-v~vP~p~~   77 (188)
T PF01163_consen    1 DVYHAID--PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAG-VPVPKPYD   77 (188)
T ss_dssp             EEEEEEE--CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT--SS--EEE
T ss_pred             CEEEEEC--CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCC-ccCCcEEE
Confidence            3788876  678899999986542111          00              012456999999998532 24566665


Q ss_pred             eeeccccccccceEEEEEeccCc--cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCcEEEeeC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD--QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDF-LHSHRIIHRDLKPQNLLITRA  169 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~--~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~-lh~~~~~H~di~p~Nilv~~~  169 (321)
                      +- .          -++||||++  |.....+....   ++......++.+++..+.. +|..|++|||+++.||+++++
T Consensus        78 ~~-~----------~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~  143 (188)
T PF01163_consen   78 YN-R----------NVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG  143 (188)
T ss_dssp             EE-T----------TEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT
T ss_pred             Ee-C----------CEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc
Confidence            52 2          279999999  73333343311   2245567777888885444 689999999999999999877


Q ss_pred             CCEEEeecCCccccc
Q psy2676         170 GGLKIADFGLAKTFD  184 (321)
Q Consensus       170 ~~~kl~dfg~~~~~~  184 (321)
                       .+.++|||.+....
T Consensus       144 -~~~iIDf~qav~~~  157 (188)
T PF01163_consen  144 -KVYIIDFGQAVDSS  157 (188)
T ss_dssp             -CEEE--GTTEEETT
T ss_pred             -eEEEEecCcceecC
Confidence             99999999887655

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.25  E-value=1.1e-10  Score=94.62  Aligned_cols=145  Identities=19%  Similarity=0.255  Sum_probs=103.4

Q ss_pred             eeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          27 LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      ++.++.|..+.+|+++.  .++..+++|+....... ........|.++++.+... +..+.+++.+.....    ....
T Consensus         3 ~~~l~~G~~n~~~~v~~--~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~-~~~vp~~~~~~~~~~----~~~~   74 (223)
T cd05154           3 VRQLSGGQSNLTYLLTA--GGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGT-GVPVPKVLALCEDPS----VLGT   74 (223)
T ss_pred             ceecCCCccceEEEEEe--cCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCC-CCCCCCEEEECCCCC----ccCC
Confidence            36789999999999976  33578999987543221 2345778999999999842 234566666654321    0124


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH---------------------------------  152 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~---------------------------------  152 (321)
                      .++|+|+++| ++.+.+..   ..+++.+...++.+++.+|..||+.                                 
T Consensus        75 ~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (223)
T cd05154          75 PFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT  151 (223)
T ss_pred             ceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence            5899999997 66665432   2367777777788888888888732                                 


Q ss_pred             -----------------------CceeccCCCCcEEEee--CCCEEEeecCCccc
Q psy2676         153 -----------------------RIIHRDLKPQNLLITR--AGGLKIADFGLAKT  182 (321)
Q Consensus       153 -----------------------~~~H~di~p~Nilv~~--~~~~kl~dfg~~~~  182 (321)
                                             .++|+|++|.||+++.  ++.+.++||+.+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                   3699999999999998  56689999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.23  E-value=2.8e-11  Score=96.85  Aligned_cols=143  Identities=22%  Similarity=0.252  Sum_probs=105.9

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC--------------------CCCCchhHHHHHHHHhc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE--------------------DGIPMSTLREISILKQL   79 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~--------------------~~~~~~~~~e~~~l~~l   79 (321)
                      -+.-..+...||-|--|.||.|.+  .++.++++|.-+....+                    .-......+|.++|.+|
T Consensus        89 r~~ve~iG~~IGvGKEsdVY~~~~--~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L  166 (304)
T COG0478          89 RGIVEAIGTKIGVGKESDVYVAID--PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL  166 (304)
T ss_pred             cChHHhhccccccCccceEEEEEC--CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence            334467789999999999999987  57899999975322111                    01223456899999999


Q ss_pred             ccCCC-CceeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy2676          80 DTFEH-PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHR  157 (321)
Q Consensus        80 ~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~  157 (321)
                      ..  . -.+.+.+++           ..-.+|||+++| .|...-       ++.+....++..|+.-+..+-..|++||
T Consensus       167 ~~--~G~~VP~P~~~-----------nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHG  226 (304)
T COG0478         167 YP--EGVKVPKPIAW-----------NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHG  226 (304)
T ss_pred             hh--cCCCCCCcccc-----------ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCcccc
Confidence            73  2 256666665           345899999998 443322       2355556677777887888889999999


Q ss_pred             cCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         158 DLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       158 di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      |+++-||++++||.+.++||..+...+
T Consensus       227 DlSefNIlV~~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         227 DLSEFNILVTEDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             CCchheEEEecCCCEEEEeCcccccCC
Confidence            999999999999999999999887655

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.21  E-value=5e-10  Score=89.47  Aligned_cols=111  Identities=23%  Similarity=0.304  Sum_probs=85.9

Q ss_pred             CchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEEEEeccCcc--CHHHHHhhCCCCCCCHHHHHHHHHHHH
Q psy2676          66 PMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ--DLGSYMEKCPPPGLSASKVKELTRQML  143 (321)
Q Consensus        66 ~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~--~L~~~~~~~~~~~~~~~~~~~i~~~l~  143 (321)
                      .....+|...+..+...+-| .++.+++....  .... ...++|+|.+++  +|.+++.....  .+......++.+++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~-tP~pva~~~~r--~~~~-~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~  128 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIP-TPEPVAYGERR--KGGG-YRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALA  128 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCC-CCcEEEEEEEc--CCCc-eeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHH
Confidence            44677888888887743232 44555555443  1122 456899999996  79999887443  67778899999999


Q ss_pred             HHHHHHHhCCceeccCCCCcEEEeeCC---CEEEeecCCccc
Q psy2676         144 KGVDFLHSHRIIHRDLKPQNLLITRAG---GLKIADFGLAKT  182 (321)
Q Consensus       144 ~~l~~lh~~~~~H~di~p~Nilv~~~~---~~kl~dfg~~~~  182 (321)
                      ..+.-||..|++|+|+++.||+++.++   .+.|+||+-+..
T Consensus       129 ~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  129 RLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999999999999887   799999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=99.10  E-value=6.7e-10  Score=87.23  Aligned_cols=148  Identities=16%  Similarity=0.199  Sum_probs=96.7

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCC-------CchhHHHHHHHHhcccCCCCceeEE
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI-------PMSTLREISILKQLDTFEHPNIVRF   90 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~~~~i~~~   90 (321)
                      ++..++|.+.+.+.......|.+..   .++..+++|.++........       .....+.+....++.....-..+.+
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIe---i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~  103 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIE---IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP  103 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEE---ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence            4566889999999999998888874   57889999988654211100       0112334444444443334444444


Q ss_pred             EeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA  169 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~  169 (321)
                      +.+....  ........++++||++| .|.+...      +++    .+...+.+++.-+|+.|++|||.+|.|++++. 
T Consensus       104 yl~~ekk--~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-  170 (229)
T PF06176_consen  104 YLAAEKK--IFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-  170 (229)
T ss_pred             eeeeeee--eccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-
Confidence            4433322  11111345689999998 6655432      233    24456778899999999999999999999985 


Q ss_pred             CCEEEeecCCcc
Q psy2676         170 GGLKIADFGLAK  181 (321)
Q Consensus       170 ~~~kl~dfg~~~  181 (321)
                      +.++++|++...
T Consensus       171 ~~i~iID~~~k~  182 (229)
T PF06176_consen  171 NGIRIIDTQGKR  182 (229)
T ss_pred             CcEEEEECcccc
Confidence            459999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.91  E-value=1.9e-08  Score=80.01  Aligned_cols=142  Identities=22%  Similarity=0.238  Sum_probs=97.3

Q ss_pred             eeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCC-----------------C-----chhHHHHHHHHhcccCCC
Q psy2676          27 LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI-----------------P-----MSTLREISILKQLDTFEH   84 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~-----------------~-----~~~~~e~~~l~~l~~~~~   84 (321)
                      ...|+.|--+.||+|..  .++..+|+|+++........                 .     .-...|+..|+++... +
T Consensus        53 ~g~istGKEA~Vy~a~~--~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eA-G  129 (268)
T COG1718          53 VGCISTGKEANVYLAET--GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEA-G  129 (268)
T ss_pred             EeeecCCcceEEEeecc--CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHc-C
Confidence            34556677778999875  57899999998765332211                 0     0123577777777632 2


Q ss_pred             CceeEEEeeeeccccccccceEEEEEeccCccC--HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCC
Q psy2676          85 PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQD--LGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKP  161 (321)
Q Consensus        85 ~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~--L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p  161 (321)
                      -.+.+.+++.           ...+|||+++..  -.-.+..   -.+...++..+..++++.+.-|-. .|+||+||+.
T Consensus       130 VrvP~Pi~~~-----------~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSE  195 (268)
T COG1718         130 VRVPEPIAFR-----------NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSE  195 (268)
T ss_pred             CCCCCceeec-----------CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchh
Confidence            3445555553           347999999853  1122222   113344678888899999998887 8999999999


Q ss_pred             CcEEEeeCCCEEEeecCCcccccCC
Q psy2676         162 QNLLITRAGGLKIADFGLAKTFDYD  186 (321)
Q Consensus       162 ~Nilv~~~~~~kl~dfg~~~~~~~~  186 (321)
                      -||++. ++.+.++|||.+.....+
T Consensus       196 yNiL~~-~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         196 YNILVH-DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             hheEEE-CCeEEEEECccccccCCC
Confidence            999999 889999999998876633

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.71  E-value=3.1e-07  Score=74.34  Aligned_cols=131  Identities=18%  Similarity=0.251  Sum_probs=78.9

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTV  107 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~  107 (321)
                      ..+|.|..+.||+.     .+..+++|......    ......+|.++++.+...+ -.+.+.+++..+.       ...
T Consensus         7 ~~i~~G~t~~~y~~-----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~g-lpvP~~~~~~~~~-------~~~   69 (226)
T TIGR02172         7 TQTGEGGNGESYTH-----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLG-IPTPHPFDLVEDG-------GRL   69 (226)
T ss_pred             eeecCCCCcceeEe-----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcC-CCCCceEEEEecC-------Cee
Confidence            56899999999974     23457888875322    2346788999999987421 1245556555443       345


Q ss_pred             EEEeccCcc-C-HHHHHhhCCCCCCCHHHHHHHHHHHHHHH---------------------------------------
Q psy2676         108 YLIFEHVDQ-D-LGSYMEKCPPPGLSASKVKELTRQMLKGV---------------------------------------  146 (321)
Q Consensus       108 ~~v~e~~~~-~-L~~~~~~~~~~~~~~~~~~~i~~~l~~~l---------------------------------------  146 (321)
                      .+|||+++| + +...+..      +......++.+++..+                                       
T Consensus        70 glv~e~i~G~~~~~~~~~~------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~  143 (226)
T TIGR02172        70 GLIYELIVGKRSFSRIISD------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKAR  143 (226)
T ss_pred             eeeeeecCCccchhhhhcC------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHH
Confidence            789999998 3 1111110      0011111111111111                                       


Q ss_pred             HHHH----hCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         147 DFLH----SHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       147 ~~lh----~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      .+|.    ...++|||++|.||++++++ +.++||+.+..
T Consensus       144 ~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       144 AFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             HHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            1111    12478999999999999888 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.69  E-value=7e-08  Score=86.45  Aligned_cols=148  Identities=21%  Similarity=0.263  Sum_probs=93.2

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCC--------------------C------------------CCchh
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED--------------------G------------------IPMST   69 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~--------------------~------------------~~~~~   69 (321)
                      ..++.++-|+||+|+.  .+|+.||||+.+......                    .                  .+.++
T Consensus       131 ~PiAsASIaQVH~A~L--~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy  208 (517)
T COG0661         131 EPIASASIAQVHRAVL--KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY  208 (517)
T ss_pred             CchhhhhHhhheeEEe--cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence            6788999999999998  459999999975432111                    0                  00123


Q ss_pred             HHHHHHHHhcccC-CCCceeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHH
Q psy2676          70 LREISILKQLDTF-EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD  147 (321)
Q Consensus        70 ~~e~~~l~~l~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~  147 (321)
                      .+|...+.+++.. ...--+.+-.++++-  .    ..-.++|||++| .+.+...... ...+...+.....++  .+.
T Consensus       209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~--t----~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~  279 (517)
T COG0661         209 RREAANAERFRENFKDDPDVYVPKVYWEY--T----TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLR  279 (517)
T ss_pred             HHHHHHHHHHHHHcCCCCCeEeceeehhc--c----CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHH
Confidence            3455555554432 122222333333221  0    234899999998 6666632222 235644444433332  244


Q ss_pred             HHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCC
Q psy2676         148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD  186 (321)
Q Consensus       148 ~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~  186 (321)
                      .+-..|++|.|.+|-||+++.+|.+.+.|||.....++.
T Consensus       280 q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         280 QLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHHhcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            455689999999999999999999999999999877643

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.64  E-value=3.3e-07  Score=74.93  Aligned_cols=144  Identities=20%  Similarity=0.269  Sum_probs=79.8

Q ss_pred             eeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          27 LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      ++.++.|..+.||++..  .+ ..+++|+....    .......+|..+++.+..... .+.+++......    .....
T Consensus         2 i~~l~~G~~n~~~~v~~--~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~-pvP~~~~~~~~~----~~~~~   69 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTT--DD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGI-PVPRVLAFDTSD----EFNGF   69 (239)
T ss_dssp             EEEEEESSSSEEEEEEE--TT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTS-BS--EEEEEEET----EETSE
T ss_pred             CccCCCCCeeeEEEEEE--CC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCC-CCceEEeecccc----ccccc
Confidence            57899999999999976  23 58899986533    223467789999988875322 355666543222    11134


Q ss_pred             EEEEeccCcc-CHHH----------------HH---hhC--CCCCCCHHH---------HHHH------------HHHHH
Q psy2676         107 VYLIFEHVDQ-DLGS----------------YM---EKC--PPPGLSASK---------VKEL------------TRQML  143 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~----------------~~---~~~--~~~~~~~~~---------~~~i------------~~~l~  143 (321)
                      .++++++++| ++..                .+   ...  +........         ....            ...+.
T Consensus        70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (239)
T PF01636_consen   70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE  149 (239)
T ss_dssp             EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred             ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence            7999999997 5544                11   111  111111000         0000            01112


Q ss_pred             H-HHHHHH-------hCCceeccCCCCcEEEe-eCCCEEEeecCCccc
Q psy2676         144 K-GVDFLH-------SHRIIHRDLKPQNLLIT-RAGGLKIADFGLAKT  182 (321)
Q Consensus       144 ~-~l~~lh-------~~~~~H~di~p~Nilv~-~~~~~kl~dfg~~~~  182 (321)
                      . .+..++       ...++|||++|.||+++ +++.+.++||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2 223333       23599999999999999 566668999997753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.57  E-value=8.1e-07  Score=67.04  Aligned_cols=135  Identities=20%  Similarity=0.194  Sum_probs=97.1

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      .....-++.+.|++|.+|.||++..   .+..+++|+-+.    +.....+..|++++..+..  ..--.++|.+-.+  
T Consensus        19 ~~~~~~~v~~~L~KG~~s~Vyl~~~---~~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g--~~~~p~vy~yg~~--   87 (201)
T COG2112          19 EGKYELRVEKELAKGTTSVVYLGEW---RGGEVALKVRRR----DSPRRNLEKEAKILEILAG--EGVTPEVYFYGED--   87 (201)
T ss_pred             ccchhhhhhhhhhcccccEEEEeec---cCceEEEEEecC----CcchhhHHHHHHHHHHhhh--cCCCceEEEechh--
Confidence            3344557889999999999999964   556888998653    3345688899999999984  3344566666433  


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC-CCcEEEeeCCCEEEee
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLK-PQNLLITRAGGLKIAD  176 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~-p~Nilv~~~~~~kl~d  176 (321)
                               .+.|||+.| +|.+.....     +    ++-+..++++.--|-..||-|+.|+ |...++..++.+.|+|
T Consensus        88 ---------~i~me~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iID  149 (201)
T COG2112          88 ---------FIRMEYIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIID  149 (201)
T ss_pred             ---------hhhhhhhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEE
Confidence                     456999998 777665541     2    3344556777788889999999986 4445555566999999


Q ss_pred             cCCccc
Q psy2676         177 FGLAKT  182 (321)
Q Consensus       177 fg~~~~  182 (321)
                      |..++.
T Consensus       150 Fd~At~  155 (201)
T COG2112         150 FDSATF  155 (201)
T ss_pred             ccchhh
Confidence            998873

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.56  E-value=3.4e-06  Score=65.79  Aligned_cols=138  Identities=22%  Similarity=0.279  Sum_probs=98.0

Q ss_pred             Ccceeeeeeeecccc-eeEEEEEEecCCCcEEEEEEeec---ccC-------CC---------CCCchhHHHHHHHHhcc
Q psy2676          21 DKKYDELCQIGCGAY-GTVFKARDLQNKGNYVAMKKLRV---KLN-------ED---------GIPMSTLREISILKQLD   80 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~-g~v~~~~~~~~~~~~~~iK~~~~---~~~-------~~---------~~~~~~~~e~~~l~~l~   80 (321)
                      ...++.++.||+|.. |.||+++.   +|+.+|+|+++.   ...       ..         .....+..|-+.+.+|+
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I---~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk  112 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEI---DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK  112 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEE---CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence            478999999999999 99999964   788999999422   100       00         12235677999999999


Q ss_pred             cCCCCce--eEEEeeeeccc-----------cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHH
Q psy2676          81 TFEHPNI--VRFFDVIHQNI-----------LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD  147 (321)
Q Consensus        81 ~~~~~~i--~~~~~~~~~~~-----------~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~  147 (321)
                      ..++.++  ++|++++.-..           ..........||.|+....-          .++...+    .+|.+-+.
T Consensus       113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~~----~~~~~dl~  178 (207)
T PF13095_consen  113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRDI----PQMLRDLK  178 (207)
T ss_pred             hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhHH----HHHHHHHH
Confidence            8777777  99999985331           11122234577888776521          2344443    45666678


Q ss_pred             HHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       148 ~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                      .+|..||+-+|+++.|..   +  =+|+|||.+
T Consensus       179 ~~~k~gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKLGIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             HHHHCCeeeccCcccccc---C--CEEEecccC
Confidence            999999999999999987   3  378999864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.56  E-value=1.4e-06  Score=71.65  Aligned_cols=134  Identities=13%  Similarity=0.120  Sum_probs=78.5

Q ss_pred             cccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEEEEe
Q psy2676          32 CGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF  111 (321)
Q Consensus        32 ~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~  111 (321)
                      ..+-+.||++..   .+..+++|+.....     ......|+++++.+..  +--+.+++++....       ...++||
T Consensus         9 g~~~~~v~~~~~---~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~--~~~vP~v~~~~~~~-------~~~~lv~   71 (244)
T cd05150           9 GQSGATVYRLDG---KNPGLYLKIAPSGP-----TYELEREAERLRWLAG--KLPVPEVIDYGSDD-------GRAWLLT   71 (244)
T ss_pred             CCCcCeEEEEcC---CCCcEEEEecCCCc-----ccchHHHHHHHHHHHh--cCCCCeEEEEEecC-------CccEEEE
Confidence            334478999954   34678888765321     3357789999999975  34466677665433       3458899


Q ss_pred             ccCcc-CHHHHH-------------------hhCCCC--CCCHH---HHHHH----------------------HHHHHH
Q psy2676         112 EHVDQ-DLGSYM-------------------EKCPPP--GLSAS---KVKEL----------------------TRQMLK  144 (321)
Q Consensus       112 e~~~~-~L~~~~-------------------~~~~~~--~~~~~---~~~~i----------------------~~~l~~  144 (321)
                      ++++| ++....                   ...+..  .+...   .....                      ..++..
T Consensus        72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (244)
T cd05150          72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA  151 (244)
T ss_pred             EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence            99987 554321                   111110  01100   00000                      111111


Q ss_pred             HHHHH----HhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         145 GVDFL----HSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       145 ~l~~l----h~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      .|...    ....++|+|+.|.||++++++...|+||+.+..
T Consensus       152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            11111    123489999999999999877788999997753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1035|consensus

Probab=98.55  E-value=2.3e-07  Score=88.07  Aligned_cols=202  Identities=19%  Similarity=0.272  Sum_probs=139.6

Q ss_pred             HHHHHHHhcccCCCCceeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH
Q psy2676          71 REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFL  149 (321)
Q Consensus        71 ~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~l  149 (321)
                      .|+..+.++.   |+|+..++.+-......+   ....+..++|.+ ++...+...  ...+....+.+..++..+|.++
T Consensus       231 ~e~~~l~k~~---~~n~~~~~~~~le~~~~g---~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  231 IELESLSKIA---HDNLGGYFVYGLERLFRG---IVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHhhc---cccccceeEEeehhhcch---HHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHH
Confidence            4666677777   999999998865542111   122344567775 777777773  4479999999999999999999


Q ss_pred             HhCCceeccCCCC---cEEEeeCCCEEEe--ecCCcccccCCCccccccccccccchhhhhcCCCCC--cchHHHHHHHH
Q psy2676         150 HSHRIIHRDLKPQ---NLLITRAGGLKIA--DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGT--PVDIWSIGCVM  222 (321)
Q Consensus       150 h~~~~~H~di~p~---Nilv~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~Di~slG~~l  222 (321)
                      |+....|.-+..+   +--++.++.+..+  ||+.+...+..........+..+.++|.......+.  ..|+|++|...
T Consensus       303 h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  303 HSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             HHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            9996666555554   4444555556665  888887766555444455566678888877766544  47999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC
Q psy2676         223 AEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI  302 (321)
Q Consensus       223 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  302 (321)
                      ..+..|..+-........   ..                                 .........+++.+|+.-++++|+
T Consensus       383 ~~~~~~~~i~~~~~~~~~---~l---------------------------------~~~~~~~~~d~~~~~~~~~~~~Rl  426 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAVPVS---LL---------------------------------DVLSTSELLDALPKCLDEDSEERL  426 (1351)
T ss_pred             hhhhhcCcccccccchhh---hh---------------------------------ccccchhhhhhhhhhcchhhhhcc
Confidence            999888665422111100   00                                 001112567889999999999999


Q ss_pred             CHHHHhCCCCCCCC
Q psy2676         303 SAADALEHPYFKEK  316 (321)
Q Consensus       303 s~~~ll~h~~f~~~  316 (321)
                      ++.+++.|+|.+..
T Consensus       427 ~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  427 SALELLTHPFLRFP  440 (1351)
T ss_pred             chhhhhhchhcccc
Confidence            99999999998743

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.49  E-value=6.9e-06  Score=64.63  Aligned_cols=136  Identities=24%  Similarity=0.400  Sum_probs=95.6

Q ss_pred             eeeeecccceeEEEEEEecCCCcEEEEEEeeccc--------------CCCCCCchhHHHHHHHHhcc---cCCCCceeE
Q psy2676          27 LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKL--------------NEDGIPMSTLREISILKQLD---TFEHPNIVR   89 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~---~~~~~~i~~   89 (321)
                      ...||+|+.-.||.-    ......+||+.....              ..........+|+..+..+.   ...+.+|.+
T Consensus         6 ~~~i~~G~~R~cy~H----P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH----PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CcccccCCCceEEEC----CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            357899999999963    556678899987654              11112345667777776666   456889999


Q ss_pred             EEeeeeccccccccceEEEEEeccCc---c----CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVD---Q----DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQ  162 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~---~----~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~  162 (321)
                      ++|..+.+       ....+|+|.+.   |    +|.+++..   +.+++ .+...   +-+-..+|-+.+|+.+|++|+
T Consensus        82 ~~G~veT~-------~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~  147 (199)
T PF10707_consen   82 FYGFVETN-------LGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPH  147 (199)
T ss_pred             EeEEEecC-------CceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHH---HHHHHHHHHHcCCeecCCCcc
Confidence            99999877       56677777653   2    78888855   23565 43443   445566778889999999999


Q ss_pred             cEEEeeCC----CEEEee-cCCc
Q psy2676         163 NLLITRAG----GLKIAD-FGLA  180 (321)
Q Consensus       163 Nilv~~~~----~~kl~d-fg~~  180 (321)
                      ||++..+.    .+.|+| ||..
T Consensus       148 NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  148 NIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             cEEEEecCCCceEEEEEeCCCCc
Confidence            99996543    477887 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0576|consensus

Probab=98.40  E-value=3.3e-08  Score=88.06  Aligned_cols=251  Identities=18%  Similarity=0.142  Sum_probs=166.1

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCc-eeEEEeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN-IVRFFDVI   94 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~-i~~~~~~~   94 (321)
                      .+.....-+...+.+++++++.+++.+.  ...+....+++...       ....-++++|.+.+   ||| .+..++-+
T Consensus       236 ~lkDk~kws~~fh~fvK~altknpKkRp--taeklL~h~fvs~~-------l~~rl~~eLLdK~n---~P~~~v~~~~d~  303 (829)
T KOG0576|consen  236 TLKDKTKWSEFFHNFVKGALTKNPKKRP--TAEKLLQHPFVSQT-------LSRRLAIELLDKVN---NPNPVVRYLEDY  303 (829)
T ss_pred             cccCCccchHHHHHHHHHHhcCCCccCC--Chhhheeceeeccc-------hhhHHHHHHHHHcc---CCCCcccccccC
Confidence            4445556678888899999999999987  23334446665532       24445778888887   999 33333322


Q ss_pred             eccccccccceEEEEEeccCccC--HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQD--LGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~~--L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      ..+       ....++++++.+.  ....+... ...+.+.+...+.+.-..+++++|+.--+|+|    ||+-+ ++..
T Consensus       304 ~~E-------~~~~i~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~  370 (829)
T KOG0576|consen  304 DGE-------DYLWIPMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEV  370 (829)
T ss_pred             Ccc-------cccchhhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-cccc
Confidence            222       5678899999852  32222221 22255566677777778899999988667887    66654 4678


Q ss_pred             EEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         173 KIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ++.+|+...............+++.++|||+.....+..+.|.|++|.-..++.-|.+|-..+-...      .-.+..+
T Consensus       371 ~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~------~~~g~~p  444 (829)
T KOG0576|consen  371 KLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVL------PMIGNGP  444 (829)
T ss_pred             ccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcccc------CCCCCCC
Confidence            9999998887765555667788999999999999999999999999988778877777765421100      0000000


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHH-HHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKAN-SLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                        +.+....          +       ...++... ++...|+..-|..|+.+...+.|.+|..-
T Consensus       445 --~s~~L~~----------~-------~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  445 --NSPMLTD----------K-------SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             --Cccccch----------h-------hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence              0000000          0       01111222 47788999999999999999999998764

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.24  E-value=3.7e-05  Score=62.86  Aligned_cols=73  Identities=19%  Similarity=0.294  Sum_probs=46.2

Q ss_pred             eeeeecccceeEEEEEEecC-CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccce
Q psy2676          27 LCQIGCGAYGTVFKARDLQN-KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYL  105 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~  105 (321)
                      ++.|..|-...+|++.. .. ++..+++|+....   ........+|..+++.+..  +.-.++++..+. .        
T Consensus         3 i~~l~gG~tN~~~~v~~-~~~~~~~~vlR~~~~~---~~~~~d~~~E~~~~~~l~~--~gl~P~v~~~~~-~--------   67 (235)
T cd05157           3 FKRFTGGITNKLVKVSN-KEDNQDAVLVRVYGNK---TELIIDRERELRIHKLLSK--HGLAPKLYATFQ-N--------   67 (235)
T ss_pred             EEEcCCcccceEEEEEc-CCCCCCeEEEEEccCC---ccceecHHHHHHHHHHHHh--CCCCCeEEEEeC-C--------
Confidence            46778888899999965 22 3567889976532   1112244578889998873  323445544331 1        


Q ss_pred             EEEEEeccCcc
Q psy2676         106 TVYLIFEHVDQ  116 (321)
Q Consensus       106 ~~~~v~e~~~~  116 (321)
                        .+++||++|
T Consensus        68 --~~l~e~i~G   76 (235)
T cd05157          68 --GLIYEFIPG   76 (235)
T ss_pred             --cEEEEeeCC
Confidence              379999887

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1093|consensus

Probab=98.16  E-value=1.2e-05  Score=70.59  Aligned_cols=173  Identities=22%  Similarity=0.315  Sum_probs=112.9

Q ss_pred             hhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHH
Q psy2676          68 STLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD  147 (321)
Q Consensus        68 ~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~  147 (321)
                      .+.-..++++.+.   |+|....++.-...    +  ....+|+|+++.+|.+.+..+..   -.....           
T Consensus        28 ~ilgr~~~lktl~---~~~l~~yl~~~r~~----~--~r~IVV~e~~~~Sled~~~~~~l---~~~s~~-----------   84 (725)
T KOG1093|consen   28 QILGRFQYLKSLQ---HDNLCQYLDFSRGK----H--ERVIVVMEHYTMSLEDILKTGNL---KDESLL-----------   84 (725)
T ss_pred             HHhhhhHHHHhhc---CccceeeEeeecCc----c--ceEEEEehhhccchHHHHHhccc---chhhhc-----------
Confidence            4556677788877   99999999886433    1  34789999999999999988542   111111           


Q ss_pred             HHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh
Q psy2676         148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR  227 (321)
Q Consensus       148 ~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~  227 (321)
                         .+|+.|     -|++       ..+| .+.+..      ..                +..+++||||+|.++.++.-
T Consensus        85 ---~~~~~~-----~~~~-------~~td-~~~t~~------~~----------------~~~pKsdVwsl~~i~~el~L  126 (725)
T KOG1093|consen   85 ---AHGVLH-----LNII-------YITD-HFLTKY------PS----------------PIGPKSDVWSLGFIILELYL  126 (725)
T ss_pred             ---ccccce-----ehhh-------hccc-cccccC------CC----------------CCCcchhhhhHHHHHHHHHH
Confidence               222222     2222       2222 111110      00                11249999999999999999


Q ss_pred             cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHH
Q psy2676         228 LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA  307 (321)
Q Consensus       228 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  307 (321)
                      |...+......+....+.+....+....               .....-.....++..+.++..+|+...|..||...++
T Consensus       127 ~~~l~~~~~~s~~l~~i~k~~~~d~~~~---------------~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  127 GISLEAELTESEYLEILLKYYTDDQELL---------------STAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             hhHHHHHHHHHHHHHHHHHhccCchhHH---------------HHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence            9988877666666665555432221111               1111124456788899999999999999999999999


Q ss_pred             hCCCCCCCC
Q psy2676         308 LEHPYFKEK  316 (321)
Q Consensus       308 l~h~~f~~~  316 (321)
                      .+++-|.+.
T Consensus       192 ~k~~i~~ev  200 (725)
T KOG1093|consen  192 SKRCSFTEV  200 (725)
T ss_pred             hcCccHHHH
Confidence            999988653

>PLN02876 acyl-CoA dehydrogenase

Probab=98.15  E-value=5.4e-05  Score=73.19  Aligned_cols=84  Identities=18%  Similarity=0.254  Sum_probs=53.8

Q ss_pred             eeeeeecccceeEEEEEEecCCC--cEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCc--eeEEEeeeecccccc
Q psy2676          26 ELCQIGCGAYGTVFKARDLQNKG--NYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN--IVRFFDVIHQNILSD  101 (321)
Q Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~--~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~--i~~~~~~~~~~~~~~  101 (321)
                      -++.++.|.+..+|++.. ..++  ..+++|+....... .....+.+|+.+++.+..  |++  +.+++.++.+...  
T Consensus        42 ~v~~l~gG~sn~ty~l~~-~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~--~~~vpVP~v~~~~~d~~v--  115 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEV-GNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGE--HTDVPVPKVYCLCTDASV--  115 (822)
T ss_pred             eEEEeCCCCcCceEEEEE-CCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhh--cCCCCCCcEEEEecCCCc--
Confidence            367789999999999876 2222  46777765432111 123467899999999963  444  4667766654311  


Q ss_pred             ccceEEEEEeccCccC
Q psy2676         102 ERYLTVYLIFEHVDQD  117 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~  117 (321)
                        ....++|||+++|.
T Consensus       116 --~G~~flVME~v~G~  129 (822)
T PLN02876        116 --IGTAFYIMEYLEGR  129 (822)
T ss_pred             --CCCceEEEEecCCc
Confidence              12458999999973

>PRK10593 hypothetical protein; Provisional

Probab=98.14  E-value=4.8e-05  Score=64.38  Aligned_cols=83  Identities=16%  Similarity=0.113  Sum_probs=56.2

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      .-.-.+.||+|..+.||...+  .++ .+++|+.+.    ......+..|...++.+.....-.+.++++.+.+...   
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~--~~~-~~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~---   84 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYD--SQG-NPMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS---   84 (297)
T ss_pred             hhheeeecCCccceeEEEEEc--CCC-CEEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc---
Confidence            455678899999999999964  233 467777432    1123478899999999975322467777776643311   


Q ss_pred             cceEEEEEeccCcc
Q psy2676         103 RYLTVYLIFEHVDQ  116 (321)
Q Consensus       103 ~~~~~~~v~e~~~~  116 (321)
                       ....++|||+++|
T Consensus        85 -~g~~~LVmE~i~G   97 (297)
T PRK10593         85 -PGPDVLLLERLRG   97 (297)
T ss_pred             -CCCeEEEEeccCC
Confidence             1346999999986

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.14  E-value=1.9e-05  Score=65.47  Aligned_cols=137  Identities=20%  Similarity=0.241  Sum_probs=76.3

Q ss_pred             eeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEE
Q psy2676          29 QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVY  108 (321)
Q Consensus        29 ~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  108 (321)
                      .+..|..+.+|++.   .++..+++|+.......  ......+|..+++.+..  +.-..+++...  .         -+
T Consensus         3 ~~~~G~tn~~y~~~---~~~~~~vlR~~~~~~~~--~~~~r~~E~~~l~~l~~--~g~~P~~i~~~--~---------~~   64 (256)
T TIGR02721         3 TLSGGLTNRSWRIE---HPGISFVWRPQSPVCKA--LGVDRQREYQILQALSA--LGLAPKPILVN--E---------HW   64 (256)
T ss_pred             cCCCcCcCCeEEEE---eCCccEEEeeCCccccc--ccCcHHHHHHHHHHHHh--cCCCCceEEEe--C---------CE
Confidence            35677888999885   45667888875432111  11245789999999874  21223344332  1         15


Q ss_pred             EEeccCcc-CHH--------------HHHh---hCC--CCCCCHH-HHHHHHHHH---------HHHHHHHHh-------
Q psy2676         109 LIFEHVDQ-DLG--------------SYME---KCP--PPGLSAS-KVKELTRQM---------LKGVDFLHS-------  151 (321)
Q Consensus       109 ~v~e~~~~-~L~--------------~~~~---~~~--~~~~~~~-~~~~i~~~l---------~~~l~~lh~-------  151 (321)
                      +|+|+++| ++.              +.+.   ..+  ...++.. .+..+..++         ...+..+-.       
T Consensus        65 ~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  144 (256)
T TIGR02721        65 LLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPL  144 (256)
T ss_pred             EEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCC
Confidence            88999887 332              1111   111  1111211 111111111         111222221       


Q ss_pred             -CCceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         152 -HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       152 -~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                       ..++|+|+.|.||++++++ +.|+||+.+....
T Consensus       145 ~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~gd  177 (256)
T TIGR02721       145 PLAPLHMDVHAYNLVVTPQG-LKLIDWEYASDGD  177 (256)
T ss_pred             CCeeecCCCCcCcEEEeCCC-CEEEeccccCcCC
Confidence             2589999999999999877 7899999886543

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.14  E-value=9.3e-05  Score=64.68  Aligned_cols=81  Identities=16%  Similarity=0.137  Sum_probs=54.0

Q ss_pred             eeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-----CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          26 ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-----EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      -.+.||.|....||++.+ ..+++.+++|.-.....     +.-.......|.+.|+.+....-.++++++.+..     
T Consensus        30 ~~~elggGn~N~VyrV~~-~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~-----  103 (401)
T PRK09550         30 TAREIGDGNLNLVFRVSD-TEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE-----  103 (401)
T ss_pred             eeeEcCCCceEEEEEEEe-CCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-----
Confidence            357899999999999988 33335899997542211     1122345667888888876533356777877732     


Q ss_pred             cccceEEEEEeccCcc
Q psy2676         101 DERYLTVYLIFEHVDQ  116 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~  116 (321)
                          ...++|||++++
T Consensus       104 ----~~~~lVME~L~~  115 (401)
T PRK09550        104 ----ELAVTVMEDLSD  115 (401)
T ss_pred             ----CCCEEEEecCCC
Confidence                235799999875

>KOG2268|consensus

Probab=98.11  E-value=1.3e-06  Score=72.41  Aligned_cols=149  Identities=19%  Similarity=0.237  Sum_probs=103.7

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC---------------C-----CCCchhHHH
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE---------------D-----GIPMSTLRE   72 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~---------------~-----~~~~~~~~e   72 (321)
                      .+.++..-+.-+.+.+.||-|--+.||.+-+  ..|++.++|+-+.-...               .     -.+....+|
T Consensus        83 AlktL~~R~~v~svGnqIGVGKESDIY~v~d--~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kE  160 (465)
T KOG2268|consen   83 ALKTLSNRGSVESVGNQIGVGKESDIYVVAD--EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKE  160 (465)
T ss_pred             HHHHHHhcchhhhhccccccccccceEEEec--CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHH
Confidence            3444444455678999999999999999986  57888988853221000               0     012244578


Q ss_pred             HHHHHhcccCCCC-ceeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy2676          73 ISILKQLDTFEHP-NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLH  150 (321)
Q Consensus        73 ~~~l~~l~~~~~~-~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh  150 (321)
                      .+.++.|..  |. -+.+.+++           ..-++|||.+.| +|...-.-        .....+...+...+.-|-
T Consensus       161 fafmkaL~e--~gfpVPkpiD~-----------~RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~Iv~la  219 (465)
T KOG2268|consen  161 FAFMKALYE--RGFPVPKPIDH-----------NRHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGLIVRLA  219 (465)
T ss_pred             HHHHHHHHH--cCCCCCCcccc-----------cceeeHHHhhcccceeeeeec--------CChHHHHHHHHHHHHHHH
Confidence            888888874  22 13344443           345899999997 55543322        223446667777888899


Q ss_pred             hCCceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         151 SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       151 ~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      .+|++|+|.+--||+|++++.++++||..+...+
T Consensus       220 ~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  220 NHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             HcCceecccchheeEEecCCCEEEeechHhhccC
Confidence            9999999999999999999999999998765544

>KOG1235|consensus

Probab=98.07  E-value=2.7e-05  Score=69.93  Aligned_cols=146  Identities=19%  Similarity=0.238  Sum_probs=89.6

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-----------------------------------CCCchhHHH
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-----------------------------------GIPMSTLRE   72 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-----------------------------------~~~~~~~~e   72 (321)
                      +.||..+.|.|++|+.  .+|+.||+|+-+......                                   ..+-++.+|
T Consensus       167 ~piaaASlaQVhrA~L--~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARL--KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             chhhhcchhheEEEEe--cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            5788999999999998  459999999864432111                                   011223344


Q ss_pred             HHHHHhccc-CCCCc---eeEEEeeeeccccccccceEEEEEeccCcc-CHH--HHHhhCCCCCCCHHHHHHHHHHHHHH
Q psy2676          73 ISILKQLDT-FEHPN---IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLG--SYMEKCPPPGLSASKVKELTRQMLKG  145 (321)
Q Consensus        73 ~~~l~~l~~-~~~~~---i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~--~~~~~~~~~~~~~~~~~~i~~~l~~~  145 (321)
                      ++...+... +.|-+   -+.+-.++++-.      ..-.++|||++| .+.  +.+..   ..++...+..-+.+..  
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s------t~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~i~~~l~~~~--  313 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDLS------TKRVLTMEYVDGIKINDLDAIDK---RGISPHDILNKLVEAY--  313 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhcC------cceEEEEEecCCccCCCHHHHHH---cCCCHHHHHHHHHHHH--
Confidence            444443321 12333   122333332220      245899999998 333  33444   2367765555444432  


Q ss_pred             HHHHHhCCceeccCCCCcEEEee----CCCEEEeecCCcccccCC
Q psy2676         146 VDFLHSHRIIHRDLKPQNLLITR----AGGLKIADFGLAKTFDYD  186 (321)
Q Consensus       146 l~~lh~~~~~H~di~p~Nilv~~----~~~~kl~dfg~~~~~~~~  186 (321)
                      +.-+=..|++|.|-+|-||++..    ++.+.+.|||+....+..
T Consensus       314 ~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  314 LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            23334568999999999999985    567999999998877643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.05  E-value=2e-05  Score=61.72  Aligned_cols=100  Identities=17%  Similarity=0.188  Sum_probs=77.9

Q ss_pred             HHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEEEEeccCc-cCHHHH---HhhCCCCCCCHHHHHHHHHHHHHH
Q psy2676          70 LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSY---MEKCPPPGLSASKVKELTRQMLKG  145 (321)
Q Consensus        70 ~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~---~~~~~~~~~~~~~~~~i~~~l~~~  145 (321)
                      .+|.-+++.+..  .+++++++|.+..           .++.|+.+ +++...   +...  -..++..+.+++.++++.
T Consensus         7 ~~E~lll~~l~~--~~~~pk~lG~CG~-----------~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~   71 (188)
T PF12260_consen    7 NNEPLLLQLLQG--SEPFPKLLGSCGR-----------FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLEL   71 (188)
T ss_pred             ccHHHHHHHcCC--CCCCCCeeeECCC-----------EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHH
Confidence            468888999985  4699999999722           46888888 455421   1111  114899999999999999


Q ss_pred             HHHHHh---CCceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         146 VDFLHS---HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       146 l~~lh~---~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      +.+++.   ..+.-.|++++|+-+++++++|++|........
T Consensus        72 l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   72 LEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             HHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            999997   357779999999999999999999998776543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.03  E-value=4e-05  Score=62.67  Aligned_cols=32  Identities=31%  Similarity=0.364  Sum_probs=26.1

Q ss_pred             CCceeccCCCCcEEEeeCCCEEEeecCCcccc
Q psy2676         152 HRIIHRDLKPQNLLITRAGGLKIADFGLAKTF  183 (321)
Q Consensus       152 ~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~  183 (321)
                      .+++|||+++.||+++.++..-++||+.+...
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g  195 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG  195 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence            35899999999999986654579999987643

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.01  E-value=6.8e-05  Score=63.62  Aligned_cols=147  Identities=18%  Similarity=0.109  Sum_probs=82.1

Q ss_pred             eeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccce
Q psy2676          26 ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYL  105 (321)
Q Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~  105 (321)
                      -++.+..|....+|++..   ++..+++|++..     ........|+.+++.+...+.| +.+++......... ....
T Consensus        18 ~i~~i~~G~~n~~y~v~~---~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~-vp~~i~~~~g~~~~-~~~~   87 (296)
T cd05153          18 SFEGISAGIENTNYFVTT---DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLP-VPRPIADRDGEYLS-ELAG   87 (296)
T ss_pred             heecccCccccceEEEEe---CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCC-CCccccCCCCcEee-eeCC
Confidence            366778888889999854   344688898753     1234566788888888643223 44544321111000 0012


Q ss_pred             EEEEEeccCcc-CHHH-----------HHh---h----CCCC----C-CCHHHH--H--------HHHHHHHHHHHHHHh
Q psy2676         106 TVYLIFEHVDQ-DLGS-----------YME---K----CPPP----G-LSASKV--K--------ELTRQMLKGVDFLHS  151 (321)
Q Consensus       106 ~~~~v~e~~~~-~L~~-----------~~~---~----~~~~----~-~~~~~~--~--------~i~~~l~~~l~~lh~  151 (321)
                      ..+.|+++++| ++..           .+.   .    ....    . ..+...  .        .....+..++..+.+
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            45789999987 3211           010   0    0000    0 000000  0        011112333444443


Q ss_pred             -------CCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         152 -------HRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       152 -------~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                             .+++|||++|.||++++++.+.|+||+.+..
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence                   4799999999999999877778999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.95  E-value=0.00014  Score=61.91  Aligned_cols=74  Identities=14%  Similarity=0.210  Sum_probs=45.9

Q ss_pred             eeeeecccceeEEEEEEec-----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          27 LCQIGCGAYGTVFKARDLQ-----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++.+..|-...+|++....     ..+..+++|+.....   .......+|..+++.+..  +.-..+++..+..     
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~--~g~~P~~~~~~~~-----   72 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSE--RNLGPKLYGIFPN-----   72 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHh--CCCCCceEEEeCC-----
Confidence            4567777778999986511     125788999865421   223466788889988874  2224455555422     


Q ss_pred             ccceEEEEEeccCcc
Q psy2676         102 ERYLTVYLIFEHVDQ  116 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~  116 (321)
                            .+|+++++|
T Consensus        73 ------~~v~e~i~G   81 (302)
T cd05156          73 ------GRIEEFIPS   81 (302)
T ss_pred             ------CchhheeCC
Confidence                  246777765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.86  E-value=0.00024  Score=60.61  Aligned_cols=150  Identities=17%  Similarity=0.184  Sum_probs=81.5

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      ...++.++.|....+|++..  .++ .+++|+.....    .......|.++++.+....-| +.+++.......... .
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t--~~~-~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~p-vp~~i~t~~g~~~~~-~   94 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTT--DVG-RYILTLYEKRV----KAEELPFFLALTTHLAARGLP-VPKPVKSRDGRQLST-L   94 (307)
T ss_pred             ceeccccCCccccceEEEEe--CCC-cEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCC-CCccccCCCCCeehh-c
Confidence            44467778888889999854  333 57788764321    123556777888777632222 444443221110000 1


Q ss_pred             ceEEEEEeccCcc-CHH-----------HHH---hhCCC----C--C-CCHH---HH--H----------HHHHHHHHHH
Q psy2676         104 YLTVYLIFEHVDQ-DLG-----------SYM---EKCPP----P--G-LSAS---KV--K----------ELTRQMLKGV  146 (321)
Q Consensus       104 ~~~~~~v~e~~~~-~L~-----------~~~---~~~~~----~--~-~~~~---~~--~----------~i~~~l~~~l  146 (321)
                      ....++++++++| .+.           ..+   .....    .  . ....   ..  .          .....+...+
T Consensus        95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~  174 (307)
T TIGR00938        95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL  174 (307)
T ss_pred             CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence            1346889999887 211           111   11000    0  0 0000   00  0          0011223344


Q ss_pred             HHHH-------hCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         147 DFLH-------SHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       147 ~~lh-------~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      .++.       ..+++|+|+++.||++++++...++||+.+..
T Consensus       175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            4443       35899999999999999887678999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.85  E-value=0.00045  Score=60.31  Aligned_cols=79  Identities=8%  Similarity=0.084  Sum_probs=52.9

Q ss_pred             eeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-----CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          26 ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-----EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ..+.+|.|....||++.+   ++..++||.-.....     +.-.......|...|+.+....-.++.+++.+..+.   
T Consensus        36 ~~~eiggGn~N~VyrV~~---~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~---  109 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS---SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM---  109 (418)
T ss_pred             eEEEcCCCceeeEEEEEc---CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC---
Confidence            477889999999999976   344588887652211     112344556677888777653235788888886533   


Q ss_pred             cccceEEEEEeccCcc
Q psy2676         101 DERYLTVYLIFEHVDQ  116 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~  116 (321)
                            .+++||++++
T Consensus       110 ------~vlvME~L~~  119 (418)
T PLN02756        110 ------ALIGMRYLEP  119 (418)
T ss_pred             ------CEEEEeecCC
Confidence                  3678999875

>PLN02236 choline kinase

Probab=97.77  E-value=0.0008  Score=58.26  Aligned_cols=142  Identities=15%  Similarity=0.218  Sum_probs=78.3

Q ss_pred             eeeeeeecccceeEEEEEEec---CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          25 DELCQIGCGAYGTVFKARDLQ---NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        25 ~~~~~lg~g~~g~v~~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      .-+..+..|-...+|++....   ..++.+++|+.....   .....-.+|..+++.+..  +.--.++++.+...    
T Consensus        39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR~~E~~~~~~l~~--~gl~P~~~~~~~~g----  109 (344)
T PLN02236         39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDRDDEIRTFECMSR--HGQGPRLLGRFPNG----  109 (344)
T ss_pred             EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---CeeechHHHHHHHHHHHH--cCCCCceEEEECCc----
Confidence            334456668888999986421   124678899875431   122234679999998884  33344566655221    


Q ss_pred             ccceEEEEEeccCcc-CHHH--------------HHh---hCC--CCC-C-CHHHHHHHHHHH-----------------
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGS--------------YME---KCP--PPG-L-SASKVKELTRQM-----------------  142 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~--------------~~~---~~~--~~~-~-~~~~~~~i~~~l-----------------  142 (321)
                             .|.+|++| ++..              .+.   ..+  ... . ....+..+..++                 
T Consensus       110 -------~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l  182 (344)
T PLN02236        110 -------RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSL  182 (344)
T ss_pred             -------eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHH
Confidence                   35666664 3321              111   111  000 1 122222222111                 


Q ss_pred             HHHHHHH--------HhCCceeccCCCCcEEEee-CCCEEEeecCCccc
Q psy2676         143 LKGVDFL--------HSHRIIHRDLKPQNLLITR-AGGLKIADFGLAKT  182 (321)
Q Consensus       143 ~~~l~~l--------h~~~~~H~di~p~Nilv~~-~~~~kl~dfg~~~~  182 (321)
                      ...+..|        +...++|+|+++.||++++ ++.+.++||.++..
T Consensus       183 ~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        183 EDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            1111111        1236899999999999986 46799999998864

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.76  E-value=0.0011  Score=57.00  Aligned_cols=84  Identities=17%  Similarity=0.099  Sum_probs=53.7

Q ss_pred             eeecccceeEEEEEEecCCCcEEEEEEeeccc-----CCCCCCchhHHHHHHHHhcccCCCC-ceeEEEeeeeccccccc
Q psy2676          29 QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKL-----NEDGIPMSTLREISILKQLDTFEHP-NIVRFFDVIHQNILSDE  102 (321)
Q Consensus        29 ~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~~~-~i~~~~~~~~~~~~~~~  102 (321)
                      .+|.|....||++.+ ..+++.++||.-....     .+.-.......|...|+..... .| ++++++.+-.       
T Consensus         2 EigdGnlN~VfrV~~-~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~-~P~~vP~vy~~D~-------   72 (370)
T TIGR01767         2 EVGDGNLNLVFHVYD-QEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEH-VPHLVPRIFHFDT-------   72 (370)
T ss_pred             cCCCCceEEEEEEEc-CCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhcc-CccccCeEEEEcc-------
Confidence            479999999999987 3333678888653221     2233445666788888887764 34 5666665532       


Q ss_pred             cceEEEEEeccCcc--CHHHHHh
Q psy2676         103 RYLTVYLIFEHVDQ--DLGSYME  123 (321)
Q Consensus       103 ~~~~~~~v~e~~~~--~L~~~~~  123 (321)
                        ....+|||+++.  .|+..+.
T Consensus        73 --e~~~~vMEdL~~~~ilR~~Li   93 (370)
T TIGR01767        73 --EMAVTVMEDLSHHKIARKGLI   93 (370)
T ss_pred             --ccceehHhhCccchHHHHHHH
Confidence              234689999863  4544443

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.73  E-value=0.00043  Score=60.09  Aligned_cols=87  Identities=15%  Similarity=0.098  Sum_probs=56.2

Q ss_pred             eeeeecccceeEEEEEEecCCCcEEEEEEeecc----cCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          27 LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK----LNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      ++.||.|.-..||++.+ ..++..++||.-...    ..+.-...+...|.+.|+.....--.++++++.+-.       
T Consensus        34 ~~eigdGnlN~VfrV~~-~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~-------  105 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWD-EQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS-------  105 (409)
T ss_pred             eeEcCCCceEEEEEEee-CCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc-------
Confidence            67889999999999987 333567888864322    222334456677899999887642235666766532       


Q ss_pred             cceEEEEEeccCcc--CHHHHHh
Q psy2676         103 RYLTVYLIFEHVDQ--DLGSYME  123 (321)
Q Consensus       103 ~~~~~~~v~e~~~~--~L~~~~~  123 (321)
                        ....+|||+++.  .|+..+.
T Consensus       106 --e~~~~vMEdL~~~~ilR~~Li  126 (409)
T PRK12396        106 --VMNCCVMEDLSDHTILRTALI  126 (409)
T ss_pred             --HHhhHHHHhCcccHHHHHHHH
Confidence              234788888863  4444433

>PRK05231 homoserine kinase; Provisional

Probab=97.73  E-value=0.00055  Score=58.76  Aligned_cols=31  Identities=29%  Similarity=0.304  Sum_probs=26.3

Q ss_pred             CCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         152 HRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       152 ~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      .+++|+|++|.||+++.+...-++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4899999999999998665568999998754

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.72  E-value=0.00026  Score=59.25  Aligned_cols=32  Identities=31%  Similarity=0.475  Sum_probs=26.3

Q ss_pred             CceeccCCCCcEEEeeCCC-EEEeecCCccccc
Q psy2676         153 RIIHRDLKPQNLLITRAGG-LKIADFGLAKTFD  184 (321)
Q Consensus       153 ~~~H~di~p~Nilv~~~~~-~kl~dfg~~~~~~  184 (321)
                      .++|||++|.||++++++. .-|+||+.+...+
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD  218 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD  218 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence            4899999999999997565 4699999886543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270|consensus

Probab=97.70  E-value=0.00056  Score=58.18  Aligned_cols=144  Identities=24%  Similarity=0.250  Sum_probs=96.6

Q ss_pred             eeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC--------------------CCCc----hhHHHHHHHHhcc
Q psy2676          25 DELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED--------------------GIPM----STLREISILKQLD   80 (321)
Q Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~--------------------~~~~----~~~~e~~~l~~l~   80 (321)
                      .+-.+|..|--+.||.|..  .+|..+|||+++-+...-                    +.+.    -...|++.|+++.
T Consensus       147 ~inGCiSTGKEANVYHat~--~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~  224 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE--EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN  224 (520)
T ss_pred             ecccccccCccceeEeeec--CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence            4556788888889999985  688889999886542111                    0111    1235778888877


Q ss_pred             cCCCCceeEEEeeeeccccccccceEEEEEeccCcc--CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceec
Q psy2676          81 TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ--DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLH-SHRIIHR  157 (321)
Q Consensus        81 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~--~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh-~~~~~H~  157 (321)
                      ...-|.--+++-            ..-.+||+++++  =-.-.+..   ..++...+..+-.+++.-+.-|. ..++||.
T Consensus       225 ~aGIP~PePIlL------------k~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHA  289 (520)
T KOG2270|consen  225 NAGIPCPEPILL------------KNHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHA  289 (520)
T ss_pred             hcCCCCCCceee------------ecceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceecc
Confidence            433332222221            224799999984  12222222   33777788888888888877776 5699999


Q ss_pred             cCCCCcEEEeeCCCEEEeecCCcccccCC
Q psy2676         158 DLKPQNLLITRAGGLKIADFGLAKTFDYD  186 (321)
Q Consensus       158 di~p~Nilv~~~~~~kl~dfg~~~~~~~~  186 (321)
                      ||+--|+++. +|.+.++|.+.+.....+
T Consensus       290 DLSEfN~Lyh-dG~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  290 DLSEFNLLYH-DGKLYIIDVSQSVEHDHP  317 (520)
T ss_pred             chhhhhheEE-CCEEEEEEccccccCCCh
Confidence            9999999995 788999999988765533

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.66  E-value=0.00088  Score=57.71  Aligned_cols=30  Identities=30%  Similarity=0.459  Sum_probs=26.2

Q ss_pred             ceeccCCCCcEEEee-CCCEEEeecCCcccc
Q psy2676         154 IIHRDLKPQNLLITR-AGGLKIADFGLAKTF  183 (321)
Q Consensus       154 ~~H~di~p~Nilv~~-~~~~kl~dfg~~~~~  183 (321)
                      ++|+|+.+.||++++ ++.++++||+.+..-
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence            899999999999975 468999999988654

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.60  E-value=0.0012  Score=55.79  Aligned_cols=146  Identities=19%  Similarity=0.210  Sum_probs=88.0

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      ..+++....|....+|...+   +++.++++ ...............+|+.+++.+... .--+...++++.+..     
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~---~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~-~vP~p~~~~~~~~~~-----   96 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGD---TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDV-DVPVPRAFGLCGEGY-----   96 (321)
T ss_pred             CceeeeccCCcccceEEEec---CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCC-CCCCcccccccccCC-----
Confidence            44555555555556666644   37888888 322222233344566788888888643 222334444443331     


Q ss_pred             ceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHH-HHHHHHHHHHHhC-----------------------------
Q psy2676         104 YLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELT-RQMLKGVDFLHSH-----------------------------  152 (321)
Q Consensus       104 ~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~-~~l~~~l~~lh~~-----------------------------  152 (321)
                      ....+.||+++.| .+.+......   .+    ...+ ..++..|..||+.                             
T Consensus        97 ~g~pf~v~~~veGe~~~~~~~~~~---~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~  169 (321)
T COG3173          97 LGTPFYVMEWVEGEVVWSALPPES---LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRA  169 (321)
T ss_pred             CCCceEEEEEecceeccCcCCccc---ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHH
Confidence            2467899999998 3333222210   11    1122 3555566666633                             


Q ss_pred             -----------------------------CceeccCCCCcEEEeeCCCEEEeecCCcccccCC
Q psy2676         153 -----------------------------RIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD  186 (321)
Q Consensus       153 -----------------------------~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~  186 (321)
                                                   .++|||+++.|++++.++-+=++||+.+...++.
T Consensus       170 ~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~  232 (321)
T COG3173         170 KKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL  232 (321)
T ss_pred             HHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence                                         1799999999999999888999999999876543

>PTZ00384 choline kinase; Provisional

Probab=97.47  E-value=0.0023  Score=56.07  Aligned_cols=30  Identities=30%  Similarity=0.305  Sum_probs=25.2

Q ss_pred             CCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         152 HRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       152 ~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      ..++|.|+.+.||+.+ ++.++++||..+..
T Consensus       227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~~  256 (383)
T PTZ00384        227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAGF  256 (383)
T ss_pred             eeeeeccCCcccEEec-CCCEEEEEeccccC
Confidence            4689999999999875 55699999998754

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.46  E-value=0.00017  Score=57.85  Aligned_cols=30  Identities=40%  Similarity=0.677  Sum_probs=21.6

Q ss_pred             CceeccCCCCcEEE-eeCCCEEEeecCCccc
Q psy2676         153 RIIHRDLKPQNLLI-TRAGGLKIADFGLAKT  182 (321)
Q Consensus       153 ~~~H~di~p~Nilv-~~~~~~kl~dfg~~~~  182 (321)
                      .++|+|+.|.||++ +.++.++|+||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            58999999999999 8899999999998854

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.02  E-value=0.018  Score=48.34  Aligned_cols=78  Identities=12%  Similarity=0.080  Sum_probs=49.4

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      -+-.+.++.|....+|++.   .++..+.+|+-..     .....+..|.+-|+.|.+..--.+.+++++....      
T Consensus        19 i~~~~~v~GG~i~~a~~~~---~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~------   84 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD---TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD------   84 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE---TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S------
T ss_pred             eeeeEecCCCChhheEEEE---CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec------
Confidence            4556788999999999984   6788899998652     2234788999999999755556677888876544      


Q ss_pred             ceEEEEEeccCcc
Q psy2676         104 YLTVYLIFEHVDQ  116 (321)
Q Consensus       104 ~~~~~~v~e~~~~  116 (321)
                       ...++|+|+++.
T Consensus        85 -~~~fLlle~l~~   96 (288)
T PF03881_consen   85 -DDAFLLLEFLEM   96 (288)
T ss_dssp             -SCCEEEEE----
T ss_pred             -CCceEEEEeecC
Confidence             233899999873

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.95  E-value=0.017  Score=49.65  Aligned_cols=29  Identities=28%  Similarity=0.384  Sum_probs=24.5

Q ss_pred             CCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         152 HRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       152 ~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      .+++|+|+.+.||+++ + .+.++||+.+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            4789999999999995 4 678999998753

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.94  E-value=0.0098  Score=50.82  Aligned_cols=30  Identities=20%  Similarity=0.277  Sum_probs=27.5

Q ss_pred             CceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         153 RIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       153 ~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      +++|+|+.++|+++++++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999997764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1826|consensus

Probab=96.75  E-value=0.00013  Score=72.11  Aligned_cols=144  Identities=16%  Similarity=0.004  Sum_probs=103.0

Q ss_pred             CCceeEEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCC--CCHHHHHHHHHHHHHHHHHHHhC-C----ce
Q psy2676          84 HPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPG--LSASKVKELTRQMLKGVDFLHSH-R----II  155 (321)
Q Consensus        84 ~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~--~~~~~~~~i~~~l~~~l~~lh~~-~----~~  155 (321)
                      |+++...+.-....     ....-+..++++. |.+.+.+.+.....  ++..-+....++...+..-+|+. +    -+
T Consensus      1288 h~~~~~~p~rI~ps-----~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v 1362 (2724)
T KOG1826|consen 1288 HYLTEVDPLRIPPS-----ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNV 1362 (2724)
T ss_pred             ceeeecccccCCCC-----CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccch
Confidence            77777655543222     2234578888888 68888887644332  33333444444445666666644 1    58


Q ss_pred             eccCCCCcEEEeeCCCEEEeecCCcc-cccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCC
Q psy2676         156 HRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLF  232 (321)
Q Consensus       156 H~di~p~Nilv~~~~~~kl~dfg~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  232 (321)
                      |.++++-|.+|..+.+++++++|+.+ ..+.........+++-|+.|+....-.++.++|+|..|+.+|....|..+|
T Consensus      1363 ~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1363 SKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             hhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            89999999999999999999999998 333333344556677788999888888888899999999999998888877

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.69  E-value=0.0047  Score=52.64  Aligned_cols=102  Identities=18%  Similarity=0.270  Sum_probs=68.0

Q ss_pred             eEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeeCCCEEEeecCCcccc
Q psy2676         105 LTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRAGGLKIADFGLAKTF  183 (321)
Q Consensus       105 ~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~  183 (321)
                      ...|++|++.++++...-.      -..+++..++.+-+..+.-+... .+-|+|++..||+|+ +|++.|+||-+++.-
T Consensus       299 ~y~yl~~kdhgt~is~ik~------~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         299 LYLYLHFKDHGTPISIIKA------DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             eEEEEEEecCCceeeeeec------ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            4567888887775543221      35777788888877777777754 789999999999999 999999999998733


Q ss_pred             cCCCccccccccccccchhhhhcCCCCCcchHHHH
Q psy2676         184 DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSI  218 (321)
Q Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  218 (321)
                      .....    ..-...--|-.+.+ .-+..-+||-+
T Consensus       372 ~~q~~----isy~rldhp~lF~G-~dd~QFeIYrl  401 (488)
T COG5072         372 YSQGI----ISYNRLDHPDLFNG-VDDYQFEIYRL  401 (488)
T ss_pred             cCCce----eeccccCchhhhcC-ccceeeeHHHH
Confidence            22211    11112333444443 33667777765

>PTZ00296 choline kinase; Provisional

Probab=96.57  E-value=0.038  Score=49.49  Aligned_cols=79  Identities=11%  Similarity=0.094  Sum_probs=46.6

Q ss_pred             CcceeeeeeeecccceeEEEEEEecC-------CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQN-------KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      .+.. -++.|..|-.-.+|++.....       .++.|++|++-...   .....-..|..+++.+..  +.--.++++.
T Consensus       105 ~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lIdR~~E~~v~~~ls~--~gi~P~l~~~  178 (442)
T PTZ00296        105 EDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELYNPISEFEVYKTMSK--YRIAPQLLNT  178 (442)
T ss_pred             cccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---cceeCHHHHHHHHHHHHH--CCCCCceEEE
Confidence            3444 667777888888999875211       14578888875321   122244568888888874  2223355665


Q ss_pred             eeccccccccceEEEEEeccCcc
Q psy2676          94 IHQNILSDERYLTVYLIFEHVDQ  116 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~  116 (321)
                      +..           +.|.+|++|
T Consensus       179 f~g-----------g~I~efi~g  190 (442)
T PTZ00296        179 FSG-----------GRIEEWLYG  190 (442)
T ss_pred             eCC-----------CEEEEeeCC
Confidence            522           346677765

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.39  E-value=0.019  Score=45.66  Aligned_cols=85  Identities=16%  Similarity=0.203  Sum_probs=57.1

Q ss_pred             hhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHH
Q psy2676          68 STLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD  147 (321)
Q Consensus        68 ~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~  147 (321)
                      .+.++..++.++.     .|+++.--         ....+.++.|.|...-.          ...   - ++..=+.+|.
T Consensus       104 ~y~nky~v~Armh-----GilrL~ND---------n~~~yGvIlE~Cy~~~i----------~~~---N-~i~agi~~L~  155 (308)
T PF07387_consen  104 LYFNKYRVFARMH-----GILRLKND---------NNYKYGVILERCYKIKI----------NFS---N-FITAGIKDLM  155 (308)
T ss_pred             hhhhhhhHHHHhh-----heeEeecC---------CCceeEEEEeeccCccc----------chh---H-HHHHhHHHHH
Confidence            4567788887775     46666511         11456888888875100          111   1 1111245678


Q ss_pred             HHH--hCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         148 FLH--SHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       148 ~lh--~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                      ..|  +.+..|||-.|+||+-|+.|.+||.|-++.
T Consensus       156 ~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  156 DFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            888  347999999999999999999999998754

The function of this family is unknown.

>PRK06148 hypothetical protein; Provisional

Probab=95.98  E-value=0.17  Score=50.56  Aligned_cols=32  Identities=28%  Similarity=0.472  Sum_probs=26.8

Q ss_pred             CCceeccCCCCcEEEeeCC--CEE-EeecCCcccc
Q psy2676         152 HRIIHRDLKPQNLLITRAG--GLK-IADFGLAKTF  183 (321)
Q Consensus       152 ~~~~H~di~p~Nilv~~~~--~~k-l~dfg~~~~~  183 (321)
                      .+++|+|+++.||+++.++  .+. |+|||.+...
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~  237 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVHA  237 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence            4799999999999999875  555 9999988653

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.93  E-value=0.014  Score=48.52  Aligned_cols=50  Identities=26%  Similarity=0.425  Sum_probs=38.2

Q ss_pred             HHHHHHHHHHHHHHHHHhC--CceeccCCCCcEEEeeCCCEEEeecCCcccc
Q psy2676         134 KVKELTRQMLKGVDFLHSH--RIIHRDLKPQNLLITRAGGLKIADFGLAKTF  183 (321)
Q Consensus       134 ~~~~i~~~l~~~l~~lh~~--~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~  183 (321)
                      .+...+..+-.++.-.+..  -++|+|+.|.|++.++.+.++|+||..+..-
T Consensus       133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~  184 (269)
T COG0510         133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN  184 (269)
T ss_pred             HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence            3344555555566665544  5899999999999999899999999988653

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.77  E-value=0.026  Score=48.26  Aligned_cols=29  Identities=21%  Similarity=0.422  Sum_probs=25.6

Q ss_pred             CCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         152 HRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       152 ~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                      .+++|||+++.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.73  E-value=0.0098  Score=46.24  Aligned_cols=31  Identities=29%  Similarity=0.467  Sum_probs=26.7

Q ss_pred             CceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         153 RIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       153 ~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      -.+|+|+.|.|+++++++ ++|+||+.+...+
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gD  108 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDGD  108 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccCCC
Confidence            369999999999998776 9999999887554

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	321
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-94
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-94
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-94
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-89
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-89
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-89
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-86
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-67
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-67
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-65
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-65
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-64
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-64
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-64
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-64
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		9e-64
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-63
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-63
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-63
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-63
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-63
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-63
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-63
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-63
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-63
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-63
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-63
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-63
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-63
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-63
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-63
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-63
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-63
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-63
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-63
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-63
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-63
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-63
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-63
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-63
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-62
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-62
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-62
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-62
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-62
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-62
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-62
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-59
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-59
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-55
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-54
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-53
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-48
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-46
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-46
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-46
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-46
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-46
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-46
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-46
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-46
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-46
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-46
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-46
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-46
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-45
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-45
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-45
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-45
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-45
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-45
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-45
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-45
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-45
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-45
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-45
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-45
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-45
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-45
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-45
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-45
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-45
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-45
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-45
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-45
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-45
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-45
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-45
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-45
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-45
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-45
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-45
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-45
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-45
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-45
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-45
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-45
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-45
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-45
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-45
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-45
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-45
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-45
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-45
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-45
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-45
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-45
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-45
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-45
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-45
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-45
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-45
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-45
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-45
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-45
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-45
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-45
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-45
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-45
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-45
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-45
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-45
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-45
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-45
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-45
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-45
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-45
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-45
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-45
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-45
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-45
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-44
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-44
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-44
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-44
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-44
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-44
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-44
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-44
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-44
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-44
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-44
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-44
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-44
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-43
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-43
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-43
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-43
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-43
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-43
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-43
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-43
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-43
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-43
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-43
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-43
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-43
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-43
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-43
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		9e-43
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-42
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-42
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-42
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-42
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-42
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-42
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-42
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-42
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-42
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-42
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-41
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-41
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-41
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-41
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-41
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-41
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-41
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-41
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-40
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-40
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-40
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-40
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-39
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-39
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-39
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-38
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-37
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-36
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-36
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-36
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-35
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-32
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-32
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-31
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-31
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-30
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-29
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-29
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-29
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-29
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-29
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-29
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		5e-29
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-29
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-29
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-29
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-29
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-29
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-29
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-29
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-29
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-29
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-29
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-29
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-29
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-29
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-29
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-29
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-28
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-28
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-28
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-28
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-27
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-27
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-26
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-26
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-26
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-26
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		9e-26
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-25
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-25
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-25
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		4e-25
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		6e-25
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		6e-25
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		7e-25
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-25
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		9e-25
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-24
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-24
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-24
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-24
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-24
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-24
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-24
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-24
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-24
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-24
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-24
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-24
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-24
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-24
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		9e-24
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-24
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-23
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-23
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-23
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-23
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-23
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-23
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-23
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-23
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-23
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-23
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-23
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-23
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-23
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-23
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-23
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-23
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-23
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-23
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-23
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-23
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-23
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-23
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-23
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-23
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-23
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-23
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-23
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-23
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-22
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-22
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-22
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-22
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-22
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-22
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-22
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-22
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-22
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-22
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-22
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-22
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-22
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-22
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-22
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		3e-22
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-22
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-22
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-22
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-22
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-22
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-22
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-22
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-22
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-22
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-21
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-21
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-21
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-21
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-21
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-21
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-21
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		5e-21
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		5e-21
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		5e-21
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		5e-21
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		6e-21
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		6e-21
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		6e-21
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		6e-21
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-21
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		6e-21
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		6e-21
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-21
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		6e-21
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		6e-21
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-21
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-21
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-20
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-20
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-20
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-20
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-20
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-20
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-20
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-20
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-20
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-20
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-20
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-20
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-20
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-20
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-20
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-20
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-20
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-20
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		5e-20
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-20
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		6e-20
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-20
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		8e-20
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-19
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-19
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-19
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-19
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-19
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-19
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-19
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-19
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-19
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-19
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-19
3soa_A	444	Full-Length Human Camkii Length = 444		3e-19
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-19
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-19
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-19
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-19
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-19
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-19
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-19
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-19
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-18
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-18
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-18
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-18
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-18
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-18
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-18
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-18
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-18
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-18
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-18
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-18
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-18
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-18
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-18
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-18
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-18
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-18
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-18
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-18
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-18
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-18
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-18
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-18
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-18
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-18
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-18
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-18
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-18
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-18
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-18
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-18
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-18
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-18
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-18
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-18
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-18
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-18
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		9e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-17
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-17
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-17
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-17
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-17
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-17
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-17
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-17
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-17
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-17
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-17
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-17
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-17
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-17
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-17
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-17
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-17
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-17
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-17
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-17
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-17
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-17
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-16
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-16
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-16
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-16
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-16
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-16
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-16
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-16
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-16
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-16
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		6e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-16
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-16
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		9e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-16
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		9e-16
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-15
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-15
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-15
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-15
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-15
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-15
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-15
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-15
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-15
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-15
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-15
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-15
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-15
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-15
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-15
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-15
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-15
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-15
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-15
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-15
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-15
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-15
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-15
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-15
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-15
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-15
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-15
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-15
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-15
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-15
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-15
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-15
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-15
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-15
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-15
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-15
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-15
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-15
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		4e-15
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-15
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-15
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-15
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		5e-15
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-15
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-15
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-15
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-15
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-15
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-15
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-15
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-15
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-15
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-15
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-15
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-15
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-15
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-15
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-15
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-15
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		9e-15
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		9e-15
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-15
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-14
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-14
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-14
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-14
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-14
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-14
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-14
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-14
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-14
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-14
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-14
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-14
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-14
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-14
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-14
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-14
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-14
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-14
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-14
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		9e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-13
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-13
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-13
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-13
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-13
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-13
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-13
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-13
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-13
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-13
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-13
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-13
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-13
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-13
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-13
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		7e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-13
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		8e-13
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-12
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-12
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		8e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-11
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-10
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		9e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-09
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-09
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		8e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-08
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-08

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  342 bits (876), Expect = 2e-94,   Method: Compositional matrix adjust.
 Identities = 155/304 (50%), Positives = 215/304 (70%), Gaps = 2/304 (0%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D L   D++Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+  E+G+P+ST+RE++
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           +L+ L+TFEHPN+VR FDV    +   +R   + L+FEHVDQDL +Y++K P PG+    
Sbjct: 64  VLRHLETFEHPNVVRLFDVC--TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +K++  Q+L+G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTSVVV
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
           TLWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLF  S++V+QL  I  VIG P   
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           +WP +++L   +F   S         D       LL   LTFNPA RISA  AL HPYF+
Sbjct: 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301
Query: 315 EKEN 318
           + E 
Sbjct: 302 DLER 305

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  341 bits (875), Expect = 3e-94,   Method: Compositional matrix adjust.
 Identities = 157/304 (51%), Positives = 215/304 (70%), Gaps = 2/304 (0%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D L   D++Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+  E+G+P+ST+RE++
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           +L+ L+TFEHPN+VR FDV   +    E  LT  L+FEHVDQDL +Y++K P PG+    
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLT--LVFEHVDQDLTTYLDKVPEPGVPTET 121
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +K++  Q+L+G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTSVVV
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
           TLWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLF  S++V+QL  I  VIG P   
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           +WP +++L   +F   S         D       LL   LTFNPA RISA  AL HPYF+
Sbjct: 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301
Query: 315 EKEN 318
           + E 
Sbjct: 302 DLER 305

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  340 bits (872), Expect = 6e-94,   Method: Compositional matrix adjust.
 Identities = 156/300 (52%), Positives = 213/300 (71%), Gaps = 2/300 (0%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D L   D++Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+  E+G+P+ST+RE++
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           +L+ L+TFEHPN+VR FDV   +    E  LT  L+FEHVDQDL +Y++K P PG+    
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLT--LVFEHVDQDLTTYLDKVPEPGVPTET 121
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +K++  Q+L+G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTSVVV
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
           TLWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLF  S++V+QL  I  VIG P   
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           +WP +++L   +F   S         D       LL   LTFNPA RISA  AL HPYF+
Sbjct: 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  326 bits (835), Expect = 1e-89,   Method: Compositional matrix adjust.
 Identities = 148/302 (49%), Positives = 210/302 (69%), Gaps = 3/302 (0%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           +   +Y+ + +IG GAYGTV+KARD  + G++VA+K +RV   E+G+P+ST+RE+++L++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
           L+ FEHPN+VR  DV   +    +R + V L+FEHVDQDL +Y++K PPPGL A  +K+L
Sbjct: 60  LEAFEHPNVVRLMDVCATS--RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWY 198
            RQ L+G+DFLH++ I+HRDLKP+N+L+T  G +K+ADFGLA+ + Y M L  VVVTLWY
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWY 177
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           RAPE+LL   Y TPVD+WS+GC+ AEM+R  PLFC ++E +QL  IF +IG P  ++WP 
Sbjct: 178 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 237
Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN 318
           ++SL   +F         ++  +       LL  MLTFNP  RISA  AL+H Y  + E 
Sbjct: 238 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 297
Query: 319 EP 320
            P
Sbjct: 298 NP 299

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  325 bits (833), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 148/302 (49%), Positives = 210/302 (69%), Gaps = 3/302 (0%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           +   +Y+ + +IG GAYGTV+KARD  + G++VA+K +RV   E+G+P+ST+RE+++L++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
           L+ FEHPN+VR  DV   +    +R + V L+FEHVDQDL +Y++K PPPGL A  +K+L
Sbjct: 60  LEAFEHPNVVRLMDVCATS--RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWY 198
            RQ L+G+DFLH++ I+HRDLKP+N+L+T  G +K+ADFGLA+ + Y M L  VVVTLWY
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWY 177
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           RAPE+LL   Y TPVD+WS+GC+ AEM+R  PLFC ++E +QL  IF +IG P  ++WP 
Sbjct: 178 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 237
Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN 318
           ++SL   +F         ++  +       LL  MLTFNP  RISA  AL+H Y  + E 
Sbjct: 238 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 297
Query: 319 EP 320
            P
Sbjct: 298 NP 299

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  324 bits (831), Expect = 4e-89,   Method: Compositional matrix adjust.
 Identities = 148/302 (49%), Positives = 210/302 (69%), Gaps = 3/302 (0%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           +   +Y+ + +IG GAYGTV+KARD  + G++VA+K +RV   E+G+P+ST+RE+++L++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
           L+ FEHPN+VR  DV   +    +R + V L+FEHVDQDL +Y++K PPPGL A  +K+L
Sbjct: 60  LEAFEHPNVVRLMDVCATS--RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWY 198
            RQ L+G+DFLH++ I+HRDLKP+N+L+T  G +K+ADFGLA+ + Y M L  VVVTLWY
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWY 177
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           RAPE+LL   Y TPVD+WS+GC+ AEM+R  PLFC ++E +QL  IF +IG P  ++WP 
Sbjct: 178 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 237
Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN 318
           ++SL   +F         ++  +       LL  MLTFNP  RISA  AL+H Y  + E 
Sbjct: 238 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 297
Query: 319 EP 320
            P
Sbjct: 298 NP 299

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  316 bits (809), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 148/305 (48%), Positives = 209/305 (68%), Gaps = 6/305 (1%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK---LNEDGIPMSTLREISI 75
           +   +Y+ + +IG GAYGTV+KARD  + G++VA+K +RV        G+P+ST+RE+++
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           L++L+ FEHPN+VR  DV   +    +R + V L+FEHVDQDL +Y++K PPPGL A  +
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATS--RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI 122
Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVT 195
           K+L RQ L+G+DFLH++ I+HRDLKP+N+L+T  G +K+ADFGLA+ + Y M LT VVVT
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 182
Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           LWYRAPE+LL   Y TPVD+WS+GC+ AEM+R  PLFC ++E +QL  IF +IG P  ++
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242
Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           WP ++SL   +F         ++  +       LL  MLTFNP  RISA  AL+H Y  +
Sbjct: 243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302
Query: 316 KENEP 320
            E  P
Sbjct: 303 DEGNP 307

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  250 bits (639), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 140/299 (46%), Positives = 193/299 (64%), Gaps = 18/299 (6%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY +L ++G G YG V+KA+D Q  G  VA+K++R+   ++GIP + +REIS+LK+L  
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQ--GRIVALKRIRLDAEDEGIPSTAIREISLLKEL-- 76
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             HPNIV   DVIH      ER LT  L+FE +++DL   +++    GL  S++K    Q
Sbjct: 77  -HHPNIVSLIDVIHS-----ERCLT--LVFEFMEKDLKKVLDENKT-GLQDSQIKIYLYQ 127
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM-LTSVVVTLWYRA 200
           +L+GV   H HRI+HRDLKPQNLLI   G LK+ADFGLA+ F   +   T  VVTLWYRA
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 201 PEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           P++L+ +  Y T VDIWSIGC+ AEM    PLF   T+ +QL  IF ++GTP+  EWP+ 
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 260 ISL-MWS--SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             L +W   +F+ + K  +S+I    C +   LL +ML F+P  RISA DA+ HPYFK+
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  250 bits (639), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 140/299 (46%), Positives = 193/299 (64%), Gaps = 18/299 (6%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY +L ++G G YG V+KA+D Q  G  VA+K++R+   ++GIP + +REIS+LK+L  
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQ--GRIVALKRIRLDAEDEGIPSTAIREISLLKEL-- 76
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             HPNIV   DVIH      ER LT  L+FE +++DL   +++    GL  S++K    Q
Sbjct: 77  -HHPNIVSLIDVIHS-----ERCLT--LVFEFMEKDLKKVLDENKT-GLQDSQIKIYLYQ 127
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM-LTSVVVTLWYRA 200
           +L+GV   H HRI+HRDLKPQNLLI   G LK+ADFGLA+ F   +   T  VVTLWYRA
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 201 PEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           P++L+ +  Y T VDIWSIGC+ AEM    PLF   T+ +QL  IF ++GTP+  EWP+ 
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 260 ISL-MWS--SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             L +W   +F+ + K  +S+I    C +   LL +ML F+P  RISA DA+ HPYFK+
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  245 bits (626), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 134/299 (44%), Positives = 186/299 (62%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 59
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FEHV QDL ++M+     G+    +K    
Sbjct: 60  --HPNIVKLLDVIHTENKL--------YLVFEHVHQDLKTFMDASALTGIPLPLIKSYLF 109
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +   T  VVTLWYR
Sbjct: 110 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  244 bits (624), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 134/299 (44%), Positives = 185/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 63
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FEHVDQDL  +M+     G+    +K    
Sbjct: 64  --HPNIVKLLDVIHTENKL--------YLVFEHVDQDLKKFMDASALTGIPLPLIKSYLF 113
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  241 bits (616), Expect = 3e-64,   Method: Compositional matrix adjust.
 Identities = 133/298 (44%), Positives = 183/298 (61%), Gaps = 17/298 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY  L +IG G YG V+KA++  N G   A+KK+R++  ++GIP +T+REISILK+L  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-- 57
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H NIV+ +DVIH    + +R   + L+FEH+DQDL   ++ C   GL +   K    Q
Sbjct: 58  -KHSNIVKLYDVIH----TKKR---LVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQ 108
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM-LTSVVVTLWYRA 200
           +L G+ + H  R++HRDLKPQNLLI R G LKIADFGLA+ F   +   T  VVTLWYRA
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRA 168
Query: 201 PEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           P++L+ +  Y T +DIWS+GC+ AEM    PLF   +E +QL  IFR++GTP+   WP  
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 260 ISLMW--SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             L     +F  Y  + + +           LL  ML  +P  RI+A  ALEH YFKE
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  241 bits (615), Expect = 4e-64,   Method: Compositional matrix adjust.
 Identities = 133/298 (44%), Positives = 183/298 (61%), Gaps = 17/298 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY  L +IG G YG V+KA++  N G   A+KK+R++  ++GIP +T+REISILK+L  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-- 57
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H NIV+ +DVIH    + +R   + L+FEH+DQDL   ++ C   GL +   K    Q
Sbjct: 58  -KHSNIVKLYDVIH----TKKR---LVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQ 108
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM-LTSVVVTLWYRA 200
           +L G+ + H  R++HRDLKPQNLLI R G LKIADFGLA+ F   +   T  VVTLWYRA
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRA 168
Query: 201 PEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           P++L+ +  Y T +DIWS+GC+ AEM    PLF   +E +QL  IFR++GTP+   WP  
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 260 ISLMW--SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             L     +F  Y  + + +           LL  ML  +P  RI+A  ALEH YFKE
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  241 bits (614), Expect = 5e-64,   Method: Compositional matrix adjust.
 Identities = 132/298 (44%), Positives = 183/298 (61%), Gaps = 17/298 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY  L +IG G YG V+KA++  N G   A+KK+R++  ++GIP +T+REISILK+L  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-- 57
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H NIV+ +DVIH    + +R   + L+FEH+DQDL   ++ C   GL +   K    Q
Sbjct: 58  -KHSNIVKLYDVIH----TKKR---LVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQ 108
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM-LTSVVVTLWYRA 200
           +L G+ + H  R++HRDLKPQNLLI R G LKIADFGLA+ F   +   T  +VTLWYRA
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 201 PEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           P++L+ +  Y T +DIWS+GC+ AEM    PLF   +E +QL  IFR++GTP+   WP  
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 260 ISLMW--SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             L     +F  Y  + + +           LL  ML  +P  RI+A  ALEH YFKE
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  240 bits (613), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 133/301 (44%), Positives = 185/301 (61%), Gaps = 17/301 (5%)
Query: 20  GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQL 79
           G + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L
Sbjct: 1   GMENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 80  DTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
           +   HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K  
Sbjct: 60  N---HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSY 108
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLW 197
             Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +   T  VVTLW
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 168
Query: 198 YRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW 256
           YRAPEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    W
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 228
Query: 257 PENISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           P   S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F+
Sbjct: 229 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288
Query: 315 E 315
           +
Sbjct: 289 D 289

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  240 bits (612), Expect = 9e-64,   Method: Compositional matrix adjust.
 Identities = 132/299 (44%), Positives = 184/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 60
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 61  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +   T  VVTLWYR
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 171 APEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  240 bits (612), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 132/299 (44%), Positives = 184/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 67
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 68  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 117
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +   T  VVTLWYR
Sbjct: 118 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 177
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 178 APEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 237
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 238 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  239 bits (611), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 132/299 (44%), Positives = 184/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 60
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 61  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +   T  VVTLWYR
Sbjct: 111 QLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  239 bits (610), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 132/299 (44%), Positives = 184/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 59
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 60  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 109
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +   T  VVTLWYR
Sbjct: 110 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  239 bits (610), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 132/299 (44%), Positives = 184/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 60
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 61  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +   T  VVTLWYR
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  239 bits (610), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 132/299 (44%), Positives = 184/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 67
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 68  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 117
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +   T  VVTLWYR
Sbjct: 118 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 177
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 178 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 237
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 238 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  239 bits (610), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 132/299 (44%), Positives = 184/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 59
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 60  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 109
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +   T  VVTLWYR
Sbjct: 110 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  239 bits (610), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 132/299 (44%), Positives = 184/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 61
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 62  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 111
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +   T  VVTLWYR
Sbjct: 112 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 171
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 132/299 (44%), Positives = 184/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 64
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 65  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 114
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +   T  VVTLWYR
Sbjct: 115 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 174
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 234
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 235 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  238 bits (606), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 131/299 (43%), Positives = 184/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 63
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL ++M+     G+    +K    
Sbjct: 64  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKTFMDASALTGIPLPLIKSYLF 113
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  237 bits (605), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 131/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 60
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 61  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  237 bits (605), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 131/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 60
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 61  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  237 bits (605), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 131/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 59
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 60  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 109
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 110 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 169
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  237 bits (605), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 131/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 60
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 61  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  237 bits (605), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 131/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 60
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 61  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  237 bits (605), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 131/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+ K+R+    +G+P + +REIS+LK+L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALXKIRLDTETEGVPSTAIREISLLKELN- 60
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 61  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +   T  VVTLWYR
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  237 bits (605), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 131/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+ K+R+    +G+P + +REIS+LK+L+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALXKIRLDTETEGVPSTAIREISLLKELN- 59
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 60  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 109
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +   T  VVTLWYR
Sbjct: 110 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  237 bits (604), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 131/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 59
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 60  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 109
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 110 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 169
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  237 bits (604), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 131/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 61
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 62  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 111
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 112 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 171
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  237 bits (604), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 131/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 64
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 65  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 114
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 115 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 174
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 234
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 235 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  237 bits (604), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 131/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 63
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 64  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 113
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  237 bits (604), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 131/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 61
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 62  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 111
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 112 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 171
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  237 bits (604), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 131/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 63
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 64  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 113
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  237 bits (604), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 131/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 62
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 63  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 112
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 113 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 172
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 233 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  237 bits (604), Expect = 8e-63,   Method: Compositional matrix adjust.
 Identities = 131/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 62
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 63  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 112
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 113 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 172
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 233 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  236 bits (601), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 130/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 60
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 61  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKDFMDASALTGIPLPLIKSYLF 110
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKP+NLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  236 bits (601), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 130/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 61
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 62  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 111
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKP+NLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 112 QLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 171
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  235 bits (600), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 130/299 (43%), Positives = 183/299 (61%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 62
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE + QDL  +M+     G+    +K    
Sbjct: 63  --HPNIVKLLDVIHTENKL--------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF 112
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKP+NLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 113 QLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 172
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 233 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  235 bits (599), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 130/299 (43%), Positives = 182/299 (60%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 62
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE +  DL  +M+     G+    +K    
Sbjct: 63  --HPNIVKLLDVIHTENKL--------YLVFEFLSMDLKDFMDASALTGIPLPLIKSYLF 112
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 113 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 172
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 233 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  234 bits (598), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 130/299 (43%), Positives = 182/299 (60%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 63
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE +  DL  +M+     G+    +K    
Sbjct: 64  --HPNIVKLLDVIHTENKL--------YLVFEFLSMDLKDFMDASALTGIPLPLIKSYLF 113
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  233 bits (595), Expect = 8e-62,   Method: Compositional matrix adjust.
 Identities = 129/299 (43%), Positives = 182/299 (60%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 61
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE +  DL  +M+     G+    +K    
Sbjct: 62  --HPNIVKLLDVIHTENKL--------YLVFEFLSMDLKKFMDASALTGIPLPLIKSYLF 111
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKP+NLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 112 QLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 171
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  233 bits (595), Expect = 8e-62,   Method: Compositional matrix adjust.
 Identities = 129/299 (43%), Positives = 182/299 (60%), Gaps = 17/299 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + + ++ +IG G YG V+KAR+ +  G  VA+KK+R+    +G+P + +REIS+LK+L+ 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 63
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNIV+  DVIH +N L        YL+FE +  DL  +M+     G+    +K    
Sbjct: 64  --HPNIVKLLDVIHTENKL--------YLVFEFLSMDLKKFMDASALTGIPLPLIKSYLF 113
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q+L+G+ F HSHR++HRDLKP+NLLI   G +K+ADFGLA+ F   +      VVTLWYR
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 200 APEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APEILL    Y T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP 
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  226 bits (576), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 130/301 (43%), Positives = 185/301 (61%), Gaps = 21/301 (6%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY++L +IG G YGTVFKA++ +     VA+K++R+  +++G+P S LREI +LK+L  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETH-EIVALKRVRLDDDDEGVPSSALREICLLKEL-- 58
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H NIVR  DV+H    SD++   + L+FE  DQDL  Y + C    L    VK    Q
Sbjct: 59  -KHKNIVRLHDVLH----SDKK---LTLVFEFCDQDLKKYFDSCNG-DLDPEIVKSFLFQ 109
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-VVTLWYRA 200
           +LKG+ F HS  ++HRDLKPQNLLI R G LK+ADFGLA+ F   +   S  VVTLWYR 
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 201 PEILLNLG-YGTPVDIWSIGCVMAEMWRLV-PLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           P++L     Y T +D+WS GC+ AE+     PLF  +   +QLK IFR++GTP+  +WP 
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANS----LLESMLTFNPADRISAADALEHPYFK 314
              L    ++ Y     +   ++   K N+    LL+++L  NP  RISA +AL+HPYF 
Sbjct: 230 MTKL--PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
Query: 315 E 315
           +
Sbjct: 288 D 288

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  224 bits (570), Expect = 7e-59,   Method: Compositional matrix adjust.
 Identities = 129/301 (42%), Positives = 185/301 (61%), Gaps = 21/301 (6%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY++L +IG G YGTVFKA++ +     VA+K++R+  +++G+P S LREI +LK+L  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETH-EIVALKRVRLDDDDEGVPSSALREICLLKEL-- 58
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H NIVR  DV+H    SD++   + L+FE  DQDL  Y + C    L    VK    Q
Sbjct: 59  -KHKNIVRLHDVLH----SDKK---LTLVFEFCDQDLKKYFDSCNG-DLDPEIVKSFLFQ 109
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-VVTLWYRA 200
           +LKG+ F HS  ++HRDLKPQNLLI R G LK+A+FGLA+ F   +   S  VVTLWYR 
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 201 PEILLNLG-YGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           P++L     Y T +D+WS GC+ AE+     PLF  +   +QLK IFR++GTP+  +WP 
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANS----LLESMLTFNPADRISAADALEHPYFK 314
              L    ++ Y     +   ++   K N+    LL+++L  NP  RISA +AL+HPYF 
Sbjct: 230 MTKL--PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
Query: 315 E 315
           +
Sbjct: 288 D 288

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  212 bits (540), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 125/313 (39%), Positives = 182/313 (58%), Gaps = 39/313 (12%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           ++ +L ++G G Y TV+K  + +  G YVA+K++++  +E+G P + +REIS++K+L   
Sbjct: 6   QFKQLEKLGNGTYATVYKGLN-KTTGVYVALKEVKLD-SEEGTPSTAIREISLMKEL--- 60
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK----CPPPGLSASKVKEL 138
           +H NIVR +DVIH      E  LT  L+FE +D DL  YM+       P GL  + VK  
Sbjct: 61  KHENIVRLYDVIHT-----ENKLT--LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLW 197
             Q+L+G+ F H ++I+HRDLKPQNLLI + G LK+ DFGLA+ F   +   +S VVTLW
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLW 173
Query: 198 YRAPEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW 256
           YRAP++L+ +  Y T +DIWS GC++AEM    PLF  + + EQLK IF ++GTP+ + W
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233
Query: 257 PENISL--------------MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI 302
           P    L              +    + ++K       MD        L  +L  NP  R+
Sbjct: 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMD-------FLHGLLQLNPDMRL 286
Query: 303 SAADALEHPYFKE 315
           SA  AL HP+F E
Sbjct: 287 SAKQALHHPWFAE 299

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  210 bits (534), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 125/308 (40%), Positives = 178/308 (57%), Gaps = 23/308 (7%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y  + ++G G YG V+KA D       VA+K++R++  E+G+P + +RE+S+LK+L   
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVT-NETVAIKRIRLEHEEEGVPGTAIREVSLLKEL--- 90
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           +H NI+    VIH N         ++LIFE+ + DL  YM+K P   +S   +K    Q+
Sbjct: 91  QHRNIIELKSVIHHN-------HRLHLIFEYAENDLKKYMDKNP--DVSMRVIKSFLYQL 141
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGG-----LKIADFGLAKTFDYDM-MLTSVVVTL 196
           + GV+F HS R +HRDLKPQNLL++ +       LKI DFGLA+ F   +   T  ++TL
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
Query: 197 WYRAPEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           WYR PEILL +  Y T VDIWSI C+ AEM    PLF   +E++QL  IF V+G P    
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 256 WPENISLM-W-SSFEQY-SKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
           WP   +L  W  SF ++  K     +      +   LL +ML  +P  RISA +ALEHPY
Sbjct: 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
Query: 313 FKEKENEP 320
           F   + +P
Sbjct: 322 FSHNDFDP 329

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  203 bits (517), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 121/299 (40%), Positives = 177/299 (59%), Gaps = 26/299 (8%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y +L ++G G Y TV+K +  +   N VA+K++R++ +E+G P + +RE+S+LK L   +
Sbjct: 4   YIKLDKLGEGTYATVYKGKS-KLTDNLVALKEIRLE-HEEGAPCTAIREVSLLKDL---K 58
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV   D+IH      E+ LT  L+FE++D+DL  Y++ C    ++   VK    Q+L
Sbjct: 59  HANIVTLHDIIHT-----EKSLT--LVFEYLDKDLKQYLDDCGNI-INMHNVKLFLFQLL 110
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-----TFDYDMMLTSVVVTLWY 198
           +G+ + H  +++HRDLKPQNLLI   G LK+ADFGLA+     T  YD    + VVTLWY
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD----NEVVTLWY 166
Query: 199 RAPEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           R P+ILL +  Y T +D+W +GC+  EM    PLF  ST  EQL  IFR++GTP+   WP
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 258 ---ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
               N      ++ +Y   A  +      S    LL  +L F   +RISA DA++HP+F
Sbjct: 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  189 bits (481), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 112/302 (37%), Positives = 174/302 (57%), Gaps = 20/302 (6%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN---EDGIPMSTLREISILKQ 78
           K+Y++L  +G G + TV+KARD +N    VA+KK+++      +DGI  + LREI +L++
Sbjct: 10  KRYEKLDFLGEGQFATVYKARD-KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 79  LDTFEHPNIVRFFDVI-HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE 137
           L    HPNI+   D   H++ +S        L+F+ ++ DL   + K     L+ S +K 
Sbjct: 69  L---SHPNIIGLLDAFGHKSNIS--------LVFDFMETDL-EVIIKDNSLVLTPSHIKA 116
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY-DMMLTSVVVTL 196
                L+G+++LH H I+HRDLKP NLL+   G LK+ADFGLAK+F   +      VVT 
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTR 176
Query: 197 WYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           WYRAPE+L     YG  VD+W++GC++AE+   VP     ++++QL  IF  +GTP+  +
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 236
Query: 256 WPENISLM-WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           WP+  SL  + +F+ +  +    IF         L++ +  FNP  RI+A  AL+  YF 
Sbjct: 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296
Query: 315 EK 316
            +
Sbjct: 297 NR 298

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 109/306 (35%), Positives = 170/306 (55%), Gaps = 23/306 (7%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY++L +IG G +G VFKAR  +  G  VA+KK+ ++  ++G P++ LREI IL+ L   
Sbjct: 19  KYEKLAKIGQGTFGEVFKARH-RKTGQKVALKKVLMENEKEGFPITALREIKILQLL--- 74
Query: 83  EHPNIVRFFDVIHQNILSDER-YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
           +H N+V   ++         R   ++YL+F+  + DL   +        + S++K + + 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQM 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-----MLTSVVVTL 196
           +L G+ ++H ++I+HRD+K  N+LITR G LK+ADFGLA+ F            + VVTL
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 197 WYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           WYR PE+LL    YG P+D+W  GC+MAEMW   P+   +TE  QL  I ++ G+ +   
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 253
Query: 256 WP--------ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           WP        E + L+    ++  K    A   D    A  L++ +L  +PA RI + DA
Sbjct: 254 WPNVDNYELYEKLELV-KGQKRKVKDRLKAYVRD--PYALDLIDKLLVLDPAQRIDSDDA 310
Query: 308 LEHPYF 313
           L H +F
Sbjct: 311 LNHDFF 316

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 109/306 (35%), Positives = 170/306 (55%), Gaps = 23/306 (7%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY++L +IG G +G VFKAR  +  G  VA+KK+ ++  ++G P++ LREI IL+ L   
Sbjct: 19  KYEKLAKIGQGTFGEVFKARH-RKTGQKVALKKVLMENEKEGFPITALREIKILQLL--- 74
Query: 83  EHPNIVRFFDVIHQNILSDERYL-TVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
           +H N+V   ++         R   ++YL+F+  + DL   +        + S++K + + 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIKRVMQM 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-----MLTSVVVTL 196
           +L G+ ++H ++I+HRD+K  N+LITR G LK+ADFGLA+ F            + VVTL
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 197 WYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           WYR PE+LL    YG P+D+W  GC+MAEMW   P+   +TE  QL  I ++ G+ +   
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 253
Query: 256 WP--------ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           WP        E + L+    ++  K    A   D    A  L++ +L  +PA RI + DA
Sbjct: 254 WPNVDNYELYEKLELVKGQ-KRKVKDRLKAYVRD--PYALDLIDKLLVLDPAQRIDSDDA 310
Query: 308 LEHPYF 313
           L H +F
Sbjct: 311 LNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 109/306 (35%), Positives = 170/306 (55%), Gaps = 23/306 (7%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY++L +IG G +G VFKAR  +  G  VA+KK+ ++  ++G P++ LREI IL+ L   
Sbjct: 18  KYEKLAKIGQGTFGEVFKARH-RKTGQKVALKKVLMENEKEGFPITALREIKILQLL--- 73
Query: 83  EHPNIVRFFDVIHQNILSDERYL-TVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
           +H N+V   ++         R   ++YL+F+  + DL   +        + S++K + + 
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIKRVMQM 132
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-----MLTSVVVTL 196
           +L G+ ++H ++I+HRD+K  N+LITR G LK+ADFGLA+ F            + VVTL
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 192
Query: 197 WYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           WYR PE+LL    YG P+D+W  GC+MAEMW   P+   +TE  QL  I ++ G+ +   
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252
Query: 256 WP--------ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           WP        E + L+    ++  K    A   D    A  L++ +L  +PA RI + DA
Sbjct: 253 WPNVDNYELYEKLELVKGQ-KRKVKDRLKAYVRD--PYALDLIDKLLVLDPAQRIDSDDA 309
Query: 308 LEHPYF 313
           L H +F
Sbjct: 310 LNHDFF 315

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 109/306 (35%), Positives = 170/306 (55%), Gaps = 23/306 (7%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY++L +IG G +G VFKAR  +  G  VA+KK+ ++  ++G P++ LREI IL+ L   
Sbjct: 19  KYEKLAKIGQGTFGEVFKARH-RKTGQKVALKKVLMENEKEGFPITALREIKILQLL--- 74
Query: 83  EHPNIVRFFDVIHQNILSDERYL-TVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
           +H N+V   ++         R   ++YL+F+  + DL   +        + S++K + + 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQM 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-----MLTSVVVTL 196
           +L G+ ++H ++I+HRD+K  N+LITR G LK+ADFGLA+ F            + VVTL
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 197 WYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           WYR PE+LL    YG P+D+W  GC+MAEMW   P+   +TE  QL  I ++ G+ +   
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 253
Query: 256 WP--------ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           WP        E + L+    ++  K    A   D    A  L++ +L  +PA RI + DA
Sbjct: 254 WPNVDNYELYEKLELV-KGQKRKVKDRLKAYVRD--PYALDLIDKLLVLDPAQRIDSDDA 310
Query: 308 LEHPYF 313
           L H +F
Sbjct: 311 LNHDFF 316

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  181 bits (458), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 119/308 (38%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 19  FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 75
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 76  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKTQ---HLSNDHIC 127
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEY 187
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 247
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 248 SQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 307
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 308 LAHPYLEQ 315

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  180 bits (457), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 167/308 (54%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G+ VA+KKL            T RE+ +LK +  
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKT-GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 88
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 89  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 143
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 144 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 201
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 261
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 262 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 321
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 322 HDPDDEPV 329

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  180 bits (457), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 121/317 (38%), Positives = 169/317 (53%), Gaps = 23/317 (7%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 21  FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 77
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
                F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 78  L---AFRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 129
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 130 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 249
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 250 SQEDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 309
Query: 308 LEHPY---FKEKENEPL 321
           L HPY   + +  +EP+
Sbjct: 310 LAHPYLAQYYDPSDEPI 326

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  180 bits (457), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 119/308 (38%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 19  FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 75
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 76  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 127
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 247
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 248 SQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 307
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 308 LAHPYLEQ 315

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  180 bits (457), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 167/308 (54%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G+ VA+KKL            T RE+ +LK +  
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKT-GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 84
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 85  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 139
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 197
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 258 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 318 HDPDDEPV 325

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  180 bits (457), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 167/308 (54%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G+ VA+KKL            T RE+ +LK +  
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKT-GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 74
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 75  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCA--KLTDDHVQFLIYQ 129
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 187
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 308 HDPDDEPV 315

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  180 bits (457), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 167/308 (54%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G+ VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  180 bits (457), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 170/308 (55%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y +L  IG GAYG V  A D   K   VA+KK+            TLREI IL
Sbjct: 39  FDVG-PRYTQLQYIGEGAYGMVSSAYDHVRKTR-VAIKKIS-PFEHQTYCQRTLREIQIL 95
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H N++   D++  + L   R   VY++ + ++ DL   ++      LS   + 
Sbjct: 96  LR---FRHENVIGIRDILRASTLEAMR--DVYIVQDLMETDLYKLLKS---QQLSNDHIC 147
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT----FDYDMMLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLLI     LKI DFGLA+      D+   LT  
Sbjct: 148 YFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEX 207
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 267
Query: 252 SMNEWPENISLMWSSFEQ----YSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I++   ++ Q     +KVA++ +F    SKA  LL+ MLTFNP  RI+  +A
Sbjct: 268 SQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEA 327
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 328 LAHPYLEQ 335

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 167/308 (54%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G+ VA+KKL            T RE+ +LK +  
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKT-GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 74
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 75  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 129
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 187
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 308 HDPDDEPV 315

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 167/308 (54%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G+ VA+KKL            T RE+ +LK +  
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKT-GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 98
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 99  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 153
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 211
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 271
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 272 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 332 HDPDDEPV 339

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 84
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 85  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 139
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM--TGYVATRWYRAP 197
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 318 HDPDDEPV 325

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 167/308 (54%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G+ VA+KKL            T RE+ +LK +  
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKT-GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 97
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 98  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 152
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 153 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 210
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 270
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 271 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 330
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 331 HDPDDEPV 338

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 121/308 (39%), Positives = 167/308 (54%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 23  FDVG-PRYTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 79
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   + KC    LS   + 
Sbjct: 80  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLL-KCQ--HLSNDHIC 131
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 312 LAHPYLEQ 319

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  179 bits (455), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 80
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 81  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 135
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM--TGYVATRWYRAP 193
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 314 HDPDDEPV 321

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  179 bits (455), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 119/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  IG GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 83
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 84  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 138
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAP 196
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 317 HDPDDEPV 324

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  179 bits (455), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 119/308 (38%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 23  FDVG-PRYTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKIS-PFEHQTYXQRTLREIKIL 79
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 80  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 131
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 312 LAHPYLEQ 319

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 115/306 (37%), Positives = 163/306 (53%), Gaps = 20/306 (6%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y +L  +G GAYG V  A D +  G  VA+KKL      +       RE+ +LK +    
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRT-GAKVAIKKLYRPFQSELFAKRAYRELRLLKHM---R 82
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H N++   DV   +   D+ +   YL+   +  DLG  M+      L   +++ L  QML
Sbjct: 83  HENVIGLLDVFTPDETLDD-FTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQML 138
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
           KG+ ++H+  IIHRDLKP NL +     LKI DFGLA+  D +M     VVT WYRAPE+
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--XGXVVTRWYRAPEV 196
Query: 204 LLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN-----EWP 257
           +LN + Y   VDIWS+GC+MAEM     LF  S  ++QLK I +V GTP        +  
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK--- 314
           E  + M     +  K  F++I  +    A +LLE ML  +   R++A +AL HPYF+   
Sbjct: 257 EAKNYM-KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315
Query: 315 EKENEP 320
           + E+EP
Sbjct: 316 DTEDEP 321

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 83
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 84  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 138
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAP 196
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 317 HDPDDEPV 324

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 119/308 (38%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 23  FDVG-PRYTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 79
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 80  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 131
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 312 LAHPYLEQ 319

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 119/308 (38%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 19  FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 75
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 76  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 127
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 247
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 248 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 307
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 308 LAHPYLEQ 315

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 89
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 90  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 144
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 145 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAP 202
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 262
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 263 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 323 HDPDDEPV 330

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 119/308 (38%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 27  FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 83
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 84  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 135
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 136 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 195
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 196 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 255
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 256 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 315
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 316 LAHPYLEQ 323

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 119/308 (38%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 19  FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 75
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 76  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 127
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 247
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 248 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 307
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 308 LAHPYLEQ 315

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 112/318 (35%), Positives = 170/318 (53%), Gaps = 21/318 (6%)
Query: 16  SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISI 75
           + D+GD+ Y+ +  IG GAYG V  AR  +  G  VA+KK+    +       TLRE+ I
Sbjct: 49  TFDVGDE-YEIIETIGNGAYGVVSSARR-RLTGQQVAIKKIPNAFDVVTNAKRTLRELKI 106
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           LK    F+H NI+   D++   +   E + +VY++ + ++ DL   +    P  L+   V
Sbjct: 107 LKH---FKHDNIIAIKDILRPTVPYGE-FKSVYVVLDLMESDLHQIIHSSQP--LTLEHV 160
Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-----DYDMMLT 190
           +    Q+L+G+ ++HS ++IHRDLKP NLL+     LKI DFG+A+       ++   +T
Sbjct: 161 RYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMT 220
Query: 191 SVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG 249
             V T WYRAPE++L+L  Y   +D+WS+GC+  EM     LF     V QL+ I  V+G
Sbjct: 221 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280
Query: 250 TPS----MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA 305
           TPS         E +     S      V +  ++     +A SLL  ML F P+ RISAA
Sbjct: 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAA 340
Query: 306 DALEHPY---FKEKENEP 320
            AL HP+   + + ++EP
Sbjct: 341 AALRHPFLAKYHDPDDEP 358

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 119/308 (38%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 24  FDVG-PRYTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 80
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 81  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 132
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 133 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 192
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 193 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 252
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 253 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 312
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 313 LAHPYLEQ 320

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 119/308 (38%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 25  FDVG-PRYTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 81
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 82  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 133
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 134 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 193
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 194 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 253
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 254 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 313
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 314 LAHPYLEQ 321

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 119/308 (38%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 16  FDVG-PRYTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 72
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 73  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 124
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 125 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 184
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 185 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 244
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 245 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 304
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 305 LAHPYLEQ 312

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 119/308 (38%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 23  FDVG-PRYTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 79
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 80  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 131
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 312 LAHPYLEQ 319

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 120/308 (38%), Positives = 164/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 39  FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 95
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VYL+   +  DL   ++      LS   + 
Sbjct: 96  LR---FRHENIIGINDIIRAPTI--EQMKDVYLVTHLMGADLYKLLKT---QHLSNDHIC 147
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 148 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 267
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 268 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 327
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 328 LAHPYLEQ 335

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 119/308 (38%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 19  FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 75
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 76  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 127
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 247
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 248 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 307
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 308 LAHPYLEQ 315

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G+ VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M     V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--AGFVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G+ VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M     V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--AGFVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 119/308 (38%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 39  FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 95
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 96  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 147
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 148 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 267
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 268 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 327
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 328 LAHPYLEQ 335

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 119/308 (38%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 17  FDVG-PRYTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 73
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 74  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 125
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 126 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 185
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 186 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 245
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 246 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 305
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 306 LAHPYLEQ 313

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGXVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 83
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 84  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 138
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 196
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 317 HDPDDEPV 324

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 77
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 78  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 132
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 133 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 190
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 250
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 251 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 310
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 311 HDPDDEPV 318

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 119/308 (38%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 21  FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 77
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 78  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 129
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 130 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 249
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 250 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 309
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 310 LAHPYLEQ 317

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 83
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 84  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 138
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 196
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 317 HDPDDEPV 324

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 85
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 86  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 140
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 198
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 319 HDPDDEPV 326

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 80
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 81  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 135
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 193
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 314 HDPDDEPV 321

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G+ VA+KKL            T RE+ +LK +  
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKT-GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 74
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 75  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 129
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M     V T WYRAP
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--AGFVATRWYRAP 187
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 308 HDPDDEPV 315

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 80
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 81  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 135
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 193
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 314 HDPDDEPV 321

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 89
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 90  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 144
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 145 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 202
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 262
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 263 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 323 HDPDDEPV 330

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 101
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 102 -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 156
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 157 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 214
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 274
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 275 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 335 HDPDDEPV 342

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 84
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 85  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 139
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 197
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 318 HDPDDEPV 325

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSKPFQSIIHAKRTYRELRLLKHM-- 90
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 91  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 145
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 203
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 324 HDPDDEPV 331

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 97
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 98  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 152
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 153 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 210
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 270
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 271 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 330
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 331 HDPDDEPV 338

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 84
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 85  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 139
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 197
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 318 HDPDDEPV 325

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 80
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 81  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 135
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 193
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 314 HDPDDEPV 321

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 75
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 76  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 130
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 131 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 188
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 248
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 249 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 309 HDPDDEPV 316

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 74
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 75  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 129
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 187
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 308 HDPDDEPV 315

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 76
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 77  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 131
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 132 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 189
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 249
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 250 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 309
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 310 HDPDDEPV 317

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 90
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 91  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 145
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 203
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 324 HDPDDEPV 331

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 90
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 91  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 145
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 203
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 324 HDPDDEPV 331

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G+ VA+KKL            T RE+ +LK +  
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKT-GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 98
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 99  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 153
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M     V T WYRAP
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--XGXVATRWYRAP 211
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 271
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 272 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 332 HDPDDEPV 339

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 116/308 (37%), Positives = 165/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + ++      L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIVKXQ---KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 98
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 99  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 153
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 211
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 271
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 272 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 332 HDPDDEPV 339

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 112/318 (35%), Positives = 170/318 (53%), Gaps = 21/318 (6%)
Query: 16  SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISI 75
           + D+GD+ Y+ +  IG GAYG V  AR  +  G  VA+KK+    +       TLRE+ I
Sbjct: 50  TFDVGDE-YEIIETIGNGAYGVVSSARR-RLTGQQVAIKKIPNAFDVVTNAKRTLRELKI 107
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           LK    F+H NI+   D++   +   E + +VY++ + ++ DL   +    P  L+   V
Sbjct: 108 LKH---FKHDNIIAIKDILRPTVPYGE-FKSVYVVLDLMESDLHQIIHSSQP--LTLEHV 161
Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-----DYDMMLT 190
           +    Q+L+G+ ++HS ++IHRDLKP NLL+     LKI DFG+A+       ++   +T
Sbjct: 162 RYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMT 221
Query: 191 SVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG 249
             V T WYRAPE++L+L  Y   +D+WS+GC+  EM     LF     V QL+ I  V+G
Sbjct: 222 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 281
Query: 250 TPS----MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA 305
           TPS         E +     S      V +  ++     +A SLL  ML F P+ RISAA
Sbjct: 282 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAA 341
Query: 306 DALEHPY---FKEKENEP 320
            AL HP+   + + ++EP
Sbjct: 342 AALRHPFLAKYHDPDDEP 359

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 75
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 76  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 130
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 131 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 188
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 248
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 249 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 309 HDPDDEPV 316

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  177 bits (450), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA++K+            TLREI IL
Sbjct: 23  FDVG-PRYTNLSYIGEGAYGMVCSAYDNLNKVR-VAIRKIS-PFEHQTYCQRTLREIKIL 79
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 80  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 131
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 312 LAHPYLEQ 319

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  177 bits (450), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 121/317 (38%), Positives = 169/317 (53%), Gaps = 23/317 (7%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 21  FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 77
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
                F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 78  L---AFRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 129
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 130 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 249
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 250 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 309
Query: 308 LEHPY---FKEKENEPL 321
           L HPY   + +  +EP+
Sbjct: 310 LAHPYLAQYYDPSDEPI 326

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  177 bits (449), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 117/311 (37%), Positives = 171/311 (54%), Gaps = 22/311 (7%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  + D+++ G  +A+KKL            T RE+ +LK +  
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKS-GLKIAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 107
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 108 -KHENVIGLLDVF-TPATSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 162
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 163 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 220
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS---MNEWP 257
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  + QL+ I R+ GTP    ++  P
Sbjct: 221 EIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMP 280
Query: 258 ENISLMW-SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK-- 314
            + +  + +S  Q  K  F+ +F+     A  LLE ML  +   RI+A++AL HPYF   
Sbjct: 281 SHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQY 340
Query: 315 -----EKENEP 320
                E E+EP
Sbjct: 341 HDPDDEPESEP 351

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  177 bits (449), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI D+GLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  177 bits (448), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 116/308 (37%), Positives = 165/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + ++      L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIVKX---QKLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  177 bits (448), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 165/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 17  FDVG-PRYTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 73
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 74  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 125
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 126 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 185
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 186 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 245
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
              +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 246 EQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 305
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 306 LAHPYLEQ 313

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 165/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 23  FDVG-PRYTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 79
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 80  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 131
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      L   
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEX 191
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 312 LAHPYLEQ 319

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 118/308 (38%), Positives = 165/308 (53%), Gaps = 20/308 (6%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G  +Y  L  IG GAYG V  A D  NK   VA+KK+            TLREI IL
Sbjct: 24  FDVG-PRYTNLSYIGEGAYGMVCSAYDNLNKVR-VAIKKIS-PFEHQTYCQRTLREIKIL 80
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +   F H NI+   D+I    +  E+   VY++ + ++ DL   ++      LS   + 
Sbjct: 81  LR---FRHENIIGINDIIRAPTI--EQMKDVYIVQDLMETDLYKLLKT---QHLSNDHIC 132
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      L   
Sbjct: 133 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEX 192
Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 193 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 252
Query: 252 SMNEWPENISLMWS----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L       S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 253 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 312
Query: 308 LEHPYFKE 315
           L HPY ++
Sbjct: 313 LAHPYLEQ 320

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 165/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 101
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 102 -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 156
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M     V T WYRAP
Sbjct: 157 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--XGYVATRWYRAP 214
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 274
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 275 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 335 HDPDDEPV 342

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  176 bits (446), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 166/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G+ VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DF LA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + ++      L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIVKS---QKLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGL +  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 165/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI  FGLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 165/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 85
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 86  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 140
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+    +M  T  V T WYRAP
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRAP 198
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 319 HDPDDEPV 326

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 165/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 85
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 86  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 140
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+    +M  T  V T WYRAP
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRAP 198
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 319 HDPDDEPV 326

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 165/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 85
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 86  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 140
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+    +M  T  V T WYRAP
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRAP 198
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 319 HDPDDEPV 326

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 165/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI D GLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  175 bits (443), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 165/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI D GLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 165/308 (53%), Gaps = 18/308 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK +  
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-- 78
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    L+   V+ L  Q
Sbjct: 79  -KHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQ--KLTDDHVQFLIYQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP NL +     LKI D GLA+  D +M  T  V T WYRAP
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEM--TGYVATRWYRAP 191
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           EI+LN + Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 316 --KENEPL 321
              ++EP+
Sbjct: 312 HDPDDEPV 319

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  174 bits (440), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 115/320 (35%), Positives = 161/320 (50%), Gaps = 32/320 (10%)
Query: 16  SLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL             
Sbjct: 12  SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRA 70
Query: 70  LREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
            RE+ ++K ++   H NI+   +V   Q  L  E +  VYL+ E +D +L   ++     
Sbjct: 71  YRELVLMKXVN---HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLXQVIQM---- 121
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M
Sbjct: 122 ELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFM 181
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 241
Query: 249 GTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESM 293
           GTP    M +    +     +  +Y+ + F  +F D              S+A  LL  M
Sbjct: 242 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 301
Query: 294 LTFNPADRISAADALEHPYF 313
           L  +PA RIS  DAL+HPY 
Sbjct: 302 LVIDPAKRISVDDALQHPYI 321

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 115/320 (35%), Positives = 161/320 (50%), Gaps = 32/320 (10%)
Query: 16  SLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL             
Sbjct: 12  SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRA 70
Query: 70  LREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
            RE+ ++K ++   H NI+   +V   Q  L  E +  VYL+ E +D +L   ++     
Sbjct: 71  YRELVLMKCVN---HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLXQVIQM---- 121
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M
Sbjct: 122 ELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFM 181
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 241
Query: 249 GTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESM 293
           GTP    M +    +     +  +Y+ + F  +F D              S+A  LL  M
Sbjct: 242 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 301
Query: 294 LTFNPADRISAADALEHPYF 313
           L  +PA RIS  DAL+HPY 
Sbjct: 302 LVIDPAKRISVDDALQHPYI 321

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 115/320 (35%), Positives = 161/320 (50%), Gaps = 32/320 (10%)
Query: 16  SLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL             
Sbjct: 5   SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRA 63
Query: 70  LREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
            RE+ ++K ++   H NI+   +V   Q  L  E +  VYL+ E +D +L   ++     
Sbjct: 64  YRELVLMKCVN---HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLXQVIQM---- 114
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M
Sbjct: 115 ELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFM 174
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234
Query: 249 GTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESM 293
           GTP    M +    +     +  +Y+ + F  +F D              S+A  LL  M
Sbjct: 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294
Query: 294 LTFNPADRISAADALEHPYF 313
           L  +PA RIS  DAL+HPY 
Sbjct: 295 LVIDPAKRISVDDALQHPYI 314

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 115/320 (35%), Positives = 161/320 (50%), Gaps = 32/320 (10%)
Query: 16  SLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL             
Sbjct: 12  SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRA 70
Query: 70  LREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
            RE+ ++K ++   H NI+   +V   Q  L  E +  VYL+ E +D +L   ++     
Sbjct: 71  YRELVLMKXVN---HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLXQVIQM---- 121
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFM 181
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 241
Query: 249 GTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESM 293
           GTP    M +    +     +  +Y+ + F  +F D              S+A  LL  M
Sbjct: 242 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 301
Query: 294 LTFNPADRISAADALEHPYF 313
           L  +PA RIS  DAL+HPY 
Sbjct: 302 LVIDPAKRISVDDALQHPYI 321

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 115/320 (35%), Positives = 161/320 (50%), Gaps = 32/320 (10%)
Query: 16  SLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL             
Sbjct: 12  SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRA 70
Query: 70  LREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
            RE+ ++K ++   H NI+   +V   Q  L  E +  VYL+ E +D +L   ++     
Sbjct: 71  YRELVLMKXVN---HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLCQVIQM---- 121
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFM 181
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 241
Query: 249 GTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESM 293
           GTP    M +    +     +  +Y+ + F  +F D              S+A  LL  M
Sbjct: 242 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 301
Query: 294 LTFNPADRISAADALEHPYF 313
           L  +PA RIS  DAL+HPY 
Sbjct: 302 LVIDPAKRISVDDALQHPYI 321

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  171 bits (434), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 111/322 (34%), Positives = 163/322 (50%), Gaps = 30/322 (9%)
Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
           N  S+++GD      K+Y  L  IG GA G V  A D   + N VA+KKL          
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
               RE+ ++K ++   H NI+   +V      S E +  VY++ E +D +L   ++   
Sbjct: 68  KRAYRELVLMKVVN---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLSQVIQM-- 121
Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
              L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T    
Sbjct: 122 --ELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
            M+T  VVT +YRAPE++L +GY   VDIWS+GC+M EM +   LF  +  ++Q   +  
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239
Query: 247 VIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLE 291
            +GTPS   M +    +     +  +Y+  +F  +F D              S+A  LL 
Sbjct: 240 QLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 299
Query: 292 SMLTFNPADRISAADALEHPYF 313
            ML  + + RIS  +AL+HPY 
Sbjct: 300 KMLVIDASKRISVDEALQHPYI 321

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  171 bits (434), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 119/311 (38%), Positives = 166/311 (53%), Gaps = 26/311 (8%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++   L  +G GAYG+V  A D + +   VA+KKL            T RE+ +LK L  
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQK-VAVKKLSRPFQSLIHARRTYRELRLLKHL-- 84
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + + KC    LS   V+ L  Q
Sbjct: 85  -KHENVIGLLDVF-TPATSIEDFSEVYLVTTLMGADLNNIV-KCQ--ALSDEHVQFLVYQ 139
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP N+ +     L+I DFGLA+  D +M  T  V T WYRAP
Sbjct: 140 LLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM--TGYVATRWYRAP 197
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           EI+LN + Y   VDIWS+GC+MAE+ +   LF  S  ++QLK I  V+GTPS    PE +
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS----PEVL 253
Query: 261 SLMWS--------SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
           + + S        S     +   S+IF      A  LL  ML  +   R+SAA+AL H Y
Sbjct: 254 AKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAY 313
Query: 313 FKE---KENEP 320
           F +    E+EP
Sbjct: 314 FSQYHDPEDEP 324

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  171 bits (432), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 115/320 (35%), Positives = 161/320 (50%), Gaps = 32/320 (10%)
Query: 16  SLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL             
Sbjct: 50  SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRA 108
Query: 70  LREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
            RE+ ++K ++   H NI+   +V   Q  L  E +  VYL+ E +D +L   ++     
Sbjct: 109 YRELVLMKCVN---HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLCQVIQM---- 159
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M
Sbjct: 160 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 219
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279
Query: 249 GTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESM 293
           GTP    M +    +     +  +Y+ + F  +F D              S+A  LL  M
Sbjct: 280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 339
Query: 294 LTFNPADRISAADALEHPYF 313
           L  +PA RIS  DAL+HPY 
Sbjct: 340 LVIDPAKRISVDDALQHPYI 359

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  171 bits (432), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 111/322 (34%), Positives = 163/322 (50%), Gaps = 30/322 (9%)
Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
           N  S+++GD      K+Y  L  IG GA G V  A D   + N VA+KKL          
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
               RE+ ++K ++   H NI+   +V      S E +  VY++ E +D +L   ++   
Sbjct: 68  KRAYRELVLMKVVN---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLSQVIQM-- 121
Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
              L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T    
Sbjct: 122 --ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
            M+T  VVT +YRAPE++L +GY   VDIWS+GC+M EM +   LF  +  ++Q   +  
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239
Query: 247 VIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLE 291
            +GTPS   M +    +     +  +Y+  +F  +F D              S+A  LL 
Sbjct: 240 QLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 299
Query: 292 SMLTFNPADRISAADALEHPYF 313
            ML  + + RIS  +AL+HPY 
Sbjct: 300 KMLVIDASKRISVDEALQHPYI 321

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  170 bits (431), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 117/311 (37%), Positives = 165/311 (53%), Gaps = 26/311 (8%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++   L  +G GAYG+V  A D + +   VA+KKL            T RE+ +LK L  
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQK-VAVKKLSRPFQSLIHARRTYRELRLLKHL-- 84
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +H N++   DV      S E +  VYL+   +  DL + ++      LS   V+ L  Q
Sbjct: 85  -KHENVIGLLDVF-TPATSIEDFSEVYLVTTLMGADLNNIVKSQ---ALSDEHVQFLVYQ 139
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L+G+ ++HS  IIHRDLKP N+ +     L+I DFGLA+  D +M  T  V T WYRAP
Sbjct: 140 LLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM--TGYVATRWYRAP 197
Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           EI+LN + Y   VDIWS+GC+MAE+ +   LF  S  ++QLK I  V+GTPS    PE +
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS----PEVL 253
Query: 261 SLMWS--------SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
           + + S        S     +   S+IF      A  LL  ML  +   R+SAA+AL H Y
Sbjct: 254 AKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAY 313
Query: 313 FKE---KENEP 320
           F +    E+EP
Sbjct: 314 FSQYHDPEDEP 324

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  170 bits (431), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 115/320 (35%), Positives = 161/320 (50%), Gaps = 32/320 (10%)
Query: 16  SLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL             
Sbjct: 50  SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRA 108
Query: 70  LREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
            RE+ ++K ++   H NI+   +V   Q  L  E +  VYL+ E +D +L   ++     
Sbjct: 109 YRELVLMKCVN---HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLCQVIQM---- 159
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M
Sbjct: 160 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 219
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279
Query: 249 GTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESM 293
           GTP    M +    +     +  +Y+ + F  +F D              S+A  LL  M
Sbjct: 280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 339
Query: 294 LTFNPADRISAADALEHPYF 313
           L  +PA RIS  DAL+HPY 
Sbjct: 340 LVIDPAKRISVDDALQHPYI 359

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  170 bits (431), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 115/320 (35%), Positives = 161/320 (50%), Gaps = 32/320 (10%)
Query: 16  SLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL             
Sbjct: 13  SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRA 71
Query: 70  LREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
            RE+ ++K ++   H NI+   +V   Q  L  E +  VYL+ E +D +L   ++     
Sbjct: 72  YRELVLMKCVN---HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLCQVIQM---- 122
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 182
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 242
Query: 249 GTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESM 293
           GTP    M +    +     +  +Y+ + F  +F D              S+A  LL  M
Sbjct: 243 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 302
Query: 294 LTFNPADRISAADALEHPYF 313
           L  +PA RIS  DAL+HPY 
Sbjct: 303 LVIDPAKRISVDDALQHPYI 322

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  170 bits (431), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 115/320 (35%), Positives = 161/320 (50%), Gaps = 32/320 (10%)
Query: 16  SLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL             
Sbjct: 6   SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRA 64
Query: 70  LREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
            RE+ ++K ++   H NI+   +V   Q  L  E +  VYL+ E +D +L   ++     
Sbjct: 65  YRELVLMKCVN---HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLCQVIQM---- 115
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M
Sbjct: 116 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 175
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 235
Query: 249 GTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESM 293
           GTP    M +    +     +  +Y+ + F  +F D              S+A  LL  M
Sbjct: 236 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 295
Query: 294 LTFNPADRISAADALEHPYF 313
           L  +PA RIS  DAL+HPY 
Sbjct: 296 LVIDPAKRISVDDALQHPYI 315

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  170 bits (431), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 115/320 (35%), Positives = 161/320 (50%), Gaps = 32/320 (10%)
Query: 16  SLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL             
Sbjct: 12  SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRA 70
Query: 70  LREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
            RE+ ++K ++   H NI+   +V   Q  L  E +  VYL+ E +D +L   ++     
Sbjct: 71  YRELVLMKCVN---HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLCQVIQM---- 121
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 181
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 241
Query: 249 GTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESM 293
           GTP    M +    +     +  +Y+ + F  +F D              S+A  LL  M
Sbjct: 242 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 301
Query: 294 LTFNPADRISAADALEHPYF 313
           L  +PA RIS  DAL+HPY 
Sbjct: 302 LVIDPAKRISVDDALQHPYI 321

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  170 bits (431), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 115/320 (35%), Positives = 161/320 (50%), Gaps = 32/320 (10%)
Query: 16  SLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL             
Sbjct: 6   SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRA 64
Query: 70  LREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
            RE+ ++K ++   H NI+   +V   Q  L  E +  VYL+ E +D +L   ++     
Sbjct: 65  YRELVLMKCVN---HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLCQVIQM---- 115
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M
Sbjct: 116 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 175
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 235
Query: 249 GTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESM 293
           GTP    M +    +     +  +Y+ + F  +F D              S+A  LL  M
Sbjct: 236 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 295
Query: 294 LTFNPADRISAADALEHPYF 313
           L  +PA RIS  DAL+HPY 
Sbjct: 296 LVIDPAKRISVDDALQHPYI 315

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  170 bits (431), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 115/320 (35%), Positives = 161/320 (50%), Gaps = 32/320 (10%)
Query: 16  SLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL             
Sbjct: 5   SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRA 63
Query: 70  LREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
            RE+ ++K ++   H NI+   +V   Q  L  E +  VYL+ E +D +L   ++     
Sbjct: 64  YRELVLMKCVN---HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLCQVIQM---- 114
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234
Query: 249 GTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESM 293
           GTP    M +    +     +  +Y+ + F  +F D              S+A  LL  M
Sbjct: 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294
Query: 294 LTFNPADRISAADALEHPYF 313
           L  +PA RIS  DAL+HPY 
Sbjct: 295 LVIDPAKRISVDDALQHPYI 314

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  170 bits (431), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 118/303 (38%), Positives = 163/303 (53%), Gaps = 26/303 (8%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G GAYG+V  A D + +   VA+KKL            T RE+ +LK L   +H N++ 
Sbjct: 28  VGSGAYGSVCSAYDARLRQK-VAVKKLSRPFQSLIHARRTYRELRLLKHL---KHENVIG 83
Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFL 149
             DV      S E +  VYL+   +  DL + + KC    LS   V+ L  Q+L+G+ ++
Sbjct: 84  LLDVF-TPATSIEDFSEVYLVTTLMGADLNNIV-KCQ--ALSDEHVQFLVYQLLRGLKYI 139
Query: 150 HSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN-LG 208
           HS  IIHRDLKP N+ +     L+I DFGLA+  D +M  T  V T WYRAPEI+LN + 
Sbjct: 140 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEM--TGYVATRWYRAPEIMLNWMH 197
Query: 209 YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS--- 265
           Y   VDIWS+GC+MAE+ +   LF  S  ++QLK I  V+GTPS    PE ++ + S   
Sbjct: 198 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS----PEVLAKISSEHA 253
Query: 266 -----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE---KE 317
                S     +   S+IF      A  LL  ML  +   R+SAA+AL H YF +    E
Sbjct: 254 RTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 313
Query: 318 NEP 320
           +EP
Sbjct: 314 DEP 316

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 115/320 (35%), Positives = 161/320 (50%), Gaps = 32/320 (10%)
Query: 16  SLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL             
Sbjct: 11  SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRA 69
Query: 70  LREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
            RE+ ++K ++   H NI+   +V   Q  L  E +  VYL+ E +D +L   ++     
Sbjct: 70  YRELVLMKCVN---HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLCQVIQM---- 120
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M
Sbjct: 121 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 180
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +
Sbjct: 181 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 240
Query: 249 GTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESM 293
           GTP    M +    +     +  +Y+ + F  +F D              S+A  LL  M
Sbjct: 241 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 300
Query: 294 LTFNPADRISAADALEHPYF 313
           L  +PA RIS  DAL+HPY 
Sbjct: 301 LVIDPAKRISVDDALQHPYI 320

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 111/322 (34%), Positives = 163/322 (50%), Gaps = 30/322 (9%)
Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
           N  S+++GD      K+Y  L  IG GA G V  A D   + N VA+KKL          
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
               RE+ ++K ++   H NI+   +V      S E +  VY++ E +D +L   ++   
Sbjct: 68  KRAYRELVLMKCVN---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLSQVIQM-- 121
Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
              L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T    
Sbjct: 122 --ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
            M+T  VVT +YRAPE++L +GY   VDIWS+GC+M EM +   LF  +  ++Q   +  
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239
Query: 247 VIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLE 291
            +GTPS   M +    +     +  +Y+  +F  +F D              S+A  LL 
Sbjct: 240 QLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 299
Query: 292 SMLTFNPADRISAADALEHPYF 313
            ML  + + RIS  +AL+HPY 
Sbjct: 300 KMLVIDASKRISVDEALQHPYI 321

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 115/320 (35%), Positives = 161/320 (50%), Gaps = 32/320 (10%)
Query: 16  SLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL             
Sbjct: 13  SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRA 71
Query: 70  LREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
            RE+ ++K ++   H NI+   +V   Q  L  E +  VYL+ E +D +L   ++     
Sbjct: 72  YRELVLMKCVN---HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLCQVIQM---- 122
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 182
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 242
Query: 249 GTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESM 293
           GTP    M +    +     +  +Y+ + F  +F D              S+A  LL  M
Sbjct: 243 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 302
Query: 294 LTFNPADRISAADALEHPYF 313
           L  +PA RIS  DAL+HPY 
Sbjct: 303 LVIDPAKRISVDDALQHPYI 322

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 115/320 (35%), Positives = 161/320 (50%), Gaps = 32/320 (10%)
Query: 16  SLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           S+++GD      K+Y  L  IG GA G V  A D     N VA+KKL             
Sbjct: 12  SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRA 70
Query: 70  LREISILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
            RE+ ++K ++   H NI+   +V   Q  L  E +  VYL+ E +D +L   ++     
Sbjct: 71  YRELVLMKCVN---HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLCQVIQM---- 121
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 181
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +T  VVT +YRAPE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 241
Query: 249 GTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESM 293
           GTP    M +    +     +  +Y+ + F  +F D              S+A  LL  M
Sbjct: 242 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 301
Query: 294 LTFNPADRISAADALEHPYF 313
           L  +PA RIS  DAL+HPY 
Sbjct: 302 LVIDPAKRISVDDALQHPYI 321

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 162/322 (50%), Gaps = 30/322 (9%)
Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
           N  S+++GD      K+Y  L  IG GA G V  A D   + N VA+KKL          
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
               RE+ ++K ++   H NI+   +V      S E +  VY++ E +D +L   ++   
Sbjct: 68  KRAYRELVLMKVVN---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLSQVIQM-- 121
Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
              L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T    
Sbjct: 122 --ELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
            M+T  VVT +YRAPE++L +GY   VDIWS+G +M EM +   LF  +  ++Q   +  
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIE 239
Query: 247 VIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLE 291
            +GTPS   M +    +     +  +Y+  +F  +F D              S+A  LL 
Sbjct: 240 QLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 299
Query: 292 SMLTFNPADRISAADALEHPYF 313
            ML  + + RIS  +AL+HPY 
Sbjct: 300 KMLVIDASKRISVDEALQHPYI 321

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 111/322 (34%), Positives = 163/322 (50%), Gaps = 30/322 (9%)
Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
           N  S+++GD      K+Y  L  IG GA G V  A D   + N VA+KKL          
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
               RE+ ++K ++   H NI+   +V      S E +  VY++ E +D +L   ++   
Sbjct: 68  KRAYRELVLMKCVN---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLSQVIQM-- 121
Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
              L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T    
Sbjct: 122 --ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
            M+T  VVT +YRAPE++L +GY   VDIWS+GC+M EM +   LF  +  ++Q   +  
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239
Query: 247 VIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLE 291
            +GTPS   M +    +     +  +Y+  +F  +F D              S+A  LL 
Sbjct: 240 QLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 299
Query: 292 SMLTFNPADRISAADALEHPYF 313
            ML  + + RIS  +AL+HPY 
Sbjct: 300 KMLVIDASKRISVDEALQHPYI 321

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 162/322 (50%), Gaps = 30/322 (9%)
Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
           N  S+++GD      K+Y  L  IG GA G V  A D   + N VA+KKL          
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
               RE+ ++K ++   H NI+   +V      S E +  VY++ E +D +L   ++   
Sbjct: 68  KRAYRELVLMKVVN---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLSQVIQM-- 121
Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
              L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T    
Sbjct: 122 --ELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
            M+T  VVT +YRAPE++L +GY   VDIWS+G +M EM +   LF  +  ++Q   +  
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIE 239
Query: 247 VIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLE 291
            +GTPS   M +    +     +  +Y+  +F  +F D              S+A  LL 
Sbjct: 240 QLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 299
Query: 292 SMLTFNPADRISAADALEHPYF 313
            ML  + + RIS  +AL+HPY 
Sbjct: 300 KMLVIDASKRISVDEALQHPYI 321

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  167 bits (424), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 113/313 (36%), Positives = 163/313 (52%), Gaps = 23/313 (7%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           Q +N  + +L  K Y     +G GAYG+V  A D +  G  VA+KKL      +      
Sbjct: 13  QDVNKTAWEL-PKTYVSPTHVGSGAYGSVCSAID-KRSGEKVAIKKLSRPFQSEIFAKRA 70
Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG 129
            RE+ +LK +   +H N++   DV      S   +   YL+   +  DL   M      G
Sbjct: 71  YRELLLLKHM---QHENVIGLLDVF-TPASSLRNFYDFYLVMPFMQTDLQKIM------G 120
Query: 130 L--SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM 187
           L  S  K++ L  QMLKG+ ++HS  ++HRDLKP NL +     LKI DFGLA+  D +M
Sbjct: 121 LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
Query: 188 MLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
             T  VVT WYRAPE++L+ + Y   VDIWS+GC+MAEM     LF     ++QL  I +
Sbjct: 181 --TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 238
Query: 247 VIGTPSMNEWPENISLMWS-----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADR 301
           V G P   E+ + ++   +     S  Q  +  F+ +F     +A  LLE ML  +   R
Sbjct: 239 VTGVPG-TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 297
Query: 302 ISAADALEHPYFK 314
           ++AA AL HP+F+
Sbjct: 298 LTAAQALTHPFFE 310

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  167 bits (424), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 111/322 (34%), Positives = 163/322 (50%), Gaps = 30/322 (9%)
Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
           N  S+++GD      K+Y  L  IG GA G V  A D   + N VA+KKL          
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
               RE+ ++K ++   H NI+   +V      S E +  VY++ E +D +L   ++   
Sbjct: 68  KRAYRELVLMKCVN---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLCQVIQM-- 121
Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
              L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T    
Sbjct: 122 --ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
            M+T  VVT +YRAPE++L +GY   VDIWS+GC+M EM +   LF  +  ++Q   +  
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239
Query: 247 VIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLE 291
            +GTPS   M +    +     +  +Y+  +F  +F D              S+A  LL 
Sbjct: 240 QLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 299
Query: 292 SMLTFNPADRISAADALEHPYF 313
            ML  + + RIS  +AL+HPY 
Sbjct: 300 KMLVIDASKRISVDEALQHPYI 321

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  167 bits (422), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 111/311 (35%), Positives = 161/311 (51%), Gaps = 19/311 (6%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           Q +N  + +L  K Y     +G GAYG+V  A D +  G  VA+KKL      +      
Sbjct: 31  QDVNKTAWEL-PKTYVSPTHVGSGAYGSVCSAID-KRSGEKVAIKKLSRPFQSEIFAKRA 88
Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG 129
            RE+ +LK +   +H N++   DV      S   +   YL+   +  DL   M       
Sbjct: 89  YRELLLLKHM---QHENVIGLLDVF-TPASSLRNFYDFYLVMPFMQTDLQKIMGM----E 140
Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
            S  K++ L  QMLKG+ ++HS  ++HRDLKP NL +     LKI DFGLA+  D +M  
Sbjct: 141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-- 198
Query: 190 TSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           T  VVT WYRAPE++L+ + Y   VDIWS+GC+MAEM     LF     ++QL  I +V 
Sbjct: 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258
Query: 249 GTPSMNEWPENISLMWS-----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS 303
           G P   E+ + ++   +     S  Q  +  F+ +F     +A  LLE ML  +   R++
Sbjct: 259 GVPG-TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 317
Query: 304 AADALEHPYFK 314
           AA AL HP+F+
Sbjct: 318 AAQALTHPFFE 328

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 162/322 (50%), Gaps = 30/322 (9%)
Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
           N  S+++GD      K+Y  L  IG GA G V  A D   + N VA+KKL          
Sbjct: 10  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 68
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
               RE+ ++K ++   H NI+   +V      S E +  VY++ E +D +L   ++   
Sbjct: 69  KRAYRELVLMKCVN---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLCQVIQM-- 122
Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
              L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T    
Sbjct: 123 --ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
            M+T  VVT +YRAPE++L +GY   VDIWS+GC+M EM +   LF  +  ++Q   +  
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 240
Query: 247 VIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLE 291
            +GTP    M +    +     +  +Y+  +F  +F D              S+A  LL 
Sbjct: 241 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 300
Query: 292 SMLTFNPADRISAADALEHPYF 313
            ML  + + RIS  +AL+HPY 
Sbjct: 301 KMLVIDASKRISVDEALQHPYI 322

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 162/322 (50%), Gaps = 30/322 (9%)
Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
           N  S+++GD      K+Y  L  IG GA G V  A D   + N VA+KKL          
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
               RE+ ++K ++   H NI+   +V      S E +  VY++ E +D +L   ++   
Sbjct: 68  KRAYRELVLMKCVN---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLCQVIQM-- 121
Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
              L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T    
Sbjct: 122 --ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
            M+T  VVT +YRAPE++L +GY   VDIWS+GC+M EM +   LF  +  ++Q   +  
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239
Query: 247 VIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLE 291
            +GTP    M +    +     +  +Y+  +F  +F D              S+A  LL 
Sbjct: 240 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 299
Query: 292 SMLTFNPADRISAADALEHPYF 313
            ML  + + RIS  +AL+HPY 
Sbjct: 300 KMLVIDASKRISVDEALQHPYI 321

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 110/322 (34%), Positives = 162/322 (50%), Gaps = 30/322 (9%)
Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
           N  S+++GD      K+Y  L  IG GA G V  A D   + N VA+KKL          
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
               RE+ ++K ++   H NI+   +V      S E +  VY++ E +D +L   ++   
Sbjct: 68  KRAYRELVLMKCVN---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLCQVIQM-- 121
Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
              L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T    
Sbjct: 122 --ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
            M+T  VVT +YRAPE++L +GY   VDIWS+GC+M EM +   LF  +  ++Q   +  
Sbjct: 180 FMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239
Query: 247 VIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLE 291
            +GTP    M +    +     +  +Y+  +F  +F D              S+A  LL 
Sbjct: 240 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLS 299
Query: 292 SMLTFNPADRISAADALEHPYF 313
            ML  + + RIS  +AL+HPY 
Sbjct: 300 KMLVIDASKRISVDEALQHPYI 321

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 106/309 (34%), Positives = 167/309 (54%), Gaps = 38/309 (12%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY+++ +IG G+YG VFK R+ ++ G  VA+KK     ++  I    LREI +LKQL  
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRN-RDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-- 59
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            +HPN+V   +V         R   ++L+FE+ D  +   +++    G+    VK +T Q
Sbjct: 60  -KHPNLVNLLEVF-------RRKRRLHLVFEYCDHTVLHELDRYQR-GVPEHLVKSITWQ 110
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYDMMLTSVVVTLW 197
            L+ V+F H H  IHRD+KP+N+LIT+   +K+ DFG A+      DY       V T W
Sbjct: 111 TLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY---YDDEVATRW 167
Query: 198 YRAPEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG--TPSMN 254
           YR+PE+L+ +  YG PVD+W+IGCV AE+   VPL+   ++V+QL  I + +G   P   
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227
Query: 255 EWPENISLMWSSFEQYSKV---------AFSAIFMDCCSKANSLLESMLTFNPADRISAA 305
           +       ++S+ + +S V              F +    A  LL+  L  +P +R++  
Sbjct: 228 Q-------VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCE 280
Query: 306 DALEHPYFK 314
             L HPYF+
Sbjct: 281 QLLHHPYFE 289

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 114/317 (35%), Positives = 155/317 (48%), Gaps = 36/317 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G GAYG V  A   +  G  VA+KK+    ++    + TLREI ILK    F+H NI+ 
Sbjct: 19  LGEGAYGVVCSATH-KPTGEIVAIKKIE-PFDKPLFALRTLREIKILKH---FKHENIIT 73
Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFL 149
            F++  Q   S E +  VY+I E +  DL   +       LS   ++    Q L+ V  L
Sbjct: 74  IFNI--QRPDSFENFNEVYIIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVL 128
Query: 150 HSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM-----------LTSVVVTLWY 198
           H   +IHRDLKP NLLI     LK+ DFGLA+  D               +T  V T WY
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWY 188
Query: 199 RAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN--- 254
           RAPE++L    Y   +D+WS GC++AE++   P+F       QL  IF +IGTP  +   
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 255 ---EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
              E P     +  S   Y       +F     K   LL+ ML F+PA RI+A +ALEHP
Sbjct: 249 RCIESPRAREYI-KSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307
Query: 312 YFK-------EKENEPL 321
           Y +       E E EP+
Sbjct: 308 YLQTYHDPNDEPEGEPI 324

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  164 bits (415), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 114/317 (35%), Positives = 155/317 (48%), Gaps = 36/317 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G GAYG V  A   +  G  VA+KK+    ++    + TLREI ILK    F+H NI+ 
Sbjct: 19  LGEGAYGVVCSATH-KPTGEIVAIKKIE-PFDKPLFALRTLREIKILKH---FKHENIIT 73
Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFL 149
            F++  Q   S E +  VY+I E +  DL   +       LS   ++    Q L+ V  L
Sbjct: 74  IFNI--QRPDSFENFNEVYIIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVL 128
Query: 150 HSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM-----------LTSVVVTLWY 198
           H   +IHRDLKP NLLI     LK+ DFGLA+  D               +T  V T WY
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWY 188
Query: 199 RAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN--- 254
           RAPE++L    Y   +D+WS GC++AE++   P+F       QL  IF +IGTP  +   
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 255 ---EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
              E P     +  S   Y       +F     K   LL+ ML F+PA RI+A +ALEHP
Sbjct: 249 RCIESPRAREYI-KSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307
Query: 312 YFK-------EKENEPL 321
           Y +       E E EP+
Sbjct: 308 YLQTYHDPNDEPEGEPI 324

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 112/310 (36%), Positives = 156/310 (50%), Gaps = 30/310 (9%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           K+Y +L  IG GA G V  A D    G  VA+KKL              RE+ +LK ++ 
Sbjct: 22  KRYQQLKPIGSGAQGIVCAAFDTV-LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN- 79
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGS--YMEKCPPPGLSASKVKEL 138
             H NI+   +V   Q  L  E +  VYL+ E +D +L    +ME      L   ++  L
Sbjct: 80  --HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLCQVIHME------LDHERMSYL 129
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWY 198
             QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T   + M+T  VVT +Y
Sbjct: 130 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYY 189
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS---MNE 255
           RAPE++L +GY   VDIWS+GC+M E+ +   +F  +  ++Q   +   +GTPS   M  
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAA 249
Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESMLTFNPADRIS 303
               +     +   Y  +AF  +F D              S+A  LL  ML  +P  RIS
Sbjct: 250 LQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRIS 309
Query: 304 AADALEHPYF 313
             +AL HPY 
Sbjct: 310 VDEALRHPYI 319

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 109/322 (33%), Positives = 161/322 (50%), Gaps = 30/322 (9%)
Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
           N  S+++GD      K+Y  L  IG GA G V  A D   + N VA+KKL          
Sbjct: 11  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 69
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
               RE+ ++K ++   H NI+   +V      S E +  VY++ E +D +L   ++   
Sbjct: 70  KRAYRELVLMKCVN---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLCQVIQM-- 123
Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
              L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T    
Sbjct: 124 --ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 181
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
            M+   VVT +YRAPE++L +GY   VDIWS+GC+M EM +   LF  +  ++Q   +  
Sbjct: 182 FMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 241
Query: 247 VIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLE 291
            +GTP    M +    +     +  +Y+  +F  +F D              S+A  LL 
Sbjct: 242 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 301
Query: 292 SMLTFNPADRISAADALEHPYF 313
            ML  + + RIS  +AL+HPY 
Sbjct: 302 KMLVIDASKRISVDEALQHPYI 323

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 113/317 (35%), Positives = 154/317 (48%), Gaps = 36/317 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G GAYG V  A   +  G  VA+KK+    ++    + TLREI ILK    F+H NI+ 
Sbjct: 19  LGEGAYGVVCSATH-KPTGEIVAIKKIE-PFDKPLFALRTLREIKILKH---FKHENIIT 73
Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFL 149
            F++  Q   S E +  VY+I E +  DL   +       LS   ++    Q L+ V  L
Sbjct: 74  IFNI--QRPDSFENFNEVYIIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVL 128
Query: 150 HSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM-----------LTSVVVTLWY 198
           H   +IHRDLKP NLLI     LK+ DFGLA+  D               +   V T WY
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 199 RAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN--- 254
           RAPE++L    Y   +D+WS GC++AE++   P+F       QL  IF +IGTP  +   
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 255 ---EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
              E P     +  S   Y       +F     K   LL+ ML F+PA RI+A +ALEHP
Sbjct: 249 RCIESPRAREYI-KSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307
Query: 312 YFK-------EKENEPL 321
           Y +       E E EP+
Sbjct: 308 YLQTYHDPNDEPEGEPI 324

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 111/310 (35%), Positives = 156/310 (50%), Gaps = 30/310 (9%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           K+Y +L  IG GA G V  A D    G  VA+KKL              RE+ +LK ++ 
Sbjct: 24  KRYQQLKPIGSGAQGIVCAAFDTV-LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN- 81
Query: 82  FEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGS--YMEKCPPPGLSASKVKEL 138
             H NI+   +V   Q  L  E +  VYL+ E +D +L    +ME      L   ++  L
Sbjct: 82  --HKNIISLLNVFTPQKTL--EEFQDVYLVMELMDANLCQVIHME------LDHERMSYL 131
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWY 198
             QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T   + M+T  VVT +Y
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYY 191
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS---MNE 255
           RAPE++L +GY   VDIWS+GC+M E+ +   +F  +  ++Q   +   +GTPS   M  
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAA 251
Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLESMLTFNPADRIS 303
               +     +  +Y  + F  +F D              S+A  LL  ML  +P  RIS
Sbjct: 252 LQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRIS 311
Query: 304 AADALEHPYF 313
             +AL HPY 
Sbjct: 312 VDEALRHPYI 321

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  160 bits (406), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 109/322 (33%), Positives = 160/322 (49%), Gaps = 30/322 (9%)
Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
           N  S+++GD      K+Y  L  IG GA G V  A D   + N VA+KKL          
Sbjct: 3   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 61
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
               RE+ ++K ++   H NI+   +V      S E +  VY++ E +D +L   ++   
Sbjct: 62  KRAYRELVLMKCVN---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLCQVIQM-- 115
Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
              L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T    
Sbjct: 116 --ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 173
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
            M+T  VVT +YRAPE++L +GY   VD+WS+GC+M EM     LF     ++Q   +  
Sbjct: 174 FMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIE 233
Query: 247 VIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLE 291
            +GTP    M +    +     +  +Y+  +F  +F D              S+A  LL 
Sbjct: 234 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 293
Query: 292 SMLTFNPADRISAADALEHPYF 313
            ML  + + RIS  +AL+HPY 
Sbjct: 294 KMLVIDASKRISVDEALQHPYI 315

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  160 bits (406), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 109/322 (33%), Positives = 160/322 (49%), Gaps = 30/322 (9%)
Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
           N  S+++GD      K+Y  L  IG GA G V  A D   + N VA+KKL          
Sbjct: 14  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 72
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
               RE+ ++K ++   H NI+   +V      S E +  VY++ E +D +L   ++   
Sbjct: 73  KRAYRELVLMKCVN---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLCQVIQM-- 126
Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
              L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T    
Sbjct: 127 --ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 184
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
            M+T  VVT +YRAPE++L +GY   VD+WS+GC+M EM     LF     ++Q   +  
Sbjct: 185 FMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIE 244
Query: 247 VIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLE 291
            +GTP    M +    +     +  +Y+  +F  +F D              S+A  LL 
Sbjct: 245 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 304
Query: 292 SMLTFNPADRISAADALEHPYF 313
            ML  + + RIS  +AL+HPY 
Sbjct: 305 KMLVIDASKRISVDEALQHPYI 326

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 109/322 (33%), Positives = 159/322 (49%), Gaps = 30/322 (9%)
Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
           N  S+++GD      K+Y  L  IG GA G V  A D   + N VA+KKL          
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
               RE+ ++K ++   H NI+   +V      S E +  VY++ E +D +L   ++   
Sbjct: 68  KRAYRELVLMKCVN---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLCQVIQM-- 121
Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
              L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T    
Sbjct: 122 --ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
            M+   VVT +YRAPE++L +GY   VDIWS+GC+M EM     LF     ++Q   +  
Sbjct: 180 FMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIE 239
Query: 247 VIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLE 291
            +GTP    M +    +     +  +Y+  +F  +F D              S+A  LL 
Sbjct: 240 QLGTPCPAFMKKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 299
Query: 292 SMLTFNPADRISAADALEHPYF 313
            ML  + + RIS  +AL+HPY 
Sbjct: 300 KMLVIDASKRISVDEALQHPYI 321

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 111/323 (34%), Positives = 172/323 (53%), Gaps = 34/323 (10%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL 70
           S+N+   DLG  +Y +L  +GCG  G VF A D  +    VA+KK  + L +       L
Sbjct: 1   SMNIHGFDLG-SRYMDLKPLGCGGNGLVFSAVD-NDCDKRVAIKK--IVLTDPQSVKHAL 56
Query: 71  REISILKQLDTFEHPNIVRFFDVIH---QNILSDERYLT----VYLIFEHVDQDLGSYME 123
           REI I+++LD   H NIV+ F+++      +  D   LT    VY++ E+++ DL + +E
Sbjct: 57  REIKIIRRLD---HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE 113
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKT 182
           + P   L     +    Q+L+G+ ++HS  ++HRDLKP NL I T    LKI DFGLA+ 
Sbjct: 114 QGP---LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170
Query: 183 FD----YDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
            D    +   L+  +VT WYR+P +LL+   Y   +D+W+ GC+ AEM     LF  + E
Sbjct: 171 MDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230
Query: 238 VEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSK-------VAFSAIFMDCCSKANSLL 290
           +EQ++ I   I  P ++E  E+   + S    Y +          + +      +A   L
Sbjct: 231 LEQMQLILESI--PVVHE--EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFL 286
Query: 291 ESMLTFNPADRISAADALEHPYF 313
           E +LTF+P DR++A +AL HPY 
Sbjct: 287 EQILTFSPMDRLTAEEALSHPYM 309

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  158 bits (399), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 108/322 (33%), Positives = 159/322 (49%), Gaps = 30/322 (9%)
Query: 13  NLDSLDLGD------KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP 66
           N  S+++GD      K+Y  L  IG GA G V  A D   + N VA+KKL          
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHA 67
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
               RE+ ++K ++   H NI+   +V      S E +  VY++ E +D +L   ++   
Sbjct: 68  KRAYRELVLMKCVN---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLCQVIQM-- 121
Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
              L   ++  L  QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T    
Sbjct: 122 --ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
            M+   VVT +YRAPE++L +GY   VD+WS+GC+M EM     LF     ++Q   +  
Sbjct: 180 FMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIE 239
Query: 247 VIGTPS---MNEWPENISLMWSSFEQYSKVAFSAIFMDC------------CSKANSLLE 291
            +GTP    M +    +     +  +Y+  +F  +F D              S+A  LL 
Sbjct: 240 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 299
Query: 292 SMLTFNPADRISAADALEHPYF 313
            ML  + + RIS  +AL+HPY 
Sbjct: 300 KMLVIDASKRISVDEALQHPYI 321

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 115/346 (33%), Positives = 173/346 (50%), Gaps = 59/346 (17%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY+ + ++G GAYG V+K+ D +  G  VA+KK+            T REI IL +L  
Sbjct: 9   RKYELVKKLGKGAYGIVWKSID-RRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             H NIV        N+L  +    VYL+F++++ DL + +       L     + +  Q
Sbjct: 68  --HENIVNLL-----NVLRADNDRDVYLVFDYMETDLHAVIRANI---LEPVHKQYVVYQ 117
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF------------------ 183
           ++K + +LHS  ++HRD+KP N+L+     +K+ADFGL+++F                  
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 184 ----DYDMMLTSVVVTLWYRAPEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV 238
               D   +LT  V T WYRAPEILL +  Y   +D+WS+GC++ E+    P+F  S+ +
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237
Query: 239 EQLKCIFRVIGTPSMNEWPENIS-----LMWSSFEQYSKVAFSA---IFM---------- 280
            QL+ I  VI  PS NE  E+I       M  S ++  ++  S    IF           
Sbjct: 238 NQLERIIGVIDFPS-NEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKIN 296
Query: 281 ---DCCSKANSLLESMLTFNPADRISAADALEHPY---FKEKENEP 320
              DC  +A  LL+ +L FNP  RISA DAL+HP+   F     EP
Sbjct: 297 PKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEP 342

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  151 bits (381), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 111/327 (33%), Positives = 171/327 (52%), Gaps = 49/327 (14%)
Query: 26  ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP 85
           E C++G G YG V+KA+    K +     K   ++   GI MS  REI++L++L   +HP
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALK---QIEGTGISMSACREIALLREL---KHP 78
Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYME-------KCPPPGLSASKVKEL 138
           N++       Q +        V+L+F++ + DL   ++          P  L    VK L
Sbjct: 79  NVISL-----QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLI----TRAGGLKIADFGLAKTFDYDMM----LT 190
             Q+L G+ +LH++ ++HRDLKP N+L+       G +KIAD G A+ F+  +     L 
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193
Query: 191 SVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLF-CASTEV--------EQ 240
            VVVT WYRAPE+LL    Y   +DIW+IGC+ AE+    P+F C   ++        +Q
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253
Query: 241 LKCIFRVIGTPSMNEW------PENISLMWSSFEQYSKVAFSAI-FMDCC-----SKANS 288
           L  IF V+G P+  +W      PE+ +LM   F + +    S I +M+       SKA  
Sbjct: 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLM-KDFRRNTYTNCSLIKYMEKHKVKPDSKAFH 312
Query: 289 LLESMLTFNPADRISAADALEHPYFKE 315
           LL+ +LT +P  RI++  A++ PYF E
Sbjct: 313 LLQKLLTMDPIKRITSEQAMQDPYFLE 339

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 114/344 (33%), Positives = 165/344 (47%), Gaps = 68/344 (19%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP-MSTLREISILKQLDTFEHPNIV 88
           IG G+YG V+ A D   + N VA+KK+  ++ ED I     LREI+IL +L +     I+
Sbjct: 34  IGRGSYGYVYLAYDKNTEKN-VAIKKVN-RMFEDLIDCKRILREITILNRLKS---DYII 88
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
           R +D+I  + L   ++  +Y++ E  D DL    +   P  L+   +K +   +L G +F
Sbjct: 89  RLYDLIIPDDLL--KFDELYIVLEIADSDLKKLFKT--PIFLTEEHIKTILYNLLLGENF 144
Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---------------------- 186
           +H   IIHRDLKP N L+ +   +K+ DFGLA+T + +                      
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 187 -MMLTSVVVTLWYRAPE-ILLNLGYGTPVDIWSIGCVMAEMWRLV-----------PLFC 233
              LTS VVT WYRAPE ILL   Y   +DIWS GC+ AE+  ++           PLF 
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 234 AS-----------------TEVEQLKCIFRVIGTPSMNEW-----PENISLMWSSFEQYS 271
            S                 +  +QL  IF +IGTP+ ++      PE I  +   F    
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYI-KLFPHRK 323
Query: 272 KVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
            +     +        +LLESML FNP  RI+   AL+HPY K+
Sbjct: 324 PINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 117/359 (32%), Positives = 169/359 (47%), Gaps = 76/359 (21%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP-MSTLREISILKQLDT 81
           +Y+    IG G+YG V +A D   K   VA+KK+ +++ ED I     LREI+IL +L+ 
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEK-RVVAIKKI-LRVFEDLIDCKRILREIAILNRLN- 110
Query: 82  FEHPNIVRFFDVIHQNILSD-ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             H ++V+  D++   I  D E++  +Y++ E  D D         P  L+   +K L  
Sbjct: 111 --HDHVVKVLDIV---IPKDVEKFDELYVVLEIADSDFKKLFRT--PVYLTELHIKTLLY 163
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY--------------- 185
            +L GV ++HS  I+HRDLKP N L+ +   +K+ DFGLA+T DY               
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 186 DM-------------MLTSVVVTLWYRAPE-ILLNLGYGTPVDIWSIGCVMAEMWRLV-- 229
           DM              LT  VVT WYRAPE ILL   Y   +D+WSIGC+ AE+  ++  
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
Query: 230 ---------PLFCAST--------------------EVEQLKCIFRVIGTPSMNEW---- 256
                    PLF  S+                      +QL  IF ++GTPS  +     
Sbjct: 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALE 343
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
            E+       F +      +  F    + A  LL+ ML FNP  RI+  + L HP+FKE
Sbjct: 344 KEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  147 bits (372), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 86/231 (37%), Positives = 137/231 (59%), Gaps = 14/231 (6%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY+ L  +G G+YG V K R+ ++ G  VA+KK     ++  +    +REI +LKQL  
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRN-KDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-- 81
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             H N+V   +V  +     +R+   YL+FE VD  +   +E   P GL    V++   Q
Sbjct: 82  -RHENLVNLLEVCKKK----KRW---YLVFEFVDHTILDDLE-LFPNGLDYQVVQKYLFQ 132
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY-DMMLTSVVVTLWYRA 200
           ++ G+ F HSH IIHRD+KP+N+L++++G +K+ DFG A+T      +    V T WYRA
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRA 192
Query: 201 PEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
           PE+L+ ++ YG  VD+W+IGC++ EM+   PLF   ++++QL  I   +G 
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  144 bits (363), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 117/353 (33%), Positives = 162/353 (45%), Gaps = 71/353 (20%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP-MSTLREISILKQLDTFEHPNIV 88
           IG G+YG V+ A D +N    VA+KK+  ++ ED I     LREI+IL +L +     I+
Sbjct: 36  IGRGSYGYVYLAYD-KNANKNVAIKKVN-RMFEDLIDCKRILREITILNRLKS---DYII 90
Query: 89  RFFD-VIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           R  D +I +++L   ++  +Y++ E  D DL    +   P  L+   VK +   +L G  
Sbjct: 91  RLHDLIIPEDLL---KFDELYIVLEIADSDLKKLFKT--PIFLTEQHVKTILYNLLLGEK 145
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD--------------------- 186
           F+H   IIHRDLKP N L+ +   +KI DFGLA+T + D                     
Sbjct: 146 FIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPH 205
Query: 187 -----MMLTSVVVTLWYRAPE-ILLNLGYGTPVDIWSIGCVMAEMWRLV----------- 229
                  LTS VVT WYRAPE ILL   Y   +DIWS GC+ AE+  ++           
Sbjct: 206 NKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRF 265
Query: 230 PLFCAS-----------------TEVEQLKCIFRVIGTPSMNEW----PENISLMWSSFE 268
           PLF  S                 +  +QL  IF VIGTP   +      + +      F 
Sbjct: 266 PLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFP 325
Query: 269 QYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL 321
               +  S  +     +   LLESML FN   RI+   AL HPY K+   E L
Sbjct: 326 TRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENL 378

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 96/299 (32%), Positives = 145/299 (48%), Gaps = 21/299 (7%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL-------REISILKQLDTF 82
           I  G+YG V    D  ++G  VA+K++   ++ DG  ++ L       R +  ++ L+ F
Sbjct: 30  ISSGSYGAVCAGVD--SEGIPVAIKRVFNTVS-DGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 83  EHPNIVRFFDV-IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            HPNI+   D+ +H     +     +YL+ E +  DL   +       +S   ++     
Sbjct: 87  HHPNILGLRDIFVH---FEEPAMHKLYLVTELMRTDLAQVIHD-QRIVISPQHIQYFMYH 142
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L G+  LH   ++HRDL P N+L+     + I DF LA+    D   T  V   WYRAP
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAP 202
Query: 202 EILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           E+++   G+   VD+WS GCVMAEM+    LF  ST   QL  I  V+GTP + +     
Sbjct: 203 ELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFS 262
Query: 257 -PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
            P     + +S       A++A+       A  L+  ML FNP  RIS   AL HPYF+
Sbjct: 263 SPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE 321

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 96/299 (32%), Positives = 145/299 (48%), Gaps = 21/299 (7%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL-------REISILKQLDTF 82
           I  G+YG V    D  ++G  VA+K++   ++ DG  ++ L       R +  ++ L+ F
Sbjct: 30  ISSGSYGAVCAGVD--SEGIPVAIKRVFNTVS-DGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 83  EHPNIVRFFDV-IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            HPNI+   D+ +H     +     +YL+ E +  DL   +       +S   ++     
Sbjct: 87  HHPNILGLRDIFVH---FEEPAMHKLYLVTELMRTDLAQVIHD-QRIVISPQHIQYFMYH 142
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           +L G+  LH   ++HRDL P N+L+     + I DF LA+    D   T  V   WYRAP
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAP 202
Query: 202 EILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW---- 256
           E+++   G+   VD+WS GCVMAEM+    LF  ST   QL  I  V+GTP + +     
Sbjct: 203 ELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFS 262
Query: 257 -PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
            P     + +S       A++A+       A  L+  ML FNP  RIS   AL HPYF+
Sbjct: 263 SPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE 321

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 160/298 (53%), Gaps = 30/298 (10%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           IG G++G VF+A+ +++  + VA+KK L+ K  ++       RE+ I++     +HPN+V
Sbjct: 48  IGNGSFGVVFQAKLVES--DEVAIKKVLQDKRFKN-------RELQIMR---IVKHPNVV 95
Query: 89  RFFDVIHQNI-LSDERYLTVYLIFEHVDQDLG------SYMEKCPPPGLSASKVKELTRQ 141
                 + N    DE +L   L+ E+V + +       + +++  P  L    +K    Q
Sbjct: 96  DLKAFFYSNGDKKDEVFLN--LVLEYVPETVYRASRHYAKLKQTMPMLL----IKLYMYQ 149
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           +L+ + ++HS  I HRD+KPQNLL+    G LK+ DFG AK         S + + +YRA
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRA 209
Query: 201 PEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE- 258
           PE++     Y T +DIWS GCVMAE+ +  PLF   + ++QL  I +V+GTPS  +    
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269
Query: 259 NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           N + M   F Q     FS +F       A  L+  +L + P+ R++A +AL HP+F E
Sbjct: 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 99/301 (32%), Positives = 150/301 (49%), Gaps = 28/301 (9%)
Query: 31  GCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRF 90
           G G +GTV   ++ ++ G  VA+KK+         P    RE+ I++ L    HPNIV+ 
Sbjct: 32  GQGTFGTVQLGKE-KSTGMSVAIKKVIQD------PRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 91  FDVIHQNILSDERYLTVYLIFEHVDQDLG----SYMEK--CPPPGLSASKVKELTRQMLK 144
               +     D R + + ++ E+V   L     +Y  +   PPP L    +K    Q+++
Sbjct: 85  QSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL----IKVFLFQLIR 140
Query: 145 GVDFLH--SHRIIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
            +  LH  S  + HRD+KP N+L+  A G LK+ DFG AK         + + + +YRAP
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAP 200
Query: 202 EILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS------MN 254
           E++  N  Y T VDIWS+GC+ AEM    P+F       QL  I RV+G PS      +N
Sbjct: 201 ELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260
Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
               ++ L  S    +S V FS   +    +A  LL ++L + P +R+   +AL HPYF 
Sbjct: 261 PSHTDVDLYNSKGIPWSNV-FSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319
Query: 315 E 315
           E
Sbjct: 320 E 320

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  127 bits (318), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 97/307 (31%), Positives = 156/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 22  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 71
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       DV++ N++ D    TVY +  H  +   +         L  
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 121
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 302 AHSFFDE 308

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 156/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 22  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQGKAFKN-------RELQIMRKLD-- 71
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQT---------LPV 121
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +    +F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 302 AHSFFDE 308

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 91/333 (27%), Positives = 159/333 (47%), Gaps = 46/333 (13%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y+ L  IG G++G V KA D      +VA+K +R   NE         EI IL+ L   
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYD-HKVHQHVALKMVR---NEKRFHRQAAEEIRILEHLRKQ 153
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           +  N +    ++      +     + + FE +  +L   ++K    G S   V++    +
Sbjct: 154 DKDNTMNVIHMLENFTFRNH----ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAG--GLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           L+ +D LH +RIIH DLKP+N+L+ + G  G+K+ DFG +  +++  + T +  + +YRA
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQRVYTXIQ-SRFYRA 267
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM-----NE 255
           PE++L   YG P+D+WS+GC++AE+    PL     E +QL C+  ++G PS      ++
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327
Query: 256 WPENISLMWSSFEQYSKVAF----SAIFMDCCSKANSL---------------------- 289
             +N  +    + +Y  V      S +     S+   L                      
Sbjct: 328 RAKNF-VSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386
Query: 290 --LESMLTFNPADRISAADALEHPYFKEKENEP 320
             L+  L ++PA R++   AL HP+ + +  +P
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKP 419

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 156/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 22  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQGKAFKN-------RELQIMRKLD-- 71
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 121
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +    +F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 302 AHSFFDE 308

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 22  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQGKAFKN-------RELQIMRKLD-- 71
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 121
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 302 AHSFFDE 308

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  124 bits (312), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 34  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 83
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 84  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 133
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 134 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 193
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 194 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 253
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 254 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 313
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 314 AHSFFDE 320

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  124 bits (312), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 30  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 79
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 80  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 129
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 130 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 189
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 190 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 249
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 250 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 309
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 310 AHSFFDE 316

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  124 bits (312), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 90/329 (27%), Positives = 157/329 (47%), Gaps = 46/329 (13%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y+ L  IG G++G V KA D      +VA+K +R   NE         EI IL+ L   
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYD-HKVHQHVALKMVR---NEKRFHRQAAEEIRILEHLRKQ 153
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           +  N +    ++      +     + + FE +  +L   ++K    G S   V++    +
Sbjct: 154 DKDNTMNVIHMLENFTFRNH----ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAG--GLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           L+ +D LH +RIIH DLKP+N+L+ + G  G+K+ DFG +  +++  + T +  + +YRA
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQRVYTXIQ-SRFYRA 267
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM-----NE 255
           PE++L   YG P+D+WS+GC++AE+    PL     E +QL C+  ++G PS      ++
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327
Query: 256 WPENISLMWSSFEQYSKVAF----SAIFMDCCSKANSL---------------------- 289
             +N  +    + +Y  V      S +     S+   L                      
Sbjct: 328 RAKNF-VSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386
Query: 290 --LESMLTFNPADRISAADALEHPYFKEK 316
             L+  L ++PA R++   AL HP+ + +
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWLRRR 415

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  124 bits (312), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 22  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 71
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 121
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 302 AHSFFDE 308

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  124 bits (312), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 50  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 99
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 100 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 149
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 150 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 209
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 210 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 269
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 270 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 329
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 330 AHSFFDE 336

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  124 bits (312), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 23  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 72
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 73  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 122
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 123 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 182
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 183 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 242
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 243 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 302
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 303 AHSFFDE 309

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  124 bits (312), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 41  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 90
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 91  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 140
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 141 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 200
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 201 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 260
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 261 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 320
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 321 AHSFFDE 327

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  124 bits (312), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 34  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 83
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 84  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 133
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 134 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 193
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 194 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 253
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 254 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 313
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 314 AHSFFDE 320

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  124 bits (312), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 26  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 75
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 76  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 125
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 126 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 185
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 186 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 245
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 246 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 305
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 306 AHSFFDE 312

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 22  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 71
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 121
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 302 AHSFFDE 308

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 56  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 105
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 106 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 155
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 216 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 336 AHSFFDE 342

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 22  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 71
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 121
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 302 AHSFFDE 308

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 101 YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 150
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 151 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 200
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 201 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 260
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 261 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 320
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 321 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 380
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 381 AHSFFDE 387

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 60  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 109
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 110 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 159
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 160 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 219
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 220 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 279
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 280 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 339
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 340 AHSFFDE 346

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 58  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 107
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 108 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 157
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 158 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 217
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 218 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 277
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 278 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 337
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 338 AHSFFDE 344

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 56  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 105
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 106 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 155
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 336 AHSFFDE 342

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 35  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 84
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 85  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 134
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 135 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 194
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 195 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 254
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 255 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 314
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 315 AHSFFDE 321

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 155/307 (50%), Gaps = 35/307 (11%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKK-LRVKLNEDGIPMSTLREISILKQLDTF 82
           Y +   IG G++G V++A+ L + G  VA+KK L+ K  ++       RE+ I+++LD  
Sbjct: 27  YTDTKVIGNGSFGVVYQAK-LCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD-- 76
Query: 83  EHPNIVR---FF-------DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            H NIVR   FF       D ++ N++ D    TVY +  H  +   +         L  
Sbjct: 77  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPV 126
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTS 191
             VK    Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S
Sbjct: 127 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 186
Query: 192 VVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            + + +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GT
Sbjct: 187 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 246
Query: 251 PSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CCSKANSLLESMLTFNPADRISAADAL 308
           P+  +  E N +     F Q     ++ +F      +A +L   +L + P  R++  +A 
Sbjct: 247 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 306
Query: 309 EHPYFKE 315
            H +F E
Sbjct: 307 AHSFFDE 313

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 102/349 (29%), Positives = 160/349 (45%), Gaps = 65/349 (18%)
Query: 16  SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISI 75
            L+   KKY     +G G++G V +  D+++ G   A+KK+     +D  P    RE+ I
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIES-GKRFALKKVL----QD--PRYKNRELDI 53
Query: 76  LKQLDTFEHPNIVRFFDVI------------------------------HQNIL---SDE 102
           +K LD   H NI++  D                                H++++   S  
Sbjct: 54  MKVLD---HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQN 110
Query: 103 RYLTVYLIFEHVDQDLGSYMEKCPPPGLS--ASKVKELTRQMLKGVDFLHSHRIIHRDLK 160
           +YL V  I E+V   L   ++     G S   + +     Q+ + V F+HS  I HRD+K
Sbjct: 111 KYLNV--IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIK 168
Query: 161 PQNLLI-TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTP-VDIWSI 218
           PQNLL+ ++   LK+ DFG AK         + + + +YRAPE++L     TP +D+WSI
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSI 228
Query: 219 GCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAI 278
           GCV  E+    PLF   T ++QL  I +++GTP+  +       M      Y++V F  +
Sbjct: 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQ-------MIRMNPHYTEVRFPTL 281
Query: 279 FMD---------CCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN 318
                         S A  LLE +L + P  RI+  +A+ HP+F    N
Sbjct: 282 KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 89/333 (26%), Positives = 156/333 (46%), Gaps = 46/333 (13%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y+ L  IG G +G V KA D      +VA+K +R   NE         EI IL+ L   
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYD-HKVHQHVALKMVR---NEKRFHRQAAEEIRILEHLRKQ 153
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           +  N +    ++      +     + + FE +  +L   ++K    G S   V++    +
Sbjct: 154 DKDNTMNVIHMLENFTFRNH----ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAG--GLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           L+ +D LH +RIIH DLKP+N+L+ + G  G+K+ DFG +  +++  +   +  + +YRA
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQRVYXXIQ-SRFYRA 267
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM-----NE 255
           PE++L   YG P+D+WS+GC++AE+    PL     E +QL C+  ++G P       ++
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLDASK 327
Query: 256 WPENISLMWSSFEQYSKVAF----SAIFMDCCSKANSL---------------------- 289
             +N  +    + +Y  V      S +     S+   L                      
Sbjct: 328 RAKNF-VSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386
Query: 290 --LESMLTFNPADRISAADALEHPYFKEKENEP 320
             L+  L ++PA R++   AL HP+ + +  +P
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKP 419

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 146/302 (48%), Gaps = 41/302 (13%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y+ +C +G G++G V K +D   +  Y A+K +     ++    + LRE+ +LK+LD 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEY-AVKVINKASAKNKDTSTILREVELLKKLD- 79
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNI++ F+++       E   + Y++ E +   +L  + E       S      + +
Sbjct: 80  --HPNIMKLFEIL-------EDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAARIIK 128
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
           Q+  G+ ++H H I+HRDLKP+N+L+    +   +KI DFGL+  F  +  +   + T +
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           Y APE+L    Y    D+WS G ++  +    P F    E + LK   RV       + P
Sbjct: 189 YIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK---RVETGKYAFDLP 244
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE 317
           +     W +                   A  L+  MLTF+P+ RI+A   LEHP+ ++  
Sbjct: 245 Q-----WRTI---------------SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284
Query: 318 NE 319
           +E
Sbjct: 285 SE 286

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 146/302 (48%), Gaps = 41/302 (13%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y+ +C +G G++G V K +D   +  Y A+K +     ++    + LRE+ +LK+LD 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEY-AVKVINKASAKNKDTSTILREVELLKKLD- 79
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNI++ F+++       E   + Y++ E +   +L  + E       S      + +
Sbjct: 80  --HPNIMKLFEIL-------EDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAARIIK 128
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
           Q+  G+ ++H H I+HRDLKP+N+L+    +   +KI DFGL+  F  +  +   + T +
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           Y APE+L    Y    D+WS G ++  +    P F    E + LK   RV       + P
Sbjct: 189 YIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK---RVETGKYAFDLP 244
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE 317
           +     W +                   A  L+  MLTF+P+ RI+A   LEHP+ ++  
Sbjct: 245 Q-----WRTI---------------SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284
Query: 318 NE 319
           +E
Sbjct: 285 SE 286

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 146/302 (48%), Gaps = 41/302 (13%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y+ +C +G G++G V K +D   +  Y A+K +     ++    + LRE+ +LK+LD 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEY-AVKVINKASAKNKDTSTILREVELLKKLD- 79
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNI++ F+++       E   + Y++ E +   +L  + E       S      + +
Sbjct: 80  --HPNIMKLFEIL-------EDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAARIIK 128
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
           Q+  G+ ++H H I+HRDLKP+N+L+    +   +KI DFGL+  F  +  +   + T +
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           Y APE+L    Y    D+WS G ++  +    P F    E + LK   RV       + P
Sbjct: 189 YIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK---RVETGKYAFDLP 244
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE 317
           +     W +                   A  L+  MLTF+P+ RI+A   LEHP+ ++  
Sbjct: 245 Q-----WRTIS---------------DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284
Query: 318 NE 319
           +E
Sbjct: 285 SE 286

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 94/298 (31%), Positives = 141/298 (47%), Gaps = 45/298 (15%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYV--AMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           Y  + ++G GAYG V   RD   K  +V  A+K +R            L E+++LK LD 
Sbjct: 39  YQRVKKLGSGAYGEVLLCRD---KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD- 94
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELTR 140
             HPNI++ +D        D+R    YL+ E +   +L  + E       +      + +
Sbjct: 95  --HPNIMKLYD-----FFEDKR--NYYLVMECYKGGEL--FDEIIHRMKFNEVDAAVIIK 143
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
           Q+L GV +LH H I+HRDLKP+NLL+    +   +KI DFGL+  F+    +   + T +
Sbjct: 144 QVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAY 203
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           Y APE+L    Y    D+WSIG ++  +    P F   T+ E L+ + +   T    EW 
Sbjct: 204 YIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEW- 261
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           +N+S                        A  L++ ML F+   RISA  ALEHP+ KE
Sbjct: 262 KNVS----------------------EGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 90/299 (30%), Positives = 146/299 (48%), Gaps = 46/299 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G G++G V   +D +  G   A+K   K +VK   D    S LRE+ +LKQLD   HPN
Sbjct: 58  LGKGSFGEVILCKD-KITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLD---HPN 111
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           I++ ++        D+ Y   YL+ E +   +L  + E       S      + RQ+L G
Sbjct: 112 IMKLYE-----FFEDKGYF--YLVGEVYTGGEL--FDEIISRKRFSEVDAARIIRQVLSG 162
Query: 146 VDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           + ++H ++I+HRDLKP+NLL+   ++   ++I DFGL+  F+    +   + T +Y APE
Sbjct: 163 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 222
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
           +L    Y    D+WS G ++  +    P F  + E + LK + +   T  + +W      
Sbjct: 223 VLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK----- 276
Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL 321
                    KV+ S         A  L+  MLT+ P+ RISA DAL+H + +    E +
Sbjct: 277 ---------KVSES---------AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 317

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 90/299 (30%), Positives = 146/299 (48%), Gaps = 46/299 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G G++G V   +D +  G   A+K   K +VK   D    S LRE+ +LKQLD   HPN
Sbjct: 57  LGKGSFGEVILCKD-KITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLD---HPN 110
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           I++ ++        D+ Y   YL+ E +   +L  + E       S      + RQ+L G
Sbjct: 111 IMKLYE-----FFEDKGYF--YLVGEVYTGGEL--FDEIISRKRFSEVDAARIIRQVLSG 161
Query: 146 VDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           + ++H ++I+HRDLKP+NLL+   ++   ++I DFGL+  F+    +   + T +Y APE
Sbjct: 162 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 221
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
           +L    Y    D+WS G ++  +    P F  + E + LK + +   T  + +W      
Sbjct: 222 VLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK----- 275
Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL 321
                    KV+ S         A  L+  MLT+ P+ RISA DAL+H + +    E +
Sbjct: 276 ---------KVSES---------AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 316

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 90/299 (30%), Positives = 146/299 (48%), Gaps = 46/299 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G G++G V   +D +  G   A+K   K +VK   D    S LRE+ +LKQLD   HPN
Sbjct: 34  LGKGSFGEVILCKD-KITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLD---HPN 87
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           I++ ++        D+ Y   YL+ E +   +L  + E       S      + RQ+L G
Sbjct: 88  IMKLYE-----FFEDKGYF--YLVGEVYTGGEL--FDEIISRKRFSEVDAARIIRQVLSG 138
Query: 146 VDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           + ++H ++I+HRDLKP+NLL+   ++   ++I DFGL+  F+    +   + T +Y APE
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
           +L    Y    D+WS G ++  +    P F  + E + LK + +   T  + +W      
Sbjct: 199 VLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK----- 252
Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL 321
                    KV+ S         A  L+  MLT+ P+ RISA DAL+H + +    E +
Sbjct: 253 ---------KVSES---------AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 89/292 (30%), Positives = 144/292 (49%), Gaps = 46/292 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G G++G V   +D +  G   A+K   K +VK   D    S LRE+ +LKQLD   HPN
Sbjct: 40  LGKGSFGEVILCKD-KITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLD---HPN 93
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           I++ ++        D+ Y   YL+ E +   +L  + E       S      + RQ+L G
Sbjct: 94  IMKLYE-----FFEDKGYF--YLVGEVYTGGEL--FDEIISRKRFSEVDAARIIRQVLSG 144
Query: 146 VDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           + ++H ++I+HRDLKP+NLL+   ++   ++I DFGL+  F+    +   + T +Y APE
Sbjct: 145 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 204
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
           +L    Y    D+WS G ++  +    P F  + E + LK + +   T  + +W      
Sbjct: 205 VLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW------ 257
Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
                    KV+ S         A  L+  MLT+ P+ RISA DAL+H + +
Sbjct: 258 --------KKVSES---------AKDLIRKMLTYVPSMRISARDALDHEWIQ 292

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score =  114 bits (284), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 92/334 (27%), Positives = 164/334 (49%), Gaps = 45/334 (13%)
Query: 16  SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISI 75
           S D+   +Y+ +  +G GA+G V +  D +  G +VA+K ++   N D    +   EI +
Sbjct: 8   SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQV 64
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           L+ L+T + PN    F  + Q +   E +  + ++FE +      ++++          +
Sbjct: 65  LEHLNTTD-PNST--FRCV-QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHI 120
Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-------------------GLKIAD 176
           +++  Q+ K V+FLHS+++ H DLKP+N+L  ++                     +K+ D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST 236
           FG A T+D D   +++V T  YRAPE++L LG+  P D+WSIGC++ E +    +F    
Sbjct: 181 FGSA-TYD-DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238
Query: 237 EVEQLKCIFRVIG--------TPSMNEWPENISLMW---SSFEQYSKVAFSAI--FMDC- 282
             E L  + R++G             ++  +  L W   SS  +Y   A   +  FM   
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298
Query: 283 ---CSKANSLLESMLTFNPADRISAADALEHPYF 313
                +   L++ ML ++PA RI+  +AL+HP+F
Sbjct: 299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 91/334 (27%), Positives = 163/334 (48%), Gaps = 45/334 (13%)
Query: 16  SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISI 75
           S D+   +Y+ +  +G GA+G V +  D +  G +VA+K ++   N D    +   EI +
Sbjct: 8   SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQV 64
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           L+ L+T + PN    F  + Q +   E +  + ++FE +      ++++          +
Sbjct: 65  LEHLNTTD-PNST--FRCV-QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHI 120
Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-------------------GLKIAD 176
           +++  Q+ K V+FLHS+++ H DLKP+N+L  ++                     +K+ D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST 236
           FG A T+D D   +++V    YRAPE++L LG+  P D+WSIGC++ E +    +F    
Sbjct: 181 FGSA-TYD-DEHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238
Query: 237 EVEQLKCIFRVIG--------TPSMNEWPENISLMW---SSFEQYSKVAFSAI--FMDC- 282
             E L  + R++G             ++  +  L W   SS  +Y   A   +  FM   
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298
Query: 283 ---CSKANSLLESMLTFNPADRISAADALEHPYF 313
                +   L++ ML ++PA RI+  +AL+HP+F
Sbjct: 299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 140/294 (47%), Gaps = 40/294 (13%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR-VKLNEDGIPMSTLREISILKQLDT 81
           +Y  + ++G GAYG V   +D +  G   A+K ++   +       + L E+++LKQLD 
Sbjct: 5   RYQRVKKLGSGAYGEVLLCKD-KLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD- 62
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             HPNI++ ++        D+R    YL+ E V +    + E       S      + +Q
Sbjct: 63  --HPNIMKLYE-----FFEDKR--NYYLVME-VYRGGELFDEIILRQKFSEVDAAVIMKQ 112
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWY 198
           +L G  +LH H I+HRDLKP+NLL+   +R   +KI DFGL+  F+    +   + T +Y
Sbjct: 113 VLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYY 172
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
            APE+L    Y    D+WS G ++  +    P F   T+ E LK + +   +    +W +
Sbjct: 173 IAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQ 231
Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                                     +A  L++ MLT+ P+ RISA +AL HP+
Sbjct: 232 -----------------------VSDEAKQLVKLMLTYEPSKRISAEEALNHPW 262

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 140/294 (47%), Gaps = 40/294 (13%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR-VKLNEDGIPMSTLREISILKQLDT 81
           +Y  + ++G GAYG V   +D +  G   A+K ++   +       + L E+++LKQLD 
Sbjct: 22  RYQRVKKLGSGAYGEVLLCKD-KLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD- 79
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             HPNI++ ++        D+R    YL+ E V +    + E       S      + +Q
Sbjct: 80  --HPNIMKLYE-----FFEDKR--NYYLVME-VYRGGELFDEIILRQKFSEVDAAVIMKQ 129
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWY 198
           +L G  +LH H I+HRDLKP+NLL+   +R   +KI DFGL+  F+    +   + T +Y
Sbjct: 130 VLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYY 189
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
            APE+L    Y    D+WS G ++  +    P F   T+ E LK + +   +    +W +
Sbjct: 190 IAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQ 248
Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                                     +A  L++ MLT+ P+ RISA +AL HP+
Sbjct: 249 -----------------------VSDEAKQLVKLMLTYEPSKRISAEEALNHPW 279

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 89/347 (25%), Positives = 161/347 (46%), Gaps = 61/347 (17%)
Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           D   ++Y+ +  +G G +G V +  D +  G  VA+K ++   N +    +   EI++L+
Sbjct: 29  DWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIK---NVEKYKEAARLEINVLE 85
Query: 78  QLDTFEHPN---IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           +++  +  N    V+ FD         + +  + + FE +      +++          +
Sbjct: 86  KINEKDPDNKNLCVQMFDWF-------DYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQ 138
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT-------------------RAGGLKIA 175
           V+ +  Q+ + V FLH +++ H DLKP+N+L                     ++  +++ 
Sbjct: 139 VRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVV 198
Query: 176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAS 235
           DFG A TFD++   +++V T  YRAPE++L LG+  P D+WSIGC++ E +    LF   
Sbjct: 199 DFGSA-TFDHEHH-STIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTH 256
Query: 236 TEVEQLKCIFRVIG-TPSMN---------------EWPENISLMWSSFEQYSKVAFSAIF 279
              E L  + R++G  PS                 +W EN     +S  +Y +     + 
Sbjct: 257 DNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDEN-----TSAGRYVRENCKPLR 311
Query: 280 MDCCSKANS------LLESMLTFNPADRISAADALEHPYFKEKENEP 320
               S+A        L+ESML + PA R++  +AL+HP+F     EP
Sbjct: 312 RYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEP 358

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 89/332 (26%), Positives = 157/332 (47%), Gaps = 45/332 (13%)
Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           D   ++Y+ +  +G G +G V +  D     + VA+K +R   N      +   EI++LK
Sbjct: 47  DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR---NVGKYREAARLEINVLK 103
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE 137
           ++   +  N  +F  V+  +  +   ++ +   FE + ++   ++++          V+ 
Sbjct: 104 KIKEKDKEN--KFLCVLMSDWFNFHGHMCI--AFELLGKNTFEFLKENNFQPYPLPHVRH 159
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLIT-------------------RAGGLKIADFG 178
           +  Q+   + FLH +++ H DLKP+N+L                     +   +++ADFG
Sbjct: 160 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 219
Query: 179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV 238
            A TFD++   T++V T  YR PE++L LG+  P D+WSIGC++ E +R   LF      
Sbjct: 220 SA-TFDHEHH-TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 277
Query: 239 EQLKCIFRVIG-TPSM-------NEWPENISLMW---SSFEQYSKVAF----SAIFMDCC 283
           E L  + +++G  PS         ++     L+W   SS  +Y K       S +  D  
Sbjct: 278 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 337
Query: 284 SKAN--SLLESMLTFNPADRISAADALEHPYF 313
                  L+  ML F+PA RI+ A+AL HP+F
Sbjct: 338 EHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 369

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 89/332 (26%), Positives = 157/332 (47%), Gaps = 45/332 (13%)
Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           D   ++Y+ +  +G G +G V +  D     + VA+K +R   N      +   EI++LK
Sbjct: 24  DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR---NVGKYREAARLEINVLK 80
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE 137
           ++   +  N  +F  V+  +  +   ++ +   FE + ++   ++++          V+ 
Sbjct: 81  KIKEKDKEN--KFLCVLMSDWFNFHGHMCI--AFELLGKNTFEFLKENNFQPYPLPHVRH 136
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLIT-------------------RAGGLKIADFG 178
           +  Q+   + FLH +++ H DLKP+N+L                     +   +++ADFG
Sbjct: 137 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 196
Query: 179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV 238
            A TFD++   T++V T  YR PE++L LG+  P D+WSIGC++ E +R   LF      
Sbjct: 197 SA-TFDHEHH-TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 254
Query: 239 EQLKCIFRVIG-TPSM-------NEWPENISLMW---SSFEQYSKVAF----SAIFMDCC 283
           E L  + +++G  PS         ++     L+W   SS  +Y K       S +  D  
Sbjct: 255 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 314
Query: 284 SKAN--SLLESMLTFNPADRISAADALEHPYF 313
                  L+  ML F+PA RI+ A+AL HP+F
Sbjct: 315 EHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 346

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 89/332 (26%), Positives = 157/332 (47%), Gaps = 45/332 (13%)
Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           D   ++Y+ +  +G G +G V +  D     + VA+K +R   N      +   EI++LK
Sbjct: 15  DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR---NVGKYREAARLEINVLK 71
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE 137
           ++   +  N  +F  V+  +  +   ++ +   FE + ++   ++++          V+ 
Sbjct: 72  KIKEKDKEN--KFLCVLMSDWFNFHGHMCI--AFELLGKNTFEFLKENNFQPYPLPHVRH 127
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLIT-------------------RAGGLKIADFG 178
           +  Q+   + FLH +++ H DLKP+N+L                     +   +++ADFG
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV 238
            A TFD++   T++V T  YR PE++L LG+  P D+WSIGC++ E +R   LF      
Sbjct: 188 SA-TFDHEHH-TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245
Query: 239 EQLKCIFRVIG-TPSM-------NEWPENISLMW---SSFEQYSKVAF----SAIFMDCC 283
           E L  + +++G  PS         ++     L+W   SS  +Y K       S +  D  
Sbjct: 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 305
Query: 284 SKAN--SLLESMLTFNPADRISAADALEHPYF 313
                  L+  ML F+PA RI+ A+AL HP+F
Sbjct: 306 EHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 142/299 (47%), Gaps = 46/299 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G G++G V   +D +  G   A+K   K +VK   D    S LRE+ +LKQLD   HPN
Sbjct: 34  LGKGSFGEVILCKD-KITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLD---HPN 87
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           I + ++        D+ Y   YL+ E +   +L  + E       S      + RQ+L G
Sbjct: 88  IXKLYE-----FFEDKGYF--YLVGEVYTGGEL--FDEIISRKRFSEVDAARIIRQVLSG 138
Query: 146 VDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           + + H ++I+HRDLKP+NLL+   ++   ++I DFGL+  F+        + T +Y APE
Sbjct: 139 ITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPE 198
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
           +L    Y    D+WS G ++  +    P F  + E + LK + +   T  + +W      
Sbjct: 199 VLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK----- 252
Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL 321
                    KV+ S         A  L+   LT+ P+ RISA DAL+H + +    E +
Sbjct: 253 ---------KVSES---------AKDLIRKXLTYVPSXRISARDALDHEWIQTYTKEQI 293

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 87/325 (26%), Positives = 157/325 (48%), Gaps = 37/325 (11%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN 61
           ++Y++  ++  N D   L       + ++G G Y  VF+A ++ N    V      VK N
Sbjct: 24  WDYASHVVEWGNQDDYQL-------VRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKN 76
Query: 62  EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY 121
           +        REI IL+ L     PNI+   D++      D    T  L+FEHV+      
Sbjct: 77  K------IKREIKILENLRG--GPNIITLADIV-----KDPVSRTPALVFEHVNNTDFKQ 123
Query: 122 MEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLA 180
           + +     L+   ++    ++LK +D+ HS  I+HRD+KP N++I      L++ D+GLA
Sbjct: 124 LYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 179
Query: 181 KTFDYDMMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEV 238
           + +         V + +++ PE+L++   Y   +D+WS+GC++A M +R  P F      
Sbjct: 180 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 239
Query: 239 EQLKCIFRVIGTPSMNEWPE----------NISLMWSSFEQYSKVAFSAIFMDCCSKANS 288
           +QL  I +V+GT  + ++ +          N  L   S +++ +   S        +A  
Sbjct: 240 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 299
Query: 289 LLESMLTFNPADRISAADALEHPYF 313
            L+ +L ++   R++A +A+EHPYF
Sbjct: 300 FLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 137/294 (46%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 20  LGKGKFGNVYLARERQSK-FILALKVLFKTQLEKAGVEHQLRREVEIQSHL---RHPNIL 75
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 76  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSRFDEQRTATYITELANALS 126
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+   G LKIADFG +         T++  TL Y  PE++   
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E    +P F A T  E                          ++
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE--------------------------TY 219
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
            + S+V F+  F D  ++ A  L+  +L  N + R++ A+ LEHP+ K   ++P
Sbjct: 220 RRISRVEFT--FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKANSSKP 271

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 152/309 (49%), Gaps = 43/309 (13%)
Query: 9   IQSLNLDSL-DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPM 67
           ++ L+ DSL    ++ +D L ++G G+YG+V+KA   +  G  VA+K++ V+ +   I  
Sbjct: 15  LKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIH-KETGQIVAIKQVPVESDLQEI-- 71
Query: 68  STLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP 127
             ++EISI++Q D+   P++V+++    +N         ++++ E+      S + +   
Sbjct: 72  --IKEISIMQQCDS---PHVVKYYGSYFKNT-------DLWIVMEYCGAGSVSDIIRLRN 119
Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM 187
             L+  ++  + +  LKG+++LH  R IHRD+K  N+L+   G  K+ADFG+A      M
Sbjct: 120 KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXM 179
Query: 188 MLTSVVV-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
              + V+ T ++ APE++  +GY    DIWS+G    EM    P +    ++  ++ IF 
Sbjct: 180 AKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA---DIHPMRAIFM 236
Query: 247 V-IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA 305
           +    P     PE    +WS         F+     C  K+           P  R +A 
Sbjct: 237 IPTNPPPTFRKPE----LWSD-------NFTDFVKQCLVKS-----------PEQRATAT 274
Query: 306 DALEHPYFK 314
             L+HP+ +
Sbjct: 275 QLLQHPFVR 283

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 43/307 (14%)
Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILK 77
           D  YD   ++G G +  V K R+      Y A  +KK R K +  G+    + RE+SILK
Sbjct: 10  DDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVK 136
           ++   +HPN++   +V        E    V LI E V   +L  ++       L+  +  
Sbjct: 70  EI---QHPNVITLHEVY-------ENKTDVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSV 192
           E  +Q+L GV +LHS +I H DLKP+N+++         +KI DFGLA   D+     ++
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  + APEI+     G   D+WSIG +   +      F   T+ E L           
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------- 227
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                 N+S +   FE          F +  + A   +  +L  +P  R++  D+L+HP+
Sbjct: 228 ------NVSAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 313 FKEKENE 319
            K K+ +
Sbjct: 275 IKPKDTQ 281

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 43/307 (14%)
Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILK 77
           D  YD   ++G G +  V K R+      Y A  +KK R K +  G+    + RE+SILK
Sbjct: 10  DDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVK 136
           ++   +HPN++   +V        E    V LI E V   +L  ++       L+  +  
Sbjct: 70  EI---QHPNVITLHEVY-------ENKTDVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSV 192
           E  +Q+L GV +LHS +I H DLKP+N+++         +KI DFGLA   D+     ++
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  + APEI+     G   D+WSIG +   +      F   T+ E L           
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------- 227
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                 N+S +   FE          F +  + A   +  +L  +P  R++  D+L+HP+
Sbjct: 228 ------NVSAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 313 FKEKENE 319
            K K+ +
Sbjct: 275 IKPKDTQ 281

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 43/307 (14%)
Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILK 77
           D  YD   ++G G +  V K R+      Y A  +KK R K +  G+    + RE+SILK
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVK 136
           ++   +HPN++   +V        E    V LI E V   +L  ++       L+  +  
Sbjct: 70  EI---QHPNVITLHEVY-------ENKTDVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSV 192
           E  +Q+L GV +LHS +I H DLKP+N+++         +KI DFGLA   D+     ++
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  + APEI+     G   D+WSIG +   +      F   T+ E L           
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------- 227
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                 N+S +   FE          F +  + A   +  +L  +P  R++  D+L+HP+
Sbjct: 228 ------NVSAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 313 FKEKENE 319
            K K+ +
Sbjct: 275 IKPKDTQ 281

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 43/307 (14%)
Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILK 77
           D  YD   ++G G +  V K R+      Y A  +KK R K +  G+    + RE+SILK
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVK 136
           ++   +HPN++   +V        E    V LI E V   +L  ++       L+  +  
Sbjct: 70  EI---QHPNVITLHEVY-------ENKTDVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSV 192
           E  +Q+L GV +LHS +I H DLKP+N+++         +KI DFGLA   D+     ++
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  + APEI+     G   D+WSIG +   +      F   T+ E L           
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------- 227
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                 N+S +   FE          F +  + A   +  +L  +P  R++  D+L+HP+
Sbjct: 228 ------NVSAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 313 FKEKENE 319
            K K+ +
Sbjct: 275 IKPKDTQ 281

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 133/293 (45%), Gaps = 43/293 (14%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 19  LGKGKFGNVYLAREKQSKF-ILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 74
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 75  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T++  TL Y  PE++   
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I RV  T     +P+ ++      
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVT------ 233
Query: 268 EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                             A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 234 ----------------EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 43/307 (14%)
Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILK 77
           D  YD   ++G G +  V K R+      Y A  +KK R K +  G+    + RE+SILK
Sbjct: 9   DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVK 136
           ++   +HPN++   +V        E    V LI E V   +L  ++       L+  +  
Sbjct: 69  EI---QHPNVITLHEVY-------ENKTDVILILELVAGGELFDFL--AEKESLTEEEAT 116
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSV 192
           E  +Q+L GV +LHS +I H DLKP+N+++         +KI DFGLA   D+     ++
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  + APEI+     G   D+WSIG +   +      F   T+ E L           
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------- 226
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                 N+S +   FE          F +  + A   +  +L  +P  R++  D+L+HP+
Sbjct: 227 ------NVSAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273
Query: 313 FKEKENE 319
            K K+ +
Sbjct: 274 IKPKDTQ 280

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 43/307 (14%)
Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILK 77
           D  YD   ++G G +  V K R+      Y A  +KK R K +  G+    + RE+SILK
Sbjct: 9   DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVK 136
           ++   +HPN++   +V        E    V LI E V   +L  ++       L+  +  
Sbjct: 69  EI---QHPNVITLHEVY-------ENKTDVILILELVAGGELFDFL--AEKESLTEEEAT 116
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSV 192
           E  +Q+L GV +LHS +I H DLKP+N+++         +KI DFGLA   D+     ++
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  + APEI+     G   D+WSIG +   +      F   T+ E L           
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------- 226
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                 N+S +   FE          F +  + A   +  +L  +P  R++  D+L+HP+
Sbjct: 227 ------NVSAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273
Query: 313 FKEKENE 319
            K K+ +
Sbjct: 274 IKPKDTQ 280

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 132/294 (44%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 33  LGKGKFGNVYLAREKQSKF-ILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 88
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 89  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T++  TL Y  PE++   
Sbjct: 140 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 198
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I RV  T                 
Sbjct: 199 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------- 241
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                      F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 242 -----------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 284

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 43/307 (14%)
Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILK 77
           D  YD   ++G G +  V K R+      Y A  +KK R K +  G+    + RE+SILK
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVK 136
           ++   +HPN++   +V        E    V LI E V   +L  ++       L+  +  
Sbjct: 70  EI---QHPNVITLHEVY-------ENKTDVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSV 192
           E  +Q+L GV +LHS +I H DLKP+N+++         +KI DFGLA   D+     ++
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  + APEI+     G   D+WSIG +   +      F   T+ E L           
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------- 227
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                 N+S +   FE          F +  + A   +  +L  +P  R++  D+L+HP+
Sbjct: 228 ------NVSAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 313 FKEKENE 319
            K K+ +
Sbjct: 275 IKPKDTQ 281

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 43/307 (14%)
Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILK 77
           D  YD   ++G G +  V K R+      Y A  +KK R K +  G+    + RE+SILK
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVK 136
           ++   +HPN++   +V        E    V LI E V   +L  ++       L+  +  
Sbjct: 70  EI---QHPNVITLHEVY-------ENKTDVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSV 192
           E  +Q+L GV +LHS +I H DLKP+N+++         +KI DFGLA   D+     ++
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  + APEI+     G   D+WSIG +   +      F   T+ E L           
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------- 227
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                 N+S +   FE          F +  + A   +  +L  +P  R++  D+L+HP+
Sbjct: 228 ------NVSAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 313 FKEKENE 319
            K K+ +
Sbjct: 275 IKPKDTQ 281

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 43/307 (14%)
Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILK 77
           D  YD   ++G G +  V K R+      Y A  +KK R K +  G+    + RE+SILK
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVK 136
           ++   +HPN++   +V        E    V LI E V   +L  ++       L+  +  
Sbjct: 70  EI---QHPNVITLHEVY-------ENKTDVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSV 192
           E  +Q+L GV +LHS +I H DLKP+N+++         +KI DFGLA   D+     ++
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  + APEI+     G   D+WSIG +   +      F   T+ E L           
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------- 227
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                 N+S +   FE          F +  + A   +  +L  +P  R++  D+L+HP+
Sbjct: 228 ------NVSAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 313 FKEKENE 319
            K K+ +
Sbjct: 275 IKPKDTQ 281

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 133/294 (45%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 21  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 76
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 77  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T++  TL Y  PE +   
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGR 186
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I                       
Sbjct: 187 XHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------------- 223
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
              S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 224 ---SRVEFT--FPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWITANSSKP 272

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 43/307 (14%)
Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILK 77
           D  YD   ++G G +  V K R+      Y A  +KK R K +  G+    + RE+SILK
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVK 136
           ++   +HPN++   +V        E    V LI E V   +L  ++       L+  +  
Sbjct: 70  EI---QHPNVITLHEVY-------ENKTDVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSV 192
           E  +Q+L GV +LHS +I H DLKP+N+++         +KI DFGLA   D+     ++
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  + APEI+     G   D+WSIG +   +      F   T+ E L           
Sbjct: 178 FGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------- 227
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                 N+S +   FE          F +  + A   +  +L  +P  R++  D+L+HP+
Sbjct: 228 ------NVSAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 313 FKEKENE 319
            K K+ +
Sbjct: 275 IKPKDTQ 281

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 133/293 (45%), Gaps = 43/293 (14%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 21  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 76
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 77  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T++  TL Y  PE++   
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I RV  T     +P+ ++      
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVT------ 235
Query: 268 EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                             A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 236 ----------------EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 43/307 (14%)
Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILK 77
           D  YD   ++G G +  V K R+      Y A  +KK R K +  G+    + RE+SILK
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVK 136
           ++   +HPN++   +V        E    V LI E V   +L  ++       L+  +  
Sbjct: 70  EI---QHPNVITLHEVY-------ENKTDVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSV 192
           E  +Q+L GV +LHS +I H DLKP+N+++         +KI DFGLA   D+     ++
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  + APEI+     G   D+WSIG +   +      F   T+ E L           
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------- 227
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                 N+S +   FE          F +  + A   +  +L  +P  R++  D+L+HP+
Sbjct: 228 ------NVSAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 313 FKEKENE 319
            K K+ +
Sbjct: 275 IKPKDTQ 281

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 132/294 (44%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 42  LGKGKFGNVYLAREKQSKF-ILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 97
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 98  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T++  TL Y  PE++   
Sbjct: 149 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 207
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I RV  T                 
Sbjct: 208 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------- 250
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                      F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 251 -----------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 293

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 134/294 (45%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 15  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 70
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 71  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T++  TL Y  PE++   
Sbjct: 122 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 180
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I                       
Sbjct: 181 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------------- 217
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
              S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 218 ---SRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 266

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 134/294 (45%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 16  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 71
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 72  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T++  TL Y  PE++   
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 181
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I                       
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------------- 218
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
              S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 219 ---SRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 134/294 (45%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 20  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 75
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 76  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T++  TL Y  PE++   
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I                       
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------------- 222
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
              S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 223 ---SRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 271

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 134/294 (45%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 17  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 72
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 73  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T++  TL Y  PE++   
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPEMIEGR 182
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I                       
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------------- 219
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
              S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 220 ---SRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 43/304 (14%)
Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILK 77
           D  YD   ++G G +  V K R+      Y A  +KK R K +  G+    + RE+SILK
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVK 136
           ++   +HPN++   +V        E    V LI E V   +L  ++       L+  +  
Sbjct: 70  EI---QHPNVITLHEVY-------ENKTDVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSV 192
           E  +Q+L GV +LHS +I H DLKP+N+++         +KI DFGLA   D+     ++
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  + APEI+     G   D+WSIG +   +      F   T+ E L           
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------- 227
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                 N+S +   FE          F +  + A   +  +L  +P  R++  D+L+HP+
Sbjct: 228 ------NVSAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 313 FKEK 316
            K K
Sbjct: 275 IKPK 278

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 136/294 (46%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 20  LGKGKFGNVYLARERQSK-FILALKVLFKTQLEKAGVEHQLRREVEIQSHL---RHPNIL 75
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 76  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSRFDEQRTATYITELANALS 126
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+   G LKIADFG +          ++  TL Y  PE++   
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 185
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E    +P F A T  E                          ++
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE--------------------------TY 219
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
            + S+V F+  F D  ++ A  L+  +L  N + R++ A+ LEHP+ K   ++P
Sbjct: 220 RRISRVEFT--FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKANSSKP 271

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 132/293 (45%), Gaps = 43/293 (14%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 21  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 76
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 77  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T +  TL Y  PE++   
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 186
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I RV  T     +P+ ++      
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVT------ 235
Query: 268 EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                             A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 236 ----------------EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 132/293 (45%), Gaps = 43/293 (14%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 16  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 71
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 72  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T +  TL Y  PE++   
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I RV  T     +P+ ++      
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVT------ 230
Query: 268 EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                             A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 231 ----------------EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 131/292 (44%), Gaps = 41/292 (14%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 21  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 76
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
           R +   H           VYLI E+  +    Y E          +      ++   + +
Sbjct: 77  RLYGYFHDAT-------RVYLILEYAPRG-EVYKELQKLSKFDEQRTATYITELANALSY 128
Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLG 208
            HS R+IHRD+KP+NLL+  AG LKIADFG +         T++  TL Y  PE++    
Sbjct: 129 CHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 187
Query: 209 YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFE 268
           +   VD+WS+G +  E     P F A+T  E  K I RV  T     +P+ ++       
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVT------- 235
Query: 269 QYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                            A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 236 ---------------EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 132/293 (45%), Gaps = 43/293 (14%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 17  LGKGKFGNVYLAREKQSKF-ILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 72
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 73  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T +  TL Y  PE++   
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I RV  T     +P+ ++      
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVT------ 231
Query: 268 EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                             A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 232 ----------------EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 132/293 (45%), Gaps = 43/293 (14%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 16  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 71
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 72  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T +  TL Y  PE++   
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I RV  T     +P+ ++      
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVT------ 230
Query: 268 EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                             A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 231 ----------------EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 43/307 (14%)
Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILK 77
           D  YD   ++G G +  V K R+      Y A  +KK R K +  G+    + RE+SILK
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVK 136
           ++   +HPN++   +V        E    V LI E V   +L  ++       L+  +  
Sbjct: 70  EI---QHPNVITLHEVY-------ENKTDVILIGELVAGGELFDFL--AEKESLTEEEAT 117
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSV 192
           E  +Q+L GV +LHS +I H DLKP+N+++         +KI DFGLA   D+     ++
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  + APEI+     G   D+WSIG +   +      F   T+ E L           
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------- 227
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                 N+S +   FE          F +  + A   +  +L  +P  R++  D+L+HP+
Sbjct: 228 ------NVSAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 313 FKEKENE 319
            K K+ +
Sbjct: 275 IKPKDTQ 281

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 133/294 (45%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 16  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 71
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 72  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T +  TL Y  PE++   
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGR 181
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I                       
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------------- 218
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
              S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 219 ---SRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 133/294 (45%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 16  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 71
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 72  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T +  TL Y  PE++   
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGR 181
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I                       
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------------- 218
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
              S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 219 ---SRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 135/302 (44%), Gaps = 43/302 (14%)
Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILK 77
           D  YD   ++G G +  V K R+      Y A  +KK R K +  G+    + RE+SILK
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVK 136
           ++   +HPN++   +V        E    V LI E V   +L  ++       L+  +  
Sbjct: 70  EI---QHPNVITLHEVY-------ENKTDVILILELVAGGELFDFL--AEKESLTEEEAT 117
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSV 192
           E  +Q+L GV +LHS +I H DLKP+N+++         +KI DFGLA   D+     ++
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  + APEI+     G   D+WSIG +   +      F   T+ E L           
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---------- 227
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                 N+S +   FE          F +  + A   +  +L  +P  R++  D+L+HP+
Sbjct: 228 ------NVSAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 313 FK 314
            K
Sbjct: 275 IK 276

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 134/294 (45%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 18  LGKGKFGNVYLAREKQSKF-ILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 73
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 74  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIA+FG +         T++  TL Y  PE++   
Sbjct: 125 YCHSKRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 183
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I                       
Sbjct: 184 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------------- 220
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
              S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 221 ---SRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 269

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 131/286 (45%), Gaps = 45/286 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 19  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 74
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 75  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T++  TL Y  PE++   
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I                       
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------------- 221
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPY 312
              S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+
Sbjct: 222 ---SRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 132/293 (45%), Gaps = 43/293 (14%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 19  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 74
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 75  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +          ++  TL Y  PE++   
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 184
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I RV  T     +P+ ++      
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVT------ 233
Query: 268 EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                             A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 234 ----------------EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 134/294 (45%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 19  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 74
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 75  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIA+FG +         T++  TL Y  PE++   
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I                       
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------------- 221
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
              S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 222 ---SRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 133/294 (45%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 16  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 71
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 72  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +          ++  TL Y  PE++   
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I                       
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------------- 218
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
              S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 219 ---SRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 132/293 (45%), Gaps = 43/293 (14%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 17  LGKGKFGNVYLAREKQSKF-ILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 72
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 73  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +          ++  TL Y  PE++   
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 182
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I RV  T     +P+ ++      
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVT------ 231
Query: 268 EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                             A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 232 ----------------EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 130/286 (45%), Gaps = 45/286 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 13  LGKGKFGNVYLAREKQRK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 68
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 69  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +         T++  TL Y  PE++   
Sbjct: 120 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 178
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I                       
Sbjct: 179 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------------- 215
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPY 312
              S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+
Sbjct: 216 ---SRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 89/314 (28%), Positives = 138/314 (43%), Gaps = 60/314 (19%)
Query: 24  YDELCQIGCGAYGTVFKARDLQ---------------NKGNYVAMKKLRVKLNEDGIPMS 68
           Y ++ ++G GAYG V   ++                 +KG Y    K   K +E+     
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE----- 92
Query: 69  TLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKC-PP 127
              EIS+LK LD   HPNI++ FDV       D++Y   YL+ E  +   G   E+    
Sbjct: 93  IYNEISLLKSLD---HPNIIKLFDV-----FEDKKYF--YLVTEFYEG--GELFEQIINR 140
Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL---KIADFGLAKTFD 184
                     + +Q+L G+ +LH H I+HRD+KP+N+L+     L   KI DFGL+  F 
Sbjct: 141 HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200
Query: 185 YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI 244
            D  L   + T +Y APE+ L   Y    D+WS G +M  +    P F    + + +K +
Sbjct: 201 KDYKLRDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259
Query: 245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA 304
            +       N+W  NIS                       +A  L++ MLT++   R +A
Sbjct: 260 EKGKYYFDFNDWK-NIS----------------------DEAKELIKLMLTYDYNKRCTA 296
Query: 305 ADALEHPYFKEKEN 318
            +AL   + K+  N
Sbjct: 297 EEALNSRWIKKYAN 310

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 131/293 (44%), Gaps = 43/293 (14%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 18  LGKGKFGNVYLAREKQSKF-ILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 73
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 74  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +           +  TL Y  PE++   
Sbjct: 125 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 183
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I RV  T     +P+ ++      
Sbjct: 184 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVT------ 232
Query: 268 EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                             A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 233 ----------------EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 269

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 132/294 (44%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 16  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 71
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 72  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +           +  TL Y  PE++   
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 181
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I                       
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------------- 218
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
              S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 219 ---SRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 130/294 (44%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 42  LGKGKFGNVYLAREKQSKF-ILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 97
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 98  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +           +  TL Y  PE++   
Sbjct: 149 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 207
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I RV  T                 
Sbjct: 208 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT----------------- 250
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                      F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 251 -----------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 293

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/294 (29%), Positives = 132/294 (44%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 19  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 74
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 75  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +           +  TL Y  PE++   
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 184
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I                       
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------------- 221
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
              S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 222 ---SRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 144/301 (47%), Gaps = 42/301 (13%)
Query: 17  LDLGD--KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           + +GD  KKY    +IG GA GTV+ A D+   G  VA++++   L +       + EI 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVAT-GQEVAIRQM--NLQQQPKKELIINEIL 69
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           ++++    ++PNIV + D     ++ DE    ++++ E++    GS  +      +   +
Sbjct: 70  VMRE---NKNPNIVNYLD---SYLVGDE----LWVVMEYLAG--GSLTDVVTETCMDEGQ 117
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +  + R+ L+ ++FLHS+++IHRD+K  N+L+   G +K+ DFG       +    S +V
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 195 -TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++    YG  VDIWS+G +  EM    P +     +  L  I    GTP +
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPEL 236
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
              PE +               SAIF D        L   L  +   R SA + L+H + 
Sbjct: 237 QN-PEKL---------------SAIFRD-------FLNRCLDMDVEKRGSAKELLQHQFL 273
Query: 314 K 314
           K
Sbjct: 274 K 274

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 144/301 (47%), Gaps = 42/301 (13%)
Query: 17  LDLGD--KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           + +GD  KKY    +IG GA GTV+ A D+   G  VA++++   L +       + EI 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVAT-GQEVAIRQM--NLQQQPKKELIINEIL 69
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           ++++    ++PNIV + D     ++ DE    ++++ E++    GS  +      +   +
Sbjct: 70  VMRE---NKNPNIVNYLD---SYLVGDE----LWVVMEYLAG--GSLTDVVTETCMDEGQ 117
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +  + R+ L+ ++FLHS+++IHRD+K  N+L+   G +K+ DFG       +    S +V
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV 177
Query: 195 -TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++    YG  VDIWS+G +  EM    P +     +  L  I    GTP +
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPEL 236
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
              PE +               SAIF D        L   L  +   R SA + L+H + 
Sbjct: 237 QN-PEKL---------------SAIFRD-------FLNRCLEMDVEKRGSAKELLQHQFL 273
Query: 314 K 314
           K
Sbjct: 274 K 274

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 142/312 (45%), Gaps = 64/312 (20%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVK------------------------LNEDG 64
           +IG G+YG V  A + +N   Y AMK L  K                        +   G
Sbjct: 20  EIGKGSYGVVKLAYN-ENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 65  IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK 124
                 +EI+ILK+LD   HPN+V+  +V     L D     +Y++FE V+Q  G  ME 
Sbjct: 79  PIEQVYQEIAILKKLD---HPNVVKLVEV-----LDDPNEDHLYMVFELVNQ--GPVMEV 128
Query: 125 CPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD 184
                LS  + +   + ++KG+++LH  +IIHRD+KP NLL+   G +KIADFG++  F 
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 185 -YDMMLTSVVVTLWYRAPEIL---LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQ 240
             D +L++ V T  + APE L     +  G  +D+W++G     ++  V   C   + E+
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT---LYCFVFGQCPFMD-ER 244
Query: 241 LKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD 300
           + C+   I + ++ E+P+                      D       L+  ML  NP  
Sbjct: 245 IMCLHSKIKSQAL-EFPDQ--------------------PDIAEDLKDLITRMLDKNPES 283
Query: 301 RISAADALEHPY 312
           RI   +   HP+
Sbjct: 284 RIVVPEIKLHPW 295

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 130/293 (44%), Gaps = 43/293 (14%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 21  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 76
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
           R +   H           VYLI E+  +    Y E          +      ++   + +
Sbjct: 77  RLYGYFHDAT-------RVYLILEYAPRG-EVYKELQKLSKFDEQRTATYITELANALSY 128
Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLG 208
            HS R+IHRD+KP+NLL+  AG LKIADFG +           +  TL Y  PE++    
Sbjct: 129 CHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGRM 187
Query: 209 YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFE 268
           +   VD+WS+G +  E     P F A+T  E  K I                        
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI------------------------ 223
Query: 269 QYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
             S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 224 --SRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 90/329 (27%), Positives = 164/329 (49%), Gaps = 41/329 (12%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN 61
           ++Y A T+Q    D        Y+ + ++G G Y  VF+  ++ N       +K  +K+ 
Sbjct: 39  WDYEALTVQWGEQDD-------YEVVRKVGRGKYSEVFEGINVNNN------EKCIIKIL 85
Query: 62  EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGS 120
           +        REI IL+ L     PNIV+  D++      D+   T  LIFE+V+  D   
Sbjct: 86  KPVKKKKIKREIKILQNLXG--GPNIVKLLDIV-----RDQHSKTPSLIFEYVNNTDF-- 136
Query: 121 YMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA-GGLKIADFGL 179
              K   P L+   ++    ++LK +D+ HS  I+HRD+KP N++I      L++ D+GL
Sbjct: 137 ---KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 193
Query: 180 AKTFDYDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEM-WRLVPLFCASTE 237
           A+ +         V + +++ PE+L++L  Y   +D+WS+GC+ A M +R  P F     
Sbjct: 194 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 253
Query: 238 VEQLKCIFRVIGTPSMNEWPENISL-----MWSSFEQYSKVAFSAIFMDC------CSKA 286
            +QL  I +V+GT  +N +     +     + +   ++S+  +   FM+         +A
Sbjct: 254 HDQLVKIAKVLGTDGLNAYLNKYRIELDPQLEALVGRHSRKPWLK-FMNADNQHLVSPEA 312
Query: 287 NSLLESMLTFNPADRISAADALEHPYFKE 315
              L+ +L ++  +R++A +A+ HPYF++
Sbjct: 313 IDFLDKLLRYDHQERLTALEAMTHPYFQQ 341

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 145/301 (48%), Gaps = 42/301 (13%)
Query: 17  LDLGD--KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           + +GD  KKY    +IG GA GTV+ A D+   G  VA++++   L +       + EI 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVAT-GQEVAIRQM--NLQQQPKKELIINEIL 69
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           ++++    ++PNIV + D     ++ DE    ++++ E++    GS  +      +   +
Sbjct: 70  VMRE---NKNPNIVNYLD---SYLVGDE----LWVVMEYLAG--GSLTDVVTETCMDEGQ 117
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL-AKTFDYDMMLTSVV 193
           +  + R+ L+ ++FLHS+++IHRD+K  N+L+   G +K+ DFG  A+        + +V
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV 177
Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++    YG  VDIWS+G +  EM    P +     +  L  I    GTP +
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPEL 236
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
              PE +               SAIF D        L   L  +   R SA + L+H + 
Sbjct: 237 QN-PEKL---------------SAIFRD-------FLNRCLDMDVEKRGSAKELLQHQFL 273
Query: 314 K 314
           K
Sbjct: 274 K 274

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 133/299 (44%), Gaps = 55/299 (18%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED--GIPMSTLR-EISILKQLDTFEHP 85
           ++G GA+G V    +  +      ++++   +N+D   +PM  +  EI +LK LD   HP
Sbjct: 29  KLGSGAFGDVHLVEERSS-----GLERVIKTINKDRSQVPMEQIEAEIEVLKSLD---HP 80
Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK-----CPPPGLSASKVKELTR 140
           NI++ F+V        E Y  +Y++ E  +   G  +E+          LS   V EL +
Sbjct: 81  NIIKIFEVF-------EDYHNMYIVMETCEG--GELLERIVSAQARGKALSEGYVAELMK 131
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
           QM+  + + HS  ++H+DLKP+N+L    +    +KI DFGLA+ F  D   T+   T  
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTAL 191
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEW 256
           Y APE+          DIWS G VM  +    +P    S E  Q K              
Sbjct: 192 YMAPEV-FKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT------------ 238
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
                        Y +  ++        +A  LL+ MLT +P  R SAA  L H +FK+
Sbjct: 239 -------------YKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 131/254 (51%), Gaps = 20/254 (7%)
Query: 17  LDLGD--KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           + +GD  KKY    +IG GA GTV+ A D+   G  VA++++   L +       + EI 
Sbjct: 14  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVAT-GQEVAIRQM--NLQQQPKKELIINEIL 70
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           ++++    ++PNIV + D     ++ DE    ++++ E++    GS  +      +   +
Sbjct: 71  VMRE---NKNPNIVNYLD---SYLVGDE----LWVVMEYLAG--GSLTDVVTETCMDEGQ 118
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +  + R+ L+ ++FLHS+++IHRD+K  N+L+   G +K+ DFG       +    S +V
Sbjct: 119 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV 178
Query: 195 -TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++    YG  VDIWS+G +  EM    P +     +  L  I    GTP +
Sbjct: 179 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPEL 237
Query: 254 NEWPENISLMWSSF 267
              PE +S ++  F
Sbjct: 238 QN-PEKLSAIFRDF 250

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/329 (27%), Positives = 164/329 (49%), Gaps = 41/329 (12%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN 61
           ++Y A T+Q    D        Y+ + ++G G Y  VF+  ++ N       +K  +K+ 
Sbjct: 18  WDYEALTVQWGEQDD-------YEVVRKVGRGKYSEVFEGINVNNN------EKCIIKIL 64
Query: 62  EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGS 120
           +        REI IL+ L     PNIV+  D++      D+   T  LIFE+V+  D   
Sbjct: 65  KPVKKKKIKREIKILQNLXG--GPNIVKLLDIV-----RDQHSKTPSLIFEYVNNTDF-- 115
Query: 121 YMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA-GGLKIADFGL 179
              K   P L+   ++    ++LK +D+ HS  I+HRD+KP N++I      L++ D+GL
Sbjct: 116 ---KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 172
Query: 180 AKTFDYDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEM-WRLVPLFCASTE 237
           A+ +         V + +++ PE+L++L  Y   +D+WS+GC+ A M +R  P F     
Sbjct: 173 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 232
Query: 238 VEQLKCIFRVIGTPSMNEWPENISL-----MWSSFEQYSKVAFSAIFMDC------CSKA 286
            +QL  I +V+GT  +N +     +     + +   ++S+  +   FM+         +A
Sbjct: 233 HDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLK-FMNADNQHLVSPEA 291
Query: 287 NSLLESMLTFNPADRISAADALEHPYFKE 315
              L+ +L ++  +R++A +A+ HPYF++
Sbjct: 292 IDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/329 (27%), Positives = 164/329 (49%), Gaps = 41/329 (12%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN 61
           ++Y A T+Q    D        Y+ + ++G G Y  VF+  ++ N       +K  +K+ 
Sbjct: 18  WDYEALTVQWGEQDD-------YEVVRKVGRGKYSEVFEGINVNNN------EKCIIKIL 64
Query: 62  EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGS 120
           +        REI IL+ L     PNIV+  D++      D+   T  LIFE+V+  D   
Sbjct: 65  KPVKKKKIKREIKILQNLXG--GPNIVKLLDIV-----RDQHSKTPSLIFEYVNNTDF-- 115
Query: 121 YMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA-GGLKIADFGL 179
              K   P L+   ++    ++LK +D+ HS  I+HRD+KP N++I      L++ D+GL
Sbjct: 116 ---KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 172
Query: 180 AKTFDYDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEM-WRLVPLFCASTE 237
           A+ +         V + +++ PE+L++L  Y   +D+WS+GC+ A M +R  P F     
Sbjct: 173 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 232
Query: 238 VEQLKCIFRVIGTPSMNEWPENISL-----MWSSFEQYSKVAFSAIFMDC------CSKA 286
            +QL  I +V+GT  +N +     +     + +   ++S+  +   FM+         +A
Sbjct: 233 HDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLK-FMNADNQHLVSPEA 291
Query: 287 NSLLESMLTFNPADRISAADALEHPYFKE 315
              L+ +L ++  +R++A +A+ HPYF++
Sbjct: 292 IDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/329 (27%), Positives = 164/329 (49%), Gaps = 41/329 (12%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN 61
           ++Y A T+Q    D        Y+ + ++G G Y  VF+  ++ N       +K  +K+ 
Sbjct: 18  WDYEALTVQWGEQDD-------YEVVRKVGRGKYSEVFEGINVNNN------EKCIIKIL 64
Query: 62  EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGS 120
           +        REI IL+ L     PNIV+  D++      D+   T  LIFE+V+  D   
Sbjct: 65  KPVKKKKIKREIKILQNLXG--GPNIVKLLDIV-----RDQHSKTPSLIFEYVNNTDF-- 115
Query: 121 YMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA-GGLKIADFGL 179
              K   P L+   ++    ++LK +D+ HS  I+HRD+KP N++I      L++ D+GL
Sbjct: 116 ---KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 172
Query: 180 AKTFDYDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEM-WRLVPLFCASTE 237
           A+ +         V + +++ PE+L++L  Y   +D+WS+GC+ A M +R  P F     
Sbjct: 173 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 232
Query: 238 VEQLKCIFRVIGTPSMNEWPENISL-----MWSSFEQYSKVAFSAIFMDC------CSKA 286
            +QL  I +V+GT  +N +     +     + +   ++S+  +   FM+         +A
Sbjct: 233 HDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLK-FMNADNQHLVSPEA 291
Query: 287 NSLLESMLTFNPADRISAADALEHPYFKE 315
              L+ +L ++  +R++A +A+ HPYF++
Sbjct: 292 IDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/329 (27%), Positives = 164/329 (49%), Gaps = 41/329 (12%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN 61
           ++Y A T+Q    D        Y+ + ++G G Y  VF+  ++ N       +K  +K+ 
Sbjct: 19  WDYEALTVQWGEQDD-------YEVVRKVGRGKYSEVFEGINVNNN------EKCIIKIL 65
Query: 62  EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGS 120
           +        REI IL+ L     PNIV+  D++      D+   T  LIFE+V+  D   
Sbjct: 66  KPVKKKKIKREIKILQNLXG--GPNIVKLLDIV-----RDQHSKTPSLIFEYVNNTDF-- 116
Query: 121 YMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA-GGLKIADFGL 179
              K   P L+   ++    ++LK +D+ HS  I+HRD+KP N++I      L++ D+GL
Sbjct: 117 ---KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 173
Query: 180 AKTFDYDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEM-WRLVPLFCASTE 237
           A+ +         V + +++ PE+L++L  Y   +D+WS+GC+ A M +R  P F     
Sbjct: 174 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 233
Query: 238 VEQLKCIFRVIGTPSMNEWPENISL-----MWSSFEQYSKVAFSAIFMDC------CSKA 286
            +QL  I +V+GT  +N +     +     + +   ++S+  +   FM+         +A
Sbjct: 234 HDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLK-FMNADNQHLVSPEA 292
Query: 287 NSLLESMLTFNPADRISAADALEHPYFKE 315
              L+ +L ++  +R++A +A+ HPYF++
Sbjct: 293 IDFLDKLLRYDHQERLTALEAMTHPYFQQ 321

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 90/329 (27%), Positives = 164/329 (49%), Gaps = 41/329 (12%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN 61
           ++Y A T+Q    D        Y+ + ++G G Y  VF+  ++ N       +K  +K+ 
Sbjct: 18  WDYEALTVQWGEQDD-------YEVVRKVGRGKYSEVFEGINVNNN------EKCIIKIL 64
Query: 62  EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGS 120
           +        REI IL+ L     PNIV+  D++      D+   T  LIFE+V+  D   
Sbjct: 65  KPVKKKKIKREIKILQNL--MGGPNIVKLLDIV-----RDQHSKTPSLIFEYVNNTDF-- 115
Query: 121 YMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA-GGLKIADFGL 179
              K   P L+   ++    ++LK +D+ HS  I+HRD+KP N++I      L++ D+GL
Sbjct: 116 ---KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 172
Query: 180 AKTFDYDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEM-WRLVPLFCASTE 237
           A+ +         V + +++ PE+L++L  Y   +D+WS+GC+ A M +R  P F     
Sbjct: 173 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 232
Query: 238 VEQLKCIFRVIGTPSMNEWPENISL-----MWSSFEQYSKVAFSAIFMDC------CSKA 286
            +QL  I +V+GT  +N +     +     + +   ++S+  +   FM+         +A
Sbjct: 233 HDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLK-FMNADNQHLVSPEA 291
Query: 287 NSLLESMLTFNPADRISAADALEHPYFKE 315
              L+ +L ++  +R++A +A+ HPYF++
Sbjct: 292 IDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 129/246 (52%), Gaps = 26/246 (10%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           PNIV+  D++      D+   T  LIFE+V+  D      K   P L+   ++    ++L
Sbjct: 88  PNIVKLLDIV-----RDQHSKTPSLIFEYVNNTDF-----KVLYPTLTDYDIRYYIYELL 137
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRA-GGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           K +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE
Sbjct: 138 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 197
Query: 203 ILLNL-GYGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           +L++L  Y   +D+WS+GC+ A M +R  P F      +QL  I +V+GT  +N +    
Sbjct: 198 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKY 257
Query: 261 SL-----MWSSFEQYSKVAFSAIFMDC------CSKANSLLESMLTFNPADRISAADALE 309
            +     + +   ++S+  +   FM+         +A   L+ +L ++  +R++A +A+ 
Sbjct: 258 RIELDPQLEALVGRHSRKPWLK-FMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMT 316
Query: 310 HPYFKE 315
           HPYF++
Sbjct: 317 HPYFQQ 322

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 129/246 (52%), Gaps = 26/246 (10%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           PNIV+  D++      D+   T  LIFE+V+  D      K   P L+   ++    ++L
Sbjct: 86  PNIVKLLDIV-----RDQHSKTPSLIFEYVNNTDF-----KVLYPTLTDYDIRYYIYELL 135
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRA-GGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           K +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE
Sbjct: 136 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 203 ILLNL-GYGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           +L++L  Y   +D+WS+GC+ A M +R  P F      +QL  I +V+GT  +N +    
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKY 255
Query: 261 SL-----MWSSFEQYSKVAFSAIFMDC------CSKANSLLESMLTFNPADRISAADALE 309
            +     + +   ++S+  +   FM+         +A   L+ +L ++  +R++A +A+ 
Sbjct: 256 RIELDPQLEALVGRHSRKPWLK-FMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMT 314
Query: 310 HPYFKE 315
           HPYF++
Sbjct: 315 HPYFQQ 320

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 129/246 (52%), Gaps = 26/246 (10%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           PNIV+  D++      D+   T  LIFE+V+  D      K   P L+   ++    ++L
Sbjct: 86  PNIVKLLDIV-----RDQHSKTPSLIFEYVNNTDF-----KVLYPTLTDYDIRYYIYELL 135
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRA-GGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           K +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE
Sbjct: 136 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 203 ILLNL-GYGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           +L++L  Y   +D+WS+GC+ A M +R  P F      +QL  I +V+GT  +N +    
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKY 255
Query: 261 SL-----MWSSFEQYSKVAFSAIFMDC------CSKANSLLESMLTFNPADRISAADALE 309
            +     + +   ++S+  +   FM+         +A   L+ +L ++  +R++A +A+ 
Sbjct: 256 RIELDPQLEALVGRHSRKPWLK-FMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMT 314
Query: 310 HPYFKE 315
           HPYF++
Sbjct: 315 HPYFQQ 320

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 129/246 (52%), Gaps = 26/246 (10%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           PNIV+  D++      D+   T  LIFE+V+  D      K   P L+   ++    ++L
Sbjct: 87  PNIVKLLDIV-----RDQHSKTPSLIFEYVNNTDF-----KVLYPTLTDYDIRYYIYELL 136
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRA-GGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           K +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE
Sbjct: 137 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 196
Query: 203 ILLNL-GYGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           +L++L  Y   +D+WS+GC+ A M +R  P F      +QL  I +V+GT  +N +    
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKY 256
Query: 261 SL-----MWSSFEQYSKVAFSAIFMDC------CSKANSLLESMLTFNPADRISAADALE 309
            +     + +   ++S+  +   FM+         +A   L+ +L ++  +R++A +A+ 
Sbjct: 257 RIELDPQLEALVGRHSRKPWLK-FMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMT 315
Query: 310 HPYFKE 315
           HPYF++
Sbjct: 316 HPYFQQ 321

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 129/286 (45%), Gaps = 45/286 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ Q+K   +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 19  LGKGKFGNVYLAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 74
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H           VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 75  RLYGYFHDAT-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS R+IHRD+KP+NLL+  AG LKIADFG +           +  TL Y  PE++   
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 184
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +  E     P F A+T  E  K I                       
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------------- 221
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPY 312
              S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+
Sbjct: 222 ---SRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 135/294 (45%), Gaps = 45/294 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V+ AR+ +N    +A+K L + +L + G+     RE+ I   L    HPNI+
Sbjct: 16  LGKGKFGNVYLARE-KNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNIL 71
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGS-YMEKCPPPGLSASKVKELTRQMLKGVD 147
           R +   H +         VYLI E+    LG+ Y E          +      ++   + 
Sbjct: 72  RLYGYFHDST-------RVYLILEYAP--LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + HS ++IHRD+KP+NLL+  AG LKIADFG +          ++  TL Y  PE++   
Sbjct: 123 YCHSKKVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            +   VD+WS+G +                     C   ++G P     P   +    ++
Sbjct: 182 MHDEKVDLWSLGVL---------------------CYEFLVGKP-----PFEANTYQDTY 215
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
           ++ S+V F+  F D  ++ A  L+  +L  NP+ R    + LEHP+     ++P
Sbjct: 216 KRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 135/288 (46%), Gaps = 44/288 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++  V++A  +   G  VA+K +  K + + G+      E+ I  QL   +HP+I+
Sbjct: 19  LGKGSFAGVYRAESIHT-GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL---KHPSIL 74
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
             +     N   D  Y  VYL+ E   + ++  Y++    P  S ++ +    Q++ G+ 
Sbjct: 75  ELY-----NYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKP-FSENEARHFMHQIITGML 126
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD--YDMMLTSVVVTLWYRAPEILL 205
           +LHSH I+HRDL   NLL+TR   +KIADFGLA      ++   T +  T  Y +PEI  
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIAT 185
Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS 265
              +G   D+WS+GC+   +                     +IG P  +      +L   
Sbjct: 186 RSAHGLESDVWSLGCMFYTL---------------------LIGRPPFDTDTVKNTLNKV 224
Query: 266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
               Y   +F +I      +A  L+  +L  NPADR+S +  L+HP+ 
Sbjct: 225 VLADYEMPSFLSI------EAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 133/254 (52%), Gaps = 20/254 (7%)
Query: 17  LDLGD--KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           + +GD  KKY    +IG GA GTV+ A D+   G  VA++++   L +       + EI 
Sbjct: 14  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVAT-GQEVAIRQM--NLQQQPKKELIINEIL 70
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           ++++    ++PNIV + D     ++ DE    ++++ E++    GS  +      +   +
Sbjct: 71  VMRE---NKNPNIVNYLD---SYLVGDE----LWVVMEYLAG--GSLTDVVTETCMDEGQ 118
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL-AKTFDYDMMLTSVV 193
           +  + R+ L+ ++FLHS+++IHR++K  N+L+   G +K+ DFG  A+        +++V
Sbjct: 119 IAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 178
Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++    YG  VDIWS+G +  EM    P +     +  L  I    GTP +
Sbjct: 179 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPEL 237
Query: 254 NEWPENISLMWSSF 267
              PE +S ++  F
Sbjct: 238 QN-PEKLSAIFRDF 250

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 127/240 (52%), Gaps = 22/240 (9%)
Query: 9   IQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMS 68
           +Q+L  D  +L    + +L +IG G++G VFK  D  N+   V   K+      +     
Sbjct: 13  MQNLKADPEEL----FTKLEKIGKGSFGEVFKGID--NRTQKVVAIKIIDLEEAEDEIED 66
Query: 69  TLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
             +EI++L Q D+   P + +++     + L D +   +++I E++    GS ++   P 
Sbjct: 67  IQQEITVLSQCDS---PYVTKYYG----SYLKDTK---LWIIMEYLGG--GSALDLLEPG 114
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDM 187
            L  +++  + R++LKG+D+LHS + IHRD+K  N+L++  G +K+ADFG+A    D  +
Sbjct: 115 PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
                V T ++ APE++    Y +  DIWS+G    E+ R  P     +E+  +K +F +
Sbjct: 175 KRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP---PHSELHPMKVLFLI 231

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 129/239 (53%), Gaps = 19/239 (7%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           ++L   S+D  ++ + +L +IG G++G VFK  D  N+   V   K+      +      
Sbjct: 16  ENLYFQSMD-PEELFTKLEKIGKGSFGEVFKGID--NRTQKVVAIKIIDLEEAEDEIEDI 72
Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG 129
            +EI++L Q D+   P + +++     + L D +   +++I E++    GS ++   P  
Sbjct: 73  QQEITVLSQCDS---PYVTKYYG----SYLKDTK---LWIIMEYLGG--GSALDLLEPGP 120
Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMM 188
           L  +++  + R++LKG+D+LHS + IHRD+K  N+L++  G +K+ADFG+A    D  + 
Sbjct: 121 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 180
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
             + V T ++ APE++    Y +  DIWS+G    E+ R  P     +E+  +K +F +
Sbjct: 181 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP---PHSELHPMKVLFLI 236

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 121/225 (53%), Gaps = 18/225 (8%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           + +L +IG G++G VFK  D  N+   V   K+      +       +EI++L Q D+  
Sbjct: 9   FTKLEKIGKGSFGEVFKGID--NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-- 64
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
            P + +++     + L D +   +++I E++    GS ++   P  L  +++  + R++L
Sbjct: 65  -PYVTKYYG----SYLKDTK---LWIIMEYLGG--GSALDLLEPGPLDETQIATILREIL 114
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLTSVVVTLWYRAPE 202
           KG+D+LHS + IHRD+K  N+L++  G +K+ADFG+A    D  +   + V T ++ APE
Sbjct: 115 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 174
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
           ++    Y +  DIWS+G    E+ R  P     +E+  +K +F +
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEP---PHSELHPMKVLFLI 216

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 120/225 (53%), Gaps = 18/225 (8%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           + +L +IG G++G VFK  D  N+   V   K+      +       +EI++L Q D+  
Sbjct: 9   FTKLEKIGKGSFGEVFKGID--NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-- 64
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
            P + +++     + L D +   +++I E++    GS ++   P  L  +++  + R++L
Sbjct: 65  -PYVTKYYG----SYLKDTK---LWIIMEYLGG--GSALDLLEPGPLDETQIATILREIL 114
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLTSVVVTLWYRAPE 202
           KG+D+LHS + IHRD+K  N+L++  G +K+ADFG+A    D  +     V T ++ APE
Sbjct: 115 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE 174
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
           ++    Y +  DIWS+G    E+ R  P     +E+  +K +F +
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEP---PHSELHPMKVLFLI 216

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 123/253 (48%), Gaps = 22/253 (8%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y+ L  IG G+YG   K R  ++ G  +  K+L      +      + E+++L++L   +
Sbjct: 8   YEVLYTIGTGSYGRCQKIRR-KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL---K 63
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG--LSASKVKELTR 140
           HPNIVR++D I      D    T+Y++ E+ +  DL S + K       L    V  +  
Sbjct: 64  HPNIVRYYDRI-----IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 141 QMLKGVDFLH-----SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV- 194
           Q+   +   H      H ++HRDLKP N+ +     +K+ DFGLA+  ++D       V 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178
Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI----FRVIGT 250
           T +Y +PE +  + Y    DIWS+GC++ E+  L+P F A ++ E    I    FR I  
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 238
Query: 251 PSMNEWPENISLM 263
              +E  E I+ M
Sbjct: 239 RYSDELNEIITRM 251

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 123/253 (48%), Gaps = 22/253 (8%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y+ L  IG G+YG   K R  ++ G  +  K+L      +      + E+++L++L   +
Sbjct: 8   YEVLYTIGTGSYGRCQKIRR-KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL---K 63
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG--LSASKVKELTR 140
           HPNIVR++D I      D    T+Y++ E+ +  DL S + K       L    V  +  
Sbjct: 64  HPNIVRYYDRI-----IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 141 QMLKGVDFLH-----SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV- 194
           Q+   +   H      H ++HRDLKP N+ +     +K+ DFGLA+  ++D       V 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG 178
Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI----FRVIGT 250
           T +Y +PE +  + Y    DIWS+GC++ E+  L+P F A ++ E    I    FR I  
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 238
Query: 251 PSMNEWPENISLM 263
              +E  E I+ M
Sbjct: 239 RYSDELNEIITRM 251

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 122/242 (50%), Gaps = 22/242 (9%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           PNI+   D++      D    T  L+FEHV+      + +     L+   ++    ++LK
Sbjct: 92  PNIITLADIV-----KDPVSRTPALVFEHVNNTDFKQLRQT----LTDYDIRFYMYEILK 142
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LLNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE--- 258
           L++   Y   +D+WS+GC++A M +R  P F      +QL  I +V+GT  + ++ +   
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 259 -------NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                  N  L   S +++ +   S        +A   L+ +L ++   R++A +A+EHP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 312 YF 313
           YF
Sbjct: 323 YF 324

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/325 (26%), Positives = 158/325 (48%), Gaps = 37/325 (11%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN 61
           ++Y +  ++  N D   L       + ++G G Y  VF+A ++ N       +K+ VK+ 
Sbjct: 24  WDYESHVVEWGNQDDYQL-------VRKLGRGKYSEVFEAINITNN------EKVAVKIL 70
Query: 62  EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY 121
           +        REI IL+ L     PNI+   D++      D    T  L+FEHV+      
Sbjct: 71  KPVKKKKIKREIKILENLRGG--PNIITLADIV-----KDPVSRTPALVFEHVNNTDFKQ 123
Query: 122 MEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLA 180
           + +     L+   ++    ++LK +D+ HS  I+HRD+KP N+LI      L++ D+GLA
Sbjct: 124 LYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLA 179
Query: 181 KTFDYDMMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEV 238
           + +         V + +++ PE+L++   Y   +D+WS+GC++A M +R  P F      
Sbjct: 180 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 239
Query: 239 EQLKCIFRVIGTPSMNEWPE----------NISLMWSSFEQYSKVAFSAIFMDCCSKANS 288
           +QL  I +V+GT  + ++ +          N  L   S +++ +   S        +A  
Sbjct: 240 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 299
Query: 289 LLESMLTFNPADRISAADALEHPYF 313
            L+ +L ++   R++A +A+EHPYF
Sbjct: 300 FLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 136/302 (45%), Gaps = 67/302 (22%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G GA+G V+KA++ +  G   A K +  K  E+      + EI IL    T +HP IV
Sbjct: 26  ELGDGAFGKVYKAKN-KETGALAAAKVIETKSEEEL--EDYIVEIEILA---TCDHPYIV 79
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP-----------PPGLSASKVKE 137
           +     +                   D  L   +E CP             GL+  +++ 
Sbjct: 80  KLLGAYYH------------------DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 121
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL-AKTFDYDMMLTSVVVTL 196
           + RQML+ ++FLHS RIIHRDLK  N+L+T  G +++ADFG+ AK         S + T 
Sbjct: 122 VCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP 181
Query: 197 WYRAPEILL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT- 250
           ++ APE+++     +  Y    DIWS+G  + EM ++ P      E+  ++ + ++  + 
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP---PHHELNPMRVLLKIAKSD 238
Query: 251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
           P     P   S+    F  + K+A                   L  NP  R SAA  LEH
Sbjct: 239 PPTLLTPSKWSV---EFRDFLKIA-------------------LDKNPETRPSAAQLLEH 276
Query: 311 PY 312
           P+
Sbjct: 277 PF 278

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 136/302 (45%), Gaps = 67/302 (22%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G GA+G V+KA++ +  G   A K +  K  E+      + EI IL    T +HP IV
Sbjct: 18  ELGDGAFGKVYKAKN-KETGALAAAKVIETKSEEEL--EDYIVEIEILA---TCDHPYIV 71
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-----------GLSASKVKE 137
           +     +                   D  L   +E CP             GL+  +++ 
Sbjct: 72  KLLGAYYH------------------DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 113
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL-AKTFDYDMMLTSVVVTL 196
           + RQML+ ++FLHS RIIHRDLK  N+L+T  G +++ADFG+ AK         S + T 
Sbjct: 114 VCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP 173
Query: 197 WYRAPEILL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT- 250
           ++ APE+++     +  Y    DIWS+G  + EM ++ P      E+  ++ + ++  + 
Sbjct: 174 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP---PHHELNPMRVLLKIAKSD 230
Query: 251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
           P     P   S+    F  + K+A                   L  NP  R SAA  LEH
Sbjct: 231 PPTLLTPSKWSV---EFRDFLKIA-------------------LDKNPETRPSAAQLLEH 268
Query: 311 PY 312
           P+
Sbjct: 269 PF 270

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 122/242 (50%), Gaps = 22/242 (9%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           PNI+   D++      D    T  L+FEHV+      + +     L+   ++    ++LK
Sbjct: 91  PNIITLADIV-----KDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILK 141
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE+
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 201
Query: 204 LLNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE--- 258
           L++   Y   +D+WS+GC++A M +R  P F      +QL  I +V+GT  + ++ +   
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 259 -------NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                  N  L   S +++ +   S        +A   L+ +L ++   R++A +A+EHP
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321
Query: 312 YF 313
           YF
Sbjct: 322 YF 323

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 122/242 (50%), Gaps = 22/242 (9%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           PNI+   D++      D    T  L+FEHV+      + +     L+   ++    ++LK
Sbjct: 91  PNIITLADIV-----KDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILK 141
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE+
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 201
Query: 204 LLNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE--- 258
           L++   Y   +D+WS+GC++A M +R  P F      +QL  I +V+GT  + ++ +   
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 259 -------NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                  N  L   S +++ +   S        +A   L+ +L ++   R++A +A+EHP
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321
Query: 312 YF 313
           YF
Sbjct: 322 YF 323

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 122/242 (50%), Gaps = 22/242 (9%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           PNI+   D++      D    T  L+FEHV+      + +     L+   ++    ++LK
Sbjct: 92  PNIITLADIV-----KDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILK 142
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LLNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE--- 258
           L++   Y   +D+WS+GC++A M +R  P F      +QL  I +V+GT  + ++ +   
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 259 -------NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                  N  L   S +++ +   S        +A   L+ +L ++   R++A +A+EHP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 312 YF 313
           YF
Sbjct: 323 YF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 122/242 (50%), Gaps = 22/242 (9%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           PNI+   D++      D    T  L+FEHV+      + +     L+   ++    ++LK
Sbjct: 92  PNIITLADIV-----KDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILK 142
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LLNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE--- 258
           L++   Y   +D+WS+GC++A M +R  P F      +QL  I +V+GT  + ++ +   
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 259 -------NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                  N  L   S +++ +   S        +A   L+ +L ++   R++A +A+EHP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 312 YF 313
           YF
Sbjct: 323 YF 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 122/242 (50%), Gaps = 22/242 (9%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           PNI+   D++      D    T  L+FEHV+      + +     L+   ++    ++LK
Sbjct: 97  PNIITLADIV-----KDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILK 147
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE+
Sbjct: 148 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 207
Query: 204 LLNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE--- 258
           L++   Y   +D+WS+GC++A M +R  P F      +QL  I +V+GT  + ++ +   
Sbjct: 208 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 267
Query: 259 -------NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                  N  L   S +++ +   S        +A   L+ +L ++   R++A +A+EHP
Sbjct: 268 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 327
Query: 312 YF 313
           YF
Sbjct: 328 YF 329

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 122/242 (50%), Gaps = 22/242 (9%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           PNI+   D++      D    T  L+FEHV+      + +     L+   ++    ++LK
Sbjct: 92  PNIITLADIV-----KDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILK 142
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LLNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE--- 258
           L++   Y   +D+WS+GC++A M +R  P F      +QL  I +V+GT  + ++ +   
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 259 -------NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                  N  L   S +++ +   S        +A   L+ +L ++   R++A +A+EHP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 312 YF 313
           YF
Sbjct: 323 YF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 122/242 (50%), Gaps = 22/242 (9%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           PNI+   D++      D    T  L+FEHV+      + +     L+   ++    ++LK
Sbjct: 92  PNIITLADIV-----KDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILK 142
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LLNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE--- 258
           L++   Y   +D+WS+GC++A M +R  P F      +QL  I +V+GT  + ++ +   
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 259 -------NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                  N  L   S +++ +   S        +A   L+ +L ++   R++A +A+EHP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 312 YF 313
           YF
Sbjct: 323 YF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 122/242 (50%), Gaps = 22/242 (9%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           PNI+   D++      D    T  L+FEHV+      + +     L+   ++    ++LK
Sbjct: 90  PNIITLADIV-----KDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILK 140
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE+
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 200
Query: 204 LLNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE--- 258
           L++   Y   +D+WS+GC++A M +R  P F      +QL  I +V+GT  + ++ +   
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 259 -------NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                  N  L   S +++ +   S        +A   L+ +L ++   R++A +A+EHP
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320
Query: 312 YF 313
           YF
Sbjct: 321 YF 322

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 139/307 (45%), Gaps = 50/307 (16%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE------DGIPMSTLREISI 75
           +KYD    IG G    V +    +  G+  A+K + V          + +  +T RE  I
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVH-RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM-EKCPPPGLSAS 133
           L+Q+    HP+I+   D       S E    ++L+F+ + + +L  Y+ EK     LS  
Sbjct: 153 LRQVAG--HPHIITLID-------SYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEK 200
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV 193
           + + + R +L+ V FLH++ I+HRDLKP+N+L+     ++++DFG +   +    L  + 
Sbjct: 201 ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC 260
Query: 194 VTLWYRAPEIL------LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
            T  Y APEIL       + GYG  VD+W+ G ++  +    P F    ++  L+ I   
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320
Query: 248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
               S  EW                        D  S    L+  +L  +P  R++A  A
Sbjct: 321 QYQFSSPEWD-----------------------DRSSTVKDLISRLLQVDPEARLTAEQA 357
Query: 308 LEHPYFK 314
           L+HP+F+
Sbjct: 358 LQHPFFE 364

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 122/242 (50%), Gaps = 22/242 (9%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           PNI+   D++      D    T  L+FEHV+      + +     L+   ++    ++LK
Sbjct: 92  PNIITLADIV-----KDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILK 142
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LLNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE--- 258
           L++   Y   +D+WS+GC++A M +R  P F      +QL  I +V+GT  + ++ +   
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 259 -------NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                  N  L   S +++ +   S        +A   L+ +L ++   R++A +A+EHP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 312 YF 313
           YF
Sbjct: 323 YF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 122/242 (50%), Gaps = 22/242 (9%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           PNI+   D++      D    T  L+FEHV+      + +     L+   ++    ++LK
Sbjct: 92  PNIITLADIV-----KDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILK 142
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LLNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE--- 258
           L++   Y   +D+WS+GC++A M +R  P F      +QL  I +V+GT  + ++ +   
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 259 -------NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                  N  L   S +++ +   S        +A   L+ +L ++   R++A +A+EHP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 312 YF 313
           YF
Sbjct: 323 YF 324

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 129/267 (48%), Gaps = 46/267 (17%)
Query: 21  DKKYDE---LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           D +YDE      +G G YG V+  RDL N+   +A+K++  + +    P+    EI++ K
Sbjct: 18  DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVR-IAIKEIPERDSRYSQPLH--EEIALHK 74
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA---SK 134
            L   +H NIV++     +N                    +  +ME+ P   LSA   SK
Sbjct: 75  HL---KHKNIVQYLGSFSENGF------------------IKIFMEQVPGGSLSALLRSK 113
Query: 135 VKEL----------TRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTF 183
              L          T+Q+L+G+ +LH ++I+HRD+K  N+LI T +G LKI+DFG +K  
Sbjct: 114 WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173
Query: 184 -DYDMMLTSVVVTLWYRAPEILLN--LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQ 240
              +    +   TL Y APEI+     GYG   DIWS+GC + EM    P F    E + 
Sbjct: 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA 233
Query: 241 LKCIFRVIGTPSMNEWPENISLMWSSF 267
              +F+V       E PE++S    +F
Sbjct: 234 --AMFKVGMFKVHPEIPESMSAEAKAF 258

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 122/242 (50%), Gaps = 22/242 (9%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           PNI+   D++      D    T  L+FEHV+      + +     L+   ++    ++LK
Sbjct: 92  PNIITLADIV-----KDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILK 142
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LLNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE--- 258
           L++   Y   +D+WS+GC++A M +R  P F      +QL  I +V+GT  + ++ +   
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 259 -------NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                  N  L   S +++ +   S        +A   L+ +L ++   R++A +A+EHP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 312 YF 313
           YF
Sbjct: 323 YF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 122/242 (50%), Gaps = 22/242 (9%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           PNI+   D++      D    T  L+FEHV+      + +     L+   ++    ++LK
Sbjct: 92  PNIITLADIV-----KDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILK 142
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +++ PE+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 204 LLNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE--- 258
           L++   Y   +D+WS+GC++A M +R  P F      +QL  I +V+GT  + ++ +   
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 259 -------NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                  N  L   S +++ +   S        +A   L+ +L ++   R++A +A+EHP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 312 YF 313
           YF
Sbjct: 323 YF 324

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 127/267 (47%), Gaps = 46/267 (17%)
Query: 21  DKKYDE---LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           D +YDE      +G G YG V+  RDL N+   +A+K++  + +    P+    EI++ K
Sbjct: 4   DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVR-IAIKEIPERDSRYSQPLH--EEIALHK 60
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA----- 132
            L   +H NIV++     +N                    +  +ME+ P   LSA     
Sbjct: 61  HL---KHKNIVQYLGSFSENGF------------------IKIFMEQVPGGSLSALLRSK 99
Query: 133 --------SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTF 183
                     +   T+Q+L+G+ +LH ++I+HRD+K  N+LI T +G LKI+DFG +K  
Sbjct: 100 WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 159
Query: 184 -DYDMMLTSVVVTLWYRAPEILLN--LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQ 240
              +    +   TL Y APEI+     GYG   DIWS+GC + EM    P F    E + 
Sbjct: 160 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA 219
Query: 241 LKCIFRVIGTPSMNEWPENISLMWSSF 267
              +F+V       E PE++S    +F
Sbjct: 220 --AMFKVGMFKVHPEIPESMSAEAKAF 244

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 106/225 (47%), Gaps = 33/225 (14%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           + E+  IG G +G VFKA+   +   YV     RVK N +       RE+  L +LD   
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIR---RVKYNNEKAE----REVKALAKLD--- 63
Query: 84  HPNIVRF----------------------FDVIHQNILSDERYLTVYLIFEHVDQD-LGS 120
           H NIV +                      +D  +    S  +   +++  E  D+  L  
Sbjct: 64  HVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQ 123
Query: 121 YMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA 180
           ++EK     L      EL  Q+ KGVD++HS ++IHRDLKP N+ +     +KI DFGL 
Sbjct: 124 WIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLV 183
Query: 181 KTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            +   D   T    TL Y +PE + +  YG  VD++++G ++AE+
Sbjct: 184 TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 123/253 (48%), Gaps = 22/253 (8%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y+ L  IG G+YG   K R  ++ G  +  K+L      +      + E+++L++L   +
Sbjct: 8   YEVLYTIGTGSYGRCQKIRR-KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL---K 63
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG--LSASKVKELTR 140
           HPNIVR++D I      D    T+Y++ E+ +  DL S + K       L    V  +  
Sbjct: 64  HPNIVRYYDRI-----IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 141 QMLKGVDFLH-----SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVV 194
           Q+   +   H      H ++HRDLKP N+ +     +K+ DFGLA+  ++D       V 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVG 178
Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI----FRVIGT 250
           T +Y +PE +  + Y    DIWS+GC++ E+  L+P F A ++ E    I    FR I  
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 238
Query: 251 PSMNEWPENISLM 263
              +E  E I+ M
Sbjct: 239 RYSDELNEIITRM 251

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 133/302 (44%), Gaps = 48/302 (15%)
Query: 24  YDELCQIGCGAYGTV----FKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQL 79
           YD   ++G GA+  V     K   L+     +  KKL  +  +        RE  I ++L
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-----KLEREARICRKL 62
Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGL-SASKVKEL 138
              +HPNIVR  D I +           YL+F+ V    G   E        S +     
Sbjct: 63  ---QHPNIVRLHDSIQEESFH-------YLVFDLVTG--GELFEDIVAREFYSEADASHC 110
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVT 195
            +Q+L+ + + HS+ I+HR+LKP+NLL+    +   +K+ADFGLA   +          T
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 170
Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
             Y +PE+L    Y  PVDIW+ G ++  +                     ++G P    
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYIL---------------------LVGYPPF-- 207
Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           W E+   +++  +  +    S  +     +A SL++SMLT NP  RI+A  AL+ P+   
Sbjct: 208 WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267
Query: 316 KE 317
           +E
Sbjct: 268 RE 269

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 133/302 (44%), Gaps = 48/302 (15%)
Query: 24  YDELCQIGCGAYGTV----FKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQL 79
           YD   ++G GA+  V     K   L+     +  KKL  +  +        RE  I ++L
Sbjct: 7   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-----KLEREARICRKL 61
Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGL-SASKVKEL 138
              +HPNIVR  D I +           YL+F+ V    G   E        S +     
Sbjct: 62  ---QHPNIVRLHDSIQEESFH-------YLVFDLVTG--GELFEDIVAREFYSEADASHC 109
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVT 195
            +Q+L+ + + HS+ I+HR+LKP+NLL+    +   +K+ADFGLA   +          T
Sbjct: 110 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 169
Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
             Y +PE+L    Y  PVDIW+ G ++  +                     ++G P    
Sbjct: 170 PGYLSPEVLKKDPYSKPVDIWACGVILYIL---------------------LVGYPPF-- 206
Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           W E+   +++  +  +    S  +     +A SL++SMLT NP  RI+A  AL+ P+   
Sbjct: 207 WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 266
Query: 316 KE 317
           +E
Sbjct: 267 RE 268

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 133/302 (44%), Gaps = 48/302 (15%)
Query: 24  YDELCQIGCGAYGTV----FKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQL 79
           YD   ++G GA+  V     K   L+     +  KKL  +  +        RE  I ++L
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-----KLEREARICRKL 62
Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGL-SASKVKEL 138
              +HPNIVR  D I +           YL+F+ V    G   E        S +     
Sbjct: 63  ---QHPNIVRLHDSIQEESFH-------YLVFDLVTG--GELFEDIVAREFYSEADASHC 110
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVT 195
            +Q+L+ + + HS+ I+HR+LKP+NLL+    +   +K+ADFGLA   +          T
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 170
Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
             Y +PE+L    Y  PVDIW+ G ++  +                     ++G P    
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYIL---------------------LVGYPPF-- 207
Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           W E+   +++  +  +    S  +     +A SL++SMLT NP  RI+A  AL+ P+   
Sbjct: 208 WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267
Query: 316 KE 317
           +E
Sbjct: 268 RE 269

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 49/303 (16%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVA----MKKLRVKLNEDGIPMSTLREISILKQ 78
           +Y    ++G GA+  V +   +     Y A     KKL  + ++        RE  I + 
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ-----KLEREARICRL 59
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK-CPPPGLSASKVKE 137
           L   +HPNIVR  D I     S+E +   YL+F+ V    G   E        S +    
Sbjct: 60  L---KHPNIVRLHDSI-----SEEGFH--YLVFDLVTG--GELFEDIVAREYYSEADASH 107
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMML-TSVV 193
             +Q+L+ V+  H + I+HRDLKP+NLL+   ++   +K+ADFGLA     D        
Sbjct: 108 CIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA 167
Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T  Y +PE+L    YG PVD+W+ G ++  +                     ++G P  
Sbjct: 168 GTPGYLSPEVLRKDPYGKPVDMWACGVILYIL---------------------LVGYPPF 206
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
             W E+   ++   +  +    S  +     +A  L+  MLT NPA RI+A++AL+HP+ 
Sbjct: 207 --WDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264
Query: 314 KEK 316
            ++
Sbjct: 265 CQR 267

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 136/303 (44%), Gaps = 49/303 (16%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVA----MKKLRVKLNEDGIPMSTLREISILKQ 78
           +Y    ++G GA+  V +   +     Y A     KKL  + ++        RE  I + 
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ-----KLEREARICRL 59
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK-CPPPGLSASKVKE 137
           L   +HPNIVR  D I     S+E +   YL+F+ V    G   E        S +    
Sbjct: 60  L---KHPNIVRLHDSI-----SEEGFH--YLVFDLVTG--GELFEDIVAREYYSEADASH 107
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMML-TSVV 193
             +Q+L+ V+  H + I+HRDLKP+NLL+   ++   +K+ADFGLA     D        
Sbjct: 108 CIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA 167
Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T  Y +PE+L    YG PVD+W+ G ++                        ++G P  
Sbjct: 168 GTPGYLSPEVLRKDPYGKPVDMWACGVIL---------------------YILLVGYPPF 206
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
             W E+   ++   +  +    S  +     +A  L+  MLT NPA RI+A++AL+HP+ 
Sbjct: 207 --WDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264
Query: 314 KEK 316
            ++
Sbjct: 265 CQR 267

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 135/291 (46%), Gaps = 47/291 (16%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V K    +  G+ VA+K L R K+    +     REI  LK    F HP+I+
Sbjct: 24  LGVGTFGKV-KVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK---LFRHPHII 79
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + + VI  +  SD     ++++ E+V   +L  Y+  C    L   + + L +Q+L GVD
Sbjct: 80  KLYQVI--STPSD-----IFMVMEYVSGGELFDYI--CKNGRLDEKESRRLFQQILSGVD 130
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + H H ++HRDLKP+N+L+      KIADFGL+        L     +  Y APE++   
Sbjct: 131 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGR 190
Query: 208 GYGTP-VDIWSIGCVMAEMWRLVPLFCAST--EVEQLKCIFRVIGTPSMNEWPENISLMW 264
            Y  P VDIWS G +      L  L C +   + + +  +F+ I                
Sbjct: 191 LYAGPEVDIWSSGVI------LYALLCGTLPFDDDHVPTLFKKIC--------------- 229
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
                   + ++  +++      SLL+ ML  +P  R +  D  EH +FK+
Sbjct: 230 ------DGIFYTPQYLN--PSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 122/225 (54%), Gaps = 18/225 (8%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           + +L +IG G++G V+K  D   K   VA+K + ++  ED I     +EI++L Q D+  
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTK-EVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDS-- 76
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
            P I R+F        S  +   +++I E++    GS ++   P  L  + +  + R++L
Sbjct: 77  -PYITRYFG-------SYLKSTKLWIIMEYLGG--GSALDLLKPGPLEETYIATILREIL 126
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLTSVVVTLWYRAPE 202
           KG+D+LHS R IHRD+K  N+L++  G +K+ADFG+A    D  +     V T ++ APE
Sbjct: 127 KGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE 186
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
           ++    Y    DIWS+G    E+ +  P    ++++  ++ +F +
Sbjct: 187 VIKQSAYDFKADIWSLGITAIELAKGEP---PNSDLHPMRVLFLI 228

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 132/302 (43%), Gaps = 48/302 (15%)
Query: 24  YDELCQIGCGAYGTV----FKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQL 79
           YD   ++G GA+  V     K   L+     +  KKL  +  +        RE  I ++L
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-----KLEREARICRKL 85
Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGL-SASKVKEL 138
              +HPNIVR  D I +           YL+F+ V    G   E        S +     
Sbjct: 86  ---QHPNIVRLHDSIQEESFH-------YLVFDLVTG--GELFEDIVAREFYSEADASHC 133
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVT 195
            +Q+L+ + + HS+ I+HR+LKP+NLL+    +   +K+ADFGLA   +          T
Sbjct: 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 193
Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
             Y +PE+L    Y  PVDIW+ G ++                        ++G P    
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVIL---------------------YILLVGYPPF-- 230
Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           W E+   +++  +  +    S  +     +A SL++SMLT NP  RI+A  AL+ P+   
Sbjct: 231 WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290
Query: 316 KE 317
           +E
Sbjct: 291 RE 292

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 132/297 (44%), Gaps = 49/297 (16%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVA----MKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           ++G GA+  V +         Y A     KKL  + ++        RE  I + L   +H
Sbjct: 38  ELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ-----KLEREARICRLL---KH 89
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK-CPPPGLSASKVKELTRQML 143
           PNIVR  D I     S+E +   YL+F+ V    G   E        S +       Q+L
Sbjct: 90  PNIVRLHDSI-----SEEGFH--YLVFDLVTG--GELFEDIVAREYYSEADASHCIHQIL 140
Query: 144 KGVDFLHSHRIIHRDLKPQNLLIT---RAGGLKIADFGLAKTFDYDMML-TSVVVTLWYR 199
           + V+ +H H I+HRDLKP+NLL+    +   +K+ADFGLA     +         T  Y 
Sbjct: 141 ESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYL 200
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           +PE+L    YG PVDIW+ G ++  +                     ++G P    W E+
Sbjct: 201 SPEVLRKDPYGKPVDIWACGVILYIL---------------------LVGYPPF--WDED 237
Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK 316
              ++   +  +    S  +     +A +L+  MLT NPA RI+A  AL+HP+  ++
Sbjct: 238 QHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQR 294

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 46/303 (15%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLREI 73
           D   +G+  Y  +  +G G++G V  A      G  VA+K +  K L +  +     REI
Sbjct: 9   DGAHIGN--YQIVKTLGEGSFGKVKLAYH-TTTGQKVALKIINKKVLAKSDMQGRIEREI 65
Query: 74  SILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSAS 133
           S L+ L    HP+I++ +DVI      DE    + ++ E+   +L  Y+       +S  
Sbjct: 66  SYLRLL---RHPHIIKLYDVIKS---KDE----IIMVIEYAGNELFDYI--VQRDKMSEQ 113
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV 193
           + +   +Q++  V++ H H+I+HRDLKP+NLL+     +KIADFGL+        L +  
Sbjct: 114 EARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC 173
Query: 194 VTLWYRAPEILLNLGYGTP-VDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTP 251
            +  Y APE++    Y  P VD+WS G ++  M  R +P      + E +  +F+     
Sbjct: 174 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF-----DDESIPVLFK----- 223
Query: 252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                  NIS    +  ++               A  L++ ML  NP +RIS  + ++  
Sbjct: 224 -------NISNGVYTLPKF-----------LSPGAAGLIKRMLIVNPLNRISIHEIMQDD 265
Query: 312 YFK 314
           +FK
Sbjct: 266 WFK 268

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 138/299 (46%), Gaps = 43/299 (14%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G YG V+K R ++  G   A+K + V  +E+       +EI++LK+     H NI  
Sbjct: 32  VGNGTYGQVYKGRHVKT-GQLAAIKVMDVTGDEE---EEIKQEINMLKKYS--HHRNIAT 85
Query: 90  FFDV-IHQNI--LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           ++   I +N   + D+ +L +         DL   ++      L    +  + R++L+G+
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL---IKNTKGNTLKEEWIAYICREILRGL 142
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAPEILL 205
             LH H++IHRD+K QN+L+T    +K+ DFG++   D  +    + + T ++ APE++ 
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202
Query: 206 -----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
                +  Y    D+WS+G    EM    P  C   ++  ++ +F +   P+    P   
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLC---DMHPMRALFLIPRNPA----PRLK 255
Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE 319
           S  WS                   K  S +ES L  N + R +    ++HP+ +++ NE
Sbjct: 256 SKKWS------------------KKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 46/303 (15%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLREI 73
           D   +G+  Y  +  +G G++G V  A      G  VA+K +  K L +  +     REI
Sbjct: 8   DGAHIGN--YQIVKTLGEGSFGKVKLAYH-TTTGQKVALKIINKKVLAKSDMQGRIEREI 64
Query: 74  SILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSAS 133
           S L+ L    HP+I++ +DVI      DE    + ++ E+   +L  Y+       +S  
Sbjct: 65  SYLRLL---RHPHIIKLYDVIKS---KDE----IIMVIEYAGNELFDYI--VQRDKMSEQ 112
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV 193
           + +   +Q++  V++ H H+I+HRDLKP+NLL+     +KIADFGL+        L +  
Sbjct: 113 EARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC 172
Query: 194 VTLWYRAPEILLNLGYGTP-VDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTP 251
            +  Y APE++    Y  P VD+WS G ++  M  R +P      + E +  +F+     
Sbjct: 173 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF-----DDESIPVLFK----- 222
Query: 252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                  NIS    +  ++               A  L++ ML  NP +RIS  + ++  
Sbjct: 223 -------NISNGVYTLPKF-----------LSPGAAGLIKRMLIVNPLNRISIHEIMQDD 264
Query: 312 YFK 314
           +FK
Sbjct: 265 WFK 267

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 138/294 (46%), Gaps = 44/294 (14%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLREISILKQLDTF 82
           Y  +  +G G++G V  A      G  VA+K +  K L +  +     REIS L+ L   
Sbjct: 6   YQIVKTLGEGSFGKVKLAYH-TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL--- 61
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            HP+I++ +DVI      DE    + ++ E+   +L  Y+ +     +S  + +   +Q+
Sbjct: 62  RHPHIIKLYDVIKS---KDE----IIMVIEYAGNELFDYIVQ--RDKMSEQEARRFFQQI 112
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           +  V++ H H+I+HRDLKP+NLL+     +KIADFGL+        L +   +  Y APE
Sbjct: 113 ISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 172
Query: 203 ILLNLGYGTP-VDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           ++    Y  P VD+WS G ++  M  R +P      + E +  +F+            NI
Sbjct: 173 VISGKLYAGPEVDVWSCGVILYVMLCRRLPF-----DDESIPVLFK------------NI 215
Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           S    +  ++               A  L++ ML  NP +RIS  + ++  +FK
Sbjct: 216 SNGVYTLPKF-----------LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 258

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 142/303 (46%), Gaps = 46/303 (15%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLREI 73
           D   +G+  Y  +  +G G++G V  A      G  VA+K +  K L +  +     REI
Sbjct: 3   DGAHIGN--YQIVKTLGEGSFGKVKLAYH-TTTGQKVALKIINKKVLAKSDMQGRIEREI 59
Query: 74  SILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSAS 133
           S L+ L    HP+I++ +DVI      DE    + ++ E+   +L  Y+ +     +S  
Sbjct: 60  SYLRLL---RHPHIIKLYDVIKS---KDE----IIMVIEYAGNELFDYIVQ--RDKMSEQ 107
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV 193
           + +   +Q++  V++ H H+I+HRDLKP+NLL+     +KIADFGL+        L +  
Sbjct: 108 EARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC 167
Query: 194 VTLWYRAPEILLNLGYGTP-VDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTP 251
            +  Y APE++    Y  P VD+WS G ++  M  R +P      + E +  +F+     
Sbjct: 168 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF-----DDESIPVLFK----- 217
Query: 252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                  NIS    +  ++               A  L++ ML  NP +RIS  + ++  
Sbjct: 218 -------NISNGVYTLPKF-----------LSPGAAGLIKRMLIVNPLNRISIHEIMQDD 259
Query: 312 YFK 314
           +FK
Sbjct: 260 WFK 262

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           + E+  IG G +G VFKA+   +   YV     RVK N +       RE+  L +LD   
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIK---RVKYNNE----KAEREVKALAKLD--- 62
Query: 84  HPNIVRF------FDV---IHQNILSDERYLTVYLIFEHVDQD-LGSYMEKCPPPGLSAS 133
           H NIV +      FD          S  +   +++  E  D+  L  ++EK     L   
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV 193
              EL  Q+ KGVD++HS ++I+RDLKP N+ +     +KI DFGL  +   D       
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK 182
Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            TL Y +PE + +  YG  VD++++G ++AE+
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 129/293 (44%), Gaps = 47/293 (16%)
Query: 30  IGCGAYGTVFKARDLQNKGNYV--AMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G++G V  A     KG  +  A KK+     ED       +EI I+K LD   HPNI
Sbjct: 34  IGRGSWGEVKIA---VQKGTRIRRAAKKIPKYFVEDVDRFK--QEIEIMKSLD---HPNI 85
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGL-SASKVKELTRQMLKGV 146
           +R ++    N         +YL+ E      G   E+     +   S    + + +L  V
Sbjct: 86  IRLYETFEDNT-------DIYLVMELCTG--GELFERVVHKRVFRESDAARIMKDVLSAV 136
Query: 147 DFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            + H   + HRDLKP+N L    +    LK+ DFGLA  F    M+ + V T +Y +P++
Sbjct: 137 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV 196
Query: 204 LLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM 263
           L  L YG   D WS G +M  +    P F A T+ E +  I     T    +W       
Sbjct: 197 LEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDW------- 248
Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK 316
                           ++   +A SL+  +LT +P  RI++  ALEH +F+++
Sbjct: 249 ----------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 285

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 136/298 (45%), Gaps = 48/298 (16%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPM---STLREISILKQLD 80
           YD L ++G GA+G V +  +      +VA      K      P+   +   EISI+ QL 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVA------KFINTPYPLDKYTVKNEISIMNQL- 105
Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG--LSASKVKEL 138
              HP ++   D        +++Y  V LI E +    G   ++       +S ++V   
Sbjct: 106 --HHPKLINLHDAF------EDKYEMV-LILEFLSG--GELFDRIAAEDYKMSEAEVINY 154
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLL--ITRAGGLKIADFGLAKTFDYDMMLTSVVVTL 196
            RQ  +G+  +H H I+H D+KP+N++    +A  +KI DFGLA   + D ++     T 
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA 214
Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW 256
            + APEI+     G   D+W+IG +   +   +  F    ++E L+ + R        +W
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-------DW 267
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
                       ++ + AFS++      +A   ++++L   P  R++  DALEHP+ K
Sbjct: 268 ------------EFDEDAFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 85/334 (25%), Positives = 154/334 (46%), Gaps = 57/334 (17%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVK---LNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G++G V KA D + +  +VA+K ++ K   LN+  I      E+ +L+ ++  +H  
Sbjct: 62  IGKGSFGQVVKAYD-RVEQEWVAIKIIKNKKAFLNQAQI------EVRLLELMN--KHDT 112
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
            ++++ V  +       +L   L+FE +  +L   +      G+S +  ++  +QM   +
Sbjct: 113 EMKYYIVHLKRHFMFRNHLC--LVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 147 DFLHSHR--IIHRDLKPQNLLIT--RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
            FL +    IIH DLKP+N+L+   +   +KI DFG   +      +   + + +YR+PE
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPE 228
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS---MNEWPE- 258
           +LL + Y   +D+WS+GC++ EM    PLF  + EV+Q+  I  V+G P    +++ P+ 
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288
Query: 259 ------------NISLMWSSFEQYS---------------------KVAFSAIFMDCCSK 285
                       N+        +Y                      +   S   +    K
Sbjct: 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348
Query: 286 ANSLLESMLTFNPADRISAADALEHPYFKEKENE 319
              L+  ML ++P  RI    AL+H +FK+  +E
Sbjct: 349 FKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 382

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 129/293 (44%), Gaps = 47/293 (16%)
Query: 30  IGCGAYGTVFKARDLQNKGNYV--AMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G++G V  A     KG  +  A KK+     ED       +EI I+K LD   HPNI
Sbjct: 17  IGRGSWGEVKIA---VQKGTRIRRAAKKIPKYFVEDVDRFK--QEIEIMKSLD---HPNI 68
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGL-SASKVKELTRQMLKGV 146
           +R ++    N         +YL+ E      G   E+     +   S    + + +L  V
Sbjct: 69  IRLYETFEDNT-------DIYLVMELCTG--GELFERVVHKRVFRESDAARIMKDVLSAV 119
Query: 147 DFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEI 203
            + H   + HRDLKP+N L    +    LK+ DFGLA  F    M+ + V T +Y +P++
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV 179
Query: 204 LLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM 263
           L  L YG   D WS G +M  +    P F A T+ E +  I     T    +W       
Sbjct: 180 LEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDW------- 231
Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK 316
                           ++   +A SL+  +LT +P  RI++  ALEH +F+++
Sbjct: 232 ----------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 85/334 (25%), Positives = 154/334 (46%), Gaps = 57/334 (17%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVK---LNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G++G V KA D + +  +VA+K ++ K   LN+  I      E+ +L+ ++  +H  
Sbjct: 43  IGKGSFGQVVKAYD-RVEQEWVAIKIIKNKKAFLNQAQI------EVRLLELMN--KHDT 93
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
            ++++ V  +       +L   L+FE +  +L   +      G+S +  ++  +QM   +
Sbjct: 94  EMKYYIVHLKRHFMFRNHLC--LVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 151
Query: 147 DFLHSHR--IIHRDLKPQNLLIT--RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
            FL +    IIH DLKP+N+L+   +   +KI DFG   +      +   + + +YR+PE
Sbjct: 152 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPE 209
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS---MNEWPE- 258
           +LL + Y   +D+WS+GC++ EM    PLF  + EV+Q+  I  V+G P    +++ P+ 
Sbjct: 210 VLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 269
Query: 259 ------------NISLMWSSFEQYS---------------------KVAFSAIFMDCCSK 285
                       N+        +Y                      +   S   +    K
Sbjct: 270 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 329
Query: 286 ANSLLESMLTFNPADRISAADALEHPYFKEKENE 319
              L+  ML ++P  RI    AL+H +FK+  +E
Sbjct: 330 FKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 363

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 49/259 (18%)
Query: 68  STLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM-EKC 125
           +TL+E+ IL+++    HPNI++  D    N          +L+F+ + + +L  Y+ EK 
Sbjct: 69  ATLKEVDILRKVSG--HPNIIQLKDTYETNTF-------FFLVFDLMKKGELFDYLTEKV 119
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
               LS  + +++ R +L+ +  LH   I+HRDLKP+N+L+     +K+ DFG +   D 
Sbjct: 120 T---LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 186 DMMLTSVVVTLWYRAPEILL------NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
              L SV  T  Y APEI+       + GYG  VD+WS G +M  +    P F    ++ 
Sbjct: 177 GEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236
Query: 240 QLKCIFR---VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTF 296
            L+ I       G+P  +++ + +  + S F                          L  
Sbjct: 237 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRF--------------------------LVV 270
Query: 297 NPADRISAADALEHPYFKE 315
            P  R +A +AL HP+F++
Sbjct: 271 QPQKRYTAEEALAHPFFQQ 289

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 85/334 (25%), Positives = 154/334 (46%), Gaps = 57/334 (17%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVK---LNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G++G V KA D + +  +VA+K ++ K   LN+  I      E+ +L+ ++  +H  
Sbjct: 62  IGKGSFGQVVKAYD-RVEQEWVAIKIIKNKKAFLNQAQI------EVRLLELMN--KHDT 112
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
            ++++ V  +       +L   L+FE +  +L   +      G+S +  ++  +QM   +
Sbjct: 113 EMKYYIVHLKRHFMFRNHLC--LVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 147 DFLHSHR--IIHRDLKPQNLLIT--RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
            FL +    IIH DLKP+N+L+   +   +KI DFG   +      +   + + +YR+PE
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPE 228
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS---MNEWPE- 258
           +LL + Y   +D+WS+GC++ EM    PLF  + EV+Q+  I  V+G P    +++ P+ 
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288
Query: 259 ------------NISLMWSSFEQYS---------------------KVAFSAIFMDCCSK 285
                       N+        +Y                      +   S   +    K
Sbjct: 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348
Query: 286 ANSLLESMLTFNPADRISAADALEHPYFKEKENE 319
              L+  ML ++P  RI    AL+H +FK+  +E
Sbjct: 349 FKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 382

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 136/314 (43%), Gaps = 52/314 (16%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPM 67
           QS+  D  ++G+       ++G G +  V K R       Y A  +KK R+  +  G+  
Sbjct: 21  QSMVEDHYEMGE-------ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSR 73
Query: 68  STL-REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC 125
             + RE++IL+++    HPNI+   D+        E    V LI E V   +L  ++   
Sbjct: 74  EEIEREVNILREI---RHPNIITLHDIF-------ENKTDVVLILELVSGGELFDFL--A 121
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAK 181
               L+  +  +  +Q+L GV +LHS RI H DLKP+N+++         +K+ DFG+A 
Sbjct: 122 EKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 181
Query: 182 TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL 241
             +      ++  T  + APEI+     G   D+WSIG +   +      F   T+ E L
Sbjct: 182 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL 241
Query: 242 KCIFRVIGTPSMNEWPENISLMWSSF-EQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD 300
                            NIS +   F E+Y        F +    A   +  +L  +P  
Sbjct: 242 T----------------NISAVNYDFDEEY--------FSNTSELAKDFIRRLLVKDPKR 277
Query: 301 RISAADALEHPYFK 314
           R+  A +LEH + K
Sbjct: 278 RMXIAQSLEHSWIK 291

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 130/307 (42%), Gaps = 50/307 (16%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMS 68
           +   +D  D+G         +G G +G V+ AR+ QNK   +A+K L + +L ++G+   
Sbjct: 10  RKFTIDDFDIGRP-------LGKGKFGNVYLAREKQNK-FIMALKVLFKSQLEKEGVEHQ 61
Query: 69  TLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
             REI I   L    HPNI+R ++  H           +YL+ E   +  G   ++    
Sbjct: 62  LRREIEIQSHL---RHPNILRMYNYFHDRK-------RIYLMLEFAPR--GELYKELQKH 109
Query: 129 G-LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM 187
           G     +      ++   + + H  ++IHRD+KP+NLL+   G LKIADFG +      +
Sbjct: 110 GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSL 168
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
               +  TL Y  PE++    +   VD+W  G +  E    +P F + +  E  + I   
Sbjct: 169 RRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV-- 226
Query: 248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
                      N+ L +  F                  +  L+  +L ++P  R+     
Sbjct: 227 -----------NVDLKFPPF--------------LSDGSKDLISKLLRYHPPQRLPLKGV 261
Query: 308 LEHPYFK 314
           +EHP+ K
Sbjct: 262 MEHPWVK 268

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 131/300 (43%), Gaps = 45/300 (15%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILKQLD 80
           Y+   ++G G +  V K R       Y A  +KK R+  +  G+    + RE++IL+++ 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI- 65
Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELT 139
              HPNI+   D+        E    V LI E V   +L  ++       L+  +  +  
Sbjct: 66  --RHPNIITLHDIF-------ENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFL 114
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSVVVT 195
           +Q+L GV +LHS RI H DLKP+N+++         +K+ DFG+A   +      ++  T
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 174
Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
             + APEI+     G   D+WSIG +   +      F   T+ E L              
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT------------- 221
Query: 256 WPENISLMWSSF-EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
              NIS +   F E+Y        F +    A   +  +L  +P  R++ A +LEH + K
Sbjct: 222 ---NISAVNYDFDEEY--------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 49/259 (18%)
Query: 68  STLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM-EKC 125
           +TL+E+ IL+++    HPNI++  D    N          +L+F+ + + +L  Y+ EK 
Sbjct: 56  ATLKEVDILRKVSG--HPNIIQLKDTYETNTF-------FFLVFDLMKKGELFDYLTEKV 106
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
               LS  + +++ R +L+ +  LH   I+HRDLKP+N+L+     +K+ DFG +   D 
Sbjct: 107 T---LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 163
Query: 186 DMMLTSVVVTLWYRAPEILL------NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
              L  V  T  Y APEI+       + GYG  VD+WS G +M  +    P F    ++ 
Sbjct: 164 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 223
Query: 240 QLKCIFR---VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTF 296
            L+ I       G+P  +++ + +  + S F                          L  
Sbjct: 224 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRF--------------------------LVV 257
Query: 297 NPADRISAADALEHPYFKE 315
            P  R +A +AL HP+F++
Sbjct: 258 QPQKRYTAEEALAHPFFQQ 276

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 49/259 (18%)
Query: 68  STLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM-EKC 125
           +TL+E+ IL+++    HPNI++  D    N          +L+F+ + + +L  Y+ EK 
Sbjct: 69  ATLKEVDILRKVSG--HPNIIQLKDTYETNTF-------FFLVFDLMKKGELFDYLTEKV 119
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
               LS  + +++ R +L+ +  LH   I+HRDLKP+N+L+     +K+ DFG +   D 
Sbjct: 120 T---LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 186 DMMLTSVVVTLWYRAPEILL------NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
              L  V  T  Y APEI+       + GYG  VD+WS G +M  +    P F    ++ 
Sbjct: 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236
Query: 240 QLKCIFR---VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTF 296
            L+ I       G+P  +++ + +  + S F                          L  
Sbjct: 237 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRF--------------------------LVV 270
Query: 297 NPADRISAADALEHPYFKE 315
            P  R +A +AL HP+F++
Sbjct: 271 QPQKRYTAEEALAHPFFQQ 289

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 122/292 (41%), Gaps = 41/292 (14%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G G +G V+ AR+ QNK         + +L ++G+     REI I   L    
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL---R 72
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELTRQM 142
           HPNI+R ++  H           +YL+ E   +  G   ++    G     +      ++
Sbjct: 73  HPNILRMYNYFHDRK-------RIYLMLEFAPR--GELYKELQKHGRFDEQRSATFMEEL 123
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
              + + H  ++IHRD+KP+NLL+   G LKIADFG +      +    +  TL Y  PE
Sbjct: 124 ADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPE 182
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
           ++    +   VD+W  G +  E    +P F + +  E  + I              N+ L
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV-------------NVDL 229
Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
            +  F                  +  L+  +L ++P  R+     +EHP+ K
Sbjct: 230 KFPPF--------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 139/300 (46%), Gaps = 46/300 (15%)
Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP-MSTLREISIL 76
           D  +K + +L +IG G++G V+ ARD++N    VA+KK+     +        ++E+  L
Sbjct: 50  DDPEKLFSDLREIGHGSFGAVYFARDVRN-SEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 108
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
           ++L    HPN +++            R  T +L+ E+        +E    P L   ++ 
Sbjct: 109 QKL---RHPNTIQYRGCYL-------REHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIA 157
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL 196
            +T   L+G+ +LHSH +IHRD+K  N+L++  G +K+ DFG A            V T 
Sbjct: 158 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTP 214
Query: 197 WYRAPEILLNLG---YGTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTPS 252
           ++ APE++L +    Y   VD+WS+G    E+  R  PLF     +  +  ++ +    +
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF----NMNAMSALYHI----A 266
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
            NE P   S  WS + +         F+D C          L   P DR ++   L+H +
Sbjct: 267 QNESPALQSGHWSEYFRN--------FVDSC----------LQKIPQDRPTSEVLLKHRF 308

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 128/295 (43%), Gaps = 45/295 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILKQLDTFEHP 85
           ++G G +  V K R       Y A  +KK R+  +  G+    + RE++IL+++    HP
Sbjct: 19  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI---RHP 75
Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLK 144
           NI+   D+        E    V LI E V   +L  ++       L+  +  +  +Q+L 
Sbjct: 76  NIITLHDIF-------ENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILD 126
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           GV +LHS RI H DLKP+N+++         +K+ DFG+A   +      ++  T  + A
Sbjct: 127 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 186
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           PEI+     G   D+WSIG +   +      F   T+ E L                 NI
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT----------------NI 230
Query: 261 SLMWSSF-EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           S +   F E+Y        F +    A   +  +L  +P  R+  A +LEH + K
Sbjct: 231 SAVNYDFDEEY--------FSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 121/241 (50%), Gaps = 22/241 (9%)
Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           NI++  D +      D    T  L+FE+++      + +     L+   ++    ++LK 
Sbjct: 99  NIIKLIDTV-----KDPVSKTPALVFEYINNTDFKQLYQI----LTDFDIRFYMYELLKA 149
Query: 146 VDFLHSHRIIHRDLKPQNLLIT-RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEIL 204
           +D+ HS  I+HRD+KP N++I  +   L++ D+GLA+ +         V + +++ PE+L
Sbjct: 150 LDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELL 209
Query: 205 LNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE---- 258
           ++   Y   +D+WS+GC++A M +R  P F      +QL  I +V+GT  +  + +    
Sbjct: 210 VDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHI 269
Query: 259 ------NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                 N  L   S +++     S        +A  LL+ +L ++   R++A +A+EHPY
Sbjct: 270 DLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 329
Query: 313 F 313
           F
Sbjct: 330 F 330

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 130/291 (44%), Gaps = 47/291 (16%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V K  + Q  G+ VA+K L R K+    +     REI  LK    F HP+I+
Sbjct: 19  LGVGTFGKV-KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK---LFRHPHII 74
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + + VI             +++ E+V   +L  Y+  C    +   + + L +Q+L  VD
Sbjct: 75  KLYQVISTPT-------DFFMVMEYVSGGELFDYI--CKHGRVEEMEARRLFQQILSAVD 125
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + H H ++HRDLKP+N+L+      KIADFGL+        L +   +  Y APE++   
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 185
Query: 208 GYGTP-VDIWSIGCVMAEMWRLVPLFCAST--EVEQLKCIFRVIGTPSMNEWPENISLMW 264
            Y  P VDIWS G +      L  L C +   + E +  +F+ I    +   PE ++   
Sbjct: 186 LYAGPEVDIWSCGVI------LYALLCGTLPFDDEHVPTLFKKI-RGGVFYIPEYLN--- 235
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
                                  +LL  ML  +P  R +  D  EH +FK+
Sbjct: 236 -------------------RSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 121/241 (50%), Gaps = 22/241 (9%)
Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           NI++  D +      D    T  L+FE+++      + +     L+   ++    ++LK 
Sbjct: 94  NIIKLIDTV-----KDPVSKTPALVFEYINNTDFKQLYQI----LTDFDIRFYMYELLKA 144
Query: 146 VDFLHSHRIIHRDLKPQNLLIT-RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEIL 204
           +D+ HS  I+HRD+KP N++I  +   L++ D+GLA+ +         V + +++ PE+L
Sbjct: 145 LDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELL 204
Query: 205 LNLG-YGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE---- 258
           ++   Y   +D+WS+GC++A M +R  P F      +QL  I +V+GT  +  + +    
Sbjct: 205 VDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHI 264
Query: 259 ------NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                 N  L   S +++     S        +A  LL+ +L ++   R++A +A+EHPY
Sbjct: 265 DLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 324
Query: 313 F 313
           F
Sbjct: 325 F 325

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 139/300 (46%), Gaps = 46/300 (15%)
Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP-MSTLREISIL 76
           D  +K + +L +IG G++G V+ ARD++N    VA+KK+     +        ++E+  L
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRN-SEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
           ++L    HPN +++            R  T +L+ E+        +E    P L   ++ 
Sbjct: 70  QKL---RHPNTIQYRGCY-------LREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIA 118
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL 196
            +T   L+G+ +LHSH +IHRD+K  N+L++  G +K+ DFG A            V T 
Sbjct: 119 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTP 175
Query: 197 WYRAPEILLNLG---YGTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTPS 252
           ++ APE++L +    Y   VD+WS+G    E+  R  PLF     +  +  ++ +    +
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF----NMNAMSALYHI----A 227
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
            NE P   S  WS + +         F+D C          L   P DR ++   L+H +
Sbjct: 228 QNESPALQSGHWSEYFRN--------FVDSC----------LQKIPQDRPTSEVLLKHRF 269

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 136/304 (44%), Gaps = 49/304 (16%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAM----KKLRVKLNEDGIPMSTLREISILK 77
           ++Y    ++G GA+  V +   +     Y AM    KKL  + ++        RE  I +
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ-----KLEREARICR 65
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK-CPPPGLSASKVK 136
            L   +HPNIVR  D I     S+E +   YLIF+ V    G   E        S +   
Sbjct: 66  LL---KHPNIVRLHDSI-----SEEGHH--YLIFDLVTG--GELFEDIVAREYYSEADAS 113
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT---RAGGLKIADFGLAKTFDYDMML-TSV 192
              +Q+L+ V   H   ++HR+LKP+NLL+    +   +K+ADFGLA   + +       
Sbjct: 114 HCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 173
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  Y +PE+L    YG PVD+W+ G ++  +                     ++G P 
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYIL---------------------LVGYPP 212
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
              W E+   ++   +  +    S  +     +A  L+  MLT NP+ RI+AA+AL+HP+
Sbjct: 213 F--WDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270
Query: 313 FKEK 316
              +
Sbjct: 271 ISHR 274

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 136/295 (46%), Gaps = 49/295 (16%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G GA   V++ +    +  Y A+K L+  +++  +      EI +L +L    HPNI+
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPY-ALKVLKKTVDKKIVRT----EIGVLLRLS---HPNII 111
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGL-SASKVKELTRQMLKGVD 147
           +  ++        E    + L+ E V    G   ++    G  S     +  +Q+L+ V 
Sbjct: 112 KLKEIF-------ETPTEISLVLELVTG--GELFDRIVEKGYYSERDAADAVKQILEAVA 162
Query: 148 FLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEIL 204
           +LH + I+HRDLKP+NLL         LKIADFGL+K  ++ +++ +V  T  Y APEIL
Sbjct: 163 YLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL 222
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS---MNEWPENIS 261
               YG  VD+WS+G +    + L+  F    +    + +FR I       ++ W + +S
Sbjct: 223 RGCAYGPEVDMWSVGII---TYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279
Query: 262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK 316
           L                       A  L+  ++  +P  R++   AL+HP+   K
Sbjct: 280 L----------------------NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 129/296 (43%), Gaps = 49/296 (16%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVA----MKKLRVKLNEDGIPMSTLREISILKQLDTFEHP 85
           IG GA+  V +   L     Y A     KKL  + ++        RE  I + L   +H 
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQ-----KLEREARICRLL---KHS 63
Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK-CPPPGLSASKVKELTRQMLK 144
           NIVR  D I     S+E +   YL+F+ V    G   E        S +      +Q+L+
Sbjct: 64  NIVRLHDSI-----SEEGFH--YLVFDLVTG--GELFEDIVAREYYSEADASHCIQQILE 114
Query: 145 GVDFLHSHRIIHRDLKPQNLLIT---RAGGLKIADFGLAKTFDYDMML-TSVVVTLWYRA 200
            V   H   ++HRDLKP+NLL+    +   +K+ADFGLA     D         T  Y +
Sbjct: 115 AVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           PE+L    YG PVDIW+ G ++                        ++G P    W E+ 
Sbjct: 175 PEVLRKEAYGKPVDIWACGVIL---------------------YILLVGYPPF--WDEDQ 211
Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK 316
             ++   +  +    S  +     +A +L+  MLT NPA RI+A +AL+HP+  ++
Sbjct: 212 HKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWVCQR 267

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 144/305 (47%), Gaps = 48/305 (15%)
Query: 26  ELCQ-IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST---LREISILKQLDT 81
           ELC+ IG GA+  V +  + +  G   A+K + V        +ST    RE SI   L  
Sbjct: 27  ELCEVIGKGAFSVVRRCIN-RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-- 83
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGL--SASKVKEL 138
            +HP+IV   +    + +       +Y++FE +D  DL   + K    G   S +     
Sbjct: 84  -KHPHIVELLETYSSDGM-------LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLIT---RAGGLKIADFGLA-KTFDYDMMLTSVVV 194
            RQ+L+ + + H + IIHRD+KP+N+L+     +  +K+ DFG+A +  +  ++    V 
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVG 195
Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSM 253
           T  + APE++    YG PVD+W  G ++  +    +P +   T+    + I +  G   M
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY--GTKERLFEGIIK--GKYKM 251
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
           N              Q+S ++ S         A  L+  ML  +PA+RI+  +AL HP+ 
Sbjct: 252 NP------------RQWSHISES---------AKDLVRRMLMLDPAERITVYEALNHPWL 290
Query: 314 KEKEN 318
           KE++ 
Sbjct: 291 KERDR 295

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 129/291 (44%), Gaps = 47/291 (16%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V K  + Q  G+ VA+K L R K+    +     REI  LK    F HP+I+
Sbjct: 19  LGVGTFGKV-KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK---LFRHPHII 74
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + + VI             +++ E+V   +L  Y+  C    +   + + L +Q+L  VD
Sbjct: 75  KLYQVISTPT-------DFFMVMEYVSGGELFDYI--CKHGRVEEMEARRLFQQILSAVD 125
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + H H ++HRDLKP+N+L+      KIADFGL+        L     +  Y APE++   
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGR 185
Query: 208 GYGTP-VDIWSIGCVMAEMWRLVPLFCAST--EVEQLKCIFRVIGTPSMNEWPENISLMW 264
            Y  P VDIWS G +      L  L C +   + E +  +F+ I    +   PE ++   
Sbjct: 186 LYAGPEVDIWSCGVI------LYALLCGTLPFDDEHVPTLFKKI-RGGVFYIPEYLN--- 235
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
                                  +LL  ML  +P  R +  D  EH +FK+
Sbjct: 236 -------------------RSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 132/297 (44%), Gaps = 49/297 (16%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVA----MKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           ++G GA+  V +   +     Y A     KKL  + ++        RE  I + L   +H
Sbjct: 29  ELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ-----KLEREARICRLL---KH 80
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK-CPPPGLSASKVKELTRQML 143
           PNIVR  D I     S+E +   YLIF+ V    G   E        S +      +Q+L
Sbjct: 81  PNIVRLHDSI-----SEEGHH--YLIFDLVTG--GELFEDIVAREYYSEADASHCIQQIL 131
Query: 144 KGVDFLHSHRIIHRDLKPQNLLIT---RAGGLKIADFGLAKTFDYDMML-TSVVVTLWYR 199
           + V   H   ++HRDLKP+NLL+    +   +K+ADFGLA   + +         T  Y 
Sbjct: 132 EAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 191
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           +PE+L    YG PVD+W+ G ++  +                     ++G P    W E+
Sbjct: 192 SPEVLRKDPYGKPVDLWACGVILYIL---------------------LVGYPPF--WDED 228
Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK 316
              ++   +  +    S  +     +A  L+  MLT NP+ RI+AA+AL+HP+   +
Sbjct: 229 QHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 285

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTF 82
           Y  L  IG G +  V  AR +   G  VA+K + + +LN   +     RE+ I+K L+  
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSL-QKLFREVRIMKILN-- 69
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELTRQ 141
            HPNIV+ F+VI       E   T+YLI E+     G   +     G +   + +   RQ
Sbjct: 70  -HPNIVKLFEVI-------ETEKTLYLIMEYASG--GEVFDYLVAHGRMKEKEARSKFRQ 119
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           ++  V + H  RI+HRDLK +NLL+     +KIADFG +  F     L +   +  Y AP
Sbjct: 120 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAP 179
Query: 202 EILLNLGYGTP-VDIWSIGCVM 222
           E+     Y  P VD+WS+G ++
Sbjct: 180 ELFQGKKYDGPEVDVWSLGVIL 201

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTF 82
           Y  L  IG G +  V  AR +   G  VA+K + + +LN   +     RE+ I+K L+  
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSL-QKLFREVRIMKILN-- 72
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELTRQ 141
            HPNIV+ F+VI       E   T+YLI E+     G   +     G +   + +   RQ
Sbjct: 73  -HPNIVKLFEVI-------ETEKTLYLIMEYASG--GEVFDYLVAHGRMKEKEARSKFRQ 122
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           ++  V + H  RI+HRDLK +NLL+     +KIADFG +  F     L +      Y AP
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAP 182
Query: 202 EILLNLGYGTP-VDIWSIGCVM 222
           E+     Y  P VD+WS+G ++
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVIL 204

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISIL 76
           DL    Y  L  IG G +  V  AR +   G  VA+K + + +LN   +     RE+ I+
Sbjct: 3   DLHIGNYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSL-QKLFREVRIM 60
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKV 135
           K L+   HPNIV+ F+VI       E   T+YL+ E+     G   +     G +   + 
Sbjct: 61  KVLN---HPNIVKLFEVI-------ETEKTLYLVMEYASG--GEVFDYLVAHGWMKEKEA 108
Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVT 195
           +   RQ++  V + H   I+HRDLK +NLL+     +KIADFG +  F +   L +   +
Sbjct: 109 RAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGS 168
Query: 196 LWYRAPEILLNLGYGTP-VDIWSIGCVM 222
             Y APE+     Y  P VD+WS+G ++
Sbjct: 169 PPYAAPELFQGKKYDGPEVDVWSLGVIL 196

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 18/210 (8%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRV-KLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +IG G +  V++A  L + G  VA+KK+++  L +       ++EI +LKQL+   HPN+
Sbjct: 39  KIGRGQFSEVYRAACLLD-GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN---HPNV 94
Query: 88  VRFF-DVIHQNILSDERYLTVYLIFEHVDQ-DLGSYME--KCPPPGLSASKVKELTRQML 143
           ++++   I  N L+        ++ E  D  DL   ++  K     +    V +   Q+ 
Sbjct: 95  IKYYASFIEDNELN--------IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT-SVVVTLWYRAPE 202
             ++ +HS R++HRD+KP N+ IT  G +K+ D GL + F        S+V T +Y +PE
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLF 232
            +   GY    DIWS+GC++ EM  L   F
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 90/342 (26%), Positives = 150/342 (43%), Gaps = 67/342 (19%)
Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR------------VKL-----NED 63
           D +Y  + ++G G + TV+ A+D+ N   +VAMK +R            +KL     + D
Sbjct: 18  DARYILVRKLGWGHFSTVWLAKDMVNN-THVAMKIVRGDKVYTEAAEDEIKLLQRVNDAD 76
Query: 64  GIPMSTLREISILKQLDTFEH--PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY 121
                ++    ILK LD F H  PN V                  V ++FE + ++L + 
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVH-----------------VVMVFEVLGENLLAL 119
Query: 122 MEKCPPPGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRAGG------LKI 174
           ++K    G+    VK++++Q+L G+D++H    IIH D+KP+N+L+           +KI
Sbjct: 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179
Query: 175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLF-- 232
           AD G A    YD   T+ + T  YR+PE+LL   +G   DIWS  C++ E+     LF  
Sbjct: 180 ADLGNACW--YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237
Query: 233 ----CASTEVEQLKCIFRVIGT-PSM----NEWPENISLMWSSFEQYSKVAFSAI----- 278
                 + + + +  I  ++G  PS      ++              SK+ F  +     
Sbjct: 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 297
Query: 279 -----FMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
                  D   + +  L  ML  +P  R  A   + HP+ K+
Sbjct: 298 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/224 (33%), Positives = 105/224 (46%), Gaps = 21/224 (9%)
Query: 21  DKKYDELCQIGCGAYGTVFKARD--LQNKGNYVAMKKLRVKLNEDGIPMSTL-REISILK 77
           +++Y  + ++G G   TV+ A D  L  K   VA+K + +   E    +    RE+    
Sbjct: 10  NERYKIVDKLGGGGMSTVYLAEDTILNIK---VAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVK 136
           QL    H NIV   DV       DE     YL+ E+++   L  Y+E   P  LS     
Sbjct: 67  QL---SHQNIVSMIDV-------DEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAI 114
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS--VVV 194
             T Q+L G+   H  RI+HRD+KPQN+LI     LKI DFG+AK      +  +  V+ 
Sbjct: 115 NFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLG 174
Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV 238
           T+ Y +PE           DI+SIG V+ EM    P F   T V
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 90/342 (26%), Positives = 150/342 (43%), Gaps = 67/342 (19%)
Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR------------VKL-----NED 63
           D +Y  + ++G G + TV+ A+D+ N   +VAMK +R            +KL     + D
Sbjct: 18  DARYILVRKLGWGHFSTVWLAKDMVNN-THVAMKIVRGDKVYTEAAEDEIKLLQRVNDAD 76
Query: 64  GIPMSTLREISILKQLDTFEH--PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY 121
                ++    ILK LD F H  PN V                  V ++FE + ++L + 
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVH-----------------VVMVFEVLGENLLAL 119
Query: 122 MEKCPPPGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRAGG------LKI 174
           ++K    G+    VK++++Q+L G+D++H    IIH D+KP+N+L+           +KI
Sbjct: 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179
Query: 175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLF-- 232
           AD G A    YD   T+ + T  YR+PE+LL   +G   DIWS  C++ E+     LF  
Sbjct: 180 ADLGNACW--YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237
Query: 233 ----CASTEVEQLKCIFRVIGT-PSM----NEWPENISLMWSSFEQYSKVAFSAI----- 278
                 + + + +  I  ++G  PS      ++              SK+ F  +     
Sbjct: 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 297
Query: 279 -----FMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
                  D   + +  L  ML  +P  R  A   + HP+ K+
Sbjct: 298 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 137/307 (44%), Gaps = 55/307 (17%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 62
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 63  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           APE+L    +   PVD+WS G V+  M             +Q          PS      
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAM------LAGELPWDQ----------PS------ 211
Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANS----LLESMLTFNPADRISAADALEHPYFK 314
                  S ++YS       +++   K +S    LL  +L  NP+ RI+  D  +  ++ 
Sbjct: 212 ------DSXQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY- 264
Query: 315 EKENEPL 321
              N+PL
Sbjct: 265 ---NKPL 268

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 62
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 63  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 63
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 64  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTF 82
           Y  L  IG G +  V  AR +   G  VA+K + + +LN   +     RE+ I+K L+  
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSL-QKLFREVRIMKVLN-- 71
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELTRQ 141
            HPNIV+ F+VI       E   T+YL+ E+     G   +     G +   + +   RQ
Sbjct: 72  -HPNIVKLFEVI-------ETEKTLYLVMEYASG--GEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           ++  V + H   I+HRDLK +NLL+     +KIADFG +  F +   L +   +  Y AP
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAP 181
Query: 202 EILLNLGYGTP-VDIWSIGCVM 222
           E+     Y  P VD+WS+G ++
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVIL 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEIXINKMLN--- 62
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 63  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 63
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 64  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEIXINKMLN--- 63
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 64  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 174
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 62
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 63  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 62
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 63  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 61
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 62  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 112
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 113 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAM 199

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEIXINKMLN--- 62
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 63  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTF 82
           Y  L  IG G +  V  AR +   G  VA+K + + +LN   +     RE+ I+K L+  
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSL-QKLFREVRIMKVLN-- 71
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELTRQ 141
            HPNIV+ F+VI       E   T+YL+ E+     G   +     G +   + +   RQ
Sbjct: 72  -HPNIVKLFEVI-------ETEKTLYLVMEYASG--GEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           ++  V + H   I+HRDLK +NLL+     +KIADFG +  F +   L +   +  Y AP
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAP 181
Query: 202 EILLNLGYGTP-VDIWSIGCVM 222
           E+     Y  P VD+WS+G ++
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVIL 203

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 111/217 (51%), Gaps = 13/217 (5%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY  L +IG G++G     +  ++   YV +K++ +          + RE+++L  +  
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYV-IKEINISRMSSKEREESRREVAVLANM-- 80
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTR 140
            +HPNIV++ +   +N        ++Y++ ++ +  DL   +           ++ +   
Sbjct: 81  -KHPNIVQYRESFEEN-------GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYR 199
           Q+   +  +H  +I+HRD+K QN+ +T+ G +++ DFG+A+  +  + L    + T +Y 
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYL 192
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST 236
           +PEI  N  Y    DIW++GCV+ E+  L   F A +
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 63
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 64  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 62
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 63  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 62
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 63  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 62
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 63  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 63
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 64  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 63
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 64  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 63
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 64  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 138/290 (47%), Gaps = 41/290 (14%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           + +L +IG G++G VFK  D  N+   V   K+      +       +EI++L Q D+  
Sbjct: 25  FTKLERIGKGSFGEVFKGID--NRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-- 80
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
                 +    + + L   +   +++I E++    GS ++          ++  + +++L
Sbjct: 81  -----SYVTKYYGSYLKGSK---LWIIMEYLGG--GSALDLLRAGPFDEFQIATMLKEIL 130
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLTSVVVTLWYRAPE 202
           KG+D+LHS + IHRD+K  N+L++  G +K+ADFG+A    D  +   + V T ++ APE
Sbjct: 131 KGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 190
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
           ++    Y +  DIWS+G    E+ +  P    ++++  ++ +F +      N  P  +  
Sbjct: 191 VIQQSAYDSKADIWSLGITAIELAKGEP---PNSDMHPMRVLFLI----PKNNPPTLVGD 243
Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
              SF++         F+D C          L  +P+ R +A + L+H +
Sbjct: 244 FTKSFKE---------FIDAC----------LNKDPSFRPTAKELLKHKF 274

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 62
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 63  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 62
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 63  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 129/297 (43%), Gaps = 47/297 (15%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           YD    +G GA+  V  A D + +   VA+K +  K  E G   S   EI++L ++   +
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQ-KLVAIKCIAKKALE-GKEGSMENEIAVLHKI---K 74
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK-VKELTRQM 142
           HPNIV   D+        E    +YLI + V    G   ++    G    +    L  Q+
Sbjct: 75  HPNIVALDDIY-------ESGGHLYLIMQLVSG--GELFDRIVEKGFYTERDASRLIFQV 125
Query: 143 LKGVDFLHSHRIIHRDLKPQNLL---ITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
           L  V +LH   I+HRDLKP+NLL   +     + I+DFGL+K  D   +L++   T  Y 
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           APE+L    Y   VD WSIG +         L C               G P    + EN
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIA------YILLC---------------GYPPF--YDEN 222
Query: 260 ISLMWSSFEQYSKVAF---SAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
            + +   FEQ  K  +   S  + D    A   +  ++  +P  R +   AL+HP+ 
Sbjct: 223 DAKL---FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTF 82
           Y  L  IG G +  V  AR +   G  VA+K + + +LN   +     RE+ I+K L+  
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSL-QKLFREVRIMKVLN-- 71
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELTRQ 141
            HPNIV+ F+VI       E   T+YL+ E+     G   +     G +   + +   RQ
Sbjct: 72  -HPNIVKLFEVI-------ETEKTLYLVMEYASG--GEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           ++  V + H   I+HRDLK +NLL+     +KIADFG +  F +   L +      Y AP
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAP 181
Query: 202 EILLNLGYGTP-VDIWSIGCVM 222
           E+     Y  P VD+WS+G ++
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVIL 203

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTF 82
           Y  L  IG G +  V  AR +   G  VA++ + + +LN   +     RE+ I+K L+  
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSL-QKLFREVRIMKVLN-- 71
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELTRQ 141
            HPNIV+ F+VI       E   T+YL+ E+     G   +     G +   + +   RQ
Sbjct: 72  -HPNIVKLFEVI-------ETEKTLYLVMEYASG--GEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           ++  V + H   I+HRDLK +NLL+     +KIADFG +  F +   L +   +  Y AP
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAP 181
Query: 202 EILLNLGYGTP-VDIWSIGCVM 222
           E+     Y  P VD+WS+G ++
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVIL 203

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 145/303 (47%), Gaps = 47/303 (15%)
Query: 27  LCQIGCGAYGTVFKARDLQNKGNYV--AMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           + ++G GA+G V+KA   QNK   V  A K +  K  E+      + EI IL   D   H
Sbjct: 42  IGELGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCD---H 93
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           PNIV+  D  +      E  L + + F      + + M +   P L+ S+++ + +Q L 
Sbjct: 94  PNIVKLLDAFYY-----ENNLWILIEF-CAGGAVDAVMLELERP-LTESQIQVVCKQTLD 146
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL-AKTFDYDMMLTSVVVTLWYRAPEI 203
            +++LH ++IIHRDLK  N+L T  G +K+ADFG+ AK         S + T ++ APE+
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 206
Query: 204 LL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           ++     +  Y    D+WS+G  + EM  + P      E+  ++ + ++    + +E P 
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVLLKI----AKSEPP- 258
Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN 318
                  +  Q S+  +S+ F D        L+  L  N   R + +  L+HP+     N
Sbjct: 259 -------TLAQPSR--WSSNFKD-------FLKKCLEKNVDARWTTSQLLQHPFVTVDSN 302
Query: 319 EPL 321
           +P+
Sbjct: 303 KPI 305

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 145/303 (47%), Gaps = 47/303 (15%)
Query: 27  LCQIGCGAYGTVFKARDLQNKGNYV--AMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           + ++G GA+G V+KA   QNK   V  A K +  K  E+      + EI IL   D   H
Sbjct: 42  IGELGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCD---H 93
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           PNIV+  D  +      E  L + + F      + + M +   P L+ S+++ + +Q L 
Sbjct: 94  PNIVKLLDAFYY-----ENNLWILIEF-CAGGAVDAVMLELERP-LTESQIQVVCKQTLD 146
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL-AKTFDYDMMLTSVVVTLWYRAPEI 203
            +++LH ++IIHRDLK  N+L T  G +K+ADFG+ AK         S + T ++ APE+
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEV 206
Query: 204 LL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           ++     +  Y    D+WS+G  + EM  + P      E+  ++ + ++    + +E P 
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVLLKI----AKSEPP- 258
Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN 318
                  +  Q S+  +S+ F D        L+  L  N   R + +  L+HP+     N
Sbjct: 259 -------TLAQPSR--WSSNFKD-------FLKKCLEKNVDARWTTSQLLQHPFVTVDSN 302
Query: 319 EPL 321
           +P+
Sbjct: 303 KPI 305

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 140/306 (45%), Gaps = 53/306 (17%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G +G VF+A++  +  NY A+K++R+  N +      +RE+  L +L   EHP IVR
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNY-AIKRIRLP-NRELAREKVMREVKALAKL---EHPGIVR 67
Query: 90  FFDVIHQNILSDERYLTVYLIFEHVD------QDLGSYME-KCPPPGLSASKVKELTRQM 142
           +F+   +   +++   +   ++ ++       ++L  +M  +C       S    +  Q+
Sbjct: 68  YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-------------MML 189
            + V+FLHS  ++HRDLKP N+  T    +K+ DFGL    D D                
Sbjct: 128 AEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 190 TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG 249
           T  V T  Y +PE +    Y   VDI+S+G ++ E+     L+  ST++E+++ +  V  
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL-----LYPFSTQMERVRTLTDV-- 240
Query: 250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE 309
                                  + F  +F         +++ ML+ +P +R  A + +E
Sbjct: 241 ---------------------RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
Query: 310 HPYFKE 315
           +  F++
Sbjct: 280 NAVFED 285

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 129/297 (43%), Gaps = 47/297 (15%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           YD    +G GA+  V  A D + +   VA+K +  K   +G   S   EI++L ++   +
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQ-KLVAIKCI-AKEALEGKEGSMENEIAVLHKI---K 74
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK-VKELTRQM 142
           HPNIV   D+        E    +YLI + V    G   ++    G    +    L  Q+
Sbjct: 75  HPNIVALDDIY-------ESGGHLYLIMQLVSG--GELFDRIVEKGFYTERDASRLIFQV 125
Query: 143 LKGVDFLHSHRIIHRDLKPQNLL---ITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
           L  V +LH   I+HRDLKP+NLL   +     + I+DFGL+K  D   +L++   T  Y 
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           APE+L    Y   VD WSIG +         L C               G P    + EN
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIA------YILLC---------------GYPPF--YDEN 222
Query: 260 ISLMWSSFEQYSKVAF---SAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
            + +   FEQ  K  +   S  + D    A   +  ++  +P  R +   AL+HP+ 
Sbjct: 223 DAKL---FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTF 82
           Y  L  IG G +  V  AR +   G  VA+K + + +LN   +     RE+ I K L+  
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSL-QKLFREVRIXKVLN-- 71
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK-VKELTRQ 141
            HPNIV+ F+VI       E   T+YL+ E+     G   +     G    K  +   RQ
Sbjct: 72  -HPNIVKLFEVI-------ETEKTLYLVXEYASG--GEVFDYLVAHGRXKEKEARAKFRQ 121
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           ++  V + H   I+HRDLK +NLL+     +KIADFG +  F +   L +      Y AP
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAP 181
Query: 202 EILLNLGYGTP-VDIWSIGCVM 222
           E+     Y  P VD+WS+G ++
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVIL 203

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 129/296 (43%), Gaps = 47/296 (15%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           YD    +G GA+  V  A D + +   VA+K +  K   +G   S   EI++L ++   +
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQ-KLVAIKCI-AKEALEGKEGSMENEIAVLHKI---K 74
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK-VKELTRQM 142
           HPNIV   D+        E    +YLI + V    G   ++    G    +    L  Q+
Sbjct: 75  HPNIVALDDIY-------ESGGHLYLIMQLVSG--GELFDRIVEKGFYTERDASRLIFQV 125
Query: 143 LKGVDFLHSHRIIHRDLKPQNLL---ITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
           L  V +LH   I+HRDLKP+NLL   +     + I+DFGL+K  D   +L++   T  Y 
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           APE+L    Y   VD WSIG +         L C               G P    + EN
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIA------YILLC---------------GYPPF--YDEN 222
Query: 260 ISLMWSSFEQYSKVAF---SAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
            + +   FEQ  K  +   S  + D    A   +  ++  +P  R +   AL+HP+
Sbjct: 223 DAKL---FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 128/297 (43%), Gaps = 43/297 (14%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILKQLD 80
           YD   ++G G +  V K R+      Y A  +KK + + +  G+    + RE+SIL+Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV- 72
Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELT 139
              HPNI+   DV        E    V LI E V   +L  ++       LS  +     
Sbjct: 73  --LHPNIITLHDVY-------ENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFI 121
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSVVVT 195
           +Q+L GV++LH+ +I H DLKP+N+++         +K+ DFGLA   +  +   ++  T
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
             + APEI+     G   D+WSIG +   +      F   T+ E L              
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------- 228
Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
              NI+ +   F++         F      A   +  +L      R++  +AL HP+
Sbjct: 229 ---NITAVSYDFDE-------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 129/296 (43%), Gaps = 47/296 (15%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           YD    +G GA+  V  A D + +   VA+K +  K   +G   S   EI++L ++   +
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQ-KLVAIKCI-AKEALEGKEGSMENEIAVLHKI---K 74
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK-VKELTRQM 142
           HPNIV   D+        E    +YLI + V    G   ++    G    +    L  Q+
Sbjct: 75  HPNIVALDDIY-------ESGGHLYLIMQLVSG--GELFDRIVEKGFYTERDASRLIFQV 125
Query: 143 LKGVDFLHSHRIIHRDLKPQNLL---ITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
           L  V +LH   I+HRDLKP+NLL   +     + I+DFGL+K  D   +L++   T  Y 
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           APE+L    Y   VD WSIG +         L C               G P    + EN
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIA------YILLC---------------GYPPF--YDEN 222
Query: 260 ISLMWSSFEQYSKVAF---SAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
            + +   FEQ  K  +   S  + D    A   +  ++  +P  R +   AL+HP+
Sbjct: 223 DAKL---FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTF 82
           Y  L  IG G +  V  AR +   G  VA++ + + +LN   +     RE+ I+K L+  
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSL-QKLFREVRIMKVLN-- 71
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELTRQ 141
            HPNIV+ F+VI       E   T+YL+ E+     G   +     G +   + +   RQ
Sbjct: 72  -HPNIVKLFEVI-------ETEKTLYLVMEYASG--GEVFDYLVAHGRMKEKEARAKFRQ 121
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           ++  V + H   I+HRDLK +NLL+     +KIADFG +  F +   L     +  Y AP
Sbjct: 122 IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAP 181
Query: 202 EILLNLGYGTP-VDIWSIGCVM 222
           E+     Y  P VD+WS+G ++
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVIL 203

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 117/251 (46%), Gaps = 40/251 (15%)
Query: 71  REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGL 130
           +EI +L++L    H N+++  DV++     +E    +Y++ E+    +   ++  P    
Sbjct: 55  KEIQLLRRL---RHKNVIQLVDVLY-----NEEKQKMYMVMEYCVCGMQEMLDSVPEKRF 106
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT---FDYDM 187
              +      Q++ G+++LHS  I+H+D+KP NLL+T  G LKI+  G+A+    F  D 
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166
Query: 188 MLTSVVVTLWYRAPEIL--LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIF 245
              +   +  ++ PEI   L+   G  VDIWS G         V L+  +T +       
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAG---------VTLYNITTGL------- 210
Query: 246 RVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA 305
                     +P     ++  FE   K ++ AI  DC    + LL+ ML + PA R S  
Sbjct: 211 ----------YPFEGDNIYKLFENIGKGSY-AIPGDCGPPLSDLLKGMLEYEPAKRFSIR 259
Query: 306 DALEHPYFKEK 316
              +H +F++K
Sbjct: 260 QIRQHSWFRKK 270

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GAYG V  A +   +   VA+K + +K   D  P +  +EI I   L+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINAMLN--- 63
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 64  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 94/340 (27%), Positives = 149/340 (43%), Gaps = 75/340 (22%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK--QLDTFEHPN 86
           ++G G +G V   + + NK  Y A+K +R   N      S   E  ILK  Q D   + N
Sbjct: 42  KMGDGTFGRVLLCQHIDNK-KYYAVKVVR---NIKKYTRSAKIEADILKKIQNDDINNNN 97
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           IV++    H   +    Y  + LIFE +   L   + +    G     +K    ++LK +
Sbjct: 98  IVKY----HGKFMY---YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKAL 150
Query: 147 DFLHSHRIIHRDLKPQNLLI-------------------------TRAGGLKIADFGLAK 181
           ++L    + H DLKP+N+L+                         T++ G+K+ DFG A 
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA- 209
Query: 182 TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL 241
           TF  D    S++ T  YRAPE++LNLG+    D+WS GCV+AE++    LF     +E L
Sbjct: 210 TFKSDYH-GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268
Query: 242 KCIFRVI---------------GTPSMNE------WPENISLMWSSFEQYS------KVA 274
             +  +I               G+  +N+      WPEN S + +S +         K+ 
Sbjct: 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSI-NSIKHVKKCLPLYKII 327
Query: 275 FSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
              +F D        L S+L  +P  R S A+ L+H + +
Sbjct: 328 KHELFCD-------FLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           L Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 18  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSL---Q 72
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + + +  YL +  +   L ++ E+     +   K+ + T Q+ 
Sbjct: 73  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER-----IDHIKLLQYTSQIC 127
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 128 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            APE L    +    D+WS G V+ E++  +
Sbjct: 188 -APESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 139/303 (45%), Gaps = 58/303 (19%)
Query: 31  GCGAYGTVFKARDLQNKG-NYVAMKKLRVKLNEDGIP-MSTLREISILKQLDTFEHPNIV 88
            CG     F+ +  +      ++ +K  +    +  P ++   EI ILK+L+   HP I+
Sbjct: 22  ACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN---HPCII 78
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT-----RQML 143
           +      +N    E Y   Y++ E ++   G   +K     +   ++KE T      QML
Sbjct: 79  KI-----KNFFDAEDY---YIVLELMEG--GELFDKV----VGNKRLKEATCKLYFYQML 124
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
             V +LH + IIHRDLKP+N+L++       +KI DFG +K      ++ ++  T  Y A
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 201 PEILLNL---GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           PE+L+++   GY   VD WS+G ++          C S             G P  +E  
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVIL--------FICLS-------------GYPPFSEHR 223
Query: 258 ENISLMWSSFEQYSKVAFS---AIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
             +SL     +Q +   ++    ++ +   KA  L++ +L  +P  R +  +AL HP+ +
Sbjct: 224 TQVSLK----DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279
Query: 315 EKE 317
           +++
Sbjct: 280 DED 282

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 139/303 (45%), Gaps = 58/303 (19%)
Query: 31  GCGAYGTVFKARDLQNKG-NYVAMKKLRVKLNEDGIP-MSTLREISILKQLDTFEHPNIV 88
            CG     F+ +  +      ++ +K  +    +  P ++   EI ILK+L+   HP I+
Sbjct: 22  ACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN---HPCII 78
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT-----RQML 143
           +      +N    E Y   Y++ E ++   G   +K     +   ++KE T      QML
Sbjct: 79  KI-----KNFFDAEDY---YIVLELMEG--GELFDKV----VGNKRLKEATCKLYFYQML 124
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
             V +LH + IIHRDLKP+N+L++       +KI DFG +K      ++ ++  T  Y A
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 201 PEILLNL---GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           PE+L+++   GY   VD WS+G ++          C S             G P  +E  
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVIL--------FICLS-------------GYPPFSEHR 223
Query: 258 ENISLMWSSFEQYSKVAFS---AIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
             +SL     +Q +   ++    ++ +   KA  L++ +L  +P  R +  +AL HP+ +
Sbjct: 224 TQVSLK----DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279
Query: 315 EKE 317
           +++
Sbjct: 280 DED 282

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 139/303 (45%), Gaps = 58/303 (19%)
Query: 31  GCGAYGTVFKARDLQNKG-NYVAMKKLRVKLNEDGIP-MSTLREISILKQLDTFEHPNIV 88
            CG     F+ +  +      ++ +K  +    +  P ++   EI ILK+L+   HP I+
Sbjct: 22  ACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN---HPCII 78
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT-----RQML 143
           +      +N    E Y   Y++ E ++   G   +K     +   ++KE T      QML
Sbjct: 79  KI-----KNFFDAEDY---YIVLELMEG--GELFDKV----VGNKRLKEATCKLYFYQML 124
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
             V +LH + IIHRDLKP+N+L++       +KI DFG +K      ++ ++  T  Y A
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 201 PEILLNL---GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           PE+L+++   GY   VD WS+G ++          C S             G P  +E  
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVIL--------FICLS-------------GYPPFSEHR 223
Query: 258 ENISLMWSSFEQYSKVAFS---AIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
             +SL     +Q +   ++    ++ +   KA  L++ +L  +P  R +  +AL HP+ +
Sbjct: 224 TQVSLK----DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279
Query: 315 EKE 317
           +++
Sbjct: 280 DED 282

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 143/307 (46%), Gaps = 61/307 (19%)
Query: 30  IGCGAYGTV---FKARDLQNKG-NYVAMKKLRVKLNEDGIP-MSTLREISILKQLDTFEH 84
           +G GA G V   F+ +  +      ++ +K  +    +  P ++   EI ILK+L+   H
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN---H 73
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT----- 139
           P I++      +N    E Y   Y++ E ++   G   +K     +   ++KE T     
Sbjct: 74  PCIIKI-----KNFFDAEDY---YIVLELMEG--GELFDKV----VGNKRLKEATCKLYF 119
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMMLTSVVVTL 196
            QML  V +LH + IIHRDLKP+N+L++       +KI DFG +K      ++ ++  T 
Sbjct: 120 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 197 WYRAPEILLNL---GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            Y APE+L+++   GY   VD WS+G ++          C S             G P  
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVIL--------FICLS-------------GYPPF 218
Query: 254 NEWPENISLMWSSFEQYSKVAFS---AIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
           +E    +SL     +Q +   ++    ++ +   KA  L++ +L  +P  R +  +AL H
Sbjct: 219 SEHRTQVSLK----DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 274
Query: 311 PYFKEKE 317
           P+ ++++
Sbjct: 275 PWLQDED 281

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 144/303 (47%), Gaps = 47/303 (15%)
Query: 27  LCQIGCGAYGTVFKARDLQNKGNYV--AMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           + ++G GA+G V+KA   QNK   V  A K +  K  E+      + EI IL   D   H
Sbjct: 42  IGELGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCD---H 93
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLK 144
           PNIV+  D  +      E  L + + F      + + M +   P L+ S+++ + +Q L 
Sbjct: 94  PNIVKLLDAFYY-----ENNLWILIEF-CAGGAVDAVMLELERP-LTESQIQVVCKQTLD 146
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL-AKTFDYDMMLTSVVVTLWYRAPEI 203
            +++LH ++IIHRDLK  N+L T  G +K+ADFG+ AK           + T ++ APE+
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEV 206
Query: 204 LL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           ++     +  Y    D+WS+G  + EM  + P      E+  ++ + ++    + +E P 
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVLLKI----AKSEPP- 258
Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN 318
                  +  Q S+  +S+ F D        L+  L  N   R + +  L+HP+     N
Sbjct: 259 -------TLAQPSR--WSSNFKD-------FLKKCLEKNVDARWTTSQLLQHPFVTVDSN 302
Query: 319 EPL 321
           +P+
Sbjct: 303 KPI 305

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 143/307 (46%), Gaps = 61/307 (19%)
Query: 30  IGCGAYGTV---FKARDLQNKG-NYVAMKKLRVKLNEDGIP-MSTLREISILKQLDTFEH 84
           +G GA G V   F+ +  +      ++ +K  +    +  P ++   EI ILK+L+   H
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN---H 80
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT----- 139
           P I++      +N    E Y   Y++ E ++   G   +K     +   ++KE T     
Sbjct: 81  PCIIKI-----KNFFDAEDY---YIVLELMEG--GELFDKV----VGNKRLKEATCKLYF 126
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMMLTSVVVTL 196
            QML  V +LH + IIHRDLKP+N+L++       +KI DFG +K      ++ ++  T 
Sbjct: 127 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 197 WYRAPEILLNL---GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            Y APE+L+++   GY   VD WS+G ++          C S             G P  
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVIL--------FICLS-------------GYPPF 225
Query: 254 NEWPENISLMWSSFEQYSKVAFS---AIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
           +E    +SL     +Q +   ++    ++ +   KA  L++ +L  +P  R +  +AL H
Sbjct: 226 SEHRTQVSLK----DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 281
Query: 311 PYFKEKE 317
           P+ ++++
Sbjct: 282 PWLQDED 288

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 132/287 (45%), Gaps = 44/287 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++G V  A   + +   VA+K + R  L +  + M   REIS LK L    HP+I+
Sbjct: 17  LGEGSFGKVKLATHYKTQQK-VALKFISRQLLKKSDMHMRVEREISYLKLL---RHPHII 72
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
           + +DVI            + ++ E+   +L  Y+       ++  + +   +Q++  +++
Sbjct: 73  KLYDVITTPT-------DIVMVIEYAGGELFDYI--VEKKRMTEDEGRRFFQQIICAIEY 123
Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLG 208
            H H+I+HRDLKP+NLL+     +KIADFGL+        L +   +  Y APE++    
Sbjct: 124 CHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKL 183
Query: 209 YGTP-VDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
           Y  P VD+WS G V+  M                     V   P  +E+  N+      F
Sbjct: 184 YAGPEVDVWSCGIVLYVML--------------------VGRLPFDDEFIPNL------F 217
Query: 268 EQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYF 313
           ++ +   +  +  D  S  A SL+  M+  +P  RI+  +    P+F
Sbjct: 218 KKVNSCVY--VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 136/308 (44%), Gaps = 62/308 (20%)
Query: 24  YDELCQIGCGAYGTVFKARDLQ--NKGNYVAMKKLR----VKLNEDGIPMSTLREISILK 77
           ++ L  +G G YG VF+ R +   N G   AMK L+    V+  +D       R I    
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI---- 74
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTV-YL----IFEHVDQDLGSYMEKCPPPGLSA 132
            L+  +HP IV   D+I+      + YL + YL    +F  ++++ G +ME      L+ 
Sbjct: 75  -LEEVKHPFIV---DLIYAFQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLA- 128
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV 192
                   ++   +  LH   II+RDLKP+N+++   G +K+ DFGL K   +D  +T  
Sbjct: 129 --------EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180
Query: 193 VV-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
              T+ Y APEIL+  G+   VD WS+G +M +M    P F      + +  I +     
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC---- 236
Query: 252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA--ADALE 309
            +N  P                           +A  LL+ +L  N A R+ A   DA E
Sbjct: 237 KLNLPPY-----------------------LTQEARDLLKKLLKRNAASRLGAGPGDAGE 273
Query: 310 ---HPYFK 314
              HP+F+
Sbjct: 274 VQAHPFFR 281

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           L Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSL---Q 100
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + + +  YL +  +   L  + E+     +   K+ + T Q+ 
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQIC 155
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 215
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            APE L    +    D+WS G V+ E++  +
Sbjct: 216 -APESLTESKFSVASDVWSFGVVLYELFTYI 245

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 139/303 (45%), Gaps = 58/303 (19%)
Query: 31  GCGAYGTVFKARDLQNKG-NYVAMKKLRVKLNEDGIP-MSTLREISILKQLDTFEHPNIV 88
            CG     F+ +  +      ++ +K  +    +  P ++   EI ILK+L+   HP I+
Sbjct: 161 ACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN---HPCII 217
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT-----RQML 143
           +      +N    E Y   Y++ E ++   G   +K     +   ++KE T      QML
Sbjct: 218 KI-----KNFFDAEDY---YIVLELMEG--GELFDKV----VGNKRLKEATCKLYFYQML 263
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
             V +LH + IIHRDLKP+N+L++       +KI DFG +K      ++ ++  T  Y A
Sbjct: 264 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 323
Query: 201 PEILLNL---GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           PE+L+++   GY   VD WS+G ++          C S             G P  +E  
Sbjct: 324 PEVLVSVGTAGYNRAVDCWSLGVIL--------FICLS-------------GYPPFSEHR 362
Query: 258 ENISLMWSSFEQYSKVAFS---AIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
             +SL     +Q +   ++    ++ +   KA  L++ +L  +P  R +  +AL HP+ +
Sbjct: 363 TQVSLK----DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 418
Query: 315 EKE 317
           +++
Sbjct: 419 DED 421

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +D +  +G GA G V  A +   +   VA+K + +K   D  P +  +EI I K L+   
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTE-EAVAVKIVDMKRAVD-CPENIKKEICINKMLN--- 62
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP-GLSASKVKELTRQM 142
           H N+V+F+    +  +        YL  E+     G   ++  P  G+     +    Q+
Sbjct: 63  HENVVKFYGHRREGNIQ-------YLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYR 199
           + GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y 
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 200 APEILLNLGY-GTPVDIWSIGCVMAEM 225
           APE+L    +   PVD+WS G V+  M
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 139/303 (45%), Gaps = 58/303 (19%)
Query: 31  GCGAYGTVFKARDLQNKG-NYVAMKKLRVKLNEDGIP-MSTLREISILKQLDTFEHPNIV 88
            CG     F+ +  +      ++ +K  +    +  P ++   EI ILK+L+   HP I+
Sbjct: 147 ACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN---HPCII 203
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT-----RQML 143
           +      +N    E Y   Y++ E ++   G   +K     +   ++KE T      QML
Sbjct: 204 KI-----KNFFDAEDY---YIVLELMEG--GELFDKV----VGNKRLKEATCKLYFYQML 249
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
             V +LH + IIHRDLKP+N+L++       +KI DFG +K      ++ ++  T  Y A
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309
Query: 201 PEILLNL---GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           PE+L+++   GY   VD WS+G ++          C S             G P  +E  
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVIL--------FICLS-------------GYPPFSEHR 348
Query: 258 ENISLMWSSFEQYSKVAFS---AIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
             +SL     +Q +   ++    ++ +   KA  L++ +L  +P  R +  +AL HP+ +
Sbjct: 349 TQVSLK----DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404
Query: 315 EKE 317
           +++
Sbjct: 405 DED 407

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 130/304 (42%), Gaps = 43/304 (14%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILKQLD 80
           YD   ++G G +  V K R+      Y A  +KK + + +  G+    + RE+SIL+Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV- 72
Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELT 139
              H N++   DV        E    V LI E V   +L  ++       LS  +     
Sbjct: 73  --LHHNVITLHDVY-------ENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFI 121
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSVVVT 195
           +Q+L GV++LH+ +I H DLKP+N+++         +K+ DFGLA   +  +   ++  T
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
             + APEI+     G   D+WSIG +   +      F   T+ E L              
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------- 228
Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
              NI+ +   F++         F      A   +  +L      R++  +AL HP+   
Sbjct: 229 ---NITAVSYDFDE-------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 316 KENE 319
            +N+
Sbjct: 279 VDNQ 282

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           L Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 21  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSL---Q 75
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + + +  YL +  +   L  + E+     +   K+ + T Q+ 
Sbjct: 76  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQIC 130
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 131 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 190
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            APE L    +    D+WS G V+ E++  +
Sbjct: 191 -APESLTESKFSVASDVWSFGVVLYELFTYI 220

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 130/304 (42%), Gaps = 43/304 (14%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILKQLD 80
           YD   ++G G +  V K R+      Y A  +KK + + +  G+    + RE+SIL+Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV- 72
Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELT 139
              H N++   DV        E    V LI E V   +L  ++       LS  +     
Sbjct: 73  --LHHNVITLHDVY-------ENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFI 121
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSVVVT 195
           +Q+L GV++LH+ +I H DLKP+N+++         +K+ DFGLA   +  +   ++  T
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
             + APEI+     G   D+WSIG +   +      F   T+ E L              
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------- 228
Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
              NI+ +   F++         F      A   +  +L      R++  +AL HP+   
Sbjct: 229 ---NITAVSYDFDE-------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 316 KENE 319
            +N+
Sbjct: 279 VDNQ 282

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           L Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 22  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSL---Q 76
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + + +  YL +  +   L  + E+     +   K+ + T Q+ 
Sbjct: 77  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQIC 131
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 132 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 191
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            APE L    +    D+WS G V+ E++  +
Sbjct: 192 -APESLTESKFSVASDVWSFGVVLYELFTYI 221

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           L Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 19  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSL---Q 73
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + + +  YL +  +   L  + E+     +   K+ + T Q+ 
Sbjct: 74  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQIC 128
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 129 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 188
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            APE L    +    D+WS G V+ E++  +
Sbjct: 189 -APESLTESKFSVASDVWSFGVVLYELFTYI 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           L Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 18  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSL---Q 72
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + + +  YL +  +   L  + E+     +   K+ + T Q+ 
Sbjct: 73  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQIC 127
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 128 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            APE L    +    D+WS G V+ E++  +
Sbjct: 188 -APESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           L Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSL---Q 69
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + + +  YL +  +   L  + E+     +   K+ + T Q+ 
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQIC 124
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 184
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            APE L    +    D+WS G V+ E++  +
Sbjct: 185 -APESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           L Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 20  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSL---Q 74
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + + +  YL +  +   L  + E+     +   K+ + T Q+ 
Sbjct: 75  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQIC 129
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 130 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 189
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            APE L    +    D+WS G V+ E++  +
Sbjct: 190 -APESLTESKFSVASDVWSFGVVLYELFTYI 219

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           L Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 14  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSL---Q 68
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + + +  YL +  +   L  + E+     +   K+ + T Q+ 
Sbjct: 69  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQIC 123
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 124 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 183
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            APE L    +    D+WS G V+ E++  +
Sbjct: 184 -APESLTESKFSVASDVWSFGVVLYELFTYI 213

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           L Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 13  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSL---Q 67
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + + +  YL +  +   L  + E+     +   K+ + T Q+ 
Sbjct: 68  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQIC 122
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 123 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 182
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            APE L    +    D+WS G V+ E++  +
Sbjct: 183 -APESLTESKFSVASDVWSFGVVLYELFTYI 212

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           L Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSL---Q 69
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + + +  YL +  +   L  + E+     +   K+ + T Q+ 
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQIC 124
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 184
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            APE L    +    D+WS G V+ E++  +
Sbjct: 185 -APESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/300 (23%), Positives = 141/300 (47%), Gaps = 42/300 (14%)
Query: 17  LDLGDKK--YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           +D GD +   D   +IG G+ G V  A  +++ G  VA+KK+ ++  +    +    E+ 
Sbjct: 144 VDPGDPRSYLDNFIKIGEGSTGIVCIA-TVRSSGKLVAVKKMDLRKQQRRELL--FNEVV 200
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           I++    ++H N+V  ++     ++ DE ++ +  +      D+ ++        ++  +
Sbjct: 201 IMRD---YQHENVVEMYN---SYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQ 248
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +  +   +L+ +  LH+  +IHRD+K  ++L+T  G +K++DFG       ++     +V
Sbjct: 249 IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV 308
Query: 195 -TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++  L YG  VDIWS+G ++ EM    P +     ++ +K I         
Sbjct: 309 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------- 360
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
               +N+     +  + S                  L+ +L  +PA R +AA+ L+HP+ 
Sbjct: 361 ----DNLPPRLKNLHKVS------------PSLKGFLDRLLVRDPAQRATAAELLKHPFL 404

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/300 (23%), Positives = 141/300 (47%), Gaps = 42/300 (14%)
Query: 17  LDLGDKK--YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           +D GD +   D   +IG G+ G V  A  +++ G  VA+KK+ ++  +    +    E+ 
Sbjct: 22  VDPGDPRSYLDNFIKIGEGSTGIVCIA-TVRSSGKLVAVKKMDLRKQQRRELL--FNEVV 78
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           I++    ++H N+V  ++     ++ DE ++ +  +      D+ ++        ++  +
Sbjct: 79  IMRD---YQHENVVEMYN---SYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQ 126
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +  +   +L+ +  LH+  +IHRD+K  ++L+T  G +K++DFG       ++     +V
Sbjct: 127 IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV 186
Query: 195 -TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++  L YG  VDIWS+G ++ EM    P +     ++ +K I         
Sbjct: 187 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------- 238
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
               +N+     +  + S                  L+ +L  +PA R +AA+ L+HP+ 
Sbjct: 239 ----DNLPPRLKNLHKVS------------PSLKGFLDRLLVRDPAQRATAAELLKHPFL 282

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           L Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSL---Q 69
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + + +  YL +  +   L  + E+     +   K+ + T Q+ 
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQIC 124
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            APE L    +    D+WS G V+ E++  +
Sbjct: 185 -APESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 136/308 (44%), Gaps = 62/308 (20%)
Query: 24  YDELCQIGCGAYGTVFKARDLQ--NKGNYVAMKKLR----VKLNEDGIPMSTLREISILK 77
           ++ L  +G G YG VF+ R +   N G   AMK L+    V+  +D       R I    
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI---- 74
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTV-YL----IFEHVDQDLGSYMEKCPPPGLSA 132
            L+  +HP IV   D+I+      + YL + YL    +F  ++++ G +ME      L+ 
Sbjct: 75  -LEEVKHPFIV---DLIYAFQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLA- 128
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV 192
                   ++   +  LH   II+RDLKP+N+++   G +K+ DFGL K   +D  +T  
Sbjct: 129 --------EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHX 180
Query: 193 VV-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
              T+ Y APEIL+  G+   VD WS+G +M +M    P F      + +  I +     
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC---- 236
Query: 252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA--ADALE 309
            +N  P                           +A  LL+ +L  N A R+ A   DA E
Sbjct: 237 KLNLPPY-----------------------LTQEARDLLKKLLKRNAASRLGAGPGDAGE 273
Query: 310 ---HPYFK 314
              HP+F+
Sbjct: 274 VQAHPFFR 281

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/300 (23%), Positives = 141/300 (47%), Gaps = 42/300 (14%)
Query: 17  LDLGDKK--YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           +D GD +   D   +IG G+ G V  A  +++ G  VA+KK+ ++  +    +    E+ 
Sbjct: 24  VDPGDPRSYLDNFIKIGEGSTGIVCIA-TVRSSGKLVAVKKMDLRKQQRRELL--FNEVV 80
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           I++    ++H N+V  ++     ++ DE ++ +  +      D+ ++        ++  +
Sbjct: 81  IMRD---YQHENVVEMYN---SYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQ 128
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +  +   +L+ +  LH+  +IHRD+K  ++L+T  G +K++DFG       ++     +V
Sbjct: 129 IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV 188
Query: 195 -TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++  L YG  VDIWS+G ++ EM    P +     ++ +K I         
Sbjct: 189 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------- 240
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
               +N+     +  + S                  L+ +L  +PA R +AA+ L+HP+ 
Sbjct: 241 ----DNLPPRLKNLHKVS------------PSLKGFLDRLLVRDPAQRATAAELLKHPFL 284

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 142/302 (47%), Gaps = 42/302 (13%)
Query: 17  LDLGDKK--YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           +D GD +   D   +IG G+ G V  A  +++ G  VA+KK+ ++  +    +    E+ 
Sbjct: 13  VDPGDPRSYLDNFIKIGEGSTGIVCIA-TVRSSGKLVAVKKMDLRKQQRRELL--FNEVV 69
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           I++    ++H N+V  ++     ++ DE ++ +  +      D+ ++        ++  +
Sbjct: 70  IMRD---YQHENVVEMYN---SYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQ 117
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +  +   +L+ +  LH+  +IHRD+K  ++L+T  G +K++DFG       ++     +V
Sbjct: 118 IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV 177
Query: 195 -TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++  L YG  VDIWS+G ++ EM    P +     ++ +K I         
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------- 229
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
               +N+     +  + S                  L+ +L  +PA R +AA+ L+HP+ 
Sbjct: 230 ----DNLPPRLKNLHKVS------------PSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
Query: 314 KE 315
            +
Sbjct: 274 AK 275

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/300 (23%), Positives = 141/300 (47%), Gaps = 42/300 (14%)
Query: 17  LDLGDKK--YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           +D GD +   D   +IG G+ G V  A  +++ G  VA+KK+ ++  +    +    E+ 
Sbjct: 67  VDPGDPRSYLDNFIKIGEGSTGIVCIA-TVRSSGKLVAVKKMDLRKQQRRELL--FNEVV 123
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           I++    ++H N+V  ++     ++ DE ++ +  +      D+ ++        ++  +
Sbjct: 124 IMRD---YQHENVVEMYN---SYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQ 171
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +  +   +L+ +  LH+  +IHRD+K  ++L+T  G +K++DFG       ++     +V
Sbjct: 172 IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV 231
Query: 195 -TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++  L YG  VDIWS+G ++ EM    P +     ++ +K I         
Sbjct: 232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------- 283
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
               +N+     +  + S                  L+ +L  +PA R +AA+ L+HP+ 
Sbjct: 284 ----DNLPPRLKNLHKVS------------PSLKGFLDRLLVRDPAQRATAAELLKHPFL 327

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           L Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 33  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSL---Q 87
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + + +  YL +  +   L  + E+     +   K+ + T Q+ 
Sbjct: 88  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQIC 142
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 143 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 202
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            APE L    +    D+WS G V+ E++  +
Sbjct: 203 -APESLTESKFSVASDVWSFGVVLYELFTYI 232

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 98/196 (50%), Gaps = 17/196 (8%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           IG G +  V  AR +   G  VA+K + + +LN   +     RE+ I+K L+   HPNIV
Sbjct: 23  IGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSL-QKLFREVRIMKILN---HPNIV 77
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELTRQMLKGVD 147
           + F+VI       E   T+YL+ E+     G   +     G +   + +   RQ++  V 
Sbjct: 78  KLFEVI-------ETEKTLYLVMEYASG--GEVFDYLVAHGRMKEKEARAKFRQIVSAVQ 128
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + H   I+HRDLK +NLL+     +KIADFG +  F     L +   +  Y APE+    
Sbjct: 129 YCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGK 188
Query: 208 GYGTP-VDIWSIGCVM 222
            Y  P VD+WS+G ++
Sbjct: 189 KYDGPEVDVWSLGVIL 204

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           L Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 33  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSL---Q 87
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + + +  YL +  +   L  + E+     +   K+ + T Q+ 
Sbjct: 88  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQIC 142
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 143 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 202
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            APE L    +    D+WS G V+ E++  +
Sbjct: 203 -APESLTESKFSVASDVWSFGVVLYELFTYI 232

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 142/302 (47%), Gaps = 42/302 (13%)
Query: 17  LDLGDKK--YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           +D GD +   D   +IG G+ G V  A  +++ G  VA+KK+ ++  +    +    E+ 
Sbjct: 17  VDPGDPRSYLDNFIKIGEGSTGIVCIA-TVRSSGKLVAVKKMDLRKQQRRELL--FNEVV 73
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           I++    ++H N+V  ++     ++ DE ++ +  +      D+ ++        ++  +
Sbjct: 74  IMRD---YQHENVVEMYN---SYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQ 121
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +  +   +L+ +  LH+  +IHRD+K  ++L+T  G +K++DFG       ++     +V
Sbjct: 122 IAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV 181
Query: 195 -TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++  L YG  VDIWS+G ++ EM    P +     ++ +K I         
Sbjct: 182 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------- 233
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
               +N+     +  + S                  L+ +L  +PA R +AA+ L+HP+ 
Sbjct: 234 ----DNLPPRLKNLHKVS------------PSLKGFLDRLLVRDPAQRATAAELLKHPFL 277
Query: 314 KE 315
            +
Sbjct: 278 AK 279

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 130/304 (42%), Gaps = 43/304 (14%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILKQLD 80
           YD   ++G G +  V K R+      Y A  +KK + + +  G+    + RE+SIL+Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV- 72
Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELT 139
              H N++   DV        E    V LI E V   +L  ++       LS  +     
Sbjct: 73  --LHHNVITLHDVY-------ENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFI 121
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSVVVT 195
           +Q+L GV++LH+ +I H DLKP+N+++         +K+ DFGLA   +  +   ++  T
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
             + APEI+     G   D+WSIG +   +      F   T+ E L              
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------- 228
Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
              NI+ +   F++         F      A   +  +L      R++  +AL HP+   
Sbjct: 229 ---NITSVSYDFDE-------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 316 KENE 319
            +N+
Sbjct: 279 VDNQ 282

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           L Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 18  LRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSL---Q 72
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + + +  +L +  + + L  + E+     +   K+ + T Q+ 
Sbjct: 73  HDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER-----IDHIKLLQYTSQIC 127
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 128 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            APE L    +    D+WS G V+ E++  +
Sbjct: 188 -APESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 130/304 (42%), Gaps = 43/304 (14%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILKQLD 80
           YD   ++G G +  V K R+      Y A  +KK + + +  G+    + RE+SIL+Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV- 72
Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELT 139
              H N++   DV        E    V LI E V   +L  ++       LS  +     
Sbjct: 73  --LHHNVITLHDVY-------ENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFI 121
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSVVVT 195
           +Q+L GV++LH+ +I H DLKP+N+++         +K+ DFGLA   +  +   ++  T
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
             + APEI+     G   D+WSIG +   +      F   T+ E L              
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------- 228
Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
              NI+ +   F++         F      A   +  +L      R++  +AL HP+   
Sbjct: 229 ---NITSVSYDFDE-------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 316 KENE 319
            +N+
Sbjct: 279 VDNQ 282

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 130/304 (42%), Gaps = 43/304 (14%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLNEDGIPMSTL-REISILKQLD 80
           YD   ++G G +  V K R+      Y A  +KK + + +  G+    + RE+SIL+Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV- 72
Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELT 139
              H N++   DV        E    V LI E V   +L  ++       LS  +     
Sbjct: 73  --LHHNVITLHDVY-------ENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFI 121
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----GLKIADFGLAKTFDYDMMLTSVVVT 195
           +Q+L GV++LH+ +I H DLKP+N+++         +K+ DFGLA   +  +   ++  T
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
             + APEI+     G   D+WSIG +   +      F   T+ E L              
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------- 228
Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
              NI+ +   F++         F      A   +  +L      R++  +AL HP+   
Sbjct: 229 ---NITSVSYDFDE-------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 316 KENE 319
            +N+
Sbjct: 279 VDNQ 282

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 144/300 (48%), Gaps = 42/300 (14%)
Query: 17  LDLGDKKY--DELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           +D GD +   D   +IG G+ G V  AR+ ++ G  VA+K + ++  +    +    E+ 
Sbjct: 38  VDQGDPRLLLDSYVKIGEGSTGIVCLARE-KHSGRQVAVKMMDLRKQQRRELL--FNEVV 94
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           I++    ++H N+V  +      ++ +E ++ +  +      D+ S +       L+  +
Sbjct: 95  IMRD---YQHFNVVEMY---KSYLVGEELWVLMEFLQGGALTDIVSQVR------LNEEQ 142
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +  +   +L+ + +LH+  +IHRD+K  ++L+T  G +K++DFG       D+     +V
Sbjct: 143 IATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV 202
Query: 195 -TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T ++ APE++    Y T VDIWS+G ++ EM    P + + + V+ +K   R+  +P  
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSPP- 258
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
                         +   KV  S +  D        LE ML  +P +R +A + L+HP+ 
Sbjct: 259 -----------PKLKNSHKV--SPVLRD-------FLERMLVRDPQERATAQELLDHPFL 298

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 92
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 93  -FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI-RKIGSFDETC---------TRFYTAEI 141
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +       S V T  Y 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 201
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 202 SPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 133/297 (44%), Gaps = 47/297 (15%)
Query: 20  GDKKYDELCQI-GCGAYGTVFKARDLQ--NKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D  + EL ++ G G++G VF  R +   + G+  AMK L+    +    + T  E  IL
Sbjct: 25  ADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDIL 84
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKV 135
             ++   HP +V+    +H    ++ +   +YLI + +   DL + + K      +   V
Sbjct: 85  ADVN---HPFVVK----LHYAFQTEGK---LYLILDFLRGGDLFTRLSK--EVMFTEEDV 132
Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMMLTSVVV 194
           K    ++  G+D LHS  II+RDLKP+N+L+   G +K+ DFGL+K   D++    S   
Sbjct: 133 KFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCG 192
Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV-IGTPSM 253
           T+ Y APE++   G+    D WS G +M EM      F      E +  I +  +G P  
Sbjct: 193 TVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQF 252
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-SAADALE 309
                                         ++A SLL ++   NPA+R+ S  D  E
Sbjct: 253 ----------------------------LSTEAQSLLRALFKRNPANRLGSGPDGAE 281

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 137/306 (44%), Gaps = 42/306 (13%)
Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISIL 76
           +L D  ++++ ++G G  G VFK   + +K + + M +  + L  +  I    +RE+ +L
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFK---VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 77
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV- 135
            + ++   P IV F+   + +         + +  EH+D   GS  +     G    ++ 
Sbjct: 78  HECNS---PYIVGFYGAFYSD-------GEISICMEHMDG--GSLDQVLKKAGRIPEQIL 125
Query: 136 KELTRQMLKGVDFLH-SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
            +++  ++KG+ +L   H+I+HRD+KP N+L+   G +K+ DFG++     D M  S V 
Sbjct: 126 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVG 184
Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTPSM 253
           T  Y +PE L    Y    DIWS+G  + EM     P+   S  +   + +  ++  P  
Sbjct: 185 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPP- 243
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
            + P  +              FS  F D  +K        L  NPA+R      + H + 
Sbjct: 244 PKLPSGV--------------FSLEFQDFVNKC-------LIKNPAERADLKQLMVHAFI 282
Query: 314 KEKENE 319
           K  + E
Sbjct: 283 KRSDAE 288

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 139/309 (44%), Gaps = 40/309 (12%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISI 75
           ++L D  ++++ ++G G  G VFK   + +K + + M +  + L  +  I    +RE+ +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK---VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           L + ++   P IV F+   + +         + +  EH+D   GS  +     G    ++
Sbjct: 58  LHECNS---PYIVGFYGAFYSD-------GEISICMEHMDG--GSLDQVLKKAGRIPEQI 105
Query: 136 -KELTRQMLKGVDFLH-SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV 193
             +++  ++KG+ +L   H+I+HRD+KP N+L+   G +K+ DFG++     D M  S V
Sbjct: 106 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV 164
Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW---RLVPLFCASTEVEQLKCIFRVIGT 250
            T  Y +PE L    Y    DIWS+G  + EM      +P   A  +      IF ++  
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDY 224
Query: 251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
             +NE P  +              FS  F D  +K        L  NPA+R      + H
Sbjct: 225 -IVNEPPPKL----------PSGVFSLEFQDFVNKC-------LIKNPAERADLKQLMVH 266
Query: 311 PYFKEKENE 319
            + K  + E
Sbjct: 267 AFIKRSDAE 275

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 27  LCQIGCGAYGTVFKAR--DLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           L Q+G G +G+V   R   LQ N G  VA+KKL+    E        REI ILK L   +
Sbjct: 16  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSL---Q 70
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H NIV++  V +     + + +  YL +  +   L  + E+     +   K+ + T Q+ 
Sbjct: 71  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQIC 125
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L + R IHR+L  +N+L+     +KI DFGL K    D     V         WY
Sbjct: 126 KGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 185
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            APE L    +    D+WS G V+ E++  +
Sbjct: 186 -APESLTESKFSVASDVWSFGVVLYELFTYI 215

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V +    Q+ G  VA+K+ R +L+        L EI I+K+L+   HPN+V
Sbjct: 22  RLGTGGFGYVLRWIH-QDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLN---HPNVV 76
Query: 89  RFFDVIH--QNILSDERYLTVYLIFEHVDQ-DLGSYM---EKCPPPGLSASKVKELTRQM 142
              +V    Q +  ++  L   L  E+ +  DL  Y+   E C   GL    ++ L   +
Sbjct: 77  SAREVPDGLQKLAPNDLPL---LAMEYCEGGDLRKYLNQFENCC--GLKEGPIRTLLSDI 131
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGL---KIADFGLAKTFDYDMMLTSVVVTLWYR 199
              + +LH +RIIHRDLKP+N+++         KI D G AK  D   + T  V TL Y 
Sbjct: 132 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 191
Query: 200 APEILLNLGYGTPVDIWSIGCVMAE 224
           APE+L    Y   VD WS G +  E
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFE 216

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V +    Q+ G  VA+K+ R +L+        L EI I+K+L+   HPN+V
Sbjct: 21  RLGTGGFGYVLRWIH-QDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLN---HPNVV 75
Query: 89  RFFDVIH--QNILSDERYLTVYLIFEHVDQ-DLGSYM---EKCPPPGLSASKVKELTRQM 142
              +V    Q +  ++  L   L  E+ +  DL  Y+   E C   GL    ++ L   +
Sbjct: 76  SAREVPDGLQKLAPNDLPL---LAMEYCEGGDLRKYLNQFENCC--GLKEGPIRTLLSDI 130
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGL---KIADFGLAKTFDYDMMLTSVVVTLWYR 199
              + +LH +RIIHRDLKP+N+++         KI D G AK  D   + T  V TL Y 
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 190
Query: 200 APEILLNLGYGTPVDIWSIGCVMAE 224
           APE+L    Y   VD WS G +  E
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFE 215

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 121/248 (48%), Gaps = 35/248 (14%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           ++E+  +G GA+G V KAR+  +   Y A+KK+R    E+ +  + L E+ +L  L+   
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALD-SRYYAIKKIR--HTEEKLS-TILSEVMLLASLN--- 60
Query: 84  HPNIVRFFDV------IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK- 136
           H  +VR++          + + + ++  T+++  E+ +   G+  +      L+  + + 
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCEN--GTLYDLIHSENLNQQRDEY 118
Query: 137 -ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-------- 187
             L RQ+L+ + ++HS  IIHRDLKP N+ I  +  +KI DFGLAK     +        
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 188 -------MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                   LTS + T  Y A E+L   G Y   +D++S+G +  EM  + P       V 
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--IYPFSTGMERVN 236
Query: 240 QLKCIFRV 247
            LK +  V
Sbjct: 237 ILKKLRSV 244

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  IG G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E++   D+ S++ +      S    + 
Sbjct: 98  VN---FPFLVKLEFSFKDNS-------NLYMVMEYMPGGDMFSHLRRIGR--FSEPHARF 145
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +K+ADFG AK          +  T  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW--XLCGTPE 203
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  IG G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E++   D+ S++ +      S    + 
Sbjct: 98  VN---FPFLVKLEFSFKDNS-------NLYMVMEYMPGGDMFSHLRRIGR--FSEPHARF 145
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +K+ADFG AK          +  T  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW--XLCGTPE 203
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 140/305 (45%), Gaps = 48/305 (15%)
Query: 26  ELCQ-IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST---LREISILKQLDT 81
           ELC+ IG G +  V +  + +  G   A+K + V        +ST    RE SI   L  
Sbjct: 27  ELCEVIGKGPFSVVRRCIN-RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-- 83
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGL--SASKVKEL 138
            +HP+IV   +    + +       +Y++FE +D  DL   + K    G   S +     
Sbjct: 84  -KHPHIVELLETYSSDGM-------LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLIT---RAGGLKIADFGLA-KTFDYDMMLTSVVV 194
            RQ+L+ + + H + IIHRD+KP  +L+     +  +K+  FG+A +  +  ++    V 
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195
Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSM 253
           T  + APE++    YG PVD+W  G ++  +    +P +   T+    + I +  G   M
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY--GTKERLFEGIIK--GKYKM 251
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
           N              Q+S ++ S         A  L+  ML  +PA+RI+  +AL HP+ 
Sbjct: 252 NP------------RQWSHISES---------AKDLVRRMLMLDPAERITVYEALNHPWL 290
Query: 314 KEKEN 318
           KE++ 
Sbjct: 291 KERDR 295

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  IG G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+V   ++ S++ +      S    + 
Sbjct: 98  VN---FPFLVKLEFSFKDNS-------NLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF 145
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +K+ADFG AK          +  T  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW--XLCGTPE 203
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 140/305 (45%), Gaps = 48/305 (15%)
Query: 26  ELCQ-IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST---LREISILKQLDT 81
           ELC+ IG G +  V +  + +  G   A+K + V        +ST    RE SI   L  
Sbjct: 29  ELCEVIGKGPFSVVRRCIN-RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-- 85
Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGL--SASKVKEL 138
            +HP+IV   +    + +       +Y++FE +D  DL   + K    G   S +     
Sbjct: 86  -KHPHIVELLETYSSDGM-------LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 137
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLIT---RAGGLKIADFGLA-KTFDYDMMLTSVVV 194
            RQ+L+ + + H + IIHRD+KP  +L+     +  +K+  FG+A +  +  ++    V 
Sbjct: 138 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 197
Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSM 253
           T  + APE++    YG PVD+W  G ++  +    +P +   T+    + I +  G   M
Sbjct: 198 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY--GTKERLFEGIIK--GKYKM 253
Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
           N              Q+S ++ S         A  L+  ML  +PA+RI+  +AL HP+ 
Sbjct: 254 NP------------RQWSHISES---------AKDLVRRMLMLDPAERITVYEALNHPWL 292
Query: 314 KEKEN 318
           KE++ 
Sbjct: 293 KERDR 297

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 120/264 (45%), Gaps = 41/264 (15%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D       D L LG         +G GA+G V  A      +D   +   VA+K 
Sbjct: 22  YELPEDPKWEFPRDKLTLGKP-------LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E+ +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 75  LKDDATEEDLS-DLVSEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 124
Query: 116 Q-DLGSYMEKCPPPGLSAS----KVKE----------LTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y+    PPG+  S    +V E           T Q+ +G+++L S + IHRDL 
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184
Query: 161 PQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 218 IGCVMAEMWRLVPLFCASTEVEQL 241
            G +M E++ L         VE+L
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 120/264 (45%), Gaps = 41/264 (15%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D    L  D L LG         +G GA+G V  A      +D  N+   VA+K 
Sbjct: 15  YELPEDPRWELPRDRLVLGKP-------LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM 67
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 68  LKSDATEKDLS-DLISEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 117
Query: 116 Q-DLGSYMEKCPPPGL--------------SASKVKELTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y++   PPGL              S+  +     Q+ +G+++L S + IHRDL 
Sbjct: 118 KGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 177
Query: 161 PQNLLITRAGGLKIADFGLAKT---FDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 218 IGCVMAEMWRLVPLFCASTEVEQL 241
            G ++ E++ L         VE+L
Sbjct: 238 FGVLLWEIFTLGGSPYPGVPVEEL 261

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 93
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 94  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 142
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +       S V T  Y 
Sbjct: 143 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 202
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 45/296 (15%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNK---GNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           K+Y     +G G +   ++  D+  K      V  K + +K ++    MST  EI+I K 
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE-KMST--EIAIHKS 98
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
           LD   +P++V F          D+ ++ V L        L  +  +     ++  + +  
Sbjct: 99  LD---NPHVVGF-----HGFFEDDDFVYVVLEICRRRSLLELHKRR---KAVTEPEARYF 147
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLW 197
            RQ ++GV +LH++R+IHRDLK  NL +     +KI DFGLA   ++D      +  T  
Sbjct: 148 MRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPN 207
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           Y APE+L   G+   VDIWS+GC++  +                     ++G P     P
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTL---------------------LVGKP-----P 241
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
              S +  ++ +  K  +S +       A++L+  ML  +P  R S A+ L   +F
Sbjct: 242 FETSCLKETYIRIKKNEYS-VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 128/284 (45%), Gaps = 44/284 (15%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D    L  D L LG         +G GA+G V  A      +D  N+   VA+K 
Sbjct: 15  YELPEDPRWELPRDRLVLGKP-------LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM 67
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 68  LKSDATEKDLS-DLISEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 117
Query: 116 Q-DLGSYMEKCPPPGL--------------SASKVKELTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y++   PPGL              S+  +     Q+ +G+++L S + IHRDL 
Sbjct: 118 KGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 177
Query: 161 PQNLLITRAGGLKIADFGLAKT---FDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 218 IGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
            G ++ E++ L         VE+L   F+++      + P N +
Sbjct: 238 FGVLLWEIFTLGGSPYPGVPVEEL---FKLLKEGHRMDKPSNCT 278

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 89
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 90  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 138
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +       S V T  Y 
Sbjct: 139 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 120/264 (45%), Gaps = 41/264 (15%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D    L  D L LG         +G GA+G V  A      +D  N+   VA+K 
Sbjct: 8   YELPEDPRWELPRDRLVLGKP-------LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM 60
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 61  LKSDATEKDLS-DLISEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 110
Query: 116 Q-DLGSYMEKCPPPGL--------------SASKVKELTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y++   PPGL              S+  +     Q+ +G+++L S + IHRDL 
Sbjct: 111 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 170
Query: 161 PQNLLITRAGGLKIADFGLAKT---FDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 171 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 230
Query: 218 IGCVMAEMWRLVPLFCASTEVEQL 241
            G ++ E++ L         VE+L
Sbjct: 231 FGVLLWEIFTLGGSPYPGVPVEEL 254

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 120/264 (45%), Gaps = 41/264 (15%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D    L  D L LG         +G GA+G V  A      +D  N+   VA+K 
Sbjct: 4   YELPEDPRWELPRDRLVLGKP-------LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM 56
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 57  LKSDATEKDLS-DLISEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 106
Query: 116 Q-DLGSYMEKCPPPGL--------------SASKVKELTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y++   PPGL              S+  +     Q+ +G+++L S + IHRDL 
Sbjct: 107 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 166
Query: 161 PQNLLITRAGGLKIADFGLAKT---FDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 167 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 226
Query: 218 IGCVMAEMWRLVPLFCASTEVEQL 241
            G ++ E++ L         VE+L
Sbjct: 227 FGVLLWEIFTLGGSPYPGVPVEEL 250

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 120/264 (45%), Gaps = 41/264 (15%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D    L  D L LG         +G GA+G V  A      +D  N+   VA+K 
Sbjct: 7   YELPEDPRWELPRDRLVLGKP-------LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM 59
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 60  LKSDATEKDLS-DLISEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 109
Query: 116 Q-DLGSYMEKCPPPGL--------------SASKVKELTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y++   PPGL              S+  +     Q+ +G+++L S + IHRDL 
Sbjct: 110 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 169
Query: 161 PQNLLITRAGGLKIADFGLAKT---FDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 170 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 229
Query: 218 IGCVMAEMWRLVPLFCASTEVEQL 241
            G ++ E++ L         VE+L
Sbjct: 230 FGVLLWEIFTLGGSPYPGVPVEEL 253

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 120/264 (45%), Gaps = 41/264 (15%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D    L  D L LG         +G GA+G V  A      +D  N+   VA+K 
Sbjct: 15  YELPEDPRWELPRDRLVLGKP-------LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM 67
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 68  LKSDATEKDLS-DLISEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 117
Query: 116 Q-DLGSYMEKCPPPGL--------------SASKVKELTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y++   PPGL              S+  +     Q+ +G+++L S + IHRDL 
Sbjct: 118 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 177
Query: 161 PQNLLITRAGGLKIADFGLAKT---FDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 218 IGCVMAEMWRLVPLFCASTEVEQL 241
            G ++ E++ L         VE+L
Sbjct: 238 FGVLLWEIFTLGGSPYPGVPVEEL 261

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 120/264 (45%), Gaps = 41/264 (15%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D    L  D L LG         +G GA+G V  A      +D  N+   VA+K 
Sbjct: 56  YELPEDPRWELPRDRLVLGKP-------LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM 108
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 109 LKSDATEKDLS-DLISEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 158
Query: 116 Q-DLGSYMEKCPPPGL--------------SASKVKELTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y++   PPGL              S+  +     Q+ +G+++L S + IHRDL 
Sbjct: 159 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 218
Query: 161 PQNLLITRAGGLKIADFGLAKT---FDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 278
Query: 218 IGCVMAEMWRLVPLFCASTEVEQL 241
            G ++ E++ L         VE+L
Sbjct: 279 FGVLLWEIFTLGGSPYPGVPVEEL 302

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 87/301 (28%), Positives = 128/301 (42%), Gaps = 53/301 (17%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG--IPMSTLREISILKQLD 80
           +Y+ +  IG G +G     RD Q      A + + VK  E G  I  +  REI   + L 
Sbjct: 20  RYELVKDIGAGNFGVARLMRDKQ------ANELVAVKYIERGEKIDENVKREIINHRSL- 72
Query: 81  TFEHPNIVRFFDVI----HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
              HPNIVRF +VI    H  I+ +  Y +   +FE +          C     S  + +
Sbjct: 73  --RHPNIVRFKEVILTPTHLAIVME--YASGGELFERI----------CNAGRFSEDEAR 118
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLI--TRAGGLKIADFGLAKTFDYDMMLTSVVV 194
              +Q++ GV + H+ ++ HRDLK +N L+  + A  LKIADFG +K         S V 
Sbjct: 119 FFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVG 178
Query: 195 TLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL-KCIFRVIGTPS 252
           T  Y APE+LL   Y G   D+WS G  +  M      F    E +   K I R++    
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNV-- 236
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                           QY+   +  I  +C      L+  +   +PA RIS  +   H +
Sbjct: 237 ----------------QYAIPDYVHISPEC----RHLISRIFVADPAKRISIPEIRNHEW 276
Query: 313 F 313
           F
Sbjct: 277 F 277

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 119/264 (45%), Gaps = 41/264 (15%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D       D L LG         +G GA+G V  A      +D   +   VA+K 
Sbjct: 22  YELPEDPKWEFPRDKLTLGKP-------LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 75  LKDDATEKDLS-DLVSEMEMMKMIG--KHKNIIHLLGACTQDG-------PLYVIVEYAS 124
Query: 116 Q-DLGSYMEKCPPPGLSAS----KVKE----------LTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y+    PPG+  S    +V E           T Q+ +G+++L S + IHRDL 
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184
Query: 161 PQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 218 IGCVMAEMWRLVPLFCASTEVEQL 241
            G +M E++ L         VE+L
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISI 75
           ++L D  ++++ ++G G  G VFK   + +K + + M +  + L  +  I    +RE+ +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK---VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           L + ++   P IV F+   + +         + +  EH+D   GS  +     G    ++
Sbjct: 58  LHECNS---PYIVGFYGAFYSD-------GEISICMEHMDG--GSLDQVLKKAGRIPEQI 105
Query: 136 -KELTRQMLKGVDFLH-SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV 193
             +++  ++KG+ +L   H+I+HRD+KP N+L+   G +K+ DFG++     D M  S V
Sbjct: 106 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV 164
Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            T  Y +PE L    Y    DIWS+G  + EM
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISI 75
           ++L D  ++++ ++G G  G VFK   + +K + + M +  + L  +  I    +RE+ +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK---VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           L + ++   P IV F+   + +         + +  EH+D   GS  +     G    ++
Sbjct: 58  LHECNS---PYIVGFYGAFYSD-------GEISICMEHMDG--GSLDQVLKKAGRIPEQI 105
Query: 136 -KELTRQMLKGVDFLH-SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV 193
             +++  ++KG+ +L   H+I+HRD+KP N+L+   G +K+ DFG++     D M  S V
Sbjct: 106 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV 164
Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            T  Y +PE L    Y    DIWS+G  + EM
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISI 75
           ++L D  ++++ ++G G  G VFK   + +K + + M +  + L  +  I    +RE+ +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK---VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           L + ++   P IV F+   + +         + +  EH+D   GS  +     G    ++
Sbjct: 58  LHECNS---PYIVGFYGAFYSD-------GEISICMEHMDG--GSLDQVLKKAGRIPEQI 105
Query: 136 -KELTRQMLKGVDFLH-SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV 193
             +++  ++KG+ +L   H+I+HRD+KP N+L+   G +K+ DFG++     D M  S V
Sbjct: 106 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV 164
Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            T  Y +PE L    Y    DIWS+G  + EM
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 45/296 (15%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNK---GNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           K+Y     +G G +   ++  D+  K      V  K + +K ++    MST  EI+I K 
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE-KMST--EIAIHKS 98
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
           LD   +P++V F          D+ ++ V L        L  +  +     ++  + +  
Sbjct: 99  LD---NPHVVGF-----HGFFEDDDFVYVVLEICRRRSLLELHKRR---KAVTEPEARYF 147
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLW 197
            RQ ++GV +LH++R+IHRDLK  NL +     +KI DFGLA   ++D      +  T  
Sbjct: 148 MRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPN 207
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           Y APE+L   G+   VDIWS+GC++  +                     ++G P     P
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTL---------------------LVGKP-----P 241
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
              S +  ++ +  K  +S +       A++L+  ML  +P  R S A+ L   +F
Sbjct: 242 FETSCLKETYIRIKKNEYS-VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISI 75
           ++L D  ++++ ++G G  G VFK   + +K + + M +  + L  +  I    +RE+ +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK---VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           L + ++   P IV F+   + +         + +  EH+D   GS  +     G    ++
Sbjct: 58  LHECNS---PYIVGFYGAFYSD-------GEISICMEHMDG--GSLDQVLKKAGRIPEQI 105
Query: 136 -KELTRQMLKGVDFLH-SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV 193
             +++  ++KG+ +L   H+I+HRD+KP N+L+   G +K+ DFG++     D M  S V
Sbjct: 106 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV 164
Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            T  Y +PE L    Y    DIWS+G  + EM
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 119/264 (45%), Gaps = 41/264 (15%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D       D L LG         +G GA+G V  A      +D   +   VA+K 
Sbjct: 22  YELPEDPKWEFPRDKLTLGKP-------LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 75  LKDDATEKDLS-DLVSEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 124
Query: 116 Q-DLGSYMEKCPPPGLSAS----KVKE----------LTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y+    PPG+  S    +V E           T Q+ +G+++L S + IHRDL 
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184
Query: 161 PQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 218 IGCVMAEMWRLVPLFCASTEVEQL 241
            G +M E++ L         VE+L
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 45/296 (15%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNK---GNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           K+Y     +G G +   ++  D+  K      V  K + +K ++    MST  EI+I K 
Sbjct: 26  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE-KMST--EIAIHKS 82
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
           LD   +P++V F          D+ ++ V L        L  +  +     ++  + +  
Sbjct: 83  LD---NPHVVGF-----HGFFEDDDFVYVVLEICRRRSLLELHKRR---KAVTEPEARYF 131
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLW 197
            RQ ++GV +LH++R+IHRDLK  NL +     +KI DFGLA   ++D      +  T  
Sbjct: 132 MRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPN 191
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           Y APE+L   G+   VDIWS+GC++  +                     ++G P     P
Sbjct: 192 YIAPEVLCKKGHSFEVDIWSLGCILYTL---------------------LVGKP-----P 225
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
              S +  ++ +  K  +S +       A++L+  ML  +P  R S A+ L   +F
Sbjct: 226 FETSCLKETYIRIKKNEYS-VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFF 280

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 119/264 (45%), Gaps = 41/264 (15%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D       D L LG         +G GA+G V  A      +D   +   VA+K 
Sbjct: 22  YELPEDPKWEFPRDKLTLGKP-------LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 75  LKDDATEKDLS-DLVSEMEMMKMIG--KHKNIITLLGACTQDG-------PLYVIVEYAS 124
Query: 116 Q-DLGSYMEKCPPPGLSAS----KVKE----------LTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y+    PPG+  S    +V E           T Q+ +G+++L S + IHRDL 
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184
Query: 161 PQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 218 IGCVMAEMWRLVPLFCASTEVEQL 241
            G +M E++ L         VE+L
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 45/296 (15%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNK---GNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           K+Y     +G G +   ++  D+  K      V  K + +K ++    MST  EI+I K 
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE-KMST--EIAIHKS 98
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
           LD   +P++V F          D+ ++ V L        L  +  +     ++  + +  
Sbjct: 99  LD---NPHVVGF-----HGFFEDDDFVYVVLEICRRRSLLELHKRR---KAVTEPEARYF 147
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLW 197
            RQ ++GV +LH++R+IHRDLK  NL +     +KI DFGLA   ++D      +  T  
Sbjct: 148 MRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPN 207
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           Y APE+L   G+   VDIWS+GC++  +                     ++G P     P
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTL---------------------LVGKP-----P 241
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
              S +  ++ +  K  +S +       A++L+  ML  +P  R S A+ L   +F
Sbjct: 242 FETSCLKETYIRIKKNEYS-VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 90
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 91  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 139
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +       + V T  Y 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 116/246 (47%), Gaps = 31/246 (12%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           ++E+  +G GA+G V KAR+  +   Y A+KK+R    E+ +  + L E+ +L  L+   
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALD-SRYYAIKKIR--HTEEKLS-TILSEVMLLASLN--- 60
Query: 84  HPNIVRFFDV------IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE 137
           H  +VR++          + + + ++  T+++  E+ +      +           +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---------- 187
           L RQ+L+ + ++HS  IIHRDLKP N+ I  +  +KI DFGLAK     +          
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 188 -----MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL 241
                 LTS + T  Y A E+L   G Y   +D++S+G +  EM  + P       V  L
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--IYPFSTGMERVNIL 238
Query: 242 KCIFRV 247
           K +  V
Sbjct: 239 KKLRSV 244

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 136/287 (47%), Gaps = 40/287 (13%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +IG G+ G V  A + ++ G  VA+KK+ ++  +    +    E+ I++    + H N+V
Sbjct: 52  KIGEGSTGIVCIATE-KHTGKQVAVKKMDLRKQQRRELL--FNEVVIMRD---YHHDNVV 105
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
              D+    ++ DE ++ +  +      D+ ++        ++  ++  +   +L+ + +
Sbjct: 106 ---DMYSSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLSVLRALSY 156
Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEILLNL 207
           LH+  +IHRD+K  ++L+T  G +K++DFG       ++     +V T ++ APE++  L
Sbjct: 157 LHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRL 216
Query: 208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
            YGT VDIWS+G ++ EM    P +     ++ ++ I         +  P  +       
Sbjct: 217 PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--------RDSLPPRV------- 261
Query: 268 EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           +   KV+         S     L+ ML   P+ R +A + L HP+ K
Sbjct: 262 KDLHKVS---------SVLRGFLDLMLVREPSQRATAQELLGHPFLK 299

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISIL 76
           +L D  ++++ ++G G  G VFK   + +K + + M +  + L  +  I    +RE+ +L
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFK---VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 120
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV- 135
            + ++   P IV F+   + +         + +  EH+D   GS  +     G    ++ 
Sbjct: 121 HECNS---PYIVGFYGAFYSD-------GEISICMEHMDG--GSLDQVLKKAGRIPEQIL 168
Query: 136 KELTRQMLKGVDFLH-SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
            +++  ++KG+ +L   H+I+HRD+KP N+L+   G +K+ DFG++     D M  S V 
Sbjct: 169 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVG 227
Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           T  Y +PE L    Y    DIWS+G  + EM
Sbjct: 228 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 258

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISIL 76
           +L D  ++++ ++G G  G VFK   + +K + + M +  + L  +  I    +RE+ +L
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFK---VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV- 135
            + ++   P IV F+   + +         + +  EH+D   GS  +     G    ++ 
Sbjct: 86  HECNS---PYIVGFYGAFYSD-------GEISICMEHMDG--GSLDQVLKKAGRIPEQIL 133
Query: 136 KELTRQMLKGVDFLH-SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
            +++  ++KG+ +L   H+I+HRD+KP N+L+   G +K+ DFG++     D M  S V 
Sbjct: 134 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVG 192
Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           T  Y +PE L    Y    DIWS+G  + EM
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 92
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 93  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 141
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 202 SPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 119/264 (45%), Gaps = 41/264 (15%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D       D L LG         +G GA+G V  A      +D   +   VA+K 
Sbjct: 22  YELPEDPKWEFPRDKLTLGKP-------LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 75  LKDDATEKDLS-DLVSEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 124
Query: 116 Q-DLGSYMEKCPPPGLSAS----KVKE----------LTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y+    PPG+  S    +V E           T Q+ +G+++L S + IHRDL 
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184
Query: 161 PQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    ++IADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 185 ARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 218 IGCVMAEMWRLVPLFCASTEVEQL 241
            G +M E++ L         VE+L
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 84/316 (26%), Positives = 143/316 (45%), Gaps = 52/316 (16%)
Query: 16  SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISI 75
           S+++     + + ++G GAYG V K R + + G  +A+K++R  +N       +  +  +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPS-GQIMAVKRIRATVN-------SQEQKRL 52
Query: 76  LKQLD----TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLS 131
           L  LD    T + P  V F+  +        R   V++  E +D  L  + ++    G +
Sbjct: 53  LMDLDISMRTVDCPFTVTFYGALF-------REGDVWICMELMDTSLDKFYKQVIDKGQT 105
Query: 132 ASK--VKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
             +  + ++   ++K ++ LHS   +IHRD+KP N+LI   G +K+ DFG++     D+ 
Sbjct: 106 IPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165
Query: 189 LTSVVVTLWYRAPEIL---LNL-GYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKC 243
                    Y APE +   LN  GY    DIWS+G  M E+  L  P     T  +QLK 
Sbjct: 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK- 224
Query: 244 IFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS 303
             +V+  PS                Q     FSA F+D  S+        L  N  +R +
Sbjct: 225 --QVVEEPS---------------PQLPADKFSAEFVDFTSQC-------LKKNSKERPT 260
Query: 304 AADALEHPYFKEKENE 319
             + ++HP+F   E++
Sbjct: 261 YPELMQHPFFTLHESK 276

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 116/260 (44%), Gaps = 60/260 (23%)
Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           DL + +Y  + ++G G + TV+   D+Q K  +VAMK ++   +     +  ++ +  ++
Sbjct: 27  DLFNGRYHVIRKLGWGHFSTVWLCWDMQGK-RFVAMKVVKSAQHYTETALDEIKLLKCVR 85
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE 137
           + D  + PN      +I    +S    + V ++FE +   L  ++ K    GL    VK 
Sbjct: 86  ESDPSD-PNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKS 144
Query: 138 LTRQMLKGVDFLHSH-RIIHRDLKPQNLLI-----------------TRAGG-------- 171
           + RQ+L+G+D+LHS  +IIH D+KP+N+L+                  +AG         
Sbjct: 145 IIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAV 204
Query: 172 ----------------------LKIADFGLA----KTFDYDMMLTSVVVTLWYRAPEILL 205
                                 +KIAD G A    K F  D+       T  YR+ E+L+
Sbjct: 205 STAPAADLLVNPLDPRNADKIRVKIADLGNACWVHKHFTEDIQ------TRQYRSIEVLI 258
Query: 206 NLGYGTPVDIWSIGCVMAEM 225
             GY TP DIWS  C+  E+
Sbjct: 259 GAGYSTPADIWSTACMAFEL 278

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 70
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 71  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 119
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y 
Sbjct: 120 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 217

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 90
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 91  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 139
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 69
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 70  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 118
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y 
Sbjct: 119 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 216

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 128/299 (42%), Gaps = 49/299 (16%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y+ +  IG G +G     RD Q+    VA+K +      + I  +  REI   + L   
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIE---RGEKIAANVKREIINHRSL--- 72
Query: 83  EHPNIVRFFDVI----HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
            HPNIVRF +VI    H  I+ +  Y +   +FE +          C     S  + +  
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVME--YASGGELFERI----------CNAGRFSEDEARFF 120
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLI--TRAGGLKIADFGLAKTFDYDMMLTSVVVTL 196
            +Q++ GV + H+ ++ HRDLK +N L+  + A  LKI DFG +K+        S V T 
Sbjct: 121 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 180
Query: 197 WYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL-KCIFRVIGTPSMN 254
            Y APE+LL   Y G   D+WS G  +  M      F    E +   K I R++      
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNV---- 236
Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
                         QY+   +  I  +C      L+  +   +PA RIS  +   H +F
Sbjct: 237 --------------QYAIPDYVHISPEC----RHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 92
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 93  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 141
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 93
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 94  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 142
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y 
Sbjct: 143 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 90
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 91  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 139
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 95
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 96  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 144
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y 
Sbjct: 145 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 205 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 242

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 111/222 (50%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL E      TL E  IL+ 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKE---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+    ++ S++ +      S    + 
Sbjct: 98  VN---FPFLVKLEFSFKDNS-------NLYMVMEYAPGGEMFSHLRRIGR--FSEPHARF 145
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NL+I + G +K+ DFGLAK          +  T  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTW--XLCGTPE 203
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 92
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 93  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 141
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 67
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 68  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 116
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y 
Sbjct: 117 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 214

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 68
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 69  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 117
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y 
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 92
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 93  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 141
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 74
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 75  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 123
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y 
Sbjct: 124 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 221

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 139/307 (45%), Gaps = 52/307 (16%)
Query: 25  DELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD---- 80
           + + ++G GAYG V K R + + G  +A+K++R  +N       +  +  +L  LD    
Sbjct: 54  EPIMELGRGAYGVVEKMRHVPS-GQIMAVKRIRATVN-------SQEQKRLLMDLDISMR 105
Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK--VKEL 138
           T + P  V F+  +        R   V++  E +D  L  + ++    G +  +  + ++
Sbjct: 106 TVDCPFTVTFYGALF-------REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 158
Query: 139 TRQMLKGVDFLHSH-RIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              ++K ++ LHS   +IHRD+KP N+LI   G +K+ DFG++      +  T       
Sbjct: 159 AVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKP 218
Query: 198 YRAPEIL---LNL-GYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRVIGTPS 252
           Y APE +   LN  GY    DIWS+G  M E+  L  P     T  +QLK   +V+  PS
Sbjct: 219 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK---QVVEEPS 275
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                           Q     FSA F+D  S+        L  N  +R +  + ++HP+
Sbjct: 276 ---------------PQLPADKFSAEFVDFTSQC-------LKKNSKERPTYPELMQHPF 313
Query: 313 FKEKENE 319
           F   E++
Sbjct: 314 FTLHESK 320

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 89
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 90  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 138
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y 
Sbjct: 139 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 92
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 93  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 141
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 114/251 (45%), Gaps = 41/251 (16%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D       D L LG         +G GA+G V  A      +D   +   VA+K 
Sbjct: 22  YELPEDPKWEFPRDKLTLGKP-------LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 75  LKDDATEKDLS-DLVSEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 124
Query: 116 Q-DLGSYMEKCPPPGLSAS----KVKE----------LTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y+    PPG+  S    +V E           T Q+ +G+++L S + IHRDL 
Sbjct: 125 KGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184
Query: 161 PQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     D     T+  + + + APE L +  Y    D+WS
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 218 IGCVMAEMWRL 228
            G +M E++ L
Sbjct: 245 FGVLMWEIFTL 255

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 112/236 (47%), Gaps = 34/236 (14%)
Query: 30  IGCGAYGTVFKA------RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           +G GA+G V  A      +D  N+   VA+K L+    E  +    + E+ ++K +   +
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEMMKMIG--K 77
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGL------------ 130
           H NI+       Q+         +Y+I E+  + +L  Y++   PPGL            
Sbjct: 78  HKNIINLLGACTQDG-------PLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEE 130
Query: 131 --SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT---FDY 185
             S+  +     Q+ +G+++L S + IHRDL  +N+L+T    +KIADFGLA+     DY
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL 241
               T+  + + + APE L +  Y    D+WS G ++ E++ L         VE+L
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 115/234 (49%), Gaps = 27/234 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  +  GN+ AMK L     VKL +    
Sbjct: 55  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKH-KESGNHYAMKILDKQKVVKLKQ---I 106
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKC 125
             TL E  IL+ ++    P +V+       N         +Y++ E+V   ++ S++ + 
Sbjct: 107 EHTLNEKRILQAVN---FPFLVKLEFSFKDNS-------NLYMVMEYVAGGEMFSHLRRI 156
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
                S    +    Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK    
Sbjct: 157 GR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-- 212
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                ++  T  Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 213 KGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 115/234 (49%), Gaps = 27/234 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  ++ GN+ AMK L     VKL +    
Sbjct: 34  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQ---I 85
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKC 125
             TL E  IL+ ++    P +V+       N         +Y++ E+V   ++ S++ + 
Sbjct: 86  EHTLNEKRILQAVN---FPFLVKLEFSFKDNS-------NLYMVMEYVAGGEMFSHLRRI 135
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
                S    +    Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK    
Sbjct: 136 GR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                 +  T  Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 194 RTW--XLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 114/251 (45%), Gaps = 41/251 (16%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D       D L LG         +G G +G V  A      +D   +   VA+K 
Sbjct: 14  YELPEDPKWEFPRDKLTLGKP-------LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM 66
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 67  LKDDATEKDLS-DLVSEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 116
Query: 116 Q-DLGSYMEKCPPPGLSAS----KVKE----------LTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y+    PPG+  S    +V E           T Q+ +G+++L S + IHRDL 
Sbjct: 117 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 176
Query: 161 PQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 177 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 236
Query: 218 IGCVMAEMWRL 228
            G +M E++ L
Sbjct: 237 FGVLMWEIFTL 247

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 104/214 (48%), Gaps = 20/214 (9%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ TV  AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP  V
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HPFFV 100
Query: 89  RFFDVIH--QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           + +      + +     Y     + +++ + +GS+ E C          +  T +++  +
Sbjct: 101 KLYFCFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEIVSAL 150
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYRAPEI 203
           ++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y +PE+
Sbjct: 151 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210
Query: 204 LLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           L         D+W++GC++ ++   +P F A  E
Sbjct: 211 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 244

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 119/264 (45%), Gaps = 41/264 (15%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D    L  D L LG         +G GA+G V  A      +D  N+   VA+K 
Sbjct: 15  YELPEDPRWELPRDRLVLGKP-------LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM 67
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 68  LKSDATEKDLS-DLISEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 117
Query: 116 Q-DLGSYMEKCPPPGL--------------SASKVKELTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y++   PPGL              S+  +     Q+ +G+++L S + IHRDL 
Sbjct: 118 KGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 177
Query: 161 PQNLLITRAGGLKIADFGLAKT---FDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     D     T+  + + + APE L +  Y    D+WS
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 218 IGCVMAEMWRLVPLFCASTEVEQL 241
            G ++ E++ L         VE+L
Sbjct: 238 FGVLLWEIFTLGGSPYPGVPVEEL 261

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 118/264 (44%), Gaps = 41/264 (15%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D       D L LG         +G G +G V  A      +D   +   VA+K 
Sbjct: 11  YELPEDPKWEFPRDKLTLGKP-------LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM 63
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 64  LKDDATEKDLS-DLVSEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 113
Query: 116 Q-DLGSYMEKCPPPGLSAS----KVKE----------LTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y+    PPG+  S    +V E           T Q+ +G+++L S + IHRDL 
Sbjct: 114 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 173
Query: 161 PQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 174 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 233
Query: 218 IGCVMAEMWRLVPLFCASTEVEQL 241
            G +M E++ L         VE+L
Sbjct: 234 FGVLMWEIFTLGGSPYPGIPVEEL 257

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 114/251 (45%), Gaps = 41/251 (16%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D       D L LG         +G G +G V  A      +D   +   VA+K 
Sbjct: 9   YELPEDPKWEFPRDKLTLGKP-------LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM 61
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 62  LKDDATEKDLS-DLVSEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 111
Query: 116 Q-DLGSYMEKCPPPGLSAS----KVKE----------LTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y+    PPG+  S    +V E           T Q+ +G+++L S + IHRDL 
Sbjct: 112 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLT 171
Query: 161 PQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 172 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 231
Query: 218 IGCVMAEMWRL 228
            G +M E++ L
Sbjct: 232 FGVLMWEIFTL 242

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 128/299 (42%), Gaps = 49/299 (16%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y+ +  IG G +G     RD Q+    VA+K +      + I  +  REI   + L   
Sbjct: 19  RYELVKDIGSGNFGVARLMRDKQS-NELVAVKYIE---RGEKIDENVKREIINHRSL--- 71
Query: 83  EHPNIVRFFDVI----HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
            HPNIVRF +VI    H  I+ +  Y +   +FE +          C     S  + +  
Sbjct: 72  RHPNIVRFKEVILTPTHLAIVME--YASGGELFERI----------CNAGRFSEDEARFF 119
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLI--TRAGGLKIADFGLAKTFDYDMMLTSVVVTL 196
            +Q++ GV + H+ ++ HRDLK +N L+  + A  LKI DFG +K+        S V T 
Sbjct: 120 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 179
Query: 197 WYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL-KCIFRVIGTPSMN 254
            Y APE+LL   Y G   D+WS G  +  M      F    E +   K I R++      
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNV---- 235
Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
                         QY+   +  I  +C      L+  +   +PA RIS  +   H +F
Sbjct: 236 --------------QYAIPDYVHISPEC----RHLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 122/291 (41%), Gaps = 45/291 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G++G VF A + +    + A+K L+  V L +D +   T+ E  +L     +EHP +
Sbjct: 26  LGKGSFGKVFLA-EFKKTNQFFAIKALKKDVVLMDDDVE-CTMVEKRVLSL--AWEHPFL 81
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
              F               ++ + E+++  DL  +++ C    LS +       +++ G+
Sbjct: 82  THMFCTFQTK-------ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEIILGL 132
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMMLTSVVVTLWYRAPEILL 205
            FLHS  I++RDLK  N+L+ + G +KIADFG+ K     D        T  Y APEILL
Sbjct: 133 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILL 192
Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS 265
              Y   VD WS G ++ EM      F    E E    I   +  P    W E       
Sbjct: 193 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLE------- 243
Query: 266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA-ADALEHPYFKE 315
                              +A  LL  +    P  R+    D  +HP F+E
Sbjct: 244 ------------------KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 276

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 114/251 (45%), Gaps = 41/251 (16%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D       D L LG         +G G +G V  A      +D   +   VA+K 
Sbjct: 68  YELPEDPKWEFPRDKLTLGKP-------LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM 120
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 121 LKDDATEKDLS-DLVSEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 170
Query: 116 Q-DLGSYMEKCPPPGLSAS----KVKE----------LTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y+    PPG+  S    +V E           T Q+ +G+++L S + IHRDL 
Sbjct: 171 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 230
Query: 161 PQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 290
Query: 218 IGCVMAEMWRL 228
            G +M E++ L
Sbjct: 291 FGVLMWEIFTL 301

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 130/290 (44%), Gaps = 42/290 (14%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G +G V K  +    G  +A K ++ +  +D   +    EIS++ QLD   H N+++
Sbjct: 97  LGGGRFGQVHKCEETAT-GLKLAAKIIKTRGMKDKEEVKN--EISVMNQLD---HANLIQ 150
Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL--TRQMLKGVD 147
            +D         E    + L+ E+VD   G   ++      + +++  +   +Q+ +G+ 
Sbjct: 151 LYDAF-------ESKNDIVLVMEYVDG--GELFDRIIDESYNLTELDTILFMKQICEGIR 201
Query: 148 FLHSHRIIHRDLKPQNLL-ITR-AGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL 205
            +H   I+H DLKP+N+L + R A  +KI DFGLA+ +     L     T  + APE++ 
Sbjct: 202 HMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS 265
                 P D+WS+G +   +   +  F    + E L  I               ++  W 
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI---------------LACRWD 306
Query: 266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             ++         F D   +A   +  +L    + RISA++AL+HP+  +
Sbjct: 307 LEDEE--------FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 112/222 (50%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 98
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+V   ++ S++ +      S    + 
Sbjct: 99  VN---FPFLVKLEFSFKDNS-------NLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF 146
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK         ++  T  
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPE 204
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 122/291 (41%), Gaps = 45/291 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G++G VF A + +    + A+K L+  V L +D +   T+ E  +L     +EHP +
Sbjct: 25  LGKGSFGKVFLA-EFKKTNQFFAIKALKKDVVLMDDDVE-CTMVEKRVLSL--AWEHPFL 80
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
              F               ++ + E+++  DL  +++ C    LS +       +++ G+
Sbjct: 81  THMFCTFQTK-------ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEIILGL 131
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMMLTSVVVTLWYRAPEILL 205
            FLHS  I++RDLK  N+L+ + G +KIADFG+ K     D        T  Y APEILL
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILL 191
Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS 265
              Y   VD WS G ++ EM      F    E E    I   +  P    W E       
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLE------- 242
Query: 266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA-ADALEHPYFKE 315
                              +A  LL  +    P  R+    D  +HP F+E
Sbjct: 243 ------------------KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 124/288 (43%), Gaps = 45/288 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR-EISILKQLDTFEHPNIV 88
           +G GA+  VF  +  +  G   A+K ++          S+L  EI++LK++   +H NIV
Sbjct: 17  LGSGAFSEVFLVKQ-RLTGKLFALKCIK---KSPAFRDSSLENEIAVLKKI---KHENIV 69
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT-RQMLKGVD 147
              D+        E     YL+ + V    G   ++    G+   K   L  +Q+L  V 
Sbjct: 70  TLEDIY-------ESTTHYYLVMQLVSG--GELFDRILERGVYTEKDASLVIQQVLSAVK 120
Query: 148 FLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEIL 204
           +LH + I+HRDLKP+NLL         + I DFGL+K  + + ++++   T  Y APE+L
Sbjct: 121 YLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVL 179
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               Y   VD WSIG +   +    P F   TE +                  E I   +
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF----------------EKIKEGY 223
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
             FE       S  + D    A   +  +L  +P +R +   AL HP+
Sbjct: 224 YEFE-------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 115/234 (49%), Gaps = 27/234 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  ++ GN+ AMK L     VKL +    
Sbjct: 34  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQ---I 85
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKC 125
             TL E  IL+ ++    P +V+       N         +Y++ E+V   ++ S++ + 
Sbjct: 86  EHTLNEKRILQAVN---FPFLVKLEFSFKDNS-------NLYMVMEYVAGGEMFSHLRRI 135
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
                S    +    Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK    
Sbjct: 136 GR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                 +  T  Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 194 RTW--XLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 112/222 (50%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 28  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 83
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+V   ++ S++ +      S    + 
Sbjct: 84  VN---FPFLVKLEFSFKDNS-------NLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF 131
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK         ++  T  
Sbjct: 132 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPE 189
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 190 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 231

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 114/251 (45%), Gaps = 41/251 (16%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D       D L LG         +G GA+G V  A      +D   +   VA+K 
Sbjct: 22  YELPEDPKWEFPRDKLTLGKP-------LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I E+  
Sbjct: 75  LKDDATEKDLS-DLVSEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVEYAS 124
Query: 116 Q-DLGSYMEKCPPPGLSAS----KVKE----------LTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y+    PPG+  S    +V E           T Q+ +G+++L S + IHRDL 
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184
Query: 161 PQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     D     T+  + + + APE L +  Y    D+WS
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 218 IGCVMAEMWRL 228
            G +M E++ L
Sbjct: 245 FGVLMWEIFTL 255

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 115/234 (49%), Gaps = 27/234 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  ++ GN+ AMK L     VKL +    
Sbjct: 34  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQ---I 85
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKC 125
             TL E  IL+ ++    P +V+       N         +Y++ E+V   ++ S++ + 
Sbjct: 86  EHTLNEKRILQAVN---FPFLVKLEFSFKDNS-------NLYMVMEYVAGGEMFSHLRRI 135
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
                S    +    Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK    
Sbjct: 136 GR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                 +  T  Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 194 RTW--XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 118/264 (44%), Gaps = 41/264 (15%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D       D L LG         +G GA+G V  A      +D   +   VA+K 
Sbjct: 22  YELPEDPKWEFPRDKLTLGKP-------LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I  +  
Sbjct: 75  LKDDATEKDLS-DLVSEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVAYAS 124
Query: 116 Q-DLGSYMEKCPPPGLSAS----KVKE----------LTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y+    PPG+  S    +V E           T Q+ +G+++L S + IHRDL 
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184
Query: 161 PQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 218 IGCVMAEMWRLVPLFCASTEVEQL 241
            G +M E++ L         VE+L
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 129/299 (43%), Gaps = 41/299 (13%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +  V +    ++ G   A K L+ +          L EI++L+   +   P ++
Sbjct: 36  ELGRGKFAVVRQCIS-KSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC--PRVI 92
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP---GLSASKVKELTRQMLKG 145
              +V        E    + LI E+     G     C P     +S + V  L +Q+L+G
Sbjct: 93  NLHEVY-------ENTSEIILILEYAAG--GEIFSLCLPELAEMVSENDVIRLIKQILEG 143
Query: 146 VDFLHSHRIIHRDLKPQNLLITRA---GGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           V +LH + I+H DLKPQN+L++     G +KI DFG+++   +   L  ++ T  Y APE
Sbjct: 144 VYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPE 203
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
           IL      T  D+W+IG +   +      F      E    I +V           N+  
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-----------NVD- 251
Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL 321
                  YS+  FS++       A   ++S+L  NP  R +A   L H + ++ + E L
Sbjct: 252 -------YSEETFSSV----SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 115/234 (49%), Gaps = 27/234 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  ++ GN+ AMK L     VKL +    
Sbjct: 34  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQ---I 85
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKC 125
             TL E  IL+ ++    P +V+       N         +Y++ E+V   ++ S++ + 
Sbjct: 86  EHTLNEKRILQAVN---FPFLVKLEFSFKDNS-------NLYMVMEYVAGGEMFSHLRRI 135
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
                S    +    Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK    
Sbjct: 136 GR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                 +  T  Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 194 RTW--XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  +  GN+ AMK L     VKL +    
Sbjct: 34  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKH-KESGNHYAMKILDKQKVVKLKQ---I 85
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKC 125
             TL E  IL+ ++    P +V+       N         +Y++ E+V   ++ S++ + 
Sbjct: 86  EHTLNEKRILQAVN---FPFLVKLEFSFKDNS-------NLYMVMEYVAGGEMFSHLRRI 135
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
                S    +    Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK    
Sbjct: 136 GR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                 +  T  Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 194 RTW--XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  +  GN+ AMK L     VKL +    
Sbjct: 35  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKH-KESGNHYAMKILDKQKVVKLKQ---I 86
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKC 125
             TL E  IL+ ++    P +V+       N         +Y++ E+V   ++ S++ + 
Sbjct: 87  EHTLNEKRILQAVN---FPFLVKLEFSFKDNS-------NLYMVMEYVAGGEMFSHLRRI 136
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
                S    +    Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK    
Sbjct: 137 GR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                 +  T  Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 195 RTW--XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
           LDL DK       +G G++    K   +  K N    +   VK+    +  +T +EI+ L
Sbjct: 12  LDLKDKP------LGEGSFSICRKC--VHKKSN----QAFAVKIISKRMEANTQKEITAL 59
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKV 135
           K  +   HPNIV+  +V H         L  +L+ E ++   G   E+       S ++ 
Sbjct: 60  KLCEG--HPNIVKLHEVFHDQ-------LHTFLVMELLNG--GELFERIKKKKHFSETEA 108
Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMM-LTS 191
             + R+++  V  +H   ++HRDLKP+NLL T       +KI DFG A+    D   L +
Sbjct: 109 SYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT 168
Query: 192 VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
              TL Y APE+L   GY    D+WS+G ++  M
Sbjct: 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTM 202

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 115/234 (49%), Gaps = 27/234 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  ++ GN+ AMK L     VKL +    
Sbjct: 34  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQ---I 85
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKC 125
             TL E  IL+ ++    P +V+       N         +Y++ E+V   ++ S++ + 
Sbjct: 86  EHTLNEKRILQAVN---FPFLVKLEFSFKDNS-------NLYMVMEYVAGGEMFSHLRRI 135
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
                S    +    Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK    
Sbjct: 136 GR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                 +  T  Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 194 RTW--XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 133/305 (43%), Gaps = 44/305 (14%)
Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISIL 76
           +L D  ++++ ++G G  G VFK   + +K + + M +  + L  +  I    +RE+ +L
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFK---VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 61
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV- 135
            + ++   P IV F+   + +         + +  EH+D   GS  +     G    ++ 
Sbjct: 62  HECNS---PYIVGFYGAFYSD-------GEISICMEHMDG--GSLDQVLKKAGRIPEQIL 109
Query: 136 KELTRQMLKGVDFLH-SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
            +++  ++KG+ +L   H+I+HRD+KP N+L+   G +K+ DFG++     D M    V 
Sbjct: 110 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDEMANEFVG 168
Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
           T  Y +PE L    Y    DIWS+G  + EM                  IF ++    +N
Sbjct: 169 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM-------AVGRYPRPPMAIFELLDY-IVN 220
Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           E P  +              FS  F D  +K        L  NPA+R      + H + K
Sbjct: 221 EPPPKL----------PSAVFSLEFQDFVNKC-------LIKNPAERADLKQLMVHAFIK 263
Query: 315 EKENE 319
             + E
Sbjct: 264 RSDAE 268

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 115/234 (49%), Gaps = 27/234 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  ++ GN+ AMK L     VKL +    
Sbjct: 34  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQ---I 85
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKC 125
             TL E  IL+ ++    P +V+       N         +Y++ E+V   ++ S++ + 
Sbjct: 86  EHTLNEKRILQAVN---FPFLVKLEFSFKDNS-------NLYMVMEYVAGGEMFSHLRRI 135
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
                S    +    Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK    
Sbjct: 136 GR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                 +  T  Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 194 RTW--XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQ 245

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 124/290 (42%), Gaps = 47/290 (16%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G GA+  V  A + +  G   A+K +  K  + G   S   EI++L+++   +H NIV 
Sbjct: 30  LGTGAFSEVVLAEE-KATGKLFAVKCIPKKALK-GKESSIENEIAVLRKI---KHENIVA 84
Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK-VKELTRQMLKGVDF 148
             D+        E    +YL+ + V    G   ++    G    K    L RQ+L  V +
Sbjct: 85  LEDIY-------ESPNHLYLVMQLVSG--GELFDRIVEKGFYTEKDASTLIRQVLDAVYY 135
Query: 149 LHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL 205
           LH   I+HRDLKP+NLL         + I+DFGL+K      ++++   T  Y APE+L 
Sbjct: 136 LHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLA 195
Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS 265
              Y   VD WSIG +         L C               G P    + EN S +  
Sbjct: 196 QKPYSKAVDCWSIGVIA------YILLC---------------GYPPF--YDENDSKL-- 230
Query: 266 SFEQYSKVAF---SAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
            FEQ  K  +   S  + D    A   + +++  +P  R +   A  HP+
Sbjct: 231 -FEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPW 279

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 133/289 (46%), Gaps = 47/289 (16%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V+ AR+   K ++ VA+K L + ++ ++G+     REI I   L    HPNI
Sbjct: 31  LGKGKFGNVYLARE--KKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHL---HHPNI 85
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEK-CPPPGLSASKVKELTRQMLKG 145
           +R +     N   D R   +YLI E+  + +L   ++K C        +   +  ++   
Sbjct: 86  LRLY-----NYFYDRR--RIYLILEYAPRGELYKELQKSC---TFDEQRTATIMEELADA 135
Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL 205
           + + H  ++IHRD+KP+NLL+   G LKIADFG +      +   ++  TL Y  PE++ 
Sbjct: 136 LMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIE 194
Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS 265
              +   VD+W IG +  E+    P F +++  E  + I +V                  
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV------------------ 236
Query: 266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
                  + F A      + A  L+  +L  NP++R+  A    HP+ +
Sbjct: 237 ------DLKFPA---SVPTGAQDLISKLLRHNPSERLPLAQVSAHPWVR 276

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL E      TL E  IL+ 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKE---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+    ++ S++ +      S    + 
Sbjct: 98  VN---FPFLVKLEFSFKDNS-------NLYMVMEYAPGGEMFSHLRRIGR--FSEPHARF 145
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NL+I + G +++ DFGLAK          +  T  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTW--XLCGTPE 203
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 117/235 (49%), Gaps = 29/235 (12%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  ++ GN+ AMK L     VKL +    
Sbjct: 34  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQ---I 85
Query: 67  MSTLREISILKQLDTFEHPNIVR--FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK 124
             TL E  IL+ ++    P +V+  F    + N+     Y+    +F H+ + +G + E 
Sbjct: 86  EHTLNEKRILQAVN---FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFXE- 140
Query: 125 CPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD 184
            P     A+       Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK   
Sbjct: 141 -PHARFYAA-------QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 185 YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                  +  T  Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 193 GRTW--XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 116/235 (49%), Gaps = 29/235 (12%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  +  GN+ AMK L     VKL +    
Sbjct: 34  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKH-KESGNHYAMKILDKQKVVKLKQ---I 85
Query: 67  MSTLREISILKQLDTFEHPNIVR--FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK 124
             TL E  IL+ ++    P +V+  F    + N+     Y+    +F H+ + +G + E 
Sbjct: 86  EHTLNEKRILQAVN---FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFXE- 140
Query: 125 CPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD 184
            P     A+       Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK   
Sbjct: 141 -PHARFYAA-------QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 185 YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                  +  T  Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 193 GRTW--XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 116/235 (49%), Gaps = 29/235 (12%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  +  GN+ AMK L     VKL +    
Sbjct: 34  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKH-KESGNHYAMKILDKQKVVKLKQ---I 85
Query: 67  MSTLREISILKQLDTFEHPNIVR--FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK 124
             TL E  IL+ ++    P +V+  F    + N+     Y+    +F H+ + +G + E 
Sbjct: 86  EHTLNEKRILQAVN---FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFXE- 140
Query: 125 CPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD 184
            P     A+       Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK   
Sbjct: 141 -PHARFYAA-------QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 185 YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                  +  T  Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 193 GRTW--XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++ T   AR+L     Y + + + R  + E+ +P  T RE  ++ +LD   HP   
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLD---HP--- 90
Query: 89  RFFDVIHQNILSDER------YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            FF  ++     DE+      Y     + +++ + +GS+ E C          +  T ++
Sbjct: 91  -FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETC---------TRFYTAEI 139
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYR 199
           +  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +         V T  Y 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           +PE+L         D+W++GC++ ++   +P F A  E
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 117/235 (49%), Gaps = 29/235 (12%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  ++ GN+ AMK L     VKL +    
Sbjct: 34  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQ---I 85
Query: 67  MSTLREISILKQLDTFEHPNIVR--FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK 124
             TL E  IL+ ++    P +V+  F    + N+     Y+    +F H+ + +G + E 
Sbjct: 86  EHTLNEKRILQAVN---FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFAE- 140
Query: 125 CPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD 184
            P     A+       Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK   
Sbjct: 141 -PHARFYAA-------QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 185 YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                  +  T  Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 193 GRTW--XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 103/222 (46%), Gaps = 26/222 (11%)
Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR 71
           LN + L LG+       QIG G +G VF  R L+     VA+K  R  L  D +    L+
Sbjct: 111 LNHEDLVLGE-------QIGRGNFGEVFSGR-LRADNTLVAVKSCRETLPPD-LKAKFLQ 161
Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-- 129
           E  ILKQ   + HPNIVR   V  Q          +Y++ E V    G ++      G  
Sbjct: 162 EARILKQ---YSHPNIVRLIGVCTQK-------QPIYIVMELVQG--GDFLTFLRTEGAR 209
Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
           L    + ++      G+++L S   IHRDL  +N L+T    LKI+DFG+++     +  
Sbjct: 210 LRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXA 269
Query: 190 TS---VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
            S     V + + APE L    Y +  D+WS G ++ E + L
Sbjct: 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSL 311

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 118/264 (44%), Gaps = 41/264 (15%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKA------RDLQNKGNYVAMKK 55
           YE   D       D L LG         +G GA+G V  A      +D   +   VA+K 
Sbjct: 22  YELPEDPKWEFPRDKLTLGKP-------LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74
Query: 56  LRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD 115
           L+    E  +    + E+ ++K +   +H NI+       Q+         +Y+I  +  
Sbjct: 75  LKDDATEKDLS-DLVSEMEMMKMIG--KHKNIINLLGACTQDG-------PLYVIVGYAS 124
Query: 116 Q-DLGSYMEKCPPPGLSAS----KVKE----------LTRQMLKGVDFLHSHRIIHRDLK 160
           + +L  Y+    PPG+  S    +V E           T Q+ +G+++L S + IHRDL 
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184
Query: 161 PQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWS 217
            +N+L+T    +KIADFGLA+     DY    T+  + + + APE L +  Y    D+WS
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 218 IGCVMAEMWRLVPLFCASTEVEQL 241
            G +M E++ L         VE+L
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 133/301 (44%), Gaps = 50/301 (16%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQ--NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
           +++ L  +G G++G VF  + +   +     AMK L+    +    + T  E  IL +++
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKELT 139
              HP IV+    +H    ++ +   +YLI + +   DL + + K      +   VK   
Sbjct: 85  ---HPFIVK----LHYAFQTEGK---LYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYL 132
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMMLTSVVVTLWY 198
            ++   +D LHS  II+RDLKP+N+L+   G +K+ DFGL+K + D++    S   T+ Y
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV-IGTPSMNEWP 257
            APE++   G+    D WS G +M EM      F      E +  I +  +G P      
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF---- 248
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA-DALE----HPY 312
                                      +A SLL  +   NPA+R+ A  D +E    H +
Sbjct: 249 ------------------------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284
Query: 313 F 313
           F
Sbjct: 285 F 285

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 117/235 (49%), Gaps = 29/235 (12%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  ++ GN+ AMK L     VKL +    
Sbjct: 29  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQ---I 80
Query: 67  MSTLREISILKQLDTFEHPNIVR--FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK 124
             TL E  IL+ ++    P +V+  F    + N+     Y+    +F H+ + +G + E 
Sbjct: 81  EHTLNEKRILQAVN---FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFXE- 135
Query: 125 CPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD 184
            P     A+       Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK   
Sbjct: 136 -PHARFYAA-------QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 187
Query: 185 YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                  +  T  Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 188 GRTW--XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 240

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 133/301 (44%), Gaps = 50/301 (16%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQ--NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
           +++ L  +G G++G VF  + +   +     AMK L+    +    + T  E  IL +++
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 85
Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKELT 139
              HP IV+    +H    ++ +   +YLI + +   DL + + K      +   VK   
Sbjct: 86  ---HPFIVK----LHYAFQTEGK---LYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYL 133
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMMLTSVVVTLWY 198
            ++   +D LHS  II+RDLKP+N+L+   G +K+ DFGL+K + D++    S   T+ Y
Sbjct: 134 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 193
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV-IGTPSMNEWP 257
            APE++   G+    D WS G +M EM      F      E +  I +  +G P      
Sbjct: 194 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF---- 249
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA-DALE----HPY 312
                                      +A SLL  +   NPA+R+ A  D +E    H +
Sbjct: 250 ------------------------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 285
Query: 313 F 313
           F
Sbjct: 286 F 286

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 133/301 (44%), Gaps = 50/301 (16%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQ--NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
           +++ L  +G G++G VF  + +   +     AMK L+    +    + T  E  IL +++
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKELT 139
              HP IV+    +H    ++ +   +YLI + +   DL + + K      +   VK   
Sbjct: 85  ---HPFIVK----LHYAFQTEGK---LYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYL 132
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMMLTSVVVTLWY 198
            ++   +D LHS  II+RDLKP+N+L+   G +K+ DFGL+K + D++    S   T+ Y
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV-IGTPSMNEWP 257
            APE++   G+    D WS G +M EM      F      E +  I +  +G P      
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF---- 248
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA-DALE----HPY 312
                                      +A SLL  +   NPA+R+ A  D +E    H +
Sbjct: 249 ------------------------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284
Query: 313 F 313
           F
Sbjct: 285 F 285

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 125/299 (41%), Gaps = 49/299 (16%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +YD +  IG G +G     RD   K   VA+K +        I  +  REI   + L   
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTK-ELVAVKYIE---RGAAIDENVQREIINHRSL--- 73
Query: 83  EHPNIVRFFDVI----HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
            HPNIVRF +VI    H  I+ +  Y +   ++E +          C     S  + +  
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIME--YASGGELYERI----------CNAGRFSEDEARFF 121
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLI--TRAGGLKIADFGLAKTFDYDMMLTSVVVTL 196
            +Q+L GV + HS +I HRDLK +N L+  + A  LKI DFG +K+        S V T 
Sbjct: 122 FQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 181
Query: 197 WYRAPEILLNLGY-GTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTPSMN 254
            Y APE+LL   Y G   D+WS G  +  M     P        +  K I R++      
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV---- 237
Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
                         +YS      I  +CC     L+  +   +PA RIS  +   H +F
Sbjct: 238 --------------KYSIPDDIRISPECC----HLISRIFVADPATRISIPEIKTHSWF 278

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 116/235 (49%), Gaps = 29/235 (12%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  +  GN+ AMK L     VKL +    
Sbjct: 55  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKH-KESGNHYAMKILDKQKVVKLKQ---I 106
Query: 67  MSTLREISILKQLDTFEHPNIVR--FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK 124
             TL E  IL+ ++    P +V+  F    + N+     Y+    +F H+ + +G + E 
Sbjct: 107 EHTLNEKRILQAVN---FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFXE- 161
Query: 125 CPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD 184
            P     A+       Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK   
Sbjct: 162 -PHARFYAA-------QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 213
Query: 185 YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                  +  T  Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 214 GRTW--XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 103/222 (46%), Gaps = 26/222 (11%)
Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR 71
           LN + L LG+       QIG G +G VF  R L+     VA+K  R  L  D +    L+
Sbjct: 111 LNHEDLVLGE-------QIGRGNFGEVFSGR-LRADNTLVAVKSCRETLPPD-LKAKFLQ 161
Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-- 129
           E  ILKQ   + HPNIVR   V  Q          +Y++ E V    G ++      G  
Sbjct: 162 EARILKQ---YSHPNIVRLIGVCTQK-------QPIYIVMELVQG--GDFLTFLRTEGAR 209
Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
           L    + ++      G+++L S   IHRDL  +N L+T    LKI+DFG+++     +  
Sbjct: 210 LRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269
Query: 190 TS---VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
            S     V + + APE L    Y +  D+WS G ++ E + L
Sbjct: 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSL 311

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+V   ++ S++ +      S    + 
Sbjct: 98  VN---FPFLVKLEFSFKDNS-------NLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF 145
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPE 203
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+V   ++ S++ +      S    + 
Sbjct: 98  VN---FPFLVKLEFSFKDNS-------NLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF 145
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPE 203
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 113/234 (48%), Gaps = 27/234 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  +  GN+ AMK L     VKL +    
Sbjct: 21  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKH-KESGNHYAMKILDKQKVVKLKQ---I 72
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKC 125
             TL E  IL+ ++    P +V+       N         +Y++ E+V   ++ S++ + 
Sbjct: 73  EHTLNEKRILQAVN---FPFLVKLEFSFKDNS-------NLYMVMEYVAGGEMFSHLRRI 122
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
                S    +    Q++   ++LHS  +I+RDLKP+NLLI   G +++ DFG AK    
Sbjct: 123 GR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG 180
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                 +  T  Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 181 RTW--XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 232

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 98
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+V   ++ S++ +      S    + 
Sbjct: 99  VN---FPFLVKLEFSFKDNS-------NLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF 146
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T  
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPE 204
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+V   ++ S++ +      S    + 
Sbjct: 98  VN---FPFLVKLEFSFKDNS-------NLYMVMEYVAGGEMFSHLRRIGR--FSEPHARF 145
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPE 203
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+V   ++ S++ +      S    + 
Sbjct: 98  VN---FPFLVKLEFSFKDNS-------NLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF 145
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPE 203
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 86/186 (46%), Gaps = 28/186 (15%)
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L+  + +   RQ++ G  +LH +R+IHRDLK  NL +     +KI DFGLA   +YD  
Sbjct: 135 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 194
Query: 189 LTSVVV-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
              V+  T  Y APE+L   G+   VD+WSIGC+M  +                     +
Sbjct: 195 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL---------------------L 233
Query: 248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           +G P     P   S +  ++ +  K  +S I       A SL++ ML  +P  R +  + 
Sbjct: 234 VGKP-----PFETSCLKETYLRIKKNEYS-IPKHINPVAASLIQKMLQTDPTARPTINEL 287
Query: 308 LEHPYF 313
           L   +F
Sbjct: 288 LNDEFF 293

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 86/186 (46%), Gaps = 28/186 (15%)
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L+  + +   RQ++ G  +LH +R+IHRDLK  NL +     +KI DFGLA   +YD  
Sbjct: 111 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170
Query: 189 LTSVVV-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
              V+  T  Y APE+L   G+   VD+WSIGC+M  +                     +
Sbjct: 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL---------------------L 209
Query: 248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           +G P     P   S +  ++ +  K  +S I       A SL++ ML  +P  R +  + 
Sbjct: 210 VGKP-----PFETSCLKETYLRIKKNEYS-IPKHINPVAASLIQKMLQTDPTARPTINEL 263
Query: 308 LEHPYF 313
           L   +F
Sbjct: 264 LNDEFF 269

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 14/219 (6%)
Query: 26  ELCQI-GCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           EL +I G G    V  ARDL++  + VA+K LR  L  D  P   LR     +      H
Sbjct: 15  ELGEILGFGGMSEVHLARDLRDHRD-VAVKVLRADLARD--PSFYLRFRREAQNAAALNH 71
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P IV  +D       +       Y++ E+VD   L   +    P  ++  +  E+     
Sbjct: 72  PAIVAVYDTGEAETPAGP---LPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADAC 126
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYDMMLTSVVVTLWYR 199
           + ++F H + IIHRD+KP N+LI+    +K+ DFG+A+      +      +V+ T  Y 
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV 238
           +PE           D++S+GCV+ E+    P F   + V
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 86/186 (46%), Gaps = 28/186 (15%)
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L+  + +   RQ++ G  +LH +R+IHRDLK  NL +     +KI DFGLA   +YD  
Sbjct: 137 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196
Query: 189 LTSVVV-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
              V+  T  Y APE+L   G+   VD+WSIGC+M  +                     +
Sbjct: 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL---------------------L 235
Query: 248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           +G P     P   S +  ++ +  K  +S I       A SL++ ML  +P  R +  + 
Sbjct: 236 VGKP-----PFETSCLKETYLRIKKNEYS-IPKHINPVAASLIQKMLQTDPTARPTINEL 289
Query: 308 LEHPYF 313
           L   +F
Sbjct: 290 LNDEFF 295

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 130/312 (41%), Gaps = 47/312 (15%)
Query: 9   IQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMS 68
           +Q L+ +S+   D  Y+    IG G+Y      R +    N     K+  K   D     
Sbjct: 10  VQQLHRNSIQFTDG-YEVKEDIGVGSYSVC--KRCIHKATNMEFAVKIIDKSKRD----- 61
Query: 69  TLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKC-PP 127
              EI IL  L   +HPNI+   DV       D +Y  VY++ E +    G  ++K    
Sbjct: 62  PTEEIEIL--LRYGQHPNIITLKDV-----YDDGKY--VYVVTELMKG--GELLDKILRQ 110
Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG----LKIADFGLAKTF 183
              S  +   +   + K V++LH+  ++HRDLKP N+L     G    ++I DFG AK  
Sbjct: 111 KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 184 DYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLK 242
             +  +L +   T  + APE+L   GY    DIWS+G ++  M      F    +     
Sbjct: 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD----- 225
Query: 243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCS-KANSLLESMLTFNPADR 301
                       + PE I     S     K + S  + +  S  A  L+  ML  +P  R
Sbjct: 226 ------------DTPEEILARIGS----GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQR 269
Query: 302 ISAADALEHPYF 313
           ++AA  L HP+ 
Sbjct: 270 LTAALVLRHPWI 281

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 113/255 (44%), Gaps = 37/255 (14%)
Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLS 131
           EI IL  L   +HPNI+   DV       D ++  VYL+ E +    G  ++K       
Sbjct: 70  EIEIL--LRYGQHPNIITLKDV-----YDDGKH--VYLVTELMRG--GELLDKILRQKFF 118
Query: 132 ASKVKELTRQML-KGVDFLHSHRIIHRDLKPQNLLITRAGG----LKIADFGLAKTFDYD 186
           + +        + K V++LHS  ++HRDLKP N+L     G    L+I DFG AK    +
Sbjct: 119 SEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE 178
Query: 187 M-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIF 245
             +L +   T  + APE+L   GY    DIWS+G ++  M      F A+   +  + I 
Sbjct: 179 NGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF-ANGPSDTPEEIL 237
Query: 246 RVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA 305
             IG+        N    W++  + +K                L+  ML  +P  R++A 
Sbjct: 238 TRIGSGKFTLSGGN----WNTVSETAK---------------DLVSKMLHVDPHQRLTAK 278
Query: 306 DALEHPYFKEKENEP 320
             L+HP+  +K+  P
Sbjct: 279 QVLQHPWVTQKDKLP 293

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 111/256 (43%), Gaps = 39/256 (15%)
Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLS 131
           EI IL  L   +HPNI+   DV       D ++  VYL+ E +    G  ++K       
Sbjct: 70  EIEIL--LRYGQHPNIITLKDV-----YDDGKH--VYLVTELMRG--GELLDKILRQKFF 118
Query: 132 ASKVKELTRQML-KGVDFLHSHRIIHRDLKPQNLLITRAGG----LKIADFGLAKTFDYD 186
           + +        + K V++LHS  ++HRDLKP N+L     G    L+I DFG AK    +
Sbjct: 119 SEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE 178
Query: 187 -MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIF 245
             +L +   T  + APE+L   GY    DIWS+G ++  M      F             
Sbjct: 179 NGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANG---------- 228
Query: 246 RVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISA 304
                PS  + PE I     S     K   S    +  S+ A  L+  ML  +P  R++A
Sbjct: 229 -----PS--DTPEEILTRIGS----GKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTA 277
Query: 305 ADALEHPYFKEKENEP 320
              L+HP+  +K+  P
Sbjct: 278 KQVLQHPWVTQKDKLP 293

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 98
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
           ++ F     + F    + N+     Y     +F H+ + +G + E  P     A+     
Sbjct: 99  VN-FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR-IGRFXE--PHARFYAA----- 149
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWY 198
             Q++   ++LHS  +I+RDLKP+NL+I + G +K+ DFG AK          +  T  Y
Sbjct: 150 --QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPEY 205
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
            APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 115/234 (49%), Gaps = 27/234 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  ++ GN+ AMK L     VKL +    
Sbjct: 34  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQ---I 85
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKC 125
             TL E  IL+ ++    P +V+       N         +Y++ E+V   ++ S++ + 
Sbjct: 86  EHTLNEKRILQAVN---FPFLVKLEFSFKDNS-------NLYMVMEYVAGGEMFSHLRRI 135
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
                S    +    Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK    
Sbjct: 136 GR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                 +  T  Y APEI+L+ GY   VD W++G ++ +M    P F A   ++
Sbjct: 194 RTW--XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQ 245

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+    ++ S++ +      S    + 
Sbjct: 98  VN---FPFLVKLEFSFKDNS-------NLYMVMEYAPGGEMFSHLRRIGR--FSEPHARF 145
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NL+I + G +K+ DFG AK          +  T  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPE 203
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/294 (22%), Positives = 120/294 (40%), Gaps = 42/294 (14%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           YD   ++G GA+G V +  +     N+ A   +    ++       ++ +S+L+      
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR------ 106
Query: 84  HPNIVRFFDVIHQN--ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
           HP +V   D    +  ++    +++   +FE V  +            +S  +  E  RQ
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---------MSEDEAVEYMRQ 157
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLIT--RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
           + KG+  +H +  +H DLKP+N++ T  R+  LK+ DFGL    D    +     T  + 
Sbjct: 158 VCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA 217
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           APE+      G   D+WS+G +   +   +  F    + E L+ +               
Sbjct: 218 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--------------- 262
Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
            S  W+        AFS I  D        +  +L  +P  R++   ALEHP+ 
Sbjct: 263 KSCDWN----MDDSAFSGISED----GKDFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 98
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
           ++ F     + F    + N+     Y     +F H+ + +G + E  P     A+     
Sbjct: 99  VN-FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR-IGRFSE--PHARFYAA----- 149
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWY 198
             Q++   ++LHS  +I+RDLKP+NL+I + G +K+ DFG AK          +  T  Y
Sbjct: 150 --QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPEY 205
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
            APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 113/223 (50%), Gaps = 25/223 (11%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 98
Query: 79  LDTFEHPNIVR--FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
           ++    P +V+  F    + N+     Y+    +F H+ + +G + E  P     A+   
Sbjct: 99  VN---FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR-IGRFXE--PHARFYAA--- 149
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL 196
               Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T 
Sbjct: 150 ----QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTP 203
Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
            Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 119/264 (45%), Gaps = 66/264 (25%)
Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           DL + +Y  + ++G G + TV+ + D+Q K  +VAMK ++   + +    + L EI +LK
Sbjct: 17  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGK-KFVAMKVVK---SAEHYTETALDEIRLLK 72
Query: 78  QLDTFE--HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
            +   +   PN      ++    +S      + ++FE +   L  ++ K    GL    V
Sbjct: 73  SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCV 132
Query: 136 KELTRQMLKGVDFLHSH-RIIHRDLKPQNLLIT-----------------RAGG------ 171
           K++ +Q+L+G+D+LH+  RIIH D+KP+N+L++                 R+G       
Sbjct: 133 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 192
Query: 172 --------------------------LKIADFGLA----KTFDYDMMLTSVVVTLWYRAP 201
                                     +KIAD G A    K F  D+       T  YR+ 
Sbjct: 193 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ------TRQYRSL 246
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E+L+  GY TP DIWS  C+  E+
Sbjct: 247 EVLIGSGYNTPADIWSTACMAFEL 270

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/294 (22%), Positives = 121/294 (41%), Gaps = 42/294 (14%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           YD   ++G GA+G V +  +     N+ A   +    ++       ++ +S+L+      
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR------ 212
Query: 84  HPNIVRFFDVIHQN--ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
           HP +V   D    +  ++    +++   +FE V  +            +S  +  E  RQ
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---------MSEDEAVEYMRQ 263
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLIT--RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
           + KG+  +H +  +H DLKP+N++ T  R+  LK+ DFGL    D    +     T  + 
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA 323
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           APE+      G   D+WS+G +   +   +  F    + E L+ +               
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--------------- 368
Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
            S  W+  +     AFS I  D        +  +L  +P  R++   ALEHP+ 
Sbjct: 369 KSCDWNMDDS----AFSGISED----GKDFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 98
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
           ++ F     + F    + N+     Y     +F H+ + +G + E  P     A+     
Sbjct: 99  VN-FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR-IGRFSE--PHARFYAA----- 149
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWY 198
             Q++   ++LHS  +I+RDLKP+NL+I + G +K+ DFG AK          +  T  Y
Sbjct: 150 --QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPEY 205
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
            APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 113/223 (50%), Gaps = 25/223 (11%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVR--FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
           ++    P +V+  F    + N+     Y+    +F H+ + +G + E  P     A+   
Sbjct: 98  VN---FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR-IGRFXE--PHARFYAA--- 148
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL 196
               Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T 
Sbjct: 149 ----QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTP 202
Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
            Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 14/219 (6%)
Query: 26  ELCQI-GCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           EL +I G G    V  ARDL++  + VA+K LR  L  D  P   LR     +      H
Sbjct: 15  ELGEILGFGGMSEVHLARDLRDHRD-VAVKVLRADLARD--PSFYLRFRREAQNAAALNH 71
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P IV  +D       +       Y++ E+VD   L   +    P  ++  +  E+     
Sbjct: 72  PAIVAVYDTGEAETPAGP---LPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADAC 126
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLT---SVVVTLWYR 199
           + ++F H + IIHRD+KP N++I+    +K+ DFG+A+   D    +T   +V+ T  Y 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV 238
           +PE           D++S+GCV+ E+    P F   + V
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 119/264 (45%), Gaps = 66/264 (25%)
Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           DL + +Y  + ++G G + TV+ + D+Q K  +VAMK ++   + +    + L EI +LK
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGK-KFVAMKVVK---SAEHYTETALDEIRLLK 88
Query: 78  QLDTFE--HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
            +   +   PN      ++    +S      + ++FE +   L  ++ K    GL    V
Sbjct: 89  SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCV 148
Query: 136 KELTRQMLKGVDFLHSH-RIIHRDLKPQNLLIT-----------------RAGG------ 171
           K++ +Q+L+G+D+LH+  RIIH D+KP+N+L++                 R+G       
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 172 --------------------------LKIADFGLA----KTFDYDMMLTSVVVTLWYRAP 201
                                     +KIAD G A    K F  D+       T  YR+ 
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ------TRQYRSL 262
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E+L+  GY TP DIWS  C+  E+
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFEL 286

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 113/223 (50%), Gaps = 25/223 (11%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVR--FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
           ++    P +V+  F    + N+     Y+    +F H+ + +G + E  P     A+   
Sbjct: 98  VN---FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR-IGRFXE--PHARFYAA--- 148
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL 196
               Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T 
Sbjct: 149 ----QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTP 202
Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
            Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 85/176 (48%), Gaps = 28/176 (15%)
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEIL 204
           G++ LH  RI++RDLKP+N+L+   G ++I+D GLA        +   V T+ Y APE++
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
            N  Y    D W++GC++ EM     +   S   ++ K I R      + E PE  S  +
Sbjct: 358 KNERYTFSPDWWALGCLLYEM-----IAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF 412
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKE 315
           S                   +A SL   +L  +PA+R+     SA +  EHP FK+
Sbjct: 413 S------------------PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 85/176 (48%), Gaps = 28/176 (15%)
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEIL 204
           G++ LH  RI++RDLKP+N+L+   G ++I+D GLA        +   V T+ Y APE++
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
            N  Y    D W++GC++ EM     +   S   ++ K I R      + E PE  S  +
Sbjct: 358 KNERYTFSPDWWALGCLLYEM-----IAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF 412
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKE 315
           S                   +A SL   +L  +PA+R+     SA +  EHP FK+
Sbjct: 413 S------------------PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 115/234 (49%), Gaps = 27/234 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  ++ GN+ AMK L     VKL +    
Sbjct: 34  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQ---I 85
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKC 125
             TL E  IL+ ++    P +V+       N         +Y++ E+V   ++ S++ + 
Sbjct: 86  EHTLNEKRILQAVN---FPFLVKLEFSFKDNS-------NLYMVMEYVAGGEMFSHLRRI 135
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
                S    +    Q++   ++LHS  +I+RDLKP+NL+I + G +++ DFG AK    
Sbjct: 136 GR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG 193
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                 +  T  Y APEI+++ GY   VD W++G ++ EM    P F A   ++
Sbjct: 194 RTW--XLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 25/223 (11%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVR--FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
           ++    P +V+  F    + N+     Y     +F H+ + +G + E  P     A+   
Sbjct: 98  VN---FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR-IGRFXE--PHARFYAA--- 148
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL 196
               Q++   ++LHS  +I+RDLKP+NL+I + G +K+ DFG AK          +  T 
Sbjct: 149 ----QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTP 202
Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
            Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   +  +  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKH-KETGNHFAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+V   ++ S++ +      S    + 
Sbjct: 98  VN---FPFLVKLEYSFKDNS-------NLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF 145
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPE 203
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   +  +  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKH-KETGNHFAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+V   ++ S++ +      S    + 
Sbjct: 98  VN---FPFLVKLEYSFKDNS-------NLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF 145
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPE 203
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   +  +  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKH-KETGNHFAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+V   ++ S++ +      S    + 
Sbjct: 98  VN---FPFLVKLEYSFKDNS-------NLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF 145
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPE 203
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   +  +  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 35  QFERIKTLGTGSFGRVMLVKH-KETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 90
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+V   ++ S++ +      S    + 
Sbjct: 91  VN---FPFLVKLEFSFKDNS-------NLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF 138
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T  
Sbjct: 139 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPE 196
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 197 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   +  +  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKH-KETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 98
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+V   ++ S++ +      S    + 
Sbjct: 99  VN---FPFLVKLEFSFKDNS-------NLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF 146
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T  
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPE 204
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   +  +  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKH-KETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 98
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+V   ++ S++ +      S    + 
Sbjct: 99  VN---FPFLVKLEFSFKDNS-------NLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF 146
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T  
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPE 204
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   +  +  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 63  QFERIKTLGTGSFGRVMLVKH-KETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 118
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+V   ++ S++ +      S    + 
Sbjct: 119 VN---FPFLVKLEFSFKDNS-------NLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF 166
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T  
Sbjct: 167 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPE 224
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   +  +  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKH-KETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 98
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+V   ++ S++ +      S    + 
Sbjct: 99  VN---FPFLVKLEFSFKDNS-------NLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF 146
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T  
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPE 204
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  ++ GN+ AMK L     VKL +    
Sbjct: 34  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQ---I 85
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKC 125
             TL E  IL+ ++    P +V+       N         +Y++ E+V   ++ S++ + 
Sbjct: 86  EHTLNEKRILQAVN---FPFLVKLEFSFKDNS-------NLYMVMEYVAGGEMFSHLRRI 135
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY 185
                S    +    Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK    
Sbjct: 136 GR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                 +  T  Y AP I+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 194 RTW--XLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 85/186 (45%), Gaps = 28/186 (15%)
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L+  + +   RQ++ G  +LH +R+IHRDLK  NL +     +KI DFGLA   +YD  
Sbjct: 113 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 172
Query: 189 LTSVVV-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
               +  T  Y APE+L   G+   VD+WSIGC+M  +                     +
Sbjct: 173 RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL---------------------L 211
Query: 248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           +G P     P   S +  ++ +  K  +S I       A SL++ ML  +P  R +  + 
Sbjct: 212 VGKP-----PFETSCLKETYLRIKKNEYS-IPKHINPVAASLIQKMLQTDPTARPTINEL 265
Query: 308 LEHPYF 313
           L   +F
Sbjct: 266 LNDEFF 271

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 82/321 (25%), Positives = 138/321 (42%), Gaps = 55/321 (17%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           ++L   S+ +  + Y  L QIG G    VF+   L  K    A+K + ++  ++    S 
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV--LNEKKQIYAIKYVNLEEADNQTLDSY 73
Query: 70  LREISILKQLDTFEHPN-IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
             EI+ L +L   +H + I+R +D      ++D+    +Y++ E  + DL S+++K    
Sbjct: 74  RNEIAYLNKLQ--QHSDKIIRLYDYE----ITDQY---IYMVMECGNIDLNSWLKK--KK 122
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-- 186
            +   + K   + ML+ V  +H H I+H DLKP N LI   G LK+ DFG+A     D  
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181
Query: 187 -MMLTSVVVTLWYRAPEILLNLGYG-----------TPVDIWSIGCVMAEM-WRLVPLFC 233
            ++  S V T+ Y  PE + ++                 D+WS+GC++  M +   P   
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
Query: 234 ASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESM 293
              ++ +L  I          + PE         +    V      + CC          
Sbjct: 242 IINQISKLHAIIDPNHEIEFPDIPE---------KDLQDV------LKCC---------- 276
Query: 294 LTFNPADRISAADALEHPYFK 314
           L  +P  RIS  + L HPY +
Sbjct: 277 LKRDPKQRISIPELLAHPYVQ 297

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 85/186 (45%), Gaps = 28/186 (15%)
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L+  + +   RQ++ G  +LH +R+IHRDLK  NL +     +KI DFGLA   +YD  
Sbjct: 113 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 172
Query: 189 LTSVVV-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
               +  T  Y APE+L   G+   VD+WSIGC+M  +                     +
Sbjct: 173 RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL---------------------L 211
Query: 248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           +G P     P   S +  ++ +  K  +S I       A SL++ ML  +P  R +  + 
Sbjct: 212 VGKP-----PFETSCLKETYLRIKKNEYS-IPKHINPVAASLIQKMLQTDPTARPTINEL 265
Query: 308 LEHPYF 313
           L   +F
Sbjct: 266 LNDEFF 271

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 27  LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT---FE 83
           L ++G G +G V         G +     + VK+ ++G    ++ E    ++  T     
Sbjct: 13  LKELGSGQFGVV-------KLGKWKGQYDVAVKMIKEG----SMSEDEFFQEAQTMMKLS 61
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           HP +V+F+ V  +          +Y++ E++         +    GL  S++ E+   + 
Sbjct: 62  HPKLVKFYGVCSKE-------YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVC 114
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVT--LWYRAP 201
           +G+ FL SH+ IHRDL  +N L+ R   +K++DFG+ +    D  ++SV     + + AP
Sbjct: 115 EGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAP 174
Query: 202 EILLNLGYGTPVDIWSIGCVMAEMWRL 228
           E+     Y +  D+W+ G +M E++ L
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSL 201

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 25/228 (10%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
            +++LG+ +      +  G +  V++A+D+   G   A+K+L    NE+    + ++E+ 
Sbjct: 21  QTVELGELRLRVRRVLAEGGFAFVYEAQDV-GSGREYALKRLLS--NEEEKNRAIIQEVC 77
Query: 75  ILKQLDTFEHPNIVRFFDVIH-QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSA 132
            +K+L    HPNIV+F          SD       L+ E     L  +++K    G LS 
Sbjct: 78  FMKKLSG--HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 133 SKVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLITRAGGLKIADFGLAKT------FD 184
             V ++  Q  + V  +H  +  IIHRDLK +NLL++  G +K+ DFG A T      + 
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195
Query: 185 YDMMLTSVV-------VTLWYRAPEIL---LNLGYGTPVDIWSIGCVM 222
           +     ++V        T  YR PEI+    N   G   DIW++GC++
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 85/186 (45%), Gaps = 28/186 (15%)
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L+  + +   RQ++ G  +LH +R+IHRDLK  NL +     +KI DFGLA   +YD  
Sbjct: 117 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 176
Query: 189 LTSVVV-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
               +  T  Y APE+L   G+   VD+WSIGC+M  +                     +
Sbjct: 177 RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL---------------------L 215
Query: 248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           +G P     P   S +  ++ +  K  +S I       A SL++ ML  +P  R +  + 
Sbjct: 216 VGKP-----PFETSCLKETYLRIKKNEYS-IPKHINPVAASLIQKMLQTDPTARPTINEL 269
Query: 308 LEHPYF 313
           L   +F
Sbjct: 270 LNDEFF 275

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 135/320 (42%), Gaps = 53/320 (16%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           ++L   S+ +  + Y  L QIG G    VF+   L  K    A+K + ++  ++    S 
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV--LNEKKQIYAIKYVNLEEADNQTLDSY 73
Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG 129
             EI+ L +L       I+R +D      ++D+    +Y++ E  + DL S+++K     
Sbjct: 74  RNEIAYLNKLQQHSD-KIIRLYDYE----ITDQ---YIYMVMECGNIDLNSWLKK--KKS 123
Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD--- 186
           +   + K   + ML+ V  +H H I+H DLKP N LI   G LK+ DFG+A     D   
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDXXX 182
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTP-----------VDIWSIGCVMAEM-WRLVPLFCA 234
           ++  S V T+ Y  PE + ++                 D+WS+GC++  M +   P    
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242
Query: 235 STEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESML 294
             ++ +L  I          + PE         +    V      + CC          L
Sbjct: 243 INQISKLHAIIDPNHEIEFPDIPE---------KDLQDV------LKCC----------L 277
Query: 295 TFNPADRISAADALEHPYFK 314
             +P  RIS  + L HPY +
Sbjct: 278 KRDPKQRISIPELLAHPYVQ 297

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 127/299 (42%), Gaps = 49/299 (16%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y+ +  IG G +G     RD Q+    VA+K +      + I  +  REI   + L   
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIE---RGEKIDENVKREIINHRSL--- 72
Query: 83  EHPNIVRFFDVI----HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
            HPNIVRF +VI    H  I+ +  Y +   +FE +          C     S  + +  
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVME--YASGGELFERI----------CNAGRFSEDEARFF 120
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLI--TRAGGLKIADFGLAKTFDYDMMLTSVVVTL 196
            +Q++ GV + H+ ++ HRDLK +N L+  + A  LKI  FG +K+        S V T 
Sbjct: 121 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTP 180
Query: 197 WYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL-KCIFRVIGTPSMN 254
            Y APE+LL   Y G   D+WS G  +  M      F    E +   K I R++      
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNV---- 236
Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
                         QY+   +  I  +C      L+  +   +PA RIS  +   H +F
Sbjct: 237 --------------QYAIPDYVHISPEC----RHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 26  ELCQI-GCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           EL +I G G    V  ARDL++  + VA+K LR  L  D  P   LR     +      H
Sbjct: 15  ELGEILGFGGMSEVHLARDLRDHRD-VAVKVLRADLARD--PSFYLRFRREAQNAAALNH 71
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P IV  +D       +       Y++ E+VD   L   +    P  ++  +  E+     
Sbjct: 72  PAIVAVYDTGEAETPAGP---LPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADAC 126
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLT---SVVVTLWYR 199
           + ++F H + IIHRD+KP N++I+    +K+ DFG+A+   D    +T   +V+ T  Y 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST 236
           +PE           D++S+GCV+ E+    P F   +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   + ++  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMET-GNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+    ++ S++ +      S    + 
Sbjct: 98  VN---FPFLVKLEFSFKDNS-------NLYMVMEYAPGGEMFSHLRRIGR--FSEPHARF 145
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NL+I + G +++ DFG AK          +  T  
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPE 203
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 115/246 (46%), Gaps = 31/246 (12%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           ++E+  +G GA+G V KAR+  +   Y A+KK+R    E+ +  + L E+ +L  L+   
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALD-SRYYAIKKIR--HTEEKLS-TILSEVXLLASLN--- 60
Query: 84  HPNIVRFFD--VIHQNILSD----ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE 137
           H  +VR++   +  +N +      ++  T+++  E+ +      +           +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---------- 187
           L RQ+L+ + ++HS  IIHR+LKP N+ I  +  +KI DFGLAK     +          
Sbjct: 121 LFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 188 -----MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL 241
                 LTS + T  Y A E+L   G Y   +D +S+G +  E   + P       V  L
Sbjct: 181 PGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEX--IYPFSTGXERVNIL 238
Query: 242 KCIFRV 247
           K +  V
Sbjct: 239 KKLRSV 244

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   +  +  GN+ AMK L     VKL +      TL E  I + 
Sbjct: 43  QFERIRTLGTGSFGRVMLVKH-KETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRIQQA 98
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+    ++ S++ +      S    + 
Sbjct: 99  VN---FPFLVKLEFSFKDNS-------NLYMVLEYAPGGEMFSHLRRIGR--FSEPHARF 146
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NLLI + G +K+ADFG AK          +  T  
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW--XLCGTPE 204
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 25/223 (11%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   +  +  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 35  QFERIKTLGTGSFGRVMLVKH-KETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 90
Query: 79  LDTFEHPNIVR--FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
           ++    P +V+  F    + N+     Y+    +F H+ + +G + E  P     A+   
Sbjct: 91  VN---FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR-IGRFXE--PHARFYAA--- 141
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL 196
               Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK          +  T 
Sbjct: 142 ----QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTP 195
Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
            Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 196 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 109/222 (49%), Gaps = 23/222 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQ 78
           +++ +  +G G++G V   +  +  GN+ AMK L     VKL +      TL E  IL+ 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKH-KETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 98
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKCPPPGLSASKVKE 137
           ++    P +V+       N         +Y++ E+    ++ S++ +      S    + 
Sbjct: 99  VN---FPFLVKLEFSFKDNS-------NLYMVMEYAPGGEMFSHLRRIGR--FSEPHARF 146
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              Q++   ++LHS  +I+RDLKP+NL+I + G +K+ DFG AK          +  T  
Sbjct: 147 YAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPE 204
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           Y APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 114/235 (48%), Gaps = 29/235 (12%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIP 66
           S N   LD    ++D +  +G G++G V   +  ++ GN+ AMK L     VKL +    
Sbjct: 34  SQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQ---I 85
Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYMEKC 125
             TL E  IL+ ++    P +V+       N         +Y++ E+V   ++ S++ + 
Sbjct: 86  EHTLNEKRILQAVN---FPFLVKLEFSFKDNS-------NLYMVMEYVAGGEMFSHLRRI 135
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD- 184
                S    +    Q++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK    
Sbjct: 136 GR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 185 YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
               L      L   APEI+L+ GY   VD W++G ++ EM    P F A   ++
Sbjct: 194 RTWXLCGTPEAL---APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVA--MKKLRVKLN---EDGIPMSTLREISIL 76
           +KY  +  +G GA+G V+ A D +     V   +KK +V  +   ED        EI+IL
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            ++   EH NI++  D     I  ++ +  + +       DL +++++ P   L      
Sbjct: 84  SRV---EHANIIKVLD-----IFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLAS 133
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL 196
            + RQ++  V +L    IIHRD+K +N++I     +K+ DFG A   +   +  +   T+
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTI 193
Query: 197 WYRAPEILLNLGYGTP-VDIWSIGCVM 222
            Y APE+L+   Y  P +++WS+G  +
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTL 220

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 89/347 (25%), Positives = 142/347 (40%), Gaps = 71/347 (20%)
Query: 1   MYEYSADTIQSLNLDSLDLG----DKK--------------YDELCQIGCGAYGTVFKAR 42
           M E +A   +  ++DS DLG    DK               Y  L QIG G    VF+  
Sbjct: 17  MKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV- 75
Query: 43  DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE 102
            L  K    A+K + ++  ++    S   EI+ L +L       I+R +D      ++D+
Sbjct: 76  -LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD-KIIRLYDYE----ITDQ 129
Query: 103 RYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQ 162
               +Y++ E  + DL S+++K     +   + K   + ML+ V  +H H I+H DLKP 
Sbjct: 130 ---YIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 184
Query: 163 NLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYRAPEILLNLGYG--------- 210
           N LI   G LK+ DFG+A     D   ++  S V T+ Y  PE + ++            
Sbjct: 185 NFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 243
Query: 211 --TPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
                D+WS+GC++  M +   P      ++ +L  I          + PE         
Sbjct: 244 ISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE--------- 294
Query: 268 EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           +    V      + CC          L  +P  RIS  + L HPY +
Sbjct: 295 KDLQDV------LKCC----------LKRDPKQRISIPELLAHPYVQ 325

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 89/347 (25%), Positives = 142/347 (40%), Gaps = 71/347 (20%)
Query: 1   MYEYSADTIQSLNLDSLDLG----DKK--------------YDELCQIGCGAYGTVFKAR 42
           M E +A   +  ++DS DLG    DK               Y  L QIG G    VF+  
Sbjct: 17  MKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV- 75
Query: 43  DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE 102
            L  K    A+K + ++  ++    S   EI+ L +L       I+R +D      ++D+
Sbjct: 76  -LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD-KIIRLYDYE----ITDQ 129
Query: 103 RYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQ 162
               +Y++ E  + DL S+++K     +   + K   + ML+ V  +H H I+H DLKP 
Sbjct: 130 ---YIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 184
Query: 163 NLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYRAPEILLNLGYG--------- 210
           N LI   G LK+ DFG+A     D   ++  S V T+ Y  PE + ++            
Sbjct: 185 NFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 243
Query: 211 --TPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
                D+WS+GC++  M +   P      ++ +L  I          + PE         
Sbjct: 244 ISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE--------- 294
Query: 268 EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           +    V      + CC          L  +P  RIS  + L HPY +
Sbjct: 295 KDLQDV------LKCC----------LKRDPKQRISIPELLAHPYVQ 325

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 29/216 (13%)
Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISIL 76
           +L D  ++ + ++G G  G V K   +Q++ + + M +  + L  +  I    +RE+ +L
Sbjct: 12  ELKDDDFERISELGAGNGGVVTK---VQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVL 68
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK-- 134
            + ++   P IV F+   + +         + +  EH+D   G  +++     L  +K  
Sbjct: 69  HECNS---PYIVGFYGAFYSD-------GEISICMEHMD---GGSLDQV----LKEAKRI 111
Query: 135 ----VKELTRQMLKGVDFLH-SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
               + +++  +L+G+ +L   H+I+HRD+KP N+L+   G +K+ DFG++     D M 
Sbjct: 112 PEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMA 170
Query: 190 TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            S V T  Y APE L    Y    DIWS+G  + E+
Sbjct: 171 NSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVEL 206

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 14/219 (6%)
Query: 26  ELCQI-GCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           EL +I G G    V  ARDL+   + VA+K LR  L  D  P   LR     +      H
Sbjct: 15  ELGEILGFGGMSEVHLARDLRLHRD-VAVKVLRADLARD--PSFYLRFRREAQNAAALNH 71
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P IV  +D       +       Y++ E+VD   L   +    P  ++  +  E+     
Sbjct: 72  PAIVAVYDTGEAETPAGP---LPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADAC 126
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLT---SVVVTLWYR 199
           + ++F H + IIHRD+KP N++I+    +K+ DFG+A+   D    +T   +V+ T  Y 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV 238
           +PE           D++S+GCV+ E+    P F   + V
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 113/237 (47%), Gaps = 31/237 (13%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P+IV   DV ++N+   +R L +  I E ++  +L S +++      +  +  E+ R + 
Sbjct: 63  PHIVCILDV-YENMHHGKRCLLI--IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 119
Query: 144 KGVDFLHSHRIIHRDLKPQNLLIT---RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
             + FLHSH I HRD+KP+NLL T   +   LK+ DFG AK    + + T    T +Y A
Sbjct: 120 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVA 178
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           PE+L    Y    D+WS+G +M  +    P F ++T         + I +P M      I
Sbjct: 179 PEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAI-SPGMK---RRI 226
Query: 261 SLMWSSF--EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
            L    F   ++S+V+           A  L+  +L  +P +R++    + HP+  +
Sbjct: 227 RLGQYGFPNPEWSEVS---------EDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 274

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/346 (23%), Positives = 144/346 (41%), Gaps = 87/346 (25%)
Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI----PMSTLREISILK 77
           KKY     IG G+YG V  A + Q +    A++ +++ +N++ I    P    R  + ++
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTR----AIRAIKI-MNKNKIRQINPKDVERIKTEVR 80
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEH-----------VDQDLGS------ 120
            +    HPNI R ++V       DE+Y+ + +   H           +D   G       
Sbjct: 81  LMKKLHHPNIARLYEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 121 YMEKCPPPGLSASKVK--------------------ELTRQMLKGVDFLHSHRIIHRDLK 160
             + CP P  +   +                      + RQ+   + +LH+  I HRD+K
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIK 195
Query: 161 PQNLLIT--RAGGLKIADFGLAKTF------DYDMMLTSVVVTLWYRAPEIL--LNLGYG 210
           P+N L +  ++  +K+ DFGL+K F      +Y  M T+   T ++ APE+L   N  YG
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM-TTKAGTPYFVAPEVLNTTNESYG 254
Query: 211 TPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQY 270
              D WS G ++  +                  +   +  P +N+  + IS + +     
Sbjct: 255 PKCDAWSAGVLLHLL------------------LMGAVPFPGVND-ADTISQVLN----- 290
Query: 271 SKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKE 315
            K+ F     +  S  A  LL ++L  N  +R  A  AL+HP+  +
Sbjct: 291 KKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 113/237 (47%), Gaps = 31/237 (13%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P+IV   DV ++N+   +R L +  I E ++  +L S +++      +  +  E+ R + 
Sbjct: 82  PHIVCILDV-YENMHHGKRCLLI--IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 144 KGVDFLHSHRIIHRDLKPQNLLIT---RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
             + FLHSH I HRD+KP+NLL T   +   LK+ DFG AK    + + T    T +Y A
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVA 197
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           PE+L    Y    D+WS+G +M  +    P F ++T         + I +P M      I
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAI-SPGMK---RRI 245
Query: 261 SLMWSSF--EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
            L    F   ++S+V+           A  L+  +L  +P +R++    + HP+  +
Sbjct: 246 RLGQYGFPNPEWSEVS---------EDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 133/290 (45%), Gaps = 33/290 (11%)
Query: 30  IGCGAYGTVFKAR---DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G G +G V   R   +  N G  VA+K L+ +   + I     +EI IL+ L    H N
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI-ADLKKEIEILRNL---YHEN 72
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR--QMLK 144
           IV++     + I +++    + LI E +    GS  E  P      +  ++L    Q+ K
Sbjct: 73  IVKY-----KGICTEDGGNGIKLIMEFLPS--GSLKEYLPKNKNKINLKQQLKYAVQICK 125
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWYR 199
           G+D+L S + +HRDL  +N+L+     +KI DFGL K  + D    +V         WY 
Sbjct: 126 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY- 184
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           APE L+   +    D+WS G  + E+      +C S +   +    ++IG P+  +    
Sbjct: 185 APECLMQSKFYIASDVWSFGVTLHELL----TYCDS-DSSPMALFLKMIG-PTHGQM--T 236
Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE 309
           ++ + ++ ++  ++       +C  +   L+     F P++R S  + +E
Sbjct: 237 VTRLVNTLKEGKRLPCPP---NCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 14/219 (6%)
Query: 26  ELCQI-GCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           EL +I G G    V  ARDL+   + VA+K LR  L  D  P   LR     +      H
Sbjct: 32  ELGEILGFGGMSEVHLARDLRLHRD-VAVKVLRADLARD--PSFYLRFRREAQNAAALNH 88
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P IV  +D       +       Y++ E+VD   L   +    P  ++  +  E+     
Sbjct: 89  PAIVAVYDTGEAETPAGP---LPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADAC 143
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLT---SVVVTLWYR 199
           + ++F H + IIHRD+KP N++I+    +K+ DFG+A+   D    +T   +V+ T  Y 
Sbjct: 144 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 203
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV 238
           +PE           D++S+GCV+ E+    P F   + V
Sbjct: 204 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 130/296 (43%), Gaps = 47/296 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +IG G++ TV+K  D +     VA  +L+ +            E   LK L   +HPNIV
Sbjct: 33  EIGRGSFKTVYKGLDTETTVE-VAWCELQDRKLTKSERQRFKEEAEXLKGL---QHPNIV 88
Query: 89  RFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELT---RQMLK 144
           RF+D     +   +    + L+ E      L +Y+++         K+K L    RQ+LK
Sbjct: 89  RFYDSWESTVKGKK---CIVLVTELXTSGTLKTYLKR-----FKVXKIKVLRSWCRQILK 140
Query: 145 GVDFLHSHR--IIHRDLKPQNLLITR-AGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           G+ FLH+    IIHRDLK  N+ IT   G +KI D GLA T        +V+ T  + AP
Sbjct: 141 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAP 199
Query: 202 EILLNLGYGTPVDIWSIG-CVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           E      Y   VD+++ G C +       P     +E +    I+R + +          
Sbjct: 200 E-XYEEKYDESVDVYAFGXCXLEXATSEYPY----SECQNAAQIYRRVTS---------- 244
Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK 316
            +  +SF+   KVA   +          ++E  +  N  +R S  D L H +F+E+
Sbjct: 245 GVKPASFD---KVAIPEV--------KEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 133/290 (45%), Gaps = 33/290 (11%)
Query: 30  IGCGAYGTVFKAR---DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G G +G V   R   +  N G  VA+K L+ +   + I     +EI IL+ L    H N
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI-ADLKKEIEILRNL---YHEN 84
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR--QMLK 144
           IV++     + I +++    + LI E +    GS  E  P      +  ++L    Q+ K
Sbjct: 85  IVKY-----KGICTEDGGNGIKLIMEFLPS--GSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWYR 199
           G+D+L S + +HRDL  +N+L+     +KI DFGL K  + D    +V         WY 
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY- 196
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           APE L+   +    D+WS G  + E+      +C S +   +    ++IG P+  +    
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELL----TYCDS-DSSPMALFLKMIG-PTHGQM--T 248
Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE 309
           ++ + ++ ++  ++       +C  +   L+     F P++R S  + +E
Sbjct: 249 VTRLVNTLKEGKRLPCPP---NCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 49/299 (16%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y+ +  IG G +G     RD Q+    VA+K +      + I  +  REI   + L   
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIE---RGEKIDENVKREIINHRSL--- 72
Query: 83  EHPNIVRFFDVI----HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
            HPNIVRF +VI    H  I+ +  Y +   +FE +          C     S  + +  
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVME--YASGGELFERI----------CNAGRFSEDEARFF 120
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLI--TRAGGLKIADFGLAKTFDYDMMLTSVVVTL 196
            +Q++ GV + H+ ++ HRDLK +N L+  + A  LKI  FG +K+          V T 
Sbjct: 121 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTP 180
Query: 197 WYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL-KCIFRVIGTPSMN 254
            Y APE+LL   Y G   D+WS G  +  M      F    E +   K I R++      
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNV---- 236
Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
                         QY+   +  I  +C      L+  +   +PA RIS  +   H +F
Sbjct: 237 --------------QYAIPDYVHISPEC----RHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 133/305 (43%), Gaps = 52/305 (17%)
Query: 27  LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD----TF 82
           + ++G GAYG V K R + + G   A+K++R  +N       +  +  +L  LD    T 
Sbjct: 39  IXELGRGAYGVVEKXRHVPS-GQIXAVKRIRATVN-------SQEQKRLLXDLDISXRTV 90
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK--VKELTR 140
           + P  V F+  +        R   V++  E  D  L  + ++    G +  +  + ++  
Sbjct: 91  DCPFTVTFYGALF-------REGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAV 143
Query: 141 QMLKGVDFLHSH-RIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
            ++K ++ LHS   +IHRD+KP N+LI   G +K  DFG++     D+          Y 
Sbjct: 144 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYX 203
Query: 200 APEIL---LNL-GYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRVIGTPSMN 254
           APE +   LN  GY    DIWS+G    E+  L  P     T  +QLK   +V+  PS  
Sbjct: 204 APERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLK---QVVEEPS-- 258
Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
                         Q     FSA F+D  S+        L  N  +R +  +  +HP+F 
Sbjct: 259 -------------PQLPADKFSAEFVDFTSQC-------LKKNSKERPTYPELXQHPFFT 298
Query: 315 EKENE 319
             E++
Sbjct: 299 LHESK 303

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 127/312 (40%), Gaps = 65/312 (20%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y  L QIG G    VF+   L  K    A+K + ++  ++    S   EI+ L +L    
Sbjct: 14  YSILKQIGSGGSSKVFQV--LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 71
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
              I+R +D      ++D+    +Y++ E  + DL S+++K     +   + K   + ML
Sbjct: 72  D-KIIRLYDYE----ITDQY---IYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNML 121
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYRA 200
           + V  +H H I+H DLKP N LI   G LK+ DFG+A     D   ++  S V T+ Y  
Sbjct: 122 EAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 180
Query: 201 PEILLNLGYG-----------TPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG 249
           PE + ++                 D+WS+GC++  M                       G
Sbjct: 181 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM---------------------TYG 219
Query: 250 TPSMNEWPENISLMWSSFEQYSKVAFSAI-------FMDCCSKANSLLESMLTFNPADRI 302
                +    IS + +  +   ++ F  I        + CC          L  +P  RI
Sbjct: 220 KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC----------LKRDPKQRI 269
Query: 303 SAADALEHPYFK 314
           S  + L HPY +
Sbjct: 270 SIPELLAHPYVQ 281

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 126/306 (41%), Gaps = 72/306 (23%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMS---TLREISILKQLDTFEHPN 86
           +G GA GT+       N+   VA+K++        +P       RE+ +L++ D  EHPN
Sbjct: 32  LGHGAEGTIVYRGMFDNRD--VAVKRI--------LPECFSFADREVQLLRESD--EHPN 79
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           ++R+F        +++     Y+  E     L  Y+E+     L    +  L +Q   G+
Sbjct: 80  VIRYF-------CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPIT-LLQQTTSGL 131
Query: 147 DFLHSHRIIHRDLKPQNLLITRA---GGLK--IADFGLAKTFDYDM----MLTSVVVTLW 197
             LHS  I+HRDLKP N+LI+     G +K  I+DFGL K            + V  T  
Sbjct: 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 198 YRAPEILLNLGYGTP---VDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
           + APE+L       P   VDI+S GCV                       + VI      
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVF----------------------YYVIS----- 224
Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSK-------ANSLLESMLTFNPADRISAADA 307
              E       S ++ + +   A  +DC          A  L+E M+  +P  R SA   
Sbjct: 225 ---EGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
Query: 308 LEHPYF 313
           L+HP+F
Sbjct: 282 LKHPFF 287

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 127/312 (40%), Gaps = 65/312 (20%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y  L QIG G    VF+   L  K    A+K + ++  ++    S   EI+ L +L    
Sbjct: 11  YSILKQIGSGGSSKVFQV--LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
              I+R +D      ++D+    +Y++ E  + DL S+++K     +   + K   + ML
Sbjct: 69  -DKIIRLYDYE----ITDQ---YIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNML 118
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYRA 200
           + V  +H H I+H DLKP N LI   G LK+ DFG+A     D   ++  S V T+ Y  
Sbjct: 119 EAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 201 PEILLNLGYG-----------TPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG 249
           PE + ++                 D+WS+GC++  M                       G
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM---------------------TYG 216
Query: 250 TPSMNEWPENISLMWSSFEQYSKVAFSAI-------FMDCCSKANSLLESMLTFNPADRI 302
                +    IS + +  +   ++ F  I        + CC          L  +P  RI
Sbjct: 217 KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC----------LKRDPKQRI 266
Query: 303 SAADALEHPYFK 314
           S  + L HPY +
Sbjct: 267 SIPELLAHPYVQ 278

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 127/312 (40%), Gaps = 65/312 (20%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y  L QIG G    VF+   L  K    A+K + ++  ++    S   EI+ L +L    
Sbjct: 10  YSILKQIGSGGSSKVFQV--LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 67
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
              I+R +D      ++D+    +Y++ E  + DL S+++K     +   + K   + ML
Sbjct: 68  D-KIIRLYDYE----ITDQ---YIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNML 117
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYRA 200
           + V  +H H I+H DLKP N LI   G LK+ DFG+A     D   ++  S V T+ Y  
Sbjct: 118 EAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 176
Query: 201 PEILLNLGYG-----------TPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG 249
           PE + ++                 D+WS+GC++  M                       G
Sbjct: 177 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM---------------------TYG 215
Query: 250 TPSMNEWPENISLMWSSFEQYSKVAFSAI-------FMDCCSKANSLLESMLTFNPADRI 302
                +    IS + +  +   ++ F  I        + CC          L  +P  RI
Sbjct: 216 KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC----------LKRDPKQRI 265
Query: 303 SAADALEHPYFK 314
           S  + L HPY +
Sbjct: 266 SIPELLAHPYVQ 277

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 89/327 (27%), Positives = 146/327 (44%), Gaps = 65/327 (19%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMS 68
           S NLD + L D  ++ L  +G G++G V  A D +      A+K L+  V + +D +   
Sbjct: 10  SNNLDRVKLTD--FNFLMVLGKGSFGKVMLA-DRKGTEELYAIKILKKDVVIQDDDVE-C 65
Query: 69  TLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGS 120
           T+ E  +L  LD         F   +H    + +R   +Y + E+V+        Q +G 
Sbjct: 66  TMVEKRVLALLDK------PPFLTQLHSCFQTVDR---LYFVMEYVNGGDLMYHIQQVGK 116
Query: 121 YMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA 180
           + E  P     A+++         G+ FLH   II+RDLK  N+++   G +KIADFG+ 
Sbjct: 117 FKE--PQAVFYAAEIS-------IGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMC 167
Query: 181 KTFDYDMMLT-SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           K    D + T     T  Y APEI+    YG  VD W+ G ++ EM    P F    E E
Sbjct: 168 KEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 227
Query: 240 QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPA 299
               +F+ I   +++ +P+++S                       +A S+ + ++T +PA
Sbjct: 228 ----LFQSIMEHNVS-YPKSLS----------------------KEAVSICKGLMTKHPA 260
Query: 300 DRISAA-----DALEHPYFKEKENEPL 321
            R+        D  EH +F+  + E L
Sbjct: 261 KRLGCGPEGERDVREHAFFRRIDWEKL 287

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 83/334 (24%), Positives = 150/334 (44%), Gaps = 52/334 (15%)
Query: 1   MYEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKL 60
           M E S+    S+N D  +L +        IG GA   V +A     K   VA+K++ ++ 
Sbjct: 1   MSEDSSALPWSINRDDYELQE-------VIGSGATAVV-QAAYCAPKKEKVAIKRINLEK 52
Query: 61  NEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYL--------IFE 112
            +  +    L+EI  + Q     HPNIV ++      ++ DE +L + L        I +
Sbjct: 53  CQTSMD-ELLKEIQAMSQC---HHPNIVSYYTSF---VVKDELWLVMKLLSGGSVLDIIK 105
Query: 113 HVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL 172
           H+    G +        L  S +  + R++L+G+++LH +  IHRD+K  N+L+   G +
Sbjct: 106 HIVAK-GEHKSGV----LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSV 160
Query: 173 KIADFGLAKTFDYDMMLT------SVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEM 225
           +IADFG++        +T      + V T  + APE++  + GY    DIWS G    E+
Sbjct: 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220
Query: 226 WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSK 285
                 +     ++ L    +    PS+    ++  ++    ++Y K +F  +   C  K
Sbjct: 221 ATGAAPYHKYPPMKVLMLTLQN-DPPSLETGVQDKEML----KKYGK-SFRKMISLCLQK 274
Query: 286 ANSLLESMLTFNPADRISAADALEHPYFKEKENE 319
                      +P  R +AA+ L H +F++ +N+
Sbjct: 275 -----------DPEKRPTAAELLRHKFFQKAKNK 297

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 88/347 (25%), Positives = 141/347 (40%), Gaps = 71/347 (20%)
Query: 1   MYEYSADTIQSLNLDSLDLG----DKK--------------YDELCQIGCGAYGTVFKAR 42
           M E +A   +  ++DS DLG    DK               Y  L QIG G    VF+  
Sbjct: 17  MKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV- 75
Query: 43  DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE 102
            L  K    A+K + ++  ++    S   EI+ L +L       I+R +D      ++D+
Sbjct: 76  -LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD-KIIRLYDYE----ITDQ 129
Query: 103 RYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQ 162
               +Y++ E  + DL S+++K     +   + K   + ML+ V  +H H I+H DLKP 
Sbjct: 130 ---YIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 184
Query: 163 NLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWYRAPEILLNLGYG--------- 210
           N LI   G LK+ DFG+A     D   ++  S V  + Y  PE + ++            
Sbjct: 185 NFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSK 243
Query: 211 --TPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF 267
                D+WS+GC++  M +   P      ++ +L  I          + PE         
Sbjct: 244 ISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE--------- 294
Query: 268 EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           +    V      + CC          L  +P  RIS  + L HPY +
Sbjct: 295 KDLQDV------LKCC----------LKRDPKQRISIPELLAHPYVQ 325

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 127/312 (40%), Gaps = 47/312 (15%)
Query: 9   IQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMS 68
           +Q L+ +S+   D  Y+    IG G+Y      R +    N     K+  K   D     
Sbjct: 10  VQQLHRNSIQFTDG-YEVKEDIGVGSYSVC--KRCIHKATNXEFAVKIIDKSKRD----- 61
Query: 69  TLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKC-PP 127
              EI IL  L   +HPNI+   DV       D +Y  VY++ E      G  ++K    
Sbjct: 62  PTEEIEIL--LRYGQHPNIITLKDV-----YDDGKY--VYVVTELXKG--GELLDKILRQ 110
Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG----LKIADFGLAKTF 183
              S  +   +   + K V++LH+  ++HRDLKP N+L     G    ++I DFG AK  
Sbjct: 111 KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 184 DYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLK 242
             +  +L +   T  + APE+L   GY    DIWS+G ++         F    +     
Sbjct: 171 RAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD----- 225
Query: 243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCS-KANSLLESMLTFNPADR 301
                       + PE I     S     K + S  + +  S  A  L+   L  +P  R
Sbjct: 226 ------------DTPEEILARIGS----GKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQR 269
Query: 302 ISAADALEHPYF 313
           ++AA  L HP+ 
Sbjct: 270 LTAALVLRHPWI 281

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 141/311 (45%), Gaps = 58/311 (18%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGI--PMSTLREIS 74
           LG   ++ +  +G G++G V  AR ++  G+  A+K L+  V L +D +   M+  R +S
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLAR-VKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSAS 133
           + +      HP + + F        + +R   ++ + E V+  DL  +++K        +
Sbjct: 79  LARN-----HPFLTQLFCCFQ----TPDR---LFFVMEFVNGGDLMFHIQKSR--RFDEA 124
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV 193
           + +    +++  + FLH   II+RDLK  N+L+   G  K+ADFG+ K    + + T+  
Sbjct: 125 RARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF 184
Query: 194 V-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFC--ASTEVEQLKCIFRVIGT 250
             T  Y APEIL  + YG  VD W++G ++ EM       C  A  E E    +F  I  
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEM------LCGHAPFEAENEDDLFEAI-- 236
Query: 251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA--- 307
             +N+  E +   W                     A  +L+S +T NP  R+ +      
Sbjct: 237 --LND--EVVYPTWLH-----------------EDATGILKSFMTKNPTMRLGSLTQGGE 275
Query: 308 ---LEHPYFKE 315
              L HP+FKE
Sbjct: 276 HAILRHPFFKE 286

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 137/308 (44%), Gaps = 39/308 (12%)
Query: 16  SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR-EIS 74
           S  LG + +D L  IG G+Y  V   R L+      AMK ++ +L  D   +  ++ E  
Sbjct: 14  SSSLGLQDFDLLRVIGRGSYAKVLLVR-LKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 72
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSAS 133
           + +Q     HP +V     +H    ++ R   ++ + E+V+  DL  +M++     L   
Sbjct: 73  VFEQASN--HPFLVG----LHSCFQTESR---LFFVIEYVNGGDLMFHMQR--QRKLPEE 121
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV 193
             +  + ++   +++LH   II+RDLK  N+L+   G +K+ D+G+ K        TS  
Sbjct: 122 HARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF 181
Query: 194 V-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  Y APEIL    YG  VD W++G +M EM                +  F ++G+  
Sbjct: 182 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM-------------AGRSPFDIVGSSD 228
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA------AD 306
             +      L     E+  ++  S        KA S+L+S L  +P +R+        AD
Sbjct: 229 NPDQNTEDYLFQVILEKQIRIPRS-----MSVKAASVLKSFLNKDPKERLGCLPQTGFAD 283
Query: 307 ALEHPYFK 314
              HP+F+
Sbjct: 284 IQGHPFFR 291

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 132/301 (43%), Gaps = 54/301 (17%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDT 81
           +D L  +G G +G V   R+ +  G Y AMK LR  V + +D +   T+ E  +L+    
Sbjct: 7   FDYLKLLGKGTFGKVILVRE-KATGRYYAMKILRKEVIIAKDEVA-HTVTESRVLQNT-- 62
Query: 82  FEHP--NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT 139
             HP    +++    H  +     Y     +F H+ +      E+      +  + +   
Sbjct: 63  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR------ERV----FTEERARFYG 111
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLWY 198
            +++  +++LHS  +++RD+K +NL++ + G +KI DFGL K    D   + +   T  Y
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
            APE+L +  YG  VD W +G VM EM    +P +    E      +F +I    +  +P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELILMEEIR-FP 225
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPY 312
             +S                       +A SLL  +L  +P  R+      A + +EH +
Sbjct: 226 RTLS----------------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
Query: 313 F 313
           F
Sbjct: 264 F 264

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 136/305 (44%), Gaps = 39/305 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR-EISILK 77
           LG + +D L  IG G+Y  V   R L+      AMK ++ +L  D   +  ++ E  + +
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVR-LKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 60
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVK 136
           Q     HP +V     +H    ++ R   ++ + E+V+  DL  +M++     L     +
Sbjct: 61  QASN--HPFLVG----LHSCFQTESR---LFFVIEYVNGGDLMFHMQRQRK--LPEEHAR 109
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-T 195
             + ++   +++LH   II+RDLK  N+L+   G +K+ D+G+ K        TS    T
Sbjct: 110 FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGT 169
Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
             Y APEIL    YG  VD W++G +M EM                +  F ++G+    +
Sbjct: 170 PNYIAPEILRGEDYGFSVDWWALGVLMFEMM-------------AGRSPFDIVGSSDNPD 216
Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA------ADALE 309
                 L     E+  ++  S        KA S+L+S L  +P +R+        AD   
Sbjct: 217 QNTEDYLFQVILEKQIRIPRS-----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 271
Query: 310 HPYFK 314
           HP+F+
Sbjct: 272 HPFFR 276

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 132/301 (43%), Gaps = 54/301 (17%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDT 81
           +D L  +G G +G V   R+ +  G Y AMK LR  V + +D +   T+ E  +L+    
Sbjct: 7   FDYLKLLGKGTFGKVILVRE-KATGRYYAMKILRKEVIIAKDEVA-HTVTESRVLQNT-- 62
Query: 82  FEHP--NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT 139
             HP    +++    H  +     Y     +F H+ +      E+      +  + +   
Sbjct: 63  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR------ERV----FTEERARFYG 111
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLWY 198
            +++  +++LHS  +++RD+K +NL++ + G +KI DFGL K    D   + +   T  Y
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
            APE+L +  YG  VD W +G VM EM    +P +    E      +F +I    +  +P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELILMEEIR-FP 225
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPY 312
             +S                       +A SLL  +L  +P  R+      A + +EH +
Sbjct: 226 RTLS----------------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
Query: 313 F 313
           F
Sbjct: 264 F 264

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           D+    ++ L  IG G++G V   +    K  Y      + K  E     +  +E+ I++
Sbjct: 11  DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE 137
            L   EHP +V  +         ++ ++ V L+   +  DL  ++++          VK 
Sbjct: 71  GL---EHPFLVNLWYSFQD---EEDMFMVVDLL---LGGDLRYHLQQNV--HFKEETVKL 119
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
              +++  +D+L + RIIHRD+KP N+L+   G + I DF +A     +  +T++  T  
Sbjct: 120 FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKP 179
Query: 198 YRAPEILLN---LGYGTPVDIWSIGCVMAEMWR 227
           Y APE+  +    GY   VD WS+G    E+ R
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 32/243 (13%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P+IVR  DV ++N+ +  + L +  + E +D  +L S ++       +  +  E+ + + 
Sbjct: 121 PHIVRIVDV-YENLYAGRKCLLI--VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 177
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           + + +LHS  I HRD+KP+NLL T       LK+ DFG AK       LT+   T +Y A
Sbjct: 178 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 237
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE---QLKCIFRVIGTPSMNEWP 257
           PE+L    Y    D+WS+G +M  +    P F ++  +     +K   R+       E+P
Sbjct: 238 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQYEFP 293
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE 317
              +  WS   +  K+               L+ ++L   P  R++  + + HP+  +  
Sbjct: 294 ---NPEWSEVSEEVKM---------------LIRNLLKTEPTQRMTITEFMNHPWIMQST 335
Query: 318 NEP 320
             P
Sbjct: 336 KVP 338

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 32/243 (13%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P+IVR  DV ++N+ +  + L +  + E +D  +L S ++       +  +  E+ + + 
Sbjct: 85  PHIVRIVDV-YENLYAGRKCLLI--VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 141
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           + + +LHS  I HRD+KP+NLL T       LK+ DFG AK       LT+   T +Y A
Sbjct: 142 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 201
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE---QLKCIFRVIGTPSMNEWP 257
           PE+L    Y    D+WS+G +M  +    P F ++  +     +K   R+       E+P
Sbjct: 202 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQYEFP 257
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE 317
              +  WS   +  K+               L+ ++L   P  R++  + + HP+  +  
Sbjct: 258 ---NPEWSEVSEEVKM---------------LIRNLLKTEPTQRMTITEFMNHPWIMQST 299
Query: 318 NEP 320
             P
Sbjct: 300 KVP 302

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 136/305 (44%), Gaps = 39/305 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR-EISILK 77
           LG + +D L  IG G+Y  V   R L+      AMK ++ +L  D   +  ++ E  + +
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVR-LKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVK 136
           Q     HP +V     +H    ++ R   ++ + E+V+  DL  +M++     L     +
Sbjct: 65  QASN--HPFLVG----LHSCFQTESR---LFFVIEYVNGGDLMFHMQRQRK--LPEEHAR 113
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-T 195
             + ++   +++LH   II+RDLK  N+L+   G +K+ D+G+ K        TS    T
Sbjct: 114 FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGT 173
Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
             Y APEIL    YG  VD W++G +M EM                +  F ++G+    +
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMM-------------AGRSPFDIVGSSDNPD 220
Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA------ADALE 309
                 L     E+  ++  S        KA S+L+S L  +P +R+        AD   
Sbjct: 221 QNTEDYLFQVILEKQIRIPRS-----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275
Query: 310 HPYFK 314
           HP+F+
Sbjct: 276 HPFFR 280

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 32/243 (13%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P+IVR  DV ++N+ +  + L +  + E +D  +L S ++       +  +  E+ + + 
Sbjct: 69  PHIVRIVDV-YENLYAGRKCLLI--VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           + + +LHS  I HRD+KP+NLL T       LK+ DFG AK       LT+   T +Y A
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 185
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE---QLKCIFRVIGTPSMNEWP 257
           PE+L    Y    D+WS+G +M  +    P F ++  +     +K   R+       E+P
Sbjct: 186 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQYEFP 241
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE 317
              +  WS   +  K+               L+ ++L   P  R++  + + HP+  +  
Sbjct: 242 ---NPEWSEVSEEVKM---------------LIRNLLKTEPTQRMTITEFMNHPWIMQST 283
Query: 318 NEP 320
             P
Sbjct: 284 KVP 286

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 32/243 (13%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P+IVR  DV ++N+ +  + L +  + E +D  +L S ++       +  +  E+ + + 
Sbjct: 115 PHIVRIVDV-YENLYAGRKCLLI--VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           + + +LHS  I HRD+KP+NLL T       LK+ DFG AK       LT+   T +Y A
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE---QLKCIFRVIGTPSMNEWP 257
           PE+L    Y    D+WS+G +M  +    P F ++  +     +K   R+       E+P
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQYEFP 287
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE 317
              +  WS   +  K+               L+ ++L   P  R++  + + HP+  +  
Sbjct: 288 ---NPEWSEVSEEVKM---------------LIRNLLKTEPTQRMTITEFMNHPWIMQST 329
Query: 318 NEP 320
             P
Sbjct: 330 KVP 332

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 56/302 (18%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDT 81
           +D L  +G G +G V   R+ +  G Y AMK LR  V + +D +   T+ E  +L+    
Sbjct: 10  FDYLKLLGKGTFGKVILVRE-KATGRYYAMKILRKEVIIAKDEVA-HTVTESRVLQNT-- 65
Query: 82  FEHP--NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT 139
             HP    +++    H  +     Y     +F H+ +      E+      +  + +   
Sbjct: 66  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR------ERV----FTEERARFYG 114
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLWY 198
            +++  +++LHS  +++RD+K +NL++ + G +KI DFGL K    D   + +   T  Y
Sbjct: 115 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 174
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMW--RLVPLFCASTEVEQLKCIFRVIGTPSMNEW 256
            APE+L +  YG  VD W +G VM EM   RL P +    E      +F +I    +  +
Sbjct: 175 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL-PFYNQDHER-----LFELILMEEIR-F 227
Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHP 311
           P  +S                       +A SLL  +L  +P  R+      A + +EH 
Sbjct: 228 PRTLS----------------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 265
Query: 312 YF 313
           +F
Sbjct: 266 FF 267

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 32/243 (13%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P+IVR  DV ++N+ +  + L +  + E +D  +L S ++       +  +  E+ + + 
Sbjct: 71  PHIVRIVDV-YENLYAGRKCLLI--VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           + + +LHS  I HRD+KP+NLL T       LK+ DFG AK       LT+   T +Y A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 187
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE---QLKCIFRVIGTPSMNEWP 257
           PE+L    Y    D+WS+G +M  +    P F ++  +     +K   R+       E+P
Sbjct: 188 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQYEFP 243
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE 317
              +  WS   +  K+               L+ ++L   P  R++  + + HP+  +  
Sbjct: 244 ---NPEWSEVSEEVKM---------------LIRNLLKTEPTQRMTITEFMNHPWIMQST 285
Query: 318 NEP 320
             P
Sbjct: 286 KVP 288

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 32/243 (13%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P+IVR  DV ++N+ +  + L +  + E +D  +L S ++       +  +  E+ + + 
Sbjct: 71  PHIVRIVDV-YENLYAGRKCLLI--VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           + + +LHS  I HRD+KP+NLL T       LK+ DFG AK       LT+   T +Y A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 187
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE---QLKCIFRVIGTPSMNEWP 257
           PE+L    Y    D+WS+G +M  +    P F ++  +     +K   R+       E+P
Sbjct: 188 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQYEFP 243
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE 317
              +  WS   +  K+               L+ ++L   P  R++  + + HP+  +  
Sbjct: 244 ---NPEWSEVSEEVKM---------------LIRNLLKTEPTQRMTITEFMNHPWIMQST 285
Query: 318 NEP 320
             P
Sbjct: 286 KVP 288

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 32/243 (13%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P+IVR  DV ++N+ +  + L +  + E +D  +L S ++       +  +  E+ + + 
Sbjct: 70  PHIVRIVDV-YENLYAGRKCLLI--VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 126
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           + + +LHS  I HRD+KP+NLL T       LK+ DFG AK       LT+   T +Y A
Sbjct: 127 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 186
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE---QLKCIFRVIGTPSMNEWP 257
           PE+L    Y    D+WS+G +M  +    P F ++  +     +K   R+       E+P
Sbjct: 187 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQYEFP 242
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE 317
              +  WS   +  K+               L+ ++L   P  R++  + + HP+  +  
Sbjct: 243 ---NPEWSEVSEEVKM---------------LIRNLLKTEPTQRMTITEFMNHPWIMQST 284
Query: 318 NEP 320
             P
Sbjct: 285 KVP 287

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 32/243 (13%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P+IVR  DV ++N+ +  + L +  + E +D  +L S ++       +  +  E+ + + 
Sbjct: 77  PHIVRIVDV-YENLYAGRKCLLI--VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 133
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           + + +LHS  I HRD+KP+NLL T       LK+ DFG AK       LT+   T +Y A
Sbjct: 134 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 193
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE---QLKCIFRVIGTPSMNEWP 257
           PE+L    Y    D+WS+G +M  +    P F ++  +     +K   R+       E+P
Sbjct: 194 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQYEFP 249
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE 317
              +  WS   +  K+               L+ ++L   P  R++  + + HP+  +  
Sbjct: 250 ---NPEWSEVSEEVKM---------------LIRNLLKTEPTQRMTITEFMNHPWIMQST 291
Query: 318 NEP 320
             P
Sbjct: 292 KVP 294

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 76/142 (53%), Gaps = 7/142 (4%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P+IVR  DV ++N+ +  + L +  + E +D  +L S ++       +  +  E+ + + 
Sbjct: 76  PHIVRIVDV-YENLYAGRKCLLI--VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 132
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           + + +LHS  I HRD+KP+NLL T       LK+ DFG AK       LT+   T +Y A
Sbjct: 133 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 192
Query: 201 PEILLNLGYGTPVDIWSIGCVM 222
           PE+L    Y    D+WS+G +M
Sbjct: 193 PEVLGPEKYDKSCDMWSLGVIM 214

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 76/142 (53%), Gaps = 7/142 (4%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P+IVR  DV ++N+ +  + L +  + E +D  +L S ++       +  +  E+ + + 
Sbjct: 75  PHIVRIVDV-YENLYAGRKCLLI--VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 131
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           + + +LHS  I HRD+KP+NLL T       LK+ DFG AK       LT+   T +Y A
Sbjct: 132 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 191
Query: 201 PEILLNLGYGTPVDIWSIGCVM 222
           PE+L    Y    D+WS+G +M
Sbjct: 192 PEVLGPEKYDKSCDMWSLGVIM 213

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 137/308 (44%), Gaps = 39/308 (12%)
Query: 16  SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR-EIS 74
           S  LG + +D L  IG G+Y  V   R L+      AM+ ++ +L  D   +  ++ E  
Sbjct: 46  SSSLGLQDFDLLRVIGRGSYAKVLLVR-LKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH 104
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSAS 133
           + +Q     HP +V     +H    ++ R   ++ + E+V+  DL  +M++     L   
Sbjct: 105 VFEQASN--HPFLVG----LHSCFQTESR---LFFVIEYVNGGDLMFHMQRQRK--LPEE 153
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV 193
             +  + ++   +++LH   II+RDLK  N+L+   G +K+ D+G+ K        TS  
Sbjct: 154 HARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 213
Query: 194 V-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  Y APEIL    YG  VD W++G +M EM                +  F ++G+  
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM-------------AGRSPFDIVGSSD 260
Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA------AD 306
             +      L     E+  ++  S        KA S+L+S L  +P +R+        AD
Sbjct: 261 NPDQNTEDYLFQVILEKQIRIPRS-----LSVKAASVLKSFLNKDPKERLGCHPQTGFAD 315
Query: 307 ALEHPYFK 314
              HP+F+
Sbjct: 316 IQGHPFFR 323

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 131/301 (43%), Gaps = 54/301 (17%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDT 81
           +D L  +G G +G V   R+ +  G Y AMK LR  V + +D +   T+ E  +L+    
Sbjct: 12  FDYLKLLGKGTFGKVILVRE-KATGRYYAMKILRKEVIIAKDEVA-HTVTESRVLQNT-- 67
Query: 82  FEHP--NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT 139
             HP    +++    H  +     Y     +F H+ +      E+      +  + +   
Sbjct: 68  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR------ERV----FTEERARFYG 116
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLWY 198
            +++  +++LHS  +++RD+K +NL++ + G +KI DFGL K    D   +     T  Y
Sbjct: 117 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEY 176
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
            APE+L +  YG  VD W +G VM EM    +P +    E      +F +I    +  +P
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELILMEEIR-FP 230
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPY 312
             +S                       +A SLL  +L  +P  R+      A + +EH +
Sbjct: 231 RTLS----------------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 268
Query: 313 F 313
           F
Sbjct: 269 F 269

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 17/217 (7%)
Query: 27  LCQIGCGAYGTVFKARD---LQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           + Q+G G +G+V   R      N G  VA+K+L+    +        REI ILK L +  
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILKALHS-- 70
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
              IV++  V +       R +  YL    +   L  +  +     L AS++   + Q+ 
Sbjct: 71  -DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSSQIC 124
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYDMMLTSVVVTLWYR 199
           KG+++L S R +HRDL  +N+L+     +KIADFGLAK      DY ++       +++ 
Sbjct: 125 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 184
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST 236
           APE L +  +    D+WS G V+ E++      C+ +
Sbjct: 185 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 221

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 17/217 (7%)
Query: 27  LCQIGCGAYGTVFKARD---LQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           + Q+G G +G+V   R      N G  VA+K+L+    +        REI ILK L +  
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILKALHS-- 83
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
              IV++  V +       R +  YL    +   L  +  +     L AS++   + Q+ 
Sbjct: 84  -DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSSQIC 137
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYDMMLTSVVVTLWYR 199
           KG+++L S R +HRDL  +N+L+     +KIADFGLAK      DY ++       +++ 
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST 236
           APE L +  +    D+WS G V+ E++      C+ +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 131/301 (43%), Gaps = 54/301 (17%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDT 81
           +D L  +G G +G V   R+ +  G Y AMK LR  V + +D +   T+ E  +L+    
Sbjct: 7   FDYLKLLGKGTFGKVILVRE-KATGRYYAMKILRKEVIIAKDEVA-HTVTESRVLQNT-- 62
Query: 82  FEHP--NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT 139
             HP    +++    H  +     Y     +F H+ +      E+      +  + +   
Sbjct: 63  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR------ERV----FTEERARFYG 111
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLWY 198
            +++  +++LHS  +++RD+K +NL++ + G +KI DFGL K    D   +     T  Y
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
            APE+L +  YG  VD W +G VM EM    +P +    E      +F +I    +  +P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELILMEEIR-FP 225
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPY 312
             +S                       +A SLL  +L  +P  R+      A + +EH +
Sbjct: 226 RTLS----------------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
Query: 313 F 313
           F
Sbjct: 264 F 264

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 14/219 (6%)
Query: 26  ELCQI-GCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           EL +I G G    V  ARDL+   + VA+K LR  L  D  P   LR     +      H
Sbjct: 15  ELGEILGFGGMSEVHLARDLRLHRD-VAVKVLRADLARD--PSFYLRFRREAQNAAALNH 71
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P IV  +        +       Y++ E+VD   L   +    P  ++  +  E+     
Sbjct: 72  PAIVAVYATGEAETPAGP---LPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADAC 126
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLT---SVVVTLWYR 199
           + ++F H + IIHRD+KP N++I+    +K+ DFG+A+   D    +T   +V+ T  Y 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV 238
           +PE           D++S+GCV+ E+    P F   + V
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 17/217 (7%)
Query: 27  LCQIGCGAYGTVFKARD---LQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           + Q+G G +G+V   R      N G  VA+K+L+    +        REI ILK L +  
Sbjct: 16  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILKALHS-- 71
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
              IV++  V +       R +  YL    +   L  +  +     L AS++   + Q+ 
Sbjct: 72  -DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSSQIC 125
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYDMMLTSVVVTLWYR 199
           KG+++L S R +HRDL  +N+L+     +KIADFGLAK      DY ++       +++ 
Sbjct: 126 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 185
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST 236
           APE L +  +    D+WS G V+ E++      C+ +
Sbjct: 186 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 222

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 131/301 (43%), Gaps = 54/301 (17%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDT 81
           +D L  +G G +G V   R+ +  G Y AMK LR  V + +D +   T+ E  +L+    
Sbjct: 7   FDYLKLLGKGTFGKVILVRE-KATGRYYAMKILRKEVIIAKDEVA-HTVTESRVLQNT-- 62
Query: 82  FEHP--NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT 139
             HP    +++    H  +     Y     +F H+ +      E+      +  + +   
Sbjct: 63  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR------ERV----FTEERARFYG 111
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLWY 198
            +++  +++LHS  +++RD+K +NL++ + G +KI DFGL K    D   +     T  Y
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
            APE+L +  YG  VD W +G VM EM    +P +    E      +F +I    +  +P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELILMEEIR-FP 225
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPY 312
             +S                       +A SLL  +L  +P  R+      A + +EH +
Sbjct: 226 RTLS----------------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
Query: 313 F 313
           F
Sbjct: 264 F 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 131/301 (43%), Gaps = 54/301 (17%)
Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDT 81
           +D L  +G G +G V   R+ +  G Y AMK LR  V + +D +   T+ E  +L+    
Sbjct: 7   FDYLKLLGKGTFGKVILVRE-KATGRYYAMKILRKEVIIAKDEVA-HTVTESRVLQNT-- 62
Query: 82  FEHP--NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT 139
             HP    +++    H  +     Y     +F H+ +      E+      +  + +   
Sbjct: 63  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR------ERV----FTEERARFYG 111
Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLWY 198
            +++  +++LHS  +++RD+K +NL++ + G +KI DFGL K    D   +     T  Y
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
            APE+L +  YG  VD W +G VM EM    +P +    E      +F +I    +  +P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELILMEEIR-FP 225
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPY 312
             +S                       +A SLL  +L  +P  R+      A + +EH +
Sbjct: 226 RTLS----------------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
Query: 313 F 313
           F
Sbjct: 264 F 264

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 110/243 (45%), Gaps = 32/243 (13%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P+IVR  DV ++N+ +  + L +  + E +D  +L S ++       +  +  E+ + + 
Sbjct: 69  PHIVRIVDV-YENLYAGRKCLLI--VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           + + +LHS  I HRD+KP+NLL T       LK+ DFG AK       LT    T +Y A
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVA 185
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE---QLKCIFRVIGTPSMNEWP 257
           PE+L    Y    D+WS+G +M  +    P F ++  +     +K   R+       E+P
Sbjct: 186 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQYEFP 241
Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE 317
              +  WS   +  K+               L+ ++L   P  R++  + + HP+  +  
Sbjct: 242 ---NPEWSEVSEEVKM---------------LIRNLLKTEPTQRMTITEFMNHPWIMQST 283
Query: 318 NEP 320
             P
Sbjct: 284 KVP 286

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 113/238 (47%), Gaps = 39/238 (16%)
Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN 61
           YE     I+ L + + D     YD +  IG GA+G V               + +R K +
Sbjct: 60  YEKIVKKIRGLQMKAED-----YDVVKVIGRGAFGEV---------------QLVRHKAS 99
Query: 62  EDGIPMSTLREISILKQLDT---FEHPNIVRFFD----VIHQNILSDERYLTVYLIFEHV 114
           +    M  L +  ++K+ D+   +E  +I+ F +    V       D++YL  Y++ E++
Sbjct: 100 QKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL--YMVMEYM 157
Query: 115 -DQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK 173
              DL + M     P   A   K  T +++  +D +HS  +IHRD+KP N+L+ + G LK
Sbjct: 158 PGGDLVNLMSNYDVPEKWA---KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLK 214
Query: 174 IADFGLAKTFDYDMML--TSVVVTLWYRAPEILLNLG----YGTPVDIWSIGCVMAEM 225
           +ADFG     D   M+   + V T  Y +PE+L + G    YG   D WS+G  + EM
Sbjct: 215 LADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 272

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/316 (26%), Positives = 131/316 (41%), Gaps = 75/316 (23%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G+ GTV      Q  G  VA+K++ +   +       L EI +L + D  +HPN++R
Sbjct: 41  LGYGSSGTVVFQGSFQ--GRPVAVKRMLIDFCD-----IALMEIKLLTESD--DHPNVIR 91
Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE-----LTRQMLK 144
           ++        S+     +Y+  E  + +L   +E       +    KE     L RQ+  
Sbjct: 92  YY-------CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 145 GVDFLHSHRIIHRDLKPQNLLI-----------TRAGGLK--IADFGLAKTFD-----YD 186
           GV  LHS +IIHRDLKPQN+L+           T A  L+  I+DFGL K  D     + 
Sbjct: 145 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 204
Query: 187 MMLTSVVVTLWYRAPEIL---LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKC 243
             L +   T  +RAPE+L           +DI+S+GCV                      
Sbjct: 205 XNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCV---------------------- 242
Query: 244 IFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDC------CSKANSLLESMLTFN 297
            F  I +   + + +     +S      +  FS   M C       ++A  L+  M+  +
Sbjct: 243 -FYYILSKGKHPFGDK----YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 297
Query: 298 PADRISAADALEHPYF 313
           P  R +A   L HP F
Sbjct: 298 PLKRPTAMKVLRHPLF 313

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 41/187 (21%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-------- 192
           Q+ + V+FLHS  ++HRDLKP N+  T    +K+ DFGL    D D    +V        
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 193 -----VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
                V T  Y +PE +    Y   VDI+S+G ++ E+     L+  ST++E+++ I  V
Sbjct: 232 THXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL-----LYSFSTQMERVRIITDV 286
Query: 248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
                                    + F  +F     + + +++ ML+ +P +R  A D 
Sbjct: 287 -----------------------RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
Query: 308 LEHPYFK 314
           +E+  F+
Sbjct: 324 IENAIFE 330

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 136/295 (46%), Gaps = 51/295 (17%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G +G V +  +  +K  Y+A K ++VK   D + +   +EISIL   +   H NI+ 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMA-KFVKVK-GTDQVLVK--KEISIL---NIARHRNILH 65
Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG--LSASKVKELTRQMLKGVD 147
               +H++  S E  + ++     +D       E+       L+  ++     Q+ + + 
Sbjct: 66  ----LHESFESMEELVMIFEFISGLD-----IFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 148 FLHSHRIIHRDLKPQNLL--ITRAGGLKIADFGLAKTF----DYDMMLTSVVVTLWYRAP 201
           FLHSH I H D++P+N++    R+  +KI +FG A+      ++ ++ T+      Y AP
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP----EYYAP 172
Query: 202 EILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
           E+  +    T  D+WS+G ++  +   +  F A T                  +  ENI 
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----------------QQIIENIM 216
Query: 262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK 316
               +F++ +       F +   +A   ++ +L      R++A++AL+HP+ K+K
Sbjct: 217 NAEYTFDEEA-------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/316 (26%), Positives = 131/316 (41%), Gaps = 75/316 (23%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G+ GTV      Q  G  VA+K++ +   +       L EI +L + D  +HPN++R
Sbjct: 41  LGYGSSGTVVFQGSFQ--GRPVAVKRMLIDFCD-----IALMEIKLLTESD--DHPNVIR 91
Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE-----LTRQMLK 144
           ++        S+     +Y+  E  + +L   +E       +    KE     L RQ+  
Sbjct: 92  YY-------CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 144
Query: 145 GVDFLHSHRIIHRDLKPQNLLI-----------TRAGGLK--IADFGLAKTFD-----YD 186
           GV  LHS +IIHRDLKPQN+L+           T A  L+  I+DFGL K  D     + 
Sbjct: 145 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 204
Query: 187 MMLTSVVVTLWYRAPEIL---LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKC 243
             L +   T  +RAPE+L           +DI+S+GCV                      
Sbjct: 205 XNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCV---------------------- 242
Query: 244 IFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDC------CSKANSLLESMLTFN 297
            F  I +   + + +     +S      +  FS   M C       ++A  L+  M+  +
Sbjct: 243 -FYYILSKGKHPFGDK----YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 297
Query: 298 PADRISAADALEHPYF 313
           P  R +A   L HP F
Sbjct: 298 PLKRPTAMKVLRHPLF 313

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 111/229 (48%), Gaps = 20/229 (8%)
Query: 104 YLTVYLIFEHVDQD----LGSY---MEKCPPPGLSASKVKELTRQMLKGVDFLHSHR-II 155
           Y  VY+I+E+++ D       Y   ++K     +    +K + + +L    ++H+ + I 
Sbjct: 115 YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC 174
Query: 156 HRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGY--GTPV 213
           HRD+KP N+L+ + G +K++DFG ++ +  D  +     T  +  PE   N     G  V
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESE-YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKV 233
Query: 214 DIWSIG-CVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSK 272
           DIWS+G C+    + +VP     + VE    +F  I T ++ E+P + +          K
Sbjct: 234 DIWSLGICLYVMFYNVVPFSLKISLVE----LFNNIRTKNI-EYPLDRNHFLYPLTN-KK 287
Query: 273 VAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL 321
              S  F+   ++    L+  L  NPA+RI++ DAL+H +  +   E L
Sbjct: 288 STCSNNFL--SNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDL 334

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 19/218 (8%)
Query: 27  LCQIGCGAYGTVFKARD---LQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           + Q+G G +G+V   R      N G  VA+K+L+    +        REI ILK L +  
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILKALHS-- 67
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
              IV++  V +     + R +  YL    +   L  +  +     L AS++   + Q+ 
Sbjct: 68  -DFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSSQIC 121
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV-----VVTLWY 198
           KG+++L S R +HRDL  +N+L+     +KIADFGLAK    D     V         WY
Sbjct: 122 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY 181
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST 236
            APE L +  +    D+WS G V+ E++      C+ +
Sbjct: 182 -APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 218

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 27/204 (13%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI--PMSTLREISILKQLDTFEHPN 86
           ++G G +G V+        G Y    K+ VK  + G   P + L E +++KQL   +H  
Sbjct: 21  RLGAGQFGEVWM-------GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQR 70
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG---LSASKVKELTRQML 143
           +VR + V+ Q          +Y+I E+++   GS ++    P    L+ +K+ ++  Q+ 
Sbjct: 71  LVRLYAVVTQE--------PIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIA 120
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT--SVVVTLWYRAP 201
           +G+ F+     IHRDL+  N+L++     KIADFGLA+  + +           + + AP
Sbjct: 121 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 180
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E +    +    D+WS G ++ E+
Sbjct: 181 EAINYGTFTIKSDVWSFGILLTEI 204

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 27/204 (13%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI--PMSTLREISILKQLDTFEHPN 86
           ++G G +G V+        G Y    K+ VK  + G   P + L E +++KQL   +H  
Sbjct: 20  RLGAGQFGEVWM-------GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQR 69
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG---LSASKVKELTRQML 143
           +VR + V+ Q          +Y+I E+++   GS ++    P    L+ +K+ ++  Q+ 
Sbjct: 70  LVRLYAVVTQE--------PIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT--SVVVTLWYRAP 201
           +G+ F+     IHRDL+  N+L++     KIADFGLA+  + +           + + AP
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 179
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E +    +    D+WS G ++ E+
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEI 203

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 27/204 (13%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI--PMSTLREISILKQLDTFEHPN 86
           ++G G +G V+        G Y    K+ VK  + G   P + L E +++KQL   +H  
Sbjct: 22  RLGAGQFGEVWM-------GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQR 71
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG---LSASKVKELTRQML 143
           +VR + V+ Q          +Y+I E+++   GS ++    P    L+ +K+ ++  Q+ 
Sbjct: 72  LVRLYAVVTQE--------PIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIA 121
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT--SVVVTLWYRAP 201
           +G+ F+     IHRDL+  N+L++     KIADFGLA+  + +           + + AP
Sbjct: 122 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 181
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E +    +    D+WS G ++ E+
Sbjct: 182 EAINYGTFTIKSDVWSFGILLTEI 205

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 27/204 (13%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI--PMSTLREISILKQLDTFEHPN 86
           ++G G +G V+        G Y    K+ VK  + G   P + L E +++KQL   +H  
Sbjct: 20  RLGAGQFGEVWM-------GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQR 69
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG---LSASKVKELTRQML 143
           +VR + V+ Q          +Y+I E+++   GS ++    P    L+ +K+ ++  Q+ 
Sbjct: 70  LVRLYAVVTQE--------PIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD--MMLTSVVVTLWYRAP 201
           +G+ F+     IHRDL+  N+L++     KIADFGLA+  + +           + + AP
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E +    +    D+WS G ++ E+
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEI 203

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 136/301 (45%), Gaps = 45/301 (14%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           IG GA   V +A     K   VA+K++ ++  +  +    L+EI  + Q     HPNIV 
Sbjct: 18  IGSGATAVV-QAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQC---HHPNIVS 72
Query: 90  FFDVIHQNILSDERYLTVYL--------IFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
           ++      ++ DE +L + L        I +H+    G +        L  S +  + R+
Sbjct: 73  YYTSF---VVKDELWLVMKLLSGGSVLDIIKHIVAK-GEHKSGV----LDESTIATILRE 124
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT------SVVVT 195
           +L+G+++LH +  IHRD+K  N+L+   G ++IADFG++        +T      + V T
Sbjct: 125 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 196 LWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
             + APE++  + GY    DIWS G    E+      +     ++ L    +    PS+ 
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN-DPPSLE 243
Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
              ++  ++    ++Y K +F  +   C  K           +P  R +AA+ L H +F+
Sbjct: 244 TGVQDKEML----KKYGK-SFRKMISLCLQK-----------DPEKRPTAAELLRHKFFQ 287
Query: 315 E 315
           +
Sbjct: 288 K 288

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 27/204 (13%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI--PMSTLREISILKQLDTFEHPN 86
           ++G G +G V+        G Y    K+ VK  + G   P + L E +++KQL   +H  
Sbjct: 20  RLGAGQFGEVWM-------GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQR 69
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG---LSASKVKELTRQML 143
           +VR + V+ Q          +Y+I E+++   GS ++    P    L+ +K+ ++  Q+ 
Sbjct: 70  LVRLYAVVTQE--------PIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT--SVVVTLWYRAP 201
           +G+ F+     IHRDL+  N+L++     KIADFGLA+  + +           + + AP
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 179
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E +    +    D+WS G ++ E+
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEI 203

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 27/204 (13%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI--PMSTLREISILKQLDTFEHPN 86
           ++G G +G V+        G Y    K+ VK  + G   P + L E +++KQL   +H  
Sbjct: 26  RLGAGQFGEVWM-------GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQR 75
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG---LSASKVKELTRQML 143
           +VR + V+ Q          +Y+I E+++   GS ++    P    L+ +K+ ++  Q+ 
Sbjct: 76  LVRLYAVVTQE--------PIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD--MMLTSVVVTLWYRAP 201
           +G+ F+     IHRDL+  N+L++     KIADFGLA+  + +           + + AP
Sbjct: 126 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 185
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E +    +    D+WS G ++ E+
Sbjct: 186 EAINYGTFTIKSDVWSFGILLTEI 209

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 27/204 (13%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI--PMSTLREISILKQLDTFEHPN 86
           ++G G +G V+        G Y    K+ VK  + G   P + L E +++KQL   +H  
Sbjct: 25  RLGAGQFGEVWM-------GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQR 74
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG---LSASKVKELTRQML 143
           +VR + V+ Q          +Y+I E+++   GS ++    P    L+ +K+ ++  Q+ 
Sbjct: 75  LVRLYAVVTQE--------PIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIA 124
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD--MMLTSVVVTLWYRAP 201
           +G+ F+     IHRDL+  N+L++     KIADFGLA+  + +           + + AP
Sbjct: 125 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 184
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E +    +    D+WS G ++ E+
Sbjct: 185 EAINYGTFTIKSDVWSFGILLTEI 208

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 27/204 (13%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI--PMSTLREISILKQLDTFEHPN 86
           ++G G +G V+        G Y    K+ VK  + G   P + L E +++KQL   +H  
Sbjct: 29  RLGAGQFGEVWM-------GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQR 78
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG---LSASKVKELTRQML 143
           +VR + V+ Q          +Y+I E+++   GS ++    P    L+ +K+ ++  Q+ 
Sbjct: 79  LVRLYAVVTQE--------PIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIA 128
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT--SVVVTLWYRAP 201
           +G+ F+     IHRDL+  N+L++     KIADFGLA+  + +           + + AP
Sbjct: 129 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 188
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E +    +    D+WS G ++ E+
Sbjct: 189 EAINYGTFTIKSDVWSFGILLTEI 212

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 27/204 (13%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI--PMSTLREISILKQLDTFEHPN 86
           ++G G +G V+        G Y    K+ VK  + G   P + L E +++KQL   +H  
Sbjct: 15  RLGAGQFGEVWM-------GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQR 64
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG---LSASKVKELTRQML 143
           +VR + V+ Q          +Y+I E+++   GS ++    P    L+ +K+ ++  Q+ 
Sbjct: 65  LVRLYAVVTQE--------PIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIA 114
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT--SVVVTLWYRAP 201
           +G+ F+     IHRDL+  N+L++     KIADFGLA+  + +           + + AP
Sbjct: 115 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 174
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E +    +    D+WS G ++ E+
Sbjct: 175 EAINYGTFTIKSDVWSFGILLTEI 198

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 28/229 (12%)
Query: 7   DTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNED 63
           DTI  +    L +  + Y+ +  IG GA+G V   R    +  Y AMK   K  +    D
Sbjct: 61  DTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVY-AMKLLSKFEMIKRSD 117
Query: 64  GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYM 122
                  R+I           P +V+ F         D+RYL  Y++ E++   DL + M
Sbjct: 118 SAFFWEERDIMAFAN-----SPWVVQLF-----YAFQDDRYL--YMVMEYMPGGDLVNLM 165
Query: 123 EKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT 182
                P   A   +  T +++  +D +HS   IHRD+KP N+L+ ++G LK+ADFG    
Sbjct: 166 SNYDVPEKWA---RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 222
Query: 183 FDYDMMLT--SVVVTLWYRAPEILLNLG----YGTPVDIWSIGCVMAEM 225
            + + M+   + V T  Y +PE+L + G    YG   D WS+G  + EM
Sbjct: 223 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 271

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 27/204 (13%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI--PMSTLREISILKQLDTFEHPN 86
           ++G G +G V+        G Y    K+ VK  + G   P + L E +++KQL   +H  
Sbjct: 28  RLGAGQFGEVWM-------GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQR 77
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG---LSASKVKELTRQML 143
           +VR + V+ Q          +Y+I E+++   GS ++    P    L+ +K+ ++  Q+ 
Sbjct: 78  LVRLYAVVTQE--------PIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIA 127
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT--SVVVTLWYRAP 201
           +G+ F+     IHRDL+  N+L++     KIADFGLA+  + +           + + AP
Sbjct: 128 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 187
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E +    +    D+WS G ++ E+
Sbjct: 188 EAINYGTFTIKSDVWSFGILLTEI 211

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 27/204 (13%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI--PMSTLREISILKQLDTFEHPN 86
           ++G G +G V+        G Y    K+ VK  + G   P + L E +++KQL   +H  
Sbjct: 26  RLGAGQFGEVWM-------GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQR 75
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG---LSASKVKELTRQML 143
           +VR + V+ Q          +Y+I E+++   GS ++    P    L+ +K+ ++  Q+ 
Sbjct: 76  LVRLYAVVTQE--------PIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT--SVVVTLWYRAP 201
           +G+ F+     IHRDL+  N+L++     KIADFGLA+  + +           + + AP
Sbjct: 126 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 185
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E +    +    D+WS G ++ E+
Sbjct: 186 EAINYGTFTIKSDVWSFGILLTEI 209

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 28/229 (12%)
Query: 7   DTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNED 63
           DTI  +    L +  + Y+ +  IG GA+G V   R    +  Y AMK   K  +    D
Sbjct: 56  DTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVY-AMKLLSKFEMIKRSD 112
Query: 64  GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYM 122
                  R+I           P +V+ F         D+RYL  Y++ E++   DL + M
Sbjct: 113 SAFFWEERDIMAFAN-----SPWVVQLF-----YAFQDDRYL--YMVMEYMPGGDLVNLM 160
Query: 123 EKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT 182
                P   A   +  T +++  +D +HS   IHRD+KP N+L+ ++G LK+ADFG    
Sbjct: 161 SNYDVPEKWA---RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217
Query: 183 FDYDMML--TSVVVTLWYRAPEILLNLG----YGTPVDIWSIGCVMAEM 225
            + + M+   + V T  Y +PE+L + G    YG   D WS+G  + EM
Sbjct: 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 30  IGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G++G V  AR    +  Y   V  KK  +K  E+   MS   E ++L  L   +HP 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMS---ERNVL--LKNVKHPF 100
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY---MEKCPPPGLSASKVKELTRQML 143
           +V     +H +  + ++   +Y + ++++     Y    E+C        + +    ++ 
Sbjct: 101 LVG----LHFSFQTADK---LYFVLDYINGGELFYHLQRERC----FLEPRARFYAAEIA 149
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMMLTSVVVTLWYRAPE 202
             + +LHS  I++RDLKP+N+L+   G + + DFGL K   +++   ++   T  Y APE
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           +L    Y   VD W +G V+ EM   +P F +    E
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 28/229 (12%)
Query: 7   DTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNED 63
           DTI  +    L +  + Y+ +  IG GA+G V   R    +  Y AMK   K  +    D
Sbjct: 61  DTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVY-AMKLLSKFEMIKRSD 117
Query: 64  GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYM 122
                  R+I           P +V+ F         D+RYL  Y++ E++   DL + M
Sbjct: 118 SAFFWEERDIMAFAN-----SPWVVQLF-----YAFQDDRYL--YMVMEYMPGGDLVNLM 165
Query: 123 EKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT 182
                P   A   +  T +++  +D +HS   IHRD+KP N+L+ ++G LK+ADFG    
Sbjct: 166 SNYDVPEKWA---RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 222
Query: 183 FDYDMMLT--SVVVTLWYRAPEILLNLG----YGTPVDIWSIGCVMAEM 225
            + + M+   + V T  Y +PE+L + G    YG   D WS+G  + EM
Sbjct: 223 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 271

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 27/204 (13%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI--PMSTLREISILKQLDTFEHPN 86
           ++G G +G V+        G Y    K+ VK  + G   P + L E +++KQL   +H  
Sbjct: 30  RLGAGQFGEVWM-------GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQR 79
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG---LSASKVKELTRQML 143
           +VR + V+ Q          +Y+I E+++   GS ++    P    L+ +K+ ++  Q+ 
Sbjct: 80  LVRLYAVVTQE--------PIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIA 129
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD--MMLTSVVVTLWYRAP 201
           +G+ F+     IHRDL+  N+L++     KIADFGLA+  + +           + + AP
Sbjct: 130 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 189
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E +    +    D+WS G ++ E+
Sbjct: 190 EAINYGTFTIKSDVWSFGILLTEI 213

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 85/320 (26%), Positives = 131/320 (40%), Gaps = 79/320 (24%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G+ GTV      Q  G  VA+K++ +   +       L EI +L + D  +HPN++R
Sbjct: 23  LGYGSSGTVVFQGSFQ--GRPVAVKRMLIDFCD-----IALMEIKLLTESD--DHPNVIR 73
Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE-----LTRQMLK 144
           ++        S+     +Y+  E  + +L   +E       +    KE     L RQ+  
Sbjct: 74  YY-------CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 145 GVDFLHSHRIIHRDLKPQNLLI-----------TRAGGLK--IADFGLAKTFD-----YD 186
           GV  LHS +IIHRDLKPQN+L+           T A  L+  I+DFGL K  D     + 
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 186
Query: 187 MMLTSVVVTLWYRAPEIL-------LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
             L +   T  +RAPE+L               +DI+S+GCV                  
Sbjct: 187 XNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV------------------ 228
Query: 240 QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDC------CSKANSLLESM 293
                F  I +   + + +     +S      +  FS   M C       ++A  L+  M
Sbjct: 229 -----FYYILSKGKHPFGDK----YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQM 279
Query: 294 LTFNPADRISAADALEHPYF 313
           +  +P  R +A   L HP F
Sbjct: 280 IDHDPLKRPTAMKVLRHPLF 299

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 27/220 (12%)
Query: 30  IGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP 85
           IG GA+G VF+AR            VA+K L+ + + D +     RE +++ +   F++P
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQADFQREAALMAE---FDNP 110
Query: 86  NIVRFFDVI--------------HQNILSDERYLTVYLI--FEHVDQDLGSYMEKCPPPG 129
           NIV+   V               + ++    R ++ + +    H D    + +    PP 
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYD 186
           LS ++   + RQ+  G+ +L   + +HRDL  +N L+     +KIADFGL++     DY 
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
               +  + + +  PE +    Y T  D+W+ G V+ E++
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 85/320 (26%), Positives = 131/320 (40%), Gaps = 79/320 (24%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G+ GTV      Q  G  VA+K++ +   +       L EI +L + D  +HPN++R
Sbjct: 23  LGYGSSGTVVFQGSFQ--GRPVAVKRMLIDFCD-----IALMEIKLLTESD--DHPNVIR 73
Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE-----LTRQMLK 144
           ++        S+     +Y+  E  + +L   +E       +    KE     L RQ+  
Sbjct: 74  YY-------CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 145 GVDFLHSHRIIHRDLKPQNLLI-----------TRAGGLK--IADFGLAKTFD-----YD 186
           GV  LHS +IIHRDLKPQN+L+           T A  L+  I+DFGL K  D     + 
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 187 MMLTSVVVTLWYRAPEIL-------LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
             L +   T  +RAPE+L               +DI+S+GCV                  
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV------------------ 228
Query: 240 QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDC------CSKANSLLESM 293
                F  I +   + + +     +S      +  FS   M C       ++A  L+  M
Sbjct: 229 -----FYYILSKGKHPFGDK----YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQM 279
Query: 294 LTFNPADRISAADALEHPYF 313
           +  +P  R +A   L HP F
Sbjct: 280 IDHDPLKRPTAMKVLRHPLF 299

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 112/236 (47%), Gaps = 24/236 (10%)
Query: 1   MYEYSADTIQSLNLDSLDLGDKKYDELC------QIGCGAYGTVFKARDLQNKGNYVAMK 54
           M +Y   T ++L       GD      C      +IG G++GTV +A   +  G+ VA+K
Sbjct: 10  MSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRA---EWHGSDVAVK 66
Query: 55  KLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ--NILSDERYLTVYLIFE 112
            L  +          LRE++I+K+L    HPNIV F   + Q  N+     YL+   ++ 
Sbjct: 67  ILMEQDFHAERVNEFLREVAIMKRL---RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 113 HVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLITRAG 170
            + +  G+  +      L   +   +   + KG+++LH+    I+HRDLK  NLL+ +  
Sbjct: 124 LLHKS-GAREQ------LDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKY 176
Query: 171 GLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            +K+ DFGL++      + +     T  + APE+L +       D++S G ++ E+
Sbjct: 177 TVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 74/141 (52%), Gaps = 7/141 (4%)
Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P+IVR  DV ++N+ +  + L +  + E +D  +L S ++       +  +  E+ + + 
Sbjct: 115 PHIVRIVDV-YENLYAGRKCLLI--VXECLDGGELFSRIQDRGDQAFTEREASEIXKSIG 171
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           + + +LHS  I HRD+KP+NLL T       LK+ DFG AK       LT+   T +Y A
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 201 PEILLNLGYGTPVDIWSIGCV 221
           PE+L    Y    D WS+G +
Sbjct: 232 PEVLGPEKYDKSCDXWSLGVI 252

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 31/208 (14%)
Query: 27  LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ----LDTF 82
           L  +G G++G V   R   N G Y AMK L+ ++      +  L+++         L   
Sbjct: 11  LRTLGTGSFGRVHLIRSRHN-GRYYAMKVLKKEI------VVRLKQVEHTNDERLMLSIV 63
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC---PPPGLSASKVKEL 138
            HP I+R +               +++I ++++  +L S + K    P P       K  
Sbjct: 64  THPFIIRMWGTFQDA-------QQIFMIMDYIEGGELFSLLRKSQRFPNP-----VAKFY 111
Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLTSVVVTLW 197
             ++   +++LHS  II+RDLKP+N+L+ + G +KI DFG AK   D    L     T  
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCG---TPD 168
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           Y APE++    Y   +D WS G ++ EM
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEM 196

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 29/205 (14%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI--PMSTLREISILKQLDTFEHPN 86
           ++G G  G V+        G Y    K+ VK  + G   P + L E +++KQL   +H  
Sbjct: 20  RLGAGQAGEVWM-------GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQR 69
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG---LSASKVKELTRQML 143
           +VR + V+ Q          +Y+I E+++   GS ++    P    L+ +K+ ++  Q+ 
Sbjct: 70  LVRLYAVVTQE--------PIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS---VVVTLWYRA 200
           +G+ F+     IHRDL+  N+L++     KIADFGLA+  + D   T+       + + A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DAEXTAREGAKFPIKWTA 178
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEM 225
           PE +    +    D+WS G ++ E+
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEI 203

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLD 80
           +++ L  +G G +G V   ++ +  G Y AMK L+  V + +D +   TL E  +L+   
Sbjct: 152 EFEYLKLLGKGTFGKVILVKE-KATGRYYAMKILKKEVIVAKDEVA-HTLTENRVLQNS- 208
Query: 81  TFEHP--NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
              HP    +++    H  +     Y     +F H+ ++             S  + +  
Sbjct: 209 --RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV----------FSEDRARFY 256
Query: 139 TRQMLKGVDFLHSHR-IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTL 196
             +++  +D+LHS + +++RDLK +NL++ + G +KI DFGL K    D   + +   T 
Sbjct: 257 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 316
Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            Y APE+L +  YG  VD W +G VM EM
Sbjct: 317 EYLAPEVLEDNDYGRAVDWWGLGVVMYEM 345

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLD 80
           +++ L  +G G +G V   ++ +  G Y AMK L+  V + +D +   TL E  +L+   
Sbjct: 149 EFEYLKLLGKGTFGKVILVKE-KATGRYYAMKILKKEVIVAKDEVA-HTLTENRVLQNS- 205
Query: 81  TFEHP--NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
              HP    +++    H  +     Y     +F H+ ++             S  + +  
Sbjct: 206 --RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV----------FSEDRARFY 253
Query: 139 TRQMLKGVDFLHSHR-IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTL 196
             +++  +D+LHS + +++RDLK +NL++ + G +KI DFGL K    D   + +   T 
Sbjct: 254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            Y APE+L +  YG  VD W +G VM EM
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEM 342

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 29/205 (14%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI--PMSTLREISILKQLDTFEHPN 86
           ++G G +G V+        G Y    K+ VK  + G   P + L E +++KQL   +H  
Sbjct: 16  RLGAGQFGEVWM-------GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL---QHQR 65
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG---LSASKVKELTRQML 143
           +VR + V+ Q          +Y+I E+++   GS ++    P    L+ +K+ ++  Q+ 
Sbjct: 66  LVRLYAVVTQE--------PIYIITEYMEN--GSLVDFLKTPSGIKLTINKLLDMAAQIA 115
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRA 200
           +G+ F+     IHR+L+  N+L++     KIADFGLA+     +Y     +     W  A
Sbjct: 116 EGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-TA 174
Query: 201 PEILLNLGYGTPVDIWSIGCVMAEM 225
           PE +    +    D+WS G ++ E+
Sbjct: 175 PEAINYGTFTIKSDVWSFGILLTEI 199

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 13  NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLRE 72
           +L  +D  + + +E+  +G GA+G V KA+    +   VA+K++  +             
Sbjct: 1   SLHMIDYKEIEVEEV--VGRGAFGVVCKAK---WRAKDVAIKQIESESERKAF------- 48
Query: 73  ISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPP-PGL 130
           I  L+QL    HPNIV+ +               V L+ E+ +   L + +    P P  
Sbjct: 49  IVELRQLSRVNHPNIVKLYGACLN---------PVCLVMEYAEGGSLYNVLHGAEPLPYY 99
Query: 131 SASKVKELTRQMLKGVDFLHSHR---IIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYD 186
           +A+       Q  +GV +LHS +   +IHRDLKP NLL+   G  LKI DFG A   D  
Sbjct: 100 TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA--CDIQ 157
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
             +T+   +  + APE+     Y    D++S G ++ E+
Sbjct: 158 THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEV 196

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLD 80
           +++ L  +G G +G V   ++ +  G Y AMK L+  V + +D +   TL E  +L+   
Sbjct: 10  EFEYLKLLGKGTFGKVILVKE-KATGRYYAMKILKKEVIVAKDEVA-HTLTENRVLQNS- 66
Query: 81  TFEHP--NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
              HP    +++    H  +     Y     +F H+ ++             S  + +  
Sbjct: 67  --RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV----------FSEDRARFY 114
Query: 139 TRQMLKGVDFLHSHR-IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTL 196
             +++  +D+LHS + +++RDLK +NL++ + G +KI DFGL K    D   +     T 
Sbjct: 115 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTP 174
Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            Y APE+L +  YG  VD W +G VM EM
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEM 203

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLD 80
           +++ L  +G G +G V   ++ +  G Y AMK L+  V + +D +   TL E  +L+   
Sbjct: 11  EFEYLKLLGKGTFGKVILVKE-KATGRYYAMKILKKEVIVAKDEV-AHTLTENRVLQNS- 67
Query: 81  TFEHP--NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
              HP    +++    H  +     Y     +F H+ ++             S  + +  
Sbjct: 68  --RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV----------FSEDRARFY 115
Query: 139 TRQMLKGVDFLHSHR-IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTL 196
             +++  +D+LHS + +++RDLK +NL++ + G +KI DFGL K    D   +     T 
Sbjct: 116 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTP 175
Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            Y APE+L +  YG  VD W +G VM EM
Sbjct: 176 EYLAPEVLEDNDYGRAVDWWGLGVVMYEM 204

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLD 80
           +++ L  +G G +G V   ++ +  G Y AMK L+  V + +D +   TL E  +L+   
Sbjct: 9   EFEYLKLLGKGTFGKVILVKE-KATGRYYAMKILKKEVIVAKDEVA-HTLTENRVLQNS- 65
Query: 81  TFEHP--NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
              HP    +++    H  +     Y     +F H+ ++             S  + +  
Sbjct: 66  --RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV----------FSEDRARFY 113
Query: 139 TRQMLKGVDFLHSHR-IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTL 196
             +++  +D+LHS + +++RDLK +NL++ + G +KI DFGL K    D   +     T 
Sbjct: 114 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTP 173
Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            Y APE+L +  YG  VD W +G VM EM
Sbjct: 174 EYLAPEVLEDNDYGRAVDWWGLGVVMYEM 202

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 113/236 (47%), Gaps = 24/236 (10%)
Query: 1   MYEYSADTIQSLNLDSLDLGDKKYDELC------QIGCGAYGTVFKARDLQNKGNYVAMK 54
           M +Y   T ++L       GD      C      +IG G++GTV +A   +  G+ VA+K
Sbjct: 10  MSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRA---EWHGSDVAVK 66
Query: 55  KLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ--NILSDERYLTVYLIFE 112
            L  +          LRE++I+K+L    HPNIV F   + Q  N+     YL+   ++ 
Sbjct: 67  ILMEQDFHAERVNEFLREVAIMKRL---RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 113 HVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLITRAG 170
            + +  G+  +      L   +   +   + KG+++LH+    I+HR+LK  NLL+ +  
Sbjct: 124 LLHKS-GAREQ------LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY 176
Query: 171 GLKIADFGLAKTFDYDMMLT-SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            +K+ DFGL++      + + S   T  + APE+L +       D++S G ++ E+
Sbjct: 177 TVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 13  NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLRE 72
           +L  +D  + + +E+  +G GA+G V KA+    +   VA+K++  +             
Sbjct: 2   SLHMIDYKEIEVEEV--VGRGAFGVVCKAK---WRAKDVAIKQIESESERKAF------- 49
Query: 73  ISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPP-PGL 130
           I  L+QL    HPNIV+ +               V L+ E+ +   L + +    P P  
Sbjct: 50  IVELRQLSRVNHPNIVKLYGACLN---------PVCLVMEYAEGGSLYNVLHGAEPLPYY 100
Query: 131 SASKVKELTRQMLKGVDFLHSHR---IIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYD 186
           +A+       Q  +GV +LHS +   +IHRDLKP NLL+   G  LKI DFG A   D  
Sbjct: 101 TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA--CDIQ 158
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
             +T+   +  + APE+     Y    D++S G ++ E+
Sbjct: 159 THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEV 197

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 106/215 (49%), Gaps = 27/215 (12%)
Query: 29  QIGCGAYGTVFKAR--DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           ++G GA+G VF A   +L  + + + +    +K   D       RE  +L  L   +H +
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL---QHEH 76
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM-----------EKCPPPGLSASK 134
           IV+F+ V    +  D     + ++FE++   DL  ++           E  PP  L+ S+
Sbjct: 77  IVKFYGVC---VEGD----PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQ 129
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYDMMLTS 191
           +  + +Q+  G+ +L S   +HRDL  +N L+     +KI DFG+++   + DY  +   
Sbjct: 130 MLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 189
Query: 192 VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
            ++ + +  PE ++   + T  D+WS+G V+ E++
Sbjct: 190 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 224

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPN 86
           ++G G +G V+K   + N    VA+KKL   V +  + +     +EI ++ +    +H N
Sbjct: 38  KMGEGGFGVVYKGY-VNN--TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC---QHEN 91
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ--DLGSYMEKCPPPGLSASKVKELTRQMLK 144
           +V           SD   L +  ++       D  S ++  PP  LS     ++ +    
Sbjct: 92  LVELL-----GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LSWHMRCKIAQGAAN 144
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT---FDYDMMLTSVVVTLWYRAP 201
           G++FLH +  IHRD+K  N+L+  A   KI+DFGLA+    F   +M + +V T  Y AP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAP 204
Query: 202 EILLNLGYGTP-VDIWSIGCVMAEMWRLVP 230
           E L   G  TP  DI+S G V+ E+   +P
Sbjct: 205 EAL--RGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 20  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 71
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    +SA  +  +  Q+   +
Sbjct: 72  VQLLGVC-------TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 185 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 236
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 237 -----------------CPEKVYELMRACWQWNPSDRPSFAE 261

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 20  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 71
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    +SA  +  +  Q+   +
Sbjct: 72  VQLLGVC-------TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 185 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 236
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 237 -----------------CPEKVYELMRACWQWNPSDRPSFAE 261

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPN 86
           ++G G +G V+K          VA+KKL   V +  + +     +EI ++ +    +H N
Sbjct: 38  KMGEGGFGVVYKGY---VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC---QHEN 91
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ--DLGSYMEKCPPPGLSASKVKELTRQMLK 144
           +V           SD   L +  ++       D  S ++  PP  LS     ++ +    
Sbjct: 92  LVELL-----GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LSWHMRCKIAQGAAN 144
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT---FDYDMMLTSVVVTLWYRAP 201
           G++FLH +  IHRD+K  N+L+  A   KI+DFGLA+    F   +M   +V T  Y AP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAP 204
Query: 202 EILLNLGYGTP-VDIWSIGCVMAEMWRLVP 230
           E L   G  TP  DI+S G V+ E+   +P
Sbjct: 205 EAL--RGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 20  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 71
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    +SA  +  +  Q+   +
Sbjct: 72  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 185 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 236
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 237 -----------------CPEKVYELMRACWQWNPSDRPSFAE 261

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 21  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 72
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    ++A  +  +  Q+   +
Sbjct: 73  VQLLGVC-------TREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 125
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 126 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL 185
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 186 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 237
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 238 -----------------CPEKVYELMRACWQWNPSDRPSFAE 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 25  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 76
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    +SA  +  +  Q+   +
Sbjct: 77  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 129
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 130 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 189
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 190 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 241
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 242 -----------------CPEKVYELMRACWQWNPSDRPSFAE 266

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 20  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 71
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    +SA  +  +  Q+   +
Sbjct: 72  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 185 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 236
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 237 -----------------CPEKVYELMRACWQWNPSDRPSFAE 261

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPN 86
           ++G G +G V+K          VA+KKL   V +  + +     +EI ++ +    +H N
Sbjct: 32  KMGEGGFGVVYKGY---VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC---QHEN 85
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ--DLGSYMEKCPPPGLSASKVKELTRQMLK 144
           +V           SD   L +  ++       D  S ++  PP  LS     ++ +    
Sbjct: 86  LVELL-----GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LSWHMRCKIAQGAAN 138
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT---FDYDMMLTSVVVTLWYRAP 201
           G++FLH +  IHRD+K  N+L+  A   KI+DFGLA+    F   +M   +V T  Y AP
Sbjct: 139 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAP 198
Query: 202 EILLNLGYGTP-VDIWSIGCVMAEMWRLVP 230
           E L   G  TP  DI+S G V+ E+   +P
Sbjct: 199 EAL--RGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 130/313 (41%), Gaps = 51/313 (16%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMS-TLREISILKQLDTFEHP-NI 87
           +G GAY  V  A  LQN   Y     +++   + G   S   RE+  L Q    ++   +
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYA----VKIIEKQAGHSRSRVFREVETLYQCQGNKNILEL 76
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           + FF+        D R+   YL+FE +    + ++++K      +  +   + R +   +
Sbjct: 77  IEFFE-------DDTRF---YLVFEKLQGGSILAHIQK--QKHFNEREASRVVRDVAAAL 124
Query: 147 DFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVV--------T 195
           DFLH+  I HRDLKP+N+L     +   +KI DF L      +   T +          +
Sbjct: 125 DFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGS 184
Query: 196 LWYRAPEILLNLG-----YGTPVDIWSIGCVMAEMWRLVPLF---CASTEVEQLKCIFRV 247
             Y APE++         Y    D+WS+G V+  M    P F   C +        + RV
Sbjct: 185 AEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRV 244
Query: 248 IGTPSMNEWPENISLMWSSFEQYSKVAF-SAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                 N+  E+I        Q  K  F    +    S+A  L+  +L  +   R+SAA 
Sbjct: 245 C----QNKLFESI--------QEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQ 292
Query: 307 ALEHPYFKEKENE 319
            L+HP+ + +  E
Sbjct: 293 VLQHPWVQGQAPE 305

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 25  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 76
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    ++A  +  +  Q+   +
Sbjct: 77  VQLLGVC-------TREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 129
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 130 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 189
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 190 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 241
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 242 -----------------CPEKVYELMRACWQWNPSDRPSFAE 266

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 124/283 (43%), Gaps = 46/283 (16%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 18  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 69
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    +SA  +  +  Q+   +
Sbjct: 70  VQLLGVC-------TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 122
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 123 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL 182
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE-NISLM 263
               +    D+W+ G ++ E                       I T  M+ +P  + S +
Sbjct: 183 AYNKFSIKSDVWAFGVLLWE-----------------------IATYGMSPYPGIDPSQV 219
Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
           +   E+  ++        C  K   L+ +   +NP+DR S A+
Sbjct: 220 YELLEKDYRMERPE---GCPEKVYELMRACWQWNPSDRPSFAE 259

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 34/214 (15%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G +G   K    +  G  + MK+L ++ +E+    + L+E+ +++ L   EHPN+++
Sbjct: 18  LGKGCFGQAIKVTHRET-GEVMVMKEL-IRFDEE-TQRTFLKEVKVMRCL---EHPNVLK 71
Query: 90  FFDVIHQNILSDER--YLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           F  V+++    D+R  ++T Y+    +   + S   + P      S+     + +  G+ 
Sbjct: 72  FIGVLYK----DKRLNFITEYIKGGTLRGIIKSMDSQYP-----WSQRVSFAKDIASGMA 122
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----------------DYDMMLTS 191
           +LHS  IIHRDL   N L+     + +ADFGLA+                  D     T 
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT- 181
Query: 192 VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           VV   ++ APE++    Y   VD++S G V+ E+
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 25  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 76
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    ++A  +  +  Q+   +
Sbjct: 77  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 129
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 130 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL 189
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 190 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 241
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 242 -----------------CPEKVYELMRACWQWNPSDRPSFAE 266

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 29  QIGCGAYGTVFKA-RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           ++GCG +G+V +    ++ K   VA+K L+ +  E       +RE  I+ QLD   +P I
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLD---NPYI 72
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEH-----VDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           VR   V     L         L+ E      + + L    E+ P      S V EL  Q+
Sbjct: 73  VRLIGVCQAEAL--------MLVMEMAGGGPLHKFLVGKREEIP-----VSNVAELLHQV 119
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY-DMMLTSVVVTLW---Y 198
             G+ +L     +HRDL  +N+L+      KI+DFGL+K     D   T+     W   +
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAE 224
            APE +    + +  D+WS G  M E
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWE 205

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 30  IGCGAYGTV-FKARDLQN--KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G G +G V     D  N   G  VA+K L+       +     REI IL+   T  H +
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQ-LRSGWQREIEILR---TLYHEH 71
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           IV++     +    D+   +V L+ E+V   LGS  +  P   +  +++    +Q+ +G+
Sbjct: 72  IVKY-----KGCCEDQGEKSVQLVMEYVP--LGSLRDYLPRHCVGLAQLLLFAQQICEGM 124
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWYRAP 201
            +LH+   IHR L  +N+L+     +KI DFGLAK        Y +         WY AP
Sbjct: 125 AYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AP 183
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E L    +    D+WS G  + E+
Sbjct: 184 ECLKECKFYYASDVWSFGVTLYEL 207

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 33  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 84
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    ++A  +  +  Q+   +
Sbjct: 85  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 137
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 138 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 197
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 198 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 249
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 250 -----------------CPEKVYELMRACWQWNPSDRPSFAE 274

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 30  IGCGAYGTV-FKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G G +G V     D  N G    VA+K L+       +     REI IL+   T  H +
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQ-LRSGWQREIEILR---TLYHEH 72
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           IV++     +    D+   +V L+ E+V   LGS  +  P   +  +++    +Q+ +G+
Sbjct: 73  IVKY-----KGCCEDQGEKSVQLVMEYVP--LGSLRDYLPRHCVGLAQLLLFAQQICEGM 125
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWYRAP 201
            +LH+   IHR L  +N+L+     +KI DFGLAK        Y +         WY AP
Sbjct: 126 AYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AP 184
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E L    +    D+WS G  + E+
Sbjct: 185 ECLKECKFYYASDVWSFGVTLYEL 208

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 25  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 76
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    ++A  +  +  Q+   +
Sbjct: 77  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 129
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 130 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 189
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 190 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 241
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 242 -----------------CPEKVYELMRACWQWNPSDRPSFAE 266

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL 70
           +LN+  L L       L  IG G +G V        +GN VA+K ++     D    + L
Sbjct: 8   ALNMKELKL-------LQTIGKGEFGDVMLG---DYRGNKVAVKCIK----NDATAQAFL 53
Query: 71  REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG 129
            E S++ QL    H N+V+   VI       E    +Y++ E++ +  L  Y+       
Sbjct: 54  AEASVMTQL---RHSNLVQLLGVIV------EEKGGLYIVTEYMAKGSLVDYLRSRGRSV 104
Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
           L    + + +  + + +++L  +  +HRDL  +N+L++     K++DFGL K        
Sbjct: 105 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 164
Query: 190 TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
             + V   + APE L    + T  D+WS G ++ E++
Sbjct: 165 GKLPVK--WTAPEALREAAFSTKSDVWSFGILLWEIY 199

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 22  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 73
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    ++A  +  +  Q+   +
Sbjct: 74  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 126
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 127 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 186
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 187 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 238
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 239 -----------------CPEKVYELMRACWQWNPSDRPSFAE 263

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 22  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 73
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    ++A  +  +  Q+   +
Sbjct: 74  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 126
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 127 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 186
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 187 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 238
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 239 -----------------CPEKVYELMRACWQWNPSDRPSFAE 263

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 25  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 76
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    ++A  +  +  Q+   +
Sbjct: 77  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 129
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 130 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 189
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 190 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 241
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 242 -----------------CPEKVYELMRACWQWNPSDRPSFAE 266

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 20  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 71
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    ++A  +  +  Q+   +
Sbjct: 72  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 124
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 185 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 236
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 237 -----------------CPEKVYELMRACWQWNPSDRPSFAE 261

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 20  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 71
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    ++A  +  +  Q+   +
Sbjct: 72  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 124
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 185 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 236
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 237 -----------------CPEKVYELMRACWQWNPSDRPSFAE 261

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 24  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 75
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    ++A  +  +  Q+   +
Sbjct: 76  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 128
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 189 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 240
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 241 -----------------CPEKVYELMRACWQWNPSDRPSFAE 265

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 22  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 73
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    ++A  +  +  Q+   +
Sbjct: 74  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 126
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 127 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESL 186
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 187 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 238
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 239 -----------------CPEKVYELMRACWQWNPSDRPSFAE 263

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 21  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 72
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    ++A  +  +  Q+   +
Sbjct: 73  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 125
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 126 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESL 185
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 186 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 237
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 238 -----------------CPEKVYELMRACWQWNPSDRPSFAE 262

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 36/223 (16%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKL-------NEDGIPMSTLREISILKQLDTF 82
           +G GA+G V +A      G   A+ K+ VK+       +E    MS L+ +S L Q    
Sbjct: 54  LGAGAFGKVVEATAF-GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ---- 108
Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGL------------ 130
            H NIV                +T Y  +     DL +++ +  PPGL            
Sbjct: 109 -HENIVNLLGACTHG--GPVLVITEYCCY----GDLLNFLRRKRPPGLEYSYNPSHNPEE 161
Query: 131 --SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-- 186
             S+  +   + Q+ +G+ FL S   IHRD+  +N+L+T     KI DFGLA+    D  
Sbjct: 162 QLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 221
Query: 187 -MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
            ++  +  + + + APE + +  Y    D+WS G ++ E++ L
Sbjct: 222 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 264

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 30  IGCGAYGTV-FKARDLQNKGN--YVAMKKLRVKLNEDGIPMST---LREISILKQLDTFE 83
           +G G +G V     D  N G    VA+K L+     D  P       +EI IL+   T  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA----DAGPQHRSGWKQEIDILR---TLY 91
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H +I+++     +    D    ++ L+ E+V   LGS  +  P   +  +++    +Q+ 
Sbjct: 92  HEHIIKY-----KGCCEDAGAASLQLVMEYVP--LGSLRDYLPRHSIGLAQLLLFAQQIC 144
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-----DYDMMLTSVVVTLWY 198
           +G+ +LH+   IHRDL  +N+L+     +KI DFGLAK        Y +         WY
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY 204
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEM 225
            APE L    +    D+WS G  + E+
Sbjct: 205 -APECLKEYKFYYASDVWSFGVTLYEL 230

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPN 86
           + G G +G V+K   + N    VA+KKL   V +  + +     +EI +  +    +H N
Sbjct: 29  KXGEGGFGVVYKGY-VNN--TTVAVKKLAAMVDITTEELKQQFDQEIKVXAKC---QHEN 82
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ--DLGSYMEKCPPPGLSASKVKELTRQMLK 144
           +V           SD   L +  ++       D  S ++  PP  LS     ++ +    
Sbjct: 83  LVELL-----GFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP--LSWHXRCKIAQGAAN 135
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT---FDYDMMLTSVVVTLWYRAP 201
           G++FLH +  IHRD+K  N+L+  A   KI+DFGLA+    F   +  + +V T  Y AP
Sbjct: 136 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 202 EILLNLGYGTP-VDIWSIGCVMAEMWRLVP 230
           E L   G  TP  DI+S G V+ E+   +P
Sbjct: 196 EAL--RGEITPKSDIYSFGVVLLEIITGLP 223

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 43/220 (19%)
Query: 26  ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF--- 82
           +L +IG GAYG+V K    +  G  +A+K++R  ++E         +  +L  LD     
Sbjct: 26  DLGEIGRGAYGSVNKMVH-KPSGQIMAVKRIRSTVDEK-------EQKQLLMDLDVVMRS 77
Query: 83  -EHPNIVRFFDVIHQN--------ILS---DERYLTVYLIFEHVDQDLGSYMEKCPPPGL 130
            + P IV+F+  + +         ++S   D+ Y  VY + + V               +
Sbjct: 78  SDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV---------------I 122
Query: 131 SASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
               + ++T   +K ++ L  + +IIHRD+KP N+L+ R+G +K+ DFG++      +  
Sbjct: 123 PEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182
Query: 190 TSVVVTLWYRAPEIL----LNLGYGTPVDIWSIGCVMAEM 225
           T       Y APE +       GY    D+WS+G  + E+
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 30  IGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G +G V+K     + G     VA+K L+    E    +  L E  I+ Q   F H N
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-RVDFLGEAGIMGQ---FSHHN 107
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           I+R   VI        +Y  + +I E+++        +      S  ++  + R +  G+
Sbjct: 108 IIRLEGVI-------SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAPE 202
            +L +   +HRDL  +N+L+      K++DFGL++  + D   T       + + + APE
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G VM E+
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEV 243

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 29  QIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           ++G   +G V+K          +   VA+K L+ K   +G      R  ++L+     +H
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--AEGPLREEFRHEAMLRA--RLQH 88
Query: 85  PNIVRFFDVIHQN-----ILS--DERYLTVYLIFEHVDQDLGSYME-KCPPPGLSASKVK 136
           PN+V    V+ ++     I S      L  +L+      D+GS  + +     L      
Sbjct: 89  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVV 193
            L  Q+  G+++L SH ++H+DL  +N+L+     +KI+D GL +     DY  +L + +
Sbjct: 149 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           + + + APE ++   +    DIWS G V+ E++
Sbjct: 209 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL 70
           +LN+  L L       L  IG G +G V        +GN VA+K ++     D    + L
Sbjct: 2   ALNMKELKL-------LQTIGKGEFGDVMLG---DYRGNKVAVKCIK----NDATAQAFL 47
Query: 71  REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG 129
            E S++ QL    H N+V+   VI       E    +Y++ E++ +  L  Y+       
Sbjct: 48  AEASVMTQL---RHSNLVQLLGVIV------EEKGGLYIVTEYMAKGSLVDYLRSRGRSV 98
Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
           L    + + +  + + +++L  +  +HRDL  +N+L++     K++DFGL K        
Sbjct: 99  LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 158
Query: 190 TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
             + V   + APE L    + T  D+WS G ++ E++
Sbjct: 159 GKLPVK--WTAPEALREKKFSTKSDVWSFGILLWEIY 193

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL 70
           +LN+  L L       L  IG G +G V        +GN VA+K ++     D    + L
Sbjct: 17  ALNMKELKL-------LQTIGKGEFGDVMLG---DYRGNKVAVKCIK----NDATAQAFL 62
Query: 71  REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG 129
            E S++ QL    H N+V+   VI       E    +Y++ E++ +  L  Y+       
Sbjct: 63  AEASVMTQL---RHSNLVQLLGVIV------EEKGGLYIVTEYMAKGSLVDYLRSRGRSV 113
Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
           L    + + +  + + +++L  +  +HRDL  +N+L++     K++DFGL K        
Sbjct: 114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173
Query: 190 TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
             + V   + APE L    + T  D+WS G ++ E++
Sbjct: 174 GKLPVK--WTAPEALREKKFSTKSDVWSFGILLWEIY 208

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 123/283 (43%), Gaps = 46/283 (16%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 18  KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 69
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    +SA  +  +  Q+   +
Sbjct: 70  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 122
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVT--LWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++    D           + + APE L
Sbjct: 123 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESL 182
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE-NISLM 263
               +    D+W+ G ++ E                       I T  M+ +P  + S +
Sbjct: 183 AYNKFSIKSDVWAFGVLLWE-----------------------IATYGMSPYPGIDPSQV 219
Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
           +   E+  ++        C  K   L+ +   +NP+DR S A+
Sbjct: 220 YELLEKDYRMERPE---GCPEKVYELMRACWQWNPSDRPSFAE 259

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 29  QIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           ++G   +G V+K          +   VA+K L+ K   +G      R  ++L+     +H
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--AEGPLREEFRHEAMLRA--RLQH 71
Query: 85  PNIVRFFDVIHQN-----ILS--DERYLTVYLIFEHVDQDLGSYME-KCPPPGLSASKVK 136
           PN+V    V+ ++     I S      L  +L+      D+GS  + +     L      
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVV 193
            L  Q+  G+++L SH ++H+DL  +N+L+     +KI+D GL +     DY  +L + +
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           + + + APE ++   +    DIWS G V+ E++
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL 70
           +LN+  L L       L  IG G +G V        +GN VA+K ++     D    + L
Sbjct: 189 ALNMKELKL-------LQTIGKGEFGDVMLG---DYRGNKVAVKCIK----NDATAQAFL 234
Query: 71  REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG 129
            E S++ QL    H N+V+   VI       E    +Y++ E++ +  L  Y+       
Sbjct: 235 AEASVMTQL---RHSNLVQLLGVIV------EEKGGLYIVTEYMAKGSLVDYLRSRGRSV 285
Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
           L    + + +  + + +++L  +  +HRDL  +N+L++     K++DFGL K        
Sbjct: 286 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 345
Query: 190 TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
             + V   + APE L    + T  D+WS G ++ E++
Sbjct: 346 GKLPVK--WTAPEALREKKFSTKSDVWSFGILLWEIY 380

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 138/319 (43%), Gaps = 64/319 (20%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
           +G + ++ L  +G GAYG VF  R +   + G   AMK               L++ +I+
Sbjct: 51  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK--------------VLKKATIV 96
Query: 77  KQLDTFEHPNIVR----------FFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC 125
           ++  T EH    R          F   +H    ++ +   ++LI ++++  +L +++ + 
Sbjct: 97  QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK---LHLILDYINGGELFTHLSQR 153
Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-- 183
                +  +V+    +++  ++ LH   II+RD+K +N+L+   G + + DFGL+K F  
Sbjct: 154 ER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211
Query: 184 DYDMMLTSVVVTLWYRAPEILL--NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL 241
           D          T+ Y AP+I+   + G+   VD WS+G +M E+      F    E    
Sbjct: 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 271
Query: 242 KCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADR 301
             I R I   S   +P+ +S +                      A  L++ +L  +P  R
Sbjct: 272 AEISRRI-LKSEPPYPQEMSAL----------------------AKDLIQRLLMKDPKKR 308
Query: 302 IS-----AADALEHPYFKE 315
           +      A +  EH +F++
Sbjct: 309 LGCGPRDADEIKEHLFFQK 327

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 30  IGCGAYGTV-FKARDLQNKGN--YVAMKKLRVKLNEDGIPMST---LREISILKQLDTFE 83
           +G G +G V     D  N G    VA+K L+     D  P       +EI IL+   T  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA----DCGPQHRSGWKQEIDILR---TLY 74
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H +I+++     +    D+   ++ L+ E+V   LGS  +  P   +  +++    +Q+ 
Sbjct: 75  HEHIIKY-----KGCCEDQGEKSLQLVMEYVP--LGSLRDYLPRHSIGLAQLLLFAQQIC 127
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWY 198
           +G+ +LHS   IHR+L  +N+L+     +KI DFGLAK        Y +         WY
Sbjct: 128 EGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 187
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEM 225
            APE L    +    D+WS G  + E+
Sbjct: 188 -APECLKEYKFYYASDVWSFGVTLYEL 213

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 227 KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 278
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    +SA  +  +  Q+   +
Sbjct: 279 VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHR+L  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 392 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 443
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 444 -----------------CPEKVYELMRACWQWNPSDRPSFAE 468

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 1/99 (1%)
Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM 187
           PG    +    T Q++ G++ LH   II+RDLKP+N+L+   G ++I+D GLA       
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 188 MLT-SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
             T     T  + APE+LL   Y   VD +++G  + EM
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEM 382

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 1/99 (1%)
Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM 187
           PG    +    T Q++ G++ LH   II+RDLKP+N+L+   G ++I+D GLA       
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 188 MLT-SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
             T     T  + APE+LL   Y   VD +++G  + EM
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEM 382

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 114/256 (44%), Gaps = 35/256 (13%)
Query: 3   EYSADTIQSL----NLDSLDLGDKKYDELCQIGCGAYGTV-FKARDLQNKGNYVAMKKLR 57
           E +A+TI       N D + L D  ++ L  +G G++G V    R   ++   V + K  
Sbjct: 320 EKTANTISKFDNNGNRDRMKLTD--FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD 377
Query: 58  VKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-- 115
           V + +D +   T+ E  +L        P    F   +H    + +R   +Y + E+V+  
Sbjct: 378 VVIQDDDV-ECTMVEKRVLAL------PGKPPFLTQLHSCFQTMDR---LYFVMEYVNGG 427
Query: 116 ------QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA 169
                 Q +G + E  P     A+++         G+ FL S  II+RDLK  N+++   
Sbjct: 428 DLMYHIQQVGRFKE--PHAVFYAAEI-------AIGLFFLQSKGIIYRDLKLDNVMLDSE 478
Query: 170 GGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           G +KIADFG+ K   +D + T     T  Y APEI+    YG  VD W+ G ++ EM   
Sbjct: 479 GHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538
Query: 229 VPLFCASTEVEQLKCI 244
              F    E E  + I
Sbjct: 539 QAPFEGEDEDELFQSI 554

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 1/99 (1%)
Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM 187
           PG    +    T Q++ G++ LH   II+RDLKP+N+L+   G ++I+D GLA       
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 188 MLT-SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
             T     T  + APE+LL   Y   VD +++G  + EM
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEM 382

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 1/99 (1%)
Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM 187
           PG    +    T Q++ G++ LH   II+RDLKP+N+L+   G ++I+D GLA       
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 188 MLT-SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
             T     T  + APE+LL   Y   VD +++G  + EM
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEM 382

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 124/283 (43%), Gaps = 46/283 (16%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G +G V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 18  KLGGGQFGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 69
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    +SA  +  +  Q+   +
Sbjct: 70  VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 122
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 123 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL 182
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE-NISLM 263
               +    D+W+ G ++ E                       I T  M+ +P  + S +
Sbjct: 183 AYNKFSIKSDVWAFGVLLWE-----------------------IATYGMSPYPGIDPSQV 219
Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
           +   E+  ++        C  K   L+ +   +NP+DR S A+
Sbjct: 220 YELLEKDYRMERPE---GCPEKVYELMRACWQWNPSDRPSFAE 259

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 114/233 (48%), Gaps = 31/233 (13%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFK--ARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLR 71
           D  ++  +K   L ++G G++G V++  ARD+  KG   A  ++ VK +NE     ++LR
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGE--AETRVAVKTVNES----ASLR 62
Query: 72  E-ISILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP 127
           E I  L +   +  F   ++VR   V+ +     +  L V  +  H   DL SY+    P
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKG----QPTLVVMELMAH--GDLKSYLRSLRP 116
Query: 128 -----PGLSASKVKELTR---QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL 179
                PG     ++E+ +   ++  G+ +L++ + +HRDL  +N ++     +KI DFG+
Sbjct: 117 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM 176
Query: 180 AKTF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            +     DY       ++ + + APE L +  + T  D+WS G V+ E+  L 
Sbjct: 177 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 91
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H   DL +++            VK+L     Q+ K
Sbjct: 92  LSLLGIC---LRSEGSPLVVLPYMKH--GDLRNFIRN----ETHNPTVKDLIGFGLQVAK 142
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA-----KTFDYDMMLTSVVVTLWYR 199
           G+ FL S + +HRDL  +N ++     +K+ADFGLA     K FD     T   + + + 
Sbjct: 143 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 202
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEM 225
           A E L    + T  D+WS G ++ E+
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWEL 228

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 30  IGCGAYGTVFKAR-DLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   R  L +K    VA+K L+V   E       L E SI+ Q   F+HPNI
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQ---FDHPNI 108
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +R   V+ ++         V ++ E+++   L S++ K      +  ++  + R +  G+
Sbjct: 109 IRLEGVVTKS-------KPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGM 160
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAPE 202
            +L     +HRDL  +N+LI      K++DFGLA+  + D           + + + +PE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G V+ E+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEV 243

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 29  QIGCGAYGTVFKA-RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           ++GCG +G+V +    ++ K   VA+K L+ +  E       +RE  I+ QLD   +P I
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLD---NPYI 398
Query: 88  VRFFDVIHQNILSDERYLTVYLIFE-----HVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           VR   V     L         L+ E      + + L    E+ P      S V EL  Q+
Sbjct: 399 VRLIGVCQAEAL--------MLVMEMAGGGPLHKFLVGKREEIP-----VSNVAELLHQV 445
Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY-DMMLTSVVVTLW---Y 198
             G+ +L     +HR+L  +N+L+      KI+DFGL+K     D   T+     W   +
Sbjct: 446 SMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 505
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAE 224
            APE +    + +  D+WS G  M E
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWE 531

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 152
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H   DL +++            VK+L     Q+ K
Sbjct: 153 LSLLGIC---LRSEGSPLVVLPYMKH--GDLRNFIRN----ETHNPTVKDLIGFGLQVAK 203
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA-----KTFDYDMMLTSVVVTLWYR 199
           G+ FL S + +HRDL  +N ++     +K+ADFGLA     K FD     T   + + + 
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEM 225
           A E L    + T  D+WS G ++ E+
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWEL 289

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 93
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H   DL +++            VK+L     Q+ K
Sbjct: 94  LSLLGIC---LRSEGSPLVVLPYMKH--GDLRNFIRN----ETHNPTVKDLIGFGLQVAK 144
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA-----KTFDYDMMLTSVVVTLWYR 199
           G+ FL S + +HRDL  +N ++     +K+ADFGLA     K FD     T   + + + 
Sbjct: 145 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEM 225
           A E L    + T  D+WS G ++ E+
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWEL 230

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 93
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H   DL +++            VK+L     Q+ K
Sbjct: 94  LSLLGIC---LRSEGSPLVVLPYMKH--GDLRNFIRN----ETHNPTVKDLIGFGLQVAK 144
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA-----KTFDYDMMLTSVVVTLWYR 199
           G+ FL S + +HRDL  +N ++     +K+ADFGLA     K FD     T   + + + 
Sbjct: 145 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEM 225
           A E L    + T  D+WS G ++ E+
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWEL 230

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 94
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H   DL +++            VK+L     Q+ K
Sbjct: 95  LSLLGIC---LRSEGSPLVVLPYMKH--GDLRNFIRN----ETHNPTVKDLIGFGLQVAK 145
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA-----KTFDYDMMLTSVVVTLWYR 199
           G+ FL S + +HRDL  +N ++     +K+ADFGLA     K FD     T   + + + 
Sbjct: 146 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 205
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEM 225
           A E L    + T  D+WS G ++ E+
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWEL 231

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 94
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H D       E   P       VK+L     Q+ K
Sbjct: 95  LSLLGIC---LRSEGSPLVVLPYMKHGDLRNFIRNETHNP------TVKDLIGFGLQVAK 145
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA-----KTFDYDMMLTSVVVTLWYR 199
           G+ FL S + +HRDL  +N ++     +K+ADFGLA     K FD     T   + + + 
Sbjct: 146 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWM 205
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEM 225
           A E L    + T  D+WS G ++ E+
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWEL 231

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 98
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H   DL +++            VK+L     Q+ K
Sbjct: 99  LSLLGIC---LRSEGSPLVVLPYMKH--GDLRNFIRN----ETHNPTVKDLIGFGLQVAK 149
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA-----KTFDYDMMLTSVVVTLWYR 199
           G+ FL S + +HRDL  +N ++     +K+ADFGLA     K FD     T   + + + 
Sbjct: 150 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 209
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEM 225
           A E L    + T  D+WS G ++ E+
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWEL 235

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 29  QIGCGAYGTVFKAR-----DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           ++G GA+G VF A        Q+K   VA+K L  K   +       RE  +L  L   +
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDK-MLVAVKAL--KEASESARQDFQREAELLTML---Q 78
Query: 84  HPNIVRFFDVIHQN-----ILSDERY--LTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
           H +IVRFF V  +      +    R+  L  +L     D  L +  E   P  L   ++ 
Sbjct: 79  HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 138
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVV 193
            +  Q+  G+ +L     +HRDL  +N L+ +   +KI DFG+++   + DY  +    +
Sbjct: 139 AVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 198
Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           + + +  PE +L   + T  D+WS G V+ E++
Sbjct: 199 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 231

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 29  QIGCGAYGTVFKAR-----DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           ++G GA+G VF A        Q+K   VA+K L  K   +       RE  +L  L   +
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDK-MLVAVKAL--KEASESARQDFQREAELLTML---Q 101
Query: 84  HPNIVRFFDVIHQN-----ILSDERY--LTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
           H +IVRFF V  +      +    R+  L  +L     D  L +  E   P  L   ++ 
Sbjct: 102 HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVV 193
            +  Q+  G+ +L     +HRDL  +N L+ +   +KI DFG+++   + DY  +    +
Sbjct: 162 AVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           + + +  PE +L   + T  D+WS G V+ E++
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 30  IGCGAYGTV-FKARDLQNKGN--YVAMKKLRVKLNEDGIPMST---LREISILKQLDTFE 83
           +G G +G V     D  N G    VA+K L+     D  P       +EI IL+   T  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA----DCGPQHRSGWKQEIDILR---TLY 74
Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
           H +I+++     +    D+   ++ L+ E+V   LGS  +  P   +  +++    +Q+ 
Sbjct: 75  HEHIIKY-----KGCCEDQGEKSLQLVMEYVP--LGSLRDYLPRHSIGLAQLLLFAQQIC 127
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWY 198
           +G+ +LH+   IHR+L  +N+L+     +KI DFGLAK        Y +         WY
Sbjct: 128 EGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 187
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEM 225
            APE L    +    D+WS G  + E+
Sbjct: 188 -APECLKEYKFYYASDVWSFGVTLYEL 213

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 29  QIGCGAYGTVFKAR-----DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           ++G GA+G VF A        Q+K   VA+K L  K   +       RE  +L  L   +
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDK-MLVAVKAL--KEASESARQDFQREAELLTML---Q 72
Query: 84  HPNIVRFFDVIHQN-----ILSDERY--LTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
           H +IVRFF V  +      +    R+  L  +L     D  L +  E   P  L   ++ 
Sbjct: 73  HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 132
Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVV 193
            +  Q+  G+ +L     +HRDL  +N L+ +   +KI DFG+++   + DY  +    +
Sbjct: 133 AVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 192
Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           + + +  PE +L   + T  D+WS G V+ E++
Sbjct: 193 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 225

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 30  IGCGAYGTVFKAR-DLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   R  L +K    VA+K L+V   E       L E SI+ Q   F+HPNI
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQ---FDHPNI 79
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +R   V+ ++         V ++ E+++   L S++ K      +  ++  + R +  G+
Sbjct: 80  IRLEGVVTKS-------KPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGM 131
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAPE 202
            +L     +HRDL  +N+LI      K++DFGL++  + D           + + + +PE
Sbjct: 132 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G V+ E+
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWEV 214

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 30  IGCGAYGTVFKAR-DLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   R  L +K    VA+K L+V   E       L E SI+ Q   F+HPNI
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQ---FDHPNI 108
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +R   V+ ++         V ++ E+++   L S++ K      +  ++  + R +  G+
Sbjct: 109 IRLEGVVTKS-------KPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGM 160
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAPE 202
            +L     +HRDL  +N+LI      K++DFGL++  + D           + + + +PE
Sbjct: 161 KYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G V+ E+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEV 243

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 105/227 (46%), Gaps = 19/227 (8%)
Query: 5   SADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG 64
           +A +   L   S ++  K    L ++G G +G V         G +     + +K+ ++G
Sbjct: 7   NAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVV-------KYGKWRGQYDVAIKMIKEG 59
Query: 65  IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQD-LGSYME 123
             MS    I   K +    H  +V+ + V  +          +++I E++    L +Y+ 
Sbjct: 60  -SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-------RPIFIITEYMANGCLLNYLR 111
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF 183
           +         ++ E+ + + + +++L S + +HRDL  +N L+   G +K++DFGL++  
Sbjct: 112 EMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170
Query: 184 DYDMMLTSVVVTLWYR--APEILLNLGYGTPVDIWSIGCVMAEMWRL 228
             D   +SV      R   PE+L+   + +  DIW+ G +M E++ L
Sbjct: 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 217

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 30  IGCGAYGTVFKAR-DLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   R  L +K    VA+K L+V   E       L E SI+ Q   F+HPNI
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQ---FDHPNI 96
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +R   V+ ++         V ++ E+++   L S++ K      +  ++  + R +  G+
Sbjct: 97  IRLEGVVTKS-------KPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGM 148
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAPE 202
            +L     +HRDL  +N+LI      K++DFGL++  + D           + + + +PE
Sbjct: 149 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 208
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G V+ E+
Sbjct: 209 AIAYRKFTSASDVWSYGIVLWEV 231

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 120/282 (42%), Gaps = 44/282 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V++    +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 266 KLGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 317
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V         R    Y+I E +   +L  Y+ +C    ++A  +  +  Q+   +
Sbjct: 318 VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 370
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHR+L  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 371 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 430
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               +    D+W+ G +   +W +     +      L  ++ ++      E PE      
Sbjct: 431 AYNKFSIKSDVWAFGVL---LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG----- 482
Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                            C  K   L+ +   +NP+DR S A+
Sbjct: 483 -----------------CPEKVYELMRACWQWNPSDRPSFAE 507

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 105/227 (46%), Gaps = 19/227 (8%)
Query: 5   SADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG 64
           +A +   L   S ++  K    L ++G G +G V         G +     + +K+ ++G
Sbjct: 7   NAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVV-------KYGKWRGQYDVAIKMIKEG 59
Query: 65  IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQD-LGSYME 123
             MS    I   K +    H  +V+ + V  +          +++I E++    L +Y+ 
Sbjct: 60  -SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-------RPIFIITEYMANGCLLNYLR 111
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF 183
           +         ++ E+ + + + +++L S + +HRDL  +N L+   G +K++DFGL++  
Sbjct: 112 EMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170
Query: 184 DYDMMLTSVVVTLWYR--APEILLNLGYGTPVDIWSIGCVMAEMWRL 228
             D   +SV      R   PE+L+   + +  DIW+ G +M E++ L
Sbjct: 171 LDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 217

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 30  IGCGAYGTVFKAR-DLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   R  L +K    VA+K L+V   E       L E SI+ Q   F+HPNI
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQ---FDHPNI 106
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +R   V+ ++         V ++ E+++   L S++ K      +  ++  + R +  G+
Sbjct: 107 IRLEGVVTKS-------KPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGM 158
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAPE 202
            +L     +HRDL  +N+LI      K++DFGL++  + D           + + + +PE
Sbjct: 159 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 218
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G V+ E+
Sbjct: 219 AIAYRKFTSASDVWSYGIVLWEV 241

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 30  IGCGAYGTVFKAR-DLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   R  L +K    VA+K L+V   E       L E SI+ Q   F+HPNI
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQ---FDHPNI 108
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +R   V+ ++         V ++ E+++   L S++ K      +  ++  + R +  G+
Sbjct: 109 IRLEGVVTKS-------KPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGM 160
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAPE 202
            +L     +HRDL  +N+LI      K++DFGL++  + D           + + + +PE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G V+ E+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEV 243

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 39/245 (15%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYV--AMKKLRVKLNEDGIPMSTLREIS 74
           LD  D K+ ++  IG G +G V KAR ++  G  +  A+K+++   ++D        E+ 
Sbjct: 12  LDWNDIKFQDV--IGEGNFGQVLKAR-IKKDGLRMDAAIKRMKEYASKDD-HRDFAGELE 67
Query: 75  ILKQLDTFEHPNIVRFFDVI-HQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC------P 126
           +L +L    HPNI+       H+  L        YL  E+    +L  ++ K       P
Sbjct: 68  VLCKLG--HHPNIINLLGACEHRGYL--------YLAIEYAPHGNLLDFLRKSRVLETDP 117
Query: 127 PPGLSASKVKELTRQML--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG 178
              ++ S    L+ Q L        +G+D+L   + IHRDL  +N+L+      KIADFG
Sbjct: 118 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 177
Query: 179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPL----FCA 234
           L++  +  +  T   + + + A E L    Y T  D+WS G +   +W +V L    +C 
Sbjct: 178 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL---LWEIVSLGGTPYCG 234
Query: 235 STEVE 239
            T  E
Sbjct: 235 MTCAE 239

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 108/242 (44%), Gaps = 31/242 (12%)
Query: 13  NLDSLDLGDKKYDELCQIGCGAYGTV-FKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR 71
           N D + L D  ++ L  +G G++G V    R   ++   V + K  V + +D +   T+ 
Sbjct: 13  NRDRMKLTD--FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVE-CTMV 69
Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYME 123
           E  +L        P    F   +H    + +R   +Y + E+V+        Q +G + E
Sbjct: 70  EKRVLAL------PGKPPFLTQLHSCFQTMDR---LYFVMEYVNGGDLMYHIQQVGRFKE 120
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF 183
             P     A+++         G+ FL S  II+RDLK  N+++   G +KIADFG+ K  
Sbjct: 121 --PHAVFYAAEIA-------IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171
Query: 184 DYDMMLTSVVV-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLK 242
            +D + T     T  Y APEI+    YG  VD W+ G ++ EM      F    E E  +
Sbjct: 172 IWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231
Query: 243 CI 244
            I
Sbjct: 232 SI 233

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 30  IGCGAYGTVFKAR-DLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   R  L +K    VA+K L+V   E       L E SI+ Q   F+HPNI
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQ---FDHPNI 108
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +R   V+ ++         V ++ E+++   L S++ K      +  ++  + R +  G+
Sbjct: 109 IRLEGVVTKS-------KPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGM 160
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAPE 202
            +L     +HRDL  +N+LI      K++DFGL++  + D           + + + +PE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G V+ E+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEV 243

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 30  IGCGAYGTVFKAR-DLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   R  L +K    VA+K L+V   E       L E SI+ Q   F+HPNI
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQ---FDHPNI 108
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +R   V+ ++         V ++ E+++   L S++ K      +  ++  + R +  G+
Sbjct: 109 IRLEGVVTKS-------KPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGM 160
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAPE 202
            +L     +HRDL  +N+LI      K++DFGL++  + D           + + + +PE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G V+ E+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEV 243

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 30  IGCGAYGTVFKAR-DLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   R  L +K    VA+K L+V   E       L E SI+ Q   F+HPNI
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQ---FDHPNI 108
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +R   V+ ++         V ++ E+++   L S++ K      +  ++  + R +  G+
Sbjct: 109 IRLEGVVTKS-------KPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGM 160
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAPE 202
            +L     +HRDL  +N+LI      K++DFGL++  + D           + + + +PE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G V+ E+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEV 243

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 112/255 (43%), Gaps = 30/255 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR----EISILKQLDTFEHP 85
           +G G +G V KA     KG       + VK+ ++    S LR    E ++LKQ++   HP
Sbjct: 31  LGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN---HP 86
Query: 86  NIVRFFDVIHQN-----ILSDERYLTVYLIFEHVDQDLGSYM-----------EKCPPPG 129
           ++++ +    Q+     I+   +Y ++        +    Y+           +      
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYD 186
           L+   +     Q+ +G+ +L   +++HRDL  +N+L+     +KI+DFGL++     D  
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
           +  +   + + + A E L +  Y T  D+WS G +   +W +V L          + +F 
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL---LWEIVTLGGNPYPGIPPERLFN 263
Query: 247 VIGTPSMNEWPENIS 261
           ++ T    E P+N S
Sbjct: 264 LLKTGHRMERPDNCS 278

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 30  IGCGAYGTVFKAR-DLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   R  L +K    VA+K L+V   E       L E SI+ Q   F+HPNI
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQ---FDHPNI 108
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +R   V+ ++         V ++ E+++   L S++ K      +  ++  + R +  G+
Sbjct: 109 IRLEGVVTKS-------KPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGM 160
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAPE 202
            +L     +HRDL  +N+LI      K++DFGL +  + D           + + + +PE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G V+ E+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEV 243

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 39/245 (15%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYV--AMKKLRVKLNEDGIPMSTLREIS 74
           LD  D K+ ++  IG G +G V KAR ++  G  +  A+K+++   ++D        E+ 
Sbjct: 22  LDWNDIKFQDV--IGEGNFGQVLKAR-IKKDGLRMDAAIKRMKEYASKDD-HRDFAGELE 77
Query: 75  ILKQLDTFEHPNIVRFFDVI-HQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC------P 126
           +L +L    HPNI+       H+  L        YL  E+    +L  ++ K       P
Sbjct: 78  VLCKLG--HHPNIINLLGACEHRGYL--------YLAIEYAPHGNLLDFLRKSRVLETDP 127
Query: 127 PPGLSASKVKELTRQML--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG 178
              ++ S    L+ Q L        +G+D+L   + IHRDL  +N+L+      KIADFG
Sbjct: 128 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 187
Query: 179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPL----FCA 234
           L++  +  +  T   + + + A E L    Y T  D+WS G +   +W +V L    +C 
Sbjct: 188 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL---LWEIVSLGGTPYCG 244
Query: 235 STEVE 239
            T  E
Sbjct: 245 MTCAE 249

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 15/224 (6%)
Query: 5   SADTIQSLNLDSL---DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN 61
           +++T+QS   D         + +  L ++G G+YG VFK R  ++ G   A+K+      
Sbjct: 37  ASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKED-GRLYAVKRSMSPFR 95
Query: 62  EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY 121
                   L E+   +++   +HP  VR      +  +    YL   L    + Q   ++
Sbjct: 96  GPKDRARKLAEVGSHEKVG--QHPCCVRLEQAWEEGGI---LYLQTELCGPSLQQHCEAW 150
Query: 122 MEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK 181
               P      ++V    R  L  +  LHS  ++H D+KP N+ +   G  K+ DFGL  
Sbjct: 151 GASLP-----EAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV 205
Query: 182 TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                           Y APE LL   YGT  D++S+G  + E+
Sbjct: 206 ELGTAGAGEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEV 248

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 114/233 (48%), Gaps = 31/233 (13%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFK--ARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLR 71
           D  ++  +K   L ++G G++G V++  ARD+  KG   A  ++ VK +NE     ++LR
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGE--AETRVAVKTVNES----ASLR 62
Query: 72  E-ISILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP 127
           E I  L +   +  F   ++VR   V+ +     +  L V  +  H   DL SY+    P
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKG----QPTLVVMELMAH--GDLKSYLRSLRP 116
Query: 128 -----PGLSASKVKELTR---QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL 179
                PG     ++E+ +   ++  G+ +L++ + +HR+L  +N ++     +KI DFG+
Sbjct: 117 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGM 176
Query: 180 AKTF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            +     DY       ++ + + APE L +  + T  D+WS G V+ E+  L 
Sbjct: 177 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKAR--DLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           +D+   K +E+  IG G +G V + R      K + VA+K L+    E       L E S
Sbjct: 11  IDVSYVKIEEV--IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEAS 67
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           I+ Q   FEHPNI+R   V+  +       + V ++ E ++        +      +  +
Sbjct: 68  IMGQ---FEHPNIIRLEGVVTNS-------MPVMILTEFMENGALDSFLRLNDGQFTVIQ 117
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD---YDMMLTS 191
           +  + R +  G+ +L     +HRDL  +N+L+      K++DFGL++  +    D   TS
Sbjct: 118 LVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTS 177
Query: 192 VV---VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            +   + + + APE +    + +  D WS G VM E+
Sbjct: 178 SLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEV 214

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 114/233 (48%), Gaps = 31/233 (13%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFK--ARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLR 71
           D  ++  +K   L ++G G++G V++  ARD+  KG   A  ++ VK +NE     ++LR
Sbjct: 11  DEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGE--AETRVAVKTVNES----ASLR 63
Query: 72  E-ISILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP 127
           E I  L +   +  F   ++VR   V+ +     +  L V  +  H   DL SY+    P
Sbjct: 64  ERIEFLNEASVMKGFTCHHVVRLLGVVSKG----QPTLVVMELMAH--GDLKSYLRSLRP 117
Query: 128 -----PGLSASKVKELTR---QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL 179
                PG     ++E+ +   ++  G+ +L++ + +HR+L  +N ++     +KI DFG+
Sbjct: 118 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGM 177
Query: 180 AKTF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            +     DY       ++ + + APE L +  + T  D+WS G V+ E+  L 
Sbjct: 178 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 230

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 109/221 (49%), Gaps = 31/221 (14%)
Query: 27  LCQIGCGAYGTVFK--ARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLRE-ISILKQ---L 79
           L ++G G++G V++  ARD+  KG   A  ++ VK +NE     ++LRE I  L +   +
Sbjct: 21  LRELGQGSFGMVYEGNARDII-KGE--AETRVAVKTVNES----ASLRERIEFLNEASVM 73
Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP-----PGLSASK 134
             F   ++VR   V+ +     +  L V  +  H   DL SY+    P     PG     
Sbjct: 74  KGFTCHHVVRLLGVVSKG----QPTLVVMELMAH--GDLKSYLRSLRPEAENNPGRPPPT 127
Query: 135 VKELTR---QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMM 188
           ++E+ +   ++  G+ +L++ + +HRDL  +N ++     +KI DFG+ +     DY   
Sbjct: 128 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 187
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
               ++ + + APE L +  + T  D+WS G V+ E+  L 
Sbjct: 188 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 228

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 30  IGCGAYGTVFKAR-DLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   R  L +K    VA+K L+V   E       L E SI+ Q   F+HPNI
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQ---FDHPNI 79
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +R   V+ ++         V ++ E ++   L S++ K      +  ++  + R +  G+
Sbjct: 80  IRLEGVVTKS-------KPVMIVTEXMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGM 131
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAPE 202
            +L     +HRDL  +N+LI      K++DFGL++  + D           + + + +PE
Sbjct: 132 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G V+ E+
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWEV 214

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 112/255 (43%), Gaps = 30/255 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR----EISILKQLDTFEHP 85
           +G G +G V KA     KG       + VK+ ++    S LR    E ++LKQ++   HP
Sbjct: 31  LGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN---HP 86
Query: 86  NIVRFFDVIHQN-----ILSDERYLTVYLIFEHVDQDLGSYM-----------EKCPPPG 129
           ++++ +    Q+     I+   +Y ++        +    Y+           +      
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYD 186
           L+   +     Q+ +G+ +L   +++HRDL  +N+L+     +KI+DFGL++     D  
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
           +  +   + + + A E L +  Y T  D+WS G +   +W +V L          + +F 
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL---LWEIVTLGGNPYPGIPPERLFN 263
Query: 247 VIGTPSMNEWPENIS 261
           ++ T    E P+N S
Sbjct: 264 LLKTGHRMERPDNCS 278

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 31/233 (13%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFK--ARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLR 71
           D  ++  +K   L ++G G++G V++  ARD+  KG   A  ++ VK +NE     ++LR
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGE--AETRVAVKTVNES----ASLR 62
Query: 72  E-ISILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP 127
           E I  L +   +  F   ++VR   V+ +     +  L V  +  H   DL SY+    P
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKG----QPTLVVMELMAH--GDLKSYLRSLRP 116
Query: 128 -----PGLSASKVKELTR---QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL 179
                PG     ++E+ +   ++  G+ +L++ + +HRDL  +N ++     +KI DFG+
Sbjct: 117 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM 176
Query: 180 AKTF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            +     D        ++ + + APE L +  + T  D+WS G V+ E+  L 
Sbjct: 177 TRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 113/234 (48%), Gaps = 33/234 (14%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFK--ARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLR 71
           D  ++  +K   L ++G G++G V++  ARD+  KG   A  ++ VK +NE     ++LR
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGE--AETRVAVKTVNES----ASLR 62
Query: 72  E-ISILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP 127
           E I  L +   +  F   ++VR   V+ +     +  L V  +  H   DL SY+    P
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKG----QPTLVVMELMAH--GDLKSYLRSLRP 116
Query: 128 -----PGLSASKVKELTR---QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL 179
                PG     ++E+ +   ++  G+ +L++ + +HRDL  +N ++     +KI DFG+
Sbjct: 117 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM 176
Query: 180 AK----TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            +    T  Y      ++   W  APE L +  + T  D+WS G V+ E+  L 
Sbjct: 177 TRDIYETAYYRKGGKGLLPVRWM-APESLKDGVFTTSSDMWSFGVVLWEITSLA 229

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 31/233 (13%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFK--ARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLR 71
           D  ++  +K   L ++G G++G V++  ARD+  KG   A  ++ VK +NE     ++LR
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGE--AETRVAVKTVNES----ASLR 62
Query: 72  E-ISILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP 127
           E I  L +   +  F   ++VR   V+ +     +  L V  +  H   DL SY+    P
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKG----QPTLVVMELMAH--GDLKSYLRSLRP 116
Query: 128 -----PGLSASKVKELTR---QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL 179
                PG     ++E+ +   ++  G+ +L++ + +HRDL  +N ++     +KI DFG+
Sbjct: 117 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM 176
Query: 180 AKTF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            +     D        ++ + + APE L +  + T  D+WS G V+ E+  L 
Sbjct: 177 TRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 30  IGCGAYGTVFKAR-DLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   R  L +K    VA+K L+V   E       L E SI+ Q   F+HPNI
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQ---FDHPNI 108
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +R   V+ ++         V ++ E ++   L S++ K      +  ++  + R +  G+
Sbjct: 109 IRLEGVVTKS-------KPVMIVTEXMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGM 160
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAPE 202
            +L     +HRDL  +N+LI      K++DFGL++  + D           + + + +PE
Sbjct: 161 KYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G V+ E+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEV 243

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 31/233 (13%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFK--ARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLR 71
           D  ++  +K   L ++G G++G V++  ARD+  KG   A  ++ VK +NE     ++LR
Sbjct: 7   DEWEVSREKITLLRELGQGSFGMVYEGNARDII-KGE--AETRVAVKTVNES----ASLR 59
Query: 72  E-ISILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP 127
           E I  L +   +  F   ++VR   V+ +     +  L V  +  H   DL SY+    P
Sbjct: 60  ERIEFLNEASVMKGFTCHHVVRLLGVVSKG----QPTLVVMELMAH--GDLKSYLRSLRP 113
Query: 128 -----PGLSASKVKELTR---QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL 179
                PG     ++E+ +   ++  G+ +L++ + +HRDL  +N ++     +KI DFG+
Sbjct: 114 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM 173
Query: 180 AKTF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
            +     D        ++ + + APE L +  + T  D+WS G V+ E+  L 
Sbjct: 174 TRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 226

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 19/200 (9%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V+      N    VA+K L+        P S L E  I+K+L   +H  +V
Sbjct: 16  RLGNGQFGEVWMG--TWNGNTKVAIKTLKPGTMS---PESFLEEAQIMKKL---KHDKLV 67
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + + V+ +          +Y++ E++++  L  +++      L    + ++  Q+  G+ 
Sbjct: 68  QLYAVVSEE--------PIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 119
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT--SVVVTLWYRAPEILL 205
           ++     IHRDL+  N+L+      KIADFGLA+  + +           + + APE  L
Sbjct: 120 YIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAAL 179
Query: 206 NLGYGTPVDIWSIGCVMAEM 225
              +    D+WS G ++ E+
Sbjct: 180 YGRFTIKSDVWSFGILLTEL 199

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 17/223 (7%)
Query: 9   IQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMS 68
           ++  +L  L +    +     +G G +G V+K R     G  VA+K+L+ +  + G    
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGR--LADGTLVAVKRLKEERXQGG---- 78
Query: 69  TLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTV-YLIFEHVDQDLGSYMEKCPP 127
            L+  + ++ +    H N++R        +   ER L   Y+    V   L    E  PP
Sbjct: 79  ELQFQTEVEMISMAVHRNLLRLRGFC---MTPTERLLVYPYMANGSVASCLRERPESQPP 135
Query: 128 PGLSASKVKELTRQMLKGVDFLHSH---RIIHRDLKPQNLLITRAGGLKIADFGLAKTFD 184
             L   K + +     +G+ +LH H   +IIHRD+K  N+L+       + DFGLAK  D
Sbjct: 136 --LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 193
Query: 185 YD--MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           Y    +  +V  T+ + APE L         D++  G ++ E+
Sbjct: 194 YKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 236

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKL-------NEDGIPMSTLREISILKQLDTF 82
           +G GA+G V +A      G   A+ K+ VK+       +E    MS L+ +S L Q    
Sbjct: 46  LGAGAFGKVVEATAF-GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ---- 100
Query: 83  EHPNIVRFFDVIHQN--ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
            H NIV           +L    Y     +   + +   + ++K     L    +   + 
Sbjct: 101 -HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 159
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ +G+ FL S   IHRD+  +N+L+T     KI DFGLA+    D   ++  +  + + 
Sbjct: 160 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 219
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 220 WMAPESIFDCVYTVQSDVWSYGILLWEIFSL 250

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 125/283 (44%), Gaps = 46/283 (16%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-LREISILKQLDTFEHPNI 87
           ++G G YG V+     +     VA+K L+    ED + +   L+E +++K++   +HPN+
Sbjct: 39  KLGGGQYGEVYVGV-WKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEI---KHPNL 90
Query: 88  VRFFDVIHQNILSDERYL-TVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   V     L    Y+ T Y+ +     +L  Y+ +C    ++A  +  +  Q+   +
Sbjct: 91  VQLLGVC---TLEPPFYIVTEYMPY----GNLLDYLRECNREEVTAVVLLYMATQISSAM 143
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPEIL 204
           ++L     IHRDL  +N L+     +K+ADFGL++  T D           + + APE L
Sbjct: 144 EYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 203
Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE-NISLM 263
               +    D+W+ G ++ E                       I T  M+ +P  ++S +
Sbjct: 204 AYNTFSIKSDVWAFGVLLWE-----------------------IATYGMSPYPGIDLSQV 240
Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
           +   E+  ++        C  K   L+ +   ++PADR S A+
Sbjct: 241 YDLLEKGYRMEQPE---GCPPKVYELMRACWKWSPADRPSFAE 280

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 30  IGCGAYGTVFKAR-DLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   R  L +K    VA+K L+V   E       L E SI+ Q   F+HPNI
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQ---FDHPNI 108
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +R   V+ ++         V ++ E ++   L S++ K      +  ++  + R +  G+
Sbjct: 109 IRLEGVVTKS-------KPVMIVTEXMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGM 160
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAPE 202
            +L     +HRDL  +N+LI      K++DFGL++  + D           + + + +PE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G V+ E+
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEV 243

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKL-------NEDGIPMSTLREISILKQLDTF 82
           +G GA+G V +A      G   A+ K+ VK+       +E    MS L+ +S L Q    
Sbjct: 54  LGAGAFGKVVEATAF-GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ---- 108
Query: 83  EHPNIVRFFDVIHQN--ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
            H NIV           +L    Y     +   + +   + ++K     L    +   + 
Sbjct: 109 -HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ +G+ FL S   IHRD+  +N+L+T     KI DFGLA+    D   ++  +  + + 
Sbjct: 168 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 227
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 228 WMAPESIFDCVYTVQSDVWSYGILLWEIFSL 258

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL 70
            L   S ++  K    L ++G G +G V         G +     + +K+ ++G  MS  
Sbjct: 4   GLGYGSWEIDPKDLTFLKELGTGQFGVV-------KYGKWRGQYDVAIKMIKEG-SMSED 55
Query: 71  REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQD-LGSYMEKCPPPG 129
             I   K +    H  +V+ + V  +          +++I E++    L +Y+ +     
Sbjct: 56  EFIEEAKVMMNLSHEKLVQLYGVCTKQ-------RPIFIITEYMANGCLLNYLREMRHR- 107
Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
               ++ E+ + + + +++L S + +HRDL  +N L+   G +K++DFGL++    D   
Sbjct: 108 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 167
Query: 190 TSVVVTLWYR--APEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           +SV      R   PE+L+   + +  DIW+ G +M E++ L
Sbjct: 168 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 208

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 111/255 (43%), Gaps = 30/255 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR----EISILKQLDTFEHP 85
           +G G +G V KA     KG       + VK+ ++    S LR    E ++LKQ++   HP
Sbjct: 31  LGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN---HP 86
Query: 86  NIVRFFDVIHQN-----ILSDERYLTVYLIFEHVDQDLGSYM-----------EKCPPPG 129
           ++++ +    Q+     I+   +Y ++        +    Y+           +      
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYD 186
           L+   +     Q+ +G+ +L    ++HRDL  +N+L+     +KI+DFGL++     D  
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
           +  +   + + + A E L +  Y T  D+WS G +   +W +V L          + +F 
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL---LWEIVTLGGNPYPGIPPERLFN 263
Query: 247 VIGTPSMNEWPENIS 261
           ++ T    E P+N S
Sbjct: 264 LLKTGHRMERPDNCS 278

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 99/220 (45%), Gaps = 21/220 (9%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           Q L  D+ ++  +      ++G G +G V+      N    VA+K L+        P + 
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS---PEAF 60
Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
           L+E  ++K+L    H  +V+ + V+ +  I     Y++   + + +  ++G Y       
Sbjct: 61  LQEAQVMKKL---RHEKLVQLYAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKY------- 110
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DY 185
            L   ++ ++  Q+  G+ ++     +HRDL+  N+L+      K+ADFGLA+     +Y
Sbjct: 111 -LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                +     W  APE  L   +    D+WS G ++ E+
Sbjct: 170 TARQGAKFPIKW-TAPEAALYGRFTIKSDVWSFGILLTEL 208

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 20/203 (9%)
Query: 30  IGCGAYGTVFKA---RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G GA+GTV+K     D +N    VA+K LR    E+  P +    +     +     P 
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR----ENTSPKANKEILDEAYVMAGVGSPY 80
Query: 87  IVRFFDVIHQNILSDERYLTVY-LIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           + R   +   + +     L  Y  + +HV ++ G          L +  +     Q+ KG
Sbjct: 81  VSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGR---------LGSQDLLNWCMQIAKG 131
Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPE 202
           + +L   R++HRDL  +N+L+     +KI DFGLA+  D D          V + + A E
Sbjct: 132 MSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +L   +    D+WS G  + E+
Sbjct: 192 SILRRRFTHQSDVWSYGVTVWEL 214

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKAR--DLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           +D+   K +E+  IG G +G V + R      K + VA+K L+    E       L E S
Sbjct: 13  IDVSYVKIEEV--IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEAS 69
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           I+ Q   FEHPNI+R   V+  +       + V ++ E ++        +      +  +
Sbjct: 70  IMGQ---FEHPNIIRLEGVVTNS-------MPVMILTEFMENGALDSFLRLNDGQFTVIQ 119
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD---YDMMLTS 191
           +  + R +  G+ +L     +HRDL  +N+L+      K++DFGL++  +    D   TS
Sbjct: 120 LVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETS 179
Query: 192 VV---VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            +   + + + APE +    + +  D WS G VM E+
Sbjct: 180 SLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEV 216

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 30  IGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G +G V   R L+  G     VA+K L+V   E       L E SI+ Q   F+HPN
Sbjct: 30  IGAGEFGEVCSGR-LKLPGKRELPVAIKTLKVGYTEKQ-RRDFLGEASIMGQ---FDHPN 84
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           I+    V+ ++         V ++ E+++   L ++++K      +  ++  + R +  G
Sbjct: 85  IIHLEGVVTKS-------KPVMIVTEYMENGSLDTFLKKNDGQ-FTVIQLVGMLRGISAG 136
Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAP 201
           + +L     +HRDL  +N+LI      K++DFGL++  + D           + + + AP
Sbjct: 137 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 196
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E +    + +  D+WS G VM E+
Sbjct: 197 EAIAFRKFTSASDVWSYGIVMWEV 220

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA----KTFDYDMMLTSVVVTL 196
           Q+ +G++FL S + IHRDL  +N+L++    +KI DFGLA    K  DY +      + L
Sbjct: 207 QVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDY-VRKGDTRLPL 265
Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
            + APE + +  Y T  D+WS G ++ E++ L
Sbjct: 266 KWMAPESIFDKIYSTKSDVWSYGVLLWEIFSL 297

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 102/218 (46%), Gaps = 19/218 (8%)
Query: 14  LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREI 73
           + S ++  K    L ++G G +G V         G +     + +K+ ++G  MS    I
Sbjct: 1   MGSWEIDPKDLTFLKELGTGQFGVV-------KYGKWRGQYDVAIKMIKEG-SMSEDEFI 52
Query: 74  SILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQD-LGSYMEKCPPPGLSA 132
              K +    H  +V+ + V  +          +++I E++    L +Y+ +        
Sbjct: 53  EEAKVMMNLSHEKLVQLYGVCTKQ-------RPIFIITEYMANGCLLNYLREMRHR-FQT 104
Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV 192
            ++ E+ + + + +++L S + +HRDL  +N L+   G +K++DFGL++    D   +SV
Sbjct: 105 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 164
Query: 193 VVTLWYR--APEILLNLGYGTPVDIWSIGCVMAEMWRL 228
                 R   PE+L+   + +  DIW+ G +M E++ L
Sbjct: 165 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 202

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 30  IGCGAYGTVFKAR-DLQNKGNY-VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V   R  L  K +  VA+K L+V   E       L E SI+ Q   F+HPN+
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQ-RRDFLCEASIMGQ---FDHPNV 106
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQD-LGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V    V+        R   V ++ E ++   L +++ K      +  ++  + R +  G+
Sbjct: 107 VHLEGVV-------TRGKPVMIVIEFMENGALDAFLRKHDGQ-FTVIQLVGMLRGIAAGM 158
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD----MMLTSVVVTLWYRAPE 202
            +L     +HRDL  +N+L+      K++DFGL++  + D       T   + + + APE
Sbjct: 159 RYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPE 218
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G VM E+
Sbjct: 219 AIQYRKFTSASDVWSYGIVMWEV 241

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 27  LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           L ++G G +G V         G +     + +K+ ++G  MS    I   K +    H  
Sbjct: 9   LKELGTGQFGVV-------KYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEK 60
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQD-LGSYMEKCPPPGLSASKVKELTRQMLKG 145
           +V+ + V  +          +++I E++    L +Y+ +         ++ E+ + + + 
Sbjct: 61  LVQLYGVCTKQ-------RPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEA 112
Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR--APEI 203
           +++L S + +HRDL  +N L+   G +K++DFGL++    D   +SV      R   PE+
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
Query: 204 LLNLGYGTPVDIWSIGCVMAEMWRL 228
           L+   + +  DIW+ G +M E++ L
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSL 197

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 39/228 (17%)
Query: 30  IGCGAYGTVFKAR--DLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP 85
           +G GA+G V  A    +   G    VA+K L+ K +      + + E+ ++ QL +  H 
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE-ALMSELKMMTQLGS--HE 109
Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHV-DQDLGSYM----EKCPPPGLSASKVKELTR 140
           NIV   +++    LS      +YLIFE+    DL +Y+    EK     +     K L  
Sbjct: 110 NIV---NLLGACTLSG----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 141 -----------------QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF 183
                            Q+ KG++FL     +HRDL  +N+L+T    +KI DFGLA+  
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 184 DYD---MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
             D   ++  +  + + + APE L    Y    D+WS G ++ E++ L
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 27  LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           L ++G G +G V         G +     + +K+ ++G  MS    I   K +    H  
Sbjct: 13  LKELGTGQFGVV-------KYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEK 64
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQD-LGSYMEKCPPPGLSASKVKELTRQMLKG 145
           +V+ + V  +          +++I E++    L +Y+ +         ++ E+ + + + 
Sbjct: 65  LVQLYGVCTKQ-------RPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEA 116
Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR--APEI 203
           +++L S + +HRDL  +N L+   G +K++DFGL++    D   +SV      R   PE+
Sbjct: 117 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 176
Query: 204 LLNLGYGTPVDIWSIGCVMAEMWRL 228
           L+   + +  DIW+ G +M E++ L
Sbjct: 177 LMYSKFSSKSDIWAFGVLMWEIYSL 201

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK 215
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK 215
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 30  IGCGAYGTVFKARDL----QNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFE 83
           +G GA+G V +A        +    VA+K L+    L E    MS L+ +S L       
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN----- 103
Query: 84  HPNIVRFFD--VIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGL--------SAS 133
           H NIV       I    L    Y     +   + +   S++     P +           
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLT 190
            +   + Q+ KG+ FL S   IHRDL  +N+L+T     KI DFGLA+    D   ++  
Sbjct: 164 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 223
Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           +  + + + APE + N  Y    D+WS G  + E++ L
Sbjct: 224 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 261

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 147 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK 206
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 207 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 237

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 147 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK 206
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 207 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 237

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 30  IGCGAYGTVFKARDL----QNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFE 83
           +G GA+G V +A        +    VA+K L+    L E    MS L+ +S L       
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN----- 85
Query: 84  HPNIVRFFDV--IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGL--------SAS 133
           H NIV       I    L    Y     +   + +   S++     P +           
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLT 190
            +   + Q+ KG+ FL S   IHRDL  +N+L+T     KI DFGLA+    D   ++  
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           +  + + + APE + N  Y    D+WS G  + E++ L
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 112/245 (45%), Gaps = 39/245 (15%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYV--AMKKLRVKLNEDGIPMSTLREIS 74
           LD  D K+ ++  IG G +G V KAR ++  G  +  A+K+++   ++D        E+ 
Sbjct: 19  LDWNDIKFQDV--IGEGNFGQVLKAR-IKKDGLRMDAAIKRMKEYASKDD-HRDFAGELE 74
Query: 75  ILKQLDTFEHPNIVRFFDVI-HQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC------P 126
           +L +L    HPNI+       H+  L        YL  E+    +L  ++ K       P
Sbjct: 75  VLCKLG--HHPNIINLLGACEHRGYL--------YLAIEYAPHGNLLDFLRKSRVLETDP 124
Query: 127 PPGLSASKVKELTRQML--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG 178
              ++ S    L+ Q L        +G+D+L   + IHR+L  +N+L+      KIADFG
Sbjct: 125 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFG 184
Query: 179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPL----FCA 234
           L++  +  +  T   + + + A E L    Y T  D+WS G +   +W +V L    +C 
Sbjct: 185 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL---LWEIVSLGGTPYCG 241
Query: 235 STEVE 239
            T  E
Sbjct: 242 MTCAE 246

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 99/220 (45%), Gaps = 21/220 (9%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           Q L  D+ ++  +      ++G G +G V+      N    VA+K L+        P + 
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS---PEAF 60
Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
           L+E  ++K+L    H  +V+ + V+ +  I     Y++   + + +  ++G Y       
Sbjct: 61  LQEAQVMKKL---RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKY------- 110
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DY 185
            L   ++ ++  Q+  G+ ++     +HRDL+  N+L+      K+ADFGLA+     +Y
Sbjct: 111 -LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                +     W  APE  L   +    D+WS G ++ E+
Sbjct: 170 TARQGAKFPIKW-TAPEAALYGRFTIKSDVWSFGILLTEL 208

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 156 QVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK 215
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 107/237 (45%), Gaps = 22/237 (9%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V+ A    NK   VA+K ++         MS    ++    + T +H  +V
Sbjct: 195 KLGAGQFGEVWMA--TYNKHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLV 246
Query: 89  RFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           +   V+ +  I     ++    + + +  D GS   K P P     K+ + + Q+ +G+ 
Sbjct: 247 KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGS---KQPLP-----KLIDFSAQIAEGMA 298
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD--MMLTSVVVTLWYRAPEILL 205
           F+     IHRDL+  N+L++ +   KIADFGLA+  + +           + + APE + 
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 358
Query: 206 NLGYGTPVDIWSIGCVMAEM--WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
              +    D+WS G ++ E+  +  +P +   +  E ++ + R    P     PE +
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRALERGYRMPRPENCPEEL 414

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 99/220 (45%), Gaps = 21/220 (9%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           Q L  D+ ++  +      ++G G +G V+      N    VA+K L+        P + 
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS---PEAF 60
Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
           L+E  ++K+L    H  +V+ + V+ +  I     Y++   + + +  ++G Y       
Sbjct: 61  LQEAQVMKKL---RHEKLVQLYAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKY------- 110
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DY 185
            L   ++ ++  Q+  G+ ++     +HRDL+  N+L+      K+ADFGLA+     +Y
Sbjct: 111 -LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                +     W  APE  L   +    D+WS G ++ E+
Sbjct: 170 TARQGAKFPIKW-TAPEAALYGRFTIKSDVWSFGILLTEL 208

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++  +K     ++G G++G V++      KG      + RV +       S    I 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEG---VAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 75  ILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY-------MEK 124
            L +   +  F   ++VR   V+ Q         T+ ++      DL SY       ME 
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQG------QPTLVIMELMTRGDLKSYLRSLRPEMEN 128
Query: 125 CP---PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK 181
            P   PP LS  K+ ++  ++  G+ +L++++ +HRDL  +N ++     +KI DFG+ +
Sbjct: 129 NPVLAPPSLS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 182 TF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
                DY       ++ + + +PE L +  + T  D+WS G V+ E+  L 
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 30  IGCGAYGTVFKARDL----QNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFE 83
           +G GA+G V +A        +    VA+K L+    L E    MS L+ +S L       
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN----- 101
Query: 84  HPNIVRFFD--VIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGL--------SAS 133
           H NIV       I    L    Y     +   + +   S++     P +           
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLT 190
            +   + Q+ KG+ FL S   IHRDL  +N+L+T     KI DFGLA+    D   ++  
Sbjct: 162 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 221
Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           +  + + + APE + N  Y    D+WS G  + E++ L
Sbjct: 222 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 259

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 30  IGCGAYGTVFKARDL----QNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFE 83
           +G GA+G V +A        +    VA+K L+    L E    MS L+ +S L       
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN----- 108
Query: 84  HPNIVRFFDV--IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGL--------SAS 133
           H NIV       I    L    Y     +   + +   S++     P +           
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLT 190
            +   + Q+ KG+ FL S   IHRDL  +N+L+T     KI DFGLA+    D   ++  
Sbjct: 169 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 228
Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           +  + + + APE + N  Y    D+WS G  + E++ L
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 266

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 93/200 (46%), Gaps = 19/200 (9%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V+ A    NK   VA+K ++         MS    ++    + T +H  +V
Sbjct: 22  KLGAGQFGEVWMA--TYNKHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLV 73
Query: 89  RFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           +   V+ +  I     ++    + + +  D GS   K P P     K+ + + Q+ +G+ 
Sbjct: 74  KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGS---KQPLP-----KLIDFSAQIAEGMA 125
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD--MMLTSVVVTLWYRAPEILL 205
           F+     IHRDL+  N+L++ +   KIADFGLA+  + +           + + APE + 
Sbjct: 126 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 185
Query: 206 NLGYGTPVDIWSIGCVMAEM 225
              +    D+WS G ++ E+
Sbjct: 186 FGSFTIKSDVWSFGILLMEI 205

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 29  QIGCGAYGTVFKAR-DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           ++G G +GTV K    ++     VA+K L+ + N+  +    L E ++++QLD   +P I
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD---NPYI 90
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           VR        I   E ++ V  + E     L  Y+++     +    + EL  Q+  G+ 
Sbjct: 91  VRMI-----GICEAESWMLVMEMAEL--GPLNKYLQQNR--HVKDKNIIELVHQVSMGMK 141
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWYRAPE 202
           +L     +HRDL  +N+L+      KI+DFGL+K        Y           WY APE
Sbjct: 142 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APE 200
Query: 203 ILLNLGYGTPVDIWSIGCVMAE 224
            +    + +  D+WS G +M E
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 29  QIGCGAYGTVFKAR-DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           ++G G +GTV K    ++     VA+K L+ + N+  +    L E ++++QLD   +P I
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD---NPYI 90
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           VR        I   E ++ V  + E     L  Y+++     +    + EL  Q+  G+ 
Sbjct: 91  VRMI-----GICEAESWMLVMEMAEL--GPLNKYLQQNR--HVKDKNIIELVHQVSMGMK 141
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWYRAPE 202
           +L     +HRDL  +N+L+      KI+DFGL+K        Y           WY APE
Sbjct: 142 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APE 200
Query: 203 ILLNLGYGTPVDIWSIGCVMAE 224
            +    + +  D+WS G +M E
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWE 222

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 29  QIGCGAYGTVFKAR-DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           ++G G +GTV K    ++     VA+K L+ + N+  +    L E ++++QLD   +P I
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD---NPYI 80
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           VR        I   E ++ V  + E     L  Y+++     +    + EL  Q+  G+ 
Sbjct: 81  VRMI-----GICEAESWMLVMEMAEL--GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMK 131
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWYRAPE 202
           +L     +HRDL  +N+L+      KI+DFGL+K        Y           WY APE
Sbjct: 132 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APE 190
Query: 203 ILLNLGYGTPVDIWSIGCVMAE 224
            +    + +  D+WS G +M E
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWE 212

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 29  QIGCGAYGTVFKAR-DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           ++G G +GTV K    ++     VA+K L+ + N+  +    L E ++++QLD   +P I
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD---NPYI 88
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           VR        I   E ++ V  + E     L  Y+++     +    + EL  Q+  G+ 
Sbjct: 89  VRMI-----GICEAESWMLVMEMAEL--GPLNKYLQQNR--HVKDKNIIELVHQVSMGMK 139
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWYRAPE 202
           +L     +HRDL  +N+L+      KI+DFGL+K        Y           WY APE
Sbjct: 140 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APE 198
Query: 203 ILLNLGYGTPVDIWSIGCVMAE 224
            +    + +  D+WS G +M E
Sbjct: 199 CINYYKFSSKSDVWSFGVLMWE 220

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++ D +     +IG G++GTV+K +   +    VA+K L V         +   E+ 
Sbjct: 5   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVG 60
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILS-DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSAS 133
           +L++     H NI+ F     +  L+   ++     ++ H+      +  K         
Sbjct: 61  VLRKT---RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMK--------- 108
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-------TFDYD 186
           K+ ++ RQ  +G+D+LH+  IIHRDLK  N+ +     +KI DFGLA        +  ++
Sbjct: 109 KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFE 168
Query: 187 MMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEM 225
            +  S+   LW  APE++    +  Y    D+++ G V+ E+
Sbjct: 169 QLSGSI---LWM-APEVIRMQDSNPYSFQSDVYAFGIVLYEL 206

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 206 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 265
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 266 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 296

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 27/230 (11%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++  +K     ++G G++G V++      KG      + RV +       S    I 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEG---VAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 75  ILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY-------MEK 124
            L +   +  F   ++VR   V+ Q         T+ ++      DL SY       ME 
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQG------QPTLVIMELMTRGDLKSYLRSLRPEMEN 121
Query: 125 CP---PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK 181
            P   PP LS  K+ ++  ++  G+ +L++++ +HRDL  +N ++     +KI DFG+ +
Sbjct: 122 NPVLAPPSLS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 182 TF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
                DY       ++ + + +PE L +  + T  D+WS G V+ E+  L
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 229

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++  +K     ++G G++G V++      KG      + RV +       S    I 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEG---VAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 75  ILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY-------MEK 124
            L +   +  F   ++VR   V+ Q         T+ ++      DL SY       ME 
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQG------QPTLVIMELMTRGDLKSYLRSLRPEMEN 122
Query: 125 CP---PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK 181
            P   PP LS  K+ ++  ++  G+ +L++++ +HRDL  +N ++     +KI DFG+ +
Sbjct: 123 NPVLAPPSLS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 180
Query: 182 TF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
                DY       ++ + + +PE L +  + T  D+WS G V+ E+  L 
Sbjct: 181 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 231

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 30  IGCGAYGTVFKARDL----QNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFE 83
           +G GA+G V +A        +    VA+K L+    L E    MS L+ +S L       
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN----- 108
Query: 84  HPNIVRFFDV--IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGL--------SAS 133
           H NIV       I    L    Y     +   + +   S++     P +           
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLT 190
            +   + Q+ KG+ FL S   IHRDL  +N+L+T     KI DFGLA+    D   ++  
Sbjct: 169 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKG 228
Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           +  + + + APE + N  Y    D+WS G  + E++ L
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 266

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 208 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 267
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 268 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 298

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 291

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++  +K     ++G G++G V++      KG      + RV +       S    I 
Sbjct: 9   DEWEVAREKITMSRELGQGSFGMVYEG---VAKGVVKDEPETRVAIKTVNEAASMRERIE 65
Query: 75  ILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY-------MEK 124
            L +   +  F   ++VR   V+ Q         T+ ++      DL SY       ME 
Sbjct: 66  FLNEASVMKEFNCHHVVRLLGVVSQG------QPTLVIMELMTRGDLKSYLRSLRPEMEN 119
Query: 125 CP---PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK 181
            P   PP LS  K+ ++  ++  G+ +L++++ +HRDL  +N ++     +KI DFG+ +
Sbjct: 120 NPVLAPPSLS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 177
Query: 182 TF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
                DY       ++ + + +PE L +  + T  D+WS G V+ E+  L 
Sbjct: 178 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 228

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 27/230 (11%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++  +K     ++G G++G V++      KG      + RV +       S    I 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEG---VAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 75  ILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY-------MEK 124
            L +   +  F   ++VR   V+ Q         T+ ++      DL SY       ME 
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQG------QPTLVIMELMTRGDLKSYLRSLRPEMEN 121
Query: 125 CP---PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK 181
            P   PP LS  K+ ++  ++  G+ +L++++ +HRDL  +N ++     +KI DFG+ +
Sbjct: 122 NPVLAPPSLS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 182 TF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
                DY       ++ + + +PE L +  + T  D+WS G V+ E+  L
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 229

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 29  QIGCGAYGTVFKAR-DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           ++G G +GTV K    ++     VA+K L+ + N+  +    L E ++++QLD   +P I
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD---NPYI 68
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           VR        I   E ++ V  + E     L  Y+++     +    + EL  Q+  G+ 
Sbjct: 69  VRMI-----GICEAESWMLVMEMAEL--GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMK 119
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWYRAPE 202
           +L     +HRDL  +N+L+      KI+DFGL+K        Y           WY APE
Sbjct: 120 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APE 178
Query: 203 ILLNLGYGTPVDIWSIGCVMAE 224
            +    + +  D+WS G +M E
Sbjct: 179 CINYYKFSSKSDVWSFGVLMWE 200

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 199 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 258
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 259 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 289

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 29  QIGCGAYGTVFKAR-DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           ++G G +GTV K    ++     VA+K L+ + N+  +    L E ++++QLD   +P I
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD---NPYI 70
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           VR        I   E ++ V  + E     L  Y+++     +    + EL  Q+  G+ 
Sbjct: 71  VRMI-----GICEAESWMLVMEMAEL--GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMK 121
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWYRAPE 202
           +L     +HRDL  +N+L+      KI+DFGL+K        Y           WY APE
Sbjct: 122 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APE 180
Query: 203 ILLNLGYGTPVDIWSIGCVMAE 224
            +    + +  D+WS G +M E
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWE 202

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 29  QIGCGAYGTVFKAR-DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           ++G G +GTV K    ++     VA+K L+ + N+  +    L E ++++QLD   +P I
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD---NPYI 74
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           VR        I   E ++ V  + E     L  Y+++     +    + EL  Q+  G+ 
Sbjct: 75  VRMI-----GICEAESWMLVMEMAEL--GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMK 125
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-----DYDMMLTSVVVTLWYRAPE 202
           +L     +HRDL  +N+L+      KI+DFGL+K        Y           WY APE
Sbjct: 126 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWY-APE 184
Query: 203 ILLNLGYGTPVDIWSIGCVMAE 224
            +    + +  D+WS G +M E
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWE 206

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++  +K     ++G G++G V++      KG      + RV +       S    I 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEG---VAKGVVKDEPETRVAIKTVNEAASMRERIE 61
Query: 75  ILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY-------MEK 124
            L +   +  F   ++VR   V+ Q         T+ ++      DL SY       ME 
Sbjct: 62  FLNEASVMKEFNCHHVVRLLGVVSQG------QPTLVIMELMTRGDLKSYLRSLRPEMEN 115
Query: 125 CP---PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK 181
            P   PP LS  K+ ++  ++  G+ +L++++ +HRDL  +N ++     +KI DFG+ +
Sbjct: 116 NPVLAPPSLS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 173
Query: 182 TF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
                DY       ++ + + +PE L +  + T  D+WS G V+ E+  L 
Sbjct: 174 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 224

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 29  QIGCGAYGTVFKAR-DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           ++G G +GTV K    ++     VA+K L+ + N+  +    L E ++++QLD   +P I
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD---NPYI 74
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           VR        I   E ++ V  + E     L  Y+++     +    + EL  Q+  G+ 
Sbjct: 75  VRMI-----GICEAESWMLVMEMAEL--GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMK 125
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWYRAPE 202
           +L     +HRDL  +N+L+      KI+DFGL+K        Y           WY APE
Sbjct: 126 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APE 184
Query: 203 ILLNLGYGTPVDIWSIGCVMAE 224
            +    + +  D+WS G +M E
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWE 206

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 92
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H   DL +++            VK+L     Q+ K
Sbjct: 93  LSLLGIC---LRSEGSPLVVLPYMKH--GDLRNFIRN----ETHNPTVKDLIGFGLQVAK 143
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP--- 201
           G+ +L S + +HRDL  +N ++     +K+ADFGLA+   YD    SV      + P   
Sbjct: 144 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEXXSVHNKTGAKLPVKW 202
Query: 202 ---EILLNLGYGTPVDIWSIGCVMAEM 225
              E L    + T  D+WS G ++ E+
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWEL 229

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLK 215
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 215
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 158 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 217
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 218 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 248

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 147 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 206
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 207 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 237

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 30  IGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G  G V   R L+  G     VA+K L+    E       L E SI+ Q   F+HPN
Sbjct: 57  IGSGDSGEVCYGR-LRVPGQRDVPVAIKALKAGYTERQ-RRDFLSEASIMGQ---FDHPN 111
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           I+R   V+ +  L+    +T Y+    +D  L ++  +      +  ++  + R +  G+
Sbjct: 112 IIRLEGVVTRGRLA--MIVTEYMENGSLDTFLRTHDGQ-----FTIMQLVGMLRGVGAGM 164
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD----MMLTSVVVTLWYRAPE 202
            +L     +HRDL  +N+L+      K++DFGL++  + D       T   + + + APE
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPE 224
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G VM E+
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEV 247

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 27/230 (11%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++  +K     ++G G++G V++      KG      + RV +       S    I 
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEG---VAKGVVKDEPETRVAIKTVNEAASMRERIE 96
Query: 75  ILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY-------MEK 124
            L +   +  F   ++VR   V+ Q         T+ ++      DL SY       ME 
Sbjct: 97  FLNEASVMKEFNCHHVVRLLGVVSQG------QPTLVIMELMTRGDLKSYLRSLRPEMEN 150
Query: 125 CP---PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK 181
            P   PP LS  K+ ++  ++  G+ +L++++ +HRDL  +N ++     +KI DFG+ +
Sbjct: 151 NPVLAPPSLS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 208
Query: 182 TF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
                DY       ++ + + +PE L +  + T  D+WS G V+ E+  L
Sbjct: 209 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 258

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 147 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 206
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 207 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 237

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++ D +     +IG G++GTV+K +   +    VA+K L V         +   E+ 
Sbjct: 17  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILS-DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSAS 133
           +L++     H NI+ F     +  L+   ++     ++ H+      +  K         
Sbjct: 73  VLRKT---RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMK--------- 120
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-------TFDYD 186
           K+ ++ RQ  +G+D+LH+  IIHRDLK  N+ +     +KI DFGLA        +  ++
Sbjct: 121 KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 187 MMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEM 225
            +  S+   LW  APE++    +  Y    D+++ G V+ E+
Sbjct: 181 QLSGSI---LWM-APEVIRMQDSNPYSFQSDVYAFGIVLYEL 218

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 105/235 (44%), Gaps = 28/235 (11%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V+ A    NK   VA+K ++         MS    ++    + T +H  +V
Sbjct: 189 KLGAGQFGEVWMA--TYNKHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLV 240
Query: 89  RFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           +   V+ +  I     ++    + + +  D GS   K P P     K+ + + Q+ +G+ 
Sbjct: 241 KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGS---KQPLP-----KLIDFSAQIAEGMA 292
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           F+     IHRDL+  N+L++ +   KIADFGLA+              + + APE +   
Sbjct: 293 FIEQRNYIHRDLRAANILVSASLVCKIADFGLAR--------VGAKFPIKWTAPEAINFG 344
Query: 208 GYGTPVDIWSIGCVMAEM--WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
            +    D+WS G ++ E+  +  +P +   +  E ++ + R    P     PE +
Sbjct: 345 SFTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRALERGYRMPRPENCPEEL 398

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 99/220 (45%), Gaps = 21/220 (9%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           Q L  D+ ++  +      ++G G +G V+      N    VA+K L+        P + 
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS---PEAF 60
Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
           L+E  ++K++    H  +V+ + V+ +  I     Y++   + + +  ++G Y       
Sbjct: 61  LQEAQVMKKI---RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKY------- 110
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DY 185
            L   ++ ++  Q+  G+ ++     +HRDL+  N+L+      K+ADFGLA+     +Y
Sbjct: 111 -LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                +     W  APE  L   +    D+WS G ++ E+
Sbjct: 170 TARQGAKFPIKW-TAPEAALYGRFTIKSDVWSFGILLTEL 208

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 21/225 (9%)
Query: 5   SADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG 64
           S    Q L  D+ ++  +      ++G G +G V+      N    VA+K L+       
Sbjct: 167 SKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS-- 222
Query: 65  IPMSTLREISILKQLDTFEHPNIVRFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYME 123
            P + L+E  ++K+L    H  +V+ + V+ +  I     Y++   + + +  + G Y  
Sbjct: 223 -PEAFLQEAQVMKKL---RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKY-- 276
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF 183
                 L   ++ ++  Q+  G+ ++     +HRDL+  N+L+      K+ADFGLA+  
Sbjct: 277 ------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 184 ---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
              +Y     +     W  APE  L   +    D+WS G ++ E+
Sbjct: 331 EDNEYTARQGAKFPIKW-TAPEAALYGRFTIKSDVWSFGILLTEL 374

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 30  IGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G  G V   R L+  G     VA+K L+    E       L E SI+ Q   F+HPN
Sbjct: 57  IGSGDSGEVCYGR-LRVPGQRDVPVAIKALKAGYTERQ-RRDFLSEASIMGQ---FDHPN 111
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           I+R   V+ +  L+    +T Y+    +D  L ++  +      +  ++  + R +  G+
Sbjct: 112 IIRLEGVVTRGRLA--MIVTEYMENGSLDTFLRTHDGQ-----FTIMQLVGMLRGVGAGM 164
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD----MMLTSVVVTLWYRAPE 202
            +L     +HRDL  +N+L+      K++DFGL++  + D       T   + + + APE
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224
Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
            +    + +  D+WS G VM E+
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEV 247

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 24/229 (10%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
           L+     +D    IG G +G V+K   +   G  VA+K+ R   +  GI        + +
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKG--VLRDGAKVALKR-RTPESSQGIEEFE----TEI 86
Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDER--YLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           + L    HP++V            DER   + +Y   E+ +     Y    P   +S  +
Sbjct: 87  ETLSFCRHPHLVSLIG------FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT---FDYDMMLTS 191
             E+     +G+ +LH+  IIHRD+K  N+L+      KI DFG++K     D   +   
Sbjct: 141 RLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXV 200
Query: 192 VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQ 240
           V  TL Y  PE  +        D++S G V+ E      + CA + + Q
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE------VLCARSAIVQ 243

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 193 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 252
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 253 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 283

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 152 QVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 242

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 21/225 (9%)
Query: 5   SADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG 64
           S    Q L  D+ ++  +      ++G G +G V+      N    VA+K L+       
Sbjct: 167 SKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS-- 222
Query: 65  IPMSTLREISILKQLDTFEHPNIVRFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYME 123
            P + L+E  ++K+L    H  +V+ + V+ +  I     Y++   + + +  + G Y  
Sbjct: 223 -PEAFLQEAQVMKKL---RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKY-- 276
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF 183
                 L   ++ ++  Q+  G+ ++     +HRDL+  N+L+      K+ADFGLA+  
Sbjct: 277 ------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 184 ---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
              +Y     +     W  APE  L   +    D+WS G ++ E+
Sbjct: 331 EDNEYTARQGAKFPIKW-TAPEAALYGRFTIKSDVWSFGILLTEL 374

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 99/220 (45%), Gaps = 21/220 (9%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           Q L  D+ ++  +      ++G G +G V+      N    VA+K L+        P + 
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS---PEAF 60
Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
           L+E  ++K+L    H  +V+ + V+ +  I     Y++   + + +  ++G Y       
Sbjct: 61  LQEAQVMKKL---RHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKY------- 110
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DY 185
            L   ++ ++  Q+  G+ ++     +HRDL+  N+L+      K+ADFGLA+     +Y
Sbjct: 111 -LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                +     W  APE  L   +    D+WS G ++ E+
Sbjct: 170 TARQGAKFPIKW-TAPEAALYGRFTIKSDVWSFGILLTEL 208

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 98/220 (44%), Gaps = 21/220 (9%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           Q L  D+ ++  +      ++G G +G V+      N    VA+K L+        P + 
Sbjct: 3   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS---PEAF 57
Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
           L+E  ++K+L    H  +V+ + V+ +  I     Y+    + + +  + G Y       
Sbjct: 58  LQEAQVMKKL---RHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKY------- 107
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DY 185
            L   ++ +++ Q+  G+ ++     +HRDL+  N+L+      K+ADFGLA+     +Y
Sbjct: 108 -LRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 166
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                +     W  APE  L   +    D+WS G ++ E+
Sbjct: 167 TARQGAKFPIKW-TAPEAALYGRFTIKSDVWSFGILLTEL 205

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D   +      + L 
Sbjct: 152 QVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + APE + +  Y    D+WS G ++ E++ L
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 242

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 99/220 (45%), Gaps = 21/220 (9%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           Q L  D+ ++  +      ++G G +G V+      N    VA+K L+        P + 
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS---PEAF 60
Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
           L+E  ++K+L    H  +V+ + V+ +  I     Y++   + + +  ++G Y       
Sbjct: 61  LQEAQVMKKL---RHEKLVQLYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKY------- 110
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DY 185
            L   ++ ++  Q+  G+ ++     +HRDL+  N+L+      K+ADFGLA+     +Y
Sbjct: 111 -LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 169
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                +     W  APE  L   +    D+WS G ++ E+
Sbjct: 170 TARQGAKFPIKW-TAPEAALYGRFTIKSDVWSFGILLTEL 208

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 98/220 (44%), Gaps = 21/220 (9%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           Q L  D+ ++  +      ++G G +G V+      N    VA+K L+        P + 
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS---PEAF 60
Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
           L+E  ++K+L    H  +V+ + V+ +  I     Y++   + + +  ++G Y       
Sbjct: 61  LQEAQVMKKL---RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKY------- 110
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DY 185
            L   ++ ++  Q+  G+ ++     +HRDL   N+L+      K+ADFGLA+     +Y
Sbjct: 111 -LRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEY 169
Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                +     W  APE  L   +    D+WS G ++ E+
Sbjct: 170 TARQGAKFPIKW-TAPEAALYGRFTIKSDVWSFGILLTEL 208

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V+      N    VA+K L+        P + L+E  ++K+L    H  +V
Sbjct: 16  KLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKL---RHEKLV 67
Query: 89  RFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + + V+ +  I     Y++   + + +  ++G Y        L   ++ ++  Q+  G+ 
Sbjct: 68  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--------LRLPQLVDMAAQIASGMA 119
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRAPEIL 204
           ++     +HRDL+  N+L+      K+ADFGLA+     +Y     +     W  APE  
Sbjct: 120 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAA 178
Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
           L   +    D+WS G ++ E+
Sbjct: 179 LYGRFTIKSDVWSFGILLTEL 199

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V+      N    VA+K L+        P + L+E  ++K+L    H  +V
Sbjct: 14  KLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKL---RHEKLV 65
Query: 89  RFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + + V+ +  I     Y++   + + +  ++G Y        L   ++ ++  Q+  G+ 
Sbjct: 66  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--------LRLPQLVDMAAQIASGMA 117
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRAPEIL 204
           ++     +HRDL+  N+L+      K+ADFGLA+     +Y     +     W  APE  
Sbjct: 118 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAA 176
Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
           L   +    D+WS G ++ E+
Sbjct: 177 LYGRFTIKSDVWSFGILLTEL 197

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           Q L  D+ ++  +      ++G G +G V+      N    VA+K L+        P + 
Sbjct: 3   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS---PEAF 57
Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
           L+E  ++K+L    H  +V+ + V+ +  I     Y+    + + +  + G Y       
Sbjct: 58  LQEAQVMKKL---RHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKY------- 107
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-- 186
            L   ++ +++ Q+  G+ ++     +HRDL+  N+L+      K+ADFGLA+  + +  
Sbjct: 108 -LRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEW 166
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                    + + APE  L   +    D+WS G ++ E+
Sbjct: 167 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 205

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           Q L  D+ ++  +      ++G G +G V+      N    VA+K L+        P + 
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS---PEAF 60
Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
           L+E  ++K+L    H  +V+ + V+ +  I     Y++   + + +  ++G Y       
Sbjct: 61  LQEAQVMKKL---RHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKY------- 110
Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
            L   ++ ++  Q+  G+ ++     +HRDL+  N+L+      K+ADFGLA+  + +  
Sbjct: 111 -LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX 169
Query: 189 LT--SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                    + + APE  L   +    D+WS G ++ E+
Sbjct: 170 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 208

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G +G V+  R   + G   AMK   K R+K+ + G  ++ L E  +L  + T + P 
Sbjct: 196 IGRGGFGEVYGCRK-ADTGKMYAMKCLDKKRIKMKQ-GETLA-LNERIMLSLVSTGDCPF 252
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           IV      H     D+    + L+      DL  ++ +      S + ++    +++ G+
Sbjct: 253 IVCMSYAFH---TPDKLSFILDLM---NGGDLHYHLSQHGV--FSEADMRFYAAEIILGL 304
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL- 205
           + +H+  +++RDLKP N+L+   G ++I+D GLA  F       S V T  Y APE+L  
Sbjct: 305 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQK 363
Query: 206 NLGYGTPVDIWSIGCVMAEMWR 227
            + Y +  D +S+GC++ ++ R
Sbjct: 364 GVAYDSSADWFSLGCMLFKLLR 385

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 31/222 (13%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++ D +     +IG G++GTV+K +   +    VA+K L V         +   E+ 
Sbjct: 17  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILS-DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSAS 133
           +L++     H NI+ F        L+   ++     ++ H+      +  K         
Sbjct: 73  VLRKT---RHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMK--------- 120
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-------TFDYD 186
           K+ ++ RQ  +G+D+LH+  IIHRDLK  N+ +     +KI DFGLA        +  ++
Sbjct: 121 KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 187 MMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEM 225
            +  S+   LW  APE++    +  Y    D+++ G V+ E+
Sbjct: 181 QLSGSI---LWM-APEVIRMQDSNPYSFQSDVYAFGIVLYEL 218

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 92
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H   DL +++            VK+L     Q+ K
Sbjct: 93  LSLLGIC---LRSEGSPLVVLPYMKH--GDLRNFIRN----ETHNPTVKDLIGFGLQVAK 143
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP--- 201
           G+ +L S + +HRDL  +N ++     +K+ADFGLA+   YD    SV      + P   
Sbjct: 144 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKW 202
Query: 202 ---EILLNLGYGTPVDIWSIGCVMAEM 225
              E L    + T  D+WS G ++ E+
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWEL 229

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 88
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H   DL +++            VK+L     Q+ K
Sbjct: 89  LSLLGIC---LRSEGSPLVVLPYMKH--GDLRNFIRN----ETHNPTVKDLIGFGLQVAK 139
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP--- 201
           G+ +L S + +HRDL  +N ++     +K+ADFGLA+   YD    SV      + P   
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKW 198
Query: 202 ---EILLNLGYGTPVDIWSIGCVMAEM 225
              E L    + T  D+WS G ++ E+
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWEL 225

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 111
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H   DL +++            VK+L     Q+ K
Sbjct: 112 LSLLGIC---LRSEGSPLVVLPYMKH--GDLRNFIRN----ETHNPTVKDLIGFGLQVAK 162
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP--- 201
           G+ +L S + +HRDL  +N ++     +K+ADFGLA+   YD    SV      + P   
Sbjct: 163 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKW 221
Query: 202 ---EILLNLGYGTPVDIWSIGCVMAEM 225
              E L    + T  D+WS G ++ E+
Sbjct: 222 MALESLQTQKFTTKSDVWSFGVLLWEL 248

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G +G V+  R   + G   AMK   K R+K+ + G  ++ L E  +L  + T + P 
Sbjct: 197 IGRGGFGEVYGCRK-ADTGKMYAMKCLDKKRIKMKQ-GETLA-LNERIMLSLVSTGDCPF 253
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           IV      H     D+    + L+      DL  ++ +      S + ++    +++ G+
Sbjct: 254 IVCMSYAFH---TPDKLSFILDLM---NGGDLHYHLSQHGV--FSEADMRFYAAEIILGL 305
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL- 205
           + +H+  +++RDLKP N+L+   G ++I+D GLA  F       S V T  Y APE+L  
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQK 364
Query: 206 NLGYGTPVDIWSIGCVMAEMWR 227
            + Y +  D +S+GC++ ++ R
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLR 386

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G +G V+  R   + G   AMK   K R+K+ + G  ++ L E  +L  + T + P 
Sbjct: 197 IGRGGFGEVYGCRK-ADTGKMYAMKCLDKKRIKMKQ-GETLA-LNERIMLSLVSTGDCPF 253
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           IV      H     D+    + L+      DL  ++ +      S + ++    +++ G+
Sbjct: 254 IVCMSYAFH---TPDKLSFILDLM---NGGDLHYHLSQHGV--FSEADMRFYAAEIILGL 305
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL- 205
           + +H+  +++RDLKP N+L+   G ++I+D GLA  F       S V T  Y APE+L  
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQK 364
Query: 206 NLGYGTPVDIWSIGCVMAEMWR 227
            + Y +  D +S+GC++ ++ R
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLR 386

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 93
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H   DL +++            VK+L     Q+ K
Sbjct: 94  LSLLGIC---LRSEGSPLVVLPYMKH--GDLRNFIRN----ETHNPTVKDLIGFGLQVAK 144
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP--- 201
           G+ +L S + +HRDL  +N ++     +K+ADFGLA+   YD    SV      + P   
Sbjct: 145 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKW 203
Query: 202 ---EILLNLGYGTPVDIWSIGCVMAEM 225
              E L    + T  D+WS G ++ E+
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWEL 230

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 35/224 (15%)
Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISI 75
           +D  +   +E+  IG G +G V++A  +   G+ VA+K  R   +ED    +  +R+ + 
Sbjct: 4   IDFAELTLEEI--IGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEA- 57
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEH---VDQDLGSYMEKCPPPGLSA 132
            K     +HPNI+       + +   E  L + + F     +++ L    ++ PP  L  
Sbjct: 58  -KLFAMLKHPNIIAL-----RGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVN 109
Query: 133 SKVKELTRQMLKGVDFLHSHRI---IHRDLKPQNLLITRA--GG------LKIADFGLAK 181
             V     Q+ +G+++LH   I   IHRDLK  N+LI +    G      LKI DFGLA+
Sbjct: 110 WAV-----QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
Query: 182 TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            +     +++     W  APE++    +    D+WS G ++ E+
Sbjct: 165 EWHRTTKMSAAGAYAWM-APEVIRASMFSKGSDVWSYGVLLWEL 207

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G +G V+  R   + G   AMK   K R+K+ + G  ++ L E  +L  + T + P 
Sbjct: 197 IGRGGFGEVYGCRK-ADTGKMYAMKCLDKKRIKMKQ-GETLA-LNERIMLSLVSTGDCPF 253
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           IV      H     D+    + L+      DL  ++ +      S + ++    +++ G+
Sbjct: 254 IVCMSYAFH---TPDKLSFILDLM---NGGDLHYHLSQHGV--FSEADMRFYAAEIILGL 305
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL- 205
           + +H+  +++RDLKP N+L+   G ++I+D GLA  F       S V T  Y APE+L  
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQK 364
Query: 206 NLGYGTPVDIWSIGCVMAEMWR 227
            + Y +  D +S+GC++ ++ R
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLR 386

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 29  QIGCGAYGTVFKAR-DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           ++G G +GTV K    ++     VA+K L+ + N+  +    L E ++++QLD   +P I
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD---NPYI 433
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           VR        I   E ++ V  + E     L  Y+++     +    + EL  Q+  G+ 
Sbjct: 434 VRMI-----GICEAESWMLVMEMAEL--GPLNKYLQQNR--HVKDKNIIELVHQVSMGMK 484
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWYRAPE 202
           +L     +HRDL  +N+L+      KI+DFGL+K        Y           WY APE
Sbjct: 485 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APE 543
Query: 203 ILLNLGYGTPVDIWSIGCVMAE 224
            +    + +  D+WS G +M E
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWE 565

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 21/225 (9%)
Query: 5   SADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG 64
           S    Q L  D+ ++  +      ++G G +G V+      N    VA+K L+       
Sbjct: 167 SKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS-- 222
Query: 65  IPMSTLREISILKQLDTFEHPNIVRFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYME 123
            P + L+E  ++K+L    H  +V+ + V+ +  I     Y++   + + +  + G Y  
Sbjct: 223 -PEAFLQEAQVMKKL---RHEKLVQLYAVVSEEPIYIVGEYMSKGSLLDFLKGETGKY-- 276
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF 183
                 L   ++ ++  Q+  G+ ++     +HRDL+  N+L+      K+ADFGLA+  
Sbjct: 277 ------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 184 ---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
              +Y     +     W  APE  L   +    D+WS G ++ E+
Sbjct: 331 EDNEYTARQGAKFPIKW-TAPEAALYGRFTIKSDVWSFGILLTEL 374

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 29  QIGCGAYGTVFKAR-DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           ++G G +GTV K    ++     VA+K L+ + N+  +    L E ++++QLD   +P I
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD---NPYI 432
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           VR        I   E ++ V  + E     L  Y+++     +    + EL  Q+  G+ 
Sbjct: 433 VRMI-----GICEAESWMLVMEMAEL--GPLNKYLQQNR--HVKDKNIIELVHQVSMGMK 483
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWYRAPE 202
           +L     +HRDL  +N+L+      KI+DFGL+K        Y           WY APE
Sbjct: 484 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APE 542
Query: 203 ILLNLGYGTPVDIWSIGCVMAE 224
            +    + +  D+WS G +M E
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWE 564

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 85
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H   DL +++            VK+L     Q+ K
Sbjct: 86  LSLLGIC---LRSEGSPLVVLPYMKH--GDLRNFIRN----ETHNPTVKDLIGFGLQVAK 136
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP--- 201
           G+ +L S + +HRDL  +N ++     +K+ADFGLA+   YD    SV      + P   
Sbjct: 137 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKW 195
Query: 202 ---EILLNLGYGTPVDIWSIGCVMAEM 225
              E L    + T  D+WS G ++ E+
Sbjct: 196 MALESLQTQKFTTKSDVWSFGVLLWEL 222

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 93
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H   DL +++            VK+L     Q+ K
Sbjct: 94  LSLLGIC---LRSEGSPLVVLPYMKH--GDLRNFIRN----ETHNPTVKDLIGFGLQVAK 144
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP--- 201
           G+ +L S + +HRDL  +N ++     +K+ADFGLA+   YD    SV      + P   
Sbjct: 145 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKW 203
Query: 202 ---EILLNLGYGTPVDIWSIGCVMAEM 225
              E L    + T  D+WS G ++ E+
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWEL 230

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 100/225 (44%), Gaps = 21/225 (9%)
Query: 5   SADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG 64
           S    Q L  D+ ++  +      ++G G +G V+      N    VA+K L+     + 
Sbjct: 168 SKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG--TWNGTTRVAIKTLKPG---NM 222
Query: 65  IPMSTLREISILKQLDTFEHPNIVRFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYME 123
            P + L+E  ++K+L    H  +V+ + V+ +  I     Y++   + + +  ++G Y  
Sbjct: 223 SPEAFLQEAQVMKKL---RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-- 277
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF 183
                 L   ++ ++  Q+  G+ ++     +HRDL+  N+L+      K+ADFGL +  
Sbjct: 278 ------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLI 331
Query: 184 ---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
              +Y     +     W  APE  L   +    D+WS G ++ E+
Sbjct: 332 EDNEYTARQGAKFPIKW-TAPEAALYGRFTIKSDVWSFGILLTEL 375

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 90
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H   DL +++            VK+L     Q+ K
Sbjct: 91  LSLLGIC---LRSEGSPLVVLPYMKH--GDLRNFIRN----ETHNPTVKDLIGFGLQVAK 141
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP--- 201
           G+ +L S + +HRDL  +N ++     +K+ADFGLA+   YD    SV      + P   
Sbjct: 142 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKW 200
Query: 202 ---EILLNLGYGTPVDIWSIGCVMAEM 225
              E L    + T  D+WS G ++ E+
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWEL 227

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 91
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H   DL +++            VK+L     Q+ K
Sbjct: 92  LSLLGIC---LRSEGSPLVVLPYMKH--GDLRNFIRN----ETHNPTVKDLIGFGLQVAK 142
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP--- 201
           G+ +L S + +HRDL  +N ++     +K+ADFGLA+   YD    SV      + P   
Sbjct: 143 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKW 201
Query: 202 ---EILLNLGYGTPVDIWSIGCVMAEM 225
              E L    + T  D+WS G ++ E+
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWEL 228

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKAR--DLQNKGNYVAMKKLRVKLNEDGIPMST-LREISI 75
           +G+K    L ++G G++G V +        K   VA+K L+  +      M   +RE++ 
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYL-----IFEHVDQDLGSYMEKCPPPGL 130
           +  LD   H N++R + V+    L+    +   L     + + + +  G ++        
Sbjct: 75  MHSLD---HRNLIRLYGVV----LTPPMKMVTELAPLGSLLDRLRKHQGHFL-------- 119
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYD 186
               +     Q+ +G+ +L S R IHRDL  +NLL+     +KI DFGL +      D+ 
Sbjct: 120 -LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHX 178
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           +M     V   + APE L    +    D W  G  + EM+
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K    F HPN+
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKD---FSHPNV 112
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR---QMLK 144
           +    +    + S+   L V    +H   DL +++            VK+L     Q+ K
Sbjct: 113 LSLLGIC---LRSEGSPLVVLPYMKH--GDLRNFIRN----ETHNPTVKDLIGFGLQVAK 163
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP--- 201
           G+ +L S + +HRDL  +N ++     +K+ADFGLA+   YD    SV      + P   
Sbjct: 164 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKW 222
Query: 202 ---EILLNLGYGTPVDIWSIGCVMAEM 225
              E L    + T  D+WS G ++ E+
Sbjct: 223 MALESLQTQKFTTKSDVWSFGVLLWEL 249

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 21/225 (9%)
Query: 5   SADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG 64
           S    Q L  D+ ++  +      ++G G +G V+      N    VA+K L+       
Sbjct: 250 SKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS-- 305
Query: 65  IPMSTLREISILKQLDTFEHPNIVRFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYME 123
            P + L+E  ++K+L    H  +V+ + V+ +  I     Y++   + + +  + G Y  
Sbjct: 306 -PEAFLQEAQVMKKL---RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKY-- 359
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF 183
                 L   ++ ++  Q+  G+ ++     +HRDL+  N+L+      K+ADFGLA+  
Sbjct: 360 ------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413
Query: 184 ---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
              +Y     +     W  APE  L   +    D+WS G ++ E+
Sbjct: 414 EDNEYTARQGAKFPIKW-TAPEAALYGRFTIKSDVWSFGILLTEL 457

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 27  LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           L ++G G +G V         G +     + +K+ ++G  MS    I   K +    H  
Sbjct: 14  LKELGTGQFGVV-------KYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEK 65
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQD-LGSYMEKCPPPGLSASKVKELTRQMLKG 145
           +V+ + V  +          +++I E++    L +Y+ +         ++ E+ + + + 
Sbjct: 66  LVQLYGVCTKQ-------RPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEA 117
Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRAPE 202
           +++L S + +HRDL  +N L+   G +K++DFGL++     +Y     S     W   PE
Sbjct: 118 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRW-SPPE 176
Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRL 228
           +L+   + +  DIW+ G +M E++ L
Sbjct: 177 VLMYSKFSSKSDIWAFGVLMWEIYSL 202

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 23/229 (10%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++  +K     ++G G++G V++      KG      + RV +       S    I 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEG---VAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 75  ILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP---- 127
            L +   +  F   ++VR   V+ Q         T+ ++      DL SY+    P    
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQG------QPTLVIMELMTRGDLKSYLRSLRPAMAN 128
Query: 128 -PGL---SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF 183
            P L   S SK+ ++  ++  G+ +L++++ +HRDL  +N ++     +KI DFG+ +  
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188
Query: 184 ---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
              DY       ++ + + +PE L +  + T  D+WS G V+ E+  L 
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST---LREISI 75
           +G+K    L ++G G++G V +       G  V++    +K +    P +    +RE++ 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYL-----IFEHVDQDLGSYMEKCPPPGL 130
           +  LD   H N++R + V+    L+    +   L     + + + +  G ++        
Sbjct: 65  MHSLD---HRNLIRLYGVV----LTPPMKMVTELAPLGSLLDRLRKHQGHFL-------- 109
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYD 186
               +     Q+ +G+ +L S R IHRDL  +NLL+     +KI DFGL +      D+ 
Sbjct: 110 -LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHX 168
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           +M     V   + APE L    +    D W  G  + EM+
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 23/229 (10%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++  +K     ++G G++G V++      KG      + RV +       S    I 
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEG---VAKGVVKDEPETRVAIKTVNEAASMRERIE 64
Query: 75  ILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP---- 127
            L +   +  F   ++VR   V+ Q         T+ ++      DL SY+    P    
Sbjct: 65  FLNEASVMKEFNCHHVVRLLGVVSQG------QPTLVIMELMTRGDLKSYLRSLRPAMAN 118
Query: 128 -PGL---SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF 183
            P L   S SK+ ++  ++  G+ +L++++ +HRDL  +N ++     +KI DFG+ +  
Sbjct: 119 NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 178
Query: 184 ---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
              DY       ++ + + +PE L +  + T  D+WS G V+ E+  L 
Sbjct: 179 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 227

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 28/205 (13%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST---LREISILKQLDTFEHP 85
           ++G G +G V+        G Y    K+ VK  + G  MS    L E +++K   T +H 
Sbjct: 20  RLGAGQFGEVWM-------GYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMK---TLQHD 68
Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLK 144
            +VR + V+        R   +Y+I E++ +  L  +++      +   K+ + + Q+ +
Sbjct: 69  KLVRLYAVVT-------REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 121
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS---VVVTLWYRAP 201
           G+ ++     IHRDL+  N+L++ +   KIADFGLA+  + D   T+       + + AP
Sbjct: 122 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAP 180
Query: 202 EILLNLG-YGTPVDIWSIGCVMAEM 225
           E  +N G +    D+WS G ++ E+
Sbjct: 181 EA-INFGCFTIKSDVWSFGILLYEI 204

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 17/229 (7%)
Query: 3   EYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE 62
           E     ++  +L  L +    +     +G G +G V+K R     G  VA+K+L+ +  +
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGR--LADGXLVAVKRLKEERTQ 68
Query: 63  DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTV-YLIFEHVDQDLGSY 121
            G     L+  + ++ +    H N++R        +   ER L   Y+    V   L   
Sbjct: 69  GG----ELQFQTEVEMISMAVHRNLLRLRGFC---MTPTERLLVYPYMANGSVASCLRER 121
Query: 122 MEKCPPPGLSASKVKELTRQMLKGVDFLHSH---RIIHRDLKPQNLLITRAGGLKIADFG 178
            E  PP  L   K + +     +G+ +LH H   +IIHRD+K  N+L+       + DFG
Sbjct: 122 PESQPP--LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179
Query: 179 LAKTFDYD--MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           LAK  DY    +  +V   + + APE L         D++  G ++ E+
Sbjct: 180 LAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 228

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 103/222 (46%), Gaps = 25/222 (11%)
Query: 17  LDLGDKKY-------DELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           L +G ++Y       + L ++G G  G V+K R  +  G+ +A+K++R   N++      
Sbjct: 13  LTIGGQRYQAEINDLENLGEMGSGTCGQVWKMR-FRKTGHVIAVKQMRRSGNKEENKRIL 71
Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG 129
           +    +LK  D    P IV+ F      I + + ++ + L+    ++ L   M+   P  
Sbjct: 72  MDLDVVLKSHDC---PYIVQCFGTF---ITNTDVFIAMELMGTCAEK-LKKRMQGPIPER 124
Query: 130 LSASKVKELTRQMLKGVDFL-HSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
           +    + ++T  ++K + +L   H +IHRD+KP N+L+   G +K+ DFG++     D  
Sbjct: 125 I----LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180
Query: 189 LTSVVVTLWYRAPEIL-----LNLGYGTPVDIWSIGCVMAEM 225
                    Y APE +         Y    D+WS+G  + E+
Sbjct: 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 101/227 (44%), Gaps = 27/227 (11%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++  +K     ++G G++G V++      KG      + RV +       S    I 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEG---VAKGVVKDEPETRVAIKTVNEAASMRERIE 61
Query: 75  ILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY-------MEK 124
            L +   +  F   ++VR   V+ Q         T+ ++      DL SY       ME 
Sbjct: 62  FLNEASVMKEFNCHHVVRLLGVVSQG------QPTLVIMELMTRGDLKSYLRSLRPEMEN 115
Query: 125 CP---PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK 181
            P   PP LS  K+ ++  ++  G+ +L++++ +HRDL  +N  +     +KI DFG+ +
Sbjct: 116 NPVLAPPSLS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTR 173
Query: 182 TF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                DY       ++ + + +PE L +  + T  D+WS G V+ E+
Sbjct: 174 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 28  CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP---MSTLREISILKQLDTFEH 84
            +IG G++GTV+K +   +    VA+K L+V    D  P    +   E+++L++     H
Sbjct: 42  TRIGSGSFGTVYKGKWHGD----VAVKILKV---VDPTPEQFQAFRNEVAVLRKT---RH 91
Query: 85  PNIVRFFDVIHQ-NILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
            NI+ F   + + N+    ++     +++H+                   ++ ++ RQ  
Sbjct: 92  VNILLFMGYMTKDNLAIVTQWCEGSSLYKHLH---------VQETKFQMFQLIDIARQTA 142
Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT---FDYDMMLTSVVVTLWYRA 200
           +G+D+LH+  IIHRD+K  N+ +     +KI DFGLA     +     +     ++ + A
Sbjct: 143 QGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA 202
Query: 201 PEILL---NLGYGTPVDIWSIGCVMAEM 225
           PE++    N  +    D++S G V+ E+
Sbjct: 203 PEVIRMQDNNPFSFQSDVYSYGIVLYEL 230

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 30  IGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G +G V   R L+  G     VA+K L+     D      L E SI+ Q   F+HPN
Sbjct: 37  IGVGEFGEVCSGR-LKVPGKREICVAIKTLKAGYT-DKQRRDFLSEASIMGQ---FDHPN 91
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           I+    V+        +   V +I E+++   L +++ K      +  ++  + R +  G
Sbjct: 92  IIHLEGVV-------TKCKPVMIITEYMENGSLDAFLRKNDGR-FTVIQLVGMLRGIGSG 143
Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAP 201
           + +L     +HRDL  +N+L+      K++DFG+++  + D           + + + AP
Sbjct: 144 MKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 203
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E +    + +  D+WS G VM E+
Sbjct: 204 EAIAYRKFTSASDVWSYGIVMWEV 227

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 91/201 (45%), Gaps = 21/201 (10%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V+      N    VA+K L+        P + L+E  ++K+L    H  +V
Sbjct: 18  KLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKL---RHEKLV 69
Query: 89  RFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + + V+ +  I     Y++   + + +  + G Y        L   ++ ++  Q+  G+ 
Sbjct: 70  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKY--------LRLPQLVDMAAQIASGMA 121
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRAPEIL 204
           ++     +HRDL+  N+L+      K+ADFGLA+     +Y     +     W  APE  
Sbjct: 122 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAA 180
Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
           L   +    D+WS G ++ E+
Sbjct: 181 LYGRFTIKSDVWSFGILLTEL 201

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 60  LNEDGIPMSTLREISILKQ--------LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF 111
           LN+D + + T+RE ++ ++        +    HP +V+ + V  +          + L+F
Sbjct: 29  LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-------PICLVF 81
Query: 112 EHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG 171
           E ++    S   +      +A  +  +   + +G+ +L    +IHRDL  +N L+     
Sbjct: 82  EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQV 141
Query: 172 LKIADFGLAKTFDYDMMLTSVVVTLW---YRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           +K++DFG+ + F  D   TS   T +   + +PE+     Y +  D+WS G +M E++
Sbjct: 142 IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 198

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKL-------NEDGIPMSTLREISILKQLDTF 82
           +G GA+G V +A      G   A+ K+ VK+       +E    MS L+ +S L Q    
Sbjct: 54  LGAGAFGKVVEATAF-GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ---- 108
Query: 83  EHPNIVRFFDVIHQN--ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK---- 136
            H NIV           +L    Y     +   + +     +E  P   ++ S +     
Sbjct: 109 -HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRK-SRVLETDPAFAIANSTLSTRDL 166
Query: 137 -ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSV 192
              + Q+ +G+ FL S   IHRD+  +N+L+T     KI DFGLA+    D   ++  + 
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
            + + + APE + +  Y    D+WS G ++ E++ L
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 30  IGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G +G V   R L+  G     VA+K L+     D      L E SI+ Q   F+HPN
Sbjct: 16  IGVGEFGEVCSGR-LKVPGKREICVAIKTLKAGYT-DKQRRDFLSEASIMGQ---FDHPN 70
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           I+    V+        +   V +I E+++   L +++ K      +  ++  + R +  G
Sbjct: 71  IIHLEGVV-------TKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSG 122
Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAP 201
           + +L     +HRDL  +N+L+      K++DFG+++  + D           + + + AP
Sbjct: 123 MKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 182
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E +    + +  D+WS G VM E+
Sbjct: 183 EAIAYRKFTSASDVWSYGIVMWEV 206

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKAR--DLQNKGNYVAMKKLRVKLNEDGIPMST-LREISI 75
           +G+K    L ++G G++G V +        K   VA+K L+  +      M   +RE++ 
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYL-----IFEHVDQDLGSYMEKCPPPGL 130
           +  LD   H N++R + V+    L+    +   L     + + + +  G ++        
Sbjct: 75  MHSLD---HRNLIRLYGVV----LTPPMKMVTELAPLGSLLDRLRKHQGHFL-------- 119
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYD 186
               +     Q+ +G+ +L S R IHRDL  +NLL+     +KI DFGL +      D+ 
Sbjct: 120 -LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 178
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           +M     V   + APE L    +    D W  G  + EM+
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V+      N    VA+K L+        P + L+E  ++K+L    H  +V
Sbjct: 15  KLGQGCFGEVWMG--TWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKL---RHEKLV 66
Query: 89  RFFDVIHQN-ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + + V+ +  I     Y++   + + +  + G Y        L   ++ ++  Q+  G+ 
Sbjct: 67  QLYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKY--------LRLPQLVDMAAQIASGMA 118
Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT--SVVVTLWYRAPEILL 205
           ++     +HRDL+  N+L+      K+ADFGLA+  + +           + + APE  L
Sbjct: 119 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAAL 178
Query: 206 NLGYGTPVDIWSIGCVMAEM 225
              +    D+WS G ++ E+
Sbjct: 179 YGRFTIKSDVWSFGILLTEL 198

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKAR--DLQNKGNYVAMKKLRVKLNEDGIPMST-LREISI 75
           +G+K    L ++G G++G V +        K   VA+K L+  +      M   +RE++ 
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYL-----IFEHVDQDLGSYMEKCPPPGL 130
           +  LD   H N++R + V+    L+    +   L     + + + +  G ++        
Sbjct: 69  MHSLD---HRNLIRLYGVV----LTPPMKMVTELAPLGSLLDRLRKHQGHFL-------- 113
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYD 186
               +     Q+ +G+ +L S R IHRDL  +NLL+     +KI DFGL +      D+ 
Sbjct: 114 -LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 172
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           +M     V   + APE L    +    D W  G  + EM
Sbjct: 173 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 30  IGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G +G V   R L+  G     VA+K L+     D      L E SI+ Q   F+HPN
Sbjct: 22  IGVGEFGEVCSGR-LKVPGKREICVAIKTLKAGYT-DKQRRDFLSEASIMGQ---FDHPN 76
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           I+    V+        +   V +I E+++   L +++ K      +  ++  + R +  G
Sbjct: 77  IIHLEGVV-------TKCKPVMIITEYMENGSLDAFLRKNDGR-FTVIQLVGMLRGIGSG 128
Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV----VTLWYRAP 201
           + +L     +HRDL  +N+L+      K++DFG+++  + D           + + + AP
Sbjct: 129 MKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 188
Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E +    + +  D+WS G VM E+
Sbjct: 189 EAIAYRKFTSASDVWSYGIVMWEV 212

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST---LREISI 75
           +G+K    L ++G G++G V +       G  V++    +K +    P +    +RE++ 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYL-----IFEHVDQDLGSYMEKCPPPGL 130
           +  LD   H N++R + V+    L+    +   L     + + + +  G ++        
Sbjct: 65  MHSLD---HRNLIRLYGVV----LTPPMKMVTELAPLGSLLDRLRKHQGHFL-------- 109
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYD 186
               +     Q+ +G+ +L S R IHRDL  +NLL+     +KI DFGL +      D+ 
Sbjct: 110 -LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           +M     V   + APE L    +    D W  G  + EM+
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKAR--DLQNKGNYVAMKKLRVKLNEDGIPMST-LREISI 75
           +G+K    L ++G G++G V +        K   VA+K L+  +      M   +RE++ 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYL-----IFEHVDQDLGSYMEKCPPPGL 130
           +  LD   H N++R + V+    L+    +   L     + + + +  G ++        
Sbjct: 65  MHSLD---HRNLIRLYGVV----LTPPMKMVTELAPLGSLLDRLRKHQGHFL-------- 109
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYD 186
               +     Q+ +G+ +L S R IHRDL  +NLL+     +KI DFGL +      D+ 
Sbjct: 110 -LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           +M     V   + APE L    +    D W  G  + EM+
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKL-------NEDGIPMSTLREISILKQLDTF 82
           +G GA+G V +A      G   A+ K+ VK+       +E    MS L+ +S L Q    
Sbjct: 54  LGAGAFGKVVEATAF-GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ---- 108
Query: 83  EHPNIVRFFDVIHQN--ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK---- 136
            H NIV           +L    Y     +   + +     +E  P   ++ S       
Sbjct: 109 -HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRK-SRVLETDPAFAIANSTASTRDL 166
Query: 137 -ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSV 192
              + Q+ +G+ FL S   IHRD+  +N+L+T     KI DFGLA+    D   ++  + 
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
            + + + APE + +  Y    D+WS G ++ E++ L
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKAR--DLQNKGNYVAMKKLRVKLNEDGIPMST-LREISI 75
           +G+K    L ++G G++G V +        K   VA+K L+  +      M   +RE++ 
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYL-----IFEHVDQDLGSYMEKCPPPGL 130
           +  LD   H N++R + V+    L+    +   L     + + + +  G ++        
Sbjct: 69  MHSLD---HRNLIRLYGVV----LTPPMKMVTELAPLGSLLDRLRKHQGHFL-------- 113
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYD 186
               +     Q+ +G+ +L S R IHRDL  +NLL+     +KI DFGL +      D+ 
Sbjct: 114 -LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 172
Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           +M     V   + APE L    +    D W  G  + EM+
Sbjct: 173 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 212

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 102/231 (44%), Gaps = 27/231 (11%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++  +K     ++G G++G V++      KG      + RV +       S    I 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEG---VAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 75  ILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY-------MEK 124
            L +   +  F   ++VR   V+ Q         T+ ++      DL SY       ME 
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQG------QPTLVIMELMTRGDLKSYLRSLRPEMEN 122
Query: 125 CP---PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK 181
            P   PP LS  K+ ++  ++  G+ +L++++ +HRDL  +N ++     +KI DFG+ +
Sbjct: 123 NPVLAPPSLS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 180
Query: 182 TF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
                D        ++ + + +PE L +  + T  D+WS G V+ E+  L 
Sbjct: 181 DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 231

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 102/231 (44%), Gaps = 27/231 (11%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++  +K     ++G G++G V++      KG      + RV +       S    I 
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEG---VAKGVVKDEPETRVAIKTVNEAASMRERIE 59
Query: 75  ILKQ---LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSY-------MEK 124
            L +   +  F   ++VR   V+ Q         T+ ++      DL SY       ME 
Sbjct: 60  FLNEASVMKEFNCHHVVRLLGVVSQG------QPTLVIMELMTRGDLKSYLRSLRPEMEN 113
Query: 125 CP---PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK 181
            P   PP LS  K+ ++  ++  G+ +L++++ +HRDL  +N ++     +KI DFG+ +
Sbjct: 114 NPVLAPPSLS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 171
Query: 182 TF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV 229
                D        ++ + + +PE L +  + T  D+WS G V+ E+  L 
Sbjct: 172 DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 222

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 60  LNEDGIPMSTLREISILKQ--------LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF 111
           LN+D + + T+RE ++ ++        +    HP +V+ + V  +          + L+F
Sbjct: 27  LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-------PICLVF 79
Query: 112 EHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG 171
           E ++    S   +      +A  +  +   + +G+ +L    +IHRDL  +N L+     
Sbjct: 80  EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV 139
Query: 172 LKIADFGLAKTFDYDMMLTSVVVTLW---YRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           +K++DFG+ + F  D   TS   T +   + +PE+     Y +  D+WS G +M E++
Sbjct: 140 IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGN---YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G +G V     L+  G    +VA+K L+    E       L E SI+ Q   F+HPN
Sbjct: 41  IGAGEFGEVCSGH-LKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQ---FDHPN 95
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           ++    V+ ++         V +I E ++   L S++ +      +  ++  + R +  G
Sbjct: 96  VIHLEGVVTKST-------PVMIITEFMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIAAG 147
Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVV---VTLWYR 199
           + +L     +HRDL  +N+L+      K++DFGL++  + D      TS +   + + + 
Sbjct: 148 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEM 225
           APE +    + +  D+WS G VM E+
Sbjct: 208 APEAIQYRKFTSASDVWSYGIVMWEV 233

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 60  LNEDGIPMSTLREISILKQ--------LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF 111
           LN+D + + T+RE ++ ++        +    HP +V+ + V  +          + L+F
Sbjct: 29  LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-------PICLVF 81
Query: 112 EHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG 171
           E ++    S   +      +A  +  +   + +G+ +L    +IHRDL  +N L+     
Sbjct: 82  EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV 141
Query: 172 LKIADFGLAKTFDYDMMLTSVVVTLW---YRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           +K++DFG+ + F  D   TS   T +   + +PE+     Y +  D+WS G +M E++
Sbjct: 142 IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 198

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 31/224 (13%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKL-------NEDGIPMSTLREISILKQLDTF 82
           +G GA+G V +A      G   A+ K+ VK+       +E    MS L+ +S L Q    
Sbjct: 39  LGAGAFGKVVEATAF-GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ---- 93
Query: 83  EHPNIVRFFDVIHQN--ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG----------- 129
            H NIV           +L    Y     +   + +   + +     PG           
Sbjct: 94  -HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDG 152
Query: 130 --LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD- 186
             L    +   + Q+ +G+ FL S   IHRD+  +N+L+T     KI DFGLA+    D 
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 212
Query: 187 --MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
             ++  +  + + + APE + +  Y    D+WS G ++ E++ L
Sbjct: 213 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 256

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMS----TLREISILKQLDTFE-H 84
           +G G +GTVF    L ++   VA+K +         P+S       E+++L ++     H
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQ-VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 85  PNIVRFFDVIHQN---ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
           P ++R  D        +L  ER L          QDL  Y+ +  P G   S+      Q
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPA--------QDLFDYITEKGPLGEGPSRC--FFGQ 147
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLIT-RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           ++  +   HS  ++HRD+K +N+LI  R G  K+ DFG +    +D   T    T  Y  
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG-SGALLHDEPYTDFDGTRVYSP 206
Query: 201 PEILLNLGY-GTPVDIWSIGCVMAEM 225
           PE +    Y   P  +WS+G ++ +M
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDM 232

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 60  LNEDGIPMSTLREISILKQ--------LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF 111
           LN+D + + T+RE ++ ++        +    HP +V+ + V  +          + L+F
Sbjct: 32  LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-------PICLVF 84
Query: 112 EHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG 171
           E ++    S   +      +A  +  +   + +G+ +L    +IHRDL  +N L+     
Sbjct: 85  EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV 144
Query: 172 LKIADFGLAKTFDYDMMLTSVVVTLW---YRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           +K++DFG+ + F  D   TS   T +   + +PE+     Y +  D+WS G +M E++
Sbjct: 145 IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 201

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 7/106 (6%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV--TLWY 198
           +M+  +D +H    +HRD+KP N+L+   G +++ADFG     + D  + S V   T  Y
Sbjct: 199 EMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 258
Query: 199 RAPEILLNL-----GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
            +PEIL  +      YG   D WS+G  M EM      F A + VE
Sbjct: 259 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 304

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 7/106 (6%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV--TLWY 198
           +M+  +D +H    +HRD+KP N+L+   G +++ADFG     + D  + S V   T  Y
Sbjct: 183 EMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 242
Query: 199 RAPEILLNL-----GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
            +PEIL  +      YG   D WS+G  M EM      F A + VE
Sbjct: 243 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 32/207 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G++G V + +D Q  G   A+KK+R+++            +  L        P IV
Sbjct: 65  RVGRGSFGEVHRMKDKQT-GFQCAVKKVRLEVFR----------VEELVACAGLSSPRIV 113
Query: 89  RFFDVIHQNILSDERYLTVYL-IFEHVDQDLGSYMEK--CPPPGLSASKVKELTRQMLKG 145
             +  + +       ++ +++ + E     LG  +++  C P      +      Q L+G
Sbjct: 114 PLYGAVREGP-----WVNIFMELLE--GGSLGQLIKQMGCLP----EDRALYYLGQALEG 162
Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYDMMLTSVVV------TLWY 198
           +++LH+ RI+H D+K  N+L++  G    + DFG A     D +  S++       T  +
Sbjct: 163 LEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEM 225
            APE+++       VDIWS  C+M  M
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHM 249

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +    ++L E   P +    +     
Sbjct: 46  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIMELREATSPKANKEILDEAYV 104
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPPPGL 130
           + + ++P++ R   +    + S  + +T  + F        EH D     Y+        
Sbjct: 105 MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-------- 153
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDM 187
                     Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + + 
Sbjct: 154 -----LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 208
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V + + A E +L+  Y    D+WS G  + E+
Sbjct: 209 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 246

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 14  LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREI 73
           L  L+     +D    IG G +G V+K   +   G  VA+K+ R   +  GI        
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKG--VLRDGAKVALKR-RTPESSQGIEEFE---- 83
Query: 74  SILKQLDTFEHPNIVRFFDVIHQNILSDER--YLTVYLIFEHVDQDLGSYMEKCPPPGLS 131
           + ++ L    HP++V            DER   + +Y   E+ +     Y    P   +S
Sbjct: 84  TEIETLSFCRHPHLVSLIG------FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137
Query: 132 ASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT---FDYDMM 188
             +  E+     +G+ +LH+  IIHRD+K  N+L+      KI DFG++K         +
Sbjct: 138 WEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHL 197
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQ 240
              V  TL Y  PE  +        D++S G V+ E      + CA + + Q
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE------VLCARSAIVQ 243

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 32/207 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G++G V + +D Q  G   A+KK+R+++            +  L        P IV
Sbjct: 81  RVGRGSFGEVHRMKDKQT-GFQCAVKKVRLEVFR----------VEELVACAGLSSPRIV 129
Query: 89  RFFDVIHQNILSDERYLTVYL-IFEHVDQDLGSYMEK--CPPPGLSASKVKELTRQMLKG 145
             +  + +       ++ +++ + E     LG  +++  C P      +      Q L+G
Sbjct: 130 PLYGAVREGP-----WVNIFMELLE--GGSLGQLIKQMGCLP----EDRALYYLGQALEG 178
Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYDMMLTSVVV------TLWY 198
           +++LH+ RI+H D+K  N+L++  G    + DFG A     D +  S++       T  +
Sbjct: 179 LEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 238
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEM 225
            APE+++       VDIWS  C+M  M
Sbjct: 239 MAPEVVMGKPCDAKVDIWSSCCMMLHM 265

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 32/207 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G++G V +  D Q  G   A+KK+R+++           E+     L +   P IV
Sbjct: 100 RLGRGSFGEVHRMEDKQT-GFQCAVKKVRLEVFR-------AEELMACAGLTS---PRIV 148
Query: 89  RFFDVIHQNILSDERYLTVYL-IFEHVDQDLGSYMEK--CPPPGLSASKVKELTRQMLKG 145
             +  + +       ++ +++ + E     LG  +++  C    L   +      Q L+G
Sbjct: 149 PLYGAVREGP-----WVNIFMELLE--GGSLGQLVKEQGC----LPEDRALYYLGQALEG 197
Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYDMMLTSVVV------TLWY 198
           +++LHS RI+H D+K  N+L++  G    + DFG A     D +  S++       T  +
Sbjct: 198 LEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETH 257
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEM 225
            APE++L       VD+WS  C+M  M
Sbjct: 258 MAPEVVLGRSCDAKVDVWSSCCMMLHM 284

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 30  IGCGAYGTVFKARDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V++     +KG    VA+K  +     D      + E  I+K LD   HP+I
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-KEKFMSEAVIMKNLD---HPHI 71
Query: 88  VRFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELTR-----Q 141
           V+   +I +           ++I E +   +LG Y+E+      + + +K LT      Q
Sbjct: 72  VKLIGIIEEE--------PTWIIMELYPYGELGHYLER------NKNSLKVLTLVLYSLQ 117
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLTSVV-VTLWYR 199
           + K + +L S   +HRD+  +N+L+     +K+ DFGL++   D D    SV  + + + 
Sbjct: 118 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 177
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEM 225
           +PE +    + T  D+W     M E+
Sbjct: 178 SPESINFRRFTTASDVWMFAVCMWEI 203

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 30  IGCGAYGTVFKARDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V++     +KG    VA+K  +     D      + E  I+K LD   HP+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-KEKFMSEAVIMKNLD---HPHI 75
Query: 88  VRFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELTR-----Q 141
           V+   +I +           ++I E +   +LG Y+E+      + + +K LT      Q
Sbjct: 76  VKLIGIIEEE--------PTWIIMELYPYGELGHYLER------NKNSLKVLTLVLYSLQ 121
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLTSVV-VTLWYR 199
           + K + +L S   +HRD+  +N+L+     +K+ DFGL++   D D    SV  + + + 
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEM 225
           +PE +    + T  D+W     M E+
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEI 207

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 20/204 (9%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G GA   VF+ R  +  G+  A+K          + +  +RE  +LK+L+   H NIV+
Sbjct: 17  LGQGATANVFRGRH-KKTGDLFAIKVFNNISFLRPVDVQ-MREFEVLKKLN---HKNIVK 71
Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFL 149
            F +  +   +  R+  + + F           E     GL  S+   + R ++ G++ L
Sbjct: 72  LFAIEEE---TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 150 HSHRIIHRDLKPQNLL--ITRAGG--LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL 205
             + I+HR++KP N++  I   G    K+ DFG A+  + D    S+  T  Y  P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 206 NL--------GYGTPVDIWSIGCV 221
                      YG  VD+WSIG  
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVT 212

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 30  IGCGAYGTVFKARDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V++     +KG    VA+K  +     D      + E  I+K LD   HP+I
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-KEKFMSEAVIMKNLD---HPHI 87
Query: 88  VRFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELTR-----Q 141
           V+   +I +           ++I E +   +LG Y+E+      + + +K LT      Q
Sbjct: 88  VKLIGIIEEE--------PTWIIMELYPYGELGHYLER------NKNSLKVLTLVLYSLQ 133
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLTSVV-VTLWYR 199
           + K + +L S   +HRD+  +N+L+     +K+ DFGL++   D D    SV  + + + 
Sbjct: 134 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 193
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEM 225
           +PE +    + T  D+W     M E+
Sbjct: 194 SPESINFRRFTTASDVWMFAVCMWEI 219

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 56/106 (52%), Gaps = 7/106 (6%)
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA-KTFDYDMMLTSVVV-TLWY 198
           +M+  +D +H    +HRD+KP N+L+   G +++ADFG   K  +   + +SV V T  Y
Sbjct: 183 EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 242
Query: 199 RAPEILLNL-----GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
            +PEIL  +      YG   D WS+G  M EM      F A + VE
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPPPGL 130
           + + ++P++ R   +    + S  + +T  + F        EH D     Y+        
Sbjct: 71  MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-------- 119
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDM 187
                     Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + + 
Sbjct: 120 -----LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V + + A E +L+  Y    D+WS G  + E+
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPPPGL 130
           + + ++P++ R   +    + S  + +T  + F        EH D     Y+        
Sbjct: 73  MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-------- 121
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDM 187
                     Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + + 
Sbjct: 122 -----LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 176
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V + + A E +L+  Y    D+WS G  + E+
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 32/207 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G++G V + +D Q  G   A+KK+R+++            +  L        P IV
Sbjct: 79  RLGRGSFGEVHRMKDKQT-GFQCAVKKVRLEVFR----------VEELVACAGLSSPRIV 127
Query: 89  RFFDVIHQNILSDERYLTVYL-IFEHVDQDLGSYMEK--CPPPGLSASKVKELTRQMLKG 145
             +  + +       ++ +++ + E     LG  +++  C P      +      Q L+G
Sbjct: 128 PLYGAVREGP-----WVNIFMELLE--GGSLGQLIKQMGCLP----EDRALYYLGQALEG 176
Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYDMMLTSVVV------TLWY 198
           +++LH+ RI+H D+K  N+L++  G    + DFG A     D +  S++       T  +
Sbjct: 177 LEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 236
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEM 225
            APE+++       VDIWS  C+M  M
Sbjct: 237 MAPEVVMGKPCDAKVDIWSSCCMMLHM 263

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 18  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 76
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPPPGL 130
           + + ++P++ R   +    + S  + +T  + F        EH D     Y+        
Sbjct: 77  MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-------- 125
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDM 187
                     Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + + 
Sbjct: 126 -----LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 180
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V + + A E +L+  Y    D+WS G  + E+
Sbjct: 181 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 218

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPPPGL 130
           + + ++P++ R   +    + S  + +T  + F        EH D     Y+        
Sbjct: 74  MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-------- 122
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDM 187
                     Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + + 
Sbjct: 123 -----LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V + + A E +L+  Y    D+WS G  + E+
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 215

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 30  IGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V +   +  +N    VA+K  +     D +    L+E   ++Q   F+HP+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQ---FDHPHI 73
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   VI +N         V++I E     +L S+++      L  + +     Q+   +
Sbjct: 74  VKLIGVITEN--------PVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTAL 124
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV--VVTLWYRAPEIL 204
            +L S R +HRD+  +N+L++    +K+ DFGL++  +      +    + + + APE +
Sbjct: 125 AYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 184
Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
               + +  D+W  G  M E+
Sbjct: 185 NFRRFTSASDVWMFGVCMWEI 205

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPPPGL 130
           + + ++P++ R   +    + S  + +T  + F        EH D     Y+        
Sbjct: 74  MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-------- 122
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDM 187
                     Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + + 
Sbjct: 123 -----LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V + + A E +L+  Y    D+WS G  + E+
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 215

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +IG G +G V       + G ++   K+ +K  ++G  MS    I   + +    HP +V
Sbjct: 34  EIGSGQFGLV-------HLGYWLNKDKVAIKTIKEG-SMSEDDFIEEAEVMMKLSHPKLV 85
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
           + + V  +          + L+FE ++    S   +      +A  +  +   + +G+ +
Sbjct: 86  QLYGVCLEQA-------PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 138
Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLW---YRAPEILL 205
           L    +IHRDL  +N L+     +K++DFG+ + F  D   TS   T +   + +PE+  
Sbjct: 139 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFS 197
Query: 206 NLGYGTPVDIWSIGCVMAEMW 226
              Y +  D+WS G +M E++
Sbjct: 198 FSRYSSKSDVWSFGVLMWEVF 218

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 128/312 (41%), Gaps = 72/312 (23%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           QIG G YG V+  +    +G  VA+K       E+    S  RE  I + +    H NI+
Sbjct: 44  QIGKGRYGEVWMGK---WRGEKVAVKVFFT--TEEA---SWFRETEIYQTV-LMRHENIL 94
Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
            F   I  +I     +  +YLI ++   + GS  +      L A  + +L    + G+  
Sbjct: 95  GF---IAADIKGTGSWTQLYLITDY--HENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCH 149
Query: 149 LHSH--------RIIHRDLKPQNLLITRAGGLKIADFGLAKTF-----DYDMMLTSVVVT 195
           LH+          I HRDLK +N+L+ + G   IAD GLA  F     + D+   + V T
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 196 LWYRAPEIL---LNLGYGTP---VDIWSIGCVMAEMWR-----------------LVPLF 232
             Y  PE+L   LN  +       D++S G ++ E+ R                 LVP  
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 233 CASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLES 292
            +  ++ ++ CI ++   PS   +P      WSS E             C  +   L+  
Sbjct: 270 PSYEDMREIVCIKKL--RPS---FPNR----WSSDE-------------CLRQMGKLMTE 307
Query: 293 MLTFNPADRISA 304
               NPA R++A
Sbjct: 308 CWAHNPASRLTA 319

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPPPGL 130
           + + ++P++ R   +    + S  + +T  + F        EH D     Y+        
Sbjct: 74  MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-------- 122
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDM 187
                     Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + + 
Sbjct: 123 -----LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 177
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V + + A E +L+  Y    D+WS G  + E+
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 215

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 22  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 80
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPPPGL 130
           + + ++P++ R   +    + S  + +T  + F        EH D     Y+        
Sbjct: 81  MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-------- 129
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDM 187
                     Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + + 
Sbjct: 130 -----LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 184
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V + + A E +L+  Y    D+WS G  + E+
Sbjct: 185 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 222

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 37  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 95
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPPPGL 130
           + + ++P++ R   +    + S  + +T  + F        EH D     Y+        
Sbjct: 96  MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-------- 144
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDM 187
                     Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + + 
Sbjct: 145 -----LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 199
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V + + A E +L+  Y    D+WS G  + E+
Sbjct: 200 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 237

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 30  IGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V +   +  +N    VA+K  +     D +    L+E   ++Q   F+HP+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQ---FDHPHI 73
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   VI +N         V++I E     +L S+++      L  + +     Q+   +
Sbjct: 74  VKLIGVITEN--------PVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTAL 124
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV--VVTLWYRAPEIL 204
            +L S R +HRD+  +N+L++    +K+ DFGL++  +      +    + + + APE +
Sbjct: 125 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESI 184
Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
               + +  D+W  G  M E+
Sbjct: 185 NFRRFTSASDVWMFGVCMWEI 205

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 30  IGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V +   +  +N    VA+K  +     D +    L+E   ++Q   F+HP+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQ---FDHPHI 73
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   VI +N         V++I E     +L S+++      L  + +     Q+   +
Sbjct: 74  VKLIGVITEN--------PVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTAL 124
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV--VVTLWYRAPEIL 204
            +L S R +HRD+  +N+L++    +K+ DFGL++  +      +    + + + APE +
Sbjct: 125 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 184
Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
               + +  D+W  G  M E+
Sbjct: 185 NFRRFTSASDVWMFGVCMWEI 205

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPPPGL 130
           + + ++P++ R   +    + S  + +T  + F        EH D     Y+        
Sbjct: 65  MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-------- 113
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDM 187
                     Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + + 
Sbjct: 114 -----LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 168
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V + + A E +L+  Y    D+WS G  + E+
Sbjct: 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 206

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++ D +     +IG G++GTV+K +   +    VA+K L V         +   E+ 
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVG 56
Query: 75  ILKQLDTFEHPNIVRFFD--------VIHQNILSDERYLTVYLI---FEHVDQDLGSYME 123
           +L++     H NI+ F          ++ Q       Y  +++I   FE +         
Sbjct: 57  VLRKT---RHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMI--------- 104
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT- 182
                     K+ ++ RQ  +G+D+LH+  IIHRDLK  N+ +     +KI DFGLA   
Sbjct: 105 ----------KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154
Query: 183 --FDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEM 225
             +        +  ++ + APE++       Y    D+++ G V+ E+
Sbjct: 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 202

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPPPGL 130
           + + ++P++ R   +    + S  + +T  + F        EH D     Y+        
Sbjct: 71  MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGXLLDYVREHKDNIGSQYL-------- 119
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDM 187
                     Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + + 
Sbjct: 120 -----LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V + + A E +L+  Y    D+WS G  + E+
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++ D +     +IG G++GTV+K +   +    VA+K L V         +   E+ 
Sbjct: 6   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVG 61
Query: 75  ILKQLDTFEHPNIVRFFD--------VIHQNILSDERYLTVYLI---FEHVDQDLGSYME 123
           +L++     H NI+ F          ++ Q       Y  +++I   FE +         
Sbjct: 62  VLRKT---RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--------- 109
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT- 182
                     K+ ++ RQ  +G+D+LH+  IIHRDLK  N+ +     +KI DFGLA   
Sbjct: 110 ----------KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 159
Query: 183 --FDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEM 225
             +        +  ++ + APE++       Y    D+++ G V+ E+
Sbjct: 160 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 207

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPPPGL 130
           + + ++P++ R   +    + S  + +T  + F        EH D     Y+        
Sbjct: 78  MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-------- 126
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDM 187
                     Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + + 
Sbjct: 127 -----LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 181
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V + + A E +L+  Y    D+WS G  + E+
Sbjct: 182 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 219

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++ D +     +IG G++GTV+K +   +    VA+K L V         +   E+ 
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVG 56
Query: 75  ILKQLDTFEHPNIVRFFD--------VIHQNILSDERYLTVYLI---FEHVDQDLGSYME 123
           +L++     H NI+ F          ++ Q       Y  +++I   FE +         
Sbjct: 57  VLRKT---RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--------- 104
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT- 182
                     K+ ++ RQ  +G+D+LH+  IIHRDLK  N+ +     +KI DFGLA   
Sbjct: 105 ----------KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154
Query: 183 --FDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEM 225
             +        +  ++ + APE++       Y    D+++ G V+ E+
Sbjct: 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 202

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPPPGL 130
           + + ++P++ R   +    + S  + +T  + F        EH D     Y+        
Sbjct: 71  MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-------- 119
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDM 187
                     Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + + 
Sbjct: 120 -----LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V + + A E +L+  Y    D+WS G  + E+
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 30  IGCGAYGTVFKARDLQNKGNYV--AMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G+V +A+  Q  G++V  A+K L+  +         LRE + +K+   F+HP++
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKE---FDHPHV 87
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE---------L 138
            +   V  ++       + + ++      DL ++        L AS++ E         L
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAF--------LLASRIGENPFNLPLQTL 139
Query: 139 TRQMLK---GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSV 192
            R M+    G+++L S   IHRDL  +N ++     + +ADFGL++     DY     + 
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
            + + + A E L +  Y    D+W+ G  M E+
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++ D +     +IG G++GTV+K +   +    VA+K L V         +   E+ 
Sbjct: 6   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVG 61
Query: 75  ILKQLDTFEHPNIVRFFD--------VIHQNILSDERYLTVYLI---FEHVDQDLGSYME 123
           +L++     H NI+ F          ++ Q       Y  +++I   FE +         
Sbjct: 62  VLRKT---RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--------- 109
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT- 182
                     K+ ++ RQ  +G+D+LH+  IIHRDLK  N+ +     +KI DFGLA   
Sbjct: 110 ----------KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 159
Query: 183 --FDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEM 225
             +        +  ++ + APE++       Y    D+++ G V+ E+
Sbjct: 160 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 207

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++ D +     +IG G++GTV+K +   +    VA+K L V         +   E+ 
Sbjct: 3   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVG 58
Query: 75  ILKQLDTFEHPNIVRFFD--------VIHQNILSDERYLTVYLI---FEHVDQDLGSYME 123
           +L++     H NI+ F          ++ Q       Y  +++I   FE +         
Sbjct: 59  VLRKT---RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--------- 106
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT- 182
                     K+ ++ RQ  +G+D+LH+  IIHRDLK  N+ +     +KI DFGLA   
Sbjct: 107 ----------KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 156
Query: 183 --FDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEM 225
             +        +  ++ + APE++       Y    D+++ G V+ E+
Sbjct: 157 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 204

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 51/232 (21%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++ D +     +IG G++GTV+K +   +    VA+K L V         +   E+ 
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVG 56
Query: 75  ILKQLDTFEHPNIVRFFD--------VIHQNILSDERYLTVYLI---FEHVDQDLGSYME 123
           +L++     H NI+ F          ++ Q       Y  +++I   FE +         
Sbjct: 57  VLRKT---RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--------- 104
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-- 181
                     K+ ++ RQ  +G+D+LH+  IIHRDLK  N+ +     +KI DFGLA   
Sbjct: 105 ----------KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEK 154
Query: 182 -----TFDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEM 225
                +  ++ +  S+   LW  APE++       Y    D+++ G V+ E+
Sbjct: 155 SRWSGSHQFEQLSGSI---LWM-APEVIRMQDKNPYSFQSDVYAFGIVLYEL 202

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 30  IGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V +   +  +N    VA+K  +     D +    L+E   ++Q   F+HP+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQ---FDHPHI 453
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   VI +N         V++I E     +L S+++      L  + +     Q+   +
Sbjct: 454 VKLIGVITEN--------PVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTAL 504
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV--VVTLWYRAPEIL 204
            +L S R +HRD+  +N+L++    +K+ DFGL++  +      +    + + + APE +
Sbjct: 505 AYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 564
Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
               + +  D+W  G  M E+
Sbjct: 565 NFRRFTSASDVWMFGVCMWEI 585

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 30  IGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V +   +  +N    VA+K  +     D +    L+E   ++Q   F+HP+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQ---FDHPHI 70
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   VI +N         V++I E     +L S+++      L  + +     Q+   +
Sbjct: 71  VKLIGVITEN--------PVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTAL 121
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV--VVTLWYRAPEIL 204
            +L S R +HRD+  +N+L++    +K+ DFGL++  +      +    + + + APE +
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
               + +  D+W  G  M E+
Sbjct: 182 NFRRFTSASDVWMFGVCMWEI 202

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 51/232 (21%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++ D +     +IG G++GTV+K +   +    VA+K L V         +   E+ 
Sbjct: 21  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVG 76
Query: 75  ILKQLDTFEHPNIVRFFD--------VIHQNILSDERYLTVYLI---FEHVDQDLGSYME 123
           +L++     H NI+ F          ++ Q       Y  +++I   FE +         
Sbjct: 77  VLRKT---RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--------- 124
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-- 181
                     K+ ++ RQ  +G+D+LH+  IIHRDLK  N+ +     +KI DFGLA   
Sbjct: 125 ----------KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEK 174
Query: 182 -----TFDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEM 225
                +  ++ +  S+   LW  APE++       Y    D+++ G V+ E+
Sbjct: 175 SRWSGSHQFEQLSGSI---LWM-APEVIRMQDKNPYSFQSDVYAFGIVLYEL 222

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 30  IGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V +   +  +N    VA+K  +     D +    L+E   ++Q   F+HP+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQ---FDHPHI 75
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   VI +N         V++I E     +L S+++      L  + +     Q+   +
Sbjct: 76  VKLIGVITEN--------PVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTAL 126
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV--VVTLWYRAPEIL 204
            +L S R +HRD+  +N+L++    +K+ DFGL++  +      +    + + + APE +
Sbjct: 127 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 186
Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
               + +  D+W  G  M E+
Sbjct: 187 NFRRFTSASDVWMFGVCMWEI 207

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 30  IGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V +   +  +N    VA+K  +     D +    L+E   ++Q   F+HP+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQ---FDHPHI 73
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   VI +N         V++I E     +L S+++      L  + +     Q+   +
Sbjct: 74  VKLIGVITEN--------PVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTAL 124
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV--VVTLWYRAPEIL 204
            +L S R +HRD+  +N+L++    +K+ DFGL++  +      +    + + + APE +
Sbjct: 125 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 184
Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
               + +  D+W  G  M E+
Sbjct: 185 NFRRFTSASDVWMFGVCMWEI 205

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 30  IGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V +   +  +N    VA+K  +     D +    L+E   ++Q   F+HP+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQ---FDHPHI 101
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   VI +N         V++I E     +L S+++      L  + +     Q+   +
Sbjct: 102 VKLIGVITEN--------PVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTAL 152
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV--VVTLWYRAPEIL 204
            +L S R +HRD+  +N+L++    +K+ DFGL++  +      +    + + + APE +
Sbjct: 153 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 212
Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
               + +  D+W  G  M E+
Sbjct: 213 NFRRFTSASDVWMFGVCMWEI 233

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 112/242 (46%), Gaps = 31/242 (12%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST---LREISILKQLDTFEHP 85
           ++G G +G V+        G Y    K+ VK  + G  MS    L E +++K   T +H 
Sbjct: 19  KLGAGQFGEVWM-------GYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMK---TLQHD 67
Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLK 144
            +VR + V+ +          +Y+I E + +  L  +++      +   K+ + + Q+ +
Sbjct: 68  KLVRLYAVVTKE-------EPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 120
Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRAP 201
           G+ ++     IHRDL+  N+L++ +   KIADFGLA+     +Y     +     W  AP
Sbjct: 121 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAP 179
Query: 202 EILLNLG-YGTPVDIWSIGCVMAEM--WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           E  +N G +    ++WS G ++ E+  +  +P +   T  + +  + +    P M   P+
Sbjct: 180 EA-INFGCFTIKSNVWSFGILLYEIVTYGKIP-YPGRTNADVMSALSQGYRMPRMENCPD 237
Query: 259 NI 260
            +
Sbjct: 238 EL 239

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 51/232 (21%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++ D +     +IG G++GTV+K +   +    VA+K L V         +   E+ 
Sbjct: 28  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVG 83
Query: 75  ILKQLDTFEHPNIVRFFD--------VIHQNILSDERYLTVYLI---FEHVDQDLGSYME 123
           +L++     H NI+ F          ++ Q       Y  +++I   FE +         
Sbjct: 84  VLRKT---RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--------- 131
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-- 181
                     K+ ++ RQ  +G+D+LH+  IIHRDLK  N+ +     +KI DFGLA   
Sbjct: 132 ----------KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 181
Query: 182 -----TFDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEM 225
                +  ++ +  S+   LW  APE++       Y    D+++ G V+ E+
Sbjct: 182 SRWSGSHQFEQLSGSI---LWM-APEVIRMQDKNPYSFQSDVYAFGIVLYEL 229

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 30  IGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V +   +  +N    VA+K  +     D +    L+E   ++Q   F+HP+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQ---FDHPHI 78
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   VI +N         V++I E     +L S+++      L  + +     Q+   +
Sbjct: 79  VKLIGVITEN--------PVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTAL 129
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV--VVTLWYRAPEIL 204
            +L S R +HRD+  +N+L++    +K+ DFGL++  +      +    + + + APE +
Sbjct: 130 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 189
Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
               + +  D+W  G  M E+
Sbjct: 190 NFRRFTSASDVWMFGVCMWEI 210

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 30  IGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V +   +  +N    VA+K  +     D +    L+E   ++Q   F+HP+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQ---FDHPHI 76
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   VI +N         V++I E     +L S+++      L  + +     Q+   +
Sbjct: 77  VKLIGVITEN--------PVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTAL 127
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV--VVTLWYRAPEIL 204
            +L S R +HRD+  +N+L++    +K+ DFGL++  +      +    + + + APE +
Sbjct: 128 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 187
Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
               + +  D+W  G  M E+
Sbjct: 188 NFRRFTSASDVWMFGVCMWEI 208

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 74
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVY-----LIFEHVDQDLGSYMEKCPPPGLSAS 133
           + + ++P++ R   +   + +     L  +      + EH D     Y+           
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL----------- 123
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLT 190
                  Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + +    
Sbjct: 124 --LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 181
Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
              V + + A E +L+  Y    D+WS G  + E+
Sbjct: 182 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 216

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 71
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVY-----LIFEHVDQDLGSYMEKCPPPGLSAS 133
           + + ++P++ R   +   + +     L  +      + EH D     Y+           
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL----------- 120
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLT 190
                  Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + +    
Sbjct: 121 --LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178
Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
              V + + A E +L+  Y    D+WS G  + E+
Sbjct: 179 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 213

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 30  IGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V +   +  +N    VA+K  +     D +    L+E   ++Q   F+HP+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQ---FDHPHI 453
Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   VI +N         V++I E     +L S+++      L  + +     Q+   +
Sbjct: 454 VKLIGVITEN--------PVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTAL 504
Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV--VVTLWYRAPEIL 204
            +L S R +HRD+  +N+L++    +K+ DFGL++  +      +    + + + APE +
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 564
Query: 205 LNLGYGTPVDIWSIGCVMAEM 225
               + +  D+W  G  M E+
Sbjct: 565 NFRRFTSASDVWMFGVCMWEI 585

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVY-----LIFEHVDQDLGSYMEKCPPPGLSAS 133
           + + ++P++ R   +   + +     L  +      + EH D     Y+           
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL----------- 122
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLT 190
                  Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + +    
Sbjct: 123 --LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
              V + + A E +L+  Y    D+WS G  + E+
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVY-----LIFEHVDQDLGSYMEKCPPPGLSAS 133
           + + ++P++ R   +   + +     L  +      + EH D     Y+           
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL----------- 121
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLT 190
                  Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + +    
Sbjct: 122 --LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179
Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
              V + + A E +L+  Y    D+WS G  + E+
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVY-----LIFEHVDQDLGSYMEKCPPPGLSAS 133
           + + ++P++ R   +   + +     L  +      + EH D     Y+           
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL----------- 119
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLT 190
                  Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + +    
Sbjct: 120 --LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
              V + + A E +L+  Y    D+WS G  + E+
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 51/232 (21%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++ D +     +IG G++GTV+K +   +    VA+K L V         +   E+ 
Sbjct: 29  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 75  ILKQLDTFEHPNIVRFFD--------VIHQNILSDERYLTVYLI---FEHVDQDLGSYME 123
           +L++     H NI+ F          ++ Q       Y  +++I   FE +         
Sbjct: 85  VLRKT---RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--------- 132
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-- 181
                     K+ ++ RQ  +G+D+LH+  IIHRDLK  N+ +     +KI DFGLA   
Sbjct: 133 ----------KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 182
Query: 182 -----TFDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEM 225
                +  ++ +  S+   LW  APE++       Y    D+++ G V+ E+
Sbjct: 183 SRWSGSHQFEQLSGSI---LWM-APEVIRMQDKNPYSFQSDVYAFGIVLYEL 230

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 51/232 (21%)
Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
           D  ++ D +     +IG G++GTV+K +   +    VA+K L V         +   E+ 
Sbjct: 29  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVG 84
Query: 75  ILKQLDTFEHPNIVRFFD--------VIHQNILSDERYLTVYLI---FEHVDQDLGSYME 123
           +L++     H NI+ F          ++ Q       Y  +++I   FE +         
Sbjct: 85  VLRKT---RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--------- 132
Query: 124 KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-- 181
                     K+ ++ RQ  +G+D+LH+  IIHRDLK  N+ +     +KI DFGLA   
Sbjct: 133 ----------KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEK 182
Query: 182 -----TFDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEM 225
                +  ++ +  S+   LW  APE++       Y    D+++ G V+ E+
Sbjct: 183 SRWSGSHQFEQLSGSI---LWM-APEVIRMQDKNPYSFQSDVYAFGIVLYEL 230

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G GA+GTV+K   +  +G  V +      LNE   P + +  +     + + +HP++VR
Sbjct: 23  LGSGAFGTVYKGIWVP-EGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 90  FFDVIHQNILSDERYLTVYL---------IFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
              V     LS    L   L         + EH D ++GS +            +     
Sbjct: 82  LLGVC----LSPTIQLVTQLMPHGCLLEYVHEHKD-NIGSQL------------LLNWCV 124
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV---VVTLW 197
           Q+ KG+ +L   R++HRDL  +N+L+     +KI DFGLA+  + D    +     + + 
Sbjct: 125 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 184
Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           + A E +    +    D+WS G  + E+
Sbjct: 185 WMALECIHYRKFTHQSDVWSYGVTIWEL 212

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 71
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVY-----LIFEHVDQDLGSYMEKCPPPGLSAS 133
           + + ++P++ R   +   + +     L  +      + EH D     Y+           
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYL----------- 120
Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLT 190
                  Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + +    
Sbjct: 121 --LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178
Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
              V + + A E +L+  Y    D+WS G  + E+
Sbjct: 179 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 213

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/193 (22%), Positives = 78/193 (40%), Gaps = 24/193 (12%)
Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           + + +   +DFLH+  I HRDLKP+N+L     +   +KI DFGL      +   + +  
Sbjct: 116 VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIST 175
Query: 195 --------TLWYRAPEILLNLG-----YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL 241
                   +  Y APE++         Y    D+WS+G ++  +    P F      +  
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD-- 233
Query: 242 KCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADR 301
                  G       P   ++++ S ++         +      A  L+  +L  +   R
Sbjct: 234 ------CGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQR 287
Query: 302 ISAADALEHPYFK 314
           +SAA  L+HP+ +
Sbjct: 288 LSAAQVLQHPWVQ 300

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 110/249 (44%), Gaps = 35/249 (14%)
Query: 29  QIGCGAYGTVFKAR--DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           ++G GA+G VF A   +L    + + +    +K           RE  +L  L   +H +
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL---QHEH 78
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG--------------LS 131
           IV+F+ V             + ++FE++   DL  ++    P                L 
Sbjct: 79  IVKFYGVCGDGD-------PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 132 ASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYDMM 188
            S++  +  Q+  G+ +L S   +HRDL  +N L+     +KI DFG+++   + DY  +
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL--VPLFCASTEVEQLKCIF- 245
               ++ + +  PE ++   + T  D+WS G ++ E++     P F  S   E ++CI  
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-TEVIECITQ 250
Query: 246 -RVIGTPSM 253
            RV+  P +
Sbjct: 251 GRVLERPRV 259

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 20/205 (9%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G GA   VF+ R  +  G+  A+K          + +  +RE  +LK+L+   H NIV+
Sbjct: 17  LGQGATANVFRGRH-KKTGDLFAIKVFNNISFLRPVDVQ-MREFEVLKKLN---HKNIVK 71
Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFL 149
            F +  +   +  R+  + + F           E     GL  S+   + R ++ G++ L
Sbjct: 72  LFAIEEE---TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 150 HSHRIIHRDLKPQNLL--ITRAGG--LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL 205
             + I+HR++KP N++  I   G    K+ DFG A+  + D     +  T  Y  P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYE 188
Query: 206 NL--------GYGTPVDIWSIGCVM 222
                      YG  VD+WSIG   
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTF 213

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 30  IGCGAYGTVFKARDLQNKGN---YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G +G V     L+  G    +VA+K L+    E       L E SI+ Q   F+HPN
Sbjct: 15  IGAGEFGEVCSGH-LKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQ---FDHPN 69
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           ++    V+ ++         V +I E ++   L S++ +      +  ++  + R +  G
Sbjct: 70  VIHLEGVVTKST-------PVMIITEFMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIAAG 121
Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVV---VTLWYR 199
           + +L     +HR L  +N+L+      K++DFGL++  + D      TS +   + + + 
Sbjct: 122 MKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 200 APEILLNLGYGTPVDIWSIGCVMAEM 225
           APE +    + +  D+WS G VM E+
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEV 207

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 27/166 (16%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G GA+GTV+K   +  +G  V +      LNE   P + +  +     + + +HP++VR
Sbjct: 46  LGSGAFGTVYKGIWVP-EGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 90  FFDVIHQNILSDERYLTVYL---------IFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
              V     LS    L   L         + EH D ++GS +            +     
Sbjct: 105 LLGVC----LSPTIQLVTQLMPHGCLLEYVHEHKD-NIGSQL------------LLNWCV 147
Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
           Q+ KG+ +L   R++HRDL  +N+L+     +KI DFGLA+  + D
Sbjct: 148 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 193

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 32/207 (15%)
Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G++G V +  D Q  G   A+KK+R+++           E+     L +   P IV
Sbjct: 81  RLGRGSFGEVHRMEDKQT-GFQCAVKKVRLEVFR-------AEELMACAGLTS---PRIV 129
Query: 89  RFFDVIHQNILSDERYLTVYL-IFEHVDQDLGSYMEK--CPPPGLSASKVKELTRQMLKG 145
             +  + +       ++ +++ + E     LG  +++  C    L   +      Q L+G
Sbjct: 130 PLYGAVREGP-----WVNIFMELLE--GGSLGQLVKEQGC----LPEDRALYYLGQALEG 178
Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYDMMLTSVVV------TLWY 198
           +++LHS RI+H D+K  N+L++  G    + DFG A     D +   ++       T  +
Sbjct: 179 LEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETH 238
Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEM 225
            APE++L       VD+WS  C+M  M
Sbjct: 239 MAPEVVLGRSCDAKVDVWSSCCMMLHM 265

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 41/243 (16%)
Query: 16  SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISI 75
           SLDL + K  EL  IG G YG V+K   L  +   VA+K       ++ I    +  + +
Sbjct: 9   SLDLDNLKLLEL--IGRGRYGAVYKG-SLDERP--VAVKVFSFANRQNFINEKNIYRVPL 63
Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           +      EH NI RF  V  + + +D R   + ++  + +  L  Y+       +S+ + 
Sbjct: 64  M------EHDNIARFI-VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCR- 115
Query: 136 KELTRQMLKGVDFLHSH---------RIIHRDLKPQNLLITRAGGLKIADFGLA------ 180
             L   + +G+ +LH+           I HRDL  +N+L+   G   I+DFGL+      
Sbjct: 116 --LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 181 ---KTFDYDMMLTSVVVTLWYRAPEIL---LNL----GYGTPVDIWSIGCVMAEMW-RLV 229
              +  + D    S V T+ Y APE+L   +NL         VD++++G +  E++ R  
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 230 PLF 232
            LF
Sbjct: 234 DLF 236

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 9   LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 67
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPPPGL 130
           + + ++P++ R   +    + S  + +T  + F        EH D     Y+        
Sbjct: 68  MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-------- 116
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDM 187
                     Q+ +G+++L   R++HRDL  +N+L+     +KI DFGLAK     + + 
Sbjct: 117 -----LNWCVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 171
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V + + A E +L+  Y    D+WS G  + E+
Sbjct: 172 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 209

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 28/218 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPPPGL 130
           + + ++P++ R   +    + S  + +T  + F        EH D     Y+        
Sbjct: 73  MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-------- 121
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDM 187
                     Q+ KG+++L   R++HRDL  +N+L+     +KI DFG AK     + + 
Sbjct: 122 -----LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 176
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V + + A E +L+  Y    D+WS G  + E+
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 28/218 (12%)
Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           L + ++ ++  +G GA+GTV+K   +  +G  V +     +L E   P +    +     
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF--------EHVDQDLGSYMEKCPPPGL 130
           + + ++P++ R   +    + S  + +T  + F        EH D     Y+        
Sbjct: 71  MASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-------- 119
Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDM 187
                     Q+ KG+++L   R++HRDL  +N+L+     +KI DFG AK     + + 
Sbjct: 120 -----LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEY 174
Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                 V + + A E +L+  Y    D+WS G  + E+
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 23/213 (10%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ---LDTFEHPN 86
           +G GA+G V++    Q  G       L+V +       S   E+  L +   +  F H N
Sbjct: 55  LGHGAFGEVYEG---QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 111
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL-----TRQ 141
           IVR   V  Q++    R++ + L+      DL S++ +  P     S +  L      R 
Sbjct: 112 IVRCIGVSLQSL---PRFILLELM---AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 165
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTF---DYDMMLTSVVVT 195
           +  G  +L  +  IHRD+  +N L+T  G     KI DFG+A+      Y       ++ 
Sbjct: 166 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 225
Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + +  PE  +   + +  D WS G ++ E++ L
Sbjct: 226 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 258

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 23/213 (10%)
Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ---LDTFEHPN 86
           +G GA+G V++    Q  G       L+V +       S   E+  L +   +  F H N
Sbjct: 45  LGHGAFGEVYEG---QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 101
Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL-----TRQ 141
           IVR   V  Q++    R++ + L+      DL S++ +  P     S +  L      R 
Sbjct: 102 IVRCIGVSLQSL---PRFILLELM---AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 155
Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTF---DYDMMLTSVVVT 195
           +  G  +L  +  IHRD+  +N L+T  G     KI DFG+A+      Y       ++ 
Sbjct: 156 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 215
Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
           + +  PE  +   + +  D WS G ++ E++ L
Sbjct: 216 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 248
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	321
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-154
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-151
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-139
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-134
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-134
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-133
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-131
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-131
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-130
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-130
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-129
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-128
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-127
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-112
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-109
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-107
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-101
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-99
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-97
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-96
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-94
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-91
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-90
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-89
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-89
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-89
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-88
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-88
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-88
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-83
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-80
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-73
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-70
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-68
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-67
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-67
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-67
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-67
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-66
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-66
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-64
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-62
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-62
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-62
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-62
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-61
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-61
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	8e-61
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-59
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-58
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-58
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-58
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-58
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-57
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-57
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-57
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-57
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-57
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-57
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-57
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-57
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-57
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-56
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-56
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-56
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-56
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-56
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-56
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-56
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-55
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-55
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-55
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-55
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-55
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-55
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-55
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-55
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-54
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-54
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-54
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-54
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-54
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-54
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-54
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-53
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-53
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-53
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-53
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-53
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-53
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-52
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-52
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-52
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-52
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-51
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-51
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-51
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-50
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-50
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-49
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-47
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-46
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-46
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-46
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-45
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-45
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-45
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-45
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-45
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-45
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-44
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-44
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-44
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-43
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-43
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-43
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-43
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-42
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-42
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-42
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-42
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-42
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-42
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-41
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-41
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-41
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-41
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-40
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-40
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-38
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-38
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-38
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-38
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-36
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-36
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-35
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-34
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-34
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-33
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-33
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-33
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-33
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-33
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-33
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-33
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-32
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-32
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-32
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-32
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-31
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-30
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-30
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-30
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-30
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-30
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-29
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-29
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-28
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-28
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-28
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-28
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-28
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-28
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-28
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-28
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-28
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-27
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-27
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-27
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-26
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-25
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-25
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-25
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-24
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-24
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-24
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-24
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-23
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-23
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-23
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-23
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-23
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-22
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-22
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-22
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-22
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-22
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-22
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-22
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-21
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-21
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-21
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-21
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-21
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-21
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-21
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-21
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-20
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-20
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-20
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-20
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-19
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-19
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-18
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-18
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-18
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-17
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-17
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-16
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-16
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-16
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-15
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-13
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-04

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  433 bits (1115), Expect = e-154
 Identities = 151/293 (51%), Positives = 209/293 (71%), Gaps = 2/293 (0%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+  E+G+P+ST+RE+++L+ L+TF
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           EHPN+VR FDV   +    E    + L+FEHVDQDL +Y++K P PG+    +K++  Q+
Sbjct: 72  EHPNVVRLFDVCTVSRTDRET--KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPE 202
           L+G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTSVVVTLWYRAPE
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 189

Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
           +LL   Y TPVD+WS+GC+ AEM+R  PLF  S++V+QL  I  VIG P   +WP +++L
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249

Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
              +F   S         D       LL   LTFNPA RISA  AL HPYF++
Sbjct: 250 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  426 bits (1097), Expect = e-151
 Identities = 148/301 (49%), Positives = 207/301 (68%), Gaps = 6/301 (1%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG---IPMSTLREISILKQL 79
           +Y+ + +IG GAYGTV+KARD  + G++VA+K +RV     G   +P+ST+RE+++L++L
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHS-GHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68

Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT 139
           + FEHPN+VR  DV   +    E  + V L+FEHVDQDL +Y++K PPPGL A  +K+L 
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDRE--IKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
           RQ L+G+DFLH++ I+HRDLKP+N+L+T  G +K+ADFGLA+ + Y M LT VVVTLWYR
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR 186

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           APE+LL   Y TPVD+WS+GC+ AEM+R  PLFC ++E +QL  IF +IG P  ++WP +
Sbjct: 187 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246

Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE 319
           +SL   +F         ++  +       LL  MLTFNP  RISA  AL+H Y  + E  
Sbjct: 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGN 306

Query: 320 P 320
           P
Sbjct: 307 P 307

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  383 bits (985), Expect = e-134
 Identities = 131/300 (43%), Positives = 178/300 (59%), Gaps = 21/300 (7%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY  L +IG G YG V+KA++  N G   A+KK+R++  ++GIP +T+REISILK+L  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKELK- 58

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             H NIV+ +DVIH           + L+FEH+DQDL   ++ C    L +   K    Q
Sbjct: 59  --HSNIVKLYDVIHTK-------KRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQ 108

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRA 200
           +L G+ + H  R++HRDLKPQNLLI R G LKIADFGLA+ F   +   T  +VTLWYRA
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168

Query: 201 PEILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           P++L  +G   Y T +DIWS+GC+ AEM    PLF   +E +QL  IFR++GTP+   WP
Sbjct: 169 PDVL--MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 258 ENISLMW--SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
               L     +F  Y  + + +           LL  ML  +P  RI+A  ALEH YFKE
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  381 bits (981), Expect = e-134
 Identities = 134/301 (44%), Positives = 188/301 (62%), Gaps = 22/301 (7%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY +L ++G G YG V+KA+D  ++G  VA+K++R+   ++GIP + +REIS+LK+L  
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKD--SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH- 77

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             HPNIV   DVIH           + L+FE +++DL   +++     L  S++K    Q
Sbjct: 78  --HPNIVSLIDVIHSE-------RCLTLVFEFMEKDLKKVLDENKTG-LQDSQIKIYLYQ 127

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRA 200
           +L+GV   H HRI+HRDLKPQNLLI   G LK+ADFGLA+ F   +   T  VVTLWYRA
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187

Query: 201 PEILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           P++L  +G   Y T VDIWSIGC+ AEM    PLF   T+ +QL  IF ++GTP+  EWP
Sbjct: 188 PDVL--MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245

Query: 258 ENISLMW---SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           +   L      +F+ + K  +S+I    C +   LL +ML F+P  RISA DA+ HPYFK
Sbjct: 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305

Query: 315 E 315
           +
Sbjct: 306 D 306

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  378 bits (974), Expect = e-133
 Identities = 125/301 (41%), Positives = 181/301 (60%), Gaps = 21/301 (6%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY++L +IG G YGTVFKA++ +     VA+K++R+  +++G+P S LREI +LK+L  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRET-HEIVALKRVRLDDDDEGVPSSALREICLLKELK- 59

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             H NIVR  DV+H +         + L+FE  DQDL  Y + C    L    VK    Q
Sbjct: 60  --HKNIVRLHDVLHSD-------KKLTLVFEFCDQDLKKYFDSCNGD-LDPEIVKSFLFQ 109

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRA 200
           +LKG+ F HS  ++HRDLKPQNLLI R G LK+A+FGLA+ F   +   ++ VVTLWYR 
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169

Query: 201 PEILLNLG---YGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRVIGTPSMNEW 256
           P++L   G   Y T +D+WS GC+ AE+     PLF  +   +QLK IFR++GTP+  +W
Sbjct: 170 PDVL--FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227

Query: 257 PENISL-MWSSFEQY-SKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           P    L  +  +  Y +  +   +     +    LL+++L  NP  RISA +AL+HPYF 
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

Query: 315 E 315
           +
Sbjct: 288 D 288

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  375 bits (966), Expect = e-131
 Identities = 124/310 (40%), Positives = 175/310 (56%), Gaps = 27/310 (8%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +Y  + ++G G YG V+KA D       VA+K++R++  E+G+P + +RE+S+LK+L   
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVT-NETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-- 91

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            H NI+    VIH N         ++LIFE+ + DL  YM+K P   +S   +K    Q+
Sbjct: 92  -HRNIIELKSVIHHN-------HRLHLIFEYAENDLKKYMDKNPD--VSMRVIKSFLYQL 141

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRA-----GGLKIADFGLAKTFDYDM-MLTSVVVTL 196
           + GV+F HS R +HRDLKPQNLL++ +       LKI DFGLA+ F   +   T  ++TL
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201

Query: 197 WYRAPEILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
           WYR PEILL  G   Y T VDIWSI C+ AEM    PLF   +E++QL  IF V+G P  
Sbjct: 202 WYRPPEILL--GSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259

Query: 254 NEWPENISLMW--SSFEQYSKVAFSAIFMDCCS-KANSLLESMLTFNPADRISAADALEH 310
             WP   +L     SF ++       +       +   LL +ML  +P  RISA +ALEH
Sbjct: 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319

Query: 311 PYFKEKENEP 320
           PYF   + +P
Sbjct: 320 PYFSHNDFDP 329

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  375 bits (965), Expect = e-131
 Identities = 121/308 (39%), Positives = 175/308 (56%), Gaps = 29/308 (9%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           ++ +L ++G G Y TV+K  +    G YVA+K++++  +E+G P + +REIS++K+L   
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTT-GVYVALKEVKLD-SEEGTPSTAIREISLMKELK-- 61

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP----PPGLSASKVKEL 138
            H NIVR +DVIH           + L+FE +D DL  YM+       P GL  + VK  
Sbjct: 62  -HENIVRLYDVIHTE-------NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLW 197
             Q+L+G+ F H ++I+HRDLKPQNLLI + G LK+ DFGLA+ F   +   +S VVTLW
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLW 173

Query: 198 YRAPEILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
           YRAP++L  +G   Y T +DIWS GC++AEM    PLF  + + EQLK IF ++GTP+ +
Sbjct: 174 YRAPDVL--MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231

Query: 255 EWPENISLMW--SSFEQYSKVAFSAIFMD-----CCSKANSLLESMLTFNPADRISAADA 307
            WP    L     + +Q        +                L  +L  NP  R+SA  A
Sbjct: 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291

Query: 308 LEHPYFKE 315
           L HP+F E
Sbjct: 292 LHHPWFAE 299

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  374 bits (964), Expect = e-130
 Identities = 110/303 (36%), Positives = 169/303 (55%), Gaps = 22/303 (7%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE---DGIPMSTLREISILKQ 78
           K+Y++L  +G G + TV+KARD       VA+KK+++       DGI  + LREI +L++
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNT-NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68

Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
           L    HPNI+   D              + L+F+ ++ DL   ++      L+ S +K  
Sbjct: 69  LS---HPNIIGLLDAFGHK-------SNISLVFDFMETDLEVIIKDNSLV-LTPSHIKAY 117

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLTSVVVTLW 197
               L+G+++LH H I+HRDLKP NLL+   G LK+ADFGLAK+F   +   T  VVT W
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRW 177

Query: 198 YRAPEILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
           YRAPE+L   G   YG  VD+W++GC++AE+   VP     ++++QL  IF  +GTP+  
Sbjct: 178 YRAPELL--FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235

Query: 255 EWPENISL-MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
           +WP+  SL  + +F+ +  +    IF         L++ +  FNP  RI+A  AL+  YF
Sbjct: 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295

Query: 314 KEK 316
             +
Sbjct: 296 SNR 298

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  372 bits (958), Expect = e-130
 Identities = 116/301 (38%), Positives = 172/301 (57%), Gaps = 22/301 (7%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + Y +L ++G G Y TV+K +      N VA+K++R++ +E+G P + +RE+S+LK L  
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLT-DNLVALKEIRLE-HEEGAPCTAIREVSLLKDLK- 58

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             H NIV   D+IH          ++ L+FE++D+DL  Y++ C    ++   VK    Q
Sbjct: 59  --HANIVTLHDIIHTE-------KSLTLVFEYLDKDLKQYLDDCGNI-INMHNVKLFLFQ 108

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRA 200
           +L+G+ + H  +++HRDLKPQNLLI   G LK+ADFGLA+          + VVTLWYR 
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRP 168

Query: 201 PEILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           P+IL  LG   Y T +D+W +GC+  EM    PLF  ST  EQL  IFR++GTP+   WP
Sbjct: 169 PDIL--LGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 258 ENISLMW---SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
             +S       ++ +Y   A  +      S    LL  +L F   +RISA DA++HP+F 
Sbjct: 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286

Query: 315 E 315
            
Sbjct: 287 S 287

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  369 bits (950), Expect = e-129
 Identities = 100/299 (33%), Positives = 154/299 (51%), Gaps = 18/299 (6%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY+++ +IG G+YG VFK R+    G  VA+KK     ++  I    LREI +LKQL   
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDT-GQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-- 60

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            HPN+V   +V  +          ++L+FE+ D  +   +++    G+    VK +T Q 
Sbjct: 61  -HPNLVNLLEVFRRK-------RRLHLVFEYCDHTVLHELDRYQR-GVPEHLVKSITWQT 111

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAP 201
           L+ V+F H H  IHRD+KP+N+LIT+   +K+ DFG A+            V T WYR+P
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171

Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           E+L+    YG PVD+W+IGCV AE+   VPL+   ++V+QL  I + +G           
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231

Query: 261 SL-MWSSFEQ---YSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           +   +S  +             F +    A  LL+  L  +P +R++    L HPYF+ 
Sbjct: 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  367 bits (945), Expect = e-128
 Identities = 107/308 (34%), Positives = 165/308 (53%), Gaps = 21/308 (6%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY++L +IG G +G VFKAR  +  G  VA+KK+ ++  ++G P++ LREI IL+ L   
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKT-GQKVALKKVLMENEKEGFPITALREIKILQLLK-- 74

Query: 83  EHPNIVRFFDVIHQNILSDERYL-TVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            H N+V   ++         R   ++YL+F+  + DL   +        + S++K + + 
Sbjct: 75  -HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQM 132

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY-----DMMLTSVVVTL 196
           +L G+ ++H ++I+HRD+K  N+LITR G LK+ADFGLA+ F           T+ VVTL
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192

Query: 197 WYRAPEILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
           WYR PE+L  LG   YG P+D+W  GC+MAEMW   P+   +TE  QL  I ++ G+ + 
Sbjct: 193 WYRPPELL--LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250

Query: 254 NEWPENISLMWS---SFEQYSKVAFSAIFMDCC--SKANSLLESMLTFNPADRISAADAL 308
             WP   +          +  K               A  L++ +L  +PA RI + DAL
Sbjct: 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310

Query: 309 EHPYFKEK 316
            H +F   
Sbjct: 311 NHDFFWSD 318

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  366 bits (942), Expect = e-127
 Identities = 95/301 (31%), Positives = 149/301 (49%), Gaps = 22/301 (7%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY+ L  +G G+YG V K R+    G  VA+KK     ++  +    +REI +LKQL   
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDT-GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-- 82

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            H N+V   +V  +           YL+FE VD  +   +E  P  GL    V++   Q+
Sbjct: 83  -HENLVNLLEVCKKK-------KRWYLVFEFVDHTILDDLELFPN-GLDYQVVQKYLFQI 133

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAP 201
           + G+ F HSH IIHRD+KP+N+L++++G +K+ DFG A+T      +    V T WYRAP
Sbjct: 134 INGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193

Query: 202 EILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           E+L  +G   YG  VD+W+IGC++ EM+   PLF   ++++QL  I   +G         
Sbjct: 194 ELL--VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251

Query: 259 NISL-MWSSF---EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
                +++     E   +      +         L +  L  +P  R   A+ L H +F+
Sbjct: 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

Query: 315 E 315
            
Sbjct: 312 M 312

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  330 bits (847), Expect = e-112
 Identities = 106/335 (31%), Positives = 166/335 (49%), Gaps = 53/335 (15%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNK-GNYVAMKKLRVKLNEDGIPMSTLREISILKQL 79
           D    E C++G G YG V+KA+    K     A+K++       GI MS  REI++L++L
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACREIALLREL 75

Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKC-------PPPGLSA 132
               HPN++    V   +         V+L+F++ + DL   ++          P  L  
Sbjct: 76  K---HPNVISLQKVFLSHADRK-----VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127

Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA----GGLKIADFGLAKTFDYDM- 187
             VK L  Q+L G+ +LH++ ++HRDLKP N+L+       G +KIAD G A+ F+  + 
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187

Query: 188 ---MLTSVVVTLWYRAPEILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEV--- 238
               L  VVVT WYRAPE+L  LG   Y   +DIW+IGC+ AE+    P+F    E    
Sbjct: 188 PLADLDPVVVTFWYRAPELL--LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 245

Query: 239 ------EQLKCIFRVIGTPSMNEWPENISLMW--SSFEQYSKVAFS---------AIFMD 281
                 +QL  IF V+G P+  +W +   +    +  + + +  ++            + 
Sbjct: 246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVK 305

Query: 282 CCSKANSLLESMLTFNPADRISAADALEHPYFKEK 316
             SKA  LL+ +LT +P  RI++  A++ PYF E 
Sbjct: 306 PDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED 340

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  321 bits (825), Expect = e-109
 Identities = 98/302 (32%), Positives = 156/302 (51%), Gaps = 20/302 (6%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
           +  Y     IG G++G VF+A+ +++  + VA+KK  V  ++        RE+ I++ + 
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVES--DEVAIKK--VLQDKR----FKNRELQIMRIVK 90

Query: 81  TFEHPNIVRFFDVIHQNI-LSDERYLTVYLIFEHVDQDLGSYMEKCPPPG--LSASKVKE 137
              HPN+V      + N    DE +L   L+ E+V + +             +    +K 
Sbjct: 91  ---HPNVVDLKAFFYSNGDKKDEVFL--NLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTSVVVTL 196
              Q+L+ + ++HS  I HRD+KPQNLL+   +G LK+ DFG AK         S + + 
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR 205

Query: 197 WYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           +YRAPE++     Y T +DIWS GCVMAE+ +  PLF   + ++QL  I +V+GTPS  +
Sbjct: 206 YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265

Query: 256 WPE-NISLMWSSFEQYSKVAFSAIFM-DCCSKANSLLESMLTFNPADRISAADALEHPYF 313
               N + M   F Q     FS +F       A  L+  +L + P+ R++A +AL HP+F
Sbjct: 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

Query: 314 KE 315
            E
Sbjct: 326 DE 327

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  319 bits (819), Expect = e-107
 Identities = 91/302 (30%), Positives = 150/302 (49%), Gaps = 19/302 (6%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
           +  Y +   IG G++G V++A+   + G  VA+KK+     +D       RE+ I+++LD
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL----QD--KRFKNRELQIMRKLD 105

Query: 81  TFEHPNIVRFFDVIHQNILS-DERYLTVYLIFEHVDQDLGSYMEKCPPPG--LSASKVKE 137
              H NIVR     + +    DE YL   L+ ++V + +             L    VK 
Sbjct: 106 ---HCNIVRLRYFFYSSGEKKDEVYL--NLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 160

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA-GGLKIADFGLAKTFDYDMMLTSVVVTL 196
              Q+ + + ++HS  I HRD+KPQNLL+      LK+ DFG AK         S + + 
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220

Query: 197 WYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           +YRAPE++     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GTP+  +
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280

Query: 256 WPE-NISLMWSSFEQYSKVAFSAIFM-DCCSKANSLLESMLTFNPADRISAADALEHPYF 313
             E N +     F Q     ++ +F      +A +L   +L + P  R++  +A  H +F
Sbjct: 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340

Query: 314 KE 315
            E
Sbjct: 341 DE 342

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  300 bits (771), Expect = e-101
 Identities = 92/305 (30%), Positives = 140/305 (45%), Gaps = 18/305 (5%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
            ++      G G +GTV   ++    G  VA+KK+     +D  P    RE+ I++ L  
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKST-GMSVAIKKVI----QD--PRFRNRELQIMQDLAV 75

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG--LSASKVKELT 139
             HPNIV+     +     D R + + ++ E+V   L                  +K   
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 140 RQMLKGVDFLH--SHRIIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYDMMLTSVVVTL 196
            Q+++ +  LH  S  + HRD+KP N+L+  A G LK+ DFG AK         + + + 
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195

Query: 197 WYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           +YRAPE++     Y T VDIWS+GC+ AEM    P+F       QL  I RV+G PS   
Sbjct: 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255

Query: 256 WPE-NISLMWSSFEQYSKVAFSAIFMDCCSKANS----LLESMLTFNPADRISAADALEH 310
             + N S           + +S +F D   K       LL ++L + P +R+   +AL H
Sbjct: 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315

Query: 311 PYFKE 315
           PYF E
Sbjct: 316 PYFDE 320

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  294 bits (755), Expect = 3e-99
 Identities = 83/310 (26%), Positives = 150/310 (48%), Gaps = 34/310 (10%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR-VKLNEDGIPMSTLREISILKQL 79
              Y  + ++G G Y  VF+A ++ N    V +K L+ VK  +        REI IL+ L
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITN-NEKVVVKILKPVKKKK------IKREIKILENL 87

Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKEL 138
                PNI+   D++      D    T  L+FEHV+  D     +      L+   ++  
Sbjct: 88  R--GGPNIITLADIVK-----DPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFY 135

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYDMMLTSVVVTLW 197
             ++LK +D+ HS  I+HRD+KP N++I      L++ D+GLA+ +         V + +
Sbjct: 136 MYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195

Query: 198 YRAPEILLNL-GYGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           ++ PE+L++   Y   +D+WS+GC++A M +R  P F      +QL  I +V+GT  + +
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255

Query: 256 WPENISLMW-----SSFEQYSKVAFSAIF-----MDCCSKANSLLESMLTFNPADRISAA 305
           + +  ++           ++S+  +              +A   L+ +L ++   R++A 
Sbjct: 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 315

Query: 306 DALEHPYFKE 315
           +A+EHPYF  
Sbjct: 316 EAMEHPYFYT 325

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  291 bits (746), Expect = 3e-97
 Identities = 92/332 (27%), Positives = 149/332 (44%), Gaps = 47/332 (14%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
            KKY     +G G++G V +  D+++ G   A+KK+         P    RE+ I+K LD
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIES-GKRFALKKVLQ------DPRYKNRELDIMKVLD 58

Query: 81  TFEHPNIVRFFDVIH-------------------------------QNILSDERYLTVYL 109
              H NI++  D  +                                 I++  +   + +
Sbjct: 59  ---HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 110 IFEHVDQDLGSYMEKCPPPG--LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI- 166
           I E+V   L   ++     G  +  + +     Q+ + V F+HS  I HRD+KPQNLL+ 
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175

Query: 167 TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEM 225
           ++   LK+ DFG AK         + + + +YRAPE++L    Y   +D+WSIGCV  E+
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235

Query: 226 WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE-NISLMWSSFEQYSKVAFSAIFMD-CC 283
               PLF   T ++QL  I +++GTP+  +    N       F       +  I  +   
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP 295

Query: 284 SKANSLLESMLTFNPADRISAADALEHPYFKE 315
           S A  LLE +L + P  RI+  +A+ HP+F  
Sbjct: 296 SLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  291 bits (746), Expect = 3e-96
 Identities = 108/367 (29%), Positives = 159/367 (43%), Gaps = 75/367 (20%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
             +Y+    IG G+YG V +A D       VA+KK+     +       LREI+IL +L+
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLE-KRVVAIKKILRVFEDLIDCKRILREIAILNRLN 110

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
              H ++V+  D++       E++  +Y++ E  D D         P  L+   +K L  
Sbjct: 111 ---HDHVVKVLDIVIPK--DVEKFDELYVVLEIADSDFKKLFRT--PVYLTELHIKTLLY 163

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM------------- 187
            +L GV ++HS  I+HRDLKP N L+ +   +K+ DFGLA+T DY               
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 188 ---------------MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLV-- 229
                           LT  VVT WYRAPE++L    Y   +D+WSIGC+ AE+  ++  
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283

Query: 230 ---------PLF--------------------CASTEVEQLKCIFRVIGTPSMNEWP--- 257
                    PLF                          +QL  IF ++GTPS  +     
Sbjct: 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALE 343

Query: 258 -ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
            E+       F +      +  F    + A  LL+ ML FNP  RI+  + L HP+FKE 
Sbjct: 344 KEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

Query: 316 --KENEP 320
              E E 
Sbjct: 404 RIAEVET 410

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  281 bits (722), Expect = 8e-94
 Identities = 95/318 (29%), Positives = 140/318 (44%), Gaps = 26/318 (8%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMS---------TLR 71
              Y     I  G+YG V    D  ++G  VA+K++   +++                LR
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVD--SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78

Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLS 131
           EI +L       HPNI+   D+       +     +YL+ E +  DL   +       +S
Sbjct: 79  EIRLLNHFH---HPNILGLRDIFVHF--EEPAMHKLYLVTELMRTDLAQVI-HDQRIVIS 132

Query: 132 ASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS 191
              ++     +L G+  LH   ++HRDL P N+L+     + I DF LA+    D   T 
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192

Query: 192 VVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
            V   WYRAPE+++   G+   VD+WS GCVMAEM+    LF  ST   QL  I  V+GT
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252

Query: 251 PSMNEW-----PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA 305
           P + +      P     + +S       A++A+       A  L+  ML FNP  RIS  
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312

Query: 306 DALEHPYFKE---KENEP 320
            AL HPYF+      +  
Sbjct: 313 QALRHPYFESLFDPLDLT 330

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  274 bits (702), Expect = 7e-91
 Identities = 109/323 (33%), Positives = 147/323 (45%), Gaps = 36/323 (11%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMS---TLREISILK 77
              +     +G GAYG V  A      G  VA+KK+         P+    TLREI ILK
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPT-GEIVAIKKIEPFDK----PLFALRTLREIKILK 64

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE 137
                 H NI+  F++   +  S E +  VY+I E +  DL   +       LS   ++ 
Sbjct: 65  HFK---HENIITIFNIQRPD--SFENFNEVYIIQELMQTDLHRVISTQM---LSDDHIQY 116

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---------- 187
              Q L+ V  LH   +IHRDLKP NLLI     LK+ DFGLA+  D             
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 188 -MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIF 245
             +   V T WYRAPE++L    Y   +D+WS GC++AE++   P+F       QL  IF
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236

Query: 246 RVIGTPSMNEWPENIS-----LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD 300
            +IGTP  +     I          S   Y       +F     K   LL+ ML F+PA 
Sbjct: 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296

Query: 301 RISAADALEHPYFKE---KENEP 320
           RI+A +ALEHPY +      +EP
Sbjct: 297 RITAKEALEHPYLQTYHDPNDEP 319

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  272 bits (697), Expect = 1e-90
 Identities = 103/331 (31%), Positives = 161/331 (48%), Gaps = 50/331 (15%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMS-------TLREI 73
             +Y +L  +GCG  G VF A D       VA+KK         I ++        LREI
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDC-DKRVAIKK---------IVLTDPQSVKHALREI 59

Query: 74  SILKQLDTFEHPNIVRFFDVI-------HQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
            I+++LD   H NIV+ F+++         ++ S     +VY++ E+++ DL + +E+ P
Sbjct: 60  KIIRRLD---HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP 116

Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFGLAKTFDY 185
              L     +    Q+L+G+ ++HS  ++HRDLKP NL I      LKI DFGLA+  D 
Sbjct: 117 ---LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173

Query: 186 DM----MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQ 240
                  L+  +VT WYR+P +LL+   Y   +D+W+ GC+ AEM     LF  + E+EQ
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233

Query: 241 LKCIFRVIGTPSMNEWPENISLMWSSFEQY-------SKVAFSAIFMDCCSKANSLLESM 293
           ++ I   I         E+   + S    Y            + +      +A   LE +
Sbjct: 234 MQLILESIPVVH----EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQI 289

Query: 294 LTFNPADRISAADALEHPYFKE---KENEPL 321
           LTF+P DR++A +AL HPY        +EP+
Sbjct: 290 LTFSPMDRLTAEEALSHPYMSIYSFPMDEPI 320

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  270 bits (692), Expect = 2e-89
 Identities = 109/308 (35%), Positives = 151/308 (49%), Gaps = 19/308 (6%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
            K Y     +G GAYG+V  A D ++ G  VA+KKL      +       RE+ +LK + 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRS-GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
              H N++   DV      S   +   YL+   +  DL   M        S  K++ L  
Sbjct: 82  ---HENVIGLLDVFTPA-SSLRNFYDFYLVMPFMQTDLQKIMGL----KFSEEKIQYLVY 133

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           QMLKG+ ++HS  ++HRDLKP NL +     LKI DFGLA+  D +M  T  VVT WYRA
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--TGYVVTRWYRA 191

Query: 201 PEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP-- 257
           PE++L+   Y   VDIWS+GC+MAEM     LF     ++QL  I +V G P        
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251

Query: 258 --ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             +       S  Q  +  F+ +F     +A  LLE ML  +   R++AA AL HP+F+ 
Sbjct: 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311

Query: 316 ---KENEP 320
               E E 
Sbjct: 312 FRDPEEET 319

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  270 bits (692), Expect = 3e-89
 Identities = 115/315 (36%), Positives = 162/315 (51%), Gaps = 28/315 (8%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMS---TLREISILK 77
             +Y  L  IG GAYG V  A D  N    VA+KK+    +          TLREI IL 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLN-KVRVAIKKISPFEH----QTYCQRTLREIKILL 80

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE 137
           +     H NI+   D+I     + E+   VY++ + ++ DL   ++      LS   +  
Sbjct: 81  RFR---HENIIGINDIIR--APTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICY 132

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM----MLTSVV 193
              Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  V
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 194 VTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
            T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+PS
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252

Query: 253 MNEWP----ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL 308
             +              S    +KV ++ +F +  SKA  LL+ MLTFNP  RI    AL
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312

Query: 309 EHPYFKE---KENEP 320
            HPY ++     +EP
Sbjct: 313 AHPYLEQYYDPSDEP 327

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  269 bits (689), Expect = 8e-89
 Identities = 105/318 (33%), Positives = 153/318 (48%), Gaps = 27/318 (8%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
            K+Y  L  IG GA G V  A D       VA+KKL              RE+ ++K ++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
              H NI+   +V      S E +  VY++ E +D +L   ++      L   ++  L  
Sbjct: 83  ---HKNIIGLLNVFTPQ-KSLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLY 134

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M+T  VVT +YRA
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS---MNEWP 257
           PE++L +GY   VDIWS+GC+M EM +   LF  +  ++Q   +   +GTP    M +  
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254

Query: 258 ENISLMWSSFEQYSKVAFSAIFMD------------CCSKANSLLESMLTFNPADRISAA 305
             +     +  +Y+  +F  +F D              S+A  LL  ML  + + RIS  
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314

Query: 306 DALEHPYFKE---KENEP 320
           +AL+HPY           
Sbjct: 315 EALQHPYINVWYDPSEAE 332

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  268 bits (688), Expect = 1e-88
 Identities = 113/308 (36%), Positives = 159/308 (51%), Gaps = 18/308 (5%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
              Y +L  +G GAYG V  A D +  G  VA+KKL      +       RE+ +LK + 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRT-GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
              H N++   DV   +  + + +   YL+   +  DLG  M+      L   +++ L  
Sbjct: 83  ---HENVIGLLDVFTPD-ETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDRIQFLVY 135

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           QMLKG+ ++H+  IIHRDLKP NL +     LKI DFGLA+  D +M  T  VVT WYRA
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--TGYVVTRWYRA 193

Query: 201 PEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP-- 257
           PE++LN   Y   VDIWS+GC+MAEM     LF  S  ++QLK I +V GTP        
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253

Query: 258 --ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             +          +  K  F++I  +    A +LLE ML  +   R++A +AL HPYF+ 
Sbjct: 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313

Query: 316 ---KENEP 320
               E+EP
Sbjct: 314 LHDTEDEP 321

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  271 bits (695), Expect = 1e-88
 Identities = 109/310 (35%), Positives = 153/310 (49%), Gaps = 24/310 (7%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
            K+Y  L  IG GA G V  A D       VA+KKL              RE+ ++K ++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
              H NI+   +V      + E +  VYL+ E +D +L   ++      L   ++  L  
Sbjct: 120 ---HKNIISLLNVFTPQ-KTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLY 171

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           QML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M+T  VVT +YRA
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS---MNEWP 257
           PE++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +GTP    M +  
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291

Query: 258 ENISLMWSSFEQYSKVAFSAIFMD------------CCSKANSLLESMLTFNPADRISAA 305
             +     +  +Y+ + F  +F D              S+A  LL  ML  +PA RIS  
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351

Query: 306 DALEHPYFKE 315
           DAL+HPY   
Sbjct: 352 DALQHPYINV 361

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  266 bits (683), Expect = 7e-88
 Identities = 115/308 (37%), Positives = 161/308 (52%), Gaps = 18/308 (5%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
            ++Y  L  +G GAYG+V  A D +  G  VA+KKL            T RE+ +LK + 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
              H N++   DV      S E +  VYL+   +  DL + ++      L+   V+ L  
Sbjct: 87  ---HENVIGLLDVFTPA-RSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIY 139

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           Q+L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+    +M  T  V T WYRA
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRA 197

Query: 201 PEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP-- 257
           PEI+LN   Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++GTP        
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257

Query: 258 --ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             E+      S  Q  K+ F+ +F+     A  LLE ML  +   RI+AA AL H YF +
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317

Query: 316 ---KENEP 320
               ++EP
Sbjct: 318 YHDPDDEP 325

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  256 bits (657), Expect = 3e-83
 Identities = 107/363 (29%), Positives = 156/363 (42%), Gaps = 75/363 (20%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
              Y     IG G+YG V+ A D       VA+KK+     +       LREI+IL +L 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNT-EKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
                 I+R +D+I  +     ++  +Y++ E  D DL     K P   L+   +K +  
Sbjct: 84  ---SDYIIRLYDLIIPD--DLLKFDELYIVLEIADSDLKKLF-KTPIF-LTEEHIKTILY 136

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM------------- 187
            +L G +F+H   IIHRDLKP N L+ +   +K+ DFGLA+T + +              
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196

Query: 188 ----------MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEM----------- 225
                      LTS VVT WYRAPE++L    Y   +DIWS GC+ AE+           
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256

Query: 226 WRLVPLF-----------------CASTEVEQLKCIFRVIGTPSMNEWPENISLMWS--- 265
               PLF                    +  +QL  IF +IGTP+     +++  +     
Sbjct: 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPT----EDDLKNINKPEV 312

Query: 266 -----SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE---KE 317
                 F     +     +        +LLESML FNP  RI+   AL+HPY K+   K+
Sbjct: 313 IKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372

Query: 318 NEP 320
            E 
Sbjct: 373 LEN 375

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  246 bits (631), Expect = 7e-80
 Identities = 108/350 (30%), Positives = 169/350 (48%), Gaps = 65/350 (18%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
            +KY+ + ++G GAYG V+K+ D +  G  VA+KK+            T REI IL +L 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRT-GEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
              H NIV   +V+       +    VYL+F++++ DL + + +     L     + +  
Sbjct: 67  --GHENIVNLLNVLR-----ADNDRDVYLVFDYMETDLHAVI-RANI--LEPVHKQYVVY 116

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----------------- 183
           Q++K + +LHS  ++HRD+KP N+L+     +K+ADFGL+++F                 
Sbjct: 117 QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 184 -----DYDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
                D   +LT  V T WYRAPEILL    Y   +D+WS+GC++ E+    P+F  S+ 
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236

Query: 238 VEQLKCIFRVIGTPSMNEWPENISLMWS--------SFEQYSKVAFSAIFM--------- 280
           + QL+ I  VI  PS     E++  + S        S ++  ++  S             
Sbjct: 237 MNQLERIIGVIDFPS----NEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292

Query: 281 -------DCCSKANSLLESMLTFNPADRISAADALEHPYFKE---KENEP 320
                  DC  +A  LL+ +L FNP  RISA DAL+HP+         EP
Sbjct: 293 LKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEP 342

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  226 bits (577), Expect = 6e-73
 Identities = 79/308 (25%), Positives = 127/308 (41%), Gaps = 51/308 (16%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
             + E+  IG G +G VFKA+   + G    +K+  VK N         RE+  L +LD 
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRID-GKTYVIKR--VKYNN----EKAEREVKALAKLD- 62

Query: 82  FEHPNIVRFFDVIHQNILSDERYL---------TVYLIFEHVDQ-DLGSYMEKCPPPGLS 131
             H NIV +           E             +++  E  D+  L  ++EK     L 
Sbjct: 63  --HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120

Query: 132 ASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS 191
                EL  Q+ KGVD++HS ++I+RDLKP N+ +     +KI DFGL  +   D   T 
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 192 VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
              TL Y +PE + +  YG  VD++++G ++AE+  +        E  +     R     
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA---FETSKFFTDLRDGIIS 237

Query: 252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
            +                + K            K  +LL+ +L+  P DR + ++ L   
Sbjct: 238 DI----------------FDK------------KEKTLLQKLLSKKPEDRPNTSEILRTL 269

Query: 312 YFKEKENE 319
              +K  E
Sbjct: 270 TVWKKSPE 277

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  220 bits (562), Expect = 2e-70
 Identities = 78/328 (23%), Positives = 134/328 (40%), Gaps = 59/328 (17%)

Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           ++L   S+ +  + Y  L QIG G    VF+  +   K    A+K + ++  ++    S 
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN--EKKQIYAIKYVNLEEADNQTLDSY 73

Query: 70  LREISILKQLDTFEHPN--IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP 127
             EI+ L +L      +  I+R +D         ++Y+  Y++ E  + DL S+++K   
Sbjct: 74  RNEIAYLNKLQ---QHSDKIIRLYDYEI-----TDQYI--YMVMECGNIDLNSWLKKKKS 123

Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM 187
             +   + K   + ML+ V  +H H I+H DLKP N LI   G LK+ DFG+A     D 
Sbjct: 124 --IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180

Query: 188 ---MLTSVVVTLWYRAPEILLN-----------LGYGTPVDIWSIGCVMAEMWRLV--PL 231
              +  S V T+ Y  PE + +                  D+WS+GC++  M        
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM--TYGKTP 238

Query: 232 FCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLE 291
           F     + Q+  +  +I      E+P+                              +L+
Sbjct: 239 F--QQIINQISKLHAIIDPNHEIEFPDIPE----------------------KDLQDVLK 274

Query: 292 SMLTFNPADRISAADALEHPYFKEKENE 319
             L  +P  RIS  + L HPY + + + 
Sbjct: 275 CCLKRDPKQRISIPELLAHPYVQIQTHP 302

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  215 bits (549), Expect = 1e-68
 Identities = 74/322 (22%), Positives = 133/322 (41%), Gaps = 56/322 (17%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
            ++E+  +G GA+G V KAR+  +   Y A+KK  ++  E+ +  + L E+ +L  L+  
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALD-SRYYAIKK--IRHTEEKLS-TILSEVMLLASLN-- 60

Query: 83  EHPNIVRFFDV------IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKV 135
            H  +VR++          + + + ++  T+++  E+ +   L   +           + 
Sbjct: 61  -HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRDEY 118

Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-------- 187
             L RQ+L+ + ++HS  IIHRDLKP N+ I  +  +KI DFGLAK     +        
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 188 -------MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
                   LTS + T  Y A E+L   G Y   +D++S+G +  EM  + P       V 
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--IYPFSTGMERVN 236

Query: 240 QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPA 299
            LK +  V      +             +   K                ++  ++  +P 
Sbjct: 237 ILKKLRSVSIEFPPDFD-----------DNKMK------------VEKKIIRLLIDHDPN 273

Query: 300 DRISAADALEHPYFKEKENEPL 321
            R  A   L   +   K  + +
Sbjct: 274 KRPGARTLLNSGWLPVKHQDEV 295

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  212 bits (542), Expect = 1e-67
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 53/319 (16%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
             ++ +  +G G +G VF+A++  +     A+K++R+   E       +RE+  L +L+ 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVD-DCNYAIKRIRLPNRELAR-EKVMREVKALAKLE- 61

Query: 82  FEHPNIVRFFDVI-----HQNILSDERYLTVYLIFEHVD-QDLGSYM-EKCPPPGLSASK 134
             HP IVR+F+        + +      + +Y+  +    ++L  +M  +C       S 
Sbjct: 62  --HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM------- 187
              +  Q+ + V+FLHS  ++HRDLKP N+  T    +K+ DFGL    D D        
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 188 ------MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL 241
                   T  V T  Y +PE +    Y   VDI+S+G ++ E+  L P       V  L
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--LYPFSTQMERVRTL 237

Query: 242 KCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADR 301
             +          ++P         F Q                   +++ ML+ +P +R
Sbjct: 238 TDVRN-------LKFPP-------LFTQKY------------PCEYVMVQDMLSPSPMER 271

Query: 302 ISAADALEHPYFKEKENEP 320
             A + +E+  F++ +   
Sbjct: 272 PEAINIIENAVFEDLDFPG 290

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  213 bits (544), Expect = 3e-67
 Identities = 76/319 (23%), Positives = 129/319 (40%), Gaps = 59/319 (18%)

Query: 20  GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQL 79
             + Y  L QIG G    VF+  +   K    A+K + ++  ++    S   EI+ L +L
Sbjct: 7   KGRIYSILKQIGSGGSSKVFQVLN--EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL 64

Query: 80  DTFEHPN--IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKE 137
                 +  I+R +D         ++Y+  Y++ E  + DL S+++K     +   + K 
Sbjct: 65  Q---QHSDKIIRLYDYEI-----TDQYI--YMVMECGNIDLNSWLKKKKS--IDPWERKS 112

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVV 194
             + ML+ V  +H H I+H DLKP N LI   G LK+ DFG+A     D    +  S V 
Sbjct: 113 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVG 171

Query: 195 TLWYRAPEILLNLG-----------YGTPVDIWSIGCVMAEMWRLV--PLFCASTEVEQL 241
           T+ Y  PE + ++                 D+WS+GC++  M        F     + Q+
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM--TYGKTPF--QQIINQI 227

Query: 242 KCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADR 301
             +  +I      E+P+                              +L+  L  +P  R
Sbjct: 228 SKLHAIIDPNHEIEFPDIPE----------------------KDLQDVLKCCLKRDPKQR 265

Query: 302 ISAADALEHPYFKEKENEP 320
           IS  + L HPY + + +  
Sbjct: 266 ISIPELLAHPYVQIQTHPV 284

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  212 bits (541), Expect = 3e-67
 Identities = 69/295 (23%), Positives = 113/295 (38%), Gaps = 40/295 (13%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
            + +  L ++G G+YG VFK R  ++ G   A+K+              L E+   +++ 
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKED-GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV- 113

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
             +HP  VR          + E    +YL  E     L  + E      L  ++V    R
Sbjct: 114 -GQHPCCVRLEQ-------AWEEGGILYLQTELCGPSLQQHCEAWGAS-LPEAQVWGYLR 164

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
             L  +  LHS  ++H D+KP N+ +   G  K+ DFGL                  Y A
Sbjct: 165 DTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMA 224

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           PE+L    YGT  D++S+G  + E+   + L       E  + + +    P   E+   +
Sbjct: 225 PELLQG-SYGTAADVFSLGLTILEVACNMELP---HGGEGWQQLRQGYLPP---EFTAGL 277

Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           S                      S+  S+L  ML  +P  R +A   L  P  ++
Sbjct: 278 S----------------------SELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  213 bits (543), Expect = 5e-67
 Identities = 67/298 (22%), Positives = 134/298 (44%), Gaps = 41/298 (13%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRV-KLNEDGIPMSTLREISILKQLD 80
           +KY  L +IG G++G     +  ++ G    +K++ + +++       + RE+++L  + 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTED-GRQYVIKEINISRMSSKER-EESRREVAVLANMK 81

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELT 139
              HPNIV++ +   +N        ++Y++ ++ +  DL   +           ++ +  
Sbjct: 82  ---HPNIVQYRESFEEN-------GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWY 198
            Q+   +  +H  +I+HRD+K QN+ +T+ G +++ DFG+A+  +  + L    + T +Y
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY 191

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
            +PEI  N  Y    DIW++GCV+ E+  L   F A +    +K +   I + S      
Sbjct: 192 LSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS----MKNLVLKIISGSFPPVSL 247

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK 316
           + S                          SL+  +   NP DR S    LE  +  ++
Sbjct: 248 HYS----------------------YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  209 bits (534), Expect = 2e-66
 Identities = 81/308 (26%), Positives = 132/308 (42%), Gaps = 46/308 (14%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRV-KLNEDGIPMSTLREISILKQLD 80
           + Y+ L  IG G+YG   K R   + G  +  K+L    + E       + E+++L++L 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSD-GKILVWKELDYGSMTEAEK-QMLVSEVNLLRELK 63

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG--LSASKVKE 137
              HPNIVR++D I      D    T+Y++ E+ +  DL S + K       L    V  
Sbjct: 64  ---HPNIVRYYDRII-----DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115

Query: 138 LTRQMLKGVDFLHS-----HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV 192
           +  Q+   +   H      H ++HRDLKP N+ +     +K+ DFGLA+  ++D      
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT 175

Query: 193 VV-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
            V T +Y +PE +  + Y    DIWS+GC++ E+  L+P F A ++ E    +   I   
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIREG 231

Query: 252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                P   S                       + N ++  ML      R S  + LE+P
Sbjct: 232 KFRRIPYRYS----------------------DELNEIITRMLNLKDYHRPSVEEILENP 269

Query: 312 YFKEKENE 319
              E  + 
Sbjct: 270 LILEHHHH 277

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  211 bits (540), Expect = 3e-66
 Identities = 77/331 (23%), Positives = 134/331 (40%), Gaps = 55/331 (16%)

Query: 5   SADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG 64
             D   S   + + +  + Y  L QIG G    VF+  +   K    A+K + ++  ++ 
Sbjct: 39  DDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN--EKKQIYAIKYVNLEEADNQ 96

Query: 65  IPMSTLREISILKQLDTFEHPN--IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYM 122
              S   EI+ L +L      +  I+R +D         ++Y+  Y++ E  + DL S++
Sbjct: 97  TLDSYRNEIAYLNKLQ---QHSDKIIRLYDYE-----ITDQYI--YMVMECGNIDLNSWL 146

Query: 123 EKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT 182
           +K     +   + K   + ML+ V  +H H I+H DLKP N LI   G LK+ DFG+A  
Sbjct: 147 KKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ 203

Query: 183 FDYD---MMLTSVVVTLWYRAPEILLNLG-----------YGTPVDIWSIGCVMAEMWRL 228
              D   ++  S V  + Y  PE + ++                 D+WS+GC++  M   
Sbjct: 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263

Query: 229 VPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANS 288
              F     + Q+  +  +I      E+P+                              
Sbjct: 264 KTPF--QQIINQISKLHAIIDPNHEIEFPDIPE----------------------KDLQD 299

Query: 289 LLESMLTFNPADRISAADALEHPYFKEKENE 319
           +L+  L  +P  RIS  + L HPY + + + 
Sbjct: 300 VLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  207 bits (529), Expect = 4e-64
 Identities = 90/341 (26%), Positives = 155/341 (45%), Gaps = 52/341 (15%)

Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           D    +Y+ L  IG G++G V KA D +    +VA+K +R   NE         EI IL+
Sbjct: 93  DHVAYRYEVLKVIGKGSFGQVVKAYDHKV-HQHVALKMVR---NEKRFHRQAAEEIRILE 148

Query: 78  QL---DTFEHPNIVRFFD-VIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSAS 133
            L   D     N++   +    +N +         + FE +  +L   ++K    G S  
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHI--------CMTFELLSMNLYELIKKNKFQGFSLP 200

Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG--GLKIADFGLAKTFDYDMMLTS 191
            V++    +L+ +D LH +RIIH DLKP+N+L+ + G  G+K+ DFG +  +++   + +
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQR-VYT 258

Query: 192 VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
            + + +YRAPE++L   YG P+D+WS+GC++AE+    PL     E +QL C+  ++G P
Sbjct: 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318

Query: 252 SM---------------NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANS-------- 288
           S                  +P   ++   S          +          S        
Sbjct: 319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALK 378

Query: 289 ---------LLESMLTFNPADRISAADALEHPYFKEKENEP 320
                     L+  L ++PA R++   AL HP+ + +  +P
Sbjct: 379 GCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKP 419

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  199 bits (508), Expect = 3e-62
 Identities = 62/313 (19%), Positives = 110/313 (35%), Gaps = 32/313 (10%)

Query: 20  GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISIL 76
            +  +     +G GA   VF+ R  +  G+  A+K    +      D      +RE  +L
Sbjct: 7   SNHLWLLSDILGQGATANVFRGRHKKT-GDLFAIKVFNNISFLRPVDVQ----MREFEVL 61

Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM-EKCPPPGLSASK 134
           K+L+   H NIV+ F +       +       LI E      L + + E     GL  S+
Sbjct: 62  KKLN---HKNIVKLFAIE-----EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG----LKIADFGLAKTFDYDMMLT 190
              + R ++ G++ L  + I+HR++KP N++           K+ DFG A+  + D    
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173

Query: 191 SVVVTLWYRAPEIL--------LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLK 242
           S+  T  Y  P++             YG  VD+WSIG            F       + K
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233

Query: 243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVA--FSAIFMDCCSKANSLLESMLTFNPAD 300
            +   I T   +     +    +    +S       ++          +L ++L  +   
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293

Query: 301 RISAADALEHPYF 313
                        
Sbjct: 294 CWGFDQFFAETSD 306

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  202 bits (516), Expect = 3e-62
 Identities = 78/320 (24%), Positives = 126/320 (39%), Gaps = 62/320 (19%)

Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS 74
             + +G   +     +G GA GT+       N+   VA+K++  +           RE+ 
Sbjct: 17  SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNR--DVAVKRILPECFSF-----ADREVQ 69

Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           +L++ D  EHPN++R+F         D ++   Y+  E     L  Y+E+         +
Sbjct: 70  LLRESD--EHPNVIRYFCTE-----KDRQF--QYIAIELCAATLQEYVEQ-KDFAHLGLE 119

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG-----LKIADFGLAKTFDYDM-- 187
              L +Q   G+  LHS  I+HRDLKP N+LI+           I+DFGL K        
Sbjct: 120 PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179

Query: 188 --MLTSVVVTLWYRAPEIL---LNLGYGTPVDIWSIGCVMAEMWRLV---PLFCASTEVE 239
               + V  T  + APE+L           VDI+S GCV   +  +      F  S + +
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV--ISEGSHPFGKSLQRQ 237

Query: 240 QLKCIFRVIGTPSMN--EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFN 297
                  ++G  S++     ++                          A  L+E M+  +
Sbjct: 238 ----ANILLGACSLDCLHPEKHED----------------------VIARELIEKMIAMD 271

Query: 298 PADRISAADALEHPYFKEKE 317
           P  R SA   L+HP+F   E
Sbjct: 272 PQKRPSAKHVLKHPFFWSLE 291

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  198 bits (505), Expect = 7e-62
 Identities = 73/301 (24%), Positives = 125/301 (41%), Gaps = 41/301 (13%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP-MSTLREISILKQLD 80
             +    +IG G +  V++A  L + G  VA+KK+++    D       ++EI +LKQL+
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLD-GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90

Query: 81  TFEHPNIVRFFD-VIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG--LSASKVK 136
              HPN+++++   I  N L         ++ E  D  DL   ++        +    V 
Sbjct: 91  ---HPNVIKYYASFIEDNEL--------NIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVT 195
           +   Q+   ++ +HS R++HRD+KP N+ IT  G +K+ D GL + F        S+V T
Sbjct: 140 KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 199

Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
            +Y +PE +   GY    DIWS+GC++ EM  L   F    +   L  + + I       
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPP 257

Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
            P          + YS             +   L+   +  +P  R       +      
Sbjct: 258 LPS---------DHYS------------EELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296

Query: 316 K 316
            
Sbjct: 297 A 297

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  200 bits (509), Expect = 8e-62
 Identities = 50/318 (15%), Positives = 87/318 (27%), Gaps = 51/318 (16%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL-REISILKQLDTFEHPNIV 88
           +  G    VF  RD++      A+K   +        +  L        +L      +  
Sbjct: 70  LRVGDRSVVFLVRDVER-LEDFALKVFTMGAENSRSELERLHEATFAAARL---LGESPE 125

Query: 89  RFFDVIHQNILSD-------------------ERYLTVYLIFEHVDQDLGSYMEKCP--- 126
              D     + SD                          L+      DL           
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVY 185

Query: 127 --PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD 184
                     +  LT Q+++    L S  ++H    P NL I   G L + D        
Sbjct: 186 VFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV- 244

Query: 185 YDMMLTSVVVTLWYRAPEILL--NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLK 242
                 +  V + Y   E L      +   ++ W +G  +  +W L   F   T   +  
Sbjct: 245 -GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303

Query: 243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI 302
                +  P  +         + S                     +L+   L F+   R+
Sbjct: 304 WKRPSLRVPGTDSLA------FGSCTPLP------------DFVKTLIGRFLNFDRRRRL 345

Query: 303 SAADALEHPYFKEKENEP 320
              +A+E P F + +NE 
Sbjct: 346 LPLEAMETPEFLQLQNEI 363

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  198 bits (506), Expect = 3e-61
 Identities = 78/336 (23%), Positives = 144/336 (42%), Gaps = 47/336 (13%)

Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
              D +Y  + ++G G + TV+ A+D+ N   +VAMK +R    +     +   EI +L+
Sbjct: 15  PYKDARYILVRKLGWGHFSTVWLAKDMVN-NTHVAMKIVR---GDKVYTEAAEDEIKLLQ 70

Query: 78  QL--------DTFEHPNIVRFFDV-IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPP 128
           ++        D+    +I++  D   H+          V ++FE + ++L + ++K    
Sbjct: 71  RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH----VVMVFEVLGENLLALIKKYEHR 126

Query: 129 GLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLI------TRAGGLKIADFGLAK 181
           G+    VK++++Q+L G+D++H    IIH D+KP+N+L+           +KIAD G A 
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA- 185

Query: 182 TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCA------S 235
            +  D   T+ + T  YR+PE+LL   +G   DIWS  C++ E+     LF        +
Sbjct: 186 CWY-DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244

Query: 236 TEVEQLKCIFRVIGTPSMN-----EWPENI------SLMWSSFEQYSKVAFSAIFMDCCS 284
            + + +  I  ++G          ++              S  + +              
Sbjct: 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304

Query: 285 KANS----LLESMLTFNPADRISAADALEHPYFKEK 316
                    L  ML  +P  R  A   + HP+ K+ 
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  196 bits (501), Expect = 6e-61
 Identities = 83/338 (24%), Positives = 152/338 (44%), Gaps = 55/338 (16%)

Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           D+   +Y+ +  +G GA+G V +  D +  G +VA+K ++   N D    +   EI +L+
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQVLE 66

Query: 78  QL---DTFEHPNIVRFFDV-IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSAS 133
            L   D       V+  +   H   +         ++FE +      ++++         
Sbjct: 67  HLNTTDPNSTFRCVQMLEWFEHHGHI--------CIVFELLGLSTYDFIKENGFLPFRLD 118

Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-------------------GLKI 174
            ++++  Q+ K V+FLHS+++ H DLKP+N+L  ++                     +K+
Sbjct: 119 HIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178

Query: 175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCA 234
            DFG A T+D +   +++V T  YRAPE++L LG+  P D+WSIGC++ E +    +F  
Sbjct: 179 VDFGSA-TYDDEHH-STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236

Query: 235 STEVEQLKCIFRVIGTPSMN----------------EWPENISLMWSSFEQYSKVAFSAI 278
               E L  + R++G    +                +W E+ S       +  K     +
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAG-RYVSRACKPLKEFM 295

Query: 279 FMDCCSKAN--SLLESMLTFNPADRISAADALEHPYFK 314
                       L++ ML ++PA RI+  +AL+HP+F 
Sbjct: 296 LSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  197 bits (502), Expect = 8e-61
 Identities = 86/341 (25%), Positives = 145/341 (42%), Gaps = 55/341 (16%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQL- 79
            ++Y+ +  +G G +G V +  D     + VA+K +R   N      +   EI++LK++ 
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR---NVGKYREAARLEINVLKKIK 74

Query: 80  --DTFEHPNIVRFFDV-IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
             D       V   D       +         + FE + ++   ++++          V+
Sbjct: 75  EKDKENKFLCVLMSDWFNFHGHM--------CIAFELLGKNTFEFLKENNFQPYPLPHVR 126

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-------------------GLKIADF 177
            +  Q+   + FLH +++ H DLKP+N+L   +                     +++ADF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186

Query: 178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           G A TFD     T++V T  YR PE++L LG+  P D+WSIGC++ E +R   LF     
Sbjct: 187 GSA-TFD-HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244

Query: 238 VEQLKCIFRVIGTPSMN----------------EWPENISLMWSSFEQYSKVAFSAIFMD 281
            E L  + +++G    +                 W EN S      ++  K   S +  D
Sbjct: 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDG-RYVKENCKPLKSYMLQD 303

Query: 282 CCSKAN--SLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                    L+  ML F+PA RI+ A+AL HP+F     E 
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  194 bits (496), Expect = 1e-59
 Identities = 83/347 (23%), Positives = 141/347 (40%), Gaps = 59/347 (17%)

Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           +    +Y+    IG G++G V KA D      +VA+K ++   N+         E+ +L+
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVE-QEWVAIKIIK---NKKAFLNQAQIEVRLLE 105

Query: 78  QL---DTFEHPNIVRFFDV-IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSAS 133
            +   DT     IV      + +N L         L+FE +  +L   +      G+S +
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHL--------CLVFEMLSYNLYDLLRNTNFRGVSLN 157

Query: 134 KVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLITRAG--GLKIADFGLAKTFDYDMML 189
             ++  +QM   + FL +    IIH DLKP+N+L+       +KI DFG +       + 
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRI- 215

Query: 190 TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG 249
              + + +YR+PE+LL + Y   +D+WS+GC++ EM    PLF  + EV+Q+  I  V+G
Sbjct: 216 YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275

Query: 250 TPSM---------------------------NEWPENISLMWSSFEQYSKVAFSAIFMDC 282
            P                             +   E              V         
Sbjct: 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRR 335

Query: 283 CSKANS----------LLESMLTFNPADRISAADALEHPYFKEKENE 319
             ++            L+  ML ++P  RI    AL+H +FK+  +E
Sbjct: 336 AGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 382

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  189 bits (482), Expect = 1e-58
 Identities = 81/313 (25%), Positives = 124/313 (39%), Gaps = 67/313 (21%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILK 77
           D  +    ++G GA+G V    +  + G    +K   K R ++  + I      EI +LK
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSS-GLERVIKTINKDRSQVPMEQI----EAEIEVLK 75

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV------------DQDLGSYMEKC 125
            LD   HPNI++ F+V       D     +Y++ E                   +  E  
Sbjct: 76  SLD---HPNIIKIFEVF-----EDYHN--MYIVMETCEGGELLERIVSAQARGKALSEG- 124

Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKT 182
                    V EL +QM+  + + HS  ++H+DLKP+N+L         +KI DFGLA+ 
Sbjct: 125 --------YVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176

Query: 183 FDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLK 242
           F  D   T+   T  Y APE+          DIWS G VM  +      F  ++  E  +
Sbjct: 177 FKSDEHSTNAAGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235

Query: 243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI 302
                   P+       ++                       +A  LL+ MLT +P  R 
Sbjct: 236 KATY--KEPNYAVECRPLT----------------------PQAVDLLKQMLTKDPERRP 271

Query: 303 SAADALEHPYFKE 315
           SAA  L H +FK+
Sbjct: 272 SAAQVLHHEWFKQ 284

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  190 bits (486), Expect = 2e-58
 Identities = 87/344 (25%), Positives = 141/344 (40%), Gaps = 67/344 (19%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQL- 79
           +  +  + ++G G +G V   + + NK  Y A+K +R   N      S   E  ILK++ 
Sbjct: 34  NNAFLVIRKMGDGTFGRVLLCQHIDNK-KYYAVKVVR---NIKKYTRSAKIEADILKKIQ 89

Query: 80  --DTFEHPNIVRFFDV-IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
             D   + NIV++    ++ +         + LIFE +   L   + +    G     +K
Sbjct: 90  NDDINNN-NIVKYHGKFMYYD--------HMCLIFEPLGPSLYEIITRNNYNGFHIEDIK 140

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-------------------------G 171
               ++LK +++L    + H DLKP+N+L+                             G
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200

Query: 172 LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPL 231
           +K+ DFG A TF  D    S++ T  YRAPE++LNLG+    D+WS GCV+AE++    L
Sbjct: 201 IKLIDFGCA-TFKSDYH-GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258

Query: 232 FCASTEVEQLKCIFRVIGTPSMN---------------------EWPENISLMWSSFEQY 270
           F     +E L  +  +I     N                      WPEN S + S     
Sbjct: 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK 318

Query: 271 SKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
             +    I           L S+L  +P  R S A+ L+H + +
Sbjct: 319 KCLPLYKIIKH--ELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  193 bits (492), Expect = 4e-58
 Identities = 81/311 (26%), Positives = 139/311 (44%), Gaps = 59/311 (18%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y+ +C +G G++G V K +D        A+K +     ++    + LRE+ +LK+LD 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRIT-QQEYAVKVINKASAKNKDTSTILREVELLKKLD- 79

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPPGLSAS 133
             HPNI++ F+++      D      Y++ E                + E          
Sbjct: 80  --HPNIMKLFEIL-----EDSSS--FYIVGELYTGGELFDEIIKRKRFSEH--------- 121

Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMMLT 190
               + +Q+  G+ ++H H I+HRDLKP+N+L+        +KI DFGL+  F  +  + 
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181

Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
             + T +Y APE+L    Y    D+WS G ++  +    P F    E + LK +    G 
Sbjct: 182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GK 238

Query: 251 PSMN--EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL 308
            + +  +W   IS                        A  L+  MLTF+P+ RI+A   L
Sbjct: 239 YAFDLPQWR-TIS----------------------DDAKDLIRKMLTFHPSLRITATQCL 275

Query: 309 EHPYFKEKENE 319
           EHP+ ++  +E
Sbjct: 276 EHPWIQKYSSE 286

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  191 bits (487), Expect = 7e-58
 Identities = 79/331 (23%), Positives = 127/331 (38%), Gaps = 77/331 (23%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
                   +G G+ GTV      Q +   VA+K++ +   +       L EI +L + D 
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGR--PVAVKRMLIDFCDI-----ALMEIKLLTESD- 66

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKC-----PPPGLSASKVK 136
            +HPN++R++        + +R+L  Y+  E  + +L   +E                  
Sbjct: 67  -DHPNVIRYYCSE-----TTDRFL--YIALELCNLNLQDLVESKNVSDENLKLQKEYNPI 118

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG-------------LKIADFGLAKTF 183
            L RQ+  GV  LHS +IIHRDLKPQN+L++ +               + I+DFGL K  
Sbjct: 119 SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178

Query: 184 DYDM-----MLTSVVVTLWYRAPEILLNL-------GYGTPVDIWSIGCVMAEMWRL--- 228
           D         L +   T  +RAPE+L               +DI+S+GCV   +  L   
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI--LSKG 236

Query: 229 VPLFCASTEVEQ--LKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKA 286
              F      E   ++ IF +           ++                       ++A
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKC--LHDRSLI----------------------AEA 272

Query: 287 NSLLESMLTFNPADRISAADALEHPYFKEKE 317
             L+  M+  +P  R +A   L HP F  K 
Sbjct: 273 TDLISQMIDHDPLKRPTAMKVLRHPLFWPKS 303

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  192 bits (489), Expect = 1e-57
 Identities = 90/314 (28%), Positives = 138/314 (43%), Gaps = 63/314 (20%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILKQ 78
           + Y  + ++G GAYG V   RD        A+K   K  V  + +      L E+++LK 
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVT-HVERAIKIIRKTSVSTSSN---SKLLEEVAVLKL 92

Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPPGL 130
           LD   HPNI++ +D        D+R    YL+ E                + E       
Sbjct: 93  LD---HPNIMKLYDFF-----EDKRN--YYLVMECYKGGELFDEIIHRMKFNEV------ 136

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDM 187
                  + +Q+L GV +LH H I+HRDLKP+NLL+        +KI DFGL+  F+   
Sbjct: 137 ---DAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193

Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
            +   + T +Y APE+ L   Y    D+WSIG ++  +    P F   T+ E L+ + + 
Sbjct: 194 KMKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK- 251

Query: 248 IGTPSMNEWP-ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
            G  + +    +N+S                        A  L++ ML F+   RISA  
Sbjct: 252 -GKYTFDSPEWKNVS----------------------EGAKDLIKQMLQFDSQRRISAQQ 288

Query: 307 ALEHPYFKEKENEP 320
           ALEHP+ KE  ++ 
Sbjct: 289 ALEHPWIKEMCSKK 302

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  191 bits (488), Expect = 2e-57
 Identities = 87/317 (27%), Positives = 140/317 (44%), Gaps = 64/317 (20%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILK 77
             +Y     +G G++G V   +D    G   A+K   K +VK   D    S LRE+ +LK
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTD--KESLLREVQLLK 81

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPPG 129
           QLD   HPNI++ ++        D+ Y   YL+ E                + E      
Sbjct: 82  QLD---HPNIMKLYEFF-----EDKGY--FYLVGEVYTGGELFDEIISRKRFSEV----- 126

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYD 186
                   + RQ+L G+ ++H ++I+HRDLKP+NLL+        ++I DFGL+  F+  
Sbjct: 127 ----DAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182

Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
             +   + T +Y APE+ L+  Y    D+WS G ++  +    P F  + E + LK + +
Sbjct: 183 KKMKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 241

Query: 247 VIGTPSMN--EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA 304
             G  +    +W   +S                        A  L+  MLT+ P+ RISA
Sbjct: 242 --GKYTFELPQWK-KVS----------------------ESAKDLIRKMLTYVPSMRISA 276

Query: 305 ADALEHPYFKEKENEPL 321
            DAL+H + +    E +
Sbjct: 277 RDALDHEWIQTYTKEQI 293

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  188 bits (480), Expect = 3e-57
 Identities = 62/310 (20%), Positives = 110/310 (35%), Gaps = 32/310 (10%)

Query: 20  GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISIL 76
            +  +     +G GA   VF+ R  +  G+  A+K    +      D      +RE  +L
Sbjct: 7   SNHLWLLSDILGQGATANVFRGRHKKT-GDLFAIKVFNNISFLRPVDVQ----MREFEVL 61

Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM-EKCPPPGLSASK 134
           K+L+   H NIV+ F +       +       LI E      L + + E     GL  S+
Sbjct: 62  KKLN---HKNIVKLFAIE-----EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG----LKIADFGLAKTFDYDMMLT 190
              + R ++ G++ L  + I+HR++KP N++           K+ DFG A+  + D    
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173

Query: 191 SVVVTLWYRAPEIL--------LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLK 242
           S+  T  Y  P++             YG  VD+WSIG            F       + K
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233

Query: 243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKV--AFSAIFMDCCSKANSLLESMLTFNPAD 300
            +   I T   +     +    +    +S       ++          +L ++L  +   
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293

Query: 301 RISAADALEH 310
                     
Sbjct: 294 CWGFDQFFAE 303

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  191 bits (487), Expect = 3e-57
 Identities = 83/323 (25%), Positives = 136/323 (42%), Gaps = 68/323 (21%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMST-------- 69
            + Y ++ ++G GAYG V   ++     +  A+K   K +                    
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNG-HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93

Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSY 121
             EIS+LK LD   HPNI++ FDV       D++Y   YL+ E  +         +   +
Sbjct: 94  YNEISLLKSLD---HPNIIKLFDVF-----EDKKY--FYLVTEFYEGGELFEQIINRHKF 143

Query: 122 MEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFG 178
            E              + +Q+L G+ +LH H I+HRD+KP+N+L+        +KI DFG
Sbjct: 144 DEC---------DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194

Query: 179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV 238
           L+  F  D  L   + T +Y APE+L    Y    D+WS G +M  +    P F    + 
Sbjct: 195 LSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253

Query: 239 EQLKCIFRVIGTPSMNEWP-ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFN 297
           + +K + +  G    +    +NIS                       +A  L++ MLT++
Sbjct: 254 DIIKKVEK--GKYYFDFNDWKNIS----------------------DEAKELIKLMLTYD 289

Query: 298 PADRISAADALEHPYFKEKENEP 320
              R +A +AL   + K+  N  
Sbjct: 290 YNKRCTAEEALNSRWIKKYANNI 312

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  187 bits (476), Expect = 3e-57
 Identities = 78/299 (26%), Positives = 123/299 (41%), Gaps = 47/299 (15%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLD 80
           ++Y     +G G +   F+  D        A K + +  L +         EISI + L 
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADT-KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELT 139
              H ++V F          D  +  V+++ E   +   S +E       L+  + +   
Sbjct: 100 ---HQHVVGFHGFFE-----DNDF--VFVVLELCRR--RSLLELHKRRKALTEPEARYYL 147

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLWY 198
           RQ++ G  +LH +R+IHRDLK  NL +     +KI DFGLA   +YD      +  T  Y
Sbjct: 148 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 207

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV--PLFCASTEVEQLKCIFRVIGTPSMNEW 256
            APE+L   G+   VD+WSIGC+M  +  LV  P F  S   E    I +   +      
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTL--LVGKPPFETSCLKETYLRIKKNEYS-----I 260

Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           P++I+                        A SL++ ML  +P  R +  + L   +F  
Sbjct: 261 PKHIN----------------------PVAASLIQKMLQTDPTARPTINELLNDEFFTS 297

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  185 bits (471), Expect = 4e-57
 Identities = 85/304 (27%), Positives = 134/304 (44%), Gaps = 47/304 (15%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLD 80
           + ++    +G G +G V+ AR+ Q+    +A+K L + +L + G+     RE+ I   L 
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQS-KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELT 139
              HPNI+R +   H     D     VYLI E+     +   ++K         +     
Sbjct: 68  ---HPNILRLYGYFH-----DATR--VYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 115

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
            ++   + + HS R+IHRD+KP+NLL+  AG LKIADFG +              TL Y 
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL-CGTLDYL 174

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLV--PLFCASTEVEQLKCIFRVIGTPSMNEWP 257
            PE++    +   VD+WS+G +  E   LV  P F A+T  E  K I RV  T     +P
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEF--LVGKPPFEANTYQETYKRISRVEFT-----FP 227

Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE 317
           + ++                        A  L+  +L  NP+ R    + LEHP+     
Sbjct: 228 DFVT----------------------EGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265

Query: 318 NEPL 321
           ++P 
Sbjct: 266 SKPS 269

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  184 bits (470), Expect = 5e-57
 Identities = 78/300 (26%), Positives = 126/300 (42%), Gaps = 48/300 (16%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLD 80
           + +     +G G++  V++A  +   G  VA+K + +  + + G+      E+ I  QL 
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHT-GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG--LSASKVKEL 138
              HP+I+  ++        D  Y  VYL+ E      G             S ++ +  
Sbjct: 70  ---HPSILELYNYFE-----DSNY--VYLVLEMCHN--GEMNRYLKNRVKPFSENEARHF 117

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLW 197
             Q++ G+ +LHSH I+HRDL   NLL+TR   +KIADFGLA           ++  T  
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177

Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV--PLFCASTEVEQLKCIFRVIGTPSMNE 255
           Y +PEI     +G   D+WS+GC+   +  L+  P F   T    L  +           
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTL--LIGRPPFDTDTVKNTLNKVVLADYE----- 230

Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
            P  +S                       +A  L+  +L  NPADR+S +  L+HP+   
Sbjct: 231 MPSFLS----------------------IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  194 bits (494), Expect = 5e-57
 Identities = 73/305 (23%), Positives = 122/305 (40%), Gaps = 20/305 (6%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
            ++   ++G G +G V +       G  VA+K+ R +L+          EI I+K+L+  
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDT-GEQVAIKQCRQELSPKNR-ERWCLEIQIMKKLN-- 70

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM-EKCPPPGLSASKVKELTR 140
            HPN+V   +V    +          L  E+ +  DL  Y+ +     GL    ++ L  
Sbjct: 71  -HPNVVSAREVP-DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMMLTSVVVTLW 197
            +   + +LH +RIIHRDLKP+N+++         KI D G AK  D   + T  V TL 
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ 188

Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV---PLFCASTEVEQLKCIFRVIGTPSMN 254
           Y APE+L    Y   VD WS G +  E   +    P       V+    +        + 
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFEC--ITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246

Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
                 ++ +SS         + +      K    L+ ML ++   R +         F+
Sbjct: 247 YDDLTGAVKFSSVLPTP----NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302

Query: 315 EKENE 319
             ++ 
Sbjct: 303 ALDSI 307

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  184 bits (470), Expect = 9e-57
 Identities = 78/299 (26%), Positives = 123/299 (41%), Gaps = 47/299 (15%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLD 80
           ++Y     +G G +   F+  D        A K + +  L +         EISI + L 
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADT-KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-LSASKVKELT 139
              H ++V F          D  +  V+++ E   +   S +E       L+  + +   
Sbjct: 74  ---HQHVVGFHGFFE-----DNDF--VFVVLELCRR--RSLLELHKRRKALTEPEARYYL 121

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLWY 198
           RQ++ G  +LH +R+IHRDLK  NL +     +KI DFGLA   +YD      +  T  Y
Sbjct: 122 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLV--PLFCASTEVEQLKCIFRVIGTPSMNEW 256
            APE+L   G+   VD+WSIGC+M  +  LV  P F  S   E    I +   +      
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTL--LVGKPPFETSCLKETYLRIKKNEYS-----I 234

Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           P++I+                        A SL++ ML  +P  R +  + L   +F  
Sbjct: 235 PKHIN----------------------PVAASLIQKMLQTDPTARPTINELLNDEFFTS 271

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  183 bits (467), Expect = 2e-56
 Identities = 59/321 (18%), Positives = 114/321 (35%), Gaps = 65/321 (20%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
            ++ EL +IG G +G+VFK     + G   A+K+ +  L       + LRE+     L  
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLD-GCIYAIKRSKKPLAGSVDEQNALREVYAHAVL-- 67

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG--LSASKVKEL 138
            +H ++VR+F        +      + +  E+ +   L   + +          +++K+L
Sbjct: 68  GQHSHVVRYFS-------AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL-------------------KIADFGL 179
             Q+ +G+ ++HS  ++H D+KP N+ I+R                       KI D G 
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 180 AKTFDYDMMLTSVVVTLWYRAPEILL-NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV 238
                             + A E+L  N  +    DI+++   +       PL     + 
Sbjct: 181 VTRIS---SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ- 236

Query: 239 EQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNP 298
                 +  I    +   P+ +S                       +   LL+ M+  +P
Sbjct: 237 ------WHEIRQGRLPRIPQVLS----------------------QEFTELLKVMIHPDP 268

Query: 299 ADRISAADALEHPYFKEKENE 319
             R SA   ++H        +
Sbjct: 269 ERRPSAMALVKHSVLLSASRK 289

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  184 bits (470), Expect = 2e-56
 Identities = 62/301 (20%), Positives = 115/301 (38%), Gaps = 54/301 (17%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G++G V + +D Q  G   A+KK+R+++           E+     L     P IV 
Sbjct: 66  VGRGSFGEVHRMKDKQT-GFQCAVKKVRLEVFRV-------EELVACAGLS---SPRIVP 114

Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
            +  +      +  ++ +++  E ++   LG  +++     L   +      Q L+G+++
Sbjct: 115 LYGAV-----REGPWVNIFM--ELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEY 165

Query: 149 LHSHRIIHRDLKPQNLLITRAGGL-KIADFGLAKTFDYDMMLT------SVVVTLWYRAP 201
           LH+ RI+H D+K  N+L++  G    + DFG A     D +         +  T  + AP
Sbjct: 166 LHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

Query: 202 EILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR-VIGTPSMNEWPENI 260
           E+++       VDIWS  C+M  M      +   T+  +     +     P + E P + 
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW---TQYFRGPLCLKIASEPPPIREIPPSC 282

Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
           +       Q          +             L   P  R SA +         +E   
Sbjct: 283 A---PLTAQ---------AIQEG----------LRKEPVHRASAMELRRKVGKALQEVGG 320

Query: 321 L 321
           L
Sbjct: 321 L 321

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  183 bits (466), Expect = 3e-56
 Identities = 81/311 (26%), Positives = 139/311 (44%), Gaps = 59/311 (18%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           ++Y+ +C +G G++G V K +D        A+K +     ++    + LRE+ +LK+LD 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRIT-QQEYAVKVINKASAKNKDTSTILREVELLKKLD- 79

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPPGLSAS 133
             HPNI++ F+++      D      Y++ E                + E          
Sbjct: 80  --HPNIMKLFEILE-----DSSS--FYIVGELYTGGELFDEIIKRKRFSEH--------- 121

Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMMLT 190
               + +Q+  G+ ++H H I+HRDLKP+N+L+        +KI DFGL+  F  +  + 
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181

Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
             + T +Y APE+L    Y    D+WS G ++  +    P F    E + LK +    G 
Sbjct: 182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GK 238

Query: 251 PSMN--EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL 308
            + +  +W   IS                        A  L+  MLTF+P+ RI+A   L
Sbjct: 239 YAFDLPQWR-TIS----------------------DDAKDLIRKMLTFHPSLRITATQCL 275

Query: 309 EHPYFKEKENE 319
           EHP+ ++  +E
Sbjct: 276 EHPWIQKYSSE 286

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  182 bits (465), Expect = 3e-56
 Identities = 83/317 (26%), Positives = 127/317 (40%), Gaps = 71/317 (22%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILKQ 78
           + Y     IG G++G V  A          A K   K  V+  +        +EI I+K 
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGT-RIRRAAKKIPKYFVEDVDR-----FKQEIEIMKS 62

Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPPGL 130
           LD   HPNI+R ++        D     +YL+ E                + E       
Sbjct: 63  LD---HPNIIRLYETF-----EDNTD--IYLVMELCTGGELFERVVHKRVFRES------ 106

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDM 187
                  + + +L  V + H   + HRDLKP+N L         LK+ DFGLA  F    
Sbjct: 107 ---DAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163

Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
           M+ + V T +Y +P++L    YG   D WS G +M  +    P F A T+ E    +   
Sbjct: 164 MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE----VMLK 218

Query: 248 I--GTPSMN--EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS 303
           I  GT +    +W  N+S                       +A SL+  +LT +P  RI+
Sbjct: 219 IREGTFTFPEKDWL-NVS----------------------PQAESLIRRLLTKSPKQRIT 255

Query: 304 AADALEHPYFKEKENEP 320
           +  ALEH +F+++ +  
Sbjct: 256 SLQALEHEWFEKQLSSS 272

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  185 bits (472), Expect = 3e-56
 Identities = 86/315 (27%), Positives = 127/315 (40%), Gaps = 62/315 (19%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
              YD   ++G GA+  V +       G   A K +  K           RE  I ++L 
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTT-GLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPPGLSA 132
              HPNIVR  D I      +E +   YL+F+ V              Y E         
Sbjct: 87  ---HPNIVRLHDSI-----QEESF--HYLVFDLVTGGELFEDIVAREFYSEA-------- 128

Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQN-LLITRAGG--LKIADFGLAKTFDYDMML 189
                  +Q+L+ + + HS+ I+HR+LKP+N LL ++A G  +K+ADFGLA   +     
Sbjct: 129 -DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187

Query: 190 TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL--VPLFCASTEVEQLKCIFRV 247
                T  Y +PE+L    Y  PVDIW+ G ++  +  L   P F    +      I   
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL--LVGYPPFWDEDQHRLYAQIKA- 244

Query: 248 IGTPSMN--EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA 305
            G       EW   ++                       +A SL++SMLT NP  RI+A 
Sbjct: 245 -GAYDYPSPEWD-TVT----------------------PEAKSLIDSMLTVNPKKRITAD 280

Query: 306 DALEHPYFKEKENEP 320
            AL+ P+   +E   
Sbjct: 281 QALKVPWICNRERVA 295

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  183 bits (466), Expect = 5e-56
 Identities = 61/311 (19%), Positives = 116/311 (37%), Gaps = 49/311 (15%)

Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
           + + +K Y  + ++G G +  V     L + G++ A+K++     +     +  RE  + 
Sbjct: 24  VIIDNKHYLFIQKLGEGGFSYVDLVEGLHD-GHFYALKRILCH-EQQDREEA-QREADMH 80

Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPG--LSAS 133
           +  +   HPNI+R      +           +L+        L + +E+    G  L+  
Sbjct: 81  RLFN---HPNILRLVAYCLR---ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED 134

Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV 193
           ++  L   + +G++ +H+    HRDLKP N+L+   G   + D G        +  +   
Sbjct: 135 QILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194

Query: 194 V----------TLWYRAPEILLNLGY---GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQ 240
           +          T+ YRAPE+     +       D+WS+GCV+  M      +    +   
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254

Query: 241 LKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD 300
              +  V    S+ + P           ++S            S    LL SM+T +P  
Sbjct: 255 SVAL-AVQNQLSIPQSP-----------RHS------------SALWQLLNSMMTVDPHQ 290

Query: 301 RISAADALEHP 311
           R      L   
Sbjct: 291 RPHIPLLLSQL 301

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  186 bits (475), Expect = 7e-56
 Identities = 83/316 (26%), Positives = 126/316 (39%), Gaps = 63/316 (19%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
            ++Y    ++G GA+  V +       G   A   +  K           RE  I + L 
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVK-VLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK 68

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPPGLSA 132
              HPNIVR  D I     S+E +   YLIF+ V              Y E         
Sbjct: 69  ---HPNIVRLHDSI-----SEEGH--HYLIFDLVTGGELFEDIVAREYYSEA-------- 110

Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLL-ITRAGG--LKIADFGLAKTFDYDM-M 188
                  +Q+L+ V   H   ++HR+LKP+NLL  ++  G  +K+ADFGLA   + +   
Sbjct: 111 -DASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169

Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL--VPLFCASTEVEQLKCIFR 246
                 T  Y +PE+L    YG PVD+W+ G ++  +  L   P F    +    + I  
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYIL--LVGYPPFWDEDQHRLYQQIKA 227

Query: 247 VIGTPSMN--EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA 304
             G       EW   ++                       +A  L+  MLT NP+ RI+A
Sbjct: 228 --GAYDFPSPEWD-TVT----------------------PEAKDLINKMLTINPSKRITA 262

Query: 305 ADALEHPYFKEKENEP 320
           A+AL+HP+   +    
Sbjct: 263 AEALKHPWISHRSTVA 278

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  181 bits (461), Expect = 1e-55
 Identities = 85/309 (27%), Positives = 126/309 (40%), Gaps = 58/309 (18%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
             YD   ++G GA+  V +       G   A K +  K           RE  I ++L  
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTT-GLEFAAKIINTKKLSARDFQKLEREARICRKLQ- 63

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPPGLSAS 133
             HPNIVR  D I      +E +   YL+F+ V              Y E          
Sbjct: 64  --HPNIVRLHDSI-----QEESF--HYLVFDLVTGGELFEDIVAREFYSEA--------- 105

Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQN-LLITRAGG--LKIADFGLAKTFDYDMMLT 190
                 +Q+L+ + + HS+ I+HR+LKP+N LL ++A G  +K+ADFGLA   +      
Sbjct: 106 DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 165

Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
               T  Y +PE+L    Y  PVDIW+ G ++  +    P F    +      I    G 
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA--GA 223

Query: 251 PSMN--EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL 308
                 EW   ++                       +A SL++SMLT NP  RI+A  AL
Sbjct: 224 YDYPSPEWD-TVT----------------------PEAKSLIDSMLTVNPKKRITADQAL 260

Query: 309 EHPYFKEKE 317
           + P+   +E
Sbjct: 261 KVPWICNRE 269

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  181 bits (461), Expect = 2e-55
 Identities = 78/309 (25%), Positives = 121/309 (39%), Gaps = 61/309 (19%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK--KLRVKLNEDGIPMSTLREISILKQL 79
           K +  +  +G GA+  VF  +     G   A+K  K      +  +      EI++LK++
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSL----ENEIAVLKKI 63

Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPPGLS 131
               H NIV   D+          +   YL+ + V          + G Y EK       
Sbjct: 64  K---HENIVTLEDIY-----ESTTH--YYLVMQLVSGGELFDRILERGVYTEK------D 107

Query: 132 ASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMM 188
           AS    + +Q+L  V +LH + I+HRDLKP+NLL         + I DFGL+K    + +
Sbjct: 108 ASL---VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGI 163

Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           +++   T  Y APE+L    Y   VD WSIG +   +    P F   TE +  + I    
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY 223

Query: 249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL 308
                  W  +IS                        A   +  +L  +P +R +   AL
Sbjct: 224 YEFESPFWD-DIS----------------------ESAKDFICHLLEKDPNERYTCEKAL 260

Query: 309 EHPYFKEKE 317
            HP+     
Sbjct: 261 SHPWIDGNT 269

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  180 bits (460), Expect = 2e-55
 Identities = 73/321 (22%), Positives = 123/321 (38%), Gaps = 63/321 (19%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK-------KLRVKLNEDGIPMSTLREIS 74
           + Y+    +G G    V +           A+K                 +  +TL+E+ 
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPT-CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCP 126
           IL+++    HPNI++  D           +   +L+F+ +          +  +  EK  
Sbjct: 76  ILRKVS--GHPNIIQLKDTY-----ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEK-- 124

Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
                  + +++ R +L+ +  LH   I+HRDLKP+N+L+     +K+ DFG +   D  
Sbjct: 125 -------ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177

Query: 187 MMLTSVVVTLWYRAPEILLNL------GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQ 240
             L  V  T  Y APEI+         GYG  VD+WS G +M  +    P F    ++  
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 237

Query: 241 LKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD 300
           L+ I          EW  + S                           L+   L   P  
Sbjct: 238 LRMIMSGNYQFGSPEWD-DYS----------------------DTVKDLVSRFLVVQPQK 274

Query: 301 RISAADALEHPYFKEKENEPL 321
           R +A +AL HP+F++   E +
Sbjct: 275 RYTAEEALAHPFFQQYVVEEV 295

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  182 bits (464), Expect = 2e-55
 Identities = 77/323 (23%), Positives = 126/323 (39%), Gaps = 71/323 (21%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILK 77
           +  Y+    IG G +  V +  + +  G   A+K     +   +         RE SI  
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRET-GQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD------------QDLGSYMEKC 125
            L    HP+IV   +       S +    +Y++FE +D                 Y E  
Sbjct: 82  MLK---HPHIVELLETY-----SSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEA- 130

Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQN-LLITRAGG--LKIADFGLAKT 182
                         RQ+L+ + + H + IIHRD+KP   LL ++     +K+  FG+A  
Sbjct: 131 --------VASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182

Query: 183 F-DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL 241
             +  ++    V T  + APE++    YG PVD+W  G ++  +      F  + E    
Sbjct: 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--- 239

Query: 242 KCIFRVI--GTPSMN--EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFN 297
             +F  I  G   MN  +W  +IS                        A  L+  ML  +
Sbjct: 240 --LFEGIIKGKYKMNPRQWS-HIS----------------------ESAKDLVRRMLMLD 274

Query: 298 PADRISAADALEHPYFKEKENEP 320
           PA+RI+  +AL HP+ KE++   
Sbjct: 275 PAERITVYEALNHPWLKERDRYA 297

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  182 bits (463), Expect = 2e-55
 Identities = 85/319 (26%), Positives = 134/319 (42%), Gaps = 65/319 (20%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTL-REISIL 76
           D  YD   ++G G +  V K R+    G   A K   K R K +  G+    + RE+SIL
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68

Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPP 128
           K++    HPN++   +V       ++    V LI E V          +  S  E+    
Sbjct: 69  KEIQ---HPNVITLHEVY-----ENKTD--VILILELVAGGELFDFLAEKESLTEE---- 114

Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG----LKIADFGLAKTFD 184
                +  E  +Q+L GV +LHS +I H DLKP+N+++         +KI DFGLA   D
Sbjct: 115 -----EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169

Query: 185 YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL---VPLFCASTEVEQL 241
           +     ++  T  + APEI+     G   D+WSIG V+  +  L      F   T+ E L
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYI--LLSGASPFLGDTKQETL 226

Query: 242 KCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADR 301
             +  V        +  N S                      + A   +  +L  +P  R
Sbjct: 227 ANVSAVNYEFEDEYFS-NTS----------------------ALAKDFIRRLLVKDPKKR 263

Query: 302 ISAADALEHPYFKEKENEP 320
           ++  D+L+HP+ K K+ + 
Sbjct: 264 MTIQDSLQHPWIKPKDTQQ 282

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  179 bits (457), Expect = 5e-55
 Identities = 78/320 (24%), Positives = 127/320 (39%), Gaps = 65/320 (20%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTL-REISIL 76
           +  Y+   ++G G +  V K R     G   A K   K R+  +  G+    + RE++IL
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGT-GKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPP 128
           +++    HPNI+   D+       ++    V LI E V          +  S  E     
Sbjct: 63  REIR---HPNIITLHDIF-----ENKTD--VVLILELVSGGELFDFLAEKESLTED---- 108

Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG----LKIADFGLAKTFD 184
                +  +  +Q+L GV +LHS RI H DLKP+N+++         +K+ DFG+A   +
Sbjct: 109 -----EATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163

Query: 185 YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL---VPLFCASTEVEQL 241
                 ++  T  + APEI+     G   D+WSIG V+  +  L      F   T+ E L
Sbjct: 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYI--LLSGASPFLGETKQETL 220

Query: 242 KCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADR 301
             I  V        +  N S                        A   +  +L  +P  R
Sbjct: 221 TNISAVNYDFDEEYFS-NTS----------------------ELAKDFIRRLLVKDPKRR 257

Query: 302 ISAADALEHPYFKEKENEPL 321
           ++ A +LEH + K      +
Sbjct: 258 MTIAQSLEHSWIKAIRRRNV 277

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  180 bits (460), Expect = 6e-55
 Identities = 72/309 (23%), Positives = 121/309 (39%), Gaps = 61/309 (19%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +  V +       G   A K L+ +          L EI++L+       P ++
Sbjct: 36  ELGRGKFAVVRQCISKST-GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK--SCPRVI 92

Query: 89  RFFDVIHQNILSDERYLTVYLIFEH----------VDQDLGSYMEKCPPPGLSASKVKEL 138
              +V       +     + LI E+          + +      E           V  L
Sbjct: 93  NLHEVY-----ENTSE--IILILEYAAGGEIFSLCLPELAEMVSEN---------DVIRL 136

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMMLTSVVVT 195
            +Q+L+GV +LH + I+H DLKPQN+L++       +KI DFG+++   +   L  ++ T
Sbjct: 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGT 196

Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL---VPLFCASTEVEQLKCIFRVIGTPS 252
             Y APEIL      T  D+W+IG ++A M  L      F      E    I +V    S
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIG-IIAYM--LLTHTSPFVGEDNQETYLNISQVNVDYS 253

Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
              +  ++S                        A   ++S+L  NP  R +A   L H +
Sbjct: 254 EETFS-SVS----------------------QLATDFIQSLLVKNPEKRPTAEICLSHSW 290

Query: 313 FKEKENEPL 321
            ++ + E L
Sbjct: 291 LQQWDFENL 299

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  181 bits (461), Expect = 7e-55
 Identities = 77/310 (24%), Positives = 130/310 (41%), Gaps = 65/310 (20%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
             ++   ++G GA   V++ +         A+K L+  +++  +      EI +L +L  
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGT-QKPYALKVLKKTVDKKIV----RTEIGVLLRLS- 106

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPPGLSAS 133
             HPNI++  ++             + L+ E V          + G Y E+         
Sbjct: 107 --HPNIIKLKEIF-----ETPTE--ISLVLELVTGGELFDRIVEKGYYSER--------- 148

Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLL-ITRAGG--LKIADFGLAKTFDYDMMLT 190
              +  +Q+L+ V +LH + I+HRDLKP+NLL  T A    LKIADFGL+K  ++ +++ 
Sbjct: 149 DAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208

Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI-- 248
           +V  T  Y APEIL    YG  VD+WS+G +   +      F      +    +FR I  
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF---MFRRILN 265

Query: 249 GTPSMNE--WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                    W   +S                        A  L+  ++  +P  R++   
Sbjct: 266 CEYYFISPWWD-EVS----------------------LNAKDLVRKLIVLDPKKRLTTFQ 302

Query: 307 ALEHPYFKEK 316
           AL+HP+   K
Sbjct: 303 ALQHPWVTGK 312

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  179 bits (455), Expect = 1e-54
 Identities = 77/298 (25%), Positives = 125/298 (41%), Gaps = 41/298 (13%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           K+D    IG G++ TV+K  D +     VA  +L+ +            E  +LK L   
Sbjct: 29  KFDIE--IGRGSFKTVYKGLDTET-TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-- 83

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQ 141
            HPNIVRF+D     +   +    + L+ E +    L +Y+++     +    ++   RQ
Sbjct: 84  -HPNIVRFYDSWESTVKGKK---CIVLVTELMTSGTLKTYLKRFKVMKIKV--LRSWCRQ 137

Query: 142 MLKGVDFLHSHR--IIHRDLKPQNLLITRAGGL-KIADFGLAKTFDYDMMLTSVVVTLWY 198
           +LKG+ FLH+    IIHRDLK  N+ IT   G  KI D GLA          +V+ T  +
Sbjct: 138 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA-KAVIGTPEF 196

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
            APE+     Y   VD+++ G  M EM      +    E +    I+R + +       +
Sbjct: 197 MAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS---ECQNAAQIYRRVTSGVKPASFD 252

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK 316
            +                    +       ++E  +  N  +R S  D L H +F+E+
Sbjct: 253 KV--------------AIPEVKE-------IIEGCIRQNKDERYSIKDLLNHAFFQEE 289

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  182 bits (463), Expect = 2e-54
 Identities = 77/320 (24%), Positives = 127/320 (39%), Gaps = 71/320 (22%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK-----KLRVKLNEDGIPMSTL-REISI 75
            +Y     +G GA G V  A + +     VA++     K  +    +  P   +  EI I
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKT-CKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPP 127
           LK+L+   HP I++  +        D      Y++ E ++               E    
Sbjct: 194 LKKLN---HPCIIKIKNFF------DAE--DYYIVLELMEGGELFDKVVGNKRLKEA--- 239

Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFD 184
                   K    QML  V +LH + IIHRDLKP+N+L++       +KI DFG +K   
Sbjct: 240 ------TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293

Query: 185 YDMMLTSVVVTLWYRAPEILLNL---GYGTPVDIWSIGCVMAEMWRLV---PLFCASTEV 238
              ++ ++  T  Y APE+L+++   GY   VD WS+G ++     L    P     T+V
Sbjct: 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC--LSGYPPFSEHRTQV 351

Query: 239 EQLKCIFR-VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFN 297
                I            W   +S                       KA  L++ +L  +
Sbjct: 352 SLKDQITSGKYNFIP-EVWA-EVS----------------------EKALDLVKKLLVVD 387

Query: 298 PADRISAADALEHPYFKEKE 317
           P  R +  +AL HP+ ++++
Sbjct: 388 PKARFTTEEALRHPWLQDED 407

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  178 bits (453), Expect = 2e-54
 Identities = 76/297 (25%), Positives = 130/297 (43%), Gaps = 47/297 (15%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDT 81
            +D    +G G +G V+ AR+ QN    +A+K L + +L ++G+     REI I   L  
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQN-KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR- 72

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTR 140
             HPNI+R ++  H      +R   +YL+ E   + +L   ++K         +      
Sbjct: 73  --HPNILRMYNYFH----DRKR---IYLMLEFAPRGELYKELQKHGR--FDEQRSATFME 121

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           ++   + + H  ++IHRD+KP+NLL+   G LKIADFG +      +   ++  TL Y  
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMCGTLDYLP 180

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLV--PLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           PE++    +   VD+W  G +  E   LV  P F + +  E  + I  V        +P 
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEF--LVGMPPFDSPSHTETHRRIVNVDLK-----FPP 233

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
            +S                        +  L+  +L ++P  R+     +EHP+ K 
Sbjct: 234 FLS----------------------DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  178 bits (454), Expect = 4e-54
 Identities = 76/319 (23%), Positives = 126/319 (39%), Gaps = 65/319 (20%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTL-REISIL 76
           +  YD   ++G G +  V K R+    G   A K   K + + +  G+    + RE+SIL
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKST-GLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69

Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPP 128
           +Q+    H N++   DV       +     V LI E V             S  E+    
Sbjct: 70  RQVL---HHNVITLHDVY-----ENRTD--VVLILELVSGGELFDFLAQKESLSEE---- 115

Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR----AGGLKIADFGLAKTFD 184
                +     +Q+L GV++LH+ +I H DLKP+N+++         +K+ DFGLA   +
Sbjct: 116 -----EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

Query: 185 YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL---VPLFCASTEVEQL 241
             +   ++  T  + APEI+     G   D+WSIG V+  +  L      F   T+ E L
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYI--LLSGASPFLGDTKQETL 227

Query: 242 KCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADR 301
             I  V        +  + S                        A   +  +L      R
Sbjct: 228 ANITSVSYDFDEEFFS-HTS----------------------ELAKDFIRKLLVKETRKR 264

Query: 302 ISAADALEHPYFKEKENEP 320
           ++  +AL HP+    +N+ 
Sbjct: 265 LTIQEALRHPWITPVDNQQ 283

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  177 bits (452), Expect = 4e-54
 Identities = 88/320 (27%), Positives = 138/320 (43%), Gaps = 49/320 (15%)

Query: 5   SADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG 64
             D    L     +  +     +  +G G YG V+  RDL N    +A+K++  + +   
Sbjct: 7   EGDCESDLLEYDYEYDENGDRVV--LGKGTYGIVYAGRDLSN-QVRIAIKEIPERDSRYS 63

Query: 65  IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGS---- 120
            P+    EI++ K L    H NIV++         S+  ++ +++  E V    GS    
Sbjct: 64  QPLH--EEIALHKHLK---HKNIVQYLGSF-----SENGFIKIFM--EQVPG--GSLSAL 109

Query: 121 YMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGL 179
              K  P   +   +   T+Q+L+G+ +LH ++I+HRD+K  N+LI T +G LKI+DFG 
Sbjct: 110 LRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGT 169

Query: 180 AKTF-DYDMMLTSVVVTLWYRAPEILL--NLGYGTPVDIWSIGCVMAEMWRLVPLFCAST 236
           +K     +    +   TL Y APEI+     GYG   DIWS+GC + EM    P F    
Sbjct: 170 SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF--YE 227

Query: 237 EVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTF 296
             E    +F+V       E PE++          S  A +  F+  C             
Sbjct: 228 LGEPQAAMFKVGMFKVHPEIPESM----------SAEAKA--FILKC----------FEP 265

Query: 297 NPADRISAADALEHPYFKEK 316
           +P  R  A D L   + K  
Sbjct: 266 DPDKRACANDLLVDEFLKVS 285

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  180 bits (458), Expect = 5e-54
 Identities = 73/313 (23%), Positives = 125/313 (39%), Gaps = 62/313 (19%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
             YD L ++G GA+G V +  +    G     K +      D    +   EISI+ QL  
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKAT-GRVFVAKFINTPYPLD--KYTVKNEISIMNQLH- 106

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLI---------FEHVDQDLGSYMEKCPPPGLSA 132
             HP ++   D        D+    + LI         F+ +  +     E         
Sbjct: 107 --HPKLINLHDAF-----EDKYE--MVLILEFLSGGELFDRIAAEDYKMSEA-------- 149

Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG--LKIADFGLAKTFDYDMMLT 190
            +V    RQ  +G+  +H H I+H D+KP+N++        +KI DFGLA   + D ++ 
Sbjct: 150 -EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208

Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL---VPLFCASTEVEQLKCIFRV 247
               T  + APEI+     G   D+W+IG V+  +  L   +  F    ++E L+ + R 
Sbjct: 209 VTTATAEFAAPEIVDREPVGFYTDMWAIG-VLGYV--LLSGLSPFAGEDDLETLQNVKRC 265

Query: 248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
                 + +  ++S                       +A   ++++L   P  R++  DA
Sbjct: 266 DWEFDEDAFS-SVS----------------------PEAKDFIKNLLQKEPRKRLTVHDA 302

Query: 308 LEHPYFKEKENEP 320
           LEHP+ K   +  
Sbjct: 303 LEHPWLKGDHSNL 315

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  179 bits (455), Expect = 9e-54
 Identities = 78/319 (24%), Positives = 137/319 (42%), Gaps = 74/319 (23%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIP---MSTLREISI 75
           +KYD    IG G    V +       G+  A+K       +L+ + +     +T RE  I
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRAT-GHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPP 127
           L+Q+    HP+I+   D           +  ++L+F+ +          +  +  EK   
Sbjct: 153 LRQV--AGHPHIITLIDSY-----ESSSF--MFLVFDLMRKGELFDYLTEKVALSEK--- 200

Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM 187
                 + + + R +L+ V FLH++ I+HRDLKP+N+L+     ++++DFG +   +   
Sbjct: 201 ------ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254

Query: 188 MLTSVVVTLWYRAPEIL------LNLGYGTPVDIWSIGCVMAEMWRL--VPLFCASTEVE 239
            L  +  T  Y APEIL       + GYG  VD+W+ G ++  +  L   P F    ++ 
Sbjct: 255 KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL--LAGSPPFWHRRQIL 312

Query: 240 QLKCIFRVI--GTPSMN--EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLT 295
               + R+I  G    +  EW  + S                      S    L+  +L 
Sbjct: 313 ----MLRMIMEGQYQFSSPEWD-DRS----------------------STVKDLISRLLQ 345

Query: 296 FNPADRISAADALEHPYFK 314
            +P  R++A  AL+HP+F+
Sbjct: 346 VDPEARLTAEQALQHPFFE 364

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  177 bits (451), Expect = 1e-53
 Identities = 77/319 (24%), Positives = 126/319 (39%), Gaps = 69/319 (21%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK-----KLRVKLNEDGIPMSTL-REISI 75
            +Y     +G GA G V  A + +     VA+K     K  +    +  P   +  EI I
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKT-CKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPP 127
           LK+L+   HP I++  +               Y++ E ++               E    
Sbjct: 69  LKKLN---HPCIIKIKNFFDAE--------DYYIVLELMEGGELFDKVVGNKRLKEA--- 114

Query: 128 PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFD 184
                   K    QML  V +LH + IIHRDLKP+N+L++       +KI DFG +K   
Sbjct: 115 ------TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168

Query: 185 YDMMLTSVVVTLWYRAPEILLNL---GYGTPVDIWSIGCVMAEMWRLV---PLFCASTEV 238
              ++ ++  T  Y APE+L+++   GY   VD WS+G ++     L    P     T+V
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC--LSGYPPFSEHRTQV 226

Query: 239 EQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNP 298
                I           W   +S                       KA  L++ +L  +P
Sbjct: 227 SLKDQITSGKYNFIPEVWA-EVS----------------------EKALDLVKKLLVVDP 263

Query: 299 ADRISAADALEHPYFKEKE 317
             R +  +AL HP+ ++++
Sbjct: 264 KARFTTEEALRHPWLQDED 282

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  177 bits (451), Expect = 1e-53
 Identities = 65/315 (20%), Positives = 120/315 (38%), Gaps = 67/315 (21%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY     +G G +G V +  +  +       K ++VK  +    +   +EISIL     
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSS-KKTYMAKFVKVKGTDQ---VLVKKEISILNIAR- 59

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD---------QDLGSYMEKCPPPGLSA 132
             H NI+   +         E    + +IFE +                 E+        
Sbjct: 60  --HRNILHLHESF-------ESMEELVMIFEFISGLDIFERINTSAFELNER-------- 102

Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG--LKIADFGLAKTFDYDMMLT 190
            ++     Q+ + + FLHSH I H D++P+N++        +KI +FG A+         
Sbjct: 103 -EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161

Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL---VPLFCASTEVEQLKCIFRV 247
            +     Y APE+  +    T  D+WS+G  +  +  L   +  F A T  + ++ I   
Sbjct: 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLG-TLVYV--LLSGINPFLAETNQQIIENIMN- 217

Query: 248 IGTPSMNE--WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA 305
               + +E  +   IS                       +A   ++ +L      R++A+
Sbjct: 218 -AEYTFDEEAFK-EIS----------------------IEAMDFVDRLLVKERKSRMTAS 253

Query: 306 DALEHPYFKEKENEP 320
           +AL+HP+ K+K    
Sbjct: 254 EALQHPWLKQKIERV 268

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  178 bits (453), Expect = 1e-53
 Identities = 77/318 (24%), Positives = 124/318 (38%), Gaps = 65/318 (20%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTL-REISILK 77
             YD   ++G G +  V K R+    G   A K   K + + +  G+    + RE+SIL+
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKST-GLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPPG 129
           Q+    HPNI+   DV       +     V LI E V             S  E+     
Sbjct: 71  QVL---HPNIITLHDVY-----ENRTD--VVLILELVSGGELFDFLAQKESLSEE----- 115

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG----LKIADFGLAKTFDY 185
               +     +Q+L GV++LH+ +I H DLKP+N+++         +K+ DFGLA   + 
Sbjct: 116 ----EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171

Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL---VPLFCASTEVEQLK 242
            +   ++  T  + APEI+     G   D+WSIG V+  +  L      F   T+ E L 
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYI--LLSGASPFLGDTKQETLA 228

Query: 243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI 302
            I  V        +    S                        A   +  +L      R+
Sbjct: 229 NITAVSYDFDEEFFS-QTS----------------------ELAKDFIRKLLVKETRKRL 265

Query: 303 SAADALEHPYFKEKENEP 320
           +  +AL HP+    + + 
Sbjct: 266 TIQEALRHPWITPVDTQQ 283

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  176 bits (448), Expect = 3e-53
 Identities = 69/314 (21%), Positives = 123/314 (39%), Gaps = 72/314 (22%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
            +G G++    K    ++     A+K +  ++  +     T +EI+ LK  +   HPNIV
Sbjct: 18  PLGEGSFSICRKCVHKKS-NQAFAVKIISKRMEAN-----TQKEITALKLCE--GHPNIV 69

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPPGLSASKVKELTR 140
           +  +V H     D+ +   +L+ E ++        +    + E          +   + R
Sbjct: 70  KLHEVFH-----DQLH--TFLVMELLNGGELFERIKKKKHFSET---------EASYIMR 113

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYD-MMLTSVVVTL 196
           +++  V  +H   ++HRDLKP+NLL T       +KI DFG A+    D   L +   TL
Sbjct: 114 KLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTL 173

Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL--VPLFCASTEVEQLKC---IFRVIGT- 250
            Y APE+L   GY    D+WS+G ++  M  L     F +            I + I   
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTM--LSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231

Query: 251 ----PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
                    W  N+S                       +A  L++ +LT +P  R+  + 
Sbjct: 232 DFSFEG-EAWK-NVS----------------------QEAKDLIQGLLTVDPNKRLKMSG 267

Query: 307 ALEHPYFKEKENEP 320
              + + ++     
Sbjct: 268 LRYNEWLQDGSQLS 281

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  177 bits (451), Expect = 4e-53
 Identities = 74/312 (23%), Positives = 125/312 (40%), Gaps = 64/312 (20%)

Query: 21  DKKYD--ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           +  Y   +   +G G +G V K  +    G  +A K ++ +  +D        EIS++ Q
Sbjct: 86  NSFYTVSKTEILGGGRFGQVHKCEETAT-GLKLAAKIIKTRGMKD--KEEVKNEISVMNQ 142

Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD---------QDLGSYMEKCPPPG 129
           LD   H N+++ +D         E    + L+ E+VD          +  +  E      
Sbjct: 143 LD---HANLIQLYDAF-------ESKNDIVLVMEYVDGGELFDRIIDESYNLTEL----- 187

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG--LKIADFGLAKTFDYDM 187
                     +Q+ +G+  +H   I+H DLKP+N+L        +KI DFGLA+ +    
Sbjct: 188 ----DTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243

Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL---VPLFCASTEVEQLKCI 244
            L     T  + APE++       P D+WS+G V+A M  L   +  F    + E L  I
Sbjct: 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVG-VIAYM--LLSGLSPFLGDNDAETLNNI 300

Query: 245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA 304
                     E+  +IS                       +A   +  +L    + RISA
Sbjct: 301 LACRWDLEDEEFQ-DIS----------------------EEAKEFISKLLIKEKSWRISA 337

Query: 305 ADALEHPYFKEK 316
           ++AL+HP+  + 
Sbjct: 338 SEALKHPWLSDH 349

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  181 bits (462), Expect = 6e-53
 Identities = 68/316 (21%), Positives = 117/316 (37%), Gaps = 66/316 (20%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
              YD   ++G GA+G V +  + +  GN  A K +      D    +  +EI  +  L 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTE-RATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLR 212

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD---------QDLGSYMEKCPPPGLS 131
              HP +V   D        D+    + +I+E +           +     E        
Sbjct: 213 ---HPTLVNLHDAF-----EDDNE--MVMIYEFMSGGELFEKVADEHNKMSED------- 255

Query: 132 ASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG--LKIADFGLAKTFDYDMML 189
             +  E  RQ+ KG+  +H +  +H DLKP+N++ T      LK+ DFGL    D    +
Sbjct: 256 --EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313

Query: 190 TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL---VPLFCASTEVEQLKCIFR 246
                T  + APE+      G   D+WS+G V++ +  L   +  F    + E L+ +  
Sbjct: 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVG-VLSYI--LLSGLSPFGGENDDETLRNVKS 370

Query: 247 VIGTPSMNE--WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA 304
                +M++  +   IS                            +  +L  +P  R++ 
Sbjct: 371 --CDWNMDDSAFS-GIS----------------------EDGKDFIRKLLLADPNTRMTI 405

Query: 305 ADALEHPYFKEKENEP 320
             ALEHP+        
Sbjct: 406 HQALEHPWLTPGNAPG 421

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  175 bits (444), Expect = 1e-52
 Identities = 75/358 (20%), Positives = 136/358 (37%), Gaps = 98/358 (27%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
             ++ +  +G G +G VF+A++  +  NY A+K++R+   E       +RE+  L +L+ 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNY-AIKRIRLPNRELAR-EKVMREVKALAKLE- 62

Query: 82  FEHPNIVRFF-------------------------------------------------- 91
             HP IVR+F                                                  
Sbjct: 63  --HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFST 120

Query: 92  DVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEK-CPPPGLSASKVKELTRQMLKGVDFL 149
                 +      + +Y+  +    ++L  +M + C            +  Q+ + V+FL
Sbjct: 121 KNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180

Query: 150 HSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM-------------LTSVVVTL 196
           HS  ++HRDLKP N+  T    +K+ DFGL    D D                T  V T 
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240

Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW 256
            Y +PE +    Y   VDI+S+G ++ E+         ST++E+++ I  V         
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELL--YSF---STQMERVRIITDVR-------- 287

Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
                           + F  +F     + + +++ ML+ +P +R  A D +E+  F+
Sbjct: 288 ---------------NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  175 bits (445), Expect = 1e-52
 Identities = 74/309 (23%), Positives = 121/309 (39%), Gaps = 65/309 (21%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G  G V +    +  G   A+K L              +E+    Q      P+IV 
Sbjct: 37  LGLGVNGKVLECFHRRT-GQKCALKLLYDS-------PKARQEVDHHWQAS--GGPHIVC 86

Query: 90  FFDVIHQNILSDERYLTVYLIFEH----------VDQDLGSYMEKCPPPGLSASKVKELT 139
             DV ++N+   +R   + +I E            ++   ++ E+         +  E+ 
Sbjct: 87  ILDV-YENMHHGKRC--LLIIMECMEGGELFSRIQERGDQAFTER---------EAAEIM 134

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMMLTSVVVTL 196
           R +   + FLHSH I HRD+KP+NLL T       LK+ DFG AK    + + T    T 
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT-PCYTP 193

Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT-----P 251
           +Y APE+L    Y    D+WS+G +M  +    P F ++T       + R I       P
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253

Query: 252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
           +  EW   +S                        A  L+  +L  +P +R++    + HP
Sbjct: 254 N-PEWS-EVS----------------------EDAKQLIRLLLKTDPTERLTITQFMNHP 289

Query: 312 YFKEKENEP 320
           +  +    P
Sbjct: 290 WINQSMVVP 298

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  174 bits (442), Expect = 4e-52
 Identities = 62/317 (19%), Positives = 125/317 (39%), Gaps = 46/317 (14%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL---------------RVKLNEDGIPMSTLREIS 74
           +  G +  +           + A+KK                  K++          E+ 
Sbjct: 39  LNQGKFNKIILCE---KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95

Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-------DLGSYMEKCPP 127
           I+  +    +   +    +I      +   +  Y+I+E+++        +    ++K   
Sbjct: 96  IITDIK---NEYCLTCEGIIT-----NYDEV--YIIYEYMENDSILKFDEYFFVLDKNYT 145

Query: 128 PGLSASKVKELTRQMLKGVDFLHSHR-IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD 186
             +    +K + + +L    ++H+ + I HRD+KP N+L+ + G +K++DFG ++    D
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV-D 204

Query: 187 MMLTSVVVTLWYRAPEILLNLG--YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI 244
             +     T  +  PE   N     G  VDIWS+G  +  M+  V  F     + +L   
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL--- 261

Query: 245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA 304
           F  I T ++ E+P + +              +    +   +    L+  L  NPA+RI++
Sbjct: 262 FNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSN---EDIDFLKLFLRKNPAERITS 317

Query: 305 ADALEHPYFKEKENEPL 321
            DAL+H +  +   E L
Sbjct: 318 EDALKHEWLADTNIEDL 334

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  173 bits (441), Expect = 5e-52
 Identities = 72/354 (20%), Positives = 121/354 (34%), Gaps = 93/354 (26%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILKQ 78
           KKY     IG G+YG V  A + Q      A+K   K +++            E+ ++K+
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQT-RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV------------------------ 114
           L    HPNI R ++V       DE+Y  + L+ E                          
Sbjct: 85  LH---HPNIARLYEVY-----EDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134

Query: 115 ---------------DQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDL 159
                                   +          +  + RQ+   + +LH+  I HRD+
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDI 194

Query: 160 KPQNLLITRAGG--LKIADFGLAKTFDY-----DMMLTSVVVTLWYRAPEILLNLG--YG 210
           KP+N L +      +K+ DFGL+K F          +T+   T ++ APE+L      YG
Sbjct: 195 KPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254

Query: 211 TPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI--GTPSMN--EWPENISLMWSS 266
              D WS G ++  +      F    + +        +           +   +S     
Sbjct: 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDAD----TISQVLNKKLCFENPNYN-VLS----- 304

Query: 267 FEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                              A  LL ++L  N  +R  A  AL+HP+  +  ++ 
Sbjct: 305 -----------------PLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKI 341

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  172 bits (437), Expect = 2e-51
 Identities = 74/317 (23%), Positives = 119/317 (37%), Gaps = 68/317 (21%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
             Y+    IG G+Y    +           A+K +               EI IL +   
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKAT-NMEFAVKIIDKS------KRDPTEEIEILLRYG- 73

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPPGLSAS 133
            +HPNI+   DV       D +Y  VY++ E +              + E+         
Sbjct: 74  -QHPNIITLKDVYD-----DGKY--VYVVTELMKGGELLDKILRQKFFSER--------- 116

Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR----AGGLKIADFGLAKTFDYD-MM 188
           +   +   + K V++LH+  ++HRDLKP N+L          ++I DFG AK    +  +
Sbjct: 117 EASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176

Query: 189 LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           L +   T  + APE+L   GY    DIWS+G ++  M      F A+   +  + I   I
Sbjct: 177 LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF-ANGPDDTPEEILARI 235

Query: 249 GT-----PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS 303
           G+          W  ++S                        A  L+  ML  +P  R++
Sbjct: 236 GSGKFSLSG-GYWN-SVS----------------------DTAKDLVSKMLHVDPHQRLT 271

Query: 304 AADALEHPYFKEKENEP 320
           AA  L HP+    +  P
Sbjct: 272 AALVLRHPWIVHWDQLP 288

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  173 bits (440), Expect = 3e-51
 Identities = 71/320 (22%), Positives = 127/320 (39%), Gaps = 69/320 (21%)

Query: 22  KKYDELCQ-IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
             Y    Q +G G  G V +  + +      A+K L+             RE+ +  +  
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRT-QEKFALKMLQDC-------PKARREVELHWRAS 112

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEH----------VDQDLGSYMEKCPPPGL 130
             + P+IVR  DV ++N+ +  +   + ++ E            D+   ++ E+      
Sbjct: 113 --QCPHIVRIVDV-YENLYAGRKC--LLIVMECLDGGELFSRIQDRGDQAFTER------ 161

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDM 187
              +  E+ + + + + +LHS  I HRD+KP+NLL T       LK+ DFG AK      
Sbjct: 162 ---EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218

Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL--VPLFCASTEVEQLKCIF 245
            LT+   T +Y APE+L    Y    D+WS+G +M  +  L   P F ++  +     + 
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL--LCGYPPFYSNHGLAISPGMK 276

Query: 246 RVIGT-----PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD 300
             I       P+  EW   +S                       +   L+ ++L   P  
Sbjct: 277 TRIRMGQYEFPN-PEWS-EVS----------------------EEVKMLIRNLLKTEPTQ 312

Query: 301 RISAADALEHPYFKEKENEP 320
           R++  + + HP+  +    P
Sbjct: 313 RMTITEFMNHPWIMQSTKVP 332

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  172 bits (437), Expect = 4e-51
 Identities = 47/328 (14%), Positives = 95/328 (28%), Gaps = 77/328 (23%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVK--------------------LNEDGIPMST 69
           +G        +A D +  G    +                          L         
Sbjct: 81  LGQEDPYAYLEATDQET-GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLG-------SYM 122
              +  +   D  + P   +   V       D   L+ + ++  +  +L        S+ 
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDE--RDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197

Query: 123 EKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT 182
                    A    +LT Q+++ +  LH + ++H  L+P ++++ + GG+ +  F     
Sbjct: 198 STHKSLVHHARL--QLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 183 FDYDMMLTSVVVTLWYRAPEILLNLG-----------YGTPVDIWSIGCVMAEMWRLVPL 231
                      V+  +  PE+                     D W++G V+  +W     
Sbjct: 256 DG---ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

Query: 232 FCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLE 291
                 +   + IFR           +NI                           +LLE
Sbjct: 313 ITKDAALGGSEWIFRS---------CKNIP----------------------QPVRALLE 341

Query: 292 SMLTFNPADRISAADALEHPYFKEKENE 319
             L +   DR+    A+E P +++   E
Sbjct: 342 GFLRYPKEDRLLPLQAMETPEYEQLRTE 369

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  169 bits (431), Expect = 1e-50
 Identities = 72/316 (22%), Positives = 131/316 (41%), Gaps = 54/316 (17%)

Query: 16  SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISI 75
           +++LG+ +      +  G +  V++A+D+ + G   A+K+L     E     + ++E+  
Sbjct: 22  TVELGELRLRVRRVLAEGGFAFVYEAQDVGS-GREYALKRLLSNEEEKN--RAIIQEVCF 78

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIF-EHVDQDLGSYMEKCPPPG-LSAS 133
           +K+L    HPNIV+F           +     +L+  E     L  +++K    G LS  
Sbjct: 79  MKKL--SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD 136

Query: 134 KVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS 191
            V ++  Q  + V  +H  +  IIHRDLK +NLL++  G +K+ DFG A T  +    + 
Sbjct: 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196

Query: 192 VVV-------------TLWYRAPEIL---LNLGYGTPVDIWSIGCVMAEMWRLVPLFCAS 235
                           T  YR PEI+    N   G   DIW++GC++  +      F   
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256

Query: 236 TEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLT 295
            ++  +   +           P + +                      +  +SL+ +ML 
Sbjct: 257 AKLRIVNGKYS---------IPPHDT--------QY------------TVFHSLIRAMLQ 287

Query: 296 FNPADRISAADALEHP 311
            NP +R+S A+ +   
Sbjct: 288 VNPEERLSIAEVVHQL 303

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  170 bits (432), Expect = 5e-50
 Identities = 44/322 (13%), Positives = 95/322 (29%), Gaps = 66/322 (20%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRV--------------------KLNEDGIPMST 69
           +G        +A D +  G    +                          L         
Sbjct: 86  LGQEDPYAYLEATDQET-GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG 129
              +  +   D  + P   +   V       D   L+ + ++  +  +L ++ E      
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDE--RDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202

Query: 130 -----LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD 184
                L      +LT Q+++ +  LH + ++H  L+P ++++ + GG+ +  F       
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 185 --YDMMLTSVVVTLWYRAPEILLNLG-----YGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
                 +          A  +L              D W++G  +  +W           
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA 322

Query: 238 VEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFN 297
           +   + IFR     ++   P+ +                           +LLE  L + 
Sbjct: 323 LGGSEWIFR--SCKNI---PQPVR--------------------------ALLEGFLRYP 351

Query: 298 PADRISAADALEHPYFKEKENE 319
             DR+    A+E P +++   E
Sbjct: 352 KEDRLLPLQAMETPEYEQLRTE 373

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  165 bits (421), Expect = 2e-49
 Identities = 86/320 (26%), Positives = 137/320 (42%), Gaps = 78/320 (24%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMK---KLRVK---------------------LNEDGI 65
           IG G+YG V  A +  +   Y AMK   K ++                      +   G 
Sbjct: 21  IGKGSYGVVKLAYNEND-NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 66  PMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKC 125
                +EI+ILK+LD   HPN+V+  +V+      +E +L  Y++FE V+Q  G  ME  
Sbjct: 80  IEQVYQEIAILKKLD---HPNVVKLVEVLDD---PNEDHL--YMVFELVNQ--GPVMEVP 129

Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-D 184
               LS  + +   + ++KG+++LH  +IIHRD+KP NLL+   G +KIADFG++  F  
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 185 YDMMLTSVVVTLWYRAPEILLNL--GY-GTPVDIWSIGCVMAEMWRLVPLFCAST----- 236
            D +L++ V T  + APE L      + G  +D+W++G           L+C        
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT---------LYCFVFGQCPF 240

Query: 237 EVEQLKCIFRVI--GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESML 294
             E++ C+   I        + P+                 +            L+  ML
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPD----------------IA-------EDLKDLITRML 277

Query: 295 TFNPADRISAADALEHPYFK 314
             NP  RI   +   HP+  
Sbjct: 278 DKNPESRIVVPEIKLHPWVT 297

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  160 bits (408), Expect = 2e-47
 Identities = 67/328 (20%), Positives = 107/328 (32%), Gaps = 91/328 (27%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G GA+  V    +L       A+K   K    +          RE+ +L Q     H N
Sbjct: 21  LGEGAHARVQTCINLIT-SQEYAVKIIEKQPGHIRSR-----VFREVEMLYQCQ--GHRN 72

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVD--------QDLGSYMEKCPPPGLSASKVKEL 138
           ++   +        +E     YL+FE +              + E        AS V   
Sbjct: 73  VLELIEFFE-----EEDR--FYLVFEKMRGGSILSHIHKRRHFNEL------EASVV--- 116

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDM-------- 187
            + +   +DFLH+  I HRDLKP+N+L         +KI DF L      +         
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176

Query: 188 MLTSVVVTLWYRAPEILLNL-----GYGTPVDIWSIGCVM-----------AEMWRLVPL 231
            L +   +  Y APE++         Y    D+WS+G ++                    
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236

Query: 232 FCASTEVEQLKCIFRVIGT-----PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKA 286
                       +F  I       P   +W  +IS                        A
Sbjct: 237 DRGEACPACQNMLFESIQEGKYEFPD-KDWA-HIS----------------------CAA 272

Query: 287 NSLLESMLTFNPADRISAADALEHPYFK 314
             L+  +L  +   R+SAA  L+HP+ +
Sbjct: 273 KDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  159 bits (403), Expect = 2e-46
 Identities = 70/309 (22%), Positives = 129/309 (41%), Gaps = 57/309 (18%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTL-----REISI 75
           +KY  +  +G GA+G V+ A D +     V +K + + K+ ED             EI+I
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEK-NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFE-HVD-QDLGSYMEKCPPPGLSAS 133
           L +++   H NI++  D+       ++ +    L+ E H    DL +++++   P L   
Sbjct: 83  LSRVE---HANIIKVLDIF-----ENQGFF--QLVMEKHGSGLDLFAFIDR--HPRLDEP 130

Query: 134 KVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVV 193
               + RQ++  V +L    IIHRD+K +N++I     +K+ DFG A   +   +  +  
Sbjct: 131 LASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC 190

Query: 194 VTLWYRAPEILLNLGY-GTPVDIWSIGCVM-AEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
            T+ Y APE+L+   Y G  +++WS+G  +   ++   P FC   E   ++         
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP-FCELEET--VEAAIHP---- 243

Query: 252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                P  +S                       +  SL+  +L   P  R +    +  P
Sbjct: 244 -----PYLVS----------------------KELMSLVSGLLQPVPERRTTLEKLVTDP 276

Query: 312 YFKEKENEP 320
           +  +  N  
Sbjct: 277 WVTQPVNLA 285

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  157 bits (400), Expect = 4e-46
 Identities = 79/301 (26%), Positives = 123/301 (40%), Gaps = 56/301 (18%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           IG G +  V  AR +   G  VA+K + + +LN   +     RE+ I+K L+   HPNIV
Sbjct: 23  IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQK-LFREVRIMKILN---HPNIV 77

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + F+VI       E   T+YLI E+    ++  Y+       +   + +   RQ++  V 
Sbjct: 78  KLFEVI-------ETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQ 128

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + H  RI+HRDLK +NLL+     +KIADFG +  F     L +      Y APE+    
Sbjct: 129 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGK 188

Query: 208 GY-GTPVDIWSIGCVMAEMWRLVPLFC------ASTEVEQLKCIFRVIGTPSMNEWPENI 260
            Y G  VD+WS+G +      L  L             E  + + R  G   +   P  +
Sbjct: 189 KYDGPEVDVWSLGVI------LYTLVSGSLPFDGQNLKELRERVLR--GKYRI---PFYM 237

Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
           S                      +   +LL+  L  NP  R +    ++  +      E 
Sbjct: 238 S----------------------TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEED 275

Query: 321 L 321
            
Sbjct: 276 E 276

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  157 bits (398), Expect = 1e-45
 Identities = 76/298 (25%), Positives = 131/298 (43%), Gaps = 50/298 (16%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G++G V  A   +     VA+K + R  L +  + M   REIS LK L    HP+I+
Sbjct: 17  LGEGSFGKVKLATHYKT-QQKVALKFISRQLLKKSDMHMRVEREISYLKLLR---HPHII 72

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
           + +DVI            + ++ E+   +L  Y+ +     ++  + +   +Q++  +++
Sbjct: 73  KLYDVI-------TTPTDIVMVIEYAGGELFDYIVEKKR--MTEDEGRRFFQQIICAIEY 123

Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLG 208
            H H+I+HRDLKP+NLL+     +KIADFGL+        L +   +  Y APE++    
Sbjct: 124 CHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKL 183

Query: 209 Y-GTPVDIWSIGCVMAEMWRLVPLFCAST--EVEQLKCIFRVI--GTPSMNEWPENISLM 263
           Y G  VD+WS G V      L  +       + E +  +F+ +      M   P+ +S  
Sbjct: 184 YAGPEVDVWSCGIV------LYVMLVGRLPFDDEFIPNLFKKVNSCVYVM---PDFLS-- 232

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL 321
                                 A SL+  M+  +P  RI+  +    P+F     + L
Sbjct: 233 --------------------PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYL 270

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  155 bits (393), Expect = 2e-45
 Identities = 83/306 (27%), Positives = 137/306 (44%), Gaps = 64/306 (20%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           KKY    +IG GA GTV+ A D+   G  VA++++ ++       +  + EI ++++   
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVAT-GQEVAIRQMNLQQQPKKELI--INEILVMRENK- 75

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP---------PPGLSA 132
             +PNIV + D               YL    V  +L   ME               +  
Sbjct: 76  --NPNIVNYLDS--------------YL----VGDELWVVMEYLAGGSLTDVVTETCMDE 115

Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM-LTS 191
            ++  + R+ L+ ++FLHS+++IHRD+K  N+L+   G +K+ DFG       +    ++
Sbjct: 116 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175

Query: 192 VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMA-EMWRLVPLFCASTEVEQLKCIFRV--I 248
           +V T ++ APE++    YG  VDIWS+G +MA EM    P +        L+ ++ +   
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMIEGEPPYL---NENPLRALYLIATN 231

Query: 249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL 308
           GTP +   PE                 SAIF D        L   L  +   R SA + L
Sbjct: 232 GTPELQN-PEK---------------LSAIFRD-------FLNRCLEMDVEKRGSAKELL 268

Query: 309 EHPYFK 314
           +H + K
Sbjct: 269 QHQFLK 274

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  155 bits (393), Expect = 3e-45
 Identities = 72/312 (23%), Positives = 115/312 (36%), Gaps = 61/312 (19%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTL-REISILK 77
            +Y     +G G +GTVF    L +    VA+K   + RV          T   E+++L 
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTD-RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89

Query: 78  QLDT-FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--QDLGSYMEKCPPPGLSASK 134
           ++     HP ++R  D         E      L+ E     QDL  Y+ +  P  L    
Sbjct: 90  KVGAGGGHPGVIRLLDWF-------ETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGP 140

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTSVV 193
            +    Q++  +   HS  ++HRD+K +N+LI  R G  K+ DFG      +D   T   
Sbjct: 141 SRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFD 199

Query: 194 VTLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCAS----TEVEQLKCIFRVI 248
            T  Y  PE +    Y   P  +WS+G +      L  + C       + E L+      
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGIL------LYDMVCGDIPFERDQEILEAELHF- 252

Query: 249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL 308
                   P ++S                   DCC    +L+   L   P+ R S  + L
Sbjct: 253 --------PAHVS------------------PDCC----ALIRRCLAPKPSSRPSLEEIL 282

Query: 309 EHPYFKEKENEP 320
             P+ +    + 
Sbjct: 283 LDPWMQTPAEDV 294

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  155 bits (393), Expect = 4e-45
 Identities = 72/306 (23%), Positives = 128/306 (41%), Gaps = 64/306 (20%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
              D   +IG G+ G V  AR+  + G  VA+K + ++  +    +    E+ I++    
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHS-GRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQ- 100

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP---------PPGLSA 132
             H N+V  +                YL    V ++L   ME               L+ 
Sbjct: 101 --HFNVVEMYKS--------------YL----VGEELWVLMEFLQGGALTDIVSQVRLNE 140

Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM-LTS 191
            ++  +   +L+ + +LH+  +IHRD+K  ++L+T  G +K++DFG       D+    S
Sbjct: 141 EQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200

Query: 192 VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMA-EMWRLVPLFCASTEVEQLKCIFRV--I 248
           +V T ++ APE++    Y T VDIWS+G +M  EM    P +        ++ + R+   
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLG-IMVIEMVDGEPPYF---SDSPVQAMKRLRDS 256

Query: 249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL 308
             P +    +                 S +  D        LE ML  +P +R +A + L
Sbjct: 257 PPPKLKNSHK----------------VSPVLRD-------FLERMLVRDPQERATAQELL 293

Query: 309 EHPYFK 314
           +HP+  
Sbjct: 294 DHPFLL 299

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  153 bits (390), Expect = 4e-45
 Identities = 82/299 (27%), Positives = 128/299 (42%), Gaps = 51/299 (17%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V         G+ VA+K L R K+    +     REI  LK      HP+I+
Sbjct: 19  LGVGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR---HPHII 74

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + + VI             +++ E+V   +L  Y+ K     +   + + L +Q+L  VD
Sbjct: 75  KLYQVI-------STPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVD 125

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + H H ++HRDLKP+N+L+      KIADFGL+        L +   +  Y APE++   
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 185

Query: 208 GY-GTPVDIWSIGCVMAEMWRLVPLFCAST--EVEQLKCIFRVI--GTPSMNEWPENISL 262
            Y G  VDIWS G +      L  L C +   + E +  +F+ I  G   +   PE ++ 
Sbjct: 186 LYAGPEVDIWSCGVI------LYALLCGTLPFDDEHVPTLFKKIRGGVFYI---PEYLN- 235

Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL 321
                                    +LL  ML  +P  R +  D  EH +FK+     L
Sbjct: 236 ---------------------RSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  155 bits (393), Expect = 4e-45
 Identities = 63/303 (20%), Positives = 121/303 (39%), Gaps = 55/303 (18%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTL---REISILK 77
            +Y     +G G +G+V+    + +    VA+K + + ++++ G   +      E+ +LK
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSD-NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 101

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD--QDLGSYMEKCPPPGLSASKV 135
           ++ +     ++R  D         ER  +  LI E  +  QDL  ++ +     L     
Sbjct: 102 KVSS-GFSGVIRLLDWF-------ERPDSFVLILERPEPVQDLFDFITERGA--LQEELA 151

Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLI-TRAGGLKIADFGLAKTFDYDMMLTSVVV 194
           +    Q+L+ V   H+  ++HRD+K +N+LI    G LK+ DFG       D + T    
Sbjct: 152 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDG 210

Query: 195 TLWYRAPEILLNLGY-GTPVDIWSIGCVM-AEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
           T  Y  PE +    Y G    +WS+G ++   +   +P F    E+  ++          
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-FEHDEEI--IRGQVFF----- 262

Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
                + +S                   +C      L+   L   P+DR +  +   HP+
Sbjct: 263 ----RQRVS------------------SECQ----HLIRWCLALRPSDRPTFEEIQNHPW 296

Query: 313 FKE 315
            ++
Sbjct: 297 MQD 299

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  153 bits (389), Expect = 1e-44
 Identities = 62/317 (19%), Positives = 114/317 (35%), Gaps = 84/317 (26%)

Query: 22  KKYDELCQ-IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
             Y    Q +G G  G V +  + +      A+K L+             RE+ +  +  
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRT-QEKFALKMLQDC-------PKARREVELHWRAS 68

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEH----------VDQDLGSYMEKCPPPGL 130
             + P+IVR  DV ++N+ +  +   + ++ E            D+   ++ E+      
Sbjct: 69  --QCPHIVRIVDV-YENLYAGRKC--LLIVMECLDGGELFSRIQDRGDQAFTER------ 117

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDM 187
              +  E+ + + + + +LHS  I HRD+KP+NLL T       LK+ DFG         
Sbjct: 118 ---EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-------- 166

Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
                       A E      Y    D+WS+G +M  +    P F ++  +     +   
Sbjct: 167 ------------AKET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 213

Query: 248 I--GTPSMN--EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS 303
           I  G       EW   +S                       +   L+ ++L   P  R++
Sbjct: 214 IRMGQYEFPNPEWS-EVS----------------------EEVKMLIRNLLKTEPTQRMT 250

Query: 304 AADALEHPYFKEKENEP 320
             + + HP+  +    P
Sbjct: 251 ITEFMNHPWIMQSTKVP 267

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  153 bits (389), Expect = 1e-44
 Identities = 73/301 (24%), Positives = 126/301 (41%), Gaps = 47/301 (15%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTL-REISILKQLDTFEHPNI 87
           +G G+YG V +  D +      A+K L + KL       + + +EI +L++L    H N+
Sbjct: 13  LGEGSYGKVKEVLDSET-LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR---HKNV 68

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           ++  DV+      +E    +Y++ E+    +   ++  P       +      Q++ G++
Sbjct: 69  IQLVDVL-----YNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA---KTFDYDMMLTSVVVTLWYRAPEIL 204
           +LHS  I+H+D+KP NLL+T  G LKI+  G+A     F  D    +   +  ++ PEI 
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183

Query: 205 LNL-GY-GTPVDIWSIGCVMAEMWRLVPLFCAST--EVEQLKCIFRVIGTPSMNEWPENI 260
             L  + G  VDIWS G        L  +       E + +  +F  IG       P + 
Sbjct: 184 NGLDTFSGFKVDIWSAGVT------LYNITTGLYPFEGDNIYKLFENIGK-GSYAIPGDC 236

Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                                     + LL+ ML + PA R S     +H +F++K    
Sbjct: 237 G----------------------PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274

Query: 321 L 321
            
Sbjct: 275 E 275

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  154 bits (390), Expect = 1e-44
 Identities = 72/325 (22%), Positives = 138/325 (42%), Gaps = 42/325 (12%)

Query: 5   SADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG 64
           S+  ++       D   +   +L +IG GAYG+V K     + G  +A+K++R  ++E  
Sbjct: 5   SSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPS-GQIMAVKRIRSTVDEKE 63

Query: 65  IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD---QDLGSY 121
                L ++ ++ +  + + P IV+F+  + +    D      ++  E +         Y
Sbjct: 64  QK-QLLMDLDVVMR--SSDCPYIVQFYGALFRE--GD-----CWICMELMSTSFDKFYKY 113

Query: 122 MEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFGLA 180
           +       +    + ++T   +K ++ L    +IIHRD+KP N+L+ R+G +K+ DFG++
Sbjct: 114 VYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173

Query: 181 KTFDYDMMLTSVVVTLWYRAPEIL----LNLGYGTPVDIWSIGCVMAEMWRLVPLFCA-S 235
                 +  T       Y APE +       GY    D+WS+G  + E+      +   +
Sbjct: 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233

Query: 236 TEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLT 295
           +  +QL  +  V G P     P    L  S   ++S    +  F++ C          LT
Sbjct: 234 SVFDQLTQV--VKGDP-----P---QLSNSEEREFSPSFIN--FVNLC----------LT 271

Query: 296 FNPADRISAADALEHPYFKEKENEP 320
            + + R    + L+HP+    E   
Sbjct: 272 KDESKRPKYKELLKHPFILMYEERA 296

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  152 bits (386), Expect = 1e-43
 Identities = 74/336 (22%), Positives = 129/336 (38%), Gaps = 62/336 (18%)

Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           +L D  ++++ ++G G  G VFK     + G  +A K + +++         +RE+ +L 
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPS-GLVMARKLIHLEIKPAIRN-QIIRELQVLH 86

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD----QDLGSYMEKCPPPGLSAS 133
           + +    P IV F+   + +         + +  EH+D      +     + P   L   
Sbjct: 87  ECN---SPYIVGFYGAFYSDG-------EISICMEHMDGGSLDQVLKKAGRIPEQILGK- 135

Query: 134 KVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV 192
               ++  ++KG+ +L   H+I+HRD+KP N+L+   G +K+ DFG++     D M  S 
Sbjct: 136 ----VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSF 190

Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM-------------WRLVPLFCASTEVE 239
           V T  Y +PE L    Y    DIWS+G  + EM                +   C      
Sbjct: 191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250

Query: 240 QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKV-----------AFSAIFMD----CCS 284
                        +N++  +     + FE    +            FS  F D    C  
Sbjct: 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 310

Query: 285 KANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
           K           NPA+R      + H + K  + E 
Sbjct: 311 K-----------NPAERADLKQLMVHAFIKRSDAEE 335

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  150 bits (380), Expect = 1e-43
 Identities = 77/300 (25%), Positives = 117/300 (39%), Gaps = 63/300 (21%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G GAYG V  A +       VA+K     R     + I     +EI I K L+   H N
Sbjct: 15  LGEGAYGEVQLAVNRVT-EEAVAVKIVDMKRAVDCPENI----KKEICINKMLN---HEN 66

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           +V+F+                YL  E+    +L   +   P  G+     +    Q++ G
Sbjct: 67  VVKFYGHR-------REGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAG 117

Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYRAPE 202
           V +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

Query: 203 ILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFC-------ASTEVEQLKCIFRVIGTPSMN 254
           +L    +   PVD+WS G V      L  +          S   ++              
Sbjct: 178 LLKRREFHAEPVDVWSCGIV------LTAMLAGELPWDQPSDSCQEYSDWKE-------- 223

Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
                        ++     +  I         +LL  +L  NP+ RI+  D  +  ++ 
Sbjct: 224 -------------KKTYLNPWKKIDSAP----LALLHKILVENPSARITIPDIKKDRWYN 266

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  150 bits (382), Expect = 2e-43
 Identities = 77/307 (25%), Positives = 120/307 (39%), Gaps = 63/307 (20%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMK---KLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G GAYG V  A +       VA+K     R     + I     +EI I K L+   H N
Sbjct: 15  LGEGAYGEVQLAVNRVT-EEAVAVKIVDMKRAVDCPENI----KKEICINKMLN---HEN 66

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           +V+F+         +      YL  E+    +L   +   P  G+     +    Q++ G
Sbjct: 67  VVKFYGHR-----REGNIQ--YLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAG 117

Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDY---DMMLTSVVVTLWYRAPE 202
           V +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y   + +L  +  TL Y APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

Query: 203 ILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFC-------ASTEVEQLKCIFRVIGTPSMN 254
           +L    +   PVD+WS G V      L  +          S   ++              
Sbjct: 178 LLKRREFHAEPVDVWSCGIV------LTAMLAGELPWDQPSDSCQEYSDWKE-------- 223

Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
                        ++     +  I         +LL  +L  NP+ RI+  D  +  ++ 
Sbjct: 224 -------------KKTYLNPWKKIDSAP----LALLHKILVENPSARITIPDIKKDRWYN 266

Query: 315 EKENEPL 321
           +   +  
Sbjct: 267 KPLKKGA 273

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  151 bits (383), Expect = 3e-43
 Identities = 84/309 (27%), Positives = 126/309 (40%), Gaps = 53/309 (17%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDT 81
           +YD +  IG G +G     RD       VA+K + R    ++ +     REI   + L  
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLT-KELVAVKYIERGAAIDENVQ----REIINHRSLR- 74

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTR 140
             HPNIVRF +VI         +L   +I E+    +L   +  C     S  + +   +
Sbjct: 75  --HPNIVRFKEVI-----LTPTHL--AIIMEYASGGELYERI--CNAGRFSEDEARFFFQ 123

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLI--TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWY 198
           Q+L GV + HS +I HRDLK +N L+  + A  LKI DFG +K+        S V T  Y
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 183

Query: 199 RAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCAST--EVEQLKCIFRVIGTPSMN- 254
            APE+LL   Y G   D+WS G        L  +   +   E  +    +R      ++ 
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVT------LYVMLVGAYPFEDPEEPRDYRKTIQRILSV 237

Query: 255 --EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
               P++I     S E                    L+  +   +PA RIS  +   H +
Sbjct: 238 KYSIPDDI---RISPE-----------------CCHLISRIFVADPATRISIPEIKTHSW 277

Query: 313 FKEKENEPL 321
           F +     L
Sbjct: 278 FLKNLPADL 286

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  152 bits (385), Expect = 1e-42
 Identities = 83/299 (27%), Positives = 132/299 (44%), Gaps = 51/299 (17%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKL-RVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +G G +G V   +     G+ VA+K L R K+    +     REI  LK      HP+I+
Sbjct: 24  LGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR---HPHII 79

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + + VI            ++++ E+V   +L  Y+ K     L   + + L +Q+L GVD
Sbjct: 80  KLYQVI-------STPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVD 130

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL 207
           + H H ++HRDLKP+N+L+      KIADFGL+        L +   +  Y APE++   
Sbjct: 131 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 190

Query: 208 GY-GTPVDIWSIGCVMAEMWRLVPLFCAST--EVEQLKCIFRVI--GTPSMNEWPENISL 262
            Y G  VDIWS G +      L  L C +   + + +  +F+ I  G       P+ ++ 
Sbjct: 191 LYAGPEVDIWSSGVI------LYALLCGTLPFDDDHVPTLFKKICDGIFYT---PQYLN- 240

Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL 321
                                    SLL+ ML  +P  R +  D  EH +FK+   + L
Sbjct: 241 ---------------------PSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYL 278

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  148 bits (375), Expect = 1e-42
 Identities = 80/300 (26%), Positives = 146/300 (48%), Gaps = 52/300 (17%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + +D L ++G G+YG+V+KA   +  G  VA+K++ V+ +   I    ++EISI++Q D 
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKET-GQIVAIKQVPVESDLQEI----IKEISIMQQCD- 82

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD----QDLGSYMEKCPPPGLSASKVKE 137
              P++V+++    +N         ++++ E+       D+   +       L+  ++  
Sbjct: 83  --SPHVVKYYGSYFKN-------TDLWIVMEYCGAGSVSDI---IRLRNKT-LTEDEIAT 129

Query: 138 LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML-TSVVVTL 196
           + +  LKG+++LH  R IHRD+K  N+L+   G  K+ADFG+A      M    +V+ T 
Sbjct: 130 ILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTP 189

Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI--GTPSMN 254
           ++ APE++  +GY    DIWS+G    EM    P +    ++  ++ IF +     P+  
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA---DIHPMRAIFMIPTNPPPTFR 246

Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           + PE     WS         F+  F+  C          L  +P  R +A   L+HP+ +
Sbjct: 247 K-PEL----WSD-------NFTD-FVKQC----------LVKSPEQRATATQLLQHPFVR 283

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  146 bits (371), Expect = 4e-42
 Identities = 75/313 (23%), Positives = 136/313 (43%), Gaps = 44/313 (14%)

Query: 16  SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISI 75
           S+++     + + ++G GAYG V K R + + G  +A+K++R  +N        L ++ I
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPS-GQIMAVKRIRATVNSQEQK-RLLMDLDI 58

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG--LSAS 133
             +  T + P  V F+  + +    D     V++  E +D  L  + ++    G  +   
Sbjct: 59  SMR--TVDCPFTVTFYGALFRE--GD-----VWICMELMDTSLDKFYKQVIDKGQTIPED 109

Query: 134 KVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV 192
            + ++   ++K ++ LHS   +IHRD+KP N+LI   G +K+ DFG++     D+     
Sbjct: 110 ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID 169

Query: 193 VVTLWYRAPEILL----NLGYGTPVDIWSIGCVMAEMWRLV-PLFCASTEVEQLKCIFRV 247
                Y APE +       GY    DIWS+G  M E+  L  P     T  +QLK +   
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE- 228

Query: 248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
             +P +              +++S       F   C          L  N  +R +  + 
Sbjct: 229 EPSPQLPA------------DKFSAEFVD--FTSQC----------LKKNSKERPTYPEL 264

Query: 308 LEHPYFKEKENEP 320
           ++HP+F   E++ 
Sbjct: 265 MQHPFFTLHESKG 277

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  146 bits (371), Expect = 4e-42
 Identities = 84/328 (25%), Positives = 143/328 (43%), Gaps = 67/328 (20%)

Query: 5   SADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG 64
               +Q+L  D  +L    + +L +IG G++G VFK  D +     VA+K + ++  ED 
Sbjct: 9   GLPGMQNLKADPEEL----FTKLEKIGKGSFGEVFKGIDNRT-QKVVAIKIIDLEEAEDE 63

Query: 65  IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK 124
           I     +EI++L Q D    P + +++                YL     D  L   ME 
Sbjct: 64  IE-DIQQEITVLSQCD---SPYVTKYYGS--------------YL----KDTKLWIIMEY 101

Query: 125 CP---------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA 175
                      P  L  +++  + R++LKG+D+LHS + IHRD+K  N+L++  G +K+A
Sbjct: 102 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 161

Query: 176 DFGLAKTFDYDMML-TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCA 234
           DFG+A       +   + V T ++ APE++    Y +  DIWS+G    E+ R  P    
Sbjct: 162 DFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS- 220

Query: 235 STEVEQLKCIFRVI--GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLES 292
             E+  +K +F +     P++                YSK      F++ C         
Sbjct: 221 --ELHPMKVLFLIPKNNPPTLE-------------GNYSK-PLKE-FVEAC--------- 254

Query: 293 MLTFNPADRISAADALEHPYFKEKENEP 320
            L   P+ R +A + L+H +      + 
Sbjct: 255 -LNKEPSFRPTAKELLKHKFILRNAKKT 281

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  147 bits (374), Expect = 4e-42
 Identities = 75/322 (23%), Positives = 136/322 (42%), Gaps = 77/322 (23%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL-REISILKQL 79
           +K + +L +IG G++G V+ ARD++N    VA+KK+     +       + +E+  L++L
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRN-SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111

Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKC----------PPPG 129
               HPN +++                 YL     +      ME C              
Sbjct: 112 R---HPNTIQYRGC--------------YL----REHTAWLVMEYCLGSASDLLEVHKKP 150

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
           L   ++  +T   L+G+ +LHSH +IHRD+K  N+L++  G +K+ DFG A        +
Sbjct: 151 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------M 204

Query: 190 T---SVVVTLWYRAPEILLNL---GYGTPVDIWSIGCVMA-EMWRLVPLFCASTEVEQLK 242
               S V T ++ APE++L +    Y   VD+WS+G +   E+    P       +  + 
Sbjct: 205 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLF---NMNAMS 260

Query: 243 CIFRVI--GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD 300
            ++ +    +P++                +S+  F   F+D C          L   P D
Sbjct: 261 ALYHIAQNESPALQS------------GHWSE-YFRN-FVDSC----------LQKIPQD 296

Query: 301 RISAADALEHPYFK-EKENEPL 321
           R ++   L+H +   E+    +
Sbjct: 297 RPTSEVLLKHRFVLRERPPTVI 318

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  145 bits (369), Expect = 8e-42
 Identities = 87/321 (27%), Positives = 141/321 (43%), Gaps = 70/321 (21%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
           ++ ++ + ++G GA+G V+KA++ +  G   A K +  K  E+      + EI IL   D
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKET-GALAAAKVIETKSEEELEDY--IVEIEILATCD 74

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP-----------PPG 129
              HP IV+                  Y      D  L   +E CP             G
Sbjct: 75  ---HPYIVKLLGA--------------YY----HDGKLWIMIEFCPGGAVDAIMLELDRG 113

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM- 188
           L+  +++ + RQML+ ++FLHS RIIHRDLK  N+L+T  G +++ADFG++      +  
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173

Query: 189 LTSVVVTLWYRAPEILLNL-----GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKC 243
             S + T ++ APE+++        Y    DIWS+G  + EM ++ P      E+  ++ 
Sbjct: 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRV 230

Query: 244 IFRVI--GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADR 301
           + ++     P++   P      WS         F   F+             L  NP  R
Sbjct: 231 LLKIAKSDPPTLLT-PSK----WSV-------EFRD-FLKIA----------LDKNPETR 267

Query: 302 ISAADALEHPYFKE-KENEPL 321
            SAA  LEHP+      N+ L
Sbjct: 268 PSAAQLLEHPFVSSITSNKAL 288

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  146 bits (370), Expect = 1e-41
 Identities = 76/328 (23%), Positives = 148/328 (45%), Gaps = 51/328 (15%)

Query: 5   SADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG 64
            A ++  ++L +L      ++ +  +G G YG V+K R ++  G   A+K   + +  D 
Sbjct: 7   PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKT-GQLAAIKV--MDVTGDE 63

Query: 65  IPMSTLREISILKQLDTFEHPNIVRFFDV-IHQNILSDERYLTVYLIFEHVD----QDLG 119
                 +EI++LK+     H NI  ++   I +N    +  L  +L+ E        DL 
Sbjct: 64  EE-EIKQEINMLKKYS--HHRNIATYYGAFIKKNPPGMDDQL--WLVMEFCGAGSVTDL- 117

Query: 120 SYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL 179
             ++      L    +  + R++L+G+  LH H++IHRD+K QN+L+T    +K+ DFG+
Sbjct: 118 --IKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175

Query: 180 AKTFDYDMM-LTSVVVTLWYRAPEILLN-----LGYGTPVDIWSIGCVMAEMWRLVPLFC 233
           +   D  +    + + T ++ APE++         Y    D+WS+G    EM    P  C
Sbjct: 176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235

Query: 234 ASTEVEQLKCIFRVI--GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLE 291
              ++  ++ +F +     P +              +++SK  F + F++ C        
Sbjct: 236 ---DMHPMRALFLIPRNPAPRLKS------------KKWSK-KFQS-FIESC-------- 270

Query: 292 SMLTFNPADRISAADALEHPYFKEKENE 319
             L  N + R +    ++HP+ +++ NE
Sbjct: 271 --LVKNHSQRPATEQLMKHPFIRDQPNE 296

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  147 bits (371), Expect = 1e-41
 Identities = 51/320 (15%), Positives = 95/320 (29%), Gaps = 69/320 (21%)

Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNK----GNYVAMKKLR-VKLNEDGIPMSTLREI 73
           LG K       +G GA+  V++A               +K  +     E  I     + +
Sbjct: 62  LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYI---GTQLM 118

Query: 74  SILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ----DLGSYMEKCPPPG 129
             LK          ++F+         +       L+ E        +  +  +  P   
Sbjct: 119 ERLKPSM---QHMFMKFYSAHLFQ---NG----SVLVGELYSYGTLLNAINLYKNTPEKV 168

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA-----------GGLKIADFG 178
           +    V     +ML  ++ +H   IIH D+KP N ++               GL + D G
Sbjct: 169 MPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228

Query: 179 LA---KTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM-WRLVPLFCA 234
            +   K F    + T+   T  ++  E+L N  +   +D + +   +  M +        
Sbjct: 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288

Query: 235 STEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESML 294
                + + +FR    P ++ W                              N     ML
Sbjct: 289 EGGECKPEGLFR--RLPHLDMW------------------------------NEFFHVML 316

Query: 295 TFNPADRISAADALEHPYFK 314
                  + + D L     K
Sbjct: 317 NIPDCHHLPSLDLLRQKLKK 336

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  144 bits (366), Expect = 3e-41
 Identities = 77/320 (24%), Positives = 136/320 (42%), Gaps = 54/320 (16%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
             Y+    IG GA   V  A         VA+K++ ++  +  +    L+EI  + Q   
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPK-KEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCH- 71

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD----QDLGSYMEKCPPPGLSASKVKE 137
             HPNIV ++     + +  +    ++L+ + +      D+   ++     G   S V +
Sbjct: 72  --HPNIVSYYT----SFVVKDE---LWLVMKLLSGGSVLDI---IKHIVAKGEHKSGVLD 119

Query: 138 ------LTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG----LAKTFDYDM 187
                 + R++L+G+++LH +  IHRD+K  N+L+   G ++IADFG    LA   D   
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179

Query: 188 ML--TSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI 244
                + V T  + APE++  + GY    DIWS G    E+      +    +   +K +
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH---KYPPMKVL 236

Query: 245 FRVI--GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI 302
              +    PS+    E         ++Y K +F    +  C          L  +P  R 
Sbjct: 237 MLTLQNDPPSL----ETGVQDKEMLKKYGK-SFRK-MISLC----------LQKDPEKRP 280

Query: 303 SAADALEHPYFKE-KENEPL 321
           +AA+ L H +F++ K  E L
Sbjct: 281 TAAELLRHKFFQKAKNKEFL 300

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  144 bits (365), Expect = 6e-41
 Identities = 64/312 (20%), Positives = 119/312 (38%), Gaps = 43/312 (13%)

Query: 16  SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISI 75
                    + L ++G G  G V+K R  +  G+ +A+K++R   N++      L ++ +
Sbjct: 19  RYQAEINDLENLGEMGSGTCGQVWKMRFRKT-GHVIAVKQMRRSGNKEENK-RILMDLDV 76

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           + +  + + P IV+ F     N         V++  E +        ++   P +    +
Sbjct: 77  VLK--SHDCPYIVQCFGTFITNT-------DVFIAMELMGTCAEKLKKRMQGP-IPERIL 126

Query: 136 KELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
            ++T  ++K + +L   H +IHRD+KP N+L+   G +K+ DFG++     D        
Sbjct: 127 GKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAG 186

Query: 195 TLWYRAPEIL-----LNLGYGTPVDIWSIGCVMAEMWRLVPLFCA-STEVEQLKCIFRVI 248
              Y APE +         Y    D+WS+G  + E+      +    T+ E L  +    
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV---- 242

Query: 249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL 308
                    +    +      +S    S  F+  C          LT +   R      L
Sbjct: 243 --------LQEEPPLLPGHMGFSGDFQS--FVKDC----------LTKDHRKRPKYNKLL 282

Query: 309 EHPYFKEKENEP 320
           EH + K  E   
Sbjct: 283 EHSFIKRYETLE 294

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  145 bits (367), Expect = 1e-40
 Identities = 67/349 (19%), Positives = 127/349 (36%), Gaps = 51/349 (14%)

Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGA--YGTVFKARDLQNKGNYVAMKKLRVK 59
           + +  + +    + S       Y+ L  IG G     TV  AR     G YV ++++ ++
Sbjct: 5   HHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPT-GEYVTVRRINLE 63

Query: 60  LNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV-IHQNILSDERYLTVYLIFEHVD--- 115
              + +      E+ + K  +   HPNIV +    I  N L        +++   +    
Sbjct: 64  ACSNEMVTFLQGELHVSKLFN---HPNIVPYRATFIADNEL--------WVVTSFMAYGS 112

Query: 116 -QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI 174
            +DL   +      G++   +  + + +LK +D++H    +HR +K  ++LI+  G + +
Sbjct: 113 AKDL---ICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYL 169

Query: 175 ADFGLAKTFDYDM--------MLTSVVVTLWYRAPEIL--LNLGYGTPVDIWSIGCVMAE 224
           +      +                  V  L + +PE+L     GY    DI+S+G    E
Sbjct: 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229

Query: 225 MWRLVP----------LF--------CASTEVEQLKCIFRVIGTPSMNEWPENISLMWSS 266
           +               L         C             +  + S+     + SL  S+
Sbjct: 230 LANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTST 289

Query: 267 FEQYSKVAFSAIFMDCCSKA-NSLLESMLTFNPADRISAADALEHPYFK 314
               +  + S  +    S   +  +E  L  NP  R SA+  L H +FK
Sbjct: 290 PRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  140 bits (353), Expect = 1e-38
 Identities = 86/383 (22%), Positives = 146/383 (38%), Gaps = 111/383 (28%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
           + +Y  + ++G G + TV+ + D+Q K  +VAMK   V  + +    + L EI +LK + 
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGK-KFVAMK---VVKSAEHYTETALDEIRLLKSVR 91

Query: 81  TF--EHPN---IVRFFDV--------IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPP 127
                 PN   +V+  D          H           + ++FE +   L  ++ K   
Sbjct: 92  NSDPNDPNREMVVQLLDDFKISGVNGTH-----------ICMVFEVLGHHLLKWIIKSNY 140

Query: 128 PGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLIT------------------- 167
            GL    VK++ +Q+L+G+D+LH+  RIIH D+KP+N+L++                   
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200

Query: 168 ------------------------------RAGGLKIADFGLAKTFDYDMMLTSVVVTLW 197
                                             +KIAD G A         T  + T  
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQ 258

Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCA------STEVEQLKCIFRVIGTP 251
           YR+ E+L+  GY TP DIWS  C+  E+     LF        + + + +  I  ++G  
Sbjct: 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKV 318

Query: 252 SMNEWPENISLMWSSFEQY----------SKVAFSAIFMDCCSK----------ANSLLE 291
                P  + +     +++          +K+    +F     K              L 
Sbjct: 319 -----PRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLL 373

Query: 292 SMLTFNPADRISAADALEHPYFK 314
            ML   P  R +AA+ L HP+  
Sbjct: 374 PMLELIPEKRATAAECLRHPWLN 396

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  137 bits (347), Expect = 2e-38
 Identities = 73/300 (24%), Positives = 121/300 (40%), Gaps = 57/300 (19%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQLDTFEHP 85
           +G G++ TV  AR+L       A+K L     +K N+        RE  ++ +LD   HP
Sbjct: 38  LGEGSFSTVVLARELAT-SREYAIKILEKRHIIKENKVP---YVTRERDVMSRLD---HP 90

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLK 144
             V+ +         D+  L  Y    +    +L  Y+ K        +  +  T +++ 
Sbjct: 91  FFVKLYFTFQ-----DDEKL--YFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVS 141

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT---SVVVTLWYRAP 201
            +++LH   IIHRDLKP+N+L+     ++I DFG AK    +       S V T  Y +P
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201

Query: 202 EILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
           E+L         D+W++GC++ ++   +P F A  E      IF            + I 
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----IF------------QKI- 244

Query: 262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI------SAADALEHPYFKE 315
                     +  F   F     KA  L+E +L  +   R+             HP+F+ 
Sbjct: 245 -------IKLEYDFPEKF---FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  137 bits (346), Expect = 3e-38
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 34/219 (15%)

Query: 13  NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLRE 72
           +   +++ +        +G GA+G V KA+    +   VA+K++  +        + + E
Sbjct: 6   DYKEIEVEEV-------VGRGAFGVVCKAK---WRAKDVAIKQIESESERK----AFIVE 51

Query: 73  ISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC-PPPGL 130
           +  L +++   HPNIV+ +      +          L+ E+ +   L + +    P P  
Sbjct: 52  LRQLSRVN---HPNIVKLYGACLNPV---------CLVMEYAEGGSLYNVLHGAEPLPYY 99

Query: 131 SASKVKELTRQMLKGVDFLHSHR---IIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYD 186
           +A+       Q  +GV +LHS +   +IHRDLKP NLL+   G  LKI DFG A   D  
Sbjct: 100 TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQ 157

Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
             +T+   +  + APE+     Y    D++S G ++ E+
Sbjct: 158 THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEV 196

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  135 bits (343), Expect = 4e-38
 Identities = 52/238 (21%), Positives = 99/238 (41%), Gaps = 38/238 (15%)

Query: 3   EYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE 62
           E+    + +L  + ++   +       IG G +G V K R L    + VA+K L +  +E
Sbjct: 7   EFPKSRLPTLADNEIEYEKQ-------IGKGGFGLVHKGR-LVKDKSVVAIKSLILGDSE 58

Query: 63  DGIPMSTL-----REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ- 116
               M        RE+ I+  L+   HPNIV+ + ++H             ++ E V   
Sbjct: 59  GETEMIEKFQEFQREVFIMSNLN---HPNIVKLYGLMHNPP---------RMVMEFVPCG 106

Query: 117 DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLITRAGG--- 171
           DL   +     P +  S    L   +  G++++ +    I+HRDL+  N+ +        
Sbjct: 107 DLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP 165

Query: 172 --LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL--NLGYGTPVDIWSIGCVMAEM 225
              K+ADFGL++   + +  + ++    + APE +      Y    D +S   ++  +
Sbjct: 166 VCAKVADFGLSQQSVHSV--SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTI 221

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  133 bits (336), Expect = 3e-36
 Identities = 72/299 (24%), Positives = 125/299 (41%), Gaps = 57/299 (19%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQLDTFEHP 85
           IG G++G V   +    K  Y AMK +     V+ NE     +  +E+ I++ L+   HP
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMY-AMKYMNKQKCVERNEVR---NVFKELQIMQGLE---HP 75

Query: 86  NIVR----FFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTR 140
            +V     F     Q    DE  +  +++ + +   DL  ++++          VK    
Sbjct: 76  FLVNLWYSF-----Q----DEEDM--FMVVDLLLGGDLRYHLQQNVH--FKEETVKLFIC 122

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           +++  +D+L + RIIHRD+KP N+L+   G + I DF +A     +  +T++  T  Y A
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMA 182

Query: 201 PEILLN---LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           PE+  +    GY   VD WS+G    E+ R    +   +     K I             
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTF--------- 232

Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL-EHPYFKE 315
                      + + V + + +     +  SLL+ +L  NP  R S    +   PY  +
Sbjct: 233 -----------ETTVVTYPSAW---SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  136 bits (343), Expect = 3e-36
 Identities = 75/321 (23%), Positives = 135/321 (42%), Gaps = 43/321 (13%)

Query: 3   EYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK--L 60
            Y    +Q   L+   +    + +   +G G +G V   + ++  G   A KKL  K   
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQ-VRATGKMYACKKLEKKRIK 223

Query: 61  NEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLG 119
              G  M  L E  IL++++      +V     +     + +    + L+   ++  DL 
Sbjct: 224 KRKGEAM-ALNEKQILEKVN---SRFVVS----LAYAYETKDA---LCLVLTLMNGGDLK 272

Query: 120 SYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL 179
            ++      G   ++      ++  G++ LH  RI++RDLKP+N+L+   G ++I+D GL
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332

Query: 180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           A        +   V T+ Y APE++ N  Y    D W++GC++ EM      F    +  
Sbjct: 333 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI 392

Query: 240 QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPA 299
           + + + R++      E+ E  S                       +A SL   +L  +PA
Sbjct: 393 KREEVERLVKEVPE-EYSERFS----------------------PQARSLCSQLLCKDPA 429

Query: 300 DRI-----SAADALEHPYFKE 315
           +R+     SA +  EHP FK+
Sbjct: 430 ERLGCRGGSAREVKEHPLFKK 450

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  136 bits (343), Expect = 7e-36
 Identities = 47/201 (23%), Positives = 87/201 (43%), Gaps = 24/201 (11%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           I  G  G ++ A D    G  V +K L    + +   M  + E   L ++    HP+IV+
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM-AMAERQFLAEVV---HPSIVQ 143

Query: 90  FFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
            F+ +       +     Y++ E+V  Q L     +  P      +      ++L  + +
Sbjct: 144 IFNFVEHTDRHGDP--VGYIVMEYVGGQSLKRSKGQKLPVA----EAIAYLLEILPALSY 197

Query: 149 LHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEILLNL 207
           LHS  +++ DLKP+N+++T    LK+ D G     +        +  T  ++APEI+   
Sbjct: 198 LHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRINS----FGYLYGTPGFQAPEIVR-- 250

Query: 208 GYGTPV---DIWSIGCVMAEM 225
               P    DI+++G  +A +
Sbjct: 251 --TGPTVATDIYTVGRTLAAL 269

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  128 bits (323), Expect = 4e-35
 Identities = 70/211 (33%), Positives = 101/211 (47%), Gaps = 21/211 (9%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR---EISILK 77
           +++Y  + ++G G   TV+ A D       VA+K + +   E     +  R   E+    
Sbjct: 10  NERYKIVDKLGGGGMSTVYLAEDTIL-NIKVAIKAIFIPPREK--EETLKRFEREVHNSS 66

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVK 136
           QL    H NIV   DV       DE     YL+ E+++   L  Y+E   P  LS     
Sbjct: 67  QLS---HQNIVSMIDV-------DEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAI 114

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLTSVVV- 194
             T Q+L G+   H  RI+HRD+KPQN+LI     LKI DFG+AK   +  +  T+ V+ 
Sbjct: 115 NFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLG 174

Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           T+ Y +PE           DI+SIG V+ EM
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEM 205

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  126 bits (320), Expect = 1e-34
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 23/203 (11%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR---EISILKQLDTFEHPN 86
           +G G  G V++A D   +   VA+K +   L+ D  P+   R   E     +L     P+
Sbjct: 42  VGRGGMGDVYEAEDTV-RERIVALKLMSETLSSD--PVFRTRMQREARTAGRLQ---EPH 95

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           +V   D         E    +Y+    ++  DL + + +  P  L+  +   + RQ+   
Sbjct: 96  VVPIHDF-------GEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSA 146

Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT---SVVVTLWYRAPE 202
           +D  H+    HRD+KP+N+L++      + DFG+A     D  LT   + V TL+Y APE
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPE 205

Query: 203 ILLNLGYGTPVDIWSIGCVMAEM 225
                      DI+++ CV+ E 
Sbjct: 206 RFSESHATYRADIYALTCVLYEC 228

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  126 bits (319), Expect = 3e-34
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 19/204 (9%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR---EISILKQLDTFEHPN 86
           +G G    V  ARDL++    VA+K LR  L  D  P   LR   E      L+   HP 
Sbjct: 20  LGFGGMSEVHLARDLRD-HRDVAVKVLRADLARD--PSFYLRFRREAQNAAALN---HPA 73

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           IV  +D               Y++ E+VD   L   +    P  ++  +  E+     + 
Sbjct: 74  IVAVYDTGEAE---TPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 128

Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD---YDMMLTSVVV-TLWYRAP 201
           ++F H + IIHRD+KP N++I+    +K+ DFG+A+        +  T+ V+ T  Y +P
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 202 EILLNLGYGTPVDIWSIGCVMAEM 225
           E           D++S+GCV+ E+
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEV 212

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  125 bits (315), Expect = 7e-34
 Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 18/202 (8%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +IG G++GTV +A      G+ VA+K L  +          LRE++I+K+L    HPNIV
Sbjct: 44  KIGAGSFGTVHRAE---WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR---HPNIV 97

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYM-EKCPPPGLSASKVKELTRQMLKGV 146
            F   + Q          + ++ E++ +  L   + +      L   +   +   + KG+
Sbjct: 98  LFMGAVTQPP-------NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150

Query: 147 DFLHSHR--IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLWYRAPEI 203
           ++LH+    I+HR+LK  NLL+ +   +K+ DFGL++      +   S   T  + APE+
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 210

Query: 204 LLNLGYGTPVDIWSIGCVMAEM 225
           L +       D++S G ++ E+
Sbjct: 211 LRDEPSNEKSDVYSFGVILWEL 232

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  128 bits (324), Expect = 1e-33
 Identities = 71/318 (22%), Positives = 128/318 (40%), Gaps = 46/318 (14%)

Query: 9   IQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK--LNEDGIP 66
           +Q   L++  +G+  + +   +G G +G VF  + ++  G   A KKL  K      G  
Sbjct: 172 LQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQ-MKATGKLYACKKLNKKRLKKRKGYQ 230

Query: 67  MSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC 125
              + E  IL ++       IV     +     +      + L+   ++  D+  ++   
Sbjct: 231 G-AMVEKKILAKVH---SRFIVS----LAYAFETKTD---LCLVMTIMNGGDIRYHIYNV 279

Query: 126 P--PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF 183
               PG    +    T Q++ G++ LH   II+RDLKP+N+L+   G ++I+D GLA   
Sbjct: 280 DEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339

Query: 184 DYDMMLTSVVV-TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLK 242
                 T     T  + APE+LL   Y   VD +++G  + EM      F A  E  + K
Sbjct: 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK 399

Query: 243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI 302
            + + +   ++  +P+  S                        +    E++L  +P  R+
Sbjct: 400 ELKQRVLEQAV-TYPDKFS----------------------PASKDFCEALLQKDPEKRL 436

Query: 303 -----SAADALEHPYFKE 315
                S      HP F++
Sbjct: 437 GFRDGSCDGLRTHPLFRD 454

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  125 bits (315), Expect = 2e-33
 Identities = 80/323 (24%), Positives = 134/323 (41%), Gaps = 62/323 (19%)

Query: 3   EYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----V 58
           ++   +  +  LD  D        +  +G G++G V   +  ++ GN+ AMK L     V
Sbjct: 29  KWETPSQNTAQLDQFDR-------IKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVV 80

Query: 59  KLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QD 117
           KL +      TL E  IL+ ++    P +V+           D   L  Y++ E+V   +
Sbjct: 81  KLKQIE---HTLNEKRILQAVN---FPFLVKLEFSFK-----DNSNL--YMVMEYVAGGE 127

Query: 118 LGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF 177
           + S++ +      S    +    Q++   ++LHS  +I+RDLKP+NLLI + G +++ DF
Sbjct: 128 MFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185

Query: 178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE 237
           G AK        T +  T    APEI+L+ GY   VD W++G ++ EM    P F A   
Sbjct: 186 GFAKRVK-GRTWT-LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

Query: 238 VEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFN 297
           ++    I+  I       +P + S                      S    LL ++L  +
Sbjct: 244 IQ----IYEKI-VSGKVRFPSHFS----------------------SDLKDLLRNLLQVD 276

Query: 298 PADRI-----SAADALEHPYFKE 315
              R         D   H +F  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFAT 299

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  123 bits (310), Expect = 2e-33
 Identities = 38/219 (17%), Positives = 75/219 (34%), Gaps = 28/219 (12%)

Query: 13  NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLRE 72
           +   L+   K       +     G ++K R    +GN + +K L+V+            E
Sbjct: 8   DFKQLNFLTK-------LNENHSGELWKGR---WQGNDIVVKVLKVRDWSTRKSRDFNEE 57

Query: 73  ISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLS 131
              L+      HPN++                    LI   +    L + + +     + 
Sbjct: 58  CPRLRIFS---HPNVLPVLGAC-----QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVD 109

Query: 132 ASKVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
            S+  +    M +G+ FLH+    I    L  ++++I      +I+   +  +F      
Sbjct: 110 QSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF----QS 165

Query: 190 TSVVVTLWYRAPEILLNLGYGTP---VDIWSIGCVMAEM 225
              +    + APE L      T     D+WS   ++ E+
Sbjct: 166 PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWEL 204

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  123 bits (311), Expect = 2e-33
 Identities = 52/230 (22%), Positives = 92/230 (40%), Gaps = 50/230 (21%)

Query: 13  NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMST 69
               + +G +       IG G++GTV+K       G +   VA+K L V         + 
Sbjct: 22  PDGQITVGQR-------IGSGSFGTVYK-------GKWHGDVAVKMLNVTAPTPQQLQAF 67

Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYME------ 123
             E+ +L++     H NI+ F        L         ++ +        + E      
Sbjct: 68  KNEVGVLRKTR---HVNILLFMGYSTAPQL--------AIVTQ--------WCEGSSLYH 108

Query: 124 --KCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK 181
                       K+ ++ RQ  +G+D+LH+  IIHRDLK  N+ +     +KI DFGLA 
Sbjct: 109 HLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168

Query: 182 ---TFDYDMMLTSVVVTLWYRAPEILLNLG---YGTPVDIWSIGCVMAEM 225
               +        +  ++ + APE++       Y    D+++ G V+ E+
Sbjct: 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYEL 218

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  125 bits (316), Expect = 4e-33
 Identities = 75/306 (24%), Positives = 116/306 (37%), Gaps = 61/306 (19%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQLDTFEHP 85
           IG GA+  V   +  Q    Y AMK +     +K  E         E  +L   D     
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVY-AMKIMNKWDMLKRGEVS---CFREERDVLVNGD---RR 121

Query: 86  NIVRF---FDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQ 141
            I +    F    Q    DE YL  YL+ E+    DL + + K     + A   +    +
Sbjct: 122 WITQLHFAF----Q----DENYL--YLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAE 170

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV--TLWYR 199
           ++  +D +H    +HRD+KP N+L+ R G +++ADFG       D  + S+V   T  Y 
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230

Query: 200 APEILLNLG-------YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
           +PEIL  +G       YG   D W++G    EM+     F A +  E    I       S
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290

Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE--- 309
           +    E +                        +A   ++ +L   P  R+    A +   
Sbjct: 291 LPLVDEGVP----------------------EEARDFIQRLLC-PPETRLGRGGAGDFRT 327

Query: 310 HPYFKE 315
           HP+F  
Sbjct: 328 HPFFFG 333

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  123 bits (310), Expect = 4e-33
 Identities = 55/230 (23%), Positives = 100/230 (43%), Gaps = 37/230 (16%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR 71
                L  G+        +G G +G   K    +  G  + MK+L  + +E+      L+
Sbjct: 7   FRPSDLIHGEV-------LGKGCFGQAIKVT-HRETGEVMVMKELI-RFDEETQRT-FLK 56

Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGL 130
           E+ +++ L+   HPN+++F  V+++    D+R      I E++    L   ++       
Sbjct: 57  EVKVMRCLE---HPNVLKFIGVLYK----DKRL---NFITEYIKGGTLRGIIKS-MDSQY 105

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML- 189
             S+     + +  G+ +LHS  IIHRDL   N L+     + +ADFGLA+    +    
Sbjct: 106 PWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165

Query: 190 --------------TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                          +VV   ++ APE++    Y   VD++S G V+ E+
Sbjct: 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  121 bits (307), Expect = 4e-33
 Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 38/227 (16%)

Query: 13  NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST--L 70
           +   L L +        IG G +G V++A      G+ VA+K  R   +ED         
Sbjct: 5   DFAELTLEEI-------IGIGGFGKVYRAF---WIGDEVAVKAARHDPDEDISQTIENVR 54

Query: 71  REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG 129
           +E  +   L    HPNI+    V  +          + L+ E      L   +       
Sbjct: 55  QEAKLFAMLK---HPNIIALRGVCLKEP-------NLCLVMEFARGGPLNRVLSG---KR 101

Query: 130 LSASKVKELTRQMLKGVDFLHSHR---IIHRDLKPQNLLITRAGG--------LKIADFG 178
           +    +     Q+ +G+++LH      IIHRDLK  N+LI +           LKI DFG
Sbjct: 102 IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161

Query: 179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           LA+ +       S      + APE++    +    D+WS G ++ E+
Sbjct: 162 LAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWEL 207

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  124 bits (313), Expect = 1e-32
 Identities = 75/331 (22%), Positives = 115/331 (34%), Gaps = 61/331 (18%)

Query: 3   EYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR----V 58
           E++      +    L   D  ++ L  IG GA+G V   +         AMK L     +
Sbjct: 57  EWAKPFTSKVKQMRLHRED--FEILKVIGRGAFGEVAVVKLKNA-DKVFAMKILNKWEML 113

Query: 59  KLNEDGIPMSTLREISILKQLDTFEHPNIVRF---FDVIHQNILSDERYLTVYLIFEHVD 115
           K  E         E  +L   D      I      F    Q    D+  L  YL+ ++  
Sbjct: 114 KRAE---TACFREERDVLVNGD---SKWITTLHYAF----Q----DDNNL--YLVMDYYV 157

Query: 116 Q-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI 174
             DL + + K     L     +    +M+  +D +H    +HRD+KP N+L+   G +++
Sbjct: 158 GGDLLTLLSKFEDR-LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRL 216

Query: 175 ADFGLAKTFDYDMMLTS--VVVTLWYRAPEILL-----NLGYGTPVDIWSIGCVMAEMWR 227
           ADFG       D  + S   V T  Y +PEIL         YG   D WS+G  M EM  
Sbjct: 217 ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

Query: 228 LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKAN 287
               F A + VE    I              ++S                        A 
Sbjct: 277 GETPFYAESLVETYGKIMNHKERFQFPTQVTDVS----------------------ENAK 314

Query: 288 SLLESMLTFNPADRISAADALE---HPYFKE 315
            L+  ++  +   R+      +   HP+F  
Sbjct: 315 DLIRRLIC-SREHRLGQNGIEDFKKHPFFSG 344

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  121 bits (307), Expect = 1e-32
 Identities = 75/296 (25%), Positives = 125/296 (42%), Gaps = 55/296 (18%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQLDTFEHP 85
           +G G++G V   R   N G Y AMK L+    V+L +      T  E  +L  +    HP
Sbjct: 14  LGTGSFGRVHLIRSRHN-GRYYAMKVLKKEIVVRLKQ---VEHTNDERLMLSIVT---HP 66

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLK 144
            I+R +         D + +  ++I ++++  +L S + K           K    ++  
Sbjct: 67  FIIRMWGTFQ-----DAQQI--FMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCL 117

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEIL 204
            +++LHS  II+RDLKP+N+L+ + G +KI DFG AK    D+  T +  T  Y APE++
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTYT-LCGTPDYIAPEVV 175

Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
               Y   +D WS G ++ EM      F  S  ++     +  I    +  +P   +   
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TYEKILNAEL-RFPPFFN--- 227

Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKE 315
                                   LL  ++T + + R+        D   HP+FKE
Sbjct: 228 -------------------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  126 bits (318), Expect = 1e-32
 Identities = 71/296 (23%), Positives = 125/296 (42%), Gaps = 47/296 (15%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVK--LNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+  R   + G   AMK L  K    + G  +  L E  +L  + T + P I
Sbjct: 197 IGRGGFGEVYGCR-KADTGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSLVSTGDCPFI 254

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V     +     + ++   +  I + ++  DL  ++ +      S + ++    +++ G+
Sbjct: 255 VC----MSYAFHTPDK---LSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGL 305

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL- 205
           + +H+  +++RDLKP N+L+   G ++I+D GLA  F       S V T  Y APE+L  
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQK 364

Query: 206 NLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
            + Y +  D +S+GC++ ++ R   P              FR   T   +E         
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSP--------------FRQHKTKDKHEIDRMT---- 406

Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKE 315
                   V     F     +  SLLE +L  +   R+      A +  E P+F+ 
Sbjct: 407 ----LTMAVELPDSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  118 bits (298), Expect = 3e-31
 Identities = 77/300 (25%), Positives = 125/300 (41%), Gaps = 56/300 (18%)

Query: 30  IGCGAYGTVFKARDLQNK--GNYVAMKKLR---VKLNEDGIPMSTLREISILKQLDTFEH 84
           +G G YG VF+ R +     G   AMK L+   +  N       T  E +IL+++    H
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT-AHTKAERNILEEVK---H 80

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P IV     +     +  +   +YLI E++   +L   +E+                ++ 
Sbjct: 81  PFIVD----LIYAFQTGGK---LYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEIS 131

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMMLTSVVVTLWYRAPE 202
             +  LH   II+RDLKP+N+++   G +K+ DFGL K +     +  +   T+ Y APE
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191

Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI--GTPSMNEWPENI 260
           IL+  G+   VD WS+G +M +M    P F      +        I     ++   P  +
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK----TIDKILKCKLNL---PPYL 244

Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA--ADALE---HPYFKE 315
           +                       +A  LL+ +L  N A R+ A   DA E   HP+F+ 
Sbjct: 245 T----------------------QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  118 bits (297), Expect = 1e-30
 Identities = 78/304 (25%), Positives = 124/304 (40%), Gaps = 63/304 (20%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR----VKLNEDGIPMSTLREISILKQLDTFEHP 85
           IG GA+G V   R    +  Y AMK L     +K ++         E  I+   +    P
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVY-AMKLLSKFEMIKRSDSA---FFWEERDIMAFAN---SP 129

Query: 86  NIVR----FFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTR 140
            +V+    F     Q    D+RYL  Y++ E++   DL + M       +     +  T 
Sbjct: 130 WVVQLFYAF-----Q----DDRYL--YMVMEYMPGGDLVNLMSN---YDVPEKWARFYTA 175

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTS--VVVTLWY 198
           +++  +D +HS   IHRD+KP N+L+ ++G LK+ADFG     + + M+     V T  Y
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235

Query: 199 RAPEILLNLG----YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
            +PE+L + G    YG   D WS+G  + EM      F A + V      +         
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TY--------- 282

Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE---HP 311
                I    +S         S        +A +L+ + LT +   R+      E   H 
Sbjct: 283 ---SKIMNHKNSLTFPDDNDIS-------KEAKNLICAFLT-DREVRLGRNGVEEIKRHL 331

Query: 312 YFKE 315
           +FK 
Sbjct: 332 FFKN 335

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  116 bits (293), Expect = 2e-30
 Identities = 71/315 (22%), Positives = 111/315 (35%), Gaps = 68/315 (21%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVK-----LNEDGIPMSTLREISILKQLDTFE 83
           QIG G YG V+  +    +G  VA+K            E         EI     +    
Sbjct: 44  QIGKGRYGEVWMGK---WRGEKVAVKVFFTTEEASWFRE--------TEIYQTVLMR--- 89

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
           H NI+ F     +   S  +    YLI + H +  L  Y++      L A  + +L    
Sbjct: 90  HENILGFIAADIKGTGSWTQL---YLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSS 143

Query: 143 LKGVDFLHSHR--------IIHRDLKPQNLLITRAGGLKIADFGLAKTFDY-----DMML 189
           + G+  LH+          I HRDLK +N+L+ + G   IAD GLA  F       D+  
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203

Query: 190 TSVVVTLWYRAPEIL------LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKC 243
            + V T  Y  PE+L       +       D++S G ++ E+ R         E +    
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL--- 260

Query: 244 IFRVIGTPSMNEWPENISLMWSSFEQYSKVAF---------SAIFMDCCSKANSLLESML 294
                  P  +  P + S      +    V                +C  +   L+    
Sbjct: 261 -------PYHDLVPSDPSYE----DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECW 309

Query: 295 TFNPADRISAADALE 309
             NPA R++A    +
Sbjct: 310 AHNPASRLTALRVKK 324

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  116 bits (293), Expect = 2e-30
 Identities = 80/300 (26%), Positives = 130/300 (43%), Gaps = 58/300 (19%)

Query: 30  IGCGAYGTVFKARDLQNK--GNYVAMKKLR---VKLNEDGIPMSTLREISILKQLDTFEH 84
           +G G++G VF  + +         AMK L+   +K+ +    + T  E  IL +++   H
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR---VRTKMERDILVEVN---H 85

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           P IV+    +H    ++ +   +YLI + +   DL + + K      +   VK    ++ 
Sbjct: 86  PFIVK----LHYAFQTEGK---LYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELA 136

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMMLTSVVVTLWYRAPE 202
             +D LHS  II+RDLKP+N+L+   G +K+ DFGL+K + D++    S   T+ Y APE
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196

Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI--GTPSMNEWPENI 260
           ++   G+    D WS G +M EM      F      E       +I      M   P+ +
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE----TMTMILKAKLGM---PQFL 249

Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA--DALE---HPYFKE 315
           S                       +A SLL  +   NPA+R+ A      E   H +F  
Sbjct: 250 S----------------------PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  116 bits (292), Expect = 4e-30
 Identities = 70/302 (23%), Positives = 129/302 (42%), Gaps = 52/302 (17%)

Query: 30  IGCGAYGTVFKARDLQNK--GNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHP 85
           +G GAYG VF  R +     G   AMK L+    + +      T  E  +L+ +   + P
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--QSP 119

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLK 144
            +V     +H    ++ +   ++LI ++++  +L +++ +      +  +V+    +++ 
Sbjct: 120 FLVT----LHYAFQTETK---LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVL 170

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTLWYRAPE 202
            ++ LH   II+RD+K +N+L+   G + + DFGL+K    D          T+ Y AP+
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230

Query: 203 ILLNL--GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI--GTPSMNEWPE 258
           I+     G+   VD WS+G +M E+      F    E      I R I    P     P+
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---PQ 287

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA--DALE---HPYF 313
            +S                      + A  L++ +L  +P  R+     DA E   H +F
Sbjct: 288 EMS----------------------ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325

Query: 314 KE 315
           ++
Sbjct: 326 QK 327

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  115 bits (289), Expect = 6e-30
 Identities = 49/232 (21%), Positives = 96/232 (41%), Gaps = 45/232 (19%)

Query: 13  NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMST 69
             + L++G+        IG G +G V+        G +   VA++ + ++ + +    + 
Sbjct: 31  PFEQLEIGEL-------IGKGRFGQVYH-------GRWHGEVAIRLIDIERDNEDQLKAF 76

Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPP 128
            RE+   +Q     H N+V F        +S        +I        L S +      
Sbjct: 77  KREVMAYRQTR---HENVVLFMGAC----MSPPHL---AIITSLCKGRTLYSVVRD-AKI 125

Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----- 183
            L  +K +++ ++++KG+ +LH+  I+H+DLK +N+     G + I DFGL         
Sbjct: 126 VLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQA 184

Query: 184 -DYDMMLTSVVVTLWYRAPEILLNLG---------YGTPVDIWSIGCVMAEM 225
              +  L      L + APEI+  L          +    D++++G +  E+
Sbjct: 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  113 bits (286), Expect = 9e-30
 Identities = 57/219 (26%), Positives = 83/219 (37%), Gaps = 35/219 (15%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
            +G G YG V++      +G  VA+K    +  +     S  RE  +        H NI+
Sbjct: 15  CVGKGRYGEVWRGS---WQGENVAVKIFSSRDEK-----SWFRETELY-NTVMLRHENIL 65

Query: 89  RFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
            F      +  S  +    +LI   H    L  Y++      L       +   +  G+ 
Sbjct: 66  GFIASDMTSRHSSTQL---WLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLA 119

Query: 148 FLHSHR--------IIHRDLKPQNLLITRAGGLKIADFGLAKTFDY-----DMMLTSVVV 194
            LH           I HRDLK +N+L+ + G   IAD GLA          D+     V 
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179

Query: 195 TLWYRAPEIL------LNLGYGTPVDIWSIGCVMAEMWR 227
           T  Y APE+L              VDIW+ G V+ E+ R
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  114 bits (288), Expect = 1e-29
 Identities = 77/291 (26%), Positives = 122/291 (41%), Gaps = 45/291 (15%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G++G VF A   +    + A+K L+  V L +D +   T+ E  +L     +EHP +
Sbjct: 25  LGKGSFGKVFLAE-FKKTNQFFAIKALKKDVVLMDDDV-ECTMVEKRVLSL--AWEHPFL 80

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
                 +     + E    ++ + E+++  DL  +++ C       S+      +++ G+
Sbjct: 81  TH----MFCTFQTKEN---LFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGL 131

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLTSVVVTLWYRAPEILL 205
            FLHS  I++RDLK  N+L+ + G +KIADFG+ K     D    +   T  Y APEILL
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 191

Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS 265
              Y   VD WS G ++ EM      F    E E    I      P     P  +     
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFY---PRWLE---- 242

Query: 266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-SAADALEHPYFKE 315
                              +A  LL  +    P  R+    D  +HP F+E
Sbjct: 243 ------------------KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  114 bits (286), Expect = 2e-29
 Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 35/219 (15%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
            IG G +G V++ +    +G  VA+K    +        S  RE  I  Q     H NI+
Sbjct: 49  SIGKGRFGEVWRGK---WRGEEVAVKIFSSREER-----SWFREAEIY-QTVMLRHENIL 99

Query: 89  RFFDVIHQNILSDERYLTVYLIFE-HVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
            F    +++  +  +    +L+ + H    L  Y+ +     ++   + +L      G+ 
Sbjct: 100 GFIAADNKDNGTWTQL---WLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLA 153

Query: 148 FLHSHR--------IIHRDLKPQNLLITRAGGLKIADFGLAKTFDY-----DMMLTSVVV 194
            LH           I HRDLK +N+L+ + G   IAD GLA   D      D+     V 
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213

Query: 195 TLWYRAPEILLNLG------YGTPVDIWSIGCVMAEMWR 227
           T  Y APE+L +             DI+++G V  E+ R
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  111 bits (280), Expect = 1e-28
 Identities = 72/297 (24%), Positives = 123/297 (41%), Gaps = 54/297 (18%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   R  +  G Y AMK LR  V + +D +   T+ E  +L+      HP +
Sbjct: 13  LGKGTFGKVILVR-EKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTR---HPFL 67

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
                 +     + +R   +  + E+ +  +L  ++ +      +  + +    +++  +
Sbjct: 68  TA----LKYAFQTHDR---LCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSAL 118

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEILL 205
           ++LHS  +++RD+K +NL++ + G +KI DFGL K    D         T  Y APE+L 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI--GTPSMNEWPENISLM 263
           +  YG  VD W +G VM EM      F           +F +I          P  +S  
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFELILMEEIRF---PRTLS-- 229

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI--SAADALE---HPYFKE 315
                                +A SLL  +L  +P  R+    +DA E   H +F  
Sbjct: 230 --------------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  110 bits (278), Expect = 2e-28
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 26/210 (12%)

Query: 29  QIGCGAYGTVFKAR---DLQNKGNYVAMKKLRVKLNEDGIPMST---LREISILKQLDTF 82
            +G G +G V   R   +  N G  VA+K L+     +          +EI IL+ L   
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK----PESGGNHIADLKKEIEILRNLY-- 81

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQ 141
            H NIV++  +      +++    + LI E +    L  Y+ K     ++  +  +   Q
Sbjct: 82  -HENIVKYKGIC-----TEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQ 134

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL----- 196
           + KG+D+L S + +HRDL  +N+L+     +KI DFGL K  + D    +V         
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194

Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           WY APE L+   +    D+WS G  + E+ 
Sbjct: 195 WY-APECLMQSKFYIASDVWSFGVTLHELL 223

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  110 bits (278), Expect = 2e-28
 Identities = 64/336 (19%), Positives = 115/336 (34%), Gaps = 56/336 (16%)

Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN 61
           + +   +   L  ++L         L     G +G V+KA+       YVA+K       
Sbjct: 4   HHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ---LLNEYVAVKIFP---I 57

Query: 62  EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGS 120
           +D        E+  L  +    H NI++F     +    D       LI    ++  L  
Sbjct: 58  QDKQSWQNEYEVYSLPGMK---HENILQFIGAEKRGTSVDVDLW---LITAFHEKGSLSD 111

Query: 121 YMEKCPPPGLSASKVKELTRQMLKGVDFLHSH----------RIIHRDLKPQNLLITRAG 170
           +++      +S +++  +   M +G+ +LH             I HRD+K +N+L+    
Sbjct: 112 FLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168

Query: 171 GLKIADFGLAKTFDYDMML---TSVVVTLWYRAPEIL-----LNLGYGTPVDIWSIGCVM 222
              IADFGLA  F+           V T  Y APE+L             +D++++G V+
Sbjct: 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228

Query: 223 AEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLM---------WSSFEQYSKV 273
            E+           +   L     +   PS+ +  E +            W      + +
Sbjct: 229 WELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML 288

Query: 274 AFSAIFMDCCSKANSLLESMLTFNPADRISAADALE 309
                           +E     +   R+SA    E
Sbjct: 289 C-------------ETIEECWDHDAEARLSAGCVGE 311

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  111 bits (279), Expect = 3e-28
 Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 53/302 (17%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR-VKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           IG G+Y  V   R L+      AMK ++   +N+D        E  + +Q     HP +V
Sbjct: 17  IGRGSYAKVLLVR-LKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ--ASNHPFLV 73

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
                +H    ++ R   ++ + E+V+  DL  +M++     L     +  + ++   ++
Sbjct: 74  G----LHSCFQTESR---LFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALN 124

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEILLN 206
           +LH   II+RDLK  N+L+   G +K+ D+G+ K        TS    T  Y APEIL  
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 184

Query: 207 LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKC-----IFRVI--GTPSMNEWPEN 259
             YG  VD W++G +M EM      F      +         +F+VI      +   P +
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---PRS 241

Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI------SAADALEHPYF 313
           +S                       KA S+L+S L  +P +R+        AD   HP+F
Sbjct: 242 LS----------------------VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279

Query: 314 KE 315
           + 
Sbjct: 280 RN 281

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  113 bits (284), Expect = 4e-28
 Identities = 68/297 (22%), Positives = 125/297 (42%), Gaps = 53/297 (17%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G++G V  +   +      A+K L+  V + +D +   T+ E  +L      + P +
Sbjct: 349 LGKGSFGKVMLSE-RKGTDELYAVKILKKDVVIQDDDV-ECTMVEKRVLALPG--KPPFL 404

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
            +    +H    + +R   +Y + E+V+  DL  ++++                ++  G+
Sbjct: 405 TQ----LHSCFQTMDR---LYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGL 455

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-TFDYDMMLTSVVVTLWYRAPEILL 205
            FL S  II+RDLK  N+++   G +KIADFG+ K      +   +   T  Y APEI+ 
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 515

Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI--GTPSMNEWPENISLM 263
              YG  VD W+ G ++ EM      F    E E    +F+ I     +    P+++S  
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQSIMEHNVAY---PKSMS-- 566

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKE 315
                                +A ++ + ++T +P  R+        D  EH +F+ 
Sbjct: 567 --------------------KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  110 bits (278), Expect = 4e-28
 Identities = 70/297 (23%), Positives = 127/297 (42%), Gaps = 53/297 (17%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G++G V  +   +      A+K L+  V + +D +   T+ E  +L      + P +
Sbjct: 28  LGKGSFGKVMLSE-RKGTDELYAVKILKKDVVIQDDDV-ECTMVEKRVLALPG--KPPFL 83

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
            +    +H    + +R   +Y + E+V+  DL  ++++                ++  G+
Sbjct: 84  TQ----LHSCFQTMDR---LYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGL 134

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEILL 205
            FL S  II+RDLK  N+++   G +KIADFG+ K   +D + T     T  Y APEI+ 
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 194

Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI--GTPSMNEWPENISLM 263
              YG  VD W+ G ++ EM      F    E E    +F+ I     +    P+++S  
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQSIMEHNVAY---PKSMS-- 245

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKE 315
                                +A ++ + ++T +P  R+        D  EH +F+ 
Sbjct: 246 --------------------KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  111 bits (279), Expect = 4e-28
 Identities = 68/295 (23%), Positives = 127/295 (43%), Gaps = 52/295 (17%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G++G V  AR  + +  + A+K L+    L +       + E ++L +    +HP +
Sbjct: 46  IGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEE-KHIMSERNVLLK--NVKHPFL 101

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V     +H +  + ++   +Y + ++++  +L  ++++         + +    ++   +
Sbjct: 102 VG----LHFSFQTADK---LYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASAL 152

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEILL 205
            +LHS  I++RDLKP+N+L+   G + + DFGL K        TS    T  Y APE+L 
Sbjct: 153 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH 212

Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI--GTPSMNEWPENISLM 263
              Y   VD W +G V+ EM   +P F +    E    ++  I      +     NI+  
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNILNKPLQL---KPNIT-- 263

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-SAADALE---HPYFK 314
                               + A  LLE +L  +   R+ +  D +E   H +F 
Sbjct: 264 --------------------NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  110 bits (276), Expect = 5e-28
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 27/210 (12%)

Query: 29  QIGCGAYGTVFKAR---DLQNKGNYVAMKKLRVKLNEDGIPMST---LREISILKQLDTF 82
           Q+G G +G+V   R      N G  VA+K+L+        P       REI ILK L   
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-----HSGPDQQRDFQREIQILKALH-- 82

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQ 141
               IV++  V            ++ L+ E++    L  ++++     L AS++   + Q
Sbjct: 83  -SDFIVKYRGVS-----YGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQ 135

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL----- 196
           + KG+++L S R +HRDL  +N+L+     +KIADFGLAK    D     V         
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195

Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           WY APE L +  +    D+WS G V+ E++
Sbjct: 196 WY-APESLSDNIFSRQSDVWSFGVVLYELF 224

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  109 bits (274), Expect = 7e-28
 Identities = 67/207 (32%), Positives = 96/207 (46%), Gaps = 21/207 (10%)

Query: 29  QIGCGAYGTVFKAR---DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP 85
           Q+G G +G+V   R      N G  VA+KKL+    E        REI ILK L    H 
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQ---HD 102

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLK 144
           NIV++  V             + LI E++    L  Y++K     +   K+ + T Q+ K
Sbjct: 103 NIVKYKGVC-----YSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICK 156

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL-----WYR 199
           G+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY 
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY- 215

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMW 226
           APE L    +    D+WS G V+ E++
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELF 242

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  110 bits (277), Expect = 8e-28
 Identities = 76/302 (25%), Positives = 127/302 (42%), Gaps = 53/302 (17%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR-VKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           IG G+Y  V   R L+      AM+ ++   +N+D        E  + +Q     HP +V
Sbjct: 60  IGRGSYAKVLLVR-LKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ--ASNHPFLV 116

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
                +H    ++ R   ++ + E+V+  DL  +M++     L     +  + ++   ++
Sbjct: 117 G----LHSCFQTESR---LFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALN 167

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEILLN 206
           +LH   II+RDLK  N+L+   G +K+ D+G+ K        TS    T  Y APEIL  
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227

Query: 207 LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL-----KCIFRVI--GTPSMNEWPEN 259
             YG  VD W++G +M EM      F      +         +F+VI      +   P +
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---PRS 284

Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI------SAADALEHPYF 313
           +S                       KA S+L+S L  +P +R+        AD   HP+F
Sbjct: 285 LS----------------------VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322

Query: 314 KE 315
           + 
Sbjct: 323 RN 324

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  110 bits (277), Expect = 1e-27
 Identities = 73/295 (24%), Positives = 126/295 (42%), Gaps = 51/295 (17%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V   +  +  G Y AMK L+  V + +D +   TL E  +L+      HP +
Sbjct: 156 LGKGTFGKVILVK-EKATGRYYAMKILKKEVIVAKDEV-AHTLTENRVLQNSR---HPFL 210

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
                 +  +  + +R   +  + E+ +  +L  ++ +      S  + +    +++  +
Sbjct: 211 TA----LKYSFQTHDR---LCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSAL 261

Query: 147 DFLHSHR-IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEIL 204
           D+LHS + +++RDLK +NL++ + G +KI DFGL K    D         T  Y APE+L
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321

Query: 205 LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW 264
            +  YG  VD W +G VM EM      F      +    +F +I    +  +P  +    
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEEIR-FPRTLG--- 373

Query: 265 SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA--DALE---HPYFK 314
                               +A SLL  +L  +P  R+     DA E   H +F 
Sbjct: 374 -------------------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  107 bits (270), Expect = 2e-27
 Identities = 67/207 (32%), Positives = 96/207 (46%), Gaps = 21/207 (10%)

Query: 29  QIGCGAYGTVFKAR---DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP 85
           Q+G G +G+V   R      N G  VA+KKL+    E        REI ILK L    H 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF--EREIEILKSLQ---HD 71

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLK 144
           NIV++  V             + LI E++    L  Y++K     +   K+ + T Q+ K
Sbjct: 72  NIVKYKGVC-----YSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICK 125

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL-----WYR 199
           G+++L + R IHRDL  +N+L+     +KI DFGL K    D     V         WY 
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY- 184

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMW 226
           APE L    +    D+WS G V+ E++
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELF 211

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  108 bits (273), Expect = 2e-27
 Identities = 78/298 (26%), Positives = 129/298 (43%), Gaps = 54/298 (18%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G++G V  AR ++  G+  A+K L+  V L +D +   T+ E  IL       HP +
Sbjct: 31  LGKGSFGKVMLAR-VKETGDLYAVKVLKKDVILQDDDV-ECTMTEKRILSLAR--NHPFL 86

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
            +    +     + +R   ++ + E V+  DL  +++K        ++ +    +++  +
Sbjct: 87  TQ----LFCCFQTPDR---LFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISAL 137

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWYRAPEILL 205
            FLH   II+RDLK  N+L+   G  K+ADFG+ K    + + T+    T  Y APEIL 
Sbjct: 138 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ 197

Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI--GTPSMNEWPENISLM 263
            + YG  VD W++G ++ EM      F A  E +    +F  I          P  +   
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD----LFEAILNDEVVY---PTWLH-- 248

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI------SAADALEHPYFKE 315
                                 A  +L+S +T NP  R+           L HP+FKE
Sbjct: 249 --------------------EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  106 bits (267), Expect = 8e-27
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 28/209 (13%)

Query: 29  QIGCGAYGTVFKAR---DLQNKGNYVAMKKLRVKLNEDGIPMST---LREISILKQLDTF 82
            +G G +G V            G  VA+K L+     D  P       +EI IL+ L   
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK----ADAGPQHRSGWKQEIDILRTLY-- 91

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQ 141
            H +I+++          D    ++ L+ E+V    L  Y+ +     +  +++    +Q
Sbjct: 92  -HEHIIKYKGCC-----EDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQ 142

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYDMMLTSVVVTL- 196
           + +G+ +LH+   IHRDL  +N+L+     +KI DFGLAK      +Y  +       + 
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202

Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
           WY APE L    +    D+WS G  + E+
Sbjct: 203 WY-APECLKEYKFYYASDVWSFGVTLYEL 230

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  106 bits (266), Expect = 1e-26
 Identities = 75/360 (20%), Positives = 117/360 (32%), Gaps = 90/360 (25%)

Query: 11  SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK-----LNEDGI 65
           SL+LD+L L +        IG G YG V+K          VA+K          +NE   
Sbjct: 9   SLDLDNLKLLEL-------IGRGRYGAVYKGS---LDERPVAVKVFSFANRQNFINE--- 55

Query: 66  PMSTLREISILKQLDTFEHPNIVRFF--DVIHQNILSDERYL-TVYLIFEHVDQDLGSYM 122
                + I  +  +   EH NI RF   D         E  L   Y          GS  
Sbjct: 56  -----KNIYRVPLM---EHDNIARFIVGDERVTADGRMEYLLVMEYY-------PNGSLX 100

Query: 123 EKCPPPGLSASKVKELTRQMLKGVDFLHS---------HRIIHRDLKPQNLLITRAGGLK 173
           +              L   + +G+ +LH+           I HRDL  +N+L+   G   
Sbjct: 101 KYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160

Query: 174 IADFGLAKTFDY---------DMMLTSVVVTLWYRAPEIL---LNLGYGTP----VDIWS 217
           I+DFGL+              D    S V T+ Y APE+L   +NL         VD+++
Sbjct: 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYA 220

Query: 218 IGCVMAEMWRLVPLFCASTEVEQLKCIF--RVIGTPSMNEWPE---------NISLMWSS 266
           +G +  E++           V + +  F   V   P+  +                 W  
Sbjct: 221 LGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE 280

Query: 267 FEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA------DALEHPYFKEKENEP 320
                + +      DC  +           +   R++A         L   + + K   P
Sbjct: 281 NSLAVR-SLKETIEDCWDQ-----------DAEARLTAQXAEERMAELMMIWERNKSVSP 328

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  104 bits (262), Expect = 2e-25
 Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 26/219 (11%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST-L 70
           +    + +  K       +G G YG V++    +     VA+K L+    ED + +   L
Sbjct: 217 MERTDITMKHK-------LGGGQYGEVYEGV-WKKYSLTVAVKTLK----EDTMEVEEFL 264

Query: 71  REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG 129
           +E +++K++    HPN+V+   V      + E     Y+I E +   +L  Y+ +C    
Sbjct: 265 KEAAVMKEIK---HPNLVQLLGVC-----TREPP--FYIITEFMTYGNLLDYLRECNRQE 314

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
           +SA  +  +  Q+   +++L     IHR+L  +N L+     +K+ADFGL++    D   
Sbjct: 315 VSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374

Query: 190 TSVVVTLWYR--APEILLNLGYGTPVDIWSIGCVMAEMW 226
                    +  APE L    +    D+W+ G ++ E+ 
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 413

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  102 bits (257), Expect = 4e-25
 Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 26/220 (11%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR 71
           LN + L LG++       IG G +G VF  R L+     VA+K  R  L  D      L+
Sbjct: 111 LNHEDLVLGEQ-------IGRGNFGEVFSGR-LRADNTLVAVKSCRETLPPDLK-AKFLQ 161

Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGL 130
           E  ILKQ     HPNIVR   V      + ++   +Y++ E V   D  +++       L
Sbjct: 162 EARILKQYS---HPNIVRLIGVC-----TQKQ--PIYIVMELVQGGDFLTFLRTEGAR-L 210

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT 190
               + ++      G+++L S   IHRDL  +N L+T    LKI+DFG+++     +   
Sbjct: 211 RVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270

Query: 191 SVVVTL----WYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
           S  +      W  APE L    Y +  D+WS G ++ E +
Sbjct: 271 SGGLRQVPVKWT-APEALNYGRYSSESDVWSFGILLWETF 309

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  104 bits (260), Expect = 5e-25
 Identities = 48/218 (22%), Positives = 96/218 (44%), Gaps = 26/218 (11%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR 71
           +  +SL L  K       +G G +G V+           VA+K L+        P + L+
Sbjct: 264 IPRESLRLEVK-------LGQGCFGEVWMGT-WNGTTR-VAIKTLKPGTMS---PEAFLQ 311

Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGL 130
           E  ++K+L    H  +V+ + V+ +          +Y++ E++ +  L  +++      L
Sbjct: 312 EAQVMKKLR---HEKLVQLYAVVSEE--------PIYIVTEYMSKGSLLDFLKGETGKYL 360

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT 190
              ++ ++  Q+  G+ ++     +HRDL+  N+L+      K+ADFGLA+  + +    
Sbjct: 361 RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420

Query: 191 SVVVTLWYR--APEILLNLGYGTPVDIWSIGCVMAEMW 226
                   +  APE  L   +    D+WS G ++ E+ 
Sbjct: 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  102 bits (256), Expect = 1e-24
 Identities = 48/218 (22%), Positives = 96/218 (44%), Gaps = 26/218 (11%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR 71
           +  +SL L  K       +G G +G V+           VA+K L+        P + L+
Sbjct: 181 IPRESLRLEVK-------LGQGCFGEVWMGT-WNGTTR-VAIKTLKPGTMS---PEAFLQ 228

Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGL 130
           E  ++K+L    H  +V+ + V+ +          +Y++ E++ +  L  +++      L
Sbjct: 229 EAQVMKKLR---HEKLVQLYAVVSEE--------PIYIVTEYMSKGSLLDFLKGETGKYL 277

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT 190
              ++ ++  Q+  G+ ++     +HRDL+  N+L+      K+ADFGLA+  + +    
Sbjct: 278 RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337

Query: 191 SVVVTLWYR--APEILLNLGYGTPVDIWSIGCVMAEMW 226
                   +  APE  L   +    D+WS G ++ E+ 
Sbjct: 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 99.4 bits (248), Expect = 2e-24
 Identities = 29/209 (13%), Positives = 57/209 (27%), Gaps = 43/209 (20%)

Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMS-TLREISILK 77
           + + +Y  L   G       ++A D       VA+  +  +       +  TL     L 
Sbjct: 28  IANGRYRLLIFHGGVPPLQFWQALDTA-LDRQVALTFVDPQGVLPDDVLQETLSRTLRLS 86

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVK 136
           ++D    P + R  DV+H             ++ E +    L    +  P P  +     
Sbjct: 87  RID---KPGVARVLDVVHTRAG-------GLVVAEWIRGGSLQEVADTSPSPVGAI---- 132

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL 196
              + +    D  H   +      P  + ++  G + +A                     
Sbjct: 133 RAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------------ 174

Query: 197 WYRAPEILLNLGYGTPVDIWSIGCVMAEM 225
                            DI  IG  +  +
Sbjct: 175 -TMPDA-------NPQDDIRGIGASLYAL 195

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  101 bits (254), Expect = 2e-24
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 26/216 (12%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR 71
           LN+  L L          IG G +G V        +GN VA+K ++     D    + L 
Sbjct: 190 LNMKELKLLQT-------IGKGEFGDVMLGDY---RGNKVAVKCIK----NDATAQAFLA 235

Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGL 130
           E S++ QL    H N+V+   VI +          +Y++ E++ +  L  Y+       L
Sbjct: 236 EASVMTQLR---HSNLVQLLGVIVEE------KGGLYIVTEYMAKGSLVDYLRSRGRSVL 286

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT 190
               + + +  + + +++L  +  +HRDL  +N+L++     K++DFGL K         
Sbjct: 287 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 346

Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
            + V  W  APE L    + T  D+WS G ++ E++
Sbjct: 347 KLPVK-WT-APEALREKKFSTKSDVWSFGILLWEIY 380

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score =   99 bits (248), Expect = 3e-24
 Identities = 52/340 (15%), Positives = 99/340 (29%), Gaps = 71/340 (20%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED------GIPMSTLREISIL 76
           K     +IG G +G VF+          VA+K + ++  +             L EI I 
Sbjct: 21  KLQRCEKIGEGVFGEVFQTI---ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 77  KQLD------TFEHPNIVRFFDVIH-----------------------QNILSDERYLTV 107
           K+L              +    V                          +     +   +
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 108 YLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLH-SHRIIHRDLKPQNLLI 166
           +++ E      G  +E+      S +  K +  Q+   +     S R  HRDL   N+L+
Sbjct: 138 FIVLEFEFG--GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195

Query: 167 TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
            +    K+      K+         + V++            Y           V  ++ 
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSC--GLQVSIID----------YTLSRLERDGIVVFCDVS 243

Query: 227 RLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE---NISLMWSSF--------EQYSKVAF 275
               LF    + +    I+R++   + N W E     +++W  +          +     
Sbjct: 244 MDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCN 301

Query: 276 SAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           +        K      +ML F+     SA D L      +
Sbjct: 302 TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  101 bits (252), Expect = 6e-24
 Identities = 60/225 (26%), Positives = 94/225 (41%), Gaps = 33/225 (14%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKAR-DLQNKGNYVAMKKLRVKLNEDGIPMST- 69
           L  D+L + D +      +GCG +G+V +    ++ K   VA+K L+    +      T 
Sbjct: 332 LKRDNLLIADIE------LGCGNFGSVRQGVYRMRKKQIDVAIKVLK----QGTEKADTE 381

Query: 70  --LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCP 126
             +RE  I+ QLD   +P IVR   V             + L+ E      L  ++    
Sbjct: 382 EMMREAQIMHQLD---NPYIVRLIGVCQAE--------ALMLVMEMAGGGPLHKFLVG-K 429

Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-- 184
              +  S V EL  Q+  G+ +L     +HR+L  +N+L+      KI+DFGL+K     
Sbjct: 430 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489

Query: 185 ---YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
              Y           WY APE +    + +  D+WS G  M E  
Sbjct: 490 DSYYTARSAGKWPLKWY-APECINFRKFSSRSDVWSYGVTMWEAL 533

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 97.7 bits (244), Expect = 7e-24
 Identities = 61/225 (27%), Positives = 92/225 (40%), Gaps = 33/225 (14%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMST- 69
           L  D+L + D +      +GCG +G+V +      K    VA+K L+    +      T 
Sbjct: 6   LKRDNLLIADIE------LGCGNFGSVRQGVYRMRKKQIDVAIKVLK----QGTEKADTE 55

Query: 70  --LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCP 126
             +RE  I+ QLD   +P IVR   V             + L+ E      L  ++    
Sbjct: 56  EMMREAQIMHQLD---NPYIVRLIGVCQAE--------ALMLVMEMAGGGPLHKFLVG-K 103

Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-- 184
              +  S V EL  Q+  G+ +L     +HRDL  +N+L+      KI+DFGL+K     
Sbjct: 104 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163

Query: 185 ---YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
              Y           WY APE +    + +  D+WS G  M E  
Sbjct: 164 DSYYTARSAGKWPLKWY-APECINFRKFSSRSDVWSYGVTMWEAL 207

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 97.7 bits (244), Expect = 8e-24
 Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 19/202 (9%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G YG V++    +     VA+K L+    E       L+E +++K++    HPN+V
Sbjct: 20  KLGGGQYGEVYEGV-WKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIK---HPNLV 72

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           +   V      + E     Y+I E +   +L  Y+ +C    +SA  +  +  Q+   ++
Sbjct: 73  QLLGVC-----TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL---WYRAPEIL 204
           +L     IHRDL  +N L+     +K+ADFGL++    D             W  APE L
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT-APESL 184

Query: 205 LNLGYGTPVDIWSIGCVMAEMW 226
               +    D+W+ G ++ E+ 
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIA 206

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 97.3 bits (243), Expect = 1e-23
 Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 27/222 (12%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTL 70
           L+   L L DK+      +G G +GTV K      K    VA+K L+ + N+  +    L
Sbjct: 13  LDRKLLTLEDKE------LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL 66

Query: 71  REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG 129
            E ++++QLD   +P IVR   +            +  L+ E  +   L  Y+++     
Sbjct: 67  AEANVMQQLD---NPYIVRMIGICEAE--------SWMLVMEMAELGPLNKYLQQNRH-- 113

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
           +    + EL  Q+  G+ +L     +HRDL  +N+L+      KI+DFGL+K    D   
Sbjct: 114 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173

Query: 190 TSVVVTL-----WYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
                       WY APE +    + +  D+WS G +M E +
Sbjct: 174 YKAQTHGKWPVKWY-APECINYYKFSSKSDVWSFGVLMWEAF 214

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 96.9 bits (242), Expect = 2e-23
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 26/216 (12%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR 71
           LN+  L L          IG G +G V        +GN VA+K ++     D    + L 
Sbjct: 18  LNMKELKLLQT-------IGKGEFGDVMLGDY---RGNKVAVKCIK----NDATAQAFLA 63

Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGL 130
           E S++ QL    H N+V+   VI +          +Y++ E++ +  L  Y+       L
Sbjct: 64  EASVMTQLR---HSNLVQLLGVIVEE------KGGLYIVTEYMAKGSLVDYLRSRGRSVL 114

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT 190
               + + +  + + +++L  +  +HRDL  +N+L++     K++DFGL K         
Sbjct: 115 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174

Query: 191 SVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
            + V  W  APE L    + T  D+WS G ++ E++
Sbjct: 175 KLPVK-WT-APEALREKKFSTKSDVWSFGILLWEIY 208

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =   99 bits (249), Expect = 2e-23
 Identities = 49/203 (24%), Positives = 90/203 (44%), Gaps = 20/203 (9%)

Query: 30  IGCGAYGTVFKARDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V +   +  +     VA+K  +   ++       L+E   ++Q D   HP+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV-REKFLQEALTMRQFD---HPHI 453

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   VI +N         V++I E     +L S+++      L  + +     Q+   +
Sbjct: 454 VKLIGVITEN--------PVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTAL 504

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRAPEI 203
            +L S R +HRD+  +N+L++    +K+ DFGL++      Y       +   W  APE 
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APES 563

Query: 204 LLNLGYGTPVDIWSIGCVMAEMW 226
           +    + +  D+W  G  M E+ 
Sbjct: 564 INFRRFTSASDVWMFGVCMWEIL 586

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 95.9 bits (239), Expect = 6e-23
 Identities = 50/219 (22%), Positives = 91/219 (41%), Gaps = 38/219 (17%)

Query: 29  QIGCGAYGTVFKA--RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
            +G G +G+V +A  +        VA+K L+  +         LRE + +K+ D   HP+
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD---HPH 86

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSAS-KVKELTR---Q 141
           + +   V  ++  +  R     +I   +   DL +++          +  ++ L R    
Sbjct: 87  VAKLVGVSLRS-RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTLWY 198
           +  G+++L S   IHRDL  +N ++     + +ADFGL++   + DY            Y
Sbjct: 146 IACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY------------Y 193

Query: 199 R------------APEILLNLGYGTPVDIWSIGCVMAEM 225
           R            A E L +  Y    D+W+ G  M E+
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 95.8 bits (239), Expect = 7e-23
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 28/208 (13%)

Query: 30  IGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMST---LREISILKQLDTFE 83
           +G GA+GTV+K   +         VA+K+LR    E   P +    L E  ++  +D   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR----EATSPKANKEILDEAYVMASVD--- 75

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQM 142
           +P++ R   +   +        TV LI + +    L  Y+ +     + +  +     Q+
Sbjct: 76  NPHVCRLLGICLTS--------TVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQI 126

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL----WY 198
            KG+++L   R++HRDL  +N+L+     +KI DFGLAK    +              W 
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMW 226
            A E +L+  Y    D+WS G  + E+ 
Sbjct: 187 -ALESILHRIYTHQSDVWSYGVTVWELM 213

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 95.0 bits (237), Expect = 7e-23
 Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 28/219 (12%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR 71
           +  ++L L ++       +G G +G V+      N    VA+K L+        P + L 
Sbjct: 10  VPRETLKLVER-------LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSMS---PDAFLA 57

Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGL 130
           E +++KQL    H  +VR + V+ Q          +Y+I E+++   L  +++      L
Sbjct: 58  EANLMKQLQ---HQRLVRLYAVVTQE--------PIYIITEYMENGSLVDFLKTPSGIKL 106

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT 190
           + +K+ ++  Q+ +G+ F+     IHRDL+  N+L++     KIADFGLA+  + +    
Sbjct: 107 TINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166

Query: 191 SVVVTL---WYRAPEILLNLGYGTPVDIWSIGCVMAEMW 226
                    W  APE +    +    D+WS G ++ E+ 
Sbjct: 167 REGAKFPIKWT-APEAINYGTFTIKSDVWSFGILLTEIV 204

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 94.2 bits (235), Expect = 1e-22
 Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 22/204 (10%)

Query: 30  IGCGAYGTVFKARDLQNKGN---YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G +G V +     +  N    VA+K  +   ++       L+E   ++Q D   HP+
Sbjct: 23  IGEGQFGDVHQGI-YMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFD---HPH 77

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           IV+   VI +N         V++I E     +L S+++      L  + +     Q+   
Sbjct: 78  IVKLIGVITEN--------PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTA 128

Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRAPE 202
           + +L S R +HRD+  +N+L++    +K+ DFGL++      Y       +   W  APE
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APE 187

Query: 203 ILLNLGYGTPVDIWSIGCVMAEMW 226
            +    + +  D+W  G  M E+ 
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEIL 211

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 93.4 bits (233), Expect = 2e-22
 Identities = 45/202 (22%), Positives = 87/202 (43%), Gaps = 21/202 (10%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           +IG G +G V          + VA+K +R            + E  ++ +L    HP +V
Sbjct: 15  EIGSGQFGLVHLGY--WLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS---HPKLV 66

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + + V       ++    + L+ E ++   L  Y+        +A  +  +   + +G+ 
Sbjct: 67  QLYGVC-----LEQAP--ICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMA 118

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL---WYRAPEIL 204
           +L    +IHRDL  +N L+     +K++DFG+ +    D   +S        W  +PE+ 
Sbjct: 119 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA-SPEVF 177

Query: 205 LNLGYGTPVDIWSIGCVMAEMW 226
               Y +  D+WS G +M E++
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVF 199

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 93.9 bits (234), Expect = 3e-22
 Identities = 49/219 (22%), Positives = 89/219 (40%), Gaps = 39/219 (17%)

Query: 29  QIGCGAYGTVFKA--RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
            +G G +G+V +   +        VA+K +++  +        L E + +K    F HPN
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKD---FSHPN 97

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC-PPPGLSASKVKELT---RQ 141
           ++R   V  +   S +      +I   +   DL +Y+       G     ++ L      
Sbjct: 98  VIRLLGVCIEM--SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTLWY 198
           +  G+++L +   +HRDL  +N ++     + +ADFGL+K   + DY            Y
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY------------Y 203

Query: 199 R------------APEILLNLGYGTPVDIWSIGCVMAEM 225
           R            A E L +  Y +  D+W+ G  M E+
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 93.5 bits (233), Expect = 3e-22
 Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 21/205 (10%)

Query: 30  IGCGAYGTVFKA--RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+     D   K  + A+K L    +   +    L E  I+K    F HPN+
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKD---FSHPNV 88

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +    +  ++        +  ++  ++   DL +++        +   +     Q+ KG+
Sbjct: 89  LSLLGICLRS------EGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGM 141

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTL---WYRA 200
            +L S + +HRDL  +N ++     +K+ADFGLA+     +Y  +       L   W  A
Sbjct: 142 KYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-A 200

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEM 225
            E L    + T  D+WS G ++ E+
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWEL 225

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 94.3 bits (235), Expect = 3e-22
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 22/207 (10%)

Query: 29  QIGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP 85
            IG G +G V+K     + G     VA+K L+    E    +  L E  I+ Q     H 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-RVDFLGEAGIMGQFS---HH 106

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLK 144
           NI+R   VI     S  +   + +I E+++   L  ++ +      S  ++  + R +  
Sbjct: 107 NIIRLEGVI-----SKYK--PMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAA 158

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF--DYDMMLTSVVVTL---WYR 199
           G+ +L +   +HRDL  +N+L+      K++DFGL++    D +   T+    +   W  
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT- 217

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMW 226
           APE +    + +  D+WS G VM E+ 
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVM 244

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 93.9 bits (234), Expect = 3e-22
 Identities = 50/226 (22%), Positives = 95/226 (42%), Gaps = 51/226 (22%)

Query: 29  QIGCGAYGTVFK--ARDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           ++G G++G V++  A+ +        VA+K +    +     +  L E S++K+   F  
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMKE---FNC 87

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
            ++VR   V+ Q            +I E + + DL SY+    P   +   +   +   +
Sbjct: 88  HHVVRLLGVVSQGQ-------PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140

Query: 144 --------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYDMMLTSV 192
                    G+ +L++++ +HRDL  +N ++     +KI DFG+ +     DY       
Sbjct: 141 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY------- 193

Query: 193 VVTLWYR------------APEILLNLGYGTPVDIWSIGCVMAEMW 226
                YR            +PE L +  + T  D+WS G V+ E+ 
Sbjct: 194 -----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 93.1 bits (232), Expect = 4e-22
 Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 22/207 (10%)

Query: 29  QIGCGAYGTVFKARDLQNKGNY--VAMKKLRV-KLNEDGIPMSTLREISILKQLDTFEHP 85
           ++G G++G V +       G    VA+K L+   L++       +RE++ +  LD   H 
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD---HR 81

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLK 144
           N++R + V+            + ++ E      L   + K          +     Q+ +
Sbjct: 82  NLIRLYGVVLTP--------PMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAE 132

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTLWYR 199
           G+ +L S R IHRDL  +NLL+     +KI DFGL +        Y M     V   W  
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC- 191

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMW 226
           APE L    +    D W  G  + EM+
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMF 218

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 94.4 bits (235), Expect = 7e-22
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 28/221 (12%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLR 71
           +  +SL L  K       +G G +G V+ A    NK   VA+K ++          + L 
Sbjct: 185 IPRESLKLEKK-------LGAGQFGEVWMAT--YNKHTKVAVKTMKPGSMS---VEAFLA 232

Query: 72  EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGL 130
           E +++K L    H  +V+   V+ +          +Y+I E + +  L  +++       
Sbjct: 233 EANVMKTLQ---HDKLVKLHAVVTKE--------PIYIITEFMAKGSLLDFLKSDEGSKQ 281

Query: 131 SASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT 190
              K+ + + Q+ +G+ F+     IHRDL+  N+L++ +   KIADFGLA+  + +    
Sbjct: 282 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341

Query: 191 SVVVTL---WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL 228
                    W  APE +    +    D+WS G ++ E+   
Sbjct: 342 REGAKFPIKWT-APEAINFGSFTIKSDVWSFGILLMEIVTY 381

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 93.2 bits (232), Expect = 7e-22
 Identities = 43/208 (20%), Positives = 82/208 (39%), Gaps = 28/208 (13%)

Query: 30  IGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMST---LREISILKQLDTFE 83
           +G G +GTV K   +    +    V +K +     +     S       +  +  LD   
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIE----DKSGRQSFQAVTDHMLAIGSLD--- 73

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQM 142
           H +IVR   +   +        ++ L+ +++    L  ++ +     L    +     Q+
Sbjct: 74  HAHIVRLLGLCPGS--------SLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQI 124

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL----WY 198
            KG+ +L  H ++HR+L  +N+L+     +++ADFG+A     D              W 
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMW 226
            A E +    Y    D+WS G  + E+ 
Sbjct: 185 -ALESIHFGKYTHQSDVWSYGVTVWELM 211

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 92.7 bits (231), Expect = 8e-22
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 23/207 (11%)

Query: 29  QIGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP 85
            IG G  G V   R L+  G     VA+K L+    E       L E SI+ Q D   HP
Sbjct: 56  IIGSGDSGEVCYGR-LRVPGQRDVPVAIKALKAGYTERQR-RDFLSEASIMGQFD---HP 110

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLK 144
           NI+R   V+     +  R     ++ E+++   L +++        +  ++  + R +  
Sbjct: 111 NIIRLEGVV-----TRGR--LAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGA 162

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK--TFDYDMMLTSVVVTL---WYR 199
           G+ +L     +HRDL  +N+L+      K++DFGL++    D D   T+    +   W  
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT- 221

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMW 226
           APE +    + +  D+WS G VM E+ 
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVL 248

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 91.5 bits (228), Expect = 1e-21
 Identities = 45/202 (22%), Positives = 95/202 (47%), Gaps = 21/202 (10%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V   +        VA+K ++            + E  ++  L    H  +V
Sbjct: 31  ELGTGQFGVVKYGK--WRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLS---HEKLV 82

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           + + V      + +R   +++I E++    L +Y+ +         ++ E+ + + + ++
Sbjct: 83  QLYGVC-----TKQRP--IFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAME 134

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL---WYRAPEIL 204
           +L S + +HRDL  +N L+   G +K++DFGL++    D   +SV       W   PE+L
Sbjct: 135 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS-PPEVL 193

Query: 205 LNLGYGTPVDIWSIGCVMAEMW 226
           +   + +  DIW+ G +M E++
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIY 215

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 93.2 bits (232), Expect = 1e-21
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 23/207 (11%)

Query: 29  QIGCGAYGTVFKARDLQNKGN---YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP 85
            +G G +G V   R L+        VA+K L+V   E       L E SI+ Q D   HP
Sbjct: 52  VVGAGEFGEVCSGR-LKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFD---HP 106

Query: 86  NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLK 144
           NI+R   V+ ++         V ++ E+++   L S++ K      +  ++  + R +  
Sbjct: 107 NIIRLEGVVTKS-------KPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIAS 158

Query: 145 GVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF--DYDMMLTSVVVTL---WYR 199
           G+ +L     +HRDL  +N+LI      K++DFGL +    D +   T+    +   W  
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT- 217

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMW 226
           +PE +    + +  D+WS G V+ E+ 
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVM 244

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 92.3 bits (230), Expect = 1e-21
 Identities = 59/240 (24%), Positives = 95/240 (39%), Gaps = 57/240 (23%)

Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGN-YVAMKKLRVKLNEDGIPMSTLREI 73
           + +   D        IG G +G V KAR  ++      A+K+++   ++D        E+
Sbjct: 25  NDIKFQDV-------IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-HRDFAGEL 76

Query: 74  SILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSY------MEKCP 126
            +L +L    HPNI+               YL  YL  E+    +L  +      +E  P
Sbjct: 77  EVLCKLG--HHPNIINLLGAC-----EHRGYL--YLAIEYAPHGNLLDFLRKSRVLETDP 127

Query: 127 PPGLSASKVKELTRQML--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG 178
              ++ S    L+ Q L        +G+D+L   + IHRDL  +N+L+      KIADFG
Sbjct: 128 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 187

Query: 179 LAKTFDYDMMLTSVVVTLWYR------------APEILLNLGYGTPVDIWSIGCVMAEMW 226
           L++  +             Y             A E L    Y T  D+WS G ++ E+ 
Sbjct: 188 LSRGQEV------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 21/205 (10%)

Query: 30  IGCGAYGTVFKA--RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+     D   K  + A+K L    +   +    L E  I+K    F HPN+
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKD---FSHPNV 152

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           +    +  ++        +  ++  ++   DL +++        +   +     Q+ KG+
Sbjct: 153 LSLLGICLRS------EGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGM 205

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTL---WYRA 200
            FL S + +HRDL  +N ++     +K+ADFGLA+     ++D +       L   W  A
Sbjct: 206 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-A 264

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEM 225
            E L    + T  D+WS G ++ E+
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWEL 289

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 90.3 bits (225), Expect = 3e-21
 Identities = 49/203 (24%), Positives = 91/203 (44%), Gaps = 20/203 (9%)

Query: 30  IGCGAYGTVFKA--RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           +G G +G V++    + + +   VA+K  +     D      + E  I+K LD   HP+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-KEKFMSEAVIMKNLD---HPHI 75

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           V+   +I +           ++I E     +LG Y+E+     L    +   + Q+ K +
Sbjct: 76  VKLIGIIEEE--------PTWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAM 126

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL---WYRAPEI 203
            +L S   +HRD+  +N+L+     +K+ DFGL++  + +    + V  L   W  +PE 
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM-SPES 185

Query: 204 LLNLGYGTPVDIWSIGCVMAEMW 226
           +    + T  D+W     M E+ 
Sbjct: 186 INFRRFTTASDVWMFAVCMWEIL 208

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 90.3 bits (225), Expect = 3e-21
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 21/202 (10%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
           ++G G +G V   +        VA+K ++             +E   + +L    HP +V
Sbjct: 15  ELGSGQFGVVKLGK--WKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLS---HPKLV 66

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           +F+ V      S E    +Y++ E++    L +Y+      GL  S++ E+   + +G+ 
Sbjct: 67  KFYGVC-----SKEY--PIYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMA 118

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL---WYRAPEIL 204
           FL SH+ IHRDL  +N L+ R   +K++DFG+ +    D  ++SV       W  APE+ 
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS-APEVF 177

Query: 205 LNLGYGTPVDIWSIGCVMAEMW 226
               Y +  D+W+ G +M E++
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVF 199

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 91.2 bits (227), Expect = 4e-21
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 45/223 (20%)

Query: 29  QIGCGAYGTVFK--ARDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
            +G GA+G V++     + N  +   VA+K L    +E    +  L E  I+ +   F H
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-ELDFLMEALIISK---FNH 92

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC-----PPPGLSASKVKEL 138
            NIVR   V  Q++         +++ E +   DL S++ +       P  L+   +  +
Sbjct: 93  QNIVRCIGVSLQSL-------PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMMLTSVVVT 195
            R +  G  +L  +  IHRD+  +N L+T  G     KI DFG+A+    D+   S    
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAS---- 197

Query: 196 LWYR------------APEILLNLGYGTPVDIWSIGCVMAEMW 226
            +YR             PE  +   + +  D WS G ++ E++
Sbjct: 198 -YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 90.9 bits (226), Expect = 4e-21
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 22/205 (10%)

Query: 30  IGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           +G GA+GTV+K   +         VA+K+LR            L E  ++  +D   +P+
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD---NPH 78

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKG 145
           + R   +   +        TV LI + +    L  Y+ +     + +  +     Q+ KG
Sbjct: 79  VCRLLGICLTS--------TVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKG 129

Query: 146 VDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTL----WYRAP 201
           +++L   R++HRDL  +N+L+     +KI DFGLAK    +              W  A 
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-AL 188

Query: 202 EILLNLGYGTPVDIWSIGCVMAEMW 226
           E +L+  Y    D+WS G  + E+ 
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELM 213

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 90.5 bits (225), Expect = 9e-21
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 45/223 (20%)

Query: 29  QIGCGAYGTVFK--ARDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
            +G GA+G V++     + N  +   VA+K L    +E    +  L E  I+ +   F H
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-ELDFLMEALIISK---FNH 133

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC-----PPPGLSASKVKEL 138
            NIVR   V  Q++         +++ E +   DL S++ +       P  L+   +  +
Sbjct: 134 QNIVRCIGVSLQSL-------PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFDYDMMLTSVVVT 195
            R +  G  +L  +  IHRD+  +N L+T  G     KI DFG+A+    D+        
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAG---- 238

Query: 196 LWYR------------APEILLNLGYGTPVDIWSIGCVMAEMW 226
            +YR             PE  +   + +  D WS G ++ E++
Sbjct: 239 -YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 89.2 bits (222), Expect = 1e-20
 Identities = 58/230 (25%), Positives = 86/230 (37%), Gaps = 52/230 (22%)

Query: 29  QIGCGAYGTVFKA--RDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
            +G GA+G V +A    L        VA+K L+   +      + + E+ +L  L    H
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-REALMSELKVLSYLG--NH 86

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPP--------PGLSASKV 135
            NIV           +        +I E+    DL +++ +           P +     
Sbjct: 87  MNIVNLLGAC-----TIGGPT--LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 136 KELTRQML--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM 187
             L  + L        KG+ FL S   IHRDL  +N+L+T     KI DFGLA     D+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA----RDI 195

Query: 188 MLTSVVVTLWYR------------APEILLNLGYGTPVDIWSIGCVMAEM 225
              S      Y             APE + N  Y    D+WS G  + E+
Sbjct: 196 KNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 88.1 bits (219), Expect = 2e-20
 Identities = 43/213 (20%), Positives = 84/213 (39%), Gaps = 30/213 (14%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRV---KLNEDGIPMST--LREISILKQLDTFE 83
            +G G +  +FK    +  G+Y  + +  V    L++     S       S++ +L    
Sbjct: 15  SLGQGTFTKIFKGV-RREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS--- 70

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQM 142
           H ++V  + V               L+ E V    L +Y++K     ++     E+ +Q+
Sbjct: 71  HKHLVLNYGVC-----VCGD--ENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQL 122

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGL--------KIADFGLAKTFDYDMMLTSVVV 194
              + FL  + +IH ++  +N+L+ R            K++D G++ T     +L   + 
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182

Query: 195 TLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMW 226
             W   PE + N        D WS G  + E+ 
Sbjct: 183 --WV-PPECIENPKNLNLATDKWSFGTTLWEIC 212

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 88.9 bits (221), Expect = 3e-20
 Identities = 58/240 (24%), Positives = 96/240 (40%), Gaps = 55/240 (22%)

Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKA--RDLQNKGNY--VAMKKLRVKLNEDGIPMSTL 70
           ++L  G         +G GA+G V +A    L  +     VA+K L+   + D    + +
Sbjct: 46  NNLQFGKT-------LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE-KEALM 97

Query: 71  REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPP- 128
            E+ I+  L   +H NIV           +    +   +I E+    DL +++ +     
Sbjct: 98  SELKIMSHLG--QHENIVNLLGAC-----THGGPV--LVITEYCCYGDLLNFLRRKSRVL 148

Query: 129 ---GLSASKVKELTRQML--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF 177
                 A      + + L        +G+ FL S   IHRD+  +N+L+T     KI DF
Sbjct: 149 ETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDF 208

Query: 178 GLAKTFDYDMMLTSVVVTLWYR------------APEILLNLGYGTPVDIWSIGCVMAEM 225
           GLA+    D+M  S      Y             APE + +  Y    D+WS G ++ E+
Sbjct: 209 GLAR----DIMNDS-----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 88.5 bits (220), Expect = 3e-20
 Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 52/230 (22%)

Query: 29  QIGCGAYGTVFKAR------DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
            +G GA+G V  A       D   +   VA+K L+    E  +    + E+ ++K +   
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIG-- 98

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKV------ 135
           +H NI+           + +  L  Y+I E+  + +L  Y+    PPG+  S        
Sbjct: 99  KHKNIINLLGAC-----TQDGPL--YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151

Query: 136 KELTRQML--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM 187
           +++T + L        +G+++L S + IHRDL  +N+L+T    +KIADFGLA+    D+
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207

Query: 188 MLTSVVVTLWYR------------APEILLNLGYGTPVDIWSIGCVMAEM 225
                    +Y+            APE L +  Y    D+WS G +M E+
Sbjct: 208 NNID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 89.0 bits (221), Expect = 4e-20
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 52/230 (22%)

Query: 29  QIGCGAYGTVFKA------RDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
            +G GA+G V  A      +D  N+   VA+K L+    E  +    + E+ ++K +   
Sbjct: 76  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIG-- 132

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSAS------KV 135
           +H NI+           + +  L  Y+I E+  + +L  Y++   PPGL  S        
Sbjct: 133 KHKNIINLLGAC-----TQDGPL--YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185

Query: 136 KELTRQML--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM 187
           ++L+ + L        +G+++L S + IHRDL  +N+L+T    +KIADFGLA+    D+
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DI 241

Query: 188 MLTSVVVTLWYR------------APEILLNLGYGTPVDIWSIGCVMAEM 225
                    +Y+            APE L +  Y    D+WS G ++ E+
Sbjct: 242 HHID-----YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 87.7 bits (218), Expect = 4e-20
 Identities = 53/228 (23%), Positives = 87/228 (38%), Gaps = 49/228 (21%)

Query: 29  QIGCGAYGTVFKARDLQNKGNY----VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
            +G GA+G V +A             VA+K L+          + + E+ IL  +    H
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIG--HH 90

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSAS------KVKE 137
            N+V       +          + +I E     +L +Y+       +             
Sbjct: 91  LNVVNLLGACTKPGGP------LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144

Query: 138 LTRQML--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
           LT + L        KG++FL S + IHRDL  +N+L++    +KI DFGLA+    D+  
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYK 200

Query: 190 TSVVVTLWYR------------APEILLNLGYGTPVDIWSIGCVMAEM 225
                   Y             APE + +  Y    D+WS G ++ E+
Sbjct: 201 DPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 88.6 bits (220), Expect = 4e-20
 Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 52/230 (22%)

Query: 29  QIGCGAYGTVFKAR------DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
            +G G +G V  A       D   +   VA+K L+    E  +    + E+ ++K +   
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIG-- 144

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKV------ 135
           +H NI+           + +  L  Y+I E+  + +L  Y+    PPG+  S        
Sbjct: 145 KHKNIINLLGAC-----TQDGPL--YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197

Query: 136 KELTRQML--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM 187
           +++T + L        +G+++L S + IHRDL  +N+L+T    +KIADFGLA+    D+
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 253

Query: 188 MLTSVVVTLWYR------------APEILLNLGYGTPVDIWSIGCVMAEM 225
                     Y+            APE L +  Y    D+WS G +M E+
Sbjct: 254 NNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 87.7 bits (218), Expect = 4e-20
 Identities = 45/208 (21%), Positives = 87/208 (41%), Gaps = 27/208 (12%)

Query: 30  IGCGAYGTVFKA--RDLQNKGNYVAMKKLRVKLNEDGIPMST---LREISILKQLDTFEH 84
           IG G +G V+     D        A+K L    +           LRE  +++      H
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSL----SRITEMQQVEAFLREGLLMRG---LNH 81

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQML 143
           PN++    ++             +++  ++   DL  ++ + P    +   +     Q+ 
Sbjct: 82  PNVLALIGIMLP------PEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVA 134

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYDMMLTSVVVTL---W 197
           +G+++L   + +HRDL  +N ++  +  +K+ADFGLA+     +Y  +       L   W
Sbjct: 135 RGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKW 194

Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEM 225
             A E L    + T  D+WS G ++ E+
Sbjct: 195 T-ALESLQTYRFTTKSDVWSFGVLLWEL 221

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 86.6 bits (215), Expect = 1e-19
 Identities = 56/230 (24%), Positives = 91/230 (39%), Gaps = 57/230 (24%)

Query: 29  QIGCGAYGTVFK--ARDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           ++G GA+G VF     +L  + +   VA+K L+             RE  +L      +H
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA--RQDFQREAELLTM---LQH 102

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPP-----PGLSASKVKEL 138
            +IVRFF V  +          + ++FE++   DL  ++    P      G        L
Sbjct: 103 QHIVRFFGVCTEG-------RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 155

Query: 139 TRQML--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYDM 187
               L         G+ +L     +HRDL  +N L+ +   +KI DFG+++   + DY  
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-- 213

Query: 188 MLTSVVVTLWYR------------APEILLNLGYGTPVDIWSIGCVMAEM 225
                     YR             PE +L   + T  D+WS G V+ E+
Sbjct: 214 ----------YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEI 253

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 85.7 bits (213), Expect = 2e-19
 Identities = 53/231 (22%), Positives = 90/231 (38%), Gaps = 58/231 (25%)

Query: 29  QIGCGAYGTVFK--ARDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           ++G GA+G VF     +L    +   VA+K L+             RE  +L  L    H
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA--RKDFQREAELLTNLQ---H 76

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSAS------KVKE 137
            +IV+F+ V             + ++FE++   DL  ++    P  +            E
Sbjct: 77  EHIVKFYGVCGDG-------DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129

Query: 138 LTRQML--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYD 186
           L    +         G+ +L S   +HRDL  +N L+     +KI DFG+++   + DY 
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY- 188

Query: 187 MMLTSVVVTLWYR------------APEILLNLGYGTPVDIWSIGCVMAEM 225
                      YR             PE ++   + T  D+WS G ++ E+
Sbjct: 189 -----------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 84.2 bits (209), Expect = 6e-19
 Identities = 51/232 (21%), Positives = 91/232 (39%), Gaps = 57/232 (24%)

Query: 29  QIGCGAYGTVFKAR----DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
           ++G   +G V+K          +   VA+K L+ K            E  +  +L    H
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-EEFRHEAMLRARLQ---H 71

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELT---- 139
           PN+V    V+     + ++   + +IF +    DL  ++    P     S   + T    
Sbjct: 72  PNVVCLLGVV-----TKDQ--PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124

Query: 140 ----------RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK---TFDYD 186
                      Q+  G+++L SH ++H+DL  +N+L+     +KI+D GL +     DY 
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY- 183

Query: 187 MMLTSVVVTLWYR------------APEILLNLGYGTPVDIWSIGCVMAEMW 226
                      Y+            APE ++   +    DIWS G V+ E++
Sbjct: 184 -----------YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 83.8 bits (208), Expect = 1e-18
 Identities = 55/236 (23%), Positives = 97/236 (41%), Gaps = 59/236 (25%)

Query: 29  QIGCGAYGTVFKAR--DLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
            +G G +G V KA    L+ +  Y  VA+K L+   +   +    L E ++LKQ++   H
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-RDLLSEFNVLKQVN---H 85

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKV-------- 135
           P++++ +        S +  L   LI E+     L  ++ +    G              
Sbjct: 86  PHVIKLYGAC-----SQDGPL--LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 136 ------KELTRQML--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK 181
                 + LT   L        +G+ +L   +++HRDL  +N+L+     +KI+DFGL++
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

Query: 182 TFDYDMMLTSVVVTLWYR------------APEILLNLGYGTPVDIWSIGCVMAEM 225
               D+          Y             A E L +  Y T  D+WS G ++ E+
Sbjct: 199 ----DVYEEDS-----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 83.1 bits (206), Expect = 3e-18
 Identities = 62/235 (26%), Positives = 92/235 (39%), Gaps = 57/235 (24%)

Query: 29  QIGCGAYGTVFKA--RDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
            +G GA+G V  A    +   G    VA+K L+ K +      + + E+ ++ QL    H
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER-EALMSELKMMTQLG--SH 108

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGL------------- 130
            NIV           +    +  YLIFE+    DL +Y+                     
Sbjct: 109 ENIVNLLGAC-----TLSGPI--YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161

Query: 131 SASKVKELTRQML--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT 182
               +  LT + L        KG++FL     +HRDL  +N+L+T    +KI DFGLA  
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA-- 219

Query: 183 FDYDMMLTSVVVTLWYR------------APEILLNLGYGTPVDIWSIGCVMAEM 225
              D+M  S      Y             APE L    Y    D+WS G ++ E+
Sbjct: 220 --RDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 82.7 bits (205), Expect = 4e-18
 Identities = 57/240 (23%), Positives = 98/240 (40%), Gaps = 65/240 (27%)

Query: 29  QIGCGAYGTVFK--ARDLQNKGNY--VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEH 84
            IG GA+G VF+  A  L     +  VA+K L+ + + D       RE +++ + D   +
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFD---N 109

Query: 85  PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG-------------- 129
           PNIV+   V      +  + +   L+FE++   DL  ++    P                
Sbjct: 110 PNIVKLLGVC-----AVGKPM--CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162

Query: 130 LSASKVKELTRQML--------KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK 181
           +S+     L+             G+ +L   + +HRDL  +N L+     +KIADFGL++
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

Query: 182 ---TFDYDMMLTSVVVTLWYR------------APEILLNLGYGTPVDIWSIGCVMAEMW 226
              + DY            Y+             PE +    Y T  D+W+ G V+ E++
Sbjct: 223 NIYSADY------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 78.6 bits (194), Expect = 8e-17
 Identities = 39/167 (23%), Positives = 66/167 (39%), Gaps = 22/167 (13%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
            Y    +IG G++G +F+  +L N    VA+K    + +   +      E    K L   
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLN-NQQVAIKFEPRRSDAPQLR----DEYRTYKLLAGC 65

Query: 83  EH-PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
              PN+  F          +  +    L+ + +   L   ++ C     S   V    +Q
Sbjct: 66  TGIPNVYYFG--------QEGLH--NVLVIDLLGPSLEDLLDLCGRK-FSVKTVAMAAKQ 114

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK-----IADFGLAKTF 183
           ML  V  +H   +++RD+KP N LI R          + DFG+ K +
Sbjct: 115 MLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 79.0 bits (195), Expect = 8e-17
 Identities = 31/179 (17%), Positives = 68/179 (37%), Gaps = 21/179 (11%)

Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           D+   ++    +IG G +G ++ A          A   ++V+  E+G       E+   +
Sbjct: 33  DMEGNQWVLGKKIGSGGFGLIYLAFPTNK-PEKDARHVVKVEYQENG---PLFSELKFYQ 88

Query: 78  QLDTFEHPNIVRFFDVIH-----------QNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
           ++   +          +                    Y   +++ E +  DL     +  
Sbjct: 89  RVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSY--RFMVMERLGIDLQKISGQNG 146

Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI--ADFGLAKTF 183
                 S V +L  +ML  ++++H +  +H D+K  NLL+      ++  AD+GL+  +
Sbjct: 147 T--FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 78.2 bits (193), Expect = 1e-16
 Identities = 42/167 (25%), Positives = 71/167 (42%), Gaps = 22/167 (13%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
            +    +IGCG +G +   ++L     YVA+K   +K     +      E    KQL + 
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYT-NEYVAIKLEPMKSRAPQLH----LEYRFYKQLGSG 64

Query: 83  EH-PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
           +  P +  F            +Y    ++ E +   L    + C     S   V  +  Q
Sbjct: 65  DGIPQVYYFG--------PCGKY--NAMVLELLGPSLEDLFDLCDRT-FSLKTVLMIAIQ 113

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK-----IADFGLAKTF 183
           ++  ++++HS  +I+RD+KP+N LI R G        I DF LAK +
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 48/166 (28%), Positives = 71/166 (42%), Gaps = 22/166 (13%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL-REISILKQLDT 81
           K+    +IG G++G ++   ++Q     VA+K   VK          L  E  I + L  
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVK-----TKHPQLLYESKIYRILQG 61

Query: 82  FEH-PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
               PN+  F          +  Y    L+ + +   L      C    LS   V  L  
Sbjct: 62  GTGIPNVRWFG--------VEGDY--NVLVMDLLGPSLEDLFNFCSRK-LSLKTVLMLAD 110

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTF 183
           QM+  V+F+HS   +HRD+KP N L+    RA  + I DFGLAK +
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 76.6 bits (189), Expect = 4e-16
 Identities = 44/166 (26%), Positives = 68/166 (40%), Gaps = 22/166 (13%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTL-REISILKQLDT 81
           +Y    +IG G++G ++   D+   G  VA+K   VK          L  E  I K +  
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAA-GEEVAIKLECVK-----TKHPQLHIESKIYKMMQG 63

Query: 82  FEH-PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
               P I            ++  Y    ++ E +   L      C     S   V  L  
Sbjct: 64  GVGIPTIRWCG--------AEGDY--NVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLAD 112

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIADFGLAKTF 183
           QM+  ++++HS   IHRD+KP N L+    +   + I DFGLAK +
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 76.3 bits (188), Expect = 7e-16
 Identities = 28/180 (15%), Positives = 68/180 (37%), Gaps = 20/180 (11%)

Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRV--KL--------NEDGIPM 67
           D   +++           G +++A            +K +   KL        NE     
Sbjct: 38  DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQ 97

Query: 68  STLR--EISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKC 125
              +  +++  K+L +     I           +  ++Y   +L+   + + L S ++  
Sbjct: 98  RAAKPLQVNKWKKLYSTPLLAIPT----CMGFGVHQDKY--RFLVLPSLGRSLQSALDVS 151

Query: 126 PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI--ADFGLAKTF 183
           P   LS   V ++  ++L  ++FLH +  +H ++  +N+ +      ++  A +G A  +
Sbjct: 152 PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 74.5 bits (184), Expect = 2e-15
 Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 39/221 (17%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
             +     +G G +G V+K R L + G  VA+K+L+ +    G  +    E+ ++     
Sbjct: 30  DNFSNKNILGRGGFGKVYKGR-LAD-GTLVAVKRLKEE-RTQGGELQFQTEVEMISMA-- 84

Query: 82  FEHPNIVRFFDVIHQNIL------SDERYLTVYLIFEHV-----DQDLGSYMEKCPPPGL 130
             H N++R         L        ER L VY    ++        L    E  PP  L
Sbjct: 85  -VHRNLLR---------LRGFCMTPTERLL-VY---PYMANGSVASCLRERPESQPP--L 128

Query: 131 SASKVKELTRQMLKGVDFLHSH---RIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM 187
              K + +     +G+ +LH H   +IIHRD+K  N+L+       + DFGLAK  DY  
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188

Query: 188 --MLTSVVVTLWYRAPEILLNLGYGTP-VDIWSIGCVMAEM 225
             + T+V  T+ + APE L   G  +   D++  G ++ E+
Sbjct: 189 THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLEL 228

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 72.2 bits (178), Expect = 1e-14
 Identities = 61/222 (27%), Positives = 92/222 (41%), Gaps = 59/222 (26%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST--LREISILKQLDTFEHPNI 87
           +G G +G V+K   +      VA+KKL   ++     +     +EI ++ +    +H N+
Sbjct: 39  MGEGGFGVVYKGY-V--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC---QHENL 92

Query: 88  VRFFDVIHQNIL------SDERYLTVYLIFEHVDQDLGSYMEKCPPPG------LSASKV 135
           V          L       D+  L VY            YM      G            
Sbjct: 93  VE---------LLGFSSDGDDLCL-VY---V--------YMPN----GSLLDRLSCLDGT 127

Query: 136 KEL---TRQML-----KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD- 186
             L    R  +      G++FLH +  IHRD+K  N+L+  A   KI+DFGLA+  +   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 187 --MMLTSVVVTLWYRAPEILLNLGYGTP-VDIWSIGCVMAEM 225
             +M + +V T  Y APE L   G  TP  DI+S G V+ E+
Sbjct: 188 QTVMTSRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEI 227

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 68.3 bits (167), Expect = 4e-13
 Identities = 31/179 (17%), Positives = 67/179 (37%), Gaps = 18/179 (10%)

Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNK----GNYVAMKKLRVK----LNEDGI--PM 67
           D+    +     IG G +G ++ A    ++         +K           E       
Sbjct: 31  DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRA 90

Query: 68  STLREISILKQLDTFEHPNIVRFFDV-IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCP 126
           +   +I    +    ++  + +++   +H       R++    I +    DL    E   
Sbjct: 91  AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRFGSDLQKIYEANA 146

Query: 127 PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI--ADFGLAKTF 183
               S   V +L+ ++L  ++++H H  +H D+K  NLL+      ++   D+GLA  +
Sbjct: 147 KR-FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 64.1 bits (157), Expect = 6e-12
 Identities = 53/206 (25%), Positives = 81/206 (39%), Gaps = 58/206 (28%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST------LREISI 75
             +D    IG G +G V+K   L++ G  VA+K+          P S+        EI  
Sbjct: 39  NNFDHKFLIGHGVFGKVYKGV-LRD-GAKVALKRRT--------PESSQGIEEFETEIET 88

Query: 76  LKQLDTFEHPNIVRFFDVIHQNIL------SDERYLTVYLIFEHVDQDLGS-----YMEK 124
           L       HP++V          L       +E  L +Y   ++++   G+     Y   
Sbjct: 89  LSFC---RHPHLVS---------LIGFCDERNEMIL-IY---KYMEN--GNLKRHLYGSD 130

Query: 125 CPPPGLSASKVKELTRQML-----KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL 179
            P   +S        R  +     +G+ +LH+  IIHRD+K  N+L+      KI DFG+
Sbjct: 131 LPTMSMSWE-----QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI 185

Query: 180 AKTFDYDMML---TSVVVTLWYRAPE 202
           +K           T V  TL Y  PE
Sbjct: 186 SKKGTELDQTHLSTVVKGTLGYIDPE 211

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.2 bits (143), Expect = 4e-10
 Identities = 33/118 (27%), Positives = 53/118 (44%), Gaps = 21/118 (17%)

Query: 120 SYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL 179
              E      L+   +   + Q+ KG++FL S + IHRDL  +N+L++    +KI DFGL
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 239

Query: 180 AKTFDYDMMLTSVVVTLWYR------------APEILLNLGYGTPVDIWSIGCVMAEM 225
           A+    D+          Y             APE + +  Y    D+WS G ++ E+
Sbjct: 240 AR----DIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 39.9 bits (93), Expect = 8e-04
 Identities = 36/179 (20%), Positives = 60/179 (33%), Gaps = 27/179 (15%)

Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKAR----DLQNKGNYVAMKKLRVKLNEDGIPMSTL 70
           D L LG         +G GA+G V +A     D       VA+K L+            +
Sbjct: 22  DRLKLGKP-------LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LM 73

Query: 71  REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPG 129
            E+ IL  +    H N+V             +    + +I E     +L +Y+       
Sbjct: 74  SELKILIHIGH--HLNVVNLLGA------CTKPGGPLMVIVEFCKFGNLSTYLRSKRN-- 123

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM 188
                 K    +  +G D++ +   I  DLK +   IT +     + F   K+      
Sbjct: 124 -EFVPYKTKGARFRQGKDYVGA---IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	321
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.49
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.13
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.88
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.83
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.65
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.5
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.49
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.48
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.37
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.27
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.22
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.13
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.06
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.03
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.0
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.81
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.65
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.65
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.63
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.5
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.48
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.44
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.43
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.4
3mes_A	424	Choline kinase; malaria, structural genomics, stru	97.04
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.83
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.92
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.7

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.4e-65  Score=424.89  Aligned_cols=261  Identities=26%  Similarity=0.445  Sum_probs=228.8

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeeccc-CCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKL-NEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      .++|++++.||+|+||+||+|++ ..+++.||+|++.+.. ........+.+|++++++++   ||||++++++|.+.  
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~-~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~--  104 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARE-LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD---HPFFVKLYFTFQDD--  104 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC---CTTBCCEEEEEECS--
T ss_pred             ccccEEEEEEecccCeEEEEEEE-CCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC---CCCCCeEEEEEEeC--
Confidence            35799999999999999999999 6889999999997653 23334557889999999998   99999999999888  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ..+|+|||||.| +|.+++..  .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       105 -----~~~yivmEy~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFG  177 (311)
T 4aw0_A          105 -----EKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG  177 (311)
T ss_dssp             -----SEEEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             -----CEEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcC
Confidence                 789999999995 99999987  3459999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         179 LAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       179 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...++.....     .
T Consensus       178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-----~  252 (311)
T 4aw0_A          178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-----D  252 (311)
T ss_dssp             TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----C
T ss_pred             CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----C
Confidence            998765332   33456899999999999999999999999999999999999999999888888877765321     1


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHH------HhCCCCCCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD------ALEHPYFKEKENEPL  321 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~------ll~h~~f~~~~~~~~  321 (321)
                      +|                      ..+++++++||++||.+||.+|||++|      |++||||++++|+.|
T Consensus       253 ~p----------------------~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l  302 (311)
T 4aw0_A          253 FP----------------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  302 (311)
T ss_dssp             CC----------------------TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             CC----------------------cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence            11                      145689999999999999999999988      589999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.1e-64  Score=416.06  Aligned_cols=255  Identities=30%  Similarity=0.482  Sum_probs=207.8

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||+|++.+.... ......+.+|+.++++++   ||||+++++++.+.   
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~~~~~~~~~---   85 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYH-TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR---HPHIIKLYDVIKSK---   85 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEEC-TTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC---CTTBCCEEEEEECS---
T ss_pred             eCeEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC---CCCCCeEEEEEEEC---
Confidence            5899999999999999999999 688999999999765433 233456789999999998   99999999999887   


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                          ..+|+||||++|+|.+++...  +.+++.+++.++.||+.||+|||++|++||||||+||+++.++++||+|||++
T Consensus        86 ----~~~~ivmEy~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla  159 (275)
T 3hyh_A           86 ----DEIIMVIEYAGNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS  159 (275)
T ss_dssp             ----SEEEEEEECCCEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC
T ss_pred             ----CEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCC
Confidence                789999999999999999884  45999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccchhhhhcCCC-CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         181 KTFDYDMMLTSVVVTLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      .............||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+..+....+.....  .   ++  
T Consensus       160 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~--~---~p--  232 (275)
T 3hyh_A          160 NIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY--T---LP--  232 (275)
T ss_dssp             ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--C---CC--
T ss_pred             eecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--C---CC--
Confidence            87766555667789999999999998886 6799999999999999999999998887777766654321  1   11  


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                                          ..+++++++||++||+.||++|||++|+++||||+..
T Consensus       233 --------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          233 --------------------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             --------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred             --------------------CCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence                                2456899999999999999999999999999999854

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.4e-65  Score=432.05  Aligned_cols=258  Identities=25%  Similarity=0.466  Sum_probs=221.2

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||+|++............+.+|+.++++++   ||||+++++++.+.    
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~---HpnIV~~~~~~~~~----   95 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKS-TEDGRQYVIKEINISRMSSKEREESRREVAVLANMK---HPNIVQYRESFEEN----   95 (350)
T ss_dssp             CCEEEEEEC------CEEEEEE-TTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC---CTTBCCEEEEEEET----
T ss_pred             cceEEeEEEecCCCeEEEEEEE-CCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC---CCCCCcEEEEEEEC----
Confidence            6899999999999999999999 688999999999765443333456789999999998   99999999999887    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ..+|+|||||+ |+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        96 ---~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla  172 (350)
T 4b9d_A           96 ---GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIA  172 (350)
T ss_dssp             ---TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred             ---CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccc
Confidence               78999999999 59999998766666899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++......+.       
T Consensus       173 ~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~-------  245 (350)
T 4b9d_A          173 RVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV-------  245 (350)
T ss_dssp             SCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-------
T ss_pred             eeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-------
Confidence            8765432 23456799999999999999999999999999999999999999999988888877766432211       


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                                         ...+|+++.+||.+||+.||.+|||++|+|+||||++.
T Consensus       246 -------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          246 -------------------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             -------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             -------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence                               12456899999999999999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.6e-63  Score=420.42  Aligned_cols=258  Identities=25%  Similarity=0.494  Sum_probs=225.7

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ....|++.+.||+|+||+||+|++ ..+++.||+|++.....  .....+.+|+.++++++   ||||++++++|.+.  
T Consensus        72 p~~~y~~~~~iG~G~fG~V~~a~~-~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~---HpnIV~l~~~~~~~--  143 (346)
T 4fih_A           72 PRSYLDNFIKIGEGSTGIVCIATV-RSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQ---HENVVEMYNSYLVG--  143 (346)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCC---CTTBCCEEEEEEET--
T ss_pred             hhHhcEEeEEeecCcCeEEEEEEE-CCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCC---CCCCCcEEEEEEEC--
Confidence            346799999999999999999999 68899999999976532  33557889999999998   99999999999887  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ..+|+|||||+| +|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       144 -----~~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFG  215 (346)
T 4fih_A          144 -----DELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFG  215 (346)
T ss_dssp             -----TEEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             -----CEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCc
Confidence                 789999999995 99999977   349999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         179 LAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       179 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      ++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..... +....  
T Consensus       216 la~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~--  292 (346)
T 4fih_A          216 FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKN--  292 (346)
T ss_dssp             TCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSC--
T ss_pred             CceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCc--
Confidence            998775443 34567899999999999999999999999999999999999999999888887777655321 11111  


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                                           ...+++++++||.+||..||++|||++|+|+||||++..
T Consensus       293 ---------------------~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          293 ---------------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             ---------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ---------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence                                 125678999999999999999999999999999998753

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.7e-64  Score=419.90  Aligned_cols=261  Identities=28%  Similarity=0.416  Sum_probs=219.0

Q ss_pred             CCcceeeeeeeecccceeEEEEEEec--CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQ--NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ..++|++++.||+|+||+||+|++..  .+++.||+|+++...........+.+|+.++++++   ||||+++++++.+.
T Consensus        22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~   98 (304)
T 3ubd_A           22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN---HPFIVKLHYAFQTE   98 (304)
T ss_dssp             CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCC---CTTEECEEEEEEET
T ss_pred             CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCC---CCCCCeEEEEEEEC
Confidence            34789999999999999999998742  35789999999765443333446778998888887   99999999999887


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ..+|+|||||+ |+|.+++..  .+.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus        99 -------~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~D  169 (304)
T 3ubd_A           99 -------GKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTD  169 (304)
T ss_dssp             -------TEEEEEECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEES
T ss_pred             -------CEEEEEEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecc
Confidence                   78999999999 599999987  34599999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccC-CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         177 FGLAKTFDY-DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       177 fg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ||++..... ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+....  +.   
T Consensus       170 FGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~---  244 (304)
T 3ubd_A          170 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LG---  244 (304)
T ss_dssp             SEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CC---
T ss_pred             cccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--CC---
Confidence            999986543 333456789999999999999999999999999999999999999999998888887776532  11   


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKENE  319 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~~  319 (321)
                      +|                      ..+|+++.+||++||+.||++|||     ++|+++||||++.+|+
T Consensus       245 ~p----------------------~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~  291 (304)
T 3ubd_A          245 MP----------------------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN  291 (304)
T ss_dssp             CC----------------------TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             CC----------------------CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence            11                      145689999999999999999998     4799999999998875

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1e-61  Score=421.96  Aligned_cols=260  Identities=25%  Similarity=0.486  Sum_probs=226.6

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ....+.|++++.||+|+||+||+|++ ..+++.||+|++....  ......+.+|+.++++++   ||||++++++|.+.
T Consensus       147 ~dp~~~y~~~~~iG~G~fG~V~~a~~-~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~---HpnIV~l~~~~~~~  220 (423)
T 4fie_A          147 GDPRSYLDNFIKIGEGSTGIVCIATV-RSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQ---HENVVEMYNSYLVG  220 (423)
T ss_dssp             SCGGGTEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCC---CTTBCCEEEEEEET
T ss_pred             CChhHhcEeeeEeccCcCcEEEEEEE-CCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCC---CCCCCceEEEEEEC
Confidence            33457899999999999999999999 6889999999997643  233557889999999998   99999999999887


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ..+|+|||||.| +|.+++..   ..+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus       221 -------~~~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~D  290 (423)
T 4fie_A          221 -------DELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSD  290 (423)
T ss_dssp             -------TEEEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECC
T ss_pred             -------CEEEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEec
Confidence                   789999999995 99999976   3499999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         177 FGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       177 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..... +....
T Consensus       291 FGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~  369 (423)
T 4fie_A          291 FGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKN  369 (423)
T ss_dssp             CTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSC
T ss_pred             CccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcc
Confidence            99998775443 34567899999999999999999999999999999999999999999888887777655321 11111


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                                             ...+++++++||.+||..||.+|||+.|+|+||||++..
T Consensus       370 -----------------------~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          370 -----------------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             -----------------------TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             -----------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence                                   125678999999999999999999999999999998753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.8e-62  Score=406.38  Aligned_cols=260  Identities=28%  Similarity=0.415  Sum_probs=212.8

Q ss_pred             Ccce-eeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          21 DKKY-DELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        21 ~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      .++| ++.+.||+|+||+||+|++ ..++..||+|++............+.+|+.++++++   ||||+++++++.+.. 
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~---HpnIV~~~~~~~~~~-   98 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLD-TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ---HPNIVRFYDSWESTV-   98 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC---CTTBCCEEEEEEEEE-
T ss_pred             CCceEEeeeEEecCcCcEEEEEEE-CCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC---CCCCCcEEEEEeecc-
Confidence            3455 7888999999999999999 688999999999765444333456789999999998   999999999986531 


Q ss_pred             ccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEee-CCCEEEe
Q psy2676         100 SDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLITR-AGGLKIA  175 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~--~~H~di~p~Nilv~~-~~~~kl~  175 (321)
                        .....+++|||||+ |+|.+++..  .+.+++..++.++.||+.||+|||++|  |+||||||+|||++. ++.+||+
T Consensus        99 --~~~~~~~lvmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~  174 (290)
T 3fpq_A           99 --KGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             --TTEEEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred             --CCCcEEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEE
Confidence              12256899999999 599999987  345999999999999999999999998  999999999999974 7899999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      |||++.... ........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..............  ..+. 
T Consensus       175 DFGla~~~~-~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~--~~~~-  249 (290)
T 3fpq_A          175 DLGLATLKR-ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--VKPA-  249 (290)
T ss_dssp             CTTGGGGCC-TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT--CCCG-
T ss_pred             eCcCCEeCC-CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC--CCCC-
Confidence            999997544 334456689999999998865 69999999999999999999999998765544433322211  1111 


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                                           .....+++++.+||.+||..||++|||++|+|+||||++
T Consensus       250 ---------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          250 ---------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ---------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ---------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                                 112345688999999999999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.1e-62  Score=423.68  Aligned_cols=291  Identities=35%  Similarity=0.597  Sum_probs=238.8

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      .+++|++++.||+|+||+||+|++ ..+++.||+|+++...........+.+|+.+++.++   ||||+++++++.....
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~-~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~  127 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARR-RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK---HDNIIAIKDILRPTVP  127 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC---CTTBCCEEEECCCSSC
T ss_pred             CCCCeEEEEEEecccCeEEEEEEE-CCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC---CCCcceEeeeeecccc
Confidence            357899999999999999999999 688999999999754333323346778999999998   9999999999865421


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                       ......+|+|||||+|+|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus       128 -~~~~~~~~ivmE~~~g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          128 -YGEFKSVYVVLDLMESDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             -TTTCCCEEEEEECCSEEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             -cccCCEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecce
Confidence             122257899999999999999987  45599999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC-----CccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         180 AKTFDYD-----MMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       180 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      +......     .......||+.|+|||++.+.. ++.++||||+||++|+|++|++||.+.+..+....+....+.++.
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9866432     2334578999999999988765 699999999999999999999999999999999999999998876


Q ss_pred             CCcchhhhhhh----hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         254 NEWPENISLMW----SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       254 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ..+........    ..+.............++++++.+||++||.+||.+|||++|+|+||||++..
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence            65543222111    11122222334455667889999999999999999999999999999999764

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2e-60  Score=403.08  Aligned_cols=254  Identities=24%  Similarity=0.383  Sum_probs=214.0

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .+.|++.++||+|+||+||+|++ ..+++.||+|+++...       ...+|+.++++++   ||||+++++++.+.   
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~-~~~g~~vAiK~i~~~~-------~~~~E~~il~~l~---HpnIV~l~~~~~~~---  122 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKD-KQTGFQCAVKKVRLEV-------FRVEELVACAGLS---SPRIVPLYGAVREG---  122 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEETTT-------CCTHHHHTTTTCC---CTTBCCEEEEEEET---
T ss_pred             hhheEeCcEeccCCCeEEEEEEE-CCCCCEEEEEEECHHH-------hHHHHHHHHHhCC---CCCCCcEEEEEEEC---
Confidence            45799999999999999999999 6889999999997532       2357999998887   99999999999887   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC-CEEEeecC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFG  178 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~-~~kl~dfg  178 (321)
                          ..+|+|||||+ |+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus       123 ----~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFG  196 (336)
T 4g3f_A          123 ----PWVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG  196 (336)
T ss_dssp             ----TEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCT
T ss_pred             ----CEEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCC
Confidence                78999999999 5999999873  4599999999999999999999999999999999999999987 59999999


Q ss_pred             CcccccCCCc------cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         179 LAKTFDYDMM------LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       179 ~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ++........      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++...  .++
T Consensus       197 la~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~  274 (336)
T 4g3f_A          197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP  274 (336)
T ss_dssp             TCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG
T ss_pred             CCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC
Confidence            9987654321      12346999999999999999999999999999999999999999887665555555431  111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHH-------------hCCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA-------------LEHPYFKEKEN  318 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l-------------l~h~~f~~~~~  318 (321)
                                            ......++++++.+||.+||+.||.+|||+.|+             ++|||+++...
T Consensus       275 ----------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~  331 (336)
T 4g3f_A          275 ----------------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE  331 (336)
T ss_dssp             ----------------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred             ----------------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence                                  112234677999999999999999999999997             68999987643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.9e-59  Score=393.04  Aligned_cols=265  Identities=26%  Similarity=0.464  Sum_probs=199.2

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc-
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS-  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~-  100 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||+|+++..... .....+.+|+.++++++   ||||+++++++.+.... 
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~-~~~~~~vAiK~i~~~~~~-~~~~~~~~E~~il~~l~---HpnIV~~~~~~~~~~~~~   79 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKN-KVDDCNYAIKRIRLPNRE-LAREKVMREVKALAKLE---HPGIVRYFNAWLEKNTTE   79 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEE-TTTCCEEEEEEEEECSSH-HHHHHHHHHHHHHTTCC---CTTBCCEEEEEEEEC---
T ss_pred             hhCEEeeEEecCCCeEEEEEEE-CCCCCEEEEEEEeccCCH-HHHHHHHHHHHHHHhCC---CCCCCeEEEEEEecCccc
Confidence            3699999999999999999999 688999999999754321 12346778999999997   99999999999765211 


Q ss_pred             ----cccceEEEEEeccCc-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676         101 ----DERYLTVYLIFEHVD-QDLGSYMEKCPP-PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus       101 ----~~~~~~~~~v~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                          ......+|+|||||. |+|.+++..... ...++..++.++.||+.||+|||++||+||||||+||+++.++.+||
T Consensus        80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence                112245899999999 599999987543 22456778999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCc-------------cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHH
Q psy2676         175 ADFGLAKTFDYDMM-------------LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL  241 (321)
Q Consensus       175 ~dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  241 (321)
                      +|||++........             .....||+.|+|||++.+..++.++|||||||++|+|++   ||...  .+..
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~  234 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERV  234 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHH
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHH
Confidence            99999987654321             223579999999999999999999999999999999996   77542  2222


Q ss_pred             HHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         242 KCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      ..+.......                       .+......++.+.+||++||++||.+|||+.|+++||||++.++.
T Consensus       235 ~~~~~~~~~~-----------------------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          235 RTLTDVRNLK-----------------------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHHHHHTTC-----------------------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred             HHHHHHhcCC-----------------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence            2222221111                       111223445778899999999999999999999999999998763

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.7e-59  Score=401.32  Aligned_cols=282  Identities=24%  Similarity=0.375  Sum_probs=217.8

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEec--CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQ--NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ....++|++.+.||+|+||+||+|++..  .+++.||+|.+...    .....+.+|+++++.+..  ||||++++++|.
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~--h~nIv~l~~~~~   90 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGG--QDNVMGVKYCFR   90 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCS--BTTBCCCSEEEE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcC--CCCCceEEEEEE
Confidence            3456899999999999999999998742  35788999988643    223467889999998853  999999999998


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC-CCEE
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA-GGLK  173 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~-~~~k  173 (321)
                      +.       ..+|+||||++ |+|.+++..     +++.+++.++.||+.||+|||++||+||||||+||+++.+ +.+|
T Consensus        91 ~~-------~~~~lvmE~~~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~k  158 (361)
T 4f9c_A           91 KN-------DHVVIAMPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYA  158 (361)
T ss_dssp             ET-------TEEEEEEECCCCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEE
T ss_pred             EC-------CEEEEEEeCCCcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEE
Confidence            87       78999999998 599999843     8999999999999999999999999999999999999877 7899


Q ss_pred             EeecCCcccccCCC-----------------------------ccccccccccccchhhhhcCC-CCCcchHHHHHHHHH
Q psy2676         174 IADFGLAKTFDYDM-----------------------------MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMA  223 (321)
Q Consensus       174 l~dfg~~~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~  223 (321)
                      |+|||++.......                             ......||+.|+|||++.+.+ ++.++||||+||++|
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~  238 (361)
T 4f9c_A          159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL  238 (361)
T ss_dssp             ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred             ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence            99999997543221                             123357999999999998765 899999999999999


Q ss_pred             HHHhcCCCCC-CCChHHHHHHHHHHhCCCCCCCc--------------chh-hhhhhhhh-------hhh-----hhhhh
Q psy2676         224 EMWRLVPLFC-ASTEVEQLKCIFRVIGTPSMNEW--------------PEN-ISLMWSSF-------EQY-----SKVAF  275 (321)
Q Consensus       224 ~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~--------------~~~-~~~~~~~~-------~~~-----~~~~~  275 (321)
                      +|++|+.||. +.+..+.+..+....|.+....+              +.. .......+       +..     .....
T Consensus       239 ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  318 (361)
T 4f9c_A          239 SLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATN  318 (361)
T ss_dssp             HHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-------------------
T ss_pred             HHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccc
Confidence            9999999984 56677778888776664321110              000 00000000       000     00011


Q ss_pred             hhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         276 SAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       276 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ......+++++++||++||.+||.+|||++|+|+||||++++
T Consensus       319 ~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          319 LEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             ccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            122446789999999999999999999999999999999875

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.1e-57  Score=383.36  Aligned_cols=299  Identities=49%  Similarity=0.941  Sum_probs=250.4

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC---CCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE---DGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ++..++|++++.||+|+||+||+|++ ..+++.||+|++......   ........+|+.+++++..+.||||+++++++
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~   83 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC   83 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEEC-TTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEE-CCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence            34578999999999999999999998 578999999999765322   22344677899999888777799999999999


Q ss_pred             eccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ...  .......+++|+|+++++|.+++.......+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||
T Consensus        84 ~~~--~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           84 ATS--RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             EEC--CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEE
T ss_pred             ecc--CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEE
Confidence            765  222334689999999999999999877666999999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       175 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      +|||++.............+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+....+.++..
T Consensus       162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            99999987776666667788999999999999999999999999999999999999999999999999999999998888


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      .|+.........+.............++++++.+||.+||++||.+|||+.++|+||||++.+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~~  306 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGN  306 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC------
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCCC
Confidence            88765544433343344444555667888999999999999999999999999999999986543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.7e-58  Score=416.17  Aligned_cols=264  Identities=25%  Similarity=0.377  Sum_probs=220.3

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      .+.-++|++++.||+|+||+||+|++ ..+++.||+|++.+.... ........+|..+++.+...+||||++++++|.+
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~-~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~  263 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRK-ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT  263 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEE-CCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence            45567899999999999999999999 689999999999765322 2233455667777777766679999999999998


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ..+|+||||+. |+|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+
T Consensus       264 ~-------~~lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~  334 (689)
T 3v5w_A          264 P-------DKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS  334 (689)
T ss_dssp             S-------SEEEEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             C-------CEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEec
Confidence            8       78999999999 599999987  3459999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCCh---HHHHHHHHHHhCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTE---VEQLKCIFRVIGTP  251 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~  251 (321)
                      |||+|....... .....||+.|+|||++.. ..++.++|+|||||++|+|++|.+||.+.+.   .+....+..  ..+
T Consensus       335 DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~  411 (689)
T 3v5w_A          335 DLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAV  411 (689)
T ss_dssp             CCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCC
T ss_pred             ccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--CCC
Confidence            999998776443 345689999999999964 5789999999999999999999999976432   222222222  111


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKENE  319 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~~  319 (321)
                         .+                      ...+++++++||.+||..||.+|++     ++||++||||++++|+
T Consensus       412 ---~~----------------------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          412 ---EL----------------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             ---CC----------------------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             ---CC----------------------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence               11                      1246689999999999999999998     7999999999999885

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-57  Score=380.35  Aligned_cols=263  Identities=21%  Similarity=0.324  Sum_probs=209.7

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ...+++..+++++.+.||+|+||+||+|+.   . ..+|||+++...........+.+|+.++++++   ||||++++++
T Consensus        28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~---~-~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~---HpNIV~l~g~  100 (307)
T 3omv_A           28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKW---H-GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTR---HVNILLFMGY  100 (307)
T ss_dssp             -CCCBCCTTSCCEEEECCCCSSSEEEEEES---S-SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCC---CTTBCCEEEE
T ss_pred             CcCcEEcHHHeEEeeEEeeCCCcEEEEEEE---C-CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCC---CCCEeeEEEE
Confidence            345788889999999999999999999975   2 25899998754333333456788999999998   9999999998


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +..+        .+++|||||+ |+|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+|||+++++++
T Consensus       101 ~~~~--------~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~  171 (307)
T 3omv_A          101 MTKD--------NLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTV  171 (307)
T ss_dssp             ECSS--------SCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEE
T ss_pred             EECC--------eEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcE
Confidence            7443        3689999999 59999997654 349999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCC---Cccccccccccccchhhhhc---CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q psy2676         173 KIADFGLAKTFDYD---MMLTSVVVTLWYRAPEILLN---LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR  246 (321)
Q Consensus       173 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  246 (321)
                      ||+|||++......   .......||+.|+|||++.+   .+++.++|||||||++|||+||+.||.+.+.......+..
T Consensus       172 Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~  251 (307)
T 3omv_A          172 KIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG  251 (307)
T ss_dssp             EECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred             EEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh
Confidence            99999999765432   22345679999999999974   3588999999999999999999999988776655555443


Q ss_pred             HhC-CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHH------hCCCCCC
Q psy2676         247 VIG-TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA------LEHPYFK  314 (321)
Q Consensus       247 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l------l~h~~f~  314 (321)
                      ... .|....                      ...++|+++.+|+.+||+.||++|||+.+|      |+|++-+
T Consensus       252 ~~~~~p~~~~----------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          252 RGYASPDLSK----------------------LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             TTCCCCCSTT----------------------SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             cCCCCCCccc----------------------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence            322 221111                      223677999999999999999999999987      4677643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.9e-57  Score=379.43  Aligned_cols=253  Identities=23%  Similarity=0.372  Sum_probs=211.2

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      .+..++|.+.+.||+|+||+||+|+...    .++..||+|+++...  ......+.+|+.++++++   ||||++++++
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~---HpnIV~l~g~   83 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQ---HEHIVKFYGV   83 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--HHHHHHHHHHHHHHTTCC---CTTBCCEEEE
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--hHHHHHHHHHHHHHHhCC---CCCCccEEEE
Confidence            4566899999999999999999998632    357889999986432  222456789999999998   9999999999


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP-----------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKP  161 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p  161 (321)
                      +.+.       ..+++|||||+ |+|.+++....           ...+++.++..++.||+.||.|||+++++||||||
T Consensus        84 ~~~~-------~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp  156 (299)
T 4asz_A           84 CVEG-------DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT  156 (299)
T ss_dssp             ECSS-------SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EeeC-------CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCH
Confidence            9876       67899999999 69999997642           34599999999999999999999999999999999


Q ss_pred             CcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCCh
Q psy2676         162 QNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTE  237 (321)
Q Consensus       162 ~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~  237 (321)
                      +||++++++.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+.
T Consensus       157 ~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~  236 (299)
T 4asz_A          157 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN  236 (299)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             hhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999999999976543322   223568999999999999999999999999999999998 8999999888


Q ss_pred             HHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHh
Q psy2676         238 VEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL  308 (321)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  308 (321)
                      .+....+......+.                          ...+|+++.+|+.+||+.||++|||+.++.
T Consensus       237 ~~~~~~i~~~~~~~~--------------------------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~  281 (299)
T 4asz_A          237 NEVIECITQGRVLQR--------------------------PRTCPQEVYELMLGCWQREPHMRKNIKGIH  281 (299)
T ss_dssp             HHHHHHHHHTCCCCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHcCCCCCC--------------------------CccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            887777665322111                          125678999999999999999999999994

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.1e-57  Score=379.07  Aligned_cols=258  Identities=22%  Similarity=0.370  Sum_probs=214.6

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      ..++..+++++.+.||+|+||+||+|+..    ..+++.||||+++... .......+.+|+.++++++   ||||++++
T Consensus        20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~---HpNIV~l~   95 (308)
T 4gt4_A           20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQ---HPNVVCLL   95 (308)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCC---CTTBCCEE
T ss_pred             cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCC---CCCCCCcc
Confidence            34556678999999999999999999852    2467899999997542 2334457889999999998   99999999


Q ss_pred             eeeeccccccccceEEEEEeccCc-cCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--------------PPGLSASKVKELTRQMLKGVDFLHSHRIIH  156 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H  156 (321)
                      +++.+.       ..+++|||||+ |+|.+++....              ...+++.++..++.||+.||+|||+++++|
T Consensus        96 g~~~~~-------~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiH  168 (308)
T 4gt4_A           96 GVVTKD-------QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVH  168 (308)
T ss_dssp             EEECSS-------SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             eEEEEC-------CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence            999776       56799999999 69999997542              234899999999999999999999999999


Q ss_pred             ccCCCCcEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCC
Q psy2676         157 RDLKPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLF  232 (321)
Q Consensus       157 ~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf  232 (321)
                      |||||+||++++++++||+|||++.......   ......||+.|+|||++.+..++.++||||||+++|||+| |..||
T Consensus       169 RDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf  248 (308)
T 4gt4_A          169 KDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY  248 (308)
T ss_dssp             SCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999997654322   2345678999999999999999999999999999999998 89999


Q ss_pred             CCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         233 CASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      .+.+..+....+......+.                          ..++|+++.+|+.+||+.||.+|||+.+|+++
T Consensus       249 ~~~~~~~~~~~i~~~~~~~~--------------------------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          249 CGYSNQDVVEMIRNRQVLPC--------------------------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             TTCCHHHHHHHHHTTCCCCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCC--------------------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99888777766654322111                          12567899999999999999999999999874

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.1e-57  Score=411.23  Aligned_cols=261  Identities=24%  Similarity=0.399  Sum_probs=227.5

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||+|+||+||+|++ +.+++.||+|++......  ....+.+|+.+++.++   ||||++++++|.+.    
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~-~~tg~~~AiK~i~~~~~~--~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~----  226 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTE-RATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLR---HPTLVNLHDAFEDD----  226 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECCSHH--HHHHHHHHHHHHHHTC---CTTBCCEEEEEECS----
T ss_pred             cccEEEEEEeeccCeEEEEEEE-CCCCCEEEEEEEeccchh--hHHHHHHHHHHHHhCC---CCCCCeEEEEEEEC----
Confidence            6899999999999999999999 688999999998754221  2346778999999998   99999999999887    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC--CCEEEeecC
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA--GGLKIADFG  178 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~--~~~kl~dfg  178 (321)
                         ..+|+|||||. |+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+||+++.+  +.+||+|||
T Consensus       227 ---~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG  302 (573)
T 3uto_A          227 ---NEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG  302 (573)
T ss_dssp             ---SEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred             ---CEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeecc
Confidence               78999999999 49999986543 349999999999999999999999999999999999999854  789999999


Q ss_pred             CcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      ++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......+..    
T Consensus       303 ~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~----  378 (573)
T 3uto_A          303 LTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS----  378 (573)
T ss_dssp             SCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSG----
T ss_pred             ceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcc----
Confidence            9998877666667789999999999999999999999999999999999999999998888877776533222211    


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                                         ....+++++++||++||..||.+|||+.|+|+||||+...+.
T Consensus       379 -------------------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          379 -------------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             -------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             -------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence                               123567899999999999999999999999999999987654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.3e-56  Score=378.78  Aligned_cols=256  Identities=23%  Similarity=0.392  Sum_probs=207.8

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      ..+..++|.+.++||+|+||+||+|+..    ..+++.||||+++...  ......+.+|++++++++   ||||+++++
T Consensus        36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~---HpnIV~l~g  110 (329)
T 4aoj_A           36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQ---HQHIVRFFG  110 (329)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--HHHHHHHHHHHHHHTTCC---CTTBCCEEE
T ss_pred             cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCC---CCCCCcEEE
Confidence            3456678999999999999999999863    2357899999986432  222456889999999998   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecc
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP-------------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRD  158 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~d  158 (321)
                      ++.+.       ..+++|||||+ |+|.+++....             ...+++.++..++.||+.||.|||+++|+|||
T Consensus       111 ~~~~~-------~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRD  183 (329)
T 4aoj_A          111 VCTEG-------RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRD  183 (329)
T ss_dssp             EECSS-------SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             EEEEC-------CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccc
Confidence            99776       67899999999 59999997643             23489999999999999999999999999999


Q ss_pred             CCCCcEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCC
Q psy2676         159 LKPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCA  234 (321)
Q Consensus       159 i~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~  234 (321)
                      |||+||++++++.+||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+
T Consensus       184 LKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~  263 (329)
T 4aoj_A          184 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ  263 (329)
T ss_dssp             CCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             ccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC
Confidence            99999999999999999999998664332   2334678999999999999999999999999999999998 8999999


Q ss_pred             CChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         235 STEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      .+..+....+......+. +                         ..+|+++.+|+.+||+.||++|||+.||+++
T Consensus       264 ~~~~~~~~~i~~g~~~~~-p-------------------------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          264 LSNTEAIDCITQGRELER-P-------------------------RACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             SCHHHHHHHHHHTCCCCC-C-------------------------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCC-c-------------------------ccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            888887777665322111 1                         2566899999999999999999999999764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.2e-55  Score=375.88  Aligned_cols=294  Identities=46%  Similarity=0.812  Sum_probs=241.8

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +....+...++|++++.||+|+||+||+|++  .+++.+|+|++............+.+|+.++++++   ||||+++++
T Consensus        12 ~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~   86 (311)
T 3niz_A           12 ENLYFQGLMEKYQKLEKVGEGTYGVVYKAKD--SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH---HPNIVSLID   86 (311)
T ss_dssp             ---CEECSSCEEEEEEEEEECSSCEEEEEEE--TTSCEEEEEEEC------CHHHHHHHHHHHHHHCC---CTTBCCEEE
T ss_pred             cceeecchHhhhHhhhhccCCCCeEEEEEEE--CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcC---CCCEeeeee
Confidence            4456677789999999999999999999998  45899999999765444333456778999999997   999999999


Q ss_pred             eeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      ++.+.       ...++|||+++++|.+++..... .+++..++.++.||+.||.|||+.|++||||||+||+++.++.+
T Consensus        87 ~~~~~-------~~~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~  158 (311)
T 3niz_A           87 VIHSE-------RCLTLVFEFMEKDLKKVLDENKT-GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGAL  158 (311)
T ss_dssp             EECCS-------SCEEEEEECCSEEHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE
T ss_pred             EEccC-------CEEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCE
Confidence            99776       67899999999999999887543 49999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCC-ccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCC
Q psy2676         173 KIADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       173 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      ||+|||++....... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+....+....+.
T Consensus       159 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  238 (311)
T 3niz_A          159 KLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT  238 (311)
T ss_dssp             EECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCC
T ss_pred             EEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCC
Confidence            999999998765332 3345578999999999876 45899999999999999999999999999999999999999998


Q ss_pred             CCCCCcchhhhhhh---hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         251 PSMNEWPENISLMW---SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       251 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      +....|+.......   ..+..............+++++.+||++||.+||.+|||++|+++||||++.+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  310 (311)
T 3niz_A          239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred             CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence            88887765433211   1111122233444556788999999999999999999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.6e-55  Score=377.41  Aligned_cols=261  Identities=22%  Similarity=0.305  Sum_probs=212.6

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecC----CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQN----KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      .+++..++|++.+.||+|+||+||+|++...    .++.||+|+++..... .....+.+|+.+++++..  ||||++++
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~-~~~~~~~~E~~il~~l~h--hpnIV~l~  134 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGH--HLNVVNLL  134 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCC--CTTBCCEE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh-HHHHHHHHHHHHHHHcCC--CCcEEEEE
Confidence            4678889999999999999999999987432    3467999998653222 123467889999999983  59999999


Q ss_pred             eeeeccccccccceEEEEEeccCc-cCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--------------PPGLSASKVKELTRQMLKGVDFLHSHRIIH  156 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H  156 (321)
                      +++..+.      ..+++|||||+ |+|.+++....              ...+++.++..++.||+.||+|||+++++|
T Consensus       135 g~~~~~~------~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiH  208 (353)
T 4ase_A          135 GACTKPG------GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH  208 (353)
T ss_dssp             EEECCTT------SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEEEecC------CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeec
Confidence            9985431      35799999999 59999997642              234899999999999999999999999999


Q ss_pred             ccCCCCcEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCC
Q psy2676         157 RDLKPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLF  232 (321)
Q Consensus       157 ~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf  232 (321)
                      |||||+||++++++.+||+|||++.......   ......+|+.|+|||++.+..++.++|||||||++|||+| |..||
T Consensus       209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf  288 (353)
T 4ase_A          209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  288 (353)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence            9999999999999999999999998664332   2334678999999999999999999999999999999998 89999


Q ss_pred             CCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         233 CASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      .+.+..+...........++.+                         ..+++++.+++.+||+.||++|||+.+|++|
T Consensus       289 ~~~~~~~~~~~~i~~g~~~~~p-------------------------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          289 PGVKIDEEFCRRLKEGTRMRAP-------------------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             TTCCCSHHHHHHHHHTCCCCCC-------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCCCCC-------------------------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            8866444444333332222222                         1456899999999999999999999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.3e-54  Score=369.10  Aligned_cols=299  Identities=51%  Similarity=0.941  Sum_probs=251.1

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ....++|++++.||+|+||+||+|++...+++.||+|++............+.+|+.+++.+..+.||||+++++++...
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            34568999999999999999999998546789999999987655555556788999999998666699999999998633


Q ss_pred             ccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          98 ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                      .  .......++|+|+++|+|.+++.......+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus        87 ~--~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           87 R--TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             E--CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             c--cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence            1  12226789999999999999999876666999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      |.+.............+++.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+....+.+....|+
T Consensus       165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          165 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             cccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence            99987765555556778999999999999999999999999999999999999999999999999999888887776665


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      .........+.............+++..+.+||.+||..||.+|||+.++++||||++.++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence            4332222222222222334455678899999999999999999999999999999998754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2e-54  Score=364.70  Aligned_cols=282  Identities=46%  Similarity=0.850  Sum_probs=232.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++++.||+|+||+||+|++  .+++.+|+|++............+.+|+.++++++   ||||+++++++.+.    
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~----   72 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKELK---HSNIVKLYDVIHTK----   72 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE--TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC---CTTBCCEEEEEECS----
T ss_pred             ccchhhhhcccCCCEEEEEEEc--CCCCEEEEEEEeccccccccchhHHHHHHHHHhcC---CCCEeeeeeEEccC----
Confidence            5899999999999999999987  56889999999765444445567788999999887   99999999999776    


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                         ...++|||+++++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus        73 ---~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  148 (288)
T 1ob3_A           73 ---KRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR  148 (288)
T ss_dssp             ---SCEEEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred             ---CeEEEEEEecCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECcccc
Confidence               6789999999999999998754 348999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCC-ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         182 TFDYDM-MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       182 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ...... ......+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+....+.+....|+..
T Consensus       149 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          149 AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (288)
T ss_dssp             HHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhh
Confidence            664322 23445789999999999764 4899999999999999999999999999999999999998888877776643


Q ss_pred             hhhhh--hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         260 ISLMW--SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       260 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .....  ..+..............+++++.+||++||+.||.+|||+.++++||||++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            22110  1111112222334455688999999999999999999999999999999875

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.9e-54  Score=369.57  Aligned_cols=292  Identities=42%  Similarity=0.726  Sum_probs=230.6

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ......++|++++.||+|+||+||+|++ ..+++.||+|+++...........+.+|+.++++++   ||||+++++++.
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~  103 (329)
T 3gbz_A           28 PSATSIDRYRRITKLGEGTYGEVYKAID-TVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ---HRNIIELKSVIH  103 (329)
T ss_dssp             ----CGGGEEEEEEEEECSSSEEEEEEE-TTTTEEEEEEECCCCC--------CHHHHHHGGGCC---CTTBCCEEEEEE
T ss_pred             CcccchhhEEEEEEEEecCCeEEEEEEE-CCCCceEEEEEEcccccccccchhHHHHHHHHHHcC---CCCcceEEEEEe
Confidence            3444557999999999999999999999 688999999999766555545567788999999997   999999999998


Q ss_pred             ccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe-----eCC
Q psy2676          96 QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT-----RAG  170 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~-----~~~  170 (321)
                      +.       ...++|||+++++|.+++...  +.+++..++.++.||+.||.|||++|++|+||||+||+++     .++
T Consensus       104 ~~-------~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  174 (329)
T 3gbz_A          104 HN-------HRLHLIFEYAENDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP  174 (329)
T ss_dssp             ET-------TEEEEEEECCSEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CC
T ss_pred             cC-------CEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccc
Confidence            77       678999999999999999884  3489999999999999999999999999999999999995     444


Q ss_pred             CEEEeecCCcccccCC-CccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHh
Q psy2676         171 GLKIADFGLAKTFDYD-MMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      .+||+|||++...... .......+|+.|+|||++.+.. ++.++||||||+++|+|++|..||.+....+....+....
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  254 (329)
T 3gbz_A          175 VLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL  254 (329)
T ss_dssp             EEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             eEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHh
Confidence            5999999999766533 2334557799999999998755 7999999999999999999999999999999999999998


Q ss_pred             CCCCCCCcchhhhhhh--hhhhhhhhh-hhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q psy2676         249 GTPSMNEWPENISLMW--SSFEQYSKV-AFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP  320 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~~  320 (321)
                      +.+....++.......  ..+...... ........+++++.+||++||+.||.+|||+.|+++||||++.+|+|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~P  329 (329)
T 3gbz_A          255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP  329 (329)
T ss_dssp             CCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSCC
T ss_pred             CCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCCC
Confidence            8888777654322110  111111111 11122334778999999999999999999999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.9e-54  Score=362.61  Aligned_cols=285  Identities=42%  Similarity=0.771  Sum_probs=234.5

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||+|++............+.+|+.++++++   ||||+++++++.+.    
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~----   73 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKN-RETHEIVALKRVRLDDDDEGVPSSALREICLLKELK---HKNIVRLHDVLHSD----   73 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC---CTTBCCEEEEEEET----
T ss_pred             CCceeeeEecCCCCeEEEEEEE-CCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC---CCCEeeEEeEEEeC----
Confidence            5899999999999999999999 678999999999866544444456778999998887   99999999999877    


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                         ...++|||++++++.+.+.... +.+++..++.++.||+.||.+||++|++|+||||+||+++.++.+||+|||.+.
T Consensus        74 ---~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  149 (292)
T 3o0g_A           74 ---KKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR  149 (292)
T ss_dssp             ---TEEEEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ---CEEEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence               6889999999998888887654 349999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC-ccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCC-CCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         182 TFDYDM-MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPL-FCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       182 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      ...... ......+|+.|+|||++.+.. ++.++||||||+++|+|++|..| |.+.+..+....+....+.+....|+.
T Consensus       150 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             ECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred             ecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence            765332 344567899999999998766 79999999999999999987666 677888888899999988888777665


Q ss_pred             hhhhhhh-hhhh-hhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         259 NISLMWS-SFEQ-YSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       259 ~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ....... .... ............+++.+.+||++||+.||.+|||++|+++||||++...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p  291 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred             hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence            4321110 0000 0011122233467889999999999999999999999999999998653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.3e-53  Score=365.34  Aligned_cols=259  Identities=28%  Similarity=0.419  Sum_probs=224.0

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ..-++|++++.||+|+||+||+|++ ..+++.||+|++............+.+|+.+++.++   ||||+++++++... 
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~-   86 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARH-ILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN---HPNIVKLFEVIETE-   86 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC---CTTBCCEEEEEECS-
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEE-CCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC---CCCEeeEEEEEEEC-
Confidence            3446899999999999999999999 688999999999765433333445778999999998   99999999999777 


Q ss_pred             cccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ...++|||++. ++|.+++...  +.+++..++.++.||+.||.|||++|++||||||+||+++.++++||+||
T Consensus        87 ------~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DF  158 (328)
T 3fe3_A           87 ------KTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADF  158 (328)
T ss_dssp             ------SEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECST
T ss_pred             ------CEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeec
Confidence                  68899999997 5999999773  44999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcCCCC-CcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYG-TPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      |++.............+|+.|+|||++.+..++ .++||||+|+++|+|++|..||.+.+..+....+.......+    
T Consensus       159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----  234 (328)
T 3fe3_A          159 GFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----  234 (328)
T ss_dssp             TCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----
T ss_pred             cCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----
Confidence            999877666666677899999999999988864 799999999999999999999999888777776655321111    


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                                             ..+++++.+||++||..||.+|||++++++||||+...
T Consensus       235 -----------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          235 -----------------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             -----------------------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             -----------------------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence                                   13458899999999999999999999999999998653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.6e-53  Score=368.83  Aligned_cols=264  Identities=28%  Similarity=0.447  Sum_probs=226.1

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC----CCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG----IPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ...++|++.+.||+|+||+||+|++ ..+++.+|+|++........    ....+.+|+.+++++.   ||||+++++++
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~-~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~   84 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCRE-KSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL---HPNIITLHDVY   84 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC---CTTBCCEEEEE
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEE-CCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC---CcCCCcEEEEE
Confidence            3457899999999999999999999 67899999999987543322    1245778999999988   99999999999


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC---
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG---  170 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~---  170 (321)
                      .+.       ..+++|||++. |+|.+++..  ...+++..++.++.||+.||.|||++|++|+||||+||+++.++   
T Consensus        85 ~~~-------~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~  155 (361)
T 2yab_A           85 ENR-------TDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI  155 (361)
T ss_dssp             ECS-------SEEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSS
T ss_pred             EeC-------CEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCc
Confidence            877       68899999997 599999977  34599999999999999999999999999999999999998877   


Q ss_pred             -CEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhC
Q psy2676         171 -GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       171 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                       .+||+|||++.............||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus       156 ~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~  235 (361)
T 2yab_A          156 PHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY  235 (361)
T ss_dssp             CCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred             cCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence             7999999999887665555667899999999999998999999999999999999999999998887777666554211


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ..     +                  ......+++.+.+||++||..||.+|||+.++++||||++..+
T Consensus       236 ~~-----~------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  281 (361)
T 2yab_A          236 DF-----D------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT  281 (361)
T ss_dssp             CC-----C------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred             CC-----C------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence            11     0                  1123467789999999999999999999999999999997654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-53  Score=365.33  Aligned_cols=284  Identities=40%  Similarity=0.722  Sum_probs=231.3

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||+|++...... .....+.+|+.++++++   ||||+++++++.+.    
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~----   72 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKS-KLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLK---HANIVTLHDIIHTE----   72 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEECC-------CCCCCCCHHHHSCCC---CTTBCCEEEEEECS----
T ss_pred             CceEEEEEEcCCCCEEEEEEEE-CCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcC---CCCCCeeeeEEeeC----
Confidence            5899999999999999999999 678999999998754322 22335567899999887   99999999999777    


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                         ...++|||+++++|.+++..... .+++..++.++.||+.||.+||+.|++|+||||+||+++.++.+||+|||++.
T Consensus        73 ---~~~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  148 (324)
T 3mtl_A           73 ---KSLTLVFEYLDKDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR  148 (324)
T ss_dssp             ---SCEEEEEECCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred             ---CEEEEEecccccCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccc
Confidence               67899999999999999987643 48999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCC-ccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         182 TFDYDM-MLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       182 ~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ...... ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+....+.+....|+..
T Consensus       149 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (324)
T 3mtl_A          149 AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI  228 (324)
T ss_dssp             CC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhh
Confidence            654332 3344577999999999877 55799999999999999999999999999999999999999999988888765


Q ss_pred             hhhhhh---hhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         260 ISLMWS---SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       260 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ......   ................+++++.+||++||+.||.+|||++|+++||||++...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            432211   11111112223344567899999999999999999999999999999997754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.7e-53  Score=361.00  Aligned_cols=287  Identities=42%  Similarity=0.761  Sum_probs=221.8

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++++.||+|+||+||+|.+ ..+++.||+|+++... .......+.+|+.++++++   ||||+++++++.+.   
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~---   75 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLN-KTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELK---HENIVRLYDVIHTE---   75 (317)
T ss_dssp             ---------------CEEEEEEC-SSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCC---BTTBCCEEEEECCT---
T ss_pred             ccceeEeeEECCCCCEEEEEEEE-CCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcC---CCCcceEEEEEEEC---
Confidence            46899999999999999999998 5789999999997653 2334457788999999987   99999999999776   


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCP----PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                          ...++|||+++++|.+++....    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|
T Consensus        76 ----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D  151 (317)
T 2pmi_A           76 ----NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGD  151 (317)
T ss_dssp             ----TEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             ----CeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECc
Confidence                6789999999999999987532    23489999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCC-ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         177 FGLAKTFDYDM-MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       177 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      ||++....... ......+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+....+....+.+...
T Consensus       152 fg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  231 (317)
T 2pmi_A          152 FGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES  231 (317)
T ss_dssp             CSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTT
T ss_pred             CccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            99998765332 33456789999999999764 58999999999999999999999999999999999999988887776


Q ss_pred             Ccchhhhhhh--hhhhh-----hhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         255 EWPENISLMW--SSFEQ-----YSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       255 ~~~~~~~~~~--~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      .|+.......  ..+..     ............++.++.+||++||+.||.+|||+.++++||||++..++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence            6654322110  00000     00111112223577899999999999999999999999999999987553

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.4e-53  Score=379.59  Aligned_cols=286  Identities=37%  Similarity=0.584  Sum_probs=226.4

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++++.||+|+||+||+|++ ..+++.||+|++............+.+|+.+++.++   ||||+++++++..... 
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~-~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~-  135 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYD-AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIISLLNVFTPQKT-  135 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEE-TTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCC---CTTBCCCSEEECSCCS-
T ss_pred             cCCeEEEEEeecCCCeEEEEEEE-CCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCC---CCCCCcEEEEEccCCc-
Confidence            47899999999999999999999 678999999999765333333456778999999997   9999999999966521 


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                      ......+++|||+++++|.+.+..    .+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus       136 ~~~~~~~~lv~E~~~~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          136 LEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             TTTCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             cccCCeEEEEEeCCCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            123357899999999988888754    2899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         181 KTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      .............+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....+.+....+....
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            88776656667789999999999999999999999999999999999999999999999999999999887654332211


Q ss_pred             hhhhhhhh---hhhhhhhh------------hhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         261 SLMWSSFE---QYSKVAFS------------AIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       261 ~~~~~~~~---~~~~~~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      ......+.   ........            ......++++.+||++||.+||.+|||++|+|+||||+.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence            11100000   00000111            111223678999999999999999999999999999985

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.4e-53  Score=362.44  Aligned_cols=260  Identities=26%  Similarity=0.418  Sum_probs=223.1

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ..++|++++.||+|+||+||+|++ ..+++.||+|+++.... .......+.+|+.+++.+.   ||||+++++++.+. 
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~~~-   77 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVRE-KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFLTALKYAFQTH-   77 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC---CTTBCCEEEEEECS-
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC---CCcCcceEEEEEeC-
Confidence            457999999999999999999999 67899999999976422 2333456778999998887   99999999999887 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ..+++||||++| +|..++..  ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+||
T Consensus        78 ------~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DF  149 (337)
T 1o6l_A           78 ------DRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             ------SEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ------CEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeec
Confidence                  688999999985 99999987  345899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccC-CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         178 GLAKTFDY-DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       178 g~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      |++..... ........||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+.......+....  ..   +
T Consensus       150 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~---~  224 (337)
T 1o6l_A          150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IR---F  224 (337)
T ss_dssp             TTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CC---C
T ss_pred             cchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CC---C
Confidence            99976432 334456678999999999999999999999999999999999999998887777666655421  11   1


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                      +                      ..+++++.+||++||+.||.+||     +++++++||||++.+|+
T Consensus       225 p----------------------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          225 P----------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             C----------------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             C----------------------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence            1                      24568999999999999999999     99999999999998764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.1e-52  Score=353.65  Aligned_cols=263  Identities=27%  Similarity=0.459  Sum_probs=224.0

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      .......++|++.+.||+|+||+||+|.+ ..+++.||+|++.....  .....+.+|+.++++++   ||||+++++++
T Consensus        13 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~---hp~iv~~~~~~   86 (297)
T 3fxz_A           13 VSVGDPKKKYTRFEKIGQGASGTVYTAMD-VATGQEVAIRQMNLQQQ--PKKELIINEILVMRENK---NPNIVNYLDSY   86 (297)
T ss_dssp             SBSSCGGGTBCCCEEEEEETTEEEEEEEB-TTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCC---CTTBCCEEEEE
T ss_pred             cCcCChhhceeeeeeeccCCCeEEEEEEE-CCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCC---CCCCCeEeEEE
Confidence            34555678999999999999999999998 68899999999875432  23456778999999987   99999999999


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      ...       ...++||||+. ++|.+++...   .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus        87 ~~~-------~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~k  156 (297)
T 3fxz_A           87 LVG-------DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVK  156 (297)
T ss_dssp             EET-------TEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred             EEC-------CEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEE
Confidence            877       67899999997 5999999873   489999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         174 IADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       174 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |+|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+..... +.
T Consensus       157 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~  235 (297)
T 3fxz_A          157 LTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE  235 (297)
T ss_dssp             ECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC
T ss_pred             EeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CC
Confidence            99999987765433 34456789999999999999999999999999999999999999988877766655544321 11


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ...                       ...++..+.+||.+||+.||.+|||+.++++||||+...
T Consensus       236 ~~~-----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          236 LQN-----------------------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             CSC-----------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             CCC-----------------------ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            111                       124668899999999999999999999999999998654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.4e-53  Score=361.69  Aligned_cols=278  Identities=26%  Similarity=0.380  Sum_probs=233.8

Q ss_pred             ccccccccccCCcceeee-eeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCcee
Q psy2676          10 QSLNLDSLDLGDKKYDEL-CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV   88 (321)
Q Consensus        10 ~~~~~~~~~~~~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~   88 (321)
                      .++.+...+...++|.+. +.||+|+||+||+|++ ..+++.||+|++............+.+|+.+++++..  ||||+
T Consensus        16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~~iv   92 (327)
T 3lm5_A           16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCIS-KSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS--CPRVI   92 (327)
T ss_dssp             CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTT--CTTBC
T ss_pred             hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEE-CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccC--CCCEE
Confidence            456667777788899998 8999999999999999 6789999999998765544445678889999999974  89999


Q ss_pred             EEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q psy2676          89 RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT  167 (321)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~  167 (321)
                      ++++++.+.       ...++|||++.+ +|.+++.......+++..++.++.||+.||.+||++|++||||||+||+++
T Consensus        93 ~~~~~~~~~-------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~  165 (327)
T 3lm5_A           93 NLHEVYENT-------SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS  165 (327)
T ss_dssp             CEEEEEECS-------SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred             EEEEEEEeC-------CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEe
Confidence            999999877       678999999985 999998765556699999999999999999999999999999999999998


Q ss_pred             e---CCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q psy2676         168 R---AGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI  244 (321)
Q Consensus       168 ~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  244 (321)
                      .   ++.++|+|||++.............+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+
T Consensus       166 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  245 (327)
T 3lm5_A          166 SIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI  245 (327)
T ss_dssp             CBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Confidence            7   7899999999998876655556678899999999999999999999999999999999999999988887777666


Q ss_pred             HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCC
Q psy2676         245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP  320 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~~  320 (321)
                      .......+...                       ...+++.+.+||.+||+.||.+|||++++++||||++.+++.
T Consensus       246 ~~~~~~~~~~~-----------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~  298 (327)
T 3lm5_A          246 SQVNVDYSEET-----------------------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN  298 (327)
T ss_dssp             HHTCCCCCTTT-----------------------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred             HhcccccCchh-----------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence            55433322222                       235668899999999999999999999999999999988764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=9.7e-53  Score=369.05  Aligned_cols=269  Identities=26%  Similarity=0.378  Sum_probs=229.2

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeeccc-CCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKL-NEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ..+.+..++|++++.||+|+||+||+|++ ..+++.||+|++.... ........+.+|+.+++.++   ||||++++++
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~-~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~  137 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRH-KSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN---SPWVVQLFYA  137 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC---CTTBCCEEEE
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEE-CCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC---CCCCCeEEEE
Confidence            34567778999999999999999999999 6789999999997632 22334556889999999998   9999999999


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +.+.       ..+++||||+. |+|.+++...   .+++..++.++.||+.||.|||++|++||||||+||+++.++.+
T Consensus       138 ~~~~-------~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~i  207 (410)
T 3v8s_A          138 FQDD-------RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL  207 (410)
T ss_dssp             EECS-------SEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCE
T ss_pred             EEEC-------CEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCE
Confidence            9887       78999999997 5999999763   48999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCc--cccccccccccchhhhhcCC----CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q psy2676         173 KIADFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLG----YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR  246 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  246 (321)
                      ||+|||++........  .....||+.|+|||++.+..    ++.++|+||||+++|+|++|..||.+.+..+....+..
T Consensus       208 kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~  287 (410)
T 3v8s_A          208 KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN  287 (410)
T ss_dssp             EECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             EEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHh
Confidence            9999999987654432  33567999999999998766    78899999999999999999999999888888777765


Q ss_pred             HhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCCCC
Q psy2676         247 VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD--RISAADALEHPYFKEKENEP  320 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~h~~f~~~~~~~  320 (321)
                      .......+.                       ...+++++++||++||..+|.+  ||+++++++||||++.+|+-
T Consensus       288 ~~~~~~~p~-----------------------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~  340 (410)
T 3v8s_A          288 HKNSLTFPD-----------------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW  340 (410)
T ss_dssp             HHHHCCCCT-----------------------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred             ccccccCCC-----------------------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence            432111111                       1245689999999999999988  99999999999999998863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.1e-53  Score=366.23  Aligned_cols=263  Identities=29%  Similarity=0.450  Sum_probs=219.0

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      .+.-++|++++.||+|+||+||+|++ ..+++.||+|+++.... .........+|..+++.+..  ||||+++++++.+
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~-~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~--hp~Iv~l~~~~~~   95 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARV-KETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFLTQLFCCFQT   95 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTT--CTTBCCEEEEEEC
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEE-cCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccC--CCceeeEEEEEEe
Confidence            34557899999999999999999999 68899999999976421 22234456789999988853  9999999999988


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ..+++||||+.| +|..++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+
T Consensus        96 ~-------~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~  166 (353)
T 3txo_A           96 P-------DRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLA  166 (353)
T ss_dssp             S-------SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             C-------CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEc
Confidence            7       689999999995 999999873  459999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccC-CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         176 DFGLAKTFDY-DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       176 dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      |||++..... ........||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....+......    
T Consensus       167 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~----  242 (353)
T 3txo_A          167 DFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV----  242 (353)
T ss_dssp             CCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----
T ss_pred             cccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            9999975432 23344567899999999999988999999999999999999999999998888887777653211    


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH------HHHhCCCCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA------ADALEHPYFKEKENE  319 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~h~~f~~~~~~  319 (321)
                       ++                      ..+++.+.+||++||..||.+||++      .++++||||++.+|+
T Consensus       243 -~p----------------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          243 -YP----------------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             -CC----------------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             -CC----------------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence             11                      1345889999999999999999999      899999999998764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-52  Score=367.64  Aligned_cols=285  Identities=36%  Similarity=0.606  Sum_probs=218.7

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++++.||+|+||+||+|.+ ..+++.||+|++..............+|+.+++.+..  ||||+++++++...   
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~--h~niv~l~~~~~~~---   81 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSID-RRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG--HENIVNLLNVLRAD---   81 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEE-TTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTT--CTTBCCEEEEEECT---
T ss_pred             cCceEEEEEeeeCCCeEEEEEEE-CCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccC--CCCCCeeeeEEecC---
Confidence            36899999999999999999999 6889999999986543333333456688999988874  99999999998654   


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                        ....+|+|||+++++|..++..   ..+++..+..++.||+.||+|||+.|++||||||+||+++.++.+||+|||++
T Consensus        82 --~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           82 --NDRDVYLVFDYMETDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             --TSSCEEEEEECCSEEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             --CCCEEEEEecccCcCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence              1146899999999999999987   34899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC----------------------Cccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCCh
Q psy2676         181 KTFDYD----------------------MMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTE  237 (321)
Q Consensus       181 ~~~~~~----------------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  237 (321)
                      ......                      .......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            765321                      12234578999999999987 5689999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCcchhhhhhhh----h---------------hhhhhhhh-hhhhhhhcchhHHHHHHHhcccC
Q psy2676         238 VEQLKCIFRVIGTPSMNEWPENISLMWS----S---------------FEQYSKVA-FSAIFMDCCSKANSLLESMLTFN  297 (321)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~---------------~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~d  297 (321)
                      .+....+....+.|....+....+....    .               +..+.... .......+++++.+||++||..|
T Consensus       237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence            9999999988887765432111100000    0               00000000 00011267889999999999999


Q ss_pred             CCCCCCHHHHhCCCCCCCC
Q psy2676         298 PADRISAADALEHPYFKEK  316 (321)
Q Consensus       298 p~~Rps~~~ll~h~~f~~~  316 (321)
                      |.+|||++|+|+||||+..
T Consensus       317 P~~R~t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          317 PNKRISANDALKHPFVSIF  335 (388)
T ss_dssp             GGGSCCHHHHTTSTTTTTT
T ss_pred             cccCCCHHHHhCCHHHHHh
Confidence            9999999999999998765

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-52  Score=358.20  Aligned_cols=263  Identities=30%  Similarity=0.479  Sum_probs=224.8

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC----CCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG----IPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ...++|++.+.||+|+||+||+|++ ..+++.+|+|++........    ....+.+|+.++++++   ||||+++++++
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~   83 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCRE-KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ---HPNVITLHEVY   83 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEE-TTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC---CTTBCCEEEEE
T ss_pred             CcccceEeceEEeeCCCeEEEEEEE-CCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC---CCCCCcEEEEE
Confidence            3457899999999999999999999 67899999999976543322    2345778999999998   99999999999


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC---
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG---  170 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~---  170 (321)
                      .+.       ...++|||++. ++|.+++..  ...+++..++.++.||+.||.|||++|++|+||||+||+++.++   
T Consensus        84 ~~~-------~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~  154 (326)
T 2y0a_A           84 ENK-------TDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK  154 (326)
T ss_dssp             ECS-------SEEEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSS
T ss_pred             EeC-------CEEEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCC
Confidence            877       67899999998 599999976  34599999999999999999999999999999999999998887   


Q ss_pred             -CEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhC
Q psy2676         171 -GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       171 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                       .+||+|||++.............+|+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+.....
T Consensus       155 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~  234 (326)
T 2y0a_A          155 PRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY  234 (326)
T ss_dssp             CCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC
T ss_pred             CCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC
Confidence             7999999999887655555667899999999999999999999999999999999999999988877776665544211


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ..                       .......++..+.+||++||..||.+|||+.++++||||++..
T Consensus       235 ~~-----------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          235 EF-----------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             CC-----------------------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             Cc-----------------------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            11                       0112346678999999999999999999999999999999764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.5e-52  Score=362.93  Aligned_cols=264  Identities=27%  Similarity=0.399  Sum_probs=217.7

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ..+..++|++++.||+|+||+||+|++ ..+++.+|+|++++.... ......+.+|..+++++..  ||||+++++++.
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~-~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~--hp~Iv~l~~~~~  123 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRL-KKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN--HPFLVGLHSCFQ  123 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTT--CTTBCCEEEEEE
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCC--CCCcCeeEEEEE
Confidence            344567999999999999999999999 688999999999875433 2334567889999988743  999999999998


Q ss_pred             ccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      +.       ..+++||||+.| +|..++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||
T Consensus       124 ~~-------~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL  194 (396)
T 4dc2_A          124 TE-------SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKL  194 (396)
T ss_dssp             CS-------SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEE
T ss_pred             EC-------CEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEE
Confidence            87       789999999985 999999873  45999999999999999999999999999999999999999999999


Q ss_pred             eecCCcccc-cCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCCh---------HHHHHHH
Q psy2676         175 ADFGLAKTF-DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE---------VEQLKCI  244 (321)
Q Consensus       175 ~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------~~~~~~~  244 (321)
                      +|||++... ..........||+.|+|||++.+..++.++|+||||+++|+|++|..||.....         ......+
T Consensus       195 ~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i  274 (396)
T 4dc2_A          195 TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI  274 (396)
T ss_dssp             CCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH
T ss_pred             eecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH
Confidence            999999763 333445567899999999999999999999999999999999999999964321         1111222


Q ss_pred             HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH------HHHhCCCCCCCCCC
Q psy2676         245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA------ADALEHPYFKEKEN  318 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~h~~f~~~~~  318 (321)
                      ...  ..                         .....+++++.+||++||+.||.+||++      +++++||||++.+|
T Consensus       275 ~~~--~~-------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w  327 (396)
T 4dc2_A          275 LEK--QI-------------------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  327 (396)
T ss_dssp             HHC--CC-------------------------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred             hcc--cc-------------------------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence            111  00                         1112466899999999999999999985      89999999999877


Q ss_pred             C
Q psy2676         319 E  319 (321)
Q Consensus       319 ~  319 (321)
                      +
T Consensus       328 ~  328 (396)
T 4dc2_A          328 D  328 (396)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.6e-52  Score=359.98  Aligned_cols=295  Identities=36%  Similarity=0.662  Sum_probs=236.2

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++++.||+|+||+||+|++ ..+++.||+|++............+.+|+.++++++   ||||+++++++.....
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~   90 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARH-RKTGQKVALKKVLMENEKEGFPITALREIKILQLLK---HENVVNLIEICRTKAS   90 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEE-TTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC---CTTBCCEEEEEEEC--
T ss_pred             cccceeEEEEEecCCCcEEEEEEE-CCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc---CCCcccHhheeecccc
Confidence            347999999999999999999999 688999999999776555555667789999999998   9999999999876521


Q ss_pred             c-cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 S-DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~-~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                      . ......+++|||+++++|.+.+..... .+++..++.++.||+.||.+||++|++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           91 PYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             ------CEEEEEEECCSEEHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ccccCCceEEEEEeccCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence            1 111246899999999999888877543 49999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCC-----CccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         179 LAKTFDYD-----MMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       179 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ++......     .......+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+.......+....+.++
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99765422     223445679999999998764 479999999999999999999999999999999999999888887


Q ss_pred             CCCcchhhhhhhhh-hhh--hhhhhhhh--hhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSS-FEQ--YSKVAFSA--IFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       253 ~~~~~~~~~~~~~~-~~~--~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      ...++......... ...  ........  .....++.+.+||.+||..||.+|||++|+++||||++.+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            77666543211100 000  00000000  111246789999999999999999999999999999987554

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.1e-53  Score=371.88  Aligned_cols=274  Identities=24%  Similarity=0.326  Sum_probs=230.2

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeeccc-CCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKL-NEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +....+..++|++++.||+|+||+||+|++ ..+++.||+|++.... ........+.+|..+++.+.   ||||+++++
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~---hp~Iv~l~~  141 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKL-KNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD---SKWITTLHY  141 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC---TTTBCCEEE
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEE-cCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC---CCCEEEEEE
Confidence            344566778999999999999999999999 6788999999997632 22333456888999999987   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      ++.+.       ..+++||||+. |+|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.
T Consensus       142 ~~~~~-------~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~  213 (437)
T 4aw2_A          142 AFQDD-------NNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH  213 (437)
T ss_dssp             EEECS-------SEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC
T ss_pred             EEeeC-------CEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC
Confidence            99887       78999999997 59999998743 34999999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCCc--cccccccccccchhhhh-----cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q psy2676         172 LKIADFGLAKTFDYDMM--LTSVVVTLWYRAPEILL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI  244 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  244 (321)
                      +||+|||++........  .....||+.|+|||++.     ...++.++||||||+++|+|++|+.||.+.+..+....+
T Consensus       214 vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i  293 (437)
T 4aw2_A          214 IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  293 (437)
T ss_dssp             EEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence            99999999976654433  23467999999999997     456899999999999999999999999998888887777


Q ss_pred             HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCC--CCCHHHHhCCCCCCCCCCCCC
Q psy2676         245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD--RISAADALEHPYFKEKENEPL  321 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~h~~f~~~~~~~~  321 (321)
                      .........+..                      ...+++++++||++||..+|.+  |++++|+++||||++.+|+.+
T Consensus       294 ~~~~~~~~~p~~----------------------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          294 MNHKERFQFPTQ----------------------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             HTHHHHCCCCSS----------------------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             hhccccccCCcc----------------------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence            643222111111                      1246689999999999988888  999999999999999998753

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.3e-52  Score=372.63  Aligned_cols=292  Identities=36%  Similarity=0.607  Sum_probs=228.4

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.+.||+|+||+||+|++ ..+++.||+|++............+.+|+.++++++   ||||+++++++.... 
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~-~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~-   98 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYD-KNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK---SDYIIRLYDLIIPDD-   98 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEE-TTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC---CTTBCCEEEECCCSC-
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEE-CCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC---CCCcceEEEEEecCC-
Confidence            357999999999999999999999 688999999999754332223346778999999998   999999999986652 


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                       ......+|+|||+++++|.+++..  ...+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus        99 -~~~~~~~~lv~e~~~~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A           99 -LLKFDELYIVLEIADSDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             -TTTCCCEEEEEECCSEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             -CCcCCeEEEEEecCCcCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence             222346899999999999999987  34599999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC-----------------------ccccccccccccchhhh-hcCCCCCcchHHHHHHHHHHHHh--------
Q psy2676         180 AKTFDYDM-----------------------MLTSVVVTLWYRAPEIL-LNLGYGTPVDIWSIGCVMAEMWR--------  227 (321)
Q Consensus       180 ~~~~~~~~-----------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~--------  227 (321)
                      +.......                       ......+|+.|+|||++ ....++.++|||||||++|+|++        
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~  255 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND  255 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence            98765332                       12456789999999986 45568999999999999999998        


Q ss_pred             ---cCCCCCCCC-----------------hHHHHHHHHHHhCCCCCCCcchhhhhh----hhhhhhhhhhhhhhhhhhcc
Q psy2676         228 ---LVPLFCAST-----------------EVEQLKCIFRVIGTPSMNEWPENISLM----WSSFEQYSKVAFSAIFMDCC  283 (321)
Q Consensus       228 ---g~~pf~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  283 (321)
                         |.++|.+..                 ..+.+..+...++.|....+.......    ..................++
T Consensus       256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  335 (432)
T 3n9x_A          256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS  335 (432)
T ss_dssp             GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred             cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence               445554433                 367777888888877654332211111    11111112223334456788


Q ss_pred             hhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         284 SKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       284 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      +++.+||++||..||.+|||++|+|+||||++..++
T Consensus       336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            999999999999999999999999999999988654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.1e-52  Score=364.49  Aligned_cols=262  Identities=30%  Similarity=0.414  Sum_probs=223.8

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ....++|++.+.||+|+||+||+|.+ ..+++.+|+|++............+.+|+.++++++   ||||+++++++.+.
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~~~~~~~~~  100 (362)
T 2bdw_A           25 TKFSDNYDVKEELGKGAFSVVRRCVH-KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ---HPNIVRLHDSIQEE  100 (362)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC---CTTBCCEEEEEECS
T ss_pred             CCcccCeEEeeEEecCCCeEEEEEEE-CCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC---CCCCCeEEEEEEeC
Confidence            34457899999999999999999999 688999999999765333222345778999999997   99999999999877


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC---CEE
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG---GLK  173 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~---~~k  173 (321)
                             ...++|||++.| +|.+.+...  ..+++..++.++.||+.||.|||++|++|+||||+||+++.++   .+|
T Consensus       101 -------~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~k  171 (362)
T 2bdw_A          101 -------SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVK  171 (362)
T ss_dssp             -------SEEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEE
T ss_pred             -------CEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEE
Confidence                   678999999995 999998773  4589999999999999999999999999999999999998654   499


Q ss_pred             EeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         174 IADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       174 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      |+|||++.............+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.......+.
T Consensus       172 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~  251 (362)
T 2bdw_A          172 LADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS  251 (362)
T ss_dssp             ECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             EeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence            99999998776555555678999999999999989999999999999999999999999988877777666554322222


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      ..                       ...+++++.+||.+||..||.+|||+.++++||||++
T Consensus       252 ~~-----------------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          252 PE-----------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             TG-----------------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             cc-----------------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            21                       2356789999999999999999999999999999975

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.9e-53  Score=377.51  Aligned_cols=292  Identities=36%  Similarity=0.613  Sum_probs=217.7

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++++.||+|+||+||+|++ ..+++.||+|++............+.+|+.+++.++   ||||+++++++...  
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~--  124 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYD-KLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN---HDHVVKVLDIVIPK--  124 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEE-CC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC---CTTBCCEEEECCCS--
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEE-CCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCC---CCCCCceEEEEecC--
Confidence            347999999999999999999999 578999999998654333223346778999999997   99999999998654  


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                      .......+|+|||+++++|.+++..  ...+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||+
T Consensus       125 ~~~~~~~~~lv~e~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          125 DVEKFDELYVVLEIADSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             CTTTCCCEEEEECCCSEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CcccCceEEEEEeccccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccccc
Confidence            1223356899999999999999987  34599999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC----------------------------ccccccccccccchhhhh-cCCCCCcchHHHHHHHHHHHHh---
Q psy2676         180 AKTFDYDM----------------------------MLTSVVVTLWYRAPEILL-NLGYGTPVDIWSIGCVMAEMWR---  227 (321)
Q Consensus       180 ~~~~~~~~----------------------------~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~---  227 (321)
                      +.......                            ......+|+.|+|||++. ...++.++|||||||++|+|++   
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            98764221                            223456799999999874 5568999999999999999998   


Q ss_pred             --------cCCCCCCCC--------------------hHHHHHHHHHHhCCCCCCCcchhhhhh----hhhhhhhhhhhh
Q psy2676         228 --------LVPLFCAST--------------------EVEQLKCIFRVIGTPSMNEWPENISLM----WSSFEQYSKVAF  275 (321)
Q Consensus       228 --------g~~pf~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~  275 (321)
                              |+++|.+..                    ..+.+..+...++.+....+.......    ...+........
T Consensus       283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (458)
T 3rp9_A          283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL  362 (458)
T ss_dssp             TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred             ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence                    777776643                    356677777777777644332211111    011111122233


Q ss_pred             hhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         276 SAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       276 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      ......+++++.+||++||..||.+|||++|+|+||||++..+.
T Consensus       363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~  406 (458)
T 3rp9_A          363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA  406 (458)
T ss_dssp             GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred             HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence            44455678999999999999999999999999999999988653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.1e-52  Score=369.00  Aligned_cols=260  Identities=30%  Similarity=0.428  Sum_probs=222.1

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.+.||+|+||+||+|.+ ..+++.+|+|++............+.+|+.++++++   ||||+++++++.+.  
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~-~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~--   82 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVK-VLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK---HPNIVRLHDSISEE--   82 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEE-TTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC---BTTBCCEEEEEECS--
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEE-CCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC---CcCCCeEEEEEEEC--
Confidence            347899999999999999999999 688999999998765333223346778999999997   99999999999877  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee---CCCEEEe
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR---AGGLKIA  175 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~---~~~~kl~  175 (321)
                           ...++|||++.| +|.+.+...  ..+++..++.++.||+.||.|||++|++||||||+||+++.   ++.+||+
T Consensus        83 -----~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~  155 (444)
T 3soa_A           83 -----GHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLA  155 (444)
T ss_dssp             -----SEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred             -----CEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEc
Confidence                 788999999985 999999884  45999999999999999999999999999999999999984   5779999


Q ss_pred             ecCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         176 DFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       176 dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      |||++....... ......||+.|+|||++.+..++.++||||+|+++|+|++|..||.+.+..+....+.......+..
T Consensus       156 DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~  235 (444)
T 3soa_A          156 DFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP  235 (444)
T ss_dssp             CCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             cCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc
Confidence            999997765433 2345678999999999999999999999999999999999999999988888877776654433333


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      .|                       ..+++++.+||.+||+.||.+|||+.++|+||||++
T Consensus       236 ~~-----------------------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          236 EW-----------------------DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             TT-----------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             cc-----------------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            32                       256689999999999999999999999999999974

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.6e-52  Score=361.94  Aligned_cols=296  Identities=27%  Similarity=0.399  Sum_probs=237.1

Q ss_pred             ccccccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhccc--CC
Q psy2676           6 ADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT--FE   83 (321)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~   83 (321)
                      .+.+..++....+...++|++++.||+|+||+||+|++ ..+++.||+|+++...   ........|+.+++.+..  ..
T Consensus        19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~   94 (360)
T 3llt_A           19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQH-IDNKKYYAVKVVRNIK---KYTRSAKIEADILKKIQNDDIN   94 (360)
T ss_dssp             -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEECSCH---HHHHHHHHHHHHHHHTCCCSTT
T ss_pred             CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEE-CCCCeEEEEEEeccch---hhhhhhHHHHHHHHHhcccCCC
Confidence            45566778888888999999999999999999999999 5789999999986321   112355678899988863  24


Q ss_pred             CCceeEEEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q psy2676          84 HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQN  163 (321)
Q Consensus        84 ~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~N  163 (321)
                      ||||+++++++...       ...++|||+++++|.+++.......+++..++.++.||+.||.|||++|++||||||+|
T Consensus        95 h~~iv~~~~~~~~~-------~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  167 (360)
T 3llt_A           95 NNNIVKYHGKFMYY-------DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPEN  167 (360)
T ss_dssp             GGGBCCEEEEEEET-------TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             CCCeecccceeeEC-------CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCccc
Confidence            99999999999877       67899999998899999998776679999999999999999999999999999999999


Q ss_pred             EEEee-------------------------CCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHH
Q psy2676         164 LLITR-------------------------AGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSI  218 (321)
Q Consensus       164 ilv~~-------------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  218 (321)
                      |+++.                         ++.+||+|||++......  .....+|+.|+|||++.+..++.++|||||
T Consensus       168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  245 (360)
T 3llt_A          168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSF  245 (360)
T ss_dssp             EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred             EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHH
Confidence            99975                         788999999999765432  345678999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhh-------------------hhhhhhhhhhhh
Q psy2676         219 GCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSF-------------------EQYSKVAFSAIF  279 (321)
Q Consensus       219 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~  279 (321)
                      ||++|+|++|+.||...+..+....+....+..+...+...........                   ........+...
T Consensus       246 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  325 (360)
T 3llt_A          246 GCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK  325 (360)
T ss_dssp             HHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHH
T ss_pred             HHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccc
Confidence            9999999999999999998888888877766554322111100000000                   000001112222


Q ss_pred             hhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q psy2676         280 MDCCSKANSLLESMLTFNPADRISAADALEHPYFK  314 (321)
Q Consensus       280 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~  314 (321)
                      ...++.+.+||++||+.||.+|||+.|+|+||||+
T Consensus       326 ~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             cchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            33457888999999999999999999999999996

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-52  Score=353.21  Aligned_cols=258  Identities=28%  Similarity=0.445  Sum_probs=222.4

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      .-++|++++.||+|+||+||+|++ ..+++.||+|+++.... .......+.+|..+++.+.   ||||+++++++.+. 
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~Iv~~~~~~~~~-   78 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRS-RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT---HPFIIRMWGTFQDA-   78 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC---BTTBCCEEEEEECS-
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEE-CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC---CCCCceEeEEEEeC-
Confidence            347899999999999999999999 67899999999976532 2223446678999998887   99999999999877 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ..+++||||+.| +|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+||
T Consensus        79 ------~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Df  150 (318)
T 1fot_A           79 ------QQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDF  150 (318)
T ss_dssp             ------SEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             ------CEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeec
Confidence                  688999999985 999999873  45899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      |++......  .....||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+.......+.....     .++
T Consensus       151 g~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----~~p  223 (318)
T 1fot_A          151 GFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-----RFP  223 (318)
T ss_dssp             SSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----CCC
T ss_pred             CcceecCCc--cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCC
Confidence            999875532  3356789999999999999999999999999999999999999998887777766655311     111


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                                            ..+++++.++|++||..||.+||     +++++++||||++.+|+
T Consensus       224 ----------------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          224 ----------------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             ----------------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             ----------------------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence                                  13458899999999999999999     99999999999988764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-53  Score=360.14  Aligned_cols=259  Identities=24%  Similarity=0.374  Sum_probs=223.5

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.+.||+|+||+||+|.+ ..+++.+++|++....   .....+.+|+.+++.++   ||||+++++++.+.  
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~--   73 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVE-TSSKKTYMAKFVKVKG---TDQVLVKKEISILNIAR---HRNILHLHESFESM--   73 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSC---CTTBCCEEEEEEET--
T ss_pred             hhhceEeeeEEecCCCeEEEEEEE-CCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCC---CCCCCeEeEEEecC--
Confidence            357999999999999999999999 6889999999986431   12345678999999998   99999999999877  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee--CCCEEEee
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR--AGGLKIAD  176 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~--~~~~kl~d  176 (321)
                           ..+++|||++.| +|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.  ++.+||+|
T Consensus        74 -----~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~D  147 (321)
T 1tki_A           74 -----EELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIE  147 (321)
T ss_dssp             -----TEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             -----CEEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEE
Confidence                 678999999985 9999997643 34899999999999999999999999999999999999987  78899999


Q ss_pred             cCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      ||.+.............+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.......+    
T Consensus       148 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----  223 (321)
T 1tki_A          148 FGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD----  223 (321)
T ss_dssp             CTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----
T ss_pred             CCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC----
Confidence            9999887666556667889999999999988889999999999999999999999998888777776665322111    


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                                         ......++.++.+||++||..||.+|||+.|+++||||++.
T Consensus       224 -------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          224 -------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             -------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             -------------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                               11234677899999999999999999999999999999865

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.2e-52  Score=359.55  Aligned_cols=265  Identities=29%  Similarity=0.431  Sum_probs=222.5

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ...+..++|++.+.||+|+||+||+|++ ..+++.||+|+++.... ..........|..+++++..  ||||+++++++
T Consensus        11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~--hp~iv~l~~~~   87 (345)
T 1xjd_A           11 QIKLKIEDFILHKMLGKGSFGKVFLAEF-KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE--HPFLTHMFCTF   87 (345)
T ss_dssp             -----CTTEEEEEEEEECSSSEEEEEEE-TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTT--CTTBCCEEEEE
T ss_pred             cCCCChHHeEEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCC--CCCCCcEEEEE
Confidence            3456678999999999999999999999 67899999999976532 22334466788888887732  99999999999


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      .+.       ..+++||||+. |+|.+++...  +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+|
T Consensus        88 ~~~-------~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vk  158 (345)
T 1xjd_A           88 QTK-------ENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIK  158 (345)
T ss_dssp             ECS-------SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred             EeC-------CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEE
Confidence            887       67999999998 5999999873  4489999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccC-CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         174 IADFGLAKTFDY-DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       174 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |+|||++..... ........||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....+....  +.
T Consensus       159 L~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~  236 (345)
T 1xjd_A          159 IADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PF  236 (345)
T ss_dssp             ECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CC
T ss_pred             EeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--CC
Confidence            999999976432 233455678999999999999999999999999999999999999999888777766665421  11


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHH-HHhCCCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA-DALEHPYFKEKENE  319 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-~ll~h~~f~~~~~~  319 (321)
                         ++                      ..+++++.+||++||..||.+||++. ++++||||++.+|+
T Consensus       237 ---~p----------------------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          237 ---YP----------------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             ---CC----------------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             ---CC----------------------cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence               11                      13558899999999999999999998 99999999998764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-52  Score=359.43  Aligned_cols=289  Identities=38%  Similarity=0.718  Sum_probs=231.7

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC---CCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED---GIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ...++|++.+.||+|+||+||+|++ ..+++.||+|++.......   .....+.+|+.+++++.   ||||+++++++.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~   82 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARD-KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS---HPNIIGLLDAFG   82 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEEC-SSCCSEEEEEEC------------CTHHHHHHHHHHHCC---CTTBCCEEEEEC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEE-CCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC---CCCCCeEEEEEe
Confidence            3457999999999999999999998 5789999999987543222   22346778999999998   999999999997


Q ss_pred             ccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          96 QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      +.       ...++|+|+++++|..++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+
T Consensus        83 ~~-------~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~  154 (346)
T 1ua2_A           83 HK-------SNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLA  154 (346)
T ss_dssp             CT-------TCCEEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             eC-------CceEEEEEcCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEE
Confidence            66       5679999999999999887644 348999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCC-ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         176 DFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       176 dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      |||++....... ......+|+.|+|||++.+. .++.++||||||+++|+|++|.+||.+.+..+....+....+.+..
T Consensus       155 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          155 DFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE  234 (346)
T ss_dssp             CCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            999998764332 34456789999999999765 4789999999999999999999999999999999999999888887


Q ss_pred             CCcchhhhhhh-hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         254 NEWPENISLMW-SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       254 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      ..|+....... ..+..............+++++.+||++||..||.+|||+.|+++||||++.++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence            77765332111 0111111122333456778999999999999999999999999999999987543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.7e-52  Score=348.29  Aligned_cols=263  Identities=31%  Similarity=0.435  Sum_probs=226.2

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.+.||+|+||+||+|.+ ..+++.+++|++............+.+|+.++++++   ||||+++++++.+.  
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~--   77 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVH-KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ---HPNIVRLHDSIQEE--   77 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC---CTTBCCEEEEEECS--
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEE-cCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC---CCCcCeEEEEEEcC--
Confidence            468999999999999999999999 678999999999765433333346678999999997   99999999999776  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC---EEEe
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIA  175 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~---~kl~  175 (321)
                           ...++|+|++.+ +|.+.+...  ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.   ++|+
T Consensus        78 -----~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           78 -----SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             -----SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             -----CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEe
Confidence                 678999999985 998888773  45899999999999999999999999999999999999987665   9999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      |||.+.............+++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.......+...
T Consensus       151 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T 3kk8_A          151 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE  230 (284)
T ss_dssp             CCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             eceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchh
Confidence            99999877766665667889999999999999999999999999999999999999998888777776665433332222


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      +                       ..+++++.+||++||+.||.+|||+.++++||||++..+
T Consensus       231 ~-----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          231 W-----------------------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             T-----------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             h-----------------------cccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            1                       256689999999999999999999999999999998743

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-52  Score=364.09  Aligned_cols=288  Identities=38%  Similarity=0.643  Sum_probs=229.5

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++++.||+|+||+||+|.+ ..+++.||+|++............+.+|+.+++.++   ||||+++++++.....
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~   98 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVD-GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR---HENVIGLLDVFTPDET   98 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEE-TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC---BTTBCCCSEEECSCSS
T ss_pred             ecceEEEeEEeeecCCeEEEEEEE-CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC---CcCCCCceeeEecCCc
Confidence            357899999999999999999999 688999999998654332222345678999999998   9999999999876521


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                       ......+++|||+++++|.+++..   ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus        99 -~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A           99 -LDDFTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             -TTTCCCCEEEEECCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             -cccCceEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence             112245699999998899999987   3489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      +......  .....+|+.|+|||++.+ ..++.++||||+||++++|++|+.||.+.+..+....+....+.++...+..
T Consensus       175 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          175 ARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             CEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            9876532  345678999999999987 6789999999999999999999999999999999999999888776433221


Q ss_pred             hhhh----hhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         259 NISL----MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       259 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ..+.    ....+.............++++.+.+||++||..||.+|||+.++|+||||++..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            1110    0111122223334455567889999999999999999999999999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.8e-52  Score=361.58  Aligned_cols=264  Identities=25%  Similarity=0.421  Sum_probs=221.7

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeeccc-CCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKL-NEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ..++..++|++++.||+|+||+||+|++ ..+++.||+|++.... ........+.+|+.+++.+.   ||||+++++++
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~-~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~   84 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQK-NDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE---HPFLVNLWYSF   84 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC---CTTBCCEEEEE
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC---CCCCCcEEEEE
Confidence            3455668999999999999999999999 6889999999997643 22333456778999999997   99999999999


Q ss_pred             eccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      .+.       ..+++|||++.| +|..++..  ...+++..++.++.||+.||.|||++|++||||||+||+++.++.++
T Consensus        85 ~~~-------~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vk  155 (384)
T 4fr4_A           85 QDE-------EDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVH  155 (384)
T ss_dssp             ECS-------SEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred             EeC-------CEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEE
Confidence            887       678999999985 99999987  44599999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCCccccccccccccchhhhhc---CCCCCcchHHHHHHHHHHHHhcCCCCCCCCh---HHHHHHHHHH
Q psy2676         174 IADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN---LGYGTPVDIWSIGCVMAEMWRLVPLFCASTE---VEQLKCIFRV  247 (321)
Q Consensus       174 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~  247 (321)
                      |+|||++.............||+.|+|||++.+   ..++.++|||||||++|+|++|..||.....   ......+.. 
T Consensus       156 L~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-  234 (384)
T 4fr4_A          156 ITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET-  234 (384)
T ss_dssp             ECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH-
T ss_pred             EeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh-
Confidence            999999988776666677889999999999974   4489999999999999999999999975432   222222211 


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-HHHHhCCCCCCCCCCC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-AADALEHPYFKEKENE  319 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~~ll~h~~f~~~~~~  319 (321)
                      ....                          ....+++.+.+||++||..||.+||+ ++++++||||++.+|+
T Consensus       235 ~~~~--------------------------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~  281 (384)
T 4fr4_A          235 TVVT--------------------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD  281 (384)
T ss_dssp             CCCC--------------------------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred             cccC--------------------------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence            1111                          11245689999999999999999998 9999999999998874

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-52  Score=367.45  Aligned_cols=274  Identities=25%  Similarity=0.337  Sum_probs=227.8

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      .+....+..++|++++.||+|+||+||+|++ ..+++.||+|++.+... .......+.+|..++..+.   ||||++++
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~-~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~---hp~Iv~l~  127 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKM-KQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD---RRWITQLH  127 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC---TTTBCCEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC---CCCeeeEE
Confidence            3445667789999999999999999999999 67899999999975321 1223346778999999887   99999999


Q ss_pred             eeeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG  170 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~  170 (321)
                      +++.+.       ..+|+||||+. |+|.+++...+ ..+++..++.++.||+.||.|||++|++||||||+||+++.++
T Consensus       128 ~~~~~~-------~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g  199 (412)
T 2vd5_A          128 FAFQDE-------NYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG  199 (412)
T ss_dssp             EEEECS-------SEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred             EEEeeC-------CEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC
Confidence            999887       78999999997 59999998743 2489999999999999999999999999999999999999999


Q ss_pred             CEEEeecCCcccccCCCc--cccccccccccchhhhhc-------CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHH
Q psy2676         171 GLKIADFGLAKTFDYDMM--LTSVVVTLWYRAPEILLN-------LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL  241 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  241 (321)
                      ++||+|||++........  .....||+.|+|||++..       ..++.++|+|||||++|+|++|+.||.+.+..+..
T Consensus       200 ~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~  279 (412)
T 2vd5_A          200 HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY  279 (412)
T ss_dssp             CEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             CEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999987654433  234578999999999973       45899999999999999999999999998887777


Q ss_pred             HHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCC---CCHHHHhCCCCCCCCCC
Q psy2676         242 KCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADR---ISAADALEHPYFKEKEN  318 (321)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~~ll~h~~f~~~~~  318 (321)
                      ..+.........+                      .....+++++++||++||. +|.+|   |+++++++||||++.+|
T Consensus       280 ~~i~~~~~~~~~p----------------------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w  336 (412)
T 2vd5_A          280 GKIVHYKEHLSLP----------------------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW  336 (412)
T ss_dssp             HHHHTHHHHCCCC--------------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred             HHHHhcccCcCCC----------------------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence            7665422111111                      1123567899999999999 99998   59999999999999999


Q ss_pred             CCC
Q psy2676         319 EPL  321 (321)
Q Consensus       319 ~~~  321 (321)
                      +.+
T Consensus       337 ~~l  339 (412)
T 2vd5_A          337 DGL  339 (412)
T ss_dssp             TTS
T ss_pred             HHH
Confidence            864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.3e-52  Score=353.79  Aligned_cols=284  Identities=36%  Similarity=0.616  Sum_probs=219.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++++.||+|+||+||+|++ ..+++.+|+|++............+.+|+.++++++   ||||+++++++.+.    
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~----   74 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRN-RDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK---HPNLVNLLEVFRRK----   74 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC---CTTBCCEEEEEEET----
T ss_pred             ccceEeeEEeecCCeEEEEEEe-CCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC---CCCccchhheeecC----
Confidence            6899999999999999999999 678999999998654332222345668999999998   99999999999877    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++|||++++ +|.+++...  ..+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+
T Consensus        75 ---~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  149 (311)
T 4agu_A           75 ---RRLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFA  149 (311)
T ss_dssp             ---TEEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ---CeEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence               678999999996 677777653  44899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC-ccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      ....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+....+.........
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          150 RLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV  229 (311)
T ss_dssp             EECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             hhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence            8765332 3345678999999999986 5579999999999999999999999999998888888877665443211000


Q ss_pred             hhhhhh-h--hhh-hhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         259 NISLMW-S--SFE-QYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       259 ~~~~~~-~--~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      .....+ .  ... ............+++..+.+||++||+.||.+|||++++++||||++..+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence            000000 0  000 00001112223467889999999999999999999999999999998854

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.1e-52  Score=359.01  Aligned_cols=263  Identities=25%  Similarity=0.383  Sum_probs=222.5

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      .+..++|++++.||+|+||+||+|++ ..+++.||+|+++.... ..........|..++..+..  ||+|+++++++.+
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~-~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~--hp~iv~l~~~~~~   92 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSER-KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK--PPFLTQLHSCFQT   92 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTC--CTTBCCEEEEEEC
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEE-CCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCC--CCEEeeEEEEEEc
Confidence            44567999999999999999999999 57889999999976532 22334456788888887743  9999999999987


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ..+++||||+.| +|.+++...  +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+
T Consensus        93 ~-------~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~  163 (353)
T 2i0e_A           93 M-------DRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIA  163 (353)
T ss_dssp             S-------SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             C-------CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEE
Confidence            7       688999999985 999999873  449999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccC-CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         176 DFGLAKTFDY-DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       176 dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      |||++..... ........||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....+.....     
T Consensus       164 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-----  238 (353)
T 2i0e_A          164 DFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-----  238 (353)
T ss_dssp             CCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----
T ss_pred             eCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-----
Confidence            9999976432 2334556789999999999999999999999999999999999999998888777777665211     


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                      .++                      ..+++++.+||++||..||.+||     ++.++++||||++.+|+
T Consensus       239 ~~p----------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          239 AYP----------------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             CCC----------------------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             CCC----------------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence            111                      14568999999999999999999     46999999999998775

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.9e-53  Score=361.85  Aligned_cols=256  Identities=28%  Similarity=0.423  Sum_probs=216.0

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      -++|++.+.||+|+||+||+|++ ..+++.||+|++..... .......+.+|+.+++.++   ||||+++++++.+.  
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~--   81 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATH-YKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR---HPHIIKLYDVITTP--   81 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC---CTTBCCEEEEEECS--
T ss_pred             cCCEEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC---CCCCCeEEEEEEeC--
Confidence            36899999999999999999999 68899999999976422 2333457889999999998   99999999999877  


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                           ...++||||++|+|.+++...  +.+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||+
T Consensus        82 -----~~~~lv~E~~~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~  154 (336)
T 3h4j_B           82 -----TDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGL  154 (336)
T ss_dssp             -----SEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred             -----CEEEEEEECCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEecc
Confidence                 678999999999999998773  4599999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccchhhhhcCCC-CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      +.............||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.........+.             
T Consensus       155 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~-------------  221 (336)
T 3h4j_B          155 SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN-------------  221 (336)
T ss_dssp             TBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC-------------
T ss_pred             ceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH-------------
Confidence            987766665666789999999999988776 789999999999999999999997643221110000             


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                                    .........+++.+.+||++||..||.+|||++|+++||||+..
T Consensus       222 --------------~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          222 --------------SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             --------------SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             --------------cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence                          00001122466899999999999999999999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.7e-51  Score=363.46  Aligned_cols=289  Identities=29%  Similarity=0.479  Sum_probs=230.2

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccC---CCCceeEEEee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF---EHPNIVRFFDV   93 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~~~~i~~~~~~   93 (321)
                      .+...++|++++.||+|+||+||+|.+ ..+++.||+|++....   .......+|+.+++.+...   +|+||++++++
T Consensus        92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~-~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~  167 (429)
T 3kvw_A           92 HDHVAYRYEVLKVIGKGSFGQVVKAYD-HKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN  167 (429)
T ss_dssp             TCEETTTEEEEEEEEESSSEEEEEEEE-TTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred             CCcccCcEEEEEEcccCccEEEEEEEE-CCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence            345567899999999999999999999 6789999999986421   1123566788888877533   58899999999


Q ss_pred             eeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC--
Q psy2676          94 IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG--  171 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~--  171 (321)
                      +...       ..+++|+|++.++|.+++.......+++..++.++.||+.||.|||+.|++||||||+||+++.++.  
T Consensus       168 ~~~~-------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~  240 (429)
T 3kvw_A          168 FTFR-------NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG  240 (429)
T ss_dssp             EEET-------TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCC
T ss_pred             cccC-------CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcc
Confidence            9877       6889999999999999999877666999999999999999999999999999999999999999887  


Q ss_pred             EEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         172 LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      +||+|||++......  .....+|+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+....+.+
T Consensus       241 vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p  318 (429)
T 3kvw_A          241 IKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP  318 (429)
T ss_dssp             EEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eEEeecccceecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            999999999765432  334578999999999999999999999999999999999999999999999999999888776


Q ss_pred             CCCCcchhhhhhh----hhh----------------------------hhhhhhhhhhhhhhcchhHHHHHHHhcccCCC
Q psy2676         252 SMNEWPENISLMW----SSF----------------------------EQYSKVAFSAIFMDCCSKANSLLESMLTFNPA  299 (321)
Q Consensus       252 ~~~~~~~~~~~~~----~~~----------------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  299 (321)
                      +...+........    ...                            ..........+....++.+.+||++||.+||.
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~  398 (429)
T 3kvw_A          319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA  398 (429)
T ss_dssp             CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred             CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence            5432211100000    000                            00000011112223468899999999999999


Q ss_pred             CCCCHHHHhCCCCCCCCCC
Q psy2676         300 DRISAADALEHPYFKEKEN  318 (321)
Q Consensus       300 ~Rps~~~ll~h~~f~~~~~  318 (321)
                      +|||++|+|+||||++...
T Consensus       399 ~Rpta~e~L~Hpw~~~~~~  417 (429)
T 3kvw_A          399 VRMTPGQALRHPWLRRRLP  417 (429)
T ss_dssp             TSCCHHHHHTSTTTC----
T ss_pred             hCCCHHHHhCChhhccCCC
Confidence            9999999999999998743

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.3e-51  Score=353.08  Aligned_cols=263  Identities=27%  Similarity=0.440  Sum_probs=204.4

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      .+...++|++.+.||+|+||+||+|++ ..+++.||+|++....    ....+.+|+.+++++.   ||||+++++++.+
T Consensus        48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~---h~niv~~~~~~~~  119 (349)
T 2w4o_A           48 RDALSDFFEVESELGRGATSIVYRCKQ-KGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLS---HPNIIKLKEIFET  119 (349)
T ss_dssp             CSCGGGTEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEC--------------CHHHHHCC---CTTBCCEEEEEEC
T ss_pred             cccccCcEEEeeEEeeCCCEEEEEEEE-CCCCcEEEEEEeccch----hHHHHHHHHHHHHhCC---CCCCcceeeeEec
Confidence            445567899999999999999999999 5788999999997542    2346778999999998   9999999999987


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee---CCCE
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR---AGGL  172 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~---~~~~  172 (321)
                      .       ...++|||++. ++|.+++..  .+.+++..++.++.||+.||.|||+.|++|+||||+||+++.   ++.+
T Consensus       120 ~-------~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~  190 (349)
T 2w4o_A          120 P-------TEISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPL  190 (349)
T ss_dssp             S-------SEEEEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCE
T ss_pred             C-------CeEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCE
Confidence            7       67899999998 599999977  345899999999999999999999999999999999999975   7889


Q ss_pred             EEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHH-HHHHHHHHhCCC
Q psy2676         173 KIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE-QLKCIFRVIGTP  251 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~  251 (321)
                      ||+|||++.............+++.|+|||++.+..++.++||||||+++|+|++|..||....... ....+.......
T Consensus       191 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~  270 (349)
T 2w4o_A          191 KIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF  270 (349)
T ss_dssp             EECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC
T ss_pred             EEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc
Confidence            9999999987665544556778999999999999999999999999999999999999997766554 333333221111


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      ...                       ...+++.++.+||++||..||.+|||+.++++||||++....
T Consensus       271 ~~~-----------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  315 (349)
T 2w4o_A          271 ISP-----------------------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN  315 (349)
T ss_dssp             CTT-----------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred             CCc-----------------------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence            111                       123566899999999999999999999999999999987654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.6e-51  Score=353.91  Aligned_cols=260  Identities=27%  Similarity=0.419  Sum_probs=223.9

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      ...-++|++++.||+|+||.||+|++ ..+++.||+|++..... .......+.+|+.+++.+.   ||||+++++++.+
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~  112 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKH-KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN---FPFLVKLEFSFKD  112 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC---CTTBCCEEEEEEC
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEE-CCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC---CCCCCeEEEEEEc
Confidence            34557999999999999999999999 67899999999976432 2233456778899888887   9999999999987


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ..+++||||+. |+|.+++...  +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+
T Consensus       113 ~-------~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~  183 (350)
T 1rdq_E          113 N-------SNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT  183 (350)
T ss_dssp             S-------SEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             C-------CEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEc
Confidence            7       68999999998 5999999874  448999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      |||++......  .....||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....+....  ..   
T Consensus       184 DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~---  256 (350)
T 1rdq_E          184 DFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VR---  256 (350)
T ss_dssp             CCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CC---
T ss_pred             ccccceeccCC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC--CC---
Confidence            99999876533  235678999999999999999999999999999999999999999888877777666531  11   


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKENE  319 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~~  319 (321)
                      ++                      ..+++++.++|++||+.||.+||+     ++++++||||++.+|+
T Consensus       257 ~p----------------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~  303 (350)
T 1rdq_E          257 FP----------------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             CC----------------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             CC----------------------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence            11                      145689999999999999999998     9999999999998764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.1e-51  Score=354.00  Aligned_cols=262  Identities=28%  Similarity=0.405  Sum_probs=215.5

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      +.-++|++++.||+|+||.||+|++ ..+++.+|+|++....... .....+.+|..+++++..  ||||+++++++.+.
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~--hp~iv~l~~~~~~~   82 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRL-KKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN--HPFLVGLHSCFQTE   82 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTT--CTTBCCEEEEEECS
T ss_pred             CchhheEEEEEEEecCCeEEEEEEE-CCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCC--CCccCeEEEEEEeC
Confidence            3457899999999999999999999 6789999999998653322 122346678889888742  99999999999877


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ..+++|||++.| +|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|
T Consensus        83 -------~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~D  153 (345)
T 3a8x_A           83 -------SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTD  153 (345)
T ss_dssp             -------SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred             -------CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEe
Confidence                   689999999985 999999873  4599999999999999999999999999999999999999999999999


Q ss_pred             cCCccccc-CCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCC---------hHHHHHHHHH
Q psy2676         177 FGLAKTFD-YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST---------EVEQLKCIFR  246 (321)
Q Consensus       177 fg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---------~~~~~~~~~~  246 (321)
                      ||++.... .........||+.|+|||++.+..++.++|+|||||++|+|++|..||....         .......+..
T Consensus       154 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~  233 (345)
T 3a8x_A          154 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  233 (345)
T ss_dssp             GGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred             ccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence            99997643 2333455678999999999999999999999999999999999999996521         1111222221


Q ss_pred             HhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH------HHHhCCCCCCCCCCC
Q psy2676         247 VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA------ADALEHPYFKEKENE  319 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~h~~f~~~~~~  319 (321)
                      .  ..   .                      ....++.++.+||++||..||.+||++      +++++||||++.+|+
T Consensus       234 ~--~~---~----------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~  285 (345)
T 3a8x_A          234 K--QI---R----------------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  285 (345)
T ss_dssp             C--CC---C----------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred             C--CC---C----------------------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence            1  00   0                      112466899999999999999999995      899999999998764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-51  Score=358.04  Aligned_cols=261  Identities=27%  Similarity=0.460  Sum_probs=221.7

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++.+.||+|+||+||+|.+ ..+++.+|+|++......  ....+.+|+.+++++.   ||||+++++++.+.   
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~-~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~---hpnIv~~~~~~~~~---  120 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVE-KATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLH---HPKLINLHDAFEDK---  120 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCC---STTBCCEEEEEECS---
T ss_pred             ccceEEEEEEecCCCEEEEEEEE-CCCCCEEEEEEecccchh--hHHHHHHHHHHHHhCC---CcCCCeEEEEEEeC---
Confidence            36899999999999999999999 678999999998753211  1235678999998887   99999999999877   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee--CCCEEEeec
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR--AGGLKIADF  177 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~--~~~~kl~df  177 (321)
                          ...++|||++.| +|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.  ++.+||+||
T Consensus       121 ----~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DF  195 (387)
T 1kob_A          121 ----YEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDF  195 (387)
T ss_dssp             ----SEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred             ----CEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEec
Confidence                688999999985 9999987643 34899999999999999999999999999999999999974  467999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      |++.............+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.......+..   
T Consensus       196 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~---  272 (387)
T 1kob_A          196 GLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED---  272 (387)
T ss_dssp             TTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS---
T ss_pred             ccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc---
Confidence            99988776655566788999999999999889999999999999999999999999888777766665432211111   


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                                          ....+++++.+||++||..||.+|||+.++++||||++...
T Consensus       273 --------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          273 --------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             --------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             --------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence                                12356789999999999999999999999999999997643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-51  Score=360.65  Aligned_cols=290  Identities=31%  Similarity=0.487  Sum_probs=227.4

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      ++...++|++++.||+|+||+||+|++ ..+++.||+|++...      .....+|+.+++.++   ||||+++++++..
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~-~~~~~~vAiK~~~~~------~~~~~~E~~il~~l~---hpnIv~l~~~~~~   71 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFD-IESGKRFALKKVLQD------PRYKNRELDIMKVLD---HVNIIKLVDYFYT   71 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEE-TTTCCEEEEEEEECC------TTSCCHHHHHHTTCC---CTTBCCEEEEEEE
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEE-CCCCCEEEEEEEecC------cchHHHHHHHHHHcC---CCCccchhheeee
Confidence            456678999999999999999999999 688999999998643      123447999999997   9999999999865


Q ss_pred             cccc-------------------------------cccceEEEEEeccCccCHHHHHhh--CCCCCCCHHHHHHHHHHHH
Q psy2676          97 NILS-------------------------------DERYLTVYLIFEHVDQDLGSYMEK--CPPPGLSASKVKELTRQML  143 (321)
Q Consensus        97 ~~~~-------------------------------~~~~~~~~~v~e~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~l~  143 (321)
                      ....                               .......++|||+++++|.+.+..  .....+++..++.++.||+
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             C-------------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence            4211                               022345899999999988887764  2245599999999999999


Q ss_pred             HHHHHHHhCCceeccCCCCcEEEe-eCCCEEEeecCCcccccCCCccccccccccccchhhhhcCC-CCCcchHHHHHHH
Q psy2676         144 KGVDFLHSHRIIHRDLKPQNLLIT-RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCV  221 (321)
Q Consensus       144 ~~l~~lh~~~~~H~di~p~Nilv~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~  221 (321)
                      .||.|||++|++||||||+||+++ .++.+||+|||.+.............+++.|+|||++.+.. ++.++||||+||+
T Consensus       152 ~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          152 RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            999999999999999999999998 58899999999998776666666778899999999988755 8999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhh-hhhhhhhhhh-hhhhhhhcchhHHHHHHHhcccCCC
Q psy2676         222 MAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMW-SSFEQYSKVA-FSAIFMDCCSKANSLLESMLTFNPA  299 (321)
Q Consensus       222 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~  299 (321)
                      +|+|++|+.||.+.+..+....+....+.+....+........ ..+....... .......+++++.+||++||..||.
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999999999999999999888775433221110000 0000001111 1112335778999999999999999


Q ss_pred             CCCCHHHHhCCCCCCCC
Q psy2676         300 DRISAADALEHPYFKEK  316 (321)
Q Consensus       300 ~Rps~~~ll~h~~f~~~  316 (321)
                      +|||+.|+++||||++.
T Consensus       312 ~R~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          312 LRINPYEAMAHPFFDHL  328 (383)
T ss_dssp             GSCCHHHHHTSGGGHHH
T ss_pred             hCCCHHHHhcCHHHHHH
Confidence            99999999999999754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.2e-51  Score=351.35  Aligned_cols=264  Identities=28%  Similarity=0.447  Sum_probs=225.0

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC----CCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG----IPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ...++|++.+.||+|+||+||+|++ ..+++.+|+|++........    ....+.+|+.+++++.   ||||+++++++
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~   84 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCRE-KSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL---HHNVITLHDVY   84 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC---CTTBCCEEEEE
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEE-CCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC---CCCcceEEEEE
Confidence            3457899999999999999999999 67899999999976543322    2345778999999998   99999999999


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC---
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG---  170 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~---  170 (321)
                      .+.       ...++|||++. ++|.+++..  ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++   
T Consensus        85 ~~~-------~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~  155 (321)
T 2a2a_A           85 ENR-------TDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI  155 (321)
T ss_dssp             ECS-------SEEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSS
T ss_pred             ecC-------CEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCc
Confidence            776       67899999997 599999987  34589999999999999999999999999999999999999888   


Q ss_pred             -CEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhC
Q psy2676         171 -GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       171 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                       .++|+|||.+.............+++.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+.....
T Consensus       156 ~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  235 (321)
T 2a2a_A          156 PHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY  235 (321)
T ss_dssp             CCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred             CCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc
Confidence             7999999999877665555667789999999999999999999999999999999999999988877766655543211


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      .     ++                  ......+++.+.+||++||..||.+|||+.++++||||++.++
T Consensus       236 ~-----~~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          236 D-----FD------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             C-----CC------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             c-----cC------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence            1     10                  1123467789999999999999999999999999999998754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3e-52  Score=362.27  Aligned_cols=292  Identities=38%  Similarity=0.622  Sum_probs=218.6

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ..+++. ++|++++.||+|+||+||+|.+ ..+++.||+|++............+.+|+.+++.++   ||||+++++++
T Consensus        23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~   97 (367)
T 2fst_X           23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFD-TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK---HENVIGLLDVF   97 (367)
T ss_dssp             EEEEEE-TTEEEEEECC----CCEEEEEE-TTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC---CTTBCCCSEEE
T ss_pred             cccCCC-CceEEeeEEeecCCeEEEEEEE-CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC---CCCCCcEEEEE
Confidence            334443 7999999999999999999999 688999999998654322222345678999999998   99999999998


Q ss_pred             eccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ..... .......++|+|+++++|.+++..   ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||
T Consensus        98 ~~~~~-~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL  173 (367)
T 2fst_X           98 TPARS-LEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI  173 (367)
T ss_dssp             CSCSS-GGGCCCCEEEEECCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             ecCCc-cccCCeEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEE
Confidence            65421 122245799999998899998876   34899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       175 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      +|||++......  .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....+.+..
T Consensus       174 ~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  251 (367)
T 2fst_X          174 LDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  251 (367)
T ss_dssp             CC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             eecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            999999765432  345678999999999987 66899999999999999999999999999999999999999888764


Q ss_pred             CCcchhhhhh----hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         254 NEWPENISLM----WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       254 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ..+.......    ...+.............++++.+.+||++||..||.+|||+.++|+||||++..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence            4332211111    111122223334455567889999999999999999999999999999999763

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.3e-51  Score=358.67  Aligned_cols=296  Identities=32%  Similarity=0.517  Sum_probs=230.2

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCC---------chhHHHHHHHHhcccCC
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP---------MSTLREISILKQLDTFE   83 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~---------~~~~~e~~~l~~l~~~~   83 (321)
                      .+..+....++|++.+.||+|+||+||+|.+  .+++.||+|++..........         ..+.+|+.++++++   
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---   87 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVD--SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH---   87 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEEC--TTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC---
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEEC--CCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC---
Confidence            3445667789999999999999999999998  358999999987654433221         45778999999998   


Q ss_pred             CCceeEEEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q psy2676          84 HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQN  163 (321)
Q Consensus        84 ~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~N  163 (321)
                      ||||+++++++...  ........++|||++.|+|.+.+.... ..+++..++.++.||+.||.|||++|++|+||||+|
T Consensus        88 h~~iv~~~~~~~~~--~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  164 (362)
T 3pg1_A           88 HPNILGLRDIFVHF--EEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGN  164 (362)
T ss_dssp             CTTBCCCSEEEEEC--CTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             CcCccceeeeEEec--cCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHH
Confidence            99999999998654  223335789999999999999988643 359999999999999999999999999999999999


Q ss_pred             EEEeeCCCEEEeecCCcccccCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHH
Q psy2676         164 LLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLK  242 (321)
Q Consensus       164 ilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  242 (321)
                      |+++.++.++|+|||.+.............+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+...
T Consensus       165 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  244 (362)
T 3pg1_A          165 ILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN  244 (362)
T ss_dssp             EEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999999987665555666788999999999887 668999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCcchhhhhhh-----hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         243 CIFRVIGTPSMNEWPENISLMW-----SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .+....+.+....+........     .................+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence            9988887765443221111000     0111111222334455678899999999999999999999999999999987

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-51  Score=350.51  Aligned_cols=254  Identities=25%  Similarity=0.351  Sum_probs=204.2

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|+++++||+|+||+||+|++ ..+++.||+|++...............|+..+.++.  .||||+++++++.+.    
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~--~h~~iv~l~~~~~~~----  129 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRS-KEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG--QHPCCVRLEQAWEEG----  129 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEE-TTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHC--CCTTBCCEEEEEEET----
T ss_pred             hheeeeheeccCCCeEEEEEEE-CCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhc--CCCcEEEEEEEEEeC----
Confidence            7899999999999999999999 578999999987654322222223444555555553  399999999999877    


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                         ...++|||+++++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++.
T Consensus       130 ---~~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~  205 (311)
T 3p1a_A          130 ---GILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV  205 (311)
T ss_dssp             ---TEEEEEEECCCCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred             ---CEEEEEEeccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeee
Confidence               6889999999999999987754 349999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhh
Q psy2676         182 TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS  261 (321)
Q Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (321)
                      ............||+.|+|||++.+ .++.++||||||+++|+|++|..|+.......   .+...    .         
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~----~---------  268 (311)
T 3p1a_A          206 ELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQG----Y---------  268 (311)
T ss_dssp             ECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTT----C---------
T ss_pred             ecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhcc----C---------
Confidence            7766555566678999999999876 68999999999999999999977765432211   11100    0         


Q ss_pred             hhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                                  ........+++++.++|.+||+.||.+|||+.++++||||++
T Consensus       269 ------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          269 ------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                        011223467799999999999999999999999999999986

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.5e-51  Score=348.38  Aligned_cols=258  Identities=31%  Similarity=0.461  Sum_probs=211.6

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++++.||+|+||+||+|++ ..+++.||+|++...... .....+.+|+.+++.++   ||||+++++++.+.   
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~---   77 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVN-RVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLN---HENVVKFYGHRREG---   77 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECC--------CHHHHHHHHHHCC---CTTBCCEEEEEECS---
T ss_pred             hhhceeeeEEecCCCEEEEEEEE-CCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCC---CCCCCeEEEEEecC---
Confidence            36899999999999999999999 678999999998754332 23457789999999998   99999999999877   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ...++||||+.+ +|.+++..  ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||+
T Consensus        78 ----~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~  151 (323)
T 3tki_A           78 ----NIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGL  151 (323)
T ss_dssp             ----SEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             ----CeEEEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeec
Confidence                688999999985 99999976  34599999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC---ccccccccccccchhhhhcCCC-CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         180 AKTFDYDM---MLTSVVVTLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       180 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      +.......   ......+|+.|+|||++.+..+ +.++||||||+++|+|++|..||...................    
T Consensus       152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----  227 (323)
T 3tki_A          152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----  227 (323)
T ss_dssp             CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT----
T ss_pred             cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc----
Confidence            97654222   2335678999999999988775 779999999999999999999997755432222211111000    


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                                          ......+++.+.+||++||..||.+|||+.|+++||||++.
T Consensus       228 --------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          228 --------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             --------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             --------------------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence                                01123567899999999999999999999999999999865

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6e-52  Score=375.16  Aligned_cols=268  Identities=26%  Similarity=0.393  Sum_probs=226.6

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +....+..++|++.+.||+|+||.||+|++ ..+++.||+|++..... .......+.+|+.+++++.   ||||+++++
T Consensus       176 l~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~-~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~  251 (576)
T 2acx_A          176 LERQPVTKNTFRQYRVLGKGGFGEVCACQV-RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN---SRFVVSLAY  251 (576)
T ss_dssp             HHTSCCCGGGEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC---CTTBCCEEE
T ss_pred             hhhcCccccceEEEEEEeeCCCEEEEEEEE-CCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC---CCCEeeEEE
Confidence            344557788999999999999999999999 67899999999976432 2233446778999999997   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      ++.+.       ..+++||||+. |+|.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.++.
T Consensus       252 ~~~~~-------~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~  324 (576)
T 2acx_A          252 AYETK-------DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH  324 (576)
T ss_dssp             EEECS-------SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC
T ss_pred             EEeeC-------CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC
Confidence            99877       68999999998 59999998866666999999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCCh----HHHHHHHHHH
Q psy2676         172 LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE----VEQLKCIFRV  247 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~  247 (321)
                      +||+|||++.............||+.|+|||++.+..++.++|+||||+++|+|++|..||.+...    ......+.. 
T Consensus       325 vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-  403 (576)
T 2acx_A          325 IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-  403 (576)
T ss_dssp             EEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-
T ss_pred             eEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-
Confidence            999999999887655555567899999999999998899999999999999999999999987532    222222221 


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                      ..    ..+                      ...+++++.+||++||..||.+||     +++++++||||++.+|+
T Consensus       404 ~~----~~~----------------------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          404 VP----EEY----------------------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             CC----CCC----------------------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             cc----ccC----------------------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence            11    111                      124568999999999999999999     89999999999998764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.7e-51  Score=361.10  Aligned_cols=293  Identities=20%  Similarity=0.264  Sum_probs=220.3

Q ss_pred             cccccCCcceeeeeeeecc--cceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          15 DSLDLGDKKYDELCQIGCG--AYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g--~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      ..+-...++|++++.||+|  +||+||+|++ ..+++.||+|++............+.+|+.++++++   ||||+++++
T Consensus        18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~   93 (389)
T 3gni_B           18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARY-KPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN---HPNIVPYRA   93 (389)
T ss_dssp             CCCCCCGGGEEEEEEEEEETTTTEEEEEEEE-TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC---CTTBCCEEE
T ss_pred             hcccCCCCcEEEEecccCCcCCceEEEEEEE-cCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC---CCCCCcEeE
Confidence            4556677899999999999  9999999999 578999999999876444333456677999999998   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      ++.+.       ..+++|||++. ++|.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.++.
T Consensus        94 ~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~  166 (389)
T 3gni_B           94 TFIAD-------NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK  166 (389)
T ss_dssp             EEEET-------TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC
T ss_pred             EEEEC-------CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC
Confidence            99877       67899999998 59999998865566999999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCC--------ccccccccccccchhhhhc--CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHH
Q psy2676         172 LKIADFGLAKTFDYDM--------MLTSVVVTLWYRAPEILLN--LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL  241 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  241 (321)
                      ++|+|||.+.......        ......+++.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus       167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  246 (389)
T 3gni_B          167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML  246 (389)
T ss_dssp             EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH
T ss_pred             EEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            9999999876542211        1223467888999999987  56899999999999999999999999876655544


Q ss_pred             HHHHHHhCCCCCCC--cchh-----hhh--h----------hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC
Q psy2676         242 KCIFRVIGTPSMNE--WPEN-----ISL--M----------WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI  302 (321)
Q Consensus       242 ~~~~~~~~~~~~~~--~~~~-----~~~--~----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  302 (321)
                      ..+...........  .+..     ...  .          ..................+++.+.+||++||+.||.+||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp  326 (389)
T 3gni_B          247 LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP  326 (389)
T ss_dssp             HHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSC
T ss_pred             HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCC
Confidence            43332111100000  0000     000  0          000000001111123456788999999999999999999


Q ss_pred             CHHHHhCCCCCCCCCC
Q psy2676         303 SAADALEHPYFKEKEN  318 (321)
Q Consensus       303 s~~~ll~h~~f~~~~~  318 (321)
                      |+.++|+||||++..+
T Consensus       327 ta~ell~hp~f~~~~~  342 (389)
T 3gni_B          327 SASTLLNHSFFKQIKR  342 (389)
T ss_dssp             CHHHHTTSGGGGGC--
T ss_pred             CHHHHhcCHHHHHHhh
Confidence            9999999999998754

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.6e-51  Score=353.80  Aligned_cols=262  Identities=29%  Similarity=0.406  Sum_probs=202.7

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ....++|++++.||+|+||+||++++ ..+++.||+|++...   ......+.+|+.+++.++   ||||+++++++.+.
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~   88 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRD-KLTKELVAVKYIERG---AAIDENVQREIINHRSLR---HPNIVRFKEVILTP   88 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEE-TTTCCEEEEEEEESS---TTSCHHHHHHHHHHHHCC---CTTBCCEEEEEECS
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEE-CCCCcEEEEEEEecC---ccccHHHHHHHHHHHhCC---CCCCCcEEEEEeeC
Confidence            34568999999999999999999999 688999999999753   223456789999999998   99999999999877


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC--EEE
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG--LKI  174 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~--~kl  174 (321)
                             ...++||||+. |+|.+++...  +.+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||
T Consensus        89 -------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl  159 (361)
T 3uc3_A           89 -------THLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKI  159 (361)
T ss_dssp             -------SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred             -------CEEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEE
Confidence                   67899999997 5999999773  44999999999999999999999999999999999999987766  999


Q ss_pred             eecCCcccccCCCccccccccccccchhhhhcCCCCCc-chHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTP-VDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       175 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      +|||++.............+|+.|+|||++.+..++.+ +||||||+++|+|++|+.||.+...................
T Consensus       160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~  239 (361)
T 3uc3_A          160 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY  239 (361)
T ss_dssp             CCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC
T ss_pred             eecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC
Confidence            99999876554445556779999999999988887655 89999999999999999999775432222222211111000


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                       ..+.                    ...+++.+.+||++||..||.+|||+.++++||||++.
T Consensus       240 -~~~~--------------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          240 -SIPD--------------------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             -CCCT--------------------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             -CCCC--------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence             0000                    11456899999999999999999999999999999654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.4e-51  Score=349.13  Aligned_cols=266  Identities=29%  Similarity=0.445  Sum_probs=214.3

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEe--cCCCcEEEEEEeecccCC--CCCCchhHHHHHHHHhcccCCCCceeEE
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNE--DGIPMSTLREISILKQLDTFEHPNIVRF   90 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~i~~~   90 (321)
                      ....+..++|++.+.||+|+||+||+|++.  ..+++.+|+|+++.....  ......+.+|+.++++++   ||||+++
T Consensus        10 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~   86 (327)
T 3a62_A           10 GPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK---HPFIVDL   86 (327)
T ss_dssp             ---CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC---CTTBCCE
T ss_pred             CCCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC---CCCccce
Confidence            344566789999999999999999999884  257899999999764321  223445678999999998   9999999


Q ss_pred             EeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA  169 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~  169 (321)
                      ++++...       ..+++|||++. ++|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.+
T Consensus        87 ~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~  157 (327)
T 3a62_A           87 IYAFQTG-------GKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ  157 (327)
T ss_dssp             EEEEECS-------SCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT
T ss_pred             eEEEEcC-------CEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC
Confidence            9999876       67899999998 5999999873  458999999999999999999999999999999999999999


Q ss_pred             CCEEEeecCCcccccCC-CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHh
Q psy2676         170 GGLKIADFGLAKTFDYD-MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       170 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      +.+||+|||++...... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+....
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~  237 (327)
T 3a62_A          158 GHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK  237 (327)
T ss_dssp             SCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred             CcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence            99999999998754322 22345678999999999999899999999999999999999999999888877776665532


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                      ..     ++                      ..+++++.+||++||..||.+||     ++.++++||||++.+|+
T Consensus       238 ~~-----~p----------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~  286 (327)
T 3a62_A          238 LN-----LP----------------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE  286 (327)
T ss_dssp             CC-----CC----------------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred             CC-----CC----------------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence            11     11                      13558899999999999999999     89999999999988664

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.1e-52  Score=361.10  Aligned_cols=287  Identities=36%  Similarity=0.535  Sum_probs=216.3

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++++.||+|+||+||+|++ ..+++.||+|++............+.+|+.+++.+.   ||||+++++++..... 
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~-   98 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIGLLNVFTPQKS-   98 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCC---CTTBCCEEEEECSCCS-
T ss_pred             hhheeEeeeeEecCCEEEEEEEE-CCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcC---CCCccceEEeeccccc-
Confidence            47999999999999999999999 678999999999754333223345678999999987   9999999999876521 


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                      .......++|||+++++|.+.+..    .+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++
T Consensus        99 ~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A           99 LEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             TTTCCEEEEEEECCSEEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             cccccceEEEEEcCCCCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence            122347899999999999998864    3899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         181 KTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      .............+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+....+.+....+....
T Consensus       175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            87765555556788999999999999999999999999999999999999999999888888887766655332211110


Q ss_pred             hhhhh---------------hhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         261 SLMWS---------------SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       261 ~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .....               .+...............+.++.+||++||..||.+|||++++++||||+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence            00000               000000000111122346789999999999999999999999999999753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.6e-51  Score=357.87  Aligned_cols=290  Identities=31%  Similarity=0.487  Sum_probs=227.7

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      +....+|++.+.||+|+||+||+|++ ..++. +++|.+...      .....+|+.+++.++   ||||+++++++...
T Consensus        36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~-~~~~~-~aikk~~~~------~~~~~~E~~il~~l~---h~niv~l~~~~~~~  104 (394)
T 4e7w_A           36 EQREIAYTNCKVIGNGSFGVVFQAKL-VESDE-VAIKKVLQD------KRFKNRELQIMRIVK---HPNVVDLKAFFYSN  104 (394)
T ss_dssp             CEEEEEEEEEEEEEEETTEEEEEEEE-TTTEE-EEEEEEECC------TTSCCHHHHHHHTCC---CTTBCCEEEEEEEE
T ss_pred             CcccceEEEeEEEeeCCCeEEEEEEE-CCCCe-EEEEEEecC------cchHHHHHHHHHhCC---CCCcceEEEEEEec
Confidence            34456899999999999999999998 34444 777776532      123347999999998   99999999999765


Q ss_pred             ccccccceEEEEEeccCccCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe-eCCCEEE
Q psy2676          98 ILSDERYLTVYLIFEHVDQDLGSYMEK--CPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT-RAGGLKI  174 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~-~~~~~kl  174 (321)
                      . .......+++||||+++++...+..  .....+++..++.++.||+.||.|||++|++||||||+||+++ .++.+||
T Consensus       105 ~-~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL  183 (394)
T 4e7w_A          105 G-DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKL  183 (394)
T ss_dssp             S-SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEE
T ss_pred             C-CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEE
Confidence            2 1223356899999999877665542  1234589999999999999999999999999999999999999 7899999


Q ss_pred             eecCCcccccCCCccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       175 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      +|||++.............+|+.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.+..+....+....+.+..
T Consensus       184 ~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  263 (394)
T 4e7w_A          184 IDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR  263 (394)
T ss_dssp             CCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             eeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9999998776555556678899999999987654 899999999999999999999999999999999999998887765


Q ss_pred             CCcchhhhhhh-hhhhhhhhhhhhh-hhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         254 NEWPENISLMW-SSFEQYSKVAFSA-IFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       254 ~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      ..+........ ..+.......... ....+++++.+||.+||..||.+|||+.++++||||++..+.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence            43322111000 0111111111111 223478899999999999999999999999999999987553

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.3e-51  Score=357.10  Aligned_cols=287  Identities=40%  Similarity=0.633  Sum_probs=232.1

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      .+++|++++.||+|+||+||+|++ ..+++.||+|++.... .......+.+|+.++++++   ||||+++++++.... 
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~-   98 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYD-NLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFR---HENIIGINDIIRAPT-   98 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCC---CTTBCCCCEEECCSS-
T ss_pred             ccccEEEEEEeecCCCeEEEEEEE-CCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcC---CCCCccceeEEecCC-
Confidence            357999999999999999999999 6789999999986421 1112245678999999998   999999999987652 


Q ss_pred             ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                       .......++|+|+++++|.+++...   .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.
T Consensus        99 -~~~~~~~~iv~e~~~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A           99 -IEQMKDVYIVQDLMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             -TTTCCCEEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             -ccccceEEEEEcccCcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcc
Confidence             2223468999999999999999873   489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc----cccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         180 AKTFDYDMM----LTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       180 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      +........    .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+....+.+...
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  254 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            987653322    234578999999998765 448999999999999999999999999999999999998888877654


Q ss_pred             Ccchhhhhh----hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         255 EWPENISLM----WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       255 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .+.......    .................++++++.+||++||.+||.+|||+.++++||||++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            332211100    01111111223344456778999999999999999999999999999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.5e-51  Score=369.81  Aligned_cols=265  Identities=29%  Similarity=0.549  Sum_probs=224.6

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      .....++|++++.||+|+||+||+|++ ..+++.||+|++............+.+|+.++++++   ||||+++++++.+
T Consensus        17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~   92 (486)
T 3mwu_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKD-RITQQEYAVKVINKASAKNKDTSTILREVELLKKLD---HPNIMKLFEILED   92 (486)
T ss_dssp             CCHHHHHEEEEEEEECCSSSEEEEEEE-TTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC---CTTBCCEEEEEEC
T ss_pred             cCChhcceEEeEEEeecCCEEEEEEEE-CCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCC---CCCcCeEEEEEEc
Confidence            334557999999999999999999999 678999999999765444445567889999999998   9999999999987


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe---eCCCE
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT---RAGGL  172 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~---~~~~~  172 (321)
                      .       ..+++|+|++.| +|.+.+...  ..+++..++.++.||+.||.|||++|++||||||+||+++   .++.+
T Consensus        93 ~-------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~  163 (486)
T 3mwu_A           93 S-------SSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDI  163 (486)
T ss_dssp             S-------SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCE
T ss_pred             C-------CEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCE
Confidence            7       788999999985 999988773  4599999999999999999999999999999999999995   45579


Q ss_pred             EEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         173 KIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ||+|||++.............+|+.|+|||++.+ .++.++||||+|+++|+|++|..||.+.+..+....+........
T Consensus       164 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (486)
T 3mwu_A          164 KIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD  242 (486)
T ss_dssp             EECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC
T ss_pred             EEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            9999999987766655666789999999999876 589999999999999999999999999888887777665432222


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      .+.                       ...+++++.+||++||..||.+|||+.++|+||||++...
T Consensus       243 ~~~-----------------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          243 LPQ-----------------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             SGG-----------------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             Ccc-----------------------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence            221                       2356789999999999999999999999999999987644

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.8e-51  Score=345.27  Aligned_cols=259  Identities=31%  Similarity=0.448  Sum_probs=209.3

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC------------------------CCCchhHHHHHH
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED------------------------GIPMSTLREISI   75 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~------------------------~~~~~~~~e~~~   75 (321)
                      ..++|++.+.||+|+||+||+|++ ..+++.||+|++.......                        .....+.+|+.+
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYN-ENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEE-TTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEE-CCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            347999999999999999999999 6889999999997643211                        123567889999


Q ss_pred             HHhcccCCCCceeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy2676          76 LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRI  154 (321)
Q Consensus        76 l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~  154 (321)
                      +++++   ||||+++++++.+.     .....++|||++++ +|.+++..   ..+++..++.++.||+.||.|||++|+
T Consensus        90 l~~l~---h~~iv~~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i  158 (298)
T 2zv2_A           90 LKKLD---HPNVVKLVEVLDDP-----NEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKI  158 (298)
T ss_dssp             HHTCC---CTTBCCEEEEEECS-----SSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHhCC---CCCCCeEEEEEEcC-----CCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            99997   99999999998753     11578999999984 88776543   459999999999999999999999999


Q ss_pred             eeccCCCCcEEEeeCCCEEEeecCCcccccCCC-ccccccccccccchhhhhcCC---CCCcchHHHHHHHHHHHHhcCC
Q psy2676         155 IHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLG---YGTPVDIWSIGCVMAEMWRLVP  230 (321)
Q Consensus       155 ~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~  230 (321)
                      +|+||||+||+++.++.+||+|||++....... ......+|+.|+|||++.+..   .+.++||||||+++|+|++|..
T Consensus       159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  238 (298)
T 2zv2_A          159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC  238 (298)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             eccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            999999999999999999999999998765433 234567899999999997765   3678999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         231 LFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ||...........+.......  +.                       ...+++++.+||.+||+.||.+|||+.++++|
T Consensus       239 pf~~~~~~~~~~~~~~~~~~~--~~-----------------------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          239 PFMDERIMCLHSKIKSQALEF--PD-----------------------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SSCCSSHHHHHHHHHHCCCCC--CS-----------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CCCCccHHHHHHHHhcccCCC--CC-----------------------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            998877666555444321111  10                       12466899999999999999999999999999


Q ss_pred             CCCCC
Q psy2676         311 PYFKE  315 (321)
Q Consensus       311 ~~f~~  315 (321)
                      |||+.
T Consensus       294 p~~~~  298 (298)
T 2zv2_A          294 PWVTR  298 (298)
T ss_dssp             HHHHC
T ss_pred             ccccC
Confidence            99963

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.7e-51  Score=355.39  Aligned_cols=263  Identities=24%  Similarity=0.378  Sum_probs=214.8

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      ....++|++++.||+|+||+||+|++ ..+++.||+|++....... .....+..|..++  +..+.||||+++++++.+
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~-~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~l--l~~~~hp~Iv~l~~~~~~  110 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL--LKNVKHPFLVGLHFSFQT  110 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEE-TTTCCEEEEEEEEGGGBC-------------CC--BCCCCCTTBCCEEEEEEC
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEE-cCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHH--HHhCCCCCCCCEEEEEEe
Confidence            34567999999999999999999999 6889999999997654322 2233444555542  233349999999999988


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ..+|+||||+.| +|.+++..  ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+
T Consensus       111 ~-------~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~  181 (373)
T 2r5t_A          111 A-------DKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLT  181 (373)
T ss_dssp             S-------SEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             C-------CEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEe
Confidence            7       789999999985 99999987  3458999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccc-CCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         176 DFGLAKTFD-YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       176 dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      |||++.... .........||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....+.....     
T Consensus       182 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-----  256 (373)
T 2r5t_A          182 DFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-----  256 (373)
T ss_dssp             CCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC-----
T ss_pred             eCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-----
Confidence            999997643 23344567899999999999999999999999999999999999999998888777776665311     


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH----HHHhCCCCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA----ADALEHPYFKEKENE  319 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~h~~f~~~~~~  319 (321)
                      .+                      ...++..+.+||++||+.||.+||++    .++++||||++.+|+
T Consensus       257 ~~----------------------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~  303 (373)
T 2r5t_A          257 QL----------------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD  303 (373)
T ss_dssp             CC----------------------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred             CC----------------------CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence            11                      12456889999999999999999987    699999999998875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.4e-51  Score=364.44  Aligned_cols=263  Identities=25%  Similarity=0.398  Sum_probs=214.0

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ..+..++|++++.||+|+||.||+|++ ..+++.||+|++..... .......+.+|+.+++.+.   ||||+++++++.
T Consensus       143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~l~~~~~  218 (446)
T 4ejn_A          143 HRVTMNEFEYLKLLGKGTFGKVILVKE-KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFLTALKYSFQ  218 (446)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEHHHHC-------------CCCCCS---CTTSCCEEEEEE
T ss_pred             cCCChHHcEEeEEEeeCcCEEEEEEEE-cCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC---CCeEeeEEEEEe
Confidence            345568899999999999999999999 68899999999976422 2223345567777777776   999999999998


Q ss_pred             ccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeeCCCEE
Q psy2676          96 QNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      +.       ..+++||||+++ +|.+++...  ..+++..++.++.||+.||.|||+ .|++||||||+||+++.++.+|
T Consensus       219 ~~-------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~k  289 (446)
T 4ejn_A          219 TH-------DRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIK  289 (446)
T ss_dssp             ET-------TEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEE
T ss_pred             eC-------CEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEE
Confidence            77       678999999985 999999773  458999999999999999999998 9999999999999999999999


Q ss_pred             EeecCCcccccC-CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         174 IADFGLAKTFDY-DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       174 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |+|||++..... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+......  
T Consensus       290 l~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--  367 (446)
T 4ejn_A          290 ITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--  367 (446)
T ss_dssp             ECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--
T ss_pred             EccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC--
Confidence            999999876432 23345567899999999999999999999999999999999999999988877776666542111  


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                         ++                      ..+++++.+||.+||+.||.+||     +++++++||||++.+|+
T Consensus       368 ---~p----------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          368 ---FP----------------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             ---CC----------------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ---CC----------------------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence               11                      24568999999999999999999     99999999999998764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.2e-51  Score=348.32  Aligned_cols=252  Identities=24%  Similarity=0.303  Sum_probs=187.1

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHH--HHHhcccCCCCceeEEEeeeecccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS--ILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~--~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      .+|.+.+.||+|+||+||+|++   +++.||||+++...     ......|.+  .+.+++   ||||+++++++.... 
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~---~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~---HpNIv~l~g~~~~~~-   70 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLR---HENILGFIAADNKDN-   70 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE---TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCC---CTTBCCEEEEEEEEC-
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCC---CCCCCcEEEEEEecC-
Confidence            5799999999999999999976   58899999986432     123333433  334455   999999999987651 


Q ss_pred             ccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCcEEEeeCC
Q psy2676         100 SDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH--------RIIHRDLKPQNLLITRAG  170 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~--------~~~H~di~p~Nilv~~~~  170 (321)
                        .....+++||||++ |+|.+++...   .++++.+..++.|++.||+|||++        +|+||||||+|||++.++
T Consensus        71 --~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~  145 (303)
T 3hmm_A           71 --GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  145 (303)
T ss_dssp             --SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             --CCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC
Confidence              22246899999999 6999999873   389999999999999999999987        999999999999999999


Q ss_pred             CEEEeecCCcccccCCCc-----cccccccccccchhhhhcCC------CCCcchHHHHHHHHHHHHhcCCCCCCCCh--
Q psy2676         171 GLKIADFGLAKTFDYDMM-----LTSVVVTLWYRAPEILLNLG------YGTPVDIWSIGCVMAEMWRLVPLFCASTE--  237 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g~~pf~~~~~--  237 (321)
                      ++||+|||++........     .....||+.|+|||++.+..      ++.++|||||||++|||+||.+||.....  
T Consensus       146 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~  225 (303)
T 3hmm_A          146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  225 (303)
T ss_dssp             CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred             CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc
Confidence            999999999976654332     22357999999999997652      56789999999999999999887743221  


Q ss_pred             ------------HHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHH
Q psy2676         238 ------------VEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA  305 (321)
Q Consensus       238 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  305 (321)
                                  .+......  ......+..|..                 ....++++.+.+|+.+||+.||++|||+.
T Consensus       226 ~p~~~~~~~~~~~~~~~~~~--~~~~~rp~~p~~-----------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~  286 (303)
T 3hmm_A          226 LPYYDLVPSDPSVEEMRKVV--CEQKLRPNIPNR-----------------WQSCEALRVMAKIMRECWYANGAARLTAL  286 (303)
T ss_dssp             CTTTTTSCSSCCHHHHHHHH--TTSCCCCCCCGG-----------------GGSSHHHHHHHHHHHTTCCSSGGGSCCHH
T ss_pred             ccchhcccccchHHHHHHHH--hcccCCCCCCcc-----------------ccchHHHHHHHHHHHHHcccCHhHCcCHH
Confidence                        11111110  000000111110                 00123446789999999999999999999


Q ss_pred             HHhC
Q psy2676         306 DALE  309 (321)
Q Consensus       306 ~ll~  309 (321)
                      +|++
T Consensus       287 ei~~  290 (303)
T 3hmm_A          287 RIKK  290 (303)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9985

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.2e-51  Score=342.01  Aligned_cols=258  Identities=31%  Similarity=0.472  Sum_probs=221.3

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.+.||+|+||+||+|.+ ..++..+++|++......  ....+.+|+.++++++   ||||+++++++.+.  
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~--   78 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQ-KGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLD---HPNIIRLYETFEDN--   78 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCC---CTTBCCEEEEEECS--
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEe-CCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCC---CCCEeeEEEEEecC--
Confidence            457899999999999999999999 678889999998764332  3457788999999997   99999999999877  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---eeCCCEEEe
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIA  175 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv---~~~~~~kl~  175 (321)
                           ...++|||++.+ +|.+++..  ...+++..++.++.|++.||.+||++|++|+||+|+||++   +.++.++|+
T Consensus        79 -----~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~  151 (277)
T 3f3z_A           79 -----TDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLI  151 (277)
T ss_dssp             -----SEEEEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             -----CeEEEEEeccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEE
Confidence                 678999999985 99999877  3448999999999999999999999999999999999999   778899999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      |||.+.............+++.|+|||++.+. ++.++||||||+++|+|++|..||......+....+.......+.  
T Consensus       152 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  228 (277)
T 3f3z_A          152 DFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE--  228 (277)
T ss_dssp             CCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH--
T ss_pred             ecccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc--
Confidence            99999887766666677899999999998664 899999999999999999999999988877776666543221111  


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                                           .....+++.+.++|++||+.||.+|||+.++++||||++.
T Consensus       229 ---------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          229 ---------------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             ---------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             ---------------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence                                 1123567899999999999999999999999999999854

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.4e-51  Score=370.02  Aligned_cols=265  Identities=30%  Similarity=0.519  Sum_probs=226.8

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ......++|++.+.||+|+||+||+|++ ..+++.||+|++...... ......+.+|+.++++++   ||||+++++++
T Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~   95 (484)
T 3nyv_A           20 STAIFSDRYKGQRVLGKGSFGEVILCKD-KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD---HPNIMKLYEFF   95 (484)
T ss_dssp             CCCCHHHHEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC---CTTBCCEEEEE
T ss_pred             CCCcccCceEEeeEEecCCCEEEEEEEE-CCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC---CCCCCcEEEEE
Confidence            3445568999999999999999999999 678999999999765332 233456788999999997   99999999999


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---eeCC
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI---TRAG  170 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv---~~~~  170 (321)
                      .+.       ...++|+|++. ++|.+.+...  ..+++..++.++.||+.||.|||++|++||||||+||++   +.++
T Consensus        96 ~~~-------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~  166 (484)
T 3nyv_A           96 EDK-------GYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDA  166 (484)
T ss_dssp             ECS-------SEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC
T ss_pred             EeC-------CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCC
Confidence            877       78899999998 5999999874  459999999999999999999999999999999999999   4678


Q ss_pred             CEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCC
Q psy2676         171 GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      .+||+|||++.............+|+.|+|||++.+ .++.++||||+|+++|+|++|..||.+.+..+....+......
T Consensus       167 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  245 (484)
T 3nyv_A          167 NIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT  245 (484)
T ss_dssp             CEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             cEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence            899999999988776666666789999999999876 6899999999999999999999999998888877777654322


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ...+.                       ...+++.+.+||++||..||.+|||+.++|+||||+...
T Consensus       246 ~~~~~-----------------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          246 FELPQ-----------------------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             CCSGG-----------------------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             CCCcc-----------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            22221                       235678999999999999999999999999999998654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.3e-50  Score=352.21  Aligned_cols=292  Identities=29%  Similarity=0.451  Sum_probs=219.6

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      .-++|++.+.||+|+||+||+|++ ..+++.||+|++...   ........+++..++.+.   ||||+++++++.....
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~~~~l~~l~---h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKE-KSTGMSVAIKKVIQD---PRFRNRELQIMQDLAVLH---HPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHTTEEEC----------CEEEEE-TTTCCEEEEEEEECC---TTCCCHHHHHHHHHHHHC---CTTBCCEEEEEEEECS
T ss_pred             hccceEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEEecC---ccccHHHHHHHHHHHhcC---CCCcccHHHhhhcccc
Confidence            346899999999999999999999 678999999988643   223345666777777776   9999999999976533


Q ss_pred             ccccceEEEEEeccCccCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCcEEEee-CCCEEE
Q psy2676         100 SDERYLTVYLIFEHVDQDLGSYMEK--CPPPGLSASKVKELTRQMLKGVDFLH--SHRIIHRDLKPQNLLITR-AGGLKI  174 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~l~~~l~~lh--~~~~~H~di~p~Nilv~~-~~~~kl  174 (321)
                      ........++|||+++++|...+..  .....+++..++.++.|++.||.+||  +.|++|+||||+||+++. ++.+||
T Consensus        94 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             SCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred             ccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence            3344456899999999987766543  23455899999999999999999999  999999999999999997 899999


Q ss_pred             eecCCcccccCCCccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       175 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      +|||++.............+|+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+.......+....+.++.
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (360)
T 3e3p_A          174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR  253 (360)
T ss_dssp             CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence            9999998877666666677899999999987655 899999999999999999999999999999999999888776654


Q ss_pred             CCcchhhhhhh-hhhhhhhhh----hhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         254 NEWPENISLMW-SSFEQYSKV----AFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       254 ~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ..+........ .........    .........++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            32211100000 000000000    111112235688999999999999999999999999999997743

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9.7e-51  Score=366.59  Aligned_cols=259  Identities=33%  Similarity=0.539  Sum_probs=218.5

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++++.||+|+||+||+|++ ..++..+|+|++............+.+|+.+++.+.   ||||+++++++.+.  
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~--  108 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRD-KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD---HPNIMKLYDFFEDK--  108 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEE-TTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCC---CTTBCCEEEEEECS--
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEE-CCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCC---CCCCCeEEEEEEeC--
Confidence            345899999999999999999999 678999999999876555555667889999999997   99999999999877  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC---CCEEEe
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIA  175 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~---~~~kl~  175 (321)
                           ...++||||+.| +|.+.+...  ..+++..++.++.||+.||.|||++|++||||||+||+++.+   +.+||+
T Consensus       109 -----~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  181 (494)
T 3lij_A          109 -----RNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIV  181 (494)
T ss_dssp             -----SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             -----CEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEE
Confidence                 678999999985 999988773  448999999999999999999999999999999999999764   449999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      |||++.............+|+.|+|||++. ..++.++||||+|+++|+|++|..||.+.+..+....+.......+.+.
T Consensus       182 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  260 (494)
T 3lij_A          182 DFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE  260 (494)
T ss_dssp             CCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG
T ss_pred             ECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh
Confidence            999998877666666778999999999886 4689999999999999999999999999888887777766433322222


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                                             ...+++.+.+||++||+.||.+|||+.++|+||||++
T Consensus       261 -----------------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          261 -----------------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             -----------------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             -----------------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence                                   2356789999999999999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.5e-51  Score=355.02  Aligned_cols=286  Identities=37%  Similarity=0.623  Sum_probs=227.8

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|.+.+.||+|+||+||+|.+ ..+++.||+|++............+.+|+.+++.++   ||||+++++++......
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~  116 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAID-KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ---HENVIGLLDVFTPASSL  116 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC---CTTBCCCSEEECSCSSS
T ss_pred             cccEEEEeEEecCCCeEEEEEEE-CCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC---CCCchhhhhheeccCCc
Confidence            36999999999999999999999 688999999999754333323446678999999998   99999999999765211


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                       ......++|+|++.++|.+.+..    .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+
T Consensus       117 -~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          117 -RNFYDFYLVMPFMQTDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             -TTCCCCEEEEECCCEEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             -ccceeEEEEEccccccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence             12234599999999999888743    3899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         181 KTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ......  .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+....+.++...+...
T Consensus       192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (371)
T 4exu_A          192 RHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  269 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             cccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence            765433  344577999999999987 67899999999999999999999999999999999999888877654322211


Q ss_pred             hhhh----hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         260 ISLM----WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       260 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ....    .....+............+++.+.+||++||+.||.+|||+.++++||||++..
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence            1100    111111122233444557789999999999999999999999999999999763

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.6e-51  Score=352.72  Aligned_cols=262  Identities=27%  Similarity=0.419  Sum_probs=215.6

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC---CCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE---DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      ..++|++.+.||+|+||+||+|++ ..+++.||+|++......   ......+.+|+.++++++   ||||+++++++.+
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~   97 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCIN-RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK---HPHIVELLETYSS   97 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC---CTTBCCEEEEEEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEE-CCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC---CCCCCcEEEEEEe
Confidence            347899999999999999999999 688999999998754221   123456789999999998   9999999999987


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC--
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCP--PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG--  171 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~--  171 (321)
                      .       ..+++|||++. ++|.+.+....  ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.  
T Consensus        98 ~-------~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~  170 (351)
T 3c0i_A           98 D-------GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSA  170 (351)
T ss_dssp             T-------TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTC
T ss_pred             C-------CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCC
Confidence            7       67899999999 59988776432  234899999999999999999999999999999999999987665  


Q ss_pred             -EEEeecCCcccccCCCc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhC
Q psy2676         172 -LKIADFGLAKTFDYDMM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       172 -~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                       +||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.. .+....+.....
T Consensus       171 ~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~  249 (351)
T 3c0i_A          171 PVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKY  249 (351)
T ss_dssp             CEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCC
T ss_pred             cEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCC
Confidence             99999999987764432 345678999999999999999999999999999999999999997743 333333332111


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ..                       .......+++++.+||++||..||.+|||+.++++||||++.
T Consensus       250 ~~-----------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          250 KM-----------------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             CC-----------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             CC-----------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            00                       011223577899999999999999999999999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.2e-51  Score=359.91  Aligned_cols=287  Identities=29%  Similarity=0.476  Sum_probs=226.4

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ..+|++.+.||+|+||+||+|++ ..+++.||+|++...      .....+|+++++.++   ||||+++++++.... .
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~~vaiK~~~~~------~~~~~~E~~il~~l~---hpniv~l~~~~~~~~-~  121 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKKVLQD------KRFKNRELQIMRKLD---HCNIVRLRYFFYSSG-E  121 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEECC------TTSCCHHHHHHHTCC---CTTBCCEEEEEEEEE-T
T ss_pred             cceEEeeeEEeeCCCEEEEEEEE-CCCCcEEEEEEeccc------chhHHHHHHHHHHcC---CCCccceeeEEeccC-C
Confidence            34799999999999999999999 578999999998643      123457999999998   999999999986541 1


Q ss_pred             cccceEEEEEeccCccCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC-CCEEEeec
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEK--CPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA-GGLKIADF  177 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~-~~~kl~df  177 (321)
                      ......+++|+||++++|.+.+..  .....+++..++.++.||+.||.|||++|++||||||+||+++.+ +.+||+||
T Consensus       122 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          122 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             TTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccc
Confidence            222356789999999988777653  223459999999999999999999999999999999999999965 56899999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      |++.............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+
T Consensus       202 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          202 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             TTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            999877655555567789999999999765 6899999999999999999999999999999999999888877654332


Q ss_pred             chhhhhhh-hhhhhhhhhhhh-hhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         257 PENISLMW-SSFEQYSKVAFS-AIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       257 ~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ........ -.+.+....... .....+++++.+||++||..||.+|||+.|+++||||++..+
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence            21100000 000000011111 122356789999999999999999999999999999987643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.2e-51  Score=346.56  Aligned_cols=264  Identities=24%  Similarity=0.404  Sum_probs=198.3

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +++..++|++++.||+|+||+||+|++ ..+++.||+|++..............++...++.+.   ||||+++++++.+
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~---h~~iv~~~~~~~~   77 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRH-VPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD---CPFTVTFYGALFR   77 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCC---CTTBCCEEEEEEC
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEe-cCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCC---CCeEEEEeeeeec
Confidence            567889999999999999999999999 678999999998754222211112223333344444   9999999999987


Q ss_pred             cccccccceEEEEEeccCccCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeeCCCEE
Q psy2676          97 NILSDERYLTVYLIFEHVDQDLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~-~~~H~di~p~Nilv~~~~~~k  173 (321)
                      .       ...++|||+++|+|.+++...  ....+++..++.++.||+.||.+||++ |++|+||||+||+++.++.++
T Consensus        78 ~-------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~k  150 (290)
T 3fme_A           78 E-------GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVK  150 (290)
T ss_dssp             S-------SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEE
T ss_pred             c-------CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEE
Confidence            6       678999999999988877542  234599999999999999999999998 999999999999999999999


Q ss_pred             EeecCCcccccCCCccccccccccccchhhh----hcCCCCCcchHHHHHHHHHHHHhcCCCCCCC-ChHHHHHHHHHHh
Q psy2676         174 IADFGLAKTFDYDMMLTSVVVTLWYRAPEIL----LNLGYGTPVDIWSIGCVMAEMWRLVPLFCAS-TEVEQLKCIFRVI  248 (321)
Q Consensus       174 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~  248 (321)
                      |+|||.+.............+++.|+|||++    .+..++.++||||+|+++|+|++|..||... .............
T Consensus       151 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  230 (290)
T 3fme_A          151 MCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP  230 (290)
T ss_dssp             BCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC
T ss_pred             EeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC
Confidence            9999999877655555556789999999996    4556889999999999999999999999763 3334333333321


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .... .                        ...+++++.++|.+||+.||.+|||+.++++||||+..
T Consensus       231 ~~~~-~------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          231 SPQL-P------------------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             CCCC-C------------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCCc-c------------------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            1111 0                        12456889999999999999999999999999999753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-50  Score=339.40  Aligned_cols=260  Identities=30%  Similarity=0.435  Sum_probs=210.4

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ...++|++.+.||+|+||+||+|++ ..++..+++|++..... ......+.+|+.++++++   ||||+++++++.+. 
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~-   92 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEE-RSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLD---HPNIIKIFEVFEDY-   92 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCC---CTTBCCEEEEEECS-
T ss_pred             ChhhheeecceeccCCCeEEEEEEE-ccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCC---CchHHhHHHheecC-
Confidence            3457999999999999999999999 67899999999876532 223457788999999997   99999999999776 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---eeCCCE
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGL  172 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv---~~~~~~  172 (321)
                            ...++|||++.+ +|.+++...  ....+++..++.++.||+.||.+||+.|++|+||||+||++   +.++.+
T Consensus        93 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~  166 (285)
T 3is5_A           93 ------HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPI  166 (285)
T ss_dssp             ------SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCE
T ss_pred             ------CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCE
Confidence                  678999999985 999988543  13459999999999999999999999999999999999999   445789


Q ss_pred             EEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         173 KIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      +|+|||++.............+++.|+|||++. ..++.++||||||+++|+|++|..||.+....+.............
T Consensus       167 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (285)
T 3is5_A          167 KIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA  245 (285)
T ss_dssp             EECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             EEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc
Confidence            999999998776555556677899999999875 4678999999999999999999999988776665554433211111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      ..                        ...+++.+.+||++||+.||.+|||+.|+++||||++
T Consensus       246 ~~------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          246 VE------------------------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             C--------------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             cc------------------------cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            00                        1135688999999999999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1e-49  Score=337.57  Aligned_cols=269  Identities=28%  Similarity=0.444  Sum_probs=222.8

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC-------CCchhHHHHHHHHhcccCCCCceeEE
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG-------IPMSTLREISILKQLDTFEHPNIVRF   90 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~i~~~   90 (321)
                      ....++|++.+.||+|++|.||+|++ ..+++.||+|++........       ....+.+|+.+++++..  ||||+++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~--h~~i~~~   89 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIH-KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG--HPNIIQL   89 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTT--CTTBCCE
T ss_pred             cchhhccceeeeecCCCceEEEEEEE-cCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcC--CCCEeee
Confidence            34568999999999999999999999 67899999999976432211       12345678999999863  9999999


Q ss_pred             EeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA  169 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~  169 (321)
                      ++++...       ...++|+|+++ ++|.+++...  ..+++..++.++.||+.||.+||++|++|+||+|+||+++.+
T Consensus        90 ~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~  160 (298)
T 1phk_A           90 KDTYETN-------TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD  160 (298)
T ss_dssp             EEEEECS-------SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred             eeeeccC-------CeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC
Confidence            9999776       68899999998 5999999873  458999999999999999999999999999999999999999


Q ss_pred             CCEEEeecCCcccccCCCccccccccccccchhhhh------cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHH
Q psy2676         170 GGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL------NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKC  243 (321)
Q Consensus       170 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  243 (321)
                      +.++|+|||.+.............+++.|+|||++.      ...++.++||||||+++++|++|..||...+.......
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  240 (298)
T 1phk_A          161 MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM  240 (298)
T ss_dssp             CCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH
Confidence            999999999998776655556677899999999985      34578899999999999999999999988877776666


Q ss_pred             HHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCCCC
Q psy2676         244 IFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEPL  321 (321)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~~~  321 (321)
                      +.......+...                       ...++..+.++|.+||..||.+|||+.++++||||++..++.+
T Consensus       241 ~~~~~~~~~~~~-----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  295 (298)
T 1phk_A          241 IMSGNYQFGSPE-----------------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV  295 (298)
T ss_dssp             HHHTCCCCCTTT-----------------------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC----
T ss_pred             HhcCCcccCccc-----------------------ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhh
Confidence            555332222111                       1356789999999999999999999999999999999877643

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.1e-50  Score=346.99  Aligned_cols=292  Identities=36%  Similarity=0.595  Sum_probs=231.4

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      .....++|++.+.||+|+||+||+|++ ..+++.||+|++.... .......+.+|+.++++++   ||||+++++++..
T Consensus         6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~   80 (353)
T 2b9h_A            6 VYNISSDFQLKSLLGEGAYGVVCSATH-KPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFK---HENIITIFNIQRP   80 (353)
T ss_dssp             CCCSCTTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCC---CTTBCCEEEECCC
T ss_pred             ccccccceEEeeEEcCCCCeEEEEEEE-CCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCc---CCCcCCeeeeecc
Confidence            344568999999999999999999999 6789999999985321 1112235568999999997   9999999998765


Q ss_pred             cccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          97 NILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                      ..  .......++|+|++.++|.+++..   ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|
T Consensus        81 ~~--~~~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~D  155 (353)
T 2b9h_A           81 DS--FENFNEVYIIQELMQTDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCD  155 (353)
T ss_dssp             SC--STTCCCEEEEECCCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECC
T ss_pred             cc--cCccceEEEEEeccCccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEe
Confidence            41  222356899999999999999987   3489999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCc-----------cccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q psy2676         177 FGLAKTFDYDMM-----------LTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI  244 (321)
Q Consensus       177 fg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  244 (321)
                      ||++........           .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+
T Consensus       156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  235 (353)
T 2b9h_A          156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI  235 (353)
T ss_dssp             CTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence            999987643221           122467899999998865 66899999999999999999999999999988888888


Q ss_pred             HHHhCCCCCCCcchhhhh-----hhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         245 FRVIGTPSMNEWPENISL-----MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ....+.+...........     ...................+++++.+||++||..||.+|||+.++++||||++..+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence            888877664432211100     00111111122233445578899999999999999999999999999999998754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.7e-50  Score=365.82  Aligned_cols=263  Identities=29%  Similarity=0.490  Sum_probs=220.6

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-----------CCCchhHHHHHHHHhcccCCCCc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-----------GIPMSTLREISILKQLDTFEHPN   86 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~~~~   86 (321)
                      ....++|++++.||+|+||+||+|++ ..+++.+|+|++.......           .....+.+|+.++++++   |||
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpn  107 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKE-KNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD---HPN  107 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEE-TTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC---CTT
T ss_pred             CCcccceEEEeEecccCCeEEEEEEE-CCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC---CCC
Confidence            34568899999999999999999999 6889999999997653221           22346778999999997   999


Q ss_pred             eeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q psy2676          87 IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLL  165 (321)
Q Consensus        87 i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nil  165 (321)
                      |+++++++.+.       ..+++|||++.| +|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+
T Consensus       108 iv~~~~~~~~~-------~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil  178 (504)
T 3q5i_A          108 IIKLFDVFEDK-------KYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL  178 (504)
T ss_dssp             BCCEEEEEECS-------SEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             CCeEEEEEEcC-------CEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEE
Confidence            99999999877       788999999985 999998773  45999999999999999999999999999999999999


Q ss_pred             EeeCC---CEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHH
Q psy2676         166 ITRAG---GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLK  242 (321)
Q Consensus       166 v~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  242 (321)
                      ++.++   .+||+|||++.............+|+.|+|||++. ..++.++||||+|+++|+|++|..||.+.+..+...
T Consensus       179 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  257 (504)
T 3q5i_A          179 LENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK  257 (504)
T ss_dssp             ESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            98776   69999999998877666666778999999999987 468999999999999999999999999988887777


Q ss_pred             HHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      .+.......+.                       .....+++++.+||++||.+||.+|||+.++|+||||++..
T Consensus       258 ~i~~~~~~~~~-----------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          258 KVEKGKYYFDF-----------------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HHHHCCCCCCH-----------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             HHHcCCCCCCc-----------------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            76653211110                       11245779999999999999999999999999999998653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-50  Score=344.11  Aligned_cols=280  Identities=25%  Similarity=0.436  Sum_probs=219.1

Q ss_pred             cccccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCc
Q psy2676           7 DTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN   86 (321)
Q Consensus         7 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   86 (321)
                      .++..+....+....++|++++.||+|+||+||+|++ ..+++.|++|++....   .....+.+|+.+++++..  |||
T Consensus         9 ~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~--h~~   82 (326)
T 2x7f_A            9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRH-VKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSH--HRN   82 (326)
T ss_dssp             -------CCCCCCCTTTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCC--STT
T ss_pred             CcchhccchhccCCCCcEEEEEEeccCCCEEEEEEEE-CCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccC--CCC
Confidence            3456677788888999999999999999999999999 5788999999987532   234578899999999843  999


Q ss_pred             eeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q psy2676          87 IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLL  165 (321)
Q Consensus        87 i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nil  165 (321)
                      |+++++++..... .......++|||++++ +|.+++.......+++..++.++.||+.||.+||+.|++|+||+|+||+
T Consensus        83 i~~~~~~~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl  161 (326)
T 2x7f_A           83 IATYYGAFIKKNP-PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL  161 (326)
T ss_dssp             BCCEEEEEEECC---CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred             eeeeeeEEeeccC-ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEE
Confidence            9999999976421 1112578999999985 9999998865566999999999999999999999999999999999999


Q ss_pred             EeeCCCEEEeecCCcccccCCC-ccccccccccccchhhhh-----cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHH
Q psy2676         166 ITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAPEILL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE  239 (321)
Q Consensus       166 v~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  239 (321)
                      ++.++.++|+|||++....... ......+++.|+|||++.     +..++.++||||||+++|+|++|..||.......
T Consensus       162 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  241 (326)
T 2x7f_A          162 LTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR  241 (326)
T ss_dssp             ECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             EcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence            9999999999999987664332 234457899999999987     4568999999999999999999999998877666


Q ss_pred             HHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         240 QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ....+........                         ....++..+.+||++||..||.+|||+.++++||||++.++
T Consensus       242 ~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          242 ALFLIPRNPAPRL-------------------------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             HHHHHHHSCCCCC-------------------------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             HHHHhhcCccccC-------------------------CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            5544433211100                         01245689999999999999999999999999999998754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-50  Score=348.36  Aligned_cols=263  Identities=29%  Similarity=0.451  Sum_probs=209.1

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      .+++.+++|++++.||+|+||+||++.+  .+++.||+|++............+.+|+.+++++.. .||||+++++++.
T Consensus         3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~~~iv~~~~~~~   79 (343)
T 3dbq_A            3 CISVKGRIYSILKQIGSGGSSKVFQVLN--EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDKIIRLYDYEI   79 (343)
T ss_dssp             CEESSSCEEEEEEEESCCSSEEEEEEEC--TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEE
T ss_pred             eeeeecCEEEEEEEEecCCCeEEEEEEe--CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhh-cCCceEEEeeeEe
Confidence            4567889999999999999999999987  468899999987653333233467789999999982 1299999999998


Q ss_pred             ccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          96 QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      +.       ..+++|||+.+++|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+++ ++.+||+
T Consensus        80 ~~-------~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~  149 (343)
T 3dbq_A           80 TD-------QYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLI  149 (343)
T ss_dssp             CS-------SEEEEEECCCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEEC
T ss_pred             eC-------CEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEe
Confidence            77       688999997778999999884  4589999999999999999999999999999999999996 7889999


Q ss_pred             ecCCcccccCCCc---cccccccccccchhhhhc-----------CCCCCcchHHHHHHHHHHHHhcCCCCCCCChH-HH
Q psy2676         176 DFGLAKTFDYDMM---LTSVVVTLWYRAPEILLN-----------LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV-EQ  240 (321)
Q Consensus       176 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~  240 (321)
                      |||++........   .....||+.|+|||++.+           ..++.++||||||+++|+|++|..||...... ..
T Consensus       150 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  229 (343)
T 3dbq_A          150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK  229 (343)
T ss_dssp             CCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred             ecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH
Confidence            9999987653322   335678999999999975           56788999999999999999999999764332 22


Q ss_pred             HHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         241 LKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ...+   ........++                      ...+.++.+||.+||..||.+|||+.++++||||+..
T Consensus       230 ~~~~---~~~~~~~~~~----------------------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          230 LHAI---IDPNHEIEFP----------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             HHHH---HCTTSCCCCC----------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             HHHH---hcCCcccCCc----------------------ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            2222   2222222222                      1234789999999999999999999999999999753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-50  Score=359.93  Aligned_cols=259  Identities=30%  Similarity=0.431  Sum_probs=221.9

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      ....++|.+.+.||+|+||+||+|++ ..+++.||+|++..... .......+.+|+.+++.++   ||||+++++++..
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~   87 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKH-ELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR---HPHIIKLYQVIST   87 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEE-TTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC---CTTBCCEEEEEEC
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC---CCCCCcEEEEEEE
Confidence            34457899999999999999999999 67899999999976422 2223446778999999887   9999999999987


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ..+++|||++. |+|.+++..  .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+
T Consensus        88 ~-------~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~  158 (476)
T 2y94_A           88 P-------SDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIA  158 (476)
T ss_dssp             S-------SEEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             C-------CEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEE
Confidence            7       67899999997 599999976  4459999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCCC-CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      |||++.............|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.......   
T Consensus       159 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---  235 (476)
T 2y94_A          159 DFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT---  235 (476)
T ss_dssp             CCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC---
T ss_pred             eccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC---
Confidence            9999988765555566789999999999988775 689999999999999999999999887776666655432111   


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                                              ...+++++.+||++||..||.+|||+.++++||||++.
T Consensus       236 ------------------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          236 ------------------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             ------------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             ------------------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                                    11345889999999999999999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.8e-50  Score=339.12  Aligned_cols=260  Identities=31%  Similarity=0.443  Sum_probs=217.0

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +...++|++.+.||+|++|+||+|.+ ..++..+++|++...... ......+.+|+.+++++.   ||||+++++++.+
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~   80 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLARE-KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR---HPNILRLYGYFHD   80 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC---CTTBCCEEEEEEC
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEE-ccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC---CCCCcchhheEec
Confidence            44568999999999999999999999 688899999998654222 223446778999998888   9999999999987


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ...++|||+++ ++|.+++...  ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+
T Consensus        81 ~-------~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~  151 (279)
T 3fdn_A           81 A-------TRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIA  151 (279)
T ss_dssp             S-------SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEEC
T ss_pred             C-------CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEE
Confidence            7       67899999999 4999999874  448999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      |||++...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.......    
T Consensus       152 Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----  226 (279)
T 3fdn_A          152 DFGWSVHAPSS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----  226 (279)
T ss_dssp             SCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC----
T ss_pred             eccccccCCcc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCC----
Confidence            99988655433 2345578999999999999999999999999999999999999999887777666654422111    


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                                             ...+++.+.+||++||+.||.+|||+.++++||||++...
T Consensus       227 -----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          227 -----------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             -----------------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             -----------------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence                                   1134588999999999999999999999999999986543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-49  Score=341.89  Aligned_cols=281  Identities=28%  Similarity=0.510  Sum_probs=219.1

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++++.||+|+||+||+|++ ..+++.||+|+++..     ....+.+|+.+++++..  ||||+++++++.+..  
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~--~~~i~~~~~~~~~~~--  104 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAIN-ITNNEKVVVKILKPV-----KKKKIKREIKILENLRG--GPNIITLADIVKDPV--  104 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTT--STTBCCEEEEEECTT--
T ss_pred             CCceEEEEEecccCCeEEEEEEE-CCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCC--CCCEEEeeeeeccCC--
Confidence            47899999999999999999999 688999999998632     23578899999999974  999999999987631  


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC-CEEEeecC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFG  178 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~-~~kl~dfg  178 (321)
                         ....++|||++.+ +|.+++..     +++..++.++.||+.||.|||++|++|+||||+||+++.++ .++|+|||
T Consensus       105 ---~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg  176 (330)
T 3nsz_A          105 ---SRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG  176 (330)
T ss_dssp             ---TCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             ---CCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence               1567999999995 88888865     89999999999999999999999999999999999999777 79999999


Q ss_pred             CcccccCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCC-CChHHHHHHHHHHhCCCCCCCc
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCA-STEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      ++.............++..|+|||++.+ ..++.++||||||+++|+|++|..||.. ....+....+....+.+....+
T Consensus       177 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  256 (330)
T 3nsz_A          177 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY  256 (330)
T ss_dssp             TCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred             CceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence            9987766666666788999999999987 5689999999999999999999999954 4555555555444432111000


Q ss_pred             --------chhhhhh--hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         257 --------PENISLM--WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       257 --------~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                              +......  ......+...........+++++.+||++||++||.+|||++++|+||||++..++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  329 (330)
T ss_dssp             HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred             HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence                    0000000  00000011111112233478999999999999999999999999999999998765

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.2e-50  Score=347.21  Aligned_cols=254  Identities=28%  Similarity=0.430  Sum_probs=210.2

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++.+.||+|+||+||+|.+ ..+++.+|+|++....      ....+|++++.++..  ||||+++++++.+.   
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~~avK~~~~~~------~~~~~E~~~l~~~~~--hp~iv~~~~~~~~~---   88 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIH-KATNMEFAVKIIDKSK------RDPTEEIEILLRYGQ--HPNIITLKDVYDDG---   88 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEETTT------CCCHHHHHHHHHHTT--STTBCCEEEEEECS---
T ss_pred             cccEEEEEEEeeCCCEEEEEEEE-CCCCCEEEEEEEEccc------CChHHHHHHHHHhcC--CCCcCeEEEEEEcC---
Confidence            46899999999999999999999 6789999999997532      245678888888853  99999999999877   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC-C---CEEEe
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA-G---GLKIA  175 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~-~---~~kl~  175 (321)
                          ..+++|||++.| +|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||++..+ +   .+||+
T Consensus        89 ----~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~  162 (342)
T 2qr7_A           89 ----KYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRIC  162 (342)
T ss_dssp             ----SEEEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred             ----CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEE
Confidence                789999999985 999999873  459999999999999999999999999999999999998543 3   49999


Q ss_pred             ecCCcccccCC-CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCC---ChHHHHHHHHHHhCCC
Q psy2676         176 DFGLAKTFDYD-MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAS---TEVEQLKCIFRVIGTP  251 (321)
Q Consensus       176 dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~---~~~~~~~~~~~~~~~~  251 (321)
                      |||++...... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||...   ...+....+.......
T Consensus       163 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  242 (342)
T 2qr7_A          163 DFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL  242 (342)
T ss_dssp             CCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC
T ss_pred             ECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc
Confidence            99999876533 2344567899999999998888899999999999999999999999763   3344444443321111


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      +..                       ....+++++.+||++||..||.+|||+.++++||||.+
T Consensus       243 ~~~-----------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          243 SGG-----------------------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             CST-----------------------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             Ccc-----------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            111                       12356789999999999999999999999999999964

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.4e-50  Score=348.01  Aligned_cols=261  Identities=26%  Similarity=0.422  Sum_probs=217.6

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ...++|++++.||+|+||+||+|++ ..+++.||+|++....... .....+.+|+.++++++   ||||+++++++.+.
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~  126 (348)
T 1u5q_A           51 DPEKLFSDLREIGHGSFGAVYFARD-VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR---HPNTIQYRGCYLRE  126 (348)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC---CTTBCCEEEEEEET
T ss_pred             chhhheeeeeEEccCCCEEEEEEEE-ccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC---CCCEeeEEEEEEEC
Confidence            3446799999999999999999998 5789999999987542211 11235678999999997   99999999999877


Q ss_pred             ccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          98 ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                             ...++|||++.|+|.+++.... ..+++..++.++.|++.||.+||++|++|+||||+||+++.++.+||+||
T Consensus       127 -------~~~~lv~e~~~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Df  198 (348)
T 1u5q_A          127 -------HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF  198 (348)
T ss_dssp             -------TEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCC
T ss_pred             -------CeEEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeec
Confidence                   6789999999999998886543 34899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccccchhhhh---cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      |++......   ....+|+.|+|||++.   ...++.++||||||+++|+|++|..||...+.......+......... 
T Consensus       199 G~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-  274 (348)
T 1u5q_A          199 GSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ-  274 (348)
T ss_dssp             TTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC-
T ss_pred             cCceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-
Confidence            999765532   3457899999999985   456899999999999999999999999888776666555442211111 


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                                              ...+++.+.+||.+||+.||.+|||++++++||||......
T Consensus       275 ------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~  315 (348)
T 1u5q_A          275 ------------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  315 (348)
T ss_dssp             ------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             ------------------------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence                                    12456889999999999999999999999999999876543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2e-49  Score=338.98  Aligned_cols=255  Identities=26%  Similarity=0.476  Sum_probs=216.3

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      .|...+.||+|+||+||+|++ ..+++.||+|++....  ......+.+|+.++++++   ||||+++++++...     
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~-----  114 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLARE-KHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQ---HFNVVEMYKSYLVG-----  114 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCC---CTTBCCEEEEEEET-----
T ss_pred             hhhccEEeccCCCeEEEEEEE-CCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCC---CCCcceEEEEEEEC-----
Confidence            588999999999999999998 5789999999987542  223446778999998887   99999999999876     


Q ss_pred             cceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                        ...++||||+.+ +|.+++..   ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++.
T Consensus       115 --~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  189 (321)
T 2c30_A          115 --EELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCA  189 (321)
T ss_dssp             --TEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             --CEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeee
Confidence              678999999985 99998875   348999999999999999999999999999999999999999999999999988


Q ss_pred             cccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         182 TFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       182 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      ...... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+..... +...      
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~------  262 (321)
T 2c30_A          190 QISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLK------  262 (321)
T ss_dssp             ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCT------
T ss_pred             ecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCcC------
Confidence            765433 33456789999999999999999999999999999999999999988877766655543211 1100      


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                                       ....+++.+.++|.+||..||.+|||+.++++||||++..
T Consensus       263 -----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          263 -----------------NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             -----------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             -----------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence                             0124568899999999999999999999999999998653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.2e-51  Score=349.68  Aligned_cols=287  Identities=32%  Similarity=0.563  Sum_probs=221.0

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      .....++|++.+.||+|+||+||+|++ ..+++.||+|++............+.+|+.++++++   ||||+++++++.+
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~   95 (331)
T 4aaa_A           20 YFQSMEKYENLGLVGEGSYGMVMKCRN-KDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR---HENLVNLLEVCKK   95 (331)
T ss_dssp             CCBCGGGEEEEEEGGGGTTSSEEEEEE-TTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC---CTTBCCEEEEEEE
T ss_pred             hhhhhhhheeeeEEeecCCEEEEEEEE-CCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC---CCCEeeEEEEeec
Confidence            334557999999999999999999999 678999999998654333222344668999999998   9999999999987


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ...++|||++++ +|.++...  ...+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+
T Consensus        96 ~-------~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~  166 (331)
T 4aaa_A           96 K-------KRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLC  166 (331)
T ss_dssp             T-------TEEEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             C-------CEEEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEE
Confidence            7       678999999997 55555554  2349999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCC-ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         176 DFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       176 dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      |||.+....... ......+++.|+|||++.+. .++.++||||||+++|+|++|..||.+....+....+....+....
T Consensus       167 Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (331)
T 4aaa_A          167 DFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP  246 (331)
T ss_dssp             CCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             eCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence            999997664332 33456789999999999876 6899999999999999999999999999988888888777665432


Q ss_pred             CCcchhhhhh-h--hhhhh-hhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         254 NEWPENISLM-W--SSFEQ-YSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       254 ~~~~~~~~~~-~--~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .......... .  ..... ............+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            1110000000 0  00000 00111222334678999999999999999999999999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.8e-50  Score=348.06  Aligned_cols=259  Identities=30%  Similarity=0.522  Sum_probs=217.5

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC------CCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG------IPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ++|++.+.||+|++|+||+|++ ..+++.||+|++........      ....+.+|+.+++++..  ||||+++++++.
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~--hp~iv~~~~~~~  170 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVH-RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG--HPHIITLIDSYE  170 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTT--CTTBCCEEEEEE
T ss_pred             hhcccceEEecCCCEEEEEEEE-CCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcC--CCCEeEEEEEEe
Confidence            6799999999999999999998 57899999999876432111      12345679999999842  999999999997


Q ss_pred             ccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ..       ...++||||+.| +|.+++..  ...+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|
T Consensus       171 ~~-------~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          171 SS-------SFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             BS-------SEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred             eC-------CEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEE
Confidence            76       688999999995 99999986  345899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCccccccccccccchhhhhcC------CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHh
Q psy2676         175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL------GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       175 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      +|||++.............+|+.|+|||++.+.      .++.++||||||+++|+|++|..||...........+....
T Consensus       242 ~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~  321 (365)
T 2y7j_A          242 SDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ  321 (365)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             EecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence            999999887766556667899999999998643      47889999999999999999999998877766665554422


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      .....                       .....++..+.++|++||..||.+|||+.++++||||+.
T Consensus       322 ~~~~~-----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          322 YQFSS-----------------------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CCCCH-----------------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCC-----------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            11110                       112356788999999999999999999999999999974

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.5e-51  Score=342.09  Aligned_cols=262  Identities=27%  Similarity=0.461  Sum_probs=217.3

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC----CCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG----IPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ..++|++.+.||+|+||+||+|++ ..+++.+++|+++.......    ....+.+|+.+++++.   ||||+++++++.
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~   78 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQ-KGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR---HPNIITLHDIFE   78 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC---CTTBCCEEEEEE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEE-cCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC---CCCeeehhheec
Confidence            347899999999999999999999 57899999999976543322    2345778999999998   999999999998


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC----
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----  170 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~----  170 (321)
                      +.       ...++|+|++. ++|.+++..  ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++    
T Consensus        79 ~~-------~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~  149 (283)
T 3bhy_A           79 NK-------TDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNP  149 (283)
T ss_dssp             CS-------SEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSC
T ss_pred             CC-------CeEEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCC
Confidence            76       67899999997 599999977  34589999999999999999999999999999999999998877    


Q ss_pred             CEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCC
Q psy2676         171 GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      .++|+|||.+.............+++.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+......
T Consensus       150 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  229 (283)
T 3bhy_A          150 RIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD  229 (283)
T ss_dssp             CEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred             ceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC
Confidence            79999999998776555555667899999999999999999999999999999999999999887776655554322110


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                           .                  .......+++.+.++|++||..||.+|||+.++++||||++..
T Consensus       230 -----~------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          230 -----F------------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             -----C------------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             -----C------------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence                 0                  0112346678999999999999999999999999999998653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3e-50  Score=354.31  Aligned_cols=293  Identities=27%  Similarity=0.434  Sum_probs=225.6

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCC-----CCcee
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE-----HPNIV   88 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-----~~~i~   88 (321)
                      +...+...++|++.+.||+|+||+||+|++ ..+++.||+|++....   .....+.+|+.+++++....     |+||+
T Consensus        29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv  104 (397)
T 1wak_A           29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWD-IQGKKFVAMKVVKSAE---HYTETALDEIRLLKSVRNSDPNDPNREMVV  104 (397)
T ss_dssp             SCTTCEETTTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred             EehhhhcCCeEEEEEEeeecCCeeEEEEEe-cCCCeEEEEEEEecCC---cchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence            344455678999999999999999999999 6889999999986421   12346678999999986433     78899


Q ss_pred             EEEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEe
Q psy2676          89 RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLIT  167 (321)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-~~~H~di~p~Nilv~  167 (321)
                      ++++++...   .......++|||+++++|.+.+.......+++..++.++.||+.||.|||++ |++||||||+||+++
T Consensus       105 ~~~~~~~~~---~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~  181 (397)
T 1wak_A          105 QLLDDFKIS---GVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS  181 (397)
T ss_dssp             CEEEEEEEE---ETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEEC
T ss_pred             eeecceeec---CCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEe
Confidence            999998733   1122678999999999998888876656699999999999999999999998 999999999999998


Q ss_pred             eCC-------------------------------------------------CEEEeecCCcccccCCCccccccccccc
Q psy2676         168 RAG-------------------------------------------------GLKIADFGLAKTFDYDMMLTSVVVTLWY  198 (321)
Q Consensus       168 ~~~-------------------------------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y  198 (321)
                      .++                                                 .++|+|||.+......  .....+|+.|
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y  259 (397)
T 1wak_A          182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQY  259 (397)
T ss_dssp             CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGG
T ss_pred             ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcc
Confidence            775                                                 7999999999876533  3455789999


Q ss_pred             cchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCC------hHHHHHHHHHHhCCCCCCCcchhhhh--hh------
Q psy2676         199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST------EVEQLKCIFRVIGTPSMNEWPENISL--MW------  264 (321)
Q Consensus       199 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~--~~------  264 (321)
                      +|||++.+..++.++|||||||++|+|++|+.||...+      .......+....+.++...+......  ..      
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  339 (397)
T 1wak_A          260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL  339 (397)
T ss_dssp             CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred             cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence            99999999999999999999999999999999997654      45566667776665543211000000  00      


Q ss_pred             hhhhhhh-------hhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         265 SSFEQYS-------KVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       265 ~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      ..+....       ...........+..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            0000000       00001112345678999999999999999999999999999974

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.1e-50  Score=345.76  Aligned_cols=250  Identities=25%  Similarity=0.441  Sum_probs=213.9

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC------CCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG------IPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      .++|++.+.||+|+||+||+|++ ..+++.||+|++........      ....+.+|+.++++++   ||||+++++++
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~   98 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVD-KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE---HANIIKVLDIF   98 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEE-TTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC---CTTBCCEEEEE
T ss_pred             ccceEEEeEEEecCCEEEEEEEE-CCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC---CCCEeeEEEEE
Confidence            36899999999999999999999 68899999999986543222      3456788999999997   99999999999


Q ss_pred             eccccccccceEEEEEeccCc-c-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-Q-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      .+.       ...++|+|++. | +|.+++...  ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+
T Consensus        99 ~~~-------~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~  169 (335)
T 3dls_A           99 ENQ-------GFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTI  169 (335)
T ss_dssp             ECS-------SEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCE
T ss_pred             eeC-------CEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcE
Confidence            877       68899999986 5 999999874  459999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCccccccccccccchhhhhcCCC-CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         173 KIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      ||+|||++.............+|+.|+|||++.+..+ +.++||||||+++|+|++|..||......         ....
T Consensus       170 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~  240 (335)
T 3dls_A          170 KLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------VEAA  240 (335)
T ss_dssp             EECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------TTTC
T ss_pred             EEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------Hhhc
Confidence            9999999988776666666789999999999988886 78999999999999999999999653210         0000


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .                        .....+++++.+||++||++||.+|||+.++++||||++.
T Consensus       241 ~------------------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          241 I------------------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             C------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             c------------------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            0                        0011356899999999999999999999999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.2e-50  Score=350.77  Aligned_cols=293  Identities=27%  Similarity=0.457  Sum_probs=225.6

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccC---CCCceeEE
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF---EHPNIVRF   90 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~~~~i~~~   90 (321)
                      +...+...++|++.+.||+|+||+||+|++ ..+++.||+|+++...   ........|+.+++.+...   .+++++++
T Consensus        46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~  121 (382)
T 2vx3_A           46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYD-RVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHL  121 (382)
T ss_dssp             CCTTCEETTTEEEEEEEEEETTEEEEEEEE-TTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred             eecCCEeeeeEEEEEEEeecCCEEEEEEEE-cCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence            344455568999999999999999999999 6789999999986421   1123456788888877641   12359999


Q ss_pred             EeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCcEEEe-
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLH--SHRIIHRDLKPQNLLIT-  167 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh--~~~~~H~di~p~Nilv~-  167 (321)
                      ++++...       ...++|||+++++|.+++.......+++..++.++.||+.||.+||  +.|++||||||+||+++ 
T Consensus       122 ~~~~~~~-------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~  194 (382)
T 2vx3_A          122 KRHFMFR-------NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN  194 (382)
T ss_dssp             EEEEEET-------TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS
T ss_pred             eeeeccC-------CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec
Confidence            9999877       6889999999999999999876566999999999999999999999  57999999999999995 


Q ss_pred             -eCCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q psy2676         168 -RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR  246 (321)
Q Consensus       168 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  246 (321)
                       .++.+||+|||++......  .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus       195 ~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~  272 (382)
T 2vx3_A          195 PKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE  272 (382)
T ss_dssp             TTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCCcEEEEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence             4678999999999876532  3456789999999999999999999999999999999999999999999999999988


Q ss_pred             HhCCCCCCCcchhhh--hhhhhhh-----------------hhhhhhhh------------------hhhhhcchhHHHH
Q psy2676         247 VIGTPSMNEWPENIS--LMWSSFE-----------------QYSKVAFS------------------AIFMDCCSKANSL  289 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~--~~~~~~~-----------------~~~~~~~~------------------~~~~~~~~~~~~l  289 (321)
                      ..+.++...++....  .....+.                 ........                  ......++++.+|
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  352 (382)
T 2vx3_A          273 VLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL  352 (382)
T ss_dssp             HHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHH
T ss_pred             HhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHH
Confidence            877665332211000  0000000                 00000000                  0001122478999


Q ss_pred             HHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         290 LESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       290 i~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      |++||++||.+|||++|+|+||||++..+|
T Consensus       353 i~~mL~~dP~~Rpta~e~L~hp~f~~~~~e  382 (382)
T 2vx3_A          353 ILRMLDYDPKTRIQPYYALQHSFFKKTADE  382 (382)
T ss_dssp             HHHHTCSCTTTSCCHHHHTTSGGGCC----
T ss_pred             HHHhcCCChhhCCCHHHHhcCcccccCCCC
Confidence            999999999999999999999999987654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.9e-50  Score=374.24  Aligned_cols=262  Identities=25%  Similarity=0.376  Sum_probs=224.7

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeeccc-CCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKL-NEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      +.-++|++++.||+|+||+||+|++ ..+++.||+|+++... ...........|..++..+..  ||+|+++++++.+.
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~-~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~--~~~i~~l~~~~~~~  414 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSER-KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK--PPFLTQLHSCFQTM  414 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEE-SSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTC--CTTBCCEEEECBCS
T ss_pred             ccccceEEEEEEccCCCEEEEEEEE-CCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccC--CCeEEEEEEEEEeC
Confidence            3456899999999999999999999 5788999999997642 233345567788888888763  99999999999877


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ..+|+||||+. |+|..++...  +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus       415 -------~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~D  485 (674)
T 3pfq_A          415 -------DRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIAD  485 (674)
T ss_dssp             -------SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECC
T ss_pred             -------CEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEee
Confidence                   68899999998 4999999874  4599999999999999999999999999999999999999999999999


Q ss_pred             cCCccccc-CCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         177 FGLAKTFD-YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       177 fg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ||++.... .........||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....+.....     .
T Consensus       486 FGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-----~  560 (674)
T 3pfq_A          486 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-----A  560 (674)
T ss_dssp             CTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-----C
T ss_pred             cceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-----C
Confidence            99998643 23344567899999999999999999999999999999999999999999888887777664211     1


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH-----HHHhCCCCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA-----ADALEHPYFKEKENE  319 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~h~~f~~~~~~  319 (321)
                      ++                      ..+++++.+||++||..||.+||++     ++|++||||++++|+
T Consensus       561 ~p----------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~  607 (674)
T 3pfq_A          561 YP----------------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  607 (674)
T ss_dssp             CC----------------------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred             CC----------------------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence            11                      2456899999999999999999997     999999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.4e-50  Score=360.64  Aligned_cols=266  Identities=24%  Similarity=0.369  Sum_probs=222.4

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ...+..++|++.+.||+|+||+||+|++ ..+++.||+|++...... ......+.+|+.+++++.   ||||+++++++
T Consensus       179 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~-~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~~  254 (543)
T 3c4z_A          179 AQPMGEDWFLDFRVLGRGGFGEVFACQM-KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH---SRFIVSLAYAF  254 (543)
T ss_dssp             TSCCCGGGEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC---CTTBCCEEEEE
T ss_pred             cccCChhheEEEEEEeeCCCeEEEEEEE-CCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC---CCCEeeEEEEE
Confidence            3456778999999999999999999999 678999999999765322 223446778999999997   99999999999


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      .+.       ..+|+||||+. |+|..++....  ...+++..++.++.||+.||.|||++|++||||||+||+++.++.
T Consensus       255 ~~~-------~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~  327 (543)
T 3c4z_A          255 ETK-------TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN  327 (543)
T ss_dssp             ECS-------SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC
T ss_pred             eeC-------CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC
Confidence            877       67899999999 59999987654  345999999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCCc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCC----hHHHHHHHHH
Q psy2676         172 LKIADFGLAKTFDYDMM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST----EVEQLKCIFR  246 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~~  246 (321)
                      +||+|||++........ .....||+.|+|||++.+..++.++|+|||||++|+|++|..||.+..    ..+....+..
T Consensus       328 vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~  407 (543)
T 3c4z_A          328 VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE  407 (543)
T ss_dssp             EEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH
T ss_pred             EEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh
Confidence            99999999987654433 334589999999999999999999999999999999999999997753    2333333332


Q ss_pred             HhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCC
Q psy2676         247 VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKENE  319 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~~  319 (321)
                      ..  .   .+                      ...+++++.+||++||..||.+||+     ++++++||||++.+|+
T Consensus       408 ~~--~---~~----------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~  458 (543)
T 3c4z_A          408 QA--V---TY----------------------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR  458 (543)
T ss_dssp             CC--C---CC----------------------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred             cc--c---CC----------------------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence            11  1   11                      1245689999999999999999995     5899999999998764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.3e-50  Score=352.58  Aligned_cols=259  Identities=25%  Similarity=0.381  Sum_probs=202.4

Q ss_pred             cceeee-eeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDEL-CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~-~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|.+. +.||+|+||+||++.+ ..+++.||+|++..       .....+|+.++.++..  ||||+++++++...   
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~-~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~--hp~iv~l~~~~~~~---  127 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFN-KRTQEKFALKMLQD-------CPKARREVELHWRASQ--CPHIVRIVDVYENL---  127 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTT--STTBCCEEEEEEEE---
T ss_pred             ccceeccceeeeccCeEEEEEEE-CCCCCEEEEEEeCc-------chhHHHHHHHHHHhcC--CCCcceEeEEEeec---
Confidence            467776 7999999999999999 68899999999863       2367788888766543  99999999998652   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee---CCCEEEee
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR---AGGLKIAD  176 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~---~~~~kl~d  176 (321)
                      ......+++||||+.| +|.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.   ++.+||+|
T Consensus       128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence            1112578999999985 9999998866566999999999999999999999999999999999999987   78899999


Q ss_pred             cCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHH----HHHHHHHHhCCCC
Q psy2676         177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE----QLKCIFRVIGTPS  252 (321)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~  252 (321)
                      ||++.............+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.....    ....+.......+
T Consensus       208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~  287 (400)
T 1nxk_A          208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  287 (400)
T ss_dssp             CTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred             cccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence            999987765555566788999999999999899999999999999999999999997654321    1122221111111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ..                       ....++.++.+||++||..||.+|||+.++++||||.+.
T Consensus       288 ~~-----------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          288 NP-----------------------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             TT-----------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             Cc-----------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            11                       123567899999999999999999999999999999754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.2e-50  Score=344.13  Aligned_cols=293  Identities=27%  Similarity=0.439  Sum_probs=230.0

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhccc---CCCCceeE
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT---FEHPNIVR   89 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~~~~i~~   89 (321)
                      .+...+...++|++.+.||+|+||+||+|.+...+++.||+|+++...   .....+.+|+.+++.+..   ..|+++++
T Consensus         5 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~   81 (339)
T 1z57_A            5 ICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQ   81 (339)
T ss_dssp             TCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred             eeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence            344566678899999999999999999999855688999999986421   123456788888888762   23446999


Q ss_pred             EEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee-
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR-  168 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~-  168 (321)
                      +++++...       ...++|||+++++|.+++.......+++..++.++.||+.||.|||++|++|+||||+||+++. 
T Consensus        82 ~~~~~~~~-------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~  154 (339)
T 1z57_A           82 MLEWFEHH-------GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQS  154 (339)
T ss_dssp             EEEEEEET-------TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCC
T ss_pred             eecccccC-------CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecc
Confidence            99999777       6889999999889999998876556899999999999999999999999999999999999987 


Q ss_pred             ------------------CCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCC
Q psy2676         169 ------------------AGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVP  230 (321)
Q Consensus       169 ------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~  230 (321)
                                        ++.++|+|||.+......  .....+|+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  232 (339)
T 1z57_A          155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT  232 (339)
T ss_dssp             CEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCC
Confidence                              667999999999765432  345578999999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCCCCc----------------chhhhhhhhhhhhhh--hhhhhhhhhhcchhHHHHHHH
Q psy2676         231 LFCASTEVEQLKCIFRVIGTPSMNEW----------------PENISLMWSSFEQYS--KVAFSAIFMDCCSKANSLLES  292 (321)
Q Consensus       231 pf~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~  292 (321)
                      ||...+..+....+....+..+...+                ........ ......  ...........++++.+||++
T Consensus       233 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~  311 (339)
T 1z57_A          233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGR-YVSRACKPLKEFMLSQDVEHERLFDLIQK  311 (339)
T ss_dssp             SCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHH-HHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccc-hhhhcCcchhhhcccchhhHHHHHHHHHH
Confidence            99998888888887777665443211                11000000 000000  000011122346789999999


Q ss_pred             hcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         293 MLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       293 ~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ||+.||.+|||+.|+++||||++.+.
T Consensus       312 ~L~~dP~~Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          312 MLEYDPAKRITLREALKHPFFDLLKK  337 (339)
T ss_dssp             HTCSSTTTSCCHHHHTTSGGGGGGGC
T ss_pred             HhCcCcccccCHHHHhcCHHHHHHhc
Confidence            99999999999999999999997653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.1e-50  Score=344.47  Aligned_cols=255  Identities=27%  Similarity=0.475  Sum_probs=191.8

Q ss_pred             cceeee---eeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          22 KKYDEL---CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        22 ~~y~~~---~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ++|++.   +.||+|+||+||+|.+ ..+++.||+|++...     ......+|+.+++.+..  ||||+++++++.+. 
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~--h~niv~~~~~~~~~-   78 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVH-KKSNQAFAVKIISKR-----MEANTQKEITALKLCEG--HPNIVKLHEVFHDQ-   78 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEE-TTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTT--CTTBCCEEEEEECS-
T ss_pred             hccccccCCCccccCCCeEEEEEEE-CCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcC--CCCeeEEEEEEEcC-
Confidence            467775   7899999999999999 678999999998753     23467789999999874  99999999999877 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC---CEEE
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG---GLKI  174 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~---~~kl  174 (321)
                            ...++|||++.| +|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++   .++|
T Consensus        79 ------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl  150 (325)
T 3kn6_A           79 ------LHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKI  150 (325)
T ss_dssp             ------SEEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEE
T ss_pred             ------CEEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEE
Confidence                  788999999985 999999884  4599999999999999999999999999999999999998766   7999


Q ss_pred             eecCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChH-------HHHHHHHH
Q psy2676         175 ADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV-------EQLKCIFR  246 (321)
Q Consensus       175 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~  246 (321)
                      +|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||...+..       +....+..
T Consensus       151 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~  230 (325)
T 3kn6_A          151 IDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK  230 (325)
T ss_dssp             CCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT
T ss_pred             eccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc
Confidence            9999997654332 334566799999999999999999999999999999999999999764331       22222211


Q ss_pred             HhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         247 VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                          ....                   ........+++++.+||++||..||.+|||+.++++||||++.
T Consensus       231 ----~~~~-------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          231 ----GDFS-------------------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             ----TCCC-------------------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             ----CCCC-------------------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence                1100                   0111234577999999999999999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.5e-50  Score=338.03  Aligned_cols=264  Identities=30%  Similarity=0.550  Sum_probs=222.8

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ...++|++++.||+|++|+||+|++ ..+++.|++|++............+.+|+.++++++   ||||+++++++.+. 
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~-~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~-   93 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKD-RITQQEYAVKVINKASAKNKDTSTILREVELLKKLD---HPNIMKLFEILEDS-   93 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCC---CTTBCCEEEEEECS-
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEE-cCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcc---CCCccEEEEEEeCC-
Confidence            3457999999999999999999999 578999999999876555555567888999999997   99999999999776 


Q ss_pred             cccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC---CEEE
Q psy2676          99 LSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG---GLKI  174 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~---~~kl  174 (321)
                            ...++|+|++. ++|.+++...  ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++   .++|
T Consensus        94 ------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL  165 (287)
T 2wei_A           94 ------SSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKI  165 (287)
T ss_dssp             ------SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             ------CeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEE
Confidence                  67899999998 5999888763  3589999999999999999999999999999999999997644   6999


Q ss_pred             eecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       175 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      +|||.+.............+++.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+....+.......+..
T Consensus       166 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (287)
T 2wei_A          166 IDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP  244 (287)
T ss_dssp             CSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG
T ss_pred             eccCcceeecCCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCch
Confidence            999999877655555566789999999998764 8999999999999999999999999887777666555432111111


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                                             ....+++++.++|++||..||.+|||+.++++||||++..++
T Consensus       245 -----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  286 (287)
T 2wei_A          245 -----------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (287)
T ss_dssp             -----------------------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCCC
T ss_pred             -----------------------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccccC
Confidence                                   113567899999999999999999999999999999876654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.2e-50  Score=353.42  Aligned_cols=288  Identities=35%  Similarity=0.659  Sum_probs=214.2

Q ss_pred             CCcceee-eeeeecccceeEEEEEEe-cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          20 GDKKYDE-LCQIGCGAYGTVFKARDL-QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        20 ~~~~y~~-~~~lg~g~~g~v~~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ..+.|++ .++||+|+||+||+|++. ..+++.||+|++...    .....+.+|+.++++++   ||||+++++++...
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~   90 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT----GISMSACREIALLRELK---HPNVISLQKVFLSH   90 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS----SCCHHHHHHHHHHHHCC---CTTBCCCCEEEEET
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC----CCCHHHHHHHHHHHhcC---CCCeeeEeeEEecC
Confidence            3457887 458999999999999963 246889999998643    23447889999999998   99999999998542


Q ss_pred             ccccccceEEEEEeccCccCHHHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----
Q psy2676          98 ILSDERYLTVYLIFEHVDQDLGSYMEKCP-------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI----  166 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~~L~~~~~~~~-------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv----  166 (321)
                      .     ...+++||||+.++|.+++....       ...+++..++.++.||+.||.|||++|++||||||+||++    
T Consensus        91 ~-----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~  165 (405)
T 3rgf_A           91 A-----DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG  165 (405)
T ss_dssp             T-----TTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSS
T ss_pred             C-----CCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCC
Confidence            1     15789999999999988886321       1238999999999999999999999999999999999999    


Q ss_pred             eeCCCEEEeecCCcccccCC----CccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCCh----
Q psy2676         167 TRAGGLKIADFGLAKTFDYD----MMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTE----  237 (321)
Q Consensus       167 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~----  237 (321)
                      +.++.+||+|||++......    .......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+...    
T Consensus       166 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  245 (405)
T 3rgf_A          166 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT  245 (405)
T ss_dssp             TTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred             CCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccc
Confidence            66789999999999876532    2234567899999999998754 89999999999999999999999976554    


Q ss_pred             -----HHHHHHHHHHhCCCCCCCcchhhhhhh--hhhhhhhhhh---------hhhhhhhcchhHHHHHHHhcccCCCCC
Q psy2676         238 -----VEQLKCIFRVIGTPSMNEWPENISLMW--SSFEQYSKVA---------FSAIFMDCCSKANSLLESMLTFNPADR  301 (321)
Q Consensus       238 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~R  301 (321)
                           .+.+..+....+.+....|+.......  ..........         ........+..+.+||++||..||.+|
T Consensus       246 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R  325 (405)
T 3rgf_A          246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR  325 (405)
T ss_dssp             -CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGS
T ss_pred             cccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccC
Confidence                 478888999999988887765422111  0000110000         011112236889999999999999999


Q ss_pred             CCHHHHhCCCCCCCCCCC
Q psy2676         302 ISAADALEHPYFKEKENE  319 (321)
Q Consensus       302 ps~~~ll~h~~f~~~~~~  319 (321)
                      ||++|+|+||||++.++.
T Consensus       326 ~ta~e~L~hp~f~~~~~~  343 (405)
T 3rgf_A          326 ITSEQAMQDPYFLEDPLP  343 (405)
T ss_dssp             CCHHHHHTSGGGTSSSCC
T ss_pred             CCHHHHhcChhhccCCCC
Confidence            999999999999987654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.4e-50  Score=352.54  Aligned_cols=258  Identities=27%  Similarity=0.403  Sum_probs=213.2

Q ss_pred             cceee--eeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          22 KKYDE--LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        22 ~~y~~--~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      +.|.+  .+.||+|+||.||+|++ ..+++.||+|+++....  .....+.+|+.++++++   ||||+++++++.+.  
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~-~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~--  158 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEE-TATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLD---HANLIQLYDAFESK--  158 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEE-TTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCC---CTTBCCEEEEEECS--
T ss_pred             cceeeecceEEecCcCEEEEEEEE-cCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCC---CCCCCeEEEEEEEC--
Confidence            34555  67899999999999999 57899999999875422  12346778999999987   99999999999877  


Q ss_pred             ccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe--eCCCEEEee
Q psy2676         100 SDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT--RAGGLKIAD  176 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~--~~~~~kl~d  176 (321)
                           ...++||||++ ++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++  .++.+||+|
T Consensus       159 -----~~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~D  232 (373)
T 2x4f_A          159 -----NDIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIID  232 (373)
T ss_dssp             -----SEEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECC
T ss_pred             -----CEEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEe
Confidence                 67899999998 49999887643 3489999999999999999999999999999999999994  456799999


Q ss_pred             cCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      ||++.............+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.......+..  
T Consensus       233 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~--  310 (373)
T 2x4f_A          233 FGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE--  310 (373)
T ss_dssp             CSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG--
T ss_pred             CCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh--
Confidence            999988766655556679999999999998889999999999999999999999999988887777776543222111  


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                                           ....+++++.+||.+||..||.+|||+.++++||||++.
T Consensus       311 ---------------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          311 ---------------------EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             ---------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             ---------------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence                                 123567899999999999999999999999999999865

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.3e-49  Score=335.62  Aligned_cols=266  Identities=27%  Similarity=0.398  Sum_probs=214.4

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      .....+..|++.+.||+|+||+||+|.+ ..++..+++|++............+.+|+.++++++   ||||+++++++.
T Consensus        20 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~   95 (290)
T 1t4h_A           20 GMSNDGRFLKFDIEIGRGSFKTVYKGLD-TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ---HPNIVRFYDSWE   95 (290)
T ss_dssp             EECTTSCEEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC---CTTBCCEEEEEE
T ss_pred             hcccCceeEEeeeeccCCCCeEEEEeEe-cCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCC---CCCeeeeeeeec
Confidence            3445667799999999999999999999 688899999998765443333456778999998887   999999999986


Q ss_pred             ccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEe-eCCC
Q psy2676          96 QNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLIT-RAGG  171 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~--~~H~di~p~Nilv~-~~~~  171 (321)
                      ...   .....+++|||++.+ +|.+++...  ..+++..++.++.||+.||.+||+.|  ++|+||||+||+++ .++.
T Consensus        96 ~~~---~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~  170 (290)
T 1t4h_A           96 STV---KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS  170 (290)
T ss_dssp             EES---SSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC
T ss_pred             ccc---CCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC
Confidence            541   223568999999985 999999873  44899999999999999999999999  99999999999997 7889


Q ss_pred             EEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         172 LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      ++|+|||++...... ......+++.|+|||++.+ .++.++||||||+++|+|++|..||.................  
T Consensus       171 ~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--  246 (290)
T 1t4h_A          171 VKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--  246 (290)
T ss_dssp             EEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC--
T ss_pred             EEEeeCCCccccccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC--
Confidence            999999998755433 3345678999999998764 589999999999999999999999987555444333222110  


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ..                      .......++++.++|++||+.||.+|||+.++++||||++.
T Consensus       247 ~~----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          247 KP----------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             CC----------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             Cc----------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            00                      11123455789999999999999999999999999999874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.4e-50  Score=349.39  Aligned_cols=286  Identities=37%  Similarity=0.620  Sum_probs=225.2

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|.+.+.||+|+||+||+|++ ..+++.||+|++............+.+|+.++++++   ||||+++++++......
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~   98 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAID-KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ---HENVIGLLDVFTPASSL   98 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC---CTTBCCCSEEECSCSSG
T ss_pred             CceEEEeeeEecCCCeEEEEEEE-CCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC---CCCcccHhheEeccccc
Confidence            46899999999999999999999 678999999998754333222345678999999987   99999999998765211


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                       ......++|||++.++|.+++..    .+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+
T Consensus        99 -~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A           99 -RNFYDFYLVMPFMQTDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             -GGCCCCEEEEECCSEEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             -ccceeEEEEeccccCCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence             11234699999999998888743    3899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         181 KTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ......  .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+....+.++...+...
T Consensus       174 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  251 (353)
T 3coi_A          174 RHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  251 (353)
T ss_dssp             TC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred             cCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence            765432  334577999999999987 66899999999999999999999999999988888888887776653322111


Q ss_pred             hhhhh----hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         260 ISLMW----SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       260 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      .....    .................+++++.+||.+||..||.+|||+.++++||||+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence            11000    01111111223334456789999999999999999999999999999999764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.8e-50  Score=341.92  Aligned_cols=263  Identities=24%  Similarity=0.354  Sum_probs=204.6

Q ss_pred             CCcceeee-eeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          20 GDKKYDEL-CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        20 ~~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ..++|++. +.||+|+||+||+|++ ..+++.||+|++...  .......+.+|+.+++++..  ||||+++++++.+. 
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~--h~~i~~~~~~~~~~-   83 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCIN-LITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQG--HRNVLELIEFFEEE-   83 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEEC-SSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCC--CTTBCCEEEEEEET-
T ss_pred             cceeEEecCceecCCceEEEEEEEE-cCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcC--CCCeeeEEEEEeeC-
Confidence            45789995 7899999999999998 578999999998754  22334567889999988643  99999999999877 


Q ss_pred             cccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC---EEE
Q psy2676          99 LSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKI  174 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~---~kl  174 (321)
                            ...++|||++. ++|.+++...  ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.   +||
T Consensus        84 ------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl  155 (316)
T 2ac3_A           84 ------DRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKI  155 (316)
T ss_dssp             ------TEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEE
T ss_pred             ------CEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEE
Confidence                  68899999998 5999999873  45899999999999999999999999999999999999988776   999


Q ss_pred             eecCCcccccCCC--------ccccccccccccchhhhhc-----CCCCCcchHHHHHHHHHHHHhcCCCCCCCChH---
Q psy2676         175 ADFGLAKTFDYDM--------MLTSVVVTLWYRAPEILLN-----LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV---  238 (321)
Q Consensus       175 ~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---  238 (321)
                      +|||++.......        ......+++.|+|||++.+     ..++.++||||||+++|+|++|..||.+....   
T Consensus       156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  235 (316)
T 2ac3_A          156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG  235 (316)
T ss_dssp             CCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred             EEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence            9999987653221        1223458999999999975     45789999999999999999999999765321   


Q ss_pred             ------------HHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHH
Q psy2676         239 ------------EQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD  306 (321)
Q Consensus       239 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  306 (321)
                                  .....+....  .   .                  ........++.++.+||++||..||.+|||+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~i~~~~--~---~------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  292 (316)
T 2ac3_A          236 WDRGEACPACQNMLFESIQEGK--Y---E------------------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQ  292 (316)
T ss_dssp             C----CCHHHHHHHHHHHHHCC--C---C------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             ccccccchhHHHHHHHHHhccC--c---c------------------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHH
Confidence                        1111111100  0   0                  001122357789999999999999999999999


Q ss_pred             HhCCCCCCCCCCC
Q psy2676         307 ALEHPYFKEKENE  319 (321)
Q Consensus       307 ll~h~~f~~~~~~  319 (321)
                      +++||||++..++
T Consensus       293 ~l~hp~~~~~~~~  305 (316)
T 2ac3_A          293 VLQHPWVQGCAPE  305 (316)
T ss_dssp             HHHSTTCC-----
T ss_pred             HhcChhhcCCCCc
Confidence            9999999987554

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.1e-50  Score=342.92  Aligned_cols=262  Identities=26%  Similarity=0.466  Sum_probs=206.3

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc-
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS-  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~-  100 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||+|+++... .......+.+|+.++++++   ||||+++++++.+.... 
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKN-KVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLE---HPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEE-TTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCC---CTTBCCEEEEEEECCSCH
T ss_pred             hcCceeeEecCCCCeEEEEEEE-cCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCC---CCCEeeEEEEEEEeccch
Confidence            5899999999999999999999 6789999999997543 2223456778999999997   99999999998654210 


Q ss_pred             -------------------------------------------------cccceEEEEEeccCcc-CHHHHHhhCCC-CC
Q psy2676         101 -------------------------------------------------DERYLTVYLIFEHVDQ-DLGSYMEKCPP-PG  129 (321)
Q Consensus       101 -------------------------------------------------~~~~~~~~~v~e~~~~-~L~~~~~~~~~-~~  129 (321)
                                                                       .......++|||++.+ +|.+++..... ..
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                             0112348999999995 99999987543 22


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCC-------------ccccccccc
Q psy2676         130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-------------MLTSVVVTL  196 (321)
Q Consensus       130 ~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~-------------~~~~~~~~~  196 (321)
                      .++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.......             ......+|+
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            5666789999999999999999999999999999999999999999999998775432             223456899


Q ss_pred             cccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhh
Q psy2676         197 WYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFS  276 (321)
Q Consensus       197 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (321)
                      .|+|||++.+..++.++||||||+++|+|++|..|+..     .........                       ....+
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~-----------------------~~~~~  292 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVR-----------------------NLKFP  292 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHH-----------------------TTCCC
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhh-----------------------ccCCC
Confidence            99999999999999999999999999999998776521     111111111                       11111


Q ss_pred             hhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         277 AIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       277 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ......++.+.+||++||+.||.+|||+.++++||||+++
T Consensus       293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            2233556788999999999999999999999999999974

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-50  Score=348.57  Aligned_cols=267  Identities=25%  Similarity=0.376  Sum_probs=217.3

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC---CCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN---EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ...++|++.+.||+|+||+||+|++ ..++..+|+|++.....   .......+.+|+.++++++   ||||+++++++.
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~   98 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIE-NQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH---HPNIARLYEVYE   98 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC---CTTBCCEEEEEE
T ss_pred             hhhhheeecceeeecCCeEEEEEEE-CCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC---CCCcceeehhhc
Confidence            3457899999999999999999999 68899999999876422   2223456778999999998   999999999998


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCC--------------------------------------CCCCCHHHHH
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--------------------------------------PPGLSASKVK  136 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--------------------------------------~~~~~~~~~~  136 (321)
                      +.       ...++|||++. |+|.+++....                                      ...+++..++
T Consensus        99 ~~-------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (345)
T 3hko_A           99 DE-------QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS  171 (345)
T ss_dssp             CS-------SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred             cC-------CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence            77       68899999998 59999885210                                      1114678899


Q ss_pred             HHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC--CEEEeecCCcccccCCC-----ccccccccccccchhhhhc--C
Q psy2676         137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG--GLKIADFGLAKTFDYDM-----MLTSVVVTLWYRAPEILLN--L  207 (321)
Q Consensus       137 ~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~--~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~  207 (321)
                      .++.||+.||.+||+.|++|+||||+||+++.++  .+||+|||.+.......     ......+++.|+|||++.+  .
T Consensus       172 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  251 (345)
T 3hko_A          172 NIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE  251 (345)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred             HHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence            9999999999999999999999999999998776  79999999997653221     2345678999999999975  5


Q ss_pred             CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHH
Q psy2676         208 GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKAN  287 (321)
Q Consensus       208 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (321)
                      .++.++||||||+++|+|++|..||.+....+....+...........                       ...+++.+.
T Consensus       252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~  308 (345)
T 3hko_A          252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPN-----------------------YNVLSPLAR  308 (345)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGG-----------------------GGGSCHHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcc-----------------------cccCCHHHH
Confidence            689999999999999999999999999888877776665332221111                       124678999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         288 SLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       288 ~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      +||++||..||.+|||+.++++||||++..++
T Consensus       309 ~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          309 DLLSNLLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence            99999999999999999999999999988654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.7e-49  Score=333.92  Aligned_cols=259  Identities=27%  Similarity=0.458  Sum_probs=219.5

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ...++|++.+.||+|++|+||+|++ ..+++.+++|++...... ......+.+|+.++++++   ||||+++++++.+.
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~   86 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLARE-KQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR---HPNILRMYNYFHDR   86 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC---CTTBCCEEEEEECS
T ss_pred             hhhhhceeeheecCCCCeEEEEEEE-cCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC---CCCEeeEEEEEEcC
Confidence            4457999999999999999999999 678899999998754222 223456788999999997   99999999999876


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ...++|+|++.+ +|.+++...  ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        87 -------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~D  157 (284)
T 2vgo_A           87 -------KRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIAD  157 (284)
T ss_dssp             -------SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECC
T ss_pred             -------CEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEec
Confidence                   678999999985 999999874  3489999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      ||++...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+.....     .+
T Consensus       158 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~  231 (284)
T 2vgo_A          158 FGWSVHAPSL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-----KF  231 (284)
T ss_dssp             CTTCEECSSS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-----CC
T ss_pred             ccccccCccc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc-----CC
Confidence            9998765532 23456789999999999999999999999999999999999999988777666555443211     11


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                                            ...++..+.++|.+||..||.+|||+.++++||||++...
T Consensus       232 ----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          232 ----------------------PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             ----------------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             ----------------------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence                                  1245688999999999999999999999999999986543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.8e-49  Score=337.01  Aligned_cols=258  Identities=28%  Similarity=0.407  Sum_probs=217.3

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.+.||+|+||+||+|++ ..+++.+++|++.....  .....+.+|+.+++++.   ||||+++++++.+.  
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~--   78 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQ-RLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIK---HENIVTLEDIYEST--   78 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEECC--------HHHHHHHHHHHCC---CTTBCCEEEEEECS--
T ss_pred             hhccceeeeeccCCCCceEEEEEE-CCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCC---CCCeeehhhhcccC--
Confidence            357999999999999999999999 57899999999975422  22346789999999997   99999999999776  


Q ss_pred             ccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---eeCCCEEEe
Q psy2676         100 SDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIA  175 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv---~~~~~~kl~  175 (321)
                           ...++|+|++. ++|.+++...  +.+++..++.++.||+.||.+||+.|++|+||+|+||++   +.++.++|+
T Consensus        79 -----~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~  151 (304)
T 2jam_A           79 -----THYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMIT  151 (304)
T ss_dssp             -----SEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBC
T ss_pred             -----CEEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEc
Confidence                 67899999998 4999998773  448999999999999999999999999999999999999   778899999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      |||.+..... .......+++.|+|||++.+..++.++||||||+++|+|++|..||...........+.......+.. 
T Consensus       152 Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-  229 (304)
T 2jam_A          152 DFGLSKMEQN-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESP-  229 (304)
T ss_dssp             SCSTTCCCCC-BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTT-
T ss_pred             cCCcceecCC-CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcc-
Confidence            9999875543 23344568999999999999889999999999999999999999998887777666665432221111 


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                                            ....+++.+.++|.+||..||.+|||+.++++||||++.
T Consensus       230 ----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          230 ----------------------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             ----------------------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             ----------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                                  123566899999999999999999999999999999865

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-49  Score=349.07  Aligned_cols=264  Identities=28%  Similarity=0.461  Sum_probs=209.7

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ....+.+.+|++.+.||+|+||+||+|.+  .+++.||+|++............+.+|+.+++++.. .||||+++++++
T Consensus        49 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~-~~~~iv~~~~~~  125 (390)
T 2zmd_A           49 ECISVKGRIYSILKQIGSGGSSKVFQVLN--EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDKIIRLYDYE  125 (390)
T ss_dssp             CCEEETTEEEEEEEEEECCSSEEEEEEEC--TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEE
T ss_pred             ccccccCCceEEEEEEccCCCeEEEEEEc--CCCCEEEEEEEecccccHHHHHHHHHHHHHHHHccc-CCCeEEEEEEEE
Confidence            34556677899999999999999999987  348899999997653333234567889999999972 259999999998


Q ss_pred             eccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ...       ..+++|||+.+++|.+++...  ..+++..++.++.||+.||.|||+.|++||||||+||+++ ++.+||
T Consensus       126 ~~~-------~~~~lv~E~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl  195 (390)
T 2zmd_A          126 ITD-------QYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKL  195 (390)
T ss_dssp             ECS-------SEEEEEEECCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEE
T ss_pred             ecC-------CEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEE
Confidence            777       678999997668999999884  3589999999999999999999999999999999999995 688999


Q ss_pred             eecCCcccccCCC---ccccccccccccchhhhhc-----------CCCCCcchHHHHHHHHHHHHhcCCCCCCCCh-HH
Q psy2676         175 ADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLN-----------LGYGTPVDIWSIGCVMAEMWRLVPLFCASTE-VE  239 (321)
Q Consensus       175 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~  239 (321)
                      +|||++.......   ......||+.|+|||++.+           ..++.++||||||+++|+|++|..||..... ..
T Consensus       196 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~  275 (390)
T 2zmd_A          196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS  275 (390)
T ss_dssp             CCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred             EecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH
Confidence            9999998765332   2335678999999999875           3578899999999999999999999976543 23


Q ss_pred             HHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         240 QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ....+..   ......++.                      ..+.++.+||++||..||.+|||+.++++||||+..
T Consensus       276 ~~~~~~~---~~~~~~~~~----------------------~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          276 KLHAIID---PNHEIEFPD----------------------IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             HHHHHHC---TTSCCCCCC----------------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             HHHHHhC---ccccCCCCc----------------------cchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            3332222   111111111                      234789999999999999999999999999999754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6e-50  Score=353.91  Aligned_cols=261  Identities=28%  Similarity=0.452  Sum_probs=203.6

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC------CCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE------DGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      .++|.+.+.||+|+||+||+|.+ ..+++.||+|++......      ......+.+|+.++++++   ||||+++++++
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~  209 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFE-RKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN---HPCIIKIKNFF  209 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC---CTTBCCCCEEE
T ss_pred             hccEEEEeEEeeCCCeEEEEEEE-CCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC---CCCEeeEEEEE
Confidence            47899999999999999999999 688999999999765321      122335788999999997   99999999998


Q ss_pred             eccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC---
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG---  170 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~---  170 (321)
                      ...        ..++|||++.+ +|.+++..  ...+++..++.++.||+.||.|||++|++||||||+||+++.++   
T Consensus       210 ~~~--------~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~  279 (419)
T 3i6u_A          210 DAE--------DYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDC  279 (419)
T ss_dssp             ESS--------EEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSC
T ss_pred             ecC--------ceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcc
Confidence            544        46899999985 99998876  34599999999999999999999999999999999999997654   


Q ss_pred             CEEEeecCCcccccCCCccccccccccccchhhhhc---CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q psy2676         171 GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN---LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  247 (321)
                      .+||+|||++.............+|+.|+|||++.+   ..++.++||||||+++|+|++|..||...............
T Consensus       280 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~  359 (419)
T 3i6u_A          280 LIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS  359 (419)
T ss_dssp             CEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT
T ss_pred             eEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc
Confidence            499999999988776555566789999999999864   55788999999999999999999999764332222222111


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ...                      ...+.....+++.+.+||++||+.||.+|||++++++||||++.+
T Consensus       360 ~~~----------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          360 GKY----------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  407 (419)
T ss_dssp             TCC----------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred             CCC----------------------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence            100                      011222346779999999999999999999999999999998753

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=340.68  Aligned_cols=291  Identities=34%  Similarity=0.572  Sum_probs=218.6

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++++.||+|++|+||+|.+ ..+++.||+|++....  ......+.+|+.++++++   ||||+++++++.....
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVD-NDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLD---HDNIVKVFEILGPSGS   82 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEE-TTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCC---CTTBCCEEEEECTTSC
T ss_pred             cCCceeEEEEeccCCCeEEEEEEE-CCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcC---CCCeeEEEEecccccc
Confidence            457999999999999999999999 5789999999986432  112345678999999987   9999999999854311


Q ss_pred             -------ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe-eCCC
Q psy2676         100 -------SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT-RAGG  171 (321)
Q Consensus       100 -------~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~-~~~~  171 (321)
                             ........++|+|++.|+|.+++..   ..+++..++.++.||+.||.+||++|++|+||||+||+++ .++.
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE
T ss_pred             ccccccccccccCceeEEeeccCCCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe
Confidence                   1123357899999999999999875   3489999999999999999999999999999999999997 4668


Q ss_pred             EEEeecCCcccccCC----Cccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q psy2676         172 LKIADFGLAKTFDYD----MMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR  246 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  246 (321)
                      +||+|||.+......    .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+....+..
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  239 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE  239 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999866432    12334567889999999876 6689999999999999999999999999888888777776


Q ss_pred             HhCCCCCCCcchhhhhhhhhhh---hhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         247 VIGTPSMNEWPENISLMWSSFE---QYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      ......................   .............++.++.+||++||+.||.+|||+.++++||||+...+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence            5433221111110000000000   000112233445688999999999999999999999999999999987654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.6e-49  Score=329.44  Aligned_cols=259  Identities=30%  Similarity=0.461  Sum_probs=212.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++.+.||+|++|+||+|++ ..+++.+++|++...... .....+.+|+.++++++   ||||+++++++.+.    
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~----   77 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVN-RVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLN---HENVVKFYGHRREG----   77 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCC---CTTBCCEEEEEEET----
T ss_pred             cceEEEEEeecCCCcEEEEEEE-CCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcC---CCCceeeeeEEEcC----
Confidence            6899999999999999999999 578899999998754322 22356778999999887   99999999999776    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++|+|++++ +|.+++..  ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        78 ---~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  152 (276)
T 2yex_A           78 ---NIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA  152 (276)
T ss_dssp             ---TEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             ---CEEEEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCc
Confidence               678999999985 99999876  345899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCC---ccccccccccccchhhhhcCCC-CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         181 KTFDYDM---MLTSVVVTLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       181 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      .......   ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||................ ...    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~----  227 (276)
T 2yex_A          153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTY----  227 (276)
T ss_dssp             EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-CTT----
T ss_pred             cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-ccc----
Confidence            7654222   2344568999999999987775 779999999999999999999998755432211111100 000    


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                                         ......+++.+.++|++||..||.+|||+.++++||||++...
T Consensus       228 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          228 -------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             -------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             -------------------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence                               0012356789999999999999999999999999999997643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.3e-49  Score=341.78  Aligned_cols=294  Identities=27%  Similarity=0.413  Sum_probs=228.5

Q ss_pred             ccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhccc---CCCCcee
Q psy2676          12 LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT---FEHPNIV   88 (321)
Q Consensus        12 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~~~~i~   88 (321)
                      +.....+...++|++++.||+|+||+||+|.+...+++.||+|+++...   .....+.+|+.+++++..   ..+.+++
T Consensus         9 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~   85 (355)
T 2eu9_A            9 LVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKIKEKDKENKFLCV   85 (355)
T ss_dssp             BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred             cccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---cchhHHHHHHHHHHHHhhcCCCCceeEE
Confidence            3455566678899999999999999999999954445899999986421   123456678899888872   1233489


Q ss_pred             EEEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE--
Q psy2676          89 RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI--  166 (321)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv--  166 (321)
                      .+++++...       ...++|||+++++|.+++.......+++..++.++.||+.||.|||++|++|+||||+||++  
T Consensus        86 ~~~~~~~~~-------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~  158 (355)
T 2eu9_A           86 LMSDWFNFH-------GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN  158 (355)
T ss_dssp             CEEEEEEET-------TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESC
T ss_pred             EeeeeeeeC-------CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec
Confidence            999998776       68899999999999999888665669999999999999999999999999999999999999  


Q ss_pred             -----------------eeCCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcC
Q psy2676         167 -----------------TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV  229 (321)
Q Consensus       167 -----------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  229 (321)
                                       +.++.+||+|||++......  .....+|+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  236 (355)
T 2eu9_A          159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF  236 (355)
T ss_dssp             CCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCC
Confidence                             66788999999999765432  34557899999999999999999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCCCCcc----------------hhhhhhhhhhhhhhh--hhhhhhhhhcchhHHHHHH
Q psy2676         230 PLFCASTEVEQLKCIFRVIGTPSMNEWP----------------ENISLMWSSFEQYSK--VAFSAIFMDCCSKANSLLE  291 (321)
Q Consensus       230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~  291 (321)
                      .||......+....+....+..+...+.                ...... ........  ..........+.++.+||+
T Consensus       237 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~  315 (355)
T 2eu9_A          237 TLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDG-RYVKENCKPLKSYMLQDSLEHVQLFDLMR  315 (355)
T ss_dssp             CSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHH-HHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchh-ccccccCCcccccccccchhHHHHHHHHH
Confidence            9999988888888887777654432110                000000 00000000  0000011223468999999


Q ss_pred             HhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         292 SMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       292 ~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      +||..||.+|||+.++++||||++..+
T Consensus       316 ~~L~~dP~~Rpt~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          316 RMLEFDPAQRITLAEALLHPFFAGLTP  342 (355)
T ss_dssp             HHTCSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred             HHhcCChhhCcCHHHHhcChhhcCCCh
Confidence            999999999999999999999998754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=332.69  Aligned_cols=258  Identities=29%  Similarity=0.480  Sum_probs=190.8

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      -++|++.+.||+|+||+||+|++ ..+++.+++|++...... ......+.+|+.++++++   ||||+++++++.+.  
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~--   83 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAES-IHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK---HPSILELYNYFEDS--   83 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC---CTTBCCEEEEEECS--
T ss_pred             cccceeeeeecCCCceEEEEEEE-ccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC---CCCeEeEEEEEccC--
Confidence            36899999999999999999998 578999999999754322 223356778999999887   99999999999876  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ...++|+|++++ +|.+++.... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus        84 -----~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg  157 (278)
T 3cok_A           84 -----NYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFG  157 (278)
T ss_dssp             -----SEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCT
T ss_pred             -----CeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeec
Confidence                 678999999984 9999998743 348999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         179 LAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       179 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      .+....... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||...........+..    .. ..  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~-~~--  230 (278)
T 3cok_A          158 LATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL----AD-YE--  230 (278)
T ss_dssp             TCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS----SC-CC--
T ss_pred             ceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh----cc-cC--
Confidence            998765332 23345689999999999988899999999999999999999999976554332221100    00 00  


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                                          ....++.++.++|.+||+.||.+|||+.++++||||++..
T Consensus       231 --------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          231 --------------------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             --------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             --------------------CccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence                                1124568899999999999999999999999999999764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5e-50  Score=348.40  Aligned_cols=289  Identities=23%  Similarity=0.374  Sum_probs=217.6

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ..++..++|++++.||+|+||+||+|++ ..++..+|+|++..... ......+.+|+.++++++   ||||+++++++.
T Consensus        27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~  101 (360)
T 3eqc_A           27 VGELKDDDFEKISELGAGNGGVVFKVSH-KPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECN---SPYIVGFYGAFY  101 (360)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEECCCC-HHHHHHHHHHHGGGGGCC---CTTBCCEEEEEE
T ss_pred             ccccccccceeeeeecCCCCeEEEEEEE-CCCCcEEEEEEeccccC-HHHHHHHHHHHHHHHHCC---CCCEEEEeEEEE
Confidence            4567788999999999999999999999 67899999999875421 112335667888888876   999999999998


Q ss_pred             ccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeeCCCEE
Q psy2676          96 QNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-~~~H~di~p~Nilv~~~~~~k  173 (321)
                      +.       ...++|||++++ +|.+++...  ..+++..++.++.|++.||.+||+. |++|+||||+||+++.++.++
T Consensus       102 ~~-------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~k  172 (360)
T 3eqc_A          102 SD-------GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIK  172 (360)
T ss_dssp             ET-------TEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEE
T ss_pred             EC-------CEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEE
Confidence            77       678999999985 999999874  3489999999999999999999996 999999999999999999999


Q ss_pred             EeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         174 IADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       174 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      |+|||++...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.........
T Consensus       173 l~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  251 (360)
T 3eqc_A          173 LCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA  251 (360)
T ss_dssp             ECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------
T ss_pred             EEECCCCcccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCC
Confidence            9999998755322 233457899999999999999999999999999999999999999887766554332211111110


Q ss_pred             CCcchhhh--h--------------hhhhhhhhhhhh-hhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         254 NEWPENIS--L--------------MWSSFEQYSKVA-FSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       254 ~~~~~~~~--~--------------~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ...+....  .              ............ .......++.++.+||++||+.||.+|||++++++||||++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             ----------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             CCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence            00000000  0              000000000000 001112467899999999999999999999999999999876


Q ss_pred             CCC
Q psy2676         317 ENE  319 (321)
Q Consensus       317 ~~~  319 (321)
                      .++
T Consensus       332 ~~~  334 (360)
T 3eqc_A          332 DAE  334 (360)
T ss_dssp             HHS
T ss_pred             hHh
Confidence            544

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.7e-49  Score=332.67  Aligned_cols=261  Identities=29%  Similarity=0.391  Sum_probs=210.9

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ..+..++|++.+.||+|++|+||+|++ ..+++.+++|++..... .......+.+|+.++++++   ||||+++++++.
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~   81 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEH-QLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR---HPHIIKLYQVIS   81 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC---CTTBCCEEEEEE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEE-CCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC---CCCEeEEEEEEe
Confidence            344567999999999999999999999 57899999999876422 2233446778999999987   999999999997


Q ss_pred             ccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ..       ...++|+|++.+ +|.+++...  ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|
T Consensus        82 ~~-------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l  152 (276)
T 2h6d_A           82 TP-------TDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKI  152 (276)
T ss_dssp             CS-------SEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEE
T ss_pred             cC-------CeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEE
Confidence            76       678999999984 999999873  44899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCccccccccccccchhhhhcCCC-CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       175 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      +|||.+.............+++.|+|||++.+... +.++||||||+++++|++|..||...........+......   
T Consensus       153 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---  229 (276)
T 2h6d_A          153 ADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY---  229 (276)
T ss_dssp             CCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---
T ss_pred             eecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc---
Confidence            99999987765555556678999999999988765 68999999999999999999999887766655554432111   


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                        .                      ...++..+.++|.+||+.||.+|||+.++++||||++..
T Consensus       230 --~----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          230 --I----------------------PEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             --C----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             --C----------------------chhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence              0                      113458899999999999999999999999999998653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.8e-49  Score=332.35  Aligned_cols=260  Identities=29%  Similarity=0.395  Sum_probs=218.7

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ...++|++.+.||+|+||+||+|++ ..+++.+++|++....... .....+.+|+.+++++.   ||||+++++++.+.
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~   87 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISD-ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA---HQHVVGFHGFFEDN   87 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC---CTTBCCEEEEEECS
T ss_pred             CcccceEEEEEEeecCCEEEEEEEE-CCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC---CCCEeeeeeeeccC
Confidence            4668999999999999999999999 6788999999987653221 12345667899999887   99999999999776


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ...++|+|+++ ++|.+++...  ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        88 -------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d  158 (294)
T 2rku_A           88 -------DFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGD  158 (294)
T ss_dssp             -------SEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             -------CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEe
Confidence                   67899999999 5999988773  4589999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         177 FGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       177 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ||.+....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+....  ..   
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~---  233 (294)
T 2rku_A          159 FGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YS---  233 (294)
T ss_dssp             CTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CC---
T ss_pred             ccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc--CC---
Confidence            99998765332 3344678999999999999889999999999999999999999998877666554443211  00   


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                                            ....+++.+.++|++||+.||.+|||+.++++||||++...
T Consensus       234 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  274 (294)
T 2rku_A          234 ----------------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  274 (294)
T ss_dssp             ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             ----------------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence                                  01245588999999999999999999999999999987643

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.5e-49  Score=337.95  Aligned_cols=260  Identities=28%  Similarity=0.459  Sum_probs=208.7

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC------CCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN------EDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      .++|++.+.||+|+||.||+|++ ..+++.||+|++.....      .......+.+|+.+++++.   ||||+++++++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~   84 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFE-RKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN---HPCIIKIKNFF   84 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECC---------------CHHHHHHHHHHCC---CTTBCCEEEEE
T ss_pred             hhceeEeeEEecCCCEEEEEEEE-cCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC---CCCCceEeeEE
Confidence            47899999999999999999999 67889999999865422      1122345778999999997   99999999998


Q ss_pred             eccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC--
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG--  171 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~--  171 (321)
                      ...        ..++|||++.+ +|.+++..  ...+++..++.++.||+.||.+||++|++|+||||+||+++.++.  
T Consensus        85 ~~~--------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~  154 (322)
T 2ycf_A           85 DAE--------DYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDC  154 (322)
T ss_dssp             ESS--------SEEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSC
T ss_pred             cCC--------ceEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCC
Confidence            654        26999999985 99999876  445999999999999999999999999999999999999987665  


Q ss_pred             -EEEeecCCcccccCCCccccccccccccchhhhh---cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q psy2676         172 -LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       172 -~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  247 (321)
                       +||+|||++.............+++.|+|||++.   ...++.++||||||+++|+|++|..||...............
T Consensus       155 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  234 (322)
T 2ycf_A          155 LIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS  234 (322)
T ss_dssp             CEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH
T ss_pred             eEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh
Confidence             9999999998776554445567899999999975   456789999999999999999999999764432222111111


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ...                      ...+.....++..+.+||++||..||.+|||+.++++||||++.
T Consensus       235 ~~~----------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          235 GKY----------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             TCC----------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             Ccc----------------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            100                      01112234677899999999999999999999999999999875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-48  Score=332.01  Aligned_cols=264  Identities=29%  Similarity=0.451  Sum_probs=213.4

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ....++|++++.||+|+||+||+|++ ..+++.+++|++....  ......+.+|+.+++++.   ||||+++++++.+.
T Consensus        15 ~~~~~~y~i~~~lg~G~~g~V~~~~~-~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~   88 (302)
T 2j7t_A           15 LDPNEVWEIVGELGDGAFGKVYKAKN-KETGALAAAKVIETKS--EEELEDYIVEIEILATCD---HPYIVKLLGAYYHD   88 (302)
T ss_dssp             SCGGGTEEEEEEEECSTTCCEEEEEE-TTTCCEEEEEEEC------CCHHHHHHHHHHHHHCC---CTTBCCEEEEEECC
T ss_pred             cCCccceeecceeccCCCeEEEEEEE-cCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCC---CCCEeeeeeeeeeC
Confidence            34567999999999999999999999 5788999999986542  223456778999999987   99999999999776


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ...++|+|++++ +|.+++.... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        89 -------~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D  160 (302)
T 2j7t_A           89 -------GKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLAD  160 (302)
T ss_dssp             --------CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECC
T ss_pred             -------CeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEE
Confidence                   678999999985 8988887643 3489999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCC-Cccccccccccccchhhhh-----cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCC
Q psy2676         177 FGLAKTFDYD-MMLTSVVVTLWYRAPEILL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       177 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      ||++...... .......+++.|+|||++.     +..++.++||||||+++|+|++|..||...+.......+..... 
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-  239 (302)
T 2j7t_A          161 FGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP-  239 (302)
T ss_dssp             CHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-
T ss_pred             CCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC-
Confidence            9987543211 1223456889999999984     56689999999999999999999999988877666555443211 


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                       +...                      ....++..+.++|.+||+.||.+|||+.++++||||++..+.
T Consensus       240 -~~~~----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  285 (302)
T 2j7t_A          240 -PTLL----------------------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN  285 (302)
T ss_dssp             -CCCS----------------------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred             -cccC----------------------CccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence             1111                      012456889999999999999999999999999999987653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=333.34  Aligned_cols=262  Identities=27%  Similarity=0.489  Sum_probs=213.0

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      +...++|++.+.||+|+||+||+|.+ ..+++.|++|++...    .....+.+|+.+++++.   ||||+++++++...
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~   96 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIH-KETGQIVAIKQVPVE----SDLQEIIKEISIMQQCD---SPHVVKYYGSYFKN   96 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEE-TTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCC---CTTBCCEEEEEEET
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEE-CCCCCEEEEEecCch----HHHHHHHHHHHHHHhCC---CCCCccEEEEEEeC
Confidence            44567899999999999999999998 578999999998753    23457888999999987   99999999999776


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ...++|+|++++ +|.+++.... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        97 -------~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d  168 (314)
T 3com_A           97 -------TDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLAD  168 (314)
T ss_dssp             -------TEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECC
T ss_pred             -------CEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEee
Confidence                   678999999985 9999987432 3489999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         177 FGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       177 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ||.+....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...........+...  .++...
T Consensus       169 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~  246 (314)
T 3com_A          169 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN--PPPTFR  246 (314)
T ss_dssp             CTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCCCS
T ss_pred             cccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC--CCcccC
Confidence            99997665332 234457899999999999988999999999999999999999999887765554433321  111111


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      .                      ...++..+.++|.+||..||.+|||+.++++||||++..+.
T Consensus       247 ~----------------------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~  288 (314)
T 3com_A          247 K----------------------PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV  288 (314)
T ss_dssp             S----------------------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred             C----------------------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence            0                      12456889999999999999999999999999999987543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.3e-51  Score=358.72  Aligned_cols=263  Identities=17%  Similarity=0.246  Sum_probs=205.2

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEE----
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFF----   91 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~----   91 (321)
                      +....++|++.+.||+|+||+||+|++ ..+++.||+|++...... ......+.+|+.+++.+..+.||||++++    
T Consensus        68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~  146 (377)
T 3byv_A           68 LGERPRTLVRGTVLGQEDPYAYLEATD-QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  146 (377)
T ss_dssp             SSCCCEEEEEEEEEEEETTEEEEEEEC--CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred             cCCCCceEEEcceeecCCCEEEEEEEE-CCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence            344568999999999999999999998 578999999999754222 22335677899888888877899999998    


Q ss_pred             ---eeeecccc----------ccccceEEEEEeccCccCHHHHHhhCCCCCCC-------HHHHHHHHHHHHHHHHHHHh
Q psy2676          92 ---DVIHQNIL----------SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLS-------ASKVKELTRQMLKGVDFLHS  151 (321)
Q Consensus        92 ---~~~~~~~~----------~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~-------~~~~~~i~~~l~~~l~~lh~  151 (321)
                         +++.+...          ........++|||+++|+|.+++....  .++       +..++.++.||+.||+|||+
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  224 (377)
T 3byv_A          147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL--SHSSTHKSLVHHARLQLTLQVIRLLASLHH  224 (377)
T ss_dssp             CCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH--HTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc--ccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence               55443310          000111379999999999999998632  234       48888899999999999999


Q ss_pred             CCceeccCCCCcEEEeeCCCEEEeecCCcccccCCCccccccccccccchhhhhcC-----------CCCCcchHHHHHH
Q psy2676         152 HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL-----------GYGTPVDIWSIGC  220 (321)
Q Consensus       152 ~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Di~slG~  220 (321)
                      +|++||||||+||+++.++.+||+|||++.....  ......| +.|+|||++.+.           .++.++||||||+
T Consensus       225 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             CCeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999999986442  2334556 999999999887           7899999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCC
Q psy2676         221 VMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPAD  300 (321)
Q Consensus       221 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  300 (321)
                      ++|+|++|+.||.+.........+.                               .....+++++.+||.+||..||.+
T Consensus       302 il~elltg~~Pf~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~L~~dp~~  350 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSEWIF-------------------------------RSCKNIPQPVRALLEGFLRYPKED  350 (377)
T ss_dssp             HHHHHHHSSCCC------CCSGGGG-------------------------------SSCCCCCHHHHHHHHHHTCSSGGG
T ss_pred             HHHHHHHCCCCCcccccccchhhhh-------------------------------hhccCCCHHHHHHHHHHcCCCchh
Confidence            9999999999996543221111000                               011366789999999999999999


Q ss_pred             CCCHHHHhCCCCCCCC
Q psy2676         301 RISAADALEHPYFKEK  316 (321)
Q Consensus       301 Rps~~~ll~h~~f~~~  316 (321)
                      |||+.++++||||++.
T Consensus       351 Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          351 RLLPLQAMETPEYEQL  366 (377)
T ss_dssp             CCCHHHHHTSHHHHHH
T ss_pred             CCCHHHHhhChHHHHH
Confidence            9999999999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.2e-48  Score=336.19  Aligned_cols=259  Identities=29%  Similarity=0.398  Sum_probs=219.0

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ...++|.+.+.||+|+||.||++++ ..+++.+++|++....... .....+.+|+.+++++.   ||||+++++++.+.
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~  113 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISD-ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA---HQHVVGFHGFFEDN  113 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC---CTTBCCEEEEEECS
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC---CCCCCeEEEEEecC
Confidence            4567999999999999999999999 6788999999987643221 12345677999999887   99999999999877


Q ss_pred             ccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIAD  176 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~d  176 (321)
                             ...++|||++. ++|.+++...  ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|
T Consensus       114 -------~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~D  184 (335)
T 2owb_A          114 -------DFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGD  184 (335)
T ss_dssp             -------SEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECC
T ss_pred             -------CeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEee
Confidence                   67899999999 5999998773  4589999999999999999999999999999999999999999999999


Q ss_pred             cCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         177 FGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       177 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+......     
T Consensus       185 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----  259 (335)
T 2owb_A          185 FGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-----  259 (335)
T ss_dssp             CTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-----
T ss_pred             ccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC-----
Confidence            99998765332 334567899999999999998999999999999999999999999887766655554432111     


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                                            ....+++.+.+||++||+.||.+|||+.++++||||++..
T Consensus       260 ----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          260 ----------------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             ----------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence                                  0124558899999999999999999999999999998753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-49  Score=337.82  Aligned_cols=277  Identities=24%  Similarity=0.378  Sum_probs=194.3

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ...+.+..++|++.+.||+|++|+||+|++ ..+++.||+|++...... .....+.+|+.+++++.   ||||++++++
T Consensus         7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~---h~~i~~~~~~   81 (303)
T 2vwi_A            7 ALPWSINRDDYELQEVIGSGATAVVQAAYC-APKKEKVAIKRINLEKCQ-TSMDELLKEIQAMSQCH---HPNIVSYYTS   81 (303)
T ss_dssp             ------CCCCCEEEEECC---CCCEEEEEC-----CEEEEECCC-----------------CCCCCC---CTTBCCEEEE
T ss_pred             ccccccchhhhhhhheeccccceEEEEEEE-CCCCcEEEEEEEEhhhcc-hhHHHHHHHHHHHhhcC---CCCEeeEEEE
Confidence            445677889999999999999999999998 578899999998654322 22345667777777776   9999999999


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhh------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEK------CPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI  166 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~------~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv  166 (321)
                      +...       ...++|+|++. ++|.+++..      .....+++..++.++.||+.||.+||+.|++|+||+|+||++
T Consensus        82 ~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~  154 (303)
T 2vwi_A           82 FVVK-------DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL  154 (303)
T ss_dssp             EESS-------SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred             Eeec-------CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE
Confidence            9776       56899999997 599999874      123458999999999999999999999999999999999999


Q ss_pred             eeCCCEEEeecCCcccccCCC------ccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHH
Q psy2676         167 TRAGGLKIADFGLAKTFDYDM------MLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE  239 (321)
Q Consensus       167 ~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  239 (321)
                      +.++.++|+|||.+.......      ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......
T Consensus       155 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  234 (303)
T 2vwi_A          155 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK  234 (303)
T ss_dssp             CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred             cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh
Confidence            999999999999887654321      1234568999999999876 568999999999999999999999998766554


Q ss_pred             HHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         240 QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      .........  ++...  .             ..........++.++.++|.+||+.||.+|||+.++++||||++.+.+
T Consensus       235 ~~~~~~~~~--~~~~~--~-------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          235 VLMLTLQND--PPSLE--T-------------GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             HHHHHHTSS--CCCTT--C------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             HHHHHhccC--CCccc--c-------------ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            443322211  11000  0             000111234567899999999999999999999999999999987654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-49  Score=342.29  Aligned_cols=264  Identities=26%  Similarity=0.429  Sum_probs=213.0

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEec--CCCcEEEEEEeecccC--CCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQ--NKGNYVAMKKLRVKLN--EDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~--~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      .+..++|++.+.||+|+||+||+|++..  .+++.||+|+++....  .......+.+|+.+++++..  ||||++++++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~iv~~~~~  127 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ--SPFLVTLHYA  127 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT--CTTBCCEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccC--CCceeEEEEE
Confidence            3445799999999999999999999842  4789999999875422  12234466789999999953  9999999999


Q ss_pred             eeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +...       ...++||||+.+ +|.+++...  ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+
T Consensus       128 ~~~~-------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~  198 (355)
T 1vzo_A          128 FQTE-------TKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHV  198 (355)
T ss_dssp             EEET-------TEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCE
T ss_pred             EeeC-------ceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcE
Confidence            9777       678999999985 999999873  458999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCC--ccccccccccccchhhhhcC--CCCCcchHHHHHHHHHHHHhcCCCCCCCCh----HHHHHHH
Q psy2676         173 KIADFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNL--GYGTPVDIWSIGCVMAEMWRLVPLFCASTE----VEQLKCI  244 (321)
Q Consensus       173 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~  244 (321)
                      ||+|||++.......  ......+|+.|+|||++.+.  .++.++||||||+++|+|++|..||.....    ......+
T Consensus       199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  278 (355)
T 1vzo_A          199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI  278 (355)
T ss_dssp             EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred             EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence            999999987654322  23345789999999999863  478999999999999999999999975332    2222222


Q ss_pred             HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                      ...  .+.                         ....++..+.+||++||..||.+||     +++++++||||++.+|+
T Consensus       279 ~~~--~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~  331 (355)
T 1vzo_A          279 LKS--EPP-------------------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  331 (355)
T ss_dssp             HHC--CCC-------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             hcc--CCC-------------------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence            111  111                         1124568899999999999999999     99999999999987654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=333.47  Aligned_cols=282  Identities=21%  Similarity=0.260  Sum_probs=216.0

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      .....++|++.+.||+|+||+||+|++ ..+++.||+|++...... .....+.+|+.++++++   ||||+++++++..
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~   78 (319)
T 4euu_A            4 QSTSNHLWLLSDILGQGATANVFRGRH-KKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLN---HKNIVKLFAIEEE   78 (319)
T ss_dssp             EECSSEEEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCC---CTTBCCEEEEEEC
T ss_pred             ccCCCCCEEEEEEecCCCCeEEEEEEE-CCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcC---CCCcceEEEEeec
Confidence            345778999999999999999999999 578999999999754322 22456678999999998   9999999999865


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----eeCC
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPP-PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI----TRAG  170 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv----~~~~  170 (321)
                      ..     ....++|||++. ++|.+++..... ..+++..++.++.||+.||.|||+.|++|+||||+||++    +.++
T Consensus        79 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~  153 (319)
T 4euu_A           79 TT-----TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS  153 (319)
T ss_dssp             TT-----TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE
T ss_pred             CC-----CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc
Confidence            41     136799999998 599999987433 238999999999999999999999999999999999999    6667


Q ss_pred             CEEEeecCCcccccCCCccccccccccccchhhhh--------cCCCCCcchHHHHHHHHHHHHhcCCCCCCCC----hH
Q psy2676         171 GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL--------NLGYGTPVDIWSIGCVMAEMWRLVPLFCAST----EV  238 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~  238 (321)
                      .+||+|||++.............+++.|+|||++.        +..++.++||||||+++|+|++|..||....    ..
T Consensus       154 ~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  233 (319)
T 4euu_A          154 VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (319)
T ss_dssp             EEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH
T ss_pred             eEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH
Confidence            79999999998877666666677899999999987        4678999999999999999999999996432    23


Q ss_pred             HHHHHHHHHhCCCCCCCcchhhhhhhhhhhhh-hhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCC
Q psy2676         239 EQLKCIFRVIGTPSMNEWPENISLMWSSFEQY-SKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP  311 (321)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  311 (321)
                      +....+....   +...+..........+... ...........++..+.++|++||+.||.+|||++|+++||
T Consensus       234 ~~~~~~~~~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          234 EVMYKIITGK---PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HHHHHHHHHC---CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHhcCC---CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            3343433322   2111111000000000000 00011123345668899999999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.2e-49  Score=332.14  Aligned_cols=255  Identities=22%  Similarity=0.307  Sum_probs=204.8

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++.+.||+|+||+||+|++ ..+++.|++|++............+.+|+..+.++..  ||||+++++++.+.   
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~--h~~iv~~~~~~~~~---   83 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVK-RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HSHVVRYFSAWAED---   83 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCS--CTTBCCEEEEEEET---
T ss_pred             cchhhhhhhhcCCCceEEEEEEE-cCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCC--CCCeeeeeeeeecC---
Confidence            47899999999999999999999 6789999999998654444344567788888888842  99999999999877   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC-------
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPP--PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-------  170 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~-------  170 (321)
                          ...++|+|++++ +|.+++.....  ..+++..++.++.||+.||.+||++|++|+||||+||+++.++       
T Consensus        84 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~  159 (289)
T 1x8b_A           84 ----DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE  159 (289)
T ss_dssp             ----TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------
T ss_pred             ----CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccc
Confidence                688999999985 99999976421  4489999999999999999999999999999999999998444       


Q ss_pred             ------------CEEEeecCCcccccCCCccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCCh
Q psy2676         171 ------------GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTE  237 (321)
Q Consensus       171 ------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  237 (321)
                                  .++|+|||.+.......   ...+++.|+|||++.+. .++.++||||||+++++|++|.+++.....
T Consensus       160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~  236 (289)
T 1x8b_A          160 EGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ  236 (289)
T ss_dssp             ----------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred             ccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence                        79999999998765433   34589999999999876 466899999999999999999988754432


Q ss_pred             HHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         238 VEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ..   .+...    ...                      .....+++.+.++|++||+.||.+|||+.++++||||++..
T Consensus       237 ~~---~~~~~----~~~----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          237 WH---EIRQG----RLP----------------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             HH---HHHTT----CCC----------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             HH---HHHcC----CCC----------------------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            21   11111    011                      11225668999999999999999999999999999999753

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1e-48  Score=341.83  Aligned_cols=290  Identities=26%  Similarity=0.437  Sum_probs=221.8

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccC--------CCCceeE
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF--------EHPNIVR   89 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--------~~~~i~~   89 (321)
                      .+..++|++.+.||+|+||+||+|++ ..+++.||+|++....   .....+.+|+.+++++...        .||||++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~   90 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKD-MVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   90 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEe-cCCCcEEEEEEecCCc---cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence            34568999999999999999999999 6889999999986421   1234567899998888732        2799999


Q ss_pred             EEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEee
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITR  168 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-~~~H~di~p~Nilv~~  168 (321)
                      +++++...   .......++|+|+++++|.+++.......+++..++.++.||+.||.+||++ |++|+||||+||+++.
T Consensus        91 ~~~~~~~~---~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~  167 (373)
T 1q8y_A           91 LLDHFNHK---GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI  167 (373)
T ss_dssp             CCEEEEEE---ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred             HHHHhhcc---CCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEec
Confidence            99998765   1222478999999988999999987666799999999999999999999998 9999999999999965


Q ss_pred             CC------CEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCC------
Q psy2676         169 AG------GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST------  236 (321)
Q Consensus       169 ~~------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------  236 (321)
                      ++      .+||+|||++......  .....+|+.|+|||++.+..++.++||||||+++|+|++|..||....      
T Consensus       168 ~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          168 VDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             cCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence            43      6999999999776533  334578999999999999999999999999999999999999997654      


Q ss_pred             hHHHHHHHHHHhCCCCCCCcchhhhh--h------hhhhhh-----hh--hhhhhhhhhhcchhHHHHHHHhcccCCCCC
Q psy2676         237 EVEQLKCIFRVIGTPSMNEWPENISL--M------WSSFEQ-----YS--KVAFSAIFMDCCSKANSLLESMLTFNPADR  301 (321)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~------~~~~~~-----~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  301 (321)
                      ..+....+....+.++...+......  .      ...+..     ..  ..........++.++.+||++||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence            45566666666665443211000000  0      000000     00  000111223567899999999999999999


Q ss_pred             CCHHHHhCCCCCCCC
Q psy2676         302 ISAADALEHPYFKEK  316 (321)
Q Consensus       302 ps~~~ll~h~~f~~~  316 (321)
                      ||+.++++||||++.
T Consensus       326 pt~~ell~hp~f~~~  340 (373)
T 1q8y_A          326 ADAGGLVNHPWLKDT  340 (373)
T ss_dssp             BCHHHHHTCGGGTTC
T ss_pred             CCHHHHhhChhhhcc
Confidence            999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.5e-49  Score=334.25  Aligned_cols=262  Identities=27%  Similarity=0.405  Sum_probs=216.7

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC--CCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE--DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      .++|++.+.||+|+||.||+|.+ ..+++.+++|++......  ......+.+|+.++++++   ||||+++++++.+. 
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~-   78 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLD-SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR---HKNVIQLVDVLYNE-   78 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEB-TTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC---CTTBCCEEEEEECC-
T ss_pred             ccceeEeeEEecCCCeEEEEEEE-CCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC---CCCeeEEEEEEEcC-
Confidence            46899999999999999999998 678899999999764221  222456778999998887   99999999998533 


Q ss_pred             cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676          99 LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                          .....++|||++.++|.+++.......+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||
T Consensus        79 ----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg  154 (305)
T 2wtk_C           79 ----EKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALG  154 (305)
T ss_dssp             -------CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ----CCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccc
Confidence                1146799999999889999888777779999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCC---CccccccccccccchhhhhcCCC--CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         179 LAKTFDYD---MMLTSVVVTLWYRAPEILLNLGY--GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       179 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      .+......   .......+++.|+|||++.+...  +.++||||||+++|+|++|..||.+.+..+....+....  .. 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--~~-  231 (305)
T 2wtk_C          155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--YA-  231 (305)
T ss_dssp             TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--CC-
T ss_pred             cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC--CC-
Confidence            99876422   22334568999999999987543  779999999999999999999998877666655544321  11 


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                                              ...++++.+.++|++||..||.+|||+.++++||||++...
T Consensus       232 ------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          232 ------------------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             ------------------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             ------------------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence                                    11245688999999999999999999999999999987643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-48  Score=331.91  Aligned_cols=266  Identities=25%  Similarity=0.348  Sum_probs=208.1

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      ....+++..++|++.+.||+|+||+||+|++   +++.+|+|++............+.+|+.++++++   ||||+++++
T Consensus        28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~  101 (309)
T 3p86_A           28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR---HPNIVLFMG  101 (309)
T ss_dssp             ----CBCCGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC---CTTBCCEEE
T ss_pred             CcccccCChhHceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC---CCCEeeEEE
Confidence            4456778889999999999999999999965   5788999998754333222345778999999998   999999999


Q ss_pred             eeeccccccccceEEEEEeccCcc-CHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEee
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPP-PGLSASKVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLITR  168 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~--~~H~di~p~Nilv~~  168 (321)
                      ++.+.       ...++|||++.+ +|.+++..... ..+++..++.++.||+.||++||+.|  ++||||||+||+++.
T Consensus       102 ~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~  174 (309)
T 3p86_A          102 AVTQP-------PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK  174 (309)
T ss_dssp             EECST-------TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECT
T ss_pred             EEEEC-------CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeC
Confidence            99776       567999999985 99999987432 22899999999999999999999999  999999999999999


Q ss_pred             CCCEEEeecCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q psy2676         169 AGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       169 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  247 (321)
                      ++.+||+|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...
T Consensus       175 ~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  254 (309)
T 3p86_A          175 KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK  254 (309)
T ss_dssp             TCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS
T ss_pred             CCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            9999999999987554332 234567899999999999999999999999999999999999999988777666554332


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC--CCCCCCC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE--HPYFKEK  316 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h~~f~~~  316 (321)
                      ......                         ...+++.+.+||++||..||.+|||+.++++  .+++++.
T Consensus       255 ~~~~~~-------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          255 CKRLEI-------------------------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             CCCCCC-------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             CCCCCC-------------------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            222111                         1256689999999999999999999999997  4555543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4e-48  Score=328.63  Aligned_cols=257  Identities=27%  Similarity=0.458  Sum_probs=217.8

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ...++|++++.||+|+||+||+|++ ..+++.|++|++...... .....+.+|+.+++++.   ||||+++++++.+. 
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~-   92 (303)
T 3a7i_A           19 DPEELFTKLEKIGKGSFGEVFKGID-NRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCD---SPYVTKYYGSYLKD-   92 (303)
T ss_dssp             CGGGTEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCC---CTTBCCEEEEEEET-
T ss_pred             ChHHHHHHhhhhcccCCeEEEEEEE-CCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCC---CCCEeEEEEEEecC-
Confidence            3457899999999999999999998 578999999999765332 23456788999999987   99999999999876 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ...++|||++++ +|.+++..   ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus        93 ------~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Df  163 (303)
T 3a7i_A           93 ------TKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADF  163 (303)
T ss_dssp             ------TEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             ------CeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeec
Confidence                  678999999985 99999875   34899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         178 GLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       178 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      |.+....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...........+..... +.    
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~----  238 (303)
T 3a7i_A          164 GVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-PT----  238 (303)
T ss_dssp             TTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC----
T ss_pred             ccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC-CC----
Confidence            9997765433 23456789999999999999999999999999999999999999988776665544433211 11    


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                                           ....++..+.+||.+||..||.+|||+.++++||||.+.
T Consensus       239 ---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          239 ---------------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             ---------------------CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             ---------------------CccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                                 112456889999999999999999999999999999654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.1e-49  Score=339.38  Aligned_cols=269  Identities=25%  Similarity=0.345  Sum_probs=210.6

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ...+...++|++.+.||+|+||+||+|++ ..+++.||+|++....... .....+.+|+.++++++   ||||++++++
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~   80 (311)
T 3ork_A            5 TTPSHLSDRYELGEILGFGGMSEVHLARD-LRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN---HPAIVAVYDT   80 (311)
T ss_dssp             CCCSEETTTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC---CTTBCCEEEE
T ss_pred             CCcceecCcEEEEEEEccCCCEEEEEEEE-CCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC---CCCcceEEEe
Confidence            34455678999999999999999999999 6889999999997542221 11123456666666665   9999999999


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +....   ......++||||++ ++|.+++...  ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+
T Consensus        81 ~~~~~---~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~  155 (311)
T 3ork_A           81 GEAET---PAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAV  155 (311)
T ss_dssp             EEEEE---TTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCE
T ss_pred             eeccC---CCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCE
Confidence            87652   11235699999998 5999999873  458999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCC----ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHh
Q psy2676         173 KIADFGLAKTFDYDM----MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       173 kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      ||+|||++.......    ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+....+.........
T Consensus       156 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~  235 (311)
T 3ork_A          156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED  235 (311)
T ss_dssp             EECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC
T ss_pred             EEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC
Confidence            999999997664332    2233568999999999999999999999999999999999999998887766655544321


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      ..+                       ......+++.++.++|.+||+.||.+||++.+++.|+|++.
T Consensus       236 ~~~-----------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          236 PIP-----------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CCC-----------------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCC-----------------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            111                       11122357789999999999999999999999999999874

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.6e-49  Score=341.46  Aligned_cols=283  Identities=22%  Similarity=0.326  Sum_probs=222.0

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCC---------------chhHHHHHHHHhc
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP---------------MSTLREISILKQL   79 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~---------------~~~~~e~~~l~~l   79 (321)
                      ...+...++|++.+.||+|+||.||+|++   +++.||+|++..........               ..+.+|+.+++++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  100 (348)
T 2pml_X           24 KEKDKYINDYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI  100 (348)
T ss_dssp             SSSCEEETTEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred             hhcccccCceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence            34455568999999999999999999987   88999999997654332211               5778899999999


Q ss_pred             ccCCCCceeEEEeeeeccccccccceEEEEEeccCcc-CHHHH------HhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-
Q psy2676          80 DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSY------MEKCPPPGLSASKVKELTRQMLKGVDFLHS-  151 (321)
Q Consensus        80 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~------~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-  151 (321)
                      +   ||||+++++++.+.       ...++|||++++ +|.++      +.......+++..++.++.||+.||.+||+ 
T Consensus       101 ~---h~~i~~~~~~~~~~-------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  170 (348)
T 2pml_X          101 K---NEYCLTCEGIITNY-------DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE  170 (348)
T ss_dssp             C---CTTBCCCSEEEESS-------SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             C---CCCcceEEEEEeeC-------CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhcc
Confidence            7   99999999999877       688999999996 99998      665445669999999999999999999999 


Q ss_pred             CCceeccCCCCcEEEeeCCCEEEeecCCcccccCCCccccccccccccchhhhhcC-CCCC-cchHHHHHHHHHHHHhcC
Q psy2676         152 HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNL-GYGT-PVDIWSIGCVMAEMWRLV  229 (321)
Q Consensus       152 ~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Di~slG~~l~~l~~g~  229 (321)
                      .|++|+||+|+||+++.++.++|+|||.+...... ......+++.|+|||++.+. .++. ++||||||+++|+|++|.
T Consensus       171 ~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~  249 (348)
T 2pml_X          171 KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV  249 (348)
T ss_dssp             SCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSS
T ss_pred             CCEeecCCChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999999876533 34456789999999999887 5555 999999999999999999


Q ss_pred             CCCCCCCh-HHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHh
Q psy2676         230 PLFCASTE-VEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL  308 (321)
Q Consensus       230 ~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  308 (321)
                      .||..... .+....+.......+ ......       ...............++.++.+||++||..||.+|||+.+++
T Consensus       250 ~pf~~~~~~~~~~~~i~~~~~~~~-~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l  321 (348)
T 2pml_X          250 VPFSLKISLVELFNNIRTKNIEYP-LDRNHF-------LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL  321 (348)
T ss_dssp             CSSCCSSCSHHHHHHHTSCCCCCC-CSSSSS-------TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             CCCCCCCcHHHHHHHHhccCcCCc-cchhhh-------hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            99988766 444444332211111 000000       000011111222346789999999999999999999999999


Q ss_pred             CCCCCCCCCCC
Q psy2676         309 EHPYFKEKENE  319 (321)
Q Consensus       309 ~h~~f~~~~~~  319 (321)
                      +||||++.+++
T Consensus       322 ~hp~f~~~~~~  332 (348)
T 2pml_X          322 KHEWLADTNIE  332 (348)
T ss_dssp             TSGGGTTCCHH
T ss_pred             cCccccCCCHH
Confidence            99999988654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.3e-49  Score=337.00  Aligned_cols=278  Identities=21%  Similarity=0.319  Sum_probs=199.0

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCc---EEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeE
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGN---YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR   89 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~   89 (321)
                      .+....+..++|++.+.||+|+||+||+|++. .++.   .||+|+++...........+.+|+.++++++   ||||++
T Consensus        14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~   89 (323)
T 3qup_A           14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLK-QEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD---HPHVAK   89 (323)
T ss_dssp             --CTTBCC---CEEEEEEEEETTEEEEEEEC--------CEEEEEEC------CHHHHHHHHHHHHHTTCC---CTTBCC
T ss_pred             HhhhcccChhHeEEeceecccCCeEEEEEEEc-ccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCC---CCceeh
Confidence            45667788899999999999999999999984 3333   7999998765434333456778999999887   999999


Q ss_pred             EEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCP----PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNL  164 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Ni  164 (321)
                      +++++...... ......++|+|++.+ +|.+++....    ...+++..++.++.||+.||.|||++|++|+||||+||
T Consensus        90 ~~~~~~~~~~~-~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NI  168 (323)
T 3qup_A           90 LVGVSLRSRAK-GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNC  168 (323)
T ss_dssp             CCEEEECC--------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             hhceeeccccc-cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceE
Confidence            99998766211 112235999999995 9999986532    12489999999999999999999999999999999999


Q ss_pred             EEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHH
Q psy2676         165 LITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQ  240 (321)
Q Consensus       165 lv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~  240 (321)
                      +++.++.+||+|||.+........   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+.
T Consensus       169 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~  248 (323)
T 3qup_A          169 MLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI  248 (323)
T ss_dssp             EECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred             EEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence            999999999999999976643322   223455778999999999999999999999999999999 9999988777666


Q ss_pred             HHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-------HHHHhCCCCC
Q psy2676         241 LKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-------AADALEHPYF  313 (321)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-------~~~ll~h~~f  313 (321)
                      ...+......+.                          ...+++++.++|.+||+.||.+|||       ++++++|||+
T Consensus       249 ~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~  302 (323)
T 3qup_A          249 YNYLIGGNRLKQ--------------------------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV  302 (323)
T ss_dssp             HHHHHTTCCCCC--------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred             HHHHhcCCCCCC--------------------------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence            655543221111                          1245688999999999999999999       8889999999


Q ss_pred             CCCCCCCC
Q psy2676         314 KEKENEPL  321 (321)
Q Consensus       314 ~~~~~~~~  321 (321)
                      ....+.+|
T Consensus       303 ~~~~~~pl  310 (323)
T 3qup_A          303 LSTSQDPL  310 (323)
T ss_dssp             --------
T ss_pred             cCCCCCCC
Confidence            98766654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.8e-48  Score=332.24  Aligned_cols=271  Identities=28%  Similarity=0.445  Sum_probs=210.6

Q ss_pred             cccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCcee
Q psy2676           9 IQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV   88 (321)
Q Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~   88 (321)
                      ..++....+++.+++|++++.||+|+||.||++.+  .+++.+|+|++............+.+|+.+++++.. .||||+
T Consensus        15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~~~iv   91 (313)
T 3cek_A           15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN--EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDKII   91 (313)
T ss_dssp             -----CCEEEETTEEEEEEEEEECCSSEEEEEEEC--TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGG-GCTTBC
T ss_pred             CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEc--CCCcEEEEEEeccccccccchHHHHHHHHHHHhccc-cCCceE
Confidence            34567778889999999999999999999999987  358899999997653333334567789999999972 259999


Q ss_pred             EEEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee
Q psy2676          89 RFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR  168 (321)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~  168 (321)
                      ++++++...       ...++|||+..++|.+++...  ..+++..++.++.||+.||.+||+.|++|+||||+||+++ 
T Consensus        92 ~~~~~~~~~-------~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-  161 (313)
T 3cek_A           92 RLYDYEITD-------QYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-  161 (313)
T ss_dssp             CEEEEEECS-------SEEEEEECCCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-
T ss_pred             EEEEEeecC-------CEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-
Confidence            999999777       678999997778999999884  4589999999999999999999999999999999999996 


Q ss_pred             CCCEEEeecCCcccccCCCc---cccccccccccchhhhhc-----------CCCCCcchHHHHHHHHHHHHhcCCCCCC
Q psy2676         169 AGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLN-----------LGYGTPVDIWSIGCVMAEMWRLVPLFCA  234 (321)
Q Consensus       169 ~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~pf~~  234 (321)
                      ++.+||+|||++........   .....+++.|+|||++.+           ..++.++||||||+++|+|++|..||..
T Consensus       162 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (313)
T 3cek_A          162 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  241 (313)
T ss_dssp             TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence            58999999999986643322   234568999999999876           4578899999999999999999999976


Q ss_pred             CChH-HHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         235 STEV-EQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       235 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      .... .....+.   .......++                      ...+.++.++|++||..||.+|||+.++++||||
T Consensus       242 ~~~~~~~~~~~~---~~~~~~~~~----------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~  296 (313)
T 3cek_A          242 IINQISKLHAII---DPNHEIEFP----------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  296 (313)
T ss_dssp             CCSHHHHHHHHH---CTTSCCCCC----------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             HHHHHHHHHHHH---hcccccCCc----------------------ccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence            5432 2222222   111111111                      1335789999999999999999999999999999


Q ss_pred             CCCC
Q psy2676         314 KEKE  317 (321)
Q Consensus       314 ~~~~  317 (321)
                      +...
T Consensus       297 ~~~~  300 (313)
T 3cek_A          297 QIQT  300 (313)
T ss_dssp             HCC-
T ss_pred             cCCC
Confidence            8763

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.4e-48  Score=327.64  Aligned_cols=263  Identities=29%  Similarity=0.486  Sum_probs=215.8

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.+.||+|+||+||+|++ ..+++.+++|++............+.+|+.++++++   ||||+++++++.+.. 
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~-   78 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRR-KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK---HPNIVRYYDRIIDRT-   78 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC---CTTBCCEEEEEEEGG-
T ss_pred             chhheeeehhccCCCCcEEEEEEE-CCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC---CCCCCeEEEEEecCC-
Confidence            357999999999999999999999 678999999999765333333446778999999997   999999999875431 


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCcEEEeeCCC
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCP--PPGLSASKVKELTRQMLKGVDFLHSHR-----IIHRDLKPQNLLITRAGG  171 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lh~~~-----~~H~di~p~Nilv~~~~~  171 (321)
                          ....++|||++++ +|.+++....  ...+++..++.++.||+.||.+||+.|     ++|+||+|+||+++.++.
T Consensus        79 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~  154 (279)
T 2w5a_A           79 ----NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN  154 (279)
T ss_dssp             ----GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC
T ss_pred             ----CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC
Confidence                1568999999985 9999997632  234899999999999999999999999     999999999999999999


Q ss_pred             EEEeecCCcccccCCCc-cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCC
Q psy2676         172 LKIADFGLAKTFDYDMM-LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      ++|+|||.+........ .....+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  234 (279)
T 2w5a_A          155 VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR  234 (279)
T ss_dssp             EEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             EEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc
Confidence            99999999877653322 23456889999999999989999999999999999999999999888776665555443211


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      .                          ....++.++.++|.+||+.||.+|||+.++++|+|+.+..
T Consensus       235 ~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          235 R--------------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             C--------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             c--------------------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            1                          1124568999999999999999999999999999998753

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.4e-49  Score=341.08  Aligned_cols=278  Identities=22%  Similarity=0.376  Sum_probs=194.6

Q ss_pred             cccccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHH-HHHhcccCCCC
Q psy2676           7 DTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREIS-ILKQLDTFEHP   85 (321)
Q Consensus         7 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~~   85 (321)
                      ...+..+...+++..++|++.+.||+|+||.||+|.+ ..+++.||+|++....... .......|+. +++.+.   ||
T Consensus         7 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~---h~   81 (327)
T 3aln_A            7 GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVH-KPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVVMRSSD---CP   81 (327)
T ss_dssp             EEEECCCCEEECCCSCSEEC-CEEEECSSEEEEEEEE-TTTTEEEEEEEEECCCCHH-HHHHHHHHHHHHHSSCC---CT
T ss_pred             CCcCCChHHhcccCHHHhhehheeccCCCEEEEEEEE-cCCCCEEEEEEeecccCch-HHHHHHHHHHHHHHcCC---CC
Confidence            3444446667888889999999999999999999999 6789999999997542211 1123334444 344444   99


Q ss_pred             ceeEEEeeeeccccccccceEEEEEeccCccCHHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCC
Q psy2676          86 NIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEK---CPPPGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKP  161 (321)
Q Consensus        86 ~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lh~~-~~~H~di~p  161 (321)
                      ||+++++++.+.       ...++|||++.++|.+++..   .....+++..++.++.|++.||.+||+. |++|+||||
T Consensus        82 niv~~~~~~~~~-------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp  154 (327)
T 3aln_A           82 YIVQFYGALFRE-------GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKP  154 (327)
T ss_dssp             TBCCEEEEEECS-------SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCG
T ss_pred             cEeeeeeEEEeC-------CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCH
Confidence            999999999877       67899999999988888763   2245589999999999999999999999 999999999


Q ss_pred             CcEEEeeCCCEEEeecCCcccccCCCccccccccccccchhhh----hcCCCCCcchHHHHHHHHHHHHhcCCCCCCCCh
Q psy2676         162 QNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEIL----LNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE  237 (321)
Q Consensus       162 ~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  237 (321)
                      +||+++.++.+||+|||++.............+++.|+|||++    .+..++.++||||||+++|+|++|..||.....
T Consensus       155 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  234 (327)
T 3aln_A          155 SNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS  234 (327)
T ss_dssp             GGEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--
T ss_pred             HHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence            9999999999999999999877655444555789999999998    456689999999999999999999999976432


Q ss_pred             HHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         238 VEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ....  +.... ......++                  ......+++.+.+||++||..||.+|||+.++++||||.+..
T Consensus       235 ~~~~--~~~~~-~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          235 VFDQ--LTQVV-KGDPPQLS------------------NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             -------CCCC-CSCCCCCC------------------CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             HHHH--HHHHh-cCCCCCCC------------------CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence            1110  00000 00000000                  001134678999999999999999999999999999997643

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=333.92  Aligned_cols=268  Identities=23%  Similarity=0.357  Sum_probs=195.3

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      ....+...-++|++++.||+|+||+||+|++ ..+++.||+|++..............++..+++.+.   ||||+++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~---h~~i~~~~~   91 (318)
T 2dyl_A           16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRF-RKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD---CPYIVQCFG   91 (318)
T ss_dssp             SSSEEECCGGGEEEEEEC------CEEEEEE-TTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTT---CTTBCCEEE
T ss_pred             cchhhhhhhccccccceeeecCCeeEEEEEE-ecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcC---CCceeeEEE
Confidence            4445666778999999999999999999999 578999999999754322211122233334455555   999999999


Q ss_pred             eeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH-RIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~-~~~H~di~p~Nilv~~~~~  171 (321)
                      ++.+.       ...++|||++++.+..+.... ...+++..++.++.||+.||.+||+. |++|+||+|+||+++.++.
T Consensus        92 ~~~~~-------~~~~lv~e~~~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~  163 (318)
T 2dyl_A           92 TFITN-------TDVFIAMELMGTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ  163 (318)
T ss_dssp             EEECS-------SEEEEEECCCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC
T ss_pred             EEecC-------CcEEEEEeccCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC
Confidence            99877       678999999976666665543 34589999999999999999999995 9999999999999999999


Q ss_pred             EEEeecCCcccccCCCccccccccccccchhhhh-----cCCCCCcchHHHHHHHHHHHHhcCCCCCCC-ChHHHHHHHH
Q psy2676         172 LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCAS-TEVEQLKCIF  245 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~  245 (321)
                      ++|+|||.+.............+++.|+|||++.     ...++.++||||||+++|+|++|..||... ...+....+.
T Consensus       164 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  243 (318)
T 2dyl_A          164 IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL  243 (318)
T ss_dssp             EEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             EEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh
Confidence            9999999997766555555667899999999994     456789999999999999999999999874 3444444443


Q ss_pred             HHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         246 RVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ... .+....                       ...+++++.++|.+||..||.+|||+.++++||||++.
T Consensus       244 ~~~-~~~~~~-----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          244 QEE-PPLLPG-----------------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             HSC-CCCCCS-----------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             ccC-CCCCCc-----------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            321 111111                       12466899999999999999999999999999999754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1e-50  Score=353.96  Aligned_cols=277  Identities=18%  Similarity=0.197  Sum_probs=196.7

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeee---
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVI---   94 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~---   94 (321)
                      ....+|++.+.||+|+||+||+|++ ..+++.||+|++...... ......+.+|+.+++.+.. .|||+++++..+   
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p  136 (371)
T 3q60_A           59 QGERKLKLVEPLRVGDRSVVFLVRD-VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLP  136 (371)
T ss_dssp             CCEEEEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCC
T ss_pred             CCceeeeeeeeccCCCCEEEEEEEE-CCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEee
Confidence            3445699999999999999999999 578999999999865321 1123355678777777776 699988866433   


Q ss_pred             ----ecccc----------ccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCc
Q psy2676          95 ----HQNIL----------SDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV------KELTRQMLKGVDFLHSHRI  154 (321)
Q Consensus        95 ----~~~~~----------~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~------~~i~~~l~~~l~~lh~~~~  154 (321)
                          .....          .......+++||||++++|.+++...+.. +++..+      ..++.||+.||+|||++|+
T Consensus       137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~-~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i  215 (371)
T 3q60_A          137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV-YVFRGDEGILALHILTAQLIRLAANLQSKGL  215 (371)
T ss_dssp             CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             ehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccc-cchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence                22210          00111458999999999999999874322 455555      6777999999999999999


Q ss_pred             eeccCCCCcEEEeeCCCEEEeecCCcccccCCCccccccccccccchhhhhc--CCCCCcchHHHHHHHHHHHHhcCCCC
Q psy2676         155 IHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN--LGYGTPVDIWSIGCVMAEMWRLVPLF  232 (321)
Q Consensus       155 ~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf  232 (321)
                      +||||||+||+++.++.+||+|||++...+...  ....+++.|+|||++.+  ..++.++||||||+++|+|++|+.||
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999998765322  24556699999999987  67899999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q psy2676         233 CASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY  312 (321)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  312 (321)
                      .........             .+....     ................+++.+.+||.+||+.||.+|||+.++++|||
T Consensus       294 ~~~~~~~~~-------------~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  355 (371)
T 3q60_A          294 GLVTPGIKG-------------SWKRPS-----LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE  355 (371)
T ss_dssp             TBCCTTCTT-------------CCCBCC-----TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred             CCcCccccc-------------chhhhh-----hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence            765321100             000000     00000000000112367799999999999999999999999999999


Q ss_pred             CCCCCC
Q psy2676         313 FKEKEN  318 (321)
Q Consensus       313 f~~~~~  318 (321)
                      |++..+
T Consensus       356 f~~~~~  361 (371)
T 3q60_A          356 FLQLQN  361 (371)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            987543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.8e-48  Score=329.49  Aligned_cols=260  Identities=24%  Similarity=0.373  Sum_probs=214.2

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC----CCCchhHHHHHHHHhcccCCCCcee
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED----GIPMSTLREISILKQLDTFEHPNIV   88 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~i~   88 (321)
                      +....+...++|++.+.||+|+||+||+|++ ..+++.||+|++.......    .....+.+|+.+++++.. .|||++
T Consensus        34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~~~i~  111 (320)
T 3a99_A           34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIR-VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS-GFSGVI  111 (320)
T ss_dssp             ------CCTTTEEEEEECSSSSSCEEEEEEE-TTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS-SSCSBC
T ss_pred             cccccCCccCceEEEEEEeeCCCeEEEEEEE-CCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhcc-CCCCce
Confidence            4556777889999999999999999999998 6789999999997764332    234567889999999972 369999


Q ss_pred             EEEeeeeccccccccceEEEEEeccCc--cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q psy2676          89 RFFDVIHQNILSDERYLTVYLIFEHVD--QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI  166 (321)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~v~e~~~--~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv  166 (321)
                      ++++++...       ...++|+|++.  ++|.+++..  ...+++..++.++.||+.||.+||+.|++|+||||+||++
T Consensus       112 ~~~~~~~~~-------~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll  182 (320)
T 3a99_A          112 RLLDWFERP-------DSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI  182 (320)
T ss_dssp             CEEEEEECS-------SEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             EEEEEEecC-------CcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEE
Confidence            999999877       67899999997  699999987  3458999999999999999999999999999999999999


Q ss_pred             e-eCCCEEEeecCCcccccCCCccccccccccccchhhhhcCCC-CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q psy2676         167 T-RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI  244 (321)
Q Consensus       167 ~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  244 (321)
                      + .++.+||+|||++...... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||.....      +
T Consensus       183 ~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~  255 (320)
T 3a99_A          183 DLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------I  255 (320)
T ss_dssp             ETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H
T ss_pred             eCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------h
Confidence            9 6789999999999876533 3344578999999999987775 6889999999999999999999965321      1


Q ss_pred             HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ..  ....                         ....+++++.+||++||..||.+|||++++++||||++..
T Consensus       256 ~~--~~~~-------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          256 IR--GQVF-------------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             HH--CCCC-------------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             hc--cccc-------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            11  1100                         1124668999999999999999999999999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.6e-47  Score=320.78  Aligned_cols=256  Identities=17%  Similarity=0.198  Sum_probs=211.9

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      .++..++|++.+.||+|++|+||+|++ ..+++.||+|++....    ....+.+|+.+++++..  |+|++++++++.+
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~--~~~i~~~~~~~~~   77 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTN-LLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAG--CTGIPNVYYFGQE   77 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEE-TTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTT--CTTCCCEEEEEEE
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEE-CCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhc--CCCCCeEEeecCC
Confidence            345678999999999999999999998 5889999999986432    33478899999999964  9999999999877


Q ss_pred             cccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC-----
Q psy2676          97 NILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG-----  171 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~-----  171 (321)
                      .       ...++|+|+++++|.+++...+. .+++..++.++.||+.||.+||++|++|+||||+||+++.++.     
T Consensus        78 ~-------~~~~lv~e~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~  149 (298)
T 1csn_A           78 G-------LHNVLVIDLLGPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANM  149 (298)
T ss_dssp             T-------TEEEEEEECCCCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTC
T ss_pred             C-------ceeEEEEEecCCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCe
Confidence            6       67899999998899999987543 4999999999999999999999999999999999999988776     


Q ss_pred             EEEeecCCcccccCCCc--------cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCC---hHHH
Q psy2676         172 LKIADFGLAKTFDYDMM--------LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST---EVEQ  240 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~  240 (321)
                      ++|+|||++........        .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+..   ....
T Consensus       150 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  229 (298)
T 1csn_A          150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK  229 (298)
T ss_dssp             EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred             EEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH
Confidence            99999999987654322        344568999999999999999999999999999999999999998743   3333


Q ss_pred             HHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         241 LKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ...+....                      ..........++++++.+++.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~----------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          230 YERIGEKK----------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHHHHH----------------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHHhhc----------------------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            22222211                      111222334467899999999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-47  Score=320.32  Aligned_cols=252  Identities=20%  Similarity=0.322  Sum_probs=212.0

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +.+..++|++.+.||+|+||+||++++  .+++.+|+|++.....   ....+.+|+.++++++   ||||+++++++.+
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~   76 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYW--LNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLS---HPKLVQLYGVCLE   76 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE--TTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCC---CTTBCCEEEEECS
T ss_pred             EEeChhhceeeheecCCCccEEEEEEe--cCCCeEEEEEeccccc---CHHHHHHHHHHHHhCC---CCCEeeEEEEEec
Confidence            456778999999999999999999998  3677899999875322   2346789999999998   9999999999977


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ...++|||++++ +|.+++.... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+
T Consensus        77 ~-------~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~  148 (269)
T 4hcu_A           77 Q-------APICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVS  148 (269)
T ss_dssp             S-------SSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEEC
T ss_pred             C-------CceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEec
Confidence            6       568999999985 9999997644 348999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCC--ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         176 DFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       176 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |||++.......  ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+........
T Consensus       149 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~  228 (269)
T 4hcu_A          149 DFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK  228 (269)
T ss_dssp             CTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             cccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC
Confidence            999997654322  2233455778999999999999999999999999999999 9999998887776666544322111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      .                          ..+++.+.+++++||+.||.+|||+.++++|
T Consensus       229 ~--------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          229 P--------------------------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             C--------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C--------------------------CcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            1                          1345889999999999999999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.3e-48  Score=328.54  Aligned_cols=261  Identities=28%  Similarity=0.352  Sum_probs=207.5

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      .+...++|++++.||+|+||+||+|++ ..+++.+|+|++....... .....+.+|+.++++++   ||||+++++++.
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~   81 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAED-TILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS---HQNIVSMIDVDE   81 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEE-TTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC---BTTBCCEEEEEE
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEE-CCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC---CCCCceEEEeee
Confidence            455678999999999999999999999 6789999999986543222 11235667888888887   999999999997


Q ss_pred             ccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      +.       ...++|||+++| +|.+++...  +.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|
T Consensus        82 ~~-------~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl  152 (294)
T 4eqm_A           82 ED-------DCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKI  152 (294)
T ss_dssp             CS-------SEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred             eC-------CeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEE
Confidence            77       688999999985 999999874  45899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCC--ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         175 ADFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       175 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      +|||++.......  ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+............   .
T Consensus       153 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~---~  229 (294)
T 4eqm_A          153 FDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS---V  229 (294)
T ss_dssp             CCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC---C
T ss_pred             EeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc---C
Confidence            9999998765332  2234568999999999999999999999999999999999999998877665544333210   0


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY  312 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  312 (321)
                       .                  ........++++.+.++|.+||..||.+||+..+.+.+.|
T Consensus       230 -~------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l  270 (294)
T 4eqm_A          230 -P------------------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL  270 (294)
T ss_dssp             -C------------------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred             -C------------------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence             0                  0111223467899999999999999999995555554433

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.2e-47  Score=321.08  Aligned_cols=266  Identities=27%  Similarity=0.407  Sum_probs=209.1

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      ......-++|.....||+|+||+||+|++ ..+++.|++|++....  ......+.+|+.+++++.   ||||+++++++
T Consensus        15 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~   88 (295)
T 2clq_A           15 LEYDYEYDENGDRVVLGKGTYGIVYAGRD-LSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLK---HKNIVQYLGSF   88 (295)
T ss_dssp             CCEEECBCTTSSBCEEEECSSSEEEEEEE-TTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCC---CTTBCCEEEEE
T ss_pred             ccccccccCCCCcEEEeecCcEEEEEEEE-CCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCC---CCCEeeEeeEE
Confidence            34444445555566999999999999999 5788999999987542  233456788999999997   99999999999


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee-CCC
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP-PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR-AGG  171 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~-~~~  171 (321)
                      ...       ...++|+|++. ++|.+++..... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++. ++.
T Consensus        89 ~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~  161 (295)
T 2clq_A           89 SEN-------GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV  161 (295)
T ss_dssp             EET-------TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC
T ss_pred             EeC-------CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC
Confidence            776       67899999997 599999987532 34679999999999999999999999999999999999998 899


Q ss_pred             EEEeecCCcccccCCC-ccccccccccccchhhhhcCC--CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHh
Q psy2676         172 LKIADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLG--YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      ++|+|||.+....... ......+++.|+|||++.+..  ++.++||||||+++|+|++|..||................
T Consensus       162 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  241 (295)
T 2clq_A          162 LKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF  241 (295)
T ss_dssp             EEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH
T ss_pred             EEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc
Confidence            9999999997665322 233457899999999997754  7889999999999999999999997644333221111111


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ...+                        .....+++++.++|.+||..||.+|||+.++++||||+...
T Consensus       242 ~~~~------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          242 KVHP------------------------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             CCCC------------------------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             cccc------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            1110                        11225668999999999999999999999999999999653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-47  Score=322.34  Aligned_cols=261  Identities=20%  Similarity=0.317  Sum_probs=212.7

Q ss_pred             ccccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCce
Q psy2676           8 TIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI   87 (321)
Q Consensus         8 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i   87 (321)
                      +........+++..++|++++.||+|+||+||++.+  .++..|++|++.....   ....+.+|+.+++++.   ||||
T Consensus        10 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~---h~~i   81 (283)
T 3gen_A           10 STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLS---HEKL   81 (283)
T ss_dssp             ------CCTTBCCGGGEEEEEECC---CEEEEEEEE--TTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCC---CTTB
T ss_pred             cccCCCCCCccCCHHHHHhHhhcCCCCCceEEEEEE--cCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCC---CCCE
Confidence            344556778889999999999999999999999987  4677899999875422   2356788999999998   9999


Q ss_pred             eEEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q psy2676          88 VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI  166 (321)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv  166 (321)
                      +++++++.+.       ...++|||++. ++|.+++..... .+++..++.++.||+.||.+||++|++|+||||+||++
T Consensus        82 ~~~~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili  153 (283)
T 3gen_A           82 VQLYGVCTKQ-------RPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV  153 (283)
T ss_dssp             CCEEEEECSS-------SSEEEEECCCTTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE
T ss_pred             eeEEEEEecC-------CCeEEEEeccCCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE
Confidence            9999999776       67899999997 599999976433 48999999999999999999999999999999999999


Q ss_pred             eeCCCEEEeecCCcccccCCC--ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHH
Q psy2676         167 TRAGGLKIADFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKC  243 (321)
Q Consensus       167 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~  243 (321)
                      +.++.++|+|||.+.......  ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....
T Consensus       154 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~  233 (283)
T 3gen_A          154 NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH  233 (283)
T ss_dssp             CTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred             cCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH
Confidence            999999999999997664322  1223445678999999999999999999999999999998 9999998887777666


Q ss_pred             HHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         244 IFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      +.........                          ..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       234 ~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          234 IAQGLRLYRP--------------------------HLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHTTCCCCCC--------------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HhcccCCCCC--------------------------CcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            5543222211                          1345789999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.6e-47  Score=319.30  Aligned_cols=253  Identities=23%  Similarity=0.345  Sum_probs=211.8

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      .+++..++|++.+.||+|+||+||++.+  .++..+|+|++.....   ....+.+|+.+++++.   ||||+++++++.
T Consensus         2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~---h~~i~~~~~~~~   73 (268)
T 3sxs_A            2 HMELKREEITLLKELGSGQFGVVKLGKW--KGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLS---HPKLVKFYGVCS   73 (268)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEE--TTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCC---CTTBCCEEEEEC
T ss_pred             ceEechhheeeeeeeccCCCceEEEEEe--cCceeEEEEEeccCCC---cHHHHHHHHHHHHhCC---CCCEeeEEEEEc
Confidence            3567889999999999999999999987  4677899999875322   2346789999999998   999999999997


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      +.       ...++|||+++ ++|.+++.... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|
T Consensus        74 ~~-------~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l  145 (268)
T 3sxs_A           74 KE-------YPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKV  145 (268)
T ss_dssp             SS-------SSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEE
T ss_pred             cC-------CceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEE
Confidence            66       66899999998 58999997743 23899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         175 ADFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       175 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      +|||.+........  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+.......
T Consensus       146 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  225 (268)
T 3sxs_A          146 SDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY  225 (268)
T ss_dssp             CCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             ccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC
Confidence            99999986654332  223445677999999999899999999999999999999 999998887776665554322111


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ..                          ..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       226 ~~--------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          226 RP--------------------------HLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             CC--------------------------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CC--------------------------CcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            11                          1345789999999999999999999999975

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.1e-47  Score=326.90  Aligned_cols=253  Identities=19%  Similarity=0.240  Sum_probs=207.7

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      +.+++|++.+.||+|+||+||+|++ ..+++.||+|++....    ....+.+|+.+++++..  ||||+++++++.+. 
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~--h~~i~~~~~~~~~~-   77 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKN-LYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGS--GDGIPQVYYFGPCG-   77 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEE-TTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCS--CTTSCCEEEEEEET-
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEE-CCCCcEEEEEEecccc----chHHHHHHHHHHHHhhC--CCCCCEEEEEEecC-
Confidence            3568999999999999999999998 6889999999987542    23468899999999943  99999999999876 


Q ss_pred             cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC-----EE
Q psy2676          99 LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG-----LK  173 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~-----~k  173 (321)
                            ...++|||+++++|.+++.... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.     ++
T Consensus        78 ------~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~k  150 (330)
T 2izr_A           78 ------KYNAMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIH  150 (330)
T ss_dssp             ------TEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEE
T ss_pred             ------CccEEEEEeCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEE
Confidence                  6789999999779999998753 45999999999999999999999999999999999999998887     99


Q ss_pred             EeecCCcccccCCCc--------cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChH---HHHH
Q psy2676         174 IADFGLAKTFDYDMM--------LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV---EQLK  242 (321)
Q Consensus       174 l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~  242 (321)
                      |+|||++........        .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+....   +...
T Consensus       151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~  230 (330)
T 2izr_A          151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ  230 (330)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH
T ss_pred             EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHH
Confidence            999999987643322        24567899999999999999999999999999999999999999874332   2222


Q ss_pred             HHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .+....                      ...........+| ++.+++..||..||.+||+++++++
T Consensus       231 ~i~~~~----------------------~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          231 KIGDTK----------------------RATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHHH----------------------HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHhhh----------------------ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            222110                      0001111223355 9999999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=328.52  Aligned_cols=256  Identities=22%  Similarity=0.337  Sum_probs=209.0

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEec--CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQ--NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ..++..++|++.+.||+|+||+||+|++..  ..+..||+|+++.... ......+.+|+.++++++   ||||++++++
T Consensus        43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~---h~~iv~~~~~  118 (325)
T 3kul_A           43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASIMGQFD---HPNIIRLEGV  118 (325)
T ss_dssp             CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC-HHHHHHHHHHHHHHTTCC---CTTBCCEEEE
T ss_pred             ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC-HHHHHHHHHHHHHHHhCC---CCCCCcEEEE
Confidence            346677899999999999999999999832  2334699999874322 112345778999999887   9999999999


Q ss_pred             eeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +.+.       ...++|||++.+ +|.+++.... ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++.+
T Consensus       119 ~~~~-------~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~  190 (325)
T 3kul_A          119 VTRG-------RLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVC  190 (325)
T ss_dssp             ECGG-------GCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred             EEeC-------CccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCE
Confidence            9776       678999999985 9999997643 349999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHH
Q psy2676         173 KIADFGLAKTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  247 (321)
                      +|+|||++........    .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+...
T Consensus       191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  270 (325)
T 3kul_A          191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG  270 (325)
T ss_dssp             EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence            9999999987653321    223345678999999999999999999999999999999 99999988887776666543


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ...+..                          ..+++.+.++|.+||..||.+|||+.++++
T Consensus       271 ~~~~~~--------------------------~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          271 YRLPAP--------------------------MGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CCCCCC--------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCC--------------------------CCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            222211                          246689999999999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-47  Score=325.66  Aligned_cols=264  Identities=27%  Similarity=0.426  Sum_probs=201.3

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc-
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL-   99 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~-   99 (321)
                      .++|++++.||+|+||+||+|++ ..+++.|++|++....   .....+.+|+.++++++   ||||+++++++.+... 
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~   77 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARN-ALDSRYYAIKKIRHTE---EKLSTILSEVMLLASLN---HQYVVRYYAAWLERRNF   77 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEEEH---HHHHHHHHHHHHHTTCC---CTTBCCEEEEEEECCCC
T ss_pred             cccchhhheeccCCcEEEEEEEE-cCCCeEEEEEEEeccH---HHHHHHHHHHHHHHhcC---chHHHHHHHHHHhhcch
Confidence            36899999999999999999998 5789999999986431   12345678898888887   9999999999865311 


Q ss_pred             -----ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676         100 -----SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus       100 -----~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                           ........++|+|++.+ +|.+++.... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++
T Consensus        78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             CC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred             hhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEE
Confidence                 11223678999999985 9999998643 3478999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCC---------------CccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCCh
Q psy2676         174 IADFGLAKTFDYD---------------MMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTE  237 (321)
Q Consensus       174 l~dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  237 (321)
                      |+|||.+......               .......+++.|+|||++.+. .++.++||||||+++|+|++   ||.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            9999998765422               122345688999999999865 58999999999999999998   5543222


Q ss_pred             -HHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         238 -VEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       238 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                       ......+.. ........                      .....+..+.++|++||+.||.+|||+.++++||||+..
T Consensus       234 ~~~~~~~~~~-~~~~~~~~----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          234 RVNILKKLRS-VSIEFPPD----------------------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHHHHS-TTCCCCTT----------------------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHHHHHhccc-cccccCcc----------------------ccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence             222222211 11111111                      122455789999999999999999999999999999876


Q ss_pred             CC
Q psy2676         317 EN  318 (321)
Q Consensus       317 ~~  318 (321)
                      .+
T Consensus       291 ~~  292 (303)
T 1zy4_A          291 HQ  292 (303)
T ss_dssp             CH
T ss_pred             Ch
Confidence            54

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.4e-48  Score=332.75  Aligned_cols=264  Identities=26%  Similarity=0.407  Sum_probs=183.8

Q ss_pred             cCCcceeeee-eeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHH-HHhcccCCCCceeEEEeeeec
Q psy2676          19 LGDKKYDELC-QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISI-LKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        19 ~~~~~y~~~~-~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      ...++|++.+ .||+|+||+||+|++ ..+++.||+|++...       ....+|+.. ++.+.   ||||+++++++..
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~---h~~i~~~~~~~~~   93 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFH-RRTGQKCALKLLYDS-------PKARQEVDHHWQASG---GPHIVCILDVYEN   93 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEESS-------HHHHHHHHHHHHHTT---STTBCCEEEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEE-CCCCCEEEEEEecCc-------HHHHHHHHHHHHhcC---CCChHHHHHHHhh
Confidence            4557899965 699999999999999 678999999998642       233344444 34444   9999999999876


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC---CCE
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA---GGL  172 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~---~~~  172 (321)
                      .   .......++|||++.| +|.+++.......+++..++.++.||+.||.|||++|++|+||||+||+++.+   +.+
T Consensus        94 ~---~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~  170 (336)
T 3fhr_A           94 M---HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL  170 (336)
T ss_dssp             E---ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCE
T ss_pred             c---cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceE
Confidence            3   1222568999999985 99999998766679999999999999999999999999999999999999764   459


Q ss_pred             EEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         173 KIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      +|+|||++...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||....................
T Consensus       171 kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  249 (336)
T 3fhr_A          171 KLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ  249 (336)
T ss_dssp             EECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred             EEeccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc
Confidence            99999999766533 33456779999999999888889999999999999999999999976554333211111110000


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ..                   ........+++++.+||++||..||.+|||+.++++||||++.
T Consensus       250 ~~-------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          250 YG-------------------FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             -C-------------------CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             cc-------------------cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            00                   0001123567899999999999999999999999999999864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.3e-47  Score=321.58  Aligned_cols=257  Identities=23%  Similarity=0.386  Sum_probs=218.0

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      .+..+++..++|++.+.||+|+||+||+|.+ ..++..+++|++...   ......+.+|+.++++++   ||||+++++
T Consensus         4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~---h~~i~~~~~   76 (288)
T 3kfa_A            4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVW-KKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIK---HPNLVQLLG   76 (288)
T ss_dssp             TCCTTBCCGGGEEEEEESGGGTTCSEEEEEE-GGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCC---CTTBCCEEE
T ss_pred             chhcccccccceeEEeecCCCCceeEEEeEe-cCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCC---CCCEeeEEE
Confidence            3467888999999999999999999999999 577899999998643   222346778999999998   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      ++.+.       ...++|+|++. ++|.+++.......+++..++.++.||+.||.+||++|++|+||||+||+++.++.
T Consensus        77 ~~~~~-------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~  149 (288)
T 3kfa_A           77 VCTRE-------PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL  149 (288)
T ss_dssp             EECSS-------SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC
T ss_pred             EEccC-------CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC
Confidence            99776       56899999999 59999999877677999999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHh
Q psy2676         172 LKIADFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      ++|+|||.+........  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+.......+....
T Consensus       150 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~  229 (288)
T 3kfa_A          150 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY  229 (288)
T ss_dssp             EEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             EEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC
Confidence            99999999987654332  233456778999999999999999999999999999999 999998876655554443321


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ....                          ...+++.+.++|++||..||.+|||+.++++
T Consensus       230 ~~~~--------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          230 RMER--------------------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             CCCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCC--------------------------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            1111                          1246689999999999999999999999975

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.1e-47  Score=332.40  Aligned_cols=258  Identities=24%  Similarity=0.364  Sum_probs=210.4

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEec------CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEE
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQ------NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRF   90 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~   90 (321)
                      +++..++|++.+.||+|+||+||+|++..      .++..||+|+++.... ......+.+|+.+++++..  ||||+++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~--hpnIv~~  152 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGK--HKNIINL  152 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB-HHHHHHHHHHHHHHHHSCC--CTTBCCE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC-HHHHHHHHHHHHHHHHhcC--CCCEeeE
Confidence            45667899999999999999999998742      3456899999865421 1123457789999999942  9999999


Q ss_pred             EeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPP--------------PGLSASKVKELTRQMLKGVDFLHSHRII  155 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~--------------~~~~~~~~~~i~~~l~~~l~~lh~~~~~  155 (321)
                      ++++.+.       ..+++||||+.+ +|.+++.....              ..+++..++.++.||+.||.|||++|++
T Consensus       153 ~~~~~~~-------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv  225 (370)
T 2psq_A          153 LGACTQD-------GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI  225 (370)
T ss_dssp             EEEECSS-------SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEEccC-------CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            9999776       568999999985 99999987532              3489999999999999999999999999


Q ss_pred             eccCCCCcEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCC
Q psy2676         156 HRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPL  231 (321)
Q Consensus       156 H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p  231 (321)
                      ||||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       226 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p  305 (370)
T 2psq_A          226 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP  305 (370)
T ss_dssp             CSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999998664332   2233456788999999999999999999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         232 FCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      |.+....+....+.......                          ....++.++.++|++||+.||.+|||+.+++++
T Consensus       306 ~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          306 YPGIPVEELFKLLKEGHRMD--------------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             STTCCGGGHHHHHHTTCCCC--------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHhcCCCCC--------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            98876655554433221111                          112566899999999999999999999999863

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-47  Score=332.06  Aligned_cols=260  Identities=24%  Similarity=0.369  Sum_probs=214.3

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEec------CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCcee
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQ------NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV   88 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~   88 (321)
                      ..+++..++|++.+.||+|+||+||+|++..      ..+..+|+|+++.... ......+.+|+.+++++..  ||||+
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~--hpnIv  138 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGK--HKNII  138 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCC--CTTBC
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC-HHHHHHHHHHHHHHHHhcC--Cchhh
Confidence            3567788999999999999999999999743      3346899999865422 1122457789999999942  99999


Q ss_pred             EEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy2676          89 RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPP--------------PGLSASKVKELTRQMLKGVDFLHSHR  153 (321)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~--------------~~~~~~~~~~i~~~l~~~l~~lh~~~  153 (321)
                      ++++++...       ...++|||++.+ +|.+++.....              ..+++..++.++.||+.||.+||+.|
T Consensus       139 ~~~~~~~~~-------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  211 (382)
T 3tt0_A          139 NLLGACTQD-------GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK  211 (382)
T ss_dssp             CEEEEECSS-------SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hheeeeccC-------CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999776       567999999985 99999987542              34899999999999999999999999


Q ss_pred             ceeccCCCCcEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cC
Q psy2676         154 IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LV  229 (321)
Q Consensus       154 ~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~  229 (321)
                      ++|+||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+..++.++||||||+++++|++ |.
T Consensus       212 ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~  291 (382)
T 3tt0_A          212 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG  291 (382)
T ss_dssp             CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999998665332   2334556788999999999999999999999999999999 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         230 PLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .||.+....+....+........                          ...+++++.+||++||+.||.+|||+.++++
T Consensus       292 ~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  345 (382)
T 3tt0_A          292 SPYPGVPVEELFKLLKEGHRMDK--------------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  345 (382)
T ss_dssp             CSSTTCCHHHHHHHHHTTCCCCC--------------------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCC--------------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99988877666555443221111                          1246689999999999999999999999986


Q ss_pred             C
Q psy2676         310 H  310 (321)
Q Consensus       310 h  310 (321)
                      +
T Consensus       346 ~  346 (382)
T 3tt0_A          346 D  346 (382)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.3e-47  Score=323.28  Aligned_cols=255  Identities=22%  Similarity=0.323  Sum_probs=205.7

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      ..+..++|++.+.||+|+||+||+|++ ..+++.+++|++...  .......+.+|+.++++++   ||||+++++++.+
T Consensus         5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~   78 (310)
T 3s95_A            5 RIFRPSDLIHGEVLGKGCFGQAIKVTH-RETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLE---HPNVLKFIGVLYK   78 (310)
T ss_dssp             EEECGGGEEEEEEEECCSSEEEEEEEE-TTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCC---CTTBCCEEEEEEE
T ss_pred             eeeChhHeeccceecCCCCEEEEEEEE-CCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCC---CcCcccEEEEEec
Confidence            345678999999999999999999999 678999999987532  1222346778999998887   9999999999987


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ...++|||++.+ +|.+++..... .+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+
T Consensus        79 ~-------~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~  150 (310)
T 3s95_A           79 D-------KRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVA  150 (310)
T ss_dssp             T-------TEEEEEEECCTTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEEC
T ss_pred             C-------CeeEEEEEecCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEe
Confidence            7       678999999985 99999987543 48999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCcc---------------ccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHH
Q psy2676         176 DFGLAKTFDYDMML---------------TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQ  240 (321)
Q Consensus       176 dfg~~~~~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  240 (321)
                      |||.+.........               ....||+.|+|||++.+..++.++||||||+++|+|++|..||....... 
T Consensus       151 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~-  229 (310)
T 3s95_A          151 DFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT-  229 (310)
T ss_dssp             CCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC-
T ss_pred             ecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH-
Confidence            99999766433221               14568999999999999999999999999999999999999986432100 


Q ss_pred             HHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         241 LKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                   .....          .............+++.+.+++.+||+.||.+|||+.++++
T Consensus       230 -------------~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          230 -------------MDFGL----------NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             -------------TTSSB----------CHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------HHHhh----------hhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                         00000          00001111123467899999999999999999999999975

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-47  Score=327.37  Aligned_cols=260  Identities=24%  Similarity=0.323  Sum_probs=210.9

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      .+++..++|++.+.||+|+||+||+|++.    ..++..||+|++.... .......+.+|+.+++++..  ||||++++
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~--hp~iv~~~  115 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGS--HENIVNLL  115 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCC--CTTBCCEE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcC--CCCeeeEE
Confidence            46778899999999999999999999973    2356789999997543 23345678899999999942  99999999


Q ss_pred             eeeeccccccccceEEEEEeccCc-cCHHHHHhhCCC---------------------CCCCHHHHHHHHHHHHHHHHHH
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP---------------------PGLSASKVKELTRQMLKGVDFL  149 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~---------------------~~~~~~~~~~i~~~l~~~l~~l  149 (321)
                      +++...       ...++|||+++ |+|.+++.....                     ..+++..++.++.||+.||.+|
T Consensus       116 ~~~~~~-------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  188 (344)
T 1rjb_A          116 GACTLS-------GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL  188 (344)
T ss_dssp             EEECSS-------SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeeC-------CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            999776       56799999998 499999987543                     2378999999999999999999


Q ss_pred             HhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHH
Q psy2676         150 HSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW  226 (321)
Q Consensus       150 h~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~  226 (321)
                      |+.|++|+||||+||+++.++.++|+|||++........   .....+++.|+|||++.+..++.++||||||+++|+|+
T Consensus       189 H~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~  268 (344)
T 1rjb_A          189 EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF  268 (344)
T ss_dssp             HHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             HhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHH
Confidence            999999999999999999999999999999976643322   23455678899999999999999999999999999999


Q ss_pred             h-cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHH
Q psy2676         227 R-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA  305 (321)
Q Consensus       227 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  305 (321)
                      + |..||.+................+..                         ...+++++.+||.+||..||.+|||+.
T Consensus       269 t~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~  323 (344)
T 1rjb_A          269 SLGVNPYPGIPVDANFYKLIQNGFKMDQ-------------------------PFYATEEIYIIMQSCWAFDSRKRPSFP  323 (344)
T ss_dssp             TTSCCSSTTCCCSHHHHHHHHTTCCCCC-------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             cCCCCCcccCCcHHHHHHHHhcCCCCCC-------------------------CCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence            8 99999876654444444332211111                         124568999999999999999999999


Q ss_pred             HHhCC
Q psy2676         306 DALEH  310 (321)
Q Consensus       306 ~ll~h  310 (321)
                      ++++|
T Consensus       324 ~l~~~  328 (344)
T 1rjb_A          324 NLTSF  328 (344)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.9e-47  Score=323.33  Aligned_cols=262  Identities=21%  Similarity=0.281  Sum_probs=214.5

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeE
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR   89 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~   89 (321)
                      ...+++..++|++.+.||+|+||+||+|++.    ..+++.|++|++...... .....+.+|+.+++++..  ||||++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~--h~~i~~   91 (313)
T 1t46_A           15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGN--HMNIVN   91 (313)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCC--CTTBCC
T ss_pred             ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH-HHHHHHHHHHHHHhhccc--CCCeee
Confidence            3457788899999999999999999999862    356789999998753211 123467789999999942  999999


Q ss_pred             EEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCC----------------CCCHHHHHHHHHHHHHHHHHHHhC
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPP----------------GLSASKVKELTRQMLKGVDFLHSH  152 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~----------------~~~~~~~~~i~~~l~~~l~~lh~~  152 (321)
                      +++++.+.       ...++|||++.+ +|.+++......                .+++..++.++.||+.||.+||++
T Consensus        92 ~~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  164 (313)
T 1t46_A           92 LLGACTIG-------GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK  164 (313)
T ss_dssp             EEEEECSS-------SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEEEEecC-------CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence            99999776       567999999985 999999875432                489999999999999999999999


Q ss_pred             CceeccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-c
Q psy2676         153 RIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-L  228 (321)
Q Consensus       153 ~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g  228 (321)
                      |++|+||||+||+++.++.++|+|||++........   .....+++.|+|||++.+..++.++||||||+++|+|++ |
T Consensus       165 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g  244 (313)
T 1t46_A          165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG  244 (313)
T ss_dssp             TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999987654432   223456788999999999999999999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHh
Q psy2676         229 VPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL  308 (321)
Q Consensus       229 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  308 (321)
                      ..||.+................+..                         ...++..+.++|.+||..||.+|||+.+++
T Consensus       245 ~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell  299 (313)
T 1t46_A          245 SSPYPGMPVDSKFYKMIKEGFRMLS-------------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIV  299 (313)
T ss_dssp             CCSSTTCCSSHHHHHHHHHTCCCCC-------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCcccchhHHHHHhccCCCCCC-------------------------cccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            9999876655544444433222111                         124568999999999999999999999998


Q ss_pred             CC
Q psy2676         309 EH  310 (321)
Q Consensus       309 ~h  310 (321)
                      ++
T Consensus       300 ~~  301 (313)
T 1t46_A          300 QL  301 (313)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.1e-47  Score=333.57  Aligned_cols=264  Identities=22%  Similarity=0.306  Sum_probs=213.1

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCcee
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV   88 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~   88 (321)
                      ....+++..++|++.+.||+|+||.||+|++.    ..+++.||+|+++..... .....+.+|+.+++++..  ||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~--hpniv   89 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGH--HLNVV   89 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCC--CTTBC
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH-HHHHHHHHHHHHHHhhcC--Cccee
Confidence            34467788899999999999999999999852    456789999999643211 122357889999999953  99999


Q ss_pred             EEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCC----------------------------------------
Q psy2676          89 RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPP----------------------------------------  127 (321)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~----------------------------------------  127 (321)
                      ++++++.+..      ...++||||+.+ +|.+++.....                                        
T Consensus        90 ~~~~~~~~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (359)
T 3vhe_A           90 NLLGACTKPG------GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA  163 (359)
T ss_dssp             CEEEEECSTT------SCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------
T ss_pred             eeeeeeecCC------CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccc
Confidence            9999986641      347899999995 99999987542                                        


Q ss_pred             ------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccc
Q psy2676         128 ------------------------PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF  183 (321)
Q Consensus       128 ------------------------~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~  183 (321)
                                              ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  243 (359)
T 3vhe_A          164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI  243 (359)
T ss_dssp             --------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             ccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence                                    12889999999999999999999999999999999999999999999999999765


Q ss_pred             cCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         184 DYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       184 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ....   ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+...........+...     
T Consensus       244 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----  318 (359)
T 3vhe_A          244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP-----  318 (359)
T ss_dssp             TSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC-----
T ss_pred             cccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCC-----
Confidence            4332   2334567889999999999999999999999999999998 999998866544444443332222211     


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                                          ..+++++.+++.+||+.||.+|||+.++++|
T Consensus       319 --------------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          319 --------------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             --------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                                2355889999999999999999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.9e-47  Score=315.55  Aligned_cols=252  Identities=25%  Similarity=0.351  Sum_probs=197.9

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC--CCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED--GIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      +++..++|++.+.||+|+||+||+|.+   .++.+++|+++......  .....+.+|+.+++.++   ||||+++++++
T Consensus         2 ~~~~~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~   75 (271)
T 3dtc_A            2 LEIDFAELTLEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK---HPNIIALRGVC   75 (271)
T ss_dssp             CBCCTTSEEEEEEEEEETTEEEEEEEE---TTEEEEEEEC----------CHHHHHHHHHHHHHCC---CTTBCCEEEEE
T ss_pred             CccchhheeeeeeeccCCCeEEEEEEE---cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC---CCCEeeEEEEE
Confidence            356678999999999999999999986   47899999987643322  22346778999999998   99999999999


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCcEEEee--
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR---IIHRDLKPQNLLITR--  168 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~---~~H~di~p~Nilv~~--  168 (321)
                      .+.       ...++|||+++ ++|.+++..   ..+++..++.++.|++.||.+||++|   ++|+||||+||+++.  
T Consensus        76 ~~~-------~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~  145 (271)
T 3dtc_A           76 LKE-------PNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKV  145 (271)
T ss_dssp             CCC---------CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCC
T ss_pred             ecC-------CceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccc
Confidence            776       66899999998 599988864   35899999999999999999999999   899999999999986  


Q ss_pred             ------CCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHH
Q psy2676         169 ------AGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLK  242 (321)
Q Consensus       169 ------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  242 (321)
                            ++.++|+|||.+....... .....+++.|+|||.+.+..++.++||||||+++++|++|+.||.+.+......
T Consensus       146 ~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~  224 (271)
T 3dtc_A          146 ENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY  224 (271)
T ss_dssp             SSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH
T ss_pred             ccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                  6779999999997665333 234578999999999999999999999999999999999999998877666555


Q ss_pred             HHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      .........+.                         ...+++.+.++|.+||+.||.+|||+.+++++
T Consensus       225 ~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          225 GVAMNKLALPI-------------------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HHHTSCCCCCC-------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhhcCCCCCCC-------------------------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            44332111111                         12566899999999999999999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.8e-47  Score=333.98  Aligned_cols=258  Identities=26%  Similarity=0.375  Sum_probs=212.6

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +...+.+..++|++.+.||+|+||+||+|++ ..+++.||+|+++.... ......+.+|+.++++++   ||||+++++
T Consensus       105 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~---hpniv~~~~  179 (377)
T 3cbl_A          105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRL-RADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYS---HPNIVRLIG  179 (377)
T ss_dssp             CCCTTBCCGGGEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEECCTTSC-HHHHTTTTHHHHHHTTCC---CTTBCCEEE
T ss_pred             cccccEEchHHeEEeeEeccCCCCeEEEEEE-ecCCeEEEEEEccccCC-HHHHHHHHHHHHHHHhCC---CCCEEEEEE
Confidence            4456778889999999999999999999998 57889999999864321 112346778999999997   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      ++...       ...++|||+++ |+|.+++.... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.
T Consensus       180 ~~~~~-------~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~  251 (377)
T 3cbl_A          180 VCTQK-------QPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV  251 (377)
T ss_dssp             EECSS-------SSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC
T ss_pred             EEecC-------CCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc
Confidence            99766       56799999998 59999997643 24899999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCCcc---ccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHH
Q psy2676         172 LKIADFGLAKTFDYDMML---TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  247 (321)
                      +||+|||++.........   ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+...
T Consensus       252 ~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~  331 (377)
T 3cbl_A          252 LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG  331 (377)
T ss_dssp             EEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT
T ss_pred             EEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            999999998765432211   12335678999999999889999999999999999998 99999888776665544332


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .. .+.                         ...+++++.+++.+||+.||.+|||+.++++
T Consensus       332 ~~-~~~-------------------------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          332 GR-LPC-------------------------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             CC-CCC-------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC-CCC-------------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            11 111                         1245688999999999999999999999975

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-47  Score=334.21  Aligned_cols=261  Identities=23%  Similarity=0.359  Sum_probs=211.9

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      ..++..++|++++.||+|+||+||+|+..    ..++..||+|+++.... ......+.+|+.++++++   ||||++++
T Consensus        65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~---hpnIv~~~  140 (367)
T 3l9p_A           65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFN---HQNIVRCI  140 (367)
T ss_dssp             SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC-HHHHHHHHHHHHHHHHCC---CTTBCCEE
T ss_pred             hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC-hhhHHHHHHHHHHHHhCC---CCCCCeEE
Confidence            34667789999999999999999999942    34677899999864321 112335678999999997   99999999


Q ss_pred             eeeeccccccccceEEEEEeccCc-cCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP-----PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLL  165 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nil  165 (321)
                      +++.+.       ...++|||++. |+|.+++.....     ..+++.+++.++.||+.||.|||++|++||||||+||+
T Consensus       141 ~~~~~~-------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl  213 (367)
T 3l9p_A          141 GVSLQS-------LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL  213 (367)
T ss_dssp             EEECSS-------SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             EEEecC-------CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEE
Confidence            999776       56699999997 499999976432     34899999999999999999999999999999999999


Q ss_pred             EeeCC---CEEEeecCCcccccCC---CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChH
Q psy2676         166 ITRAG---GLKIADFGLAKTFDYD---MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEV  238 (321)
Q Consensus       166 v~~~~---~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  238 (321)
                      ++.++   .+||+|||++......   .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       214 l~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~  293 (367)
T 3l9p_A          214 LTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ  293 (367)
T ss_dssp             ESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             EecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99655   4999999998754221   22334567889999999999999999999999999999998 99999988877


Q ss_pred             HHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         239 EQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      +....+........                          ...++..+.+||.+||+.||.+|||+.+++++.++
T Consensus       294 ~~~~~i~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          294 EVLEFVTSGGRMDP--------------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             HHHHHHHTTCCCCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCC--------------------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            76666554322111                          12456889999999999999999999999987554

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-47  Score=323.42  Aligned_cols=259  Identities=23%  Similarity=0.350  Sum_probs=200.5

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC----CCCchhHHHHHHHHhccc-CCCCceeEE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED----GIPMSTLREISILKQLDT-FEHPNIVRF   90 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~-~~~~~i~~~   90 (321)
                      ..+...++|++.+.||+|+||+||+|++ ..+++.||+|++.......    .....+.+|+.+++++.. ..||||+++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHR-LTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEEC-TTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEE-ccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            3456678999999999999999999998 5788999999997543221    123456689999998831 129999999


Q ss_pred             EeeeeccccccccceEEEEEecc-Cc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe-
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEH-VD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT-  167 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~-~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~-  167 (321)
                      ++++...       ...++|+|+ +. ++|.+++...  ..+++..++.++.||+.||.+||+.|++|+||+|+||+++ 
T Consensus       104 ~~~~~~~-------~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~  174 (312)
T 2iwi_A          104 LDWFETQ-------EGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL  174 (312)
T ss_dssp             EEEC------------CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET
T ss_pred             EEEEecC-------CeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC
Confidence            9998766       567899998 55 5999999873  4489999999999999999999999999999999999999 


Q ss_pred             eCCCEEEeecCCcccccCCCccccccccccccchhhhhcCCC-CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q psy2676         168 RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR  246 (321)
Q Consensus       168 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  246 (321)
                      .++.++|+|||.+...... ......++..|+|||++.+..+ +.++||||||+++|+|++|+.||.....      +..
T Consensus       175 ~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~  247 (312)
T 2iwi_A          175 RRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE  247 (312)
T ss_dssp             TTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH
T ss_pred             CCCeEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh
Confidence            7899999999999876543 3345668999999999987776 4589999999999999999999965321      111


Q ss_pred             HhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         247 VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      .  ..   .                      ....++..+.++|++||..||.+|||+.++++||||++...
T Consensus       248 ~--~~---~----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          248 A--EL---H----------------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             T--CC---C----------------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             h--cc---C----------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence            0  00   0                      11245688999999999999999999999999999998643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.6e-47  Score=324.33  Aligned_cols=266  Identities=21%  Similarity=0.323  Sum_probs=213.7

Q ss_pred             ccccccccccccCCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCC
Q psy2676           8 TIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE   83 (321)
Q Consensus         8 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   83 (321)
                      ..+-+....+++..++|++.+.||+|+||.||+|++..    .++..|++|++..... ......+.+|+.++++++   
T Consensus         9 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~---   84 (314)
T 2ivs_A            9 AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVN---   84 (314)
T ss_dssp             -----CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHTTCC---
T ss_pred             ceeccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCC---
Confidence            34445566788899999999999999999999998742    3458899999864321 112245677888888887   


Q ss_pred             CCceeEEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCC----------------------CCCCHHHHHHHHH
Q psy2676          84 HPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP----------------------PGLSASKVKELTR  140 (321)
Q Consensus        84 ~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~----------------------~~~~~~~~~~i~~  140 (321)
                      ||||+++++++.+.       ...++|+|++. ++|.+++.....                      ..+++..++.++.
T Consensus        85 hp~iv~~~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  157 (314)
T 2ivs_A           85 HPHVIKLYGACSQD-------GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAW  157 (314)
T ss_dssp             CTTBCCEEEEECSS-------SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHH
T ss_pred             CCceeeEEEEEecC-------CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHH
Confidence            99999999999766       56799999998 599999987532                      2389999999999


Q ss_pred             HHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHH
Q psy2676         141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWS  217 (321)
Q Consensus       141 ~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  217 (321)
                      ||+.||.|||++|++|+||||+||+++.++.++|+|||++........   .....+++.|+|||++.+..++.++||||
T Consensus       158 qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  237 (314)
T 2ivs_A          158 QISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWS  237 (314)
T ss_dssp             HHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHH
T ss_pred             HHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHH
Confidence            999999999999999999999999999999999999999976643322   23345678899999999988999999999


Q ss_pred             HHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhccc
Q psy2676         218 IGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTF  296 (321)
Q Consensus       218 lG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  296 (321)
                      ||+++|+|++ |..||.+.........+......    .                      ....+++.+.++|.+||+.
T Consensus       238 lG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~----~----------------------~~~~~~~~~~~li~~~l~~  291 (314)
T 2ivs_A          238 FGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRM----E----------------------RPDNCSEEMYRLMLQCWKQ  291 (314)
T ss_dssp             HHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC----C----------------------CCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcC----C----------------------CCccCCHHHHHHHHHHccC
Confidence            9999999999 99999887665554443322111    1                      1125668999999999999


Q ss_pred             CCCCCCCHHHHhCC
Q psy2676         297 NPADRISAADALEH  310 (321)
Q Consensus       297 dp~~Rps~~~ll~h  310 (321)
                      ||.+|||+.+++++
T Consensus       292 dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          292 EPDKRPVFADISKD  305 (314)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-47  Score=327.50  Aligned_cols=259  Identities=25%  Similarity=0.386  Sum_probs=213.0

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEE
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRF   90 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~   90 (321)
                      ..+++..++|++++.||+|+||.||+|++..    .+++.||+|+++.... ......+.+|+.++++++   ||||+++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~---hp~iv~~  115 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFD---NPNIVKL  115 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCC---CTTBCCE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC-HHHHHHHHHHHHHHHhCC---CCCEEEE
Confidence            3567788999999999999999999999853    3558999999875321 112345778999999997   9999999


Q ss_pred             EeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCC----------------------CCCCHHHHHHHHHHHHHHHH
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPP----------------------PGLSASKVKELTRQMLKGVD  147 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~----------------------~~~~~~~~~~i~~~l~~~l~  147 (321)
                      ++++.+.       ...++||||+.+ +|.+++.....                      ..+++..++.++.||+.||.
T Consensus       116 ~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~  188 (343)
T 1luf_A          116 LGVCAVG-------KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA  188 (343)
T ss_dssp             EEEECSS-------SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHH
T ss_pred             EEEEccC-------CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHH
Confidence            9999766       567999999985 99999987431                      45899999999999999999


Q ss_pred             HHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHH
Q psy2676         148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAE  224 (321)
Q Consensus       148 ~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~  224 (321)
                      +||++|++|+||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+
T Consensus       189 ~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e  268 (343)
T 1luf_A          189 YLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE  268 (343)
T ss_dssp             HHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             HHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHH
Confidence            9999999999999999999999999999999987654322   2234567889999999999999999999999999999


Q ss_pred             HHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC
Q psy2676         225 MWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS  303 (321)
Q Consensus       225 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  303 (321)
                      |++ |..||.+....+....+.......                          ....++..+.++|++||+.||.+|||
T Consensus       269 l~t~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps  322 (343)
T 1luf_A          269 IFSYGLQPYYGMAHEEVIYYVRDGNILA--------------------------CPENCPLELYNLMRLCWSKLPADRPS  322 (343)
T ss_dssp             HHTTTCCTTTTSCHHHHHHHHHTTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHhcCCCcCCCCChHHHHHHHhCCCcCC--------------------------CCCCCCHHHHHHHHHHcccCcccCCC
Confidence            999 999998887766665544321111                          11256689999999999999999999


Q ss_pred             HHHHhCC
Q psy2676         304 AADALEH  310 (321)
Q Consensus       304 ~~~ll~h  310 (321)
                      +.+++++
T Consensus       323 ~~~~~~~  329 (343)
T 1luf_A          323 FCSIHRI  329 (343)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999863

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-46  Score=317.23  Aligned_cols=261  Identities=23%  Similarity=0.330  Sum_probs=207.2

Q ss_pred             ccccccccccCCcceeeee-eeecccceeEEEEEEe-cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCce
Q psy2676          10 QSLNLDSLDLGDKKYDELC-QIGCGAYGTVFKARDL-QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI   87 (321)
Q Consensus        10 ~~~~~~~~~~~~~~y~~~~-~lg~g~~g~v~~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i   87 (321)
                      +.++..+..+..++|++.+ .||+|+||+||+|.+. ...++.+++|++............+.+|+.++++++   ||||
T Consensus         4 ~~i~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i   80 (291)
T 1xbb_A            4 EEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD---NPYI   80 (291)
T ss_dssp             -------CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC---CTTB
T ss_pred             cccCcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC---CCCE
Confidence            3455667788889999999 9999999999999653 355789999999765333333456778999999997   9999


Q ss_pred             eEEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q psy2676          88 VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI  166 (321)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv  166 (321)
                      +++++++..        ...++|+|++. ++|.+++...  ..+++..++.++.||+.||.+||+.|++|+||||+||++
T Consensus        81 ~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~  150 (291)
T 1xbb_A           81 VRMIGICEA--------ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL  150 (291)
T ss_dssp             CCEEEEEES--------SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             EEEEEEECC--------CCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE
Confidence            999999833        35789999998 5999999884  448999999999999999999999999999999999999


Q ss_pred             eeCCCEEEeecCCcccccCCCc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHH
Q psy2676         167 TRAGGLKIADFGLAKTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQL  241 (321)
Q Consensus       167 ~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~  241 (321)
                      +.++.++|+|||++........    .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+..
T Consensus       151 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~  230 (291)
T 1xbb_A          151 VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT  230 (291)
T ss_dssp             EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred             eCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            9999999999999987654332    122345678999999998889999999999999999999 99999888776655


Q ss_pred             HHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         242 KCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ..+..... +.   .                      ...+++.+.++|++||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~-~~---~----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          231 AMLEKGER-MG---C----------------------PAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHTTCC-CC---C----------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHcCCC-CC---C----------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            54433211 11   1                      1256689999999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.6e-47  Score=334.04  Aligned_cols=263  Identities=29%  Similarity=0.355  Sum_probs=200.9

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      .....+...+|.+.+.||+|+||+|+...  ..+++.||+|++...     ......+|+.+++.+..  ||||++++++
T Consensus        16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~--~~~~~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~--HpnIv~l~~~   86 (432)
T 3p23_A           16 TSVVIVGKISFCPKDVLGHGAEGTIVYRG--MFDNRDVAVKRILPE-----CFSFADREVQLLRESDE--HPNVIRYFCT   86 (432)
T ss_dssp             --CEEETTEEEEEEEEEEECGGGCEEEEE--ESSSSEEEEEEECTT-----TEEECHHHHHHHHHSCC--CTTBCCEEEE
T ss_pred             CCcEEEccEEEecCCeeecCcCEEEEEEE--EeCCeEEEEEEECHH-----HHHHHHHHHHHHHhccC--CCCcCeEEEE
Confidence            34566677899999999999999976433  367899999998642     23356789999999843  9999999999


Q ss_pred             eeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC----
Q psy2676          94 IHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA----  169 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~----  169 (321)
                      +.+.       ...++|||++.|+|.+++...... .++..++.++.||+.||.|||++|++||||||+||+++.+    
T Consensus        87 ~~~~-------~~~~lv~E~~~g~L~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~  158 (432)
T 3p23_A           87 EKDR-------QFQYIAIELCAATLQEYVEQKDFA-HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHG  158 (432)
T ss_dssp             EEET-------TEEEEEEECCSEEHHHHHHSSSCC-CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTT
T ss_pred             EecC-------CEEEEEEECCCCCHHHHHHhcCCC-ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCC
Confidence            9877       678999999999999999875433 5566778999999999999999999999999999999532    


Q ss_pred             -CCEEEeecCCcccccCCC----ccccccccccccchhhhh---cCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHH
Q psy2676         170 -GGLKIADFGLAKTFDYDM----MLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQ  240 (321)
Q Consensus       170 -~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~  240 (321)
                       ..++|+|||++.......    ......||+.|+|||++.   ...++.++|||||||++|+|++ |..||........
T Consensus       159 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~  238 (432)
T 3p23_A          159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA  238 (432)
T ss_dssp             BCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH
T ss_pred             ceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH
Confidence             248899999998765332    233467899999999997   4557889999999999999999 9999976544332


Q ss_pred             HHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         241 LKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ...    .+.........                    ....+..+.+||.+||+.||.+|||+.++++||||.+..
T Consensus       239 ~~~----~~~~~~~~~~~--------------------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          239 NIL----LGACSLDCLHP--------------------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             HHH----TTCCCCTTSCT--------------------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             HHH----hccCCccccCc--------------------cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence            211    11111111100                    012336688999999999999999999999999998743

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.1e-47  Score=317.88  Aligned_cols=258  Identities=22%  Similarity=0.363  Sum_probs=198.8

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecC--CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQN--KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      ...+++..++|++.+.||+|+||+||+|.+...  .+..+++|++..... ......+.+|+.+++++.   ||||++++
T Consensus         7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~---h~~iv~~~   82 (281)
T 1mp8_A            7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFD---HPHIVKLI   82 (281)
T ss_dssp             --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCC---CTTBCCEE
T ss_pred             ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHHhCC---CCccceEE
Confidence            345678889999999999999999999998422  345789998764321 112335678899998887   99999999


Q ss_pred             eeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG  170 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~  170 (321)
                      +++.+.        ..++|||++.+ +|.+++.... ..+++..++.++.|++.||.+||++|++|+||||+||+++.++
T Consensus        83 ~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  153 (281)
T 1mp8_A           83 GVITEN--------PVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND  153 (281)
T ss_dssp             EEECSS--------SCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT
T ss_pred             EEEccC--------ccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC
Confidence            997433        46899999995 9999998753 3489999999999999999999999999999999999999999


Q ss_pred             CEEEeecCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHH
Q psy2676         171 GLKIADFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  247 (321)
                      .++|+|||++........  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+...
T Consensus       154 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~  233 (281)
T 1mp8_A          154 CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG  233 (281)
T ss_dssp             EEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             CEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC
Confidence            999999999987654332  223455778999999999999999999999999999996 99999887766655554432


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ...+                          ....+++.+.++|.+||+.||.+|||+.+++++
T Consensus       234 ~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          234 ERLP--------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCC--------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            1111                          112566899999999999999999999999863

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-46  Score=321.35  Aligned_cols=254  Identities=19%  Similarity=0.261  Sum_probs=204.5

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcE----EEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNY----VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~----~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      ..+..++|++++.||+|+||+||+|++. .+++.    +++|.+... ........+.+|+.++++++   ||||+++++
T Consensus         8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~~~kv~~K~~~~~-~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~   82 (325)
T 3kex_A            8 RIFKETELRKLKVLGSGVFGTVHKGVWI-PEGESIKIPVCIKVIEDK-SGRQSFQAVTDHMLAIGSLD---HAHIVRLLG   82 (325)
T ss_dssp             CBCCTTTEEEEEEEECCSSCEEEEEEEC-CTTCSCCEEEEEEEECCT-TSCSCBCSCCHHHHHHHTCC---CTTBCCEEE
T ss_pred             hhcCHhHceeeeeeeecCCceEEEEEEc-CCCceEEEEEEEEecccc-ccHHHHHHHHHHHHHHhcCC---CCCcCeEEE
Confidence            3456789999999999999999999984 55555    667766433 22333456778999999987   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      ++.+.        ..++|+|++. |+|.+++.... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.
T Consensus        83 ~~~~~--------~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~  153 (325)
T 3kex_A           83 LCPGS--------SLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ  153 (325)
T ss_dssp             EECBS--------SEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC
T ss_pred             EEcCC--------ccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe
Confidence            88543        4789999998 59999997743 34899999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHH
Q psy2676         172 LKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  247 (321)
                      +||+|||++.......   ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+...
T Consensus       154 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  233 (325)
T 3kex_A          154 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG  233 (325)
T ss_dssp             EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT
T ss_pred             EEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence            9999999998764332   2334567789999999999999999999999999999999 99999887665555444332


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      .....                          ...++.++.++|.+||..||.+|||+.+++++
T Consensus       234 ~~~~~--------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          234 ERLAQ--------------------------PQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CBCCC--------------------------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CCCCC--------------------------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            11111                          11355788999999999999999999999864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.7e-46  Score=311.62  Aligned_cols=252  Identities=20%  Similarity=0.305  Sum_probs=210.5

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +.+..++|++.+.||+|++|+||++.+  .+++.+++|++.....   ....+.+|+.++++++   ||||+++++++.+
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~   74 (267)
T 3t9t_A            3 WVIDPSELTFVQEIGSGQFGLVHLGYW--LNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLS---HPKLVQLYGVCLE   74 (267)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEE--TTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCC---CTTBCCEEEEECS
T ss_pred             eEEchhheeeeeEecCCCceeEEEEEe--cCCCeEEEEEccccCC---CHHHHHHHHHHHHhCC---CCCEeeEEEEEcc
Confidence            456778999999999999999999998  3678899999875422   2356788999999997   9999999999977


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ...++|+|+++ ++|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+
T Consensus        75 ~-------~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~  146 (267)
T 3t9t_A           75 Q-------APICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVS  146 (267)
T ss_dssp             S-------SSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEEC
T ss_pred             C-------CCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEc
Confidence            6       56799999998 59999998754 348999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCC--ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         176 DFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       176 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |||.+.......  ......++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+........
T Consensus       147 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~  226 (267)
T 3t9t_A          147 DFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK  226 (267)
T ss_dssp             CTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             ccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence            999987654322  1223456778999999999999999999999999999999 8999988877666655543211111


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                                                ...++..+.+++.+||+.||.+|||+.+++++
T Consensus       227 --------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          227 --------------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             --------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                      11345889999999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.2e-46  Score=317.30  Aligned_cols=259  Identities=23%  Similarity=0.349  Sum_probs=198.4

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ....++..++|++.+.||+|+||+||++++    ...+++|+++...........+.+|+.++++++   ||||++++++
T Consensus        16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~   88 (289)
T 3og7_A           16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKW----HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR---HVNILLFMGY   88 (289)
T ss_dssp             --CCBCCTTSCEEEEEEEECSSEEEEEEES----SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCC---CTTBCCEEEE
T ss_pred             CCCCccCccceeeeeEecCCCCeEEEEEEE----cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCC---CCcEEEEEee
Confidence            456788999999999999999999999975    225999998755333333345778999998887   9999999997


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      ....        ..++|+|++. ++|.+++.... ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++.+
T Consensus        89 ~~~~--------~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~  159 (289)
T 3og7_A           89 STAP--------QLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTV  159 (289)
T ss_dssp             ECSS--------SCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred             ccCC--------ccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCE
Confidence            5333        4689999998 59999997644 348999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccC---CCccccccccccccchhhhh---cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q psy2676         173 KIADFGLAKTFDY---DMMLTSVVVTLWYRAPEILL---NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR  246 (321)
Q Consensus       173 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  246 (321)
                      +|+|||++.....   ........+++.|+|||++.   +..++.++||||||+++|+|++|+.||......+.......
T Consensus       160 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  239 (289)
T 3og7_A          160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG  239 (289)
T ss_dssp             EECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH
T ss_pred             EEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc
Confidence            9999999875542   22233456899999999986   56678899999999999999999999988666655554444


Q ss_pred             HhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         247 VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .....+..                     .....++++.+.+||.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          240 RGSLSPDL---------------------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HTSCCCCT---------------------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccCcch---------------------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            32221111                     1112356789999999999999999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.9e-46  Score=321.64  Aligned_cols=255  Identities=25%  Similarity=0.346  Sum_probs=206.4

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEE--EEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYV--AMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~--~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +..++|++.+.||+|+||.||+|++ ..++..+  ++|.++... .......+.+|+.+++++..  ||||+++++++.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~--hp~iv~~~~~~~~   97 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARI-KKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGH--HPNIINLLGACEH   97 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEE-EETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCC--CTTBCCEEEEEEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEE-ccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccC--CCchhhhceeeee
Confidence            4458999999999999999999998 4566644  888886432 23345578889999999942  9999999999977


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCP--------------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKP  161 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p  161 (321)
                      .       ...++|||++++ +|.+++....              ...+++..++.++.||+.||.+||++|++|+||||
T Consensus        98 ~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp  170 (327)
T 1fvr_A           98 R-------GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA  170 (327)
T ss_dssp             T-------TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             C-------CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCcc
Confidence            7       678999999984 9999998743              23589999999999999999999999999999999


Q ss_pred             CcEEEeeCCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHH
Q psy2676         162 QNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQ  240 (321)
Q Consensus       162 ~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~  240 (321)
                      +||+++.++.++|+|||++.............+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+.
T Consensus       171 ~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~  250 (327)
T 1fvr_A          171 RNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL  250 (327)
T ss_dssp             GGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             ceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH
Confidence            999999999999999999875544444445567889999999998889999999999999999998 9999988876665


Q ss_pred             HHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         241 LKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ...+.......                          ....+++.+.++|.+||..||.+|||+.+++++
T Consensus       251 ~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          251 YEKLPQGYRLE--------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HHHGGGTCCCC--------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhhcCCCCC--------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            54433211110                          112566899999999999999999999999864

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.7e-46  Score=315.69  Aligned_cols=255  Identities=28%  Similarity=0.440  Sum_probs=210.7

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++++.||+|+||.||+|++ ..+++.|++|++...      ...+.+|+.+++++.   ||||+++++++.....
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKH-RIDGKTYVIKRVKYN------NEKAEREVKALAKLD---HVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEE-TTTCCEEEEEEEECC------SGGGHHHHHHHHHCC---CTTBCCEEEEEEEEEE
T ss_pred             hccccceeeeeccCCceEEEEEEE-cCCCeEEEEEEeccc------cHHHHHHHHHHHhCC---CCCEEEEeeeEecccc
Confidence            457899999999999999999999 578999999998753      246789999999998   9999999999865211


Q ss_pred             c---------cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC
Q psy2676         100 S---------DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA  169 (321)
Q Consensus       100 ~---------~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~  169 (321)
                      .         .......++|||++++ +|.+++.......+++..++.++.||+.||.+||+.|++|+||+|+||+++.+
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence            0         1223568999999995 99999987655669999999999999999999999999999999999999999


Q ss_pred             CCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhC
Q psy2676         170 GGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       170 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      +.++|+|||.+.............+++.|+|||++.+..++.++||||||+++|+|++|..|+....  .....+.   .
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~---~  233 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR---D  233 (284)
T ss_dssp             TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH---T
T ss_pred             CCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh---c
Confidence            9999999999987766555556678999999999999999999999999999999999998874211  1111110   0


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                       .                         .....++..+.++|.+||+.||.+|||+.++++|.+.-.
T Consensus       234 -~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 -G-------------------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             -T-------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             -c-------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence             0                         011245688999999999999999999999999876543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.9e-46  Score=314.53  Aligned_cols=255  Identities=24%  Similarity=0.366  Sum_probs=212.2

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      --+.+++..++|++++.||+|+||+||+|.+  .++..+++|++....   .....+.+|+.+++++.   ||||+++++
T Consensus         4 ~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~---h~~i~~~~~   75 (279)
T 1qpc_A            4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQ---HQRLVRLYA   75 (279)
T ss_dssp             TTCTTBCCGGGEEEEEEEEEETTEEEEEEEE--TTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCC---CTTBCCEEE
T ss_pred             chhhcccCHHhhhheeeecCCCCeEEEEEEE--cCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCC---CcCcceEEE
Confidence            3457788899999999999999999999987  467789999986532   23456788999999997   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      ++.+.        ..++|+|++. ++|.+++.......+++..++.++.|++.||.+||++|++|+||+|+||+++.++.
T Consensus        76 ~~~~~--------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~  147 (279)
T 1qpc_A           76 VVTQE--------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS  147 (279)
T ss_dssp             EECSS--------SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC
T ss_pred             EEcCC--------CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC
Confidence            98543        3689999997 59999997643335899999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHh
Q psy2676         172 LKIADFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      ++|+|||.+........  .....++..|+|||++.+..++.++||||||+++++|++ |..||.+.+..+....+....
T Consensus       148 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  227 (279)
T 1qpc_A          148 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY  227 (279)
T ss_dssp             EEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             EEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc
Confidence            99999999987654332  223456778999999998889999999999999999999 999998887766655544321


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ....                          ...+++.+.+++.+||..||.+|||+.++++
T Consensus       228 ~~~~--------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          228 RMVR--------------------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CCCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCC--------------------------cccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1111                          1245689999999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2e-46  Score=332.83  Aligned_cols=260  Identities=29%  Similarity=0.389  Sum_probs=196.8

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      +...+.|.+.+.||+|+||+||.+..  .+++.||+|++....     .....+|+.+++++..  ||||+++++++.+.
T Consensus        11 ~~l~~~~~~~~~LG~G~~g~V~~~~~--~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~--HpnIv~~~~~~~~~   81 (434)
T 2rio_A           11 QSLKNLVVSEKILGYGSSGTVVFQGS--FQGRPVAVKRMLIDF-----CDIALMEIKLLTESDD--HPNVIRYYCSETTD   81 (434)
T ss_dssp             CSCSSCEEEEEEEEECSTTCEEEEEE--SSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTT--STTBCCEEEEEECS
T ss_pred             hhhhheeeccCeEeeCCCeEEEEEEE--ECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccC--CCCcCeEEEEEecC
Confidence            34556788889999999999987643  678999999986532     2356789999988742  99999999998776


Q ss_pred             ccccccceEEEEEeccCccCHHHHHhhCCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC---
Q psy2676          98 ILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG-----LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA---  169 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~-----~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~---  169 (321)
                             ..+++|||+++|+|.+++.......     .++..++.++.||+.||.|||++|++||||||+||+++.+   
T Consensus        82 -------~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~  154 (434)
T 2rio_A           82 -------RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRF  154 (434)
T ss_dssp             -------SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHH
T ss_pred             -------CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccc
Confidence                   6889999999999999998754221     1333467899999999999999999999999999999754   


Q ss_pred             ----------CCEEEeecCCcccccCCCc-----cccccccccccchhhhhc-------CCCCCcchHHHHHHHHHHHHh
Q psy2676         170 ----------GGLKIADFGLAKTFDYDMM-----LTSVVVTLWYRAPEILLN-------LGYGTPVDIWSIGCVMAEMWR  227 (321)
Q Consensus       170 ----------~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~  227 (321)
                                +.+||+|||++........     .....||+.|+|||++.+       ..++.++|||||||++|+|++
T Consensus       155 ~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt  234 (434)
T 2rio_A          155 TADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS  234 (434)
T ss_dssp             HSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             ccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHh
Confidence                      3799999999987654321     234578999999999976       568999999999999999999


Q ss_pred             -cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHH
Q psy2676         228 -LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD  306 (321)
Q Consensus       228 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  306 (321)
                       |..||......+  ..+.......+.....                    ....+++++.+||.+||+.||.+|||+.+
T Consensus       235 ~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~--------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e  292 (434)
T 2rio_A          235 KGKHPFGDKYSRE--SNIIRGIFSLDEMKCL--------------------HDRSLIAEATDLISQMIDHDPLKRPTAMK  292 (434)
T ss_dssp             TSCCTTCSTTTHH--HHHHHTCCCCCCCTTC--------------------CCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCchhhH--HHHhcCCCCccccccc--------------------ccccchHHHHHHHHHHhhCChhhCCCHHH
Confidence             999997654433  2222221111110000                    01235578999999999999999999999


Q ss_pred             HhCCCCCCC
Q psy2676         307 ALEHPYFKE  315 (321)
Q Consensus       307 ll~h~~f~~  315 (321)
                      +++||||.+
T Consensus       293 il~hp~f~~  301 (434)
T 2rio_A          293 VLRHPLFWP  301 (434)
T ss_dssp             HHTSGGGSC
T ss_pred             HHhCCccCC
Confidence            999999975

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.5e-46  Score=322.19  Aligned_cols=252  Identities=23%  Similarity=0.348  Sum_probs=199.5

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcE----EEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNY----VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~----~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      +..++|++.+.||+|+||+||+|++ ..+++.    +++|.+.... .......+.+|+.++++++   ||||+++++++
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~   86 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLW-IPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVD---NPHVCRLLGIC   86 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEE-CC----CCEEEEEEEC--------CHHHHHHHHHHHHHCC---BTTBCCEEEEE
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEE-cCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCC---CCCEeEEEEEE
Confidence            4567999999999999999999998 355554    4777665332 2233457788999999998   99999999998


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      ...        ..++|++++. |+|.+++..... .+++..++.++.||+.||.|||++|++||||||+||+++.++.+|
T Consensus        87 ~~~--------~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~k  157 (327)
T 3poz_A           87 LTS--------TVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVK  157 (327)
T ss_dssp             ESS--------SEEEEEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEE
T ss_pred             ecC--------CeEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEE
Confidence            765        2567888888 699999987543 489999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhC
Q psy2676         174 IADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       174 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      |+|||++........   .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+.....
T Consensus       158 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  237 (327)
T 3poz_A          158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER  237 (327)
T ss_dssp             ECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             EccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC
Confidence            999999986653332   223445778999999999999999999999999999999 9999988776655544433221


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      .+.                          ...++..+.+++.+||+.||.+|||+.+++++
T Consensus       238 ~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          238 LPQ--------------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CCC--------------------------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CCC--------------------------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            111                          12456889999999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.3e-47  Score=325.70  Aligned_cols=268  Identities=22%  Similarity=0.337  Sum_probs=217.3

Q ss_pred             ccccccccCCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCce
Q psy2676          12 LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI   87 (321)
Q Consensus        12 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i   87 (321)
                      .....+++..++|++.+.||+|+||+||+|++..    .+++.+++|++...... .....+.+|+.+++++.   ||||
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~---h~~i   90 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFN---CHHV   90 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCC---CTTB
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH-HHHHHHHHHHHHHHhcC---CCCE
Confidence            4566888999999999999999999999998742    35788999998643211 11234667888888887   9999


Q ss_pred             eEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecc
Q psy2676          88 VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCP--------PPGLSASKVKELTRQMLKGVDFLHSHRIIHRD  158 (321)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~--------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~d  158 (321)
                      +++++++.+.       ...++|||++.+ +|.+++....        ...+++..++.++.||+.||.+||++|++|+|
T Consensus        91 ~~~~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d  163 (322)
T 1p4o_A           91 VRLLGVVSQG-------QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRD  163 (322)
T ss_dssp             CCEEEEECSS-------SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSC
T ss_pred             eeeEEEEccC-------CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCC
Confidence            9999999766       567999999985 9999987532        13478999999999999999999999999999


Q ss_pred             CCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCC
Q psy2676         159 LKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCA  234 (321)
Q Consensus       159 i~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~  234 (321)
                      |||+||+++.++.++|+|||++........   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus       164 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  243 (322)
T 1p4o_A          164 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG  243 (322)
T ss_dssp             CSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred             CccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence            999999999999999999999876543321   223456788999999999999999999999999999999 8999988


Q ss_pred             CChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC----
Q psy2676         235 STEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH----  310 (321)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h----  310 (321)
                      .+..+....+......+                          ....++..+.++|.+||..||.+|||+.++++|    
T Consensus       244 ~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          244 LSNEQVLRFVMEGGLLD--------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             SCHHHHHHHHHTTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             CCHHHHHHHHHcCCcCC--------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence            87766655544321111                          112566889999999999999999999999986    


Q ss_pred             --CCCCCC
Q psy2676         311 --PYFKEK  316 (321)
Q Consensus       311 --~~f~~~  316 (321)
                        ++|++.
T Consensus       298 ~~~~~~~~  305 (322)
T 1p4o_A          298 MEPGFREV  305 (322)
T ss_dssp             SCTTHHHH
T ss_pred             hccCCccc
Confidence              666543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.4e-47  Score=327.11  Aligned_cols=280  Identities=21%  Similarity=0.309  Sum_probs=215.4

Q ss_pred             ccccccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCC
Q psy2676           6 ADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP   85 (321)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   85 (321)
                      .+.+..++..+++...++|++.+.||+|+||+||+|++  .+++.||+|++...... .....+.+|+.+++++.   ||
T Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~---h~   87 (326)
T 3uim_A           14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL--ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAV---HR   87 (326)
T ss_dssp             -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECC--SSSCCEEEEECCC------CCCHHHHHHHGGGTCC---CT
T ss_pred             cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEe--cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhcc---CC
Confidence            34566778889999999999999999999999999975  46889999998765332 23346788999888887   99


Q ss_pred             ceeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeccC
Q psy2676          86 NIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPP--PGLSASKVKELTRQMLKGVDFLHSH---RIIHRDL  159 (321)
Q Consensus        86 ~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lh~~---~~~H~di  159 (321)
                      ||+++++++.+.       ...++|||++.+ +|.+++.....  ..+++..++.++.|++.||.+||+.   |++|+||
T Consensus        88 ~iv~~~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dl  160 (326)
T 3uim_A           88 NLLRLRGFCMTP-------TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDV  160 (326)
T ss_dssp             TBCCCCEEECCS-------SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCC
T ss_pred             CccceEEEEecC-------CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC
Confidence            999999999776       567899999985 99999987543  3389999999999999999999999   9999999


Q ss_pred             CCCcEEEeeCCCEEEeecCCcccccCCC--ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-
Q psy2676         160 KPQNLLITRAGGLKIADFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST-  236 (321)
Q Consensus       160 ~p~Nilv~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-  236 (321)
                      ||+||+++.++.++|+|||++.......  ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.... 
T Consensus       161 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  240 (326)
T 3uim_A          161 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL  240 (326)
T ss_dssp             SGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHH
T ss_pred             chhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccc
Confidence            9999999999999999999998765332  2334558999999999999889999999999999999999999995210 


Q ss_pred             ---hHHHHHHHHHH-hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCC
Q psy2676         237 ---EVEQLKCIFRV-IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP  311 (321)
Q Consensus       237 ---~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  311 (321)
                         ........... .........             .............+..+.+++.+||+.||.+|||+.++++|-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  306 (326)
T 3uim_A          241 ANDDDVMLLDWVKGLLKEKKLEAL-------------VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML  306 (326)
T ss_dssp             TTTSCSBHHHHHTTTTSSCCSTTS-------------SCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             ccccchhHHHHHHHHhhchhhhhh-------------cChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence               00000000000 000000000             000001112234558899999999999999999999999873

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.5e-46  Score=313.52  Aligned_cols=252  Identities=20%  Similarity=0.235  Sum_probs=199.1

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee-eccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI-HQNI   98 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~-~~~~   98 (321)
                      .+++|++.+.||+|+||+||+|++ ..+++.||+|++.....    ...+.+|+.+++++.   |++++..+..+ ... 
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~---~~~~i~~~~~~~~~~-   77 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTD-IAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQ---GGVGIPTIRWCGAEG-   77 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEE-TTTTEEEEEEEEEC-------CCCHHHHHHHHHHHT---TSTTCCCEEEEEEET-
T ss_pred             cCCceEEeeeecCCCCeEEEEEEE-cCCCceEEEEeeccccc----chHHHHHHHHHHHhc---CCCCCCeeeeecCCC-
Confidence            457999999999999999999998 58899999998765422    336889999999998   66655555544 433 


Q ss_pred             cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---eeCCCEEEe
Q psy2676          99 LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIA  175 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv---~~~~~~kl~  175 (321)
                            ...++|||+++++|.+++..... .+++..++.++.||+.||.|||++|++|+||||+||++   +.++.+||+
T Consensus        78 ------~~~~lv~e~~~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~  150 (296)
T 4hgt_A           78 ------DYNVMVMELLGPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             ------TEEEEEEECCCCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEEC
T ss_pred             ------CceEEEEEccCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEe
Confidence                  57799999998899999986543 49999999999999999999999999999999999999   788999999


Q ss_pred             ecCCcccccCCCc--------cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChH---HHHHHH
Q psy2676         176 DFGLAKTFDYDMM--------LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV---EQLKCI  244 (321)
Q Consensus       176 dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~  244 (321)
                      |||.+........        .....+++.|+|||++.+..++.++||||||+++|+|++|+.||.+....   .....+
T Consensus       151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 4hgt_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence            9999987654322        23457899999999999999999999999999999999999999764321   111111


Q ss_pred             HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ...                      ...........++++++.++|.+||+.||.+|||+.++++
T Consensus       231 ~~~----------------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          231 SEK----------------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHH----------------------HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hcc----------------------cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            110                      0111122233567899999999999999999999999985

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1e-45  Score=321.62  Aligned_cols=266  Identities=13%  Similarity=0.174  Sum_probs=200.0

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecC----CCcEEEEEEeecccCCCCCCchhHHHHHHHHhc------------cc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQN----KGNYVAMKKLRVKLNEDGIPMSTLREISILKQL------------DT   81 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l------------~~   81 (321)
                      +...++|++.+.||+|+||+||+|.+...    .++.||+|++....      ....+|+.+++++            ..
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~~~~~~~~~~~~e~~~~~~  104 (364)
T 3op5_A           31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN------GPLFTELKFYQRAAKPEQIQKWIRTRK  104 (364)
T ss_dssp             CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC------HHHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc------hhHHHHHHHHHhhhhhHHHHHHHHHhh
Confidence            34567999999999999999999998422    25889999986431      2344455544443            23


Q ss_pred             CCCCceeEEEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q psy2676          82 FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKP  161 (321)
Q Consensus        82 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p  161 (321)
                      +.||||+++++++...   .......++|||+++++|.+++.... ..+++..++.++.||+.||.|||++|++||||||
T Consensus       105 l~h~~iv~~~~~~~~~---~~~~~~~~lv~e~~g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp  180 (364)
T 3op5_A          105 LKYLGVPKYWGSGLHD---KNGKSYRFMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKA  180 (364)
T ss_dssp             CSCCCSCCEEEEEEEE---ETTEEEEEEEEECEEEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             ccCCCCCeEEeeeeec---cCCcceEEEEEeCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCH
Confidence            4599999999998664   12225689999999779999998753 4499999999999999999999999999999999


Q ss_pred             CcEEEe--eCCCEEEeecCCcccccCCCc--------cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCC
Q psy2676         162 QNLLIT--RAGGLKIADFGLAKTFDYDMM--------LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPL  231 (321)
Q Consensus       162 ~Nilv~--~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  231 (321)
                      +||+++  .++.+||+|||++........        .....+|+.|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus       181 ~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~P  260 (364)
T 3op5_A          181 SNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP  260 (364)
T ss_dssp             GGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999  889999999999976643321        1234589999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         232 FCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      |.+...............              ...+......+.  ...++++++.+++..||..||.+||++.++++
T Consensus       261 f~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          261 WEDNLKDPKYVRDSKIRY--------------RENIASLMDKCF--PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             TGGGTTCHHHHHHHHHHH--------------HHCHHHHHHHHS--CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ccccccCHHHHHHHHHHh--------------hhhHHHHHHHhc--ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            985332222211111000              000000000000  01467899999999999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.3e-46  Score=334.43  Aligned_cols=260  Identities=21%  Similarity=0.355  Sum_probs=216.9

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ...+++..++|++.+.||+|+||+||+|.+  .++..||+|+++...   .....+.+|+.++++++   ||||++++++
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~---h~~iv~l~~~  251 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATY--NKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQ---HDKLVKLHAV  251 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEE--TTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCC---CTTBCCEEEE
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEE--CCccEEEEEEecCCC---ccHHHHHHHHHHHhhCC---CCCEeeEEEE
Confidence            456788899999999999999999999987  457789999987532   23457889999999997   9999999999


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +..        ...++|||++. |+|.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.++.+
T Consensus       252 ~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~  323 (454)
T 1qcf_A          252 VTK--------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVC  323 (454)
T ss_dssp             ECS--------SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCE
T ss_pred             EeC--------CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcE
Confidence            853        24689999998 599999986443458999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCC--ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhC
Q psy2676         173 KIADFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       173 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      ||+|||++.......  ......++..|+|||++....++.++||||||+++|+|++ |+.||.+.+..+....+.....
T Consensus       324 kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~  403 (454)
T 1qcf_A          324 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR  403 (454)
T ss_dssp             EECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC
T ss_pred             EEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999998764322  1223445778999999999999999999999999999999 9999998888777766655332


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC--CCCCCC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE--HPYFKE  315 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h~~f~~  315 (321)
                      .+..                          ..+++++.++|.+||+.||.+|||+.++++  ..+++.
T Consensus       404 ~~~~--------------------------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          404 MPRP--------------------------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             CCCC--------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             CCCC--------------------------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            2211                          246689999999999999999999999986  455543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3e-46  Score=333.38  Aligned_cols=263  Identities=22%  Similarity=0.360  Sum_probs=214.1

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      ....+++..++|++.+.||+|+||+||+|.+  .++..||+|+++...   .....+.+|+.++++++   ||||+++++
T Consensus       175 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~---hp~iv~~~~  246 (452)
T 1fmk_A          175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTW--NGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLR---HEKLVQLYA  246 (452)
T ss_dssp             STTCSBCCGGGEEEEEEEEECSSCEEEEEEE--TTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCC---CTTBCCEEE
T ss_pred             CccccccChhHceeeeeecCCCCeEEEEEEE--CCCceEEEEEeccCC---CCHHHHHHHHHHHHhCC---CCCEeeEEE
Confidence            3566788899999999999999999999988  345779999987532   22457889999999998   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      ++.+.        ..++|||++. |+|.+++.......+++..+..++.||+.||+|||++|++||||||+||+++.++.
T Consensus       247 ~~~~~--------~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~  318 (452)
T 1fmk_A          247 VVSEE--------PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV  318 (452)
T ss_dssp             EECSS--------SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             EEcCC--------ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC
Confidence            98543        4689999998 59999997644455899999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCC--ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHh
Q psy2676         172 LKIADFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      +||+|||++.......  ......++..|+|||++....++.++||||||+++|+|++ |..||.+....+....+....
T Consensus       319 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~  398 (452)
T 1fmk_A          319 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY  398 (452)
T ss_dssp             EEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             EEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999998664322  1223456778999999999999999999999999999999 999999888777666654432


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC--CCCCCCCC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE--HPYFKEKE  317 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h~~f~~~~  317 (321)
                      ..+.                          ...+++.+.++|.+||+.||.+|||++++++  ..+|+..+
T Consensus       399 ~~~~--------------------------~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          399 RMPC--------------------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             CCCC--------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CCCC--------------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence            2111                          1256688999999999999999999999998  47776553

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.3e-46  Score=337.53  Aligned_cols=256  Identities=23%  Similarity=0.374  Sum_probs=216.1

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ...+++..++|++.+.||+|+||.||+|.+ ..++..||+|+++...   .....+.+|+.++++++   ||||++++++
T Consensus       212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~---hpniv~l~~~  284 (495)
T 1opk_A          212 YDKWEMERTDITMKHKLGGGQYGEVYEGVW-KKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIK---HPNLVQLLGV  284 (495)
T ss_dssp             SSCCBCCGGGEEEEEESGGGTTSSEEEEEE-GGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCC---CTTBCCEEEE
T ss_pred             ccccccCHHHceeeeEecCCCCeEEEEEEE-cCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcC---CCCEeeEEEE
Confidence            356778889999999999999999999998 5678999999986432   23457889999999998   9999999999


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +...       ...++|||++. |+|.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.++.+
T Consensus       285 ~~~~-------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~  357 (495)
T 1opk_A          285 CTRE-------PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLV  357 (495)
T ss_dssp             ECSS-------SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred             EecC-------CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcE
Confidence            9766       56799999999 699999988666669999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhC
Q psy2676         173 KIADFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      ||+|||++........  .....++..|+|||++....++.++||||||+++|+|++ |..||.+.+..+....+.....
T Consensus       358 kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~  437 (495)
T 1opk_A          358 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR  437 (495)
T ss_dssp             EECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred             EEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999999987643321  223445678999999999899999999999999999999 9999988776655544432211


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .+                          ....+++.+.+||.+||+.||.+|||+.++++
T Consensus       438 ~~--------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          438 ME--------------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             CC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC--------------------------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            11                          11256689999999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.4e-46  Score=317.96  Aligned_cols=272  Identities=27%  Similarity=0.381  Sum_probs=202.8

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEE---ecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARD---LQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~---~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      .++..++|++++.||+|+||+||+|+.   ...+++.||+|++....  ......+.+|+.++++++   ||||++++++
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~---h~~iv~~~~~   79 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQ---HDNIVKYKGV   79 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCC---CTTBCCEEEE
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCC---CCCEeeEEEE
Confidence            456789999999999999999999983   14678999999986431  112245678999999998   9999999999


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +....     ...+++|||++. ++|.+++..... .+++..++.++.||+.||.+||+.|++|+||||+||+++.++.+
T Consensus        80 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~  153 (295)
T 3ugc_A           80 CYSAG-----RRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV  153 (295)
T ss_dssp             ECHHH-----HTSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred             EecCC-----CCceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeE
Confidence            85431     134789999997 599999987543 38999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCC----ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHh
Q psy2676         173 KIADFGLAKTFDYDM----MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       173 kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      ||+|||++.......    ......++..|+|||++.+..++.++||||||+++|+|++|..|+.......     ....
T Consensus       154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-----~~~~  228 (295)
T 3ugc_A          154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRMI  228 (295)
T ss_dssp             EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH-----HHHH
T ss_pred             EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH-----Hhhh
Confidence            999999998765332    2223456777999999999999999999999999999999999986532211     1111


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      +........     ...................+++++.++|++||+.||.+|||+.++++
T Consensus       229 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          229 GNDKQGQMI-----VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             CTTCCTHHH-----HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCccccchh-----HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            111110000     00000111111111223467899999999999999999999999975

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.6e-46  Score=312.98  Aligned_cols=251  Identities=24%  Similarity=0.333  Sum_probs=203.3

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC-----CCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG-----IPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      .+..++|++.+.||+|+||+||+|++ ..+++.||+|++........     ....+.+|+.++++++   ||||+++++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~   90 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRL-VKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN---HPNIVKLYG   90 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEE-TTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC---CTTBCCEEE
T ss_pred             hhhhccceehhccccCCceeEEEEEE-cCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC---CCCchhhhe
Confidence            46678999999999999999999999 57899999999875433321     1246778999999987   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeeC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLITRA  169 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~--~~H~di~p~Nilv~~~  169 (321)
                      ++.+.       .  ++|||++. ++|.+.+.... ..+++..++.++.|++.||.+||+.|  ++|+||||+||+++.+
T Consensus        91 ~~~~~-------~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~  160 (287)
T 4f0f_A           91 LMHNP-------P--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL  160 (287)
T ss_dssp             EETTT-------T--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC
T ss_pred             eecCC-------C--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc
Confidence            98655       2  69999998 69998887644 34999999999999999999999999  9999999999999887


Q ss_pred             CC-----EEEeecCCcccccCCCccccccccccccchhhhh--cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHH--
Q psy2676         170 GG-----LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL--NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQ--  240 (321)
Q Consensus       170 ~~-----~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--  240 (321)
                      +.     ++|+|||.+.....  ......+++.|+|||++.  ...++.++||||||+++|+|++|..||........  
T Consensus       161 ~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  238 (287)
T 4f0f_A          161 DENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF  238 (287)
T ss_dssp             CTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH
T ss_pred             CCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH
Confidence            76     99999999875443  334567899999999984  44478899999999999999999999976543332  


Q ss_pred             HHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         241 LKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ...+......+   .                      ....+++.+.++|.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~---~----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          239 INMIREEGLRP---T----------------------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHHHHHSCCCC---C----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccCCCC---C----------------------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            22222211111   1                      11256689999999999999999999999985

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.5e-46  Score=331.05  Aligned_cols=252  Identities=22%  Similarity=0.338  Sum_probs=209.9

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ...+++..++|++.+.||+|+||+||++.+   .++.||+|+++..    .....+.+|+.++++++   ||||++++++
T Consensus       185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~---~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~---h~niv~~~~~  254 (450)
T 1k9a_A          185 RSGWALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKND----ATAQAFLAEASVMTQLR---HSNLVQLLGV  254 (450)
T ss_dssp             HTTCBCCGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEESSC----TTSHHHHHHHHHHHTCC---CTTBCCEEEE
T ss_pred             ccccccChHHeEEEeeecCcCCeeEEEEEe---cCCeEEEEEeCCc----hHHHHHHHHHHHHHhcc---CCCEEEEEEE
Confidence            345678889999999999999999999976   4779999998743    24567889999999998   9999999999


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +....      ...++|||++. |+|.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.++.+
T Consensus       255 ~~~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~  328 (450)
T 1k9a_A          255 IVEEK------GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVA  328 (450)
T ss_dssp             EECTT------SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCE
T ss_pred             EEcCC------CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCE
Confidence            76541      35799999998 599999988655558999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         173 KIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      ||+|||++.......  ....++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+......+
T Consensus       329 kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~  406 (450)
T 1k9a_A          329 KVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD  406 (450)
T ss_dssp             EECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC
T ss_pred             EEeeCCCcccccccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            999999987554322  23356788999999999999999999999999999998 999998776655555444321111


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                                ....+++.+.++|++||+.||.+|||+.++++
T Consensus       407 --------------------------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          407 --------------------------APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             --------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                      11256789999999999999999999999874

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.7e-45  Score=310.16  Aligned_cols=252  Identities=20%  Similarity=0.226  Sum_probs=202.8

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee-eccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI-HQNI   98 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~-~~~~   98 (321)
                      ..++|++.+.||+|+||+||+|++ ..+++.||+|++....    ....+.+|+.+++.+.   |++++..+..+ ... 
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~---~~~~i~~~~~~~~~~-   77 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTD-IAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQ---GGVGIPTIRWCGAEG-   77 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEE-TTTTEEEEEEEEESCS----SCCHHHHHHHHHHHHT---TSTTCCCEEEEEEET-
T ss_pred             eccEEEEEEEEccCCCeEEEEEEE-cCCCcEEEEEEecCCc----chhHHHHHHHHHHHhh---cCCCCCccccccCCC-
Confidence            457999999999999999999998 6889999999986542    2347889999999998   66655555544 333 


Q ss_pred             cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe---eCCCEEEe
Q psy2676          99 LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT---RAGGLKIA  175 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~---~~~~~kl~  175 (321)
                            ...++|+|+++++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++   .++.+||+
T Consensus        78 ------~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~  150 (296)
T 3uzp_A           78 ------DYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             ------TEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred             ------CceEEEEEecCCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEe
Confidence                  5679999999889999998644 3499999999999999999999999999999999999994   78899999


Q ss_pred             ecCCcccccCCCc--------cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCCh---HHHHHHH
Q psy2676         176 DFGLAKTFDYDMM--------LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTE---VEQLKCI  244 (321)
Q Consensus       176 dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~  244 (321)
                      |||.+........        .....+++.|+|||++.+..++.++||||||+++|+|++|+.||.....   ......+
T Consensus       151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 3uzp_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             eCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh
Confidence            9999987654332        2456789999999999999999999999999999999999999976322   1111111


Q ss_pred             HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ...                      ............+++++.+++++||+.||.+|||+.++++
T Consensus       231 ~~~----------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          231 SEK----------------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHH----------------------HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ccc----------------------ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            111                      0111122233567899999999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.8e-46  Score=313.06  Aligned_cols=257  Identities=21%  Similarity=0.326  Sum_probs=206.9

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecCC--CcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNK--GNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      ..+.+..++|++.+.||+|+||+||+|++....  +..+++|++...... .....+.+|+.++++++   ||||+++++
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~---h~~i~~~~~   80 (281)
T 3cc6_A            5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL-DNKEKFMSEAVIMKNLD---HPHIVKLIG   80 (281)
T ss_dssp             CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH-HHHHHHHHHHHHHHHHC---CTTBCCEEE
T ss_pred             ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc-hHHHHHHHHHHHHHhCC---CCCcceEEE
Confidence            456778899999999999999999999874333  346999998754211 12346778999999997   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      ++.+.        ..++|+|++. ++|.+++.... ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.
T Consensus        81 ~~~~~--------~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~  151 (281)
T 3cc6_A           81 IIEEE--------PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC  151 (281)
T ss_dssp             EECSS--------SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE
T ss_pred             EEcCC--------CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc
Confidence            98544        3489999999 59999997643 34899999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCC--ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHh
Q psy2676         172 LKIADFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      ++|+|||.+.......  ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+....
T Consensus       152 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~  231 (281)
T 3cc6_A          152 VKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD  231 (281)
T ss_dssp             EEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC
T ss_pred             EEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC
Confidence            9999999988665332  2233456778999999999999999999999999999998 999998766665555444322


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ..+.                          ...+++.+.++|.+||..||.+|||+.+++++
T Consensus       232 ~~~~--------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          232 RLPK--------------------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             CCCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCC--------------------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            1111                          12456889999999999999999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.5e-46  Score=320.87  Aligned_cols=262  Identities=24%  Similarity=0.361  Sum_probs=212.7

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEec------CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCc
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQ------NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN   86 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   86 (321)
                      ....+++..++|++.+.||+|+||+||+|++..      .++..||+|++..... ......+.+|+.+++++..  |||
T Consensus        26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~--hp~  102 (334)
T 2pvf_A           26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGK--HKN  102 (334)
T ss_dssp             CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC-HHHHHHHHHHHHHHHHHCC--CTT
T ss_pred             CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc-HHHHHHHHHHHHHHHHhhc--CCC
Confidence            334667888999999999999999999998732      4567899999864321 1123456789999999942  999


Q ss_pred             eeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHh
Q psy2676          87 IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPP--------------PGLSASKVKELTRQMLKGVDFLHS  151 (321)
Q Consensus        87 i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~--------------~~~~~~~~~~i~~~l~~~l~~lh~  151 (321)
                      |+++++++.+.       ...++|+|++.+ +|.+++.....              ..+++..++.++.||+.||.+||+
T Consensus       103 iv~~~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  175 (334)
T 2pvf_A          103 IINLLGACTQD-------GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS  175 (334)
T ss_dssp             BCCEEEEECSS-------SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeeEEEEEccC-------CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999766       567999999985 99999987532              238999999999999999999999


Q ss_pred             CCceeccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-
Q psy2676         152 HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-  227 (321)
Q Consensus       152 ~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-  227 (321)
                      .|++|+||||+||+++.++.+||+|||++........   .....+++.|+|||++.+..++.++||||||+++|+|++ 
T Consensus       176 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~  255 (334)
T 2pvf_A          176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL  255 (334)
T ss_dssp             TTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             CCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999986654322   233456788999999999889999999999999999999 


Q ss_pred             cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHH
Q psy2676         228 LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA  307 (321)
Q Consensus       228 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  307 (321)
                      |..||.+....+....+........                          ...++..+.++|++||+.||.+|||+.++
T Consensus       256 g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~el  309 (334)
T 2pvf_A          256 GGSPYPGIPVEELFKLLKEGHRMDK--------------------------PANCTNELYMMMRDCWHAVPSQRPTFKQL  309 (334)
T ss_dssp             SCCSSTTCCHHHHHHHHHHTCCCCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCcCcCCHHHHHHHHhcCCCCCC--------------------------CccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9999988877666655544321111                          12466899999999999999999999999


Q ss_pred             hCC
Q psy2676         308 LEH  310 (321)
Q Consensus       308 l~h  310 (321)
                      +++
T Consensus       310 l~~  312 (334)
T 2pvf_A          310 VED  312 (334)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3e-46  Score=318.56  Aligned_cols=267  Identities=19%  Similarity=0.270  Sum_probs=204.7

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecC--CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEE
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQN--KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRF   90 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~   90 (321)
                      .+..+.+..++|++.+.||+|+||+||+|.+...  ++..||+|++............+.+|+.++++++   ||||+++
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~  101 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS---HPNVIRL  101 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC---CTTBCCC
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC---CCCeeee
Confidence            4567778889999999999999999999988533  4558999998754333222345778999999987   9999999


Q ss_pred             EeeeeccccccccceEEEEEeccCcc-CHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC----PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLL  165 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nil  165 (321)
                      ++++....  .......++|+|++.+ +|.+++...    ....+++..++.++.||+.||.+||+.|++|+||||+||+
T Consensus       102 ~~~~~~~~--~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIl  179 (313)
T 3brb_A          102 LGVCIEMS--SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCM  179 (313)
T ss_dssp             CEEEEC---------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEE
T ss_pred             eEEEeecc--ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEE
Confidence            99987652  1122356999999995 999998542    2345999999999999999999999999999999999999


Q ss_pred             EeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHH
Q psy2676         166 ITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQL  241 (321)
Q Consensus       166 v~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~  241 (321)
                      ++.++.++|+|||.+.......   ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+..
T Consensus       180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  259 (313)
T 3brb_A          180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY  259 (313)
T ss_dssp             ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence            9999999999999987664332   2233456788999999999999999999999999999999 89999887766655


Q ss_pred             HHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         242 KCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ..+.......                          ....+++.+.++|.+||..||.+|||+.+++++
T Consensus       260 ~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          260 DYLLHGHRLK--------------------------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HHHHTTCCCC--------------------------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCC--------------------------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5444321111                          112566899999999999999999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4e-46  Score=311.18  Aligned_cols=254  Identities=18%  Similarity=0.200  Sum_probs=208.0

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ..++..++|++.+.||+|+||+||+|++   .++.+|+|++............+.+|+.++++++   ||||+++++++.
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~   77 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRW---QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS---HPNVLPVLGACQ   77 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCS---CTTEECEEEEEC
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEE---CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcC---CCchhheEEEEc
Confidence            3456778999999999999999999987   4888999999765333323345667887777776   999999999986


Q ss_pred             ccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeeCCCE
Q psy2676          96 QNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~--~~H~di~p~Nilv~~~~~~  172 (321)
                      +..     ....++|+|++.+ +|.+++.......+++..++.++.||+.||.|||++|  ++|+||||+||+++.++.+
T Consensus        78 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~  152 (271)
T 3kmu_A           78 SPP-----APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTA  152 (271)
T ss_dssp             TTT-----SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCE
T ss_pred             cCC-----CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcce
Confidence            541     1356999999985 9999999866556999999999999999999999999  9999999999999999999


Q ss_pred             EEeecCCcccccCCCccccccccccccchhhhhcCCCCC---cchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhC
Q psy2676         173 KIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGT---PVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      +++|||+......    ....+|+.|+|||++.+...+.   ++||||||+++|+|++|..||...+..+....+.....
T Consensus       153 ~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  228 (271)
T 3kmu_A          153 RISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL  228 (271)
T ss_dssp             EEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC
T ss_pred             eEEeccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC
Confidence            9998887654332    2356789999999998766544   79999999999999999999988877776655544322


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .+..+                         ..+++.+.++|.+||+.||.+|||+.++++
T Consensus       229 ~~~~~-------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          229 RPTIP-------------------------PGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CCCCC-------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCC-------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            22211                         246689999999999999999999999985

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.7e-46  Score=326.98  Aligned_cols=255  Identities=24%  Similarity=0.371  Sum_probs=198.5

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEe--cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      .++..++|++.+.||+|+||+||+|++.  ..++..||+|+++.... ......+.+|+.+++++.   ||||+++++++
T Consensus        40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~  115 (373)
T 2qol_A           40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFD---HPNIIRLEGVV  115 (373)
T ss_dssp             CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC-HHHHHHHHHHHHHHTTCC---CTTBCCEEEEE
T ss_pred             hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhCC---CCCCCeEEEEE
Confidence            4556679999999999999999999873  14577899999865321 112345778999999887   99999999999


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      .+.       ...++||||++ ++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+|
T Consensus       116 ~~~-------~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k  187 (373)
T 2qol_A          116 TKS-------KPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCK  187 (373)
T ss_dssp             CSS-------SSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred             eeC-------CceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEE
Confidence            766       56799999997 59999998753 3489999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCCc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHh
Q psy2676         174 IADFGLAKTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       174 l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      |+|||++........    .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+....
T Consensus       188 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~  267 (373)
T 2qol_A          188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY  267 (373)
T ss_dssp             ECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE
T ss_pred             ECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999987653321    112334678999999999999999999999999999998 999998887766665554332


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ..+.                          ...++..+.+++.+||+.||.+||++.++++
T Consensus       268 ~~~~--------------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          268 RLPP--------------------------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ECCC--------------------------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCC--------------------------CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            2111                          1246688999999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.5e-47  Score=324.68  Aligned_cols=272  Identities=23%  Similarity=0.271  Sum_probs=209.3

Q ss_pred             ccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          12 LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        12 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      ++...++...++|++.+.||+|+||+||+|++  .+++.||+|++....  ......+.+|+.++++++   ||||++++
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~---h~~iv~~~  101 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL--RDGAKVALKRRTPES--SQGIEEFETEIETLSFCR---HPHLVSLI  101 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEEC--TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCC---CTTBCCEE
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEE--CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCC---CCCEeeEE
Confidence            45566777889999999999999999999986  468899999876432  122345677888888877   99999999


Q ss_pred             eeeeccccccccceEEEEEeccCc-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP--PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR  168 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~  168 (321)
                      +++...       ...++|||++. ++|.+++.....  ..+++..++.++.||+.||.+||++|++|+||||+||+++.
T Consensus       102 ~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~  174 (321)
T 2qkw_B          102 GFCDER-------NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE  174 (321)
T ss_dssp             EECCCT-------TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECT
T ss_pred             EEEcCC-------CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECC
Confidence            998766       56799999998 599999876432  34899999999999999999999999999999999999999


Q ss_pred             CCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHH-
Q psy2676         169 AGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI-  244 (321)
Q Consensus       169 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-  244 (321)
                      ++.+||+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++|+.||......+..... 
T Consensus       175 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~  254 (321)
T 2qkw_B          175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE  254 (321)
T ss_dssp             TCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH
T ss_pred             CCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHH
Confidence            9999999999987654222   223456899999999999999999999999999999999999999764322111000 


Q ss_pred             --HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         245 --FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       245 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                        ............             ...........+++..+.+++.+||+.||.+|||+.+++++
T Consensus       255 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          255 WAVESHNNGQLEQI-------------VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             HTHHHHTTTCCCSS-------------SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhhhccccccHHHh-------------cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              000000000000             00000111223566889999999999999999999999975

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.4e-46  Score=317.34  Aligned_cols=251  Identities=23%  Similarity=0.355  Sum_probs=198.2

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEE----EEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYV----AMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~----~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      +..++|++++.||+|+||+||+|++ ..+++.+    ++|.+... ........+.+|+.++++++   ||||+++++++
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~   86 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLW-IPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD---NPHVCRLLGIC   86 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEE-CCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCC---BTTBCCCCEEE
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEE-cCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCC---CCCeeEEEEEE
Confidence            4568999999999999999999998 4556555    55555432 22233456778999999987   99999999998


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      ...        ..+++++++. |+|.+++..... .+++..++.++.||+.||.|||++|++|+||||+||+++.++.+|
T Consensus        87 ~~~--------~~~~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~k  157 (327)
T 3lzb_A           87 LTS--------TVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVK  157 (327)
T ss_dssp             ESS--------SEEEEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEE
T ss_pred             ecC--------CceEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEE
Confidence            765        2578888888 599999987543 489999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhC
Q psy2676         174 IADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       174 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      |+|||++........   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+.....
T Consensus       158 L~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  237 (327)
T 3lzb_A          158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER  237 (327)
T ss_dssp             ECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             EccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999987643322   223445778999999999999999999999999999999 9999988776665554443221


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .+.                          ...++.++.++|++||..||.+|||+.++++
T Consensus       238 ~~~--------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          238 LPQ--------------------------PPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             CCC--------------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCC--------------------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            111                          1245688999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.6e-46  Score=320.07  Aligned_cols=265  Identities=15%  Similarity=0.147  Sum_probs=196.2

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecC---CCcEEEEEEeecccCCC---------CCCchhHHHHHHHHhcccCCC
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQN---KGNYVAMKKLRVKLNED---------GIPMSTLREISILKQLDTFEH   84 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~~iK~~~~~~~~~---------~~~~~~~~e~~~l~~l~~~~~   84 (321)
                      .+...++|++.+.||+|+||+||+|++. .   ++..+++|++.......         .....+.+|+..++.+.   |
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~---h  107 (345)
T 2v62_A           32 DDMEGNQWVLGKKIGSGGFGLIYLAFPT-NKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD---Y  107 (345)
T ss_dssp             ECTTSCEEEEEEEC------CEEEEEES-SSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS---C
T ss_pred             ccccCceEEEEeeEeecCCeEEEEEEec-CCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc---c
Confidence            3456689999999999999999999983 4   77899999987532110         01123345555566665   9


Q ss_pred             CceeEEEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q psy2676          85 PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNL  164 (321)
Q Consensus        85 ~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Ni  164 (321)
                      |||+++++++....   ......++|||+++++|.+++....  .+++..++.++.||+.||.|||+.|++|+||||+||
T Consensus       108 ~ni~~~~~~~~~~~---~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  182 (345)
T 2v62_A          108 LGIPLFYGSGLTEF---KGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANL  182 (345)
T ss_dssp             CCCCCEEEEEEEES---SSCEEEEEEEECEEEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             cCcceeeccccccc---CCCcEEEEEEeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHE
Confidence            99999999987731   1126789999999779999998744  599999999999999999999999999999999999


Q ss_pred             EEeeCC--CEEEeecCCcccccCCC--------ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCC
Q psy2676         165 LITRAG--GLKIADFGLAKTFDYDM--------MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCA  234 (321)
Q Consensus       165 lv~~~~--~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  234 (321)
                      +++.++  .+||+|||++.......        ......+++.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus       183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999887  99999999997664322        12345789999999999999999999999999999999999999964


Q ss_pred             C-ChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhh--hhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         235 S-TEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAI--FMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       235 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      . ................    .               .......  ...+++++.++|.+||..||.+|||+.++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~----~---------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          263 NLKDPVAVQTAKTNLLDE----L---------------PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             GTTCHHHHHHHHHHHHHT----T---------------THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cccccHHHHHHHHhhccc----c---------------cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            2 2222222111110000    0               0000011  1167789999999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.9e-46  Score=311.48  Aligned_cols=256  Identities=25%  Similarity=0.336  Sum_probs=209.1

Q ss_pred             ccccCCcceeeee-eeecccceeEEEEEEe-cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          16 SLDLGDKKYDELC-QIGCGAYGTVFKARDL-QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        16 ~~~~~~~~y~~~~-~lg~g~~g~v~~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      .+.+..++|.+.+ .||+|+||+||+|.+. ..++..|++|+++... .......+.+|+.++++++   ||||++++++
T Consensus         3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~   78 (287)
T 1u59_A            3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLD---NPYIVRLIGV   78 (287)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCC---CTTBCCEEEE
T ss_pred             cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCC---CCCEeEEEEE
Confidence            4566778999988 9999999999999863 3467889999987542 1122345778999999997   9999999999


Q ss_pred             eeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +...        ..++|+|++.+ +|.+++.... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.+
T Consensus        79 ~~~~--------~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~  149 (287)
T 1u59_A           79 CQAE--------ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA  149 (287)
T ss_dssp             EESS--------SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEE
T ss_pred             ecCC--------CcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCE
Confidence            8433        47999999995 9999997543 349999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHH
Q psy2676         173 KIADFGLAKTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  247 (321)
                      +|+|||.+........    .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+...
T Consensus       150 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~  229 (287)
T 1u59_A          150 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG  229 (287)
T ss_dssp             EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT
T ss_pred             EECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC
Confidence            9999999987653322    223445788999999998889999999999999999998 99999887776665554432


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ...    .                      ....+++++.++|.+||..||.+||++.+++++
T Consensus       230 ~~~----~----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  266 (287)
T 1u59_A          230 KRM----E----------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQR  266 (287)
T ss_dssp             CCC----C----------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CcC----C----------------------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            111    1                      112566899999999999999999999999976

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.6e-46  Score=318.44  Aligned_cols=262  Identities=22%  Similarity=0.305  Sum_probs=211.0

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEE
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRF   90 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~   90 (321)
                      ..+++..++|++.+.||+|+||+||+|++.    ..+++.|++|++...... .....+.+|+.+++++..  ||||+++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~--hp~iv~~   96 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGH--HLNVVNL   96 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCC--CTTBCCE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc-HHHHHHHHHHHHHHhccc--CCCeeeE
Confidence            356778899999999999999999999863    356789999998753221 122356789999999953  9999999


Q ss_pred             EeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPP--------------GLSASKVKELTRQMLKGVDFLHSHRII  155 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~--------------~~~~~~~~~i~~~l~~~l~~lh~~~~~  155 (321)
                      ++++....      ...++|+|++.+ +|.+++......              .+++..++.++.||+.||.+||+.|++
T Consensus        97 ~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~  170 (316)
T 2xir_A           97 LGACTKPG------GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI  170 (316)
T ss_dssp             EEEECCTT------SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             EEEEecCC------CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            99986541      347999999995 999999875431              278999999999999999999999999


Q ss_pred             eccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCC
Q psy2676         156 HRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPL  231 (321)
Q Consensus       156 H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p  231 (321)
                      |+||||+||+++.++.++|+|||.+........   .....+++.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p  250 (316)
T 2xir_A          171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  250 (316)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999976643322   234566888999999999999999999999999999998 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         232 FCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      |.+....................                         ..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          251 YPGVKIDEEFCRRLKEGTRMRAP-------------------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             STTCCCSHHHHHHHHHTCCCCCC-------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccchhHHHHHHhccCccCCCC-------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            98765444333333322211111                         2355889999999999999999999999875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.9e-46  Score=313.17  Aligned_cols=249  Identities=19%  Similarity=0.262  Sum_probs=201.1

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCC-------cEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeE
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKG-------NYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR   89 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~-------~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~   89 (321)
                      .++..++|++.+.||+|+||+||+|++. .++       ..+++|++....  ......+.+|+.++++++   ||||++
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~---h~~iv~   76 (289)
T 4fvq_A            3 HKIRNEDLIFNESLGQGTFTKIFKGVRR-EVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLS---HKHLVL   76 (289)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEEE-EECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSC---CTTBCC
T ss_pred             EEechhHeeeeeeeccCCCceEEEEEEe-cccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCC---CCCEeE
Confidence            3567789999999999999999999984 333       579999986532  222356778999999998   999999


Q ss_pred             EEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR  168 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~  168 (321)
                      +++++.+.       ...++|||++. ++|.+++..... .+++..++.++.||+.||.+||++|++|+||||+||+++.
T Consensus        77 ~~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~  148 (289)
T 4fvq_A           77 NYGVCVCG-------DENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIR  148 (289)
T ss_dssp             EEEEECCT-------TCCEEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEE
T ss_pred             EEEEEEeC-------CCCEEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEec
Confidence            99999776       56689999998 599999987542 3899999999999999999999999999999999999999


Q ss_pred             CCC--------EEEeecCCcccccCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhc-CCCCCCCChH
Q psy2676         169 AGG--------LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRL-VPLFCASTEV  238 (321)
Q Consensus       169 ~~~--------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~  238 (321)
                      ++.        ++|+|||.+......   ....+++.|+|||++.+ ..++.++||||||+++|+|++| .+||......
T Consensus       149 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~  225 (289)
T 4fvq_A          149 EEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ  225 (289)
T ss_dssp             CCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             CCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH
Confidence            887        999999998755422   34457889999999987 6689999999999999999995 5555554443


Q ss_pred             HHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         239 EQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ..... .......                           ....++++.++|++||+.||.+|||+.++++|
T Consensus       226 ~~~~~-~~~~~~~---------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          226 RKLQF-YEDRHQL---------------------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHHHH-HHTTCCC---------------------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHH-hhccCCC---------------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            33322 2211110                           11335789999999999999999999999975

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.5e-46  Score=313.66  Aligned_cols=259  Identities=22%  Similarity=0.328  Sum_probs=200.6

Q ss_pred             cccccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCc
Q psy2676           7 DTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN   86 (321)
Q Consensus         7 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   86 (321)
                      ...+++....+.+..++|++.+.||+|++|+||++++   .++.+++|+++..    .....+.+|+.++++++   |||
T Consensus         6 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~---h~~   75 (278)
T 1byg_A            6 AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKND----ATAQAFLAEASVMTQLR---HSN   75 (278)
T ss_dssp             ---------CCBCCGGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCC----C--HHHHHTHHHHTTCC---CTT
T ss_pred             cchhhhhhccccCChhhceEEeEEecCCCceEEEEEE---cCCEEEEEEecch----hHHHHHHHHHHHHHhCC---CCC
Confidence            3444555666778889999999999999999999976   4789999998643    23456788999999987   999


Q ss_pred             eeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q psy2676          87 IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLL  165 (321)
Q Consensus        87 i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nil  165 (321)
                      |+++++++....      ...++|+|++.+ +|.+++.......+++..++.++.|++.||.+||++|++|+||+|+||+
T Consensus        76 iv~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil  149 (278)
T 1byg_A           76 LVQLLGVIVEEK------GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL  149 (278)
T ss_dssp             BCCEEEEECCC--------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EeeEEEEEEcCC------CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEE
Confidence            999999875431      357999999985 9999998754334799999999999999999999999999999999999


Q ss_pred             EeeCCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHH
Q psy2676         166 ITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCI  244 (321)
Q Consensus       166 v~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~  244 (321)
                      ++.++.++|+|||++.......  ....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+
T Consensus       150 ~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~  227 (278)
T 1byg_A          150 VSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV  227 (278)
T ss_dssp             ECTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH
T ss_pred             EeCCCcEEEeeccccccccccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999999987654332  23456888999999999999999999999999999998 99999877655544433


Q ss_pred             HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .....    .                      .....+++.+.++|++||+.||.+|||+.++++
T Consensus       228 ~~~~~----~----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          228 EKGYK----M----------------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             TTTCC----C----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcCCC----C----------------------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            22111    0                      112256689999999999999999999999975

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.9e-46  Score=321.71  Aligned_cols=261  Identities=23%  Similarity=0.359  Sum_probs=207.6

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      ..++..++|++++.||+|+||+||+|++.    ..++..||+|++..... ......+.+|+.+++++.   ||||++++
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~---h~~iv~~~   99 (327)
T 2yfx_A           24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFN---HQNIVRCI   99 (327)
T ss_dssp             SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC-HHHHHHHHHHHHHHHHCC---CTTBCCEE
T ss_pred             cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc-hhhHHHHHHHHHHHhhCC---CCCCCeEE
Confidence            44678899999999999999999999841    35678999999864321 122345678999999987   99999999


Q ss_pred             eeeeccccccccceEEEEEeccCc-cCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP-----PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLL  165 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nil  165 (321)
                      +++.+.       ...++|||+++ ++|.+++.....     ..+++..++.++.||+.||.+||+.|++|+||||+||+
T Consensus       100 ~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIl  172 (327)
T 2yfx_A          100 GVSLQS-------LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL  172 (327)
T ss_dssp             EEECSS-------SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             EEEcCC-------CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEE
Confidence            999776       56799999997 599999987542     34899999999999999999999999999999999999


Q ss_pred             EeeCC---CEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChH
Q psy2676         166 ITRAG---GLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEV  238 (321)
Q Consensus       166 v~~~~---~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~  238 (321)
                      ++.++   .++|+|||.+.......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       173 i~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  252 (327)
T 2yfx_A          173 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ  252 (327)
T ss_dssp             ESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             EecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH
Confidence            98544   59999999987553222   2234567889999999999999999999999999999998 99999887776


Q ss_pred             HHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         239 EQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                      +....+........                          ...+++.+.++|.+||+.||.+|||+.++++|.|+
T Consensus       253 ~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          253 EVLEFVTSGGRMDP--------------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             HHHHHHHTTCCCCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCC--------------------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            66555443221111                          12456889999999999999999999999998664

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.3e-46  Score=326.70  Aligned_cols=280  Identities=21%  Similarity=0.265  Sum_probs=212.5

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      ....+++|++.+.||+|+||+||+|++ ..+++.||+|++...... .....+.+|+.++++++   ||||+++++++..
T Consensus         4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~   78 (396)
T 4eut_A            4 QSTSNHLWLLSDILGQGATANVFRGRH-KKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLN---HKNIVKLFAIEEE   78 (396)
T ss_dssp             EECSSEEEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCC---CTTBCCEEEEEEC
T ss_pred             CCCCCCceEEEEEEEcCCCeEEEEEEE-CCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcC---CCCCCeEEEeecc
Confidence            345778999999999999999999999 678999999999754322 23446678999999998   9999999999865


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE----eeCC
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPP-PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI----TRAG  170 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv----~~~~  170 (321)
                      ..     ....++||||+. |+|.+++..... ..+++..++.++.||+.||.|||+.|++||||||+||++    +.++
T Consensus        79 ~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  153 (396)
T 4eut_A           79 TT-----TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS  153 (396)
T ss_dssp             TT-----TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE
T ss_pred             CC-----CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce
Confidence            51     136799999998 599999976432 238999999999999999999999999999999999999    6666


Q ss_pred             CEEEeecCCcccccCCCccccccccccccchhhhhc--------CCCCCcchHHHHHHHHHHHHhcCCCCCCC----ChH
Q psy2676         171 GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN--------LGYGTPVDIWSIGCVMAEMWRLVPLFCAS----TEV  238 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~----~~~  238 (321)
                      .+||+|||++.............+++.|+|||++.+        ..++.++||||||+++|+|++|..||...    ...
T Consensus       154 ~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~  233 (396)
T 4eut_A          154 VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (396)
T ss_dssp             EEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH
T ss_pred             eEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH
Confidence            799999999988766655566778999999999875        45678999999999999999999999642    233


Q ss_pred             HHHHHHHHHhCCCCCCCcchhhhhhhhhhhhh-hhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         239 EQLKCIFRVIGTPSMNEWPENISLMWSSFEQY-SKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      +....+..   ..+...+..........+... ...........++..+.++|++||..||.+|||+.++++
T Consensus       234 ~~~~~~~~---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          234 EVMYKIIT---GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HHHHHHHH---SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             HHHHHHhc---CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            44444333   222221111000000000000 000111223456688999999999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.4e-46  Score=320.94  Aligned_cols=259  Identities=22%  Similarity=0.310  Sum_probs=209.6

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCC-----cEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKG-----NYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRF   90 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~   90 (321)
                      .+++..++|++.+.||+|+||+||+|.+. ..+     ..+++|++...... .....+.+|+.+++++..  ||||+++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~--h~~iv~~  115 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAF-GLGKEDAVLKVAVKMLKSTAHA-DEKEALMSELKIMSHLGQ--HENIVNL  115 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEET-TCSSSCCCCEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCC--CTTBCCE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEec-CCCcccchhHHHHHhcccccCh-HHHHHHHHHHHHHHhhcC--CCCeeeE
Confidence            57788899999999999999999999984 333     47999998653211 123457789999999942  9999999


Q ss_pred             EeeeeccccccccceEEEEEeccCcc-CHHHHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCP------------PPGLSASKVKELTRQMLKGVDFLHSHRIIHR  157 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~  157 (321)
                      ++++...       ...++|||++++ +|.+++....            ...+++..++.++.||+.||.+||+.|++|+
T Consensus       116 ~~~~~~~-------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  188 (333)
T 2i1m_A          116 LGACTHG-------GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHR  188 (333)
T ss_dssp             EEEECSS-------SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             EEEEecC-------CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence            9999766       567999999985 9999987532            2348999999999999999999999999999


Q ss_pred             cCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCC
Q psy2676         158 DLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFC  233 (321)
Q Consensus       158 di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~  233 (321)
                      ||||+||+++.++.++|+|||++........   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       189 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  268 (333)
T 2i1m_A          189 DVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP  268 (333)
T ss_dssp             CCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence            9999999999999999999999976543322   233456788999999999999999999999999999998 999998


Q ss_pred             CCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         234 ASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      +................+..+                         ..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          269 GILVNSKFYKLVKDGYQMAQP-------------------------AFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             TCCSSHHHHHHHHHTCCCCCC-------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccchhHHHHHHHhcCCCCCCC-------------------------CCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            766555444444332222111                         1345889999999999999999999999863

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=323.00  Aligned_cols=257  Identities=12%  Similarity=0.173  Sum_probs=201.2

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecC-------CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeE--
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQN-------KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR--   89 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~--   89 (321)
                      ..+++|++.+.||+|+||+||+|++...       .++.||+|++...       ..+.+|+.+++++.   ||||++  
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~---h~niv~~~  108 (352)
T 2jii_A           39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAA---KPLQVNKW  108 (352)
T ss_dssp             TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHC---CHHHHHHH
T ss_pred             ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhc---ccchhhhh
Confidence            3468999999999999999999998432       4889999998743       37889999999998   998887  


Q ss_pred             -------------EEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy2676          90 -------------FFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIH  156 (321)
Q Consensus        90 -------------~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H  156 (321)
                                   +++++...      ....++|||+++++|.+++.......+++..++.++.||+.||.|||++|++|
T Consensus       109 ~~~~~~~~~~i~~~~~~~~~~------~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH  182 (352)
T 2jii_A          109 KKLYSTPLLAIPTCMGFGVHQ------DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVH  182 (352)
T ss_dssp             HHHTTCTTCSCCCCCEEEEET------TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             hhhccCCccCccchhhccccC------CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence                         45554331      15789999999779999999864466999999999999999999999999999


Q ss_pred             ccCCCCcEEEeeCC--CEEEeecCCcccccCCC--------ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHH
Q psy2676         157 RDLKPQNLLITRAG--GLKIADFGLAKTFDYDM--------MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW  226 (321)
Q Consensus       157 ~di~p~Nilv~~~~--~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~  226 (321)
                      +||||+||+++.++  .++|+|||++.......        ......+++.|+|||++.+..++.++||||||+++|+|+
T Consensus       183 ~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~  262 (352)
T 2jii_A          183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL  262 (352)
T ss_dssp             SCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence            99999999999988  89999999997664322        123457899999999999999999999999999999999


Q ss_pred             hcCCCCCCCC--hHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCH
Q psy2676         227 RLVPLFCAST--EVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA  304 (321)
Q Consensus       227 ~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  304 (321)
                      +|..||....  ..............+. . +..                .......+++++.++|++||..||.+|||+
T Consensus       263 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-~~~----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  324 (352)
T 2jii_A          263 YGFLPWTNCLPNTEDIMKQKQKFVDKPG-P-FVG----------------PCGHWIRPSETLQKYLKVVMALTYEEKPPY  324 (352)
T ss_dssp             HSCCTTGGGTTCHHHHHHHHHHHHHSCC-C-EEC----------------TTSCEECCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred             hCCCCcccCCcCHHHHHHHHHhccCChh-h-hhh----------------hccccCCCcHHHHHHHHHHHhCChhhCCCH
Confidence            9999998753  2222222221111111 0 000                000012457899999999999999999999


Q ss_pred             HHHhC
Q psy2676         305 ADALE  309 (321)
Q Consensus       305 ~~ll~  309 (321)
                      .++++
T Consensus       325 ~~l~~  329 (352)
T 2jii_A          325 AMLRN  329 (352)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99964

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-45  Score=316.63  Aligned_cols=256  Identities=24%  Similarity=0.357  Sum_probs=203.3

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCC---CcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNK---GNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      .++..++|++.+.||+|+||+||+|.+...+   +..|++|+++.... ......+.+|+.++++++   ||||++++++
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~---h~~iv~~~~~  114 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFS---HHNIIRLEGV  114 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCC---CTTBCCEEEE
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC-HHHHHHHHHHHHHHHhCC---CCCCCcEEEE
Confidence            4667889999999999999999999884332   34699999864321 112335678999999987   9999999999


Q ss_pred             eeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +.+.       ...++|||++.+ +|.+++.... ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.+
T Consensus       115 ~~~~-------~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~  186 (333)
T 1mqb_A          115 ISKY-------KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVC  186 (333)
T ss_dssp             ECSS-------SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred             EecC-------CCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcE
Confidence            9766       678999999985 9999998743 348999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHH
Q psy2676         173 KIADFGLAKTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  247 (321)
                      ||+|||.+........    .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+...
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  266 (333)
T 1mqb_A          187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG  266 (333)
T ss_dssp             EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC
Confidence            9999999987653321    122345678999999999999999999999999999998 99999888776666555432


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ...+.                          ...++..+.++|.+||+.||.+||++.+++++
T Consensus       267 ~~~~~--------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          267 FRLPT--------------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CCCCC--------------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CcCCC--------------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            21111                          12456889999999999999999999999863

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.5e-46  Score=320.04  Aligned_cols=281  Identities=21%  Similarity=0.263  Sum_probs=200.6

Q ss_pred             ccccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCce
Q psy2676           8 TIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI   87 (321)
Q Consensus         8 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i   87 (321)
                      +.....-..+.+..++|++.+.||+|+||+||+|++   .++.||+|++.....   .......|+.++++++   ||||
T Consensus        10 ~~~~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~---hpni   80 (322)
T 3soc_A           10 SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL---LNEYVAVKIFPIQDK---QSWQNEYEVYSLPGMK---HENI   80 (322)
T ss_dssp             ----CCCCCEEETTEEEEEEEEEECSTTCEEEEEEE---TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCC---CTTB
T ss_pred             cccccCccccccchhhchhhheecccCceEEEEEEE---CCCEEEEEEeecCch---HHHHHHHHHHHHhcCC---CCCc
Confidence            344455667778889999999999999999999976   378999999864321   1223344666666665   9999


Q ss_pred             eEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------Ccee
Q psy2676          88 VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH----------RIIH  156 (321)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~----------~~~H  156 (321)
                      +++++++....   .....+++|||++.+ +|.+++...   .+++..++.++.||+.||.|||+.          |++|
T Consensus        81 v~~~~~~~~~~---~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH  154 (322)
T 3soc_A           81 LQFIGAEKRGT---SVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISH  154 (322)
T ss_dssp             CCEEEEEEEEC---SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEEC
T ss_pred             hhhcceeccCC---CCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEe
Confidence            99999997651   112457999999985 999999873   389999999999999999999999          9999


Q ss_pred             ccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcC-----CCCCcchHHHHHHHHHHHHhc
Q psy2676         157 RDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNL-----GYGTPVDIWSIGCVMAEMWRL  228 (321)
Q Consensus       157 ~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g  228 (321)
                      +||||+||+++.++.+||+|||++........   .....+|+.|+|||++.+.     .++.++||||||+++|+|++|
T Consensus       155 ~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg  234 (322)
T 3soc_A          155 RDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR  234 (322)
T ss_dssp             SCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhC
Confidence            99999999999999999999999976643322   3345789999999999874     345688999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhh--hhhhcchhHHHHHHHhcccCCCCCCCHHH
Q psy2676         229 VPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSA--IFMDCCSKANSLLESMLTFNPADRISAAD  306 (321)
Q Consensus       229 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~  306 (321)
                      +.||.+................+...      .................  .....++++.+||++||+.||.+|||+.+
T Consensus       235 ~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  308 (322)
T 3soc_A          235 CTAADGPVDEYMLPFEEEIGQHPSLE------DMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC  308 (322)
T ss_dssp             BTTSSSCCCCCCCTTHHHHCSSCCHH------HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCcchhccchhhhhccCCchh------hhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHH
Confidence            99997643211000000000000000      00000000000000000  01134467999999999999999999999


Q ss_pred             HhC
Q psy2676         307 ALE  309 (321)
Q Consensus       307 ll~  309 (321)
                      +++
T Consensus       309 ll~  311 (322)
T 3soc_A          309 VGE  311 (322)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            985

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.1e-45  Score=311.71  Aligned_cols=279  Identities=23%  Similarity=0.384  Sum_probs=209.3

Q ss_pred             ccccccccccCCcceeeeeeeecccceeEEEEEE---ecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCc
Q psy2676          10 QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARD---LQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN   86 (321)
Q Consensus        10 ~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~---~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   86 (321)
                      .........+..++|++++.||+|+||.||+|+.   ...+++.||+|++.... .......+.+|+.++++++   |||
T Consensus         9 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~---h~~   84 (302)
T 4e5w_A            9 PATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLY---HEN   84 (302)
T ss_dssp             CCCCCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCC---CTT
T ss_pred             cceecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCC---CCC
Confidence            3445566667778899999999999999999983   14688999999997543 2233456788999999998   999


Q ss_pred             eeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q psy2676          87 IVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLL  165 (321)
Q Consensus        87 i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nil  165 (321)
                      |+++++++.+..     ...+++|||++.+ +|.+++.... ..+++..++.++.||+.||++||++|++|+||||+||+
T Consensus        85 i~~~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil  158 (302)
T 4e5w_A           85 IVKYKGICTEDG-----GNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVL  158 (302)
T ss_dssp             BCCEEEEEEC--------CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             eeeeeeEEecCC-----CceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEE
Confidence            999999986541     1347899999985 9999996543 34899999999999999999999999999999999999


Q ss_pred             EeeCCCEEEeecCCcccccCCC----ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHH
Q psy2676         166 ITRAGGLKIADFGLAKTFDYDM----MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQL  241 (321)
Q Consensus       166 v~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  241 (321)
                      ++.++.++|+|||++.......    ......++..|+|||++.+..++.++||||||+++|+|++|..|+......   
T Consensus       159 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---  235 (302)
T 4e5w_A          159 VESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL---  235 (302)
T ss_dssp             EEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---
T ss_pred             EcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH---
Confidence            9999999999999998765443    233456778899999999999999999999999999999999987432111   


Q ss_pred             HHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         242 KCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                        ......... ....  .   ..................+++.+.++|++||+.||.+|||+.++++
T Consensus       236 --~~~~~~~~~-~~~~--~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          236 --FLKMIGPTH-GQMT--V---TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             --HHHHHCSCC-GGGH--H---HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             --HhhccCCcc-cccC--H---HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence              111111100 0000  0   0000011111111123467789999999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.8e-46  Score=321.81  Aligned_cols=267  Identities=27%  Similarity=0.429  Sum_probs=195.7

Q ss_pred             ccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeE
Q psy2676          10 QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR   89 (321)
Q Consensus        10 ~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~   89 (321)
                      +.+.-..+++...+|++.+.||+|+||+||+|++ ..+++.||+|++....  ......+.+|+.+++++..  ||||++
T Consensus        16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~--h~~iv~   90 (337)
T 3ll6_A           16 SDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQD-VGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSG--HPNIVQ   90 (337)
T ss_dssp             CSSTTCEEEETTEEEEEEEEEECCSSEEEEEEEE-TTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTT--STTBCC
T ss_pred             HHhhcceeeccCceEEEEEEEccCCceEEEEEEE-CCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhcc--CCChhh
Confidence            3445567788889999999999999999999999 5789999999985432  1123456789999999863  999999


Q ss_pred             EEeeeecccc-ccccceEEEEEeccCccCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEE
Q psy2676          90 FFDVIHQNIL-SDERYLTVYLIFEHVDQDLGSYMEKC-PPPGLSASKVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLL  165 (321)
Q Consensus        90 ~~~~~~~~~~-~~~~~~~~~~v~e~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lh~~~--~~H~di~p~Nil  165 (321)
                      +++++..... ........++++|+++|+|.+++... ....+++..++.++.||+.||.|||+.|  ++|+||||+||+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl  170 (337)
T 3ll6_A           91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL  170 (337)
T ss_dssp             EEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCE
T ss_pred             ccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEE
Confidence            9999854321 12333678999999999999988652 2345999999999999999999999999  999999999999


Q ss_pred             EeeCCCEEEeecCCcccccCCCcc-------------ccccccccccchhhh---hcCCCCCcchHHHHHHHHHHHHhcC
Q psy2676         166 ITRAGGLKIADFGLAKTFDYDMML-------------TSVVVTLWYRAPEIL---LNLGYGTPVDIWSIGCVMAEMWRLV  229 (321)
Q Consensus       166 v~~~~~~kl~dfg~~~~~~~~~~~-------------~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~~l~~g~  229 (321)
                      ++.++.+||+|||++.........             ....+++.|+|||++   .+..++.++||||||+++|+|++|.
T Consensus       171 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~  250 (337)
T 3ll6_A          171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ  250 (337)
T ss_dssp             ECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSS
T ss_pred             ECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCC
Confidence            999999999999999876543221             134588999999998   5666888999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         230 PLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .||...........   ....+.                          ....+..+.+||++||+.||.+|||+.++++
T Consensus       251 ~p~~~~~~~~~~~~---~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  301 (337)
T 3ll6_A          251 HPFEDGAKLRIVNG---KYSIPP--------------------------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVH  301 (337)
T ss_dssp             CCC---------------CCCCT--------------------------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCcchhHHHhhcC---cccCCc--------------------------ccccchHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99976443322111   111111                          1234477889999999999999999999997


Q ss_pred             C
Q psy2676         310 H  310 (321)
Q Consensus       310 h  310 (321)
                      |
T Consensus       302 ~  302 (337)
T 3ll6_A          302 Q  302 (337)
T ss_dssp             H
T ss_pred             H
Confidence            6

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.6e-45  Score=326.37  Aligned_cols=263  Identities=21%  Similarity=0.234  Sum_probs=211.6

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ...++|++.+.||+|+||.||+|++ ..+++.||+|++.....    ...+.+|+.+++.+..  ++++..+..+.... 
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~-~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~--~~~i~~i~~~~~~~-   75 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTN-IQTNEEVAIKLENVKTK----HPQLLYESKIYRILQG--GTGIPNVRWFGVEG-   75 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEE-TTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTT--STTCCCEEEEEEET-
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEE-CCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcC--CCCCCeEEEEEeeC-
Confidence            3468999999999999999999998 57899999998865432    3468899999999983  46666666665544 


Q ss_pred             cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE---eeCCCEEEe
Q psy2676          99 LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI---TRAGGLKIA  175 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv---~~~~~~kl~  175 (321)
                            ...++|||+++++|.+++..... .+++..++.++.||+.||.|||++|++|+||||+||++   +.++.+||+
T Consensus        76 ------~~~~lvme~~g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~  148 (483)
T 3sv0_A           76 ------DYNVLVMDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII  148 (483)
T ss_dssp             ------TEEEEEEECCCCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEEC
T ss_pred             ------CEEEEEEECCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEE
Confidence                  57899999998899999986543 49999999999999999999999999999999999999   588899999


Q ss_pred             ecCCcccccCCCc--------cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChH---HHHHHH
Q psy2676         176 DFGLAKTFDYDMM--------LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV---EQLKCI  244 (321)
Q Consensus       176 dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~  244 (321)
                      |||++........        .....+|+.|+|||++.+..++.++||||||+++|+|++|..||.+....   +....+
T Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i  228 (483)
T 3sv0_A          149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (483)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH
T ss_pred             eCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH
Confidence            9999987654332        22567899999999999999999999999999999999999999875432   222222


Q ss_pred             HHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC----------CCCCC
Q psy2676         245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE----------HPYFK  314 (321)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~----------h~~f~  314 (321)
                      ...                      ............++.++.+||..||..||.+||++.+|++          ++|+.
T Consensus       229 ~~~----------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~  286 (483)
T 3sv0_A          229 SEK----------------------KVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDY  286 (483)
T ss_dssp             HHH----------------------HHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSS
T ss_pred             hhc----------------------cccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccC
Confidence            111                      1111222334577899999999999999999999998764          56766


Q ss_pred             CCCC
Q psy2676         315 EKEN  318 (321)
Q Consensus       315 ~~~~  318 (321)
                      ..+|
T Consensus       287 ~~dW  290 (483)
T 3sv0_A          287 VFDW  290 (483)
T ss_dssp             CCHH
T ss_pred             CcCc
Confidence            5544

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-45  Score=314.00  Aligned_cols=253  Identities=23%  Similarity=0.317  Sum_probs=196.1

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC-CCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG-IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      .-++|++.+.||+|+||+||+|++ ..+++.|++|++........ ....+.+|+.+++++.   ||||+++++++... 
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~~~~~~~~-  106 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAED-TVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ---EPHVVPIHDFGEID-  106 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEE-TTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC---CTTBCCEEEEEEET-
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEE-cCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC---CCCeeEEEEEEeeC-
Confidence            347899999999999999999998 57899999999875432221 1245678888888887   99999999999776 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ...++|+|++++ +|.+++...  ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus       107 ------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Df  178 (309)
T 2h34_A          107 ------GQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDF  178 (309)
T ss_dssp             ------TEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSC
T ss_pred             ------CeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecC
Confidence                  678999999995 999999873  45899999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCC--ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         178 GLAKTFDYDM--MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       178 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      |++.......  ......+++.|+|||++.+..++.++||||||+++|+|++|..||...........+ .... +.   
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~-~~---  253 (309)
T 2h34_A          179 GIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAI-PR---  253 (309)
T ss_dssp             CC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCC-CC---
T ss_pred             ccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCC-CC---
Confidence            9987665332  233456889999999999988999999999999999999999999876554322222 1110 00   


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-CHHHHhC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-SAADALE  309 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~~ll~  309 (321)
                                         ......+++.++.++|.+||..||.+|| +++++++
T Consensus       254 -------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          254 -------------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             -------------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             -------------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                               1112246778999999999999999999 8888875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2e-45  Score=334.30  Aligned_cols=263  Identities=22%  Similarity=0.362  Sum_probs=218.4

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      ....+++..++|++.+.||+|+||+||++.+  .++..||+|+++...   .....+.+|+.++++++   ||||+++++
T Consensus       258 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~---hpniv~~~~  329 (535)
T 2h8h_A          258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTW--NGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLR---HEKLVQLYA  329 (535)
T ss_dssp             STTCSBCCGGGEEEEEEEEECSSEEEEEEEE--TTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCC---CTTBCCEEE
T ss_pred             CccceecchhhhhhheecccCCCeEEEEEEE--CCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCC---CCCEeeEEE
Confidence            3567888999999999999999999999988  345779999987532   22457889999999998   999999999


Q ss_pred             eeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      ++.+.        ..++|||++.+ +|.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.++.
T Consensus       330 ~~~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~  401 (535)
T 2h8h_A          330 VVSEE--------PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV  401 (535)
T ss_dssp             EECSS--------SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             EEeec--------cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc
Confidence            98543        46899999985 9999997644445899999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCC--ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHh
Q psy2676         172 LKIADFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      +||+|||++.......  ......++..|+|||++....++.++||||||+++|+|++ |..||.+....+....+....
T Consensus       402 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~  481 (535)
T 2h8h_A          402 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY  481 (535)
T ss_dssp             EEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             EEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999997664321  1223445778999999999999999999999999999999 999999888777666654332


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC--CCCCCCC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH--PYFKEKE  317 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h--~~f~~~~  317 (321)
                      ..+.                          ...++..+.+||.+||+.||.+|||+.+|++.  .+|....
T Consensus       482 ~~~~--------------------------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          482 RMPC--------------------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             CCCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             CCCC--------------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            1111                          12566889999999999999999999999984  7776553

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-45  Score=316.87  Aligned_cols=270  Identities=26%  Similarity=0.370  Sum_probs=205.6

Q ss_pred             cCCcceeeeeeeecccceeEEEEEE---ecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARD---LQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~---~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      +..++|++++.||+|+||+||+|+.   ...+++.|++|++....  ......+.+|+.+++++.   ||||+++++++.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~   94 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALH---SDFIVKYRGVSY   94 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCC---CTTBCCEEEEEE
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcC---CCceeEEEEEEe
Confidence            4568999999999999999999983   14688999999986432  112345778999999997   999999999886


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ..     .....++|||+++ ++|.+++..... .+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|
T Consensus        95 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl  168 (327)
T 3lxl_A           95 GP-----GRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKI  168 (327)
T ss_dssp             CS-----SSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred             cC-----CCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEE
Confidence            43     1156899999997 599999976432 3899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCC----ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCC
Q psy2676         175 ADFGLAKTFDYDM----MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       175 ~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      +|||.+.......    ......++..|+|||++.+..++.++||||||+++|+|++|..||...........     ..
T Consensus       169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-----~~  243 (327)
T 3lxl_A          169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-----GC  243 (327)
T ss_dssp             CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-----C-
T ss_pred             cccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-----cc
Confidence            9999998765333    22345577889999999998899999999999999999999999965433211100     00


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                        ....+.. .   .................+++.+.+||++||+.||.+|||+.+++++
T Consensus       244 --~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          244 --ERDVPAL-S---RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             -----CCHH-H---HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --ccccccH-H---HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              0000000 0   0000011111111234677899999999999999999999999653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.6e-45  Score=310.65  Aligned_cols=250  Identities=23%  Similarity=0.371  Sum_probs=192.5

Q ss_pred             cccccccCCcceeee-eeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          13 NLDSLDLGDKKYDEL-CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      .+...++. ++|.+. +.||+|+||.||+|.+ ..+++.||+|++..       .....+|+.++.++..  ||||++++
T Consensus         9 ~~~~~~~~-~~y~~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~--h~~i~~~~   77 (299)
T 3m2w_A            9 QIKKNAII-DDYKVTSQVLGLGINGKVLQIFN-KRTQEKFALKMLQD-------CPKARREVELHWRASQ--CPHIVRIV   77 (299)
T ss_dssp             CCBCSCGG-GTEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTT--STTBCCEE
T ss_pred             cCcccccc-cchhhcCcccccCCCeEEEEEEE-cCCCcEEEEEEecc-------cHHHHHHHHHHHHhcc--CCCchhHH
Confidence            33334444 567777 8899999999999999 68899999999863       3367788888855543  99999999


Q ss_pred             eeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee--
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR--  168 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~--  168 (321)
                      +++...   .......++|||++.+ +|.+++.......+++..++.++.||+.||.|||++|++|+||||+||+++.  
T Consensus        78 ~~~~~~---~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  154 (299)
T 3m2w_A           78 DVYENL---YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR  154 (299)
T ss_dssp             EEEEEE---ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS
T ss_pred             hhhhhh---cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCC
Confidence            998762   1112678999999985 9999999876667999999999999999999999999999999999999998  


Q ss_pred             -CCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q psy2676         169 -AGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       169 -~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  247 (321)
                       ++.++|+|||++.....                     ..++.++||||||+++|+|++|..||...........+...
T Consensus       155 ~~~~~kl~Dfg~a~~~~~---------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  213 (299)
T 3m2w_A          155 PNAILKLTDFGFAKETTG---------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR  213 (299)
T ss_dssp             TTCCEEECCCTTCEECTT---------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS
T ss_pred             CCCcEEEecccccccccc---------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH
Confidence             78899999998865431                     23577899999999999999999999765433221100000


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ..   ...                ..........+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       214 ~~---~~~----------------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          214 IR---MGQ----------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             SC---TTC----------------CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             Hh---hcc----------------ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            00   000                000111224678999999999999999999999999999999865

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=312.55  Aligned_cols=258  Identities=21%  Similarity=0.287  Sum_probs=209.1

Q ss_pred             cccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEE
Q psy2676          11 SLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRF   90 (321)
Q Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~   90 (321)
                      +..+..+++..++|++.+.||+|+||+||+|++.    ..+++|++............+.+|+.++++++   ||||+++
T Consensus        22 ~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~----~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~   94 (319)
T 2y4i_B           22 SIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTR---HENVVLF   94 (319)
T ss_dssp             CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEES----SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCC---CTTBCCC
T ss_pred             ccccccccCCHHHeEEeeEeccCCceEEEEEEEc----CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCC---CCCEeEE
Confidence            3466788889999999999999999999999872    24899998776555555567788999988887   9999999


Q ss_pred             EeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA  169 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~  169 (321)
                      ++++.+.       ...++|+|++. ++|.+++.... ..+++..++.++.||+.||.+||++|++|+||+|+||+++ +
T Consensus        95 ~~~~~~~-------~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~  165 (319)
T 2y4i_B           95 MGACMSP-------PHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-N  165 (319)
T ss_dssp             CEEEECS-------SCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--
T ss_pred             EEEEecC-------CceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-C
Confidence            9999876       56899999998 59999997743 3489999999999999999999999999999999999998 7


Q ss_pred             CCEEEeecCCcccccC------CCccccccccccccchhhhhc---------CCCCCcchHHHHHHHHHHHHhcCCCCCC
Q psy2676         170 GGLKIADFGLAKTFDY------DMMLTSVVVTLWYRAPEILLN---------LGYGTPVDIWSIGCVMAEMWRLVPLFCA  234 (321)
Q Consensus       170 ~~~kl~dfg~~~~~~~------~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Di~slG~~l~~l~~g~~pf~~  234 (321)
                      +.++|+|||++.....      ........+++.|+|||++..         ..++.++||||||+++|+|++|..||..
T Consensus       166 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  245 (319)
T 2y4i_B          166 GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT  245 (319)
T ss_dssp             -CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS
T ss_pred             CCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            8999999998765431      122334568899999999875         3468899999999999999999999988


Q ss_pred             CChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         235 STEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .........+.........                         ...++.++.++|.+||..||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          246 QPAEAIIWQMGTGMKPNLS-------------------------QIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             CCHHHHHHHHHTTCCCCCC-------------------------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHhccCCCCCCC-------------------------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            8776665554432111110                         1145689999999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-45  Score=311.28  Aligned_cols=256  Identities=23%  Similarity=0.325  Sum_probs=199.6

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCc--EEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~--~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ..+..++|++.+.||+|+||+||+|++...+++  .|++|+++..... ......+.+|+.++++++   ||||++++++
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~   89 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD---HRNLIRLYGV   89 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC---CTTBCCEEEE
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC---CCCcccEEEE
Confidence            455678999999999999999999987444444  6899988754322 122346678999999997   9999999999


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +...        ..++|+|++. ++|.+++.... ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.+
T Consensus        90 ~~~~--------~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~  160 (291)
T 1u46_A           90 VLTP--------PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV  160 (291)
T ss_dssp             ECSS--------SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEE
T ss_pred             EccC--------CceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCE
Confidence            8665        2689999998 59999997643 348999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHH
Q psy2676         173 KIADFGLAKTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  247 (321)
                      +|+|||.+........    .....++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+...
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~  240 (291)
T 1u46_A          161 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE  240 (291)
T ss_dssp             EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred             EEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc
Confidence            9999999987654332    223456778999999999889999999999999999999 99999988877666555432


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ...++.                         ...++.++.++|.+||..||.+|||+.++++
T Consensus       241 ~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          241 GERLPR-------------------------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             CCCCCC-------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCC-------------------------CcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            211111                         1256689999999999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.7e-45  Score=308.46  Aligned_cols=258  Identities=25%  Similarity=0.331  Sum_probs=197.0

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ....++|++.+.||+|+||+||++++   +++.||+|++....     ......|.+++.... +.||||+++++++...
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~-l~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSRD-----EKSWFRETELYNTVM-LRHENILGFIASDMTS   74 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGGG-----HHHHHHHHHHHHHTC-CCCTTBCCEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE---CCEEEEEEEecccc-----chhhHHHHHHHHHhh-ccCcCeeeEEEeeccc
Confidence            45678999999999999999999976   68899999986431     234556777776632 2399999999987554


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCcEEEee
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLH--------SHRIIHRDLKPQNLLITR  168 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh--------~~~~~H~di~p~Nilv~~  168 (321)
                         .......++|||++.+ +|.+++..   ..+++..++.++.||+.||.|||        +.|++|+||||+||+++.
T Consensus        75 ---~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~  148 (301)
T 3q4u_A           75 ---RHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK  148 (301)
T ss_dssp             ---ETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECT
T ss_pred             ---cCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcC
Confidence               1222568999999985 99999965   34899999999999999999999        999999999999999999


Q ss_pred             CCCEEEeecCCcccccCCCc-----cccccccccccchhhhhcC------CCCCcchHHHHHHHHHHHHhc---------
Q psy2676         169 AGGLKIADFGLAKTFDYDMM-----LTSVVVTLWYRAPEILLNL------GYGTPVDIWSIGCVMAEMWRL---------  228 (321)
Q Consensus       169 ~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g---------  228 (321)
                      ++.+||+|||++........     .....+|+.|+|||++.+.      .++.++||||||+++|+|++|         
T Consensus       149 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~  228 (301)
T 3q4u_A          149 NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED  228 (301)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccc
Confidence            99999999999876543332     2234789999999999876      344689999999999999999         


Q ss_pred             -CCCCCCCC----hHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC
Q psy2676         229 -VPLFCAST----EVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS  303 (321)
Q Consensus       229 -~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  303 (321)
                       ..||....    .............  .....+.                 ......+++.+.+|+++||+.||.+|||
T Consensus       229 ~~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-----------------~~~~~~~~~~l~~li~~cl~~dP~~Rps  289 (301)
T 3q4u_A          229 YKPPFYDVVPNDPSFEDMRKVVCVDQ--QRPNIPN-----------------RWFSDPTLTSLAKLMKECWYQNPSARLT  289 (301)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHHTTSC--CCCCCCG-----------------GGGGSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred             ccccccccCCCCcchhhhhHHHhccC--CCCCCCh-----------------hhccCccHHHHHHHHHHHhhcChhhCCC
Confidence             78885422    1122222111111  1111111                 0112245578999999999999999999


Q ss_pred             HHHHhC
Q psy2676         304 AADALE  309 (321)
Q Consensus       304 ~~~ll~  309 (321)
                      +.++++
T Consensus       290 ~~~i~~  295 (301)
T 3q4u_A          290 ALRIKK  295 (301)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.6e-45  Score=310.61  Aligned_cols=263  Identities=20%  Similarity=0.260  Sum_probs=204.7

Q ss_pred             ccccccccccCCcceeeeeeeecccceeEEEEEEecCC--CcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCce
Q psy2676          10 QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNK--GNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI   87 (321)
Q Consensus        10 ~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i   87 (321)
                      +......+.-...+|++.+.||+|+||+||+|++...+  ...+++|.+.... .......+.+|+.++++++   ||||
T Consensus        13 ~~~~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~---h~~i   88 (298)
T 3f66_A           13 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFS---HPNV   88 (298)
T ss_dssp             HHHGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCC---CTTB
T ss_pred             hhhhheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCC---CCCE
Confidence            33444456666788999999999999999999874333  3357888876421 1112345678999999987   9999


Q ss_pred             eEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q psy2676          88 VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI  166 (321)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv  166 (321)
                      +++++++....      ...++|||++++ +|.+++.... ..+++..++.++.||+.||.+||++|++|+||||+||++
T Consensus        89 v~~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~  161 (298)
T 3f66_A           89 LSLLGICLRSE------GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML  161 (298)
T ss_dssp             CCCCEEECCSS------SCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             eeeeeEEEcCC------CceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE
Confidence            99999864331      456899999995 9999997643 348999999999999999999999999999999999999


Q ss_pred             eeCCCEEEeecCCcccccCCC-----ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHH
Q psy2676         167 TRAGGLKIADFGLAKTFDYDM-----MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQ  240 (321)
Q Consensus       167 ~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~  240 (321)
                      +.++.++|+|||.+.......     ......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+.
T Consensus       162 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~  241 (298)
T 3f66_A          162 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI  241 (298)
T ss_dssp             CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH
T ss_pred             CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH
Confidence            999999999999997664322     2233456788999999999999999999999999999999 6777777665555


Q ss_pred             HHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         241 LKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ...+........                          ...++..+.+++++||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          242 TVYLLQGRRLLQ--------------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHHTTCCCCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCCCCC--------------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            444433221111                          1235588999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.6e-45  Score=308.81  Aligned_cols=255  Identities=26%  Similarity=0.428  Sum_probs=193.1

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ...++|++.+.||+|+||.||+|.+ ..+++.+++|++...... ......+.+|+.++++++   ||||+++++++...
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~  104 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAAC-LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN---HPNVIKYYASFIED  104 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEE-TTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC---CTTBCCEEEEEEET
T ss_pred             ccccceEEEEeecCCCCceEEEEEE-cCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC---CCCEeeEEEEEEcC
Confidence            3456899999999999999999998 578899999998753221 112345678999999887   99999999999876


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                             ...++|+|++.+ +|.+++...  ....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|
T Consensus       105 -------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl  177 (310)
T 2wqm_A          105 -------NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKL  177 (310)
T ss_dssp             -------TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred             -------CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEE
Confidence                   678999999995 999988652  2345899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCC--hHHHHHHHHHHhCCC
Q psy2676         175 ADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST--EVEQLKCIFRVIGTP  251 (321)
Q Consensus       175 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~  251 (321)
                      +|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+..  .......+.. ...+
T Consensus       178 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~  256 (310)
T 2wqm_A          178 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYP  256 (310)
T ss_dssp             CCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCSC
T ss_pred             EeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccCC
Confidence            9999987654332 2334568899999999999999999999999999999999999996542  2222222211 1111


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      +..                        ...++.++.++|.+||..||.+|||+.++++
T Consensus       257 ~~~------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          257 PLP------------------------SDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             CCC------------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCc------------------------ccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            100                        1246689999999999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=314.79  Aligned_cols=264  Identities=21%  Similarity=0.308  Sum_probs=204.1

Q ss_pred             ccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          12 LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        12 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      .+-..+.+..++|++.+.||+|+||+||+|++ ..+++.||+|++....  ......+.+|+.++++++   ||||++++
T Consensus        19 ~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~---h~~iv~~~   92 (317)
T 2buj_A           19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHE--QQDREEAQREADMHRLFN---HPNILRLV   92 (317)
T ss_dssp             EEEEEEEETTEEEEEEEEEEC--CEEEEEEEE-TTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCC---CTTBCCCC
T ss_pred             ecccEEEECCeEEEEEEEecCCCCeEEEEEEe-cCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcC---CCCeeeEE
Confidence            34455667789999999999999999999998 5789999999986532  122346778999999987   99999999


Q ss_pred             eeeeccccccccceEEEEEeccCcc-CHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR  168 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~  168 (321)
                      +++...   .......++|+|++.+ +|.+++...  ....+++..++.++.||+.||.+||+.|++|+||||+||+++.
T Consensus        93 ~~~~~~---~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~  169 (317)
T 2buj_A           93 AYCLRE---RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD  169 (317)
T ss_dssp             EEEEEE---ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred             EEEEec---cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC
Confidence            998643   1222578999999995 999998763  2345899999999999999999999999999999999999999


Q ss_pred             CCCEEEeecCCcccccCCCc----------cccccccccccchhhhhcCC---CCCcchHHHHHHHHHHHHhcCCCCCCC
Q psy2676         169 AGGLKIADFGLAKTFDYDMM----------LTSVVVTLWYRAPEILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCAS  235 (321)
Q Consensus       169 ~~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~  235 (321)
                      ++.++|+|||.+........          .....+++.|+|||++.+..   ++.++||||||+++|+|++|..||...
T Consensus       170 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  249 (317)
T 2buj_A          170 EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV  249 (317)
T ss_dssp             TSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHH
T ss_pred             CCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhh
Confidence            99999999998876532111          12345689999999987654   688999999999999999999999431


Q ss_pred             Ch--HHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         236 TE--VEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       236 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ..  ......+......+                          ....+++++.++|.+||+.||.+|||+.+++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          250 FQKGDSVALAVQNQLSIP--------------------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHTTSCHHHHHHCC--CC--------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcccchhhHHhhccCCCC--------------------------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            10  00011111000000                          012466899999999999999999999999975

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.8e-44  Score=333.26  Aligned_cols=254  Identities=24%  Similarity=0.344  Sum_probs=205.6

Q ss_pred             cccCCcceeee-eeeecccceeEEEEEEe-cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          17 LDLGDKKYDEL-CQIGCGAYGTVFKARDL-QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        17 ~~~~~~~y~~~-~~lg~g~~g~v~~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      +.+....+.+. +.||+|+||+||+|.+. ...++.||+|+++...........+.+|+.++++++   ||||+++++++
T Consensus       363 ~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~  439 (635)
T 4fl3_A          363 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD---NPYIVRMIGIC  439 (635)
T ss_dssp             SBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC---CTTBCCEEEEE
T ss_pred             ccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC---CCCEeeEEEEE
Confidence            34444555554 48999999999999653 345689999999765444334457889999999998   99999999998


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      ...        ..++|||++. |+|.+++..  ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+|
T Consensus       440 ~~~--------~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~k  509 (635)
T 4fl3_A          440 EAE--------SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAK  509 (635)
T ss_dssp             ESS--------SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred             ecC--------CEEEEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEE
Confidence            544        3689999998 599999987  34589999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCC----ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHh
Q psy2676         174 IADFGLAKTFDYDM----MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       174 l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      |+|||++.......    ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+....
T Consensus       510 L~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~  589 (635)
T 4fl3_A          510 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE  589 (635)
T ss_dssp             ECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             EEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999998664332    1223445788999999999999999999999999999998 999999888877666655432


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ..+.                          ...+++++.+||.+||+.||.+|||+.++++
T Consensus       590 ~~~~--------------------------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          590 RMGC--------------------------PAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             CCCC--------------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCC--------------------------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            1111                          1256689999999999999999999999975

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=306.29  Aligned_cols=258  Identities=19%  Similarity=0.262  Sum_probs=201.7

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEecC--CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQN--KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      ..++....+|++.+.||+|+||+||+|++...  ++..+++|++.... .......+.+|+.++++++   ||||+++++
T Consensus        14 ~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~---h~~iv~~~~   89 (298)
T 3pls_A           14 VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLN---HPNVLALIG   89 (298)
T ss_dssp             GBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCC---CTTBCCCCE
T ss_pred             eEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCC---CCCeeeEEE
Confidence            34444555788889999999999999987422  23378999886421 1112345678999999987   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      ++.+..      ...++|+|++. ++|.+++.... ..+++..++.++.|++.||.+||++|++|+||||+||+++.++.
T Consensus        90 ~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~  162 (298)
T 3pls_A           90 IMLPPE------GLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT  162 (298)
T ss_dssp             EECCSS------SCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC
T ss_pred             EEecCC------CCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence            986551      23489999997 69999997743 44899999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCC-----CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhc-CCCCCCCChHHHHHHHH
Q psy2676         172 LKIADFGLAKTFDYD-----MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIF  245 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~  245 (321)
                      ++|+|||++......     .......+++.|+|||.+.+..++.++||||||+++|+|++| .+||...+..+....+.
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~  242 (298)
T 3pls_A          163 VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA  242 (298)
T ss_dssp             EEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH
T ss_pred             EEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh
Confidence            999999999755332     123345668899999999999999999999999999999995 55566555555444433


Q ss_pred             HHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         246 RVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .....+.                          ...+++.+.+++++||+.||.+|||+.++++
T Consensus       243 ~~~~~~~--------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          243 QGRRLPQ--------------------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             TTCCCCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCC--------------------------CccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            3221111                          1245688999999999999999999999885

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=305.28  Aligned_cols=246  Identities=27%  Similarity=0.384  Sum_probs=192.6

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      +..++|++.+.||+|+||+||++++   .++.+++|++...    .....+.+|+.++++++   ||||+++++++.+. 
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~-   73 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKW---RAKDVAIKQIESE----SERKAFIVELRQLSRVN---HPNIVKLYGACLNP-   73 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEE---TTEEEEEEECSST----THHHHHHHHHHHHHHCC---CTTBCCEEEBCTTT-
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEE---CCeeEEEEEecCh----hHHHHHHHHHHHHhcCC---CCCcCeEEEEEcCC-
Confidence            4567999999999999999999976   4788999998532    22346778999999997   99999999987543 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCCCcEEEeeCCC-E
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPP-PGLSASKVKELTRQMLKGVDFLHS---HRIIHRDLKPQNLLITRAGG-L  172 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~---~~~~H~di~p~Nilv~~~~~-~  172 (321)
                              .++||||+.+ +|.+++..... ..+++..++.++.|++.||.|||+   +|++|+||||+||+++.++. +
T Consensus        74 --------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~  145 (307)
T 2eva_A           74 --------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVL  145 (307)
T ss_dssp             --------TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEE
T ss_pred             --------cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEE
Confidence                    4899999984 99999987442 237899999999999999999999   89999999999999998887 7


Q ss_pred             EEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         173 KIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      ||+|||.+......  .....+++.|+|||++.+..++.++||||||+++|+|++|+.||................+.. 
T Consensus       146 kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-  222 (307)
T 2eva_A          146 KICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR-  222 (307)
T ss_dssp             EECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC-
T ss_pred             EEcccccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC-
Confidence            99999998765432  234568999999999999999999999999999999999999997543222111111111111 


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                             ......++..+.++|.+||+.||.+|||+.++++
T Consensus       223 -----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          223 -----------------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             -----------------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                   0112356789999999999999999999999987

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.9e-44  Score=328.55  Aligned_cols=255  Identities=25%  Similarity=0.326  Sum_probs=205.2

Q ss_pred             ccccCCcceeeee-eeecccceeEEEEEEec-CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          16 SLDLGDKKYDELC-QIGCGAYGTVFKARDLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        16 ~~~~~~~~y~~~~-~lg~g~~g~v~~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      .+.+..+++.+.+ .||+|+||+||+|.+.. .++..||+|+++... .......+.+|+.++++++   ||||++++++
T Consensus       329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~---hpniv~l~~~  404 (613)
T 2ozo_A          329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLD---NPYIVRLIGV  404 (613)
T ss_dssp             CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCC---CTTBCCEEEE
T ss_pred             ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCC---CCCEeeEEEE
Confidence            3445556677777 89999999999998742 356789999997542 2234457889999999997   9999999999


Q ss_pred             eeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +...        .+++|||++.+ +|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+
T Consensus       405 ~~~~--------~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~v  475 (613)
T 2ozo_A          405 CQAE--------ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYA  475 (613)
T ss_dssp             EESS--------SEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred             eccC--------CeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcE
Confidence            8653        37999999994 9999997643 349999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHH
Q psy2676         173 KIADFGLAKTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  247 (321)
                      ||+|||++........    .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+...
T Consensus       476 kL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~  555 (613)
T 2ozo_A          476 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG  555 (613)
T ss_dssp             EECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT
T ss_pred             EEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999987643321    122345678999999999999999999999999999998 99999988877766655432


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ...+.                          ...+++++.++|.+||..||.+||++.++++
T Consensus       556 ~~~~~--------------------------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          556 KRMEC--------------------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             CCCCC--------------------------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CCCCC--------------------------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            21111                          1256789999999999999999999999864

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.4e-46  Score=343.41  Aligned_cols=287  Identities=26%  Similarity=0.326  Sum_probs=209.7

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++.+.||+|+||+||+|.+ ..+++.||+|++..... ......+.+|+.++++++   ||||+++++++......
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~-~~tg~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~---HpnIV~l~~v~~~~~~~   87 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIH-QDTGEQVAIKQCRQELS-PKNRERWCLEIQIMKKLN---HPNVVSAREVPDGLQKL   87 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCC-TTTTCCEEECCCCSCCC-HHHHHHHHHHHHHHHHCC---BTTBCCEEECCTTTCCC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEE-CCCCcEEEEEEecccCC-HHHHHHHHHHHHHHHhCC---CCCCCceeeeecccccc
Confidence            47999999999999999999998 57899999999865321 112345678999999997   99999999997653111


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC---EEEe
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPP-PGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIA  175 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~---~kl~  175 (321)
                       ......++||||+. |+|.+++..... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.   ++|+
T Consensus        88 -~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           88 -APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             -CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             -cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence             11245799999997 599999987543 34899999999999999999999999999999999999997765   9999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      |||.+.............+++.|+|||++.+..++.++||||||+++|+|++|..||.......................
T Consensus       167 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             SCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            99999887766666667889999999999999999999999999999999999999976543321100000000000000


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ......  ...+ .............+++.+.++|++||.+||.+|||+.++++||||++.
T Consensus       247 ~~~l~g--~~~~-~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          247 YDDLTG--AVKF-SSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             CCCCSS--SCCC-CSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             hhhhcc--cccc-ccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence            000000  0000 000001112334567899999999999999999999999999999754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6.5e-45  Score=316.68  Aligned_cols=253  Identities=18%  Similarity=0.233  Sum_probs=202.8

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEE-----EecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCce
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKAR-----DLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI   87 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~-----~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i   87 (321)
                      +...+++..++|++.+.||+|+||+||+|.     + ..+++.||+|++...     ....+..|.++++.+....|+|+
T Consensus        56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~i  129 (365)
T 3e7e_A           56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLND-AKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMF  129 (365)
T ss_dssp             SSCEEECSSSEEEEEEEEEECSSEEEEEEEC--------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGB
T ss_pred             cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcc-cccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhh
Confidence            456677888999999999999999999994     4 468899999998643     24467889999999887779999


Q ss_pred             eEEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q psy2676          88 VRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKC---PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQN  163 (321)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~N  163 (321)
                      +++++++...       ...++||||++ |+|.+++...   ....+++..++.++.||+.||+|||++|++||||||+|
T Consensus       130 v~~~~~~~~~-------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~N  202 (365)
T 3e7e_A          130 MKFYSAHLFQ-------NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDN  202 (365)
T ss_dssp             CCEEEEEECS-------SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGG
T ss_pred             hhhheeeecC-------CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHH
Confidence            9999999777       67899999998 5999999742   24459999999999999999999999999999999999


Q ss_pred             EEEee-----------CCCEEEeecCCccccc---CCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcC
Q psy2676         164 LLITR-----------AGGLKIADFGLAKTFD---YDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV  229 (321)
Q Consensus       164 ilv~~-----------~~~~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  229 (321)
                      |+++.           ++.+||+|||++....   .........||+.|+|||++.+..++.++||||||+++|+|++|+
T Consensus       203 Ill~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~  282 (365)
T 3e7e_A          203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT  282 (365)
T ss_dssp             EEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred             EEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence            99998           8999999999996543   233345567899999999999999999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         230 PLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .||.........      ... ....                        ...++.+.+++..||+.+|.+|++..+.+.
T Consensus       283 ~pf~~~~~~~~~------~~~-~~~~------------------------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          283 YMKVKNEGGECK------PEG-LFRR------------------------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             CCCEEEETTEEE------ECS-CCTT------------------------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             CccccCCCCcee------ech-hccc------------------------cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence            999543220000      000 0000                        012367889999999999999975544443

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-45  Score=317.00  Aligned_cols=256  Identities=21%  Similarity=0.279  Sum_probs=192.6

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCC--cEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKG--NYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~--~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      .....+|++.+.||+|+||+||+|++...++  ..+++|.+... ........+.+|+.++++++   ||||+++++++.
T Consensus        85 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~---hpnIv~~~~~~~  160 (373)
T 3c1x_A           85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFS---HPNVLSLLGICL  160 (373)
T ss_dssp             CSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCC---CTTBCCCCEEEC
T ss_pred             ChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCC---CCCcceEEEEEE
Confidence            3344568999999999999999998754443  46788887542 11222345667888887776   999999999864


Q ss_pred             ccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ...      ...++|||++.+ +|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||
T Consensus       161 ~~~------~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL  233 (373)
T 3c1x_A          161 RSE------GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKV  233 (373)
T ss_dssp             CCS------SCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred             cCC------CCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEE
Confidence            331      356899999995 9999997643 34899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCC-----ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHh
Q psy2676         175 ADFGLAKTFDYDM-----MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       175 ~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      +|||++.......     ......+++.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+....+....
T Consensus       234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~  313 (373)
T 3c1x_A          234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR  313 (373)
T ss_dssp             CCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC
T ss_pred             eeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC
Confidence            9999997654322     1223456778999999999999999999999999999999 788887765544444333221


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ....                          ...++..+.+++.+||+.||.+|||+.+++++
T Consensus       314 ~~~~--------------------------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          314 RLLQ--------------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             CCCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCC--------------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1111                          12466889999999999999999999999863

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4e-45  Score=310.73  Aligned_cols=277  Identities=23%  Similarity=0.302  Sum_probs=205.6

Q ss_pred             ccccccccccccCCccee------eeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC--CCCCchhHHHHHHHHhc
Q psy2676           8 TIQSLNLDSLDLGDKKYD------ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE--DGIPMSTLREISILKQL   79 (321)
Q Consensus         8 ~~~~~~~~~~~~~~~~y~------~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l   79 (321)
                      ....++...+....+.|.      ..+.||+|+||+||+|.+   +++.+++|++......  ......+.+|+.+++++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l   87 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC   87 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES---SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE---CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc
Confidence            344444444444444444      449999999999999964   6789999998654322  22234677899999999


Q ss_pred             ccCCCCceeEEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy2676          80 DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP-PPGLSASKVKELTRQMLKGVDFLHSHRIIHR  157 (321)
Q Consensus        80 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~  157 (321)
                      +   ||||+++++++.+.       ...++|+|+++ ++|.+++.... ...+++..++.++.||+.||.+||+.|++|+
T Consensus        88 ~---h~~i~~~~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~  157 (307)
T 2nru_A           88 Q---HENLVELLGFSSDG-------DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR  157 (307)
T ss_dssp             C---CTTBCCEEEEECSS-------SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             C---CCCeEEEEEEEecC-------CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecC
Confidence            7   99999999999766       56799999997 59999987532 3458999999999999999999999999999


Q ss_pred             cCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCC
Q psy2676         158 DLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCA  234 (321)
Q Consensus       158 di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  234 (321)
                      ||+|+||+++.++.++|+|||.+........   .....+++.|+|||++.+ .++.++||||||+++|+|++|..||..
T Consensus       158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~  236 (307)
T 2nru_A          158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE  236 (307)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred             CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence            9999999999999999999999876653321   233568999999998865 478999999999999999999999976


Q ss_pred             CChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         235 STEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      .........+.........            .+..+...........++..+.+++.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          237 HREPQLLLDIKEEIEDEEK------------TIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             TBSSSBTTHHHHHHHTTSC------------CHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CcchHHHHHHHHHhhhhhh------------hhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            5432222222111110000            000000111111223456789999999999999999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=308.20  Aligned_cols=273  Identities=27%  Similarity=0.372  Sum_probs=204.4

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEE---ecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARD---LQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~---~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      ..++..++|++++.||+|+||.||+|+.   ...+++.||+|++...  .......+.+|+.++++++   ||||+++++
T Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~---h~~iv~~~~  109 (326)
T 2w1i_A           35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ---HDNIVKYKG  109 (326)
T ss_dssp             --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCC---CTTBCCEEE
T ss_pred             ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCC---CCCeeeEEE
Confidence            4566778999999999999999999984   1467899999998653  1222346778999999997   999999999


Q ss_pred             eeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      ++....     ....++|+|++++ +|.+++.... ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++.
T Consensus       110 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~  183 (326)
T 2w1i_A          110 VCYSAG-----RRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR  183 (326)
T ss_dssp             EECC---------CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE
T ss_pred             EEEecC-----CCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc
Confidence            986541     1357899999985 9999998754 34899999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCCc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q psy2676         172 LKIADFGLAKTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  247 (321)
                      ++|+|||++........    .....++..|+|||++.+..++.++||||||+++|+|++|..||......-     ...
T Consensus       184 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~-----~~~  258 (326)
T 2w1i_A          184 VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF-----MRM  258 (326)
T ss_dssp             EEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHH-----HHH
T ss_pred             EEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHH-----HHh
Confidence            99999999987654432    223456777999999999889999999999999999999999986432111     111


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .+.........     ..................+++++.++|++||..||.+|||+.++++
T Consensus       259 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          259 IGNDKQGQMIV-----FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HCTTCCTHHHH-----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hccccchhhhH-----HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            11111000000     0000000000011122467789999999999999999999999975

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-44  Score=308.52  Aligned_cols=267  Identities=21%  Similarity=0.294  Sum_probs=200.5

Q ss_pred             CCcce-eeeeeeecccceeEEEEEEe---cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          20 GDKKY-DELCQIGCGAYGTVFKARDL---QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        20 ~~~~y-~~~~~lg~g~~g~v~~~~~~---~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ..++| ++++.||+|+||+||++...   ..+++.||+|+++.... ......+.+|+.++++++   ||||+++++++.
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~  103 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQEIDILRTLY---HEHIIKYKGCCE  103 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCC---CTTBCCEEEEEE
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-hHHHHHHHHHHHHHHhCC---CcchhhEEEEEe
Confidence            44555 99999999999999887531   34788999999875421 112345778999999998   999999999987


Q ss_pred             ccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      +..     ...+++|||++.+ +|.+++...   .+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|
T Consensus       104 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl  175 (318)
T 3lxp_A          104 DAG-----AASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKI  175 (318)
T ss_dssp             ETT-----TTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred             cCC-----CceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEE
Confidence            641     1468999999985 999999873   3899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCC
Q psy2676         175 ADFGLAKTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       175 ~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      +|||.+........    .....++..|+|||++.+..++.++||||||+++|+|++|..||..........     ...
T Consensus       176 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-----~~~  250 (318)
T 3lxp_A          176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-----IGI  250 (318)
T ss_dssp             CCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-----HCS
T ss_pred             CCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh-----hcc
Confidence            99999987654332    234556778999999999899999999999999999999999996542211100     000


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                            .........................++.++.+||++||+.||.+|||+.++++
T Consensus       251 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          251 ------AQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             ------CCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------cccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                  00000000000000111111123457789999999999999999999999985

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.5e-44  Score=307.50  Aligned_cols=284  Identities=22%  Similarity=0.269  Sum_probs=193.7

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ...+..++|++.+.||+|+||+||+|++   +++.||+|++....     ......|.++.. +..+.||||+++++.+.
T Consensus         7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~-----~~~~~~e~~~~~-~~~~~h~~i~~~~~~~~   77 (336)
T 3g2f_A            7 EPSLDLDNLKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFAN-----RQNFINEKNIYR-VPLMEHDNIARFIVGDE   77 (336)
T ss_dssp             --CCCTTSEEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGGG-----HHHHHHHHHHHT-STTCCCTTBCCEEEEEE
T ss_pred             CCCcChHHhheeeecccCCCeEEEEEEE---CCeEEEEEEeeccc-----hhhHHHHHHHHH-HHhccCcchhhheeccc
Confidence            3456678999999999999999999965   67899999987532     123344444433 33345999999998765


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCcEE
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH---------RIIHRDLKPQNLL  165 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~---------~~~H~di~p~Nil  165 (321)
                      ...  ......+++||||++ |+|.+++....   .++..++.++.||+.||.|||+.         |++|+||||+||+
T Consensus        78 ~~~--~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nil  152 (336)
T 3g2f_A           78 RVT--ADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL  152 (336)
T ss_dssp             EEC--TTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEE
T ss_pred             ccc--cCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEE
Confidence            431  222356799999997 59999998743   58999999999999999999999         9999999999999


Q ss_pred             EeeCCCEEEeecCCcccccCCC---------ccccccccccccchhhhhc-------CCCCCcchHHHHHHHHHHHHhcC
Q psy2676         166 ITRAGGLKIADFGLAKTFDYDM---------MLTSVVVTLWYRAPEILLN-------LGYGTPVDIWSIGCVMAEMWRLV  229 (321)
Q Consensus       166 v~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~  229 (321)
                      ++.++.+||+|||++.......         ......+|+.|+|||++.+       ..++.++||||||+++|+|++|.
T Consensus       153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~  232 (336)
T 3g2f_A          153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC  232 (336)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence            9999999999999997664322         1224568999999999977       34567899999999999999997


Q ss_pred             CCCCCCCh-HHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhh---hhhhcchhHHHHHHHhcccCCCCCCCHH
Q psy2676         230 PLFCASTE-VEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSA---IFMDCCSKANSLLESMLTFNPADRISAA  305 (321)
Q Consensus       230 ~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~  305 (321)
                      .||..... .+.........+..+..     ................+.   ....+++.+.+||.+||..||.+|||+.
T Consensus       233 ~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  307 (336)
T 3g2f_A          233 TDLFPGESVPEYQMAFQTEVGNHPTF-----EDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQ  307 (336)
T ss_dssp             GGGSTTSCCCCCCCTTHHHHCSSCCH-----HHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             CcCCCccchhHHHHhhhcccCCCchH-----HHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchH
Confidence            66533211 00000000000000000     000000000000000000   0112456899999999999999999999


Q ss_pred             HH------hCCCCCCCCCC
Q psy2676         306 DA------LEHPYFKEKEN  318 (321)
Q Consensus       306 ~l------l~h~~f~~~~~  318 (321)
                      ++      +-++|-++...
T Consensus       308 e~l~~L~~ll~~~~~~~~~  326 (336)
T 3g2f_A          308 XAEERMAELMMIWERNKSV  326 (336)
T ss_dssp             HHHHHHHHHHHCCCC----
T ss_pred             HHHHHHHHHHHHHHhcccC
Confidence            99      45788887644

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.6e-45  Score=323.69  Aligned_cols=265  Identities=17%  Similarity=0.220  Sum_probs=195.9

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCc-------ee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPN-------IV   88 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~-------i~   88 (321)
                      ......+|...+.||+|+||+||+|++ ..+++.||+|++...... ......+.+|+.+++.+....+++       ++
T Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~-~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~  151 (413)
T 3dzo_A           73 LGERPRTLVRGTVLGQEDPYAYLEATD-QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  151 (413)
T ss_dssp             SSSCCEEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred             CCCCceeEEEecccccCCCEEEEEEEe-cCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence            334455699999999999999999999 578999999998743222 223556778998888887322221       11


Q ss_pred             EEEeeeecc----------ccccccceEEEEEeccCccCHHHHHhh-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy2676          89 RFFDVIHQN----------ILSDERYLTVYLIFEHVDQDLGSYMEK-----CPPPGLSASKVKELTRQMLKGVDFLHSHR  153 (321)
Q Consensus        89 ~~~~~~~~~----------~~~~~~~~~~~~v~e~~~~~L~~~~~~-----~~~~~~~~~~~~~i~~~l~~~l~~lh~~~  153 (321)
                      ...+.....          ..........+++++.+.++|.+++..     .....+++..+..++.||+.||.|||++|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  231 (413)
T 3dzo_A          152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  231 (413)
T ss_dssp             CCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            111111100          000111234788999999999999852     22334788899999999999999999999


Q ss_pred             ceeccCCCCcEEEeeCCCEEEeecCCcccccCCCccccccccccccchhhh----------hcCCCCCcchHHHHHHHHH
Q psy2676         154 IIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEIL----------LNLGYGTPVDIWSIGCVMA  223 (321)
Q Consensus       154 ~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Di~slG~~l~  223 (321)
                      ++||||||+||+++.++.+||+|||++...+..  .....| +.|+|||++          ....++.++|||||||++|
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            999999999999999999999999998765533  334566 999999999          4444788999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC
Q psy2676         224 EMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS  303 (321)
Q Consensus       224 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  303 (321)
                      +|++|+.||...+.......+                               ......+|+.+.+||.+||..||.+|||
T Consensus       309 elltg~~Pf~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rpt  357 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGGSEWI-------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLL  357 (413)
T ss_dssp             HHHHSSCCCCTTGGGSCSGGG-------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHCCCCCCCcchhhhHHHH-------------------------------HhhcccCCHHHHHHHHHHccCChhhCcC
Confidence            999999999765422111000                               0011256789999999999999999999


Q ss_pred             HHHHhCCCCCCCC
Q psy2676         304 AADALEHPYFKEK  316 (321)
Q Consensus       304 ~~~ll~h~~f~~~  316 (321)
                      +.++++||||++.
T Consensus       358 ~~~~l~~~~~~~~  370 (413)
T 3dzo_A          358 PLQAMETPEYEQL  370 (413)
T ss_dssp             HHHHTTSHHHHHH
T ss_pred             HHHHHhCHHHHHH
Confidence            9999999999764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=304.97  Aligned_cols=264  Identities=27%  Similarity=0.353  Sum_probs=197.3

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +........++|++.+.||+|+||+||+|++   .++.||+|++....     ......|.+++.... ..||||+++++
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~-~~h~~i~~~~~   98 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW---RGEKVAVKVFFTTE-----EASWFRETEIYQTVL-MRHENILGFIA   98 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTT-CCCTTBCCEEE
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEE---CCceEEEEEEeccc-----cchhhhHHHHHHHHh-hcCCCeeeEEE
Confidence            3344455568999999999999999999976   38899999986431     224455666655542 34999999999


Q ss_pred             eeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCc
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH--------RIIHRDLKPQN  163 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~--------~~~H~di~p~N  163 (321)
                      ++....   ......++|||++.+ +|.+++...   .+++..++.++.|++.||.|||+.        |++|+||||+|
T Consensus        99 ~~~~~~---~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~N  172 (337)
T 3mdy_A           99 ADIKGT---GSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN  172 (337)
T ss_dssp             EEEESC---GGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGG
T ss_pred             EEccCC---CCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHH
Confidence            986651   222468999999985 999999773   489999999999999999999999        99999999999


Q ss_pred             EEEeeCCCEEEeecCCcccccCCCc-----cccccccccccchhhhhcCCCCCc------chHHHHHHHHHHHHhc----
Q psy2676         164 LLITRAGGLKIADFGLAKTFDYDMM-----LTSVVVTLWYRAPEILLNLGYGTP------VDIWSIGCVMAEMWRL----  228 (321)
Q Consensus       164 ilv~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~------~Di~slG~~l~~l~~g----  228 (321)
                      |+++.++.+||+|||++........     .....+|+.|+|||++.+...+..      +||||||+++|+|++|    
T Consensus       173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~  252 (337)
T 3mdy_A          173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG  252 (337)
T ss_dssp             EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence            9999999999999999976643322     124578999999999988776665      9999999999999999    


Q ss_pred             ------CCCCCCCC----hHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCC
Q psy2676         229 ------VPLFCAST----EVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNP  298 (321)
Q Consensus       229 ------~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  298 (321)
                            ..||....    ............  ......+..                 ....++++++.++|++||+.||
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dP  313 (337)
T 3mdy_A          253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIK--KLRPSFPNR-----------------WSSDECLRQMGKLMTECWAHNP  313 (337)
T ss_dssp             TBCCCCCCTTTTTSCSSCCHHHHHHHHTTS--CCCCCCCGG-----------------GGGSHHHHHHHHHHHHHSCSSG
T ss_pred             cccccccccHhhhcCCCCchhhhHHHHhhh--ccCcccccc-----------------chhhHHHHHHHHHHHHhhhhCh
Confidence                  56664321    111111111110  001111110                 0122566889999999999999


Q ss_pred             CCCCCHHHHhCC
Q psy2676         299 ADRISAADALEH  310 (321)
Q Consensus       299 ~~Rps~~~ll~h  310 (321)
                      .+|||+.++++|
T Consensus       314 ~~Rps~~ell~~  325 (337)
T 3mdy_A          314 ASRLTALRVKKT  325 (337)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hhCCCHHHHHHH
Confidence            999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.6e-44  Score=307.01  Aligned_cols=265  Identities=23%  Similarity=0.294  Sum_probs=201.9

Q ss_pred             ccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          12 LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        12 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      .++...+...++|++.+.||+|+||+||++++   +++.||+|++....     ...+.+|.++++.+. +.||||++++
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~-l~h~ni~~~~  102 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSRE-----ERSWFREAEIYQTVM-LRHENILGFI  102 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECGGG-----HHHHHHHHHHHHHSC-CCCTTBCCEE
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEE---cCccEEEEEeCchh-----HHHHHHHHHHHHHhh-cCCCcEEEEE
Confidence            34444455568999999999999999999976   48899999986432     235677888888732 2399999999


Q ss_pred             eeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCC
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLH--------SHRIIHRDLKPQ  162 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh--------~~~~~H~di~p~  162 (321)
                      +++....   ......++|+|++.+ +|.+++...   .+++..++.++.|++.||.+||        +.|++|+||||+
T Consensus       103 ~~~~~~~---~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~  176 (342)
T 1b6c_B          103 AADNKDN---GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK  176 (342)
T ss_dssp             EEEECCC---SSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGG
T ss_pred             eeecccC---CccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHH
Confidence            9987651   122368999999995 999999873   4899999999999999999999        899999999999


Q ss_pred             cEEEeeCCCEEEeecCCcccccCCC-----ccccccccccccchhhhhcCC------CCCcchHHHHHHHHHHHHhc---
Q psy2676         163 NLLITRAGGLKIADFGLAKTFDYDM-----MLTSVVVTLWYRAPEILLNLG------YGTPVDIWSIGCVMAEMWRL---  228 (321)
Q Consensus       163 Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g---  228 (321)
                      ||+++.++.+||+|||++.......     ......+++.|+|||++.+..      ++.++||||||+++|+|++|   
T Consensus       177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~  256 (342)
T 1b6c_B          177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI  256 (342)
T ss_dssp             GEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred             HEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCc
Confidence            9999999999999999997665433     223457899999999998763      23689999999999999999   


Q ss_pred             -------CCCCCCCCh----HHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccC
Q psy2676         229 -------VPLFCASTE----VEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFN  297 (321)
Q Consensus       229 -------~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  297 (321)
                             ..||.....    .........  ........+..                 ....+++..+.+||.+||+.|
T Consensus       257 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~cl~~d  317 (342)
T 1b6c_B          257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVC--EQKLRPNIPNR-----------------WQSCEALRVMAKIMRECWYAN  317 (342)
T ss_dssp             TTBCCCCCCTTTTTSCSSCCHHHHHHHHT--TSCCCCCCCGG-----------------GGTSHHHHHHHHHHHHHCCSS
T ss_pred             CCcccccccCccccCcCcccHHHHHHHHH--HHHhCCCCccc-----------------ccchhHHHHHHHHHHHHhccC
Confidence                   778765321    111111111  11111111110                 011245578999999999999


Q ss_pred             CCCCCCHHHHhCC
Q psy2676         298 PADRISAADALEH  310 (321)
Q Consensus       298 p~~Rps~~~ll~h  310 (321)
                      |.+|||+.++++|
T Consensus       318 p~~Rps~~~i~~~  330 (342)
T 1b6c_B          318 GAARLTALRIKKT  330 (342)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             hhhCCCHHHHHHH
Confidence            9999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4e-43  Score=325.37  Aligned_cols=255  Identities=22%  Similarity=0.364  Sum_probs=206.4

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecC--CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQN--KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      ..++..++|++.+.||+|+||+||+|.+...  .+..+++|++..... ......+.+|+.++++++   ||||++++++
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~---HpnIv~l~~~  459 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALTMRQFD---HPHIVKLIGV  459 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC-HHHHHHHHHHHHHHHHCC---CTTBCCEEEE
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC-HHHHHHHHHHHHHHHhCC---CCCCCeEEEE
Confidence            4566778999999999999999999988422  346788998754211 112246778999999997   9999999999


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +.+.        ..++|||++. |+|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+
T Consensus       460 ~~~~--------~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~v  530 (656)
T 2j0j_A          460 ITEN--------PVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV  530 (656)
T ss_dssp             ECSS--------SCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred             EecC--------ceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCE
Confidence            8433        4689999999 59999998753 348999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhC
Q psy2676         173 KIADFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      ||+|||++........  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+.....
T Consensus       531 kL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~  610 (656)
T 2j0j_A          531 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER  610 (656)
T ss_dssp             EECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC
T ss_pred             EEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999999987653332  223455778999999999999999999999999999997 9999998887777666654322


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      .+.                          ...+++.+.++|.+||..||.+|||+.++++
T Consensus       611 ~~~--------------------------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          611 LPM--------------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             CCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCC--------------------------CccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            111                          1256689999999999999999999999975

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.9e-44  Score=308.38  Aligned_cols=260  Identities=20%  Similarity=0.204  Sum_probs=193.8

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC------CCCCchhHHHHHHHHhcccC------CCCc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE------DGIPMSTLREISILKQLDTF------EHPN   86 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~------~~~~   86 (321)
                      +..++|++.+.||+|+||+||+|++   +++.||+|++......      ......+.+|+.+++.+..+      .|||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n   93 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG   93 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred             cccccchheeeecccCceEEEEEEe---CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence            4457899999999999999999987   5799999999875332      11225678899998888621      3788


Q ss_pred             eeEEEeeeeccccc-----------------------cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHH
Q psy2676          87 IVRFFDVIHQNILS-----------------------DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQM  142 (321)
Q Consensus        87 i~~~~~~~~~~~~~-----------------------~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l  142 (321)
                      |+++.+.+......                       ......+++||||+. |++.+.+..   ..+++..++.++.||
T Consensus        94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQL  170 (336)
T ss_dssp             BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHH
T ss_pred             hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHH
Confidence            88777764311000                       001257899999997 556666543   348999999999999


Q ss_pred             HHHHHHHH-hCCceeccCCCCcEEEeeCC--------------------CEEEeecCCcccccCCCccccccccccccch
Q psy2676         143 LKGVDFLH-SHRIIHRDLKPQNLLITRAG--------------------GLKIADFGLAKTFDYDMMLTSVVVTLWYRAP  201 (321)
Q Consensus       143 ~~~l~~lh-~~~~~H~di~p~Nilv~~~~--------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP  201 (321)
                      +.||.||| ++|++||||||+||+++.++                    .+||+|||++......    ...||+.|+||
T Consensus       171 ~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aP  246 (336)
T 2vuw_A          171 TASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCS
T ss_pred             HHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccCh
Confidence            99999999 99999999999999999987                    8999999999876532    45789999999


Q ss_pred             hhhhcCCCCCcchHHHHHHH-HHHHHhcCCCCCCCChHH-HHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhh
Q psy2676         202 EILLNLGYGTPVDIWSIGCV-MAEMWRLVPLFCASTEVE-QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIF  279 (321)
Q Consensus       202 E~~~~~~~~~~~Di~slG~~-l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (321)
                      |++.+.. +.++||||+|++ .+++++|..||....... ....+.........                    ......
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~  305 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK--------------------CNTPAM  305 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSC--------------------CCSHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcc--------------------cchhhh
Confidence            9998776 889999998777 777888999984321111 11222211111111                    011123


Q ss_pred             hhcchhHHHHHHHhcccCCCCCCCHHHHh-CCCCCC
Q psy2676         280 MDCCSKANSLLESMLTFNPADRISAADAL-EHPYFK  314 (321)
Q Consensus       280 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll-~h~~f~  314 (321)
                      ..+++++.+||++||..|     |++|+| +||||+
T Consensus       306 ~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          306 KQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            457789999999999977     999999 999996

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-42  Score=324.90  Aligned_cols=250  Identities=22%  Similarity=0.305  Sum_probs=196.6

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      .+...++|++.+.||+|+||+||++.+...+++.|++|++..... ......+.+|+.+++++.   ||||+++++++..
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~  150 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVV---HPSIVQIFNFVEH  150 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCC---CTTBCCEEEEEEE
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcC---CCCcCeEeeeEee
Confidence            345668999999999999999999999544789999998864311 112234567888888887   9999999999976


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      ...  ......|+||||++| +|.+++..    .+++..++.++.||+.||.|||++|++|+||||+||+++.+ .+||+
T Consensus       151 ~~~--~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~  223 (681)
T 2pzi_A          151 TDR--HGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLI  223 (681)
T ss_dssp             ECT--TSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEEC
T ss_pred             cCC--CCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEE
Confidence            621  122347999999995 88887654    48999999999999999999999999999999999999875 89999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      |||++......   ....||+.|+|||++.+.. +.++||||||+++++|++|..||.+....                .
T Consensus       224 DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------~  283 (681)
T 2pzi_A          224 DLGAVSRINSF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD----------------G  283 (681)
T ss_dssp             CCTTCEETTCC---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS----------------S
T ss_pred             ecccchhcccC---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc----------------c
Confidence            99999876543   4557899999999998765 88999999999999999999988642110                0


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK  314 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~  314 (321)
                      .+..                 ......++.+.++|.+||.+||.+||+..+.+.|+|+.
T Consensus       284 ~~~~-----------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          284 LPED-----------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             CCTT-----------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cccc-----------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            0000                 00113457899999999999999999998888887753

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.7e-41  Score=281.29  Aligned_cols=235  Identities=16%  Similarity=0.092  Sum_probs=183.6

Q ss_pred             cccccc-cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEE
Q psy2676          13 NLDSLD-LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRF   90 (321)
Q Consensus        13 ~~~~~~-~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~   90 (321)
                      .+...+ +..++|++.+.||+|+||+||+|++ ..+++.||+|++....... .....+.+|+..++++.   ||||+++
T Consensus        21 ~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---hp~iv~~   96 (286)
T 3uqc_A           21 QLVPGARIANGRYRLLIFHGGVPPLQFWQALD-TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID---KPGVARV   96 (286)
T ss_dssp             CCCTTCEETTTTEEEEEEEEBSTTCEEEEEEE-TTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC---CTTBCCE
T ss_pred             cCCCCCEEecCcEEEEEEEcccCCeEEEEEEe-cCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC---CCCccee
Confidence            334444 6678999999999999999999999 6789999999997543221 11246778888888887   9999999


Q ss_pred             EeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA  169 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~  169 (321)
                      ++++.+.       ...++||||++| +|.+++..  +  ....++..++.||+.||.|||++|++|+||||+||+++.+
T Consensus        97 ~~~~~~~-------~~~~lv~e~~~g~~L~~~l~~--~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~  165 (286)
T 3uqc_A           97 LDVVHTR-------AGGLVVAEWIRGGSLQEVADT--S--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID  165 (286)
T ss_dssp             EEEEEET-------TEEEEEEECCCEEEHHHHHTT--C--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT
T ss_pred             eEEEEEC-------CcEEEEEEecCCCCHHHHHhc--C--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC
Confidence            9999876       678999999985 99999854  2  4667789999999999999999999999999999999999


Q ss_pred             CCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhC
Q psy2676         170 GGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       170 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      +.++|++++.                   ++       +++.++||||||+++|+|++|+.||.+.+..+.......   
T Consensus       166 g~~kl~~~~~-------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~---  216 (286)
T 3uqc_A          166 GDVVLAYPAT-------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER---  216 (286)
T ss_dssp             SCEEECSCCC-------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB---
T ss_pred             CCEEEEeccc-------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH---
Confidence            9999985442                   22       258899999999999999999999976543210000000   


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                                       ..............++++++.++|.+||+.||.+| |+.++++
T Consensus       217 -----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          217 -----------------DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             -----------------CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             -----------------HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence                             00000111223345788999999999999999999 9999985

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.3e-33  Score=257.30  Aligned_cols=183  Identities=15%  Similarity=0.092  Sum_probs=128.3

Q ss_pred             ecccceeEEEEEEecCCCcEEEEEEeecccCCCC--------CCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          31 GCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG--------IPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        31 g~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      +.|+.|....++. ...|+.+++|++........        ....+.+|+++|+++..  |+||+++++++++.     
T Consensus       243 ~~~~~~~h~~~rr-~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~--~~~i~~~~~~~ed~-----  314 (569)
T 4azs_A          243 YAGAGLAHKRSRR-YFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPA--GFDAPAVLAHGENA-----  314 (569)
T ss_dssp             C--------CCEE-EEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCT--TCCCCCEEEEEECS-----
T ss_pred             ccCCccccccccc-ccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCC--CCCeeEEEEEEEEC-----
Confidence            4555555555555 35688899999976532221        12357789999999974  99999999999988     


Q ss_pred             cceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         103 RYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       103 ~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                        ..+|+||||++| +|.+++...  +.+++.   .|+.||+.||+|+|++||+||||||+|||++.+|.+||+|||++.
T Consensus       315 --~~~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr  387 (569)
T 4azs_A          315 --QSGWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIV  387 (569)
T ss_dssp             --SEEEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEE
T ss_pred             --CEEEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCe
Confidence              789999999997 999999873  446664   588999999999999999999999999999999999999999998


Q ss_pred             cccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcC
Q psy2676         182 TFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV  229 (321)
Q Consensus       182 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  229 (321)
                      ...... ......||+.|+|||++.+. +..++|+||+|++++.+.++.
T Consensus       388 ~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          388 TTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             SCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             eCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence            765433 34557899999999998764 567899999999887775543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.1e-27  Score=217.21  Aligned_cols=183  Identities=21%  Similarity=0.181  Sum_probs=137.7

Q ss_pred             eeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCC------CchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          25 DELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI------PMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ...+.||+|+||+||++.   ..+..+++|....+......      ...+.+|+.++++++   ||||+++..+.... 
T Consensus       339 ~~~~~LG~G~fg~Vy~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~~~~~~~~~-  411 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS---YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK---DFGIPAPYIFDVDL-  411 (540)
T ss_dssp             ---------CCEEEEEEE---CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG---GGTCCCCCEEEEET-
T ss_pred             CCCCEEeeCCCEEEEEEE---ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC---CCCcCceEEEEEeC-
Confidence            345689999999999993   46778888876543221110      123678999999998   99999444443333 


Q ss_pred             cccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ...++||||++ ++|.+++..          +..++.|++.||.|||++|++||||||+||+++.  ++||+||
T Consensus       412 ------~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DF  473 (540)
T 3en9_A          412 ------DNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDF  473 (540)
T ss_dssp             ------TTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCC
T ss_pred             ------CccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEEC
Confidence                  23499999998 599999876          4689999999999999999999999999999998  9999999


Q ss_pred             CCcccccCCCc--------cccccccccccchhhhhc--CCCCCcchHHHHHHHHHHHHhcCCCC
Q psy2676         178 GLAKTFDYDMM--------LTSVVVTLWYRAPEILLN--LGYGTPVDIWSIGCVMAEMWRLVPLF  232 (321)
Q Consensus       178 g~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf  232 (321)
                      |++........        .....+|+.|+|||++..  ..++..+|+|+..+-..+-..++.+|
T Consensus       474 Gla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          474 GLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             TTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            99988764322        135678999999999987  55777889999998888888777666

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=1.2e-24  Score=181.63  Aligned_cols=147  Identities=21%  Similarity=0.174  Sum_probs=111.7

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC----------------CCchhHHHHHHHHhcccCCC
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG----------------IPMSTLREISILKQLDTFEH   84 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~----------------~~~~~~~e~~~l~~l~~~~~   84 (321)
                      +..|.+.+.||+|++|.||+|++  .+++.+|+|+++.......                ....+.+|+.+++++.   |
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~---~  163 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ---G  163 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT---T
T ss_pred             CeEEEecCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc---C
Confidence            34455669999999999999998  6789999999865322111                1234678999999997   3


Q ss_pred             CceeEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q psy2676          85 PNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQN  163 (321)
Q Consensus        85 ~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~N  163 (321)
                      +++..+++   .        ...++|||+++| +|.+ +..        .....++.|++.||.+||++|++|+||||+|
T Consensus       164 ~~v~~~~~---~--------~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~N  223 (282)
T 1zar_A          164 LAVPKVYA---W--------EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYN  223 (282)
T ss_dssp             SSSCCEEE---E--------ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTS
T ss_pred             CCcCeEEe---c--------cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHH
Confidence            55555432   2        235899999986 8988 321        2245799999999999999999999999999


Q ss_pred             EEEeeCCCEEEeecCCcccccCCCccccccccccccchhhhh
Q psy2676         164 LLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL  205 (321)
Q Consensus       164 ilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  205 (321)
                      |+++ ++.++|+|||++...            ..+.|||.+.
T Consensus       224 ILl~-~~~vkl~DFG~a~~~------------~~~~a~e~l~  252 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSVEV------------GEEGWREILE  252 (282)
T ss_dssp             EEEE-TTEEEECCCTTCEET------------TSTTHHHHHH
T ss_pred             EEEE-CCcEEEEECCCCeEC------------CCCCHHHHHH
Confidence            9999 999999999998643            3357888874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=1.1e-21  Score=161.75  Aligned_cols=143  Identities=20%  Similarity=0.224  Sum_probs=107.9

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcE--EEEEEeecccCCCCC----------------------CchhHHHHHH
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNY--VAMKKLRVKLNEDGI----------------------PMSTLREISI   75 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~--~~iK~~~~~~~~~~~----------------------~~~~~~e~~~   75 (321)
                      .+.-|++.+.||+|+||.||+|.+ ..+++.  ||+|+++........                      ...+.+|+.+
T Consensus        45 ~~~~~~i~~~ig~G~~g~Vy~a~~-~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  123 (258)
T 1zth_A           45 KGYITAMGGVISTGKEANVFYADG-VFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRN  123 (258)
T ss_dssp             TTSEEEEEEEEEECSSEEEEEEEE-EETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHH
T ss_pred             CCCchhhCCEEeecceEEEEEEEE-cCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHH
Confidence            344588999999999999999988 367888  999997543211100                      0146789999


Q ss_pred             HHhcccCCCCce--eEEEeeeeccccccccceEEEEEeccCcc------CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHH
Q psy2676          76 LKQLDTFEHPNI--VRFFDVIHQNILSDERYLTVYLIFEHVDQ------DLGSYMEKCPPPGLSASKVKELTRQMLKGVD  147 (321)
Q Consensus        76 l~~l~~~~~~~i--~~~~~~~~~~~~~~~~~~~~~~v~e~~~~------~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~  147 (321)
                      ++++.   |+++  ..+++.           ...++||||+++      +|.+....     .++..+..++.|++.+|.
T Consensus       124 l~~l~---~~~i~~p~~~~~-----------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~  184 (258)
T 1zth_A          124 LERAK---EAGVSVPQPYTY-----------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVK  184 (258)
T ss_dssp             HHHHH---HTTCCCCCEEEE-----------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHH
T ss_pred             HHHHH---hCCCCCCeEEEc-----------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHH
Confidence            99987   5543  333332           134899999953      66666433     245677899999999999


Q ss_pred             HHH-hCCceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         148 FLH-SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       148 ~lh-~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      +|| +.|++|+||||+||+++.  .++|+|||++....
T Consensus       185 ~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          185 RLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             HHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             HHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence            999 999999999999999987  99999999997653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=9.7e-19  Score=149.76  Aligned_cols=141  Identities=19%  Similarity=0.218  Sum_probs=100.0

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCC------------ch--------hHHHHHHHHhc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP------------MS--------TLREISILKQL   79 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~------------~~--------~~~e~~~l~~l   79 (321)
                      .+.-|++.++||.|++|.||+|.+  .+|+.||+|+++.........            ..        ...|...+.++
T Consensus        93 rg~iY~I~~~IG~Gk~a~VY~a~d--~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL  170 (397)
T 4gyi_A           93 RKDVYSVGSRIGVGKESDIMIVAD--EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL  170 (397)
T ss_dssp             TTSCSEEEEEEEECSSEEEEEEEC--TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCEEEecCEeeeCCceEEEEEEC--CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence            344599999999999999999987  578999999986542221100            00        12355566666


Q ss_pred             ccCCCCce--eEEEeeeeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy2676          80 DTFEHPNI--VRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIH  156 (321)
Q Consensus        80 ~~~~~~~i--~~~~~~~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H  156 (321)
                      .   +.++  ...++.           ...++|||+++| +|..+..        ......++.||+.+|.+||+.|++|
T Consensus       171 ~---~~gv~vp~p~~~-----------~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~gIVH  228 (397)
T 4gyi_A          171 Y---EEGFPVPEPIAQ-----------SRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHGLIH  228 (397)
T ss_dssp             H---HTTCSCCCEEEE-----------ETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             H---hcCCCCCeeeec-----------cCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCCCcC
Confidence            4   2222  222222           112799999997 6654322        2234678899999999999999999


Q ss_pred             ccCCCCcEEEeeCCC----------EEEeecCCccccc
Q psy2676         157 RDLKPQNLLITRAGG----------LKIADFGLAKTFD  184 (321)
Q Consensus       157 ~di~p~Nilv~~~~~----------~kl~dfg~~~~~~  184 (321)
                      |||||.|||+++++.          +.++||+.+....
T Consensus       229 rDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          229 GDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            999999999988773          8999999887654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.49  E-value=3.5e-13  Score=111.17  Aligned_cols=139  Identities=14%  Similarity=0.175  Sum_probs=108.1

Q ss_pred             ceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          23 KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        23 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      .|++...++.|+.+.||++..   ++..+++|+......  .....+.+|+.+++.+..  +..+.+++++..+.     
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~---~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~--~~~vP~v~~~~~~~-----   82 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEG--KLPVPKVLHFERHD-----   82 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC---SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTT--TSCCCCEEEEEEET-----
T ss_pred             cceeEeeccCCCCCeEEEEEC---CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhc--CCCCCeEEEEEecC-----
Confidence            589999999999999999964   467899999865321  223468899999999975  66778888887654     


Q ss_pred             cceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------
Q psy2676         103 RYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS------------------------------  151 (321)
Q Consensus       103 ~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~------------------------------  151 (321)
                        ...++|||+++| +|.+...       +......++.+++.+|..||+                              
T Consensus        83 --~~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (263)
T 3tm0_A           83 --GWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV  153 (263)
T ss_dssp             --TEEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred             --CceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence              567999999998 7776532       122234678899999999998                              


Q ss_pred             -----------------------------CCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         152 -----------------------------HRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       152 -----------------------------~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                                                   ..++|||++|.||++++++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                         4489999999999998655567999997753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.30  E-value=3.5e-11  Score=98.90  Aligned_cols=136  Identities=19%  Similarity=0.121  Sum_probs=97.8

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCC-ceeEEEeeeecccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHP-NIVRFFDVIHQNIL   99 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~-~i~~~~~~~~~~~~   99 (321)
                      ...|.+....+.|..+.||++..  .++..+++|+....     ....+..|+.+++.+..  +. .+.+++++....  
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~--~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~--~~~~vP~~~~~~~~~--   87 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSA--QGRPVLFVKTDLSG-----ALNELQDEAARLSWLAT--TGVPCAAVLDVVTEA--   87 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEEC--TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHT--TTCCBCCEEEEEECS--
T ss_pred             cCCCceEecccCCCCceEEEEec--CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHh--CCCCCCeEEEeccCC--
Confidence            34577766556777799999964  45678999987532     23467899999999974  32 255677776544  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR-------------------------  153 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~-------------------------  153 (321)
                           ...++|||+++| +| + ...     .+.   ..++.+++.+|..||+..                         
T Consensus        88 -----~~~~~v~e~i~G~~l-~-~~~-----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (264)
T 1nd4_A           88 -----GRDWLLLGEVPGQDL-L-SSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGL  152 (264)
T ss_dssp             -----SCEEEEEECCSSEET-T-TSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTC
T ss_pred             -----CCCEEEEEecCCccc-C-cCc-----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCC
Confidence                 457999999998 66 3 111     222   356677888888888653                         


Q ss_pred             ---------------------------------ceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         154 ---------------------------------IIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       154 ---------------------------------~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                                                       ++|||++|.||++++++.+.|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          153 VDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                             99999999999998665567999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=7.4e-11  Score=101.73  Aligned_cols=147  Identities=18%  Similarity=0.227  Sum_probs=104.8

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEee--cccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR--VKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~--~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ...++.++.|.++.||++..   .+..+++|+..  .... ......+.+|..+++.+.. .+..+.+++.++.+...  
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~---~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~-~~vpvP~~~~~~~~~~~--  112 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVT---PGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAG-TDVPVAKMYALCEDESV--  112 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEEC---SSCEEEEECCCC-----------CHHHHHHHHHHHTT-SSSCCCCEEEEECCTTT--
T ss_pred             CceEEEcCCcccceEEEEEE---CCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhc-CCCCCCcEEEECCCCCc--
Confidence            34577889999999999965   34678888765  3211 1223477889999999985 23457788877654411  


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS-----------------------------  151 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-----------------------------  151 (321)
                        ....++|||+++| ++.+..    ...++..+...++.+++.+|..||+                             
T Consensus       113 --~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (359)
T 3dxp_A          113 --IGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQY  186 (359)
T ss_dssp             --TSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHH
T ss_pred             --cCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHH
Confidence              1235899999998 553311    1237888889999999999999997                             


Q ss_pred             -----------------------------CCceeccCCCCcEEEeeCCC--EEEeecCCcccc
Q psy2676         152 -----------------------------HRIIHRDLKPQNLLITRAGG--LKIADFGLAKTF  183 (321)
Q Consensus       152 -----------------------------~~~~H~di~p~Nilv~~~~~--~kl~dfg~~~~~  183 (321)
                                                   .+++|||++|.||+++.++.  +.|+||+.+...
T Consensus       187 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          187 KLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                         36899999999999987754  689999988654

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.13  E-value=7.7e-11  Score=99.23  Aligned_cols=188  Identities=16%  Similarity=0.127  Sum_probs=119.7

Q ss_pred             eeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          27 LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      ++.++.|....||++.      ..+++|+....    .....+.+|...++.+.....-.+.+++.....    ......
T Consensus        25 i~~~~~G~~n~v~~v~------~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~----~~~~~~   90 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN------RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP----SETYQM   90 (304)
T ss_dssp             CCEEEECSSEEEEEST------TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC----CSSCSC
T ss_pred             eEecCCCCcceEEEEC------CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC----CCCCCc
Confidence            4568999999999862      45888886432    123467789999988853111113344433221    122224


Q ss_pred             EEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------
Q psy2676         107 VYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS----------------------------------  151 (321)
Q Consensus       107 ~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~----------------------------------  151 (321)
                      .++||++++| ++.+....    .++..+...++.+++..|..||+                                  
T Consensus        91 ~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (304)
T 3sg8_A           91 SFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK  166 (304)
T ss_dssp             SCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred             ceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence            5889999998 66543322    26788888888899998888886                                  


Q ss_pred             ------------------------CCceeccCCCCcEEEee--CCCEEEeecCCcccccCCCccccccccccccchhhhh
Q psy2676         152 ------------------------HRIIHRDLKPQNLLITR--AGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL  205 (321)
Q Consensus       152 ------------------------~~~~H~di~p~Nilv~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  205 (321)
                                              ..++|||++|.||++++  +..+.++||+.+.................-.+|+...
T Consensus       167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~  246 (304)
T 3sg8_A          167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVS  246 (304)
T ss_dssp             HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHH
T ss_pred             cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHH
Confidence                                    13699999999999998  4557899999887644322111111100002333221


Q ss_pred             ----cC-CCC---------CcchHHHHHHHHHHHHhcCCCC
Q psy2676         206 ----NL-GYG---------TPVDIWSIGCVMAEMWRLVPLF  232 (321)
Q Consensus       206 ----~~-~~~---------~~~Di~slG~~l~~l~~g~~pf  232 (321)
                          .. ..+         ...+.|++|.+++.+.+|..+|
T Consensus       247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                11 111         1268999999999999998877

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.88  E-value=3.3e-08  Score=81.57  Aligned_cols=132  Identities=14%  Similarity=0.142  Sum_probs=95.1

Q ss_pred             eecccc-eeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEE
Q psy2676          30 IGCGAY-GTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVY  108 (321)
Q Consensus        30 lg~g~~-g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  108 (321)
                      +..|.. +.||++.. ..++..+++|+....     ....+..|...++.+..  +--+.+++.+..+.       ...+
T Consensus        32 ~~~G~S~~~v~rl~~-~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~--~vPVP~v~~~~~~~-------~~~~   96 (272)
T 4gkh_A           32 DNVGQSGATIYRLYG-KPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTA--FMPLPTIKHFIRTP-------DDAW   96 (272)
T ss_dssp             EECSSSSCEEEEEEC-CTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTT--TSCCCCEEEEEEET-------TEEE
T ss_pred             ccCCCcCCeEEEEEe-cCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhcc--CCCcCeEEEEEEEC-------CeEE
Confidence            344544 47999877 567778999987543     23367789999998874  33466777777665       5679


Q ss_pred             EEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q psy2676         109 LIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR----------------------------------  153 (321)
Q Consensus       109 ~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~----------------------------------  153 (321)
                      +|||+++| ++.+....      .......+..++...|..||+..                                  
T Consensus        97 lvme~l~G~~~~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (272)
T 4gkh_A           97 LLTTAIPGKTAFQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE  170 (272)
T ss_dssp             EEEECCCSEEHHHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred             EEEEeeCCccccccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence            99999998 77666544      12233456677777788887531                                  


Q ss_pred             ------------------------ceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         154 ------------------------IIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       154 ------------------------~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                                              ++|||+++.||+++.++.+-|+||+.+..
T Consensus       171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                    58999999999998776677999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.65  E-value=2.5e-07  Score=77.71  Aligned_cols=139  Identities=21%  Similarity=0.199  Sum_probs=91.2

Q ss_pred             eeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccce
Q psy2676          26 ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYL  105 (321)
Q Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~  105 (321)
                      -++.++.|....||++      +..+++|+....    .....+..|..+++.+.....-.+.+.+.+....      ..
T Consensus        23 ~v~~l~~G~~n~v~~v------g~~~VlR~~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~------~g   86 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV------NGDWVFRFPKSQ----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS------DG   86 (306)
T ss_dssp             CEEEEEECSSEEEEEE------TTTEEEEEESSH----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT------TS
T ss_pred             eeeecCCCcceeEEEE------CCEEEEEecCCc----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC------CC
Confidence            3566889999999987      356888885321    1134677899999999741111244555554311      13


Q ss_pred             EEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------
Q psy2676         106 TVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH--------------------------------  152 (321)
Q Consensus       106 ~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~--------------------------------  152 (321)
                      ..++||++++| ++.+..-.    .++..+...++.++...|..||+.                                
T Consensus        87 ~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~  162 (306)
T 3tdw_A           87 NPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFP  162 (306)
T ss_dssp             CEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGG
T ss_pred             ceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccc
Confidence            45799999998 66553211    145555566666666666666642                                


Q ss_pred             ----------------------------CceeccCCCCcEEEee---CCCE-EEeecCCccccc
Q psy2676         153 ----------------------------RIIHRDLKPQNLLITR---AGGL-KIADFGLAKTFD  184 (321)
Q Consensus       153 ----------------------------~~~H~di~p~Nilv~~---~~~~-kl~dfg~~~~~~  184 (321)
                                                  .++|+|++|.||+++.   ++.+ .|+||+.+...+
T Consensus       163 ~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          163 LLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             GSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             ccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                                        3599999999999987   4554 899999886544

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.49  E-value=1.3e-06  Score=76.10  Aligned_cols=82  Identities=17%  Similarity=0.068  Sum_probs=50.4

Q ss_pred             eeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC--C---CCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          25 DELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN--E---DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~--~---~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      .-++.+|.|..+.||++.+ ..++..+++|.......  .   .........|.++++.+.......+.+++.+.  .  
T Consensus        33 ~~~~~lg~G~~n~vyrv~~-~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~--  107 (397)
T 2olc_A           33 LTCQEIGDGNLNYVFHIYD-QEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--  107 (397)
T ss_dssp             CEEEECCSSSSEEEEEEEC-----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--
T ss_pred             eEEEECCCCceEEEEEEEE-CCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C--
Confidence            3467899999999999976 34567899998653211  1   11234567899999988642122344555442  2  


Q ss_pred             ccccceEEEEEeccCcc
Q psy2676         100 SDERYLTVYLIFEHVDQ  116 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~  116 (321)
                           ...++|||+++|
T Consensus       108 -----~~~~lvmE~l~g  119 (397)
T 2olc_A          108 -----EMAVTVMEDLSH  119 (397)
T ss_dssp             -----TTTEEEECCCTT
T ss_pred             -----CccEEEEEeCCC
Confidence                 123789999986

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.37  E-value=1.3e-06  Score=74.89  Aligned_cols=89  Identities=4%  Similarity=-0.018  Sum_probs=54.4

Q ss_pred             eeeeeee-ecccceeEEEEEEec--C---CCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          24 YDELCQI-GCGAYGTVFKARDLQ--N---KGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        24 y~~~~~l-g~g~~g~v~~~~~~~--~---~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      ....+.| +.|....+|++....  .   ++..+++|+...... .......+.+|..+++.+.....-.+.+++.+..+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            4456778 889899999986510  0   156788898654220 01113467889999998874211245666666543


Q ss_pred             cccccccceEEEEEeccCcc
Q psy2676          97 NILSDERYLTVYLIFEHVDQ  116 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~  116 (321)
                      ...    ....++|||+++|
T Consensus       102 ~~~----~g~~~~v~e~l~G  117 (357)
T 3ats_A          102 GDV----LGTPFFLMDYVEG  117 (357)
T ss_dssp             STT----TSSCEEEEECCCC
T ss_pred             CCc----cCCceEEEEecCC
Confidence            311    1234789999987

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.27  E-value=5.3e-06  Score=70.63  Aligned_cols=32  Identities=19%  Similarity=0.261  Sum_probs=28.4

Q ss_pred             hCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         151 SHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       151 ~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      ..+++|||+++.||+++.++.+.|+||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            36899999999999998888999999997753

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.22  E-value=1.2e-05  Score=62.43  Aligned_cols=101  Identities=12%  Similarity=0.023  Sum_probs=67.3

Q ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee-ccCCCCcEEEeeCCCEEEeecCCcccccCCCcccccccc
Q psy2676         117 DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIH-RDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVT  195 (321)
Q Consensus       117 ~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H-~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  195 (321)
                      +|.+.+...+.+ ++++++|.++.|.+.+|..+-...-.| .=+.|..|++..+|++.+.+ ..+.           ...
T Consensus        34 SL~eIL~~~~~P-lsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQP-INEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGE  100 (229)
T ss_dssp             EHHHHHHHHTSC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             cHHHHHHHcCCC-cCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccc
Confidence            799999887655 999999999999999988873211122 33567999999999988764 1110           112


Q ss_pred             ccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCC
Q psy2676         196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPL  231 (321)
Q Consensus       196 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  231 (321)
                      ..+.|||... ...+.+.=|||||+++|..+--..|
T Consensus       101 ~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A          101 PPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            2356777652 3446788999999999999764443

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.13  E-value=2e-05  Score=65.86  Aligned_cols=69  Identities=9%  Similarity=-0.010  Sum_probs=44.8

Q ss_pred             eeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceE
Q psy2676          27 LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLT  106 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~  106 (321)
                      ++.|+.|....+|++       ..+++|+.....   .......+|..+++.+...+-+  .+++....+.         
T Consensus        23 i~~l~gG~tN~~~~~-------~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~--P~~~~~~~~~---------   81 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-------GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVS--PEVLHVDPAT---------   81 (301)
T ss_dssp             CEEEESCSSEEEEEE-------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSS--CCEEEECTTT---------
T ss_pred             eeEcCCcccccccee-------eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCC--CceEEEECCC---------
Confidence            788999999999998       458889876421   1123446788888888753222  5666543221         


Q ss_pred             EEEEeccC-cc
Q psy2676         107 VYLIFEHV-DQ  116 (321)
Q Consensus       107 ~~~v~e~~-~~  116 (321)
                      -++++|++ +|
T Consensus        82 ~~~v~e~i~~g   92 (301)
T 3dxq_A           82 GVMVTRYIAGA   92 (301)
T ss_dssp             CCEEEECCTTC
T ss_pred             CEEEEeecCCC
Confidence            25789998 65

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.06  E-value=3.6e-05  Score=64.45  Aligned_cols=77  Identities=13%  Similarity=0.118  Sum_probs=56.0

Q ss_pred             eeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccc
Q psy2676          25 DELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERY  104 (321)
Q Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~  104 (321)
                      .-++.++.|....+|++..   ++..+++|+....     ....+..|...++.+.......+.+++......       
T Consensus        39 ~~~~~l~gG~~n~~y~v~~---~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-------  103 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND---EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-------  103 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES---SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-------
T ss_pred             eeeEEeCCccceeeeEEEE---CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-------
Confidence            4467889999999999964   5678889987642     134677899999988753235566777665443       


Q ss_pred             eEEEEEeccCcc
Q psy2676         105 LTVYLIFEHVDQ  116 (321)
Q Consensus       105 ~~~~~v~e~~~~  116 (321)
                      ...++|||+++|
T Consensus       104 g~~~lvme~l~G  115 (312)
T 3jr1_A          104 GHSFLLLEALNK  115 (312)
T ss_dssp             SEEEEEEECCCC
T ss_pred             CceEEEEEeccC
Confidence            467999999986

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.03  E-value=4.8e-05  Score=63.07  Aligned_cols=83  Identities=14%  Similarity=0.059  Sum_probs=56.3

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ..+....-++.+|.|..+.||+++.  .+|+.+++|+.....  ......+..|...|+.+....---+.+++..-  . 
T Consensus        12 l~G~~v~~v~~~g~G~~~~vyrv~l--~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~-   84 (288)
T 3f7w_A           12 LTGREVAAVAERGHSHRWHLYRVEL--ADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D-   84 (288)
T ss_dssp             HHCCCEEEEEEEEEETTEEEEEEEE--TTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T-
T ss_pred             hcCCCeEEEEecCCCCCeEEEEEEE--CCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C-
Confidence            4456778889999999999999986  678899999865321  22234577899999988642112234444431  1 


Q ss_pred             cccccceEEEEEeccCcc
Q psy2676          99 LSDERYLTVYLIFEHVDQ  116 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~  116 (321)
                              -++|||++.+
T Consensus        85 --------~~lv~e~l~~   94 (288)
T 3f7w_A           85 --------RTLAMEWVDE   94 (288)
T ss_dssp             --------TEEEEECCCC
T ss_pred             --------ceEEEEeecc
Confidence                    2678888763

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.00  E-value=4.3e-05  Score=67.04  Aligned_cols=78  Identities=12%  Similarity=0.041  Sum_probs=47.0

Q ss_pred             HhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCCccccccc--cccccchhhhhcCCC---CCcchHHHHHHHHHH
Q psy2676         150 HSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV--TLWYRAPEILLNLGY---GTPVDIWSIGCVMAE  224 (321)
Q Consensus       150 h~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~  224 (321)
                      +...++|||++|.||+++.++ +.++||+.+..............  ...|++|+......-   .....+.++...++.
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            466899999999999998776 99999998876543222211111  133555554431111   112444566666676


Q ss_pred             HHhc
Q psy2676         225 MWRL  228 (321)
Q Consensus       225 l~~g  228 (321)
                      .+.+
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6553

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.81  E-value=0.00014  Score=62.50  Aligned_cols=145  Identities=13%  Similarity=0.130  Sum_probs=83.2

Q ss_pred             CcceeeeeeeecccceeEEEEEEec------CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQ------NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      .+..+ ++.+..|-...+|++....      .++..+++|+....   ........+|..+++.+..  +.-..++++.+
T Consensus        50 ~~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~--~gv~P~ll~~~  123 (379)
T 3feg_A           50 PEELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAE--RSLGPQLYGVF  123 (379)
T ss_dssp             GGGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHH--TTSSCCEEEEE
T ss_pred             cCceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHh--cCCCCeEEEEc
Confidence            34455 3567788888999997521      13478999986321   1123455689999999886  33346666665


Q ss_pred             eccccccccceEEEEEeccCcc-CHHH--------------HH---hhCC---CCCCC--HHHHHHHHHHHHH-------
Q psy2676          95 HQNILSDERYLTVYLIFEHVDQ-DLGS--------------YM---EKCP---PPGLS--ASKVKELTRQMLK-------  144 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~-~L~~--------------~~---~~~~---~~~~~--~~~~~~i~~~l~~-------  144 (321)
                      .+           .+|+|+++| +|..              .+   ....   .....  +.++.++..++..       
T Consensus       124 ~~-----------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~  192 (379)
T 3feg_A          124 PE-----------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLP  192 (379)
T ss_dssp             TT-----------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCC
T ss_pred             CC-----------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccc
Confidence            21           288899886 3321              11   1111   11111  3455555544322       


Q ss_pred             ------------HHHHH----Hh----CCceeccCCCCcEEEeeC----CCEEEeecCCccc
Q psy2676         145 ------------GVDFL----HS----HRIIHRDLKPQNLLITRA----GGLKIADFGLAKT  182 (321)
Q Consensus       145 ------------~l~~l----h~----~~~~H~di~p~Nilv~~~----~~~kl~dfg~~~~  182 (321)
                                  .+..|    ..    ..++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       193 ~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          193 EMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             SCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             hhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                        12222    22    259999999999999876    6899999998864

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.65  E-value=0.00034  Score=59.20  Aligned_cols=34  Identities=32%  Similarity=0.382  Sum_probs=28.7

Q ss_pred             hCCceeccCCCCcEEEeeC----CCEEEeecCCccccc
Q psy2676         151 SHRIIHRDLKPQNLLITRA----GGLKIADFGLAKTFD  184 (321)
Q Consensus       151 ~~~~~H~di~p~Nilv~~~----~~~kl~dfg~~~~~~  184 (321)
                      ...++|||+++.||+++.+    +.+.++||+.+....
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            3479999999999999874    679999999887654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.65  E-value=0.00033  Score=61.51  Aligned_cols=74  Identities=15%  Similarity=0.128  Sum_probs=48.4

Q ss_pred             eeeeeecccceeEEEEEEec------CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          26 ELCQIGCGAYGTVFKARDLQ------NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        26 ~~~~lg~g~~g~v~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      -++.|+.|....+|++....      ..+..+++|+....    .....+.+|..+++.+..  +.-..++++.+.+   
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~--~g~~P~l~~~~~~---  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSE--RHLGPKLYGIFSG---  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHH--TTSSSCEEEEETT---
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHh--CCCCCcEEEEeCC---
Confidence            45678888889999997521      12578999987421    111356689999998875  3233566665421   


Q ss_pred             ccccceEEEEEeccCcc
Q psy2676         100 SDERYLTVYLIFEHVDQ  116 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~  116 (321)
                              .+|+|+++|
T Consensus       148 --------g~v~e~l~G  156 (429)
T 1nw1_A          148 --------GRLEEYIPS  156 (429)
T ss_dssp             --------EEEECCCCE
T ss_pred             --------CEEEEEeCC
Confidence                    278888876

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.63  E-value=0.00031  Score=59.05  Aligned_cols=150  Identities=15%  Similarity=0.077  Sum_probs=78.1

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      ..-++.++.|....+|++..  .++ .+++|+....    .....+..|..+++.+...+-| +.+++........ ...
T Consensus        24 ~~~~~~i~~G~~n~~~~v~~--~~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~-vP~~~~~~~g~~~-~~~   94 (322)
T 2ppq_A           24 LTSYKGIAEGVENSNFLLHT--TKD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLS-CPLPLPRKDGELL-GEL   94 (322)
T ss_dssp             EEEEEEECC---EEEEEEEE--SSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCC-CCCBCCBTTCCSC-EEE
T ss_pred             ceEeeccCCCcccceEEEEe--CCc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCC-CCcccCCCCCCEE-EEE
Confidence            34456778888899999975  233 6888987642    1234667788888887742211 2333321100000 000


Q ss_pred             ceEEEEEeccCcc-CHH---------------HHHh---hCCCCC---CCHHHHHH---------------HHHHHHHHH
Q psy2676         104 YLTVYLIFEHVDQ-DLG---------------SYME---KCPPPG---LSASKVKE---------------LTRQMLKGV  146 (321)
Q Consensus       104 ~~~~~~v~e~~~~-~L~---------------~~~~---~~~~~~---~~~~~~~~---------------i~~~l~~~l  146 (321)
                      ....++++++++| .+.               .+-.   ......   ........               +...+...+
T Consensus        95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~  174 (322)
T 2ppq_A           95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  174 (322)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence            1245889999986 321               1111   111110   11110000               001133344


Q ss_pred             HHHH-------hCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         147 DFLH-------SHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       147 ~~lh-------~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      ..+.       ..+++|+|+++.||++++++.+.++||+.+..
T Consensus       175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            5554       23699999999999998765568999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.50  E-value=0.00034  Score=59.35  Aligned_cols=33  Identities=18%  Similarity=0.267  Sum_probs=28.6

Q ss_pred             CCceeccCCCCcEEEeeCCCEEEeecCCccccc
Q psy2676         152 HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD  184 (321)
Q Consensus       152 ~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~  184 (321)
                      ..++|+|+.+.||++++++.+.++||+.+....
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            469999999999999988889999998876543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.48  E-value=0.00092  Score=56.30  Aligned_cols=145  Identities=16%  Similarity=0.134  Sum_probs=78.8

Q ss_pred             eeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEE
Q psy2676          28 CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTV  107 (321)
Q Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~  107 (321)
                      ..++ |....||++..  .+++.+++|+.....   .....+..|..+++.+....- .+++++..  +...........
T Consensus        32 ~~l~-g~~n~~y~v~~--~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~-~vp~~~~~--~g~~~~~~~g~~  102 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD--EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEV-PVAAPVAF--NGQTLLNHQGFY  102 (328)
T ss_dssp             EEEC-CSSSEEEEECC--TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTC-SBCCCCCB--TTBSCEEETTEE
T ss_pred             Eeec-CcccceEEEEc--CCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCC-eecceeec--CCcEEEEECCEE
Confidence            4556 77788998854  356679999875321   123466778888888874222 13444433  110000001345


Q ss_pred             EEEeccCcc-CHH-----------HHH---h----hCC---CCCCCHHHH----------------------HHHHHHHH
Q psy2676         108 YLIFEHVDQ-DLG-----------SYM---E----KCP---PPGLSASKV----------------------KELTRQML  143 (321)
Q Consensus       108 ~~v~e~~~~-~L~-----------~~~---~----~~~---~~~~~~~~~----------------------~~i~~~l~  143 (321)
                      ++++++++| ++.           ..+   .    ..+   ...++....                      ...+.+++
T Consensus       103 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  182 (328)
T 1zyl_A          103 FAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELI  182 (328)
T ss_dssp             EEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHH
T ss_pred             EEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHH
Confidence            789999986 221           111   0    001   011221111                      11122222


Q ss_pred             HHHHHH----HhCCceeccCCCCcEEEeeCCCEEEeecCCcccc
Q psy2676         144 KGVDFL----HSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF  183 (321)
Q Consensus       144 ~~l~~l----h~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~  183 (321)
                      ..+..+    ....++|||+++.||+++ + .+.++||+.+...
T Consensus       183 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          183 AAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             HHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             HHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            223222    234589999999999998 5 8999999987543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.44  E-value=0.0016  Score=57.56  Aligned_cols=74  Identities=20%  Similarity=0.130  Sum_probs=46.7

Q ss_pred             eeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccce
Q psy2676          26 ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYL  105 (321)
Q Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~  105 (321)
                      -++.|+.|....+|++.. ...+..+++|+.....   .....-.+|..+++.+..  +.-..++++.+. .        
T Consensus       112 ~i~~lsgG~tN~~y~v~~-~~~~~~~vLRi~g~~~---~~~idR~~E~~vl~~L~~--~gl~P~ll~~~~-~--------  176 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKD-MSKQAKYLIRLYGPKT---DEIINREREKKISCILYN--KNIAKKIYVFFT-N--------  176 (458)
T ss_dssp             EEEEECC--CEEEEEEEE-TTTTEEEEEEEECC-C---CSCSCHHHHHHHHHHHTT--SSSBCCEEEEET-T--------
T ss_pred             EEEEcCCCeEeEEEEEEE-CCCCceEEEEECCCCh---hhhcCHHHHHHHHHHHHh--cCCCCCEEEEeC-C--------
Confidence            356788898999999976 2234788899874321   111223689999999985  333456777652 1        


Q ss_pred             EEEEEeccCcc
Q psy2676         106 TVYLIFEHVDQ  116 (321)
Q Consensus       106 ~~~~v~e~~~~  116 (321)
                        ..|+||++|
T Consensus       177 --G~v~e~I~G  185 (458)
T 2qg7_A          177 --GRIEEFMDG  185 (458)
T ss_dssp             --EEEEECCCS
T ss_pred             --eEEEEeeCC
Confidence              248888876

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.43  E-value=0.00061  Score=58.52  Aligned_cols=75  Identities=13%  Similarity=0.112  Sum_probs=42.9

Q ss_pred             eeeeeecccceeEEEEEEecC-------CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          26 ELCQIGCGAYGTVFKARDLQN-------KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        26 ~~~~lg~g~~g~v~~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      -++.++.|....+|++.....       .+..+++|+......   .......|..+++.+..  +.-..++++.+ .. 
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~~~~E~~~l~~L~~--~g~~P~~~~~~-~~-  109 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---ELYNTISEFEVYKTMSK--YKIAPQLLNTF-NG-  109 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---GTSCHHHHHHHHHHHHH--TTSSCCEEEEE-TT-
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---ceecHHHHHHHHHHHHh--cCCCCceEEec-CC-
Confidence            355678888889999975210       126888998754211   11234678889988875  22244555543 11 


Q ss_pred             cccccceEEEEEeccCcc
Q psy2676          99 LSDERYLTVYLIFEHVDQ  116 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~  116 (321)
                               ++|+++++|
T Consensus       110 ---------~~v~e~i~G  118 (369)
T 3c5i_A          110 ---------GRIEEWLYG  118 (369)
T ss_dssp             ---------EEEEECCCS
T ss_pred             ---------cEEEEEecC
Confidence                     578888876

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=97.04  E-value=0.0023  Score=55.80  Aligned_cols=75  Identities=16%  Similarity=0.113  Sum_probs=48.3

Q ss_pred             eeeeeecccceeEEEEEEecC------CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          26 ELCQIGCGAYGTVFKARDLQN------KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        26 ~~~~lg~g~~g~v~~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      -++.+..|-...+|++.....      .+..+++|+....   ........+|..+++.+..  +.-..++++.+. .  
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~---t~~~idR~~E~~~l~~L~~--~gi~P~l~~~~~-~--  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH---VGKFYDSKVELDVFRYLSN--INIAPNIIADFP-E--  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC---C-CCCCHHHHHHHHHHHHH--TTSSCCEEEEET-T--
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC---cchhcCHHHHHHHHHHHHh--cCCCCCEEEEcC-C--
Confidence            355677888889999976211      1578999986432   1223345689999998875  333456665431 1  


Q ss_pred             ccccceEEEEEeccCcc
Q psy2676         100 SDERYLTVYLIFEHVDQ  116 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~  116 (321)
                              +.|+++++|
T Consensus       146 --------~~I~efI~G  154 (424)
T 3mes_A          146 --------GRIEEFIDG  154 (424)
T ss_dssp             --------EEEEECCCS
T ss_pred             --------CEEEEEeCC
Confidence                    678999987

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.83  E-value=0.0096  Score=51.66  Aligned_cols=30  Identities=23%  Similarity=0.347  Sum_probs=25.3

Q ss_pred             ceeccCCCCcEEEe------eCCCEEEeecCCcccc
Q psy2676         154 IIHRDLKPQNLLIT------RAGGLKIADFGLAKTF  183 (321)
Q Consensus       154 ~~H~di~p~Nilv~------~~~~~kl~dfg~~~~~  183 (321)
                      ++|+|+.+.||++.      +++.+.++||.++..-
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            78999999999993      4567999999988643

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.92  E-value=0.26  Score=38.23  Aligned_cols=112  Identities=11%  Similarity=0.090  Sum_probs=74.0

Q ss_pred             CCceeEEEeeeeccccccccceEEEEEeccCc-c-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q psy2676          84 HPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-Q-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKP  161 (321)
Q Consensus        84 ~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~-~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p  161 (321)
                      +|++++. .+-...       ..+.+.++.-. + +... +..     ++....++++.+|+....++++  =+|--++|
T Consensus        44 ~~~Fl~~-~I~e~e-------D~v~~~y~~~~~~~~f~~-ik~-----~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P  107 (215)
T 4ann_A           44 SPYFIDA-ELTELR-------DSFQIHYDINDNHTPFDN-IKS-----FTKNEKLRYLLNIKNLEEVNRT--RYTFVLAP  107 (215)
T ss_dssp             CTTBCCE-EEEECS-------SEEEEEECCCTTSEEGGG-GGG-----SCHHHHHHHHHHGGGGGGGGGS--SEECCCSG
T ss_pred             CCcccce-EEEEcc-------cEEEEEEEcCcccCCHHH-HHh-----cCHHHHHHHHHHHHHHHHHhcC--ceEEEEec
Confidence            8889877 344433       34555555544 3 3333 444     6899999999999888754443  36778999


Q ss_pred             CcEEEeeCCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCC
Q psy2676         162 QNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLF  232 (321)
Q Consensus       162 ~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  232 (321)
                      +|++++.++.+++.-.|....+.+..                     .+...=+-.+=|++..+++++..|
T Consensus       108 ~NL~f~~~~~p~i~~RGik~~l~P~~---------------------~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          108 DELFFTRDGLPIAKTRGLQNVVDPLP---------------------VSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             GGEEECTTSCEEESCCEETTTBSCCC---------------------CCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             ceEEEcCCCCEEEEEccCccCCCCCC---------------------CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999999999998766543322111                     111222334677888888888887

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.70  E-value=0.98  Score=35.14  Aligned_cols=98  Identities=13%  Similarity=0.086  Sum_probs=63.2

Q ss_pred             EEEEEeccCc-c-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         106 TVYLIFEHVD-Q-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD-FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       106 ~~~~v~e~~~-~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~-~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      .+.+.++.-. + +.. .+..     ++....++++.+|+.... +++  .-+|--++|+|++++.++.+++.-.|.-..
T Consensus        62 ~~~i~y~~~~~~~~f~-~i~~-----~~~~eKlrll~nl~~L~~~~~~--~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~  133 (219)
T 4ano_A           62 EVKVVIKPPSSFLTFA-AIRK-----TTLLSRIRAAIHLVSKVKHHSA--RRLIFIVCPENLMFNRALEPFFLHVGVKES  133 (219)
T ss_dssp             EEEEEEECCTTCEEHH-HHHT-----SCHHHHHHHHHHHHHHHSSCCS--SSEECCCCGGGEEECTTCCEEESCCEETTT
T ss_pred             EEEEEEEcCcccCcHH-HHHh-----cCHHHHHHHHHHHHHHHHHhhh--CceeEEEeCceEEEeCCCcEEEEEcCCccc
Confidence            4455555443 2 444 3433     689999999998887666 443  347788999999999999999987775443


Q ss_pred             ccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCC
Q psy2676         183 FDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLF  232 (321)
Q Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  232 (321)
                      +.+..           ..+|          .=+-.+=|++..++.++..|
T Consensus       134 lpP~e-----------~~ee----------~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          134 LPPDE-----------WDDE----------RLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             BSSCS-----------CCHH----------HHHHHHHHHHHHHTTCSSCH
T ss_pred             CCCCC-----------CCHH----------HHHHHHHHHHHHHHcCCCCH
Confidence            32111           1112          12234667777777777776

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	321
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-92
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-75
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-73
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-71
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-71
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-71
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-70
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-69
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-68
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-68
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-68
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-67
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-67
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-66
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-66
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-66
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-66
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-65
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-65
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-65
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-64
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-64
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-64
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-63
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-63
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-62
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-61
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-60
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-55
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-55
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-54
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-54
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-52
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-52
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-52
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-51
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-50
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-50
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-50
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-49
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-49
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-49
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-48
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-47
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-47
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	9e-47
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-46
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-46
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-45
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-45
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-44
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-44
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-44
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-43
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-41
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-41
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-39
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-38
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-24

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  273 bits (699), Expect = 8e-92
 Identities = 156/302 (51%), Positives = 214/302 (70%), Gaps = 6/302 (1%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
           D++Y+ + +IG GAYG VFKARDL+N G +VA+K++RV+  E+G+P+ST+RE+++L+ L+
Sbjct: 6   DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
           TFEHPN+VR FDV   +    E  L   L+FEHVDQDL +Y++K P PG+    +K++  
Sbjct: 66  TFEHPNVVRLFDVCTVSRTDRETKL--TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           Q+L+G+DFLHSHR++HRDLKPQN+L+T +G +K+ADFGLA+ + + M LTSVVVTLWYRA
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 183

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           PE+LL   Y TPVD+WS+GC+ AEM+R  PLF  S++V+QL  I  VIG P   +WP ++
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE----K 316
           +L   +F   S         D       LL   LTFNPA RISA  AL HPYF++    K
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 303

Query: 317 EN 318
           EN
Sbjct: 304 EN 305

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (590), Expect = 2e-75
 Identities = 131/303 (43%), Positives = 183/303 (60%), Gaps = 16/303 (5%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
            + ++ +IG G YG V+KAR+    G  VA+KK+R+    +G+P + +REIS+LK+L+  
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELN-- 59

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            HPNIV+  DVIH           +YL+FE + QDL  +M+     G+    +K    Q+
Sbjct: 60  -HPNIVKLLDVIHTE-------NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 111

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRAP 201
           L+G+ F HSHR++HRDLKPQNLLI   G +K+ADFGLA+ F   +   T  VVTLWYRAP
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

Query: 202 EILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           EILL   Y  T VDIWS+GC+ AEM     LF   +E++QL  IFR +GTP    WP   
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231

Query: 261 SL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN 318
           S+     SF ++++  FS +         SLL  ML ++P  RISA  AL HP+F++   
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD-VT 290

Query: 319 EPL 321
           +P+
Sbjct: 291 KPV 293

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 9e-73
 Identities = 117/317 (36%), Positives = 166/317 (52%), Gaps = 23/317 (7%)

Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
            D+G + Y  L  IG GAYG V  A D  N    VA+KK+            TLREI IL
Sbjct: 4   FDVGPR-YTNLSYIGEGAYGMVCSAYDNVN-KVRVAIKKIS-PFEHQTYCQRTLREIKIL 60

Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
            +     H NI+   D+I    +   + +  YL+   +  DL   ++      LS   + 
Sbjct: 61  LRFR---HENIIGINDIIRAPTIEQMKDV--YLVTHLMGADLYKLLKT---QHLSNDHIC 112

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD----MMLTSV 192
               Q+L+G+ ++HS  ++HRDLKP NLL+     LKI DFGLA+  D D      LT  
Sbjct: 113 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 172

Query: 193 VVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP 251
           V T WYRAPEI+LN  GY   +DIWS+GC++AEM    P+F     ++QL  I  ++G+P
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232

Query: 252 SMNEWPENISLMWSSFE----QYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA 307
           S  +    I+L   ++       +KV ++ +F +  SKA  LL+ MLTFNP  RI    A
Sbjct: 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

Query: 308 LEHPYFKE---KENEPL 321
           L HPY ++     +EP+
Sbjct: 293 LAHPYLEQYYDPSDEPI 309

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (565), Expect = 2e-71
 Identities = 108/305 (35%), Positives = 166/305 (54%), Gaps = 17/305 (5%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY++L +IG G +G VFKAR  +  G  VA+KK+ ++  ++G P++ LREI IL+ L   
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKT-GQKVALKKVLMENEKEGFPITALREIKILQLLK-- 67

Query: 83  EHPNIVRFFDVIHQNILSDERYL-TVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
            H N+V   ++         R   ++YL+F+  + DL   +        + S++K + + 
Sbjct: 68  -HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQM 125

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVVTL 196
           +L G+ ++H ++I+HRD+K  N+LITR G LK+ADFGLA+ F           T+ VVTL
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 197 WYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
           WYR PE+LL    YG P+D+W  GC+MAEMW   P+   +TE  QL  I ++ G+ +   
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245

Query: 256 WPENISL-----MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
           WP   +      +     Q  KV            A  L++ +L  +PA RI + DAL H
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305

Query: 311 PYFKE 315
            +F  
Sbjct: 306 DFFWS 310

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  220 bits (562), Expect = 2e-71
 Identities = 130/297 (43%), Positives = 175/297 (58%), Gaps = 17/297 (5%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY  L +IG G YG V+KA++  N G   A+KK+R++  ++GIP +T+REISILK+L   
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKELK-- 58

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQM 142
            H NIV+ +DVIH           + L+FEH+DQDL   ++ C    L +   K    Q+
Sbjct: 59  -HSNIVKLYDVIHTKK-------RLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQL 109

Query: 143 LKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD-MMLTSVVVTLWYRAP 201
           L G+ + H  R++HRDLKPQNLLI R G LKIADFGLA+ F       T  +VTLWYRAP
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169

Query: 202 EILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           ++L+    Y T +DIWS+GC+ AEM    PLF   +E +QL  IFR++GTP+   WP   
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229

Query: 261 SLMW--SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
            L     +F  Y  + + +           LL  ML  +P  RI+A  ALEH YFKE
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (562), Expect = 3e-71
 Identities = 106/293 (36%), Positives = 162/293 (55%), Gaps = 18/293 (6%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKL---NEDGIPMSTLREISILKQLDTFEHPN 86
           +G G + TV+KARD       VA+KK+++      +DGI  + LREI +L++L    HPN
Sbjct: 6   LGEGQFATVYKARDKNT-NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS---HPN 61

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           I+   D              + L+F+ ++ DL   ++      L+ S +K      L+G+
Sbjct: 62  IIGLLDAFGHKS-------NISLVFDFMETDLEVIIKDNSLV-LTPSHIKAYMLMTLQGL 113

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML-TSVVVTLWYRAPEILL 205
           ++LH H I+HRDLKP NLL+   G LK+ADFGLAK+F       T  VVT WYRAPE+L 
Sbjct: 114 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173

Query: 206 NL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL-M 263
               YG  VD+W++GC++AE+   VP     ++++QL  IF  +GTP+  +WP+  SL  
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 264 WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK 316
           + +F+ +  +    IF         L++ +  FNP  RI+A  AL+  YF  +
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (560), Expect = 2e-70
 Identities = 75/323 (23%), Positives = 133/323 (41%), Gaps = 34/323 (10%)

Query: 17  LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
           ++L D  ++++ ++G G  G VFK     + G  +A K + +++    I    +RE+ +L
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPS-GLVMARKLIHLEIKP-AIRNQIIRELQVL 58

Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKV 135
            + +    P IV F+   + +         + +  EH+D   L   ++K     +    +
Sbjct: 59  HECN---SPYIVGFYGAFYSDG-------EISICMEHMDGGSLDQVLKKAGR--IPEQIL 106

Query: 136 KELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
            +++  ++KG+ +L   H+I+HRD+KP N+L+   G +K+ DFG++     D M  S V 
Sbjct: 107 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVG 165

Query: 195 TLWYRAPEILLNLGYGTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTPSM 253
           T  Y +PE L    Y    DIWS+G  + EM     P+     +  +L    +V G  + 
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225

Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFM---------------DCCSK-ANSLLESMLTFN 297
                       S          AIF                   S      +   L  N
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285

Query: 298 PADRISAADALEHPYFKEKENEP 320
           PA+R      + H + K  + E 
Sbjct: 286 PAERADLKQLMVHAFIKRSDAEE 308

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 2e-69
 Identities = 85/298 (28%), Positives = 143/298 (47%), Gaps = 17/298 (5%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE 83
           Y +   IG G++G V++A+   + G  VA+KK+              RE+ I+++LD   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVLQD------KRFKNRELQIMRKLD--- 71

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG--LSASKVKELTRQ 141
           H NIVR     + +    +  + + L+ ++V + +             L    VK    Q
Sbjct: 72  HCNIVRLRYFFYSSG-EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGL-KIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           + + + ++HS  I HRD+KPQNLL+     + K+ DFG AK         S + + +YRA
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190

Query: 201 P-EILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE- 258
           P  I     Y + +D+WS GCV+AE+    P+F   + V+QL  I +V+GTP+  +  E 
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSK-ANSLLESMLTFNPADRISAADALEHPYFKE 315
           N +     F Q     ++ +F       A +L   +L + P  R++  +A  H +F E
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 1e-68
 Identities = 115/307 (37%), Positives = 159/307 (51%), Gaps = 18/307 (5%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
             Y +L  +G GAYG V  A D +  G  VA+KKL      +       RE+ +LK +  
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRT-GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR- 75

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             H N++   DV   +   D+     YL+   +  DLG  M+      L   +++ L  Q
Sbjct: 76  --HENVIGLLDVFTPDETLDDFT-DFYLVMPFMGTDLGKLMKHEK---LGEDRIQFLVYQ 129

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           MLKG+ ++H+  IIHRDLKP NL +     LKI DFGLA+  D +M  T  VVT WYRAP
Sbjct: 130 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--TGYVVTRWYRAP 187

Query: 202 EILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           E++LN + Y   VDIWS+GC+MAEM     LF  S  ++QLK I +V GTP         
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247

Query: 261 SL----MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE- 315
           S           +  K  F++I  +    A +LLE ML  +   R++A +AL HPYF+  
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307

Query: 316 --KENEP 320
              E+EP
Sbjct: 308 HDTEDEP 314

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  215 bits (549), Expect = 1e-68
 Identities = 65/296 (21%), Positives = 113/296 (38%), Gaps = 40/296 (13%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
            YD   ++G GA+G V +  +    GN  A K +      D    +  +EI  +  L   
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERAT-GNNFAAKFVMTPHESD--KETVRKEIQTMSVLR-- 81

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQ 141
            HP +V   D        D+  +   +I+E +   +L   +       +S  +  E  RQ
Sbjct: 82  -HPTLVNLHDAFE-----DDNEM--VMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQ 132

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLIT--RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
           + KG+  +H +  +H DLKP+N++ T  R+  LK+ DFGL    D    +     T  + 
Sbjct: 133 VCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA 192

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           APE+      G   D+WS+G +   +   +  F    + E L+ +         + +   
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS-- 250

Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
                                         +  +L  +P  R++   ALEHP+   
Sbjct: 251 ---------------------GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 2e-68
 Identities = 82/296 (27%), Positives = 129/296 (43%), Gaps = 43/296 (14%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR-VKLNEDGIPMSTLREISILKQLD 80
           + ++    +G G +G V+ AR+ Q+    +A+K L   +L + G+     RE+ I   L 
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQS-KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELT 139
              HPNI+R +   H           VYLI E+     +   ++K         +     
Sbjct: 65  ---HPNILRLYGYFHDAT-------RVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 112

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
            ++   + + HS R+IHRD+KP+NLL+  AG LKIADFG +         T +  TL Y 
Sbjct: 113 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYL 171

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
            PE++    +   VD+WS+G +  E     P F A+T  E  K I RV  T     +P+ 
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDF 226

Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
           ++                        A  L+  +L  NP+ R    + LEHP+   
Sbjct: 227 VT----------------------EGARDLISRLLKHNPSQRPMLREVLEHPWITA 260

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  212 bits (540), Expect = 4e-67
 Identities = 72/301 (23%), Positives = 125/301 (41%), Gaps = 40/301 (13%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
            YD L ++G GA+G V +  +    G     K +      D    +   EISI+ QL   
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKAT-GRVFVAKFINTPYPLD--KYTVKNEISIMNQLH-- 84

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQ 141
            HP ++   D        D+  +   LI E +   +L   +       +S ++V    RQ
Sbjct: 85  -HPKLINLHDAFE-----DKYEM--VLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQ 135

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLI--TRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
             +G+  +H H I+H D+KP+N++    +A  +KI DFGLA   + D ++     T  + 
Sbjct: 136 ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA 195

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           APEI+     G   D+W+IG +   +   +  F    ++E L+ + R       + +   
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS-- 253

Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE 319
                                    +A   ++++L   P  R++  DALEHP+ K   + 
Sbjct: 254 ---------------------SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292

Query: 320 P 320
            
Sbjct: 293 L 293

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 4e-67
 Identities = 75/307 (24%), Positives = 132/307 (42%), Gaps = 43/307 (14%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
           +  ++ + ++G GA+G V+KA++ +      A K +  K  E+      + EI IL   D
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKET-SVLAAAKVIDTKSEEE--LEDYMVEIDILASCD 67

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
              HPNIV+  D  +      E  L  +++ E         +       L+ S+++ + +
Sbjct: 68  ---HPNIVKLLDAFY-----YENNL--WILIEFCAGGAVDAVMLELERPLTESQIQVVCK 117

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYR 199
           Q L  +++LH ++IIHRDLK  N+L T  G +K+ADFG++      +    S + T ++ 
Sbjct: 118 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 177

Query: 200 APEILL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
           APE+++     +  Y    D+WS+G  + EM  + P       +  L  I +    P   
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK--SEPPTL 235

Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
             P   S                      S     L+  L  N   R + +  L+HP+  
Sbjct: 236 AQPSRWS----------------------SNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273

Query: 315 EKENEPL 321
              N+P+
Sbjct: 274 VDSNKPI 280

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 2e-66
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 44/299 (14%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
            Y+ L  IG G+YG   K R   + G  +  K+L      +      + E+++L++L   
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSD-GKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-- 61

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPG--LSASKVKELT 139
            HPNIVR++D I      D    T+Y++ E+ +  DL S + K       L    V  + 
Sbjct: 62  -HPNIVRYYDRII-----DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115

Query: 140 RQMLKGVDFLH-----SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVV 193
            Q+   +   H      H ++HRDLKP N+ +     +K+ DFGLA+  ++D     + V
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV 175

Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T +Y +PE +  + Y    DIWS+GC++ E+  L+P F A ++ E    I         
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE----GKF 231

Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
              P   S                       + N ++  ML      R S  + LE+P 
Sbjct: 232 RRIPYRYS----------------------DELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 4e-66
 Identities = 75/294 (25%), Positives = 134/294 (45%), Gaps = 40/294 (13%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           KKY    +IG GA GTV+ A D+   G  VA++++ ++          + EI ++++   
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVAT-GQEVAIRQMNLQQQPK--KELIINEILVMRENK- 75

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             +PNIV + D              ++++ E++    GS  +      +   ++  + R+
Sbjct: 76  --NPNIVNYLDSYLVGD-------ELWVVMEYLAG--GSLTDVVTETCMDEGQIAAVCRE 124

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRA 200
            L+ ++FLHS+++IHRD+K  N+L+   G +K+ DFG       +    +++V T ++ A
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           PE++    YG  VDIWS+G +  EM    P +     +  L  I    GTP + + PE +
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPEL-QNPEKL 242

Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           S                      +     L   L  +   R SA + L+H + K
Sbjct: 243 S----------------------AIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 5e-66
 Identities = 118/320 (36%), Positives = 168/320 (52%), Gaps = 19/320 (5%)

Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           Q LN    ++ ++ Y  L  +G GAYG+V  A D +  G  VA+KKL            T
Sbjct: 7   QELNKTIWEVPER-YQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRT 64

Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG 129
            RE+ +LK +    H N++   DV       +E +  VYL+   +  DL + ++      
Sbjct: 65  YRELRLLKHMK---HENVIGLLDVFTPARSLEE-FNDVYLVTHLMGADLNNIVKC---QK 117

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
           L+   V+ L  Q+L+G+ ++HS  IIHRDLKP NL +     LKI DFGLA+  D +M  
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-- 175

Query: 190 TSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           T  V T WYRAPEI+LN   Y   VDIWS+GC+MAE+     LF  +  ++QLK I R++
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

Query: 249 GTPSMNEWPENISL----MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA 304
           GTP      +  S        S  Q  K+ F+ +F+     A  LLE ML  +   RI+A
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295

Query: 305 ADALEHPYFKEK---ENEPL 321
           A AL H YF +    ++EP+
Sbjct: 296 AQALAHAYFAQYHDPDDEPV 315

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (526), Expect = 7e-66
 Identities = 117/299 (39%), Positives = 172/299 (57%), Gaps = 17/299 (5%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +KY++L +IG G YGTVFKA++ +     VA+K++R+  +++G+P S LREI +LK+L  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRET-HEIVALKRVRLDDDDEGVPSSALREICLLKELK- 59

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             H NIVR  DV+H    SD++   V+   +   +           P      VK    Q
Sbjct: 60  --HKNIVRLHDVLH----SDKKLTLVFEFCDQDLKKYFDSCNGDLDP----EIVKSFLFQ 109

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM-MLTSVVVTLWYRA 200
           +LKG+ F HS  ++HRDLKPQNLLI R G LK+A+FGLA+ F   +   ++ VVTLWYR 
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169

Query: 201 PEILLNLG-YGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
           P++L     Y T +D+WS GC+ AE+     PLF  +   +QLK IFR++GTP+  +WP 
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229

Query: 259 NISL--MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
              L          +  +   +     +    LL+++L  NP  RISA +AL+HPYF +
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 1e-65
 Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 41/298 (13%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           + +D +  +G GAYG V  A +       VA+K + +K   D  P +  +EI I K L+ 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVT-EEAVAVKIVDMKRAVD-CPENIKKEICINKMLN- 61

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             H N+V+F+    +  +        YL  E+          + P  G+     +    Q
Sbjct: 62  --HENVVKFYGHRREGNI-------QYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQ 111

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLWY 198
           ++ GV +LH   I HRD+KP+NLL+     LKI+DFGLA  F Y+    +L  +  TL Y
Sbjct: 112 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171

Query: 199 RAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
            APE+L    +   PVD+WS G V+  M      +   ++  Q    ++      +N W 
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-EKKTYLNPWK 230

Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE 315
                                     S   +LL  +L  NP+ RI+  D  +  ++ +
Sbjct: 231 -----------------------KIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 3e-65
 Identities = 64/297 (21%), Positives = 120/297 (40%), Gaps = 41/297 (13%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           KY     +G G +G V +  +  +       K ++VK  +    +   +EISIL      
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSS-KKTYMAKFVKVKGTDQ---VLVKKEISILNIAR-- 59

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQ 141
            H NI+   +            L   +IFE +   D+   +       L+  ++     Q
Sbjct: 60  -HRNILHLHESFE-----SMEEL--VMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQ 110

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLIT--RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
           + + + FLHSH I H D++P+N++    R+  +KI +FG A+          +     Y 
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY 170

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           APE+  +    T  D+WS+G ++  +   +  F A T  + ++ I     T     +   
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK-- 228

Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK 316
                                +   +A   ++ +L      R++A++AL+HP+ K+K
Sbjct: 229 ---------------------EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  204 bits (520), Expect = 3e-65
 Identities = 76/307 (24%), Positives = 126/307 (41%), Gaps = 49/307 (15%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-------GIPMSTLREISI 75
            Y+    +G G    V +           A+K + V             +  +TL+E+ I
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPT-CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASK 134
           L+++    HPNI++  D    N          +L+F+ + + +L  Y+ +     LS  +
Sbjct: 63  LRKVS--GHPNIIQLKDTYETNT-------FFFLVFDLMKKGELFDYLTEKVT--LSEKE 111

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV 194
            +++ R +L+ +  LH   I+HRDLKP+N+L+     +K+ DFG +   D    L  V  
Sbjct: 112 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG 171

Query: 195 TLWYRAPEILL------NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           T  Y APEI+       + GYG  VD+WS G +M  +    P F    ++  L+ I    
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231

Query: 249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL 308
                 EW                        D       L+   L   P  R +A +AL
Sbjct: 232 YQFGSPEWD-----------------------DYSDTVKDLVSRFLVVQPQKRYTAEEAL 268

Query: 309 EHPYFKE 315
            HP+F++
Sbjct: 269 AHPFFQQ 275

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  204 bits (520), Expect = 1e-64
 Identities = 77/302 (25%), Positives = 132/302 (43%), Gaps = 44/302 (14%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPM-STLREISILKQL 79
           +K + +L +IG G++G V+ ARD++N    VA+KK+     +        ++E+  L++L
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRN-SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72

Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELT 139
               HPN +++           E     +L+ E+        +E    P L   ++  +T
Sbjct: 73  R---HPNTIQYRGCYL-----REHTA--WLVMEYCLGSASDLLEVHKKP-LQEVEIAAVT 121

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYR 199
              L+G+ +LHSH +IHRD+K  N+L++  G +K+ DFG A          S V T ++ 
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANSFVGTPYWM 178

Query: 200 APEILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW 256
           APE++L +    Y   VD+WS+G    E+    P       +  L  I +       NE 
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------NES 231

Query: 257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK 316
           P   S  WS                      + ++S L   P DR ++   L+H +   +
Sbjct: 232 PALQSGHWS------------------EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273

Query: 317 EN 318
             
Sbjct: 274 RP 275

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  204 bits (519), Expect = 2e-64
 Identities = 80/301 (26%), Positives = 122/301 (40%), Gaps = 42/301 (13%)

Query: 18  DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           D+ D  YD    +G GA+  V  A D +     VA+K +  K   +G   S   EI++L 
Sbjct: 6   DIRDI-YDFRDVLGTGAFSEVILAEDKRT-QKLVAIKCIA-KKALEGKEGSMENEIAVLH 62

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVK 136
           ++    HPNIV   D+          +L  YLI + V   +L   + +      +     
Sbjct: 63  KIK---HPNIVALDDIYE-----SGGHL--YLIMQLVSGGELFDRIVEKGF--YTERDAS 110

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA---GGLKIADFGLAKTFDYDMMLTSVV 193
            L  Q+L  V +LH   I+HRDLKP+NLL         + I+DFGL+K  D   +L++  
Sbjct: 111 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 170

Query: 194 VTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM 253
            T  Y APE+L    Y   VD WSIG +   +    P F    + +  + I +       
Sbjct: 171 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 230

Query: 254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF 313
             W                        D    A   +  ++  +P  R +   AL+HP+ 
Sbjct: 231 PYWD-----------------------DISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267

Query: 314 K 314
            
Sbjct: 268 A 268

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 3e-64
 Identities = 108/309 (34%), Positives = 152/309 (49%), Gaps = 24/309 (7%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           K+Y  L  IG GA G V  A D       VA+KKL              RE+ ++K ++ 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 74

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             H NI+   +V      + E +  VYL+ E +D +L   ++          ++  L  Q
Sbjct: 75  --HKNIISLLNVFTPQK-TLEEFQDVYLVMELMDANLCQVIQMELDH----ERMSYLLYQ 127

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           ML G+  LHS  IIHRDLKP N+++     LKI DFGLA+T     M+T  VVT +YRAP
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187

Query: 202 EILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
           E++L +GY   VDIWS+GC+M EM R   LF     ++Q   +   +GTP      +   
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247

Query: 262 LMWSSFE---QYSKVAFSAIFMD------------CCSKANSLLESMLTFNPADRISAAD 306
            + +  E   +Y+ + F  +F D              S+A  LL  ML  +PA RIS  D
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307

Query: 307 ALEHPYFKE 315
           AL+HPY   
Sbjct: 308 ALQHPYINV 316

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 1e-63
 Identities = 67/295 (22%), Positives = 119/295 (40%), Gaps = 36/295 (12%)

Query: 30  IGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR 89
           +G G  G V +  + +      A+K L+             RE+ +  +    + P+IVR
Sbjct: 20  LGLGINGKVLQIFNKRT-QEKFALKMLQDC-------PKARREVELHWRA--SQCPHIVR 69

Query: 90  FFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDF 148
             DV        +      ++ E +D  +L S ++       +  +  E+ + + + + +
Sbjct: 70  IVDVYENLYAGRKCL---LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126

Query: 149 LHSHRIIHRDLKPQNLLITRA---GGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILL 205
           LHS  I HRD+KP+NLL T       LK+ DFG AK       LT+   T +Y APE+L 
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186

Query: 206 NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWS 265
              Y    D+WS+G +M  +    P F ++  +     +   I         E  +  WS
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYEFPNPEWS 242

Query: 266 SFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENEP 320
                          +   +   L+ ++L   P  R++  + + HP+  +    P
Sbjct: 243 ---------------EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  200 bits (510), Expect = 4e-63
 Identities = 85/328 (25%), Positives = 156/328 (47%), Gaps = 39/328 (11%)

Query: 2   YEYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN 61
           ++Y +  ++  N D        Y  + ++G G Y  VF+A ++ N    V +K L+    
Sbjct: 22  WDYESHVVEWGNQD-------DYQLVRKLGRGKYSEVFEAINITN-NEKVVVKILKPVKK 73

Query: 62  EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGS 120
           +        REI IL+ L     PNI+   D++      D    T  L+FEHV+  D   
Sbjct: 74  KK-----IKREIKILENL--RGGPNIITLADIVK-----DPVSRTPALVFEHVNNTDFKQ 121

Query: 121 YMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG-LKIADFGL 179
             +      L+   ++    ++LK +D+ HS  I+HRD+KP N++I      L++ D+GL
Sbjct: 122 LYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 176

Query: 180 AKTFDYDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMW-RLVPLFCASTE 237
           A+ +         V + +++ PE+L++   Y   +D+WS+GC++A M  R  P F     
Sbjct: 177 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236

Query: 238 VEQLKCIFRVIGTPSMNEWPENISLMW----------SSFEQYSKVAFSAIFMDCCSKAN 287
            +QL  I +V+GT  + ++ +  ++             S +++ +   S        +A 
Sbjct: 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL 296

Query: 288 SLLESMLTFNPADRISAADALEHPYFKE 315
             L+ +L ++   R++A +A+EHPYF  
Sbjct: 297 DFLDKLLRYDHQSRLTAREAMEHPYFYT 324

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 9e-62
 Identities = 69/304 (22%), Positives = 124/304 (40%), Gaps = 51/304 (16%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLREISILKQLDT 81
            +     +G G++ TV  AR+L       A+K L  + + ++       RE  ++ +LD 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELAT-SREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 66

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTR 140
             HP  V+ +         D+  L  Y    +    +L  Y+ K        +  +  T 
Sbjct: 67  --HPFFVKLYFTFQ-----DDEKL--YFGLSYAKNGELLKYIRKIGS--FDETCTRFYTA 115

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD---MMLTSVVVTLW 197
           +++  +++LH   IIHRDLKP+N+L+     ++I DFG AK    +       S V T  
Sbjct: 116 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175

Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           Y +PE+L         D+W++GC++ ++   +P F A  E    + I ++       ++P
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-----DFP 230

Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA------LEHP 311
           E                          KA  L+E +L  +   R+   +         HP
Sbjct: 231 EKFF----------------------PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268

Query: 312 YFKE 315
           +F+ 
Sbjct: 269 FFES 272

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 3e-61
 Identities = 75/299 (25%), Positives = 123/299 (41%), Gaps = 40/299 (13%)

Query: 21  DKKYDEL-CQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQL 79
           D ++ +   +IG G++ TV+K  D +     VA  +L+ +            E  +LK L
Sbjct: 7   DGRFLKFDIEIGRGSFKTVYKGLDTET-TVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65

Query: 80  DTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKEL 138
               HPNIVRF+D     +   +    + L+ E +    L +Y+++     +    ++  
Sbjct: 66  Q---HPNIVRFYDSWESTVKGKKC---IVLVTELMTSGTLKTYLKRFKV--MKIKVLRSW 117

Query: 139 TRQMLKGVDFLHSH--RIIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYDMMLTSVVVT 195
            RQ+LKG+ FLH+    IIHRDLK  N+ IT   G +KI D GLA          +V+ T
Sbjct: 118 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA-KAVIGT 176

Query: 196 LWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
             + APE+     Y   VD+++ G  M EM      +       Q+    RV        
Sbjct: 177 PEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVTSGVKPAS 233

Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
           + +                          +   ++E  +  N  +R S  D L H +F+
Sbjct: 234 FDKVAI----------------------PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 6e-60
 Identities = 78/309 (25%), Positives = 127/309 (41%), Gaps = 43/309 (13%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLR---VKLNEDGIPM-STLREISIL 76
           D  YD   ++G G +  V K R+    G   A K ++    K +  G+      RE+SIL
Sbjct: 9   DDYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67

Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
           K++    HPN++   +V             V LI E V      +        L+  +  
Sbjct: 68  KEIQ---HPNVITLHEVYENK-------TDVILILELVAGG-ELFDFLAEKESLTEEEAT 116

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG----LKIADFGLAKTFDYDMMLTSV 192
           E  +Q+L GV +LHS +I H DLKP+N+++         +KI DFGLA   D+     ++
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176

Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
             T  + APEI+     G   D+WSIG +   +      F   T+ E L  +  V     
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236

Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPY 312
              +                        +  + A   +  +L  +P  R++  D+L+HP+
Sbjct: 237 DEYFS-----------------------NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273

Query: 313 FKEKENEPL 321
            K K+ +  
Sbjct: 274 IKPKDTQQA 282

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 3e-55
 Identities = 58/295 (19%), Positives = 106/295 (35%), Gaps = 44/295 (14%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTF 82
           +     +IG G++GTV+K +        VA+K L V         +   E+ +L++    
Sbjct: 9   QITVGQRIGSGSFGTVYKGKW----HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-- 62

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQ 141
            H NI+ F        L         ++ +  +   L  ++           K+ ++ RQ
Sbjct: 63  -HVNILLFMGYSTAPQL--------AIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQ 112

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWY 198
             +G+D+LH+  IIHRDLK  N+ +     +KI DFGLA              +  ++ +
Sbjct: 113 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172

Query: 199 RAPEILLNLG---YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE 255
            APE++       Y    D+++ G V+ E+      +      +Q+  +           
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------- 223

Query: 256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
                         Y     S +  +C      L+   L     +R      L  
Sbjct: 224 ------------RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 7e-55
 Identities = 76/296 (25%), Positives = 121/296 (40%), Gaps = 43/296 (14%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRV-KLNEDGIPMSTLREISILKQLDTF 82
           +     +G G++G VF A   +    + A+K L+   +  D     T+ E  +L     +
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKT-NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA--W 60

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQ 141
           EHP +   F          +  L  + + E+++  DL  +++ C       S+      +
Sbjct: 61  EHPFLTHMFCTFQ-----TKENL--FFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAE 111

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF-DYDMMLTSVVVTLWYRA 200
           ++ G+ FLHS  I++RDLK  N+L+ + G +KIADFG+ K     D    +   T  Y A
Sbjct: 112 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIA 171

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           PEILL   Y   VD WS G ++ EM      F    E E    I   +  P    +P  +
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNP---FYPRWL 226

Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA-DALEHPYFKE 315
                                   +A  LL  +    P  R+    D  +HP F+E
Sbjct: 227 E----------------------KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  177 bits (449), Expect = 1e-54
 Identities = 69/299 (23%), Positives = 114/299 (38%), Gaps = 39/299 (13%)

Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILK 77
           L D+ Y+    +G G    V  ARDL+     VA+K LR  L  D    +   RE     
Sbjct: 5   LSDR-YELGEILGFGGMSEVHLARDLRL-HRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 78  QLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVK 136
            L+   HP IV  +D               Y++ E+VD   L   +    P  ++  +  
Sbjct: 63  ALN---HPAIVAVYDTGEAE---TPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAI 114

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYDMMLTSV 192
           E+     + ++F H + IIHRD+KP N++I+    +K+ DFG+A+      +      +V
Sbjct: 115 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174

Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
           + T  Y +PE           D++S+GCV+ E+    P F   + V       R    P 
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234

Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHP 311
                                          +  ++++   L  NP +R   A  +   
Sbjct: 235 SARHE-----------------------GLSADLDAVVLKALAKNPENRYQTAAEMRAD 270

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-54
 Identities = 59/301 (19%), Positives = 111/301 (36%), Gaps = 49/301 (16%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST----LREISIL 76
           + +Y     +G G +G+V+    + +    VA+K +      D   +        E+ +L
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSD-NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVK 136
           K++ +     ++R  D   +         +  LI E  +     +        L     +
Sbjct: 62  KKVSS-GFSGVIRLLDWFERPD-------SFVLILERPEPVQDLFDFITERGALQEELAR 113

Query: 137 ELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG-LKIADFGLAKTFDYDMMLTSVVVT 195
               Q+L+ V   H+  ++HRD+K +N+LI    G LK+ DFG       D + T    T
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGT 172

Query: 196 LWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN 254
             Y  PE +    Y G    +WS+G ++ +M      F    E+ + +  F         
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF--------- 223

Query: 255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK 314
              + +S                      S+   L+   L   P+DR +  +   HP+ +
Sbjct: 224 --RQRVS----------------------SECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

Query: 315 E 315
           +
Sbjct: 260 D 260

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  175 bits (444), Expect = 1e-52
 Identities = 62/299 (20%), Positives = 116/299 (38%), Gaps = 41/299 (13%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLREISILKQLDTF 82
           +     IG G +G V+  R     G   AMK L  K +         L E  +L  + T 
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADT-GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 83  EHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQ 141
           + P IV      H         L    I + ++  DL  ++ +      +   ++    +
Sbjct: 65  DCPFIVCMSYAFH-----TPDKL--SFILDLMNGGDLHYHLSQHGVFSEA--DMRFYAAE 115

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           ++ G++ +H+  +++RDLKP N+L+   G ++I+D GLA  F       SV    +    
Sbjct: 116 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 175

Query: 202 EILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
            +   + Y +  D +S+GC++ ++ R    F      ++ +     +      E P++ S
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--ELPDSFS 233

Query: 262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKE 315
                                  +  SLLE +L  +   R+      A +  E P+F+ 
Sbjct: 234 ----------------------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  173 bits (439), Expect = 1e-52
 Identities = 71/300 (23%), Positives = 119/300 (39%), Gaps = 47/300 (15%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLREISILKQLD 80
           + +  L  +G G++G V   R   N G Y AMK L+ + +        T  E  +L  + 
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHN-GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
              HP I+R +          + ++ +  I       L    ++ P P       K    
Sbjct: 63  ---HPFIIRMWGTFQDA---QQIFMIMDYIEGGELFSLLRKSQRFPNP-----VAKFYAA 111

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
           ++   +++LHS  II+RDLKP+N+L+ + G +KI DFG AK         ++  T  Y A
Sbjct: 112 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--YTLCGTPDYIA 169

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           PE++    Y   +D WS G ++ EM      F  S  ++  + I       +   +P   
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-----AELRFPPFF 224

Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKE 315
           +                           LL  ++T + + R+        D   HP+FKE
Sbjct: 225 N----------------------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 7e-52
 Identities = 57/290 (19%), Positives = 115/290 (39%), Gaps = 44/290 (15%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           K+   L  IG G +G V        +GN VA+K ++     D    + L E S++ QL  
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIK----NDATAQAFLAEASVMTQLR- 58

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTR 140
             H N+V+   VI +    ++  L  Y++ E++ +  L  Y+       L    + + + 
Sbjct: 59  --HSNLVQLLGVIVE----EKGGL--YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 110

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRA 200
            + + +++L  +  +HRDL  +N+L++     K++DFGL K         +  + + + A
Sbjct: 111 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTA 168

Query: 201 PEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI 260
           PE L    + T  D+WS G ++ E++    +      ++    +   +      + P+  
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGYKMDAPDGC 225

Query: 261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
                                       ++++    + A R S     E 
Sbjct: 226 P----------------------PAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 3e-51
 Identities = 68/317 (21%), Positives = 119/317 (37%), Gaps = 54/317 (17%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNK-GNYVAMKKLRVKLNEDGIPMSTL 70
           L+   L L DK+      +G G +GTV K      K    VA+K L+ + N+  +    L
Sbjct: 3   LDRKLLTLEDKE------LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL 56

Query: 71  REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG 129
            E ++++QLD   +P IVR   +            +  L+ E  +   L  Y+++     
Sbjct: 57  AEANVMQQLD---NPYIVRMIGICEAE--------SWMLVMEMAELGPLNKYLQQNRH-- 103

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMML 189
           +    + EL  Q+  G+ +L     +HRDL  +N+L+      KI+DFGL+K    D   
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163

Query: 190 ----TSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCI 244
               T     + + APE +    + +  D+WS G +M E +      +      E    +
Sbjct: 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----V 219

Query: 245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA 304
             ++        P                           +   L+    T++  +R   
Sbjct: 220 TAMLEKGERMGCPAGCP----------------------REMYDLMNLCWTYDVENRPGF 257

Query: 305 ADALE--HPYFKEKENE 319
           A        Y+ +  NE
Sbjct: 258 AAVELRLRNYYYDVVNE 274

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  168 bits (425), Expect = 4e-50
 Identities = 69/299 (23%), Positives = 123/299 (41%), Gaps = 47/299 (15%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRV-KLNEDGIPMSTLREISILKQLDT 81
           ++D +  +G G++G V   +  ++ GN+ AMK L   K+ +      TL E  IL+ ++ 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
              P +V+            +      ++      ++ S++ +      S    +    Q
Sbjct: 100 --FPFLVKLEFSFK------DNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQ 149

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAP 201
           ++   ++LHS  +I+RDLKP+NLLI + G +++ DFG AK         ++  T    AP
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAP 207

Query: 202 EILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
           EI+L+ GY   VD W++G ++ EM    P F A   ++  + I           +P + S
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS-----GKVRFPSHFS 262

Query: 262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKE 315
                                 S    LL ++L  +   R         D   H +F  
Sbjct: 263 ----------------------SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 5e-50
 Identities = 69/302 (22%), Positives = 118/302 (39%), Gaps = 48/302 (15%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK-LNEDGIPMSTLREISILKQLD 80
             +D L  +G G +G V   R+    G Y AMK LR + +        T+ E  +L+   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT-GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQD-LGSYMEKCPPPGLSASKVKELT 139
              HP +         +         +  + E+ +   L  ++ +      +  + +   
Sbjct: 64  ---HPFLTALKYAFQTHD-------RLCFVMEYANGGELFFHLSRERV--FTEERARFYG 111

Query: 140 RQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSVVV-TLWY 198
            +++  +++LHS  +++RD+K +NL++ + G +KI DFGL K    D         T  Y
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
            APE+L +  YG  VD W +G VM EM      F         + I           +P 
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEI---RFPR 226

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYF 313
            +S                       +A SLL  +L  +P  R+      A + +EH +F
Sbjct: 227 TLS----------------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

Query: 314 KE 315
             
Sbjct: 265 LS 266

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 5e-50
 Identities = 63/302 (20%), Positives = 118/302 (39%), Gaps = 48/302 (15%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           +    + ++G G +G V+      N    VA+K L+        P + L E +++KQL  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYY--NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQ- 66

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQD-LGSYMEKCPPPGLSASKVKELTR 140
             H  +VR + V+ Q          +Y+I E+++   L  +++      L+ +K+ ++  
Sbjct: 67  --HQRLVRLYAVVTQE--------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF--DYDMMLTSVVVTLWY 198
           Q+ +G+ F+     IHRDL+  N+L++     KIADFGLA+    +           + +
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
            APE +    +    D+WS G ++ E+       +   T  E ++ + R       +  P
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP 236

Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE--HPYFKE 315
           E                          +   L+       P DR +          +F  
Sbjct: 237 E--------------------------ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

Query: 316 KE 317
            E
Sbjct: 271 TE 272

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 1e-49
 Identities = 60/317 (18%), Positives = 118/317 (37%), Gaps = 48/317 (15%)

Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
           Q L  D+ ++  +      ++G G +G V+      N    VA+K L+          + 
Sbjct: 5   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW--NGTTRVAIKTLKPGTMSP---EAF 59

Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQD-LGSYMEKCPPP 128
           L+E  ++K+L    H  +V+ + V+ +          +Y++ E++ +  L  +++     
Sbjct: 60  LQEAQVMKKLR---HEKLVQLYAVVSEE--------PIYIVTEYMSKGSLLDFLKGETGK 108

Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF--DYD 186
            L   ++ ++  Q+  G+ ++     +HRDL+  N+L+      K+ADFGLA+    +  
Sbjct: 109 YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168

Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIF 245
                    + + APE  L   +    D+WS G ++ E+       +      E L  + 
Sbjct: 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228

Query: 246 RVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA 305
           R    P   E PE                            + L+       P +R +  
Sbjct: 229 RGYRMPCPPECPE--------------------------SLHDLMCQCWRKEPEERPTFE 262

Query: 306 DALE--HPYFKEKENEP 320
                   YF   E + 
Sbjct: 263 YLQAFLEDYFTSTEPQY 279

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-49
 Identities = 67/313 (21%), Positives = 109/313 (34%), Gaps = 55/313 (17%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQ-NKGNYVAMKKLRVKLNEDGIPMSTL 70
           L  D+L + D +      +GCG +G+V +       K   VA+K L+    +       +
Sbjct: 5   LKRDNLLIADIE------LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-EMM 57

Query: 71  REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG 129
           RE  I+ QLD   +P IVR   V             + L+ E      L  ++       
Sbjct: 58  REAQIMHQLD---NPYIVRLIGVCQAE--------ALMLVMEMAGGGPLHKFLVGKREE- 105

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD----Y 185
           +  S V EL  Q+  G+ +L     +HRDL  +N+L+      KI+DFGL+K       Y
Sbjct: 106 IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165

Query: 186 DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCI 244
               ++    L + APE +    + +  D+WS G  M E        +      E    +
Sbjct: 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----V 221

Query: 245 FRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISA 304
              I      E P                           +  +L+     +   DR   
Sbjct: 222 MAFIEQGKRMECPPECP----------------------PELYALMSDCWIYKWEDRPDF 259

Query: 305 AD---ALEHPYFK 314
                 +   Y+ 
Sbjct: 260 LTVEQRMRACYYS 272

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 9e-49
 Identities = 61/300 (20%), Positives = 107/300 (35%), Gaps = 44/300 (14%)

Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGN--YVAMKKLRV-KLNEDGIPMSTLREISI 75
           +G+K    L ++G G++G V +       G    VA+K L+   L++       +RE++ 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 76  LKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           +  LD   H N++R + V+    +         ++ E           +          +
Sbjct: 65  MHSLD---HRNLIRLYGVVLTPPM--------KMVTELAPLGSLLDRLRKHQGHFLLGTL 113

Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYDMMLTS 191
                Q+ +G+ +L S R IHRDL  +NLL+     +KI DFGL +      D+ +M   
Sbjct: 114 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173

Query: 192 VVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRVIGT 250
             V   + APE L    +    D W  G  + EM+      +      + L  I +    
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 233

Query: 251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
               E                         DC     +++       P DR +     + 
Sbjct: 234 LPRPE-------------------------DCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  163 bits (413), Expect = 2e-48
 Identities = 76/333 (22%), Positives = 145/333 (43%), Gaps = 45/333 (13%)

Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
             D +Y  + ++G G + TV+ A+D+ N   +VAMK +R    +     +   EI +L++
Sbjct: 10  YKDARYILVRKLGWGHFSTVWLAKDMVN-NTHVAMKIVR---GDKVYTEAAEDEIKLLQR 65

Query: 79  LDTFEHPNIVRFFDVIHQNILS--------DERYLTVYLIFEHVDQDLGSYMEKCPPPGL 130
           ++     +  +   +   +IL             + V ++FE + ++L + ++K    G+
Sbjct: 66  VN---DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 122

Query: 131 SASKVKELTRQMLKGVDFLHSHR-IIHRDLKPQNLLITRAGG------LKIADFGLAKTF 183
               VK++++Q+L G+D++H    IIH D+KP+N+L+           +KIAD G A  +
Sbjct: 123 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182

Query: 184 DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCA------STE 237
           D      + + T  YR+PE+LL   +G   DIWS  C++ E+     LF        + +
Sbjct: 183 DEHYT--NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240

Query: 238 VEQLKCIFRVIGTPSMNEWPE--------NISLMWSSFEQYSKVAFSAIFM-------DC 282
            + +  I  ++G                 N   +  +  +        +         D 
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300

Query: 283 CSKANSLLESMLTFNPADRISAADALEHPYFKE 315
             + +  L  ML  +P  R  A   + HP+ K+
Sbjct: 301 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 333

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 2e-47
 Identities = 68/338 (20%), Positives = 119/338 (35%), Gaps = 72/338 (21%)

Query: 3   EYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNY----VAMKKLRV 58
           EY  D       ++L+ G         +G GA+G V  A             VA+K L+ 
Sbjct: 25  EYEYDLKWEFPRENLEFGKV-------LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE 77

Query: 59  KLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-D 117
           K +      + + E+ ++ QL    H NIV        +         +YLIFE+    D
Sbjct: 78  KADSSER-EALMSELKMMTQLG--SHENIVNLLGACTLSG-------PIYLIFEYCCYGD 127

Query: 118 LGSYMEKCPPPG---------------------LSASKVKELTRQMLKGVDFLHSHRIIH 156
           L +Y+                            L+   +     Q+ KG++FL     +H
Sbjct: 128 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187

Query: 157 RDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPV 213
           RDL  +N+L+T    +KI DFGLA+        ++  +  + + + APE L    Y    
Sbjct: 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS 247

Query: 214 DIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSK 272
           D+WS G ++ E++ L V  +           + +        + P   +           
Sbjct: 248 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM---DQPFYAT----------- 293

Query: 273 VAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
                       +   +++S   F+   R S  +    
Sbjct: 294 -----------EEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 6e-47
 Identities = 56/293 (19%), Positives = 107/293 (36%), Gaps = 43/293 (14%)

Query: 23  KYDELCQIGCGAYGTVFKARDL--QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
           + +    IG G +G V +   +  +N    VA+K  +     D +    L+E   ++Q D
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFD 66

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
              HP+IV+   VI +N +        ++I E           +     L  + +     
Sbjct: 67  ---HPHIVKLIGVITENPV--------WIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYD--MMLTSVVVTLWY 198
           Q+   + +L S R +HRD+  +N+L++    +K+ DFGL++  +       +   + + +
Sbjct: 116 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAEM-WRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
            APE +    + +  D+W  G  M E+    V  F      + +  I      P     P
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP----MP 231

Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
            N                            SL+     ++P+ R    +    
Sbjct: 232 PNCP----------------------PTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 9e-47
 Identities = 70/310 (22%), Positives = 129/310 (41%), Gaps = 46/310 (14%)

Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNK--GNYVAMKKLRVK--LNEDGIPMSTLREIS 74
           +G + ++ L  +G GAYG VF  R +     G   AMK L+    + +      T  E  
Sbjct: 21  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80

Query: 75  ILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASK 134
           +L+ +   + P +V             E  L + L + +   +L +++ +      +  +
Sbjct: 81  VLEHIR--QSPFLVTLHYAFQ-----TETKLHLILDYINGG-ELFTHLSQRER--FTEHE 130

Query: 135 VKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFD--YDMMLTSV 192
           V+    +++  ++ LH   II+RD+K +N+L+   G + + DFGL+K F           
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 190

Query: 193 VVTLWYRAPEILL--NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT 250
             T+ Y AP+I+   + G+   VD WS+G +M E+      F    E      I R I  
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250

Query: 251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AA 305
                +P+ +S                      + A  L++ +L  +P  R+      A 
Sbjct: 251 SEP-PYPQEMS----------------------ALAKDLIQRLLMKDPKKRLGCGPRDAD 287

Query: 306 DALEHPYFKE 315
           +  EH +F++
Sbjct: 288 EIKEHLFFQK 297

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  156 bits (394), Expect = 3e-46
 Identities = 65/303 (21%), Positives = 121/303 (39%), Gaps = 42/303 (13%)

Query: 10  QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMST 69
            S N D  ++         ++G G YG V++    +     VA+K L+    E       
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKEDTMEVE---EF 60

Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPP 128
           L+E +++K++    HPN+V+   V  +           Y+I E +   +L  Y+ +C   
Sbjct: 61  LKEAAVMKEIK---HPNLVQLLGVCTREP-------PFYIITEFMTYGNLLDYLRECNRQ 110

Query: 129 GLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF--DYD 186
            +SA  +  +  Q+   +++L     IHRDL  +N L+     +K+ADFGL++    D  
Sbjct: 111 EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170

Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
                    + + APE L    +    D+W+ G ++ E+           ++ Q   ++ 
Sbjct: 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE 227

Query: 247 VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
           ++      E PE                          K   L+ +   +NP+DR S A+
Sbjct: 228 LLEKDYRMERPEGCP----------------------EKVYELMRACWQWNPSDRPSFAE 265

Query: 307 ALE 309
             +
Sbjct: 266 IHQ 268

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (392), Expect = 9e-46
 Identities = 53/315 (16%), Positives = 101/315 (32%), Gaps = 49/315 (15%)

Query: 19  LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           +G++ Y    +IG G++G ++   D+   G  VA+K   VK     +      E  I K 
Sbjct: 5   VGNR-YRLGRKIGSGSFGDIYLGTDIAA-GEEVAIKLECVKTKHPQL----HIESKIYKM 58

Query: 79  LDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKEL 138
           +        +            +  Y    ++ E +   L      C     S   V  L
Sbjct: 59  MQ---GGVGIPTIRWCGA----EGDYN--VMVMELLGPSLEDLFNFCSRK-FSLKTVLLL 108

Query: 139 TRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG---LKIADFGLAKTFD--------YDM 187
             QM+  ++++HS   IHRD+KP N L+        + I DFGLAK +            
Sbjct: 109 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 168

Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
              ++  T  Y +    L +      D+ S+G V+         +       + +   R+
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228

Query: 248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA-- 305
                                         +     S+  + L    +    D+   +  
Sbjct: 229 SEKKMSTPIEV-------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYL 269

Query: 306 -DALEHPYFKEKENE 319
                + + ++  + 
Sbjct: 270 RQLFRNLFHRQGFSY 284

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 1e-45
 Identities = 51/292 (17%), Positives = 112/292 (38%), Gaps = 44/292 (15%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
           K    L ++G G +G V   +        VA+K ++     +      + E  ++  L  
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLS- 57

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             H  +V+ + V      + +R +  ++I E++         +         ++ E+ + 
Sbjct: 58  --HEKLVQLYGVC-----TKQRPI--FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 108

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF--DYDMMLTSVVVTLWYR 199
           + + +++L S + +HRDL  +N L+   G +K++DFGL++    D           + + 
Sbjct: 109 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 168

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRVIGTPSMNEWPE 258
            PE+L+   + +  DIW+ G +M E++ L    +   T  E  + I + +     +   E
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE 228

Query: 259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
                                     K  +++ S       +R +    L +
Sbjct: 229 --------------------------KVYTIMYSCWHEKADERPTFKILLSN 254

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 1e-45
 Identities = 53/291 (18%), Positives = 107/291 (36%), Gaps = 42/291 (14%)

Query: 22  KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT 81
            +   + +IG G +G V     L    + VA+K +R     +      + E  ++ +L  
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLS- 58

Query: 82  FEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQ 141
             HP +V+ + V  +          + L+FE ++    S   +      +A  +  +   
Sbjct: 59  --HPKLVQLYGVCLEQA-------PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 109

Query: 142 MLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF--DYDMMLTSVVVTLWYR 199
           + +G+ +L    +IHRDL  +N L+     +K++DFG+ +    D     T     + + 
Sbjct: 110 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 169

Query: 200 APEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN 259
           +PE+     Y +  D+WS G +M E++    +   +    +   +   I T      P  
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTGFRLYKPRL 226

Query: 260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
            S                      +    ++       P DR + +  L  
Sbjct: 227 AS----------------------THVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 2e-45
 Identities = 64/301 (21%), Positives = 113/301 (37%), Gaps = 40/301 (13%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIV 88
            IG G +G V++ +    +G  VA+K    +            EI     L    H NI+
Sbjct: 10  SIGKGRFGEVWRGKW---RGEEVAVKIFSSREERSWF---REAEIYQTVMLR---HENIL 60

Query: 89  RFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
            F    +++   +  +  ++L+ ++ +   L  Y+ +     ++   + +L      G+ 
Sbjct: 61  GFIAADNKD---NGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLA 114

Query: 148 FLHSH--------RIIHRDLKPQNLLITRAGGLKIADFGLAKTFD-----YDMMLTSVVV 194
            LH           I HRDLK +N+L+ + G   IAD GLA   D      D+     V 
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 195 TLWYRAPEILL------NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI 248
           T  Y APE+L       +       DI+++G V  E+ R   +     E  QL     V 
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233

Query: 249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL 308
             PS+ E  + +          ++        +       ++      N A R++A    
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSC----EALRVMAKIMRECWYANGAARLTALRIK 289

Query: 309 E 309
           +
Sbjct: 290 K 290

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-44
 Identities = 64/311 (20%), Positives = 112/311 (36%), Gaps = 50/311 (16%)

Query: 12  LNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNY-VAMKKLRVKLNEDGIPMSTL 70
           L+ + +   D        IG G +G V KAR  ++      A+K+++   ++D       
Sbjct: 7   LDWNDIKFQDV-------IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFA 58

Query: 71  REISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLI-----------FEHVDQDLG 119
            E+ +L +L    HPNI+               YL +                 ++ D  
Sbjct: 59  GELEVLCKLG--HHPNIINLLGACEHR---GYLYLAIEYAPHGNLLDFLRKSRVLETDPA 113

Query: 120 SYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL 179
             +       LS+ ++      + +G+D+L   + IHRDL  +N+L+      KIADFGL
Sbjct: 114 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 173

Query: 180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVE 239
           ++  +  +  T   + + + A E L    Y T  D+WS G ++ E+  L           
Sbjct: 174 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 233

Query: 240 QLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPA 299
           +L   +  +      E P N                         +   L+       P 
Sbjct: 234 EL---YEKLPQGYRLEKPLNCD----------------------DEVYDLMRQCWREKPY 268

Query: 300 DRISAADALEH 310
           +R S A  L  
Sbjct: 269 ERPSFAQILVS 279

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (383), Expect = 2e-44
 Identities = 59/305 (19%), Positives = 110/305 (36%), Gaps = 48/305 (15%)

Query: 15  DSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNY--VAMKKLRVKLNEDGIPMSTLRE 72
             +D+   K +++  IG G +G V              VA+K L+    E       L E
Sbjct: 21  KEIDISCVKIEQV--IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSE 77

Query: 73  ISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSA 132
            SI+ Q D   HPN++    V+ ++         V +I E ++        +      + 
Sbjct: 78  ASIMGQFD---HPNVIHLEGVVTKST-------PVMIITEFMENGSLDSFLRQNDGQFTV 127

Query: 133 SKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLTSV 192
            ++  + R +  G+ +L     +HRDL  +N+L+      K++DFGL++  + D    + 
Sbjct: 128 IQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 187

Query: 193 ------VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIF 245
                  + + + APE +    + +  D+WS G VM E+       +   T  + +  I 
Sbjct: 188 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247

Query: 246 RVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA 305
           +    P                            MDC S  + L+      +   R    
Sbjct: 248 QDYRLP--------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFG 281

Query: 306 DALEH 310
             +  
Sbjct: 282 QIVNT 286

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-44
 Identities = 53/293 (18%), Positives = 105/293 (35%), Gaps = 43/293 (14%)

Query: 24  YDELCQIGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLD 80
           + ++  +G GA+GTV+K   +         VA+K+LR   +        L E  ++  +D
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVD 69

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
              +P++ R   +   +        TV LI + +         +     + +  +     
Sbjct: 70  ---NPHVCRLLGICLTS--------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 118

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLW 197
           Q+ KG+++L   R++HRDL  +N+L+     +KI DFGLAK     + +       V + 
Sbjct: 119 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178

Query: 198 YRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP 257
           + A E +L+  Y    D+WS G  + E+              +   I  ++        P
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKGERLPQP 235

Query: 258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
              +                           ++      +   R    + +  
Sbjct: 236 PICT----------------------IDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (377), Expect = 1e-43
 Identities = 73/327 (22%), Positives = 127/327 (38%), Gaps = 68/327 (20%)

Query: 14  LDSLDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMST 69
           L SL+      + +  IG GA+G VF+AR            VA+K L+ + + D      
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADF 63

Query: 70  LREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKC--- 125
            RE +++ + D   +PNIV+   V             + L+FE++   DL  ++      
Sbjct: 64  QREAALMAEFD---NPNIVKLLGVCAVGK-------PMCLLFEYMAYGDLNEFLRSMSPH 113

Query: 126 -------------------PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLI 166
                               PP LS ++   + RQ+  G+ +L   + +HRDL  +N L+
Sbjct: 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV 173

Query: 167 TRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMA 223
                +KIADFGL++     DY     +  + + +  PE +    Y T  D+W+ G V+ 
Sbjct: 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233

Query: 224 EMW-RLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDC 282
           E++   +  +      E    +   +   ++   PEN  L                    
Sbjct: 234 EIFSYGLQPYYGMAHEE----VIYYVRDGNILACPENCPL-------------------- 269

Query: 283 CSKANSLLESMLTFNPADRISAADALE 309
             +  +L+    +  PADR S      
Sbjct: 270 --ELYNLMRLCWSKLPADRPSFCSIHR 294

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 2e-43
 Identities = 57/287 (19%), Positives = 103/287 (35%), Gaps = 43/287 (14%)

Query: 30  IGCGAYGTVFKARDLQNKGNY---VAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPN 86
           IG G +G V+K     + G     VA+K L+    E    +  L E  I+ Q     H N
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAGIMGQFS---HHN 70

Query: 87  IVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGV 146
           I+R   VI +          + +I E+++        +      S  ++  + R +  G+
Sbjct: 71  IIRLEGVISKYK-------PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123

Query: 147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF----DYDMMLTSVVVTLWYRAPE 202
            +L +   +HRDL  +N+L+      K++DFGL++      +     +   + + + APE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 203 ILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISL 262
            +    + +  D+WS G VM E+              +   + + I        P +   
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAINDGFRLPTPMDCP- 239

Query: 263 MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE 309
                                S    L+        A R   AD + 
Sbjct: 240 ---------------------SAIYQLMMQCWQQERARRPKFADIVS 265

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  145 bits (366), Expect = 4e-42
 Identities = 48/294 (16%), Positives = 87/294 (29%), Gaps = 47/294 (15%)

Query: 21  DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLD 80
              Y    +IG G++G +F+  +L N    VA+K    + +   +      E    K L 
Sbjct: 4   GVHYKVGRRIGEGSFGVIFEGTNLLN-NQQVAIKFEPRRSDAPQL----RDEYRTYKLLA 58

Query: 81  TFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTR 140
                  V +F     +           L+ + +   L   ++ C     S   V    +
Sbjct: 59  GCTGIPNVYYFGQEGLHN---------VLVIDLLGPSLEDLLDLCGRK-FSVKTVAMAAK 108

Query: 141 QMLKGVDFLHSHRIIHRDLKPQNLLITR-----AGGLKIADFGLAKTFDYD--------M 187
           QML  V  +H   +++RD+KP N LI R     A  + + DFG+ K +            
Sbjct: 109 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 168

Query: 188 MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRV 247
              ++  T  Y +    L        D+ ++G V     R    +         +   R+
Sbjct: 169 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228

Query: 248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADR 301
                     E                   +      +    +           
Sbjct: 229 GEKKQSTPLRE-------------------LCAGFPEEFYKYMHYARNLAFDAT 263

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-41
 Identities = 71/312 (22%), Positives = 130/312 (41%), Gaps = 59/312 (18%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQ------NKGNYVAMKKLRVKLNEDGIPMSTLREISIL 76
           +      +G GA+G V  A  +       N+   VA+K L+    E  +    + E+ ++
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMM 72

Query: 77  KQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPG------ 129
           K +   +H NI+       Q+         +Y+I E+  + +L  Y++   PPG      
Sbjct: 73  KMIG--KHKNIINLLGACTQDG-------PLYVIVEYASKGNLREYLQARRPPGLEYSYN 123

Query: 130 --------LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK 181
                   LS+  +     Q+ +G+++L S + IHRDL  +N+L+T    +KIADFGLA+
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183

Query: 182 TF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV 238
                DY    T+  + + + APE L +  Y    D+WS G ++ E++ L         V
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243

Query: 239 EQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNP 298
           E+L   F+++      + P N +                      ++   ++       P
Sbjct: 244 EEL---FKLLKEGHRMDKPSNCT----------------------NELYMMMRDCWHAVP 278

Query: 299 ADRISAADALEH 310
           + R +    +E 
Sbjct: 279 SQRPTFKQLVED 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 5e-41
 Identities = 63/331 (19%), Positives = 116/331 (35%), Gaps = 65/331 (19%)

Query: 3   EYSADTIQSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRV 58
           +   D       + L  G         +G GA+G V +A        +    VA+K L+ 
Sbjct: 11  QLPYDHKWEFPRNRLSFGKT-------LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 63

Query: 59  KLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQ-D 117
             +      + + E+ +L  L    H NIV                    +I E+    D
Sbjct: 64  SAHLTER-EALMSELKVLSYLG--NHMNIVNLLGACTIGG-------PTLVITEYCCYGD 113

Query: 118 LGSYMEKC----------------PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKP 161
           L +++ +                     L    +   + Q+ KG+ FL S   IHRDL  
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173

Query: 162 QNLLITRAGGLKIADFGLAKTF---DYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSI 218
           +N+L+T     KI DFGLA+        ++  +  + + + APE + N  Y    D+WS 
Sbjct: 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233

Query: 219 GCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAI 278
           G  + E++ L         V+     +++I        PE+                   
Sbjct: 234 GIFLWELFSLGSSPYPGMPVDSK--FYKMIKEGFRMLSPEHAP----------------- 274

Query: 279 FMDCCSKANSLLESMLTFNPADRISAADALE 309
                ++   ++++    +P  R +    ++
Sbjct: 275 -----AEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 6e-41
 Identities = 55/289 (19%), Positives = 102/289 (35%), Gaps = 44/289 (15%)

Query: 30  IGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNI 87
           IG G +G V+    L N G   + A+K L  ++ + G     L E  I+K      HPN+
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFS---HPNV 90

Query: 88  VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVD 147
           +    +  +     E      ++  ++         +      +   +     Q+ KG+ 
Sbjct: 91  LSLLGICLR----SEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144

Query: 148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK-----TFDYDMMLTSVVVTLWYRAPE 202
           FL S + +HRDL  +N ++     +K+ADFGLA+      FD     T   + + + A E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 203 ILLNLGYGTPVDIWSIGCVMAEMW-RLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS 261
            L    + T  D+WS G ++ E+  R  P +      +    + +          P+   
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD--- 261

Query: 262 LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH 310
                                      ++          R S ++ +  
Sbjct: 262 -----------------------PLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 1e-39
 Identities = 59/309 (19%), Positives = 120/309 (38%), Gaps = 44/309 (14%)

Query: 22  KKYDELCQIGCGAYGTVFKARD----LQNKGNYVAMKKLRVKLNEDGIPMSTLREISILK 77
           +K     ++G G++G V++              VA+K +    +     +  L E S++K
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASVMK 78

Query: 78  QLDTFEHPNIVRFFDVIH--QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKV 135
           + +     ++VR   V+   Q  L     +T   +  ++     +          S SK+
Sbjct: 79  EFN---CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 136 KELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYDMMLTSV 192
            ++  ++  G+ +L++++ +HRDL  +N ++     +KI DFG+ +     DY       
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 193 VVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS 252
           ++ + + +PE L +  + T  D+WS G V+ E+  L          EQ   + R +    
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLRFVMEGG 252

Query: 253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE--- 309
           + + P+N                             L+     +NP  R S  + +    
Sbjct: 253 LLDKPDNCP----------------------DMLFELMRMCWQYNPKMRPSFLEIISSIK 290

Query: 310 ---HPYFKE 315
               P F+E
Sbjct: 291 EEMEPGFRE 299

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 4e-38
 Identities = 55/304 (18%), Positives = 113/304 (37%), Gaps = 43/304 (14%)

Query: 23  KYDELCQIGCGAYGTVFKARDLQNK----GNYVAMKKLRVKLNEDGIPMSTLREISILKQ 78
           +      +G GA+G V +A             VA+K L+          + + E+ IL  
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIH 72

Query: 79  LDTFEHPNIVRFFDVIHQ---NILSDERYLTVYLIFEHVDQDLGSYMEKCPPPG------ 129
           +    H N+V       +    ++    +     +  ++      ++     P       
Sbjct: 73  IG--HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 130 LSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTF---DYD 186
           L+   +   + Q+ KG++FL S + IHRDL  +N+L++    +KI DFGLA+        
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 187 MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR 246
           +      + L + APE + +  Y    D+WS G ++ E++ L        ++++     R
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR 248

Query: 247 VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD 306
            +   +    P+  +                       +    +       P+ R + ++
Sbjct: 249 RLKEGTRMRAPDYTT----------------------PEMYQTMLDCWHGEPSQRPTFSE 286

Query: 307 ALEH 310
            +EH
Sbjct: 287 LVEH 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 96.4 bits (239), Expect = 1e-24
 Identities = 30/206 (14%), Positives = 59/206 (28%), Gaps = 31/206 (15%)

Query: 29  QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-----GIPMSTLREISILKQLDTFE 83
            +G G    VF       K     +K  +V                L    +  +    E
Sbjct: 7   LMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 84  HPNIVRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQML 143
              + +        +     +    ++ E +D      +    P         E+   +L
Sbjct: 65  FRALQKLQ---GLAVPKVYAWEGNAVLMELIDAKELYRVRVENP--------DEVLDMIL 113

Query: 144 KGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMMLT-----SVVVTLWY 198
           + V   +   I+H DL   N+L++   G+ I DF  +     +            +  ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172

Query: 199 RAPEILLNLGYGTPVDIWSIGCVMAE 224
                     Y T  DI S    + +
Sbjct: 173 SRT-------YRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	321
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.91
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.51
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.4
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.68
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.55
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.15

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-63  Score=416.53  Aligned_cols=296  Identities=52%  Similarity=0.956  Sum_probs=254.4

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      .++|++++.||+|+||+||+|++...+++.||+|+++.............+|+.+++.+...+||||++++++|....  
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~--   83 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR--   83 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE--
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc--
Confidence            479999999999999999999995556788999999877666666667889999999987777999999999986542  


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                      .......++++|++.+.+..+........+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence            22335789999999987766666656667999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         181 KTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      .............||+.|+|||++.+.+++.++||||+||++|+|++|+.||.+.+..+....+....+.+....++...
T Consensus       164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (305)
T d1blxa_         164 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  243 (305)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             hhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence            87766666677889999999999999999999999999999999999999999999999999999999988877776655


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         261 SLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ......+..............+++.+.+||++||++||++|||++|+|+||||+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            4443333333344445556678899999999999999999999999999999998754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-62  Score=402.03  Aligned_cols=258  Identities=30%  Similarity=0.464  Sum_probs=214.0

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||+|++...... .....+.+|+.++++++   ||||+++++++.+.    
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~-~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~---HpnIv~~~~~~~~~----   75 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVN-RVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLN---HENVVKFYGHRREG----   75 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECC--------CHHHHHHHHHTCC---CTTBCCEEEEEEET----
T ss_pred             cceEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCC---CCCEeeEeeeeccC----
Confidence            5799999999999999999999 678999999999765332 23457889999999998   99999999999887    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ..+++||||+.| +|.+++..  ...+++..++.++.||+.||+|||++|++||||||+||++++++.+||+|||++
T Consensus        76 ---~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a  150 (271)
T d1nvra_          76 ---NIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA  150 (271)
T ss_dssp             ---TEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ---ceeEEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhh
Confidence               788999999995 99999976  445999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC---ccccccccccccchhhhhcCCC-CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         181 KTFDYDM---MLTSVVVTLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       181 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      .......   ......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.................  ..   
T Consensus       151 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~--~~---  225 (271)
T d1nvra_         151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TY---  225 (271)
T ss_dssp             EECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC--TT---
T ss_pred             eeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CC---
Confidence            8764332   2345679999999999998876 6789999999999999999999977554333222222111  10   


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                                         ......+++++.+||++||+.||++|||++|+++||||++.-
T Consensus       226 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         226 -------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             -------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             -------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence                               011235678999999999999999999999999999998653

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-61  Score=403.48  Aligned_cols=260  Identities=27%  Similarity=0.465  Sum_probs=224.1

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      .....++|++++.||+|+||+||+|++ ..+++.||+|++.....  .....+.+|+.++++++   ||||+++++++.+
T Consensus        15 ~~dp~~~Y~~~~~iG~G~fg~Vy~a~~-~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~---HpnIv~~~~~~~~   88 (293)
T d1yhwa1          15 VGDPKKKYTRFEKIGQGASGTVYTAMD-VATGQEVAIRQMNLQQQ--PKKELIINEILVMRENK---NPNIVNYLDSYLV   88 (293)
T ss_dssp             SSCTTTTBCSCEECCCSSSCEEEEEEB-TTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCC---CTTBCCEEEEEEE
T ss_pred             CCCcccccEEEEEEecCcCcEEEEEEE-CCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCC---CCCEeeEeEEEEE
Confidence            333467899999999999999999999 57899999999876532  23456889999999998   9999999999988


Q ss_pred             cccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ..+|+||||++| +|.+++..   +.+++.+++.++.||+.||+|||++|++||||||+||+++.++++||+
T Consensus        89 ~-------~~~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~  158 (293)
T d1yhwa1          89 G-------DELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLT  158 (293)
T ss_dssp             T-------TEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             C-------CEEEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeec
Confidence            7       688999999995 99998876   348999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         176 DFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       176 dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      |||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..... +...
T Consensus       159 DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~~  237 (293)
T d1yhwa1         159 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQ  237 (293)
T ss_dssp             CCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCCS
T ss_pred             cchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCC
Confidence            999998775433 44566799999999999999999999999999999999999999998887777666554321 1111


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .                       ...+++++++||++||++||.+|||++|+|+||||+..
T Consensus       238 ~-----------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         238 N-----------------------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             S-----------------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             C-----------------------cccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            1                       12566899999999999999999999999999999854

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-62  Score=401.07  Aligned_cols=253  Identities=31%  Similarity=0.481  Sum_probs=220.3

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++.+.||+|+||+||+|++ ..+++.||+|++..... .......+.+|+.++++++   ||||+++++++.+.   
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~~~~~~~~~---   78 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLARE-KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR---HPNILRLYGYFHDA---   78 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC---CTTBCCEEEEEECS---
T ss_pred             hHeEEEEEEecCCCcEEEEEEE-CCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC---CCCCCeEEEEEEEC---
Confidence            5799999999999999999999 68899999999875432 2334556788999999998   99999999999887   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..+++||||++ |+|.+++...  ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus        79 ----~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~  152 (263)
T d2j4za1          79 ----TRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW  152 (263)
T ss_dssp             ----SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred             ----CEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccce
Confidence                78999999999 5999999873  4599999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      +...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....  +.   +|  
T Consensus       153 a~~~~~~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~---~p--  224 (263)
T d2j4za1         153 SVHAPSS-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FT---FP--  224 (263)
T ss_dssp             CSCCCCC-CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CC---CC--
T ss_pred             eeecCCC-cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CC---CC--
Confidence            9776533 3345679999999999999999999999999999999999999999888777766654321  11   11  


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                                          ..+++++.+||.+||++||.+|||++|+|+||||++
T Consensus       225 --------------------~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         225 --------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             --------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             --------------------ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                                245689999999999999999999999999999974

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-61  Score=405.51  Aligned_cols=261  Identities=29%  Similarity=0.419  Sum_probs=207.7

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ...++|++.+.||+|+||+||+|++ ..+++.||+|++....... ....+.+|+.++++++   ||||+++++++.+. 
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~-~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~-   79 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAED-KRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIK---HPNIVALDDIYESG-   79 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEE-TTTCCEEEEEEEEC-----------CHHHHHHHTCC---CTTBCCEEEEEECS-
T ss_pred             CCccceEEEEEEeeccCeEEEEEEE-CCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCC---CCCCCcEEEEEEEC-
Confidence            3457899999999999999999999 5789999999997654332 2446778999999998   99999999999887 


Q ss_pred             cccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe---eCCCEEE
Q psy2676          99 LSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT---RAGGLKI  174 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~---~~~~~kl  174 (321)
                            ..+|+||||++ |+|.+++..  .+.+++..++.++.||+.||+|||++|++||||||+||++.   +++.+||
T Consensus        80 ------~~~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl  151 (307)
T d1a06a_          80 ------GHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMI  151 (307)
T ss_dssp             ------SEEEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             ------CEEEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEE
Confidence                  78899999999 599999987  44599999999999999999999999999999999999995   4788999


Q ss_pred             eecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         175 ADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       175 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      +|||++.............||+.|+|||++.+..++.++||||+||++|+|++|..||.+....+....+.......+.+
T Consensus       152 ~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  231 (307)
T d1a06a_         152 SDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP  231 (307)
T ss_dssp             CCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTT
T ss_pred             eccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCc
Confidence            99999987766666666789999999999999999999999999999999999999999888777776665533222211


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .                       ..++|+++.+||++||.+||.+|||++|+++||||++.
T Consensus       232 ~-----------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         232 Y-----------------------WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             T-----------------------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             c-----------------------ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            1                       23567899999999999999999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-61  Score=402.34  Aligned_cols=261  Identities=26%  Similarity=0.454  Sum_probs=223.4

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      .++|++++.||+|+||+||+|++ ..+++.||+|++..... .......+.+|++++++++   ||||+++++++.+.  
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~--   80 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARE-LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD---HPFFVKLYFTFQDD--   80 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC---STTBCCEEEEEECS--
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC---CCCeeEEEEEEEEC--
Confidence            36799999999999999999999 57899999999976432 2334557889999999998   99999999999887  


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ..+|+||||++| +|.+++...  +.+++..++.++.||+.||+|||++|++||||||+||++++++.+||+|||
T Consensus        81 -----~~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG  153 (288)
T d1uu3a_          81 -----EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG  153 (288)
T ss_dssp             -----SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             -----CEEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccc
Confidence                 788999999995 999998873  459999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         179 LAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       179 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...++....  +   .
T Consensus       154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--~---~  228 (288)
T d1uu3a_         154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--Y---D  228 (288)
T ss_dssp             TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--C---C
T ss_pred             cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC--C---C
Confidence            998765332   2334679999999999999999999999999999999999999999988877777665421  1   1


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHH------HhCCCCCCCCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD------ALEHPYFKEKENEPL  321 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~------ll~h~~f~~~~~~~~  321 (321)
                      ++                      ..+++++++||++||..||.+|||++|      +++||||++++|+.|
T Consensus       229 ~p----------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l  278 (288)
T d1uu3a_         229 FP----------------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  278 (288)
T ss_dssp             CC----------------------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             CC----------------------ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence            11                      245689999999999999999999998      588999999998754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-60  Score=400.00  Aligned_cols=264  Identities=30%  Similarity=0.481  Sum_probs=225.4

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCC----CCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDG----IPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ..++|++.+.||+|+||+||+|++ ..+++.||+|++........    ....+.+|+.++++++   ||||+++++++.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~-~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~~~~~~~   83 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCRE-KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ---HPNVITLHEVYE   83 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC---CTTBCCEEEEEE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEE-CCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC---CCCCCcEEEEEE
Confidence            357899999999999999999999 68899999999976543322    2345778999999998   999999999998


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC----
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG----  170 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~----  170 (321)
                      +.       ..+++|||||. |+|.+++...  +.+++..++.++.||+.||+|||++|++||||||+||+++.++    
T Consensus        84 ~~-------~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~  154 (293)
T d1jksa_          84 NK-------TDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP  154 (293)
T ss_dssp             CS-------SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSC
T ss_pred             EC-------CEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCccc
Confidence            87       78999999999 5999999873  4599999999999999999999999999999999999998776    


Q ss_pred             CEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCC
Q psy2676         171 GLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       171 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      .+||+|||++.............+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+......
T Consensus       155 ~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~  234 (293)
T d1jksa_         155 RIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE  234 (293)
T ss_dssp             CEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC
T ss_pred             ceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC
Confidence            49999999998887666666778899999999999999999999999999999999999999988887777665542111


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      .                       ......++|+++.+||++||..||.+|||++|+++||||++.+++
T Consensus       235 ~-----------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~  280 (293)
T d1jksa_         235 F-----------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ  280 (293)
T ss_dssp             C-----------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred             C-----------------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence            1                       011234677899999999999999999999999999999988764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-60  Score=398.82  Aligned_cols=286  Identities=45%  Similarity=0.819  Sum_probs=240.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||+|+++...........+.+|++++++++   ||||+++++++.+.    
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~---Hp~Iv~~~~~~~~~----   73 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN---HPNIVKLLDVIHTE----   73 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEEC-------CCHHHHHHHHHHTTCC---CTTBCCEEEEEEET----
T ss_pred             CCCEeccEEecCcCeEEEEEEE-CCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC---CCcEEEeccccccc----
Confidence            5899999999999999999999 578899999999766544455668889999999998   99999999999887    


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                         ..+|+|||++.+++..++.......+++..++.++.||+.||.|||++|++||||||+||+++.++++||+|||.+.
T Consensus        74 ---~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~  150 (298)
T d1gz8a_          74 ---NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR  150 (298)
T ss_dssp             ---TEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred             ---cceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcce
Confidence               78999999999988888877666679999999999999999999999999999999999999999999999999997


Q ss_pred             cccCC-CccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         182 TFDYD-MMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       182 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ..... .......+|+.|+|||++.... .+.++||||+|+++|+|++|+.||.+.+..+....+....+.+....++..
T Consensus       151 ~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         151 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             HHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             eccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence            76543 3444568899999999987766 588999999999999999999999999999999999988888777666543


Q ss_pred             hhhh--hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         260 ISLM--WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       260 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ....  ..................+++++.+||++||..||.+|||+.|+++||||++...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence            2211  1122223333444555678899999999999999999999999999999998754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-61  Score=399.09  Aligned_cols=259  Identities=27%  Similarity=0.453  Sum_probs=219.4

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      +.|++++.||+|+||+||+|++ ..+++.||+|++....  ......+.+|++++++++   ||||+++++++.+.    
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~-~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~----   81 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQN-KETSVLAAAKVIDTKS--EEELEDYMVEIDILASCD---HPNIVKLLDAFYYE----   81 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCC---CTTBCCEEEEEEET----
T ss_pred             cCeEEeEEEeeCCCcEEEEEEE-CCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCC---CCCCCeEEEEEeeC----
Confidence            5799999999999999999999 6889999999987542  233457889999999998   99999999999887    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ..+++||||+. |+|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++++||+|||++
T Consensus        82 ---~~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a  157 (288)
T d2jfla1          82 ---NNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVS  157 (288)
T ss_dssp             ---TEEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ---CeEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhh
Confidence               68899999999 49999876543 34999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCC-ccccccccccccchhhhh-----cCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILL-----NLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      ....... ......||+.|+|||++.     +..++.++||||+||++|+|++|+.||.+.+..+...++....  ++..
T Consensus       158 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~~~~  235 (288)
T d2jfla1         158 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--PPTL  235 (288)
T ss_dssp             EECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--CCCC
T ss_pred             hccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CCCC
Confidence            7654322 234567899999999984     4457899999999999999999999999888777776665432  1111


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      ..                      ...+++++.+||++||+.||.+|||++|+++||||+....
T Consensus       236 ~~----------------------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~~  277 (288)
T d2jfla1         236 AQ----------------------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN  277 (288)
T ss_dssp             SS----------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCCC
T ss_pred             Cc----------------------cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            11                      1256689999999999999999999999999999986543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-60  Score=407.33  Aligned_cols=261  Identities=24%  Similarity=0.401  Sum_probs=226.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||+|++......  ....+.+|+.++++++   ||||+++++++.+.    
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~-~~~g~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~---HpnIv~~~~~~~~~----   95 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTE-RATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLR---HPTLVNLHDAFEDD----   95 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEE-TTTTEEEEEEEECCCSHH--HHHHHHHHHHHHHHTC---CTTBCCEEEEEEET----
T ss_pred             cCeEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEEcccchh--hHHHHHHHHHHHHhCC---CCCCCcEEEEEEEC----
Confidence            5899999999999999999999 688999999998654221  2346778999999998   99999999999887    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee--CCCEEEeecC
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR--AGGLKIADFG  178 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~--~~~~kl~dfg  178 (321)
                         ..+++||||++ |+|.+++.... +.+++..++.++.||+.||.|||++|++||||||+||+++.  ++.+||+|||
T Consensus        96 ---~~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG  171 (350)
T d1koaa2          96 ---NEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG  171 (350)
T ss_dssp             ---TEEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred             ---CEEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecc
Confidence               78999999999 59999986543 34999999999999999999999999999999999999964  5789999999


Q ss_pred             CcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      ++.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.......+..    
T Consensus       172 ~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~----  247 (350)
T d1koaa2         172 LTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS----  247 (350)
T ss_dssp             TCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG----
T ss_pred             hheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc----
Confidence            9998877776777889999999999999999999999999999999999999999988888877776543222211    


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                                         ....+++++++||++||.+||++|||++|+|+||||++.++.
T Consensus       248 -------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         248 -------------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             -------------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             -------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence                               123567899999999999999999999999999999977543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-62  Score=412.10  Aligned_cols=288  Identities=24%  Similarity=0.400  Sum_probs=218.4

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecc
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQN   97 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~   97 (321)
                      ++..++|++++.||+|+||+||+|++ ..+++.||+|+++.... ......+.+|+.++++++   ||||++++++|.+.
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~-~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~   76 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSH-KPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECN---SPYIVGFYGAFYSD   76 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEE-TTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCC---CTTBCCEEEEEECS
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEE-CCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCC---CCCCCcEEEEEEEC
Confidence            56788999999999999999999999 68899999999976432 223446778999999887   99999999999887


Q ss_pred             ccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeeCCCEEEe
Q psy2676          98 ILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        98 ~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                             ..+++||||+.| +|.+++...  +.+++..++.++.||+.||.|||+ +||+||||||+||+++.++++||+
T Consensus        77 -------~~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~  147 (322)
T d1s9ja_          77 -------GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC  147 (322)
T ss_dssp             -------SEEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEEC
T ss_pred             -------CEEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEe
Confidence                   679999999995 999999873  459999999999999999999997 599999999999999999999999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHH-HHHhCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCI-FRVIGTPSMN  254 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~  254 (321)
                      |||+|...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+..... ....+.+...
T Consensus       148 DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  226 (322)
T d1s9ja_         148 DFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET  226 (322)
T ss_dssp             CCCCCHHHHHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred             eCCCccccCCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence            99999866432 234568999999999999999999999999999999999999999876543322111 1111110000


Q ss_pred             ----Ccchhhhhh-----------hhhhhhhhhhhhhh-hhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         255 ----EWPENISLM-----------WSSFEQYSKVAFSA-IFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       255 ----~~~~~~~~~-----------~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                          ..+......           ............+. ....++.++.+||++||..||.+|||++|+|+||||++.++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~  306 (322)
T d1s9ja_         227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  306 (322)
T ss_dssp             -------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             CcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence                000000000           00000000000000 11236789999999999999999999999999999987655


Q ss_pred             CC
Q psy2676         319 EP  320 (321)
Q Consensus       319 ~~  320 (321)
                      +.
T Consensus       307 ~~  308 (322)
T d1s9ja_         307 EE  308 (322)
T ss_dssp             SC
T ss_pred             cc
Confidence            43

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.3e-60  Score=405.63  Aligned_cols=258  Identities=28%  Similarity=0.472  Sum_probs=225.3

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||+|++......  ....+.+|+.++++++   ||||++++++|.+.    
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~-~~~~~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~---HpnIv~~~~~~~~~----   98 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVE-KATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLH---HPKLINLHDAFEDK----   98 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCC---STTBCCEEEEEECS----
T ss_pred             cceEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEECCcchh--HHHHHHHHHHHHHhCC---CCCCCcEEEEEEEC----
Confidence            5799999999999999999999 578999999998754221  1345678999999987   99999999999887    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe--eCCCEEEeecC
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT--RAGGLKIADFG  178 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~--~~~~~kl~dfg  178 (321)
                         ..+++|||||+ |+|.+.+.... ..+++.+++.++.||+.||.|||++|++||||||+||+++  .++.+||+|||
T Consensus        99 ---~~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFG  174 (352)
T d1koba_          99 ---YEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG  174 (352)
T ss_dssp             ---SEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             ---CEEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecc
Confidence               78899999999 59998876643 3499999999999999999999999999999999999997  56889999999


Q ss_pred             CcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcch
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPE  258 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (321)
                      ++.............+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......+...   
T Consensus       175 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~---  251 (352)
T d1koba_         175 LATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA---  251 (352)
T ss_dssp             TCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST---
T ss_pred             cceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc---
Confidence            99988877767778899999999999999999999999999999999999999999888888877766433322222   


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         259 NISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                                          ...+++++.+||++||++||.+|||++|+|+||||++.
T Consensus       252 --------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         252 --------------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             --------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             --------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                                23567899999999999999999999999999999865

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-60  Score=390.81  Aligned_cols=259  Identities=28%  Similarity=0.415  Sum_probs=211.0

Q ss_pred             Ccce-eeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          21 DKKY-DELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        21 ~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      .+|| ++.++||+|+||+||+|++ ..+++.||+|++............+.+|++++++++   ||||+++++++.+.. 
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~-~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~~~~~~~~~~-   81 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLD-TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ---HPNIVRFYDSWESTV-   81 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC---CTTBCCEEEEEEEES-
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEE-CCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC---CCCeeeEEEEEeecc-
Confidence            3455 7888999999999999999 678899999998765443333456778999999988   999999999986641 


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEe-eCCCEEEe
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR--IIHRDLKPQNLLIT-RAGGLKIA  175 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~--~~H~di~p~Nilv~-~~~~~kl~  175 (321)
                        .....+++||||+++ +|.+++...  ..+++..++.++.||+.||+|||++|  ++||||||+||+++ +++.+||+
T Consensus        82 --~~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~  157 (270)
T d1t4ha_          82 --KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG  157 (270)
T ss_dssp             --SSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             --ccCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence              222568999999995 999999873  45899999999999999999999998  99999999999996 57899999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      |||++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||..........+.....  .... 
T Consensus       158 DFGla~~~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~--~~~~-  232 (270)
T d1t4ha_         158 DLGLATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--VKPA-  232 (270)
T ss_dssp             CTTGGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT--CCCG-
T ss_pred             ecCcceeccC-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC--CCCc-
Confidence            9999976543 33445689999999998865 58999999999999999999999998765444333222111  1111 


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFK  314 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~  314 (321)
                                           .....+++++.+||++||++||++|||++|+|+||||+
T Consensus       233 ---------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         233 ---------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             ---------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ---------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                                 11234668899999999999999999999999999997

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.6e-59  Score=387.71  Aligned_cols=260  Identities=29%  Similarity=0.468  Sum_probs=225.2

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCC-------chhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIP-------MSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~-------~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      .++|++.+.||+|+||+||+|++ ..+++.||+|++..........       ..+.+|+.+++++..  ||||++++++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~--hpnIv~~~~~   78 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIH-KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG--HPNIIQLKDT   78 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTT--CTTBCCEEEE
T ss_pred             cccCEEceEEecCcCeEEEEEEE-CCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcC--CCCeEEEEee
Confidence            46899999999999999999999 6789999999998754333221       246789999999975  9999999999


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +.++       ..+|+||||++ |+|.+++..  .+.+++.+++.++.||+.||+|||++|++||||||+||+++.++.+
T Consensus        79 ~~~~-------~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~  149 (277)
T d1phka_          79 YETN-------TFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNI  149 (277)
T ss_dssp             EECS-------SEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred             cccC-------cceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCe
Confidence            9887       78999999998 599999987  3459999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCCccccccccccccchhhhhc------CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q psy2676         173 KIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLN------LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFR  246 (321)
Q Consensus       173 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  246 (321)
                      ||+|||++...+.........||+.|.|||.+.+      ..++.++||||+||++|+|++|+.||.+.+..+....+..
T Consensus       150 kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~  229 (277)
T d1phka_         150 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  229 (277)
T ss_dssp             EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh
Confidence            9999999998876666666789999999999864      3368899999999999999999999999988887777766


Q ss_pred             HhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         247 VIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      ....++...                       ..++|+++++||.+||++||++|||++|+++||||++
T Consensus       230 ~~~~~~~~~-----------------------~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         230 GNYQFGSPE-----------------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             TCCCCCTTT-----------------------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CCCCCCCcc-----------------------cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            432222221                       2367799999999999999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-60  Score=400.27  Aligned_cols=259  Identities=26%  Similarity=0.421  Sum_probs=225.7

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      -++|++++.||+|+||+||+|++ ..+++.||+|++++... .......+.+|+.++++++   ||||+++++++.+.  
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~-~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~--   77 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVRE-KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFLTALKYAFQTH--   77 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC---CTTBCCEEEEEECS--
T ss_pred             hHhcEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC---CCCEEEEEeeeccc--
Confidence            46899999999999999999999 68899999999976532 2334556788999999998   99999999999888  


Q ss_pred             ccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ..+|+||||+. |+|.+++..  ...+++..++.++.||+.||+|||++|++||||||+||+++.+|.+||+|||
T Consensus        78 -----~~~~iv~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG  150 (337)
T d1o6la_          78 -----DRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG  150 (337)
T ss_dssp             -----SEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             -----cccccceeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecc
Confidence                 78999999999 599999988  4458999999999999999999999999999999999999999999999999


Q ss_pred             CcccccC-CCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         179 LAKTFDY-DMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       179 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      ++..... ........||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+....  +.   +|
T Consensus       151 ~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~~---~p  225 (337)
T d1o6la_         151 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IR---FP  225 (337)
T ss_dssp             TCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CC---CC
T ss_pred             cccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--CC---CC
Confidence            9987643 334456789999999999999999999999999999999999999999988877776665422  11   11


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKENE  319 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~~  319 (321)
                                            ..+++++++||++||++||.+|++     +.++++||||++.+|+
T Consensus       226 ----------------------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~  270 (337)
T d1o6la_         226 ----------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             ----------------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ----------------------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence                                  245689999999999999999994     9999999999987653

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-59  Score=396.22  Aligned_cols=281  Identities=38%  Similarity=0.723  Sum_probs=230.2

Q ss_pred             eeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC---CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccc
Q psy2676          26 ELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED---GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDE  102 (321)
Q Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~  102 (321)
                      .++.||+|+||+||+|++ ..+++.||+|+++......   .....+.+|+.++++++   ||||+++++++.+.     
T Consensus         2 ~l~~lG~G~fg~Vy~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~~~~~~~~~-----   72 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARD-KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS---HPNIIGLLDAFGHK-----   72 (299)
T ss_dssp             EEEEEEEETTEEEEEEEC-SSCCSEEEEEEC------------CTHHHHHHHHHHHCC---CTTBCCEEEEECCT-----
T ss_pred             cceEeccCcCeEEEEEEE-CCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC---CCCEeEEEeeeccC-----
Confidence            468999999999999999 5789999999987653322   22456889999999998   99999999999877     


Q ss_pred             cceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         103 RYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       103 ~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                        ..+++||||+.+.+...+... ...+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.+..
T Consensus        73 --~~~~ivmE~~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~  149 (299)
T d1ua2a_          73 --SNISLVFDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS  149 (299)
T ss_dssp             --TCCEEEEECCSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             --CceeehhhhhcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccc
Confidence              678999999997555555443 34599999999999999999999999999999999999999999999999999977


Q ss_pred             ccCCC-ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhh
Q psy2676         183 FDYDM-MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENI  260 (321)
Q Consensus       183 ~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (321)
                      ..... ......+|+.|+|||++... .++.++||||+||++|+|++|.+||.+.+..+.+.++.+..+.+....++...
T Consensus       150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~  229 (299)
T d1ua2a_         150 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  229 (299)
T ss_dssp             TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             cCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchh
Confidence            65433 33456789999999998755 47999999999999999999999999999999999999999988887776544


Q ss_pred             hhhh-hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         261 SLMW-SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       261 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      .... .................+++++.+||++||+.||++|||++|+|+||||++.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence            3221 111222223344455678899999999999999999999999999999998754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-60  Score=392.59  Aligned_cols=257  Identities=29%  Similarity=0.491  Sum_probs=206.1

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||+|++............+.+|++++++++   ||||+++++++.+..   
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~~~~~~~~~~---   76 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRR-KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK---HPNIVRYYDRIIDRT---   76 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCC---CTTBCCEEEEEEC-----
T ss_pred             hhCEEeEEEecCCCeEEEEEEE-CCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCC---CCCEeeEEEEEEeCC---
Confidence            5799999999999999999999 688999999999765433333445778999888887   999999999986531   


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCcEEEeeCCCEE
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKC--PPPGLSASKVKELTRQMLKGVDFLHSHR-----IIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lh~~~-----~~H~di~p~Nilv~~~~~~k  173 (321)
                        ...+|+|||||+ |+|.+++...  ....+++..++.++.||+.||.|||++|     ++||||||+||+++.++.+|
T Consensus        77 --~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          77 --NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred             --CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence              145799999999 5999998642  2345999999999999999999999876     99999999999999999999


Q ss_pred             EeecCCcccccCCC-ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         174 IADFGLAKTFDYDM-MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       174 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+ 
T Consensus       155 l~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~-  233 (269)
T d2java1         155 LGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR-  233 (269)
T ss_dssp             ECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-
T ss_pred             EeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence            99999998765433 3345788999999999999999999999999999999999999999888877776665432111 


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                         .                      ...+|+++.+||++||+.||.+|||++|+++|||+
T Consensus       234 ---~----------------------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         234 ---I----------------------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ---C----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ---C----------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence               1                      12456899999999999999999999999999995

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.2e-59  Score=393.65  Aligned_cols=256  Identities=28%  Similarity=0.453  Sum_probs=223.6

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||+|+++.... .......+.+|+.++++++   ||||+++++++.+.   
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~~~~~~~~~---   76 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRS-RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT---HPFIIRMWGTFQDA---   76 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC---BTTBCCEEEEEECS---
T ss_pred             hHeEEEEEEecCcCcEEEEEEE-CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc---CcChhheeeeEeeC---
Confidence            5799999999999999999999 68899999999976432 2334556788999999998   99999999999887   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..+|+||||+.| +|..++..  ...+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus        77 ----~~~~ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~  150 (316)
T d1fota_          77 ----QQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF  150 (316)
T ss_dssp             ----SEEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             ----CeeeeEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCcc
Confidence                789999999995 88888887  44489999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      +......  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++......     ++  
T Consensus       151 a~~~~~~--~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-----~p--  221 (316)
T d1fota_         151 AKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR-----FP--  221 (316)
T ss_dssp             CEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC-----CC--
T ss_pred             ceEeccc--cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC-----CC--
Confidence            9876533  34568999999999999999999999999999999999999999998888887776653211     11  


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                                          ..+++++.++|++||..||.+|+     |++++++||||++.+|+
T Consensus       222 --------------------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         222 --------------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             --------------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             --------------------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence                                13558899999999999999996     99999999999998765

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-59  Score=395.29  Aligned_cols=257  Identities=26%  Similarity=0.424  Sum_probs=216.0

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ...+|++++.||+|+||+||+|++ ..+++.||+|++....... .....+.+|+.++++++   ||||+++++++.+. 
T Consensus        13 p~~~y~~l~~lG~G~fg~Vy~a~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~~~~~~~~~-   87 (309)
T d1u5ra_          13 PEKLFSDLREIGHGSFGAVYFARD-VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR---HPNTIQYRGCYLRE-   87 (309)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEE-TTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC---CTTBCCEEEEEEET-
T ss_pred             cHHhcEeeEEEecCCCeEEEEEEE-CCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC---CCCEeeEEEEEEEC-
Confidence            446799999999999999999999 6889999999987543221 12235778999999988   99999999999877 


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                            ..+++|||||.+ +|..++..  ...+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+||
T Consensus        88 ------~~~~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DF  159 (309)
T d1u5ra_          88 ------HTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF  159 (309)
T ss_dssp             ------TEEEEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCC
T ss_pred             ------CEEEEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeec
Confidence                  688999999996 66655555  345999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhc---CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLN---LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      |++......   ....||+.|+|||++.+   ..++.++|||||||++|+|++|..||.+.+..+....+......+...
T Consensus       160 G~a~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  236 (309)
T d1u5ra_         160 GSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS  236 (309)
T ss_dssp             TTCBSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred             ccccccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC
Confidence            999865532   35679999999999864   347899999999999999999999999888877776665532221111


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                                               ..+|+++.+||++||+.||.+|||++|+|+||||++..
T Consensus       237 -------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         237 -------------------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             -------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             -------------------------CCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence                                     24568999999999999999999999999999997643

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.2e-58  Score=387.45  Aligned_cols=281  Identities=47%  Similarity=0.852  Sum_probs=234.1

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++++.||+|+||+||+|++  .+++.||+|++............+.+|+.++++++   ||||+++++++.+.    
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~~~~~~~~~----   72 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKELK---HSNIVKLYDVIHTK----   72 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE--TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC---CTTBCCEEEEEECS----
T ss_pred             CCceeccEEecCCCcEEEEEEe--CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC---CCcEEeeeeecccC----
Confidence            6999999999999999999998  47899999999776555555678889999999998   99999999999887    


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                         ...++++|++.+.+...+.... +.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+.
T Consensus        73 ---~~~~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~  148 (286)
T d1ob3a_          73 ---KRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR  148 (286)
T ss_dssp             ---SCEEEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred             ---CceeEEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccce
Confidence               6789999999986666665543 459999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCc-cccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         182 TFDYDMM-LTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       182 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      ....... .....+++.|.|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+...++....+.+....++..
T Consensus       149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         149 AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (286)
T ss_dssp             HHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch
Confidence            7654332 34456889999999987654 699999999999999999999999999999999999999998888777654


Q ss_pred             hhhhh--hhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCC
Q psy2676         260 ISLMW--SSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKE  315 (321)
Q Consensus       260 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~  315 (321)
                      .....  .................+++.+.+||++||++||++|||++|+++||||++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            33221  111222223344455678899999999999999999999999999999985

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.6e-59  Score=400.62  Aligned_cols=264  Identities=25%  Similarity=0.363  Sum_probs=217.2

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCC-CCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNE-DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      -++|++++.||+|+||+||+|++ ..+++.||+|++...... ......+.+|..+++.+...+||||+++++++.+.  
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~-~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--   79 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRK-ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--   79 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--
T ss_pred             HHhCeeeeEEecCCCeEEEEEEE-CCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--
Confidence            46899999999999999999999 678999999998654221 22233456677777777777799999999999887  


Q ss_pred             ccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ..+|+||||+. |+|.+++..  ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||
T Consensus        80 -----~~~~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFG  152 (364)
T d1omwa3          80 -----DKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG  152 (364)
T ss_dssp             -----SEEEEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCT
T ss_pred             -----CEEEEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeec
Confidence                 78899999999 599999987  3458999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      ++...... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+....+....... ....+ ..+ 
T Consensus       153 la~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~-~~~~~-~~~-  228 (364)
T d1omwa3         153 LACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMA-VEL-  228 (364)
T ss_dssp             TCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-SSSCC-CCC-
T ss_pred             eeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cccCC-CCC-
Confidence            99877643 3345679999999999975 5589999999999999999999999987554333222221 11111 111 


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC-----HHHHhCCCCCCCCCCC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS-----AADALEHPYFKEKENE  319 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~h~~f~~~~~~  319 (321)
                                           ...+++++.+||.+||.+||.+|||     ++++++||||++.+|+
T Consensus       229 ---------------------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~  274 (364)
T d1omwa3         229 ---------------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  274 (364)
T ss_dssp             ---------------------CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred             ---------------------CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence                                 1246689999999999999999999     7999999999998764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-58  Score=395.64  Aligned_cols=256  Identities=27%  Similarity=0.407  Sum_probs=223.3

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeeccc-CCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKL-NEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||+|++.... ........+.+|+.+++.++   ||||+++++++.+.   
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~-~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~~~~~~~~~---  113 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKH-KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN---FPFLVKLEFSFKDN---  113 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC---CTTBCCEEEEEECS---
T ss_pred             cCeEEEEEeecCcCcEEEEEEE-CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC---CCcEeecccccccc---
Confidence            6899999999999999999999 6889999999987542 22333456788999999987   99999999999887   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCC
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGL  179 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~  179 (321)
                          ..+++|+|++.| +|..++...  +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus       114 ----~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~  187 (350)
T d1rdqe_         114 ----SNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF  187 (350)
T ss_dssp             ----SEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ----cccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeecee
Confidence                788999999994 999998873  4599999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchh
Q psy2676         180 AKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPEN  259 (321)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (321)
                      +......  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+......++.......        
T Consensus       188 a~~~~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--------  257 (350)
T d1rdqe_         188 AKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--------  257 (350)
T ss_dssp             CEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------
T ss_pred             eeecccc--cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC--------
Confidence            9877533  345679999999999999999999999999999999999999999988887777766532111        


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         260 ISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                                         ...+++++.+||++||.+||.+|+     |++++++||||++.+|+
T Consensus       258 -------------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~  303 (350)
T d1rdqe_         258 -------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             -------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             -------------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence                               124568999999999999999995     99999999999998764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-59  Score=392.67  Aligned_cols=258  Identities=24%  Similarity=0.390  Sum_probs=223.5

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      -++|++.+.||+|+||+||+|++ ..+++.||+|+++.....   ...+.+|++++++++   ||||++++++|.+.   
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~-~~~~~~~AiK~i~~~~~~---~~~~~~Ei~il~~l~---HpnIv~~~~~~~~~---   73 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVE-TSSKKTYMAKFVKVKGTD---QVLVKKEISILNIAR---HRNILHLHESFESM---   73 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSC---CTTBCCEEEEEEET---
T ss_pred             ccceEEEEEEecCCCeEEEEEEE-CCCCcEEEEEEEcCCccc---HHHHHHHHHHHHhCC---CCCCCeEEEEEEEC---
Confidence            46899999999999999999999 678999999999754221   235678999999998   99999999999887   


Q ss_pred             cccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC--CCEEEeec
Q psy2676         101 DERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA--GGLKIADF  177 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~--~~~kl~df  177 (321)
                          ..+|+|||||.| +|.+++...+ ..+++.+++.++.||+.||+|||++|++||||||+||+++.+  ..++|+||
T Consensus        74 ----~~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DF  148 (321)
T d1tkia_          74 ----EELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEF  148 (321)
T ss_dssp             ----TEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             ----CEEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEccc
Confidence                789999999995 9999997743 249999999999999999999999999999999999999854  47999999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      |.+.............+++.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..+....+.......+     
T Consensus       149 G~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-----  223 (321)
T d1tkia_         149 GQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-----  223 (321)
T ss_dssp             TTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-----
T ss_pred             chhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----
Confidence            999887766666677889999999999999999999999999999999999999999888888777765322111     


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                                        ......+++++++||++||..||.+|||++|+++||||++.
T Consensus       224 ------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         224 ------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             ------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ------------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                              11233577899999999999999999999999999999754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-58  Score=387.14  Aligned_cols=258  Identities=28%  Similarity=0.426  Sum_probs=220.0

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccC-CCCCCchhHHHHHHHH-hcccCCCCceeEEEeeeecccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLN-EDGIPMSTLREISILK-QLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~-~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||+|++++... ..........|..++. .++   ||||+++++++.+.  
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~-~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~---hp~Iv~~~~~~~~~--   75 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEF-KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE---HPFLTHMFCTFQTK--   75 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE-TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTT---CTTBCCEEEEEECS--
T ss_pred             CCeEEeeEEecCCCcEEEEEEE-CCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCC---CCcEEEEEEEEccC--
Confidence            5799999999999999999999 68899999999976432 2223345566666655 466   99999999999888  


Q ss_pred             ccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ..+|+||||+. |+|.+++..  ...+++..++.++.||+.||+|||++|++||||||+||++++++++||+|||
T Consensus        76 -----~~~yivmEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG  148 (320)
T d1xjda_          76 -----ENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG  148 (320)
T ss_dssp             -----SEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             -----CceeEEEeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccc
Confidence                 78999999999 599999987  3458999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCC-CccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         179 LAKTFDYD-MMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       179 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      .+...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+...++...  .+..   |
T Consensus       149 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~---p  223 (320)
T d1xjda_         149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFY---P  223 (320)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCC---C
T ss_pred             hhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCC---C
Confidence            99866433 3344568899999999999999999999999999999999999999998888877766542  2211   1


Q ss_pred             hhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHH-HHhCCCCCCCCCCC
Q psy2676         258 ENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAA-DALEHPYFKEKENE  319 (321)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-~ll~h~~f~~~~~~  319 (321)
                                            ..+++++.+||++||..||.+|||+. ++++||||++.+|+
T Consensus       224 ----------------------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~  264 (320)
T d1xjda_         224 ----------------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  264 (320)
T ss_dssp             ----------------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             ----------------------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHH
Confidence                                  24568999999999999999999995 89999999987654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-58  Score=388.96  Aligned_cols=263  Identities=25%  Similarity=0.415  Sum_probs=213.6

Q ss_pred             cceeeee-eeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          22 KKYDELC-QIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        22 ~~y~~~~-~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      ++|+++. .||+|+||+||+|++ ..+++.||+|+++.       .....+|+.++.++..  ||||++++++|.+.   
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~-~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~--hpnIv~l~~~~~~~---   77 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFN-KRTQEKFALKMLQD-------CPKARREVELHWRASQ--CPHIVRIVDVYENL---   77 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTT--STTBCCEEEEEEEE---
T ss_pred             cCEEEeeEEeeeccCeEEEEEEE-CCCCCEEEEEEECC-------cHHHHHHHHHHHHhcC--CCCCCeEEEEEeec---
Confidence            5799885 599999999999999 57889999999863       3467789988766532  99999999999753   


Q ss_pred             cccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee---CCCEEEee
Q psy2676         101 DERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR---AGGLKIAD  176 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~---~~~~kl~d  176 (321)
                      ......+|+|||||+ |+|.+++...+...+++.+++.++.||+.||+|||++|++||||||+||+++.   ++.+||+|
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence            111257899999998 59999998876667999999999999999999999999999999999999986   45699999


Q ss_pred             cCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCc
Q psy2676         177 FGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEW  256 (321)
Q Consensus       177 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (321)
                      ||++.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......... .+
T Consensus       158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~-~~  236 (335)
T d2ozaa1         158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EF  236 (335)
T ss_dssp             CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS-SC
T ss_pred             cceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC-CC
Confidence            99998877666667788999999999999999999999999999999999999999876654444333322211111 11


Q ss_pred             chhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         257 PENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      +.                  .....+++++.+||++||+.||++|||+.|+++||||++.
T Consensus       237 ~~------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         237 PN------------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             CT------------------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             CC------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            10                  1123577999999999999999999999999999999754

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-57  Score=388.69  Aligned_cols=291  Identities=38%  Similarity=0.642  Sum_probs=232.0

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      .+++ .++|++++.||+|+||+||+|++ ..+++.||+|+++...........+.+|+.++++++   ||||++++++|.
T Consensus        13 ~~~~-~~~Y~~i~~lG~G~fg~V~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~---hpniv~l~~~~~   87 (346)
T d1cm8a_          13 AWEV-RAVYRDLQPVGSGAYGAVCSAVD-GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR---HENVIGLLDVFT   87 (346)
T ss_dssp             EECC-BSSEEEEEEC------CEEEEEE-TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC---BTTBCCCSEEEC
T ss_pred             eeec-CCcEEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcC---CCCeeEEEEEec
Confidence            3444 57999999999999999999999 678999999999754433333446778999999998   999999999997


Q ss_pred             ccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          96 QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      ..... .....+++|||+++.+|..++..   ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+|++
T Consensus        88 ~~~~~-~~~~~~~lv~e~~~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~  163 (346)
T d1cm8a_          88 PDETL-DDFTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL  163 (346)
T ss_dssp             SCSST-TTCCCCEEEEECCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             cCccc-cccceEEEEEecccccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccc
Confidence            65221 22246799999998888888776   349999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      |||.+......  .....+|+.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.+..+....+....+.++..
T Consensus       164 Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (346)
T d1cm8a_         164 DFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE  241 (346)
T ss_dssp             CCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             cccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence            99999876543  34567899999999988754 6899999999999999999999999999999999888888776644


Q ss_pred             Ccchhhh----hhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         255 EWPENIS----LMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       255 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      .+.....    ....................+++++.+||++||..||.+|||+.|+|+||||++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            3221111    11122222333344555567889999999999999999999999999999999763

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-56  Score=378.78  Aligned_cols=292  Identities=36%  Similarity=0.680  Sum_probs=226.8

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc-
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS-  100 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~-  100 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||||++............+.+|+.++++++   |||++++++++...... 
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~---h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARH-RKTGQKVALKKVLMENEKEGFPITALREIKILQLLK---HENVVNLIEICRTKASPY   85 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC---CTTBCCEEEEEEC-----
T ss_pred             CCEEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhc---CCCccceEeeeecccccc
Confidence            7999999999999999999999 588999999999776555556677889999999998   99999999998664211 


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                      ......+++|||++.+.+....... ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cccCceEEEEEeccCCCccchhhhc-ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeeccee
Confidence            1222468999999997666555443 345899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC-----ccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         181 KTFDYDM-----MLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       181 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      ...+...     ......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+....+.+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            7664322     22345689999999998765 58999999999999999999999999999999999999988887766


Q ss_pred             Ccchhhhhhh-hhhhhh--hhhhhhh--hhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCC
Q psy2676         255 EWPENISLMW-SSFEQY--SKVAFSA--IFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKEN  318 (321)
Q Consensus       255 ~~~~~~~~~~-~~~~~~--~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~  318 (321)
                      .+........ ..+...  .......  .....++.+.+||.+||.+||++|||++|+|+||||++.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~  313 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  313 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence            4433221110 000000  0001111  12234678899999999999999999999999999997654

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-57  Score=372.97  Aligned_cols=252  Identities=24%  Similarity=0.378  Sum_probs=210.5

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC----CCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED----GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      .++|++.+.||+|+||+||+|++ ..+++.||+|++.......    .....+.+|+.++++++. .||||+++++++.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~-~h~nIv~~~~~~~~   80 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIR-VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS-GFSGVIRLLDWFER   80 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS-SSCSBCCEEEEEEC
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEE-CCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhcc-CCCCccEEEEEEee
Confidence            46899999999999999999999 5789999999997653322    223457799999999873 48999999999988


Q ss_pred             cccccccceEEEEEeccCcc--CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeC-CCEE
Q psy2676          97 NILSDERYLTVYLIFEHVDQ--DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRA-GGLK  173 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~~--~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~-~~~k  173 (321)
                      .       ...++|||++.+  ++.+++..  ...+++..++.++.||+.||.|||++|++||||||+||+++.+ +.+|
T Consensus        81 ~-------~~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vk  151 (273)
T d1xwsa_          81 P-------DSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK  151 (273)
T ss_dssp             S-------SEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEE
T ss_pred             C-------CeEEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEE
Confidence            7       788999999974  78888876  3459999999999999999999999999999999999999865 6899


Q ss_pred             EeecCCcccccCCCccccccccccccchhhhhcCCC-CCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCC
Q psy2676         174 IADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGY-GTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPS  252 (321)
Q Consensus       174 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (321)
                      |+|||++..... .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.      +...  ...
T Consensus       152 l~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~--~~~  222 (273)
T d1xwsa_         152 LIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--QVF  222 (273)
T ss_dssp             ECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--CCC
T ss_pred             ECccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhhc--ccC
Confidence            999999976553 33455679999999999988775 6779999999999999999999965321      1111  110


Q ss_pred             CCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         253 MNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                                               ....+|+++.+||++||..||++|||++|+++||||++..
T Consensus       223 -------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         223 -------------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             -------------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             -------------------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                                     1124678999999999999999999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-57  Score=385.79  Aligned_cols=285  Identities=29%  Similarity=0.455  Sum_probs=227.4

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      -+|+.+++||+|+||+||+|++ ..+++.||+|++...      .....+|++++++++   ||||++++++|..... .
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~-~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~---h~niv~~~~~~~~~~~-~   88 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKKVLQD------KRFKNRELQIMRKLD---HCNIVRLRYFFYSSGE-K   88 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECC------SSSCCHHHHHHHHCC---CTTBCCEEEEEEEC---C
T ss_pred             CCcEeeeEEeeCcCeEEEEEEE-CCCCCEEEEEEECcc------chHHHHHHHHHHhcC---CCCCCcEEEEEEecCc-c
Confidence            3799999999999999999999 578999999998753      224458999999997   9999999999865421 2


Q ss_pred             ccceEEEEEeccCccCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC-CEEEeecC
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEK--CPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADFG  178 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~-~~kl~dfg  178 (321)
                      ....++++||||+++++...+..  .....+++.+++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||
T Consensus        89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEeccc
Confidence            23357899999999866555532  2345599999999999999999999999999999999999999775 79999999


Q ss_pred             CcccccCCCccccccccccccchhhhhcC-CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         179 LAKTFDYDMMLTSVVVTLWYRAPEILLNL-GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      ++.............++..|+|||.+.+. .++.++||||+||++|+|++|+.||...+..+....+.+..+.+....+.
T Consensus       169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            99887766666677899999999988754 58999999999999999999999999999999999999888876654332


Q ss_pred             hhhhhhh-hhhhhhhhh-hhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         258 ENISLMW-SSFEQYSKV-AFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       258 ~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ....... ..+...... ........+++++.+||++||.+||.+|||+.|+|+||||++..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            2211100 000000000 11122335778999999999999999999999999999998763

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-56  Score=372.09  Aligned_cols=257  Identities=23%  Similarity=0.366  Sum_probs=215.4

Q ss_pred             cccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          13 NLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        13 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +.+.+++..++|++.+.||+|+||+||+|++ ..+++.||+|+++..   ......+.+|+.++++++   ||||+++++
T Consensus         8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~-~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~---HpnIv~~~~   80 (287)
T d1opja_           8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVW-KKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIK---HPNLVQLLG   80 (287)
T ss_dssp             TCCTTBCCGGGEEEEEETTTTTTSSEEEEEE-GGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCC---CTTBCCEEE
T ss_pred             CCcccEecHHHeEEeeEEeeCCCeEEEEEEE-CCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCC---CCCEecCCc
Confidence            4567888999999999999999999999999 578899999998643   223457889999999998   999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCC
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGG  171 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~  171 (321)
                      ++.+.       ...++||||++ |+|.+++.......+++..+..++.||+.||+|||++|++||||||+||+++.++.
T Consensus        81 ~~~~~-------~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~  153 (287)
T d1opja_          81 VCTRE-------PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL  153 (287)
T ss_dssp             EECSS-------SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             cEeeC-------CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc
Confidence            99776       56799999999 69999998876677999999999999999999999999999999999999999999


Q ss_pred             EEEeecCCcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCC-CCChHHHHHHHHHHh
Q psy2676         172 LKIADFGLAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFC-ASTEVEQLKCIFRVI  248 (321)
Q Consensus       172 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~  248 (321)
                      +||+|||++........  .....+++.|+|||++.+..++.++||||+|+++|+|++|..||. +.+..+....+.. .
T Consensus       154 ~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~-~  232 (287)
T d1opja_         154 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-D  232 (287)
T ss_dssp             EEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-T
T ss_pred             EEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc-C
Confidence            99999999987654432  234567889999999999999999999999999999999766554 4444443333322 1


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ..++.                         ...+++++.+||++||+.||.+|||++++++
T Consensus       233 ~~~~~-------------------------~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         233 YRMER-------------------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             CCCCC-------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCC-------------------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            11111                         1256689999999999999999999999976

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-56  Score=383.11  Aligned_cols=286  Identities=37%  Similarity=0.553  Sum_probs=221.2

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ++|++++.||+|+||+||+|++ ..+++.||+|++............+.+|+.++++++   ||||++++++|..... .
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d-~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~~~~~f~~~~~-~   91 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYD-AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIISLLNVFTPQKT-L   91 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEE-TTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC---CTTBCCCSEEECSCCS-T
T ss_pred             CCeEEEEEeecCcCeEEEEEEE-CCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcC---CCCeeEEEEEEecccc-c
Confidence            6899999999999999999999 578999999999765443333446779999999997   9999999999975521 1


Q ss_pred             ccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcc
Q psy2676         102 ERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAK  181 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~  181 (321)
                      .....+|+||||+.+++.+.+..    .+++..++.++.||+.||.|||++|++||||||+||+++.++.++++|||.+.
T Consensus        92 ~~~~~~~iv~Ey~~~~l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          92 EEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             TTCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             ccCceeEEEEeccchHHHHhhhc----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence            23368899999999887776643    38999999999999999999999999999999999999999999999999988


Q ss_pred             cccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhh
Q psy2676         182 TFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNEWPENIS  261 (321)
Q Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (321)
                      ............+|+.|+|||++.+..++.++||||+||++++|++|+.||.+.+......++....+.+....+.....
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            87766666777899999999999999999999999999999999999999999999999999988887765543322221


Q ss_pred             hhhhhhh---------------hhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         262 LMWSSFE---------------QYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       262 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      .......               ..............++++.+||++||..||++|||++|+|+||||++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            1110000               001111112233467889999999999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-56  Score=369.76  Aligned_cols=258  Identities=22%  Similarity=0.321  Sum_probs=208.4

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      .+++..++|++.+.||+|+||+||+|+.   . ..||+|+++...........+.+|+.++++++   ||||+++++++.
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~---~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~   74 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKW---H-GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR---HVNILLFMGYST   74 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEES---S-SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCC---CTTBCCEEEEEC
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEE---C-CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC---CCCEeeeeEEEe
Confidence            4678889999999999999999999964   2 35999999765444444557778999999997   999999999864


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      .+        .+++||||++ |+|.+++.... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||
T Consensus        75 ~~--------~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl  145 (276)
T d1uwha_          75 AP--------QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI  145 (276)
T ss_dssp             SS--------SCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEE
T ss_pred             cc--------EEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEE
Confidence            33        3689999999 59999997654 34999999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCC---ccccccccccccchhhhhcC---CCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHh
Q psy2676         175 ADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNL---GYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVI  248 (321)
Q Consensus       175 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  248 (321)
                      +|||++.......   ......||+.|+|||++.+.   .++.++||||||+++|+|++|+.||.+.+............
T Consensus       146 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~  225 (276)
T d1uwha_         146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG  225 (276)
T ss_dssp             CCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT
T ss_pred             ccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC
Confidence            9999997664322   23456789999999998643   47889999999999999999999998877666555444432


Q ss_pred             CCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         249 GTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ..++.                     ......++|+++.+|+.+||+.||++|||+++++++
T Consensus       226 ~~~p~---------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         226 YLSPD---------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             SCCCC---------------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCc---------------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            22111                     112234677999999999999999999999999876

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=369.39  Aligned_cols=283  Identities=41%  Similarity=0.716  Sum_probs=232.3

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      +||++++.||+|+||+||+|++ ..+++.||+|+++...........+.+|+.+++.++   ||||+++++++.+.    
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~---h~niv~~~~~~~~~----   73 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKN-RETHEIVALKRVRLDDDDEGVPSSALREICLLKELK---HKNIVRLHDVLHSD----   73 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC---CTTBCCEEEEEECS----
T ss_pred             CCCEeeeEEecCcCeEEEEEEE-CCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcC---cCCEEeeccccccc----
Confidence            5899999999999999999999 588999999999876555444567789999999988   99999999999888    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...+++++++.+ +|..++..  .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||.+
T Consensus        74 ---~~~~iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a  148 (292)
T d1unla_          74 ---KKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA  148 (292)
T ss_dssp             ---SEEEEEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             ---cceeEEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchh
Confidence               788999999996 66666555  345899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC-ccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCC-CCCCChHHHHHHHHHHhCCCCCCCcc
Q psy2676         181 KTFDYDM-MLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPL-FCASTEVEQLKCIFRVIGTPSMNEWP  257 (321)
Q Consensus       181 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~  257 (321)
                      ....... ......+++.|.|||++.... ++.++||||+||++|+|++|+.| |.+.+..+....+....+.+....++
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (292)
T d1unla_         149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             EECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred             hcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhh
Confidence            8775433 334456778899999987765 69999999999999999999887 46677777888888888887776665


Q ss_pred             hhhhhhhhhh--hhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         258 ENISLMWSSF--EQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       258 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ..........  ..............+++.+.+||++||++||.+|||++|+|+||||++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence            5433221100  00011223334456778999999999999999999999999999999764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-56  Score=370.53  Aligned_cols=260  Identities=24%  Similarity=0.382  Sum_probs=216.3

Q ss_pred             ccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          14 LDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        14 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      .+.+++..++|++.+.||+|+||+||+|++  .+++.||||+++...   .....+.+|+.++++++   ||||++++++
T Consensus         5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~---HpnIv~~~g~   76 (272)
T d1qpca_           5 EDEWEVPRETLKLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQ---HQRLVRLYAV   76 (272)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEE--TTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCC---CTTBCCEEEE
T ss_pred             CCCeecCHHHeEEeEEEecCCCcEEEEEEE--CCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCC---CCCEeEEEee
Confidence            456788899999999999999999999987  467889999986432   23457889999999998   9999999998


Q ss_pred             eeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +.+.        ..++||||++ |+|.+++.......+++..+..++.||+.||.|||++|++||||||+||++++++.+
T Consensus        77 ~~~~--------~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~  148 (272)
T d1qpca_          77 VTQE--------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSC  148 (272)
T ss_dssp             ECSS--------SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCE
T ss_pred             eccC--------CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccce
Confidence            7543        3589999999 599998766544458999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCC--ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhc-CCCCCCCChHHHHHHHHHHhC
Q psy2676         173 KIADFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       173 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      ||+|||++.......  ......+++.|+|||++.+..++.++||||||+++|+|+|| .+||...+..+....+.....
T Consensus       149 Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~  228 (272)
T d1qpca_         149 KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR  228 (272)
T ss_dssp             EECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred             eeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC
Confidence            999999998775433  23346788999999999999999999999999999999995 566666666665555543221


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC--CCCCCC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE--HPYFKE  315 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h~~f~~  315 (321)
                       +..+                         ..+++++.+|+++||+.||++|||++++++  |+||..
T Consensus       229 -~~~p-------------------------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         229 -MVRP-------------------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             -CCCC-------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CCCc-------------------------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence             1111                         246689999999999999999999999998  788753

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=377.97  Aligned_cols=286  Identities=40%  Similarity=0.641  Sum_probs=224.3

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      +.+|++++.||+|+||+||+|++ ..+++.||+|++.... .......+.+|+.++++++   |||++++++++....  
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~-~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~---hp~iv~~~~~~~~~~--   79 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYD-NVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFR---HENIIGINDIIRAPT--   79 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEE-TTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCC---CTTBCCCCEEECCSS--
T ss_pred             CCCeEEEEEEeeccCeEEEEEEE-CCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcC---CCCCCcEEEEEeecc--
Confidence            46899999999999999999999 6889999999986432 1222346778999999998   999999999986652  


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                      ......++++++.++|+|.+++...   .+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus        80 ~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a  156 (345)
T d1pmea_          80 IEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA  156 (345)
T ss_dssp             TTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCce
Confidence            2222346777777778999999773   4999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC----ccccccccccccchhhhhc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         181 KTFDYDM----MLTSVVVTLWYRAPEILLN-LGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       181 ~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      .......    ......+++.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+..+...........+....
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence            7664332    2345678999999999854 5578999999999999999999999999988888888877766554332


Q ss_pred             cchhhhhh----hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCC
Q psy2676         256 WPENISLM----WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEK  316 (321)
Q Consensus       256 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~  316 (321)
                      ........    ..................+++++++||.+||..||.+|||++|+|+||||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            21111100    01111111222334556778899999999999999999999999999999965

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.1e-55  Score=373.03  Aligned_cols=282  Identities=28%  Similarity=0.519  Sum_probs=220.1

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++++.||+|+||+||+|++ ..+++.||+|+++..     ....+.+|+.+++++..  ||||++++++|.... 
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~-~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~--hpnIv~~~~~~~~~~-  103 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAIN-ITNNEKVVVKILKPV-----KKKKIKREIKILENLRG--GPNIITLADIVKDPV-  103 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTT--STTBCCEEEEEECTT-
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccC--CCCCcEEEEEEEecC-
Confidence            346899999999999999999999 688999999998642     23477899999999964  999999999986431 


Q ss_pred             ccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCC-CEEEeec
Q psy2676         100 SDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAG-GLKIADF  177 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~-~~kl~df  177 (321)
                          ...+++|||++.+ +|..+.     +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+||
T Consensus       104 ----~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DF  174 (328)
T d3bqca1         104 ----SRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDW  174 (328)
T ss_dssp             ----TCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCG
T ss_pred             ----CCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccc
Confidence                1457999999995 776653     2389999999999999999999999999999999999998765 5899999


Q ss_pred             CCcccccCCCccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCC-hHHHHHHHHHHhCCCCCCC
Q psy2676         178 GLAKTFDYDMMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCAST-EVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       178 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~  255 (321)
                      |++.............+|+.|+|||.+.+.. ++.++||||+||++++|++|+.||.... ..+....+....+.+....
T Consensus       175 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~  254 (328)
T d3bqca1         175 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD  254 (328)
T ss_dssp             GGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred             ccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence            9998877666667778899999999987765 7999999999999999999999997654 4444445554444221111


Q ss_pred             cchhhhh---------h-hhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCCCC
Q psy2676         256 WPENISL---------M-WSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKENE  319 (321)
Q Consensus       256 ~~~~~~~---------~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~~~  319 (321)
                      +......         . ..................+++++.+||++||.+||.+|||++|+|+||||+++.||
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~~  328 (328)
T d3bqca1         255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  328 (328)
T ss_dssp             HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCCC
T ss_pred             hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            1000000         0 00000111112222334577899999999999999999999999999999999886

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=365.61  Aligned_cols=267  Identities=22%  Similarity=0.365  Sum_probs=216.5

Q ss_pred             ccccccccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeE
Q psy2676          10 QSLNLDSLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR   89 (321)
Q Consensus        10 ~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~   89 (321)
                      ..+..+.+++..++|++.+.||+|+||+||+|++  .+++.||+|+++...   .....+.+|+.++++++   ||||++
T Consensus         5 ~~~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~--~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~---h~nIv~   76 (285)
T d1fmka3           5 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW--NGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLR---HEKLVQ   76 (285)
T ss_dssp             SSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEE--TTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCC---CTTBCC
T ss_pred             CCCCCcceEcCHHHEEEeeEEeeCCCeEEEEEEE--CCCCEEEEEEECccc---CCHHHHHHHHHHHHhcc---cCCEeE
Confidence            4567788999999999999999999999999988  355679999986432   23457889999999998   999999


Q ss_pred             EEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR  168 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~  168 (321)
                      +++++.+.        ..++||||++ |+|..++.....+.+++..+..++.||+.||+|||+.|++||||||+||+++.
T Consensus        77 ~~g~~~~~--------~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~  148 (285)
T d1fmka3          77 LYAVVSEE--------PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE  148 (285)
T ss_dssp             EEEEECSS--------SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             EEEEEecC--------CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECC
Confidence            99998543        3589999999 58988887654456999999999999999999999999999999999999999


Q ss_pred             CCCEEEeecCCcccccCCC--ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhc-CCCCCCCChHHHHHHHH
Q psy2676         169 AGGLKIADFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIF  245 (321)
Q Consensus       169 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~  245 (321)
                      ++++||+|||++.......  ......+|+.|+|||++....++.++||||+|+++|+|++| .+|+......+....+.
T Consensus       149 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~  228 (285)
T d1fmka3         149 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE  228 (285)
T ss_dssp             GGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             CCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999999997664332  23346789999999999999999999999999999999996 55555666655555554


Q ss_pred             HHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC--CCCCCCCCC
Q psy2676         246 RVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE--HPYFKEKEN  318 (321)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h~~f~~~~~  318 (321)
                      .....+.                          ...+++++.+||.+||+.||++|||+++|++  ++||++...
T Consensus       229 ~~~~~~~--------------------------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p  277 (285)
T d1fmka3         229 RGYRMPC--------------------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  277 (285)
T ss_dssp             TTCCCCC--------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             hcCCCCC--------------------------CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence            3221111                          1256689999999999999999999999998  999987743

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=373.67  Aligned_cols=259  Identities=24%  Similarity=0.322  Sum_probs=211.8

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCC----cEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEe
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKG----NYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFD   92 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~   92 (321)
                      +++..++|++.+.||+|+||+||+|++...+.    ..||+|.+..... ......+.+|+.+++++..  ||||+++++
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~--HpnIv~l~~  108 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGS--HENIVNLLG  108 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCC--CTTBCCEEE
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcC--CCcEeEEEE
Confidence            46777899999999999999999999853322    3688888865432 3345578899999999843  999999999


Q ss_pred             eeeccccccccceEEEEEeccCc-cCHHHHHhhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy2676          93 VIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPP---------------------PGLSASKVKELTRQMLKGVDFLH  150 (321)
Q Consensus        93 ~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~---------------------~~~~~~~~~~i~~~l~~~l~~lh  150 (321)
                      ++.+.       ..+++||||++ |+|.+++.....                     ..+++..++.++.||+.||+|||
T Consensus       109 ~~~~~-------~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH  181 (325)
T d1rjba_         109 ACTLS-------GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE  181 (325)
T ss_dssp             EECSS-------SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeeC-------CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            99877       67899999999 599999976432                     34899999999999999999999


Q ss_pred             hCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh
Q psy2676         151 SHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR  227 (321)
Q Consensus       151 ~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~  227 (321)
                      ++|++||||||+||+++.++.+||+|||++........   .....+|+.|+|||++.+..++.++|||||||++|+|++
T Consensus       182 ~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt  261 (325)
T d1rjba_         182 FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS  261 (325)
T ss_dssp             HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred             hCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHh
Confidence            99999999999999999999999999999976654332   234567999999999999999999999999999999997


Q ss_pred             -cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHH
Q psy2676         228 -LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD  306 (321)
Q Consensus       228 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  306 (321)
                       |..||.+.+..+...++......++.+                         ..+|+++.+||.+||+.||++|||++|
T Consensus       262 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~p-------------------------~~~~~~l~~li~~cl~~dP~~RPt~~e  316 (325)
T d1rjba_         262 LGVNPYPGIPVDANFYKLIQNGFKMDQP-------------------------FYATEEIYIIMQSCWAFDSRKRPSFPN  316 (325)
T ss_dssp             TSCCSSTTCCCSHHHHHHHHTTCCCCCC-------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHhcCCCCCCC-------------------------CcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence             899998876666655555433222221                         246689999999999999999999999


Q ss_pred             HhCC
Q psy2676         307 ALEH  310 (321)
Q Consensus       307 ll~h  310 (321)
                      |++|
T Consensus       317 i~~~  320 (325)
T d1rjba_         317 LTSF  320 (325)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-55  Score=360.87  Aligned_cols=249  Identities=20%  Similarity=0.328  Sum_probs=200.9

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.+.||+|+||+||+|++  .+++.||+|+++..   ......+.+|+.++++++   ||||+++++++...  
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~--~~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~---HpnIv~~~g~~~~~--   72 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYW--LNKDKVAIKTIREG---AMSEEDFIEEAEVMMKLS---HPKLVQLYGVCLEQ--   72 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEE--TTTEEEEEEECCSS---SSCHHHHHHHHHHHHHCC---CTTBCCEEEEECSS--
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEE--CCCCEEEEEEECCC---cCcHHHHHHHHHHHHhcC---CCCcccccceeccC--
Confidence            457899999999999999999987  36778999998643   223457889999999998   99999999999776  


Q ss_pred             ccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ...++||||+. |+|.+++.... ..+++..+..++.||+.||.|||+++++||||||+||++++++.+||+|||
T Consensus        73 -----~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFG  146 (263)
T d1sm2a_          73 -----APICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG  146 (263)
T ss_dssp             -----SSCEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC
T ss_pred             -----CceEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccc
Confidence                 56799999999 69999987643 348999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         179 LAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       179 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ++........  .....+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+....+......+. + 
T Consensus       147 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~-p-  224 (263)
T d1sm2a_         147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-P-  224 (263)
T ss_dssp             ------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC-C-
T ss_pred             hheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC-c-
Confidence            9976654332  234568899999999999999999999999999999999 5777777777666666554322111 1 


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                                              ..+++++.+|+.+||+.||.+|||++++++|
T Consensus       225 ------------------------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         225 ------------------------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------cccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                                    1455889999999999999999999999975

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-55  Score=357.56  Aligned_cols=249  Identities=20%  Similarity=0.317  Sum_probs=212.9

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNIL   99 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~   99 (321)
                      ..++|++.++||+|+||+||+|+.  .+++.||+|+++....   ....+.+|+.++++++   ||||+++++++.+.  
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~---HpnIv~~~g~~~~~--   71 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLS---HEKLVQLYGVCTKQ--   71 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEE--TTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCC---CTTBCCEEEEECCS--
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEE--CCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcC---CCceeeEEEEEeeC--
Confidence            357899999999999999999997  4778999999975422   3457889999999998   99999999999776  


Q ss_pred             ccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecC
Q psy2676         100 SDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFG  178 (321)
Q Consensus       100 ~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg  178 (321)
                           ..+++||||+. |+|..++.... ..+++..+++++.||+.||.|||+.|++||||||+||+++.++.+||+|||
T Consensus        72 -----~~~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG  145 (258)
T d1k2pa_          72 -----RPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG  145 (258)
T ss_dssp             -----SSEEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCS
T ss_pred             -----CceEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcch
Confidence                 67899999998 68888876644 348999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCc--cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         179 LAKTFDYDMM--LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       179 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ++........  .....+|+.|+|||++.+..++.++||||||+++|+|+| |+.||.+.+..+....+......+.+  
T Consensus       146 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p--  223 (258)
T d1k2pa_         146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP--  223 (258)
T ss_dssp             SCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC--
T ss_pred             hheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc--
Confidence            9976643332  334668899999999999999999999999999999998 89999999888877766543222111  


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                                              ..+++++.+||++||+.||++|||++++++|
T Consensus       224 ------------------------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         224 ------------------------HLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ------------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------ccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                                    1455889999999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-55  Score=374.83  Aligned_cols=291  Identities=38%  Similarity=0.623  Sum_probs=228.8

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      .+++ .+||++++.||+|+||+||+|++ ..+++.||+|+++...........+.+|+.++++++   |||++++++++.
T Consensus        13 ~~~~-~~rY~i~~~LG~G~fg~Vy~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~---h~~iv~~~~~~~   87 (348)
T d2gfsa1          13 IWEV-PERYQNLSPVGSGAYGSVCAAFD-TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK---HENVIGLLDVFT   87 (348)
T ss_dssp             EEEE-ETTEEEEEECGGGTTSSEEEEEE-TTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC---CTTBCCCSEEEC
T ss_pred             cccC-CCCeEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC---CCCeeeEEEEEe
Confidence            3444 47899999999999999999999 588999999999765433333446778999999998   999999999986


Q ss_pred             ccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          96 QNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      ..... ......+++++..+|+|.+++..   +.+++..++.++.||+.||+|||++|++||||||+||+++.++.++++
T Consensus        88 ~~~~~-~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~  163 (348)
T d2gfsa1          88 PARSL-EEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL  163 (348)
T ss_dssp             SCSST-TTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             ecccc-ccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccccc
Confidence            54211 12234566666666799999865   349999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCC-CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLG-YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      |||.+.....  ......+++.|+|||+..+.. ++.++|||||||++|+|++|+.||.+.+.......+....+.+...
T Consensus       164 dfg~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~  241 (348)
T d2gfsa1         164 DFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE  241 (348)
T ss_dssp             CC----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ccchhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            9999876542  234567889999999887765 6899999999999999999999999999999999998887765543


Q ss_pred             Ccchhhhh----hhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCCCCCC
Q psy2676         255 EWPENISL----MWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYFKEKE  317 (321)
Q Consensus       255 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f~~~~  317 (321)
                      ........    ..................++++++++||++||..||.+|||++|+|+||||++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence            22211111    1111222223344455567889999999999999999999999999999999763

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-54  Score=364.20  Aligned_cols=255  Identities=23%  Similarity=0.357  Sum_probs=199.6

Q ss_pred             ccCCcceeeeeeeecccceeEEEEEEecCCC--cEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          18 DLGDKKYDELCQIGCGAYGTVFKARDLQNKG--NYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        18 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~--~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      ++..++|++.+.||+|+||+||+|++...++  ..||+|.+...... .....+.+|+.++++++   ||||+++++++.
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~---HpnIv~l~g~~~   97 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSEASIMGQFD---HPNVIHLEGVVT   97 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH-HHHHHHHHHHHHHTTCC---CTTBCCEEEEEC
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH-HHHHHHHHHHHHHHhCC---CCCCccEEEEEe
Confidence            4566799999999999999999999842222  35778877543222 22346788999999997   999999999997


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ..       ..+++||||++ |+|.+++.... +.+++.++..++.||+.||+|||++|++||||||+||+++.++.+||
T Consensus        98 ~~-------~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl  169 (299)
T d1jpaa_          98 KS-------TPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKV  169 (299)
T ss_dssp             SS-------SSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred             eC-------CEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEE
Confidence            76       56799999999 59999887643 34899999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCc------cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHH
Q psy2676         175 ADFGLAKTFDYDMM------LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       175 ~dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~  247 (321)
                      +|||++........      .....+|+.|+|||.+.+..++.++|||||||++|+|+| |..||.+.+..+....+...
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~  249 (299)
T d1jpaa_         170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD  249 (299)
T ss_dssp             CCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             CCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999987653322      112456889999999999999999999999999999998 89999988887777666543


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ...+..                          .++++++.+|+.+||+.||.+|||+.+|+++
T Consensus       250 ~~~~~~--------------------------~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         250 YRLPPP--------------------------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCCCCC--------------------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCCCCC--------------------------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            222211                          2466899999999999999999999998764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.1e-55  Score=363.99  Aligned_cols=262  Identities=25%  Similarity=0.354  Sum_probs=207.5

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      ..++|++.+.||+|+||+||+|++ ..+++.||+|+++.....+ .....+.+|+.++++++   ||||+++++++....
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~---hpniv~~~~~~~~~~   80 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARD-LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN---HPAIVAVYDTGEAET   80 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC---CTTBCCEEEEEEEEC
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEE-CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC---CCCCCcccceeeecc
Confidence            357899999999999999999999 5789999999997653322 12335678999999887   999999999987652


Q ss_pred             cccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeec
Q psy2676          99 LSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADF  177 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~df  177 (321)
                         .....+|+||||++| +|.+++...  +.+++.+++.++.||+.||+|||++|++||||||+||+++.++..+++||
T Consensus        81 ---~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~  155 (277)
T d1o6ya_          81 ---PAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF  155 (277)
T ss_dssp             ---SSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCC
T ss_pred             ---CCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehh
Confidence               222458999999995 999988773  45999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCC----ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC
Q psy2676         178 GLAKTFDYDM----MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTPSM  253 (321)
Q Consensus       178 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (321)
                      |.+.......    ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+...++......++.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~  235 (277)
T d1o6ya_         156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS  235 (277)
T ss_dssp             TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG
T ss_pred             hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc
Confidence            9886553222    334567899999999999999999999999999999999999999988887776666543222111


Q ss_pred             CCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCCCCC
Q psy2676         254 NEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEHPYF  313 (321)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~f  313 (321)
                                             ....++|+++.+||++||.+||.+||+..+.+.|+|.
T Consensus       236 -----------------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         236 -----------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             -----------------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             -----------------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence                                   1123677999999999999999999954444445554

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-55  Score=361.26  Aligned_cols=252  Identities=24%  Similarity=0.359  Sum_probs=203.0

Q ss_pred             eeee-eeeecccceeEEEEEEe-cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          24 YDEL-CQIGCGAYGTVFKARDL-QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        24 y~~~-~~lg~g~~g~v~~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      +.+. ++||+|+||+||+|... ...++.||+|+++...........+.+|+.++++++   ||||+++++++.++    
T Consensus         8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~~~g~~~~~----   80 (277)
T d1xbba_           8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD---NPYIVRMIGICEAE----   80 (277)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC---CTTBCCEEEEEESS----
T ss_pred             CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCC---CCCCceEEEEeccC----
Confidence            4443 57999999999999863 234678999999755433333456889999999998   99999999998544    


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                          ..++||||++ |+|.+++..  ...+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus        81 ----~~~lvmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla  154 (277)
T d1xbba_          81 ----SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS  154 (277)
T ss_dssp             ----SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             ----CEEEEEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhh
Confidence                3589999999 599999987  345999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy2676         181 KTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNE  255 (321)
Q Consensus       181 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (321)
                      ........    .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+.... .++.  
T Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~--  231 (277)
T d1xbba_         155 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGC--  231 (277)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCC--
T ss_pred             hhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-CCCC--
Confidence            87653322    223568899999999999999999999999999999997 899999888777665554321 1111  


Q ss_pred             cchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHh---CCCCCC
Q psy2676         256 WPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL---EHPYFK  314 (321)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll---~h~~f~  314 (321)
                                             ...+|+++.+||.+||+.||++|||+++|+   +|+|++
T Consensus       232 -----------------------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         232 -----------------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             -----------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -----------------------CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                                   125678999999999999999999999984   566653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=360.51  Aligned_cols=257  Identities=25%  Similarity=0.330  Sum_probs=210.4

Q ss_pred             ccCCcceeeeee-eecccceeEEEEEEec-CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          18 DLGDKKYDELCQ-IGCGAYGTVFKARDLQ-NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        18 ~~~~~~y~~~~~-lg~g~~g~v~~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      -+..++|.+.+. ||+|+||+||+|.+.. .++..||||+++.... ......+.+|+.++++++   ||||+++++++.
T Consensus         4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~   79 (285)
T d1u59a_           4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLD---NPYIVRLIGVCQ   79 (285)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCC---CTTBCCEEEEEE
T ss_pred             eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC-HHHHHHHHHHHHHHHhCC---CCCEeeEeeeec
Confidence            355678999885 9999999999998632 3456899999865422 222346788999999998   999999999986


Q ss_pred             ccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEE
Q psy2676          96 QNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKI  174 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl  174 (321)
                      ++        .+++||||++ |+|.+++.... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||
T Consensus        80 ~~--------~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl  150 (285)
T d1u59a_          80 AE--------ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKI  150 (285)
T ss_dssp             SS--------SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEE
T ss_pred             cC--------eEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceee
Confidence            54        3689999999 59999886543 34999999999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCCCc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhC
Q psy2676         175 ADFGLAKTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       175 ~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      +|||++........    .....+|+.|+|||++.+..++.++||||||+++|+|+| |+.||.+.+..+....+.....
T Consensus       151 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~  230 (285)
T d1u59a_         151 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR  230 (285)
T ss_dssp             CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC
T ss_pred             ccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999987654332    223467889999999999999999999999999999998 8999998887776665544221


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHH---hCCCCC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA---LEHPYF  313 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l---l~h~~f  313 (321)
                      .+.                          ...+|+++.+||.+||+.||++|||+.+|   |+|+|+
T Consensus       231 ~~~--------------------------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         231 MEC--------------------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             CCC--------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCC--------------------------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            111                          12566899999999999999999999988   567776

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-54  Score=365.25  Aligned_cols=265  Identities=25%  Similarity=0.384  Sum_probs=216.2

Q ss_pred             CcceeeeeeeecccceeEEEEEEec--CCCcEEEEEEeecccC--CCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQ--NKGNYVAMKKLRVKLN--EDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~--~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      -++|++++.||+|+||+||+|++..  .+++.||+|+++....  .......+.+|++++++++.  ||||+++++++.+
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h--~pnIv~~~~~~~~  100 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ--SPFLVTLHYAFQT  100 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT--CTTBCCEEEEEEE
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccC--CCeEEEeeeeecc
Confidence            3789999999999999999998743  3688999999865422  22334577899999999982  4899999999988


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       ..+++++|++. |+|.+++...  +.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+
T Consensus       101 ~-------~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~  171 (322)
T d1vzoa_         101 E-------TKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT  171 (322)
T ss_dssp             T-------TEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEES
T ss_pred             C-------CceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEe
Confidence            8       78999999999 5999999884  447899999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCC--CccccccccccccchhhhhcCC--CCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         176 DFGLAKTFDYD--MMLTSVVVTLWYRAPEILLNLG--YGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       176 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      |||++......  .......+++.|+|||.+.+..  ++.++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus       172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~  251 (322)
T d1vzoa_         172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  251 (322)
T ss_dssp             CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence            99999765432  2344567899999999997654  6889999999999999999999998765444433333322111


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC-----CHHHHhCCCCCCCCCCC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI-----SAADALEHPYFKEKENE  319 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~f~~~~~~  319 (321)
                      ..                       .....+++++.+||++||.+||.+||     |++|+++||||++.+|+
T Consensus       252 ~~-----------------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~  301 (322)
T d1vzoa_         252 EP-----------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  301 (322)
T ss_dssp             CC-----------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             CC-----------------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence            11                       11225679999999999999999999     58999999999987653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-53  Score=350.78  Aligned_cols=255  Identities=25%  Similarity=0.382  Sum_probs=199.0

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCC---cEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKG---NYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDV   93 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~   93 (321)
                      -++..+.|++.+.||+|+||+||+|.....++   ..||+|++....... ....+.+|+.++++++   ||||++++++
T Consensus         2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~E~~il~~l~---H~nIv~~~g~   77 (283)
T d1mqba_           2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFS---HHNIIRLEGV   77 (283)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHTCC---CTTBCCEEEE
T ss_pred             CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-HHHHHHHHHHHHHhcC---CCCEeeeeEE
Confidence            35667889999999999999999998743322   479999986543221 2335778999999998   9999999999


Q ss_pred             eeccccccccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCE
Q psy2676          94 IHQNILSDERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~  172 (321)
                      +.+.       ...++|+|++.+ ++.+++.... ..+++.++..++.||+.||+|||+++++||||||+||+++.++.+
T Consensus        78 ~~~~-------~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~  149 (283)
T d1mqba_          78 ISKY-------KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVC  149 (283)
T ss_dssp             ECSS-------SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred             EecC-------CceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeE
Confidence            9776       568999999995 7887776643 449999999999999999999999999999999999999999999


Q ss_pred             EEeecCCcccccCCC----ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhc-CCCCCCCChHHHHHHHHHH
Q psy2676         173 KIADFGLAKTFDYDM----MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL-VPLFCASTEVEQLKCIFRV  247 (321)
Q Consensus       173 kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~  247 (321)
                      ||+|||++.......    ......||+.|+|||++.+..++.++||||||+++|+|+++ .+|+......+....+...
T Consensus       150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~  229 (283)
T d1mqba_         150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG  229 (283)
T ss_dssp             EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             EEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc
Confidence            999999997664332    12234678999999999999999999999999999999996 5555555555555544432


Q ss_pred             hCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         248 IGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ...+.                          ..+++.++.+||.+||+.||++|||+.+|++
T Consensus       230 ~~~~~--------------------------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         230 FRLPT--------------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CCCCC--------------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCC--------------------------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            21111                          1246688999999999999999999999975

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=352.52  Aligned_cols=255  Identities=22%  Similarity=0.365  Sum_probs=200.0

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCC--CcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeee
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNK--GNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVI   94 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~   94 (321)
                      +++..++|++.+.||+|+||+||+|++...+  +..||+|.++... .......+.+|+.++++++   ||||+++++++
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~   77 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFD---HPHIVKLIGVI   77 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCC---CTTBCCEEEEE
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCC---CCCEeeEEEEE
Confidence            5678899999999999999999999884333  3467777765332 2222346778999999997   99999999998


Q ss_pred             eccccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEE
Q psy2676          95 HQNILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLK  173 (321)
Q Consensus        95 ~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~k  173 (321)
                      .+.        .+++|||++. |+|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+|
T Consensus        78 ~~~--------~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~K  148 (273)
T d1mp8a_          78 TEN--------PVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK  148 (273)
T ss_dssp             CSS--------SCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred             ecC--------eEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEE
Confidence            543        4689999999 58888876644 3489999999999999999999999999999999999999999999


Q ss_pred             EeecCCcccccCCC--ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCC
Q psy2676         174 IADFGLAKTFDYDM--MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       174 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      |+|||++.......  ......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..+....+......
T Consensus       149 l~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~  228 (273)
T d1mp8a_         149 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL  228 (273)
T ss_dssp             ECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred             EccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999998765332  2334567899999999999999999999999999999998 89999988877777666543221


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      +.                          ..++|+++.+||.+||..||.+|||+.+|++|
T Consensus       229 ~~--------------------------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         229 PM--------------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC--------------------------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            11                          12567899999999999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-53  Score=350.86  Aligned_cols=253  Identities=23%  Similarity=0.334  Sum_probs=199.8

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCC--cEEEEEEeecccCCC-CCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKG--NYVAMKKLRVKLNED-GIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~--~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      ..++|++.+.||+|+||+||+|+....++  ..||+|+++...... .....+.+|+.++++++   ||||+++++++.+
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~~~g~~~~   82 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD---HRNLIRLYGVVLT   82 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC---CTTBCCEEEEECS
T ss_pred             chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC---CCCEEEEEEEEee
Confidence            45789999999999999999998744444  378999887543322 22346789999999998   9999999999965


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      +        ..++|+||++ |++.+++..... .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+
T Consensus        83 ~--------~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~  153 (273)
T d1u46a_          83 P--------PMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIG  153 (273)
T ss_dssp             S--------SCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEEC
T ss_pred             c--------chheeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeec
Confidence            4        3589999999 588888776433 49999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCc----cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCC
Q psy2676         176 DFGLAKTFDYDMM----LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGT  250 (321)
Q Consensus       176 dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  250 (321)
                      |||++........    .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+......
T Consensus       154 DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~  233 (273)
T d1u46a_         154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER  233 (273)
T ss_dssp             CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC
T ss_pred             cchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC
Confidence            9999987754432    223456788999999999999999999999999999998 89999998888887776553322


Q ss_pred             CCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         251 PSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ++..                         .++|+++.+||.+||+.||++|||+.+|++
T Consensus       234 ~~~~-------------------------~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         234 LPRP-------------------------EDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CCCC-------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCc-------------------------ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            2211                         256689999999999999999999999863

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=353.84  Aligned_cols=250  Identities=22%  Similarity=0.340  Sum_probs=200.7

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCc----EEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGN----YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      .++|++++.||+|+||+||+|++. .+++    .||+|.++... .......+.+|+.++++++   ||||+++++++.+
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~-~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~---HpnIv~l~g~~~~   82 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVD---NPHVCRLLGICLT   82 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEEC-C----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCC---CTTBCCEEEEEES
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEc-CCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCC---CCCEeeEEEEEec
Confidence            357999999999999999999983 4544    57788775432 2334557889999999998   9999999999876


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      .       . .+++++++. |+|.+.+.... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+
T Consensus        83 ~-------~-~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~  153 (317)
T d1xkka_          83 S-------T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT  153 (317)
T ss_dssp             S-------S-EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEEC
T ss_pred             C-------C-eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEee
Confidence            5       2 456666666 69998887754 349999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCC
Q psy2676         176 DFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTP  251 (321)
Q Consensus       176 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  251 (321)
                      |||++........   .....+|+.|+|||++.+..++.++||||||+++|+|+| |.+||.+.+..+....+...... 
T Consensus       154 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~-  232 (317)
T d1xkka_         154 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-  232 (317)
T ss_dssp             CCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-
T ss_pred             ccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            9999987653332   233467999999999999999999999999999999998 79999887776665555443221 


Q ss_pred             CCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         252 SMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      +.+                         ..+++++.+|+.+||+.||.+|||+.++++|
T Consensus       233 ~~p-------------------------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         233 PQP-------------------------PICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             CCC-------------------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC-------------------------cccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            111                         2466899999999999999999999999976

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=349.23  Aligned_cols=250  Identities=22%  Similarity=0.336  Sum_probs=202.7

Q ss_pred             cccCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          17 LDLGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        17 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +++..++|++.+.||+|+||.||+|+.   .++.||+|+++.+    .....+.+|+.++++++   ||||+++++++.+
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~---HpnIv~~~g~~~~   71 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKND----ATAQAFLAEASVMTQLR---HSNLVQLLGVIVE   71 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCC----C--HHHHHTHHHHTTCC---CTTBCCEEEEECC
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEE---CCeEEEEEEECcH----HHHHHHHHHHHHHHhCC---CCCEeeEEEEEEe
Confidence            567788999999999999999999976   4778999998643    23457889999999997   9999999998854


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEe
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIA  175 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~  175 (321)
                      ..      ..+++||||++ |+|.+++.......+++..++.++.||+.||.|||+.+++||||||+||+++.++.+||+
T Consensus        72 ~~------~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~  145 (262)
T d1byga_          72 EK------GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVS  145 (262)
T ss_dssp             C--------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred             cC------CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeec
Confidence            31      34699999998 599999976544458999999999999999999999999999999999999999999999


Q ss_pred             ecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCC
Q psy2676         176 DFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVPLFCASTEVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       176 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (321)
                      |||++......  .....++..|+|||++.+..++.++||||||+++|+|++ |++||...+..+....+......+   
T Consensus       146 dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~---  220 (262)
T d1byga_         146 DFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---  220 (262)
T ss_dssp             CCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC---
T ss_pred             ccccceecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence            99999865433  334567889999999999999999999999999999998 789998877776666554321111   


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                       .                      ...+++++.+||++||+.||.+|||+.+++++
T Consensus       221 -~----------------------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         221 -A----------------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             -C----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -C----------------------CccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence             1                      12456899999999999999999999999864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=351.21  Aligned_cols=262  Identities=22%  Similarity=0.318  Sum_probs=201.8

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEE
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRF   90 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~   90 (321)
                      +.+++..++|++.+.||+|+||+||+|++..    .+++.||+|+++...... ....+.+|...+.++..  |+||+.+
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~e~~~l~~~~~--h~~iv~~   82 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGH--HLNVVNL   82 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-HHHHHHHHHHHHHHHCC--CTTBCCE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-HHHHHHHHHHHHHhhcC--CCeEEEe
Confidence            3456778899999999999999999999743    244689999986432221 23356677777777763  9999999


Q ss_pred             EeeeeccccccccceEEEEEeccCc-cCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--------------PPGLSASKVKELTRQMLKGVDFLHSHRII  155 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~~  155 (321)
                      ++++....      ..+++||||++ |+|.+++....              ...+++.++..++.||+.||+|||++|++
T Consensus        83 ~~~~~~~~------~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iv  156 (299)
T d1ywna1          83 LGACTKPG------GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI  156 (299)
T ss_dssp             EEEECSTT------SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             eeeeccCC------CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCc
Confidence            99875541      45799999999 69999997642              23488999999999999999999999999


Q ss_pred             eccCCCCcEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhc-CCC
Q psy2676         156 HRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL-VPL  231 (321)
Q Consensus       156 H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p  231 (321)
                      ||||||+||+++.++++||+|||++.......   ......||+.|+|||++.+..++.++||||+||++|+|++| .+|
T Consensus       157 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p  236 (299)
T d1ywna1         157 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  236 (299)
T ss_dssp             CSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCC
Confidence            99999999999999999999999997654332   23346789999999999999999999999999999999986 568


Q ss_pred             CCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         232 FCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      |.+....+...........+..+                         ..+++++.++|.+||+.||.+|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         237 YPGVKIDEEFCRRLKEGTRMRAP-------------------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             STTCCCSHHHHHHHHHTCCCCCC-------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHhcCCCCCCC-------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            87766555444444433222221                         2456899999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.4e-52  Score=349.45  Aligned_cols=258  Identities=26%  Similarity=0.390  Sum_probs=212.4

Q ss_pred             cccccCCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEE
Q psy2676          15 DSLDLGDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRF   90 (321)
Q Consensus        15 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~   90 (321)
                      ..+++..++|++++.||+|+||+||+|+...    .+++.||||+++.... ......+.+|+.++++++   |||++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~il~~l~---h~niv~~   81 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFD---NPNIVKL   81 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCC---CTTBCCE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC-hHHHHHHHHHHHHHHhcC---CCCcccc
Confidence            3577888999999999999999999998742    3567899999864322 222346789999999998   9999999


Q ss_pred             EeeeeccccccccceEEEEEeccCc-cCHHHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHH
Q psy2676          91 FDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP----------------------PPGLSASKVKELTRQMLKGVD  147 (321)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~----------------------~~~~~~~~~~~i~~~l~~~l~  147 (321)
                      ++++...       ...++++|++. |+|.+++....                      ...+++..+..++.||+.||+
T Consensus        82 ~~~~~~~-------~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~  154 (301)
T d1lufa_          82 LGVCAVG-------KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA  154 (301)
T ss_dssp             EEEECSS-------SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHH
T ss_pred             eeeeccC-------CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhh
Confidence            9999776       56799999998 69999986532                      223789999999999999999


Q ss_pred             HHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHH
Q psy2676         148 FLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAE  224 (321)
Q Consensus       148 ~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~  224 (321)
                      |||+++++||||||+||+++.++.+||+|||++.......   ......+++.|+|||.+.+..++.++||||||+++|+
T Consensus       155 ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~e  234 (301)
T d1lufa_         155 YLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE  234 (301)
T ss_dssp             HHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             hcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHH
Confidence            9999999999999999999999999999999997654332   2334567889999999999999999999999999999


Q ss_pred             HHhcC-CCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCC
Q psy2676         225 MWRLV-PLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRIS  303 (321)
Q Consensus       225 l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  303 (321)
                      |++|. +||.+.+..+....+......    ..                      ..++++++.+||.+||+.||++|||
T Consensus       235 ll~~~~~p~~~~~~~e~~~~v~~~~~~----~~----------------------p~~~~~~~~~li~~cl~~~P~~RPt  288 (301)
T d1lufa_         235 IFSYGLQPYYGMAHEEVIYYVRDGNIL----AC----------------------PENCPLELYNLMRLCWSKLPADRPS  288 (301)
T ss_dssp             HHTTTCCTTTTSCHHHHHHHHHTTCCC----CC----------------------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHccCCCCCCCCCHHHHHHHHHcCCCC----CC----------------------CccchHHHHHHHHHHcCCChhHCcC
Confidence            99985 788888887777665543211    11                      1256689999999999999999999


Q ss_pred             HHHHhC
Q psy2676         304 AADALE  309 (321)
Q Consensus       304 ~~~ll~  309 (321)
                      +.||++
T Consensus       289 ~~ev~~  294 (301)
T d1lufa_         289 FCSIHR  294 (301)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999964

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=346.66  Aligned_cols=258  Identities=24%  Similarity=0.365  Sum_probs=208.0

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEecC------CCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQN------KGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVR   89 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~   89 (321)
                      .+++..++|++.+.||+|+||.||+|++...      ++..||+|+++..... .....+.+|...+.++..  ||||++
T Consensus         7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~e~~~l~~~~~--HpnIv~   83 (299)
T d1fgka_           7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGK--HKNIIN   83 (299)
T ss_dssp             TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH-HHHHHHHHHHHHHHHHCC--CTTBCC
T ss_pred             cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh-HHHHHHHHHHHHHHHhcC--CCeEEe
Confidence            4778889999999999999999999987432      2357999998654322 223466778888888853  999999


Q ss_pred             EEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy2676          90 FFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP--------------PPGLSASKVKELTRQMLKGVDFLHSHRI  154 (321)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l~~~l~~lh~~~~  154 (321)
                      +++++.+.       ..+++||||+. |+|.+++....              ...+++..++.++.||+.||+|||+.|+
T Consensus        84 ~~~~~~~~-------~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~i  156 (299)
T d1fgka_          84 LLGACTQD-------GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC  156 (299)
T ss_dssp             EEEEECSS-------SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             cccccccC-------CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCE
Confidence            99999776       67899999999 59999997653              2348999999999999999999999999


Q ss_pred             eeccCCCCcEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHh-cCC
Q psy2676         155 IHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWR-LVP  230 (321)
Q Consensus       155 ~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~  230 (321)
                      +||||||+||+++.++.+||+|||.+.......   ......+++.|+|||++.+..++.++||||||+++|+|++ |.+
T Consensus       157 vHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~  236 (299)
T d1fgka_         157 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS  236 (299)
T ss_dssp             CCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             EeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCC
Confidence            999999999999999999999999998665433   2334678899999999999999999999999999999998 799


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC
Q psy2676         231 LFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE  309 (321)
Q Consensus       231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  309 (321)
                      ||.+.+..+....+... ..++.   +                      ..+++++.+||.+||+.||.+|||+.||++
T Consensus       237 p~~~~~~~~~~~~i~~~-~~~~~---p----------------------~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         237 PYPGVPVEELFKLLKEG-HRMDK---P----------------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             SSTTCCHHHHHHHHHTT-CCCCC---C----------------------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHHcC-CCCCC---C----------------------ccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            99888777665554432 11211   1                      245689999999999999999999999985

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=346.21  Aligned_cols=255  Identities=25%  Similarity=0.348  Sum_probs=207.8

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCc--EEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeec
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGN--YVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQ   96 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~--~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~   96 (321)
                      +.-++|++.+.||+|+||+||+|++. .++.  .|++|.++.... ......+.+|+.+++++..  ||||+++++++.+
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~--HpnIv~~~~~~~~   82 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGH--HPNIINLLGACEH   82 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEE-ETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCC--CTTBCCEEEEEEE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEEC-CCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccC--CCCEeeEEEEEec
Confidence            34479999999999999999999984 4554  466777654322 2345678999999999843  9999999999987


Q ss_pred             cccccccceEEEEEeccCc-cCHHHHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q psy2676          97 NILSDERYLTVYLIFEHVD-QDLGSYMEKC--------------PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKP  161 (321)
Q Consensus        97 ~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~--------------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p  161 (321)
                      .       ...++||||++ |+|.+++...              ....+++..+..++.||+.||.|||+.|++||||||
T Consensus        83 ~-------~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp  155 (309)
T d1fvra_          83 R-------GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA  155 (309)
T ss_dssp             T-------TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             C-------CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCcccccccc
Confidence            7       67899999999 5999998753              234589999999999999999999999999999999


Q ss_pred             CcEEEeeCCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcC-CCCCCCChHHH
Q psy2676         162 QNLLITRAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLV-PLFCASTEVEQ  240 (321)
Q Consensus       162 ~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~~~~~  240 (321)
                      +||+++.++.+||+|||++.............+|..|+|||.+.+..++.++||||||+++|+|++|. +||.+.+..+.
T Consensus       156 ~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~  235 (309)
T d1fvra_         156 RNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL  235 (309)
T ss_dssp             GGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             ceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999999998766555555667899999999999999999999999999999999964 67888877776


Q ss_pred             HHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC
Q psy2676         241 LKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH  310 (321)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  310 (321)
                      ...+..... +.                         ....+++++.+||.+||+.||++|||+.+|++|
T Consensus       236 ~~~i~~~~~-~~-------------------------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         236 YEKLPQGYR-LE-------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HHHGGGTCC-CC-------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCC-CC-------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            655543211 11                         112566899999999999999999999999976

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-51  Score=343.48  Aligned_cols=266  Identities=22%  Similarity=0.296  Sum_probs=217.4

Q ss_pred             ccccccc-ccccCCcceeeeeeeecccceeEEEEEEe----cCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCC
Q psy2676           9 IQSLNLD-SLDLGDKKYDELCQIGCGAYGTVFKARDL----QNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFE   83 (321)
Q Consensus         9 ~~~~~~~-~~~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   83 (321)
                      .+.++.+ .+++..++|++.+.||+|+||.||+|+..    ..+++.||+|+++..... .....+.+|+.+++++..  
T Consensus         9 ~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~E~~~~~~l~~--   85 (311)
T d1t46a_           9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGN--   85 (311)
T ss_dssp             TTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCC--
T ss_pred             cccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH-HHHHHHHHHHHHHHhccC--
Confidence            4445533 47888899999999999999999999863    246678999998754222 223467789999999853  


Q ss_pred             CCceeEEEeeeeccccccccceEEEEEeccCc-cCHHHHHhhCC----------------CCCCCHHHHHHHHHHHHHHH
Q psy2676          84 HPNIVRFFDVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKCP----------------PPGLSASKVKELTRQMLKGV  146 (321)
Q Consensus        84 ~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~~----------------~~~~~~~~~~~i~~~l~~~l  146 (321)
                      ||||+++++++.+.       ...++||||++ |+|.+++....                ...+++..+..++.||+.||
T Consensus        86 HpnIv~~~g~~~~~-------~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl  158 (311)
T d1t46a_          86 HMNIVNLLGACTIG-------GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM  158 (311)
T ss_dssp             CTTBCCEEEEECSS-------SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHH
T ss_pred             CCCEEEEEEEEeeC-------CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHH
Confidence            99999999999776       56799999999 59999987643                22489999999999999999


Q ss_pred             HHHHhCCceeccCCCCcEEEeeCCCEEEeecCCcccccCCC---ccccccccccccchhhhhcCCCCCcchHHHHHHHHH
Q psy2676         147 DFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLAKTFDYDM---MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMA  223 (321)
Q Consensus       147 ~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~  223 (321)
                      +|||++|++||||||+||+++.++.++++|||.+.......   ......+|+.|+|||++.+..++.++||||||+++|
T Consensus       159 ~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~  238 (311)
T d1t46a_         159 AFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW  238 (311)
T ss_dssp             HHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             HHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHH
Confidence            99999999999999999999999999999999998765332   234467899999999999999999999999999999


Q ss_pred             HHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCC
Q psy2676         224 EMWR-LVPLFCASTEVEQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRI  302 (321)
Q Consensus       224 ~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  302 (321)
                      +|++ |.+||.+.+..+....+......+..+                         ..+++++.+||.+||+.||.+||
T Consensus       239 ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~l~~Li~~cl~~dP~~RP  293 (311)
T d1t46a_         239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP-------------------------EHAPAEMYDIMKTCWDADPLKRP  293 (311)
T ss_dssp             HHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC-------------------------TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc-------------------------ccccHHHHHHHHHHcCCChhHCc
Confidence            9998 677777766666665555443333222                         14568999999999999999999


Q ss_pred             CHHHHhC
Q psy2676         303 SAADALE  309 (321)
Q Consensus       303 s~~~ll~  309 (321)
                      |+++|++
T Consensus       294 s~~~il~  300 (311)
T d1t46a_         294 TFKQIVQ  300 (311)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999985

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-51  Score=342.13  Aligned_cols=263  Identities=22%  Similarity=0.351  Sum_probs=216.8

Q ss_pred             ccccCCcceeeeeeeecccceeEEEEEEec----CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEE
Q psy2676          16 SLDLGDKKYDELCQIGCGAYGTVFKARDLQ----NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFF   91 (321)
Q Consensus        16 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~   91 (321)
                      .+++..++|++.+.||+|+||+||+|.+..    .+++.||||+++..... .....+.+|+.++++++   ||||++++
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~-~~~~~~~~E~~il~~l~---h~nIv~~~   89 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFN---CHHVVRLL   89 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCC---CTTBCCEE
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh-HHHHHHHHHHHHHHHcC---CCCEeeee
Confidence            578888999999999999999999998742    24578999998643221 22335678999999987   99999999


Q ss_pred             eeeeccccccccceEEEEEeccCc-cCHHHHHhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVD-QDLGSYMEKC--------PPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQ  162 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~-~~L~~~~~~~--------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~  162 (321)
                      +++...       ...++|||++. |+|.+++...        ....+++..+..++.|++.||.|||+++++||||||+
T Consensus        90 ~~~~~~-------~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~  162 (308)
T d1p4oa_          90 GVVSQG-------QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR  162 (308)
T ss_dssp             EEECSS-------SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGG
T ss_pred             eEEecC-------CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCC
Confidence            999766       56799999999 6999987642        1133789999999999999999999999999999999


Q ss_pred             cEEEeeCCCEEEeecCCcccccCCCc---cccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhc-CCCCCCCChH
Q psy2676         163 NLLITRAGGLKIADFGLAKTFDYDMM---LTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRL-VPLFCASTEV  238 (321)
Q Consensus       163 Nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~  238 (321)
                      ||+++.++++||+|||++........   .....+++.|+|||.+.+..++.++||||||+++|+|++| ..||.+.+..
T Consensus       163 NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~  242 (308)
T d1p4oa_         163 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE  242 (308)
T ss_dssp             GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred             ceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999976643322   3344688999999999999999999999999999999998 5888888887


Q ss_pred             HHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhC------CCC
Q psy2676         239 EQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALE------HPY  312 (321)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------h~~  312 (321)
                      +....+.+....+.                          ...+++.+.++|.+||+.||++|||+.+|++      +|+
T Consensus       243 ~~~~~i~~~~~~~~--------------------------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         243 QVLRFVMEGGLLDK--------------------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             HHHHHHHTTCCCCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             HHHHHHHhCCCCCC--------------------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            77776654322111                          1246689999999999999999999999997      787


Q ss_pred             CCC
Q psy2676         313 FKE  315 (321)
Q Consensus       313 f~~  315 (321)
                      |++
T Consensus       297 ~~~  299 (308)
T d1p4oa_         297 FRE  299 (308)
T ss_dssp             HHH
T ss_pred             CcC
Confidence            764

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.3e-49  Score=332.99  Aligned_cols=253  Identities=18%  Similarity=0.199  Sum_probs=207.7

Q ss_pred             cCCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccc
Q psy2676          19 LGDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNI   98 (321)
Q Consensus        19 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~   98 (321)
                      +.+++|++++.||+|+||+||+|++ ..+++.||+|+++...    ....+.+|++.++.+..  |+|++.+++++... 
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~-~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~--~~~i~~~~~~~~~~-   73 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTN-LLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAG--CTGIPNVYYFGQEG-   73 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEE-TTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTT--CTTCCCEEEEEEET-
T ss_pred             CCCCceEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcC--CCCCCEEEEEeecC-
Confidence            4678999999999999999999999 5789999999986542    23467889999999984  69999999998776 


Q ss_pred             cccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee-----CCCEE
Q psy2676          99 LSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR-----AGGLK  173 (321)
Q Consensus        99 ~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~-----~~~~k  173 (321)
                            ...++|||+++++|.+++..... .+++..+..++.|++.||++||++|++||||||+||+++.     ++.++
T Consensus        74 ------~~~~~vme~~~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vk  146 (293)
T d1csna_          74 ------LHNVLVIDLLGPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIY  146 (293)
T ss_dssp             ------TEEEEEEECCCCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred             ------CccEEEEEecCCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceE
Confidence                  67899999999999999877543 4999999999999999999999999999999999999974     56799


Q ss_pred             EeecCCcccccCCC--------ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChH---HHHH
Q psy2676         174 IADFGLAKTFDYDM--------MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEV---EQLK  242 (321)
Q Consensus       174 l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~  242 (321)
                      |+|||++.......        ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+....   ....
T Consensus       147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~  226 (293)
T d1csna_         147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE  226 (293)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred             EcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH
Confidence            99999998764321        233457899999999999999999999999999999999999999764332   2222


Q ss_pred             HHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHh
Q psy2676         243 CIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADAL  308 (321)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll  308 (321)
                      .+....                      .......+..++|+++.+++..|+..+|++||+.+.+.
T Consensus       227 ~i~~~~----------------------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~  270 (293)
T d1csna_         227 RIGEKK----------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ  270 (293)
T ss_dssp             HHHHHH----------------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             HHHhcc----------------------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence            222111                      11122334457889999999999999999999877654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-49  Score=334.67  Aligned_cols=260  Identities=20%  Similarity=0.236  Sum_probs=204.2

Q ss_pred             CcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccc
Q psy2676          21 DKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILS  100 (321)
Q Consensus        21 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~  100 (321)
                      +++|++++.||+|+||+||+|++ ..+++.||+|++..+..    ...+..|+++++++..  |++|+.+.+++.+.   
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~-~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~--~~~i~~~~~~~~~~---   75 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTD-IAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQG--GVGIPTIRWCGAEG---   75 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEE-TTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTT--STTCCCEEEEEEET---
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEE-CCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccC--CCcccEEEEEEecC---
Confidence            46899999999999999999999 57889999999875422    3467889999999982  44566666666555   


Q ss_pred             cccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee---CCCEEEeec
Q psy2676         101 DERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITR---AGGLKIADF  177 (321)
Q Consensus       101 ~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~---~~~~kl~df  177 (321)
                          ...++|||+++++|...+.... ..+++..+..++.|++.||+|||++|++||||||+||+++.   +..++|+||
T Consensus        76 ----~~~~ivme~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DF  150 (299)
T d1ckia_          76 ----DYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDF  150 (299)
T ss_dssp             ----TEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             ----CEEEEEEEEcCCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeecc
Confidence                6789999999998888877654 34999999999999999999999999999999999999864   446999999


Q ss_pred             CCcccccCCC--------ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhC
Q psy2676         178 GLAKTFDYDM--------MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCASTEVEQLKCIFRVIG  249 (321)
Q Consensus       178 g~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  249 (321)
                      |++.......        ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+.... 
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~-  229 (299)
T d1ckia_         151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-  229 (299)
T ss_dssp             SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH-
T ss_pred             CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh-
Confidence            9998765332        2234578999999999999999999999999999999999999998765544433332211 


Q ss_pred             CCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHH---HhCCCCCC
Q psy2676         250 TPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAAD---ALEHPYFK  314 (321)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~---ll~h~~f~  314 (321)
                                        ........+....++|+++.+++.+||+.+|++||++++   +|+|+|.+
T Consensus       230 ------------------~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         230 ------------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             ------------------HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ------------------cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence                              001111223344578899999999999999999999874   46777654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-50  Score=337.18  Aligned_cols=256  Identities=21%  Similarity=0.278  Sum_probs=198.5

Q ss_pred             eeeeeeeecccceeEEEEEEecCCC--cEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKG--NYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~--~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      +.+.++||+|+||+||+|++...++  ..||+|+++.. ........+.+|+.++++++   ||||+++++++....   
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~---HpnIv~~~g~~~~~~---  101 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFS---HPNVLSLLGICLRSE---  101 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCC---CTTBCCCCEEEEETT---
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCC---CCCEeEEeEEEEecC---
Confidence            3447899999999999999843333  36889988642 22223356889999999998   999999999875431   


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeeCCCEEEeecCCc
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLITRAGGLKIADFGLA  180 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~~~~~~kl~dfg~~  180 (321)
                         ...++||||++ |+|.+++.... ..+++..+..++.|++.||.|||+.+++||||||+||++++++.+||+|||++
T Consensus       102 ---~~~~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~  177 (311)
T d1r0pa_         102 ---GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA  177 (311)
T ss_dssp             ---TEEEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGG
T ss_pred             ---CceEEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccch
Confidence               46799999999 58988887644 34788899999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC-----ccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-hHHHHHHHHHHhCCCCCC
Q psy2676         181 KTFDYDM-----MLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST-EVEQLKCIFRVIGTPSMN  254 (321)
Q Consensus       181 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~  254 (321)
                      .......     ......+|+.|+|||.+....++.++||||||+++|+|++|..||.... ..+....+... ..+.. 
T Consensus       178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~~~~-  255 (311)
T d1r0pa_         178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQ-  255 (311)
T ss_dssp             CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CCCCC-
T ss_pred             hhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCC-
Confidence            8764332     2223567899999999999999999999999999999999877775433 33333332221 11111 


Q ss_pred             CcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHHhCC------CCCCCC
Q psy2676         255 EWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADALEH------PYFKEK  316 (321)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h------~~f~~~  316 (321)
                                              ...+++++.+||.+||+.||++|||+.||++|      +|..+.
T Consensus       256 ------------------------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~  299 (311)
T d1r0pa_         256 ------------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH  299 (311)
T ss_dssp             ------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred             ------------------------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence                                    12456899999999999999999999999988      666543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.1e-49  Score=339.23  Aligned_cols=289  Identities=26%  Similarity=0.441  Sum_probs=212.0

Q ss_pred             CCcceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhccc--------CCCCceeEEE
Q psy2676          20 GDKKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDT--------FEHPNIVRFF   91 (321)
Q Consensus        20 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--------~~~~~i~~~~   91 (321)
                      ..+||++++.||+|+||+||+|++ ..+++.||+|+++....   ......+|+.+++.+..        +.|+||++++
T Consensus        11 ~~~rY~i~~~LG~G~fg~Vy~~~~-~~~g~~vAvKvi~~~~~---~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          11 KDARYILVRKLGWGHFSTVWLAKD-MVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             cCCcEEEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEecccc---chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            346899999999999999999999 68899999999874321   12356788888888752        1368999999


Q ss_pred             eeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeeCC
Q psy2676          92 DVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS-HRIIHRDLKPQNLLITRAG  170 (321)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~~H~di~p~Nilv~~~~  170 (321)
                      +++...   .......++.++...+.............+++..++.++.||+.||.+||+ .||+||||||+||+++.++
T Consensus        87 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~  163 (362)
T d1q8ya_          87 DHFNHK---GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD  163 (362)
T ss_dssp             EEEEEE---ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred             EEeeec---cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccC
Confidence            988543   122233444445555566666666666779999999999999999999997 8999999999999998766


Q ss_pred             C------EEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHHHHHHHhcCCCCCCCC------hH
Q psy2676         171 G------LKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCVMAEMWRLVPLFCAST------EV  238 (321)
Q Consensus       171 ~------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~  238 (321)
                      .      ++++|||.+.....  ......+|+.|+|||++.+..++.++|+||+||++++|++|+.||....      ..
T Consensus       164 ~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         164 SPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             TTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence            4      99999999876543  3345678999999999999999999999999999999999999997543      34


Q ss_pred             HHHHHHHHHhCCCCCCCcchhhhhh--h------hhhhhhh-------hhhhhhhhhhcchhHHHHHHHhcccCCCCCCC
Q psy2676         239 EQLKCIFRVIGTPSMNEWPENISLM--W------SSFEQYS-------KVAFSAIFMDCCSKANSLLESMLTFNPADRIS  303 (321)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~--~------~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps  303 (321)
                      +........++.++...+.......  .      ..+....       ...........++++.+||.+||.+||.+|||
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence            4555666666654332211100000  0      0000000       00011122356788999999999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q psy2676         304 AADALEHPYFKEKE  317 (321)
Q Consensus       304 ~~~ll~h~~f~~~~  317 (321)
                      ++|+|+||||++..
T Consensus       322 a~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         322 AGGLVNHPWLKDTL  335 (362)
T ss_dssp             HHHHHTCGGGTTCT
T ss_pred             HHHHhcCcccCCCC
Confidence            99999999999663

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-48  Score=324.50  Aligned_cols=254  Identities=24%  Similarity=0.297  Sum_probs=188.1

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      .+|.+.+.||+|+||+||+|+.   +++.||+|+++.+.     ......|.+++ .+..++||||+++++++.+..   
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~~~-----~~~~~~e~ei~-~~~~~~HpnIv~~~~~~~~~~---   70 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSRE-----ERSWFREAEIY-QTVMLRHENILGFIAADNKDN---   70 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE---TTEEEEEEEECGGG-----HHHHHHHHHHH-TSTTCCCTTBCCEEEEEEEEC---
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccc-----hhHHHHHHHHH-HHhhCCCCcCcceEEEEEeCC---
Confidence            5799999999999999999975   67899999986432     22344454443 223344999999999987652   


Q ss_pred             ccceEEEEEeccCc-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCcEEEeeCCCE
Q psy2676         102 ERYLTVYLIFEHVD-QDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHS--------HRIIHRDLKPQNLLITRAGGL  172 (321)
Q Consensus       102 ~~~~~~~~v~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~--------~~~~H~di~p~Nilv~~~~~~  172 (321)
                      .....+++||||++ |+|.+++...   .+++..++.++.|++.||.|||+        +|++||||||+||+++.++.+
T Consensus        71 ~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~  147 (303)
T d1vjya_          71 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred             CcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence            22346899999998 5999999873   48999999999999999999996        599999999999999999999


Q ss_pred             EEeecCCcccccCCC-----ccccccccccccchhhhhcCC------CCCcchHHHHHHHHHHHHhcCCCCCCCChH---
Q psy2676         173 KIADFGLAKTFDYDM-----MLTSVVVTLWYRAPEILLNLG------YGTPVDIWSIGCVMAEMWRLVPLFCASTEV---  238 (321)
Q Consensus       173 kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---  238 (321)
                      ||+|||++.......     ......||+.|+|||++.+..      ++.++|||||||++|+|++|..||......   
T Consensus       148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~  227 (303)
T d1vjya_         148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence            999999998765432     223467899999999987643      466899999999999999998887432211   


Q ss_pred             -----------HHHHHHHHHhCCCCCCCcchhhhhhhhhhhhhhhhhhhhhhhhcchhHHHHHHHhcccCCCCCCCHHHH
Q psy2676         239 -----------EQLKCIFRVIGTPSMNEWPENISLMWSSFEQYSKVAFSAIFMDCCSKANSLLESMLTFNPADRISAADA  307 (321)
Q Consensus       239 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  307 (321)
                                 ........  .....+..+                 ......+.+..+.+|+.+||+.||++|||+.||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~--~~~~~p~~~-----------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei  288 (303)
T d1vjya_         228 YYDLVPSDPSVEEMRKVVC--EQKLRPNIP-----------------NRWQSCEALRVMAKIMRECWYANGAARLTALRI  288 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHT--TSCCCCCCC-----------------GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred             hhhcccccchHHHHHHHHh--ccccCCCCC-----------------cccCChHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence                       11111000  000000000                 000112344678999999999999999999999


Q ss_pred             hC
Q psy2676         308 LE  309 (321)
Q Consensus       308 l~  309 (321)
                      ++
T Consensus       289 ~~  290 (303)
T d1vjya_         289 KK  290 (303)
T ss_dssp             HH
T ss_pred             HH
Confidence            76

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=2.1e-26  Score=179.45  Aligned_cols=171  Identities=18%  Similarity=0.119  Sum_probs=117.4

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCC----------------CchhHHHHHHHHhcccCCCCce
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGI----------------PMSTLREISILKQLDTFEHPNI   87 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~----------------~~~~~~e~~~l~~l~~~~~~~i   87 (321)
                      +.+.++||+|+||+||+|++  .+++.||+|+++........                ......|...+.++.   |+++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~--~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~v   76 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ---GLAV   76 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT---TSSS
T ss_pred             chhCCEeeeCcceEEEEEEC--CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc---CCCc
Confidence            46789999999999999988  46889999987643221100                012234677777777   8888


Q ss_pred             eEEEeeeeccccccccceEEEEEeccCccCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q psy2676          88 VRFFDVIHQNILSDERYLTVYLIFEHVDQDLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHRIIHRDLKPQNLLIT  167 (321)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~~H~di~p~Nilv~  167 (321)
                      +..+++.           ..+++||++++....        .++...+..++.|++.+|.+||++|++||||||+||+++
T Consensus        77 ~~~~~~~-----------~~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~  137 (191)
T d1zara2          77 PKVYAWE-----------GNAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS  137 (191)
T ss_dssp             CCEEEEE-----------TTEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred             ceEEEec-----------CCEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee
Confidence            8877653           126899999973211        145555678999999999999999999999999999998


Q ss_pred             eCCCEEEeecCCcccccCCCccccccccccccchhhhhcCCCCCcchHHHHHHH
Q psy2676         168 RAGGLKIADFGLAKTFDYDMMLTSVVVTLWYRAPEILLNLGYGTPVDIWSIGCV  221 (321)
Q Consensus       168 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~  221 (321)
                      ++ .++|+|||.+.....+........+... -.+ +..+.++.++|+||+.--
T Consensus       138 ~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~-~~~-~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         138 EE-GIWIIDFPQSVEVGEEGWREILERDVRN-IIT-YFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             TT-EEEECCCTTCEETTSTTHHHHHHHHHHH-HHH-HHHHHHCCCCCHHHHHHH
T ss_pred             CC-CEEEEECCCcccCCCCCcHHHHHHHHHH-HHH-HHcCCCCCcccHHHHHHH
Confidence            54 5999999998766533221110000000 011 234567889999998543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.91  E-value=1.1e-08  Score=81.91  Aligned_cols=140  Identities=14%  Similarity=0.174  Sum_probs=94.7

Q ss_pred             cceeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      ..|++++..+.++.+.||++.   .++..+++|+....  .......+.+|...++.+..  +--+.+++.+..+.    
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~---~~~~~~vlk~~~~~--~~~~~~~~~~E~~~l~~l~~--~vpvP~vl~~~~~~----   82 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV---GENENLYLKMTDSR--YKGTTYDVEREKDMMLWLEG--KLPVPKVLHFERHD----   82 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE---CSSCEEEEEEECGG--GTTSTTCHHHHHHHHHHHTT--TSCCCCEEEEEEET----
T ss_pred             hceEEEEcCCCCCCCcEEEEE---eCCCeEEEEEcCCC--cccchhhHHHHHHHHHHHhc--cCCCCcEEEEEecC----
Confidence            467888876667778999884   46666778876543  22234467889999888864  43356666666554    


Q ss_pred             ccceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------
Q psy2676         102 ERYLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSHR---------------------------  153 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~~---------------------------  153 (321)
                         ...++||++++| ++.+....       ......++.+++..+..||+..                           
T Consensus        83 ---~~~~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (263)
T d1j7la_          83 ---GWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD  152 (263)
T ss_dssp             ---TEEEEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred             ---CceEEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence               567899999998 65544322       1112334555666666666421                           


Q ss_pred             --------------------------------ceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         154 --------------------------------IIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       154 --------------------------------~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                                                      ++|+|+.|.||++++++...|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                            58999999999998766667999998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.51  E-value=4.8e-07  Score=71.75  Aligned_cols=134  Identities=20%  Similarity=0.128  Sum_probs=83.4

Q ss_pred             eeeeeeeecccceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccccc
Q psy2676          24 YDELCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDER  103 (321)
Q Consensus        24 y~~~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~  103 (321)
                      ++....-+..+.+.||++..  .++..+++|.....     ....+..|...++.+....- .+.+++.+..+.      
T Consensus        13 ~~~~~~~~G~s~~~v~r~~~--~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gv-pvP~v~~~~~~~------   78 (255)
T d1nd4a_          13 YDWAQQTIGCSDAAVFRLSA--QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGV-PCAAVLDVVTEA------   78 (255)
T ss_dssp             CEEEECSCTTSSCEEEEEEC--TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTC-CBCCEEEEEECS------
T ss_pred             CceEEcCCcccCCeEEEEEe--CCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCC-CCCceeeecccc------
Confidence            33333333334468999875  56667888876432     23467889999988875322 256677665554      


Q ss_pred             ceEEEEEeccCcc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------
Q psy2676         104 YLTVYLIFEHVDQ-DLGSYMEKCPPPGLSASKVKELTRQMLKGVDFLHSH------------------------------  152 (321)
Q Consensus       104 ~~~~~~v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~lh~~------------------------------  152 (321)
                       ...++||++++| ++.+.       ..+..   ..+.++...|..||+.                              
T Consensus        79 -~~~~~v~~~i~G~~~~~~-------~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (255)
T d1nd4a_          79 -GRDWLLLGEVPGQDLLSS-------HLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD  147 (255)
T ss_dssp             -SCEEEEEECCSSEETTTS-------CCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred             -cceEEEEEeeeccccccc-------cccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccc
Confidence             457899999987 43221       01111   1122333334444421                              


Q ss_pred             ----------------------------CceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         153 ----------------------------RIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       153 ----------------------------~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                                                  .++|+|+.|.||+++++...-|+||+.+..
T Consensus       148 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         148 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                                        169999999999998776678999997753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.40  E-value=1.6e-06  Score=73.21  Aligned_cols=80  Identities=18%  Similarity=0.102  Sum_probs=49.4

Q ss_pred             eeeeecccceeEEEEEEecCCCcEEEEEEeecc--cCC---CCCCchhHHHHHHHHhcccCCCCceeEEEeeeecccccc
Q psy2676          27 LCQIGCGAYGTVFKARDLQNKGNYVAMKKLRVK--LNE---DGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSD  101 (321)
Q Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~~~~iK~~~~~--~~~---~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~  101 (321)
                      .+.+|.|....||++.+ ..+++.+++|.....  ...   .........|.+.++.+...-...+.+++.+..+     
T Consensus        31 ~~eig~G~~N~vfrV~~-~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~-----  104 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYD-QEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE-----  104 (392)
T ss_dssp             EEECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT-----
T ss_pred             EEEeCCCceEeEEEEEe-CCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC-----
Confidence            55789999999999987 466778899975432  111   1123345678888888765322345666655322     


Q ss_pred             ccceEEEEEeccCcc
Q psy2676         102 ERYLTVYLIFEHVDQ  116 (321)
Q Consensus       102 ~~~~~~~~v~e~~~~  116 (321)
                          ..++|||++++
T Consensus       105 ----~~~lvmE~L~~  115 (392)
T d2pula1         105 ----MAVTVMEDLSH  115 (392)
T ss_dssp             ----TTEEEECCCTT
T ss_pred             ----CCEEEEeccCC
Confidence                23689999975

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.68  E-value=0.0001  Score=61.91  Aligned_cols=77  Identities=14%  Similarity=0.103  Sum_probs=51.2

Q ss_pred             cceeeeeeeecccceeEEEEEEec------CCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeee
Q psy2676          22 KKYDELCQIGCGAYGTVFKARDLQ------NKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIH   95 (321)
Q Consensus        22 ~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~   95 (321)
                      +.+++ +.|+.|-.-.+|++....      ...+.+++++.-.    ........+|..+++.+..  +.-..++++++.
T Consensus        43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~----~~~~idr~~E~~i~~~ls~--~gl~Pkll~~~~  115 (395)
T d1nw1a_          43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN----PETESHLVAESVIFTLLSE--RHLGPKLYGIFS  115 (395)
T ss_dssp             GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS----CCCHHHHHHHHHHHHHHHH--TTSSSCEEEEET
T ss_pred             cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC----cchhhHHHHHHHHHHHHHh--CCCCCeEEEEcC
Confidence            44544 568888888999998631      2345677777642    1123355689999999885  444567787763


Q ss_pred             ccccccccceEEEEEeccCcc
Q psy2676          96 QNILSDERYLTVYLIFEHVDQ  116 (321)
Q Consensus        96 ~~~~~~~~~~~~~~v~e~~~~  116 (321)
                      +           .+|+|+++|
T Consensus       116 ~-----------g~I~efi~g  125 (395)
T d1nw1a_         116 G-----------GRLEEYIPS  125 (395)
T ss_dssp             T-----------EEEECCCCE
T ss_pred             C-----------ceEEEEecc
Confidence            2           478888886

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.55  E-value=0.00013  Score=59.60  Aligned_cols=138  Identities=17%  Similarity=0.171  Sum_probs=75.5

Q ss_pred             ceeEEEEEEecCCCcEEEEEEeecccCCCCCCchhHHHHHHHHhcccCCCCceeEEEeeeeccccccccceEEEEEeccC
Q psy2676          35 YGTVFKARDLQNKGNYVAMKKLRVKLNEDGIPMSTLREISILKQLDTFEHPNIVRFFDVIHQNILSDERYLTVYLIFEHV  114 (321)
Q Consensus        35 ~g~v~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~v~e~~  114 (321)
                      --.||+++.  .+|+.+++|+.+..   ......+..|...+..|...+-|-...+ ..  +...........+.+++++
T Consensus        35 EN~vy~v~~--~dg~~~VlK~~rp~---~~s~~~i~~E~~~l~~L~~~gipv~~p~-~~--~g~~~~~~~~~~~~l~~~~  106 (325)
T d1zyla1          35 ENRVYQFQD--EDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPV-AF--NGQTLLNHQGFYFAVFPSV  106 (325)
T ss_dssp             SSEEEEECC--TTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCC-CB--TTBSCEEETTEEEEEEECC
T ss_pred             cceeEEEEc--CCCCEEEEEEeCCC---CCCHHHHHHHHHHHHHHHhcCCCCCCce-ec--CCCeeeeeeeEEEEEEeec
Confidence            458999975  67889999998642   2234567788888888875434422222 11  1111111223567788888


Q ss_pred             ccC-H-----H------HHH-------hhCC---CCCC-------------------CHH---HHHHHHHHHHHHHHHHH
Q psy2676         115 DQD-L-----G------SYM-------EKCP---PPGL-------------------SAS---KVKELTRQMLKGVDFLH  150 (321)
Q Consensus       115 ~~~-L-----~------~~~-------~~~~---~~~~-------------------~~~---~~~~i~~~l~~~l~~lh  150 (321)
                      .|. +     .      ..+       ....   ...+                   +..   .....+.++...+...-
T Consensus       107 ~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~  186 (325)
T d1zyla1         107 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  186 (325)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhc
Confidence            751 1     0      000       0000   0011                   111   12223333333333322


Q ss_pred             ----hCCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         151 ----SHRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       151 ----~~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                          ..+++|+|+++.||++++ + ..++||+.+..
T Consensus       187 ~~~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         187 REDFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             CSCSCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             cccCCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence                236899999999999963 3 45899998864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.15  E-value=0.00057  Score=55.28  Aligned_cols=31  Identities=26%  Similarity=0.283  Sum_probs=27.3

Q ss_pred             CCceeccCCCCcEEEeeCCCEEEeecCCccc
Q psy2676         152 HRIIHRDLKPQNLLITRAGGLKIADFGLAKT  182 (321)
Q Consensus       152 ~~~~H~di~p~Nilv~~~~~~kl~dfg~~~~  182 (321)
                      .|++|+|+.++||+++.+...-++||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            3799999999999999887778999998864